<SEC-DOCUMENT>0001539497-24-001980.txt : 20240923
<SEC-HEADER>0001539497-24-001980.hdr.sgml : 20240923
<ACCEPTANCE-DATETIME>20240920180822
ACCESSION NUMBER:		0001539497-24-001980
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		150
CONFORMED PERIOD OF REPORT:	20240630
FILED AS OF DATE:		20240923
DATE AS OF CHANGE:		20240920

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NIOCORP DEVELOPMENTS LTD
		CENTRAL INDEX KEY:			0001512228
		STANDARD INDUSTRIAL CLASSIFICATION:	METAL MINING [1000]
		ORGANIZATION NAME:           	01 Energy & Transportation
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41655
		FILM NUMBER:		241314311

	BUSINESS ADDRESS:	
		STREET 1:		7000 S. YOSEMITE STREET
		STREET 2:		STE. 115
		CITY:			CENTENNIAL
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		720-639-4647

	MAIL ADDRESS:	
		STREET 1:		7000 S. YOSEMITE STREET
		STREET 2:		STE. 115
		CITY:			CENTENNIAL
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUANTUM RARE EARTH DEVELOPMENTS CORP.
		DATE OF NAME CHANGE:	20110204
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>n2574_x219-10k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:niobf="http://niocorp.com/20240630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2023_currency -->
<!-- Field: Set; Name: xdx; ID: xdx_037_niobf_niocorp.com_20240630 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20230701_20240630 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DDocumentPeriodEndDate_Jun. 30, 2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DDocumentFiscalYearFocus_2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0wNi0zMA== -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001512228 -->
<!-- Field: Set; Name: xdx; ID: xdx_073_XDX_n2574__x219%2D10k.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_060_USDPShares_0_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_066_NUMBER_5_N -->
<!-- Field: Set; Name: xdx; ID: xdx_061_CADPShares_3_iso4217%2D%2DCAD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000004" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000005" name="dei:DocumentPeriodEndDate">2024-06-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000006" name="dei:DocumentFiscalYearFocus">2024</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000007" name="dei:CurrentFiscalYearEndDate">--06-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000008" name="dei:EntityCentralIndexKey">0001512228</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0022" name="dei:EntityIncorporationStateCountryCode">A1</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-06-30" id="xdx2ixbrl0097" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-06-30" id="xdx2ixbrl0100" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2024-06-30" id="xdx2ixbrl0111" unitRef="USD" xs:nil="true"/>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0142" name="us-gaap:CommonStockSharesAuthorizedUnlimited">Unlimited</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0144" name="us-gaap:CommonStockSharesAuthorizedUnlimited">Unlimited</ix:nonNumeric>
  <ix:nonFraction name="niobf:ChangeInFairValueOfConvertibleNotes" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0187" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ExtinguishmentOfDebtAmount" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0189" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0228" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:AssumptionOfEarnoutLiability" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0255" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:AssumptionOfPrivateAndPublicWarrants" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0261" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:ChangeInFairValueOfConvertibleNote" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0268" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:LossesOnExtinguishmentOfDebt" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0276" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:ForeignCurrencyTransactionGainLossBeforeTax1" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0282" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0315" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0318" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0330" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0333" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0345" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0360" unitRef="USD" xs:nil="true"/>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0369" name="niobf:RecognitionOfOperatingLeaseLiabilities" xs:nil="true"/>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0372" name="niobf:ValueOfWarrantsIssued" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0379" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0384" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0385" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0387" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0392" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0395" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:CommonSharesIssuedInTheGXIITransaction" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0397" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:CommonSharesIssuedInTheGXIITransaction" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0398" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:CommonSharesIssuedInTheGXIITransaction" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0399" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:CommonSharesIssuedInTheGXIITransaction" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0400" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:CommonSharesIssuedInTheGXIITransaction" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0406" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0407" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0409" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0414" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0422" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0425" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0430" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0431" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0433" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0438" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0439" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0441" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:RedeemableNoncontrollingInterest" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0444" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:RedeemableNoncontrollingInterest" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0445" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0450" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0451" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0453" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0455" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0456" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0459" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0461" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0463" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0475" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0476" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0478" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0479" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:PrivatePlacementValue" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0484" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="niobf:PrivatePlacementValue" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0485" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="niobf:PrivatePlacementValue" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0487" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0492" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0493" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0495" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0500" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0501" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0508" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0509" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0511" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0514" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0515" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0517" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0520" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0528" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0529" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0531" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0533" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0535" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NumberOfReportableSegments" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0549" decimals="INF" unitRef="NUMBER">1</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0652" decimals="-3" scale="3" sign="-" unitRef="USD">11898</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0656" decimals="-3" scale="3" unitRef="USD">463</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0658" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0712" decimals="-3" scale="3" sign="-" unitRef="USD">11898</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0713" decimals="-3" scale="3" sign="-" unitRef="USD">40308</ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30" id="xdx2ixbrl0782" decimals="INF" unitRef="Shares">38062647</ix:nonFraction>
  <ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2024-06-30" id="xdx2ixbrl0830" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember" id="xdx2ixbrl0854" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-06-30_custom_April2024ConvertibleSecurityMember" id="xdx2ixbrl0858" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember" id="xdx2ixbrl0862" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2024-06-30_custom_ConvertibleSecurityMember" id="xdx2ixbrl0864" unitRef="USD" xs:nil="true"/>
  <ix:nonNumeric contextRef="AsOf2023-06-30" id="xdx2ixbrl0875" name="us-gaap:LongTermDebtTerm">P24M</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-06-30_custom_LindIIIConvertibleSecurityMember" id="xdx2ixbrl0889" name="us-gaap:IntermediateLifePlantsUsefulLife">P4Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember7264156" id="xdx2ixbrl0916" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1016" decimals="-3" scale="3" unitRef="USD">3338</ix:nonFraction>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MinimumMember" id="xdx2ixbrl1026" name="niobf:DebtMaturityPeriod">P6M</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MaximumMember" id="xdx2ixbrl1028" name="niobf:DebtMaturityPeriod">P18M</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:PaymentsOfFinancingCosts" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl1050" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction>
  <ix:nonNumeric contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember" id="xdx2ixbrl1229" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P2Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember" id="xdx2ixbrl1266" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P2Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember" id="xdx2ixbrl1282" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P2Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl1322" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">P3Y5M9D</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl1326" decimals="-3" scale="3" unitRef="USD">2881</ix:nonFraction>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl1344" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1346" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P3Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-06-30_custom_ExercisePrice9.70Member" id="xdx2ixbrl1393" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">2025-02-19</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-06-30_custom_ExercisePrice4.60Member" id="xdx2ixbrl1401" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">2025-09-01</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-06-30_custom_ExercisePrice3.54Member" id="xdx2ixbrl1406" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">2025-12-22</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-06-30_custom_ExercisePrice2.20Member" id="xdx2ixbrl1411" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">2025-06-24</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-06-30_custom_ExercisePrice3.25Member" id="xdx2ixbrl1416" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">2027-04-12</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-06-30_custom_ExercisePrice11.50Member" id="xdx2ixbrl1421" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">2028-03-17</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1472" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P3Y8M12D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1474" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P4Y8M12D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-03-152023-03-17_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1476" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P5Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:RelatedPartyDepositLiabilities" contextRef="AsOf2023-06-30" id="xdx2ixbrl1520" unitRef="USD" xs:nil="true"/>
  <ix:nonNumeric contextRef="AsOf2024-06-30" id="xdx2ixbrl1556" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm">P2Y7M6D</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-06-30" id="xdx2ixbrl1558" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm">P3Y7M6D</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-06-30_us-gaap_DomesticCountryMember" id="xdx2ixbrl1616" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:GxiiTransactionCosts" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl1648" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:ConvertibleNoteValuation" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1658" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ExtinguishmentOfDebtGainLossIncomeTax" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl1660" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:EffectOfLegislativeChanges" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl1663" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl1675" decimals="-3" scale="3" sign="-" unitRef="USD">139</ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1677" decimals="-3" scale="3" sign="-" unitRef="USD">304</ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2024-06-30" id="xdx2ixbrl1708" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2023-06-30" id="xdx2ixbrl1709" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CostsIncurredDevelopmentCosts" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl1721" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-06-30_us-gaap_DomesticCountryMember" id="xdx2ixbrl1753" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1776" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1777" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1781" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1782" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1786" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1787" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1790" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1791" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1795" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1796" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1800" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1805" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1810" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1811" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1814" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1815" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1818" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1819" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1821" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1822" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1825" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1829" unitRef="USD" xs:nil="true"/>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="niobf-20240630.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-07-01to2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_CommonSharesWithoutParValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:CommonSharesWithoutParValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:WarrantsEachExercisableFor1.11829212CommonSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_Entity0896800BCLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_Entity0896800BCLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_Entity0896800BCLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_Entity0896800BCLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ElkCreekResourcesCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ElkCreekResourcesCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ElkCreekResourcesCorpECRCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpECRCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ElkCreekResourcesCorpECRCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ElkCreekResourcesCorpECRCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_NioCorpTechnologiesLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:NioCorpTechnologiesLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_NioCorpTechnologiesLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:NioCorpTechnologiesLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_NioCorpTechnologiesLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:NioCorpTechnologiesLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_WarrantAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:WarrantAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_LegacyNioCorpShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LegacyNioCorpShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_LegacyNioCorpShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LegacyNioCorpShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_GXIIClassAShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIClassAShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_GXIIClassAShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIClassAShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_YorkvilleConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:YorkvilleConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_April2024ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:April2024ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_April2024ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:April2024ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-162021-02-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-16</xbrli:startDate>
        <xbrli:endDate>2021-02-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember7263812">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_LindIIIConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_LindIIIConvertibleSecurityMember7263843">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-172021-02-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-17</xbrli:startDate>
        <xbrli:endDate>2021-02-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_UnsecuredDebtMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-26_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-16_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-04-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ConvertibleSecurityMember7264156">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ProbabilityOfIssuanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">niobf:ProbabilityOfIssuanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ProbabilityOfIssuanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">niobf:ProbabilityOfIssuanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_custom_ProbabilityOfIssuanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">niobf:ProbabilityOfIssuanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:MonteCarloModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:MonteCarloModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:MonteCarloModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:MonteCarloModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-11</xbrli:startDate>
        <xbrli:endDate>2024-04-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-11</xbrli:startDate>
        <xbrli:endDate>2024-04-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-10_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-112024-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-11</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-302023-09-02_us-gaap_PrivatePlacementMember_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-30</xbrli:startDate>
        <xbrli:endDate>2023-09-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-02_us-gaap_PrivatePlacementMember_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_currency_CAD_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-232024-06-24_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-23</xbrli:startDate>
        <xbrli:endDate>2024-06-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-272023-04-28_custom_KingdonCapitalManagementLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:KingdonCapitalManagementLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-27</xbrli:startDate>
        <xbrli:endDate>2023-04-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-082023-06-09_custom_YorkvilleEquityFacilityFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleEquityFacilityFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-08</xbrli:startDate>
        <xbrli:endDate>2023-06-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_GXIIPublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_GXIIPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ExercisePrice9.70Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice9.70Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_currency_CAD_custom_ExercisePrice9.70Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice9.70Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ExercisePrice8.94Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice8.94Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ExercisePrice4.60Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice4.60Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ExercisePrice3.54Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.54Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ExercisePrice2.20Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.20Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ExercisePrice3.25Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.25Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ExercisePrice11.50Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.50Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-17_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:GeneralSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-22_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:NonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31_custom_MarkSmithMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_MarkSmithMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_FeasibilityStudyAndEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_FeasibilityStudyAndEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_FieldManagementAndOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_FieldManagementAndOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_MetallurgicalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:MetallurgicalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_MetallurgicalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:MetallurgicalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_GeologistsAndFieldStaffMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_GeologistsAndFieldStaffMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_CorporateOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">niobf:CorporateOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-022024-09-04_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-02</xbrli:startDate>
        <xbrli:endDate>2024-09-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-302024-09-01_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-30</xbrli:startDate>
        <xbrli:endDate>2024-09-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-292024-12-01_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-29</xbrli:startDate>
        <xbrli:endDate>2024-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-11_custom_MarkSmithMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-092024-09-11_custom_MarkSmithMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-09</xbrli:startDate>
        <xbrli:endDate>2024-09-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-162024-09-17_us-gaap_SubsequentEventMember_custom_LindConsentWarrantIssuanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LindConsentWarrantIssuanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-16</xbrli:startDate>
        <xbrli:endDate>2024-09-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-17_us-gaap_SubsequentEventMember_custom_LindConsentWarrantIssuanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LindConsentWarrantIssuanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="NUMBER">
      <xbrli:measure>niobf:N</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="CADPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:CAD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000571" toRefs="Footnote000580"/>
  <ix:relationship fromRefs="Fact000573" toRefs="Footnote000580"/>
  <ix:relationship fromRefs="Fact000682" toRefs="Footnote000697 Footnote000698"/>
  <ix:relationship fromRefs="Fact000684" toRefs="Footnote000697 Footnote000698"/>
  <ix:relationship fromRefs="Fact000686" toRefs="Footnote000697 Footnote000698"/>
  <ix:relationship fromRefs="Fact000688" toRefs="Footnote000697 Footnote000698"/>
  <ix:relationship fromRefs="Fact000690" toRefs="Footnote000697 Footnote000698"/>
  <ix:relationship fromRefs="Fact000692" toRefs="Footnote000697 Footnote000698"/>
  <ix:relationship fromRefs="Fact000694" toRefs="Footnote000697 Footnote000698"/>
  <ix:relationship fromRefs="Fact000696" toRefs="Footnote000697 Footnote000698"/>
  <ix:relationship fromRefs="Fact000775" toRefs="Footnote000785"/>
  <ix:relationship fromRefs="Fact000777" toRefs="Footnote000785"/>
  <ix:relationship fromRefs="Fact000778" toRefs="Footnote000786"/>
  <ix:relationship fromRefs="Fact000780" toRefs="Footnote000786"/>
  <ix:relationship fromRefs="Fact000928" toRefs="Footnote000931"/>
  <ix:relationship fromRefs="Fact000954" toRefs="Footnote001423"/>
  <ix:relationship fromRefs="Fact000956" toRefs="Footnote001423"/>
  <ix:relationship fromRefs="Fact000958" toRefs="Footnote001423"/>
  <ix:relationship fromRefs="Fact000960" toRefs="Footnote001423"/>
  <ix:relationship fromRefs="Fact000962" toRefs="Footnote001423"/>
  <ix:relationship fromRefs="Fact000964" toRefs="Footnote001423"/>
  <ix:relationship fromRefs="Fact000966" toRefs="Footnote001423"/>
  <ix:relationship fromRefs="Fact000968" toRefs="Footnote001423"/>
  <ix:relationship fromRefs="Fact000970" toRefs="Footnote001423"/>
  <ix:relationship fromRefs="Fact000972" toRefs="Footnote001423"/>
  <ix:relationship fromRefs="Fact000974" toRefs="Footnote001423"/>
  <ix:relationship fromRefs="Fact000976" toRefs="Footnote001423"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 0; margin-bottom: 0"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington,
D. C. 20549 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 100%; padding-top: 2pt; padding-bottom: 2pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b>FORM
    <span id="xdx_90C_edei--DocumentType_c20230701__20240630_zr6RGmLGVtLg"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000016" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Mark
One)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 5pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_edei--DocumentAnnualReport_c20230701__20240630_zhPhz0z6zs45"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleantrue" id="Fact000017" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 91%; padding-right: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNUAL
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1in; text-align: center; text-indent: 76.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the fiscal year ended <span id="xdx_906_edei--DocumentPeriodEndDate_c20230701__20240630_zUQKTaGYy4Cb"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:datemonthdayyearen" id="Fact000018" name="dei:DocumentPeriodEndDate">June 30, 2024</ix:nonNumeric></span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1in; text-align: center; text-indent: 63pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_edei--DocumentTransitionReport_c20230701__20240630_zMh6ifSYdkT5"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000019" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the transition period from &#160;&#160;&#160;&#160;&#160;&#160;to</b></span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto">
<tr style="vertical-align: top; text-align: left">
    <td style="border: Black 1pt solid; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
    file number: <span id="xdx_90A_edei--EntityFileNumber_c20230701__20240630_znGPgNcI6OQ7"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000020" name="dei:EntityFileNumber">001-41655</ix:nonNumeric></span></b></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><img src="n257410kimg001.jpg" alt=""/></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b><span id="xdx_906_edei--EntityRegistrantName_c20230701__20240630_z8i9XD7y1gGc"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000021" name="dei:EntityRegistrantName">NioCorp
Developments Ltd.</ix:nonNumeric></span></b></span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 52%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_dxL_c20230701__20240630_z5dba5MeBhOd" title="::XDX::A1"><span style="-sec-ix-hidden: xdx2ixbrl0022">British
    Columbia, Canada</span></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 19%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20230701__20240630_zQdFtAppk1dd"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000023" name="dei:EntityTaxIdentificationNumber">98-1262185</ix:nonNumeric></span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of incorporation or organization)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer Identification No.)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b><span id="xdx_908_edei--EntityAddressAddressLine1_c20230701__20240630_zhIvHD22MNkg"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000024" name="dei:EntityAddressAddressLine1">7000
                                         South Yosemite Street</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressAddressLine2_c20230701__20240630_zV7FfG4EMN8f"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000025" name="dei:EntityAddressAddressLine2">Suite 115</ix:nonNumeric></span> <span id="xdx_90B_edei--EntityAddressCityOrTown_c20230701__20240630_zWQhs8y6VIe9"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000026" name="dei:EntityAddressCityOrTown">Centennial</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20230701__20240630_zft9xxmMb6q4"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000027" name="dei:EntityAddressStateOrProvince">CO</ix:nonNumeric></span></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
        of principal executive offices)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityAddressPostalZipCode_c20230701__20240630_z89H5EjD6DIe"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000028" name="dei:EntityAddressPostalZipCode">80112</ix:nonNumeric></span></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
        Code)</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="4" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
    telephone number, including area code: <span id="xdx_901_edei--CityAreaCode_c20230701__20240630_zAuqnzsqN5R4"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000029" name="dei:CityAreaCode">(720)</ix:nonNumeric></span> <span id="xdx_90D_edei--LocalPhoneNumber_c20230701__20240630_zJk0tEyeeAt9"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000030" name="dei:LocalPhoneNumber">334-7066</ix:nonNumeric></span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="4" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 37%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--Security12bTitle_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonSharesWithoutParValueMember_z3MwjIvQ3NG3"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_CommonSharesWithoutParValueMember" id="Fact000031" name="dei:Security12bTitle">Common
    Shares, without par value</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--TradingSymbol_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonSharesWithoutParValueMember_z7bxDxT9DQr4"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_CommonSharesWithoutParValueMember" id="Fact000032" name="dei:TradingSymbol">NB</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--SecurityExchangeName_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonSharesWithoutParValueMember_zrKZ89GJxPK5"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_CommonSharesWithoutParValueMember" format="ixt-sec:exchnameen" id="Fact000033" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--Security12bTitle_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableFor1.11829212CommonSharesMember_zkBEq61KiQBb"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember" id="Fact000034" name="dei:Security12bTitle">Warrants,
    each exercisable for 1.11829212 Common Shares</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableFor1.11829212CommonSharesMember_zcLlkPqNH4Zb"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember" id="Fact000035" name="dei:TradingSymbol">NIOBW</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--SecurityExchangeName_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableFor1.11829212CommonSharesMember_zoSsZKvF80uj"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember" format="ixt-sec:exchnameen" id="Fact000036" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to section 12(g) of the Act: None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
&#9744; <span id="xdx_900_edei--EntityWellKnownSeasonedIssuer_c20230701__20240630_zS2pOIEB1iAc"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000037" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
&#9744; <span id="xdx_90A_edei--EntityVoluntaryFilers_c20230701__20240630_zhiefGzzkDS"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000038" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityCurrentReportingStatus_c20230701__20240630_zxC0UzF5Ig3l"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000039" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>
&#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit such files).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityInteractiveDataCurrent_c20230701__20240630_zegy65r0fVb1"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000040" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>
&#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    Accelerated Filer&#160;&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    Filer&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.5in"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntityFilerCategory_c20230701__20240630_ziamKGzURbPl"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:entityfilercategoryen" id="Fact000041" name="dei:EntityFilerCategory">Non-Accelerated
                                         Filer</ix:nonNumeric></span></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
                                         Reporting Company &#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--EntitySmallBusiness_c20230701__20240630_z9SVKWg7mkG4"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleantrue" id="Fact000042" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    Growth Company </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20230701__20240630_zj6ASVMmCkr"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000043" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report.  &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the
registrant included in the filing reflect the correction of an error to previously issued financial statements. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).
&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; <span id="xdx_902_edei--EntityShellCompany_c20230701__20240630_zcnMz7U30L52"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000044" name="dei:EntityShellCompany">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2023, the aggregate market value of the registrant&#8217;s voting and non-voting common equity held by non-affiliates
of the registrant was $<span id="xdx_902_edei--EntityPublicFloat_iI_dm_c20231231_zwuoyUA1xmfe"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2023-12-31" id="Fact000045" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">100.6</ix:nonFraction> million</span> based on the closing sale price as reported on the Nasdaq Stock Market. There were <span id="xdx_90A_edei--EntityCommonStockSharesOutstanding_iI_pid_uShares_c20240920_zSkmMFz9HW4i"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-09-20" id="Fact000046" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,660,244</ix:nonFraction></span>
common shares outstanding on September 20, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DOCUMENTS
INCORPORATED BY REFERENCE </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->








<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a001"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Select Mining Definitions</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a002"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Metric Equivalents</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a003"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Mineral Reserves and Resources</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a004"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Currency and Exchange Rates</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a005"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Risk Factors Summary</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#a006"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">PART I</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a007"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;1.&#160;&#160;&#160; BUSINESS</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a008"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Introduction</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a009"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Historical Development of the Business</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a010"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Business Operations</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a011"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Competitive Business Conditions</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a012"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Cycles</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a013"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Economic Dependence</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a014"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Government Regulation</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a015"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Human Capital</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a016"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Forward-Looking Statements</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a017"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Available Information</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a018"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;1A.&#160;&#160;&#160; RISK FACTORS</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a019"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Risks Related to Our Business</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a020"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Risks Related to Mining and Development</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a021"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Risks Related to Government Regulation</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a022"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Risks Related to Our Debt</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a023"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Risks Related to the Common Shares</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a024"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM 1B.&#160;UNRESOLVED STAFF COMMENTS</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a025"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM 1C.&#160;CYBERSECURITY</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a026"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;2.&#160;&#160; PROPERTIES</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a027"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;3.&#160;&#160; LEGAL PROCEEDINGS</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a028"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;4.&#160;&#160; MINE SAFETY DISCLOSURES</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#a029"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">PART II</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a030"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;5.&#160;&#160; MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a031"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Market Information</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a032"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Holders</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a033"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Dividends</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a034"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Securities Authorized for Issuance Under Equity Compensation Plans</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a035"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Purchases of Equity Securities by the Company</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a036"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Recent Sales of Unregistered Securities</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a037"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Exchange Controls</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a038"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Certain Canadian Federal Income Tax Considerations for U.S. Residents</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a039"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;6.&#160;&#160;&#160;<i>RESERVED</i></span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a040"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;7.&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a041"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Summary of Consolidated Financial and Operating Performance</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a042"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Results of Operations</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a043"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Liquidity and Capital Resources</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a044"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Cash Flow Considerations</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a045"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Environmental</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a046"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Forward-Looking Statements</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a047"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Accounting Developments</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a048"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Critical Accounting Estimates and Recent Accounting Pronouncements</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a049"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Other</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a050"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;7A.&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a051"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Interest rate risk</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a052"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Foreign currency exchange risk</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a053"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Commodity price risk</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt; width: 90%"><a href="#a054"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;8.&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; width: 10%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a055"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;9.&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a056"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;9A.&#160;CONTROLS AND PROCEDURES</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a057"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;9B.&#160;OTHER INFORMATION</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a058"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM 9C.&#160;DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTION</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#a059"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">PART III</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a060"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM 10.&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a061"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Directors and Executive Officers</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a062"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM 11.&#160;EXECUTIVE COMPENSATION</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a063"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM 12.&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a064"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM 13.&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a065"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM 14.&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#a066"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">PART IV</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">117</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a067"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160; 15.&#160;EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">117</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a068"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">ITEM&#160;16.&#160;&#160;&#160;FORM 10&#8211;K SUMMARY</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#a069"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">SIGNATURES</span></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-top: 0in; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">121</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.85pt; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a001"></span>Select
Mining Definitions</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.85pt; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>carbonatite</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    type of intrusive or extrusive igneous rock defined by mineralogic composition consisting of greater than 50% carbonate minerals.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>cut-off
    grade</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    grade (i.e., the concentration of metal or mineral in rock) that determines the destination of the material during mining.
    For purposes of establishing &#8220;prospects of economic extraction,&#8221; the cut-off grade is the grade that distinguishes
    material deemed to have no economic value (it will not be mined in underground mining or if mined in surface mining, its destination
    will be the waste dump) from material deemed to have economic value (its ultimate destination during mining will be a processing
    facility). Other terms used in similar fashion as cut-off grade include net smelter return, pay limit, and break-even stripping
    ratio.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>deposit</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    mineralized body which has been physically delineated by sufficient drilling, trenching, and/or underground work, and found
    to contain a sufficient average grade of metal or metals to warrant further exploration and/or development expenditures. Such
    a deposit does not qualify as a commercially mineable ore body or as containing reserves or ore, unless final legal, technical,
    and economic factors are resolved.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>development
    stage issuer</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    issuer that is engaged in the preparation of mineral reserves for extraction on at least one material property</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>development
    stage property </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    property that has mineral reserves disclosed, pursuant to Regulation S-K 1300, but no material extraction</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>diamond
    drilling</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    type of rotary drilling in which diamond bits are used as the rock-cutting tool to produce a recoverable drill core sample
    of rock for observation and analysis</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: -5.25pt; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>dysprosium
    or Dy</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    element dysprosium (atomic number&#160;66), a rare-earth element in the lanthanide series.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: -5.25pt; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>dysprosium
    oxide</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    chemical compound composed of dysprosium and oxygen with the formula Dy<sub>2</sub>O<sub>3</sub></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>economically
    viable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    used in the context of mineral reserve determination, means that the qualified person has determined, using a discounted cash
    flow analysis, or has otherwise analytically determined, that extraction of the mineral reserve is economically viable under
    reasonable investment and market assumptions</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>feasibility
    study</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         comprehensive technical and economic study of the selected development option for a mineral
                                         project, which includes detailed assessments of all applicable modifying factors, as
                                         defined under S-K 1300, together with any other relevant operational factors, and detailed
                                         financial analysis that are necessary to demonstrate, at the time of reporting, that
                                         extraction is economically viable. The results of the study may serve as the basis for
                                         a final decision by a proponent or financial institution to proceed with, or finance,
                                         the development of the project.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
        A feasibility study is more comprehensive, and with a higher degree of accuracy, than a pre-feasibility study. It must
        contain mining, infrastructure, and process designs completed with sufficient rigor to serve as the basis for an investment
        decision or to support project financing.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
        The confidence level in the results of a feasibility study is higher than the confidence level in the results of a pre-feasibility
        study. Terms such as <i>full</i>, <i>final</i>, <i>comprehensive</i>, <i>bankable</i>, or <i>definitive</i> feasibility
        study are equivalent to feasibility study.</span></p></td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ferroniobium
    or FeNb</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    iron-niobium alloy, with a niobium content of 60-70%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>indicated
    mineral resource</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    part of a mineral resource for which quantity and grade or quality are estimated on the basis of adequate geological evidence
    and sampling. The level of geological certainty associated with an indicated mineral resource is sufficient to allow a qualified
    person to apply modifying factors in sufficient detail to support mine planning and evaluation of the economic viability of
    the deposit. Because an indicated mineral resource has a lower level of confidence than the level of confidence of a measured
    mineral resource, an indicated mineral resource may only be converted to a probable mineral reserve.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>inferred
    mineral resource</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    part of a mineral resource for which quantity and grade or quality are estimated on the basis of limited geological evidence
    and sampling. The level of geological uncertainty associated with an inferred mineral resource is too high to apply relevant
    technical and economic factors likely to influence the prospects of economic extraction in a manner useful for evaluation
    of economic viability. Because an inferred mineral resource has the lowest level of geological confidence of all mineral resources,
    which prevents the application of the modifying factors in a manner useful for evaluation of economic viability, an inferred
    mineral resource may not be considered when assessing the economic viability of a mining project, and may not be converted
    to a mineral reserve.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LoM</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life
    of Mine, the period from the beginning of construction to the end of mine life</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>measured
    mineral resource</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    part of a mineral resource for which quantity and grade or quality are estimated on the basis of conclusive geological evidence
    and sampling. The level of geological certainty associated with a measured mineral resource is sufficient to allow a qualified
    person to apply modifying factors, as defined in this section, in sufficient detail to support detailed mine planning and
    final evaluation of the economic viability of the deposit. Because a measured mineral resource has a higher level of confidence
    than the level of confidence of either an indicated mineral resource or an inferred mineral resource, a measured mineral resource
    may be converted to a proven mineral reserve or to a probable mineral reserve.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>mineral
    reserve</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    estimate of tonnage and grade or quality of indicated and measured mineral resources that, in the opinion of the qualified
    person, can be the basis of an economically viable project. More specifically, it is the economically mineable part of a measured
    or indicated mineral resource, which includes diluting materials and allowances for losses that may occur when the material
    is mined or extracted.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>mineral
    resource</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    concentration or occurrence of material of economic interest in or on the Earth&#8217;s crust in such form, grade or quality,
    and quantity that there are reasonable prospects for economic extraction. A mineral resource is a reasonable estimate of mineralization,
    taking into account relevant factors such as cut-off grade, likely mining dimensions, location or continuity, that, with the
    assumed and justifiable technical and economic conditions, is likely to, in whole or in part, become economically extractable.
    It is not merely an inventory of all mineralization drilled or sampled.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>modifying
    factors</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    factors that a qualified person must apply to indicated and measured mineral resources and then evaluate in order to
    establish     the economic viability of mineral reserves. A qualified person must apply and evaluate modifying factors to
    convert measured     and indicated mineral resources to proven and probable mineral reserves. These factors include, but are
    not restricted to:     mining; processing; metallurgical; infrastructure; economic; marketing; legal; environmental
    compliance; plans, negotiations,
    or agreements with local individuals or groups; and governmental factors. </span></td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify">The number, type and specific characteristics of
    the modifying factors applied will necessarily be a function of and depend upon the mineral, mine, property, or project.</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>niobium
    or Nb </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    element niobium (atomic number 41), a transition metal primarily used in the production of high-strength, low-alloy steel</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<sub>2</sub>O<sub>5</sub></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
    pentoxide, a commercial form of refined niobium</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>neodymium
    oxide</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    chemical compound composed of neodymium and oxygen with the formula Nd<sub>2</sub>O<sub>3</sub></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NSR</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Smelter Return, the net revenue that the owner of a mining property receives from the sale of the mine&#8217;s products less
    transportation and refining costs</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>praseodymium
    oxide</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    chemical compound composed of praseodymium and oxygen with the formula Pr<sub>2</sub>O<sub>3</sub></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>probable
    mineral reserve</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    economically mineable part of an indicated and, in some cases, a measured mineral resource</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>production
    stage property</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    property with material extraction of mineral reserves</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>proven
    mineral reserve</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    economically mineable part of a measured mineral resource and can only result from conversion of a measured mineral resource</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>qualified
    person</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         individual who is:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&#160;&#160;A
        mineral industry professional with at least five years of relevant experience in the type of mineralization and type of
        deposit under consideration and in the specific type of activity that person is undertaking on behalf of the registrant;
        and</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&#160;&#160;An
        eligible member or licensee in good standing of a recognized professional organization at the time the technical report
        is prepared. For an organization to be a recognized professional organization, it must:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
        Be either:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
        An organization recognized within the mining industry as a reputable professional association; or</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
        A board authorized by Unites States federal, state, or foreign statute to regulate professionals in the mining, geoscience,
        or related field;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
        &#160;&#160;Admit eligible members primarily on the basis of their academic qualifications and experience;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
        &#160;&#160;Establish and require compliance with professional standards of competence and ethics;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&#160;&#160;&#160;Require
        or encourage continuing professional development;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
        &#160;&#160;&#160;Have and apply disciplinary powers, including the power to suspend or expel
        a member regardless of where the member practices or resides; and</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) &#160;&#160;Provide a public list of members in good standing.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>rare
    earth elements, rare earths or REEs </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    group of 15 elements referred to as the lanthanide series in the periodic table of elements. Scandium and yttrium, while not
    true REEs, are also included in this categorization because they exhibit similar properties to the lanthanides and are found
    in the same ore bodies. Individual mineral deposits may not contain all REEs in economically
    recoverable quantities.</span></td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>rare
    earth products</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial
    rare earth products currently being examined for production by the Company, including neodymium-praseodymium oxide (sometimes
    referred to as didymium oxide), dysprosium oxide, and terbium oxide. These are the primary rare earths compounds used to manufacture
    the world&#8217;s most powerful permanent magnets.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>relevant
    experience</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         purposes of determining whether a party is a qualified person, that the party has experience
                                         in the specific type of activity that the person is undertaking on behalf of the registrant.
                                         If the qualified person is preparing or supervising the preparation of a technical report
                                         concerning exploration results, the relevant experience must be in exploration. If the
                                         qualified person is estimating, or supervising the estimation of mineral resources, the
                                         relevant experience must be in the estimation, assessment and evaluation of mineral resources
                                         and associated technical and economic factors likely to influence the prospect of economic
                                         extraction. If the qualified person is estimating, or supervising the estimation of mineral
                                         reserves, the relevant experience must be in engineering and other disciplines required
                                         for the estimation, assessment, evaluation, and economic extraction of mineral reserves.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&#160;&#160;Relevant
        experience also means, for purposes of determining whether a party is a qualified person, that the party has experience
        evaluating the specific type of mineral deposit under consideration (e.g., coal, metal, base metal, industrial mineral,
        or mineral brine). The type of experience necessary to qualify as relevant is a facts and circumstances determination.
        For example, experience in a high-nugget, vein-type mineralization such as tin or tungsten would likely be relevant experience
        for estimating mineral resources for vein-gold mineralization, whereas experience in a low grade disseminated gold deposit
        likely would not be relevant.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Note
        1 to Paragraph (1) of the Definition of Relevant Experience</i>: It is not always necessary for a person to have five
        years&#8217; experience in each and every type of deposit in order to be an eligible qualified person if that person has
        relevant experience in similar deposit types. For example, a person with 20 years&#8217; experience in estimating mineral
        resources for a variety of metalliferous hard-rock deposit types may not require as much as five years of specific experience
        in porphyry-copper deposits to act as a qualified person. Relevant experience in the other deposit types could count towards
        the experience in relation to porphyry-copper deposits.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
        For a qualified person providing a technical report for exploration results or mineral resource estimates, relevant experience
        also requires, in addition to experience in the type of mineralization, sufficient experience with the sampling and analytical
        techniques, as well as extraction and processing techniques, relevant to the mineral deposit under consideration. Sufficient
        experience means that level of experience necessary to be able to identify, with substantial confidence, problems that
        could affect the reliability of data and issues associated with processing.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
        For a qualified person applying the modifying factors, as defined by this section, to convert mineral resources to mineral
        reserves, relevant experience also requires:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;&#160;&#160;Sufficient
knowledge and experience in the application of these factors to the mineral deposit under consideration; and</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#160;&#160;Experience
        with the geology, geostatistics, mining, extraction, and processing that is applicable to the type of mineral and mining
        under consideration.</span></p></td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>S-K
    1300</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subpart
    1300 of Regulation S-K promulgated by the SEC</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>S-K
    1300 Elk Creek Technical Report Summary</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
technical report summary for the Elk Creek Project that conforms to S-K 1300 reporting standards, with an effective date of June
30, 2022, originally filed as Exhibit</span></td></tr>
</table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; width: 24%"/>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 96.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended
    June 30, 2022, and incorporated by reference into this Annual Report on Form 10-K</span></td></tr>
</table>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>scandium
    or Sc</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    element scandium (atomic number 21), a transition metal used as an alloying agent with aluminum that provides high strength
    and lower weight for aerospace industry components and other applications that need lightweight metals. It also is used in
    the electrolyte layer of solid oxide fuel cells.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc<sub>2</sub>O<sub>3</sub></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scandium
    trioxide, the primary form of refined scandium</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>terbium
    oxide</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    chemical compound composed of terbium and oxygen with the formula Tb<sub>2</sub>O<sub>3</sub></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>titanium
    or Ti</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    element titanium (atomic number 22), a transition metal which in its oxide form is a common pigment in paper, paint, and plastic.
    In its metallic form, titanium is used in aerospace applications, armor, chemical processing applications, marine hardware
    applications, medical implants, power generation, and in sporting goods.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<sub>2</sub></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titanium
    dioxide, a commercial form of refined titanium</span></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a002"></span>Metric
Equivalents</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
ease of reference, the following factors for converting Imperial measurements into metric equivalents are provided:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To
                                         convert from Imperial</b>&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To
                                         metric</b>&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Multiply
                                         by</b>&#160;</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acres</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hectares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.4047</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Feet
    (&#8220;ft&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meters
    (&#8220;m&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.3048</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miles</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kilometers
    (&#8220;km&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6093</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tons</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tonnes
    (&#8220;t&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.9072</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
mile = 1.6093 kilometers</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
acre = 0.4047 hectares</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,204.62
pounds = 1 metric tonne = 1 tonne</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2000
pounds (1 short ton) = 0.9072 tonnes</span></p>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 57.85pt; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 57.85pt; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a003"></span>Mineral
Reserves and Resources</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 57.85pt; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
concerning our mining property in this Annual Report on Form 10-K has been prepared in accordance with the requirements of S-K
1300, which first became applicable to us for the fiscal year ended June 30, 2022. All mineral resource and mineral reserve estimates
included in this Annual Report on Form 10-K have been prepared in accordance with S-K 1300. Previously, we prepared our estimates
of mineral resources and mineral reserves following only National Instrument 43-101 of the Canadian Securities Administrators
entitled &#8220;Standards of Disclosure for Mineral Projects&#8221; (&#8220;NI 43-101&#8221;) and the Canadian Institute of Mining
and Metallurgy (&#8220;CIM&#8221;) &#8220;Definition Standards &#8211; For Mineral Resources and Mineral Reserves, May 10, 2014.&#8221;
The CIM-compliant NI 43-101 technical report (the &#8220;NI 43-101 Elk Creek Technical Report&#8221;) for the Company&#8217;s
niobium, scandium, and titanium project (the &#8220;Elk Creek Project&#8221;) and S-K 1300 Elk Creek Technical Report Summary,
filed as Exhibit 96.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2022 and incorporated
by reference into this Annual Report on Form 10-K, are based on a feasibility study prepared by qualified persons (the &#8220;2022
Elk Creek Feasibility Study&#8221;) and are substantively identical to one another except for internal references to the regulations
under which the report is made, and certain organizational differences. In addition, S-K 1300 requires
us to disclose our mineral resources, in addition to our mineral reserves, as of the end of our most recently completed fiscal
year. You are cautioned that mineral resources are subject to further exploration and development and are subject to additional
risks and no assurance can be given that they will eventually convert to future reserves. Inferred resources, in particular, have
a great amount of uncertainty as to their existence and their economic and legal feasibility. Investors are cautioned not to assume
that any part or all of the inferred resource exists or is economically or legally mineable. See Item 1A., Risk Factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7pt; text-align: center; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a004"></span>Currency
and Exchange Rates</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7pt; text-align: center; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
dollar amounts in this Annual Report on Form 10-K are expressed in United States (&#8220;U.S.&#8221;) dollars unless otherwise
indicated. The Company&#8217;s accounts are maintained in U.S. dollars and the Company&#8217;s consolidated financial statements
are prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Some of the Company&#8217;s
significant agreements, as well as certain vendors, use Canadian dollars. As used herein, &#8220;C$&#8221; represents Canadian
dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the rate of exchange for the Canadian dollar, expressed in U.S. dollars in effect at the end of the
periods indicated, the average of exchange rates in effect during such periods, and the high and low exchange rates during such
periods based on the daily rate of exchange as reported by the Bank of Canada for conversion of Canadian dollars into U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
                                         Year Ended June 30,</b>&#160;</span></p></td>
    </tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b>&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b>&#160;</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Canadian
    Dollars to U.S. Dollars</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 3pt; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rate
    at end of period</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7306</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7553</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    rate for period</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7380</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7467</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
    for period</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7617</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7841</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Low
    for period</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7207</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7217</span></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a005"></span>Risk
Factors Summary</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investing
in our Common Shares (as defined herein) involves numerous risks and uncertainties, as more fully described below. You should
read these risks before you invest in our Common Shares. In particular, risks associated with our business include, but are not
limited to, the following:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Risks
Related to Our Business&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
                                         ability to operate as a going concern is in doubt.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                         will require significant additional capital to fund our business plan.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                         have a limited operating history on which to base an evaluation of our business and prospects.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                         have a history of losses and expect to continue to incur losses in the future.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font: normal 10pt Times New Roman, Times, Serif">The
                                         Company may not realize all or any of the anticipated benefits expected as a result of
                                         the 2023 Transactions (as defined herein).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         may not recognize the full value of the Yorkville Equity Facility Financing Agreement
                                         (as defined herein) and may not receive any proceeds from the exercise of the NioCorp
                                         Assumed Warrants (as defined herein), the April 2024 Warrants (as defined herein) and
                                         our other outstanding Common Share purchase warrants (&#8220;Warrants&#8221;), and the
                                         potential adverse effect on the prevailing market prices for our Common Shares as a result
                                         of sales, or the perception of future sales, of Common Shares could adversely affect
                                         our ability to raise additional capital.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font: normal 10pt Times New Roman, Times, Serif">The
                                         Company has identified material weaknesses in its internal control over financial reporting.
                                         If not remediated, the Company&#8217;s failure to establish and maintain effective disclosure
                                         controls and procedures and internal control over financial reporting could result in
                                         material misstatements in its financial statements and a failure to meet its reporting
                                         and financial obligations, each of which could have a material adverse effect on the
                                         Company&#8217;s financial condition and the trading price of the Common Shares. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Risks
Related to Mining and Development&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                         face numerous uncertainties in estimating our mineral reserves and resources and inaccuracies
                                         in our estimates could result in lower than expected revenues, higher than expected costs
                                         and decreased profitability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
                                         nature of mineral exploration and production activities involves a high degree of risk
                                         and the possibility of uninsured losses.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                         have no history of producing commercial products from our current mining properties and
                                         there can be no assurance that we will successfully establish mining operations or profitably
                                         produce minerals.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Any
                                         material changes in mineral resource/reserve estimates and grades of mineralization will
                                         affect the economic viability of placing a property into production and a property&#8217;s
                                         return on capital.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
                                         properties and operations may be subject to litigation or other claims.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                         do not currently insure against all the risks and hazards of mineral exploration, development,
                                         and mining operations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Risks
Related to Government Regulation</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                         may not be able to obtain or renew all required permits and licenses to place any of
                                         our properties into production.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                         are subject to significant governmental regulations that affect our operations and costs
                                         of conducting our business.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">Land
                                         reclamation requirements for our properties may be burdensome and expensive.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Risks
Related to Our Debt</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">The
                                         level of our indebtedness from time to time could impair our ability to obtain additional
                                         financing.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         may not have the ability to service our debt, including, without limitation, to pay the
                                         installments on the April 2024 Notes (as defined herein).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Risks
Related to the Common Shares</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
                                         sales, or the perception of future sales, of Common Shares by existing shareholders or
                                         by us, or future dilutive issuances of Common Shares by us, could adversely affect prevailing
                                         market prices for the Common Shares and cause investors to suffer dilution in their net
                                         book value per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                         are subject to the continued listing criteria of the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
                                         and our failure to satisfy these criteria may result in delisting of the Common Shares.
                                         </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a006"></span>PART
I</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;1.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b><span id="a007"></span>BUSINESS
                                         &#160;</b></span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a008"></span>Introduction&#160;</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd. (&#8220;NioCorp,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or the &#8220;Company&#8221;)
was incorporated under the laws of the Province of British Columbia under the Business Corporations Act (British Columbia) on
February 27, 1987, under the name &#8220;IPC International Prospector Corp.&#8221; On May&#160;22, 1991, we changed our name to
&#8220;Kingston Resources Ltd.&#8221; On June 29, 2001, we changed our name to &#8220;Butler Developments Corp.&#8221; On February
12, 2009, we changed our name to &#8220;Butler Resource Corp.&#8221; On March&#160;4, 2010, we changed our name to &#8220;Quantum
Rare Earth Developments Corp.&#8221; On March 4, 2013, we changed our name to &#8220;NioCorp Developments Ltd.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
is an SEC  (as defined herein) reporting company, and we are also a Canadian reporting issuer in British Columbia, Alberta, Saskatchewan, Ontario,
and New Brunswick. Our registered and records office is located at 1133 Melville Street, Suite 3500, Vancouver, British Columbia
V6E 4E5 (ATTN: Blake, Cassels &amp; Graydon LLP). Our principal executive office is located at 7000 South Yosemite Street, Suite
115, Centennial, Colorado 80112.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a009"></span>Historical
Development of the Business</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition of the carbonatite property located in Southeast Nebraska, USA (the &#8220;Elk Creek Property&#8221;) was closed in
December 2010 and involved the purchase by NioCorp of all of the issued and outstanding common shares of a private British Columbia
company, which in turn held 100% of the issued and outstanding shares of Elk Creek Resources Corp., a Nebraska corporation (&#8220;Old
ECRC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company commenced a field exploration program in 2011, which included verification of previous work that was completed on the
Elk Creek Property in the 1970s and 1980s, re-assaying of historic drill core, an airborne geophysical survey and the completion
of five new diamond drillholes. The available data for the Elk Creek Property was compiled into an updated NI 43-101 resource
estimate for the Elk Creek Project, which was issued in April 2012. Additional drilling and NI 43-101 technical reports, including
resource updates and preliminary economic assessments, were completed and issued by the Company in 2014 and 2015.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal years 2016 and 2017, the Company focused on feasibility study development, and on June 30, 2017, we announced the completion
of a NI 43-101 technical report for the Elk Creek Project (the &#8220;2017 NI 43-101 Elk Creek Technical Report&#8221;). In connection
with a review by the Ontario Securities and Exchange Commission, on December 15, 2017, the Company filed a revised 2017 NI 43-101
Elk Creek Technical Report. This revised report contained no changes to any previously reported numbers or forecasted economic
returns of the Elk Creek Project from those contained in the originally filed 2017 NI 43-101 Elk Creek Technical Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2019, we received a new mine design based on detailed underground engineering conducted by The Nordmin Group of Companies
(&#8220;Nordmin&#8221;) along with an updated mineral resource and mineral reserve. On April 16, 2019, we announced the results
of the updated underground mine design and supporting infrastructure, the results of an update to the Elk Creek Project, and the
filing of an NI 43-101 technical report for the Elk Creek Project based on the new mine design. During fiscal year 2020, the Company
focused efforts on advancing detailed engineering of the surface and underground facilities and negotiating the follow-on contracts
associated with the planned construction of the surface and underground features of the project, as well as obtaining a State
of Nebraska permit which describes all the prospective air emissions from the facility (the &#8220;Air Permit&#8221;). The Air
Permit required the completion of an air quality model that demonstrates compliance with the U.S. National Ambient Air Quality
Standards limits on atmospheric concentration of six pollutants that cause smog, acid rain, and other health hazards, as established
by the EPA (&#8220;NAAQS&#8221;). The final Air Permit was issued by the State of Nebraska on June 2, 2020, for the Elk Creek
Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2021, we obtained funding which allowed us to purchase land and mineral rights at the Elk Creek Property and continue
early project execution activities. With the acquisition of the land and mineral rights, the Company now owns the surface land
on which the Elk Creek Project&#8217;s mine infrastructure and supporting operations will be located once sufficient project financing
is obtained, along with ownership of the mineral rights to more than 90% of the Elk Creek Project&#8217;s mineral resources and
mineral reserves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 12; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2022, we focused efforts towards refining our Elk Creek Project mineral resource and mineral reserve estimates with
respect to REEs. This work included additional assays of historical drill core to fill data gaps in the existing resource database
and re-modeling. Based on this re-interpretation of the geologic data, an update to the mine plan was also completed. Based on
this work, we issued the 2022 NI 43-101 Elk Creek Technical Report on June 28, 2022, and filed the S-K 1300 Elk Creek Technical
Report Summary as an exhibit to our Annual Report on Form 10-K for the year ended June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2022, we also advanced our efforts to optimize our process design to contemplate the recovery and production of REEs,
including completion of bench and pilot scale testing on elements of the current metallurgical flowsheet. This work illustrated
that NioCorp could recover and produce high purity, fully separated magnetic rare earth oxide products, specifically neodymium-praseodymium
oxide, dysprosium oxide, and terbium oxide in addition to the niobium, scandium, and titanium products already planned for production
by the Company, once project financing is secured and additional work has been completed on the technical and economic feasibility
of potentially adding REEs to the Elk Creek Project&#8217;s existing planned product suite. Following the success of this testing,
the Company advanced the construction of a demonstration-scale processing plant located in Trois-Rivieres, Quebec built by the
Company and L3 Process Development (&#8220;L3&#8221;) and operated by L3 (the &#8220;Demonstration Plant&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2023, we completed the 2023 Transactions and construction and operated the Demonstration Plant. The Demonstration
Plant results showed higher recoveries for our primary niobium product, higher recoveries and a higher value titanium product
in the form of titanium tetrachloride, and a high recovery rate for the three planned rare earth oxides of consequence: neodymium/praseodymium
oxide, dysprosium oxide and terbium oxide. In addition, we completed initial site preparation work at the Elk Creek Project, which
consisted of tree and brush clearing. A geotechnical investigation at the Elk Creek Project site was also completed, which involved
excavated test pits, geotechnical borings and the installation of shallow groundwater piezometers. The geotechnical program generated
valuable data for the firms that are working on the detailed design of the facilities and infrastructure associated with the Elk
Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
February 2024, we completed operations at the Demonstration Plant. In addition to establishing, at demonstration-scale, metallurgical
recoveries for potential rare earth products from an improved flowsheet, the Demonstration Plant also established improved recoveries
and higher purities for the Company&#8217;s planned niobium and titanium products. In addition, the Company retained a mine engineering
consultant in February 2024 to evaluate, at a scoping level, the costs and benefits of electrifying the mine and accessing it
via ramps instead of vertical shafts along with using Railveyor technology in one of the ramps to move ore and waste rock to surface.
The evaluation did not include the detailed examination of geotechnical or hydrogeologic issues. The findings of the evaluation
indicated a potential savings in upfront capital cost, a shorter schedule to get the mine to full production, and potential operating
cost savings. The Company plans a more detailed evaluation of this option for the design of the underground mine as part of a
future technical report for the Elk Creek Project. Information regarding the Elk Creek Project is discussed below under Item 2.,
&#8220;Properties.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
2023 Transactions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2023 (the &#8220;Closing Date&#8221;), the Company closed a series of transactions (the &#8220;GXII Transaction&#8221;)
pursuant to the Business Combination Agreement, dated as of September 25, 2022 (the &#8220;Business Combination Agreement&#8221;),
by and among the Company, GX Acquisition Corp. II, a Delaware corporation (&#8220;GXII&#8221;), and Big Red Merger Sub Ltd., a
Delaware corporation and a direct, wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;). Pursuant to the Business
Combination Agreement, the GXII Transaction was accounted for as an equity raise transaction in accordance with U.S. GAAP. At
the closing of the GXII Transaction (the &#8220;Closing&#8221;), the following transactions occurred:&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96%; padding-right: 2.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    a result of a series of transactions, including, without limitation, the mergers of Merger Sub and Old ECRC with and into
    GXII, with GXII surviving such mergers, GXII became an indirect, majority-owned subsidiary of NioCorp and changed its name
    to &#8220;Elk Creek Resources Corp&#8221;, which we refer to as &#8220;ECRC&#8221;. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    the parent company of the merged entity, NioCorp issued 1,753,821 post-Reverse Stock Split (as defined below) common shares
    of the Company (the &#8220;Common Shares&#8221;) in exchange for all of the Class A shares of GXII issued and outstanding
    immediately prior to the Closing, including 83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII
    that it received as partial payment for advisory services.</span></td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; text-align: justify; width: 96%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    of the Class B shares of GXII issued and outstanding immediately prior to the Closing (after giving effect to the surrender
    of certain Class B shares of GXII in accordance with the Sponsor Support Agreement, dated September 25, 2022 (the &#8220;Sponsor
    Support Agreement&#8221;), among GX Sponsor II LLC (the &#8220;Sponsor&#8221;), GXII, the Company, and the other persons party
    thereto, were converted into 7,957,404 shares of Class B common stock of GXII (now known as ECRC) as the surviving entity
    of the mergers that occurred on the Closing Date as part of the GXII Transaction. Pursuant to the Business Combination Agreement,
    the Sponsor Support Agreement and the Exchange Agreement, dated as of March 17, 2023 (as amended, supplemented or otherwise
    modified, the &#8220;Exchange Agreement&#8221;), by and among NioCorp, ECRC and the Sponsor, after the Closing, the shares
    of Class B common stock of ECRC are exchangeable into Common Shares on a one-for-one basis, subject to certain equitable adjustments,
    under certain conditions. Of the issued and outstanding shares of Class B common stock of ECRC, 4,565,808 shares (the &#8220;Vested
    Shares&#8221;)&#8201;were vested as of the Closing Date and are exchangeable at any time, and from time to time, until the
    tenth anniversary of the Closing Date (the &#8220;Ten-Year Anniversary&#8221;) and 3,391,596 shares (the &#8220;Earnout Shares&#8221;)
    are exchangeable until the Ten-Year Anniversary, subject to certain vesting conditions. See Note 10 to the consolidated financial
    statements included in Part II, Item 8 hereof for additional information regarding the Class B common stock of ECRC.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    assumed GXII&#8217;s obligations under the agreement governing the GXII share purchase warrants (the &#8220;GXII Warrants&#8221;)
    and issued an aggregate of 15,666,626 warrants (the &#8220;NioCorp Assumed Warrants&#8221;) to purchase up to an aggregate
    of 17,519,864 Common Shares. The NioCorp Assumed Warrants issued at the Closing consisted of (a) 9,999,959 public NioCorp
    Assumed Warrants (the &#8220;Public Warrants&#8221;) that were issued in respect of the GXII Warrants that were publicly traded
    prior to the Closing and (b) 5,666,667 NioCorp Assumed Warrants (the &#8220;Private Warrants&#8221;) that were issued to the
    Sponsor in respect of the GXII Warrants that it held prior to the Closing, which NioCorp Assumed Warrants were subsequently
    distributed by the Sponsor to its members in connection with the Closing. See Note 11b to the consolidated financial statements
    included in Part II, Item 8 hereof for additional information regarding the NioCorp Assumed Warrants.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Closing Date, the Company also effected a reverse stock split (the &#8220;Reverse Stock Split&#8221;) based on one (1) post-Reverse
Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding effectuated by the Company
on the Closing Date. Any fractional shares resulting from the Reverse Stock Split were rounded down to the nearest whole Common
Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the GXII Transaction, on January 26, 2023, the Company entered into definitive agreements with respect to two separate
financing packages with YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (&#8220;Yorkville&#8221;),
including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Securities Purchase Agreement, dated January 26, 2023 (as amended, the &#8220;Yorkville
                                         Convertible Debt Financing Agreement&#8221;), between the Company and Yorkville, under
                                         which the Company issued to Yorkville unsecured convertible debentures in the original
                                         aggregate principal amount of $16.0 million (the &#8220;Convertible Debentures&#8221;)
                                         and Common Share purchase warrants, exercisable for up to 1,789,267 Common Shares for
                                         cash or, if at any time there is no effective registration statement registering, or
                                         no current prospectus available for, the resale of the underlying Common Shares, on a
                                         cashless basis, at the option of the holder, at a price per Common Share of approximately
                                         $8.9422, subject to adjustment to give effect to any stock dividend, stock split, reverse
                                         stock split or similar transaction (the &#8220;Financing Warrants&#8221;), on the Closing
                                         Date, for gross proceeds of $15.36 million (the &#8220;Yorkville Convertible Debt Facility
                                         Financing&#8221;); and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 19pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Standby Equity Purchase Agreement, dated January 26, 2023 (the &#8220;Yorkville Equity
                                         Facility Financing Agreement&#8221;), between the Company and Yorkville, under which
                                         Yorkville agreed to purchase up to $65.0 million of Common Shares over a three-year period,
                                         at NioCorp&#8217;s direction and subject to certain restrictions (the &#8220;Yorkville
                                         Equity Facility Financing&#8221;).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financing packages are further discussed below under &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition
and Results of Operations &#8211; Liquidity and Capital Resources &#8211; Financing Activities</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transactions contemplated by the Business Combination Agreement, including the GXII Transaction, the Yorkville Convertible Debt
Facility Financing, the Yorkville Equity Facility Financing, and the Reverse Stock Split are referred to, collectively, as the
&#8220;2023 Transactions.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; width: 96%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Shares</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
    NioCorp Shareholders</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,246,621</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.90</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former
    GXII Class A Shareholders<sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,753,821</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.83</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<sup>(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,213</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.27</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Common Shares Outstanding Upon Completion of 2023 Transactions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,081,655</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; width: 96%; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; width: 96%; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    Commitment Shares (as defined below) issued under the Yorkville Equity Facility Financing Agreement.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
consideration of GXII expenses incurred in connection with the 2023 Transactions, the Company acquired net cash of approximately
$2.2 million and assumed net liabilities of approximately $0.4 million. We also assumed Private Warrant liabilities and the Earnout
Shares liability, which were initially recorded at their non-cash fair market value of approximately $3.0 million and approximately
$13.2 million, respectively. The Company incurred expenses related to the 2023 Transactions of approximately $6.8 million, all
of which were recorded as other operating expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in connection with the 2023 Transactions, the Common Shares and the NioCorp Assumed Warrants were listed for trading
on Nasdaq. The Common Shares and the NioCorp Assumed Warrants began trading on the Nasdaq Global Market and the Nasdaq Capital
Market, respectively, on March 21, 2023, under the symbols &#8220;NB&#8221; and &#8220;NIOBW,&#8221; respectively. The Common
Shares continued to trade on the Toronto Stock Exchange (the &#8220;TSX&#8221;) under the symbol &#8220;NB,&#8221; and began trading
on the Nasdaq on a post-Reverse Stock Split basis on March 21, 2023. The Common Shares ceased being quoted on the U.S. over the
counter markets in connection with the commencement of trading on the Nasdaq Global Market, and the Company voluntarily delisted
from the TSX effective as of close of markets on May 3, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: justify; text-indent: -0.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Structure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: justify; text-indent: -0.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s business operations are conducted primarily through ECRC (as defined below). The table below provides an overview
of the Company&#8217;s current subsidiaries and their activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b>&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>State/Province
                                         of Formation</b>&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership</b>&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 39%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business</b>&#160;</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800
    B.C. Ltd. (&#8220;0896800&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">British
    Columbia</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 2pt 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span><span style="font-family: Times New Roman, Times, Serif"><br/>
    <span style="font-size: 10pt">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    only business of 0896800 is to hold the shares of Class A common stock of ECRC</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp. (&#8220;ECRC&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 2pt 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79.7%<sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    business of ECRC is the development of the Elk Creek Project</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    Technologies Limited</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    Kingdom</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 2pt 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span><span style="font-family: Times New Roman, Times, Serif"><br/>
    <br/></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    business of NioCorp Technologies Limited is the research and development of aluminum-scandium alloys and other business opportunities</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 4.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                         100% of Class A common stock owned by 0896800, and 4,282,116 Vested Shares and 3,391,596
                                         Earnout Shares (each as defined below) held by third parties, and outstanding
                                         as of June 30, 2024.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: justify; text-indent: -0.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Corporate Events</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: justify; text-indent: -0.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2023, we announced an aluminum-scandium (&#8220;Al-Sc&#8221;) master alloy initiative (the &#8220;Al-Sc master alloy initiative&#8221;),
in partnership with Boston-based Nanoscale Powders LLC (&#8220;Nanoscale&#8221;). Al-Sc master alloy, which generally
contains 2% by weight scandium, is used to introduce scandium into aluminum for the purpose of producing various Al-Sc alloys,
which generally contain a fraction of a percent scandium by weight. These alloys help to reduce weight, increase strength and
corrosion resistance, and make the material weldable in automotive and mass transit, aerospace, defense, space, and other systems.
Two of the three planned 1-kilogram ingots were manufactured at a</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 1.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">contract metallurgical facility operated by Creative Engineers
in the quarter ended December 31, 2023. The third ingot was manufactured in the quarter ended March 31, 2024. These trials were
successful in producing an Al-Sc master alloy. The technology is sensitive to the purity of the starting materials and requires
isolation from oxygen and moisture while manufacturing is conducted. The Company is also evaluating other pathways for the manufacture
of Al-Sc master alloy.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 14, 2023, the Company announced the production of scandium metal at pilot-scale at a facility owned and operated by Creative
Engineers in New Freedom, Pennsylvania. The production of scandium metal represented the first phase in the Al-Sc master alloy
initiative. Subsequently, on October 18, 2023, the Company announced the successful pilot-scale production of a 1-kilogram ingot
of Al-Sc alloy at the Creative Engineers facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 30, 2024, we announced that the Company entered into an agreement with London-based Brunel University London, a leading
research university focused on the application of cast aluminum alloys globally, The Company is sponsoring a PhD student who is
evaluating the properties of a number of common aluminum alloys with Sc added and is participating in a consortium focused on
lightweighting vehicles using recycled aluminum by using scandium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously disclosed, on March 6, 2023, the Company announced the receipt of a Letter of Interest from the Export-Import Bank
of the United States (&#8220;EXIM&#8221;) for potential debt financing, with an initial indication of interest of up to $800
million, through EXIM&#8217;s &#8220;Make More In America&#8221; initiative to fund a portion of the project costs of the
Elk Creek Project (the &#8220;EXIM Financing&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
submitted a formal application to EXIM for a loan under EXIM&#8217;s &#8220;Make More in America&#8221; initiative on June 6,
2023. The Company was informed that its application received approval by the first of three reviews by the EXIM Transaction Review
Committee on October 2, 2023. EXIM deployed additional resources to the processing of the Company&#8217;s application during the
quarter ended December 31, 2023, and has retained financial and legal consultants to support EXIM&#8217;s due diligence on the
Elk Creek Project. On April 15, 2024, the Company received a Preliminary Project Letter (the &#8220;PPL&#8221;) from EXIM. The
PPL is a summary of EXIM&#8217;s initial due diligence findings and also includes a preliminary Indicative Term Sheet. The PPL
identified additional project activities to be undertaken by the Company in conjunction with the EXIM evaluation process. These
include an updated mine plan and updated Elk Creek Project capital costs on a final or close-to-final basis reflecting updated
process flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is working with EXIM to continue to advance the project through the next stages of EXIM&#8217;s due diligence and loan application
process. We are currently unable to estimate how long the application process, including the additional project activities identified
in the PPL, may take, and there can be no assurances that we will be able to successfully negotiate a final commitment of debt
financing from EXIM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a010"></span>Business
Operations</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
is a mineral exploration company engaged in the acquisition, exploration, and development of mineral properties. NioCorp, through
ECRC, is developing a superalloy materials project that, if and when developed, will produce niobium, scandium, titanium, and
potentially, rare earth products. Known as the &#8220;Elk Creek Project,&#8221; it is located near Elk Creek, Nebraska, in the
southeast portion of the state.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
                                         is used to produce various superalloys that are extensively used in high performance
                                         aircraft and jet turbines. It also is used in high-strength, low-alloy steel, a stronger
                                         steel used in automobiles, bridges, structural systems, buildings, pipelines, and other
                                         applications that generally enables those applications to be stronger and lighter in
                                         mass. This &#8220;lightweighting&#8221; benefit often results in environmental benefits,
                                         including reduced fuel consumption and material usage, which can result in fewer air
                                         emissions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scandium
                                         can be combined with aluminum to make super-high-performance alloys with increased strength
                                         and improved corrosion resistance. Scandium also is a critical component of advanced
                                         solid oxide fuel cells, an environmentally preferred technology for high-reliability,
                                         distributed electricity generation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titanium
                                         is a component of various superalloys and other applications that are used for aerospace
                                         applications, weapons systems, protective armor, medical implants and many others. It
                                         also is used in pigments for paper, paint, and plastics.</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">Operations
were completed at the Demonstration Plant in February 2024. In addition to establishing, at demonstration-scale, metallurgical
recoveries for potential rare earth products from an improved flowsheet, the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Demonstration Plant also established improved recoveries
and higher purities for the Company&#8217;s planned niobium and titanium products. The results from the Demonstration Plant are
expected to be utilized in a future update to the Company&#8217;s technical report for the Elk Creek Project, as well as to advance
offtake discussions with potential customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company retained a mine engineering consultant in February 2024 to evaluate, at a scoping level, the costs and benefits of electrifying
the mine and accessing it via ramps instead of vertical shafts along with using Railveyor technology in one of the ramps to move
ore and waste rock to surface. The evaluation did not include the detailed examination of geotechnical or hydrogeologic issues.
The findings of the evaluation indicated a potential savings in upfront capital cost, a shorter schedule to get the mine to full
production, and potential operating cost savings. These findings are preliminary but encouraging, and the Company plans a more
detailed evaluation of this option for the design of the underground mine as part of a future technical report for the Elk Creek
Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
primary business strategy is to advance our Elk Creek Project to commercial production. We are focused on obtaining additional
funds to carry out our near-term planned work programs associated with securing the project financing necessary to complete detailed
design, development, and construction of the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a011"></span>Competitive
Business Conditions</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is significant competition within the minerals industry to discover and acquire mineral properties considered to have commercial
potential. We compete for the opportunity to participate in promising exploration projects with other entities. In addition, we
compete with others in efforts to obtain financing to acquire and explore mineral properties, acquire and utilize mineral exploration
equipment, and hire qualified mineral exploration personnel. We may compete with other mining companies for mining claims in regions
adjacent to our existing claims, or in other parts of the world should we dedicate resources to doing so in the future. These
companies may be better capitalized than us and we may have difficulty in expanding our holdings through the staking or acquisition
of additional mining claims or other mineral tenures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
competing for qualified mineral exploration personnel, we may be required to pay compensation or benefits relatively higher than
those paid in the past, and the availability of qualified personnel may be limited in high-demand mining periods, such as was
the case in past years when the price of gold and other metals was higher than it is now.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a012"></span>Cycles</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mining business is subject to mineral price cycles. The marketability of minerals and mineral concentrates is also affected by
worldwide economic cycles. At the present time, strong demand for some minerals in many countries is lifting commodity prices,
although it is difficult to assess how long such trends may continue. Fluctuations in supply and demand in various regions throughout
the world are common.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth commodity prices for the last five calendar years for the ferroniobium, scandium trioxide and titanium
dioxide products the Company anticipates extracting from its Elk Creek Project. These pricing surveys may not be representative
of the pricing that the Company anticipates achieving for its products if commercial production begins from its Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 21%; padding-right: 5.75pt; padding-left: 5.75pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b>&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 27%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ferroniobium</b></span><span style="font-family: Times New Roman, Times, Serif"><br/>
                                         <span style="font-size: 10pt"><b>U.S. Price ($/kg-Nb)<sup>(</sup></b><sup>1)</sup>&#160;</span></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 26%; padding-right: 5.75pt; padding-left: 5.75pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc<sub>2</sub>O<sub>3</sub></b></span><span style="font-family: Times New Roman, Times, Serif"><br/>
                                         <span style="font-size: 10pt"><b>U.S. Price ($/kg)<sup>(</sup></b><sup>2)</sup>&#160;</span></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 26%; padding-right: 5.75pt; padding-left: 5.75pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<sub>2</sub></b></span><span style="font-family: Times New Roman, Times, Serif"><br/>
                                         <span style="font-size: 10pt"><b>U.S. Price ($/kg)<sup>(</sup></b><sup>3)</sup>&#160;</span></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$51</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$-<sup>(4)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.49</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,100</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;1.47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,200</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.30</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,800</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,900</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>





<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source:
                                         Argus Metal Prices, average annual ending price, 2023. Ferroniobium 65% niobium content,
                                         FOB U.S. warehouse.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source:
                                         United States Geological Service (&#8220;USGS&#8221;) Mineral Commodity Summary, 214.
                                         Sc<sub>2</sub>O<sub>3</sub>, 99.99% purity, 5-kilogram (&#8220;kg&#8221;) lot size.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source:
                                         USGS Mineral Commodity Summary, 2024. Rutile mineral concentrate, bulk, minimum 95% TiO<sub>2</sub>,
                                         f.o.b. Australia.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing
                                         information was not provided by the USGS for 2023.</span></td></tr></table>


<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on results of the Company&#8217;s Demonstration Plant, a higher value titanium tetrachloride product can be produced with a substantially
higher metallurgical recovery than TiO<sub>2</sub>. The Company is in the process of completing feasibility level cost estimates
to replace the previous TiO<sub>2</sub> production equipment with new equipment that would produce titanium tetrachloride.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
NioCorp is a development stage issuer and has not yet generated any revenue from the operation of the Elk Creek Project, it is
not currently significantly affected by changes in commodity demand and prices, except to the extent that same impact the availability
of capital for mineral exploration and development projects. As it does not carry on production activities, NioCorp&#8217;s ability
to fund ongoing exploration is affected by the availability of financing, which is, in turn, affected by the strength of the economy
and other general economic factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a013"></span>Economic
Dependence</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than land and mineral right option agreements and agreements between NioCorp and third parties for the purchase and sale of products
to be produced from the Elk Creek Project (&#8220;offtake agreements&#8221;), NioCorp&#8217;s business is not substantially dependent
on any contract such as a contract to sell the major part of its product or services or to purchase the major part of its requirements
for goods, services or its raw materials, or any franchise or license or other agreement to use a patent, formula, trade secret,
process or trade name upon which its business depends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a014"></span>Government
Regulation</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exploration and development of a mining prospect is subject to regulation by a number of federal and state government authorities.
These include the United States Environmental Protection Agency (the &#8220;EPA&#8221;) and the United States Army Corps of Engineers
(the &#8220;USACE&#8221;) as well as the various state and local environmental protection agencies. The regulations address many
environmental issues relating to air, soil, and water contamination, and apply to many mining related activities including exploration,
mine construction, mineral extraction, ore milling, water use, waste disposal, and use of toxic substances. In addition, we are
subject to regulations relating to labor standards, occupational health and safety, mine safety, general land use, export of minerals,
taxation, data protection, and data security. Many of the regulations require permits or licenses to be obtained, the absence
of which and/or inability to obtain such permits or licenses will adversely affect our ability to conduct our exploration, development,
and operation activities. The failure to comply with the regulations and terms of permits and licenses may result in fines or
other penalties or in revocation of a permit or license or loss of a prospect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
none of the lands on which the Elk Creek Project is proposed to be built are owned by the U.S. Government, mining rights on public
lands are governed by the General Mining Law of 1872, as amended, which allows for the location of mining claims on certain federal
lands upon the discovery of a valuable mineral deposit and compliance with location requirements. The exploration of mining properties
and development and operation of mines is governed by both federal and state laws. Federal laws that govern mining claim location
and maintenance and mining operations on federal lands are generally administered by the Bureau of Land Management. Additional
federal laws, governing mine safety and health, also apply. State laws also require various permits and approvals before exploration,
development or production operations can begin. Among other things, a reclamation plan must typically be prepared and approved,
with financial assurance provided in the amount of projected reclamation costs. The financial assurance is used to ensure that
proper reclamation takes place and will not be released until that time. Local jurisdictions may also impose permitting requirements,
such as conditional use permits or zoning approvals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
Regulation</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mineral projects are subject to various federal, state and local laws and regulations governing protection of the environment.
These laws are continually changing and, in general, are becoming more restrictive. The development, operation, closure, and reclamation
of mining projects in the U.S. requires numerous notifications, permits, authorizations, and public agency decisions. Compliance
with environmental and related laws and regulations requires us to obtain permits issued by regulatory agencies and to file various
reports and keep records of our operations. Certain of these permits require periodic renewal or review of their conditions and
may be subject to a public review process during which opposition to our proposed operations may be encountered. We are currently
operating under various permits for activities connected to mineral exploration, reclamation, and environmental</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">considerations.
Our policy is to conduct business in a way that safeguards public health and the environment. We believe that our operations are
conducted in material compliance with applicable laws and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
to current local, state, or federal laws and regulations in the jurisdictions where we operate could require additional capital
expenditures and increased operating and/or reclamation costs. Although we are unable to predict what additional legislation,
if any, might be proposed or enacted, additional regulatory requirements could impact the economics of our projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
Regulation - U.S. Federal Laws</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Comprehensive Environmental, Response, Compensation, and Liability Act (&#8220;CERCLA&#8221;), and comparable state statutes,
impose strict, joint, and several liability on current and former owners and operators of sites and on persons who disposed of
or arranged for the disposal of hazardous substances found at such sites. It is not uncommon for the government to file claims
requiring clean-up actions and/or demands for reimbursement for government-incurred clean-up costs or natural resource damages.
It is also not uncommon for neighboring landowners and other third parties to file claims for personal injury and property damage
allegedly caused by hazardous substances released into the environment. The Resource Conservation and Recovery Act (&#8220;RCRA&#8221;),
and comparable state statutes, govern the disposal of solid waste and hazardous waste and authorize the imposition of substantial
fines and penalties for noncompliance, as well as requirements for corrective actions. CERCLA, RCRA, and comparable state statutes
can impose liability for clean-up of sites and disposal of substances found on exploration, mining and processing sites long after
activities on such sites have been completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Clean Air Act, as amended (&#8220;CAA&#8221;), restricts the emission of air pollutants from many sources, including mining and
processing activities. Any future mining operations by the Company may produce air emissions, including fugitive dust and other
air pollutants from stationary equipment, storage facilities, and the use of mobile sources such as trucks and heavy construction
equipment, which are subject to review, monitoring and/or control requirements under the CAA and state air quality laws. New facilities
may be required to obtain permits before work can begin, and existing facilities may be required to incur capital costs in order
to remain in compliance. In addition, permitting rules may impose limitations on our production levels or result in additional
capital expenditures in order to comply with the rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
National Environmental Policy Act (&#8220;NEPA&#8221;) requires federal agencies to integrate environmental considerations into
their decision-making processes by evaluating the environmental impacts of their proposed actions, including issuance of permits
to mining facilities and assessing alternatives to those actions. If a proposed action could significantly affect the environment,
the agency must prepare either a detailed statement known as an Environmental Impact Statement (&#8220;EIS&#8221;), or a less
detailed statement known as an Environmental Assessment (&#8220;EA&#8221;). The EPA, other federal agencies, and any interested
third parties can review and comment on the scope of the EIS or EA and the adequacy of any findings set forth in the draft and
final EIS or EA. This process can cause delays in issuance of required permits or result in changes to a project to mitigate its
potential environmental impacts, which can in turn impact the economic feasibility of a proposed project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Clean Water Act (&#8220;CWA&#8221;), and comparable state statutes, impose restrictions and controls on the discharge of pollutants
into waters of the U.S. The discharge of pollutants into regulated waters is prohibited, except in accordance with the terms of
a permit issued by the EPA or an analogous state agency. The CWA regulates storm water from mining facilities and requires a storm
water discharge permit or Stormwater Pollution Prevention Plan for certain activities. Such a permit requires the regulated facility
to monitor and sample storm water run-off from its operations.
The CWA and regulations implemented thereunder also prohibit discharges of dredged and fill material in wetlands and other waters
of the U.S. unless authorized by an appropriately issued permit. The CWA and comparable state statutes provide for civil, criminal,
and administrative penalties for unauthorized discharges of pollutants, and impose liability on parties responsible for those
discharges for the costs of cleaning up any environmental damage caused by the release and for natural resource damages resulting
from the release.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Safe Drinking Water Act (&#8220;SDWA&#8221;) and the Underground Injection Control (&#8220;UIC&#8221;) program promulgated thereunder,
regulate the drilling and operation of subsurface injection wells. The EPA directly administers the UIC program in some states
and in others the responsibility for the program has been delegated to the state. The program requires that a permit be obtained
before drilling a disposal or injection well. Violation of these regulations and/or contamination of groundwater by mining-related
activities may result in fines, penalties, and remediation costs, among</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">other sanctions and liabilities under the SDWA and state
laws. In addition, third-party claims may be filed by landowners and other parties claiming damages for alternative water supplies,
property damages, and bodily injury.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
Regulation &#8722; Nebraska</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nebraska
has a well-developed set of environmental regulations and responsible agencies but does not have clearly defined regulations with
respect to permitting mines. As such, review of the project and the issuance of permits by Nebraska agencies and regulatory bodies
could potentially impact the total time to market for our Elk Creek Project. Other Nebraska regulations govern operating and design
standards for the construction and operation of any source of air emissions and landfill operations. Any changes to these laws
and regulations could have an adverse impact on our financial performance and results of operations by, for example, requiring
changes to operating conditions, technical criteria, fees, or surety requirements. The most stringent permit related to air quality
is known as a Prevention of Significant Deterioration (&#8220;PSD&#8221;) permit, which requires the applicant to demonstrate
compliance with NAAQS and Best Available Control Technology (&#8220;BACT&#8221;) for the control of air emissions. If the facility
exceeds the potential to emit thresholds for such a permit and is thus subject to PSD requirements, permanent construction at
the project site may not begin until the responsible agency issues the PSD permit. For facilities in Nebraska with potential emissions
below PSD thresholds, a state air construction permit is needed. The state permit also requires a demonstration of compliance
with NAAQS but does not require a BACT demonstration and further allows construction at a subject facility to proceed ahead of
permit issuance through an established variance process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a015"></span>Human
Capital</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ability to continue to progress the Elk Creek Project will depend on its ability to attract and retain individuals
with (among other skills) financial, administrative, engineering, geological and mining skills, and knowledge of our industry
and targeted markets. Much of the necessary specialized skills and knowledge required by the Company as a mineral exploration
company are available from the Company&#8217;s current management team and Board of Directors (the &#8220;Board&#8221;). The Company
retains outside consultants if additional specialized skills and knowledge are required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, we had seven full-time employees as well as one contract employee. In addition, we use consultants with specific
skills to assist with various aspects of our corporate affairs, project evaluation, due diligence, corporate governance and property
management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compensation programs are designed to align compensation of our employees with the Company&#8217;s performance and to provide
the proper incentives to attract, retain and motivate employees to achieve superior results. The structure of our compensation
programs balances competitive wages and benefits and incentive earnings for both short-term and long-term performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
priority to maintain a culture of ethical performance as a core value is reflected in the Company&#8217;s Code of Business Conduct
and Ethics (the &#8220;Code of Conduct&#8221;) and other related policies. Oversight is provided by the Company&#8217;s Board
and, for specific areas of performance, by committees of the Board. Employees are required to review the Code of Conduct on a
periodic basis. Our compensation programs also include consideration of ethical performance in determining incentive awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also provides a robust suite of benefits to our employees, including 401(k) participation, medical-insurance options,
and programs to encourage and support the whole person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a016"></span>Forward-Looking
Statements</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 10-K and the exhibits attached hereto contain &#8220;forward-looking statements&#8221; within the meaning
of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities
Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and &#8220;forward-looking information&#8221; within the meaning
of applicable Canadian securities legislation (collectively, &#8220;forward-looking statements&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements have been based upon our current business and operating plans, as approved by the Board, and may include statements
regarding the anticipated benefits of the 2023 Transactions, including NioCorp&#8217;s ability to access the full amount of the
expected net proceeds of the Yorkville Equity Facility Financing Agreement;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">NioCorp&#8217;s ability to receive a final commitment
of financing from EXIM; anticipated benefits of the listing of the Common Shares on Nasdaq; the financial and business performance
of NioCorp; NioCorp&#8217;s anticipated results and developments in the operations of NioCorp in future periods; NioCorp&#8217;s
planned exploration activities; the adequacy of NioCorp&#8217;s financial resources; NioCorp&#8217;s ability to secure sufficient
project financing to complete construction and commence operation of the Elk Creek Project; NioCorp&#8217;s expectation and ability
to produce niobium, scandium, and titanium and the potential to produce rare earth elements at the Elk Creek Project; NioCorp&#8217;s
plans to produce and supply specific products and market demand for those products; the outcome of current recovery process improvement
testing and the evaluation of the benefits and costs of electrifying the mine using Railveyor technology, and NioCorp&#8217;s
expectation that such process and design improvements could lead to greater efficiencies and cost savings in the Elk Creek Project;
the Elk Creek Project&#8217;s ability to produce multiple critical metals; the Elk Creek Project&#8217;s projected ore production
and mining operations over its expected mine life; the completion of technical and economic analyses on the potential addition
of magnetic rare earth oxides to NioCorp&#8217;s planned product suite; NioCorp&#8217;s updating its technical report for the Elk Creek Project; statements with respect to the estimation of mineral resources and mineral reserves; the exercise of options to purchase additional land parcels;
the execution of contracts with engineering, procurement and construction companies; NioCorp&#8217;s ongoing evaluation of the
impact of inflation, supply chain issues and geopolitical unrest on the Elk Creek Project&#8217;s economic model; and the creation
of full time and contract construction jobs over the construction period of the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in">Forward-looking
statements are frequently, but not always, identified by words such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221;
&#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;potential,&#8221; &#8220;possible,&#8221; and similar expressions, or statements
that events, conditions, or results &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; or &#8220;should&#8221; (or the
negative and grammatical variations of any of these terms) occur or be achieved. Any statements that express or involve discussions
with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, or future events or performance
(often, but not always, using words or phrases such as &#8220;expects&#8221; or &#8220;does not expect,&#8221; &#8220;is expected,&#8221;
&#8220;anticipates&#8221; or &#8220;does not anticipate,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; or &#8220;intends,&#8221;
or stating that certain actions, events, or results &#8220;may,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;might,&#8221;
or &#8220;will&#8221; be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements.
Forward-looking statements reflect material expectations and assumptions, including, without limitation, expectations and assumptions
relating to: NioCorp&#8217;s ability to receive sufficient project financing for the construction of the Elk Creek Project on acceptable
terms or at all; NioCorp&#8217;s ability to service its existing debt and meet the payment obligations thereunder; the future price
of metals; the stability of the financial and capital markets; and current estimates and assumptions regarding the 2023 Transactions
and their benefits. Such forward-looking statements reflect the Company&#8217;s current views with respect to future events and
are subject to certain known and unknown risks, uncertainties, and assumptions. Many factors could cause actual results, performance,
or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied
by such forward-looking statements, including, among others, risks related to the following: NioCorp&#8217;s ability to operate
as a going concern; NioCorp&#8217;s requirement of significant additional capital; NioCorp&#8217;s ability to receive sufficient
project financing for the construction of the Elk Creek Project on acceptable terms or at all; NioCorp&#8217;s ability to receive
a final commitment of financing from EXIM on an acceptable timeline, on acceptable terms, or at all&#160;; NioCorp&#8217;s ability
to recognize the anticipated benefits of the 2023 Transactions, including NioCorp&#8217;s ability to access the full amount of
the expected net proceeds under the Yorkville Equity Facility Financing Agreement over the next 18 months; NioCorp&#8217;s ability
to continue to meet Nasdaq listing standards; risks relating to the Common Shares, including price volatility, lack of dividend
payments and dilution or the perception of the likelihood of any of the foregoing; the extent to which NioCorp&#8217;s level of
indebtedness and/or the terms contained in agreements governing NioCorp&#8217;s indebtedness or the Yorkville Equity Facility Financing
Agreement may impair NioCorp&#8217;s ability to obtain additional financing; covenants contained in agreements with NioCorp&#8217;s
secured creditors that may affect its assets; NioCorp&#8217;s limited operating history; NioCorp&#8217;s history of losses; the
material weaknesses in NioCorp&#8217;s internal control over financial reporting, NioCorp&#8217;s efforts to remediate such material
weaknesses and the timing of remediation; the possibility that NioCorp may qualify as a PFIC under the Code; the potential that
the 2023 Transactions could result in NioCorp becoming subject to materially adverse U.S. federal income tax consequences as a
result of the application of Section 7874 and related sections of the Code; cost increases for NioCorp&#8217;s exploration and,
if warranted, development projects; a disruption in, or failure of, NioCorp&#8217;s information technology systems, including those
related to cybersecurity; equipment and supply shortages; variations in the market demand for, and prices of, niobium, scandium,
titanium and rare earth products; current and future offtake agreements, joint ventures, and partnerships; NioCorp&#8217;s ability
to attract qualified management; estimates of mineral resources and reserves; mineral exploration and production activities; feasibility
study results; the results of metallurgical testing; the results of technological research; changes in demand for and price of
commodities (such as fuel and electricity) and currencies; competition in the mining industry; changes or disruptions in the securities
markets; legislative, political or economic</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">developments, including changes in federal
and/or state laws that may significantly affect the mining industry; the impacts of climate change, as well as actions taken or
required by governments related to strengthening resilience in the face of potential impacts from climate change; the need to
obtain permits and comply with laws and regulations and other regulatory requirements; the timing and reliability of sampling
and assay data; the possibility that actual results of work may differ from projections/expectations or may not realize the perceived
potential of NioCorp&#8217;s projects; risks of accidents, equipment breakdowns, and labor disputes or other unanticipated difficulties
or interruptions; the possibility of cost overruns or unanticipated expenses in development programs; operating or technical difficulties
in connection with exploration, mining, or development activities; management of the water balance at the Elk Creek Project site;
land reclamation requirements related to the Elk Creek Project; the speculative nature of mineral exploration and development,
including the risks of diminishing quantities of grades of reserves and resources; claims on the title to NioCorp&#8217;s properties;
potential future litigation; and NioCorp&#8217;s lack of insurance covering all of NioCorp&#8217;s operations.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may
vary materially from those described herein. This list is not exhaustive of the factors that may affect any of the Company&#8217;s
forward-looking statements. Forward-looking statements are statements about the future and are inherently uncertain, and actual
achievements of the Company or other future events or conditions may differ materially from those reflected in the forward-looking
statements due to a variety of risks, uncertainties, and other factors, including without limitation those discussed under Item
1A., Risk Factors below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s forward-looking statements contained in this Annual Report on Form 10-K are based on the beliefs, expectations,
and opinions of management as of the date of this Annual Report on Form 10-K. The Company does not assume any obligation to update
forward-looking statements if circumstances or management&#8217;s beliefs, expectations, or opinions should change, except as
required by law. For the reasons set forth above, investors should not attribute undue certainty to, or place undue reliance on,
forward-looking statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 2pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a017"></span>Available
Information</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a website at http://www.niocorp.com. Our Common Shares are currently registered under Section 12(b) of the Exchange Act,
and we are currently required to file reports on Forms 10-K, 10-Q, or 8-K. Our Annual Report on Form 10-K (which includes our
audited consolidated financial statements), Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to reports
filed or furnished pursuant to Sections 13(a) and 15(d) of the Exchange Act, are available on our website, free of charge, as
soon as reasonably practicable after we electronically file such reports with, or furnish those reports to, the United States
Securities and Exchange Commission (the &#8220;SEC&#8221;). The SEC maintains an internet site that contains reports, proxy and
information statements, and other information regarding issuers that file electronically with the SEC (http://www.sec.gov). We
do not intend to send security holders a printed version of our Annual Report as it will be available online.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a Code of Conduct, a copy of which may be found on our website in the &#8220;About Us&#8221; section under the main title
&#8220;Corporate Governance.&#8221; Our Code of Conduct contains information regarding whistleblower procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not including the information contained on or accessible through our website or the SEC&#8217;s website as a part of, or incorporating
it by reference into, this Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;1A.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b><span id="a018"></span>RISK
                                         FACTORS</b></span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
business activities are subject to significant risks, including those described below. You should carefully consider these risks.
If any of the described risks occurs, our business, financial position, and results of operations could be materially adversely
affected. Such risks are not the only ones we face, and additional risks and uncertainties not presently known to us or that we
currently deem immaterial may also affect our business. This report contains forward-looking statements that involve risks and
uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result
of a number of factors, including the risks described below. See &#8220;Forward-Looking Statements&#8221; under Item 1., &#8220;Business.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a019"></span>Risks
Related to Our Business</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to operate as a going concern is in doubt.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
notes that accompany our consolidated financial statements for the year ended June 30, 2024, disclose that substantial doubt exists
as to our ability to continue as a going concern. The consolidated financial statements included in this Annual Report on Form
10-K have been prepared under the assumption that we will continue as a going concern. We are a development stage issuer and we
have incurred losses since our inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have no historical recurring source of revenue and our ability to continue as a going concern is dependent on our ability
to raise capital to fund our future exploration and working capital requirements or our ability to profitably execute our business
plan. Our plans for the long-term return to and continuation as a going concern include financing our future operations through
sales of our Common Shares and/or debt and the potential profitable exploitation of our Elk Creek Project. Additionally, capital
markets and general economic conditions in the U.S. and Canada may impose significant obstacles to raising the required funds.
As discussed further below, while we have been successful in doing so in the past, there can be no assurance we will be able to
raise funds in the future. These factors raise substantial doubt about our ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will require significant additional capital to fund our business plan.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be required to expend significant funds to develop our existing properties and to identify and acquire additional properties
to diversify our property portfolio. We anticipate that we will be required to make substantial capital expenditures for the development
of our Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, the Company had cash of $2.0 million and working capital deficit of $9.0 million, compared to cash of $2.3 million
and working capital of $0.2 million on June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, the Company&#8217;s current planned operational needs are approximately $26.0 million through the end of fiscal
2025. From the date of this Annual Report on Form 10-K, the Company anticipates that it does not have sufficient cash to continue
to fund basic operations for the next twelve months. This includes general overhead costs, satisfying outstanding accounts payable,
and repayment of our short-term debt obligations. This also includes anticipated financing costs associated with the Elk Creek
Project, including an updated mine plan in connection with the EXIM application process. The scope of these financing costs remains
under discussion with EXIM. Access to additional funds will be utilized to fund basic operations as well as to further advance
the Elk Creek Project through substantive near-term milestones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except for funding
under a $2.0 million non-revolving credit facility pursuant to the Smith Loan Agreement  (as defined herein), and the potential for additional funding
under the Yorkville Equity Facility Financing, each of which are discussed below under &#8220;<i>Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations &#8211; Liquidity and Capital Resources &#8211; Financing Activities</i>,&#8221;
and the potential exercise of Options and Warrants, we currently have no further funding commitments or arrangements for additional
financing at this time, and there is no assurance that we will be able to obtain any such additional financing on acceptable terms,
if at all. In addition, pursuant to the Exchange Agreement, NioCorp is restricted from issuing equity or equity-linked securities
(other than Common Shares) or any preferred equity or non-voting equity if such issuance would adversely impact the rights of the
holders of the shares of Class B common stock of ECRC, without the consent of the holders of a majority of the shares of Class
B common stock of ECRC. The April 2024 Purchase Agreement (as defined herein) also contains certain covenants that, among other
things, limit NioCorp&#8217;s ability to use the proceeds from the sale of the April 2024 Notes and the exercise of April 2024
Warrants to repay related party debt or to enter into any variable rate transaction, including issuances of equity or debt securities
that are convertible into Common Shares at variable rates and any equity line of credit, ATM agreement, or other continuous offering
of Common Shares, other than with Yorkville, subject to certain exceptions. Notwithstanding the restrictions set forth in the Exchange
Agreement and the April 2024 Purchase Agreement, there is significant uncertainty that we would be able to secure any additional
financing in the current equity or debt markets.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are actively pursuing additional sources of debt and equity financing, and while we have been successful in doing so in the past,
there can be no assurance we will be able to do so in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to obtain necessary funding for these purposes, in turn, depends upon a number of factors, including the status of the
national and worldwide economy and the price of the products we intend to produce. We may not be successful in obtaining the required
financing or, if we can obtain such financing, such financing may not be on terms that are favorable to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the potential EXIM Financing is subject to, among other matters, the satisfactory completion of due diligence, including
the additional project activities identified in the PPL, the negotiation and settlement of final terms, and the negotiation of
definitive documentation. There can be no assurance that the EXIM Financing will be completed on the terms described herein or
at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
inability to access sufficient capital for our operations could have a material adverse effect on our financial condition, results
of operations, or prospects. Sales of substantial amounts of securities may have a highly dilutive effect on our ownership or
share structure. Sales of a large number of Common Shares in the public markets, or the potential for such sales, could decrease
the trading price of the Common Shares and could impair our ability to raise capital through future sales of Common Shares. We
have not yet commenced commercial production at any of our properties and, as such, have not generated positive cash flows to
date and have no reasonable prospects of doing so unless successful commercial production can be achieved at our Elk Creek Project.
We expect to continue to incur negative investing and operating cash flows until such time as we enter into successful commercial
production. This will require us to deploy our working capital to fund such negative cash flow and to seek additional sources
of financing. There is no assurance that any such financing sources will be available or sufficient to meet our requirements.
There is no assurance that we will be able to continue to raise equity capital or to secure additional debt financing, or that
we will not continue to incur losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We
have a limited operating history on which to base an evaluation of our business and prospects.</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, we have had no revenue from operations. We have no history of producing products from any of our properties. Our
Elk Creek Project is a development stage property. Advancing our Elk Creek Project from a development stage property to a production
stage property will require significant capital and time, and successful commercial production from the Elk Creek Property will
be subject to permitting and construction of the mine, processing plants, roads, and other related works and infrastructure. As
a result, we are subject to all of the risks associated with developing and establishing new mining operations and business enterprises
including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         timing and cost, which can be considerable, of further exploration, preparing feasibility
                                         studies, permitting, engineering and construction of infrastructure, mining, and processing
                                         facilities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         availability and costs of drilling equipment, exploration personnel, skilled labor, and
                                         mining and processing equipment, if required;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         availability and cost of appropriate smelting and/or refining arrangements, if required;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
                                         with environmental and other governmental approval and permit requirements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         availability of funds to finance exploration, development, permitting, and construction
                                         activities, as warranted;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         opposition from non-governmental organizations, local groups, or local residents that
                                         may delay or prevent development activities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         increases in exploration, construction, and operating costs due to changes in the cost
                                         of fuel, power, materials, and supplies; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         shortages of mining, mineral processing, hydrometallurgical, pyrometallurgical, construction,
                                         and other facilities-related supplies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
costs, timing, and complexities of exploration, development, engineering, and construction activities may be increased by the
location of our properties and competition from other mineral exploration and mining companies. It is common for exploration companies
to experience unexpected problems and delays during development, if commenced, including engineering, procurement, construction,
commissioning, and ramp-up. Accordingly, our activities may not result in profitable operations and we may not succeed in establishing
operations or profitably producing products at any of our current or future properties, including our Elk Creek Project.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a history of losses and expect to continue to incur losses in the future.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred losses since inception, have negative cash flow from operating activities, and expect to continue to incur losses
in the future. We incurred the following net losses attributable to the Company during each of the following periods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$11.4
                                         million for the year ended June 30, 2024; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$40.1
                                         million for the year ended June 30, 2023.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to continue to incur losses unless and until such time as one of our properties enters into commercial production and generates
sufficient revenues to fund continuing operations. We recognize that if we are unable to generate significant revenues from operations
and dispositions of our properties, we will not be able to earn profits or continue operations. At this early stage of our operation,
we also expect to face the risks, uncertainties, expenses, and difficulties frequently encountered by companies at the start-up
stage of their business development. We cannot be sure that we will be successful in addressing these risks and uncertainties
and our failure to do so could have a materially adverse effect on our financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increased
costs could affect our financial condition.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that costs at our projects that we may explore or develop will frequently be subject to variation from one year to
the next due to a number of factors, such as changing ore grade, metallurgical performance, and revisions to mine plans, if any,
in response to the physical shape and location of the ore body. In addition, costs are affected by the price of commodities such
as fuel, steel, aluminum, iron, chemicals, natural gas, fresh water, and electricity, as well as by government actions such as
tariffs. Such commodities are at times subject to volatile price movements, including increases that could make production at
certain operations less profitable or not profitable at all. A material increase in costs at any significant location could have
a significant effect on our profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
disruption in, or failure of our third-party service providers&#8217; IT systems, including those related to cybersecurity, could
adversely affect our business operations and financial performance.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on the accuracy, capacity, and security of our third-party service providers&#8217; IT systems for the operations of many
of our business processes and to comply with regulatory, legal, and tax requirements. We are dependent on third parties to provide
important IT services relating to, among other things, operational technology at our facilities, human resources, electronic communications,
and certain finance functions. Despite the security measures that our third-party service providers have implemented, including
those related to cybersecurity, their systems could be breached or damaged by computer viruses, natural or man-made incidents
or disasters, or unauthorized physical or electronic access. Though our third-party service providers have controls in place,
we cannot provide assurance that a cyber-attack will not occur. Furthermore, we may have little or no oversight with respect to
security measures employed by third-party service providers, which may ultimately prove to be ineffective at countering threats.
Failures of our third-party service providers&#8217; IT systems, whether caused maliciously or inadvertently, may result in the
disruption of our business processes, or in the unauthorized release of sensitive, confidential, or otherwise protected information
or result in the corruption of data, which could adversely affect our business operations and financial performance. In addition,
we may be required to incur significant costs to protect against and, if required, remediate the damage caused by such disruptions
or system failures in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
shortage of equipment and supplies could adversely affect our ability to operate our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are dependent on various supplies and equipment to carry out our mining exploration and, if warranted, project development operations.
The shortage of such supplies, equipment, and parts could have a material adverse effect on our ability to carry out our operations
and could therefore limit, or increase the cost of, production. Ongoing
disruptions to the world&#8217;s economy, including issues related to supply chains, inflation, and increased raw material and
labor costs, may delay our ability to secure supplies and equipment for the Elk Creek Project on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint
ventures and other partnerships, including offtake arrangements, may expose us to risks.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into three offtake agreements and one letter of intent related to our Elk Creek Project as well as agreements related
to the supply of natural gas and electricity to the project site, and may enter into joint ventures or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">partnership arrangements,
including additional offtake agreements, with other parties in relation to the exploration, development, and production of certain
of the properties in which we have an interest. Any failure of such other companies to meet their obligations to us or to third
parties, or any disputes with respect to the parties&#8217; respective rights and obligations, or price fluctuations and termination
provisions related to such agreements, could have a material adverse effect on us, the development and production at our properties,
including the Elk Creek Project, the joint ventures, if any, or their properties and therefore could have a material adverse effect
on our results of operations, financial performance, cash flows, and the price of our Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may experience difficulty attracting and retaining qualified management to meet the needs of our anticipated growth, and the failure
to manage our growth effectively could have a material adverse effect on our business and financial condition.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are dependent on a relatively small number of key employees, including our Chief Executive Officer. The loss of any officer could
have an adverse effect on us. We have no life insurance on any individual, and we may be unable to hire a suitable replacement
for them on favorable terms, should that become necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effect on the capital markets and the economy of recent global events, including inflation, volatility in commodity prices, supply
chain uncertainty, and increases in raw material and labor costs, could have an adverse effect on NioCorp&#8217;s business plans,
financial condition, and liquidity.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
events have effected, and continue to effect, the global and United States economies, including increased inflation, volatility
in commodity prices, supply chain uncertainty, and increases in raw material and labor costs. We cannot predict how this will
affect our business, but the impact may be adverse.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
it is not possible to predict the ultimate impact of these factors on NioCorp&#8217;s business plans, financial position, or liquidity,
such impacts that may be material include, but are not limited to: (i) delays in the completion of the mine and surface engineering
designs and uncertainty regarding our ability to finalize necessary Engineering, Procurement, and Construction (&#8220;EPC&#8221;)
agreements as a result of disruptions in the businesses of our engineering consultants and key contractors for the Elk Creek Project,
(ii) reduced availability and increased costs of employees, (iii) a negative impact on our liquidity position, and (iv) increased
costs and less ability to access funds in the capital markets. The full extent to which these factors may continue to impact our
business will depend on future developments, which continue to be highly uncertain and cannot be predicted at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 1pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we cannot predict the impact that recent global events, including inflation, volatility in commodity prices, supply
chain uncertainty, and increases in raw material and labor costs will have on our customers, suppliers, vendors, and other business
partners, and each of their financial conditions; however, any material effect on these parties could adversely impact us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 1pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
may be difficult to enforce judgments or bring actions outside the U.S. against us and certain of our directors.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a Canadian corporation and, as a result, it may be difficult or impossible for an investor to do the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enforce
                                         in courts outside the U.S. judgments obtained in U.S. courts based upon the civil liability
                                         provisions of U.S. federal securities laws against these persons and the Company; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">bring
                                         in courts outside the U.S. an original action to enforce liabilities based upon U.S.
                                         federal securities laws against these persons and the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may not realize all or any of the anticipated benefits expected as a result of the 2023 Transactions.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
listing of the Common Shares on Nasdaq may not provide the anticipated benefits of broader access to capital and financing alternatives
or otherwise enhance NioCorp&#8217;s public profile. If the Company is not successful in realizing these anticipated benefits,
including the anticipated benefits of listing the Common Shares on the Nasdaq and the anticipated acceleration of financing efforts
to advance, complete construction, and commence operation of the Elk Creek Project, such consequences may adversely affect the
Company&#8217;s results of operations, cash flows, financial position, and the price of our Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not recognize the full value of the Yorkville Equity Facility Financing Agreement and may not receive any proceeds from the
exercise of the NioCorp Assumed Warrants, the April 2024 Warrants and our other outstanding Warrants, and the potential adverse
effect on the prevailing market prices for our Common Shares as a result of sales, or the perception of future sales, of Common
Shares could adversely affect our ability to raise additional capital.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we have entered into the Yorkville Equity Facility Financing Agreement, we may not recognize the full value thereof. Specifically,
our ability to sell Common Shares to Yorkville pursuant to the Yorkville Equity Facility Financing Agreement is subject to certain
restrictions and limitations, which may prevent us from selling the full commitment amount prior to the expiration of the commitment
period. Our ability to recognize the full value of the Yorkville Equity Facility Financing Agreement may be further impeded by
the potential negative pressure on the market price of our Common Shares as a result of sales, or the perception of future sales,
of Common Shares by us or by other security holders. As a result, there can be no assurance that we will receive all or even a
significant portion of the proceeds that we expect to receive in connection with the Yorkville Equity Facility Financing Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, upon exercise, we will receive the cash exercise price of the NioCorp Assumed Warrants, the April 2024 Warrants and
our other outstanding Warrants (assuming, with respect to the NioCorp Assumed Warrants and the April 2024 Warrants that they are
not exercised on a cashless basis). We believe the likelihood that holders of the NioCorp Assumed Warrants, April 2024 Warrants
or other outstanding Warrants will exercise their NioCorp Assumed Warrants, April 2024 Warrants or other outstanding Warrants,
and therefore, the amount of cash proceeds that we would receive, is, among other things, dependent upon the market price of our
Common Shares. For so long as the market price for our Common Shares is less than the applicable exercise price of the NioCorp
Assumed Warrants, April 2024 Warrants, or other outstanding Warrants, we believe such holders will be unlikely to exercise their
Financing Warrants, NioCorp Assumed Warrants, April 2024 Warrants or other outstanding Warrants. The potential adverse effect
on the prevailing market price of our Common Shares as a result of sales of Common Shares by us or by other security holders,
or the perception that such sales may occur, could keep the market price for our Common Shares below the applicable exercise price
of the NioCorp Assumed Warrants, April 2024 Warrants or other outstanding Warrants. Accordingly, the holders of the NioCorp Assumed
Warrants, April 2024 Warrants or other outstanding Warrants may not exercise their NioCorp Assumed Warrants, April 2024 Warrants
or other outstanding Warrants before they expire, and we may not receive any proceeds from the exercise of the NioCorp Assumed
Warrants, April 2024 Warrants or other outstanding Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred significant debt in connection with the April 2024 Purchase Agreement and we require significant additional capital to
operate our business. We are obligated to repay or issue Common Shares upon settlement of the full aggregate principal amount
of the April 2024 Notes, plus premium, if any, and accrued interest, if any. Such significant additional debt could adversely
affect our business, which may prevent us from fulfilling our obligations with respect to our existing debt or obtaining future
financing. Further, the April 2024 Purchase Agreement restricts us from pursuing certain variable rate financing transactions,
which could impair our ability to obtain additional financing on terms that are favorable, or at all. In addition, if the market
price of the Common Shares were to drop as a result of sales, or the perception of future sales, of Common Shares by us or by
other security holders, this might impede our ability to raise additional capital. Our inability to obtain additional financing
on terms that are favorable, or at all, could have a material adverse effect on our financial condition, results of operations
and prospects.</span></p>
<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Company has identified material weaknesses in its internal control over financial reporting. If not remediated, the Company&#8217;s
failure to establish and maintain effective disclosure controls and procedures and internal
control over financial reporting could result in material misstatements in its financial statements and a failure to meet its
reporting and financial obligations, each of which could have a material adverse effect on the Company&#8217;s financial condition
and the trading price of the Common Shares.</b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our management has identified deficiencies in the principles associated with the control environment,
risk assessment, control activities, and monitoring components of internal control that constitute material weaknesses, either
individually or in the aggregate. A material weakness is a deficiency, or a combination of deficiencies, in internal control over
financial reporting, such that there is a reasonable possibility </span></p>


<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">that a material misstatement of a company&#8217;s annual or interim
financial statements will not be prevented or detected on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in Item 9A, &#8220;Controls and Procedures,&#8221; of this Annual Report on Form 10-K, the Company&#8217;s management
has assessed the effectiveness of its internal control over financial reporting and its disclosure controls and procedures and
concluded that they were not effective as of June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is committed to remediating its material weaknesses as promptly as possible. Management is in the process of implementing
its remediation plan. However, there can be no assurance as to when the material weaknesses will be remediated or that additional
material weaknesses will not arise in the future. If the Company is unable to maintain effective internal control over financial
reporting, its ability to record, process and report financial information timely and accurately could be adversely affected,
which could subject the Company to litigation or investigations, require management resources, increase costs, negatively affect
investor confidence and adversely impact the trading price of the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may face litigation and other risks as a result of the material weaknesses in our internal control over financial reporting.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
identified material weaknesses in our internal control over financial reporting that exist as of June 30, 2024. As a result of
such material weaknesses and other matters raised or that may in the future be raised by the SEC or the Canadian securities regulators,
we face potential for litigation or other disputes, which may include, among others, claims invoking the federal and state securities
laws, contractual claims or other claims arising from the material weaknesses in our internal control over financial reporting
and the preparation of our financial statements. As of the date of this Annual Report on Form 10-K, we have no knowledge of any
such litigation or dispute. However, we can provide no assurance that such litigation or dispute will not arise in the future.
Any such litigation or dispute, whether successful or not, could adversely affect our business, financial condition and results
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a020"></span>Risks
Related to Mining and Development</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face numerous uncertainties in estimating our mineral reserves and resources and inaccuracies in our estimates could result in
lower than expected revenues, higher than expected costs and decreased profitability.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
mineral is economically recoverable when the price at which we may sell the mineral exceeds the costs and expenses of mining and
selling the mineral. Forecasts of our future performance are based on, among other things, estimates of our mineral reserves.
We base our reserve and resource information on engineering, economic and geological data assembled and analyzed by qualified
persons, which include various engineers and geologists on our staff and of third parties. Our estimates are also subject to SEC
regulations regarding classification of reserves and resources, including S-K 1300. Our reserve and resource estimates as to both
quantity and quality are updated from time to time to reflect additional information received. There are numerous uncertainties
inherent in estimating quantities and qualities of mineral reserves and resources, including many factors beyond our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
of mineral reserves and resources necessarily depend upon a number of variable factors and assumptions, any one of which may,
if incorrect, result in an estimate that varies considerably from actual results. These factors and assumptions include, but are
not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">geologic
                                         and mining conditions, which may not be fully identified by available exploration data
                                         and may differ from our experience;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">demand
                                         for the minerals that we plan to produce;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">current
                                         and future market prices for minerals and contractual arrangements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">current
                                         and future operating costs and capital expenditures may exceed estimates, notwithstanding
                                         that, under S-K 1300, operating cost and capital expenditure estimates in feasibility
                                         studies must have an accuracy level of at least &#177;15% and a contingency range not
                                         exceeding 10%;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additional
                                         capital expenditure related to the modification of the proposed surface plant related
                                         to the potential addition of rare earth elements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">severance
                                         and excise taxes, royalties and development and reclamation costs;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
                                         mining technology improvements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         effects of regulation by governmental agencies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         ability to obtain, maintain and renew all required permits;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">employee
                                         health and safety; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">historical
                                         production from the area compared with production from other producing areas.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conversion of reported mineral resources to mineral reserves should not be assumed, and the reclassification of reported mineral
resources from lower to higher levels of geological confidence should not be assumed. As such, actual mineral tonnage recovered
from identified reserves, and revenues and expenditures with respect to our reserves, may vary materially from estimates. Thus,
these estimates may not accurately reflect our actual reserves. Any material inaccuracy in our estimates related to our reserves
could result in lower than expected revenues, higher than expected costs, or decreased profitability, which could materially and
adversely affect our business, results of operations, financial position, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
nature of mineral exploration and production activities involves a high degree of risk and the possibility of uninsured losses.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exploration
for and the production of minerals is highly speculative and involves much greater risk than many other businesses. Most exploration
programs do not result in the discovery of mineralization, and any mineralization discovered may not be of sufficient quantity
or quality to be profitably mined. Our operations are, and any future development or mining operations we may conduct will be,
subject to all of the operating hazards and risks normally incident to exploring for and developing mineral properties, such as,
but not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">economically
                                         insufficient mineralized material;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuation
                                         in production costs that make production uneconomical;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">labor
                                         disputes;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unanticipated
                                         variations in grade and other geologic problems;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">environmental
                                         hazards;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">water
                                         conditions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficult
                                         surface or underground conditions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">industrial
                                         accidents;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">metallurgical,
                                         pyrometallurgical, and other processing problems;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">mechanical
                                         and equipment performance problems;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                         of dams, stockpiles, wastewater transportation systems, or impoundments;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unusual
                                         or unexpected rock formations; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">personal
                                         injury, fire, flooding, cave-ins, and landslides.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these risks can materially and adversely affect, among other things, the development of properties, production quantities and
rates, costs and expenditures, potential revenues, and production dates. We currently have very limited insurance to guard against
some of these risks. If we determine that capitalized costs associated with any of our mineral interests are not likely to be
recovered, we would incur a write-down of our investment in these interests. All of these factors may result in losses in relation
to amounts spent that are not recoverable, or that result in additional expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no history of producing commercial products from our current mining properties and there can be no assurance that we will
successfully establish mining operations or profitably produce minerals.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no history of producing commercial products from our current mining properties. We do not produce commercial products and
do not currently generate operating earnings. While we seek to move our Elk Creek Project from a development stage property to
a production stage property, such efforts will be subject to all of the risks associated with establishing new mining operations
and business enterprises, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         timing and cost, which are considerable, of the construction of mining and processing
                                         facilities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         availability and costs of skilled labor and equipment;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
                                         with environmental and other governmental approval and permit requirements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         availability of funds to finance construction and development activities;</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         opposition from non-governmental organizations, local groups, or local residents that
                                         may delay or prevent development activities; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         increases in construction and operating costs due to changes in the cost and availability
                                         of labor, fuel, power, materials, and equipment and supplies, and the time elapsed since
                                         the most recent estimates of cost and availability were made.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is common in new mining and processing operations to experience unexpected problems and delays during engineering, procurement,
construction, commissioning, and initial operations. In addition, our management and workforce will need to be expanded, and sufficient
housing and other support systems for our workforce will have to be established. This could result in delays in the commencement
of production and increased costs of production. Accordingly, we cannot assure you that our activities will result in profitable
operations or that we will successfully establish mining and processing operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results
of metallurgical testing by us may not be favorable to, or as expected by, us.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have completed significant bench, mini-pilot, and pilot scale metallurgical testing on material from the Elk Creek Project and
will continue to complete necessary metallurgical testing at the bench, mini-pilot, and pilot scale as the exploration and, if
warranted, development of the Elk Creek Project progresses. There can be no assurance that the results of such metallurgical testing
will be favorable to, or will be as expected by, us. Furthermore, there can be no certainty that metallurgical recoveries obtained
in bench or pilot scale tests will be achieved in either subsequent testing or commercial operations. The development of a complete
metallurgical process to produce saleable final products from the Elk Creek Project is a complex and resource-intensive undertaking
that may result in overall schedule delays and increased project costs for us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
volatility could have dramatic effects on our results of operations and our ability to execute our business plan.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
price of commodities varies on a daily basis. Niobium is a specialty metal and not a commonly traded commodity such as copper,
zinc, gold, or iron ore. The price of niobium tends to be set through a limited long-term offtake market, contracted between very
few suppliers and purchasers. The world&#8217;s largest supplier of niobium, Companhia Brasileira de Metalurgia e Minera&#231;&#227;o,
supplies approximately 85% of the world&#8217;s niobium. Any attempt to suppress the price of niobium by such supplier, or an
increase in production by any supplier in excess of any increased demand, would have negative consequences on the price of niobium
and, potentially, on our value. The price of niobium may also be reduced by the discovery of new niobium deposits, which could
not only increase the overall supply of niobium (causing downward pressure on its price) but could draw new firms into the niobium
industry that would compete with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc<sub>2</sub>O<sub>3
</sub>is used in solid oxide fuel cells and has the potential to become a valuable alloy with aluminum in the aerospace and automotive
industries. Supply of scandium has been sporadic in recent years, and there are no primary scandium mines in the world at present.
Production primarily occurs as a by-product from existing metallurgical plants, primarily in Russia, Canada, the Philippines,
and China. Our management believes the Elk Creek Project would significantly increase the world&#8217;s supply of scandium trioxide.
Although the Company&#8217;s market studies indicate a positive outlook for demand, there is no assurance at present that the
Company could sell all of its production. In addition, the sale of scandium represents a significant portion of the Elk Creek
Project revenue;
achieving the revenue projected in the Company&#8217;s studies is subject to market growth in scandium, which is a developing
market with a risk of oversupply and/or undersupply disrupting pricing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titanium
metal is used in various superalloys and other applications for aerospace applications, armor, and medical implants, and in oxide
form is a key component of pigments used in paper, paint, and plastics. The Elk Creek Project would produce a small quantity of
titanium dioxide relative to other producers. As a small producer, we would be subject to fluctuations in the price of TiO<sub>2
</sub>that would result from normal variations in supply and demand for this commodity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to establish a viable recovery process for REEs<span style="font-style: normal">. </span></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for rare earth products requires particular levels of purity and chemical form, which are achieved through the extraction
and separation of individual REEs from each other as well as from the other constituents in the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">rare earth ore. At present, the
Company has substantially completed the engineering and testing of a process for producing commercial rare earth products but
has not completed all work necessary to declare a REE reserve estimate for the Elk Creek deposit. The completion of the work necessary
to demonstrate an economically feasible rare earth recovery system will require additional expenditures of cash and time to complete.
There is no guarantee that the Company will be successful in demonstrating positive economics for a rare earth recovery system
tied to the Elk Creek Project, nor is there any guarantee that once constructed, the rare earth recovery system will operate as
designed and produce saleable commercial products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
of resources and reserves are subject to evaluation uncertainties that could result in project failure.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
exploration and future mining operations, if any, are and would be faced with risks associated with being able to accurately predict
the quantity and quality of resources/reserves within the earth using statistical sampling techniques. Estimates of any resources/reserves
on any of our properties would be made using samples obtained from appropriately placed trenches, test pits, underground workings,
and intelligently designed drilling. There is an inherent variability of assays between check and duplicate samples taken adjacent
to each other and between sampling points that cannot be reasonably eliminated. Additionally, there also may be unknown geologic
details that have not been identified or correctly appreciated at the current level of accumulated knowledge about our properties.
This could result in uncertainties that cannot be reasonably eliminated from the process of estimating resources/reserves. If
these estimates were to prove to be unreliable, we could implement an exploitation plan that may not lead to commercially viable
operations in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
material changes in mineral resource/reserve estimates and grades of mineralization will affect the economic viability of placing
a property into production and a property&#8217;s return on capital.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
resource/reserve estimates may require adjustments or downward revisions. In addition, the grade of ore ultimately mined, if any,
may differ from that indicated by our feasibility studies and drill results. Minerals recovered in small scale tests may not be
duplicated in large scale tests under on-site conditions or at commercial production scale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mineral resource and mineral reserve estimates included in the S-K 1300 Elk Creek Technical Report Summary and contained in this
Annual Report on Form 10-K have been determined based on assumed future prices, cut-off grades, and operating costs that may prove
to be inaccurate. Extended declines in market prices for our products may render portions of our resource/reserve estimates uneconomic
and may result in reduced reported resources/reserves or may adversely affect any commercial viability determinations we may reach.
Any material reductions in estimates of resources/reserves could have a material adverse effect on our Common Share price and
on the value of our properties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face intense competition in the mining industry.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mining industry is intensely competitive in all of its phases. As a result of this competition, some of which is with large established
mining companies with substantial capabilities and with greater financial and technical resources than ours, we may be unable
to acquire additional properties, if any, or financing on terms we consider acceptable. We also compete with other mining companies
in the recruitment and retention of qualified managerial and technical employees. If we are unable to successfully compete for
qualified employees, our exploration and development
programs may be slowed down or suspended. We compete with other companies that produce our planned commercial products for capital.
If we are unable to raise sufficient capital, our exploration and development programs may be jeopardized or we may not be able
to acquire, develop, or operate additional mining projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Difficulties
in water balance management at our Elk Creek Project could negatively affect our potential production and economics at the project.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has conducted three field investigations and two major technical studies into the hydrogeology of the Elk Creek carbonatite,
which is the geologic formation which hosts the mineralized material that would be extracted by the Company&#8217;s mining operations.
The Company expects to encounter significant amounts of water in the carbonatite, which will need to be pumped out of the formation
to facilitate a mining operation. Water quality analyses have demonstrated that this water will have elevated temperature and
salt content when compared to other water resources in the area. While the Company has developed plans to treat water produced
from the mine for use in</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">its operations, there is no guarantee that the permits needed for the treatment of the water or the disposal
of the resultant waste products will be issued by the State of Nebraska, nor is there any guarantee that such permits will be
issued in a timely fashion. Further, based on such plans, the operations will rely on a water treatment system to achieve zero
discharge of wastewater, and there is no guarantee that this system will function as designed or achieve nameplate treatment capacity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
to our properties may be subject to other claims that could affect our property rights and claims.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are risks that title to our properties may be challenged or impugned. Our Elk Creek Project is located in Nebraska and may be
subject to prior unrecorded agreements or transfers or native land claims, and title may be affected by undetected defects. Our
current land and/or mineral rights lease agreements between ECRC and individual landowners give us an option to purchase additional
property (&#8220;OTP&#8221;), which, along with the property we already own, will allow us to construct the Elk Creek Project
once sufficient project financing is obtained. The rights of the current owners to sell the property subject to these options
may be subject to prior unrecorded or unknown claims to title. Further, our current OTP agreements, some of which are important
for our planned operations, are of fixed duration and expire between December 2024 and May 2040, and we may incur additional cost
and delays in securing renewals of such OTPs. We have investigated our rights to explore and exploit the Elk Creek Project resource/reserve
and, to the best of our knowledge, our rights in relation to lands covering the Elk Creek Project resource/reserve are in good
standing. However, there may be valid challenges to the title of our properties that, if successful, could impair development
and/or operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
properties and operations may be subject to litigation or other claims.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time our properties or operations may be subject to disputes that may result in litigation or other legal claims. We may
be required to assert or defend against these claims, which will divert resources and management time from operations. The costs
of these claims or adverse filings may have a material effect on our business and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently insure against all the risks and hazards of mineral exploration, development, and mining operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exploration,
development, mining, and surface operations involve various hazards, including environmental hazards, industrial accidents, metallurgical
and other processing problems, unusual or unexpected rock formations, structural cave-ins or slides, flooding, fires, and periodic
interruptions due to inclement or hazardous weather conditions. These risks could result in damage to or destruction of mineral
properties, facilities, or other property, personal injury, environmental damage, delays in operations, increased cost of operations,
monetary losses, and possible legal liability. We may not be able to obtain insurance to cover these risks at economically feasible
premiums or at all. We may elect not to insure where premium costs are disproportionate to our perception of the relevant risks.
The payment of such insurance premiums and of such liabilities would reduce the funds available for exploration and production
activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a021"></span>Risks
Related to Government Regulation</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to obtain or renew all required permits and licenses to place any of our properties into production.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current and future operations, including development activities and commencement of production, if warranted, on the Elk Creek
Project, require permits from governmental authorities and such operations are and will be governed by laws and regulations governing
prospecting, development, mining, production, exports, taxes, labor standards, occupational health, waste disposal, toxic substances,
land use, environmental protection, mine safety, and other matters. Companies engaged in mineral property exploration and the
development or operation of mines and related facilities generally experience increased costs, as well as delays in production
and other schedules as a result of the need to comply with applicable laws, regulations, and permits. We cannot predict if all
permits that we may require for continued exploration, development, or construction of mining facilities and conduct of mining
operations will be obtainable or renewable on reasonable terms, if at all. Costs related to applying for and obtaining permits
and licenses may be prohibitive and could delay our planned exploration and development activities. Failure to comply with applicable
laws, regulations, and permitting requirements may result in enforcement actions, including orders</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">issued by regulatory or judicial
authorities causing operations to cease or be curtailed, and may include corrective measures requiring capital expenditures, installation
of additional equipment, or remedial actions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facilities
associated with the Elk Creek Project, such as the mine, surface plant, tailings facilities, stockpiles and supporting infrastructure,
are likely to either temporarily or permanently impact waterbodies and wetlands that are subject to regulation by the USACE as
Waters of the United States (&#8220;WOUS&#8221;). We believe that we have obtained the necessary USACE permits to construct the
project, but changes to the design or layout of the facility may trigger the USACE to require us to obtain and maintain additional
permits for the Elk Creek Project. The duration of this permitting exercise is dictated by the USACE and would need to be completed
before facilities that would impact WOUS could be constructed. We may experience delays or additional costs in relation to obtaining
the necessary permits and these delays and additional costs could negatively affect the economics of the Elk Creek Project and
our results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
engaged in mining operations may be required to compensate those suffering loss or damage by reason of the mining activities and
may have civil or criminal fines or penalties imposed for violations of applicable laws or regulations. Amendments to current
laws, regulations, and permits governing operations and activities of mining companies, or more stringent implementation thereof,
could have a material adverse impact on our operations and cause increases in capital expenditures or production costs or reduction
in levels of production at producing properties or require abandonment or delays in development of new mining properties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to significant governmental regulations that affect our operations and costs of conducting our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current and future operations, including development of the Elk Creek Project, are and will be governed by laws and regulations,
including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">laws
                                         and regulations governing mineral concession acquisition, prospecting, development, mining,
                                         and production;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">laws
                                         and regulations related to exports, taxes, and fees;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">labor
                                         standards and regulations related to occupational health and mine safety; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">environmental
                                         standards and regulations related to waste disposal, toxic substances, land use reclamation,
                                         and environmental protection.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
engaged in development activities often experience increased costs and delays in production and other schedules as a result of
the need to comply with applicable laws, regulations, and permits. Failure to comply with applicable laws, regulations, and permits
may result in enforcement actions, including the forfeiture of mineral claims or other mineral tenures and/or orders issued by
regulatory or judicial authorities requiring operations to cease or be curtailed, and may include corrective measures requiring
capital expenditures, installation of additional equipment, or costly remedial actions. We may be required to compensate those
suffering loss or damage by reason of our development activities and may have civil or criminal fines or penalties imposed for
violations of such laws, regulations, and permits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existing
and possible future laws, regulations, and permits governing operations and activities of mineral development companies, or more
stringent implementation, could have a material adverse impact on our business and cause increases in capital expenditures or
require abandonment or delays in development. Our Elk Creek Project is located in Nebraska, and while the State does have a comprehensive
and modern set of environmental regulations, it does not have specific regulations with respect to permitting or reclaiming mines
which could potentially impact the total time to market for the project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
activities are subject to environmental laws and regulations that may change, thereby increasing our costs of doing business and
restricting our operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
phases of our operations are subject to environmental regulation in the jurisdictions in which we operate. Environmental legislation
is evolving in a manner that may require stricter standards and enforcement, increased fines and penalties for non-compliance,
more stringent environmental assessments of proposed projects, and a heightened degree of responsibility for companies and their
officers, directors, and employees. These laws address emissions into the air, discharges into water, management of waste, management
of hazardous substances, protection of natural</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">resources, antiquities and endangered species, and reclamation of lands disturbed
by mining operations. Compliance with environmental laws and regulations, and future changes in these laws and regulations, may
require significant capital outlays and may cause material changes or delays in our operations and future activities. It is possible
that future changes in these laws or regulations could have a significant adverse impact on our properties or some portion of
our business, causing us to re-evaluate those activities at that time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulations
and pending legislation governing issues involving climate change could result in increased operating costs, which could have
a material adverse effect on our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of governments or governmental bodies have introduced or are contemplating legislative and/or regulatory changes in response
to concerns about the potential impact of climate change. Legislation and increased regulation regarding climate change could
impose significant costs on us, on our future venture partners, if any, and on our suppliers, including costs related to increased
energy requirements, capital equipment, environmental monitoring and reporting, and other costs necessary to comply with such
regulations. Any adopted future climate change regulations could also negatively impact our ability to compete with companies
situated in areas not subject to such limitations. Given the emotion, political significance, and uncertainty surrounding the
impact of climate change and how it should be dealt with, we cannot predict how legislation and regulation will affect our financial
condition, operating performance, and ability to compete. Furthermore, even without such regulation, increased awareness and any
adverse publicity in the global marketplace about potential impacts on climate change by us or other companies in our industry
could harm our reputation. The potential physical impacts of climate change on our operations are highly uncertain and could be
particular to the geographic circumstances in areas in which we operate and may include changes in rainfall and storm patterns
and intensities, water shortages, changing sea levels, and changing temperatures. These impacts may adversely impact the cost,
production, and financial performance of our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land
reclamation requirements for our properties may be burdensome and expensive.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
variable depending on location and the governing authority, land reclamation requirements are generally imposed on mineral exploration
companies (as well as companies with mining operations) in order to minimize long-term effects of land disturbance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reclamation
may include requirements to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">control
                                         dispersion of potentially deleterious effluents;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">treat
                                         ground and surface water to achieve water quality standards; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonably
                                         re-establish pre-disturbance landforms and vegetation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to carry out reclamation obligations imposed on us in connection with our potential development activities, we must allocate
financial resources that might otherwise be spent on further exploration and development programs. We plan to set up a provision
for our reclamation obligations on our properties, as appropriate, but this provision may not be adequate. If we are required
to carry out unanticipated reclamation work, our financial position could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a022"></span>Risks
Related to Our Debt</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
level of our indebtedness from time to time could impair our ability to obtain additional financing.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may enter into transactions to acquire assets or the shares of other companies or to fund development of the
Elk Creek Project. These transactions may be financed partially or wholly with debt, which may increase our debt levels above
industry standards. Our articles of incorporation do not limit the amount of indebtedness that we may incur. Our indebtedness
could impair our ability to obtain additional financing in the future on a timely basis to take advantage of business opportunities
that may arise. Our ability to service our debt obligations will depend on our future operations, which are subject to prevailing
industry conditions and other factors, many of which are beyond our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: -0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not have the ability to service our debt, including, without limitation, to pay the installments on the April 2024 Notes.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: -0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30,
2024, we had $7.1 million outstanding under the April 2024 Notes. The payments with respect to the April 2024 Notes are due on
the monthly Payment Dates (as defined herein), if the Equity Conditions (as defined herein) are not satisfied, and at maturity.
If we are unable to satisfy the Equity Conditions, we will be required to pay all amounts due on any Payment Date in cash. Our
ability to pay the principal and interest on the April 2024 Notes, to fund working capital needs, and fund planned capital expenditures
depends on our ability to obtain additional financing and to generate cash flow in the future. To some extent, this is subject
to general economic, financial, competitive, legislative and regulatory factors, and other factors that are beyond our control.
We presently intend to use cash generated by advances under the Yorkville Equity Facility Financing Agreement and the net proceeds
from borrowings under the Smith Loan Agreement to meet our payment obligations under the April 2024 Notes, and we may not be able
to make advances under the Yorkville Equity Facility Financing Agreement or borrowings under the Smith Loan Agreement in the necessary
amounts or at the necessary times. If we are unable to generate sufficient cash through advances under the Yorkville Equity Facility
Financing Agreement or borrowings under the Smith Loan Agreement, we cannot assure you that we will maintain sufficient cash reserves,
that our business will generate cash flow from operations or that we will have access to additional funds at a level sufficient
to permit us to make payments on the April 2024 Notes. Absent a consent, forbearance or a waiver from the holders of the April
2024 Notes, our failure to make the required payments on the April 2024 Notes would trigger an 18% per annum interest rate under
the April 2024 Notes on the remaining principal amount outstanding and would permit the holders of the April 2024 Notes to accelerate
our obligations under the April 2024 Notes. Such default may also lead to a default under our agreements governing any of our current
and future indebtedness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 4, 2024, we entered into the Consents (as defined herein), which, among other things, reduced the amounts due to the
April 2024 Purchasers (as defined herein) on September 1, 2024 by an aggregate of $1,176,476 to an aggregate of $335,524, increased
the amounts due to the April 2024 Purchasers on December 1, 2024 by an aggregate of $1,176,476, and prospectively waived any term
of the April 2024 Notes that would otherwise be triggered upon a failure of the Company to pay to the April 2024 Purchasers the
remainder of the amount due on September 1, 2024. Except as modified by the Consents, the terms of the April 2024 Notes as previously
disclosed are unchanged.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to obtain additional financing and to generate sufficient cash flow from our operations in the future to service
our indebtedness and meet our other needs, we may have to refinance all or a portion of the indebtedness, seek forbearance or
a waiver, obtain additional financing, reduce expenditures, or sell assets that we deem necessary to our business. We cannot assure
you that any of these measures would be possible or that additional financing could be obtained on favorable terms, if at all.
The inability to service our indebtedness, or to refinance, obtain a forbearance or waiver, obtain additional financing, reduce
expenditures, sell assets or obtain additional financing on commercially reasonable terms would have a material adverse effect
on our financial condition and our ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>In
the event of certain breaches under our agreements with our secured creditors, our assets may be affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b>We
have, in connection with the Smith Loan Agreement, granted security interests to Mark Smith (the &#8220;Secured Creditor&#8221;)
over all of the assets of the Company in consideration of the debt facilities provided by the Secured
Creditor. In the event of certain breaches of the terms of the Smith Loan Agreement, the Secured Creditor may be entitled to execute
on its security interest and seize or retain our assets, including the shares of 0896800. Certain rights of the Secured Creditor
to execute on its security interests are subject to notice and cure provisions in respect of default by us; however, any such
exercise could materially damage our value and our ability to retain or progress development of the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a023"></span>Risks
Related to the Common Shares</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>NioCorp
may be a &#8220;passive foreign investment company&#8221; for the current taxable year and for one or more future taxable years,
which may result in materially adverse U.S. federal income tax consequences for U.S. investors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
NioCorp is a passive foreign investment company (&#8220;PFIC&#8221;) for any taxable year, or portion thereof, that is included
in the holding period of a U.S. holder of Common Shares or other securities of NioCorp, such U.S. holder may be subject to certain
adverse U.S. federal income tax consequences. These adverse tax consequences include</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">requirements to treat any gain realized upon
a disposition of Common Shares or other securities, or any &#8220;excess distribution&#8221; received on Common Shares, as ordinary
income, to pay an interest charge on a portion of such gain or distribution, and certain additional reporting requirements. Such
consequences may be mitigated with respect to Common Shares (but not with respect to warrants or other securities of NioCorp)
if the holder thereof makes a timely and effective &#8220;qualified electing fund&#8221; or &#8220;QEF&#8221; election or a &#8220;mark-to-market&#8221;
election. A U.S. holder of Common Shares that makes a QEF election generally must include in income on a current basis for U.S.
federal income tax purposes its share of NioCorp&#8217;s net capital gain and ordinary earnings for any taxable year in which
it is a PFIC, whether or not NioCorp distributes any amount to its shareholders. A U.S. holder of Common Shares that makes a mark-to-market
election generally must include as ordinary income each year the excess of the fair market value of the Common Shares over the
taxpayer&#8217;s basis therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
generally will be classified as a PFIC for a taxable year if (a) 75% or more of its gross income for such year is &#8220;passive
income&#8221; (generally, dividends, interest, rents, royalties, and gains from the disposition of assets producing passive income)
or (b) at least 50% or more of the value of its assets produce, or are held for the production of, passive income, based on the
quarterly average of the fair market value of such assets. NioCorp believes that it was classified as a PFIC for its taxable years
ended June 30, 2024 and 2023 and, based on the current composition of its income and assets, as well as current business plans
and financial expectations, may be classified as a PFIC for future taxable years. Any conclusion regarding PFIC status is a factual
determination that must be made annually at the close of each taxable year and, thus, is subject to change. In addition, even
if NioCorp concluded it did not qualify as a PFIC, it is possible that the U.S. Internal Revenue Service (the &#8220;IRS&#8221;)
could assert, and that a court could sustain, a determination that NioCorp is a PFIC. Accordingly, there can be no assurance that
NioCorp will not be treated as a PFIC for any taxable year. The PFIC rules are complex and each holder of Common Shares or other
securities of NioCorp should consult its own tax advisors regarding these rules and the U.S. federal income tax consequences of
the acquisition, ownership, and disposition of such securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
2023 Transactions could result in NioCorp becoming subject to materially adverse U.S. federal income tax consequences.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7874 and related sections of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), provide for certain
adverse tax consequences when the stock of a U.S. corporation is acquired by a non-U.S. corporation in certain transactions in
which former shareholders of the U.S. corporation come to own 60% or more of the stock of the non-U.S. corporation (by vote or
value, and applying certain specific counting and ownership rules). These adverse tax consequences include (i) potential additional
required gain recognition by the U.S. corporation, (ii) treatment of certain payments to the non-U.S. corporation that reduce
gross income as &#8220;base erosion payments,&#8221; (iii) an excise tax on certain options and stock-based compensation of the
U.S. corporation, (iv) disallowance of &#8220;qualified dividend&#8221; treatment for distributions by the non-U.S. corporation,
and (v) if former shareholders of the U.S. corporation come to own 80% or more of the stock of the non-U.S. corporation, treatment
of the non-U.S. corporation as a U.S. corporation subject to U.S. federal income tax on its worldwide income (in addition to any
tax imposed by non-U.S. jurisdictions). If the 2023 Transactions result in the application of any of these, or any other, adverse
tax consequences, NioCorp could incur significant additional tax costs. While NioCorp currently does not believe the 2023 Transactions
will cause such adverse tax consequences as a result of Section 7874 and related sections of the Code, this determination is subject
to significant legal and factual uncertainty. NioCorp
has not sought and will not seek any rulings from the IRS as to the tax treatment of any of the 2023 Transactions. Further, there
can be no assurance that your tax advisor, the IRS, or a court, will agree with the position that NioCorp is not subject to these
adverse tax consequences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Share price may be volatile and as a result you could lose all or part of your investment.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to volatility associated with equity securities in general, the value of your investment could decline due to the impact
of any of the following factors upon the market price of the Common Shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disappointing
                                         results from our exploration and/or, if warranted, project development efforts;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">decline
                                         in demand for Common Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">downward
                                         revisions in securities analysts&#8217; estimates or changes in general market conditions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">technological
                                         innovations by competitors or in competing technologies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investor
                                         perception of our industry or our prospects; and</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                         economic trends.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the past fiscal year, the trading price of our stock on the Nasdaq has ranged from a low of $1.65 to a high of $5.36.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, stock markets in general have experienced extreme price and volume fluctuations, and the market prices of securities
have been highly volatile. These fluctuations are often unrelated to operating performance and may adversely affect the market
price of the Common Shares. As a result, you may be unable to sell any Common Shares you acquire at a desired price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never paid dividends on the Common Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid dividends on the Common Shares to date, and we may not be in a position to pay dividends for the foreseeable future.
Our ability to pay dividends with respect to the Common Shares will depend on our ability to successfully develop one or more
properties and generate earnings from operations. Further, our initial earnings, if any, will likely be retained to finance our
operations. Any future dividends on Common Shares will depend upon our earnings, our then-existing financial requirements, and
other factors, and will be at the discretion of our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Future
sales, or the perception of future sales, of Common Shares by existing shareholders or by us, or future dilutive issuances of
Common Shares by us, could adversely affect prevailing market prices for the Common Shares and cause investors to suffer dilution
in their net book value per Common Share.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of a substantial number of Common Shares in the public market could occur at any time, including issuances and sales of additional
Common Shares by us and sales by other security holders. These sales, or the market perception that the holders of a large number
of Common Shares or securities convertible, exercisable, or exchangeable into Common Shares intend to sell Common Shares, could
reduce the prevailing market price of the Common Shares. The effect, if any, that future public sales of these securities or the
availability of these securities for sale will have on the market price of the Common Shares is uncertain. If the market price
of the Common Shares were to drop as a result, this might impede our ability to raise additional capital and might cause remaining
shareholders to lose all or part of their investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Articles of NioCorp,
as amended in connection with the 2023 Transactions, permit us to issue an unlimited number of Common Shares. Subject to the requirements
of the British Columbia Business Corporations Act and Nasdaq, we will not be required to obtain the approval of the NioCorp shareholders
for the issuance of additional Common Shares. We have issued Common Shares in the past and will continue to issue Common Shares
to finance our activities in the future. In addition, outstanding options and warrants to purchase Common Shares and securities
convertible into or exchangeable for Common Shares may be exercised, converted, or exchanged resulting in the issuance of additional
Common Shares. If we issue additional Common Shares or decide to enter into joint ventures with other parties in order to raise
financing through the sale of equity securities, investors&#8217; interests in the Company will be diluted and investors may suffer
dilution in their net book value per Common Share depending on the price at which such securities are sold.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
pursuant to the Yorkville Equity Facility Financing Agreement, Yorkville has committed to purchase up to an additional $58.7 million
of our Common Shares, at our direction from time to time during the remaining 18 months of the commitment period, subject to certain
limitations and the satisfaction of the conditions in the Yorkville Equity Facility Financing Agreement. We have filed a registration
statement under the Securities Act covering resales by Yorkville of the Common Shares issuable pursuant to the Yorkville Equity
Facility Financing Agreement. Accordingly, any Common Shares that we issue pursuant to the Yorkville Equity Facility Financing
Agreement will be available for sale into the public market, subject to applicable securities laws, which could reduce the prevailing
market price for the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the continued listing criteria of the Nasdaq and our failure to satisfy these criteria may result in delisting
of the Common Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Shares are currently listed on the Nasdaq Global Market under the symbol &#8220;NB&#8221;. The public NioCorp Assumed Warrants
are currently listed on Nasdaq under the symbol &#8220;NIOBW.&#8221; The Nasdaq Capital Market</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">has rules for continued listing.
In order to maintain the listings, we must maintain certain financial and share distribution targets, including maintaining a
minimum number of public shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Nasdaq delists the Common Shares, investors may face material adverse consequences, including, but not limited to, a lack of a
trading market for the Common Shares, reduced liquidity, a determination that our Common Shares are a &#8220;penny stock,&#8221;
decreased analyst coverage of the Company, and an inability for us to obtain additional financing to fund our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our Common Shares are considered a penny stock and are subject to the penny stock rules, broker-dealers may be discouraged from
effecting transactions in Common Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Shares have in the past, and may in the future, be considered a &#8220;penny stock.&#8221; The SEC has adopted Rule 15g-9
which generally defines &#8220;penny stock&#8221; to be any equity security that has a market price (as defined) less than $5.00
per share or an exercise price of less than $5.00 per share, subject to certain exceptions. Applicable penny stock rules impose
additional sales practice requirements on broker-dealers who sell to persons other than established customers and &#8220;accredited
investors.&#8221; The term &#8220;accredited investor&#8221; refers generally to institutions with assets in excess of $5.0 million
or individuals with a net worth in excess of $1.0 million or annual income exceeding $200,000 or $300,000, jointly with their
spouse. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules,
to deliver a standardized risk disclosure document in a form prepared by the SEC, which provides information about penny stocks
and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid
and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and monthly
account statements showing the market value of each penny stock held in the customer&#8217;s account. The bid and offer quotations,
and the broker-dealer and salesperson compensation information, must be given to the customer orally or in writing prior to effecting
the transaction and must be given to the customer in writing before or with the customer&#8217;s confirmation. In addition, the
penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from these rules, the broker-dealer
must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser&#8217;s
written agreement to the transaction. If and when applicable, these disclosure requirements may have the effect of reducing the
level of trading activity in the secondary market for the Common Shares. Consequently, these penny stock rules may affect the
ability of broker-dealers to trade in the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.0035in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.7465in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a024"></span>ITEM
                                         1B.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>UNRESOLVED
                                         STAFF COMMENTS</b></span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.0035in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.7465in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a025"></span>ITEM
                                         1C.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>CYBERSECURITY</b></span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Cybersecurity risk
management is integrated into the Company&#8217;s enterprise-wide risk management. Our Board has overall oversight responsibility
for our risk management and management is responsible for identifying, considering, and assessing material risks to the Company.
Our Chief Financial Officer is responsible for assessing and managing cybersecurity risks; however, as a smaller reporting company,
we currently do not have a dedicated cybersecurity team. &#160;Our Chief Financial Officer reports to the Board regarding financial and operating risks, including
cybersecurity risks. Our Chief Financial Officer has experience in managing public companies and assessing financial and operating
risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cybersecurity risk management is designed to provide a framework for assessing, identifying, and managing material risks from
cybersecurity threats and to respond to cybersecurity incidents, including material risks associated with the use of services
provided by third-party service providers. We rely on the cybersecurity protections of many of our third-party service providers.
Our primary third-party service providers utilize two-factor authentication as well as login and password protections with email
verifications.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in">For the year ended June 30, 2024, the Company had no material cybersecurity incidents or cybersecurity
threats that have materially affected or were reasonably likely to materially affect our business strategy, results of operations
or financial condition.&#160;Despite our efforts, we cannot eliminate all risks from cybersecurity threats or provide assurances
that we have not experienced an undetected cybersecurity incident.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.0035in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.7465in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;2.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b><span id="a026"></span>PROPERTIES</b></span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Elk
Creek Project, Nebraska </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal mineral property is the Elk Creek Property, a niobium, scandium and titanium development stage property. The Elk Creek
Project has established indicated and inferred resources along with probable reserves and the Company has completed a feasibility
study for the project. The below information is in part summarized or extracted from our S-K 1300 Elk Creek Technical Report Summary,
which was filed as Exhibit 96.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2022, and
is incorporated by reference into this Annual Report on Form 10-K. The Company does not have any other material properties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
qualified persons responsible for preparing the S-K 1300 Elk Creek Technical Report Summary are Dahrouge Geological Consulting
USA Ltd.; Understood Mineral Resources Ltd.; Optimize Group; Tetra Tech; Adrian Brown Consultants Inc.; Metallurgy Concept Solutions;
Magemi Mining Inc.; L3 Process Development; A2GC; Scott Honan, M.Sc, SME-RM, NioCorp; Everett Bird, P.E., Cementation; Matt Hales,
P.E., Cementation; Mahmood Khwaja, P.E., CDM Smith; Martin Lepage, P.Eng, Ing., Cementation; and Wynand Marx, M.Eng, BBE Consulting.
A matrix of the sections for which each qualified person is responsible is included in the S-K 1300 Elk Creek Technical Report
Summary. Except for Scott Honan, none of the qualified persons is affiliated with the Company. Mr. Honan is the Chief Operating
Officer of the Company. The disclosure of scientific or technical information in this Annual Report on Form 10-K was reviewed
and approved by Mr. Honan who is a qualified person as defined in NI 43-101, and Mr. Honan has verified the data disclosed herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
Description and Location</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Property is a carbonatite deposit located in Johnson County, southeast Nebraska, USA. The carbonatite contains elements
of economic significance, including niobium, titanium, and scandium, as well as potential economic significance for rare earth
products. The Elk Creek Property is situated as shown below and is located within the USGS Tecumseh Quadrangle Nebraska SE (7.5
minute series) mapsheet in Sections 1-6, 9-11; Township 3N; Range 11E and Sections 19-23, 25-36; Township 4N, Range 11E, at approximately
40&#176;16&#8217; north and 96&#176;11&#8217; west in the State of Nebraska, in central USA. The Elk Creek Property is approximately
45 miles southeast of Lincoln, Nebraska, the state capital of Nebraska.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><img src="n257410kimg002.jpg" alt="" style="height: 386px; width: 500px"/><br/></span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
and Ownership</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land
in the project area is exclusively owned by private entities, and there is no federal or state land in the project area. The Company
has secured its rights to the project area by purchasing land from private landowners or by entering into agreements with the
landowners as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently owns one approximately 225-acre parcel of land and associated mineral rights, and an additional 40 acres of
mineral rights, within the carbonatite footprint. The Elk Creek Project&#8217;s mine infrastructure and a portion of the supporting
operations is planned to be located on this land parcel. Ownership of the mineral rights discussed above includes a 2% NSR royalty
and grants us access to more than 90% of the Elk Creek Project&#8217;s mineral resources and mineral reserves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, the total book value of the Elk Creek Property and associated buildings and equipment was $16.9 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also holds eight OTPs that are associated with the Elk Creek Project and one perpetual easement on a land parcel adjacent
to the Missouri River. The current optioned land package covers an area of 1,396 acres and is reflective of the land needed to
secure the remaining mineral resources and mineral reserves held under the OTPs along with the land needed for the development
and operations of the Elk Creek Project for its proposed 38-year operating life.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, exercise of an OTP is accomplished by paying the greater of a fixed amount per acre or a multiple of the appraised value
at the time of purchase. If the land is not purchased by the Company during the term of the OTP and the land in question is needed
for the project, the Company intends to negotiate a new OTP with the landowner. The OTP is accompanied by a negotiated payment
to the landowner that is paid upon execution of the OTP by the Company and the landowner. As of June 30, 2024, the Company is
obligated to make payments totalling approximately $45,000 over the next 11 years to maintain our rights under these OTPs. Details
on the current OTPs held by the Company are shown in the table below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Active
Lease Agreements (OTPs) Covering the Elk Creek Project as of September 2024</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Agreement
    Identifier</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Hectares</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Acres</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Agreement
    Expiry</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beethe007</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66.27</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">163.75</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20-Jan-26</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Heidemann005</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79.55</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">196.57</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16-Mar-25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nielsen001</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.90</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">249.32</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Jun-25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nielsen002</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.91</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.43</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Jun-25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woltemath80S</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.37</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.00</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4-Dec-24</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woltemath002</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152.49</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">376.81</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4-Dec-24</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woltemath003J</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89.03</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220.00</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Mar-25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shuey001</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.37</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.00</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27-May-40</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
OTPs are between NioCorp&#8217;s subsidiary ECRC and the individual landowners. Land subject to the OTP agreements is currently
used for agricultural purposes, including growing row crops (corn and soybeans) and pasturing livestock. The land owned by ECRC
houses the Company&#8217;s drill core inventory and geological sample repository in two steel core shed buildings and the Company
maintains a cover crop (sorghum and rye) on portions of the property that were formerly used for growing row crops. The former
landowner maintains a residence and several outbuildings on the property subject to a life estate that accompanied the purchase
of the property by the Company in fiscal year 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agreements that involve mineral rights include a 2% NSR royalty attached with the OTP. The OTPs grant the Company an exclusive
right to explore and evaluate the property for the term thereof, with an option to purchase the surface rights or a combination
of the mineral and surface rights at any time during the term. As the Woltemath80S agreement is limited to an option to purchase
the surface rights only, it does not contain an NSR provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land
Tenure Map as of September 2024</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><img src="n257410kimg003.jpg" alt="" style="height: 379px; width: 600px"/><span style="font-size: 10pt">&#160;</span></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current estimated mineral resource and reserve is wholly contained within land owned by the Company and parcel Woltemath003J.
The Company considers these two properties to be the only properties on which the Company&#8217;s development of the Elk Creek
Project is substantially dependent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the OTPs, where required, the Company has also secured surface rights, which allow for access to the land for drilling
activities and associated mineral exploration and project development work.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accessibility,
Physiography, Climate and Infrastructure</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Property is easily accessible year-round as it is situated approximately 45 miles southeast of Lincoln, Nebraska, the
state capital, and approximately 68 miles south of Omaha, Nebraska. Access to the site can be completed via road or from one of
the regional airports. There are several regular flights to both Lincoln and Omaha; however, the Elk Creek Property is most easily
accessible from Lincoln. From Lincoln Municipal Airport, the Elk Creek Property is accessed via paved roads on the main network
and a secondary network of gravel roads. The drive from the Lincoln Municipal Airport to the property is typically 1 hour and
15 minutes, and from Omaha&#8217;s Eppley Airport, the drive is approximately 1 hour and 45 minutes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Property is immediately adjacent to paved Nebraska state highway 50, and the mineral resource and mineral reserve are
centered in Township 4N, Range 11E, Section 33. This section is immediately southwest of the junction of Nebraska state highways
50 and 62. Rail access is available in the town of Elk Creek, which is located 3 miles east of the project area. Water is available
at the project site from a well, as well as from Elk Creek, which crosses Section 33. Water is also available from the Johnson
County Rural Water system, which has distribution infrastructure on the north side of the Section 33 and from the Pawnee County
Rural Water system, which has distribution infrastructure on the south side of Section 33. Electricity is provided at the Company&#8217;s
Core Storage sheds located on the west side of Section 33 on land owned by the Company from the Omaha Public Power District (&#8220;OPPD&#8221;).
Personnel are available from the local surrounding towns, including Elk Creek (3 miles east), Tecumseh (6 miles north), Steinauer
(5 miles south), Pawnee City (10 miles south) and Syracuse (27 miles north). Due to the project&#8217;s location in Nebraska,
there are no ports nearby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Southeast
Nebraska is situated in a humid continental climate (Dfa) on the K&#246;ppen climate classification system. In eastern Nebraska,
this climate is generally characterized by hot humid summers and cold winters. Average winter temperatures vary between 13&#176;F
to 35&#176;F. Average summer temperatures vary between 64&#176;F to 90&#176;F. Exploration, construction and operational activities
may be conducted all year round.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
monthly precipitation (rain and snowfall) varies between 0.9 and 5.0 inches. Average yearly precipitation is between 31 and 33
inches with an average yearly snowfall of approximately 28 inches. Nebraska is located within an area known for tornadoes which
runs through the central U.S. where thunderstorms are common in the spring and summer months. Tornadoes primarily occur during
the spring and summer and may occur into the autumn months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are several local communities near the Elk Creek Property, including Elk Creek and Tecumseh, that will provide local housing for
the Elk Creek Project. There are a number of other communities within driving distance and the large cities of Lincoln and Omaha
are within reasonable driving distance. Mining activities currently taking place in the area are limited to limestone and aggregate
operations to support the local cement manufacturing and construction industries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Project is expected to incorporate surface and underground infrastructure, as well as tailings storage facilities. The
offsite infrastructure is expected to include a new high voltage transmission line constructed by the local utility company and
providing power to an on-site primary sub-station and a natural gas pipeline built by the owner of the interstate pipeline. Water
used for all on-site process needs and activities will be supplied from mine dewatering activities, local groundwater wells and
from a local water utility. See &#8220;<i>2022 Elk Creek Feasibility Study</i>&#8221; below for additional information regarding
proposed infrastructure related to the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
local topography of eastern Nebraska is relatively low-relief with shallow rolling hills intersected by shallow river valleys.
Elevation varies from about 1,066 to 1,280 ft above sea level. Bedrock outcrop exposure is nonexistent in the Elk Creek Project
area.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
majority of the area around the Elk Creek Project is used for cultivation of corn and soybeans, along with uses as grazing land.
Native vegetation typical of eastern Nebraska is upland tall-grass, prairie and upland deciduous forests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Geology
and Mineralization</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Geology</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Property includes a carbonatite that has intruded older Precambrian granitic and low- to medium-grade metamorphic basement
rocks. The carbonatite is an elliptical magmatic body with a northwest-trending long axis perpendicular to the strike of the Midcontinent
Rift System, near the northern part of the Nemaha uplift. The carbonatite consists predominantly of dolomite, calcite and ankerite,
with lesser chlorite, barite, phlogopite, pyrochlore, serpentine, fluorite, sulfides, bastnasite, monazite, and quartz. It is,
however, believed from stratigraphic reconstruction based on drill core observation in the area that the carbonatite is unconformably
overlain by approximately 200 m of essentially flat-lying Palaeozoic marine sedimentary rocks, including carbonates, sandstones
and shales of Pennsylvanian age.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Mineralization</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
property hosts niobium, titanium, and scandium mineralization as well as REE mineralization that occurs within the Elk Creek carbonatite.
The current known extents of the carbonatite unit are approximately 950 m along strike, 300 m wide, and 750 m in dip extent, below
the unconformity. Niobium, titanium, scandium, and rare earths are considered the main elements of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
deposit contains significant concentrations of niobium. Based on the metallurgical testwork completed to date at a number of laboratories
using QEMSCAN&#174; analysis, the niobium mineralization is known to be fine grained, and that 77% of the niobium occurs in the
mineral pyrochlore, while the balance occurs in an iron-titanium-niobium oxide mineral of varying composition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
the Elk Creek carbonatite, a host of other elements exist with varying degrees of concentration. The Company has completed both
whole rock analysis and multi-element analysis on all samples for the 2014 drilling program, described below, plus resampling
of selected historical core/pulps between 2011 and 2014.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Historical
Exploration</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drilling
at the Elk Creek Property was conducted in three phases. The first was during the 1970&#8217;s and 1980&#8217;s by the Molybdenum
Company of America (&#8220;Molycorp&#8221;), the second in 2011 by Quantum Rare Earth Developments Corp (&#8220;Quantum&#8221;
- NioCorp under its former name), and the third and latest program from 2014 to 2016 by NioCorp. To date, 129 diamond core holes
have been completed for a total of 64,981 m over the entire geological complex. Of these, a total of 48 holes (33,909 m) have
been completed to date in the mineralized area and are used in the current mineral resource and reserve estimates. Five additional
holes, with a total length of 3,353.1 m, were drilled for hydrogeologic and geotechnical purposes in 2015. No sampling has been
completed of these five holes to date and therefore they have not been considered for the mineral resource or reserve estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
drilling has been completed using a combination of Tricone, Reverse Circulation (&#8220;RC&#8221;) or Diamond Drilling (&#8220;DDH&#8221;)
in the upper portion of the hole within the Pennsylvanian sediments. All drilling within the underlying carbonatite has been completed
using DDH methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of Drilling Database within Elk Creek Deposit Area</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Holes</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
    Depth (m)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sum
    Length (m)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1970-1980</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">596.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,108.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2011</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quantum</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">772.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,317.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2014-2015</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">845.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,482.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">700.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,908.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Molycorp,
1973-1986</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
1973 and 1974, Molycorp completed six drillholes: EC-1 to EC-4, targeting the Elk Creek anomaly, and two other holes outside the
Elk Creek anomaly area. Drillholes were typically carried out by RC drilling through the overlying sedimentary rocks and diamond
drilling through the Ordovician-Cambrian basement rocks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
continued their drill program from 1977 and, in May 1978, Molycorp made its discovery of the current mineral resource with drillhole
EC-11. EC-11 is located on Section 33, Township 4N, and Range 11. The carbonatite hosting the Elk Creek Project was intersected
at a vertical depth of 203.61 m (668 ft).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
continued its drilling program through to 1984, which mainly centered on the Elk Creek Project within a radius of roughly 2 km.
By 1984, Molycorp had completed 57 drillholes within the Elk Creek gravity anomaly area, which included 25 drillholes over the
Elk Creek Project area.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
1984 to 1986, drilling was focused on the Elk Creek gravity anomaly area. The anomaly area is roughly 7 km in diameter and drilling
was conducted on a grid pattern of approximately 610 m by 610 m (roughly 2,000 ft by 2,000 ft) with some closer spaced drillholes
in selected areas.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
1986, a total of 106 regional drillholes were completed for a total of approximately 46,797 m (153,532 ft). The deepest hole reached
a depth of 1,038 m (3,406 ft) and bottomed in carbonatite.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Quantum,
2010-2011</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2011, Quantum conducted a preliminary drill program (three holes) on the Elk Creek deposit and two REE exploration targets
(two holes), which have been excluded from the current mineral resource and reserve estimation, as they do not intersect the Nb<sub>2</sub>O<sub>5</sub>&#160;anomaly
and are located to the east. The objectives of the drill program over the Elk Creek Property were to verify the presence of higher-grade
niobium mineralization at depth, and to infill drill the known niobium deposit in order to upgrade the resource category of the
previous resource estimate and expand the known resource. The drill program was also established to collect sufficient sample
material for metallurgical characterization and process development studies of the niobium mineralization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2011 program consisted of five inclined drillholes, totaling 3,420 m of NQ size diameter core. Inclusive of this total, three
drillholes, totaling 2,318 m, were drilled into the known Elk Creek deposit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">NioCorp,
2014 to Present</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
commenced drilling on the Elk Creek Property using a three-phased program. The three-phased program was originally based on 14
drillholes for approximately 12,150 m (announced in a press release on April 29, 2014), but was subsequently expanded during the
program to 18 drillholes for approximately 15,482 m. Three of the 18 drillholes were drilled for the purpose of metallurgical
characterization and process development studies. Two of these drillholes, NEC14-MET-01 and NEC14-MET-02, were not assayed, while
NEC14-MET-03 was quarter cored with one quarter being assayed and the remainder used for metallurgical testwork. The drilling
has been orientated to intersect the geological model from the southwest and northeast (perpendicular to the strike), with the
exception of NEC14-011 and NEC14-012, which were oriented southeast and northwest, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2022, NioCorp collected a total of 1,095 samples originating from 18 diamond drill holes completed by MolyCorp, as
discussed above. These samples were collected, and subsequently assayed, in order to fill in gaps in our records regarding REE
grades and tonnage that may exist in the deposit. Assaying was conducted at Actlabs in Ancaster, Ontario. The assay results were
subjected to a Quality Assurance and Quality Control (&#8220;QA/QC&#8221;) program consistent with industry best practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
list of the drillholes, sample storage location, and number of assay results, related to the records gaps noted above, are presented
below and are represented as blue segments on the drillhole figure below. Each sample represented a 5-foot section of drill core.
All of the holes noted below were drilled into the Elk Creek carbonatite in the vicinity of the mineral resource for the Elk Creek
Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-2021
Hole Sampling Summary</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resource
    Area <br/>
Drillholes</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Source
                                         / Storage Facility</b>&#160;</span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Samples
    selected for <br/>
REE and Sc Assays</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-011</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-014</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-015</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-016</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-018</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-019</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-020</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-021</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-022</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-026</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-027</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-029</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-030</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-031</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-032</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-034</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-037</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-054</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,095</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resource
Area Assay Distribution Showing REE Assays (Red) and REE Assay Gaps (Blue).</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><img src="n257410kimg004.jpg" alt="" style="height: 363px; width: 350px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Internal
Controls</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
integrated a series of routine QA/QC procedures throughout the sampling and analysis portion of the drilling programs to ensure
the highest level of quality was maintained throughout the process leading to the estimate of mineral reserves and mineral resources
for the Elk Creek Project. This included the insertion of duplicate
samples taken from various stages of the process, insertion of known control samples (standard reference materials, certified
reference materials (&#8220;CRM&#8221;), and blanks) and sending third-party pulps to a secondary lab (SGS Canada Inc.).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sample
tickets were assigned initially at the core shed using barcodes with duplicate tickets placed inside and on the outside of the
bag. Sample identification was confirmed using barcode labelling and visual sample type comparisons before sample shipment. The
use of barcoded samples ensured both shipment forms and analytical labs used accurate information. Multiple types of QC samples
were inserted at this stage of the process, which includes the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Field
                                         quartz blanks (1 in 20, or 5%) were inserted within or immediately after samples collected
                                         from mineralized intervals, targeting zones of elevated visual mineralization, where
                                         possible.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CRMs
                                         (1 in 20, or 5%) were inserted in the field with the sample sequence.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Field
                                         quarter-core duplicates (1 in 20, or 5%) were inserted to test mineralization and sampling
                                         variability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
details on the QA/QC program can be found in Section 8 of the S-K 1300 Elk Creek Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
deposits, including the Elk Creek deposit, are inherently uncertain because of variability at all scales and sparse sampling.
In addition to uncertainty associated with estimation, there are specific risks and sources of uncertainty associated with the
Elk Creek deposit. See Item 1A., Risk Factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-K
1300 and other similarly purposed International Codes (JORC, 2012; NI 43-101, 2014) are designed to require disclosure to the
public of risks relating to mineral resource and reserve estimation as identified and evaluated by a qualified person. The qualified
persons responsible for the S-K 1300 Elk Creek Technical Report Summary address the technical risks in various sections and consider
that no material technical risks are identified. Additional</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">descriptions of the risks and uncertainty associated with reported
mineral reserves and resources can be found in Section 11 of the S-K 1300 Elk Creek Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022
Elk Creek Feasibility Study</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2022, the Company launched geological, metallurgical, engineering, and other analyses to assess the feasibility of
adding REE production to its plans once sufficient work has been completed. The Company and its consultants were required to complete
additional assays of historical drill core to fill data gaps in the existing resource database to establish an REE mineral resource.
The mine plan was also updated and the S-K 1300 Elk Creek Technical Report Summary was filed with the SEC as an exhibit to the
Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2022. The S-K 1300 Elk Creek Technical Report Summary
was based on the economic and process results of the feasibility study conducted by the qualified persons, which were also presented
in the 2022 NI 43-101 Elk Creek Technical Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Project is planned as an underground mining operation using a long-hole stoping mining method and paste backfill, operating
with a processing rate of 2,764 tonnes per day. Expected total production over the 38-year mine life includes 171,140 tonnes of
payable niobium, 3,676 tonnes of Sc<sub>2</sub>O<sub>3</sub>, and 431,793 tonnes of TiO<sub>2</sub>. Estimated up-front direct
capital costs are $760 million, in addition to indirect costs of $187 million, pre-production capital costs of $92 million, an
overall contingency of $102 million, and pre-production net revenue credit of $257 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Financial
Analysis Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
metrics reported in the S-K 1300 Elk Creek Technical Report Summary are based on the cash flow model results. The metrics are
on both a pre-tax and after-tax basis, on a 100% equity basis with no Elk Creek Project financing inputs and are in first quarter
2019 U.S. constant dollars. Foreign exchange impacts were deemed negligible as most, if not all, costs and revenues are denominated
in U.S. dollars. Key criteria used in the analysis are discussed in detail throughout this section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Principal
Project Assumptions Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 30%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 30%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Production
    Period</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4
    years</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process
    Plant Life</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38
    years</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mine
    Operating Days per Year</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">365</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mill
    Operating Days per Year</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">365</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount
    Rate, End of Period</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">@
    8%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial
    Production Year</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025
    </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Summary
of Key Evaluation Metrics Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 40%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ore
    Mined (kt)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,655</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ore
    Mining Rate (t/d)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,764</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
    Grade</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.81%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scandium
    Grade (parts per million, &#8220;ppm&#8221;)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.2</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>Grade</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.92%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contained
    Nb<sub>2</sub>O<sub>5</sub> (kt)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contained
    Sc (t)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,573</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contained
    TiO<sub>2</sub> (kt)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,071</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Ore Processed (kt)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,655</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
    Rate (kt/y)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,009</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    Recovery, Nb<sub>2</sub>O<sub>5</sub></span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82.4%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    Recovery Sc</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.1%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    Recovery TiO<sub>2</sub></span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.3%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recovered
    Nb<sub>2</sub>O<sub>5</sub> (kt)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recovered
    Sc (t)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,395</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recovered
    TiO<sub>2</sub> (kt)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">432</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized
    Market Prices</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nb
    ($/kg)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$46.55</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>($/kg)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.99</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc<sub>2</sub>O<sub>3
    </sub>($/kg)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,674</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payable
    Metal</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nb
    (t)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,140</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc<sub>2</sub>O<sub>3
    </sub>(t)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,676</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>(t)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,793</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Summary
Projected Economic Results Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 40%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif"><br/>
    <span style="font-size: 10pt"><b>Description </b></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
    ($000)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Gross Revenue </span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$21,899,726</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Costs:</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,553,325)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process
    Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,911,116)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    G&amp;A Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(300,400)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentrate
    Freight Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,472)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Infrastructure Costs</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(200,407)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Water
    Management Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(609,195)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tailings
    Management Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(73,822)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    Tax</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(217,540)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(300,503)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    Bond Premium</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,500)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Operating Costs</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,182,280)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Margin (EBITDA<sup>(1)</sup>)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,717,445</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    Tax Rate</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.42%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Taxes</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,246,186)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working
    Capital</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Cash Flow</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$12,471,258</span></td></tr>
</table>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto 0pt 3in; width: 60%">                                                                                                                                                        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Totals
may not sum due to rounding.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         term &#8220;EBITDA&#8221; refers to earnings before interest, taxes depreciation and
                                         amortization. See &#8220;Non-GAAP Financial Performance Measures&#8221; below for a discussion
                                         of the use of non-GAAP financial measures.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Capital
Cost Estimates Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.2pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the breakout in LoM initial capital and sustaining capital cost estimates (excluding closure and reclamation
of $44 million), which total $1,562 million. This includes a total initial capital cost of $1,141 million, including a 10% contingency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.2pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 45%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($000,000)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sustaining</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
    Preproduction Expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$&#160;&#160;&#160;77</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$&#160;&#160;&#160;-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$&#160;&#160;&#160;&#160;77</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    Preparation and Infrastructure</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
    Plant</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">367</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">464</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Water
    Management and Treatment</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Infrastructure</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">257</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">198</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">455</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tailings
    Management</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    Wide Indirects</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
    Indirects</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Indirects</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commissioning</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owner&#8217;s
    Costs</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mine
    Water Management Indirects</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingency</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Capital Costs</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,141</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$422</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,562</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.75in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 45%; margin-right: auto">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 100%; padding-left: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">Totals
may not sum due to rounding.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.75in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Operating
Cost Estimates Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following LoM unit operating costs include the pre-production and first/last years of production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 40%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LoM
    $/t ore </b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Cost</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$42.38</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process
    Cost</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106.70</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Water
    Management Cost</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.62</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    G&amp;A Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.20</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Infrastructure</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tailings
    Management Cost</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Expenses</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.22</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subtotal
    </span></td>
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187.59
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties/Annual
    Bond Premium</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.35</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    LoM Operating Costs</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$195.94</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 85.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 100%"><span style="font: 10pt Times New Roman, Times, Serif">Totals
may not sum due to rounding.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 85.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 85.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Planned
Mining Operations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Project is planned as an underground mining operation using a long-hole stoping mining method and paste backfill, with
shaft access to minimize development through water bearing horizons. The mine will utilize jumbo drills for lateral development
and tophammer and down-the-hole drills for vertical development and production stoping. Rock bolters will be used for ground support
and probe holes will be used to support mine grouting where required. Ore will be remotely mucked from the bottom stope accesses
using 14 tonne Load-Haul-Dump units (&#8220;LHD&#8221;). The LHDs will transport the ore to an ore pass directly or to remuck
bays to maximize the efficiency of the stope mucking operations. When needed, a second LHD and a fleet of 40 tonne haul trucks
will be used to transport ore from the remuck bays to the grizzly feeding the underground material handling system. Multiple remuck
bays are used on each level to avoid interference between the LHD and the haul trucks. The ore is fed through the grizzlys with
rock breakers into an underground crusher (the &#8220;Primary Crusher&#8221;) and via a material handling system to the surface.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Planned
Processing Operations </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Planned
ore process operations include mineral processing, hydrometallurgical processing (&#8220;Hydromet&#8221;), and pyrometallurgical
processing (&#8220;Pyromet&#8221;) housed in separate buildings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mineral processing building will house all of its equipment within a single large building. Ore from the Primary Crusher (located
in the underground mine) will be fed to the secondary cone crusher system, operating in closed circuit with a double deck screen.
The screen undersize from the cone crusher system will be fed to a high-pressure grinding roll unit (&#8220;HPGR&#8221;), operating
in closed circuit with another double deck screen. The HPGR screen undersize is the comminution product that will report to the
Hydromet process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Hydromet plant building will be a multi-level engineered steel structure, which will house equipment on two levels. Ore from mineral
processing will be fed through 15 individual processes required to separate the three recoverable products. The purpose of the
Hydromet processing steps is to leach the pay metals into solution using two separate acid leaches (Hydrochloric Acid Leach and
Sulfuric Acid Bake), remove impurities, separate the three pay metals, and perform precipitation/processing to final solid oxide
forms. Outputs from the Hydromet Process include saleable TiO<sub>2</sub> and Sc<sub>2</sub>O<sub>3</sub>, with Nb<sub>2</sub>O<sub>5
</sub>reporting to the Pyromet plant for final processing. The Hydromet plant will be supported by a Hydrochloric Acid Regeneration
plant and a Sulfuric Acid Plant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pyromet building will house most of its equipment within a single building. The purpose of the Pyromet plant is to reduce the
Nb<sub>2</sub>O<sub>5</sub> coming from the Hydromet plant by converting it into a saleable FeNb metal. Aluminum shots and iron
oxide pellets will be introduced to an electric arc furnace on a continuous basis along with fluxing agents and Nb<sub>2</sub>O<sub>5
</sub>to produce a saleable ferroniobium metal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Production Plan and Schedule </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the 2022 Elk Creek Feasibility Study, the operating mine life is approximately 38 years with a nominal processing rate of 2,764
tonnes per day. The Elk Creek Project timeline is based on 39 months to mechanical completion after Authorization to Proceed,
plus an additional six months of commissioning and ramp-up to 100% of production capacity for a total of 45&#160;months and assumes
no financing constraints. The Board must approve a construction program and budget before construction of the Elk Creek Project
can begin. This approval, along with the receipt of all required governmental permits and approvals and the completion of project
financings, will determine whether and when construction of the Elk Creek Project can begin.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Tailings Storage</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tailings produced by the process plant will consist of filtered water leach residue, calcined excess oxide, and slag. Four engineered
and lined tailings storage facilities (&#8220;TSFs&#8221;) will be constructed sequentially to contain the tailings over the life
of the Elk Creek Project and would contain approximately 14.5&#160;million tonnes of tailings. The tailings facilities have been
designed to incorporate two independent areas: a composite-lined tailings solids storage area; and an area with double lined containment,
including a leak collection and recovery system for management of stormwater runoff and drainage from the tailings solids. The
TSFs will store predominantly dry (i.e., not in a slurry consistency) tailings from the plant with embankment construction based
on a &#8220;downstream&#8221; construction method. Facility closure is considered in the design.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Salt Management</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
crystalline salt produced as a waste product of heating and evaporating brine from the reverse osmosis (&#8220;RO&#8221;) water
treatment plant will be transported by conveyor to the temporary salt staging area and then be transported by truck to the dedicated
salt management cells (&#8220;SMC&#8221;). Two SMCs will be constructed sequentially to contain the salt over the life of the
project and would contain approximately 1.63 million cubic meters of salt. The SMCs design will incorporate a composite-lined
storage area with double-lined containment including a leak collection and recovery system for management of stormwater runoff
and drainage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Water Management</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the first several years of construction, the advancement of the shaft and underground workings will require limited dewatering,
anticipated to be through lower-level sumping and pumping for surface collection and disposal. Initially, water will be stored
in the lined SMC #1 during construction or will be trucked off-site for treatment at a local publicly owned treatment works. Excess
water in the SMCs will be spray evaporated within the footprint of the SMC, to avoid the reintroduction of soluble salts into
the water treatment system. Temporary on-site storage or off-site shipment and disposal of the crystallizer solid waste may be
necessary until construction of SMC #1 is completed.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
full operations commence, we anticipate a shortfall of approximately 3,700 gallons per minute of operational and processing water,
as the underground mine dewatering is only expected to produce 1,000 gallons per minute. To make up this shortfall, we would purchase
fresh water from a local utility and from local landowners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
tailings begin being deposited in the TSF, internal contact water (from residual moisture in the tailings and precipitation falling
within the impoundment footprint) will need to be actively managed. This water will be collected and treated using lime softening
to precipitate hydroxide and carbonate solid forms for many of the inorganic constituents. The treated water will be filtered
to remove the solids (which will be returned to the TSF for disposal), and the clean water will be pumped to the process plant
RO system for further treatment. The clean water from the process plant RO unit will be used in the process plant, and the reject
concentrate will be crystallized and deposited into the SMCs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Source of Power </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
local power utility (Omaha Public Power District) will provide power from nearby transmission lines to the site. This will require
that an approximate 18-mile transmission line be installed by the utility to provide the site sub-station with the required site
power demand. The local power utility will also design and install the main substation that will be owned and maintained by the
utility. This infrastructure will be paid back through rate charges on the electrical usage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Source of Natural Gas</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Natural
gas, to be used throughout the Elk Creek Project during the construction and operation phases of the project, will be brought
to the site via pipeline from the local utility company. NioCorp has a natural gas transportation contract with Tallgrass Energy,
which operates the Rockies Express (&#8220;REX&#8221;) pipeline. Tallgrass will construct a 45 kilometer (28 mile) gas pipeline
lateral from the main REX pipeline system in Kansas to the project site. The lateral will be sized to provide a minimum of 27.5
dekatherms of gas per day. Natural gas will be distributed to all on-site facilities utilizing buried high-density polyethylene
natural gas distribution pipe. Natural gas piping above ground and located inside of facilities will consist predominately of
carbon steel pipe. Maximum on-site pipeline distribution pressure will be 100 pounds per square inch gauge. Natural gas will be
used for facility heating, water heating, and for gas-fired process equipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Markets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
studies for niobium, TiO<sub>2</sub>, and Sc<sub>2</sub>O<sub>3</sub> are an important part of the proposed Elk Creek operation.
These commodities, especially niobium and Sc<sub>2</sub>O<sub>3</sub>, are thinly traded without an established publicly available
price discovery mechanism. Hence, detailed third-party market studies provide the basis for assumptions used in the economic analysis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
economic analysis in the 2022 Elk Creek Feasibility Study used the 2019 U.S. dollar base price of $47/kg Nb as the forward-looking
price for steel grade (65%) ferroniobium based on published independent third-party reports. The base price is adjusted to a realized
price to account for the discount provisions contained in the two ferroniobium offtake agreements that the Company has concluded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
engaged OnG Commodities LLC (&#8220;OnG&#8221;) to produce a market assessment in April 2017. The study examines current scandium
production trends (approximately 20&#160;tons/year) from existing and emerging producers plus an outlook for supply to 2028. The
outlook then reviewed the current and emerging applications for scandium, including fuel cells, aerospace, industrial and other
uses, plus an outlook for demand to 2028. Based on these inputs, OnG provided pricing forecasts and global demand volumes by year
to 2028 based estimated production costs and supply-demand balances. The pricing for the OnG Commodities report was updated for
NioCorp in 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
formal market study was done for TiO<sub>2</sub> as it only represents 2% of overall revenue in the economic analysis. All market
information for titanium and TiO<sub>2</sub> is derived from USGS Commodity Market Summaries (Bedinger, 2019).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Taxation
Rates Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes
that may be levied on the Elk Creek Project include corporate income tax rates of 21% for federal and 5.84% for Nebraska. The
Elk Creek Project is eligible for federal depletion allowances and credits, as well as various state incentives. The calculated
effective income tax rate for the Elk Creek Project is 16.42% for the 2022 Feasibility Study.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Design
Considerations for Environmental Performance</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current mine design incorporates the following strategies and technologies designed to minimize environmental impacts of operation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zero
                                         Process Liquid Discharge: The Elk Creek facility will now operate as a &#8220;Zero Process
                                         Liquid Discharge&#8221; facility, with no releases of process liquids. Instead, both
                                         naturally occurring, brackish (slightly salty) water produced during mining operations,
                                         and water used in ore processing, will be treated on site for
                                         use in operations. A solid salt will be produced from water treatment operations which
                                         will be stored on site.</span></td></tr></table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
                                         Protection of Groundwater Resources Through Artificial Ground Freezing: The Elk Creek
                                         Project&#8217;s new mine design will utilize artificial ground freezing as part of the
                                         process of sinking the production and ventilation shafts. Artificial ground freezing
                                         creates a temporary frozen barrier that helps to protect groundwater resources in the
                                         area while shaft-sinking operations are underway.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avoidance
                                         of Permanent Impacts to Federally Jurisdictional Waters: We designed the layout of the
                                         Elk Creek Project to minimize or avoid permanent impacts to any federally jurisdictional
                                         waters and/or wetlands on the property. This reduced the expected environmental impacts
                                         and allowed the Elk Creek Project to secure a Clean Water Act Section 404 permit from
                                         the USACE under the Nationwide Permit Program, a much more efficient and less expensive
                                         process than an individual Section 404 permit. No other NEPA-level federal permits are
                                         now expected to be required for the Elk Creek Project.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recycling
                                         of Reagents Used in Mineral Processing: Metallurgical and process advances made in 2016
                                         and 2017 are expected to help reduce the volume of material planned for disposal in the
                                         Elk Creek Project&#8217;s tailings storage areas. As more of this material is recycled,
                                         the environmental footprint of the Elk Creek Project is reduced.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utilizing
                                         Tailings as Underground Mine Backfill: We plan to fill underground voids concurrently
                                         with mining operations using a paste backfill material that contains mine waste material
                                         that typically would be stored in above-ground tailings storage areas.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company has not identified any significant encumbrances to the property it owns or holds under OTP agreements. The Company has
not had any permit violations or fines since the filing of our Annual Report on Form 10-K for the fiscal year ended June 30, 2023.</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permitting
requirements for the project have been identified. The Company holds an Air Construction Permit from the State of Nebraska and
a Special Use Permit from Johnson County, both of which are necessary to allow the start of project construction. In addition,
the Elk Creek Project will be required to obtain a series of permits for operations from federal, state, and local agencies. The
majority of these permits are ministerial in nature and present minimal risk to the Company, and typically involve the completion
of an application and the payment of a nominal fee. Three permits from the state of Nebraska are discretionary in nature, where
an application and fee are provided to the state and the state must make a decision as to whether or not the permit will be granted.
While the risk involved in such permits is low, such discretionary permits require more processing time by the state and do require
the state agency to make a decision in favor of issuance of the permit. These three permits include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solid
                                         Waste Permit;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Air
                                         Operating Permit; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Radioactive
                                         Materials License.</span></td></tr></table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->






<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost and schedule for obtaining both the discretionary and ministerial permits is included in the overall execution plan for the
Elk Creek Project. Additional details on the project&#8217;s permitting requirements can be found in Section 17 of the S-K 1300
Elk Creek Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Mineral
Reserves and Resources</span></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mineral reserves and mineral resources disclosed below are based on the S-K 1300 Elk Creek Technical Report Summary, which was
originally filed as Exhibit 96.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2022. Mineral
reserves and mineral resources at the Elk Creek Project as of June 30, 2024, are summarized in the tables below. Further discussion
and background regarding the approaches used to establish mineral reserves and mineral resources is contained in Chapters 11 and
12 of the S-K 1300 Elk Creek Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
Creek Project In Situ Mineral Resource Estimate (niobium, titanium, and scandium) Excluding Reserves</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
of June 30, 2024</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NSR
    Cutoff</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tonnage
    (Mt)</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Indicated</span></td>
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">$180</span></td>
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">151.7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<span style="color: black"><sub>2</sub>O<sub>5
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<span style="color: black"><sub>2</sub>O<sub>5
    </sub>(kt)</span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.43</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">649.8</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<span style="color: black"><sub>2
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<span style="color: black"><sub>2
    </sub>(kt)</span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">2.02</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">3,067</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
    (ppm)</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
    (t)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">56.42</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">8,558</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Inferred</span></td>
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">$180</span></td>
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">108.3</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<span style="color: black"><sub>2</sub>O<sub>5
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<span style="color: black"><sub>2</sub>O<sub>5
    </sub>(kt)</span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.39</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">426.6</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<span style="color: black"><sub>2
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<span style="color: black"><sub>2
    </sub>(kt)</span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.92</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">2,082</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
    (ppm)</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
    (t)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">52.28</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">5,660</span></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.7pt; text-align: center; text-indent: -67.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.7pt; text-align: center; text-indent: -67.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
Creek Project In Situ Mineral Resource Estimate (rare earth oxides) Excluding Reserves</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
of June 30, 2024</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 96%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class</b></span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NSR
    </b></span><span style="font-family: Times New Roman, Times, Serif"><br/>
    <span style="font-size: 10pt"><b>Cut-off</b></span></span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tonnage
    (Mt)</b></span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Indicated</span></td>
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">$180</span></td>
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">151.7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>La<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>La<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ce<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ce<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pr<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pr<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0766</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">116.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.1320</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">200.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0140</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">21.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0511</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">77.5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0116</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">17.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0040</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">6.0</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dy<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dy<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0096</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">14.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0011</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0044</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">6.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ho<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ho<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Er<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Er<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tm<span style="color: black"><sub>2</sub>O<sub>3</sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0006</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.0</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0015</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">2.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0002</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Y<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Y<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0010</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0001</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0187</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">28.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;LREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;LREO
    (kt) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;HREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;HREO
    (kt) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;TREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;TREO
    (kt) </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.2737</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">415.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0528</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">80.0</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.3265</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">495.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Inferred</span></td>
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">$180</span></td>
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">108.3</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>La<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>La<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ce<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ce<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pr<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pr<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0943</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">102.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.1576</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">170.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0163</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">17.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0575</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">62.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0116</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">12.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0038</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dy<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dy<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0090</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">9.8</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0010</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0042</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ho<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ho<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Er<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Er<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tm<span style="color: black"><sub>2</sub>O<sub>3</sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0006</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0014</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0002</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Y<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Y<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0010</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0001</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0182</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">19.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;LREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;LREO
    (kt) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;HREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;HREO
    (kt) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;TREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;TREO
    (kt) </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.3257</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">352.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0512</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">55.5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.3769</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">408.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Notes:</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification
                                         of mineral resources in the above tables is in accordance with the S-K 1300 classification
                                         system. Mineral resources in this table are reported exclusive of mineral reserves.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
                                         resources that are not mineral reserves do not have demonstrated economic viability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         mineral resources are reported at a Diluted Net Smelter Return (NSR) Cut-off of $180/tonne.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         diluted NSR is defined as:</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 40.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt; padding-top: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: middle; width: 0.6in; padding-right: 5pt"><img src="n257410kimg004a.jpg" alt="" style="height: 13px; width: 80px"/></td>
                                                                                                                                                                                                                                          <td style="font: 10pt Times New Roman, Times, Serif"><img src="n257410kimg004b.jpg" alt=""/></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 40.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         diluted revenue from Nb<sub>2</sub>O<sub>5</sub>, TiO<sub>2</sub>, and Sc per block used
                                         the following factors:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 58.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nb<sub>2</sub>O<sub>5
                                         </sub>Revenue: a 94% grade recovery, a 0.696 factor to convert Nb<sub>2</sub>O<sub>5
                                         </sub>to Nb, 82.36% assumption for plant recovery, and a $39.60 selling price per kg
                                         of ferroniobium as of June 30, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 58.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
                                         </sub>Revenue: a 94% grade recovery, a 40.31% assumption for plant recovery, and an $0.88
                                         kg selling price per kg of titanium oxide as of June 30, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 58.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc
                                         Revenue: a 94% grade recovery, a 1.534 factor to convert Sc to Sc<sub>2</sub>O<sub>3</sub>,
                                         93.14% assumption for plant recovery, and a $3,675 selling price per kg of scandium oxide
                                         as of June 30, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 40.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         diluted tonnes are a 6% increase in the total tonnes of the block.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                         assumptions for FeNb, Sc<sub>2</sub>O<sub>3</sub>, and TiO<sub>2</sub> as shown in note
                                         d, above, are based upon independent market analyses for each product.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numbers
                                         may not sum due to rounding. The rounding is not considered to be material.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rare
                                         Earth Oxides (REO) were evaluated as a potential by-product to the mining of niobium,
                                         titanium, and scandium; thus, the estimated values of the REOs are reported using the
                                         previously determined diluted NSR as derived from the Nb<sub>2</sub>O<sub>5</sub>, TiO<sub>2</sub>,
                                         and Sc mineral resources and are assigned a price of $0.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         stated Light Rare Earth Oxides (LREO) grade (%) is the summation of La<sub>2</sub>O<sub>3
                                         </sub>(%), Ce<sub>2</sub>O<sub>3</sub> (%), Pr<sub>2</sub>O<sub>3</sub> (%), and Nd<sub>2</sub>O<sub>3
                                         </sub>(%) estimates.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         stated Heavy Rare Earth Oxides (HREO) grade (%) is the summation of Sm<sub>2</sub>O<sub>3
                                         </sub>(%), Eu<sub>2</sub>O<sub>3</sub> (%), Gd<sub>2</sub>O<sub>3</sub> (%), Tb<sub>2</sub>O<sub>3
                                         </sub>(%), Dy<sub>2</sub>O<sub>3</sub> (%), Ho<sub>2</sub>O<sub>3</sub> (%), Er<sub>2</sub>O<sub>3
                                         </sub>(%), Tm<sub>2</sub>O<sub>3</sub> (%), Yb<sub>2</sub>O<sub>3</sub> (%), Lu<sub>2</sub>O<sub>3
                                         </sub>(%), and Y<sub>2</sub>O<sub>3</sub> (%) estimates.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         stated Total Rare Earth Oxide (TREO) grade (%) is the summation of LREO (%) and HREO
                                         (%).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         effective date of the mineral resource, including by-products, is June 30, 2024.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: -49.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Elk
Creek Project Underground In Situ Mineral Reserves Estimate for Elk Creek</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: -0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as
of June 30, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: -0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tonnage</b>&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(kt)</b></span></p>
</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<sub>2</sub>O<sub>5
                                         </sub>Grade </b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(%)</b></span></p>
</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contained
                                         Nb<sub>2</sub>O<sub>5 </sub></b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p>
</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payable
                                         Nb </b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p>
</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<sub>2</sub></b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grade</b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(%)</b></span></p>
</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contained
                                         TiO<sub>2 </sub></b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p>
</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payable</b></span><span style="font-family: Times New Roman, Times, Serif"><br/>
                                         <span style="font-size: 10pt"><b>TiO<sub>2</sub></b></span></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p>
</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc</b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grade
        (ppm)</b></span></p>
</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contained
                                         </b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
        </b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p>
</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payable
                                         Sc<sub>2</sub>O<sub>3</sub></b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p>
</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.75pt; padding-left: 0.125in; text-indent: -3.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proven</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 17.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.75pt; padding-left: 0.125in; text-indent: -3.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Probable</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,656</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 0.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.81</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297,278</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,409</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.92</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,071,182</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,793</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,573</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,677</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.75pt; padding-left: 17.85pt; text-indent: -17.85pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,656</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 0.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.81</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297,278</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,409</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.92</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,071,182</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,793</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,573</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,677</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
figures are rounded to reflect the relative accuracy of the estimates. Totals may not sum due to rounding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         qualified person for the mineral reserve estimate is Optimize Group Inc. The estimate
                                         has an effective date of June 30, 2024.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         mineral reserve is based on the mine design, mine plan, and cash-flow model utilizing
                                         an average cut-off grade of 0.679% Nb<sub>2</sub>O<sub>5</sub> with an NSR of $180/mt.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         estimate of mineral reserves may be materially affected by metal prices, environmental,
                                         permitting, legal, title, taxation, socio-political, marketing, infrastructure development,
                                         or other relevant issues.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         economic assumptions used to define mineral reserve cut-off grade are as follows:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                         life of mine (LoM) production rate of ~7,450 tonnes of FeNb/annum during the years of
                                         full production.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
                                         elevated five-year production rate ~ 7,500 tonnes of FeNb/annum when full production
                                         is reached.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
                                         dilution of ~6% was applied to all stopes and development, based on 3% for the primary
                                         stopes, 9% for the secondary stopes, and 5% for ore development.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
                                         recoveries of 95% were applied in longhole stopes and 62.5% in sill pillar stopes.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Parameter</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unit</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Cost</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.38</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
    </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106.70</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Water
    Management and Infrastructure </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.62</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tailings
    Management</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Infrastructure</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.47</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    and Administrative</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.91</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties/Annual
    Bond Premium</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.34</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Costs </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.29</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Cost</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>196.72</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$/t
    mined</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nb<sub>2</sub>O<sub>5
    </sub>to Niobium Conversion</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69.60</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
    Process Recovery</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82.36</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
    Price</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.60</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/kg</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>Process Recovery</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.31</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>Price</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.88</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/kg</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc
    Process Recovery</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.14</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc
    to Sc<sub>2</sub>O<sub>3</sub> Conversion</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153.40</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc
    Price</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,675.00</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/kg</span></td></tr>
</table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                         assumptions are as follows: FeNb $39.60/kg Nb, Sc<sub>2</sub>O<sub>3</sub> $3,675/kg,
                                         and TiO<sub>2</sub> $0.88/kg. Price assumptions are based upon independent market analyses
                                         for each product as of June 30, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                         and cost assumptions are based on the pricing of products at the &#8220;mine-gate,&#8221;
                                         with no additional down-stream costs required. The assumed products are ferroniobium
                                         (metallic alloy shots consisting of 65%Nb and 35% Fe), a titanium dioxide product in
                                         powder form, and scandium trioxide in powder form.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         mineral reserve has an average LoM NSR of $563.06/tonne.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
                                         Group has provided detailed estimates of the expected costs based on the knowledge of
                                         the style of mining (underground) and potential processing methods (by third-party qualified
                                         persons).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
                                         reserve effective date is June 30, 2024. The financial model was run after the estimate
                                         of the NSR above, which reflects a total cost per tonne of $196.72 versus $189.91. This
                                         is not considered a material change.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                         variances for commodities are based on independent market studies versus earlier projected
                                         pricing. The independent market studies do not have a negative effect on the reserve.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Comparison
of Mineral Resources and Mineral Reserves</span></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes in the Elk Creek Project mineral resource or reserve estimates as of June 30, 2024, as compared to the Elk Creek
Project mineral resource and reserve estimates as of June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
and Social</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of key permits and environmental management requirements have been identified for the Elk Creek Project, some of which
need to be implemented as soon as practicable in order to maintain the proposed Elk Creek Project schedule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
                                         not necessarily complex, the timing generally required to complete permitting through
                                         any federal regulatory agency requires that NioCorp engage key agencies (in this case
                                         the USACE and possibly the EPA) early on in Elk Creek Project development and consider
                                         the siting and orientation of facilities carefully to minimize the risk of a protracted
                                         National Environmental Policy Act analysis of the Elk Creek Project. At the present time,
                                         the Company believes that we have completed the major federal permitting actions needed
                                         for project construction, although changes to the design or location of project facilities
                                         may require that additional federal permits be obtained.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction
                                         at the facility requires an Air Permit from the State of Nebraska, which was issued to
                                         the Company on June 2, 2020. The Air Permit describes all the prospective air emissions
                                         from the facility and required the completion of an air quality model that demonstrates
                                         compliance with the NAAQS. On April 15, 2022, the Company announced that the Nebraska
                                         Department of Environment and Energy advised the Company that periodic extensions to
                                         the Elk Creek Project&#8217;s Air Permit are no longer required because the Company has
                                         met the regulatory definition of &#8220;construction, reconstruction, or modification
                                         of the source&#8221; since the permit was issued.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         radioactive materials license will be needed from the Nebraska Department of Health and
                                         Human Services (&#8220;NDHHS&#8221;), Office of Radiological Health. Because of their
                                         limited experience with hard rock mining in the State of Nebraska, much less mining that
                                         includes Naturally Occurring Radioactive Material, the NDHHS may require additional information
                                         and more time to approve the Elk Creek Project under a Broad Scope License. The Company
                                         has been working with NDHHS on this aspect of project permitting since 2014.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documentation
                                         of existing baseline environmental conditions at the Elk Creek Project site was initiated
                                         in 2014 and will continue as needed throughout the permitting process.</span></td></tr></table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surface
                                         water monitoring will continue throughout the permitting process and extend into construction
                                         and operations as part of the Environmental Management System and likely State of Nebraska
                                         permit requirements.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         wetland delineation and potential jurisdictional waters assessment was conducted in late
                                         2014 to identify wetland and drainage features within the proposed Elk Creek Project
                                         boundary which resulted in a formal JD being issued by the USACE on September 6, 2016.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.95pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         major land-use authorization for the project was received from Johnson County, Nebraska,
                                         on December 24, 2019, in the form of a Special Use Permit for the project. This land-use
                                         permit is a necessary precursor to any project-related construction activities. County
                                         zoning permits will be required for individual buildings constructed at the site, and
                                         the County requirement is that such applications must be submitted five days before construction
                                         commences.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closure
                                         costs for the Elk Creek Project have been estimated at just over $44 million, including
                                         approximately $13.5 million for reclamation and closure of the TSFs and $16.6 million
                                         for plant and building removal and reclamation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Community
                                         engagement has occurred in parallel with Nebraska field operations and has included public
                                         meetings, presentations to public agencies, communications with local and state politicians,
                                         meetings with environmental groups, and one-on-one meetings with area landowners.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Elk Creek Project Activities</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company completed the installation and commissioning of a continuous groundwater level monitoring system during the quarter ended
September 30, 2023. The system collects and records data in three geologic strata of interest: the upper glacial till, the Pennsylvanian
limestone that underlies the glacial till, and the carbonatite that underlies the limestone. The data collected from this effort
will assist the Company&#8217;s contract hydrogeologists to refine and improve the hydrogeologic model for the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company completed a mine geotechnical review and a site visit by a qualified person, as defined in NI 43-101 and subpart 1300
of Regulation S-K, during the quarter ended September 30, 2023. The Company&#8217;s contract geotechnical engineering firm inspected
drill core and conducted a site inspection. As funding becomes available, the geotechnical firm will review and update their geomechanical
model of the project to ensure that the mining operation will be conducted under safe and stable ground conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Demonstration Plant completed metallurgical operations during the quarter ended September 30, 2023. The impetus for the Demonstration
Plant was to address recommendations in the Company&#8217;s most recent S-K 1300 Elk Creek Technical Report Summary and to establish
metallurgical performance criteria for the rare earths. The Demonstration Plant was successful in this regard, and the measured
improvements in metallurgical performance are summarized in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: center; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><img src="n257410kimg005.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: center; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the quarter ended December 31, 2023, the Company&#8217;s Demonstration Plant located in Trois-Rivieres, Quebec also completed
the production of waste materials for follow-on characterization to support tailings impoundment and paste backfill engineering
design. Additional work at the Demonstration Plant is underway to further
explore improvements to solvent extraction operations and to produce product samples for prospective customers. Operations were
completed at the Demonstration Plant in February 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the quarter ended December 31, 2023, the Company, through a contract engineering firm (Olsson), completed a 90% engineering package
for various road improvements in the vicinity of the Elk Creek Project site, and shared the 90% engineering drawings with the
Nebraska Department of Transportation and Johnson County as part of the normal process for permitting road improvements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company retained a mine engineering consultant in February 2024 to evaluate, at a scoping level, the costs and benefits of electrifying
the mine and accessing it via ramps instead of vertical shafts along with using Railveyor technology in one of the ramps to move
ore and waste rock to surface. The evaluation did not include the detailed examination of geotechnical or hydrogeologic issues.
The findings of the evaluation indicated a potential savings in upfront capital cost, a shorter schedule to get the mine to full
production, and potential operating cost savings. These findings are preliminary but encouraging, and the Company plans a more
detailed evaluation of this option for the design of the underground mine as part of a future update to the S-K 1300 Elk Creek
Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed
Activities</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, the Company is maintaining the Elk Creek Property in anticipation of obtaining project financing that will facilitate
the construction, commissioning, and operation of the Elk Creek Project. The property is characterized as a development stage
property and is expected to move to a production stage property should financing be obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
funds become available through the Company&#8217;s fundraising efforts, we expect to undertake the following activities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuation
    of the Company&#8217;s efforts to secure federal, state and local operating permits;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continued
    evaluation of the potential to produce rare earth products and sell such products under offtake agreements;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Negotiation
    and completion of offtake agreements for the remaining uncommitted production of Nb, Sc, and Ti from the project, including
    the potential sale of Ti as titanium tetrachloride, as well as potential REE production;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Negotiation
    and completion of engineering, procurement, and construction agreements;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completion
    of the final detailed engineering for the underground portion of the Elk Creek Project;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation
    and completion of the final detailed engineering for surface project facilities;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction
    of natural gas and electrical infrastructure under existing agreements to serve the Elk Creek Project site;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completion
    of water supply agreements and related infrastructure to deliver fresh water to the project site;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation
    of revised mine groundwater investigation and control activities; </span></td>
    </tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation
    of long-lead equipment procurement activities; and </span></td>
    </tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    a follow-on to the Company&#8217;s Demonstration Plant operations, complete characterization and testing of waste materials
    to support tailings impoundment and paste backfill plant designs.</span></td></tr>
</table>
<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-GAAP
Financial Performance Measures</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-GAAP
financial performance measures are intended to provide additional information only and do not have any standard meaning prescribed
by U.S. GAAP. These measures should not be considered in isolation or as a substitute for performance measures prepared in accordance
with U.S. GAAP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
S-K 1300 Elk Creek Technical Report Summary uses non-GAAP financial performance measures, such as EBITDA, Averaged Annual EBITDA,
and Averaged EBITDA Margin, for purposes of projecting the economic</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">results of the Elk Creek Project. We are unable to provide
a reconciliation of these forward-looking non-GAAP measures to the most comparable U.S. GAAP financial performance measures because
certain information needed to
reconcile those non-GAAP measures to the most comparable U.S. GAAP financial performance measures is dependent on future events,
some of which are outside the control of the Company, such as FeNb, Sc<sub>2</sub>O<sub>3,</sub> and TiO<sub>2</sub> prices, interest
rates, and exchange rates. Moreover, estimating such U.S. GAAP measures with the required precision necessary to provide a meaningful
reconciliation is extremely difficult and could not be accomplished without unreasonable effort.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Headquarters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
lease our principal executive office space at 7000 South Yosemite Street, Suite 115, Centennial, Colorado.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;3.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b><span id="a027"></span>LEGAL
                                         PROCEEDINGS</b></span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 20, 2024, we are not a party to any legal proceedings that could have a material adverse effect on the Company&#8217;s
business, financial condition, or operating results. Further, to the Company&#8217;s knowledge, no such proceedings have been
threatened against the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;4.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b><span id="a028"></span>MINE
                                         SAFETY DISCLOSURES</b></span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 1503(a) of the United States Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &#8220;Dodd-Frank
Act&#8221;), issuers that are operators, or that have a subsidiary that is an operator, of a coal or other mine in the U.S. are
required to disclose specified information about mine health and safety in their periodic reports. These reporting requirements
are based on the safety and health requirements applicable to mines under the Federal Mine Safety and Health Act of 1977 (the
&#8220;Mine Act&#8221;) which is administered by the U.S. Department of Labor&#8217;s Mine Safety and Health Administration (&#8220;MSHA&#8221;).
During the fiscal year ended June 30, 2024, the Company and its subsidiaries and their properties or operations were not subject
to regulation by MSHA under the Mine Act and thus no disclosure is required under Section 1503(a) of the Dodd-Frank Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a029"></span>PART
II</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;5.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b><span id="a030"></span>MARKET
                                         FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES
                                         OF EQUITY SECURITIES</b></span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a031"></span>Market
Information</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Shares are listed for trading on the Nasdaq under the trading symbol &#8220;NB&#8221;. The Company voluntarily
delisted from the TSX effective as of close of markets on May 3, 2024. The Company also trades on the Frankfurt Stock Exchange
as &#8220;BR3.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a032"></span>&#160;Holders</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 13, 2024, we had 18,311 holders of record of the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a033"></span>Dividends</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid any cash dividends on the Common Shares since our inception and do not anticipate paying any cash dividends in the
foreseeable future. We plan to retain our earnings, if any, to provide funds for the expansion of our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a034"></span>Securities
Authorized for Issuance Under Equity Compensation Plans</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See&#160;Equity
Compensation Plan information&#160;under&#160;<i>Item 12</i>, &#8220;<i>Security Ownership of Certain Beneficial Owners and Management
and Related Stockholder Matters</i>,&#8221; for information on plans approved by our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a035"></span>Purchases
of Equity Securities by the Company</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
did not make any repurchases in the quarter ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a036"></span>Recent
Sales of Unregistered Securities</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 31%; padding-right: 0.25pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross
    Proceeds ($000)</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    Issued</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price/Share</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    25, 2024<sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$510</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">230,560</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2.2123</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    6, 2024<sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">502</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">234,142</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1435</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    13, 2024<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90,000</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4590</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">169</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,000</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2551</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    21, 2024<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">177</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,500</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1400</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    24, 2024<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,000</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.0597</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2024<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">344</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2909</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2024<sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">202</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94,455</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1435</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    4, 2024<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">303</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,000</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2467</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    10, 2024<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">223</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,000</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.0059</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    18, 2024<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">203</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,000</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9377</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    27, 2024<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">113</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,000</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7196</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued
    in reliance on Section 3(a)(9) of the Securities Act, in connection with the voluntary conversion of a portion of the amount
    outstanding under the Convertible Debentures and based upon representations and warranties of Yorkville in connection therewith.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued
    in reliance on Section 4(a)(2) of the Securities Act in connection with the closing of an advance under the Yorkville Equity
    Facility Financing Agreement and based upon representations and warranties of Yorkville in connection therewith.</span></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a037"></span>Exchange
Controls</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no governmental laws, decrees, or regulations in Canada that restrict the export or import of capital, including foreign exchange
controls, or that affect the remittance of dividends, interest or other payments to non-resident holders of the securities of
NioCorp, other than Canadian withholding tax. See &#8220;Certain Canadian Federal Income Tax Considerations for U.S. Residents&#8221;
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a038"></span>Certain
Canadian Federal Income Tax Considerations for U.S. Residents</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following generally summarizes certain Canadian federal income tax consequences generally applicable under the Income Tax Act
(Canada) and the regulations enacted thereunder (collectively, the &#8220;Canadian Tax Act&#8221;) and the Canada-United States
Tax Convention (1980) (the &#8220;Convention&#8221;) to the holding and disposition of Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comment
is restricted to holders of Common Shares each of whom, at all material times for the purposes of the Canadian Tax Act and the
Convention, (i) is resident solely in the U.S. for tax purposes, (ii) is a &#8220;qualifying person&#8221; under and entitled
to the benefits of the Convention, (iii) holds all Common Shares as capital property, (iv) holds no Common Shares that are &#8220;taxable
Canadian property&#8221; (as defined in the Canadian Tax Act) of the holder, (v) deals at arm&#8217;s-length with and is not affiliated
with NioCorp, (vi) does not and is not deemed to use or hold any Common Shares in a business carried on in Canada, (vii) is not
an insurer that carries on business in Canada and elsewhere, (viii) is not an &#8220;authorized foreign bank&#8221; (as defined
in the Canadian Tax Act), and (ix) has not entered into a &#8220;derivative forward agreement&#8221; (as defined in the Canadian
Tax Act) with respect to the Common Shares (each such holder, a &#8220;U.S. Resident Holder&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
U.S.-resident entities that are fiscally transparent for U.S. federal income tax purposes (including limited liability companies)
may not in all circumstances be entitled to the benefits of the Convention. Members of or
holders of an interest in such an entity that holds Common Shares should consult their own tax advisers regarding the extent,
if any, to which the benefits of the Convention will apply to the entity in respect of its Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a U.S. Resident Holder&#8217;s Common Shares will be considered to be capital property of such holder provided that the U.S. Resident
Holder is not a trader or dealer in securities, did not acquire, hold, or dispose of the Common Shares in one or more transactions
considered to be an adventure or concern in the nature of trade (i.e. speculation), and does not hold the Common Shares in the
course of carrying on a business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary is based on the current provisions of the Canadian Tax Act and the Convention in effect as of the date prior to the date
hereof, all specific proposals to amend the Canadian Tax Act and Convention publicly announced by or on behalf of the Minister
of Finance (Canada) prior to the date hereof, and the current published administrative policies and assessing practices of the
Canada Revenue Agency (the &#8220;CRA&#8221;). It is assumed that all such amendments will be enacted as currently proposed, and
that there will be no other material change to any applicable law or administrative policy or assessing practice, whether by way
of judicial, legislative or governmental decision or action, although no assurance can be given in these respects. This summary
is not exhaustive of all possible Canadian federal income tax considerations. Except as otherwise expressly provided, this summary
does not take into account any provincial, territorial, or foreign tax considerations, which may differ materially from those
set out herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
summary is of a general nature only, is not exhaustive of all possible Canadian federal income tax considerations and is not intended
to be and should not be construed as legal or tax advice to any particular U.S. Resident Holder. U.S. Resident Holders are urged
to consult their own tax advisers for advice with respect to their particular circumstances. The discussion below is qualified
accordingly.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a U.S. Resident Holder&#8217;s Common Shares will not constitute &#8220;taxable Canadian property&#8221; of such holder at a particular
time at which the Common Shares are listed on a &#8220;designated stock exchange&#8221; (which currently includes Nasdaq) unless,
at any time during the 60-month period that ends at the particular time both of the following conditions are concurrently met:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%
                                         or more of the issued shares of any class of the capital stock of NioCorp were owned
                                         by or belonged to one or any combination of:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         U.S. Resident Holder,</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                         with whom the U.S. Resident Holder did not deal at arm&#8217;s length, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships
                                         in which the U.S. Resident Holder or a person referred to in clause (b) holds a membership
                                         interest directly or indirectly through one or more partnerships, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">more
                                         than 50% of the fair market value of the Common Shares was derived directly or indirectly
                                         from, one or any combination of, real or immovable property situated in Canada, &#8220;Canadian
                                         resource properties&#8221; (as defined in the Canadian Tax Act), &#8220;timber resource
                                         properties&#8221; (as defined in the Canadian Tax Act), or options in respect of, or
                                         interests in any of the foregoing, whether or not the property exists.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Shares may also be deemed to be &#8220;taxable Canadian property&#8221; in certain circumstances set out in the Canadian Tax Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Resident Holder who disposes or is deemed to dispose of one or more Common Shares generally should not thereby incur any
liability for Canadian federal income tax in respect of any capital gain arising as a consequence of the disposition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Resident Holder to whom NioCorp pays or credits or is deemed to pay or credit a dividend on such holder&#8217;s Common
Shares will be subject to Canadian withholding tax, and NioCorp will be required to withhold the tax from the dividend and
remit it to the CRA for the holder&#8217;s account. The rate of withholding tax under the Canadian Tax Act is 25% of the
gross amount of the dividend, but should generally be reduced under the Convention to 15% (or, if the U.S. Resident Holder is
a company which is the beneficial owner of at least 10% of the voting stock of NioCorp, 5%) of the gross amount of the
dividend. For this purpose, a company that is a resident of the United States for purposes of the Canadian Tax Act and the
Convention and is entitled to the benefits of the Convention shall be considered to own the voting stock of NioCorp owned by
an entity that is considered fiscally transparent
under the laws of the United States and that is not a resident of Canada, in proportion to such company&#8217;s ownership interest
in that entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;6.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b><i><span id="a039"></span>RESERVED</i></b></span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;7.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b><span id="a040"></span>MANAGEMENT&#8217;S
                                         DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following Management&#8217;s Discussion and Analysis (&#8220;MD&amp;A&#8221;) provides information that management believes is
relevant to an assessment and understanding of the consolidated financial condition and results of operations of NioCorp and subsidiaries.
This item should be read in conjunction with our consolidated financial statements and the notes thereto included in this Annual
Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0.25in">See Item
1, &#8220;<i>Business&#8212;Historical Development of the Business</i>,&#8221; for a description of the 2023 Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a041"></span>Summary
of Consolidated Financial and Operating Performance</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no revenues from mining operations during the fiscal years presented below. Operating expenses incurred related primarily
to performing exploration and feasibility study related activities, as well as the activities necessary to support corporate and
shareholder duties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the year ended June 30,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($000)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,757</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 2.8pt; text-indent: -2.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,410</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss attributable to the Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: right">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,435</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 2.8pt; text-indent: -2.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(40,080</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss per share (basic and diluted)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.31</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.34</span>)</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net loss attributable to the Company decreased to $11.4 million for fiscal year 2024 from $40.1 million for fiscal year 2023.
This decreased net loss in fiscal year 2024 as compared to fiscal year 2023 is primarily due to the recognition of general transaction
expenses, Earnout Shares, and warrant liabilities associated with the fiscal year 2023 GXII Transaction as well as a decrease
in exploration expenditures and fiscal year 2024 non-cash gains associated with changes in Earnout Share valuations and warrant
liability valuations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a042"></span>Results
of Operations</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no revenues from mining operations during the fiscal years presented below. Operating expenses incurred related primarily
to costs incurred in connection with the 2023 Transactions, as well as performing exploration and feasibility study related activities,
and the activities necessary to support corporate and shareholder duties, as detailed in the following table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the year ended June 30,</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>($000)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 31%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
    expenses:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    related costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,509</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,323</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
    fees</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,533</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,581</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exploration
    expenditures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,552</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,348</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    operating expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,163</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,158</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    operating expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,757</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,410</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td colspan="4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-indent: 9pt"><span style="font: 10pt Times New Roman, Times, Serif">Change in fair value of earnout shares liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,704</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,674</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value of warrant liabilities </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,875</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,414</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value of convertible note</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,542</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,922</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,490</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,336</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    exchange (gain) loss</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(31</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">216</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 8.55pt; width: 31%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    gains</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(147</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    on equity securities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
    tax benefit</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(139</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(304</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    attributable to noncontrolling interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(463</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(228</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
    loss attributable to the Company </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,435</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(40,080</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
</table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fiscal
Year 2024 as Compared to Fiscal Year 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
items affecting operating expenses are noted below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><i>Other operating
expenses </i>include costs incurred in connection with the 2023 Transactions, including direct transaction expenses, and the fair
value of warrant and Earnout Shares liabilities assumed, as well as costs related to investor relations, general office expenditures,
equity offering and proxy expenditures, Board-related expenditures, and other miscellaneous costs. These costs decreased in fiscal
year 2024 as compared to fiscal year 2023 primarily due to $23.8 million of costs incurred in connection with the 2023 Transactions,
which closed on March 17, 2023, as well as overall lower expenditures during fiscal year 2024 for financial services, Board stipends
and share-based compensation, and investor relation services. This decline was partially offset by the fiscal year 2024 impact
of $1.0 million of additional director and officer insurance premiums associated with our listing on Nasdaq.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employee-related
costs </i>increased in 2024 as compared to 2023, primarily due to an increase in the number of options issued to employees in
2024 partially offset by a lower fair value per option as well as the impact of board-authorized employee salary increases which
became effective April 1, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exploration
expenditures&#160;decreased </i>in fiscal year 2024 as compared to fiscal year 2023, reflecting work performed in fiscal year
2023 to complete the development of the Demonstration Plant and the subsequent operation of the Demonstration Plant to verify
process improvement efforts and advance the technical and economic analyses on the potential addition of magnetic rare earth oxides
to NioCorp&#8217;s planned product suite. In addition, 2023 costs increased due to costs related to the completion and filing
of the Technical Report Summary based on the Company&#8217;s 2022 Feasibility Study for the Elk Creek Project, which was filed
with the SEC on September 6, 2022.<i>&#160;</i>Demonstration Plant costs were lower in 2024 as project objectives were completed
and the Demonstration Plant operations ended in February 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
fees </i>increased in fiscal year 2024 as compared to fiscal year 2023, primarily due to additional accounting fees incurred in
2024 associated with our change in auditors as well as legal costs associated with corporate funding initiatives and Form S-1
and S-3 filings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
significant items impacting the change in the Company&#8217;s net loss are noted below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in fair value of Earnout Shares liability </i>represents the change in fair value related to the Earnout Shares based on the results
of Monte Carlo financial modeling. Overall, the decline in the liability corresponds to the overall decline in our share value
during fiscal year 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in fair value of warrant liability </i>represents the change in fair value related to (i) the additional Warrants (the &#8220;Contingent
Consent Warrants&#8221;) that the Company agreed to issue to Lind Global Asset Management III, LLC (&#8220;Lind&#8221;) upon certain
conditions in connection with the Waiver and Consent Agreement, dated September 25, 2022, between the Company and Lind (the &#8220;Lind
Consent&#8221;), as discussed in Note 9 to the consolidated financial statements included in Part II, Item 8 hereof, and (ii)
the change in fair value of the April 2024 Warrants, as discussed in Note 9 to the consolidated financial statements included
in Part II, Item 8 hereof, partially offset by the change in the fair value of the Private Warrants based primarily on the impacts
of a lower closing Common Share price, which increases the probability of these Contingent Consent Warrants being issued under
the Lind Consent terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in fair value of convertible notes </i>represents the impact of the initial allocation of fair value to the April 2024 Notes,
which are carried at fair value, as well as the change in fair value for the period ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<i>Loss
on debt extinguishment </i>represents the loss incurred under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 470,
Debt, related to the convertible security issued to Lind (the &#8220;Lind III Convertible Security&#8221;)
with a face value of $11.7 million (representing $10.0 million in funding plus an implied 8.5% interest rate per annum for the
term of the Lind III Convertible Security) pursuant to the Convertible Security Funding Agreement, dated February 16, 2021, as
amended by Amendment #1 to the Convertible Security Funding Agreement, dated</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">December 2, 2021, between the Company and Lind (as
amended, the &#8220;Lind III Agreement&#8221;), as discussed in Note 9 to the consolidated financial statements included in Part
II, Item 8 hereof.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<i>Interest
expense</i> increased in fiscal year 2024 as compared to fiscal year 2023 due to the impacts of Convertible Debenture interest
expense incurred in fiscal year 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loss
attributable to noncontrolling interest</i> represents the portion of net loss in ECRC attributable to the Vested Shares, which
are not owned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a043"></span>Liquidity
and Capital Resources</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no revenue generating operations from which we can internally generate funds. To date, our ongoing operations have been financed
by the sale of our equity securities by way of private placements, convertible securities issuances, the exercise of incentive
Options and Warrants, and related party loans. With respect to currently outstanding Options and Warrants, we believe that exercise
of these instruments, and cash proceeds from such exercises, will not occur unless and until the market price for our Common Shares
equals or exceeds the related exercise price of each instrument.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Closing of the 2023 Transactions, the Company received net cash proceeds of $8.3 million, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($000)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 81%; padding-right: 1.45pt; padding-bottom: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash received from GXII trust account, after payment of direct and incremental transaction costs incurred by GXII</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%; padding-right: 1.45pt; padding-bottom: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 1.45pt; padding-bottom: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; padding-right: 1.45pt; padding-bottom: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,168</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    proceeds from the Yorkville Convertible Debt Financing Agreement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,857</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash costs incurred in connection with Yorkville Equity Facility Financing Agreement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,996)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    direct and incremental transaction costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,715)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;Net
    proceeds from 2023 Transactions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-bottom: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,314</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Transactions delivered to NioCorp several important benefits, including a ready pathway to an up-listing to the Nasdaq, which
is expected to allow additional institutional firms to invest in the Company for the first time. Further, we believe it has given
NioCorp and the Elk Creek Project a much higher profile among institutional investors evaluating projects in the critical materials
space.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The sale of the April
2024 Notes has provided, and the Yorkville Equity Facility Financing is expected to provide, near-term and longer-term access to
capital. The ability of the Company to draw down on the Yorkville Equity Facility Financing Agreement, at its discretion, is subject
to certain limitations and the satisfaction of certain conditions. When available, the Yorkville Equity Facility Financing Agreement
provides an opportunity to actively manage the cash needs of the Company more closely. Historically, cash has generally been available
to the Company through private placements of equity for which the timing did not always coincide with the Company&#8217;s cash
needs. In the near term, the Company intends to utilize the Yorkville Equity Facility Financing Agreement to offset amounts owed
under the April 2024 Notes. The Company may also utilize the Yorkville Equity Facility Financing Agreement to potentially generate
funds at a time when they are in need. Alternatively, the Company can also utilize the Yorkville Equity Facility Financing Agreement
for opportunistic share sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2024, the Company and Yorkville entered into a make-whole payment agreement under which Yorkville agreed to convert the
remaining principal and accrued interest of $553,767 under the Convertible Debenture into Common Shares in exchange for a $95,000
make-whole payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 17, 2024, all the remaining outstanding Financing Warrants expired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On September 17, 2024, the
Company&#8217;s Common Share price was below the threshold price set forth in the Lind Consent, and accordingly, the Company issued
2,816,742 Contingent Consent Warrants to Lind. Each Contingent Consent Warrant is exercisable for one Common Share at an exercise
price of $2.308 and may be exercised at any time prior to</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">their expiration on September 17, 2028. The number
of Contingent Consent Warrants issued was based on $5.0 million divided by the five-day volume weighted average price of the Common
Shares on September 16, 2024.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in">As
of June 30, 2024, the Company had cash of $2.0 million and a working capital deficit of $9.0 million, compared to cash of $2.3
million and working capital of $0.2 million on June 30, 2023. Subsequent to June 30, 2024, the Company issued 339,250 Common
Shares under the Yorkville Equity Facility Financing Agreement in exchange for $0.6 million in gross cash proceeds. On
September 11, 2024, the Company and Mark Smith, Chief Executive Officer, President and Executive Chairman of NioCorp, entered into
a loan agreement (the &#8220;Smith Loan Agreement&#8221;), which provides for a $2.0 million non-revolving credit facility. An
initial drawdown under the Smith Loan Agreement of $33,000 was completed on September 11, 2024. NioCorp intends to use the
net proceeds from these transactions to satisfy amounts due under the April 2024 Notes and for general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that the Company will operate at a loss for the foreseeable future. The Company&#8217;s current planned cash needs are
approximately $26.0 million until June 30, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition to outstanding
accounts payable and short-term liabilities, our average monthly planned expenditures through June 30, 2025 are expected to be
approximately $1.6 million per month, of which approximately $375,000 is for corporate overhead and estimated costs related to
securing financing necessary for advancement of the Elk Creek Project. This includes general overhead costs, satisfying outstanding
accounts payable, and repayment of the April 2024 Notes and the Smith Loan Agreement. This also includes anticipated financing
costs associated with the Elk Creek Project, including an updated mine plan in connection with the EXIM application process. The
scope of these financing costs remains under discussion with EXIM. Approximately $1.2 million per month is planned for expenditures
relating to the advancement of the Elk Creek Project by NioCorp&#8217;s majority owned subsidiary, ECRC. The Company&#8217;s ability
to continue operations and fund our current work plan is dependent on management&#8217;s ability to secure additional financing.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company anticipates that it does not have sufficient cash on hand to continue to fund basic operations for the next twelve months,
and additional funds totaling $25.0 million to $26.0 million, net of funds raised from advances under the Yorkville Equity Facility
Financing Agreement and borrowings under the Smith Loan Agreement, are likely to be necessary to continue advancing the project
in the areas of financing, permitting, and detailed engineering. While the Yorkville Equity Facility Financing Agreement may provide
the Company with access to additional capital, the Company will likely require additional capital to meet its cash needs. Management
is actively pursuing such additional sources of debt and equity financing, and while it has been successful in doing so in the
past, there can be no assurance it will be able to do so in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
Creek Property and lease commitments are $15,000 through June 30, 2025. To maintain our currently held properties and fund our
currently anticipated general and administrative costs and planned exploration and development activities at the Elk Creek Project
for the fiscal year ending June 30, 2025, the Company will likely require additional financing during the current fiscal year.
Should such financing not be available in that timeframe, we will be required to reduce our activities and will not be able to
carry out all our presently planned activities at the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 6, 2023, the Company announced that it had submitted an application to EXIM to obtain EXIM Financing to fund the project
costs for the Elk Creek Project, under EXIM&#8217;s &#8220;Make More in America&#8221; initiative. The Company was informed that
its application received approval by the first of three reviews by the EXIM Transaction Review Committee on October 2, 2023. EXIM
deployed additional resources to the processing of the Company&#8217;s application during the quarter ended December 31, 2023
and has retained financial and legal consultants to support EXIM&#8217;s due diligence on the Elk Creek Project. On April 15,
2024, the Company received the PPL from EXIM. The PPL is a summary of EXIM&#8217;s initial due diligence findings and also includes
a preliminary Indicative Term Sheet. The PPL identified additional project activities to be undertaken by the Company in conjunction
with the EXIM evaluation process. These include an updated mine plan and updated Elk Creek Project capital costs on a final or
close-to-final basis reflecting updated process flows. Management is working with EXIM to continue to advance the project through
the next stages of EXIM&#8217;s due diligence and loan application process. We are currently unable to estimate how long the application
process may take, and there can be no assurances that we will be able to successfully negotiate a final commitment of debt financing
from EXIM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Except for potential
funding from advanced under the Yorkville Equity Facility Financing and potential funding under the Smith Loan Agreement, each
as discussed above, and the potential exercise of Options and Warrants, we currently have no further funding commitments or arrangements
for additional financing at this time, and there is no assurance that we will be able to obtain any such additional financing on
acceptable terms, if at all. Pursuant to the Exchange Agreement, NioCorp is restricted from issuing equity or equity-linked securities
(other than Common Shares) or any preferred equity or non-voting equity if such issuance would adversely impact the rights of the
holders of the shares of Class B common stock of ECRC, without the consent of the holders of a majority of the shares of Class
B common stock of ECRC. The April 2024 Purchase Agreement also contains certain covenants that, among other things, limit NioCorp&#8217;s
ability to use the proceeds from the April 2024 Purchase Agreement to pay related party debt or to enter into any variable rate
transaction, including issuances of equity or debt securities that are convertible into Common Shares at variable rates and any
equity line of credit, ATM agreement or other continuous offering of Common Shares, other than with Yorkville, subject to certain
exceptions. Notwithstanding the restrictions set forth in the Exchange Agreement and the April 2024 Purchase Agreement, there is
significant uncertainty that we would be able to secure any additional financing in the current equity or debt markets. The quantity
of funds to be raised and the terms of any proposed equity or debt financing that may be undertaken will be negotiated by management
as opportunities to raise funds arise. Management may pursue funding sources of both debt and equity financing, including but not
limited to the issuance of equity securities in the form of Common Shares, Warrants, subscription receipts, or any combination
thereof in units of the Company pursuant to private placements to accredited investors or pursuant to public offerings in the form
of underwritten/brokered offerings, registered direct offerings, or other forms of equity financing and public or private issuances
of debt securities, including secured and unsecured convertible debt instruments or secured debt project financing. Management
does not currently know the terms pursuant to which such financings may be completed in the future, but any such financings will
be negotiated at arm&#8217;s-length. Future financings involving the issuance of equity securities or derivatives thereof will
likely be completed at a discount to the then-current market price of the Company&#8217;s securities and will likely be dilutive
to current shareholders. In addition, we could raise funds through the sale of interests in our mineral properties, although current
market conditions and other recent worldwide events have substantially reduced the number of potential buyers/acquirers of any
such interests. However, we cannot provide any assurances that we will be able to be successful in raising such funds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Based on the conditions
described within, management has concluded and the audit opinion and notes that accompany our consolidated financial statements
for the year ended June 30, 2024, disclose that substantial doubt exists as to our ability to continue as a going concern. The
consolidated financial statements included in this Annual Report on Form 10-K have been prepared under the assumption that we will
continue as a going concern. As defined under S-K 1300, we are a development stage issuer, and we have incurred losses since our
inception. We may not have sufficient cash, including option and warrant exercises subsequent to June 30, 2024, to fund normal
operations and meet debt obligations for the next twelve months without deferring payment on certain current liabilities and raising
additional funds. Uncertainty in capital markets, supply chain disruptions, increased interest rates and inflation, and the potential
for geographic recessions have contributed to general global economic uncertainty. During fiscal year 2024, these events continued
to create uncertainty with respect to overall project funding and timelines. We believe that the going concern uncertainty cannot
be alleviated with confidence until the Company has entered into a business climate where funding of its planned ongoing operating
activities is secured. Therefore, these factors raise substantial doubt as to our ability to continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no exposure to any asset-backed commercial paper. Other than cash held by our subsidiaries for their immediate operating
needs in Colorado and Nebraska, all of our cash reserves are on deposit with major U.S. and Canadian chartered banks. We do not
believe that the credit, liquidity, or market risks with respect thereto have increased as a result of the current market conditions.
However, in order to achieve greater security for the preservation of our capital, we have, of necessity, been required to accept
lower rates of interest, which has also lowered our potential interest income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">During the year ended
June 30, 2024, the Company&#8217;s operating activities consumed $11.7 million of cash (2023: $17.3 million). Overall, operational
outflows during fiscal year 2024 decreased from the corresponding period of 2023 due to fiscal year 2023 cash expenses related
to the 2023 Transactions and a decrease in fiscal year 2024 exploration-</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">related spending at the Elk Creek Project. Going forward,
the Company&#8217;s working capital requirements are expected to increase substantially in connection with the development of the
Elk Creek Project.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investing
Activities </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had minimal investing activities during the years ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 18.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financing
Activities </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 18.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities was $11.4 million in fiscal year 2024 (2023: $14.6 million). This decrease in financing
inflows primarily reflects the timing of cash inflows from the financing transactions disclosed below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024
inflows reflect the gross receipts of $1.0 million from the September 2023 Private Placement (as defined below), $1.3 million
from the December 2023 Private Placement (as defined below), $0.6 million from the June 2024 Private Placement (as defined below)
and $3.3 million from Common Share issuances under the Yorkville Equity Facility Financing Agreement, as well as $6.5 million
of net proceeds from the issuance of the April 2024 Notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a discussion of significant financing transactions since the beginning of fiscal year 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         September 1, 2023, the Company closed a non-brokered private placement (the &#8220;September
                                         2023 Private Placement&#8221;) with a single investor and issued 250,000 units of the
                                         Company (the &#8220;September 2023 Units&#8221;), at a price of $4.00 per September 2023
                                         Unit, for aggregate gross proceeds of $1.0 million. Each September 2023 Unit consisted
                                         of one Common Share and one Warrant (the &#8220;September 2023 Warrants&#8221;). Each
                                         September 2023 Warrant is exercisable for one Common Share at a price of $4.60 until
                                         September 1, 2025.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         December 22, 2023, the Company closed a non-brokered private placement (the &#8220;December
                                         2023 Private Placement&#8221;) and issued an aggregate of 413,432 units of the Company
                                         (the &#8220;December 2023 Units&#8221;), including an aggregate of 274,587 December 2023
                                         Units to certain non-affiliated accredited investors at a price of $3.08 per December
                                         2023 Unit and an aggregate of 138,845 December 2023 Units to certain of the Company&#8217;s
                                         officers and directors at a price of $3.205 per December 2023 Unit, for aggregate gross
                                         proceeds of approximately $1.29 million. Each December 2023 Unit consisted of one Common
                                         Share and one Warrant (the &#8220;December 2023 Warrants&#8221;). Each December 2023
                                         Warrant is exercisable for one Common Share at a price of $3.54 until December 22, 2025.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         April 12, 2024, the Company issued and sold to Yorkville and Lind Global Fund II LP (together
                                         with Yorkville, the &#8220;April 2024 Purchasers&#8221;) $8.0 million aggregate principal
                                         amount of unsecured notes (the &#8220;April 2024 Notes&#8221;), pursuant to a securities
                                         purchase agreement, dated April 11, 2024 (the &#8220;April 2024 Purchase Agreement&#8221;),
                                         between the Company and each of the April 2024 Purchasers. Pursuant to the terms of the
                                         April 2024 Notes, subject to certain exceptions, on the first day of each calendar month,
                                         beginning on June 1, 2024 (excluding August 2024) (the &#8220;Payment Date&#8221;), the
                                         Company will be required to repay a portion of the outstanding balance of all of the
                                         April 2024 Notes, on a pro-rata basis, in an amount equal to the sum of (i) $1.4 million
                                         of principal (or the outstanding principal if less than such amount) in the aggregate
                                         among all of the outstanding April 2024 Notes, plus (ii) 8.0% of the principal amount
                                         being paid (the &#8220;Payment Premium&#8221;), and (iii) accrued and unpaid interest,
                                         if any, as of the Payment Date. The Company is required to make payments on each Payment
                                         Date until the entire outstanding principal is repaid but will not have an obligation
                                         to make a payment on a Payment Date if certain equity conditions (the &#8220;Equity Conditions&#8221;)
                                         are satisfied.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also issued to the April 2024 Purchasers, in proportion to the aggregate principal amount of April 2024 Notes issued to
each April 2024 Purchaser, Warrants (the &#8220;April 2024 Warrants&#8221;) to purchase up to 615,385 Common Shares (the &#8220;April
2024 Warrants Shares&#8221;), which are equal to 25% of the aggregate principal amount of April 2024 Notes issued to the April
2024 Purchasers divided by the exercise price of $3.25, subject to any adjustment to give effect to any stock dividend, stock
split or recapitalization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the April 2024 Purchase Agreement, the April 2024 Purchasers advanced an aggregate of $6.935 million to the Company in consideration
of the issuance by the Company to the April 2024 Purchasers of $8.0 million aggregate principal amount of the April 2024 Notes
and April 2024 Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
from the April 2024 Purchase Agreement were used for general working capital purposes, including for accounts payable, other payables
and operating expenses, and to satisfy the fees and expenses incurred in connection with the April 2024 Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations contained within the April 2024 Notes, holders of the April 2024 Notes will be entitled to convert the
principal amount of, accrued and unpaid interest, if any, and any Payment Premium that has become due and payable on each April
2024 Note, from time to time over their term, into a number of Common Shares equal to the quotient of the amount being converted
divided by a fixed conversion price of $2.75 per Common Share up to a maximum of 3,141,817 Common Shares (together with the April
2024 Warrant Shares, the &#8220;April 2024 Underlying Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes are the unsecured obligations of the Company and will mature on December 31, 2024. The April 2024 Notes incur
a simple interest rate obligation of 0.0% per annum (which will increase to 18.0% per annum upon the occurrence of an event of
default). The outstanding principal amount of, accrued and unpaid interest, if any, on, and the Payment Premium, if any, on the
April 2024 Notes must be paid by NioCorp in cash when the same becomes due and payable under the terms of the April 2024 Notes
at their stated maturity, upon their redemption or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 36.25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Purchase Agreement also contains certain covenants that, among other things, limit NioCorp&#8217;s ability to use the
proceeds from the sale of the April 2024 Notes and the exercise of the April 2024 Warrants to repay related party debt or to enter
into any variable rate transaction other than with Yorkville, subject to certain exceptions, and to distribute proceeds from the
sale of the April 2024 Notes and the exercise of the April 2024 Warrants to subsidiaries other than ECRC and 0896800 B.C. Ltd.
(together with ECRC, the &#8220;Guarantors&#8221;), upon the entry by the Guarantors into a global guaranty agreement, dated as
of April 11, 2024, among the Guarantors in favor of the Purchasers (the &#8220;Guaranty Agreement&#8221;). Pursuant to the Guaranty
Agreement, the Guarantors guaranteed the full, prompt and unconditional payment when due (whether at maturity, by acceleration
or otherwise), and the performance of all liabilities, agreements and other obligations of NioCorp to the April 2024 Purchasers
contained in the April 2024 Purchase Agreement, the April 2024 Notes, and the April 2024 Warrants, to the extent such liabilities,
agreements and obligations are payable in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 36.25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 36.25pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 36.25pt; text-align: justify; text-indent: 0in">On September
4, 2024, NioCorp entered into (i) a consent and waiver (the &#8220;Yorkville Consent&#8221;) to the April 2024 Note issued and
sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together with the Yorkville Consent,
the &#8220;Consents&#8221;) to the April 2024 Note issued and sold to Lind Global Fund II LP pursuant to the April 2024 Purchase
Agreement. The Consents, among other things, reduced the amounts due to the April 2024 Purchasers on September 1, 2024 by an aggregate
of $1.2 million to an aggregate of $0.3 million, increased the amounts due to the April 2024 Purchasers on December 1, 2024 by
an aggregate of $1.2 million, and prospectively waived any term of the April 2024 Notes that would otherwise be triggered upon
a failure of the Company to pay to the April 2024 Purchasers the remainder of the amount due on September 1, 2024. Except as modified
by the Consents, the terms of the April 2024 Notes as previously disclosed are unchanged.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 36.25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         June 24, 2024, the Company closed a non-brokered private placement (the &#8220;June 2024
                                         Private Placement&#8221;) with a single investor of 315,000 units of the Company (the
                                         &#8220;June 2024 Units&#8221;), at a price of $1.91 per June 2024 Unit, for aggregate
                                         gross proceeds of $0.6 million. Each June 2024 Unit consisted of one
                                         Common Share and one Warrant (the &#8220;June 2024 Warrants&#8221;). Each June 2024 Warrant
                                         is exercisable for one Common Share at a price of $2.20 until June 24, 2026.</span></td></tr></table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 1.25pt">On September 11, 2024, the Company entered into the Smith Loan Agreement
with Mark Smith, our Chief Executive Officer, President and Executive Chairman, pursuant to which Mr. Smith agreed to make available
to the Company a non-revolving, multiple draw credit facility of up to $2.0 million. Borrowings under the Smith Loan Agreement
bear interest at a rate of 10% per annum and are subject to an establishment fee equal to 2.5% of the amount of any drawdown payable
at the time of the drawdown. Any outstanding balance on</td></tr></table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
                                                                                                                      <tr style="vertical-align: top">
<td style="width: 18.25pt">&#160;</td><td style="width: 18pt">&#160;</td><td style="text-align: justify; padding-right: 1.25pt"> the Loan, including accrued interest, shall be immediately due and payable
by the Company on the earlier of the date of expiration of the Smith Loan Agreement on June 30, 2025 and the occurrence of an event
of default thereunder (the &#8220;Due Date&#8221;). The Company can repay the Loan at any time without notice and without penalty,
but any amount of principal or interest repaid by the Company prior to the Due Date will be subject to an early payment fee of
2.5% of the value of any such payment. Amounts outstanding under the Smith Loan Agreement are secured by all of the Company&#8217;s
assets pursuant to a general security agreement between the Company and Mr. Smith, dated September 11, 2024.</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a044"></span>Cash
Flow Considerations</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has historically relied upon debt and equity financings to finance its activities. Subject to the restrictions set forth
in the Exchange Agreement and the April 2024 Purchase Agreement, the Company may pursue additional debt and/or equity financing
in the medium term; however, there can be no assurance the Company will be able to obtain any required financing in the future
on acceptable terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;The
Company has limited financial resources compared to its proposed expenditures, no source of operating income, and no assurance
that additional funding will be available to it for current or future projects, although the Company has been successful in the
past in financing its activities through the sale of equity securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability of the Company to arrange additional financing in the future will depend, in part, on the prevailing capital market conditions,
and its success in developing the Elk Creek Project. Any quoted market for the Common Shares may be subject to market trends generally,
notwithstanding any potential success of the Company in creating revenue, cash flows, or earnings, and any depression of the trading
price of the Common Shares could impact its ability to obtain equity financing on acceptable terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
the Company has used net proceeds from issuances of Common Shares to provide sufficient funds to meet its near-term exploration
and development plans and other contractual obligations when due. However, development and construction of the Elk Creek Project
will require substantial additional capital resources. This includes near-term funding and, ultimately, funding for Elk Creek
Project construction and other costs. See &#8220;<i>Liquidity and Capital Resources&#8221; </i>above, for the Company&#8217;s
discussion of arrangements related to possible future financings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Debt
Covenants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes contain events of default customary for instruments of their type (with customary grace periods, as applicable)
and provide that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to NioCorp, all outstanding April 2024 Notes will become due and payable immediately without further action or notice. If any
other type of event of default occurs and is continuing, then any holder may declare all of its April 2024 Notes to be due and
payable immediately. The April 2024 Purchase Agreement also contains certain covenants that, among other things, limit NioCorp&#8217;s
ability to use the proceeds from the April 2024 Purchase Agreement to repay related party debt or to enter into any variable rate
transaction other than with Yorkville, subject to certain exceptions. The Company was in compliance with these covenants as of
June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a045"></span>Environmental</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mining and exploration activities are subject to various federal and state laws and regulations governing the protection of the
environment. We have made, and expect to make in the future, expenditures to comply with such laws and regulations, but cannot
predict the full amount of such future expenditures. As of June 30, 2024 and 2023, we had accrued $48,000 and $48,000, respectively,
related to estimated environmental obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a046"></span>Forward-Looking
Statements</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing discussion and analysis, as well as certain information contained elsewhere in this Annual Report on Form 10-K, contain
&#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act
and Section&#160;21E of the Exchange Act, and are intended to be covered by the safe harbor created thereby. See the discussion
in &#8220;Forward-Looking Statements&#8221; in Item&#160;1., &#8220;Business.&#8221;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a047"></span>Accounting
Developments&#160;&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a discussion of Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements, see Note&#160;3 to the
consolidated financial statements included in this Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a048"></span>Critical
Accounting Estimates and Recent Accounting Pronouncements</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
significant accounting policies are described in&#160;Note 3&#160;to the Consolidated Financial Statements included in this Annual
Report on Form 10-K.&#160;As described in Note 3, we are required to make estimates and assumptions that affect the reported amounts
and related disclosures of assets, liabilities, revenue, and expenses. Our estimates are based on our experience and our interpretation
of economic, political, regulatory, and other factors that affect our business prospects. Many of the inputs into our estimation
process are subjective and are subject to uncertainty over time and therefore, actual results may differ significantly from our
estimates. Note 3 also discloses recent accounting pronouncements applicable to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe that our
most critical accounting estimates are related to the carrying value of our long term assets; accounting for income taxes and the
valuation of deferred tax assets; and the valuation of liabilities associated with warrants, convertible debt carried at fair value,
and Earnout Shares, as they require us to make assumptions that are highly uncertain at the time the accounting estimates are made
and changes in them are reasonably likely to occur from period to period. Management has discussed the development and selection
of these critical accounting estimates with the Audit Committee of our Board (the &#8220;Audit Committee&#8221;), and the Audit
Committee has reviewed the disclosures presented below. In addition, there are other items within our financial statements that
require estimation, but are not deemed to be critical. However, changes in estimates used in these and other items could have a
material impact on our consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Carrying
Value of Long-Lived Assets </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#8217;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. Key inputs include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Many of these inputs are subjective and are subject to uncertainty over time. Such evaluations compare estimated future
net cash flows with our carrying costs and future obligations on an undiscounted basis. If it is determined that the estimated
future undiscounted cash flows are less than the carrying value of the property, an impairment loss will be recorded, measured
by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Where estimates of future net cash
flows are not determinable and where other conditions indicate the potential for impairment, management uses available market
information and/or third-party valuation experts to assess if the carrying value can be recovered and to estimate fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
review and evaluate our long-lived assets, other than mineral properties, for impairment when events or changes in circumstances
indicate that the related carrying amounts may not be recoverable. An impairment loss is measured and recorded based on the estimated
fair value of the long-lived assets being tested for impairment and their carrying amounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have assets, hold interests, and conduct activities in the U.S. and Canada and are subject to their tax regimes. Tax laws are
complex and continue to evolve. While we have a history of losses, our assumptions made in tax returns are subject to review and
interpretation by taxing authorities and could be modified. Management judgment
is required in determining our provision for income taxes, our deferred tax assets and liabilities, and any valuation allowance
recorded against our deferred tax assets. We consider factors such as the cumulative income or loss in recent years; reversal
of deferred tax liabilities; projected future taxable income exclusive of temporary differences;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the character of the income tax
asset, including income tax positions; tax planning strategies and the period over which we expect the deferred tax assets to
be recovered in the determination of the valuation allowance. In the event that actual results differ from these estimates or
we adjust our estimates in the future, we may need to adjust our valuation allowance, which could materially impact our financial
position and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial
Instruments Carried at Fair Value</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair values of our Earnout Shares, Private Warrants, Contingent Consent Warrants, and convertible debt carried at fair value were
determined using various significant unobservable inputs, including a discount rate and our best estimate of expected volatility
and expected holding periods. Changes in the estimated fair values of these liabilities may have material impacts on our results
of operations in any given period, as any increases in these liabilities have a corresponding negative impact on our U.S. GAAP
results of operations. See Notes 9, 10, and 11c to our consolidated financial statements included in this Annual Report on Form
10-K for additional details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a049"></span>Other</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has one class of shares, being Common Shares. A summary of outstanding shares, share options, warrants, and convertible
debt option as of September 20, 2024, is set out below, on a fully diluted basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 96%; border-collapse: collapse; margin-left: 27pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 70%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
                                         Shares Outstanding </b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(fully
        diluted)</b></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,660,244</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    Shares<sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,282,116</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    options<sup>(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,455,500</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants<sup>(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,932,985</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    Debt<sup>(4)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,920,173</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         exchangeable into one Common Share at any time, and from time to time, until the tenth
                                         anniversary of the Closing Date.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 23pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         exercisable into one Common Share.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27pt"/><td style="width: 18pt">(3)</td><td style="text-align: justify; padding-right: 5pt">Includes 15,666,626 NioCorp Assumed Warrants that are each exercisable into
1.11829212 Common Shares, and 38,660,244 Warrants that are each exercisable into one Common Share.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27pt"/><td style="width: 18pt">(4)</td><td style="text-align: justify; padding-right: 9.5pt">Represents Common Shares issuable on conversion of April 2024 Notes with
an aggregate outstanding principal and accrued interest balance of $5.3 million as of September 20, 2024, at the fixed
conversion price of $2.75 per share.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in">ITEM&#160;7A.</td><td><span id="a050"></span>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a051"></span>Interest
rate risk</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s exposure to changes in market interest rates, relates primarily to the Company&#8217;s earned interest income
on cash deposits and short-term investments. The Company maintains a balance between the liquidity of cash assets and the interest
rate return thereon. The carrying amount of financial assets, net of any provisions for losses, represents the Company&#8217;s
maximum exposure to credit risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a052"></span>Foreign
currency exchange risk</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurs expenditures in both U.S. and Canadian dollars. Canadian dollar expenditures are primarily related to engineering
and metallurgical expenses, as well as certain professional services. As a result, currency exchange fluctuations may impact the
costs of our operating activities. To reduce this risk, we maintain sufficient cash balances in Canadian dollars to fund expected
near-term expenditures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><span id="a053"></span>Commodity
price risk</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is exposed to commodity price risk related to the elements associated with the Elk Creek Project. A significant decrease
in the global demand for these elements may have a material adverse effect on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Elk Creek Project is not in production,
and the Company does not currently hold any commodity derivative positions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;8.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b><span id="a054"></span>FINANCIAL
                                         STATEMENTS AND SUPPLEMENTARY DATA</b></span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="b001"></span><span style="font-size: 10pt"><b>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">To the shareholders&#160;and
the Board of Directors of NioCorp Developments Ltd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Opinion on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">We have audited the accompanying
consolidated balance sheet of NioCorp Developments Ltd. and subsidiaries (the "Company") as of June 30, 2024, the related
consolidated statements of operations and comprehensive loss, cash flows, and shareholders' equity (deficit) and redeemable noncontrolling
interest, for the year ended June 30, 2024, and the related notes (collectively referred to as the "financial statements").
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of
June 30, 2024, and the results of its operations and its cash flows for the year ended June 30, 2024, in conformity with accounting
principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">The accompanying financial statements
have been prepared assuming that the Company will continue as a going concern. As discussed in Note 4 to the financial statements,
the Company has a working capital deficit, an accumulated deficit, and does not generate any revenue. Further, the Company does
not have sufficient cash on hand to fund normal operations or the repayment of the April 2024 Notes for the next twelve months
These conditions raise substantial doubt about its ability to continue as a going concern. Management's plans in regard to these
matters are also described in Note 4. The consolidated financial statements do not include any adjustments that might result from
the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Basis for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">These financial statements are
the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements
based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States)
(PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and
the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">We conducted our audit in accordance
with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required
to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are
required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">Our audit included performing
procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing
procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and
disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates
made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Critical Audit Matter</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">The critical audit matter communicated
below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated
to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved
our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any
way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below,
providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>April 2024 Notes and Warrants
&#8212; Refer to Notes 3, 9, and 16 to the financial statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><i>Critical Audit Matter Description</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">On April 12, 2024, the Company
closed a private placement of convertible promissory notes with Yorkville and Lind Global for a principal amount of $8,000,000
(&#8220;April 2024 Notes&#8221;). As part of the transaction, the Company also issued warrants to the holders of the notes, which
gave the holders the right to purchase up to 615,385 common shares of NioCorp stock at a price of $3.25 per share. The notes will
mature on December 31, 2024 and the warrants will expire on April 12, 2027.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">The Company accounts for the
convertible promissory notes within Convertible Debt in current liabilities and has elected to value the notes at fair value in
accordance with Accounting Standards Codification (ASC) 815, <i>Derivatives and Hedging</i>. The Company uses a simulation model
to estimate the fair value of the convertible promissory notes and embedded features. Estimates and assumptions impacting the
fair value of the convertible promissory notes include the fair value per share of the underlying shares of common stock, the
term of the instruments, the expected volatility of the price of the underlying common stock and public warrants, the risk-free
interest rate, and the implied discount rate. The Company based the volatility assumption used to value the notes on the weighted
average of the Company&#8217;s common share volatility and the implied volatility of its public warrants over a timeframe consistent
with the expected term of the instrument. As of June 30, 2024, the fair value of the convertible promissory notes was $7,089,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">The Company accounts for the
associated warrants in accordance with ASC Topic 815, <i>Derivatives and Hedging</i>, and determined that at as of April 12, 2024,
the warrants should be classified as a warrant liability. The warrant liabilities are recognized at fair value at their inception
date and are remeasured each reporting period with changes in value recognized as non-operating gains and losses. The Company
uses a Black-Scholes option pricing model to determine the fair value of the warrants. Estimates and assumptions impacting the
fair value of the warrants include the fair value per share of the underlying shares of common stock, the term of the instruments,
the historical volatility of common shares and the risk-free interest rate. As of June 30, 2024, the fair value of the warrant
liability was $298,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
the significant assumptions made by management in determining the accounting treatment for the transaction and associated fair
value of the convertible promissory notes and warrants, performing audit procedures to evaluate the reasonableness of management's
conclusions and assumptions for determining the fair value of the instruments, required a high degree of auditor judgment and
an increased extent of effort, including the need to involve our fair value specialists and professionals with expertise in accounting
for complex financial instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><i>How the Critical Audit Matter
Was Addressed in the Audit</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">Our audit procedures related
to the April 2024 Notes and Warrants included the following, among others:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-size: 10pt">We
                                         evaluated management&#8217;s accounting position through the following procedures:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td><span style="font-size: 10pt">Obtained
                                         and evaluated the Company&#8217;s accounting memoranda regarding the application of the
                                         relevant accounting guidance for private placement warrants and embedded derivative features.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td><span style="font-size: 10pt">Obtained,
                                         read and compared the underlying terms and conditions of the relevant contracts to the
                                         Company&#8217;s accounting memoranda and evaluated management&#8217;s identification
                                         of significant terms and conditions for completeness and accuracy.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td><span style="font-size: 10pt">Evaluated
                                         the Company&#8217;s conclusions regarding the accounting treatment applied to the private
                                         placement transaction with the assistance of professionals with expertise in accounting
                                         for complex financial instruments.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-size: 10pt">Tested
                                         the fair value of the warrants at issuance and June 30, 2024, including the model and
                                         relevant assumptions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-size: 10pt">Independently
                                         calculated the loss on issuance and change in fair value between issuance and June 30,
                                         2024 for the convertible promissory notes and warrants.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-size: 10pt">Confirmed
                                         the outstanding principal balance of the convertible promissory notes as of June 30,
                                         2024 with the holders of the notes.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-size: 10pt">With
                                         the assistance of our fair value specialists, we:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
                                         the reasonableness of the valuation methodologies used for the convertible promissory
                                         notes.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#9675;</span></td><td><span style="font-size: 10pt">Assessed
                                         the mathematical accuracy of the valuation model used for convertible promissory notes.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
                                         assumptions including the risk-free rates, discount rates, and the volatility assumptions,
                                         including the underlying source information and mathematical accuracy of the calculations,
                                         based on a range of independent estimates that we compared to the risk-free rates, discount
                                         rate and the volatility assumptions selected by management to value the convertible promissory
                                         notes.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#9675;</span></td><td><span style="font-size: 10pt">Compared
                                         the fair value of the convertible promissory notes selected by management to an independently
                                         calculated value at issuance and June 30, 2024.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#9675;</span></td><td><span style="font-size: 10pt">Evaluated
                                         the appropriateness of the volatility assumptions and use of the Black-Sholes option
                                         pricing model to value the warrant liability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-size: 10pt">Evaluated
                                         the completeness and accuracy of the disclosures related to the April private placement
                                         transaction.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><i>/s/ <span id="xdx_906_edei--AuditorName_c20230701__20240630_zLLVLHDygNp6"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000047" name="dei:AuditorName">DELOITTE &amp; TOUCHE
LLP</ix:nonNumeric></span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><span id="xdx_90A_edei--AuditorLocation_c20230701__20240630_zZ2hW9aO0Bdh"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000048" name="dei:AuditorLocation">Denver, Colorado&#160;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">September 20, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="display: none; font-size: 10pt; visibility: hidden">&#160;<span id="xdx_900_edei--AuditorFirmId_c20230701__20240630_zUVVZQx7bB4j"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000049" name="dei:AuditorFirmId">34</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">We have served as the Company's
auditor since fiscal year 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif"><br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><b><span id="b002"></span>Report
of Independent Registered Public Accounting Firm</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
and Board of Directors&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Centennial,
Colorado</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of NioCorp Developments Ltd. (the &#8220;Company&#8221;) as of June
30, 2023, the related consolidated statement of operations and comprehensive loss, shareholders&#8217; deficit and redeemable
noncontrolling interest, and cash flows for the year then ended, and the related notes (collectively referred to as the &#8220;consolidated
financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects,
the financial position of the Company at June 30, 2023, and the results of its operations and its cash flows for the year then
ended, in conformity with accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern Uncertainty</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern.
As discussed in Note 4 to the consolidated financial statements, the Company has an accumulated deficit and suffered recurring
losses without any current revenue generating operations. These conditions raise substantial doubt about the Company&#8217;s ability
to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 4. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an
opinion on the Company&#8217;s consolidated financial statements based on our audit. We are a public accounting firm registered
with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with
respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether
due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting
but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.
Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the
accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the
consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>/s/
BDO USA, P.C.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
served as the Company&#8217;s auditor from 2015 to 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spokane,
Washington</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
6, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>





<p style="margin: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NioCorp
Developments Ltd.&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b003"></span>Consolidated
Balance Sheets</b></span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(expressed
in thousands of U.S. dollars, except share data)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_111_pn3n3_zDAP06hBJfL9" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_495_20240630_z1VDpJwF3Jdh" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49C_20230630_z9dWS5jG9Q4" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td/></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AssetsAbstract_iB_z4w5lb6Ufz43" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-left: 0.25in; text-indent: -0.125in">ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--AssetsCurrentAbstract_iB_zENtBdW4ilI7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-left: 0.25in; text-indent: -0.125in">Current</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_409_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01I_maACz3Gm_zZN1lzLMZx1k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left; padding-left: 0.375in; text-indent: -0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-06-30" id="Fact000057" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-06-30" id="Fact000058" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,341</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--PrepaidExpenseCurrent_i01I_maACz3Gm_zhyDmGtSul8a" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Prepaid expenses and other</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2024-06-30" id="Fact000060" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">916</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2023-06-30" id="Fact000061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,385</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--AssetsCurrent_i01TI_mtACz3Gm_maAzvMa_zVAbZfUXdBDi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-06-30" id="Fact000063" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,928</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-06-30" id="Fact000064" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,726</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--AssetsNoncurrentAbstract_iB_zqSpxcL9Ht74" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-left: 0.25in; text-indent: -0.125in">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--DepositsAssets_i01I_maAzvMa_zlOLuRTODQm2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepositsAssets" contextRef="AsOf2024-06-30" id="Fact000069" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepositsAssets" contextRef="AsOf2023-06-30" id="Fact000070" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--LongTermInvestmentsAndReceivablesNet_i01I_maAzvMa_zF2cCStahQJg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Investment in equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermInvestmentsAndReceivablesNet" contextRef="AsOf2024-06-30" id="Fact000072" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermInvestmentsAndReceivablesNet" contextRef="AsOf2023-06-30" id="Fact000073" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--FinanceLeaseRightOfUseAsset_i01I_maAzvMa_z0n9ieAycWo" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2024-06-30" id="Fact000075" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">181</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2023-06-30" id="Fact000076" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">236</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_i01I_maAzvMa_zEAl7pXC4cpl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Land and buildings, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30" id="Fact000078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">837</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30" id="Fact000079" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">839</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--CapitalizedCostsMineralInterestsInUnprovedProperties_i01I_maAzvMa_zeECo6CciSvi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Mineral properties</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties" contextRef="AsOf2024-06-30" id="Fact000081" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,085</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties" contextRef="AsOf2023-06-30" id="Fact000082" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,085</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--Assets_i01TI_mtAzvMa_zdJBdaLVQNV7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Total assets</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-06-30" id="Fact000084" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,070</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-06-30" id="Fact000085" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,930</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--LiabilitiesAbstract_iB_zu48h3idlje6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-left: 0.25in; text-indent: -0.125in">LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesCurrentAbstract_iB_zqA8qFw1zWHi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-left: 0.25in; text-indent: -0.125in">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--AccountsPayableCurrent_i01I_maLCznIq_zFColLte63wf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-06-30" id="Fact000093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,843</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-06-30" id="Fact000094" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,491</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--OtherLiabilitiesCurrent_i01I_maLCznIq_zbm2n7oq5RYb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Warrant liabilities, at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000096" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,365</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0097">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ConvertibleDebtCurrent_i01I_maLCznIq_z54A8E2DF7Ib" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2024-06-30" id="Fact000099" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,660</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0100">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_maLCznIq_zT8y9QZ3S2qe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Operating lease liability</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-06-30" id="Fact000102" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">96</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-06-30" id="Fact000103" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">71</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--LiabilitiesCurrent_i01TI_mtLCznIq_maLzxGP_zptGOCAtKnnj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000105" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,964</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-06-30" id="Fact000106" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,562</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--LiabilitiesNoncurrentAbstract_iB_zs0qOHaizYT1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ConvertibleDebtNoncurrent_i01I_maLzxGP_zXFdvjJ5VNU" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0111">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2023-06-30" id="Fact000112" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,561</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLzxGP_zhwfhzIg2W61" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Warrant liabilities, at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2024-06-30" id="Fact000114" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,651</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-06-30" id="Fact000115" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,989</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--EarnoutLiabilityAtFairValue_i01I_pn3n3_uUSD_maLzxGP_zwmL2kRcdJ5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Earnout liability, at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:EarnoutLiabilityAtFairValue" contextRef="AsOf2024-06-30" id="Fact000117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,817</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:EarnoutLiabilityAtFairValue" contextRef="AsOf2023-06-30" id="Fact000118" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,521</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maLzxGP_zoaej0otmmaj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Operating lease liability</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact000120" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-06-30" id="Fact000121" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">164</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--Liabilities_i01TI_mtLzxGP_maLASEzODM_zzmfG7yczE71" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-06-30" id="Fact000123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,536</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-06-30" id="Fact000124" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,797</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzODM_zpBRIAUsjYi1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Commitments and contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--RedeemableNoncontrollingInterestEquityCarryingAmount_i01I_maLASEzODM_zE2FC3ZXZaJ1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Redeemable noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" contextRef="AsOf2024-06-30" id="Fact000129" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,534</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" contextRef="AsOf2023-06-30" id="Fact000130" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,100</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_iB_z1fxZpVwlYi1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.25in; text-indent: -0.125in">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--CommonStockValue_i01I_maSEzQdU_zsDyB1KvKLU9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Common stock, <span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20240630_zl7MTx0jNYF7" title="Common stock, par value (in dollars per share)"><span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20230630_zMdUaUXIrQU1" title="Common stock, par value (in dollars per share)"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30" id="Fact000138" format="ixt-sec:numwordsen" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30" id="Fact000140" format="ixt-sec:numwordsen" decimals="INF" unitRef="USDPShares">no</ix:nonFraction></ix:nonFraction></span></span> par value, <span id="xdx_906_eus-gaap--CommonStockSharesAuthorizedUnlimited_dxL_c20230701__20240630_zANukZ2Ey9Wg" title="Common stock, authorized::XDX::Unlimited"><span id="xdx_906_eus-gaap--CommonStockSharesAuthorizedUnlimited_dxL_c20220701__20230630_zEoajSjLjSWb" title="Common stock, authorized::XDX::Unlimited"><span style="-sec-ix-hidden: xdx2ixbrl0142"><span style="-sec-ix-hidden: xdx2ixbrl0144">unlimited</span></span></span></span> shares authorized; <span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630_zOcq3wXdQd5f" title="Common stock, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30" id="Fact000146" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,062,647</ix:nonFraction></span> and <span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630_zgmLmoFsxsCe" title="Common stock, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30" id="Fact000148" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,202,131</ix:nonFraction></span> shares outstanding, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30" id="Fact000135" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">163,823</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-06-30" id="Fact000136" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140,421</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maSEzQdU_zo7lxEd4VQgi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-06-30" id="Fact000150" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">161,912</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-06-30" id="Fact000151" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">150,477</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i01I_maSEzQdU_zmw781ICQP6a" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Accumulated other comprehensive loss</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2024-06-30" id="Fact000153" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2023-06-30" id="Fact000154" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--StockholdersEquity_i01TI_mtSEzQdU_maLASEzODM_zM5puqD1Zcqe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Total shareholders&#8217; equity(deficit)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000156" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" id="Fact000157" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,967</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzODM_zbaVLzc4uZWe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Total liabilities, redeemable noncontrolling interest, and shareholders&#8217; equity (deficit)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000159" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,070</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-06-30" id="Fact000160" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,930</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NioCorp
Developments Ltd.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b004"></span>Consolidated
Statements of Operations and Comprehensive Loss</b></span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">(expressed in thousands of U.S. dollars,
except share and per share data)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_113_pn3n3_z3lCG3H8rrui" summary="xdx: Statement - Consolidated Statements of Operations and Comprehensive Loss" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_492_20230701__20240630_zPIWTFvVxHt1" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49A_20220701__20230630_zquOSr5LHVH2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year <br/>ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--OperatingExpensesAbstract_iB_zEITEH5lm3ie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--LaborAndRelatedExpense_i01_maOEzpnM_zOCXRsRg2F52" style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left; padding-left: 0.375in; text-indent: -0.125in">Employee related costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000165" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,509</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2022-07-012023-06-30" id="Fact000166" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,323</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ProfessionalFees_i01_maOEzpnM_z0X4tke5C2Kj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-07-01to2024-06-30" id="Fact000168" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,533</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2022-07-012023-06-30" id="Fact000169" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,581</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--ExplorationExpenditures_i01_maOEzpnM_z27rQnVOaTSl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Exploration expenditures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ExplorationExpenditures" contextRef="From2023-07-01to2024-06-30" id="Fact000171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,552</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ExplorationExpenditures" contextRef="From2022-07-012023-06-30" id="Fact000172" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,348</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OtherGeneralExpense_i01_maOEzpnM_zmEF6kEOBLn8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Other operating expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000174" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,163</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2022-07-012023-06-30" id="Fact000175" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">27,158</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingExpenses_i01T_mtOEzpnM_msILFCOz2SY_z9sUViK5EXy1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Total operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-07-01to2024-06-30" id="Fact000177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,757</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-07-012023-06-30" id="Fact000178" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,410</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--ChangeInFairValueOfEarnoutLiability_i01N_di_maILFCOz2SY_zu613avZvBc4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Change in fair value of earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutLiability" contextRef="From2023-07-01to2024-06-30" id="Fact000180" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,704</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutLiability" contextRef="From2022-07-012023-06-30" id="Fact000181" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,674</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_408_ecustom--ChangeInFairValueOfWarrantLiability_i01N_di_maILFCOz2SY_zE80f2sS8394" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2023-07-01to2024-06-30" id="Fact000183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,875</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2022-07-012023-06-30" id="Fact000184" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,414</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--ChangeInFairValueOfConvertibleNotes_i01N_di_maILFCOz2SY_zL6XF2Dm5agl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Change in fair value of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfConvertibleNotes" contextRef="From2023-07-01to2024-06-30" id="Fact000186" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,542</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0187">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--ExtinguishmentOfDebtAmount_i01_msILFCOz2SY_zLRyLqXKV7Qf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0189">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ExtinguishmentOfDebtAmount" contextRef="From2022-07-012023-06-30" id="Fact000190" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,922</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--InterestExpense_i01_msILFCOz2SY_zgzuNVS9KZwf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000192" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,490</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-07-012023-06-30" id="Fact000193" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,336</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i01N_di_maILFCOz2SY_zaN6HZ6F3x5g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Foreign exchange loss (gain)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2023-07-01to2024-06-30" id="Fact000195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2022-07-012023-06-30" id="Fact000196" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">216</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OtherIncome_i01N_di_maILFCOz2SY_zEZv3Hgq2T2l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Other gains</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2023-07-01to2024-06-30" id="Fact000198" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">147</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2022-07-012023-06-30" id="Fact000199" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_i01N_di_maILFCOz2SY_z2knspUblkQc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Loss on equity securities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" contextRef="From2023-07-01to2024-06-30" id="Fact000201" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" contextRef="From2022-07-012023-06-30" id="Fact000202" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_i01T_mtILFCOz2SY_maPLzawJ_zGFVKoyRPzuc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" contextRef="From2023-07-01to2024-06-30" id="Fact000204" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,037</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" contextRef="From2022-07-012023-06-30" id="Fact000205" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,612</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_i01_msPLzawJ_zE0T2pDnmEk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Income tax benefit</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-01to2024-06-30" id="Fact000207" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">139</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-07-012023-06-30" id="Fact000208" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">304</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40A_ecustom--ProfitLoss1_i01NT_di_mtPLzawJ_maPLzJP1_zBhGhSenxPSi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ProfitLoss1" contextRef="From2023-07-01to2024-06-30" id="Fact000210" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,898</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ProfitLoss1" contextRef="From2022-07-012023-06-30" id="Fact000211" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,308</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_i01_msPLzJP1_zZzrPziLpLAd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Net loss attributable to redeemable noncontrolling interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-01to2024-06-30" id="Fact000213" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">463</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-06-30" id="Fact000214" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--ProfitLoss_i01NT_di_mtPLzJP1_z7xmutz8iDy4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Net loss attributable to the Company</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000216" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,435</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30" id="Fact000217" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,080</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract_iB_zsAohSQTS6Hc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Other comprehensive loss:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_maCINOTzAqm_z5hWTAfjjuJb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net loss</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000222" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,898</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30" id="Fact000223" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,308</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_i01B_zOeYuFjNtYCe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Other comprehensive gain:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_i01_maCINOTzAqm_ztViWvcL9Dtb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Reporting currency translation</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0228">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" contextRef="From2022-07-012023-06-30" id="Fact000229" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">82</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_400_eus-gaap--ComprehensiveIncomeNetOfTax_i01NT_di_mtCINOTzAqm_maOEMIBz0EM_zK1er7KqS0L7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Total comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-07-01to2024-06-30" id="Fact000231" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,898</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-07-012023-06-30" id="Fact000232" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,226</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest_i01_msOEMIBz0EM_zPQrkq1ITf85" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Comprehensive loss attributable to redeemable noncontrolling interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" contextRef="From2023-07-01to2024-06-30" id="Fact000234" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">463</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" contextRef="From2022-07-012023-06-30" id="Fact000235" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_i01NT_di_mtOEMIBz0EM_zvqc0PNRj1eg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Comprehensive loss attributable to the Company</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2023-07-01to2024-06-30" id="Fact000237" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,435</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2022-07-012023-06-30" id="Fact000238" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39,998</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--EarningsLossPerShareBasicAndDiluted_i01_pid_uUSDPShares_zfkvOy86bB6d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Loss per common share, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2023-07-01to2024-06-30" id="Fact000240" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.31</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2022-07-012023-06-30" id="Fact000241" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.34</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_i01_pid_uShares_zyQm3pCBX6I6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-left: 0.25in; text-indent: -0.125in">Weighted average common shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2023-07-01to2024-06-30" id="Fact000243" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,320,024</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2022-07-012023-06-30" id="Fact000244" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,705,840</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements</span></p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: left"><b>NioCorp Developments Ltd.</b></p>

<p style="margin-top: 0; margin-bottom: 0; text-align: left"><b><span id="b005"></span>Consolidated Statements of Cash Flows</b></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; text-align: left"><b></b></p>

<p style="margin-top: 0; margin-bottom: 0; text-align: left">(expressed in thousands of U.S. dollars)<span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_112_pn3n3_zfh6g9mdU8zk" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49C_20230701__20240630_zTjdMyf3W8wc" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_490_20220701__20230630_zlv9Jl126MI2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year <br/>ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zVOEnsDDgHc7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.25in; text-indent: -0.125in">CASH FLOWS FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--NetIncomeLoss_i01_maNCPBUzn2M_msATRNIzdo4_zyl2BRjnRqV2" style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left; padding-left: 0.375in; text-indent: -0.125in">Net loss for the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000249" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,898</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30" id="Fact000250" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,308</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zjz8aDsWMkE7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Adjustments for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--AssumptionOfEarnoutLiability_i01_maNCPBUzn2M_maATRNIzdo4_zIFT0gkItfPf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Initial valuation of earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0255">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:AssumptionOfEarnoutLiability" contextRef="From2022-07-012023-06-30" id="Fact000256" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,195</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--ChangeInFairValueOfEarnoutShareLiability_i01_maNCPBUzn2M_maATRNIzdo4_zNs13I0tD2p8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Change in valuation of earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutShareLiability" contextRef="From2023-07-01to2024-06-30" id="Fact000258" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,704</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutShareLiability" contextRef="From2022-07-012023-06-30" id="Fact000259" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,674</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40D_ecustom--AssumptionOfPrivateAndPublicWarrants_i01_maNCPBUzn2M_maATRNIzdo4_zvRkVhgZgZf5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Initial valuation of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0261">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:AssumptionOfPrivateAndPublicWarrants" contextRef="From2022-07-012023-06-30" id="Fact000262" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,987</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ChangeInValuationOfWarrantLiabilities_i01_maNCPBUzn2M_maATRNIzdo4_zG5s8LAsaRxl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Change in valuation of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInValuationOfWarrantLiabilities" contextRef="From2023-07-01to2024-06-30" id="Fact000264" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,875</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInValuationOfWarrantLiabilities" contextRef="From2022-07-012023-06-30" id="Fact000265" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,414</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--ChangeInFairValueOfConvertibleNote_i01_maNCPBUzn2M_maATRNIzdo4_zyWGRqQjNL25" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Change in fair value of convertible note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfConvertibleNote" contextRef="From2023-07-01to2024-06-30" id="Fact000267" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,542</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0268">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--AccretionExpense_i01_maNCPBUzn2M_maATRNIzdo4_zHrUYGhcuXk7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Accretion of convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000270" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,490</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2022-07-012023-06-30" id="Fact000271" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,157</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--ShareBasedCompensation_i01_maNCPBUzn2M_maATRNIzdo4_zCRb7GhzATkh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-07-01to2024-06-30" id="Fact000273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,881</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-07-012023-06-30" id="Fact000274" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,794</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--LossesOnExtinguishmentOfDebt_i01_maNCPBUzn2M_maATRNIzdo4_zrq2GMDihiCk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0276">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:LossesOnExtinguishmentOfDebt" contextRef="From2022-07-012023-06-30" id="Fact000277" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,422</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--FairValueOfCommitmentSharesIssued_i01_maATRNIzdo4_zehl0sQNfRSc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Yorkville share issuances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:FairValueOfCommitmentSharesIssued" contextRef="From2023-07-01to2024-06-30" id="Fact000279" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">105</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:FairValueOfCommitmentSharesIssued" contextRef="From2022-07-012023-06-30" id="Fact000280" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">663</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--ForeignCurrencyTransactionGainLossBeforeTax1_i01_maNCPBUzn2M_maATRNIzdo4_zd7sU5mF3UAe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Foreign exchange loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ForeignCurrencyTransactionGainLossBeforeTax1" contextRef="From2022-07-012023-06-30" id="Fact000283" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--Depreciation_i01_maNCPBUzn2M_maATRNIzdo4_zAvSJNJGnADh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-07-01to2024-06-30" id="Fact000285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-07-012023-06-30" id="Fact000286" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--UnrealizedGainLossOnInvestments_i01N_di_msNCPBUzn2M_msATRNIzdo4_z0a0qE1czyu1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Unrealized loss on equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2023-07-01to2024-06-30" id="Fact000288" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2022-07-012023-06-30" id="Fact000289" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseImpairmentLoss_i01_maNCPBUzn2M_maATRNIzdo4_zCrUjO7JvDHi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Noncash lease activity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="From2022-07-012023-06-30" id="Fact000292" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_402_ecustom--OtheroperatingGainsLosses_i01N_di_msNCPBUzn2M_msATRNIzdo4_zUBwMgEiyay6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.5in; text-indent: -0.125in">Other gains</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:OtheroperatingGainsLosses" contextRef="From2023-07-01to2024-06-30" id="Fact000294" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:OtheroperatingGainsLosses" contextRef="From2022-07-012023-06-30" id="Fact000295" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt">)</td></tr>

<tr id="xdx_402_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_i01T_mtATRNIzdo4_zy0dlIzy200h" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000297" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,580</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2022-07-012023-06-30" id="Fact000298" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19,171</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_iB_zHkfh6y26GC8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Change in working capital items:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01N_di_msNCPBUzn2M_zoaeDtKwBIlf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000303" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">469</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-07-012023-06-30" id="Fact000304" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">985</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i01_maNCPBUzn2M_zcy4S11V49o2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.5in; text-indent: -0.125in">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-07-01to2024-06-30" id="Fact000306" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,621</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-07-012023-06-30" id="Fact000307" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,861</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzU7j_mtNCPBUzn2M_zbFSQcpevzyb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Net cash used in operating activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000309" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,732</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-07-012023-06-30" id="Fact000310" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,295</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zWl8dAIsnRyk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 0.25in; text-indent: -0.125in">CASH FLOWS FROM INVESTING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ProceedsFromSaleOfProductiveAssets_i01_maNCPBUzDV6_zAMhbktKBFM2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Proceeds from sale of assets</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0315">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2022-07-012023-06-30" id="Fact000316" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUzDV6_maCCERCzU7j_zE3GfFhRNgt1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Net cash provided by investing activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0318">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-07-012023-06-30" id="Fact000319" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zwujkdm0OPD9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 0.25in; text-indent: -0.125in">CASH FLOWS FROM FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUz6yL_zOSNzwq1OSsl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Issuance of debt, net of costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-07-01to2024-06-30" id="Fact000324" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,935</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-07-012023-06-30" id="Fact000325" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,857</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maNCPBUz6yL_zA0A3LjR48j5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Proceeds from issuance of capital stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-07-01to2024-06-30" id="Fact000327" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,185</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-07-012023-06-30" id="Fact000328" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,499</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--ProceedsFromRelatedPartyDebt_i01_maNCPBUz6yL_znZhexjGSTpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Related party debt draws</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0330">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2022-07-012023-06-30" id="Fact000331" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,130</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--RepaymentsOfRelatedPartyDebt_i01N_di_msNCPBUz6yL_zOaC41wFWLJd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Related party debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0333">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2022-07-012023-06-30" id="Fact000334" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,130</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--RepaymentsOfDebt_i01N_di_msNCPBUz6yL_z7xhDNJhJ3me" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2023-07-01to2024-06-30" id="Fact000336" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,512</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2022-07-012023-06-30" id="Fact000337" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">515</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--PaymentsOfStockIssuanceCosts_i01N_di_msNCPBUz6yL_zti6six0vnpi" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Share issue costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-07-01to2024-06-30" id="Fact000339" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">205</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2022-07-012023-06-30" id="Fact000340" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">204</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUz6yL_maCCERCzU7j_z6q6EFjhVfYh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000342" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,403</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-07-012023-06-30" id="Fact000343" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,637</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01_maCCERCzU7j_zLPHr1Ywoc6h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Exchange rate effect on cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0345">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2022-07-012023-06-30" id="Fact000346" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">302</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_i01T_mtCCERCzU7j_zEqX24ZwDjr3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Change in cash and cash equivalents during period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-07-01to2024-06-30" id="Fact000348" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">329</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-07-012023-06-30" id="Fact000349" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,939</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01S_zC2tou3aG3fc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Cash and cash equivalents, beginning of period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000351" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,341</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-06-30" id="Fact000352" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,280</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01E_zdDcX8Bwru7c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Cash and cash equivalents, end of period</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000354" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000355" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,341</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zEv0O6r1T36j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Supplemental cash flow information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--InterestPaidNet_i01_zTcG7sXdue7c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Amounts paid for interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0360">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-07-012023-06-30" id="Fact000361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">264</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_z4BEODsvYAY" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Non-cash investing and financing transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--ConversionsOfDebtForCommonShares_i01_zcqPVjm4syO5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Conversion of debt for common shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000366" name="niobf:ConversionsOfDebtForCommonShares">14,479</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonNumeric contextRef="From2022-07-012023-06-30" id="Fact000367" name="niobf:ConversionsOfDebtForCommonShares">5,175</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--RecognitionOfOperatingLeaseLiabilities_i01_z3rw11pal3f1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Recognition of operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0369">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="From2022-07-012023-06-30" id="Fact000370" name="niobf:RecognitionOfOperatingLeaseLiabilities">199</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--ValueOfWarrantsIssued_i01_zfGQHqcllv14" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Value of warrants issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0372">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="From2022-07-012023-06-30" id="Fact000373" name="niobf:ValueOfWarrantsIssued">3,337</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p>

<p style="margin-top: 0; margin-bottom: 0"><b><span id="b006"></span>Consolidated Statements of Shareholders&#8217; Equity (Deficit) and Redeemable Noncontrolling
Interest</b></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"><b></b></p>

<p style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars, except share data)</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_304_114_pn3n3_zixpGUjAVfke" summary="xdx: Statement - Consolidated Statements of Shareholders' Equity (Deficit) and Redeemable Noncontrolling Interest" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: right">Common Shares Outstanding</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zV4XozMYunyi" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Common Stock</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zExny31pBUM6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Accumulated Deficit</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zNASf0lXXIu4" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Accumulated Other Comprehensive Loss</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td colspan="2" id="xdx_4BD_z2picYwqGvC7" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Total</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_custom--RedeemableNoncontrollingInterestMember_zxOcu8Adb3t5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Redeemable Noncontrolling Interest</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_438_c20220701__20230630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zOXWrXJEZ4B1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; font-weight: bold; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Balance, June 30, 2022</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--CommonStockSharesOutstanding_iS_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVI7NBvzmvEa" title="Beginning balance (in shares)" style="border-bottom: Black 1pt solid; width: 8%; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" id="Fact000381" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,667,060</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" id="Fact000375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">129,055</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" id="Fact000376" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">110,397</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000377" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">993</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" id="Fact000378" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,665</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0379">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_z1zqwRp2mYa9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Exercise of options</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCB9EKVlmpHd" title="Exercise of options (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000389" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">265,138</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000383" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0384">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0385">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-07-012023-06-30" id="Fact000386" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0387">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--FairValueAdjustmentOfWarrants_zRE25nOOmTpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Fair value of warrants granted</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000391" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,338</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0392">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0393">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-07-012023-06-30" id="Fact000394" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,338</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0395">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--CommonSharesIssuedInTheGXIITransaction_zCLf3F07smfk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Common Shares issued in the GXII Transaction</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--CommonSharesIssuedInTheGXIITransactionShares_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zr4wruhasJge" title="Common Shares issued in the GXII Transaction (in shares)" style="text-align: right"><ix:nonFraction name="niobf:CommonSharesIssuedInTheGXIITransactionShares" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000403" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,753,821</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0397">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0398">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0399">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0400">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0401">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueOther_zysYLWohaila" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Commitment shares issued</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzzYIvdqVI61" title="Commitment shares issued (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000411" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">81,213</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000405" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0406">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0407">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-07-012023-06-30" id="Fact000408" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0409">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_zYuTgRySviX4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Registered direct offering &#8211; May 2023</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztrWEJV8DTw4" title="Registered direct offering May 2023 (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000419" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">314,465</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000413" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0414">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0415">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-07-012023-06-30" id="Fact000416" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0417">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--SharesIssuedUnderTheYorkvilleEquityFacility_zTf2dsuPHwAb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Shares issued under the Yorkville equity facility</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--SharesIssuedUnderTheYorkvilleEquityFacilityShares_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGTjLAFKvwi4" title="Shares issued under the Yorkville equity facility (in shares)" style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000427" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000421" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">501</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0422">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2022-07-012023-06-30" id="Fact000424" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">501</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0425">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_zXKJBO7nJXy2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Debt conversions</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxlSMqTkGX61" title="Debt conversions (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000435" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,020,434</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000429" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,604</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0430">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0431">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2022-07-012023-06-30" id="Fact000432" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,604</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0433">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z5aTimK8JXM8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Share issuance costs</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000437" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">204</ix:nonFraction></td><td style="text-align: left">)</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0438">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0439">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-07-012023-06-30" id="Fact000440" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">204</ix:nonFraction></td><td style="text-align: left">)</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0441">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--RedeemableNoncontrollingInterest_zebTadEdTaW6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Redeemable noncontrolling interest</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:RedeemableNoncontrollingInterest" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000443" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,328</ix:nonFraction></td><td style="text-align: left">)</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0444">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0445">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:RedeemableNoncontrollingInterest" contextRef="From2022-07-012023-06-30" id="Fact000446" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,328</ix:nonFraction></td><td style="text-align: left">)</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:RedeemableNoncontrollingInterest" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000447" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,328</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_z9AonHOwCe59" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Share-based compensation</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000449" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,794</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0450">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0451">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-07-012023-06-30" id="Fact000452" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,794</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0453">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zO44uJMLuKy7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Reporting currency presentation</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0455">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0456">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000457" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">82</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30" id="Fact000458" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">82</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0459">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--ProfitLoss_iN_di_zxaxKXESWT2f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Loss for the year</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0461">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="Fact000462" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,080</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0463">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30" id="Fact000464" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,080</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000465" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_437_c20230701__20240630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zDfvhlQY2cpa" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--CommonStockSharesOutstanding_iS_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfKDbTEMmm1c" title="Beginning balance (in shares)" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000473" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,202,131</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000467" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140,421</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000468" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">150,477</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000469" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" id="Fact000470" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,967</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000471" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,100</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zJqlClLo1Ohl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Exercise of options</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4fCmBvPOrDb" title="Exercise of options (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000481" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0475">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0476">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0477">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0478">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0479">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--PrivatePlacementValue_zwzoPvZdr9c6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Private placements</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--PrivatePlacementShares_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4sOSpgsIqY9" title="Private placement  (in shares)" style="text-align: right"><ix:nonFraction name="niobf:PrivatePlacementShares" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000489" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">978,432</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:PrivatePlacementValue" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000483" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">2,995</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0484">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0485">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:PrivatePlacementValue" contextRef="From2023-07-01to2024-06-30" id="Fact000486" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">2,995</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0487">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--SharesIssuedUnderTheYorkvilleEquityFacility_zjmkfwWNgNkj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Yorkville equity facility draws</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--SharesIssuedUnderTheYorkvilleEquityFacilityShares_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znpfB9J6TMyh" title="Shares issued under the Yorkville equity facility (in shares)" style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000497" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,358,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000491" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,398</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0492">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0493">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2023-07-01to2024-06-30" id="Fact000494" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,398</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0495">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_zzVIf34OEp41" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Debt conversions</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHKhjp2wuo8g" title="Debt conversions (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000505" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,232,592</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000499" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,479</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0500">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0501">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-01to2024-06-30" id="Fact000502" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,479</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zi5E8U1AdA45" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Share issuance costs</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000507" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">204</ix:nonFraction></td><td style="text-align: left">)</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0508">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-01to2024-06-30" id="Fact000510" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">204</ix:nonFraction></td><td style="text-align: left">)</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueStockDividend_iN_di_zLxUmXxZd5n" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Option liability valuations</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000513" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></td><td style="text-align: left">)</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0514">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2023-07-01to2024-06-30" id="Fact000516" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></td><td style="text-align: left">)</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0517">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_z7y2RDWbXFxk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Exchange of Class B shares</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTjTvLYOIkSa" title="Exchange of Class B shares (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000525" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">283,692</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000519" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0520">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0521">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-07-01to2024-06-30" id="Fact000522" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000523" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">103</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zJL8rEgeb24d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Share-based compensation</td><td>&#160;</td>
    <td style="border-left: Black 1pt solid; text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000527" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,779</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0528">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0529">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-07-01to2024-06-30" id="Fact000530" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,779</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0531">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ProfitLoss_iN_di_zVoCyVzb0yq3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Loss for the year</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0533">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="Fact000534" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,435</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0535">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000536" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,435</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000537" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">463</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_438_c20230701__20240630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zbVXvxaa5mkj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Balance, June 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; border-left: Black 1pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--CommonStockSharesOutstanding_iE_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z82bckq2pnS7" title="Ending balance (in shares)" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000545" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,062,647</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000539" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">163,823</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000540" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">161,912</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">)</td><td style="border-bottom: Black 2pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000541" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">)</td><td style="border-bottom: Black 2pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30" id="Fact000542" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000543" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,534</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p>

<p style="margin-top: 0; margin-bottom: 0"><b><span id="b007"></span>Notes to Consolidated Financial Statements</b></p>

<p style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p>

<!-- Field: Rule-Page --><div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000547" name="us-gaap:NatureOfOperations"><p id="xdx_80F_eus-gaap--NatureOfOperations_zD6PtwSAtQel" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_821_zW6VRr1DoiE">DESCRIPTION
                                         OF BUSINESS</span></span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd. (the &#8220;Company&#8221; or &#8220;NioCorp&#8221;) was incorporated on February 27, 1987, under the laws of
the Province of British Columbia and currently operates in <span id="xdx_90F_eus-gaap--NumberOfReportableSegments_dxL_uNUMBER_c20230701__20240630_zJc3cWKtp6z2" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0549">one</span></span> reportable operating segment consisting of exploration and development
of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property (the &#8220;Elk Creek Project&#8221;)
located in southeastern Nebraska.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed in Notes 5, 9, 10, and 11, on March 17, 2023 (the &#8220;Closing Date&#8221;), the Company closed the GXII Transaction
(as defined below) with GX Acquisition Corp. II (&#8220;GXII&#8221;), pursuant to the Business Combination Agreement, dated September
25, 2022 (the &#8220;Business Combination Agreement&#8221;), among the Company, GXII and Big Red Merger Sub Ltd (the &#8220;Closing&#8221;).
At the Closing, the Company also closed convertible debt financings (the &#8220;Yorkville Convertible Debt Financing&#8221;) with
YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (together with YA II PN, Ltd., &#8220;Yorkville&#8221;),
and the standby equity purchase facility with Yorkville (the &#8220;Yorkville Equity Facility Financing&#8221; and, together with
the Yorkville Convertible Debt Financing, the &#8220;Yorkville Financings&#8221;) became effective. The transactions contemplated
by the Business Combination Agreement, including the GXII Transaction, the Yorkville Financings and the Reverse Stock Split (as
defined below), are referred to, collectively, as the &#8220;2023 Transactions.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
GXII Transaction was accounted for as an equity raise transaction in accordance with generally accepted accounting principles
of the United States of America (&#8220;U.S. GAAP&#8221;). Under this method of accounting, GXII is treated as the &#8220;acquired&#8221;
company for financial reporting purposes. Accordingly, the GXII Transaction is treated as the equivalent of NioCorp issuing common
shares, no par value, of the Company (&#8220;Common Shares&#8221;) for the assets and liabilities of GXII. The net assets of GXII
are stated at historical cost, with no goodwill or other intangible assets recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 4, these matters raise substantial doubt about the Company&#8217;s
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing and maintaining continued support from its shareholders and creditors.</span></p>

</ix:nonNumeric><p id="xdx_817_zdmquZSWMZYk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000551" name="us-gaap:BasisOfAccounting"><p id="xdx_802_eus-gaap--BasisOfAccounting_zsQVKD3gUrj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82D_z5hzFCKjEWSc">BASIS
                                         OF PREPARATION</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
                                         of Preparation and Consolidation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements have been prepared in conformity with U.S. GAAP and the rules and regulations of the U.S. Securities
and Exchange Commission. The consolidated financial statements include the consolidated accounts of the Company and its wholly
owned subsidiaries with all significant intercompany transactions eliminated. Certain transactions include reference to Canadian
dollars (&#8220;C$&#8221;) where applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000553" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"><p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zf69pR31uxh6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; width: 97%; border-collapse: collapse">
<tr>
    <td rowspan="2" colspan="2" style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiary</span></td>
    <td rowspan="2" style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction
    of incorporation</span></td>
    <td>&#160;</td>
    <td colspan="3" style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    at June 30,</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="border-top: Black 1pt solid; width: 28%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800 BC Ltd. (&#8220;0896800&#8221;)</span></td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="border-top: Black 1pt solid; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zjCmO2yFTGz4" title="Country of incorporation"><span id="xdx_903_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zLkrTedR6Li4" title="Country of incorporation"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_Entity0896800BCLtdMember" id="Fact000555" name="niobf:IncorporationStateCountryName"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_Entity0896800BCLtdMember" id="Fact000557" name="niobf:IncorporationStateCountryName">British
    Columbia, Canada</ix:nonNumeric></ix:nonNumeric></span></span></span></td>
    <td style="width: 1%">&#160;</td>
    <td id="xdx_98D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_z8rt1hY4BU3k" style="border-top: Black 1pt solid; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2024-06-30_custom_Entity0896800BCLtdMember" id="Fact000558" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span></td>
    <td style="width: 1%">&#160;</td>
    <td id="xdx_98E_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zaMVCXvGfrKf" style="border-top: Black 1pt solid; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2023-06-30_custom_Entity0896800BCLtdMember" id="Fact000559" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zThpzWj8ANz1" title="Country of incorporation"><span id="xdx_909_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_z64JqIVxOu5i" title="Country of incorporation"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_ElkCreekResourcesCorpMember" id="Fact000561" name="niobf:IncorporationStateCountryName"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpMember" id="Fact000563" name="niobf:IncorporationStateCountryName">Nebraska,
    USA</ix:nonNumeric></ix:nonNumeric></span></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zWG4d2e4K7Ck" title="Percentage of ownership"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2023-06-30_custom_ElkCreekResourcesCorpMember" id="Fact000565" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% </span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp. (&#8220;ECRC&#8221;)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zOzbwCizq231" title="Country of incorporation"><span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zvuBARcqoNpk" title="Country of incorporation"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_ElkCreekResourcesCorpECRCMember" id="Fact000567" name="niobf:IncorporationStateCountryName"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpECRCMember" id="Fact000569" name="niobf:IncorporationStateCountryName">Delaware,
    USA</ix:nonNumeric></ix:nonNumeric></span></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zw7RJNX49Ww2" title="Percentage of ownership"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2024-06-30_custom_ElkCreekResourcesCorpECRCMember" id="Fact000571" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">79.7</ix:nonFraction></span>%<sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zi1J736PuuGf" title="Percentage of ownership"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2023-06-30_custom_ElkCreekResourcesCorpECRCMember" id="Fact000573" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">79.1</ix:nonFraction></span>%<sup>(1)</sup></span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    Technologies Limited</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zIJCeRfSoK58" title="Country of incorporation"><span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zc2xV3GIE6R7" title="Country of incorporation"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_NioCorpTechnologiesLimitedMember" id="Fact000575" name="niobf:IncorporationStateCountryName"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_NioCorpTechnologiesLimitedMember" id="Fact000577" name="niobf:IncorporationStateCountryName">United
    Kingdom</ix:nonNumeric></ix:nonNumeric></span></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zqOqhWwkifdi" title="Percentage of ownership"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2024-06-30_custom_NioCorpTechnologiesLimitedMember" id="Fact000579" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span id="xdx_F09_zSzo3oHuagfl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F1C_zdZyBZKB7Z3f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000580" xml:lang="en-US">Represents 100% of Class A common stock owned by 0896800, and 4,282,116 and 4,565,808 Vested Shares and 3,391,596 and 3,391,596
Earnout Shares (each as defined below) held by third parties, and outstanding as of June 30, 2024 and 2023, respectively.</ix:footnote></span></td></tr></table>

</ix:nonNumeric><p id="xdx_8A1_zBJ4Q2TIiE0k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zGn4eWA6n4lc" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zMpT1vlgYzj3" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zpkGwriKXCC6" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_z7Vauyn6mYY" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_231_zwjxcbG7SoYh" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_23A_z8AFAdlWLRY3" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
                                         of Estimates</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the consolidated financial statements, and the reported amounts of expenses during the reporting period. The Company regularly
evaluates estimates and assumptions related to the valuation of mineral properties, deferred income tax asset valuations, convertible
debt valuations, earnout valuation, derivative liabilities, warrant liabilities, and share-based compensation. The Company bases
its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable
under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results
experienced by the Company may differ materially and adversely from the Company&#8217;s estimates. To the extent there are material
differences between estimates and the actual results, future results of operations will be affected.</span></p>

</ix:nonNumeric><p id="xdx_81A_zxrA99euZMi5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000588" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zt4CN23jWZra" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_820_zPeyYA2MXzB8">SIGNIFICANT
                                         ACCOUNTING POLICIES</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000590" name="niobf:DevelopmentStageIssuerPolicyTextBlock"><p id="xdx_84B_ecustom--DevelopmentStageIssuerPolicyTextBlock_z6Ky6LyWq3Wg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zOxMMr2INzx4">Development
                                         Stage Issuer</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#8220;S-K 1300&#8221;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#8217;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#8217;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.</span></p>

</ix:nonNumeric><p id="xdx_85E_zBYenB0qbRz5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000592" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zyKcv3ZE804d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
                                         and Cash Equivalents</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90
days or less, and money market funds. The Company maintains the majority of its cash balances with two financial institutions.
Accounts at banks in the United States (&#8220;U.S.&#8221;) are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;)
up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance Corporation (&#8220;CDIC&#8221;) up
to C$100. At June 30, 2024, the Company had $1,406 and $0 in excess of the FDIC and CDIC insured limits, respectively.</span></p>

</ix:nonNumeric><p id="xdx_85F_zyACynnHwCae" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000594" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_849_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zFpeUIPaGY17" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_863_zlLDdyLwxws8">Foreign
                                         Currency Translation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Functional
and reporting currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
included in the financial statements of each of the Company&#8217;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#8220;the functional currency&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency for these consolidated financial statements is U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in functional currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to March 17, 2023, the Company&#8217;s functional currency was the Canadian dollar. The Company re-assessed its functional currency
and determined that on March 17, 2023, its functional currency changed from the Canadian dollar to the U.S. dollar based on significant
changes in economic facts and circumstances in our organization. The change in functional currency was accounted for prospectively
from March 17, 2023 and prior-period consolidated financial statements were not restated for the change in functional currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
both monetary and non-monetary assets and liabilities, translated balances as of March 17, 2023 became the new accounting basis.
The exchange rate on the date of change became the historical rate at which non-monetary assets and liabilities were translated
in subsequent periods. There was no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded
cumulative translation adjustments were not reversed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zXntVM71kA0h" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_z2nZLo9ZrY5c" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zBNSiH6L8Os4" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zYtlvqWJtwfa" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23F_zMsTNdQEvd4b" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_235_zDyOWROKw5P3" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency for the Company&#8217;s Canadian subsidiary, 0896800 BC Ltd., which has no independent operations from its
parent, also changed from the Canadian dollar to the U.S. dollar. The functional currency for Elk Creek Resources Corp. remains
as the U.S. dollar.</span></p>





<ix:exclude><p id="xdx_238_zxPYw1R5aIxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transactions
in foreign currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation
to reporting currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
gains and losses from the application of the U.S. dollar as the reporting currency for all periods prior to March 17, 2023 (when
the Canadian dollar was the functional currency) are included as part of cumulative currency translation adjustment, which is
reported as a component of shareholders&#8217; equity under accumulated other comprehensive loss.</span></p>

</ix:nonNumeric><p id="xdx_853_zu1ogsAIjjoj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000603" name="niobf:MineralPropertiesPolicyTextBlock"><p id="xdx_84F_ecustom--MineralPropertiesPolicyTextBlock_z871pBas3l0e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zFugxpbaTuvl">Mineral
                                         Properties</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of Common Shares issued as consideration. Properties acquired under option agreements,
whereby payments are made at the sole discretion of the Company, are capitalized as mineral property acquisition costs at such
time as the payments are made. Exploration costs are expensed as incurred. When it is determined that a mining deposit can be
economically and legally extracted or produced based on established proven and probable reserves under S-K 1300, and the Company&#8217;s
board of directors (the &#8220;Board&#8221;) has approved the commencement of formal development activities, development costs
related to such reserves and incurred after such board approval will be considered for capitalization. The establishment of proven
and probable reserves is based on results of feasibility studies, which indicate whether a property is economically feasible.
Upon commencement of commercial production, capitalized costs will be amortized over their estimated useful lives or units of
production, whichever is a more reliable measure. Capitalized amounts relating to a property that is abandoned or otherwise considered
uneconomic for the foreseeable future are written off.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#8217;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was no impairment recorded to mineral properties as of
June 30, 2024 or 2023, respectively.</span></p>

</ix:nonNumeric><p id="xdx_85C_zosz9HQMWyZ3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000605" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBC9mEc6STt1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zEaiVHlVtH27">Long
                                         Lived Assets</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zw8COhlRJSF7" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zGT9KjWcHD1g" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zYZrE9gjyXUi" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zzolmX8MvAp3" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_236_zn5Rl10zXfB2" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_238_zDpbBWNRfW9j" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was no impairment recorded to long-lived assets as of June 30, 2024 or 2023, respectively.</span></p>

</ix:nonNumeric><p id="xdx_851_zRDcCnhtaOr4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000613" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zw3U6fHn81tj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_z26z4m9B3eV7">Leases</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Accounting Standards Codification (&#8220;ASC&#8221;) 842, <i>Leases</i>, we determine if a contractual arrangement is, or contains,
a lease at the inception date. Right-of-use (&#8220;ROU&#8221;) assets and liabilities related to operating leases are separately
reported in the consolidated balance sheets. The Company currently has no finance leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.</span></p>

</ix:nonNumeric><p id="xdx_852_zMZ3v4YoUK2f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000615" name="niobf:ConvertibleDebtCarriedatFairValueTextBlock"><p id="xdx_84B_ecustom--ConvertibleDebtCarriedatFairValueTextBlock_zFf3LGmktr5j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
                                         Debt Carried at Fair Value</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With regard to the Company&#8217;s debt related to the convertible promissory notes issued in April 2024 (as further discussed in
Note 9), the Company has elected to account for these notes at fair value per the provisions of ASC Topic 815, <i>Derivatives
and Hedging</i> (&#8220;ASC 815&#8221;). Under ASC 815-15-25, an election can be taken at the inception of a financial instrument
to account for the instrument at fair value. The notes were recorded at fair value at inception and assessed quarterly thereafter
using a Monte Carlo simulation methodology which incorporates multiple conversion scenarios. All changes in fair value subsequent
to the initial recording, excluding the impact of the change in fair value related to the Company&#8217;s own credit risk, are
recorded as a component of non-operating income/expense, within Change in fair value of convertible debt in the consolidated statements
of operations. Changes in fair value related to the Company&#8217;s own credit risk, if any, are recorded through other comprehensive loss.</span></p>

</ix:nonNumeric><p id="xdx_856_z8PrHWApeFwb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000617" name="niobf:WarrantsPolicyTextBlock"><p id="xdx_84D_ecustom--WarrantsPolicyTextBlock_zVzXuHVnB1jg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_zFBuDFHSSjra">Warrants</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
apply relevant accounting guidance for warrants to purchase our stock based on the nature of the relationship with the counterparty.
For warrants issued to investors or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC
480, <i>Distinguishing Liabilities from Equity</i>, and ASC 815, to assist in the determination of whether the warrants should
be classified as liabilities or equity. The fair value of warrants is estimated using Black Scholes modeling or Monte Carlo modeling,
depending on the settlement features embedded in the warrant. Inputs under both models include inputs such as NioCorp&#8217;s
Common Share price, the risk-free interest rate, the expected term, the volatility, and the dividend rate. Warrants that are determined
to require liability classifications are measured at fair value upon issuance and are subsequently remeasured to their then fair
value at each subsequent reporting period with changes in fair value recorded in current earnings. Warrants that are determined
to require equity classifications measured at fair value upon issuance and are not subsequently remeasured unless they are required
to be reclassified.</span></p>

</ix:nonNumeric><p id="xdx_85F_zqVQtxg8taF9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000619" name="niobf:EarnoutSharesPolicy"><p id="xdx_844_ecustom--EarnoutSharesPolicy_zXvZc6JpFmed" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
                                         Shares</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The Earnout Shares
are measured at fair value upon issuance and subsequently remeasured at each reporting period using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#8217;s Common Share price, the risk-free interest rate, the expected term, the weighted
average of historical Common Share volatility and implied volatility underlying the Company&#8217;s Public Warrants, the dividend
rate, the conversion price, and the number of Earnout Shares outstanding. Assumptions used in the model are subjective and require
significant judgment.</span>&#160;</p>

</ix:nonNumeric><p id="xdx_857_zOo0ojmXRhib" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>







<ix:exclude><!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_ziBj0oQi4YT8" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zMipKBmO7c62" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z1Fdws3B7fg7" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zAmxi09h5fJ3" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_230_zC8tLxWxBTId" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_237_zEjxHGgtBSMb" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000627" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zeSl7pShaLzl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zymGassAsrg2">Financial
                                         Instruments</span></span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, receivables, equity securities, accounts payable and
accrued liabilities, notes payable, convertible debt, and the related party loan. It is management&#8217;s opinion that the Company
is not exposed to significant interest, currency or credit risks arising from its financial instruments. The fair values of these
instruments approximate their carrying value unless otherwise noted.</span></p>

</ix:nonNumeric><p id="xdx_852_zTwingViNPT2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000629" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_ziM19jf9lqHl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zxxEgvrMFbk">Concentration
                                         of Credit Risk</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver, British Columbia and Santa Clara, California.
As part of its cash management process, the Company regularly monitors the relative credit standing of these institutions.</span></p>

</ix:nonNumeric><p id="xdx_853_zXx6f6rixo32" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000631" name="us-gaap:AssetRetirementObligationsPolicy"><p id="xdx_845_eus-gaap--AssetRetirementObligationsPolicy_ze2r2G0Eiqnb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zLzHOWeAYgJ3">Asset
                                         Retirement Obligation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $<span id="xdx_908_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20240630_zOV4XPJ3gpjc"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2024-06-30" id="Fact000632" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span> as an accrued liability related to
estimated obligations as of June 30, 2024 (2023 - $<span id="xdx_900_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20230630_zaXUsPjc7Ke4" title="Accrued exploration stage expense"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2023-06-30" id="Fact000634" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss
in the period an estimate is revised.</span></p>

</ix:nonNumeric><p id="xdx_85F_zhmYRDK7YtY6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000636" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zCv3nwIbVBba" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zgf1SsEh0XDb">Income
                                         Taxes</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, <i>&#8220;Income Taxes &#8211; Recognition.&#8221;
</i>Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#8220;more likely than not&#8221; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#8220;Income Taxes &#8211; Disclosure,&#8221;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2024 and 2023, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.</span></p>

</ix:nonNumeric><p id="xdx_853_zHPq2BRxIFqh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000638" name="niobf:ReverseStockSplitPolicyTextBlock"><p id="xdx_84A_ecustom--ReverseStockSplitPolicyTextBlock_zcryDoHkjpUg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zixf7ipR0xk5">Reverse
                                         Stock Split</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2023, the Company effected a reverse stock split (the &#8220;Reverse Stock Split&#8221;) on the basis of one (1) post-Reverse
Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding, with any fractional
shares resulting from the Reverse Stock Split rounded down to the nearest whole share. Immediately after the Reverse Stock Split,
there were 30,000,442 Common Shares issued and outstanding. All references to share and per share amounts (excluding authorized
shares) in the consolidated financial statements and accompanying notes have been retroactively restated to reflect the Reverse
Stock Split.</span></p>

</ix:nonNumeric><p id="xdx_85B_zMeiKcNYisq6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000640" name="niobf:RedeemableNoncontrollingInterestPolicyTextBlock"><p id="xdx_849_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zZYz7a3R8b5l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_z98S5JPclJ1a">Redeemable
                                         Noncontrolling Interest</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#8217;s control and is reported in the mezzanine section between total liabilities
and shareholders&#8217; deficit, as temporary equity in the Company&#8217;s consolidated balance sheets. The Company&#8217;s non-controlling
interest is redeemable at fair value, and no adjustment to the earnings per share numerator is required because redemption at
fair value is not considered an economic distribution different from other common stockholders.&#160;</span></p>

</ix:nonNumeric><p id="xdx_854_zevX8FbQDsyi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>







<ix:exclude><!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zX7QeFTKO7v5" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_z1RKqHZFT9Ea" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_z5qVrpwUqjYl" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zErzaqeRtItj" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_239_zHeqDtjiAxc4" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_233_zEW5BR65uhkd" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000648" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_z8mz8hNA0fja" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_z61ows0CsP4a">Basic
                                         and Diluted Per Share Disclosure</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average number
of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout Shares (each as defined
in Note 10), to be participating securities, requiring the use of the two-class method. Diluted earnings (loss) per share represents
net earnings (loss) attributable to common shareholders divided by the weighted average number of Common Shares outstanding, inclusive
of the dilutive impact of all potentially dilutive securities outstanding during the period, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000650" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z4oXpvuz7yij" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zmPdZGo8Jldb" title="Net loss::XDX::-11898" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0652">(11,898</span></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230630_zZ8ZK7ESqopj" title="Net loss" style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30" id="Fact000654" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,308</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Adjust: &#160;Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20230701__20240630_ztoS73kIOKx3" title="Adjust: net loss attributable to noncontrolling interest::XDX::463" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0656">458</span></td><td style="padding-bottom: 1pt; text-align: left"/><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zORNxPZyMr5f" title="Adjust: net loss attributable to noncontrolling interest::XDX::228" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0658">(251</span></td><td style="padding-bottom: 1pt; text-align: left"/></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net loss available to participating securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zOIH99mkHtGl" title="Net loss available to participating securities" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-01to2024-06-30" id="Fact000660" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,440</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zS9EcMMR2GMc" title="Net loss available to participating securities" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-07-012023-06-30" id="Fact000662" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,057</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Net loss attributable to Vested Shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zqM20nkHogYb" title="Net loss attributable to vested shares" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2023-07-01to2024-06-30" id="Fact000664" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">967</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"/><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zbdm4thPBHWk" title="Net loss attributable to vested shares" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-06-30" id="Fact000666" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,528</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"/></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zg6rjKR1gZY5" title="Net loss attributed to common shareholders - basic and diluted" style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" contextRef="From2023-07-01to2024-06-30" id="Fact000668" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,473</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_zXsSreWXTDt5" title="Net loss attributed to common shareholders - basic and diluted" style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" contextRef="From2022-07-012023-06-30" id="Fact000670" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38,529</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_znEa4o0ILxi4" title="Weighted average shares outstanding basic and diluted" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-01to2024-06-30" id="Fact000672" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,320,024</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zVCao1x4Trsc" title="Weighted average shares outstanding basic and diluted" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012023-06-30" id="Fact000674" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,705,840</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Loss per Common Share outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20240630_z6niy4YWEVQ" title="Loss per common share outstanding basic and diluted" style="text-align: right">(<ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2023-07-01to2024-06-30" id="Fact000676" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.31</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_zxQjh92qxab4" title="Loss per common share outstanding basic and diluted" style="text-align: right">(<ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2022-07-012023-06-30" id="Fact000678" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.34</ix:nonFraction></td><td style="text-align: left">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A6_zoFmaRWAIf1b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following shares underlying options, warrants, and outstanding convertible debt were antidilutive due to a net loss in the periods
presented and, therefore, were excluded from the dilutive securities computation for the years ended June 30, 2024 and 2023, as
indicated below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000680" name="us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zBrtvXc7lCd2" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; visibility: hidden"><span id="xdx_8B8_zZeo1Pcp509">Schedule of excluded from the dilutive securities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; border-collapse: collapse; width: 91%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded potentially dilutive securities <sup id="xdx_F69_zLunV1ebYId4">(1)(2)</sup>:</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; padding-left: 0.25in; text-indent: -0.125in">Options</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zvapHnoAM9w6" title="Options" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions" contextRef="From2023-07-01to2024-06-30" id="Fact000682" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,495,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zWphhe01Uuyi" title="Options" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions" contextRef="From2022-07-012023-06-30" id="Fact000684" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,541,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_z2ofRW7Lmgk" title="Warrants" style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2023-07-01to2024-06-30" id="Fact000686" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,563,561</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zBJov0ZymEgi" title="Warrants" style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2022-07-012023-06-30" id="Fact000688" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,816,304</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Convertible debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zlzyJMRW9Uj5" title="Convertible debt" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2023-07-01to2024-06-30" id="Fact000690" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,849,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_zYJcZ1sPSRk5" title="Convertible debt" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2022-07-012023-06-30" id="Fact000692" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,871,660</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Total potentially dilutive securities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_zaGrLyZ7nwpf" title="Total potentially dilutive securities" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:DilutiveSecurities" contextRef="From2023-07-01to2024-06-30" id="Fact000694" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,908,061</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zfyvgekKOY25" title="Total potentially dilutive securities" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:DilutiveSecurities" contextRef="From2022-07-012023-06-30" id="Fact000696" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,229,464</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify"><span id="xdx_F02_zLNq355T4bGf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F15_zGoQRZD8Ae11" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000697" xml:lang="en-US">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.</ix:footnote></span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span id="xdx_F0C_ztq3eT2kaFPj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span id="xdx_F1B_z7xqga9FTee9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000698" xml:lang="en-US">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;</ix:footnote></span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A3_zqXUp5Ok9Uw2" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="margin-top: 0; margin-bottom: 0"></p>

</ix:nonNumeric><p id="xdx_855_zGTaXDfAX5Ml" style="margin-top: 0; margin-bottom: 0"></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000700" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zNUCQi67FfWd" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                    <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)</span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zCtXI4XN2huk">Share
                                         Based Compensation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants stock options to directors, officers, employees, and business advisors. Option terms and vesting conditions are
at the discretion of the Board. Prior to March 31, 2023, the option exercise price was equal to the closing market price on The
Toronto Stock Exchange (the &#8220;TSX&#8221;) on the day preceding the date of grant. Effective March 21, 2023, the option exercise
price is equal to the closing market price on the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) on the day preceding the date
of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of stock options using the Black-Scholes option pricing model. The Company recognizes forfeitures
as they occur.&#160;</span></p>

</ix:nonNumeric><p id="xdx_85D_zyHZ54Jr96Di" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>







<ix:exclude><!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zTOZqZps3dtj" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zZqMFaXXS0jl" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_z1cqHvjC2xBl" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zlbh5VDZC56b" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_236_zP7vplHW9yTg" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_23F_zEs6Wwd4rS8j" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000708" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zxAhxkbPKgP9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">r)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_zloV9IAt35fk">Recent
                                         Accounting Standards</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Not Effective</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, <i>Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures</i>, which is intended to improve reportable segment disclosure requirements, primarily through
enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses
that are regularly provided to the chief operating decision maker and included within segment profit and loss. The amendments
are effective for the Company&#8217;s annual periods beginning July 1, 2024, and interim periods beginning July 1, 2025, with
early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. The
Company has evaluated the ASU and has determined that implementation will have limited impact on the Company&#8217;s disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>, which includes
amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation
categories and income taxes paid by jurisdiction. The amendments are effective for the Company&#8217;s annual periods beginning
June 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively. The Company is currently
evaluating the ASU to determine its impact on the Company&#8217;s disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#8217;s consolidated financial statements upon adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><p id="xdx_853_zG1Q0u67xNt2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_81A_zyO1Mp79aUwi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000710" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_803_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zD3Y051Eptji" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82A_zNS4kjR0vWpa">GOING
                                         CONCERN ISSUES</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred a net loss of $<span id="xdx_907_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zGFZ4HE3dWui" title="Net loss::XDX::-11898"><span style="-sec-ix-hidden: xdx2ixbrl0712">11,435</span></span> for the year ended June 30, 2024 (2023 - $<span id="xdx_90B_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230630_zWXvkh5dWsPe" title="::XDX::-40308"><span style="-sec-ix-hidden: xdx2ixbrl0713">40,080</span></span>) and had a working capital deficit of
$<span id="xdx_905_ecustom--WorkingCapitalDeficit_pn3n3_c20230701__20240630_zmhiPMfjOad9" title="Working capital deficit"><ix:nonFraction name="niobf:WorkingCapitalDeficit" contextRef="From2023-07-01to2024-06-30" id="Fact000715" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,036</ix:nonFraction></span> and an accumulated deficit of $<span id="xdx_901_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20240630_zoaMe1B4oPR3" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-06-30" id="Fact000717" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">161,912</ix:nonFraction></span> as of June 30, 2024. As a development stage issuer, the Company has not yet commenced
its mining operations and accordingly does not generate any revenue. As of June 30, 2024, the Company had cash of $<span id="xdx_905_ecustom--CashAndCashEquivalentsAtCarryingValue1_pn3n3_c20230701__20240630_zexyJvPSKJid" title="Cash"><ix:nonFraction name="niobf:CashAndCashEquivalentsAtCarryingValue1" contextRef="From2023-07-01to2024-06-30" id="Fact000719" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></span>, which
will not be sufficient to fund normal operations or the repayment of the April 2024 Notes for the next twelve months. These conditions
and events raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_z4SGRNvtFIk8" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zVuvV8qEzlpi" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_znRCTiKaZA1b" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zYekGGxiPWuk" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_230_zYJPF1dzGABg" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_237_zZyYCTbgYHfd" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<ix:exclude><p id="xdx_233_z7X15CqSUb92" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to these conditions and events, the Company plans to obtain additional financing. Subject to the conditions discussed
in Note 11d, NioCorp expects to have access to up to $<span id="xdx_90B_eus-gaap--ProceedsFromRepaymentsOfDebt_pn3n3_c20230701__20240630_znLqm2vKB2Ua" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfDebt" contextRef="From2023-07-01to2024-06-30" id="Fact000728" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59,269</ix:nonFraction></span> in net proceeds from the Standby Equity Purchase Agreement, dated
January 26, 2023 (the &#8220;Yorkville Equity Facility Financing Agreement&#8221;), between the Company and YA II PN, Ltd., an
investment fund managed by Yorkville Advisors Global, LP (&#8220;Yorkville&#8221;), through April 1, 2026. In addition, the Company
may pursue additional sources of financing, and while it has been successful in doing so in the past, there can be no assurance
it will be able to do so in the future. Other than the potential issuance of Common Shares under the Yorkville Equity Facility
Financing Agreement, the Company did not have any further funding commitments or arrangements for additional financing as of June
30, 2024. The Company&#8217;s plans to obtain additional financing have not been finalized, are subject to market conditions,
and are not within the Company&#8217;s control and therefore cannot be deemed probable. Further, the Company will be required
to raise additional funds for the construction and commencement of operations. As a result, the Company has concluded that management&#8217;s
plans do not alleviate substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></p>

<ix:exclude><p id="xdx_23F_zL4S05xlnevg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p></ix:exclude>









<ix:exclude><p id="xdx_230_z6fOl9KFGjBe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

</ix:nonNumeric><p id="xdx_810_ztpXk9KuQne9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000732" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_zMqEPDRef7V9" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82F_z9wu9DvZZi79">2023
                                                                                                                                              GXII                                          TRANSACTION</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the following transactions (collectively, the &#8220;GXII Transaction&#8221;) occurred
on the Closing Date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.625in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a
    result of a series of transactions, GXII became an indirect, majority-owned subsidiary of NioCorp and changed its name to
    &#8220;Elk Creek Resources Corp&#8221; (&#8220;ECRC&#8221;).</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the
    parent company of the merged entity, NioCorp issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFgBUZOKQRb1" title="Post reverse stock split shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000734" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,753,821</ix:nonFraction></span> post-Reverse Stock Split Common Shares in exchange for all of
    the Class A shares of GXII issued and outstanding immediately prior to the Closing, including 83,770 Common Shares issued
    to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory services.</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    of the Class B shares of GXII issued and outstanding immediately prior to the Closing (after giving effect to the surrender
    of certain Class B shares of GXII in accordance with the Sponsor Support Agreement, dated September 25, 2022 (the &#8220;Sponsor
    Support Agreement&#8221;), among GX Sponsor II LLC (the &#8220;Sponsor&#8221;), GXII, NioCorp and the other persons party
    thereto) were converted into <span id="xdx_908_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_uShares_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zuxE9VyS3UE3" title="Convertible shares issued upon conversion"><ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000736" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,957,404</ix:nonFraction></span> shares of Class B common stock of GXII (now known as ECRC) as the surviving entity
    of the mergers that occurred on the Closing Date as part of the GXII Transaction. Pursuant to the Business Combination Agreement,
    the Sponsor Support Agreement and the Exchange Agreement, dated as of March 17, 2023 (as amended, supplemented or otherwise
    modified, the &#8220;Exchange Agreement&#8221;), by and among NioCorp, ECRC and the Sponsor, after the Closing, the shares
    of Class B common stock of ECRC are exchangeable into Common Shares on a one-for-one basis, subject to certain equitable adjustments,
    under certain conditions. See Note 10 for additional information regarding the Class B common stock of ECRC.</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    assumed GXII&#8217;s obligations under the agreement (the &#8220;GXII Warrant Agreement&#8221;) governing the GXII share purchase
    warrants (the &#8220;GXII Warrants&#8221;) and issued an aggregate of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember_zJQNuttuZSSh" title="Number of shares purchase"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2023-07-012024-06-30_custom_WarrantAgreementMember" id="Fact000738" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,666,626</ix:nonFraction></span> warrants (the &#8220;NioCorp Assumed Warrants&#8221;)
    to purchase up to an aggregate of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkxt8uhfFemh" title="Number of shares purchase"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000740" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,519,864</ix:nonFraction></span> Common Shares. See Note 11c for additional information regarding the NioCorp
    Assumed Warrants. </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000742" name="srt:ScheduleOfCondensedFinancialStatementsTableTextBlock"><p id="xdx_897_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zKUVvNELzpWg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the distribution of funds to GXII redeeming shareholders and prior to paying transaction costs incurred by GXII, $15,676 became
available to the Company. <span id="xdx_8B5_zTrPe6YC7z0a">The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements
of Operations and Comprehensive Loss for the year ended June 30, 2023:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td id="xdx_497_20240630_zDLUSx4h8pj3" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_pn3n3_zi1H2eW1ntTi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 79%; text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Gross cash proceeds, net of transaction costs incurred by GXII</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" contextRef="AsOf2024-06-30" id="Fact000744" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,168</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zmURVwpgdLe8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Cash costs associated with the 2023 Transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_zNLMqDZy6U37" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net liabilities assumed</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2024-06-30" id="Fact000748" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">392</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_iI_pn3n3_zabKhGg8SDZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Yorkville Equity Facility Financing Agreement &#8211; cash costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" contextRef="AsOf2024-06-30" id="Fact000750" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,996</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_iI_pn3n3_zgg3OYDVUrzd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Transaction costs expensed</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" contextRef="AsOf2024-06-30" id="Fact000752" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,715</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_pn3n3_zA4xcJ5lWgtl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Non-cash costs associated with the 2023 Transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_iI_pn3n3_z3WnogewIok8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Private Warrants assumed at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" contextRef="AsOf2024-06-30" id="Fact000756" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,987</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--EarnoutSharesAssumedAtFairValue_iI_pn3n3_zuyWFtL9oZ09" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Earnout Shares assumed at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:EarnoutSharesAssumedAtFairValue" contextRef="AsOf2024-06-30" id="Fact000758" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,195</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_pn3n3_znImeCHUfwpi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Yorkville Equity Facility Financing Agreement &#8211; shares issued</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" contextRef="AsOf2024-06-30" id="Fact000760" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pn3n3_zWeKgiDlfUgl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">&#160;Total transaction related losses incurred</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" contextRef="AsOf2024-06-30" id="Fact000762" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,767</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zppruokwxdna" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>







<ix:exclude><!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zKxPPTlh8H19" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zOfwTNGQ1Cbi" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zxtdO0zk3CLk" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zQOIOQwvQWQh" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_234_z9ev16vKdUB9" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_238_zy0NNh39ySrg" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000770" name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock"><p id="xdx_891_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_zC7xeqbOOV0j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zxM4hW8dTdzj">The
number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Common Shares</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Percentage</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Legacy NioCorp Shareholders</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zWOIlnILdPP5" title="Common stock, shares outstanding" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_custom_LegacyNioCorpShareholdersMember" id="Fact000772" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,246,621</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zW4jrfzTP7ue" title="Number of shares, percentage"><ix:nonFraction name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" contextRef="From2023-07-012024-06-30_custom_LegacyNioCorpShareholdersMember" id="Fact000774" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">93.90</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former GXII Class A Shareholders<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zOkXCQtlUpi4" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_custom_GXIIClassAShareholdersMember" id="Fact000775" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,753,821</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zjbTVwksDMg" title="Number of shares, percentage"><ix:nonFraction name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" contextRef="From2023-07-012024-06-30_custom_GXIIClassAShareholdersMember" id="Fact000777" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.83</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<sup>(2)</sup></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--OtherMember_fKDIp_z6u5pI41BQMa" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_custom_OtherMember" id="Fact000778" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">81,213</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--OtherMember_fKDIp_z5IF8MmrkA0h" title="Number of shares, percentage"><ix:nonFraction name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" contextRef="From2023-07-012024-06-30_custom_OtherMember" id="Fact000780" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.27</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Total Common Shares Outstanding Upon Completion of 2023 Transactions</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_dxL_uShares_c20240630_zAmY6gSaz2Jf" title="Common stock, shares outstanding::XDX::38062647" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0782">30,081,655</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; text-align: right"><span id="xdx_908_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630_zS4TL18wCk9j" title="Number of shares, percentage"><ix:nonFraction name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" contextRef="From2023-07-01to2024-06-30" id="Fact000784" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left">%</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span id="xdx_F0F_zeKfNxmYnfgg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_zf9p9PT20DCa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000785" xml:lang="en-US">Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.</ix:footnote></span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span id="xdx_F0F_zSrKWsF1MpYe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_zGgsi7nrWCx7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000786" xml:lang="en-US">Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.</ix:footnote></span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A1_zcfdafWdovXl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the GXII Transaction, the Company also closed the Yorkville Convertible Debt Financing and the Yorkville Equity
Facility Financing, as discussed in Notes 9 and 11d.</span></p>

</ix:nonNumeric><p id="xdx_817_zT6SHaAPwnj8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000788" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z6gENgu6aRng" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_827_zMRmoXbiTvc8">LAND
                                         AND BUILDINGS, NET</span></span></td></tr></table>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000790" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_89F_eus-gaap--PropertyPlantAndEquipmentTextBlock_zsf5VlsY2OS6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zjH7iNtlzLg1" style="display: none; visibility: hidden">Schedule of properties</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="22" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Depreciation</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Depreciation</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%">Land</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zdsre1YFxA19" title="Cost" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2024-06-30_us-gaap_LandMember" id="Fact000792" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">807</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_z8IUo9bs8WCa" title="Accumulated depreciation" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-06-30_us-gaap_LandMember" id="Fact000794" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">-</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_ze0jotrhr99" title="Net" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30_us-gaap_LandMember" id="Fact000796" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">807</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zgzb5HDz3Gv5" title="Cost" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2023-06-30_us-gaap_LandMember" id="Fact000798" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">807</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zPDF3VqB2a11" title="Accumulated depreciation" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-06-30_us-gaap_LandMember" id="Fact000800" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">-</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zcM9L3E1goE8" title="Net" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30_us-gaap_LandMember" id="Fact000802" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">807</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Buildings and other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zIruABl0K3Vd" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2024-06-30_us-gaap_BuildingMember" id="Fact000803" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zK2z9QutyQH9" title="Accumulated depreciation" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-06-30_us-gaap_BuildingMember" id="Fact000805" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zXXhxMlWSw7j" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30_us-gaap_BuildingMember" id="Fact000806" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zecxZ01MMXsk" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2023-06-30_us-gaap_BuildingMember" id="Fact000807" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zxcPsPXvzPvi" title="Accumulated depreciation" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-06-30_us-gaap_BuildingMember" id="Fact000809" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_ztpKRWIFA8Rf" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30_us-gaap_BuildingMember" id="Fact000810" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630_zTFX7EcRu9ei" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2024-06-30" id="Fact000811" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">848</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630_zyi03axIe7R8" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-06-30" id="Fact000812" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630_zSD4lpbEdZd6" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30" id="Fact000813" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">837</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630_zl74fad9yrjh" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2023-06-30" id="Fact000814" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">848</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630_zV0lmdm7Fp4k" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-06-30" id="Fact000815" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630_zMxKOpXKn491" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30" id="Fact000816" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">839</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_zu8iSU907OHf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_815_z2fKkJv1Efpd" style="margin-top: 0; margin-bottom: 0"></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000818" name="us-gaap:MineralIndustriesDisclosuresTextBlock"><p id="xdx_80D_eus-gaap--MineralIndustriesDisclosuresTextBlock_zdHNZcuWRo51" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82C_zwlrceSJtaL">MINERAL
                                         PROPERTIES</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
properties consist of original acquisition costs and purchased mineral rights related to the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the land and mineral rights currently owned by the Company, the property interests of Elk Creek include eight prepaid
mineral exploration option-to-purchase agreements and include a pre-determined buyout for permanent ownership of the mineral and/or
surface rights. Terms of the agreements require no further significant payments, and the Company may negotiate lease extensions
or elect to purchase the mineral and/or surface rights any time. Agreements that allow for the purchase of mineral rights contain
provisions whereby the landowners would retain a 2% net smelter return.</span></p>

</ix:nonNumeric><p id="xdx_81C_zHgWVJAYeyG3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000820" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_803_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zD93zpi8CChd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_820_zJYXNHkCrH5e">ACCOUNTS
                                         PAYABLE AND ACCRUED LIABILITIES</span></span></td></tr></table>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000822" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zUzytk9bw3B5" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; visibility: hidden"><span id="xdx_8BE_zOLTfAnTn5S7">Schedule of account payable and accrued liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_498_20240630_z0efgPplLRZ6" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49F_20230630_ztm9nDAsd6ke" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zEzHFlCkCtdj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-left: 5pt">Accounts payable, trade</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2024-06-30" id="Fact000824" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,417</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2023-06-30" id="Fact000825" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,990</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_zQP2rw5TezS1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Trade payable accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000827" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">350</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2023-06-30" id="Fact000828" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,324</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zSiuC12OJN7h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Income taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2023-06-30" id="Fact000831" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zzpM6NFCfkoh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Environmental accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-06-30" id="Fact000833" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2023-06-30" id="Fact000834" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zn7w7eYXPj3g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt">Loan origination fees payable to related party</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact000836" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30" id="Fact000837" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_ziNEuC5jSt1d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 5pt">Total accounts payable and accrued liabilities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000839" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,843</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2023-06-30" id="Fact000840" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,491</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A3_zlT2aGd9kVua" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

</ix:nonNumeric><p id="xdx_815_zbGSuAwkodlb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>







<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p id="xdx_232_z2x9RSoDexEj" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p id="xdx_23D_zfuI5OQkEGvd" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p>

<p id="xdx_23C_z7ldnjtVnsr6" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p>

<p id="xdx_23F_zGVJicImxXll" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p>

<!-- Field: Rule-Page --><div id="xdx_235_zeHZAktWszEk" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p id="xdx_232_zjMpilPtitNd" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000848" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_809_eus-gaap--LongTermDebtTextBlock_z2WMKBOT1zW4" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_823_z9E9m23ZRkd7">CONVERTIBLE
                                         DEBT</span></span></td></tr></table>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000850" name="niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock"><p id="xdx_891_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_znt2ASmxe8F3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"><span id="xdx_8B2_zuddybIb4Vbi">Schedule
of convertible debt</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Current Portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-left: 0.25in">Yorkville convertible debentures:</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleSecurityMember_z4al58ZIKgad" title="Convertibled debt, current" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleSecurityMember" id="Fact000852" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">571</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zm6prukscnK8" title="Convertibled debt, current" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in">April 2024 notes</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zlWSwZHZYha8" title="Convertibled debt, current" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2024-06-30_custom_April2024ConvertibleSecurityMember" id="Fact000856" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,089</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zA3WMLa7U3Ok" title="Convertibled debt, current" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Total Current Portion</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zqhajbNKEC34" title="Convertibled debt, current" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2024-06-30_custom_ConvertibleSecurityMember" id="Fact000860" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,660</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zPkuDigqFcJ" title="Convertibled debt, current" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Noncurrent Portion &#8211; Yorkville convertible debenture</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zyU1pL7QKcPe" title="Convertible debt, noncurrent" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zH3wR4pfycCb" title="Convertible debt, noncurrent" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember" id="Fact000866" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,561</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AC_zjjKW2eKpPoc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Lind
III Convertible Security</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 16, 2021, the Company issued to Lind Global Asset Management III, LLC (&#8220;Lind&#8221;), an entity managed by The
Lind Partners, the convertible security (the &#8220;Lind III Convertible Security&#8221;) pursuant to the Convertible Security
Funding Agreement, dated February 16, 2021, as amended by Amendment #1 to the Convertible Security Funding Agreement, dated December
2, 2021, between the Company and Lind (as amended, the &#8220;Lind III Agreement&#8221;). The Lind III Convertible Security had
a face value of $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pn3n3_c20210216__20210219_ztalY4bPS2p6" title="Face value"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" contextRef="From2021-02-162021-02-19" id="Fact000868" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,700</ix:nonFraction></span> (representing $10,000 in funding plus an implied <span id="xdx_90E_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20210219_z3ADXCANTKxi"><ix:nonFraction name="us-gaap:InvestmentInterestRate" contextRef="AsOf2021-02-19" id="Fact000869" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span>% interest rate per annum for the term of the Lind
III Convertible Security). After deducting a $<span id="xdx_902_eus-gaap--OtherCommitment_iI_pn3n3_c20210219_zhnpdhlI2OZk" title="Commitment fee"><ix:nonFraction name="us-gaap:OtherCommitment" contextRef="AsOf2021-02-19" id="Fact000871" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">350</ix:nonFraction></span> commitment fee as set forth in the Lind III Agreement, NioCorp received net
proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromInterestReceived_pn3n3_c20210216__20210219_zLVcmKMSYo6e" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromInterestReceived" contextRef="From2021-02-162021-02-19" id="Fact000873" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,650</ix:nonFraction></span> from the funding of the Lind III Convertible Security. The Company used a portion of the proceeds from the
funding of the Lind III Convertible Security to purchase a key land parcel associated with the Company&#8217;s Elk Creek Project,
with the remainder spent for general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Lind III Convertible Security had a term of (i) <span id="xdx_905_eus-gaap--LongTermDebtTerm_iI_dxL_c20230630_zTHMjVeU5fs8" title="Long term debt duration::XDX::P24M"><span style="-sec-ix-hidden: xdx2ixbrl0875">24</span></span> months or (ii) 30 calendar days after the date on which the face value of the
Lind III Convertible Security is nil due to such amount having been fully converted and/or fully repaid (including with any applicable
premium) in accordance with the terms of the Lind III Agreement, whichever is earlier.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--DebtConversionDescription_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zdjDo22Y0aqf"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember" id="Fact000876" name="us-gaap:DebtConversionDescription">Pursuant
to the Lind III Agreement, Lind was entitled to convert the Lind III Convertible Security into Common Shares in monthly installments
over its term at a price per Common Share equal to 85% of the volume-weighted average price Common Shares on the TSX for the five
trading days immediately preceding to the date on which Lind provides notice to the Company of its election to convert. The Lind
III Agreement provided that Common Shares issuable upon conversion, together with the number of Common Shares issued upon exercise
of Warrants, shall not exceed 4,358,800 Common Shares.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 19, 2021, in connection with the funding and issuance of the Lind III Convertible Security, the Company issued <span id="xdx_90A_eus-gaap--CommonUnitIssued_iI_uShares_c20210219_zOJHsBsos0K5" title="Common share purchase warrants"><ix:nonFraction name="us-gaap:CommonUnitIssued" contextRef="AsOf2021-02-19" id="Fact000878" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">855,800</ix:nonFraction></span>
Common Share purchase warrants, exercisable at a price per Common Share of C$<span id="xdx_907_eus-gaap--AcceleratedShareRepurchasesFinalPricePaidPerShare_uCADPShares_c20230701__20240630_zVye1cz2NWVl" title="Exercisable at a price per share"><ix:nonFraction name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" contextRef="From2023-07-01to2024-06-30" id="Fact000880" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">9.70</ix:nonFraction></span>, expiring February 19, 2025 (the &#8220;Lind
III Warrants&#8221;), to Lind pursuant to the Lind III Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company identified embedded derivatives in the Lind III Convertible Security that were evaluated to be immaterial at both the
closing date and at June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocated the net proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pn3n3_uUSD_c20230701__20240630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_zzJNZYejqTJ1"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" contextRef="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember7263812" id="Fact000881" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,477</ix:nonFraction></span> from the Lind III Convertible Security as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,712
    was allocated to Common Stock, representing the fair value of the Lind III Warrants based on the Black Scholes pricing model
    using a risk-free interest rate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_ziJ3vqAv1Lu3" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember" id="Fact000883" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.40</ix:nonFraction></span>%, an expected dividend yield of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zqAFBIPanAZ4" title="Expected dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember" id="Fact000885" format="ixt:numdotdecimal" decimals="-3" scale="1" unitRef="Pure">0</ix:nonFraction></span>%, a volatility of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_ztVBm41AMT41" title="Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember" id="Fact000887" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51.60</ix:nonFraction></span>%, and an expected life of
    <span id="xdx_907_eus-gaap--IntermediateLifePlantsUsefulLife_iI_dxL_c20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zUAtHjSa5Iw9" title="Expected life::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0889">4.0</span></span> years. </span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_z0opgOtbN14l" title="Convertible debt liabilit"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2024-06-30_custom_LindIIIConvertibleSecurityMember7263843" id="Fact000891" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,938</ix:nonFraction></span> was allocated
to the convertible debt liability. Transaction costs of $<span id="xdx_90C_ecustom--TransactionCost_pn3n3_uUSD_c20230701__20240630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_z1h87Ma9HVfe" title="Transaction costs"><ix:nonFraction name="niobf:TransactionCost" contextRef="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember7263812" id="Fact000893" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">173</ix:nonFraction></span>, in addition to a commitment fee of $<span id="xdx_900_eus-gaap--LineOfCreditFacilityCommitmentFeeAmount_pn3n3_c20210217__20210219_z21sULxUbHqd" title="Commitment fee"><ix:nonFraction name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" contextRef="From2021-02-172021-02-19" id="Fact000895" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">350</ix:nonFraction></span>, were recognized as a direct
deduction from the debt liability, resulting in a net opening balance of $7,765. This balance was accreted up to the face value
of the Lind III Convertible Security at maturity using the effective interest method and recorded as non-cash interest expense
in the consolidated
statement of operations and comprehensive loss.</span></td></tr>
</table>
<ix:exclude><p id="xdx_23D_ziIElGwTey24" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p></ix:exclude>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zKIMDbg3xm0c" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zgNFMEe0BT63" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zwvgIjCl4zkc" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zvD52YVWiHa2" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_232_zcC21u3A1zIj" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_235_zvjBrTniIHaj" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000904" name="niobf:ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock"><p id="xdx_895_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_z1i0WPYFDhT9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zhg0BZ2GTAlh">Changes
in the Lind III Convertible Security are as follows</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ending <br/>
June 30, 2023</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
    balance</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_znePfQEwOtqi" title="Beginning balance" style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2022-06-30_custom_ConvertibleSecurityMember" id="Fact000906" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,169</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value increase due to debt extinguishment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_ztsEgdWtpGJj" title="Fair value increase due to debt extinguishment" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ExtinguishmentOfDebtAmount" contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember" id="Fact000908" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">201</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversions</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"/>
    <td id="xdx_98E_eus-gaap--ConversionOfStockAmountIssued1_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zC9ggsIYxk2" title="Conversions" style="text-align: right">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember" id="Fact000910" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,950</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion
    expense</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zynamc468rZ5" title="Accretion expense" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember" id="Fact000912" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    at maturity</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"/>
    <td id="xdx_989_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zutaLWwXJZkh" title="Payment at maturity" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember" id="Fact000914" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">515</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June
    30, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zt6CCQWihBv3" title="Ending balance" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0916">-</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A2_zlMYM4oQCMol" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 25, 2022, the Company and Lind entered into the Waiver and Consent Agreement, dated September 25, 2022, between the
Company and Lind (the &#8220;Lind Consent&#8221;), which included the following principal terms: (i) the consent of Lind to the
GXII Transaction disclosed in Note 5 and Yorkville Financings disclosed below and in Note 11d, including all actions taken by
NioCorp as set out in the Business Combination Agreement to permit the completion of the 2023 Transactions; (ii) the consent of
Lind to NioCorp&#8217;s expected cross-listing to the Nasdaq and the consolidation of the Common Shares in order to meet the minimum
listing requirements thereof; (iii) the waiver of Lind of its participation right for up to 15% of the total offering in the Yorkville
Equity Facility Financing; and (iv) the waiver of Lind of certain restrictive covenants in the Lind III Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As consideration for entering into the
Lind Consent, Lind received, amongst other things: (i) the right to receive a payment of $500, which would have been reduced to
$200 if the 2023 Transactions had not been consummated on or before April 30, 2023 (collectively, the &#8220;Consent Payment&#8221;);
(ii) an extension of its existing participation rights under the Lind III Agreement in future financings of NioCorp for a further
two-year period, subject to certain exceptions as well as an extension of such participation rights beyond the additional two-year
period if Yorkville or any affiliate is a party to any such applicable transaction; and (iii) the right to receive additional Warrants
(the &#8220;Contingent Consent Warrants&#8221;) if on the date that is 18 months following the Closing Date, the closing trading
price of the Common Shares on the TSX or such other stock exchange on which such shares may then be listed, is less than C$10.00
(on a post-Reverse Stock Split basis), subject to adjustments. The number of Contingent Consent Warrants to be issued, if any,
is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate as reported by Bloomberg,
LP) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date of issuance, unless otherwise
agreed. Further, the number of Contingent Consent Warrants issued will be proportionately adjusted based on the percentage of Warrants
currently held by Lind that are exercised, if any, prior to the issuance of any Contingent Consent Warrants. The Lind Consent was
signed as an amendment to the existing Lind III Agreement.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
determined that the Lind Consent should be evaluated using ASC 470, which requires an evaluation of the contract amendment under
debt modification guidance. The Company performed a comparison of the discounted cash flows of the Lind III Convertible Security
pursuant to the existing Lind III Agreement and pursuant to the Lind III Agreement as amended by the Lind Consent and determined
that a debt extinguishment loss of $201 had occurred. Further, ASC 470 requires that the minimum estimated Consent Payment of
$200 also be included in the calculation of the initial loss on debt extinguishment. The Company also evaluated the Contingent
Consent Warrant feature included in the Lind Consent and determined that the Contingent Consent Warrants meet the criteria to
be considered separate, freestanding instruments, should be accounted for as a liability under ASC 480, and should be booked at
fair value on the date of the Lind Consent, with subsequent changes in valuation recorded as a non-operating gain or loss in the
consolidated statement of operations and comprehensive loss. <span>The following table summarizes the components of the initial loss
and final loss on extinguishment:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000918" name="us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfExtinguishmentOfDebtTextBlock_z5sVttqay9U8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">&#160;<span id="xdx_8BC_zCpNCSkq0uk1">The following table summarizes the components of the initial loss and final loss on extinguishment:</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Component
    of loss</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20230701__20240630_zuwKBTzqeyhe" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--MinimumConsentPaymentAtInception_pn3n3_z0lvL9KTt57k" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 77%; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum
    Consent Payment at inception</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:MinimumConsentPaymentAtInception" contextRef="From2023-07-01to2024-06-30" id="Fact000920" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--ASC470LossOnExtinguishment_pn3n3_zUh8DOXqOWIk" style="vertical-align: bottom">
    <td style="text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on debt extinguishment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:ASC470LossOnExtinguishment" contextRef="From2023-07-01to2024-06-30" id="Fact000922" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">201</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--AdjustmentOfWarrantsGrantedForServices_pn3n3_zVOTyhwsJj76" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; width: 77%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    fair value of Contingent Consent Warrants</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentOfWarrantsGrantedForServices" contextRef="From2023-07-01to2024-06-30" id="Fact000924" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,221</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_pn3n3_zAI1LwFFQNHl" style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    loss on debt extinguishment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" contextRef="From2023-07-01to2024-06-30" id="Fact000926" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,622</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--AdditionalConsentPaymentbooked_pn3n3_zJow2YPMqar3" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    Consent Payment booked<sup id="xdx_F4F_zp1q7smy2gme">(1)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:AdditionalConsentPaymentbooked" contextRef="From2023-07-01to2024-06-30" id="Fact000928" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">300</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--GainsLossesOnRestructuringOfDebt_pn3n3_zJTCgIi1gapg" style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    loss on debt extinguishment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainsLossesOnRestructuringOfDebt" contextRef="From2023-07-01to2024-06-30" id="Fact000930" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,922</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify"><span id="xdx_F02_zkh2PLuTpzb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F10_zhOm4ESnSM54" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000931" xml:lang="en-US">Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.</ix:footnote></span></td></tr>
</table>
<ix:exclude><p id="xdx_239_z6POV4tk26w7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><p id="xdx_8AA_zLWtklORCwk4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>







<ix:exclude><!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zePfbLR2VKgf" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_z3q10Rxp2u7e" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zlA8ki94XEkk" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zHXBlZmdf3c8" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_230_zcqSlokeKUJd" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_23D_zKkf8AJshWNk" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000940" name="niobf:ScheduleOfWarrantValuationTableTextblock"><p id="xdx_89C_ecustom--ScheduleOfWarrantValuationTableTextblock_zhE2hs07LbYc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zUGu0r4iMI85">The
change in the fair value of the Contingent Consent Warrants is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 37%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    valuation, September 25, 2022</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iS_c20220701__20230630_zQIK8izaqrz6" title="Initial valuation, at beginning" style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-06-30" id="Fact000942" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,221</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_ecustom--ChangeInValuationOfWarrants_c20220701__20230630_zEMPS1TodF55" title="Change in valuation" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:ChangeInValuationOfWarrants" contextRef="From2022-07-012023-06-30" id="Fact000944" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">489</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    at June 30, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iE_c20220701__20230630_zPAsfAyTEG52" title="Valuation, at ending" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-06-30" id="Fact000946" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,710</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ChangeInValuationOfWarrants_c20230701__20240630_zf3RqufC5qwc" title="Change in valuation" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:ChangeInValuationOfWarrants" contextRef="From2023-07-01to2024-06-30" id="Fact000948" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">655</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    at June 30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iE_c20230701__20240630_zUJWpt80Idq6" title="Valuation, at ending" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-06-30" id="Fact000950" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,365</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8AC_ziatf9pxJRjb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contingent Consent Warrants are classified as a Level 3 financial instrument and were valued utilizing a Monte Carlo simulation
pricing model, which calculates multiple potential outcomes for future share prices based on historic volatility of the Common
Shares to determine the probability of issuance at 18 months following the applicable valuation date and to determine the value
of the Contingent Consent Warrants. The following table discloses the primary inputs into the Monte Carlo model at each valuation
date, and the probability of issuance calculated by the model.</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000952" name="niobf:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock"><p id="xdx_892_ecustom--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_zSUmcTMTX2Ac" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; visibility: hidden"><span id="xdx_8BA_zBUzmwMhlFg3">Schedule of valuation date and the probability calculated</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto">
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
    Valuation Input</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></p></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></p></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&#160;25,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="background-color: #CCECFF">
    <td style="vertical-align: bottom; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    price on valuation date</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zmA2MRDKFa6b" title="Share price" style="vertical-align: bottom; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30_us-gaap_MeasurementInputSharePriceMember" id="Fact000954" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.73</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zxaoQRZH10k3" title="Share price" style="vertical-align: bottom; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-06-30_us-gaap_MeasurementInputSharePriceMember" id="Fact000956" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.03</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zfbGiT624Uak" title="Share price" style="vertical-align: bottom; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-09-25_us-gaap_MeasurementInputSharePriceMember" id="Fact000958" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.82</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_z8DzHiw5SFZ5" title="Volatility" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-06-30_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact000960" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">68.0</ix:nonFraction></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zmTiN5M68p39" title="Volatility" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-06-30_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact000962" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">63.0</ix:nonFraction></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zfGp98M0egGa" title="Volatility" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-09-25_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact000964" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">62.4</ix:nonFraction></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="background-color: #CCECFF">
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    free rate</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zD3RKNi7vBcd" title="Risk free rate" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact000966" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">4.40</ix:nonFraction></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zxLbhvVnRKpf" title="Risk free rate" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact000968" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">4.11</ix:nonFraction></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_z7RRe4dMVIHe" title="Risk free rate" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-09-25_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact000970" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">3.93</ix:nonFraction></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Probability
    of issuance</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_z5dUA5BPSK76" title="Probability of issuance" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-06-30_custom_ProbabilityOfIssuanceMember" id="Fact000972" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">100.0</ix:nonFraction></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zxbvx5XAiIQj" title="Probability of issuance" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-06-30_custom_ProbabilityOfIssuanceMember" id="Fact000974" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">80.8</ix:nonFraction></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zd04jufot4vl" title="Probability of issuance" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-09-25_custom_ProbabilityOfIssuanceMember" id="Fact000976" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">59.4</ix:nonFraction></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A2_zFc2oTm3AVrl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
on debt extinguishment is presented as a non-operating expense in the Company&#8217;s consolidated statements of operations and
comprehensive loss. This accounting also resulted in a decrease in the amount of accretion to be recognized over the remaining
life of the Lind III Convertible Security through February 2023. Accretion expenses are disclosed as a part of interest expense,
which is not included as a component of operating costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Yorkville
Convertible Debentures</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the GXII Transaction, on January 26, 2023, NioCorp entered into definitive agreements with respect to the Yorkville
Financings, including a Securities Purchase Agreement, dated January 26, 2023 (as amended the &#8220;Yorkville Convertible Debt
Financing Agreement&#8221;), between the Company and Yorkville, and a Standby Equity Purchase Agreement, dated January 26, 2023
(the &#8220;Yorkville Equity Facility Financing Agreement&#8221;), between the Company and Yorkville.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Yorkville Convertible Debt Financing Agreement, at the Closing, Yorkville advanced a total amount of $15,360 to NioCorp
in consideration of the issuance by NioCorp to Yorkville of (i) $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240630__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zH70YXD2Nwpc" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-06-30_us-gaap_UnsecuredDebtMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact000978" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,000</ix:nonFraction></span> aggregate principal amount of unsecured convertible debentures
(the &#8220;Convertible Debentures&#8221;) and (ii) Common Share purchase warrants, exercisable for up to <span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zjQF16gscUL" title="Number of shares purchase"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockOptionsExercise" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact000980" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,789,267</ix:nonFraction></span> Common Shares
for cash or, if at any time there is no effective registration statement registering, or no current prospectus available for,
the resale of the underlying Common Shares, on a cashless basis, at the option of the holder, at a price per Common Share of approximately
$<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zIDjSTqPvsA8" title="Number of shares purchase"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact000982" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.9422</ix:nonFraction></span>, subject to adjustment to give effect to any stock dividend, stock split, reverse stock split or similar transaction (the
&#8220;Financing Warrants&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Convertible Debenture issued under the Yorkville Convertible Debt Financing Agreement is an unsecured obligation of NioCorp, has
an <span id="xdx_906_eus-gaap--LongTermDebtMaturitiesRepaymentTerms_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zT6JJlmFCzy6" title="Debt term"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact000984" name="us-gaap:LongTermDebtMaturitiesRepaymentTerms">18-month</ix:nonNumeric></span> term from the Closing Date, which may be extended for one six-month period in certain circumstances at the option
of NioCorp, and incurs a simple interest rate obligation of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MinimumMember_zoF428AtYo9a" title="Interest rate obligation"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MinimumMember" id="Fact000986" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.0</ix:nonFraction></span>% per annum (which will increase to <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MaximumMember_zbHcDWkUUXu7" title="Interest rate obligation"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MaximumMember" id="Fact000988" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15.0</ix:nonFraction></span>% per annum upon the occurrence
of an event of default). The outstanding principal amount of, accrued and unpaid interest, if any, on, and premium, if any, on
the Convertible Debentures must be paid by NioCorp in cash when the same becomes due and payable under the terms of the Convertible
Debentures at their stated maturity, upon their redemption or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>





<ix:exclude><p id="xdx_23A_zvoLyovWUNW6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations contained within the Yorkville Convertible Debt Financing Agreement and the Convertible Debentures, including
those as described below, holders of the Convertible Debentures will be entitled to convert the principal amount of, and accrued
and unpaid interest, if any, on each Convertible Debenture, in whole or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zOiWkDcpHJh5" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zVRkRerZMA12" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zioZdCAnFMC1" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_zSznSwsY1Be3" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23B_zL4I1lQnvD8l" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_231_zW0NZE6jGMDa" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">in part, from time to time over their term, into a number
of Common Shares equal to the quotient of the principal amount and accrued and unpaid interest, if any, being converted divided
by the Conversion Price. The &#8220;Conversion Price&#8221; means, as of any Conversion Date (as defined below) or other date
of determination, the greater of (i) 90% of the average of the daily U.S. dollar volume-weighted average price of the Common Shares
on the principal U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading
days immediately preceding the date on which the holder exercises its conversion right in accordance with the requirements of
the Yorkville Convertible Debt Financing Agreement (the &#8220;Conversion Date&#8221;) or other date of determination, but not
lower than the Floor Price (as defined below), and (ii) the five-day volume-weighted average price of the Common Shares on the
TSX (or on the principal U.S. market if the majority of the trading volume and value of the Common Shares occurred on Nasdaq during
the relevant period) for the five consecutive trading days immediately prior to the Conversion Date or other date of determination
less the maximum applicable discount allowed by TSX. The &#8220;Floor Price&#8221; means a price of $2.1435 per share, which is
equal to the lesser of (a) 30% of the average of the daily volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
preceding the Debenture Closing and (b) 30% of the average of the volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
following the Debenture Closing, subject to certain adjustments to give effect to any stock dividend, stock split, reverse stock
split, recapitalization or similar event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Convertible Debentures restrict the number of Convertible Debentures that may be converted during each calendar month
by Yorkville at a Conversion Price below a fixed price equal to approximately $8.9422 (i.e., the quotient of $10.00 divided by
1.11829212 (being the number of Common Shares that were exchanged for each share of GXII at the Closing, after giving effect to
the Reverse Stock Split)), subject to adjustment to give effect to any stock dividend, stock split, reverse stock split, recapitalization
or similar event. The Convertible Debentures are subject to customary anti-dilution adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Convertible Debentures restrict the conversion of Convertible Debentures by Yorkville if such a conversion would
cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or such a conversion would cause the aggregate number
of Common Shares issued pursuant to the Yorkville Convertible Debt Financing Agreement to exceed the thresholds for issuance of
Common Shares under the rules of Nasdaq, unless prior shareholder approval is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Convertible Debentures, following certain trigger events, and until a subsequent cure event, NioCorp will
be required to redeem $1,125 aggregate principal amount of Convertible Debentures (the &#8220;Triggered Principal Amount&#8221;)
each month by making cash payments to the Investors, on a pro rata basis, in an amount equal to the Triggered Principal Amount,
plus accrued and unpaid interest thereon, if any, plus a redemption premium of 7% of the Triggered Principal Amount. Such monthly
prepayments under the terms of the Convertible Debentures are triggered (i) at the time when NioCorp has issued 95% of the total
amount of Common Shares pursuant to the Yorkville Convertible Debt Financing that it may issue under applicable Nasdaq rules or
(ii) when NioCorp has delayed or suspended the effectiveness or use of the Convertible Debt Financing Registration Statement for
more than 20 consecutive calendar days, and such monthly prepayment obligations will continue until, with respect to (i) above,
shareholder approval is obtained or, with respect to (ii) above, the Investors may once again resell Common Shares under the Convertible
Debt Financing Registration Statement, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Debentures may also be redeemed at NioCorp&#8217;s option at any time and from time to time over their term at a redemption
price equal to <span id="xdx_901_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zDNf4iIPaZB2" title="Principal percentage"><ix:nonFraction name="us-gaap:DebtInstrumentRedemptionPricePercentage" contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact000997" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">110</ix:nonFraction></span>% of the principal amount being redeemed, plus accrued and unpaid interest, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with the issuance of the Convertible Debentures, NioCorp issued to Yorkville <span id="xdx_90D_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zdABP6yjf5e5" title="Issuance of the convertible debentures"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockOptionsExercise" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact000999" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,789,267</ix:nonFraction></span>
Financing Warrants at an exercise price of approximately $<span id="xdx_902_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise1_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zPQ4aqM8ohn3" title="Issuance of the convertible debentures"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockOptionsExercise1" contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact001001" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">8.9422</ix:nonFraction></span>
per Common Share (the &#8220;Financing Warrant Exercise Price&#8221;), subject to adjustment to
give effect to any stock dividend, stock split, reverse stock split recapitalization or similar event. The Financing Warrants
are exercisable, in whole or in part, but not in increments of less than $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__srt--RangeAxis__srt--MaximumMember_zxMkrK1VDK33" title="Aggregate exercise price, per shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30_srt_MaximumMember" id="Fact001003" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">50</ix:nonFraction></span> aggregate Financing Warrant Exercise Price (unless
the remaining aggregate Financing Warrant Exercise Price is less than $50), beginning on May 4, 2023, and may be exercised at
any time prior to their expiration. Holders of the Financing Warrants may exercise their Financing Warrants, at their election,
by paying the Financing Warrant Exercise Price in</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zBGJJt9WIUNh" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zbYTgFF0UBT3" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zr82NywiQUN9" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zeDMSc0uWra9" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_239_zgTHRGd9bMrc" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_23C_zERU9iA59zOb" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">cash or, if at any time there is no effective registration statement registering,
or no current prospectus available for, the resale of the underlying Common Shares, on a cashless exercise basis. 1/12th of the
Financing Warrants will expire on each of the first 12 monthly anniversaries of the date that is six months following the Closing
Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>









<ix:exclude><p id="xdx_23F_z5yG73hUxv59" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Financing Warrants have customary anti-dilution adjustments. The terms of the Financing Warrants restrict the exercise of Financing
Warrants by Yorkville if such an exercise would cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or
such an exercise would cause the aggregate number of Common Shares issued pursuant to the Yorkville Convertible Debt Financing
Agreement to exceed the thresholds for issuance of Common Shares under the rules of the Nasdaq, unless prior shareholder approval
is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Financing Warrants were originally recorded as a $<span id="xdx_903_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_pn3n3_c20230126__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIelF8H5emV1" title="Contingent liability"><ix:nonFraction name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="AsOf2023-01-26_us-gaap_WarrantMember" id="Fact001012" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,704</ix:nonFraction></span> contingent liability on January 26, 2023, and were subsequently marked
to market of $<span id="xdx_90E_eus-gaap--ServicingLiability_iI_pn3n3_c20230316__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxjptlUhgbc" title="Contingent liability"><ix:nonFraction name="us-gaap:ServicingLiability" contextRef="AsOf2023-03-16_us-gaap_WarrantMember" id="Fact001014" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,337</ix:nonFraction></span> through March 16, 2023. The change in fair value during this period resulted in a loss of $<span id="xdx_90E_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_dxL_c20220701__20230630_zKbOOHaCibTl" title="Fair value of warrant liability::XDX::3338"><span style="-sec-ix-hidden: xdx2ixbrl1016">633</span></span>, which was
booked to change in fair value of warrant liability in the consolidated statement of operations and comprehensive loss. The Financing
Warrants were reclassified to shareholders equity on March 17, 2023, in connection with the closing of the Convertible Debentures
as noted below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocated the net proceeds of $15,360 from the Convertible Debentures as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zwBEgamIuQT" title="Fair value"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact001018" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,704</ix:nonFraction></span>
    was booked to Common Shares, representing the initial fair value of the Financing Warrant tranches on January 26, 2023 based
    on the Black Scholes pricing model using a risk-free interest rate <span style="color: #353535">of <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_z4VF79aiO6Sd" title="Fair value"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact001020" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.33</ix:nonFraction></span>%, an expected dividend
    yield of <span id="xdx_90C_ecustom--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_pid_dp_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z8lyEiMtiEPk" title="Fair value"><ix:nonFraction name="niobf:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="Fact001022" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>%, a volatility of <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zbSZWcFbtsgd" title="Fair value"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact001024" format="ixt:numdotdecimal" decimals="INF" unitRef="NUMBER">64.6</ix:nonFraction></span>%, and an expected life of <span id="xdx_901_ecustom--DebtMaturityPeriod_dxL_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MinimumMember_zIztXPQML6kk" title="Expected life::XDX::P6M"><span style="-sec-ix-hidden: xdx2ixbrl1026">6</span></span> months to <span id="xdx_90F_ecustom--DebtMaturityPeriod_dxL_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MaximumMember_zVvscG6PK5a" title="Expected life::XDX::P18M"><span style="-sec-ix-hidden: xdx2ixbrl1028">18</span></span> months</span>. </span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90E_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zTPSIZJhPmje" title="Convertible debt liability"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact001030" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,656</ix:nonFraction></span>
    was booked to the convertible debt liability. In addition, transaction costs of $<span id="xdx_907_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zGZCHj3EqGz2" title="Transaction costs"><ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact001032" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">503</ix:nonFraction></span> were recognized as a direct deduction
    from the debt liability, resulting in a net opening balance of $12,153 at an effective interest rate of 29.9%. This balance
    will be accreted to face value of the Convertible Debentures at maturity plus the conversion premium, using the effective
    interest method and recorded as interest expense in the consolidated statement of operations and comprehensive loss.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001034" name="us-gaap:ConvertibleDebtTableTextBlock"><p id="xdx_89A_eus-gaap--ConvertibleDebtTableTextBlock_zCZIt9LXAG1b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_ziH8btiidYhl">Changes
in the Convertible Debentures are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 2%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opening balance,
    March 17, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230315__20230630_zmxNCG0LTaxa" title="Opening balance, March 17, 2023" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2023-03-14" id="Fact001036" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,153</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion expense</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230315__20230630_z7wTzvPSLpPe" title="Accretion expense" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccretionExpenseIncludingAssetRetirementObligations" contextRef="From2023-03-152023-06-30" id="Fact001038" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,962</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal and accrued
    interest converted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: left"/>
    <td id="xdx_98B_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230315__20230630_zCfSSCzz9So1" title="Principal and accrued interest converted" style="border-bottom: black 1pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:PrincipalAndAccruedInterestConverted" contextRef="From2023-03-152023-06-30" id="Fact001040" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,554</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30,
    2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230701__20240630_zPQTp9SJcDme" title="Balance, June 30, 2023" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2023-06-30" id="Fact001042" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,561</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion expense</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230701__20240630_zDYYc4CSjGa3" title="Accretion expense" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccretionExpenseIncludingAssetRetirementObligations" contextRef="From2023-07-01to2024-06-30" id="Fact001044" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,489</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal and accrued
    interest converted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_987_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230701__20240630_zICELzkeyOA" title="Principal and accrued interest converted" style="border-bottom: black 1pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:PrincipalAndAccruedInterestConverted" contextRef="From2023-07-01to2024-06-30" id="Fact001046" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,479</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30,
    2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--ConvertibleDebt_iE_pn3n3_c20230701__20240630_zPFMd0apsUA3" title="Balance, June 30, 2023" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2024-06-30" id="Fact001048" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">571</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Less: Unamortized
    debt issuance costs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_98E_eus-gaap--PaymentsOfFinancingCosts_pn3n3_dxL_c20230701__20240630_z329JUk6wQ66" title="Add: uamortized debt issuance costs::XDX::0" style="border-bottom: black 1pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1050">(</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining principal
    balance, June 30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iE_pn3n3_c20230701__20240630_z89uW0w9kQQl" title="Balance, June 30, 2023" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InvestmentOwnedBalancePrincipalAmount" contextRef="AsOf2024-06-30" id="Fact001052" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">550</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8AA_zY2YhXXZfl11" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001054" name="us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_zWJVatfuywXk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
conversion, the portion of remaining unamortized issuance costs associated with the conversion are recognized as a component of
interest expense. <span id="xdx_8BF_zvWjZ9Y2PN97">The following table discloses the components of interest expense associated with the Convertible Debentures.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ending June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Component of Interest Expense</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: justify">Contractual &#160;interest</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--ContractualInterest_c20230701__20240630_zNFOoCJrv9K" title="Contractual interest" style="width: 14%; text-align: right"><ix:nonFraction name="niobf:ContractualInterest" contextRef="From2023-07-01to2024-06-30" id="Fact001056" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">279</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--ContractualInterest_c20220701__20230630_zvrniZHfvDw8" title="Contractual interest" style="width: 14%; text-align: right"><ix:nonFraction name="niobf:ContractualInterest" contextRef="From2022-07-012023-06-30" id="Fact001058" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Amortization of discount and issuance costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AmortizationOfFinancingCosts_c20230701__20240630_zq65XXL4La31" title="Amortization of discount and issuance costs" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2023-07-01to2024-06-30" id="Fact001060" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,210</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AmortizationOfFinancingCosts_c20220701__20230630_zE9KM6YtcXGb" title="Amortization of discount and issuance costs" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2022-07-012023-06-30" id="Fact001062" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,737</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--InterestAndDebtExpense_c20230701__20240630_zad4crZ0IL64" title="Total" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2023-07-01to2024-06-30" id="Fact001064" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,489</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--InterestAndDebtExpense_c20220701__20230630_zfgz1HD72KHf" title="Total" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2022-07-012023-06-30" id="Fact001066" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,962</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AD_z9LaIIKzUr3a" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>









<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Debentures contain events of default customary for instruments of their type (with customary grace periods, as applicable)
and provide that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to NioCorp, all outstanding Convertible Debentures will become due and payable immediately without further action or notice. If
any other type of event of default occurs and is continuing, then any holder may declare all of its Convertible Debentures to
be due and payable immediately. The Company</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_z8VzcUYEagkb" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zbSO8UeGC2pb" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_z9eJI9YzgWE8" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zb2EK5ze9JHe" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_236_zC2aOqQVdzXc" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_23C_zT88Phvjjxjl" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">obtained a waiver from Yorkville with respect to any acceleration rights it may have
under the Convertible Debentures in connection with the restatements of the Company&#8217;s consolidated financial statements for the
periods ended September 30, 2022 and December 31, 2022 and the delay in filing the Company&#8217;s Quarterly Report on Form 10-Q for
the quarterly period ended March 31, 2023. The Yorkville Convertible Debt Financing Agreement also contains certain covenants
that, among other things, limit NioCorp&#8217;s ability to use the proceeds from the Yorkville Convertible Debt Financing to repay
related party debt or to enter into any variable rate transaction other than with Yorkville, subject to certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the Company&#8217;s closing Common Share price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z5kz1rz5fw47"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30_us-gaap_MeasurementInputSharePriceMember" id="Fact001073" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">1.73</ix:nonFraction></span> as of June 30, 2024, conversion of the remaining Convertible Debenture
principal balance of $552, including accrued interest, would require the issuance of approximately 257,000 Common Shares.
For each $0.10 change in the fair value of one Common Share, the total shares the Company would be obligated to issue would change
by approximately <span id="xdx_90E_eus-gaap--OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_iI_c20240630_ziyBVOVqCHaa"><ix:nonFraction name="us-gaap:OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" contextRef="AsOf2024-06-30" id="Fact001074" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500</ix:nonFraction></span> shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2024, the Company and Yorkville entered into a make-whole payment agreement under which Yorkville agreed to convert the
remaining principal and outstanding accrued interest of $554 remaining under the Convertible Debenture into Common Shares in exchange
for a $95 make-whole payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">April
2024 Notes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2024, the Company issued and sold to Yorkville and Lind Global Fund II LP (together with Yorkville, the &#8220;April
2024 Purchasers&#8221;), $8,000 aggregate principal amount of unsecured notes (the &#8220;April 2024 Notes&#8221;), pursuant to
a securities purchase agreement, dated April 11, 2024 (the &#8220;April 2024 Purchase Agreement&#8221;), between the Company and
each of the April 2024 Purchasers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also issued to the April 2024 Purchasers, in proportion to the aggregate principal amount of April 2024 Notes issued to
each April 2024 Purchaser, Warrants (the &#8220;April 2024 Warrants&#8221;) to purchase up to 615,385 Common Shares (the &#8220;April
2024 Warrants Shares&#8221;), which are equal to 25% of the aggregate principal amount of April 2024 Notes issued to the April
2024 Purchasers divided by the exercise price of $3.25, subject to any adjustment to give effect to any stock dividend, stock
split or recapitalization. The April 2024 Warrants expire on April 12, 2027.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the April 2024 Purchase Agreement, the April 2024 Purchasers advanced an aggregate of $6,935 to the Company in consideration
of the issuance by the Company to the April 2024 Purchasers of $8,000 aggregate principal amount of the April 2024 Notes and April
2024 Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the April 2024 Notes, subject to certain exceptions, on the first day of each calendar month, beginning on June 1,
2024 (excluding August 2024) (the &#8220;Payment Date&#8221;), the Company will be required to repay a portion of the outstanding
balance of all of the April 2024 Notes, on a pro-rata basis, in an amount equal to the sum of (i) $1,400 of principal (or the
outstanding principal if less than such amount) in the aggregate among all of the outstanding Notes, plus (ii) 8.0% of the principal
amount being paid (the &#8220;Payment Premium&#8221;), and (iii) accrued and unpaid interest, if any, as of the Payment Date.
The Company is required to make payments on each Payment Date until the entire outstanding principal is repaid but will not have
an obligation to make a payment on a Payment Date if certain equity conditions (the &#8220;Equity Conditions&#8221;) are satisfied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations contained within the April 2024 Notes, holders of the April 2024 Notes will be entitled to convert the
principal amount of, accrued and unpaid interest, if any, and any Payment Premium that has become due and payable on each April
2024 Note, from time to time over their term, into a number of Common Shares equal to the quotient of the amount being converted
divided by a fixed conversion price of $2.75 per Common Share up to a maximum of 3,141,817 Common Shares (together with the April
2024 Warrant Shares, the &#8220;April 2024 Underlying Shares&#8221;). The terms of the April 2024 Notes restrict the conversion
of the April 2024 Notes by a holder if such a conversion would cause such holder to exceed certain ownership thresholds in the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
noted above, the Company is required to make payments on each Payment Date until the entire outstanding principal is repaid,
but will not have an obligation to make a payment on a Payment Date if the Equity Conditions are satisfied (a &#8220;deferred
payment&#8221;). The Equity Conditions means (i) on each of the five consecutive trading days prior a Payment Date (the
&#8220;Measuring Period&#8221;) the Underlying Shares Registration Statement (as defined below) is effective</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zEiMtIewpHld" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zd7FdfkI4fpg" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zJfsB0xszY7f" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zCGnOnjCnzt7" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23C_z6f76nPOjn6b" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_234_z4Zw3jYra0qi" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">and available
for the resale by the Purchasers of all Underlying Shares, (ii) the Company has no knowledge of any fact that would cause the
Underlying Shares Registration Statement not to be effective and available for the resale of the Underlying Shares, (iii) on
each day during the Measuring Period, the Common Shares are designated for quotation on Nasdaq, or on such other market or
exchange on which the Common Shares are then listed or traded to the extent such other market or exchange is the principal
U.S. trading market for the Common Shares (the &#8220;Principal U.S. Market&#8221;), and have not been suspended from trading
nor have delisting or suspension of trading been threatened or pending, (iv) during the Measuring Period, an event of default
has not occurred, (v) on each trading day during the Measuring Period, the daily U.S. dollar volume-weighted average price
(&#8220;VWAP&#8221;) for a Common Share on the Principal U.S. Market as reported by Bloomberg Financial Markets is greater
than 120% of the Conversion Price, (vi) on each trading day during the Measuring Period the average daily volume traded
exceeded $500, and (vii) there is no limitation on conversion under the terms of Notes. Deferred payments, if any, that are
not subsequently converted into Common Shares by the holders of the April 2024 Notes will require repayment by
the Company upon maturity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes are the unsecured obligations of the Company and will mature on December 31, 2024. The April 2024 Notes will
incur a simple interest rate obligation of 0.0% per annum (which will increase to 18.0% per annum upon the occurrence of an event
of default). The outstanding principal amount, accrued and unpaid interest, if any, and the Payment Premium, if any, on the April
2024 Notes must be paid by NioCorp in cash when the same becomes due and payable under the terms of the April 2024 Notes at their
stated maturity, upon their redemption, or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes may also be redeemed at the Company&#8217;s option at any time and from time to time over their term at a redemption
price equal to the principal amount being redeemed, plus the Payment Premium, plus accrued and unpaid interest, if any, as of
the redemption date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes contain events of default customary for instruments of their type (with customer grace periods, as applicable)
and provide that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to the company, all outstanding April 2024 Notes will become due and payable immediately without further action or notice. If
any other type of event of default occurs and is continuing, then any holder may declare all of its April 2024 Notes to be due
and payable immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Purchase Agreement contains customary representations, warranties, conditions and indemnification obligations by each
party. The representations, warranties and covenants contained in the April 2024 Purchase Agreement were made only for purposes
of the April 2024 Purchase Agreement and as of specific dates, were solely for the benefit of the parties to such agreement and
are subject to certain important limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Purchase Agreement also contains certain covenants that, among other things, limit NioCorp&#8217;s ability to use the
proceeds from the April 2024 Purchase Agreement to repay related party debt or to enter into any variable rate transaction other
than with Yorkville, subject to certain exceptions, and to distribute proceeds from the April 2024 Purchase Agreement to subsidiaries
other than ECRC and 0896800 B.C. Ltd. (together with ECRC, the &#8220;Guarantors&#8221;), upon the entry by the Guarantors into
a global guaranty agreement, dated as of April 11, 2024, among the Guarantors in favor of the Purchasers (the &#8220;Guaranty Agreement&#8221;).
Pursuant to the Guaranty Agreement, the Guarantors guaranteed the full, prompt and unconditional payment when due (whether at
maturity , by acceleration or otherwise), and the performance of all liabilities, agreements and other obligations of NioCorp
to the April 2024 Purchasers contained in the April 2024 Notes, the April 2024 Warrants and the April 2024 Purchase Agreement,
to the extent such liabilities, agreements and obligations are payable in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the Company&#8217;s analysis of the criteria contained in ASC 815, the Company determined that April 2024 Warrants met the
definition of a&#160;derivative liability, as any warrant exercise that could cause the holder to exceed 19.9% ownership of NioCorp
Common Shares would require shareholder approval. As such, the April 2024 Warrants were recognized as warrant liabilities on the
consolidated balance sheet and were measured at their inception date fair value and subsequently remeasured at each reporting
period with changes being recorded as a non-operating gain or loss in the consolidated statement of operations and comprehensive
loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company elected to value the April 2024 Notes at fair value in accordance with ASC 815-15-25. The fair value of the April 2024
Notes was estimated using a Monte Carlo simulation pricing model and the April 2024 Notes were</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zb5xZNt0pBF9" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_z5oOQvmfASje" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zquhuc0xh7P8" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_z1uGuOWAgBg5" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23D_zxUKPwXwYuNg" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_234_zJsbcwq0TDq5" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">classified as Level 3 instruments.
The Company incurred transaction costs totaling $<span id="xdx_90E_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zarXN1Tl7me" title="Transaction loss"><ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" contextRef="AsOf2024-04-30_us-gaap_FairValueMeasurementsRecurringMember" id="Fact001088" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">474</ix:nonFraction></span> in connection with the issuance of the April 2024 Notes and due to the fair
value election noted above, these costs were expensed at closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Components
and initial valuations associated with the April 2024 Notes were comprised of the following amounts:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_902_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240401__20240430_zo5PWB31vEwk" title="Warrant liabilities"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-04-012024-04-30" id="Fact001090" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">902</ix:nonFraction></span>
    was recorded to warrant liabilities, representing the initial fair value of the April 2024 Warrants based on the assumptions
    outlined below.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_903_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_pn3n3_c20240401__20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zZNfCdGpUTM7" title="Fair value"><ix:nonFraction name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" contextRef="From2024-04-012024-04-30_us-gaap_FairValueMeasurementsRecurringMember" id="Fact001092" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,315</ix:nonFraction></span> was recorded
    to the April 2024 Notes, representing the fair value based on the assumptions outlined below. The Company also recognized
    an opening transaction loss of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pn3n3_c20240401__20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zqEHBE2MnU2d" title="Transaction loss"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-04-012024-04-30_us-gaap_FairValueMeasurementsRecurringMember" id="Fact001094" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,256</ix:nonFraction></span>, representing the difference between the fair value of the April 2024 Notes, including
    the fair value of the variable conversion features embedded therein, and cash received in the transaction.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001096" name="us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfInterestRateDerivativesTableTextBlock_zHNvXdAmOAT3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zfUrMHRhCZu5">The
following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left">Key Valuation Input</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">June 30,&#160; <br/>2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">April 12,&#160; <br/>2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98C_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhqSFnTS9d7e" title="Closing common share price" style="width: 21%; text-align: center">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember" id="Fact001098" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.73</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98F_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zmBICTXydg34" title="Closing common share price" style="width: 21%; text-align: center">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember" id="Fact001100" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.11</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zaJ72QA4j4Ce" title="Term (expiry)"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" id="Fact001102" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">December 31, 2024</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zADAFpNQqTH9" title="Term (expiry)"><ix:nonNumeric contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" id="Fact001104" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">December 31, 2024</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted average of the equity volatility and implied volatility of the public warrants</td><td>&#160;</td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zBICEfh0rBGg" title="Weighted average of the equity volatility and implied volatility of the public warrants" style="text-align: center"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember" id="Fact001106" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction>%</td><td style="text-align: left"/><td>&#160;</td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIUl1VeCkHje" title="Weighted average of the equity volatility and implied volatility of the public warrants" style="text-align: center"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember" id="Fact001108" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66.0</ix:nonFraction>%</td><td style="text-align: left"/></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zdy5tTkY5Qdb" title="Risk-free rate" style="text-align: center"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember" id="Fact001110" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.33</ix:nonFraction>%</td><td style="text-align: left"/><td>&#160;</td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zqR3GtXVGbL4" title="Risk-free rate" style="text-align: center"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember" id="Fact001112" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.26</ix:nonFraction>%</td><td style="text-align: left"/></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Implied discount rate</td><td>&#160;</td>
    <td id="xdx_982_ecustom--ImpliedDiscountRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zyuehdXX7kk3" title="Implied discount rate" style="text-align: center"><ix:nonFraction name="niobf:ImpliedDiscountRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember" id="Fact001114" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15.0</ix:nonFraction>%</td><td style="text-align: left"/><td>&#160;</td>
    <td id="xdx_984_ecustom--ImpliedDiscountRate_pid_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z4V10XbqMFRl" title="Implied discount rate" style="text-align: center"><ix:nonFraction name="niobf:ImpliedDiscountRate" contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember" id="Fact001116" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15.0</ix:nonFraction>%</td><td style="text-align: left"/></tr>
</table>

</ix:nonNumeric><p id="xdx_8AB_z6XJa1PWXF9e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001118" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_zJ9Smiw7Z0uf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zpAR7ydiCVOb">The
following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 47%; text-align: justify">Fair value, April 12, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20230701__20240630_z2jv5DxV4aAj" title="Fair value, April 12, 2024" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FairValueHedgeAssetsAtFairValue" contextRef="AsOf2023-06-30" id="Fact001120" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,315</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Principal payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20230701__20240630_zJI5vBB9C5pf" title="Principal payments" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2023-07-01to2024-06-30" id="Fact001122" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,512</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Change in fair value</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--ChangeInFairValue_iN_di_c20230701__20240630_zx4TGDsCPam" title="Change in fair value" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValue" contextRef="From2023-07-01to2024-06-30" id="Fact001124" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,714</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2pt">Balance, June 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_c20230701__20240630_zHeWpD3PZia7" title="Balance, June 30, 2024" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueHedgeAssetsAtFairValue" contextRef="AsOf2024-06-30" id="Fact001126" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,089</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Remaining principal balance, June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_c20230701__20240630_zjHqglcvRBN3" title="Remaining principal balance, June 30, 2024" style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" contextRef="From2023-07-01to2024-06-30" id="Fact001128" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,128</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A1_zmFHIGoaU1j8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001130" name="niobf:ShareholdersEquityAndShareBasedWarrantsTextBlock"><p id="xdx_89F_ecustom--ShareholdersEquityAndShareBasedWarrantsTextBlock_zh3qMPNxLzI3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zQEb40a2NLt7">The
following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,&#160; <br/>2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">April 12,&#160; <br/>2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zPmCPTpX0pW3" title="Closing Common Share price" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" id="Fact001132" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.73</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z20QFBugWrD5" title="Closing Common Share price" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" id="Fact001134" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.24</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFsziBESTP1e" title="Term (years)" style="text-align: right"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" format="ixt-sec:duryear" id="Fact001136" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.78</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQd3COrPHMv7" title="Term (years)" style="text-align: right"><ix:nonNumeric contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" format="ixt-sec:duryear" id="Fact001138" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.0</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFipjWoRMIF9" title="Expected volatility" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" id="Fact001140" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66.34</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwkJ8FX3AS7l" title="Expected volatility" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" id="Fact001142" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">62.39</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zURmgUpQIT27" title="Risk-free rate" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" id="Fact001144" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.57</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZymoChGO0h6" title="Risk-free rate" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" id="Fact001146" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.77</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A6_zSvcJIS5Y6s5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001148" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_z5JKzlucfzUh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zrCdDv1tM1Nh">The
following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June
30, 2024.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 47%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of April 12, 2024</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z0iuzQNGBL5" style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-04-10_custom_EarnoutMember" id="Fact001149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">902</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_988_eus-gaap--FairValueAdjustmentOfWarrants_iN_pn3n3_di_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z3qby1HDA9Jj" style="border-bottom: black 1pt solid; text-align: right">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-04-112024-06-30_custom_EarnoutMember" id="Fact001150" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">604</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of June 30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zRvILZ43JrPb" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_custom_EarnoutMember" id="Fact001151" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">298</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AD_zdO0PJW0XbP6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

</ix:nonNumeric><p id="xdx_81E_zFD6eVgu42cd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001153" name="niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock"><p id="xdx_800_ecustom--ScheduleOfClassBCommonStockOfECRCTableTextBlock_zzNEzJKKYE82" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>









<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</span></td><td id="xdx_825_z2mAKcvliIuj" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLASS
                                         B COMMON STOCK OF ECRC</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the Sponsor Support Agreement, and the Exchange Agreement, after the Closing, the GXII
founders have the right to exchange shares of Class B common stock of ECRC for Common Shares on a one-for-one basis, subject to
certain equitable adjustments, under certain conditions. All <span style="color: #353535"><span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zTqmkU1m8Oz1" title="Common stock, shares, issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zyGs29QzoyI2" title="Common stock, shares, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" id="Fact001155" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" id="Fact001157" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,957,404</ix:nonFraction></ix:nonFraction></span></span> shares of Class B common stock
of ECRC that were issued in connection with the Closing were issued and outstanding as of</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zLjPWjXxMCFb" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zBd5nQ9D3eW5" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zBec2Y18hXR1" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_z0nBMs1xI6se" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_238_zkatmMuVfjWh" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_23F_zHKbm5yZ8Bub" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="color: #353535">June 30, 2023. </span>Of the issued
and outstanding shares of Class B common stock of ECRC, <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zeziB1rUy7t4" title="Earnout shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassBMember" id="Fact001165" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,565,808</ix:nonFraction></span> shares (the &#8220;Vested Shares&#8221;)&#8201;were vested
as of the Closing Date and are exchangeable at any time, and from time to time, until the tenth anniversary of the Closing Date
(the &#8220;Ten-Year Anniversary&#8221;) and <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTH8QWiKpXu7" title="Earnout shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-07-012024-06-30_custom_EarnoutMember" id="Fact001167" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,391,596</ix:nonFraction></span> shares (the &#8220;Earnout Shares&#8221;) are exchangeable until the Ten-Year
Anniversary, subject to certain vesting conditions. Under certain circumstances, and subject to certain exceptions, NioCorp may
instead settle all or a portion of any exchange pursuant to the terms of the Exchange Agreement in cash, in lieu of Common Shares,
based on a volume-weighted average price of Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2024 and May 16, 2024, 243,692 Vested Shares and 40,000 Vested Shares, respectively, were exchanged for an equivalent
number of Common Shares. This exchange resulted in a change in the Company&#8217;s ownership interest in ECRC and was accounted
for as an equity transaction in accordance with ASC 810-10-45-23, with no gain or loss recognized. Accordingly, the carrying amount
of the noncontrolling interest was adjusted to reflect the change in the Company&#8217;s ownership interest with a corresponding
offset booked to equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the shares of Class B common stock of ECRC are subject to the Amended and Restated Registration Rights Agreement, dated as
of March 17, 2023 (the &#8220;Registration Rights and Lock-up Agreement&#8221;), among NioCorp, GXII, the Sponsor, the pre-Closing
directors and officers of NioCorp and the other parties thereto, including the members of the Sponsor. Pursuant to Registration
Rights and Lock-up Agreement, all shares of Class B common Stock of ECRC (including the Vested Shares and the Released Earnout
Shares) are subject to certain &#8220;lock-up&#8221; restrictions on transfer beginning upon the Closing and ending upon the earlier
of (i) one year after the Closing and (ii) the date on which the trading price of Common Shares exceeds certain thresholds or
the date on which NioCorp completes a transaction that results in all of NioCorp&#8217;s shareholders having the right to exchange
their Common Shares for cash, securities or other property. Both Vested Shares and Released Earnout Shares may be exchanged by
the holders into Common Shares at any time. Under the Exchange Agreement, all Vested Shares and Earnout Shares must be exchanged
for Common Shares by the Ten-Year Anniversary except for Released Earnout Shares that have been vested for a period of fewer than
twenty-four months as of the Ten-Year Anniversary. Such Released Earnout Shares will be forfeited if not exchanged for Common
Shares by the date that is twenty-four months after the vesting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Vested
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the exchange of Vested Shares are contingently redeemable at the option of the noncontrolling interest shareholders, the Company
classifies the carrying amount of the redeemable noncontrolling interest in the mezzanine section on the consolidated balance
sheet, which is presented above the equity section and below liabilities. Adjustments to the carrying value of the redeemable noncontrolling interest associated with redemptions are recorded by reclassifying the proportionate amount of mezzanine equity to permanent equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Earnout
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--DescriptionOfEarnOutShares_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_ze2DrMfIJODg" title="Description of earnout shares"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_EarnoutMember" id="Fact001169" name="niobf:DescriptionOfEarnOutShares">The
Earnout Shares vest (the &#8220;Released Earnout Shares&#8221;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement.</ix:nonNumeric></span> These shares will be forfeited if the market
share price milestones or an acceleration event is not reached prior to the Ten-Year Anniversary. At such time that the Earnout
Shares shall become vested, and therefore, become Released Earnout Shares, the shares will be transferred to the redeemable noncontrolling
interest in the mezzanine section of the Consolidated Balance Sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Earnout Shares were classified as a liability due to failure to meet the equity classification criteria under ASC 815-40, as Level
3 instruments under the fair value hierarchy and are considered a financial liability under ASC 480, Distinguishing Liabilities
from Equity. The Earnout Shares were measured at fair value on the Closing Date with subsequent changes in fair value recorded
in earnings. The Earnout Shares were valued utilizing a Monte Carlo simulation pricing model. The following table discloses the
primary inputs into the Monte Carlo models.</span></p>

<ix:exclude><p id="xdx_230_zTwNzn9SITG6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p></ix:exclude>







<ix:exclude><!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zQiyO9i9fktj" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zDzNpaLzY5cj" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zXCzkRvsDZD" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zUodOuUzNzMg" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_236_z6ohIdEccnp3" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_23C_z91XsLzWhG34" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001178" name="niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock"><p id="xdx_89C_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zDefajNB1qE" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zmVlM2iqUTHk" style="display: none; visibility: hidden">The following table discloses the primary inputs into the Monte Carlo models.</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left">Key Valuation Input</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>
2023</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">March 17, <br/>
2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: left">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJv4vq5K4bTb" title="Closing common share price" style="width: 13%; text-align: center">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact001180" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.73</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJydUB0JDn5k" title="Closing common share price" style="width: 13%; text-align: center">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact001182" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.03</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_981_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zjcDHDNjyqr3" title="Closing common share price" style="width: 13%; text-align: center">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact001184" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlN1m5Fe2Jm8" title="Term (expiry)"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" id="Fact001186" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">March 17, 2033</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zW1FZ1Te9q55" title="Term (expiry)"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" id="Fact001188" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">March 17, 2033</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zLuZFFoxgCEa" title="Term (expiry)"><ix:nonNumeric contextRef="From2023-03-152023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" id="Fact001190" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">March 17, 2033</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zu1umMnDVy6a" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact001192" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65.0</ix:nonFraction></span>%</td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zCKwC7xnccL2" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact001194" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">33.5</ix:nonFraction></span>%</td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zw3II2SHIbH8" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-03-152023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact001196" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19.5</ix:nonFraction></span>%</td><td style="text-align: left"/></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zPFG7rb1vSrb" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact001198" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.35</ix:nonFraction></span>%</td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTZ1viASsVS8" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact001200" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.83</ix:nonFraction></span>%</td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zOOGRta5PSok" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-03-152023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact001202" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.39</ix:nonFraction></span>%</td><td style="text-align: left"/></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_z4GaHVg2OTEi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001204" name="niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock"><p id="xdx_891_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z9eWTOTSPLte" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zNWKTfXspJW4">The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 47%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of March 17, 2023</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230315__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zw5yyEtakKkc" title="Fair value at beginning" style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAmount" contextRef="AsOf2023-03-14_custom_EarnoutMember" id="Fact001206" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,195</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20230315__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z437Lf6iNWm7" title="Change in fair value" style="border-bottom: black 1pt solid; text-align: right">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAdditions" contextRef="From2023-03-152023-06-30_custom_EarnoutMember" id="Fact001208" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,674</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of June 30, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zMQCqvLOjN0c" title="Fair value at beginning" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAmount" contextRef="AsOf2023-06-30_custom_EarnoutMember" id="Fact001210" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,521</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_987_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zL4LH2VZupBd" title="Change in fair value" style="border-bottom: black 1pt solid; text-align: right">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAdditions" contextRef="From2023-07-012024-06-30_custom_EarnoutMember" id="Fact001212" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,704</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of June 30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zGe47ofFlYRh" title="Fair value at ending" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAmount" contextRef="AsOf2024-06-30_custom_EarnoutMember" id="Fact001214" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,817</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8AE_zrItpNfeQrrd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

</ix:nonNumeric><p id="xdx_81A_z9qWoWxKBIQ4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001216" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock"><p id="xdx_80B_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_z6HNmwl1pUEf" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</span></td><td id="xdx_821_zE1qMkJmXF2l" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMON
                                         SHARES</span></td></tr></table>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuances</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal
Year 2024 Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 1, 2023, the Company closed a non-brokered private placement (the &#8220;September 2023 Private Placement&#8221;) of
units of the Company (the &#8220;September 2023 Units&#8221;). A total of <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230830__20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zA7YiU6lOAkf" title="Shares issue"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-08-302023-09-02_us-gaap_PrivatePlacementMember_currency_CAD" id="Fact001218" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></span> September 2023 Units were issued at a price
per September 2023 Unit of $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zzge53SsQWwh" title="Price per unit"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-09-02_us-gaap_PrivatePlacementMember_currency_CAD" id="Fact001220" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.00</ix:nonFraction></span>, for total gross proceeds to the Company of $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20230830__20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_z6CFZ3WVVRvh" title="Gross proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-08-302023-09-02_us-gaap_PrivatePlacementMember_currency_CAD" id="Fact001222" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></span>. Each September 2023 Unit consists of one
Common Share and one Warrant (&#8220;September 2023 Warrant&#8221;). Each September 2023 Warrant entitles the holder to acquire
one Common Share at a price of $<span id="xdx_90E_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zXB5cVt35Lze" title="Shares price"><ix:nonFraction name="niobf:SaleOfStockPricePerShare1" contextRef="AsOf2023-09-02_us-gaap_PrivatePlacementMember_currency_CAD" id="Fact001224" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.60</ix:nonFraction></span> at any time prior to September 1, 2025. Proceeds of the September 2023 Private Placement
will be used for continued advancement of the Elk Creek Project and for working capital and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
September 2023 Warrants were classified as an equity instrument and accordingly, the net proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930_zm232uZKM6nf"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2023-09-012023-09-30" id="Fact001225" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">962</ix:nonFraction></span> were allocated based
on the relative fair values of the Common Shares and the September 2023 Warrants on the date of issuance. The amount allocated
to the fair value of the September 2023 Warrants was $<span id="xdx_904_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpCaj6U5T0g1"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember" id="Fact001226" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">254</ix:nonFraction></span> and the balance of the proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztcC797dXS9c"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2023-09-012023-09-30_us-gaap_CommonStockMember" id="Fact001227" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">708</ix:nonFraction></span> was allocated to the Common
Shares. The fair value of the September 2023 Warrants issued was computed using the Black Scholes pricing model using the following
assumptions: an expected life of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmL4yKo4V1K9" title="Expected life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1229">2.0</span></span> years, a risk-free interest rate of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrzudoLdJ8i2" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember" id="Fact001231" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.85</ix:nonFraction></span>%, an expected volatility of <span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uPure_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJ6syQxiY3J1" title="Expected volatility"><ix:nonFraction name="niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember" id="Fact001233" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">71.63</ix:nonFraction></span>%, and an expected
dividend rate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrsFszMVX2n1" title="Expected dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember" id="Fact001235" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2023, the Company closed a non-brokered private placement (the &#8220;December 2023 Private Placement&#8221;) of
<span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zvqVeAdD0gL8" title="Shares issue"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD" id="Fact001237" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">413,432</ix:nonFraction></span> units of the Company (the &#8220;December 2023 Units&#8221;). Each December 2023 Unit consists of one Common Share and
one Warrant (&#8220;December 2023 Warrant&#8221;). Each December 2023 Warrant entitles the holder to acquire one Common Share
at a price of $<span id="xdx_903_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zn1oBfdpF6og" title="Shares price"><ix:nonFraction name="niobf:SaleOfStockPricePerShare1" contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_currency_CAD" id="Fact001239" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.54</ix:nonFraction></span> at any time until December 22, 2025. <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zOCReH2wGVTc" title="Units issue and sold"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_InvestorMember" id="Fact001241" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">274,587</ix:nonFraction></span> of the December 2023 Units were issued and sold to certain accredited
investors, who are not affiliated with the Company but with whom the Company had a pre-existing relationship, at a price of $<span id="xdx_906_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_ziziWDmkS82" title="Shares price"><ix:nonFraction name="niobf:SaleOfStockPricePerShare1" contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_InvestorMember" id="Fact001243" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.08</ix:nonFraction></span>
per December 2023 Unit, and <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__srt--TitleOfIndividualAxis__srt--DirectorMember_zxzxscOG9kHc" title="Units issue and sold"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD_srt_DirectorMember" id="Fact001245" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">138,845</ix:nonFraction></span> of the December 2023 Units were issued and sold to certain officers and directors of the Company
(the &#8220;Insider Investors&#8221;), at a price of $<span id="xdx_909_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__srt--TitleOfIndividualAxis__srt--DirectorMember_zN8E7lQG4wA5" title="Shares price"><ix:nonFraction name="niobf:SaleOfStockPricePerShare1" contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_currency_CAD_srt_DirectorMember" id="Fact001247" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.205</ix:nonFraction></span> per December 2023 Unit. The price per December 2023 Unit paid by the
Insider Investors included $0.125 per December 2023 Warrant underlying each December 2023 Unit purchased by the Insider Investors
which allowed the Insider Investors to participate in the December 2023 Private Placement in accordance with the rules of Nasdaq.
The Company received aggregate gross proceeds from the December 2023 Private Placement of approximately $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zIwH0dvqb8C" title="Gross proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD" id="Fact001249" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,290</ix:nonFraction></span>. Proceeds of the
December 2023 Private Placement will be used for continued advancement of the Elk Creek Project and for working capital and general
corporate purposes. The Company recorded a non-cash expense of $<span id="xdx_90C_eus-gaap--OtherCostAndExpenseOperating_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbU1WvBc5pMd" title="Other operating expenses"><ix:nonFraction name="us-gaap:OtherCostAndExpenseOperating" contextRef="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember" id="Fact001251" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">92</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--OperatingCostsAndExpenses_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z80GviyR3sFd" title="Employee related costs"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember" id="Fact001253" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span> to other operating expense and employee related costs,
respectively, representing the excess of fair value of the December 2023 Units over the purchase price paid by Insider Investors.</span></p>

<ix:exclude><p id="xdx_23D_zfjAMWptH7i8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p></ix:exclude>







<ix:exclude><!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_z9m2Tyt6sFH2" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_z7SHI76ppkda" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z4NZbiUpdyq" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zZcIgQwxaKsb" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_230_z8Zib1XR9H24" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_23E_zSulXspDikU6" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
December 2023 Warrants were classified as an equity instrument and accordingly, the estimated net proceeds of $1,241 were allocated
based on the relative fair values of the Common Shares and the December 2023 Warrants on the date of issuance. The amount allocated
to the fair value of the December 2023 Warrants was $<span id="xdx_908_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVIdjTUGMow" title="Proceeds from equity"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember" id="Fact001262" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">264</ix:nonFraction></span> and the balance of the proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze4zM8VnzkE" title="Proceeds from equity"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact001264" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">977</ix:nonFraction></span> was allocated to the Common Shares.
The fair value of the December 2023 Warrants issued was computed using the Black Scholes pricing model using the following assumptions:
an expected life of <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zicL57i0zUog" title="Expected life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1266">2.0</span></span> years, a risk-free interest rate of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrlPhIYkDDta" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember" id="Fact001268" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.33</ix:nonFraction></span>%, an expected volatility of <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uPure_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvJVRb30H41a" title="Expected volatility"><ix:nonFraction name="niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember" id="Fact001270" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">54.8</ix:nonFraction></span>%, and an expected dividend rate
of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpo4b9gKhX5d" title="Expected dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember" id="Fact001272" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 24, 2024, <span id="xdx_90E_eus-gaap--SaleOfStockDescriptionOfTransaction_c20240623__20240624__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_znrjaRmmEF18" title="Description of stock transaction"><ix:nonNumeric contextRef="From2024-06-232024-06-24_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember" id="Fact001274" name="us-gaap:SaleOfStockDescriptionOfTransaction">the Company closed a non-brokered private placement (the &#8220;June 2024 Private Placement&#8221;) of units of
the Company (the &#8220;June 2024 Units&#8221;). A total of 315,000 June 2024 Units were issued at a price per June 2024 Unit
of $1.91, for total gross proceeds to the Company of $<span id="xdx_903_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240623__20240624__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_za58kwM0qHt7" title="Proceeds from equity"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2024-06-232024-06-24_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember" id="Fact001276" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">602</ix:nonFraction></span>. Each June 2024 Unit consists of one Common Share and one Warrant (&#8220;June
2024 Warrant&#8221;). Each June 2024 Warrant entitles the holder to acquire one Common Share at a price of $2.20 at any time prior
to June 24, 2026. Proceeds of the June 2024 Private Placement will be used for continued advancement of the Elk Creek Project
and for working capital and general corporate purposes.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
June 2024 Warrants were classified as an equity instrument and accordingly, the net proceeds of $602 were allocated based on the
relative fair values of the Common Shares and the June 2024 Warrants on the date of issuance. The amount allocated to the fair
value of the June 2024 Warrants was $<span id="xdx_90E_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYNadUl6HeZh" title="Proceeds from equity"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember" id="Fact001278" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">161</ix:nonFraction></span> and the balance of the proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEsilUOwKh69" title="Proceeds from equity"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2024-06-012024-06-30_us-gaap_CommonStockMember" id="Fact001280" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">441</ix:nonFraction></span> was allocated to Common Shares. The fair value
of the June 2024 Warrants issued was computed using the Black Scholes pricing model using the following assumptions: an expected
life of <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zM52UVP5Y9d3" title="Expected life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1282">2.0</span></span> years, a risk-free interest rate of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z28LnKRE7yVg" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember" id="Fact001284" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.73</ix:nonFraction></span>%, an expected volatility of <span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uPure_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZhpJwDOWXwe" title="Expected volatility"><ix:nonFraction name="niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember" id="Fact001286" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">73.92</ix:nonFraction></span>%, and an expected dividend rate of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSPSuv7Vip8i" title="Expected dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember" id="Fact001288" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal
Year 2023 Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the Common Shares issued in connection with the GXII Transaction, as discussed in Note 5, the following Common Share
issuances occurred during fiscal year 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 28, 2023, <span id="xdx_90F_eus-gaap--ConversionOfStockNewIssuance_c20230427__20230428__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--KingdonCapitalManagementLLCMember_zg605uNWs6y2"><ix:nonNumeric contextRef="From2023-04-272023-04-28_custom_KingdonCapitalManagementLLCMember" id="Fact001289" name="us-gaap:ConversionOfStockNewIssuance">the Company closed a registered direct offering and issued 314,465 Common Shares for $2,000, before deducting
share issuance costs of $172. The Common Shares were sold pursuant to a securities purchase agreement, dated April 26, 2023, between
the Company and a fund managed by Kingdon Capital Management, LLC.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 9, 2023, <span id="xdx_90C_eus-gaap--ConversionOfStockNewIssuance_c20230608__20230609__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleEquityFacilityFinancingAgreementMember_zjKwF4ksuwzf"><ix:nonNumeric contextRef="From2023-06-082023-06-09_custom_YorkvilleEquityFacilityFinancingAgreementMember" id="Fact001290" name="us-gaap:ConversionOfStockNewIssuance">the Company issued 100,000 Common Shares under the Yorkville Equity Facility Financing Agreement (discussed below)
in exchange for $488 in cash proceeds. The Company recorded a non-cash operating expense of $13 which represented the difference
between the proceeds received and the fair value of the Common Shares issued based on Nasdaq closing price per Common Share on
the issuance date.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
                                         Options</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2024, the Company&#8217;s shareholders voted to approve an amendment and restatement of its long-term incentive plan
(the &#8220;2017 Amended Long-Term Incentive Plan&#8221;) and the granting of incentive securities thereunder until January 19,
2027. Under the 2017 Amended Long-Term Incentive Plan, the Board may, in its discretion from time to time, grant options and share
units (in the form of restricted share units and performance share units) to directors, employees and certain other service providers
(as defined in the 2017 Amended Long-Term Incentive Plan) of the Company and affiliated entities selected by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to adjustment as described in the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares that may be reserved
for issuance to participants under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, may not exceed 10% of the issued and outstanding Common Shares from time to time, and the Common
Shares reserved for issuance upon settlement of share units will not exceed 5% of the issued and outstanding Common Shares from
time to time. The 2017 Amended Long-Term Incentive Plan limits the maximum number of Common Shares issued to insiders (as defined
under TSX rules for this purpose) within any 1-year period, or issuable to insiders at any time, in the aggregate, under all security-based
compensation arrangements (including the 2017 Amended Long-Term</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_z8qDVPjv7snc" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zocLcTQohtNg" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zQFQnq4HSRhj" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zEZlUIS3QsS4" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_233_zDvNCXuwtUj1" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_234_zTVqIQDd0uE6" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Incentive Plan) to 10% of the then issued and outstanding Common
Shares. The 2017 Amended Long-Term Incentive Plan also limits the aggregate number of Common Shares that may be reserved for issuance
to any one participant under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation arrangements
of the Company, to 5% of the then issued and outstanding Common Shares (on a non-diluted basis). Subject to the adjustment provisions
of the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares actually issued or transferred by the Company
upon the exercise of incentive stock options will be limited as described above.</span></p>

<ix:exclude><p id="xdx_238_zuZgzcpo7mRl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p></ix:exclude>









<ix:exclude><p id="xdx_23C_zBgssdKYzHR" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has power over the granting, amendment, administration, or settlement of any award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
option transactions are summarized as follows:</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001300" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_zWGZKuGVAEe2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_z0jy0iletlJc" style="display: none; visibility: hidden">Schedule of stock option</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Number of Options</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Exercise Price</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Aggregate Intrinsic Value</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Remaining Contractual Life</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2023</span></td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230701__20240630_zye0TeAXrv1b" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-06-30" id="Fact001302" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,541,500</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20230701__20240630_zqAAL9m57Goh" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-06-30" id="Fact001304" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">7.19</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Granted</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230701__20240630_zUeNkdqhxVWd" title="Granted, in shares" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-07-01to2024-06-30" id="Fact001306" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,625,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zwKafKcDrL35" title="Granted, per share" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-07-01to2024-06-30" id="Fact001308" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">2.99</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Exercised</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230701__20240630_zWX5btsMY8Zb" title="Cancelled/expired, in shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-07-01to2024-06-30" id="Fact001310" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,800</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zd1ix0BCB8Yg" title="Cancelled/expired, per share" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-07-01to2024-06-30" id="Fact001312" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">3.95</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Cancelled/expired</span></td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230701__20240630_zYPoYl8DeWhh" title="Cancelled/expired, in shares" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2023-07-01to2024-06-30" id="Fact001314" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">663,200</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zkovxxki1jm2" title="Cancelled/expired, per share" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2023-07-01to2024-06-30" id="Fact001316" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">5.88</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20230701__20240630_zb2buhWzOMM3" title="Ending balance" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-06-30" id="Fact001318" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,495,500</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20230701__20240630_zWtr5uPr8tR6" title="Ending balance" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-06-30" id="Fact001320" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">4.78</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">-</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20230701__20240630_zyNXfsZgVxv2" title="Weighted average remaining contractual life::XDX::P3Y5M9D"><span style="-sec-ix-hidden: xdx2ixbrl1322">3.44</span></span> years</span></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AB_zq5LTkXk7RSl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_pid_dp_uPure_c20230701__20240630_zkgY6nZaXhe6" title="Outstanding stock options vested"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" contextRef="From2023-07-01to2024-06-30" id="Fact001324" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the outstanding stock options were fully vested. The total intrinsic value of options exercised during
the year ended June 30, 2024 <span style="background-color: white">was immaterial, and as of June 30, 2024, </span>there were
no unrecognized compensation costs related to unvested share-based compensation arrangements granted. The Company recognized share-based
compensation expense of $<span id="xdx_906_eus-gaap--ShareBasedCompensation_pn3n3_dxL_c20230701__20240630_zuzaPTNtLga5" title="Share based compensation expense::XDX::2881"><span style="-sec-ix-hidden: xdx2ixbrl1326">2,779</span></span> and $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_pn3n3_c20220701__20230630_zJmibczMz0tc" title="Share based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-07-012023-06-30" id="Fact001328" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,794</ix:nonFraction></span> for the years ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001330" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z2kBH6g6jsd2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the weighted average information and assumptions used to determine option costs:&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 70%; margin-left: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_491_20230701__20240630_zJT66EgqTjpc" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_492_20220701__20230630_zMJX0iLpVci" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 4pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">Year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 4pt">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">2023</td><td>&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_za4ZZCglBnD3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-left: 4pt">Fair value per option granted during the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 10%; text-align: right">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-07-01to2024-06-30" id="Fact001332" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.71</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 10%; text-align: right">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-07-012023-06-30" id="Fact001333" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.09</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_zKro84PDHlkd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 4pt">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-07-01to2024-06-30" id="Fact001335" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.25</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-07-012023-06-30" id="Fact001336" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.30</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zf36kUWNMGyg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 4pt">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-07-01to2024-06-30" id="Fact001338" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-07-012023-06-30" id="Fact001339" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_zS7Liq7OcSJl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 4pt">Expected stock price volatility (historical basis)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-01to2024-06-30" id="Fact001341" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">63.2</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-07-012023-06-30" id="Fact001342" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">63.6</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 4pt">Expected option life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630_zUuwWwGG7Rlg" title="Expected option life in years::XDX::P5Y" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1344">5.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220701__20230630_zh9CTGbFc9Pl" title="Expected option life in years::XDX::P3Y" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1346">3.0</span></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_zVO1iM18sgtj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to January 1, 2024, the Company concluded that under ASU 718, <i>Compensation &#8211; Stock Compensation (Topic 718)</i>, Options
previously issued on December 31, 2021, May 30, 2022, and March 27, 2023, which included a C$ strike price should remain equity-classified
as management determined that the Options qualified for an exemption from liability classification as the Options were denominated
in a currency in which a substantial portion of the Company&#8217;s equity securities traded. Effective January 1, 2024, the Company
determined that due to historically decreasing trading volume on the TSX, this exemption no longer applied and accordingly, these
Options were classified as a liability based on their fair values on that date. The Company recorded a mark-to-market gain of
$147 in other operating expenses related to these option liabilities for the year ended June 30, 2024. The associated liability
related to these Canadian-denominated Options was nil at June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Board approved a modification to Options previously issued on March 27, 2023, with dual strike prices of $6.95
and C$9.52, under which the option to exercise in C$ was removed. No other terms or conditions were amended by the Board. Based
on this amendment, the Company re-classified these Options to equity on March 28, 2024, based on their fair value on that date.</span></p>

<ix:exclude><p id="xdx_234_zNGsUKgMYYz9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p></ix:exclude>







<ix:exclude><!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zPf9Y2SHxL87" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_z3D7iYuCmI56" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zriQ2c9hSUY9" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zJyBsQ6lFQn2" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_234_zt9mZvExjkjc" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_231_zhGnhC7PruA1" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001355" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zajsKuOKR16b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
transactions are summarized as follows. <span id="xdx_8BC_zyqEmpR0lZz1">Weighted average exercise prices related to Canadian dollar denominated warrants were
converted to U.S. dollars using end of period foreign currency exchange rates.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0"></p>
                                   <p style="margin-top: 0; margin-bottom: 0"></p></td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Warrants</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Exercise Price</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Balance, June 30, 2022</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20220701__20230630_z8XckUuBZlg4" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-06-30" id="Fact001357" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,851,622</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20220701__20230630_zlPFz7KFYO25" title="Balance at beginning average price" style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2022-06-30" id="Fact001359" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.99</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Granted:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Yorkville financing warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--YorkvilleFinancingWarrants_pid_uShares_c20220701__20230630_zsM2GDSooiDh" title="Yorkville financing warrants" style="text-align: right"><ix:nonFraction name="niobf:YorkvilleFinancingWarrants" contextRef="From2022-07-012023-06-30" id="Fact001361" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,789,267</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_pid_uUSDPShares_c20220701__20230630_zuRZJAtK8XX7" title="Yorkville financing warrants average price" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" contextRef="From2022-07-012023-06-30" id="Fact001363" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.94</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">GXII warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--GxiiWarrants_pid_uShares_c20220701__20230630_zHMJkushqd4a" title="GXII warrants" style="text-align: right"><ix:nonFraction name="niobf:GxiiWarrants" contextRef="From2022-07-012023-06-30" id="Fact001365" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,666,626</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_pid_uUSDPShares_c20220701__20230630_zJ7RdbGA8fG" title="GXII warrant average price" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" contextRef="From2022-07-012023-06-30" id="Fact001367" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20220701__20230630_zwtkNzObpjxd" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:ClassOfWarrantOrRightExpired" contextRef="From2022-07-012023-06-30" id="Fact001368" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">491,211</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20220701__20230630_z9twSZGNm2y1" title="Cancelled" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceExpired" contextRef="From2022-07-012023-06-30" id="Fact001370" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.67</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20230701__20240630_zurKJrQeN0hh" title="Beginning balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-06-30" id="Fact001372" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,816,304</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20230701__20240630_zjTCrM0X5K51" title="Balance at beginning average price" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2023-06-30" id="Fact001374" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.98</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20230701__20240630_z0W5fkGoigqf" title="Granted" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightGranted" contextRef="From2023-07-01to2024-06-30" id="Fact001376" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,593,817</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20230701__20240630_zPvax70AxKZh" title="Granted" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceGranted" contextRef="From2023-07-01to2024-06-30" id="Fact001378" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.33</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20230701__20240630_z3hKFny45BZb" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:ClassOfWarrantOrRightExpired" contextRef="From2023-07-01to2024-06-30" id="Fact001379" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">1,846,560</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20230701__20240630_zcw1PQYD0wEb" title="Cancelled" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceExpired" contextRef="From2023-07-01to2024-06-30" id="Fact001381" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.67</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Balance, June 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20230701__20240630_zpRUOUmiGBv8" title="Ending balance" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30" id="Fact001383" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,563,561</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iE_pid_uUSDPShares_c20230701__20240630_zE325rBL0CJ7" title="Balance at ending average price" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2024-06-30" id="Fact001385" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.53</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_z7veq4cSjdr8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001387" name="niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock"><p id="xdx_89E_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zfZlJxw1mQ28" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zpt6fAXGWFI7">At
June 30, 2024, the Company has outstanding exercisable warrants, as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
    Date</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zoXC4JVPcOGg" title="Number of share outstanding" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30_custom_ExercisePrice9.70Member" id="Fact001389" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">855,800</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zGpJ8aCGpI45" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30_currency_CAD_custom_ExercisePrice9.70Member" id="Fact001391" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">9.70</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zeHof6GKu6p" title="Expiry date::XDX::2025-02-19" style="width: 60%; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1393">February
    19, 2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zDEglaeylwUe" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30_custom_ExercisePrice8.94Member" id="Fact001394" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">447,318</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"/><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zOMzWTH7SnI3" title="Exercise price" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30_custom_ExercisePrice8.94Member" id="Fact001396" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.94</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zhUsGKRWEASg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30_custom_ExercisePrice4.60Member" id="Fact001397" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"/><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zdGPamuZW8j" title="Exercise price" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30_custom_ExercisePrice4.60Member" id="Fact001399" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.60</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_z2x4fRJLJVIj" title="Expiry date::XDX::2025-09-01" style="text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1401">September
    1, 2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zYi3g4pIj88e" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30_custom_ExercisePrice3.54Member" id="Fact001402" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">413,432</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"/><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zntLCYZYgUF1" title="Exercise price" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30_custom_ExercisePrice3.54Member" id="Fact001404" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.54</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zSP9E4t43nVc" title="Expiry date::XDX::2025-12-22" style="text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1406">December
    22, 2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zIJjZwTBQP0d" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30_custom_ExercisePrice2.20Member" id="Fact001407" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">315,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zQIyFNHSsqQb" title="Exercise price" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30_custom_ExercisePrice2.20Member" id="Fact001409" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.20</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zE506OVXL2qa" title="Expiry date::XDX::2025-06-24" style="text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1411">June
    24, 2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_z6HnfquTlHxc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30_custom_ExercisePrice3.25Member" id="Fact001412" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">615,385</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"/><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zFf6iyBUoy03" title="Exercise price" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30_custom_ExercisePrice3.25Member" id="Fact001414" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.25</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zpbNSKQf8iMl" title="Expiry date::XDX::2027-04-12" style="text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1416">April
    12, 2027</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z9oNsluQzth" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30_custom_ExercisePrice11.50Member" id="Fact001417" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,666,626</ix:nonFraction></span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"/><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z0pvMgx2Hztl" title="Exercise price" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30_custom_ExercisePrice11.50Member" id="Fact001419" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zJ17oOr84gIc" title="Expiry date::XDX::2028-03-17" style="text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1421">March
    17, 2028</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630_zjf9tMeF7pac" style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30" id="Fact001422" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,563,561</ix:nonFraction></span></td><td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; padding-right: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 2.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span id="xdx_F0F_zHWjoLgb5ZYh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: left"><span id="xdx_F1E_zX2isN3oIiNc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001423" xml:lang="en-US">Expires
    in 3 equal monthly tranches on July 17, 2024, August 17, 2024, and September 17, 2024.</ix:footnote></span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A5_zwecu1KHXiVc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Closing, pursuant to the Business Combination Agreement, the Company assumed the GXII Warrant Agreement and
each GXII Warrant thereunder that was issued and outstanding immediately prior to the Closing Date was converted into one NioCorp
Assumed Warrant pursuant to the GXII Warrant Agreement, as amended by an Assignment, Assumption and Amendment Agreement, dated
March 17, 2023, among the Company, GXII, Continental Stock Transfer &amp; Trust Company, as the existing warrant agent, and Computershare
Inc. and its affiliate, Computershare Trust Company, N.A, together as the successor warrant agent (the &#8220;NioCorp Assumed
Warrant Agreement&#8221;). In connection with the Closing, NioCorp issued (a) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--GXIIPublicWarrantsMember_z1SYUjMrhvBf" title="Warrants traded prior to the closing"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-07-012024-06-30_custom_GXIIPublicWarrantsMember" id="Fact001425" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,999,959</ix:nonFraction></span> public NioCorp Assumed Warrants (the &#8220;Public
Warrants&#8221;) in respect of the GXII Warrants that were publicly traded prior to the Closing and (b) <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--GXIIPrivateWarrantsMember_z7lUvDhskIcl" title="Warrants traded prior to the closing"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-07-012024-06-30_custom_GXIIPrivateWarrantsMember" id="Fact001427" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,666,667</ix:nonFraction></span> NioCorp Assumed
Warrants (the &#8220;Private Warrants&#8221;) to the Sponsor in respect of the GXII Warrants that it held prior to the Closing,
which NioCorp Assumed Warrants were subsequently distributed by the Sponsor to its members in connection with the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zi7DUScxqMG7" title="Description of warrants"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember" id="Fact001429" name="us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees">Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like).</ix:nonNumeric></span> No fractional shares will be issued upon exercise of any NioCorp Assumed Warrants, and fractional shares that would otherwise
be due to the exercising holder will be rounded down to the nearest whole Common Share. In no event will the Company be required
to net cash settle any NioCorp Assumed Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Public
Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may elect to redeem the Public Warrants subject to certain conditions, in whole and not in part, at a price of $0.01 per
Public Warrant if (i) 30 days&#8217; prior written notice of redemption is provided to the holders, </span><span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20230701__20240630_zsbTlpE3ms8g" title="Description of warrants"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact001431" name="us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees">(ii)
the last reported sale price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span title="Description of warrants">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span title="Description of warrants"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zzbuGr6lqkUc" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zBrROS2AL9Se" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_ztpaqUm89PS7" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zrUEXQbPTVT9" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_236_zmGflJRFeekj" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_235_zEJ4yqZmRf4b" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span title="Description of warrants">within a 30-trading day period ending
on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders</span> and <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
there is an effective registration statement covering the Common Shares issuable upon exercise of the Public Warrants, and a current
prospectus relating thereto, available through the redemption date. Upon issuance of a redemption notice by the Company, the warrant
holders will have until the redemption date to exercise for cash, or, at the Company&#8217;s election, on a cashless basis. The
Public Warrants are not precluded from equity classification and are accounted for as such on the date of issuance, and each balance
sheet date thereafter. Because the 2023 Transactions resulted in an excess of liabilities over assets acquired, no value was ascribed
to the Public Warrants.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>








<ix:exclude><p id="xdx_231_zxWOFwPQavJe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Warrants </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants: (i) will be exercisable either for cash or on a cashless basis at the holder&#8217;s option and (ii) will not
be redeemable by the Company, in either case as long as the Private Warrants are held by the Sponsor, its members or any of their
permitted transferees (as prescribed in the NioCorp Assumed Warrant Agreement). In accordance with the NioCorp Assumed Warrant
Agreement, any Private Warrants that are held by someone other than the Sponsor, its members or any of their permitted transferees
are treated as Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the Private Warrants assumed in the 2023 Transactions in accordance with the guidance contained in ASC 815-40.
Such guidance provides that because the Private Warrants do not meet the criteria for equity treatment thereunder, each Private
Warrant must be recorded as a liability. This liability is carried as a component of Warrant Liabilities on the consolidated balance
sheet and is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be
adjusted to its current fair value, with the change in fair value recognized in the consolidated statement of operations and comprehensive
loss. The Company will reassess the classification at each balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001440" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zHgR48wJZmoa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zLLrOhG6vMfk">The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a
Black Scholes model with the following assumptions:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 17, 2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 31%; text-align: justify">Stock price on valuation date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1Z5rDZjdkV4" title="Stock price on valuation date" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001442" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.73</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFE6f8V4pHcc" title="Stock price on valuation date" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001444" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.03</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKti9c2iZ2ub" title="Stock price on valuation date" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member" id="Fact001446" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zOtZwGvw2vs9" title="Strike price" style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001448" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWcBARjHuf42" title="Strike price" style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001450" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhgD62xwvIt6" title="Strike price" style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member" id="Fact001452" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4ENW3fVdG78" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001454" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">69.0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zCWPeAEkl5yl" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001456" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">33.5</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeImYtHqK0Mf" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-03-152023-03-17_us-gaap_FairValueInputsLevel2Member" id="Fact001458" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19.5</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXiirYGbXKZb" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001460" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.45</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFq3HWAZU19c" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001462" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.18</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zMKev04i1UE2" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2023-03-152023-03-17_us-gaap_FairValueInputsLevel2Member" id="Fact001464" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.47</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zcsificTC6ej" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001466" format="ixt:numdotdecimal" decimals="-3" scale="1" unitRef="Pure">0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDKPV2q7L2Wl" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001468" format="ixt:numdotdecimal" decimals="-3" scale="1" unitRef="Pure">0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zvsYn0LvsLYd" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-03-152023-03-17_us-gaap_FairValueInputsLevel2Member" id="Fact001470" format="ixt:numdotdecimal" decimals="-3" scale="1" unitRef="Pure">0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected warrant life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zcG5EAX3qLbj" title="Expected warrant life in years::XDX::P3Y8M12D"><span style="-sec-ix-hidden: xdx2ixbrl1472">3.7</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjMLr3IZqMDe" title="Expected warrant life in years::XDX::P4Y8M12D"><span style="-sec-ix-hidden: xdx2ixbrl1474">4.7</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znJ3gJPKi7ci" title="Expected warrant life in years::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1476">5.0</span></span></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zlDiwfsl7V6j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001478" name="niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock"><p id="xdx_89B_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zbDEDzsTxw83" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zN3GUDOwHwG3">The
change in the Private Warrants liability is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%">Initial valuation, March 17, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230315__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_ze4dEjbfLz13" title="Initial valuation, at begining" style="width: 10%; text-align: right"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation" contextRef="AsOf2023-03-14_us-gaap_NoteWarrantMember" id="Fact001480" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,987</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in valuation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230315__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zAkWZjJgEmzl" title="Change in valuation" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" contextRef="From2023-03-152023-06-30_us-gaap_NoteWarrantMember" id="Fact001482" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">292</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Valuation at June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zN4GuycS7h48" title="Initial valuation, at begining" style="text-align: right"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation" contextRef="AsOf2023-06-30_us-gaap_NoteWarrantMember" id="Fact001484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,279</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in valuation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zXXIPqLb19rj" title="Change in valuation" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" contextRef="From2023-07-012024-06-30_us-gaap_NoteWarrantMember" id="Fact001486" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,926</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Valuation at June 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zNiq6OhMP5qk" title="Initial valuation, at ending" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation" contextRef="AsOf2024-06-30_us-gaap_NoteWarrantMember" id="Fact001488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,353</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zVzwu0rhjBTa" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
                                         Equity Facility Financing</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrent
with the closing of the GXII Transaction, the Yorkville Equity Facility Financing became effective. Pursuant to the
Yorkville Equity Facility Financing Agreement, Yorkville committed to purchase up to $65,000 of Common Shares (the
&#8220;Commitment Amount&#8221;), at NioCorp&#8217;s direction from time to time for a period commencing upon the Closing
Date and ending on the earliest of (i) the first day of the month next following the 36-month anniversary of the Closing,
(ii) the date on which Yorkville shall have made payment of the full Commitment Amount and (iii) the date that the Yorkville
Equity Facility Financing Agreement otherwise terminates in accordance with its terms (the &#8220;Commitment Period&#8221;), subject to certain limitations and the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zDpUMwpZRCk1" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zCoVJAwwnNd2" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z2TdmghfnVw7" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zxfMeLdXwDjh" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_238_zfOs20Plo1S8" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_23A_zJHx8niW54a9" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">satisfaction
of the conditions in the Yorkville Equity Facility Financing Agreement. The Common Shares that may be sold pursuant to the Yorkville
Equity Facility Financing Agreement would be purchased by Yorkville at a purchase price equal to 97% of the daily volume-weighted
average price of the Common Shares on Nasdaq or such other principal U.S. market for the Common Shares if the Common Shares are
ever listed or traded on the New York Stock Exchange or the NYSE American as reported by Bloomberg Financial Markets (or, if not
available, a similar service provider of national recognized standing) during the applicable pricing period, which is a period
during a single trading day or a period of three consecutive trading days, at the Company&#8217;s option and subject to certain
restrictions, in each case, defined based on when an Advance Notice (as defined in the Yorkville Equity Facility Financing Agreement)
is submitted, subject to certain limitations.</span></p>

<ix:exclude><p id="xdx_23B_zNz1XuKansFb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p></ix:exclude>









<ix:exclude><p id="xdx_239_zRNAaRj2oyMi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Yorkville Equity Facility Financing Agreement, NioCorp issued 81,213 of Common Shares (the &#8220;Commitment
Shares&#8221;) valued at $650 to Yorkville as consideration for its irrevocable commitment to purchase Common Shares under the
Yorkville Equity Facility Financing Agreement. On June 9, 2023, NioCorp issued and sold 100,000 Common Shares to Yorkville under
the Yorkville Equity Facility Financing Agreement. Additionally, NioCorp is required to pay Yorkville an aggregate fee of $1,500
in cash (the &#8220;Cash Fee&#8221;), including $500 that NioCorp paid on the Closing Date and an additional $250 NioCorp was
paid as of June 30, 2023. NioCorp will pay the remaining $750 balance in installments over a 12-month period following the Closing
Date, provided that it will have the right to prepay without penalty all or part of the remaining installments of the Cash Fee
at any time. In addition, legal and other costs of $496 were incurred in connection with the Yorkville Equity Facility Financing
and were expensed on the effective date. The following amounts related to the Yorkville Equity Facility Financing Agreement were
expensed as other operating costs during the year ended June 30, 2023:</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001498" name="us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_z3ASikrYjJu1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zzt2wXsBEeM6" style="display: none; visibility: hidden">Schedule of expenses as other operating costs</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zeU06pPLzlEi" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_ecustom--YorkvilleCashFee_zCo8eoTA9VL9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%; text-align: justify">Yorkville Cash Fee</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="niobf:YorkvilleCashFee" contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact001500" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zMxZ7zqa5Uci" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Fair value of Commitment Shares issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact001502" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--OtherCostAndExpenseOperating_z0jMHASx6W26" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Legal and other related costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherCostAndExpenseOperating" contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact001504" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">496</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--OperatingCostsAndExpenses_z85GnfZNKj0e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2pt">Costs expensed to other operating expense</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact001506" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,646</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_zBQ86SNeRFa6" style="margin-top: 0; margin-bottom: 0"></p>

</ix:nonNumeric><p id="xdx_81F_z40aH50XZlY4" style="margin-top: 0; margin-bottom: 0"></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001508" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4eKlHaWxKOf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</span></td><td id="xdx_829_z8tIyz7Feacf" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RELATED
                                         PARTY TRANSACTIONS AND BALANCES</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was party to a non-revolving credit facility agreement (the &#8220;Smith Credit Facility&#8221;) with Mark Smith, Chief
Executive Officer, President, and Executive Chairman of NioCorp, which expired on June 30, 2023. The Smith Credit Facility bore
interest at a rate of <span id="xdx_903_eus-gaap--RelatedPartyTransactionRate_pid_dp_uPure_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zFLs49Ru3Er6" title="Interest at a rate"><ix:nonFraction name="us-gaap:RelatedPartyTransactionRate" contextRef="From2023-07-012024-06-30_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember" id="Fact001510" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% and drawdowns from the Smith Credit Facility were subject to a <span id="xdx_904_ecustom--LineOfCreditFacilityPrepaymentFee_pid_dp_uPure_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zdoV39mhXN3d" title="Prepayment fee"><ix:nonFraction name="niobf:LineOfCreditFacilityPrepaymentFee" contextRef="From2023-07-012024-06-30_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember" id="Fact001512" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.5</ix:nonFraction></span>% establishment fee. Amounts outstanding
under the Smith Credit Facility were secured by all of the Company&#8217;s assets pursuant to a general security agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001514" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zi0DW29dRwp2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zbYcDYi02tPc">Changes
in the Smith Credit Agreement principal balance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the year ending June 30,2023</span></td>
    <td style="text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 57%; background-color: #CCEEFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
    balance</span></td>
    <td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20220701__20230630_zvLcTJ5yFCRl" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:RelatedPartyDepositLiabilities" contextRef="AsOf2022-06-30" id="Fact001515" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Amounts
    advanced</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_ecustom--AmountsAdvanced_pn3n3_c20220701__20230630_zGvahmC47mrb" title="Amounts advanced" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:AmountsAdvanced" contextRef="From2022-07-012023-06-30" id="Fact001517" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,130</ix:nonFraction></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom; background-color: #CCECFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Repayments</span></td>
    <td style="vertical-align: bottom; background-color: #CCECFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: #CCECFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_984_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20220701__20230630_zFkN7hObNvhd" title="Repayments" style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: #CCECFF; text-align: right">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2022-07-012023-06-30" id="Fact001519" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,130</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; background-color: #CCECFF; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance,
    end of period</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20220701__20230630_z2ENjS0AcD5j" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1520">-</span></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
</table>
</ix:nonNumeric><p id="xdx_8AA_zUbKMvpONWhf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 22, 2023, the Company repaid Mr. Smith $<span id="xdx_901_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230322__us-gaap--TypeOfArrangementAxis__custom--NonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zdbedpl4zKKb" title="Credit agreement"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2023-03-22_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember" id="Fact001522" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,841</ix:nonFraction></span> of principal borrowed under the Smith Credit Facility. This repayment was
made out of funds transferred to the Company from the GXII trust account on the Closing Date. The Company repaid the remaining
principal balance of $<span id="xdx_907_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_z3kHivj0Nai7" title="Principal amount outstanding"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2023-05-31_custom_MarkSmithMember" id="Fact001524" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,289</ix:nonFraction></span> on May 31, 2023. Accounts payable and accrued liabilities as of June 30, 2024 includes $<span id="xdx_907_ecustom--EstablishmentFeesPayable_pn3n3_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_zK1bq0V0XkW5" title="Establishment fees payable"><ix:nonFraction name="niobf:EstablishmentFeesPayable" contextRef="From2023-07-012024-06-30_custom_MarkSmithMember" id="Fact001526" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span> of origination
fees payable under the Smith Credit Agreement. During fiscal year 2023 the Company paid a total of $<span id="xdx_900_eus-gaap--AccruedLiabilitiesCurrent_iI_pn3n3_c20230630_zsKcCa1LoaJh"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-06-30" id="Fact001527" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">183</ix:nonFraction></span>, representing accrued
interest on the Smith Credit Agreement.</span></p>

</ix:nonNumeric><p id="xdx_817_zrW4eB5kERJf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>







<!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p id="xdx_234_zZsmgsHLw0di" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p id="xdx_233_zwMQwmlSUY02" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p>

<p id="xdx_236_ztg2vAwcnOdj" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p>

<p id="xdx_233_zIl9y4edkanf" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p>

<!-- Field: Rule-Page --><div id="xdx_23C_zbuWiG5feO78" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p id="xdx_232_zJpnQ65JWaS1" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001535" name="niobf:ExplorationExpendituresDisclosuresTextBlock"><p id="xdx_808_ecustom--ExplorationExpendituresDisclosuresTextBlock_zAPlN4B9j978" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</span></td><td id="xdx_82C_zxLiF2y2jxa1" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPLORATION
                                         EXPENDITURES</span></td></tr></table>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001537" name="niobf:ScheduleOfExplorationExpendituresTableTextBlock"><p id="xdx_893_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zrUmCPvNDG57" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zEW02sgRxMqk" style="display: none; visibility: hidden">Schedule of exploration expenditures</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td><td colspan="6" style="padding-bottom: 1pt; text-align: center">For the year ended <br/>
June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td><td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-left: 5.4pt">&#160;Feasibility study and engineering</td>
    <td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td>
    <td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_z0TgLiCc3Xya" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012024-06-30_custom_FeasibilityStudyAndEngineeringMember" id="Fact001538" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">353</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zZw16AZyDUGh" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2022-07-012023-06-30_custom_FeasibilityStudyAndEngineeringMember" id="Fact001539" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">410</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">&#160;Field management and other</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td>
    <td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_ztJXK1DHfYU1" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012024-06-30_custom_FieldManagementAndOtherMember" id="Fact001540" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">503</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zjIM2zz2poy4" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2022-07-012023-06-30_custom_FieldManagementAndOtherMember" id="Fact001541" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">738</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">&#160;Metallurgical</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td>
    <td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--MetallurgicalMember_zwIzBzW08n1b" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012024-06-30_custom_MetallurgicalMember" id="Fact001542" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,678</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--MetallurgicalMember_zVKXQvCj98Cb" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2022-07-012023-06-30_custom_MetallurgicalMember" id="Fact001543" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,174</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">&#160;Geologists and field staff</td>
    <td>&#160;</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z29Ug68eIXCh" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012024-06-30_custom_GeologistsAndFieldStaffMember" id="Fact001544" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z4lMg6XsyCeh" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2022-07-012023-06-30_custom_GeologistsAndFieldStaffMember" id="Fact001545" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; padding-left: 5.4pt">&#160;Total</td>
    <td>&#160;</td><td style="border-bottom: Black 2pt solid; text-align: left">$</td>
    <td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630_znMH3N4wvcZ" title="Exploration expenditures" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-01to2024-06-30" id="Fact001547" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,552</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630_zpJ67NrBhQeh" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2022-07-012023-06-30" id="Fact001548" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,348</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A3_zwFN6yUj2lnk" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_810_zulMQlH4ExOl" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001550" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_80F_eus-gaap--LesseeOperatingLeasesTextBlock_zGxsbcstybTa" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</span></td><td id="xdx_826_zq6vjV7Y0CU4" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEASES</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
February 2023, the Company entered into a <span id="xdx_90F_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20230701__20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CorporateOfficeMember_zsLN8BflOW15" title="Other lease description"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_CorporateOfficeMember" id="Fact001552" name="us-gaap:LesseeOperatingLeaseOptionToExtend">39-month corporate office lease extension and recognized a corresponding ROU asset and
lease liability of $198 associated with this extension, based on a discount rate of <span id="xdx_90D_ecustom--DiscountRate_dp_uPure_c20230701__20240630_zR36QQLX1Tmd" title="Discount rate"><ix:nonFraction name="niobf:DiscountRate" contextRef="From2023-07-01to2024-06-30" id="Fact001554" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16</ix:nonFraction></span>%.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024 and 2023, the Company had one corporate office lease with a remaining lease term of <span id="xdx_907_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20240630_zzCUMc7n15Bj" title="Remaining lease term::XDX::P2Y7M6D"><span style="-sec-ix-hidden: xdx2ixbrl1556">2.6</span></span> years and <span id="xdx_903_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20230630_zUEDHhLfWTKb" title="Remaining lease term::XDX::P3Y7M6D"><span style="-sec-ix-hidden: xdx2ixbrl1558">3.6</span></span> years,
respectively. During the year ended June 30, 2024 and 2023, operating cash flows included cash payments of $<span id="xdx_905_eus-gaap--OperatingLeasePayments_c20230701__20240630_zyu7tCP0eKd7" title="Cash payment"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2023-07-01to2024-06-30" id="Fact001560" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--OperatingLeasePayments_c20220701__20230630_zSm28HK1LF29" title="Cash payment"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2022-07-012023-06-30" id="Fact001562" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93</ix:nonFraction></span>, respectively
related to the measurement of lease liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001564" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zFMDPesBUyD4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zZwNhVP7znVa">The
Company incurred lease costs as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49A_20230701__20240630_zdpHnoiu8ZHk" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_494_20220701__20230630_zfGHLIRpd2B2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_ztcs0JNenlYa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;Operating Lease Cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--FixedRentExpense_z8wiWrFQMm9a" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-left: 0.125in">&#160;&#160;Fixed rent expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="niobf:FixedRentExpense" contextRef="From2023-07-01to2024-06-30" id="Fact001569" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="niobf:FixedRentExpense" contextRef="From2022-07-012023-06-30" id="Fact001570" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--VariableLeaseCost_zYilEpcHe0me" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">&#160;&#160;Variable rent expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2023-07-01to2024-06-30" id="Fact001572" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2022-07-012023-06-30" id="Fact001573" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">&#160;&#160;Short term lease cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2023-07-01to2024-06-30" id="Fact001575" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2022-07-012023-06-30" id="Fact001576" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_zMx8rbZIbR35" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">&#160;&#160;Sublease income</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2023-07-01to2024-06-30" id="Fact001578" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2022-07-012023-06-30" id="Fact001579" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zVDNB18iZSb3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">&#160;&#160;Net lease cost &#8211; other operating expense</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2023-07-01to2024-06-30" id="Fact001581" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">81</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2022-07-012023-06-30" id="Fact001582" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">73</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AD_zHKUfcwJmSg2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001584" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zIBH6df4xrIb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zIL0QupF7Sh">The
maturity of lease liabilities is as follows at June 30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt; padding-left: 10pt"/><td>&#160;</td>
    <td colspan="2" id="xdx_498_20240630_zVO867MS1l3i" style="border-bottom: Black 1pt solid; text-align: center">&#160;Fiscal Year Lease Maturities</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zOLwY093Fgn2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%; text-align: left; padding-left: 0.125in">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2024-06-30" id="Fact001586" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">96</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_znOgn2YDFFx7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2024-06-30" id="Fact001588" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">98</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzI5d_z6iGPLc1xjm7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">2027</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2024-06-30" id="Fact001590" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_409_ecustom--TotalLeasePayments_iI_pn3n3_mtLOLLPzI5d_zHxp79pTNTA5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:TotalLeasePayments" contextRef="AsOf2024-06-30" id="Fact001592" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_ecustom--LessAmountOfPaymentsRepresentingInterest_iNI_pn3n3_di_zB2RmiaocxGb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less amount of payments representing interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:LessAmountOfPaymentsRepresentingInterest" contextRef="AsOf2024-06-30" id="Fact001594" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_z7RPNTFnrOh5" style="vertical-align: bottom; background-color: White">
    <td>Present value of lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2024-06-30" id="Fact001596" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_402_ecustom--LessCurrentPortionOfOperatingLeaseLiability_iNI_pn3n3_di_zRkoiw9xk6U9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less current portion of operating lease liability</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:LessCurrentPortionOfOperatingLeaseLiability" contextRef="AsOf2024-06-30" id="Fact001598" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_409_ecustom--OperatingLeasesLiabilityNoncurrent_iI_pn3n3_z8eJ9hvacpNd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Noncurrent operating lease liability</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="niobf:OperatingLeasesLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact001600" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">105</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2pt">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_z3Su5hebItt" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_81B_zLZPjWzzi9I6" style="margin-top: 0; margin-bottom: 0"></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001602" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zMXvECizM2db" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</span></td><td id="xdx_82D_z6W5ECWpJsb2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCOME
                                         TAXES</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001604" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_z9bgB1OQuWef" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_z2BFpEQH5sRh">Domestic
and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows:</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; padding-left: 5pt">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z57vaDVMMEd6" title="Total" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30_us-gaap_ForeignCountryMember" id="Fact001606" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,319</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_znIGbYlP5VUj" title="Total" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-06-30_us-gaap_ForeignCountryMember" id="Fact001608" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,606</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zjd2vsIFj6Xi" title="Total" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30_us-gaap_StateAndLocalJurisdictionMember" id="Fact001610" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,679</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zWVpHypcitNa" title="Total" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-06-30_us-gaap_StateAndLocalJurisdictionMember" id="Fact001612" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,006</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt">United Kingdom</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zzAPDkmYszX2" title="Total" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30_us-gaap_DomesticCountryMember" id="Fact001614" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zcE2d0hva516" title="Total" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1616">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt; padding-left: 5pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zfJxujeMcwoe" title="Total" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-07-01to2024-06-30" id="Fact001618" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,037</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zHNyoDRvRkii" title="Total" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-06-30" id="Fact001620" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,612</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_z6gUo2qyACbf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>






<ix:exclude><!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zP6qMnwZT3I7" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_z1c6XBzSbrw" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_z8DGXA7oUHyc" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zqlWxqUlVW4i" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23A_zJLk2t9MeTT9" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_23E_z7YKUMmZEhT2" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001628" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zQKS2yZlaJyk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zKmOYbnYfTne">The
following table is a reconciliation of income taxes at statutory rates:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_495_20230701__20240630_zkoJDe5peD99" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_494_20220701__20230630_zcURCFmpWzj5" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_zLcapFBp6554" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left; padding-left: 5pt">Loss before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2023-07-01to2024-06-30" id="Fact001630" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,037</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2022-07-012023-06-30" id="Fact001631" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,612</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_z4Aj6nOFUsbk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Combined Canadian federal and provincial statutory income tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2023-07-01to2024-06-30" id="Fact001633" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-07-012023-06-30" id="Fact001634" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_z0kWdi5AgPzc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Income tax benefit at statutory tax rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2023-07-01to2024-06-30" id="Fact001636" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2022-07-012023-06-30" id="Fact001637" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,965</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_zgmSZqkdF78l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Foreign rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2023-07-01to2024-06-30" id="Fact001639" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">62</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2022-07-012023-06-30" id="Fact001640" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">131</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--EarnoutSharesLiability_zvAOBQaeeGK" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5pt">Earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:EarnoutSharesLiability" contextRef="From2023-07-01to2024-06-30" id="Fact001642" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,810</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:EarnoutSharesLiability" contextRef="From2022-07-012023-06-30" id="Fact001643" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,841</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40A_ecustom--WarrantLiability_z13vU622ux3c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:WarrantLiability" contextRef="From2023-07-01to2024-06-30" id="Fact001645" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">506</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:WarrantLiability" contextRef="From2022-07-012023-06-30" id="Fact001646" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,518</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--GxiiTransactionCosts_zY0iqsfhNwX7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">GXII transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1648">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:GxiiTransactionCosts" contextRef="From2022-07-012023-06-30" id="Fact001649" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">925</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zVXkJ8u5iGy1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt">Share based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="From2023-07-01to2024-06-30" id="Fact001651" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">747</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="From2022-07-012023-06-30" id="Fact001652" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">412</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--AssetRetirementObligationAccretionExpense_iN_di_zMM7wzlve5oe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AssetRetirementObligationAccretionExpense" contextRef="From2023-07-01to2024-06-30" id="Fact001654" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,138</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AssetRetirementObligationAccretionExpense" contextRef="From2022-07-012023-06-30" id="Fact001655" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">496</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_ecustom--ConvertibleNoteValuation_iN_di_zzNlctPWi7hc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Convertible note valuation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ConvertibleNoteValuation" contextRef="From2023-07-01to2024-06-30" id="Fact001657" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">607</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1658">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--ExtinguishmentOfDebtGainLossIncomeTax_zyMdhRxpNHHf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1660">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ExtinguishmentOfDebtGainLossIncomeTax" contextRef="From2022-07-012023-06-30" id="Fact001661" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">54</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40D_ecustom--EffectOfLegislativeChanges_zvRSKnwWjus" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Capital loss rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1663">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:EffectOfLegislativeChanges" contextRef="From2022-07-012023-06-30" id="Fact001664" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_zNTU5WJBgTx8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Change in estimates related to prior years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="From2023-07-01to2024-06-30" id="Fact001666" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">160</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="From2022-07-012023-06-30" id="Fact001667" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_zuHweNmP1zfb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt">Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2023-07-01to2024-06-30" id="Fact001669" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2022-07-012023-06-30" id="Fact001670" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zRe8hs5irF0b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-07-01to2024-06-30" id="Fact001672" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,718</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-07-012023-06-30" id="Fact001673" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,341</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 5pt">Income tax benefit</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20230701__20240630_zHg9FOUnnAz1" title="Income tax benefit::XDX::-139" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1675">139</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20220701__20230630_z1ZhZermPT97" title="Income tax benefit::XDX::-304" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1677">304</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_zdEoOZ2VSwl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax benefit for the year ends June 30, 2024 and 2023 were derived solely from our U.S. operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001679" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z8sr4ADEJGdf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zFluBkuRj1Tf">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_491_20240630_zcsLRmqQm5X7" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_495_20230630_zjZzn2nJl5Ll" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzakr_zHHYB11mTGj5" style="vertical-align: bottom; background-color: White">
    <td style="width: 54%; text-align: left; padding-left: 0.25in">Net operating losses available for future periods</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2024-06-30" id="Fact001681" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,177</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2023-06-30" id="Fact001682" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,893</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zxQyGBDpziZ8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Mineral interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsMineralInterest" contextRef="AsOf2024-06-30" id="Fact001684" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,438</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsMineralInterest" contextRef="AsOf2023-06-30" id="Fact001685" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,477</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_z12T6eRhe5Pa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Startup and organizational costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsStartupAndOorganizationalCosts" contextRef="AsOf2024-06-30" id="Fact001687" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,987</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsStartupAndOorganizationalCosts" contextRef="AsOf2023-06-30" id="Fact001688" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,132</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zQ0ysepiv2D3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Research and development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsResearchAndDevelopmentCosts" contextRef="AsOf2024-06-30" id="Fact001690" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,419</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsResearchAndDevelopmentCosts" contextRef="AsOf2023-06-30" id="Fact001691" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,060</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zuIAc0JPPD21" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in">Share issuance/financing costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsShareIssuanceCosts" contextRef="AsOf2024-06-30" id="Fact001693" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">635</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsShareIssuanceCosts" contextRef="AsOf2023-06-30" id="Fact001694" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">446</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zM7WHQZtgW6j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Capital losses available for future periods</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:CapitalLossesAvailableForFuturePeriods" contextRef="AsOf2024-06-30" id="Fact001696" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:CapitalLossesAvailableForFuturePeriods" contextRef="AsOf2023-06-30" id="Fact001697" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">419</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzakr_zPHUuuadLk09" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.25in">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2024-06-30" id="Fact001699" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2023-06-30" id="Fact001700" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iI_mtDTAGzakr_maDTALNz97R_zH8FslKJJ5z8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2024-06-30" id="Fact001702" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,181</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2023-06-30" id="Fact001703" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,463</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNz97R_zGnLV8BaggNf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">&#160;Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2024-06-30" id="Fact001705" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,181</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-06-30" id="Fact001706" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,463</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNz97R_zKvv3YhPtfs9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Net deferred tax assets</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_zAEXbRBhj7s5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001711" name="us-gaap:SummaryOfValuationAllowanceTextBlock"><p id="xdx_895_eus-gaap--SummaryOfValuationAllowanceTextBlock_znJg9a2MUMp" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zlgJc4C0A8Y">Changes
in the valuation allowance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left">Valuation allowance, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20230701__20240630_zy8O1HuJiqMl" title="Valuation allowance, beginning of year" style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-06-30" id="Fact001713" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,463</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20220701__20230630_zpQNsLKSooqe" title="Valuation allowance, beginning of year" style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-06-30" id="Fact001715" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,948</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Current year additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20230701__20240630_z8oKQuFi0Bk3" title="Current year additions" style="text-align: right">(<ix:nonFraction name="niobf:DeferredTaxAssetsValuationAllowanceAdditions" contextRef="From2023-07-01to2024-06-30" id="Fact001717" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,718</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20220701__20230630_z85LpOCidlBc" title="Current year additions" style="text-align: right">(<ix:nonFraction name="niobf:DeferredTaxAssetsValuationAllowanceAdditions" contextRef="From2022-07-012023-06-30" id="Fact001719" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,341</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Startup and organizational costs acquired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20230701__20240630_z0bO8mMe3TD3" title="Startup and organizational costs acquired" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1721">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20220701__20230630_zzoiCwC6VpGf" title="Startup and organizational costs acquired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CostsIncurredDevelopmentCosts" contextRef="From2022-07-012023-06-30" id="Fact001723" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,174</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Valuation allowance, end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20230701__20240630_zmbFKoM7NRxj" title="Valuation allowance, end of year" style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2024-06-30" id="Fact001725" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,181</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20220701__20230630_zRbdcmhhLzKe" title="Valuation allowance, end of year" style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-06-30" id="Fact001727" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,463</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A1_zOdriCJbK0Bg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>









<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acquired a federal income tax payable of $<span id="xdx_90C_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_pn3n3_c20230701__20240630_zYjQPwyq48I3" title="Federal income tax payable"><ix:nonFraction name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" contextRef="From2023-07-01to2024-06-30" id="Fact001729" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">443</ix:nonFraction></span> in connection with the GXII Transaction. As a result of a post-transaction
loss at ECRC, partial releases of the valuation allowance attributed to the reduction of the acquired federal income tax payable
of $139 and $304 were recorded as an income tax benefit in the consolidated statement of operations and comprehensive loss for
the year ended June 30, 2024 and 2023, respectively. The Company establishes a valuation allowance against future income tax assets
if, based on available information, it is more likely than not that all of the assets will not be realized. The valuation allowance
of $<span id="xdx_90E_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pn3n3_c20240630_zwtwN4vSnHe" title="Valuation allowance"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2024-06-30" id="Fact001731" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,181</ix:nonFraction></span> at June 30, 2024, relates mainly to net</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_z3sqOwdZkeZ3" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zwTTIXNRxLE" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zOjsBtCXE8W4" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zo2Fl8grMLV8" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23D_zAbk2rhWskL" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_23C_zXfwFjL0Mnpc" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">operating loss carryforwards in Canada and mineral interests due to deferred
exploration expenditures in the United States, where the utilization of such attributes is not more likely than not.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the following cumulative net operating losses for Canadian and U.S. income tax purposes and these carryforwards will
generally expire between 2028 and 2044. As a result of the Tax Cuts and Jobs Act of 2017, U.S. tax losses incurred for our tax
years ending on and after June 30, 2019, totaling $<span id="xdx_900_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_c20190630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zd3Ac0dpWetc" title="Tax losses incurred"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOtherLossCarryforwards" contextRef="AsOf2019-06-30_us-gaap_DomesticCountryMember" id="Fact001739" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,924</ix:nonFraction></span>, have no expiration.</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001741" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock"><p id="xdx_896_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zcb4TTHIh5xb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zUlCkb3Tqdy1" style="display: none; visibility: hidden">Schedule of cumulative net operating losses</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 4pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-left: 4pt">Jurisdiction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; padding-left: 4pt">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zFYEneDdpFnc" title="Total" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-06-30_us-gaap_ForeignCountryMember" id="Fact001743" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,623</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z9aOqr2g4Un1" title="Total" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-06-30_us-gaap_ForeignCountryMember" id="Fact001745" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,267</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 4pt">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_z9HoM3kIozy7" title="Total" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-06-30_us-gaap_StateAndLocalJurisdictionMember" id="Fact001747" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,905</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zjMnTpQKmzl" title="Total" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-06-30_us-gaap_StateAndLocalJurisdictionMember" id="Fact001749" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,491</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 4pt">United Kingdom</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zaGPbrYeEioc" title="Total" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-06-30_us-gaap_DomesticCountryMember" id="Fact001751" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zFqvrzdgQatb" title="Total" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1753">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt; padding-left: 4pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630_zurE3MeGlGec" title="Total" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-06-30" id="Fact001755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,567</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630_zQtPWQ385yo5" title="Total" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-06-30" id="Fact001757" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,758</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zoygixFsPxV1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company has a Canadian capital loss carryforward of $<span id="xdx_907_ecustom--CapitalLossCaryforward_iI_c20240630__srt--CurrencyAxis__currency--CAD_zsIFwOVeDd3e" title="Capital loss carryforward"><ix:nonFraction name="niobf:CapitalLossCaryforward" contextRef="AsOf2024-06-30_currency_CAD" id="Fact001759" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,388</ix:nonFraction></span> as of June 30, 2024, which has no expiration date and
can be used to offset future capital gains, and U.S. state net operating loss carryforwards of $<span id="xdx_909_ecustom--CapitalLossCaryforward_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zGKTfiJ2enU" title="Net operating loss carryforwards"><ix:nonFraction name="niobf:CapitalLossCaryforward" contextRef="AsOf2024-06-30_us-gaap_DomesticCountryMember" id="Fact001761" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,018</ix:nonFraction></span> as of June 30, 2024 which
generally expire between 2031 and 2044.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At June 30, 2024 and 2023, we had no undistributed earnings of foreign subsidiaries that would be subject to income tax upon distribution to Canada from a foreign subsidiary. As such, as of June 30, 2024 and 2023, we did not provide for deferred taxes on any such earnings of our foreign subsidiaries.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no unrecognized tax benefits as of June 30, 2024 or 2023. The Company recognizes interest accrued related to unrecognized
tax benefits and penalties in its income tax provision. The Company has not recognized any interest or penalties in the fiscal
years presented in these consolidated financial statements. The Company is subject to income tax in the U.S. federal jurisdiction,
the United Kingdom, and Canada. Certain years remain subject to examination but there are currently no ongoing exams in any taxing
jurisdictions.</span></p>

</ix:nonNumeric><p id="xdx_81F_zNe20xSfXsm9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001763" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock"><p id="xdx_80B_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_z6kSW9bwKGYb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_828_zhdaTYuH8g9h">FAIR VALUE MEASUREMENTS</span> </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures the fair value of financial assets and liabilities based on U.S. GAAP guidance which defines fair value, establishes
a framework for measuring fair value, and expands disclosures about fair value measurements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies financial assets and liabilities as held-for-trading, available-for-sale, held-to-maturity, loans and receivables,
or other financial liabilities depending on their nature. Financial assets and financial liabilities are recognized at fair value
on their initial recognition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and liabilities classified as held-for-trading are measured at fair value, with gains and losses recognized in net income.
Financial assets classified as held-to-maturity, loans and receivables, and financial liabilities other than those classified
as held-for-trading are measured at amortized cost, using the effective interest method of amortization. Financial assets classified
as available-for-sale, including investments in equity securities, are measured at fair value, with unrealized gains and losses
being recognized in income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments including receivables, accounts payable and accrued liabilities, and related party loans are carried at amortized
cost, which management believes approximates fair value due to the short-term nature of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of June 30, 2024, and 2023, respectively, and indicate the fair value hierarchy of the valuation techniques the Company utilized
to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active
markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable, such as quoted
prices, interest rates, and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the financial
instrument and include situations where there is little, if any, market activity for the instrument.</span></p>

<ix:exclude><p id="xdx_232_zXxJAZb46T64" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p></ix:exclude>








<ix:exclude><!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zX8fyfNCwoV4" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zOio0SO0LtS9" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zpD3ejvKYNT9" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_zTGwWaxI8BCj" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_235_ztCOJDyzabx" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_230_zTWMhMRCmmEd" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001772" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock"><p id="xdx_89A_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zqR1VBqKFzgc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B4_ztZC8PdC0OQi" style="display: none; visibility: hidden">Schedule of fair values determined by level 3 inputs are unobservable data</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630_zHfnRgmMcD5k" title="Cash and cash equivalents" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact001774" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyRxZhHo8qo8" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact001775" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuDVZt1TPtDh" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1776">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zN369ejReXih" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1777">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630_zOIyZjI5NWh5" title="Cash and cash equivalents" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-06-30" id="Fact001779" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqe2eCldhxH8" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact001780" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQ4l33XBWen" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1781">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zihji5P0r9K6" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1782">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240630_zvcKadMnfjh7" title="Cash and cash equivalents" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact001784" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,016</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zeI8BTDUYdN4" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact001785" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,016</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzvUB5OU6Ip4" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1786">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoeVxg1XDiUg" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1787">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Cash and cash equivalents" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">April 2024 notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--NotesPayable_iI_c20240630_zuYPO2SS3pS7" title="Cash and cash equivalents" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30" id="Fact001789" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,089</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayable_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0beG8D1zJu1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1790">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPpARldt2JD1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1791">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqDGw7MQKQmc" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001792" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,089</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630_zcECAf2SJC42" title="Cash and cash equivalents" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact001794" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,817</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zuniSErcRgH8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1795">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1QuLWobF3Pg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1796">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zRpHCnxP2JZd" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001797" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,817</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630_zvCFGjvx2cca" title="Cash and cash equivalents" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact001799" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,016</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMAd9oqQPJV4" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1800">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSL8Gmr1BLkg" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001801" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,651</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkpM0PKAKxhc" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001802" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,365</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630_zTzQMwOS31Eg" title="Cash and cash equivalents" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact001804" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,922</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zf6BSJcdfyqb" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1805">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfKOJWWtknL9" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001806" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,651</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zR1PuZxqKHR4" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001807" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,271</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630_zjKL33g94I7c" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-06-30" id="Fact001808" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,341</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z016rH6Konm5" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact001809" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,341</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLnMX4mSWxud" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1810">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbU94EDQpM84" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1811">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630_zesl4AemIP5f" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2023-06-30" id="Fact001812" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZoSGIGJ00H8" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact001813" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPoMcCvmtIPk" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1814">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z6q6OpuNSPm1" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1815">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20230630_zmdeNUGbcMhe" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-06-30" id="Fact001816" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,350</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ztxdhphe9fXg" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact001817" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,350</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zk2To6FAGcQi" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0ojJd3792ii" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630_z8xu1VMvKUS3" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30" id="Fact001820" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,521</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpcoCm9ZFpuf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1821">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKDHPxK7uY1i" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1822">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zte778YsURXj" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001823" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,521</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630_zEfg3D4LhXyf" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2023-06-30" id="Fact001824" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,989</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zN7hMLfrEA44" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1825">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zo58gZJhjfmf" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001826" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,279</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYb5UcoqWp1i" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001827" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,710</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630_zgFQkBE7jSZ8" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30" id="Fact001828" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,510</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6MWMm3HZeZ2" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1829">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zp8Ki3EXr6A4" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001830" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,279</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zSLNZntZD21i" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001831" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,231</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A2_zZ4z7AS8qs52" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
<span style="color: #353535">Yorkville Convertible Debt Financing </span>discussed in Note 9 was initially recorded at fair value,
which represented a nonrecurring fair value measurement using a Level 3 input. At June 30, 2024, the estimated fair value of this
instrument approximated carrying value given that the instrument was issued in March 2023 and has a short time period until maturity.</span></p>

</ix:nonNumeric><p id="xdx_818_zpQs8dFg65A7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001833" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zCjkZIUAAiy6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</span></td><td style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_82F_zCq3f7wrP0b3">SUBSEQUENT
                                         EVENTS</span> </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Yorkville
Consents</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SubsequentEventDescription_c20240902__20240904__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyuGoKceutHh" title="Subsequent event description"><ix:nonNumeric contextRef="From2024-09-022024-09-04_us-gaap_SubsequentEventMember" id="Fact001835" name="us-gaap:SubsequentEventDescription">On
September 4, 2024, NioCorp entered into (i) a consent and waiver (the &#8220;Yorkville Consent&#8221;) to the April 2024 Note
issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together with the
Yorkville Consent, the &#8220;Consents&#8221;) to the April 2024 Note issued and sold to Lind Global Fund II LP pursuant to
the April 2024 Purchase Agreement. The Consents, among other things, reduced the amounts due to the April 2024 Purchasers
on September 1, 2024 by an aggregate of $<span id="xdx_90C_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20240830__20240901__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrPFfZLz1xr2" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentIssuedPrincipal" contextRef="From2024-08-302024-09-01_us-gaap_SubsequentEventMember" id="Fact001837" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1,176</ix:nonFraction></span> to an aggregate of $<span id="xdx_90A_eus-gaap--DebtInstrumentIncreaseDecreaseOtherNet_pn5n6_c20240830__20240901__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zs7Hvk4DJPK1" title="Increased the amounts due"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseDecreaseOtherNet" contextRef="From2024-08-302024-09-01_us-gaap_SubsequentEventMember" id="Fact001839" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">336</ix:nonFraction></span>, increased the amounts due to the April 2024 Purchasers on December 1, 2024 by an aggregate of $<span id="xdx_907_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20241129__20241201__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zkSGqnsT48Ul" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentIssuedPrincipal" contextRef="From2024-11-292024-12-01_us-gaap_SubsequentEventMember" id="Fact001841" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1,176</ix:nonFraction></span>, and prospectively waived any term of the April 2024 Notes that would otherwise be triggered upon a failure of
the Company to pay to the April 2024 Purchasers the remainder of the amount due on September 1, 2024. Except as modified by
the Consents, the terms of the April 2024 Notes as previously disclosed are unchanged.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Smith
Loan Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2024, the Company and Mark Smith entered into a Loan Agreement (the &#8220;Smith Loan Agreement&#8221;) pursuant
to which Mr. Smith agreed to make available to the Company a non-revolving, multiple draw credit facility of up to $<span id="xdx_90D_eus-gaap--LineOfCreditFacilityFairValueOfAmountOutstanding_iI_c20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPCxwh2lKd51" title="Line of credit facility"><ix:nonFraction name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" contextRef="AsOf2024-09-11_custom_MarkSmithMember_us-gaap_SubsequentEventMember" id="Fact001843" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000</ix:nonFraction></span>
(the &#8220;Loan&#8221;). The Loan is non-revolving and amounts paid back under the terms of the Smith Loan Agreement do not again
become available for drawdowns at the request of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will pay interest to Mr. Smith on amounts outstanding under the Loan and on any overdue interest at a rate equal to <span id="xdx_906_eus-gaap--LongTermDebtPercentageBearingVariableInterestRate_iI_pid_dp_uPure_c20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPfkxf2b6hih" title="Interest rate"><ix:nonFraction name="us-gaap:LongTermDebtPercentageBearingVariableInterestRate" contextRef="AsOf2024-09-11_custom_MarkSmithMember_us-gaap_SubsequentEventMember" id="Fact001845" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>%
per annum, calculated monthly in arrears, through to the date of repayment of the Loan. Mr. Smith</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zzWwmmPkA9U" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zG2YMuP2nmTa" style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z32Cw2lNyIV4" style="margin-top: 0; margin-bottom: 0"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zLiLlHsNQ8D2" style="margin-top: 0; margin-bottom: 0"><b>June 30, 2024</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_236_zjlJ7e9Vlr8b" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><p id="xdx_233_zMD0Anet2ZD6" style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">will also receive an
establishment fee equal to <span id="xdx_90C_eus-gaap--InvestmentCompanyExpenseRatioIncludingIncentiveFee_pid_dp_uPure_c20240909__20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdF9V3V2kD2i" title="Establishment fee"><ix:nonFraction name="us-gaap:InvestmentCompanyExpenseRatioIncludingIncentiveFee" contextRef="From2024-09-092024-09-11_custom_MarkSmithMember_us-gaap_SubsequentEventMember" id="Fact001853" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.5</ix:nonFraction></span>%
of the amount of any drawdown payable at the time of the drawdown as consideration of the advancement of such drawdown. Any
outstanding balance on the Loan, including accrued interest, shall be immediately due and payable by the Company on the
earlier of the date of expiration of the Smith Loan Agreement on June 30, 2025 and the occurrence of an event of default (the &#8220;Due Date&#8221;). The Company can repay the Loan at any time without notice and
without penalty, but any amount of principal or interest repaid by the Company prior to the Due Date will be subject to an
early payment fee of 2.5% of the value of any such payment. Amounts outstanding under the Smith Loan Agreement are secured by all of the Company&#8217;s assets pursuant to a general
security agreement between the Company and Mr. Smith, dated September 11, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lind
Consent Warrant Issuance</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 17, 2024, the Company&#8217;s Common Share price was below the threshold price set forth in the Lind Consent,
and accordingly, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20240916__20240917__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_ztWGhcl6704j" title="Number of share issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-09-162024-09-17_us-gaap_SubsequentEventMember_custom_LindConsentWarrantIssuanceMember" id="Fact001855" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,816,742</ix:nonFraction></span> Contingent Consent Warrants to Lind. Each Contingent Consent Warrant is
exercisable for one Common Share at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240917__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zZjnyfVO80tc" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-17_us-gaap_SubsequentEventMember_custom_LindConsentWarrantIssuanceMember" id="Fact001857" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.308</ix:nonFraction></span> and may be exercised at any time prior
to their expiration on September 17, 2028. The number of Contingent Consent Warrants issued was based on $<span id="xdx_904_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20240916__20240917__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zmFZvJcF4Ujj" title="Warrants issued"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2024-09-162024-09-17_us-gaap_SubsequentEventMember_custom_LindConsentWarrantIssuanceMember" id="Fact001859" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></span> divided by
the five-day volume weighted average price of the Common Shares on September 16, 2024.</span></p>

</ix:nonNumeric><p id="xdx_816_za5zRCIcfkw9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>








<!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0%"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;9.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a055"></span>CHANGES
                                         IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;9A.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a056"></span>CONTROLS
                                         AND PROCEDURES</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Evaluation
of Disclosure Controls and Procedures</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
management of NioCorp Developments Ltd. has evaluated, under the supervision and with the participation of our Chief Executive
Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;), the effectiveness of our disclosure controls and
procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2024. Based on that evaluation,
the CEO and the CFO have concluded that, as of June 30, 2024, our disclosure controls and procedures were not effective due to
the material weaknesses in internal control over financial reporting described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in">Notwithstanding the material weaknesses in our internal control over financial reporting, our CEO and
CFO have concluded that the audited consolidated financial statements included in this Annual Report on Form 10-K fairly present,
in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity
with U.S. GAAP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Management&#8217;s
Report on Internal Control over Financial Reporting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The management of NioCorp Developments Ltd. is responsible for establishing and maintaining adequate internal
control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act for the Company. Management assessed
the effectiveness of our internal control over financial reporting as of June 30, 2024. In making this assessment, our management
used the criteria set forth in the Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations
of the Treadway Commission (the &#8220;COSO Framework&#8221;). Based on that evaluation, the CEO and the CFO have concluded that,
as of June 30, 2024, our internal control over financial reporting was not effective due to the material weaknesses in internal
control over financial reporting described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Material
Weaknesses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there
is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be
prevented or detected on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
concluded that the material weaknesses disclosed
in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2023 continued to exist as of June 30, 2024.
Specifically, management identified deficiencies in the principles associated with the control environment, risk assessment, control
activities, and monitoring components of internal control, based on the criteria established by the COSO Framework, that constitute material weaknesses, either individually or in the
aggregate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 19.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Control
                                         Environment:</span> The Company does not have sufficient personnel with the appropriate levels of knowledge, experience, and
training in accounting and internal control over financial reporting commensurate with the complexity of the Company&#8217;s financing
transactions and associated reporting requirements. This material weakness contributed to additional material weaknesses further
described below.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 19.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Risk
                                         Assessment:</span> The Company does not have a formal process to identify, update, and assess financial reporting risks due to</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 19.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">changes in the
Company&#8217;s business practices, including
entering into increasingly complex transactions that could significantly impact the design and operation of the Company&#8217;s
control activities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 19.75pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Control
                                         Activities:</span> Management did not maintain effective controls over:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 55pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify; padding-right: 1.25pt">monitoring and assessing the work of third-party specialists, including
the evaluation of the appropriateness of accounting conclusions, and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 55pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify; padding-right: 1.25pt">the evaluation of certain inputs and assumptions used to estimate the fair
value of instruments and features associated with complex debt and equity transactions.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Monitoring
                                         Activities:</span> Management did not appropriately:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 55pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify; padding-right: 1.25pt">select, develop, and perform ongoing evaluation to ascertain whether the
components of internal controls are present and functioning, and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 55pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify; padding-right: 1.25pt">evaluate and communicate internal control deficiencies in a timely manner
to those parties responsible for taking corrective action.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As previously disclosed, these material weaknesses resulted in errors that required the restatement of
Company&#8217;s consolidated financial statements as of and for the fiscal years ended June 30, 2022 and 2021, as well as the restatement
of the Company&#8217;s condensed consolidated financial statements as of and for the interim periods ended September 30, 2021,
December 31, 2021, March 31, 2022, September 30, 2022 and December 31, 2022. Additionally, these material weaknesses could result
in a misstatement of the account balances or disclosures that would result in a material misstatement to the annual or interim
consolidated financial statements that would not be prevented or timely detected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Remediation
Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To address our material weaknesses existing as of June 30<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
2024, we have implemented a detailed plan to address each individual material weakness identified, including the following:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We have, and will continue to, engage outside accounting and internal control consultants with
subject matter expertise to supplement our level of knowledge, experience, and training in accounting and internal control over
financial reporting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We plan to develop a formal risk assessment process to ensure that it is robust and frequent
enough for the Company&#8217;s business, including the identification of risks, the level of detail in our risk assessment, and
the clarity of the linkage between risks and internal controls associated with the material weaknesses. The results of this effort
are expected to enable us to effectively identify, develop, evolve and implement controls and procedures to address risks.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We plan to develop and provide incremental training to the accounting and financial reporting team
regarding accounting for and valuation of complex financial instruments.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Management will develop a monitoring program to periodically evaluate and assess whether those
responsible for controls are conducting their activities in accordance with their design, such that there is contemporaneous evidence
that the controls are present and functioning and will communicate internal control deficiencies in a timely manner to those parties
responsible for taking corrective action.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
process of designing and maintaining effective internal control over financial reporting is a continuous effort that requires
management to anticipate and react to changes in our business, economic and regulatory environments and to expend significant
resources. As we continue to evaluate our internal control over financial reporting, we may take additional actions to remediate
the material weaknesses or modify the remediation actions described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we continue to devote significant time and attention to these remediation efforts, the material weaknesses will not be considered
remediated until management completes the design and implementation of the actions described above and the controls operate for
a sufficient period of time, and management has concluded, through testing, that these controls are effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in Internal Control over Financial Reporting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as discussed above, there has been no change in our internal control over financial reporting during the quarter ended June
30, 2024, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;9B.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a057"></span>OTHER
                                         INFORMATION</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the quarter ended June 30, 2024, no director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act) of the
Company adopted or terminated a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement&#8221;
(as each term is defined in Item 408 of Regulation S-K).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><b><i>Unregistered Sales of Equity Securities</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 24.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lind
Contingent Consent Warrant Issuance</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">On September 17, 2024, the
Company's Common Share price was below the threshold price set forth in the Lind Consent, and accordingly, the Company issued 2,816,742
Contingent Consent Warrants to Lind. Each Contingent Consent Warrant is exercisable for one Common Share at an exercise price of
$2.308 and may be exercised at any time prior to their expiration on September 17, 2028. The number of Contingent Consent Warrants
issued was based on $5.0 million divided by the five-day volume weighted average price of the Common Shares on September 16, 2024.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Contingent Consent Warrants
were issued as part of the consideration for entering into the Lind Consent, which included the following principal terms:
(i) the consent of Lind to the GXII Transaction and Yorkville Financings disclosed in the notes to the consolidated financial
statements included in Part II, Item 8 hereof, including all actions taken by NioCorp as set out in the Business Combination
Agreement to permit the completion of the 2023 Transactions; (ii) the consent of Lind to NioCorp&#8217;s expected cross-listing
to the Nasdaq and the consolidation of the Common Shares in order to meet the minimum listing requirements thereof; (iii)
the waiver of Lind of its participation right for up to 15% of the total offering in the Yorkville Equity Facility Financing;
and (iv) the waiver of Lind of certain restrictive covenants in the Lind III Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As consideration for entering into
the Lind Consent, Lind received, amongst other things: (i) the right to receive a payment of $500, which would have been reduced
to $200 if the 2023 Transactions had not been consummated on or before April 30, 2023 (collectively, the &#8220;Consent Payment&#8221;);
(ii) an extension of its existing participation rights under the Lind III Agreement in future financings of NioCorp for a
further two-year period, subject to certain exceptions as well as an extension of such participation rights beyond the additional
two-year period if Yorkville or any affiliate is a party to any such applicable transaction; and (iii) the right to receive
Contingent Consent Warrants if on the date that is 18 months following the Closing Date, the closing trading price of the
Common Shares on the TSX or such other stock exchange on which such shares may then be listed, is less than C$10.00 (on a
post-Reverse Stock Split basis), subject to adjustments. The Lind Consent was signed as an amendment to the existing Lind
III Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Contingent Consent Warrants were issued pursuant to the exemption from the registration requirements of the Securities
Act provided by Section 4(a)(2) thereof based upon the representations and warranties of Lind in the Lind III Agreement.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         9C.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a058"></span>DISCLOSURE
                                         REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTION&#160;</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a059"></span>PART
III&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         10.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a060"></span>DIRECTORS,
                                         EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a061"></span>Directors
and Executive Officers</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth as of September 20, 2024, the names and ages of, and position or positions held by, our executive
officers and directors, the employment background of these persons, and any directorships held by the current directors during
the last five years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 7%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Age</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 30%; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    of Appointment</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    A. Smith</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, President, Executive Chairman, and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                         Executive Officer and Director:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.12in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
23, 2013&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
        and Executive Chairman:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.12in"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.12in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
31, 2015&#160;</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal
    Shah</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer and Corporate Secretary</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                         Financial Officer:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.12in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
1, 2016&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
        Secretary:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.12in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
3, 2021&#160;</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
    Honan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Operating Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    6, 2014</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jim
    Sims</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Communications Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    2, 2015</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    J. Morris</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lead
    Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    27, 2014</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    C. Beling</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    6, 2011</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nilsa
    Guerrero-Mahon</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    28, 2017</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean
    C. Kehler</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    17, 2023</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Michael
    G. Maselli&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">64</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">March
    17, 2023</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Oliver</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    25, 2022</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following sets forth a brief description of the business experience of each executive officer and director of the Company, including
current directorships and directorships held in, at least, the past five years for each director:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
A. Smith &#8211; Executive Chairman, Director, President, and Chief Executive Officer</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Smith has over 42 years of experience in operating, developing, and financing mining and strategic materials projects in the Americas
and abroad. In September 2013, he was appointed CEO and a Director of NioCorp. From April 2015 to September 2019, Mr. Smith served
as the President and Director for Largo Resources Ltd. (&#8220;Largo&#8221;), a mineral company with an operating property in
Brazil and projects in Brazil and Canada. In addition, from April 2015 to October 2018, Mr. Smith also served as the CEO of Largo.
Mr. Smith has also served on the board of directors of IBC Advanced Alloys Corp., a leading beryllium and copper advanced alloys
company (&#8220;IBC&#8221;), since May 2016 and as CEO of IBC since July 2020. From October 2008 through December 2012, Mr. Smith
served as President, CEO and Director of Molycorp, Inc., a rare earths producer (&#8220;Molycorp&#8221;), where he was instrumentally
involved in taking it from a private company to a publicly traded company with a producing mine. From November 2011 through May
2015, he served on the board of directors at Avanti Mining, a mining company (TSX-V: AVT; Avanti Mining changed its name to AlloyCorp
in early 2015). From December 2012 through September 2013, he served as the Managing Director of KMSmith LLC, a business strategy
and finance advisory firm, where he served as a consultant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to Molycorp, Mr. Smith held numerous engineering, environmental, and legal positions within Unocal Corporation, a former petroleum
explorer and marketer (&#8220;Unocal&#8221;), and later served as the President and CEO of Chevron Mining Inc., a coal and metal
mining company and wholly owned subsidiary of Chevron Corporation (&#8220;Chevron Mining&#8221;). Mr. Smith also served for over
seven years as the shareholder representative of Companhia Brasileira Metal&#250;rgica e Minera&#231;&#227;o (&#8220;CBMM&#8221;),
a private company that currently produces approximately 85% of the world supply of niobium. During his tenure with Chevron Mining,
Mr. Smith was responsible for Chevron Mining&#8217;s three coal mines, one molybdenum mine, a petroleum coke calcining operation
and Molycorp&#8217;s Mountain Pass mine. At Unocal, he served as the Vice-President from June 2000 to April 2006, and managed
the real estate, remediation, mining and carbon divisions. Mr. Smith is a Registered Professional Engineer and serves as an active
member of the State Bars of California and Colorado. He received his Bachelor of Science degree in Agricultural</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Engineering from
Colorado State University in 1981 and his Juris Doctor, cum laude, from Western State University, College of Law, in 1990.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal
Shah &#8211; Chief Financial Officer and Corporate Secretary</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Shah joined NioCorp in September 2014 as Vice President of Finance, and now serves as the Company&#8217;s CFO and Corporate Secretary.
Mr. Shah served as Finance Manager at Covidien Ltd., a medical device company since acquired by Medtronic, from May 2014 through
September 2014. From April 2011 until May 2014, he held the positions of Senior Manager of Corporate Development and M&amp;A and
more recently the Director of Strategy and Business Planning at Molycorp. Mr. Shah graduated from the University of Colorado with
a BSc in Mechanical Engineering in 1996, and from Purdue University with an MBA in 2002. Since the completion of his MBA, Mr.
Shah also held key finance roles with Intel Corporation and IBM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
Honan &#8211; Chief Operating Officer</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Honan joined NioCorp in May 2014 as Vice President, Business Development, and since July 2020, has served as the Company&#8217;s
Chief Operating Officer (&#8220;COO&#8221;). He also serves as President of Elk Creek Resources Corporation, the NioCorp subsidiary
that is developing the Elk Creek Project in Nebraska. Prior to his work at NioCorp, Mr. Honan served in several leadership capacities
at Molycorp from February 2001 until May 2014, including as Vice President/Director Health, Environment, Safety and Sustainability
and General Manager and Environmental Manager from July 2011 to May 2014. With over 31 years of experience in the gold and rare
earth industries, Mr. Honan is a graduate of Queen&#8217;s University in Mining Engineering in both Mineral Processing (B.Sc.
Honors) and Environmental Management (M.Sc.) disciplines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jim
Sims &#8211; Chief Communications Officer</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Sims has more than 31 years of experience in devising and executing marketing, media relations, public affairs, and investor relations
operations for companies in the mining, chemical, manufacturing, utility, and renewable energy sectors. He joined NioCorp in November
2015 as Vice President, External Affairs, and now serves as its Chief Communications Officer, effective June 7, 2022. Prior to
NioCorp, Mr. Sims served for more than five years as Director (and then Vice President) of Corporate Communications for Molycorp
from March 2010 through November 2015. Since May 2016, Mr. Sims has also served as Director of Investor and Public Relations for
IBC. Mr. Sims was President and CEO of Policy Communications, Inc. from 1998 until 2010, and served as White House Director of
Communications for the Energy Policy Development Group. A former U.S. Senate Chief of Staff, he is the co-founder and former Executive
Director of the Geothermal Energy Association, and he has served as Board Chairman of the Rare Earth Technology Alliance. He is
an honors graduate of Georgetown University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
J. Morris &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Morris was formerly the Chairman of the board of directors of Heritage Oaks Bankcorp (&#8220;Heritage Oaks&#8221;), the holding
company of Heritage Oaks Bank. When Heritage Oaks Bank merged with Pacific Premier Bancorp on April 1, 2017, Mr. Morris became
a member of the Pacific Premier Bancorp&#8217;s board of directors, a position he held until May 31, 2020. He joined Heritage
Oaks&#8217; board of directors in January 2001 and assumed the board&#8217;s chairmanship in 2007. In addition, Mr. Morris has
worked since 1972 at Andre, Morris &amp; Buttery, a professional law corporation, where he serves as Senior Principal and has
served as Chairman of the board since 2005. From 2000 to late 2006, Mr. Morris served on the board of Molycorp, a rare earths
producer, which at the time was a wholly owned subsidiary of Unocal and then Chevron Mining. Mr. Morris was the only independent
director of Molycorp at that time. Mr. Morris is a graduate of Georgetown University and received his law degree from the University
of San Francisco School of Law. He has practiced business and environmental law for over 41 years. Mr. Morris served as a member
of the Board of Governors and Vice President of the State Bar of California. He served as a 1st Lieutenant in the U.S. Army from
1970 to 1972.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
C. Beling &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Beling is a Registered Professional Mining Engineer with 59 years of project and corporate experience. He has served as a director
on the boards of 14 mining companies starting in 1981, including NioCorp since 2011. Mr. Beling is the owner of D.C. Beling &amp;
Assoc., LLC, which provides strategic advisory, project, and corporate development services to the mining industry. His previous
employment and consulting included 14 years with five</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">major mining companies and then 44 years with 30+ U.S. and Canadian junior
mining companies. He was the President, CEO, and Director of Bullfrog Gold Corp. from 2011 until October 2020; and the Executive
Vice President and COO of Geovic Mining Corp. from 2004 through 2010. Mr. Beling has examined, significantly reviewed, or been
directly involved with 90 underground mines, 136 open pit mines, and 174 process plants in the global metal, energy, and industrial
mineral sectors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nilsa
Guerrero-Mahon &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
former CFO and Controller for global corporations in the technology, energy, and government sectors, Ms. Guerrero-Mahon provides
consulting services to domestic and international corporations as the principal at NG Mahon Business Consulting, LLC. In addition,
Ms. Guerrero-Mahon was appointed to the Board of FinGoal Inc. in April 2022, a finance technology company building artificial
intelligence tools for the financial services industry and other financial technology developers. She also serves on the Board
of the State of Colorado Division of Securities. From 2016 to August 2019, she served on the board of directors of Centura Health
Mountains &amp; North Denver Operating Group, the largest division in the Centura Health Care System. From 2014 to 2016, she served
as the Vice Chair of the board of directors and Chaired the Strategy Committee at St. Anthony Hospital. From 2009 to 2017, Ms.
Guerrero-Mahon served as a gubernatorial appointed Board Member of the State of Colorado Financial Services Commission. Among
other prior positions, from 2004 to 2007, she was the Global Services Controller at Microsoft Corporation, overseeing internal
controls and corporate finance activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Guerrero-Mahon stays current with the latest Corporate Governance practices and the integration of ESG into the strategy. She
is an NACD Board Leadership Fellow, a member of the SASB Alliance, holds a CERT Certificate in Cybersecurity Oversight from the
Carnegie Mellon University and is currently enrolled in the Climate Leadership Certification program with Diligent Corporation.
Ms. Guerrero-Mahon received an Executive MBA from the Daniels College of Business at the University of Denver, a BS in Business
Administration - Accounting from the Interamerican University in San Juan, Puerto Rico, and an AS in Computer Science from the
EDP School of Computer Programming in San Juan, Puerto Rico. She is a Certified Public Accountant registered in the State of Colorado.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
Oliver &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a background in chemistry, Mr. Oliver began working at Greenbushes, Western Australia, for Sons of Gwalia, a mining company, in
May 2003. After Sons of Gwalia went into administration in 2004, Mr. Oliver was hired by Talison Lithium Limited (&#8220;Talison&#8221;),
a mining company, where he served as General Manager of Talison&#8217;s Greenbushes and Wodgina Mines and as Talison&#8217;s COO,
until Mr. Oliver was appointed as the CEO/Managing director. As Talison&#8217;s CEO/Managing director, Mr. Oliver led the listing
of Talison on the Toronto Stock Exchange in September 2010.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Oliver guided Talison through its acquisition in 2013 by Tianqi Lithium Corporation (&#8220;Tianqi&#8221;). He then served as
a corporate adviser to Tianqi, focusing on M&amp;A opportunities and global expansion, including advising on the sale of 49% of
Talison to Albermarle Corp. and the acquisition of 24% of Sociedad Quimica y Minera de Chile S.A., as well as significant expansions
of Talison&#8217;s Greenbushes lithium concentrate production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Oliver also was a founding member of Tianqi Lithium Energy Australia Pty Ltd, a wholly owned subsidiary of Tianqi, which was established
to build a major Lithium Hydroxide manufacturing facility in Western Australia. Until June 2021, Mr. Oliver remained as a director
of Talison, a joint venture between Tianqi and Albemarle Corp. In September 2022, Mr. Oliver was appointed to the Board of Latin
Resources, a lithium exploration company in Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean
C. Kehler &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Kehler co-founded Trimaran Fund Management, L.L.C. (&#8220;Trimaran Fund&#8221;) in 1998, where he is a Managing Partner, and serves
as a Manager of Trimaran Fund II. Mr. Kehler was also the Co-Chairman and Chief Executive Officer of GX Acquisition Corp. II,
a position he held from August 2018 to March 2023. From 1995 to 2000, Mr. Kehler held senior positions at Canadian Imperial Bank
of Commerce (&#8220;CIBC&#8221;), including Vice Chairman of CIBC World Markets Corp. Mr. Kehler currently serves on the Boards
of Directors of Portman Ridge Finance Corporation (formerly KCAP Financial Inc.) and Celularity, Inc. Within the last five years,
he has served a director of Inviva Inc.,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Security First Corp. and Graphene Frontiers, LLC. He holds a bachelor&#8217;s degree from the
Wharton School of the University of Pennsylvania.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
G. Maselli &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Maselli is a managing director of Trimaran Fund, a position he has held since 2006, and was the President of Acquisitions of GX
Acquisition Corp. II from August 2018 to March 2023. Before joining Trimaran Fund in February 2006, Mr. Maselli worked in the
Corporate and Leverage Finance Groups of CIBC World Markets. Prior to joining CIBC in 1997, Mr. Maselli served as a Managing Director
in Bear Stearns&#8217; corporate finance group and, prior to that, as a Vice President at Kidder Peabody &amp; Co. Incorporated.
Since 2010, Mr. Maselli served on the board of directors of El Pollo Loco Holdings from 2010 to 2024, and he served as their Chairman
of the Board from 2011 to 2023.&#160; He served on the board of ChanceLight, Inc. (f/k/a Educational Services of America, Inc.)
until 2018. From 2013 to 2015, he served on the board of directors of Norcraft Companies, Inc., and also served on the board of
managers of its predecessor company beginning in 2003. Additionally, Mr. Maselli served on the board of directors of Standard
Steel, LLC, and was director as well as Chairman of the Board of CB Holding Corp. Mr. Maselli received an MBA with distinction
from The A.B. Freeman School at Tulane University and a bachelor&#8217;s degree in economics from the University of Colorado.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Directorships</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a list of directorships held over the past five years by our directors. Except as listed below, no directors of the
Company are also directors of reporting issuers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Reporting Issuer (or equivalent)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    C. Beling</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bullfrog
    Gold</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CSE</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    J. Morris</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pacific
    Premier Bancorp</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
A. Smith</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IBC
    Advanced Alloys Corp.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TSX-V</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Oliver</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Latin
    Resources</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASX</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean
    C. Kehler</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">El
                                         Pollo Loco Holdings, Inc.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">Portman
Ridge Finance Corporation&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">Nasdaq</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">Celularity,
        Inc.</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">Nasdaq</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">GX
Acquisition Corp. II&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">Nasdaq</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    G. Maselli</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">El
    Pollo Loco Holdings, Inc.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
director or executive officer of the Company is a party adverse to the Company or any of its subsidiaries or has a material interest
adverse to the Company or any of its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the past ten years, none of the persons serving as executive officers and/or directors of the Company and, with respect to promoters
or control persons, for the past five years, none have been the subject matter of any of the legal proceedings that are required
to be disclosed pursuant to Item 401(f) of Regulation S-K. Further, no such legal proceedings are believed to be contemplated
by governmental authorities against any director or executive officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ethical
Business Conduct</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board expects management to operate the business of the Company in a manner that enhances shareholder value and is consistent
with the highest level of integrity. Management is expected to execute the Company&#8217;s business plan and to meet performance
goals and objectives according to the highest ethical standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, directors and senior officers are bound by the provisions of the Company&#8217;s Articles and the British Columbia Business
Corporations Act (&#8220;BCBCA&#8221;), which set forth how any conflicts of interest are to be dealt with. In particular, any
director who has a material interest in a particular transaction is required to disclose such interest and to refrain from voting
with respect to the approval of any such transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Insider
Trading Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has also adopted an insider trading policy (the &#8220;Insider Trading Policy&#8221;) to help ensure, among other things:
(i) that persons to whom the policy applies understand their obligations to preserve the confidentiality of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#8220;Material Nonpublic
Information&#8221; (as defined in the Insider Trading Policy); (ii) strict compliance by all insiders with all requirements relating
to the reporting of insider trading and with respect to trading when in possession of &#8220;Material Nonpublic Information&#8221;;
and (iii) that individuals subject to scheduled and unscheduled blackout periods adhere to the restrictions on trading as set
out in the Insider Trading Policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Business Conduct and Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has adopted a written Code of Business Conduct and Ethics applicable to our employees, officers, and directors, including
those officers responsible for financial reporting. The Code of Business Conduct and Ethics is available on our website at www.niocorp.com.
If the Board amends the Code of Business Conduct and Ethics or grants a waiver, including an implicit waiver, from the Code of
Business Conduct and Ethics, the Company will disclose the information on its internet website. The waiver information will remain
on the website for at least 12 months after the initial disclosure of such waiver. Given the current size of the Company workforce,
and the lack of significant operations, the Board monitors compliance through periodic discussions with executive management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee and Audit Committee Financial Experts</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee is currently comprised of Nilsa Guerrero-Mahon, Michael J. Morris, and Michael Maselli, all of whom are independent
directors. Our Board has determined that each of the three members are audit committee financial experts, as defined by the rules
of the SEC. Further, all Audit Committee members are financially literate as defined in NI 52-110. The Audit Committee was established
in accordance with Section 3(a)(58)(A) of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         11.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a062"></span>EXECUTIVE
                                         COMPENSATION</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets out the compensation for the fiscal years ended June 30, 2024 and 2023 for the individual who served as the
Company&#8217;s CEO during fiscal year 2024, as well as the Company&#8217;s two other most highly compensated executive officers
other than the CEO who were serving at the end of the last fiscal year (collectively, the &#8220;named executive officers&#8221;):&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
2024 Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 95%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 25%; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name and Principal</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">Position</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year</span>&#160;</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary</span>&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($)</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bonus</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($)</span>&#160;</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awards
        <sup>(1)</sup></span>&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($)</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($)</span>&#160;</p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    A. Smith, Chief Executive Officer, President <sup>(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$325,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    &#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$641,250</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$966,250</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">304,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">216,300</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">620,300</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
    Honan, Chief Operating Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">427,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">707,500</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123,600</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">438,600</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal
    Shah, Chief Financial Officer and Corporate Secretary</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">427,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">677,500</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">227,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123,600</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">401,100</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
    the grant date fair value of the stock options (&#8220;Options&#8221;) granted during the reported fiscal years. Fiscal year
    2024 grants consisted of     375,000     Options for Mr. Smith and 250,000 Options for each of Messrs. Honan and Shah, in
    each case at an exercise price     of $2.99 per     share. Fiscal year 2023 grants consisted of 70,000 Options for Mr. Smith
    and 40,000 Options for each of     Messrs. Honan and     Shah, in each case at an exercise price of $6.95 per share. Grant
    date fair values were computed in     accordance with FASB ASC     Topic 718. Assumptions used in the calculation of these
    amounts are described in Note 11 in the     Company&#8217;s consolidated     financial statements included in this Annual
    Report on Form 10-K. These Options were fully     vested on the grant date and generally     remain exercisable until a
    period of three or five years after the grant     date.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    amounts were paid to 76 Resources, LLC, an entity controlled by Mr. Smith, as further described below under &#8220;Employment
    Agreements and Severance Arrangements.&#8221;</span></td></tr>
</table>
<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Narrative
Disclosure to Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Governance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Compensation Committee determines the amount of compensation for the Company&#8217;s executives, which is designed
to reflect the need to provide incentives and compensation for the time and effort expended by the executives while taking into
account the financial and other resources of the Company. The Compensation Committee has the authority to engage and compensate,
at the expense of the Company, any outside advisor that it determines to be necessary to permit it to carry out its duties (including
compensation consultants and advisers), and generally utilized information provided by Insperity PEO Services LP (&#8220;Insperity&#8221;),
the Company&#8217;s Professional Employer Organization, in February 2023, to assess employee salaries relative to industry and
market peers and engaged Bedford Resources Inc. (&#8220;Bedford&#8221;) in November 2023 to provide competitive data in executive
compensation. The Company has assessed the independence of both Insperity and Bedford, and has found no conflicts of interest raised by
their work.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Program Design</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board, in conjunction with the Compensation Committee, determines compensation and rewards to senior management on the basis of
individual and corporate performance, both in the short term and the long term, while at the same time being mindful of the responsibility
that the Company has to its shareholders. In general, the Compensation Committee considers that its compensation program should
be relatively simple in concept, given the current stage of the Company&#8217;s development, and that its focus should be balanced
between reasonable current compensation and longer-term compensation tied to performance of the Company as a whole.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Compensation
Committee has not established a formal set of benchmarks or performance criteria to be met by the Company&#8217;s named executive
officers; rather, the members of the Compensation Committee use the information provided by Insperity and Bedford, and their own
subjective assessments of the level of success of the Company to determine, collectively, whether or not the named executive officers
are successfully achieving the Company&#8217;s business plan and strategy and the degree to which they have performed in that regard.
The Compensation Committee has not established any set or formal formula for determining named executive officer compensation,
either as to the amount thereof or the specific mix of compensation elements, and compensation (and adjustments from time to time)
is set through informal discussions at the Compensation Committee level.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Key
Elements of Named Executive Officer Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Base
Salaries</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of the Compensation Committee use their own experience and familiarity with the industry, and consider the factors described
above, to determine what they believe to be reasonable base salaries for our named executive officers. The base salaries of the
named executive officers are set at levels which are considered by the members of the Compensation Committee to be competitive,
thereby enabling the Company to compete for and retain executives critical to the long-term success of the Company. Initially,
base salaries (or, for Mr. Smith, base consulting fees) are set through negotiation when executive officers join the Company (with
direct input from the Compensation Committee) and are subsequently reviewed each fiscal year to determine if adjustments are required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bonus
Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has discretion, where deemed appropriate and financially affordable for the Company, to grant a cash bonus to a named executive
officer based on the performance of both the individual named executive officer and the Company. No cash bonuses were approved
or paid for the named executive officers for fiscal year 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Option-Based
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
incentive portion of each named executive officer&#8217;s compensation package consists primarily of Options awarded under the
2017 Amended Long-Term Incentive Plan. Share ownership opportunities through the grant of Options are provided to align the interests
of senior management of the Company with the longer-term interests of the shareholders of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2017 Amended Long-Term Incentive Plan is administered by the Compensation Committee, and is intended to advance the interests
of the Company through the motivation, attraction and retention of officers and other key employees, directors and consultants
of the Company and affiliates of the Company and to secure for the Company and its shareholders the benefits inherent in the ownership
of Common Shares of the Company by officers and other key employees, directors and consultants of the Company and affiliates of
the Company. Grants of Options under the 2017 Amended Long-Term Incentive Plan are proposed and recommended by the CEO and reviewed
by the Compensation Committee, or are proposed by the Compensation Committee. The Compensation Committee can approve, modify,
or reject any proposed grants, in whole or in part. In general, the allocation of available Options among the eligible participants
in the 2017 Amended Long-Term Incentive Plan is on an ad hoc basis, and there is no set formula for allocating available Options,
nor is there any fixed benchmark or performance criteria to be achieved in order to receive an award of or vest in Options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee does not consider the accounting value of any such Option grants in determining the number of Options to
award to any individual, as any such &#8220;value&#8221; is an accounting measure that is not relevant to incentivizing the individual.
The timing of the grants of Options is determined by the Compensation Committee, and there is no regular interval for the awarding
of Option grants. In general, a higher level of responsibility will result in a larger grant of Options. Because the number of
Options available is limited, in general, the Compensation Committee aims to have individuals at what it subjectively considers
to be the same levels of responsibility holding equivalent numbers of Options, with additional grants being allocated for individuals
who the Compensation Committee believes are in a position to more directly affect the success of the Company through their efforts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee looks at the overall number of Options held by an individual (plus the exercise prices and remaining terms
of existing Options and whether any previously granted Options have expired out of the money or were exercised) and takes such
information into consideration when reviewing proposed new grants. After considering the CEO&#8217;s recommendations, if any,
and the foregoing factors, the resulting proposed Option grant is then submitted to the Board for final approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended June 30, 2024, the Compensation Committee approved all recommendations for the grant of Options proposed
by management, and the named executive officers were granted the following number of Options effective February 15, 2024, each
with an exercise price per share of $2.99 per share: Mr. Smith, 375,000 Options; Mr. Honan, 250,000 Options; and Mr. Shah, 250,000
Options. These Options were fully vested and exercisable on the grant date and generally remain exercisable until five years after
the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Board approved a modification to Options previously issued on March 27, 2023, with dual strike prices of $6.95
and C$9.52, under which the option to exercise in C$ was removed. No other terms or conditions were amended by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Agreements and Severance Arrangements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and KMSmith, LLC (&#8220;KMSmith&#8221;), an entity controlled by Mark A. Smith, entered into a Consulting Agreement effective
September 23, 2013 (as amended, the &#8220;Smith Agreement&#8221;). On August 31, 2020, the Company, KMSmith and 76 Resources,
Inc., an entity controlled by Mr. Smith, entered into a Contract Assignment and Novation Agreement, pursuant to which KMSmith
assigned all of its rights under the Smith Agreement to 76 Resources, Inc. and 76 Resources, Inc. assumed all of KMSmith&#8217;s
obligations under the Smith Agreement by novation. On August 1, 2021, the Company, 76 Resources, Inc. and 76 Resources, LLC, an
entity controlled by Mr. Smith, entered into a Contract Assignment and Novation Agreement, pursuant to which 76 Resources, Inc.
assigned all of its rights under the Smith Agreement to 76 Resources, LLC and 76 Resources, LLC assumed all of 76 Resources, Inc.&#8217;s
obligations under the Smith Agreement by novation. Under the terms of the Smith Agreement, 76 Resources, LLC (as ultimate successor
in interest to KMSmith), through Mr. Smith, performs the duties and responsibilities of the CEO of the Company and related services,
for an indefinite term at a base rate of $325,000 per year, generally payable in equal monthly installments of $27,083. Any bonuses
and incentive payments are payable at the discretion of the Board. Mr. Smith is eligible to receive Options under the 2017 Amended
Long-Term Incentive Plan, as determined by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may terminate the Smith Agreement at any time without notice or payment if (1) 76 Resources, LLC commits a material breach
of the Smith Agreement (subject to a cure period in certain circumstances), (2) Mr. Smith dies or becomes permanently disabled,
or (3) certain other &#8220;for cause&#8221; scenarios occur (as further described in the Smith Agreement). In the event the Smith
Agreement is terminated by the Company for any other reason or if 76</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Resources, LLC terminates the Smith Agreement on the occurrence
of a Triggering Event, the Company shall pay 76 Resources, LLC a lump sum termination fee equal to the base fee in effect at the
termination date as well as the average of any annual bonuses or other cash incentive payments for two calendar years immediately
preceding the year the termination occurs. A Triggering Event is defined as: a substantial change in the nature of services to
be performed by 76 Resources, LLC; a material breach by the Company of the Smith Agreement that is not remedied within 30 days
of notice; the cessation of the Company as a going concern; the failure of the Company to pay a material amount due pursuant to
the Smith Agreement within 30 days of the due date; or a material reduction in base fee or any other form of compensation payable
by the Company to 76 Resources, LLC, except where all senior executives or consultants of the Company are subject to relatively
similar reductions in such values. 76 Resources, LLC may terminate the Smith Agreement for a reason other than a Triggering Event
on 90 days&#8217; written notice and, should the Company immediately accept such termination notice, it shall pay 76 Resources,
LLC the sum of $69,904. Should a change of control of the Company occur (as that term is defined in the Smith Agreement) and,
within one year, either a Triggering Event occurs and 76 Resources, LLC terminates the Smith Agreement or 76 Resources, LLC&#8217;s
engagement is terminated by the Company under circumstances that would give rise to a termination payment in the absence of a
change of control, then 76 Resources, LLC shall be entitled to receive an amount equal to the base fee in effect at the termination
date as well as the average of any annual bonuses or other cash payments for two calendar years immediately preceding the year
the termination occurs. In the event 76 Resources, LLC is entitled to a termination payment with respect to a change of control,
any Options previously granted to Mr. Smith shall become fully vested and shall remain exercisable for the original term of grant
despite a termination of the services of 76 Resources, LLC. Termination payments under the Smith Agreement are generally contingent
on a release of claims by 76 Resources, LLC. The Smith Agreement also includes customary confidentiality and six-month employee
non-solicitation provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Smith Agreement had been terminated by the Company for any reason other than as set out in the Smith Agreement, if 76 Resources,
LLC terminated the Smith Agreement on the occurrence of a Triggering Event, or had a change of control of the Company occurred
and within one year, either a Triggering Event occurred and 76 Resources, LLC terminated the Smith Agreement or 76 Resources,
LLC&#8217;s engagement was terminated by the Company without the occurrence of a Triggering Event for any reason other than as
set out in the Smith Agreement, effective as of June 30, 2024, 76 Resources, LLC (as ultimate successor in interest to KMSmith)
would have been entitled to a payment of $375,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously disclosed, on September 25, 2022, in connection with our entry into the Business Combination Agreement, Messrs. Shah
and Honan (the &#8220;Covered Officers&#8221;) entered into employment agreements with a United States affiliate (the &#8220;U.S.
Affiliate&#8221;) of the Company (the &#8220;Employment Agreements&#8221;). The Employment Agreements became effective upon the
closing of the GXII Transaction, and will continue until either the Covered Officer or the U.S. Affiliate terminates the Covered
Officer&#8217;s employment for any reason. Pursuant to the Employment Agreements, Mr. Shah continues to serve as Chief Financial
Officer of the Company, and Mr. Honan continues to serve as the COO of the Company and serves as President of the U.S. Affiliate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Employment Agreement for Mr. Shah provides for an initial annual base salary of $220,000 per year, and Mr. Honan&#8217;s Employment
Agreement provides for an initial annual base salary of $260,000 per year. The annual base salary rates for the Covered Officers
will be reviewed at least annually for potential increases. As described above, the base salary rates of Messrs. Shah and Honan
were increased in fiscal 2023 to $250,000 for Mr. Shah and $280,000 for Mr. Honan. The Employment Agreements also provide each
of the Covered Officers with eligibility to participate in (1) any annual cash bonus plan and/or any long-term incentive compensation
plan as may be established by the U.S. Affiliate or its affiliates, and (2) any employee benefit plan, program, or policy of the
U.S. Affiliate or its affiliates as may be in effect for senior executives of the U.S. Affiliate or its affiliates generally.
The Employment Agreements also include the following additional features: (1) severance benefits upon certain qualifying terminations
of employment, consisting of: (a) for a qualifying termination of the Covered Officer&#8217;s employment by the U.S. Affiliate
without Cause (as such term is defined in the Employment Agreements) that does not occur within two years after a Change in Control
of the U.S. Affiliate (as defined in the Employment Agreements), certain accrued obligations, plus 12 months of salary continuation,
and (b) for a qualifying termination of the Covered Officer&#8217;s employment by the U.S. Affiliate without Cause or by the Covered
Officer for Good Reason (as such term is defined in the Employment Agreements) that occurs within two years after a Change in
Control (a &#8220;Change in Control Termination&#8221;), certain accrued obligations, and a lump sum cash amount equal to two
times the Covered Officer&#8217;s annual base salary as in effect at the time of such termination; and (2) a requirement that
each Covered Executive execute a customary release of claims in favor of the U.S. Affiliate to receive severance compensation.
In connection</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">with the Covered Officers entering into the Employment Agreements each Covered Officer also entered into a restrictive
covenant agreement (a &#8220;Restrictive Covenant Agreement&#8221;). The Restrictive Covenant Agreements include customary restrictive
covenants, including non-competition and non-solicitation obligations that remain in effect both during the employment term and
for one year following termination of the Covered Officer&#8217;s employment other than a Change in Control Termination (in which
case the period will be two years following such Change in Control Termination), as well as other customary restrictive covenants,
such as confidentiality provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
Options Under the 2017 Amended Long-Term Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the 2017 Amended Long-Term Incentive Plan, the Company granted Options to its named executive officers during
the Company&#8217;s 2024 fiscal year; no other equity-based awards were granted to the named executive officers during the 2024
fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the outstanding equity awards for each named executive officer at June 30, 2024. The Company has not
granted full value stock-based awards to any of its named executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at 2024 Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 95%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="9" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
    Awards<sup></sup></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant
    Date</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
                                         of</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underlying</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unexercised</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(#)</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable<sup></sup></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
                                         of</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underlying</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unexercised</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(#)</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unexercisable</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span>&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
        ($)</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiration</span>&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    A. Smith</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/17/2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$9.94</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/17/2024</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/27/2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.95</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/27/2026</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/15/2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">375,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.99</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/15/2029</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
    Honan&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/17/2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.94</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/17/2024</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/27/2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.95</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/27/2026</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/15/2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.99</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/15/2029</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal
    Shah&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/17/2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.94</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/17/2024</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/27/2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.95</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/27/2026</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/15/2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.99</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/15/2029</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
    exercise price based on a spot exchange rate of C$1.3687 to US$1.00 on June 30, 2024.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Retirement
Plan Benefits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Messrs.
Honan and Shah are each eligible to participate in the Company&#8217;s 401(k) savings plan, which is designed to reward continued
employment with the Company and assist participants with financial preparation for retirement. All amounts credited under the
401(k) savings plan relate to participant contributions. The Company does not currently make matching or other contributions to
the 401(k) savings plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Termination
and Change of Control Benefits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described above, the Company has not entered into any plans or arrangements in respect of remuneration received or that may
be received by the named executive officers in respect of compensating such officers or directors in the event of a change of
control, termination of employment (as a result of resignation, retirement, change of control, etc.) or a change in responsibilities
following a change of control. Options are generally subject to clawback provisions, and provide for post-employment exercise
periods, pursuant to the terms of such awards and the 2017 Amended Long-Term Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
2024 Director Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
of the directors serving on the Board (Mark A. Smith) is also a named executive officer. For a description of the compensation
paid to Mr. Smith, see &#8220;Fiscal 2024 Summary Compensation Table&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth all compensation the Company granted to our directors, other than Mr. Smith, for the fiscal year ended
June 30, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 33%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 16%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees
                                         Earned or Paid in Cash</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($)</span>&#160;</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 17%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
    Awards</span><br/>
    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($)<sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 14%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                         Other Compensation</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($)</span>&#160;</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total<br/>
    ($)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    C. Beling</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$85,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$85,500</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    J. Morris</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128,250</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128,250</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nilsa
    Guerrero-Mahon</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128,250</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128,250</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Oliver</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,500</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean
    C. Kehler</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,500</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    G. Maselli</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,500</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anna
    Castner Wightman <sup>(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 98%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects the grant date fair value of Options granted during the 2024 fiscal year, consisting of 75,000 Options each for Mr.
Morris, and Ms. Guerrero-Mahon, and 50,000 Options each for Messrs. Beling, Oliver, Kehler, and Maselli, in each case at an exercise
price of $2.99 per share, computed in accordance with FASB ASC Topic 718. Assumptions used in the calculation of these amounts
are described in Note 11 in the Company&#8217;s consolidated financial statements included in this Annual Report on Form 10-K.
These Options were fully vested on the grant date and generally remain exercisable until three years after the grant date.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 2%; text-align: left">(2)</td><td style="text-align: justify; width: 98%">Ms. Wightman served as a member of the Board until January
19, 2024, and did not receive a grant of Options during the 2024 fiscal year.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended June 30, 2024, the directors of the Company did not receive any cash fees for serving on the Board. The
directors of the Company have no standard compensation arrangements, or any other arrangements, with the Company, except as herein
disclosed. Option grants are determined by the Compensation and Organization Committee of the Board (the &#8220;Compensation Committee&#8221;)
on a discretionary basis each year. Executive officers of the Company who also act as directors of the Company do not receive
any additional compensation for services rendered in such capacity. See &#8220;Fiscal 2024 Summary Compensation Table&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate number of Option awards outstanding at the end of fiscal year 2024 for each non-employee director who served during
fiscal 2024 was as follows: Mr. Beling, 117,500 Options; Mr. Morris, 157,500 Options; Ms. Guerrero-Mahon, 150,000 Options; Mr.
Oliver, 140,000 Options; Mr. Kehler, 50,000 Options; and Mr. Maselli, 50,000 Options. As of June 30, 2024, all the above Options
were 100% vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
of the 2017 Amended Long-Term Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2024, NioCorp&#8217;s shareholders approved the adoption of the 2017 Amended Long-Term Incentive Plan. Under the 2017
Amended Long-Term Incentive Plan, the Board may in its discretion from time-to-time grant stock options, share units (in the form
of restricted share units (&#8220;RSUs&#8221;) and performance share units (&#8220;PSUs&#8221;)) and dividend equivalents to non-employee
directors, employees and certain other service providers (as further described in the 2017 Amended Long-Term Incentive Plan) of
the Company and affiliated entities selected by the Board. Subject to adjustment as provided in the 2017 Amended Long-Term Incentive
Plan, the aggregate number of Common Shares that may be reserved for issuance to participants under the 2017 Amended Long-Term
Incentive Plan, together with all other security-based compensation arrangements of the Company, may not exceed 10% of the issued
and outstanding Common Shares from time to time, and the Common Shares reserved for issuance upon settlement of share units shall
not exceed 5% of the issued and outstanding Common Shares from time to time. Further, the aggregate number of Common Shares reserved
for issuance to any one participant under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, must not exceed 5% of the then issued and outstanding Common Shares (on a non-diluted basis). The
maximum number of Common Shares (1) issued to insiders (for purposes of the Toronto Stock Exchange Company Manual) within any
one-year period and (2) issuable to insiders at any time, under the 2017 Amended Long-Term</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Incentive Plan, or when combined with
the Company&#8217;s other security-based compensation arrangements, will not exceed 10% of the number of the then issued and outstanding
Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the burn rates for the 2017 Amended Long-Term Incentive Plan since inception:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal
    Year<br/>
    Ending June 30</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of awards</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">granted (1)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of Common</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">Shares outstanding</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Burn
    rate</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,625,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,320,024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">578,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,705,840</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.0%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">447,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,373,722</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">370,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,196,711</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,461,012</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0%</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         12.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a063"></span>SECURITY
                                         OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the beneficial ownership of Common Shares of NioCorp for the following: (1) each person who is known
by NioCorp to beneficially own more than 5% of the outstanding shares of NioCorp&#8217;s Common Shares; (2) each of the named
executive officers (as defined in the &#8220;Fiscal 2024 Summary Compensation Table,&#8221; above); (3) each of NioCorp&#8217;s
directors; and (4) all directors and executive officers of NioCorp as a group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership
of Common Shares in the table below is determined in accordance with the rules of the SEC and includes voting or investment power
with respect to the Common Shares. Common Shares that may be acquired by an individual or group within 60 days of September 20,
2024, pursuant to the exercise of options to purchase Common Shares (&#8220;Options&#8221;), the exercise of Common Share purchase
warrants (&#8220;Warrants&#8221;) or the exchange of shares of Class B common stock of ECRC (formerly known as GXII), are deemed
to be outstanding for the purpose of computing the percentage ownership of such individual or group but are not deemed to be outstanding
for the purpose of computing the percentage ownership of any other person shown in the table. Percentage of ownership is based
on 38,660,244 Common Shares outstanding as of September 20, 2024. Unless otherwise noted in the table below, Options vested at the
grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as indicated in footnotes to this table, we believe that the shareholders named in this table have sole voting and investment
power with respect to all Common Shares shown to be beneficially owned by them, based on information provided to us by such shareholders.
Unless otherwise indicated, the address for each director and executive officer listed is: c/o NioCorp Developments Ltd., 7000
South Yosemite Street, Suite 115, Centennial, CO 80112.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Address of<br/>
    Beneficial Owner</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount and</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">Nature of</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">Beneficial</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership</span><br/>
                                         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 6%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 15%; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Percent
                                         of</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">Common Shares</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mark
                                         A. Smith, PE, Esq.</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Highlands
Ranch, Colorado, USA&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, President, Executive Chairman and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,645,397</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.75%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neal
                                         Shah</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Superior,
Colorado, USA&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer and Corporate Secretary</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">395,032</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.01%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scott
                                         Honan</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Centennial,
Colorado, USA&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Operating Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">375,762</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(4)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jim
                                         Sims</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Golden
Colorado, USA&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VP
    &#8211; External Affairs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">377,928</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(5)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Michael
                                         J. Morris</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Luis Obispo, California, USA&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lead
    Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">219,698</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(6)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>David
                                         C. Beling</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grand
Junction, Colorado, USA&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">189,513</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(7)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nilsa
                                         Guerrero-Mahon</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brighton,
Colorado, USA&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">196,068</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(8)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dean
    Kehler</b><br/>
    New York, New York, USA</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,369</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(9)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.32%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Michael
                                         Maselli</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pelham,
New York, USA&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">588,235</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(10)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.50%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Peter
                                         Oliver</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bunbury,
Western Australia, Australia&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(11)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    current directors, executive officers and named executive officers as a group (11 persons)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,628,002</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.28%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cooper
                                         Road, LLC</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miami
Beach, Florida, USA&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,126,231</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(12)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.48%</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Represents ownership of less than 1%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
                                         in accordance with Rule 13d-3 of the Exchange Act.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0%"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of September 20, 2024, Mr. Smith beneficially owns 2,088,596 outstanding Common
                                         Shares. In addition, Mr. Smith beneficially owns 46,801 Common Shares issuable upon exercise
                                         of 46,801 Warrants issued in connection with the December 2023 Private Placement. In
                                         addition, he beneficially owns 510,000 vested Options comprised of the following: (i)
                                         on December 17, 2021, Mr. Smith was granted 65,000 Options for a period of three years
                                         at a price of C$13.60 per Common Share; (ii) on March 27, 2023, Mr. Smith was granted
                                         70,000 Options for a period of three years at a price of $6.95 per Common Share, and
                                         (iii) on February 15, 2024, Mr. Smith was granted 375,000 Options for a period of five
                                         years at a price of $2.99 per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of September 20, 2024, Mr. Shah beneficially owns 65,671 outstanding Common Shares.
                                         In addition, Mr. Shah beneficially owns 9,361 Common Shares issuable upon exercise of
                                         9,361 Warrants issued in connection with the December 2023 Private Placement. In addition,
                                         he beneficially owns 320,000 vested Options comprised of the following: (i) on December
                                         17, 2021, Mr. Shah was granted 30,000 Options for a period of three years at a price
                                         of C$13.60 per Common Share; (ii) on March 27, 2023, Mr. Shah was granted 40,000 Options
                                         for a period of three years at a price of $6.95 per Common Share; and (iii) on February
                                         15, 2024, Mr. Shah was granted 250,000 Options for a period of five years at a price
                                         of $2.99 per Common Share.</span></td></tr></table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of September 20, 2024, Mr. Honan beneficially owns 55,762 outstanding Common Shares.
                                         In addition, he beneficially owns 320,000 vested Options comprised of the following:
                                         (i) on December 17, 2021, Mr. Honan was granted 30,000 Options for a period of three
                                         years at a price of C$13.60 per Common Share; (ii) on March 27, 2023, Mr. Honan was granted
                                         40,000 Options for a period of three years at a price of $6.95 per Common Share; and
                                         (iii) on February 15, 2024, Mr. Honan was granted 250,000 Options for a period of five
                                         years at a price of $2.99 per Common Share.</span></td></tr>
</table>
<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of September 20, 2024, Mr. Sims beneficially owns 57,928 outstanding Common Shares
                                         In addition, he beneficially owns 320,000 vested Options comprised of the following:
                                         (i) on December 17, 2021, Mr. Sims was granted 30,000 Options for a period of three years
                                         at a price of C$13.60 per Common Share; (ii) on March 27, 2023, Mr. Sims was granted
                                         40,000 Options for a period of three years at a price of $6.95 per Common Share; and
                                         (iii) on February 15, 2024, Mr. Sims was granted 250,000 Options for a period of five
                                         years at a price of $2.99 per Common Share.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of September 20, 2024, Mr. Morris beneficially owns 62,198 outstanding Common
                                         Shares. He shares both voting and investment power with respect to 5,525 of such Common
                                         Shares with his wife as the only trustees of the Michael </span></td></tr></table>
<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and Sandra Morris Trust. In
                                         addition, he beneficially owns 157,500 vested Options comprised of the following: (i)
                                         on December 17, 2021, Mr. Morris was granted 32,500 Options for a period of three years
                                         at a price of C$13.60 per Common Share; (ii) on March 27, 2023, Mr. Morris was granted
                                         50,000 Options for a period of three years at a price of $6.95 per Common Share; and
                                         (iii) on February 15, 2024, Mr. Morris was granted 75,000 Options for a period of five
                                         years at a price of $2.99 per Common Share.</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of September 20, 2024, Mr. Beling beneficially owns 72,013 outstanding Common
                                         Shares. In addition, he beneficially owns 117,500 vested Options comprised of the following:
                                         (i) on December 17, 2021, Mr. Beling was granted 27,500 Options for a period of three
                                         years at a price of C$13.60 per Common Share; (ii) on March 27, 2023, Mr. Beling was
                                         granted 40,000 Options for a period of three years at a price of $6.95 per Common Share;
                                         and (iii) on February 15, 2024, Mr. Behling was granted 50,000 Options for a period of
                                         five years at a price of $2.99 per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of September 20, 2024, Ms. Guerrero-Mahon beneficially owns 46,068 Common Shares.
                                         In addition, she beneficially owns 150,000 vested Options comprised of the following:
                                         (i) on December 17, 2021, Ms. Guerrero-Mahon was granted 30,000 Options for a period
                                         of three years at a price of C$13.60 per Common Share; (ii) on March 27, 2023, Ms. Guerrero-Mahon
                                         was granted 45,000 Options for a period of three years at a price of $6.95 per Common
                                         Share; and (iii) on February 15, 2024, Ms. Guerrero-Mahon was granted 75,000 Options
                                         for a period of five years at a price of $2.99 per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%">
<tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman,serif; width: 48px"><span style="font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">As of September 20, 2024, Mr. Kehler beneficially owns 78,003 Common Shares. In addition, Mr. Kehler beneficially owns 78,003 Common Shares issuable upon exercise of 78,003 Warrants issued in connection with the December 2023 Private Placement, and he beneficially owns 50,000 vested Options comprised of the following: on February 15, 2024, Mr. Kehler was granted 50,000 Options for a period of five years at a price of $2.99 per Common Share. In addition, Mr. Kehler beneficially owns 1,441,290 Common Shares issuable upon the exchange of shares of Vested Shares. He shares both voting and investment power with respect to 318,480 such Vested Shares with U.S. Trust Company of Delaware, as co-trustee of the Elizabeth Kehler 2012 Family Trust under Declaration of Trust dated December 12, 2012 (the &#8220;Elizabeth Kehler Trust&#8221;). In addition, Mr. Kehler beneficially owns 1,853,073 Common Shares issuable upon exercise of 1,657,057 Private Warrants held by Mr. Kehler. Does not include Common Shares that may be issuable upon exchange of (i) 417,030 Common Shares issuable upon the exchange of Earnout Shares held by Mr. Kehler that will vest when the volume-weighted average price of the Common Shares on the principal exchange of the Common Shares as reported by Bloomberg (&#8220;VWAP&#8221;) equals or exceeds approximately $12.00 per share for 20 of any 30 consecutive trading days during the period from March 17, 2023 to March 17, 2033 (such period, the &#8220;Earnout Share Period&#8221;) on any stock exchange on which the Common Shares are then trading (such Common Shares, the &#8220;Tranche I Earnout Shares&#8221;), (ii) 417,030 Common Shares issuable upon the exchange of Earnout Shares held by Mr. Kehler that will vest when the VWAP of the Common Shares equals or exceeds approximately $15.00 per share for 20 of any 30 consecutive trading days during the Earnout Share Period on any stock exchange on which the Common Shares are then trading (such Common Shares, the &#8220;Tranche II Earnout Shares&#8221;), (iii) 118,284 Tranche I Earnout Shares held by the Elizabeth Kehler Trust and (iv) 118,284 Tranche II Earnout Shares held by the Elizabeth Kehler Trust.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman,serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%">
<tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman,serif; width: 48px"><span style="font-size: 10pt">(10)</span></td>
    <td style="font: 10pt Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">As of September 20, 2024, Mr. Maselli beneficially owns 323, 085 Common Shares issuable upon the exchange of Vested Shares. In addition, he beneficially owns 50,000 vested Options comprised of the following: on February 15, 2024, Mr. Maselli was granted 50,000 Options for a period of five years at a price of $2.99 per Common Share. In addition, Mr. Maselli beneficially owns 215,150 Common Shares issuable upon exercise of 192,392 Private Warrants held by Mr. Maselli. Does not include Common Shares that may be issuable upon exchange of (i) 119,998 Tranche I Earnout Shares held by Mr. Maselli and (ii) 119,998 Tranche II Earnout Shares held by Mr. Maselli.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of September 20, 2024, Mr. Oliver beneficially owns 140,000 vested Options comprised
                                         of the following: (i) on May 30, 2022, Mr. Oliver was granted 50,000 Options for a period
                                         of three years at a price of C$11.00; and (ii) on March 27, 2023, Mr. Oliver was granted
                                         40,000 Options for a period of three years at a price of $6.95 per Common Share; and
                                         (iii) on February 15, 2024, Mr. Oliver was granted 50,000 Options for a period of five
                                         years at a price of $2.99 per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         reported by Cooper Road, LLC on a Schedule 13G filed with the SEC on December 18, 2023.
                                         Cooper Road, LLC is controlled by Jay Bloom.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EQUITY
COMPENSATION PLANS<sup></sup></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has maintained equity compensation plans under which Options have been granted. Option grants have been determined by
the Company&#8217;s directors and are only provided in compliance with applicable laws and regulatory policy. The following information
is provided with respect to compensation plans (including individual compensation arrangements) under which equity securities
were authorized for issuance as of June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Compensation Plan Information</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 21%">Plan
Category&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 21%"><p style="margin-top: 0; margin-bottom: 0">Number of Securities</p>
                                                                             <p style="margin-top: 0; margin-bottom: 0">to be Issued Upon</p>
                                                                             <p style="margin-top: 0; margin-bottom: 0">Exercise of</p>
                                                                             <p style="margin-top: 0; margin-bottom: 0">Outstanding Options,</p>
                                                                             <p style="margin-top: 0; margin-bottom: 0">Warrants, and Rights</p></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 21%"><p style="margin-top: 0; margin-bottom: 0">Weighted-Average</p>
                                                                             <p style="margin-top: 0; margin-bottom: 0">Exercise
Price of</p>
                                                                             <p style="margin-top: 0; margin-bottom: 0">Outstanding</p>
                                                                             <p style="margin-top: 0; margin-bottom: 0">Options, Warrants,</p>
                                                                             <p style="margin-top: 0; margin-bottom: 0">and Rights</p></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 34%"><p style="margin-top: 0; margin-bottom: 0">Number of Securities Remaining</p>
                                                                             <p style="margin-top: 0; margin-bottom: 0">Available for Future Issuance Under</p>
                                                                             <p style="margin-top: 0; margin-bottom: 0">Equity Compensation Plans</p>
                                                                             <p style="margin-top: 0; margin-bottom: 0">(Excluding Securities Reflected in</p>
                                                                             <p style="margin-top: 0; margin-bottom: 0">Second
Column)</p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Compensation Plans Approved by Security Holders&#160;<sup>(1)</sup></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,495,500</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.78</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,310,764<sup>(2)</sup></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Compensation Plans Not Approved by Security Holders</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total<sup>(3)</sup></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,495,500</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.78</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,310,764<sup>(3)</sup></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    Options granted pursuant to the 2017 Amended Long-Term Incentive Plan.</span></td></tr>
</table>

<p style="margin: 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
    the aggregate number of Common Shares reserved for issuance to participants under the 2017 Amended Long-Term Incentive Plan,
    together with all other security-based compensation arrangements of the Company may not exceed 10% of the issued and outstanding
    Common Shares from time to time, and the Common Shares reserved for issuance upon settlement of share units shall not exceed
    5% of the issued and outstanding Common Shares from time to time. Common Shares subject to any grant (or any portion thereof)
    that are issued upon exercise or settlement, forfeited, surrendered, cancelled, unearned, or otherwise terminated will again
    be available for grant under the 2017 Amended Long-Term Incentive Plan.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of the date of this report there are: (i) 2,455,500 outstanding securities awarded under the 2017 Amended Long-Term Incentive
    Plan representing 6.35% of the Company&#8217;s currently issued and outstanding Common Shares; and (ii) 1,410,524 remaining
    securities available for grant representing 3.65% of the Company&#8217;s currently issued and outstanding Common Shares.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Performance Graph</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in">The following
graph compares total cumulative shareholder return for $100 invested in Common Shares from July 1, 2019, to June 30, 2024, with
cumulative total returns for the S&amp;P/TSX Composite Index and S&amp;P/TSX Mining Index:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.25in; color: Red"><img src="n257410kimg006.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.25in; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall,
the Company&#8217;s cumulative return for the five-year period ended below the range of returns for the two selected indices.
As an exploration stage company, executive officer compensation has not historically been adjusted to reflect share performance
trends. Compensation to executive officers remained flat from 2013 through February 2023, except for increases supported by additional
job responsibilities and/or job promotions. Effective September 1, 2019, the Board approved a 10% base rate increase for all NioCorp
employees and effective April 1, 2023, the Compensation Committee approved a base rate average increase of 12% for all NioCorp
employees. There were no salary increases granted during fiscal year 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         13.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a064"></span>CERTAIN
                                         RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following sets forth certain information regarding transactions between the Company (and its subsidiaries) and its officers, directors,
and significant shareholders. There have been no other transactions since the end of the Company&#8217;s most recently completed
fiscal year and there are no currently proposed transactions in which the Company was or is to be a participant and the amount
involved exceeds $120,000, and in which any related person (for purposes of Item 404 of Regulation S-K) had or will have a direct
or indirect material interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loan
Transactions: </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Smith is our Chief Executive Officer, President, Executive Chairman, and Director. On January 16, 2017, the Company and Mr. Smith
entered into a credit agreement (the &#8220;Smith Credit Agreement&#8221;) pursuant to which Mr. Smith agreed to make available
to the Company a credit facility of initially up to $2,000,000. On January 17, 2020, the Company entered into an amending agreement
to the Smith Credit Agreement, increasing the limit of the credit facility to $2,500,000 from the previous limit of $2,000,000.
On April 3, 2020, the Smith Credit Agreement was amended to increase the limit of the credit facility to $3,000,000 and on June
10, 2020, the Smith Credit Agreement was amended to increase the limit of the credit facility to $3,500,000. In addition, on June
10, 2020, the maturity date for the Smith Credit Agreement was extended to December 15, 2020. On December 14, 2020, the maturity
date for the Smith Credit Agreement was extended to December 15, 2021. On December 13, 2021, the maturity date for the Smith Credit
Agreement was extended to June 30, 2022. On June 29, 2022, the maturity date for the Smith Credit Agreement was extended to June
30, 2023. On February 28, 2023, the Smith Credit Agreement was amended to increase the borrowing limit to $4,000,000 from the
previous limit of $3,500,000. The Company subsequently drew down $1,130,000, leaving an available balance under the Smith Credit
Agreement of $52,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
largest aggregate amount of principal outstanding under the Smith Credit Agreement during the year ended June 30, 2023, was $3,130,000.
Principal repayments of $3,130,000 were made under the Smith Credit Agreement during the year ended June 30, 2023. In addition,
interest payments of $183,343 were paid under the Smith Credit Agreement during the year ended June 30, 2023, and $0 of interest
remained payable as of June 30, 2023. As of June 30, 2023, all principal and accrued interest outstanding under the Smith Credit
Agreement had been repaid and the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Smith Credit Agreement expired on June 30, 2023. Accounts payable and accrued liabilities as
of June 30, 2024, includes $28,250 of origination fees payable under the Smith Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2024, the Company and Mr. Mark Smith entered into a Loan Agreement (the &#8220;Smith Loan Agreement&#8221;)
pursuant to which Mr. Smith agreed to make available to the Company a non-revolving, multiple draw credit facility of up to
$2,000,000 (the &#8220;Loan&#8221;). The Loan is non-revolving and amounts paid back under the terms of the Smith Loan
Agreement do not again become available for drawdowns at the request of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will pay interest to Mr. Smith on amounts outstanding under the Loan and on any overdue interest at a rate equal to
10% per annum, calculated monthly in arrears, through to the date of repayment of the Loan. Mr. Smith will also receive an
establishment fee equal to 2.5% of the amount of any drawdown payable at the time of the drawdown as consideration of the
advancement of such drawdown. Any outstanding balance on the Loan, including accrued interest, shall be immediately due and
payable by the Company on the earlier of the date of expiration of the Smith Loan Agreement on June 30, 2025 and the
occurrence of an event of default thereunder, (the &#8220;Due Date&#8221;). The Company can repay
the Loan at any time without notice and without penalty, but any amount of principal or interest repaid by the Company prior
to the Due Date will be subject to an early payment fee of 2.5% of the value of any such payment. Amounts outstanding under the Smith Loan Agreement are secured by all of the Company&#8217;s assets pursuant to a general
security agreement between the Company and Mr. Smith, dated September 11, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 20, 2024, $33,000 had been borrowed under the Smith Loan Agreement. The largest aggregate amount of principal
outstanding under the Smith Loan Agreement during the period ended September 20, 2024, was $33,000, and there have been
no loan repayments or interest repayments as of September 20, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0"><i>Related Person Transactions Entered into in Connection with the 2023
Transactions</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The disclosure under Item
1, &#8220;<i>Business&#8212;Historical Development of the Business&#8212;The 2023 Transactions</i>,&#8221; is incorporated by reference
herein.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection with the Closing,
all of the shares of Class B common stock of ECRC were issued to the Sponsor in respect of shares of Class B common stock of GXII
that were originally issued to the Sponsor for $25,000 in the aggregate. In connection with the Closing, the Sponsor distributed
all of the outstanding shares of Class B common stock of ECRC to its members, including Messrs. Maselli and Kehler, for no additional
consideration, and such members joined the Sponsor Support Agreement and the Exchange Agreement, as parties thereto.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection with the Closing,
the Private Warrants and shares of Class B common stock of ECRC issued to the Sponsor were subsequently distributed by the Sponsor
to its members, including Messrs. Maselli and Kehler, for no additional consideration, and such members joined the Sponsor Support
Agreement and the Exchange Agreement, as parties thereto. The Sponsor acquired the shares of Class B common stock of GXII in respect
of which the shares of Class B common stock of ECRC were issued for $25,000 in the aggregate. The Sponsor acquired the GXII Warrants
in respect of which the Private Warrants were issued in a private placement that occurred simultaneously with the closing of the
initial public offering of GXII at a purchase price of $1.50 per GXII Warrant.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the Business Combination
Agreement, at the Closing, NioCorp, ECRC, the Sponsor, the pre-Closing directors and officers of NioCorp and the other parties
thereto, including Messrs. Maselli and Kehler (collectively, the &#8220;RRA Shareholders&#8221;), entered into the Amended and
Restated Registration Rights Agreement, dated March 17, 2023 (the &#8220;Registration Rights and Lockup Agreement&#8221;), pursuant
to which, among other things, NioCorp became obligated to file a shelf registration statement to register the resale of (i) outstanding
Common Shares, (ii) Common Shares exchangeable for the shares of Class B common stock of ECRC, (iii) Private Warrants and (iv)
Common Shares issuable upon exercise of the NioCorp Assumed Warrants, in each case, held by the RRA Shareholders immediately after
the Closing. The Registration Rights and Lockup Agreement also provides the RRA Shareholders with certain &#8220;demand&#8221;
and &#8220;piggy-back&#8221; registration rights, subject to certain requirements and customary conditions, and provides for certain
&#8220;lock-up&#8221; restrictions on transfer by the RRA Shareholders of such securities held by them after the Closing.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The shares of Class B common stock of ECRC and Private Warrants beneficially owned by Messrs. Maselli
and Kehler, as disclosed under Item 12, &#8220;<i>Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters</i>&#8221; above, have an aggregate market value of approximately $3.0 million and $0.2 million, respectively, based on
the closing price of the Common Shares of $1.72 and the closing price of the Public Warrants of $0.10 on Nasdaq on September 19,
2024.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Effective immediately upon
the Closing, the Board increased the size of the Board to nine members and appointed each of Messrs. Maselli and Kehler to the
Board. Messrs. Maselli and Kehler served on the board of directors of GXII prior to the Closing. Pursuant to the Business Combination
Agreement, the Company was required to cause two directors identified by GXII to become directors of the Company as of Closing,
and the Board appointed Messrs. Maselli and Kehler to the Board pursuant to such requirement.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>December 2023 Private Placement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Certain of the Company&#8217;s officers and directors, including Messrs.
Kehler, Smith and Shah, subscribed to purchase an aggregate of 138,845 December 2023 Units in the December 2023 Private Placement. Each
officer and director of the Company who subscribed to purchase December 2023 Units in the December 2023 Private Placement paid a purchase
price of US$3.205 per unit (the &#8220;Insider Unit Price&#8221;) upon the closing of the December 2023 Private Placement. The Insider
Unit Price included US$0.125 per December 2023 Warrant underlying each December 2023 Unit purchased by officers and directors of the Company.
Messrs. Kehler, Smith and Shah purchased 78,003 December 2023 Units, 46,801 December 2023 Units, and 9,361 December 2023 Units, respectively,
for aggregate purchase prices of $249,999.62, $149,997.21, and $30,002.01, respectively. The remaining investors in the December 2023
Private Placement, who are not affiliated with the Company but with whom the Company had a pre-existing relationship, subscribed to purchase
an aggregate of 274,587 December 2023 Units at a purchase price per December 2023 Unit of US$3.08, which is equal to the consolidated
closing bid price for the Common Shares as reported by Nasdaq on December 13, 2023. Gross proceeds to the Company from the December 2023
Private Placement were approximately US$1.29 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Review,
Approval or Ratification of Related Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other than as
described below, the Company does not currently have in place any specific policy or procedure in respect of the review, approval
or ratification of any transaction required to be reported under Item 404(a) of Regulation S-K. Sections 147-153 of the BCBCA set
out rules and procedures applicable to all British Columbia corporations, pursuant to which a director presented with a resolution
in respect of any matter (including an equity issuance) in respect of which he/she has an interest must disclose that interest
in writing to the corporation&#8217;s board of directors prior to the approval of such matter. This procedure ensures that each
equity issuance to a director or officer of the Company is approved by all directors of the Company not involved in such sale.
All loan transactions from directors and officers are typically subject to review and approval by the Board prior to acceptance
and are documented in the meeting minutes or resolutions related to same. Under its charter, the Audit Committee is responsible
for reviewing and approving any related party transaction in advance of such transaction, unless the Chief Financial Officer or
General Counsel determines that it is not practicable to wait until the next Audit Committee meeting, in which case the related
party transaction will be submitted to the Chair of the Audit Committee, who will have delegated authority to act between Audit
Committee meetings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">The
Company&#8217;s Board consists of Messrs. Smith, Morris, Beling, Oliver, Kehler, and Maselli and Ms. Guerrero-Mahon. The </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
<span style="color: #212529">utilizes the definition of &#8220;independent&#8221; as it is set forth in Nasdaq Listing Rule 5605(a)(2)
(&#8220;Rule 5605(a)(2)&#8221;) and National Instrument 52-110&#160;<i>Audit Committees</i>&#160;(&#8220;NI 52-110&#8221;). Further,
the Board considers all relevant facts and circumstances in its determination of independence of all members of the Board (including
any relationships). Currently, Messrs. Morris, Beling, Oliver, Kehler, and Maselli and Ms. Guerrero-Mahon are considered independent
directors. </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         14.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a065"></span>PRINCIPAL
                                         ACCOUNTANT FEES AND SERVICES</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents fees for professional services rendered by Deloitte &amp;&#160;Touche LLP for the fiscal year ended June 30, 2024
and BDO USA, P.C. for the fiscal year ended June 30, 2023 for the audit of the Company&#8217;s annual consolidated financial statements
and review of consolidated financial statements included in the Company&#8217;s filings and fees billed for other services rendered
by the firms during those periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 90%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 18%; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal Year Ending</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">June 30,</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Fees<sup>(1)</sup> ($)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 19%; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">Fees<sup>(2)</sup> ($)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 15%; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Fees<sup>(3)</sup></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">($)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 15%; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Other</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">Fees<sup>(4)</sup> ($)</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,292,312</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,263</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,205,765</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,356</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0%"/><td style="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Audit
                                         Fees&#8221; include fees necessary to perform the annual audit and quarterly reviews
                                         of the Company&#8217;s consolidated financial statements. Audit Fees include fees for
                                         review of tax provisions and for accounting consultations on matters reflected in the
                                         consolidated financial statements. Audit Fees also include audit or other attest services
                                         required by legislation or regulation, such as comfort letters, consents, reviews of
                                         securities filings and statutory audits.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Audit-Related
                                         Fees&#8221; include services that are traditionally performed by the auditor. These audit-related
                                         services include employee benefit audits, due diligence assistance, accounting consultations
                                         on proposed transactions, internal control reviews and audit or attest services not required
                                         by legislation or regulation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Tax
                                         Fees&#8221; include fees for all tax services other than those included in &#8220;Audit
                                         Fees&#8221; and &#8220;Audit-Related Fees.&#8221; This category includes fees for tax
                                         compliance, tax planning and tax advice. Tax planning and tax advice includes assistance
                                         with tax audits and appeals, tax advice related to mergers and acquisitions, and requests
                                         for rulings or technical advice from tax authorities. For the financial years ended June
                                         30, 2024 and 2023, these tax services included the preparation of Canadian and U.S. federal
                                         and state tax returns and tax planning and tax advice services.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;All
                                         Other Fees&#8221; includes all other non-audit services.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-approval
Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
policy of the Audit Committee has been to pre-approve all audit, audit-related and non-audit services performed by our
independent auditors and to subsequently review the actual fees and expenses paid to our independent auditors. Accordingly,
the Audit Committee pre-approved all audit, audit-related and non-audit services performed by Deloitte &amp; Touche LLP and
BDO and subsequently reviewed the actual fees and expenses paid for these services. The Audit Committee has determined that
the fees paid to Deloitte &amp; Touche LLP for services are compatible with maintaining Deloitte &amp; Touche LLP&#8217;s
independence as our auditor. All of the services provided during the year ended June 30, 2024, were approved by the Audit
Committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.75pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.75pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>






















<p style="margin: 0"></p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><span id="a066"></span>PART IV&#160;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman,serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in">ITEM&#160; 15.</td><td><span id="a067"></span>EXHIBITS AND FINANCIAL STATEMENT SCHEDULES&#160;</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following documents
are filed as a part of this report:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 2.75pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0pt"/><td style="width: 17.95pt"><b>(a)</b></td><td><b><i>Financial Statements</i>&#160;</b></td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 48.95pt; text-indent: -24.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(1)</td><td style="text-align: justify">The Consolidated Financial Statements, together with the reports thereon of Deloitte &amp; Touche
LLP, dated September 20, 2024, and BDO USA, P.C., dated October 6, 2023, are included as part of Item&#160;8, &#8220;Financial
Statements and Supplementary Data,&#8221; commencing on page 59 above.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="margin-left: 0.5in; width: 90%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.1in; font-family: Times New Roman,serif; text-indent: -0.1in; width: 93%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td>
    </tr>
<tr style="vertical-align: bottom">
    <td style="font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b001">Report of Independent Registered Public Accounting Firms<br/> &#160;(Deloitte &amp; Touche LLP; Denver, Colorado; PCAOB ID#34)</a>&#160;</span></td>
    <td style="font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    </tr>
<tr style="vertical-align: bottom">
    <td style="font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; font-family: Times New Roman,serif; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b002">Report of Independent Registered Public Accounting Firms<br/> &#160;(BDO USA, P.C.; Spokane, Washington; PCAOB ID#243)</a>&#160;</span></td>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: center">63</td>
    </tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; font-family: Times New Roman,serif; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; font-family: Times New Roman,serif; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b003">Consolidated Balance Sheets</a></span></td>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: center">64</td>
    </tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; font-family: Times New Roman,serif; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; font-family: Times New Roman,serif; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b004">Consolidated Statements of Operations and Comprehensive Loss</a></span></td>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: center">65</td>
    </tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; font-family: Times New Roman,serif; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; font-family: Times New Roman,serif; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b005">Consolidated Statements of Cash Flows</a></span></td>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: center">66</td>
    </tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; font-family: Times New Roman,serif; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; font-family: Times New Roman,serif; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b006">Consolidated Statements of Shareholders&#8217; (Deficit) Equity and Redeemable Noncontrolling Interest</a></span></td>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: center">67</td>
    </tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; font-family: Times New Roman,serif; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 12pt; font-family: Times New Roman,serif; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b007">Notes to Consolidated Financial Statements</a></span></td>
    <td style="font-family: Times New Roman,serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: center">68</td>
    </tr>
</table>

<p style="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 17.95pt"><b>(b)</b></td><td><b><i>Exhibits</i></b></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 15%">
        <p style="border-bottom: black 1pt solid; font: 10pt Times New Roman,serif; margin: 0pt 0"><b>Exhibit No.</b></p>
</td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 83%">
        <p style="border-bottom: black 1pt solid; font: 10pt Times New Roman,serif; margin: 0pt 0"><b>Title</b></p>
</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh2-1.htm"><span style="font-size: 10pt">2.1(1)**</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh2-1.htm"><span style="font-size: 10pt">Business Combination Agreement, dated September 25, 2022, by and among NioCorp Developments Ltd., GX Acquisition Corp. II and Big Red Merger Sub Ltd</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename2.htm"><span style="font-size: 10pt">3.1(2)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename2.htm"><span style="font-size: 10pt">Notice of Articles of NioCorp Developments Ltd., dated April 5, 2016</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename3.htm"><span style="font-size: 10pt">3.2(2)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename3.htm"><span style="font-size: 10pt">Articles of NioCorp Developments Ltd., as amended, effective as of January 27, 2015</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh3-1.htm"><span style="font-size: 10pt">3.3(3)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh3-1.htm"><span style="font-size: 10pt">Amendment to Articles, effective March 17, 2023</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598221000044/sf0095h_ex4-1.htm"><span style="font-size: 10pt">4.1(4)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598221000044/sf0095h_ex4-1.htm"><span style="font-size: 10pt">Convertible Security Funding Agreement, dated February 16, 2021, between the Company and Lind Global Asset Management III, LLC</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598221000044/sf0095h_ex4-2.htm"><span style="font-size: 10pt">4.2(4)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598221000044/sf0095h_ex4-2.htm"><span style="font-size: 10pt">Form of Lind III Warrant Certificate, in respect of the Lind III Warrants</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722000259/n2574_x23exh10-2.htm"><span style="font-size: 10pt">4.3(5)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722000259/n2574_x23exh10-2.htm"><span style="font-size: 10pt">Amendment #1 to Convertible Security Funding Agreement, dated December 2, 2021, between the Company and Lind Global Asset Management III, LLC</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001757/n2574s4_ex4-17waiveconsent.htm"><span style="font-size: 10pt">4.4(6)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001757/n2574s4_ex4-17waiveconsent.htm"><span style="font-size: 10pt">Waiver and Consent Agreement, dated September 25, 2022, between NioCorp Developments Ltd. and Lind Global Asset Management III, LLC</span></a></td></tr>
    <tr style="vertical-align: top">
    <td><a href="n2574_x219ex4-5.htm"><span style="font-size: 10pt">4.5</span></a></td>
    <td>&#160;</td>
    <td><a href="n2574_x219ex4-5.htm"><span style="font-size: 10pt">Form of Lind Contingent Consent Warrants</span></a></td></tr>


<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-1.htm"><span style="font-size: 10pt">4.6(1)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-1.htm"><span style="font-size: 10pt">Sponsor Support Agreement, dated as of September 25, 2022, by and among GX Acquisition Corp. II, NioCorp Developments Ltd., GX Sponsor II LLC, in its capacity as a shareholder of GX Acquisition Corp. II, and certain other shareholders of GX Acquisition Corp. II</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000670/exh4-5.htm"><span style="font-size: 10pt">4.7(7)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000670/exh4-5.htm"><span style="font-size: 10pt">Joinder to Sponsor Support Agreement, dated as of March 17, 2023, by and among NioCorp Developments Ltd. and each of the Holders party thereto</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-1.htm"><span style="font-size: 10pt">4.8(3)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-1.htm"><span style="font-size: 10pt">Amended and Restated Registration Rights Agreement, dated as of March 17, 2023, by and among NioCorp Developments Ltd., GX Acquisition Corp. II, GX Sponsor II LLC, certain holders of the common shares of the NioCorp Developments Ltd. listed on Schedule 1 thereto, certain current and former stockholders of GX Acquisition Corp. II, and other persons and entities listed on Schedule 2 thereto</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-2.htm"><span style="font-size: 10pt">4.9(3)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-2.htm"><span style="font-size: 10pt">Registration Rights Agreement Joinder, dated as of March 17, 2023, by and among NioCorp Developments Ltd. and each of the parties listed on Schedule A thereto</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-3.htm"><span style="font-size: 10pt">4.10(3)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-3.htm"><span style="font-size: 10pt">Exchange Agreement, dated as of March 17, 2023, by and among NioCorp Developments Ltd., GX Acquisition Corp. II and GX Sponsor II LLC</span></a></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; width: 15%"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000670/exh4-9.htm"><span style="font-size: 10pt">4.11(7)</span></a></td>
    <td style="font-family: Times New Roman,serif; width: 2%">&#160;</td>
    <td style="font-family: Times New Roman,serif; width: 83%"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000670/exh4-9.htm"><span style="font-size: 10pt">Joinder to Exchange Agreement, dated as of March 17, 2023, by and among NioCorp Developments Ltd., Elk Creek Resources Corp (f/k/a GX Acquisition Corp. II) and each of the Holders party thereto</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1826669/000121390021017023/ea138188ex4-1gxacquisit2.htm"><span style="font-size: 10pt">4.12(8)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1826669/000121390021017023/ea138188ex4-1gxacquisit2.htm"><span style="font-size: 10pt">Warrant Agreement, dated March 17, 2021, by and between GX Acquisition Corp. II and Continental Stock Transfer &amp; Trust Company</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh4-2.htm"><span style="font-size: 10pt">4.13(3)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh4-2.htm"><span style="font-size: 10pt">Assignment, Assumption and Amendment Agreement, dated as of March 17, 2023, by and among GX Acquisition Corp. II, NioCorp Developments Ltd., Continental Stock Transfer &amp; Trust Company, as the existing Warrant Agent, and Computershare Inc. and its affiliate Computershare Trust Company, N.A., as the successor Warrant Agent</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh4-2.htm"><span style="font-size: 10pt">4.14(3)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh4-2.htm"><span style="font-size: 10pt">Form of Warrant (included in Exhibit 4.13)</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-1.htm"><span style="font-size: 10pt">4.15(9)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-1.htm"><span style="font-size: 10pt">Securities Purchase Agreement, dated as of January 26, 2023, by and between NioCorp Developments Ltd. and each of the investors listed on the Schedule of Buyers attached thereto</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000339/exh4-1.htm"><span style="font-size: 10pt">4.16(10)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000339/exh4-1.htm"><span style="font-size: 10pt">Amendment No. 1 to Securities Purchase Agreement, dated February 24, 2023, by and between NioCorp Developments Ltd. and YA II PN, Ltd.</span></a></td></tr>

<tr style="vertical-align: top">
    <td><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949723000339/exh4-1.htm"><span style="font-size: 10pt">4.17(10)</span></a></td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949723000339/exh4-1.htm"><span style="font-size: 10pt">Form of Convertible Debenture (included in Exhibit 4.16)</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-1.htm#a_002"><span style="font-size: 10pt">4.18(9)</span></a></td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-1.htm#a_002"><span style="font-size: 10pt">Form of Financing Warrants (included in Exhibit 4.15)</span></a></td></tr>

<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-4.htm"><span style="font-size: 10pt">4.19(9)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-4.htm"><span style="font-size: 10pt">Registration Rights Agreement, dated as of January 26, 2023, by and between NioCorp Developments Ltd. and YA II PN, Ltd.</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-2subscription.htm"><span style="font-size: 10pt">4.20(11)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-2subscription.htm"><span style="font-size: 10pt">Form of Subscription Agreement in respect of units issued in September 2023</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-1warrant.htm"><span style="font-size: 10pt">4.21(11)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-1warrant.htm"><span style="font-size: 10pt">Form of Warrants issued in September 2023</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-2subscription.htm"><span style="font-size: 10pt">4.22(12)</span></a></td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-2subscription.htm"><span style="font-size: 10pt">Form of Subscription Agreement in respect of units issued in December 2023</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-1warrant.htm"><span style="font-size: 10pt">4.23(12)</span></a></td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-1warrant.htm"><span style="font-size: 10pt">Form of Warrants issued in December 2023</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949724000818/exh10-1.htm"><span style="font-size: 10pt">4.24(13)</span></a></td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949724000818/exh10-1.htm"><span style="font-size: 10pt">Securities Purchase Agreement, dated as of April
    11, 2024, by and between NioCorp Developments Ltd. and each of YA II PN, Ltd. and Lind Global Fund II LP</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949724000818/exh10-1.htm#st-a_001"><span style="font-size: 10pt">4.25(13)</span></a></td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949724000818/exh10-1.htm#st-a_001"><span style="font-size: 10pt">Form of Unsecured Convertible Note (included
    in Exhibit 4.24)</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949724000818/exh10-1.htm#st-a_002"><span style="font-size: 10pt">4.26(13)</span></a></td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949724000818/exh10-1.htm#st-a_002"><span style="font-size: 10pt">Form of Common Stock Purchase Warrant (included
    in Exhibit 4.24)</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949724000818/exh10-2.htm"><span style="font-size: 10pt">4.27(13)</span></a></td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949724000818/exh10-2.htm"><span style="font-size: 10pt">Global Guaranty Agreement, dated as of April
    11, 2024, by Elk Creek Resources Corporation and 0896800 B.C. Ltd.</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949724000818/exh10-3.htm"><span style="font-size: 10pt">4.28(13)</span></a></td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949724000818/exh10-3.htm"><span style="font-size: 10pt">Registration Rights Agreement, dated as of April
    11, 2024, by and between NioCorp Developments Ltd. and each of YA II PN, Ltd. and Lind Global Fund II LP</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex4-29.htm"><span style="font-size: 10pt">4.29</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex4-29.htm"><span style="font-size: 10pt">Consent and Waiver, dated as of September 4, 2024, between NioCorp Developments Ltd. and YA II PN, Ltd.</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex4-30.htm"><span style="font-size: 10pt">4.30</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex4-30.htm"><span style="font-size: 10pt">Consent and Waiver, dated as of September 4, 2024, between NioCorp Developments Ltd. and Lind Global Fund II LP</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-2subscription.htm">4.31(14)</a></span></td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-2subscription.htm"><span style="font-size: 10pt">Form of Subscription Agreement in respect of units issued in June 2024</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-1warrant.htm">4.32(14)</a></span></td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-1warrant.htm"><span style="font-size: 10pt">Form of Warrants issued in June 2024</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex4-33.htm"><span style="font-size: 10pt">4.33</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex4-33.htm"><span style="font-size: 10pt">Description of Securities</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000161577417006460/s108109_ex10-1.htm"><span style="font-size: 10pt">10.1(15)#</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000161577417006460/s108109_ex10-1.htm"><span style="font-size: 10pt">NioCorp Developments Ltd. Long Term Incentive Plan, effective as of November 9, 2017</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename9.htm"><span style="font-size: 10pt">10.2(2)#</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename9.htm"><span style="font-size: 10pt">Consulting Agreement, dated May 13, 2014, between the Company and KMSmith, LLC</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-3.htm"><span style="font-size: 10pt">10.3(16)#</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-3.htm"><span style="font-size: 10pt">Amendment to Contract, dated September 1, 2019, between the Company and KMSmith, LLC</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-4.htm"><span style="font-size: 10pt">10.4(16)#</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-4.htm"><span style="font-size: 10pt">Contract Assignment and Novation Agreement, dated as of August 31, 2020, among the Company, KMSmith, LLC and 76 Resources, Inc.</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949721001306/exh10-5agreement.htm"><span style="font-size: 10pt">10.5(17)#</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949721001306/exh10-5agreement.htm"><span style="font-size: 10pt">Contract Assignment and Novation Agreement, dated as of August 1, 2021, among the Company, 76 Resources, Inc. and 76 Resources, LLC</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001504/exh10-6_amndtmnt.htm"><span style="font-size: 10pt">10.6(18)#</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001504/exh10-6_amndtmnt.htm"><span style="font-size: 10pt">Amendment to Contract, dated April 1, 2023, between the Company and 76 Resources, LLC</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416122587/v448164_ex10-3.htm"><span style="font-size: 10pt">10.7(19)*</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416122587/v448164_ex10-3.htm"><span style="font-size: 10pt">Offtake agreement, dated June 13, 2016, between the Company and CMC Cometals, a division of Commercial Metals Company</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001717/n2574_x60ex10-7.htm"><span style="font-size: 10pt">10.8(20)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001717/n2574_x60ex10-7.htm"><span style="font-size: 10pt">Amendment No. 1 to Offtake Agreement, dated April 13, 2020, between the Company and Traxys North America LLC, as assignee</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000161577417004839/s107345_ex10-4.htm"><span style="font-size: 10pt">10.9(21)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000161577417004839/s107345_ex10-4.htm"><span style="font-size: 10pt">Offtake agreement with ThyssenKrupp Metallurgical Products GmbH</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-8.htm"><span style="font-size: 10pt">10.10(16)*, **</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-8.htm"><span style="font-size: 10pt">Woltemath 003J Amended and Restated Option to Purchase, dated January 4, 2017, among ECRC and Victor L. and Juanita E. Woltemath</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-9.htm"><span style="font-size: 10pt">10.11(16)*, **</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-9.htm"><span style="font-size: 10pt">Woltemath 003J Extension to Option to Purchase, dated December 23, 2019, among ECRC and Victor L. and Juanita E. Woltemath</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000066/n2574_x188exh10-1.htm"><span style="font-size: 10pt">10.13(22)#</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000066/n2574_x188exh10-1.htm"><span style="font-size: 10pt">NioCorp Developments Ltd. Long Term Incentive Plan, as amended</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh10-1.htm"><span style="font-size: 10pt">10.14(9)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh10-1.htm"><span style="font-size: 10pt">Standby Equity Purchase Agreement, dated as of January 26, 2023, by and between NioCorp Developments Ltd. and YA II PN, Ltd.</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949724000948/exh10-1.htm"><span style="font-size: 10pt">10.15(23)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949724000948/exh10-1.htm"><span style="font-size: 10pt">Amendment #1 to Standby Equity Purchase Agreement, dated as of May 3, 2024, by and between NioCorp Developments Ltd. and YA II PN, Ltd.</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949723000458/exh10-4.htm"><span style="font-size: 10pt">10.16(3)#</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949723000458/exh10-4.htm"><span style="font-size: 10pt">Form of Director and Officer Indemnification Agreement</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-3.htm"><span style="font-size: 10pt">10.17(1)#</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-3.htm"><span style="font-size: 10pt">Employment Agreement, dated as of September 25, 2022, by and between Elk Creek Resources Corporation and Neal Shah</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-4.htm"><span style="font-size: 10pt">10.18(1)#</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-4.htm"><span style="font-size: 10pt">Employment Agreement, dated as of September 25, 2022, by and between Elk Creek Resources Corporation and Scott Honan</span></a></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; width: 15%"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-5.htm"><span style="font-size: 10pt">10.19(1)#</span></a></td>
    <td style="font-family: Times New Roman,serif; width: 2%">&#160;</td>
    <td style="font-family: Times New Roman,serif; width: 83%"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-5.htm"><span style="font-size: 10pt">Employment Agreement, dated as of September 25, 2022, by and between Elk Creek Resources Corporation and Jim Sims</span></a></td></tr>
</table>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; width: 15%"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-6.htm"><span style="font-size: 10pt">10.20(1)#</span></a></td>
    <td style="font-family: Times New Roman,serif; width: 2%">&#160;</td>
    <td style="font-family: Times New Roman,serif; width: 83%"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-6.htm"><span style="font-size: 10pt">Form of Restrictive Covenant Agreement</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001909/n2574_x218exh10-1.htm"><span style="font-size: 10pt">10.21(24)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001909/n2574_x218exh10-1.htm"><span style="font-size: 10pt">Loan
    Agreement, dated as of September 11, 2024, between the Company and Mark Smith</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001909/n2574_x218exh10-2.htm"><span style="font-size: 10pt">10.22(24)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001909/n2574_x218exh10-2.htm"><span style="font-size: 10pt">Security
    Agreement, dated as of September 11, 2024, between the Company and Mark Smith</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex19-1.htm"><span style="font-size: 10pt">19.1</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex19-1.htm"><span style="font-size: 10pt">NioCorp Developments Ltd. Insider Trading Policy</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex21-1.htm"><span style="font-size: 10pt">21.1</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex21-1.htm"><span style="font-size: 10pt">Subsidiaries of NioCorp Developments Ltd.</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex23-1.htm"><span style="font-size: 10pt">23.1</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex23-1.htm"><span style="font-size: 10pt">Consent of Deloitte&#160;&amp;&#160;Touche LLP</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex23-2.htm"><span style="font-size: 10pt">23.2</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex23-2.htm"><span style="font-size: 10pt">Consent of BDO USA, P.C.</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-3.htm">23.3</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-3.htm">Consent of Dahrouge Geological Consulting USA Ltd.</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-4.htm">23.4</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-4.htm">Consent of Understood Mineral Resources Ltd.</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-5.htm">23.5</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-5.htm">Consent of Optimize Group Inc.</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-6.htm">23.6</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-6.htm">Consent of Tetra Tech</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-7.htm">23.7</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-7.htm">Consent of Adrian Brown Consultants Inc.</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-8.htm">23.8</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-8.htm">Consent of Magemi Mining Inc.</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-9.htm">23.9</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-9.htm">Consent of L3 Process Development</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-10.htm">23.10</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-10.htm">Consent of Olsson</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-11.htm">23.11</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-11.htm">Consent of A2GC</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-12.htm">23.12</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-12.htm">Consent of Metallurgy Concept Solutions</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-13.htm">23.13</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-13.htm">Consent of Scott Honan, M.Sc., SME-RM, NioCorp</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-14.htm">23.14</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-14.htm">Consent of Cementation</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-15.htm">23.15</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-15.htm">Consent of Mahmood Khwaja, P.E., CDM Smith</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-16.htm">23.16</a></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex23-16.htm">Consent of Wynand Marx, M.Eng., BBE Consulting</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex31-1.htm">31.1</a></span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex31-1.htm">Certification of the Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex31-2.htm">31.2</a></span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex31-2.htm">Certification of the Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex32-1.htm">32.1</a></span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex32-1.htm">Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex32-2.htm">32.2</a></span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt"><a href="n2574_x219ex32-2.htm">Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001510/n2574_x36exh96-1.htm"><span style="font-size: 10pt">96.1(25)</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001510/n2574_x36exh96-1.htm"><span style="font-size: 10pt">S-K
    1300 Elk Creek Technical Report Summary</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex97-1.htm"><span style="font-size: 10pt">97.1</span></a></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><a href="n2574_x219ex97-1.htm"><span style="font-size: 10pt">Compensation Clawback Policy</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">101.INS(26)</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">XBRL Instance Document</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">101.SCH(26)</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">XBRL Taxonomy Extension &#8211; Schema</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">101.CAL(26)</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">XBRL Taxonomy Extension &#8211; Calculations</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">101.DEF(26)</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">XBRL Taxonomy Extension &#8211; Definitions</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">101.LAB(26)</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">XBRL Taxonomy Extension &#8211; Labels</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">101.PRE(26)</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">XBRL Taxonomy Extension &#8211; Presentations</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">104</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Cover Page Interactive Data File (formatted as
    Inline XBRL and contained in Exhibit 101)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 27.35pt; text-align: justify; text-indent: -27.35pt">&#160;&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 36px; font-family: Times New Roman,serif"><span style="font-size: 10pt">#</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Management compensation plan, arrangement or agreement.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 27.35pt; text-align: justify; text-indent: -27.35pt">&#160;&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 36px; font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">*</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, which portions will be furnished to the Securities and Exchange Commission upon request.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 27.35pt; text-align: justify; text-indent: -27.35pt">&#160;&#160;&#160;</p>


<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 36px; font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">**</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Certain exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted exhibit will be furnished to the Securities and Exchange Commission upon request.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 27.35pt; text-align: justify; text-indent: -27.35pt">&#160;&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">

    <td style="width: 36px; font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(1)</span></td>
    <td>
        <p style="font: 10pt Times New Roman,serif; margin: 0pt 0.25pt 0pt 0; text-align: justify; text-indent: 0.25pt">Previously filed
        as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on September 29, 2022 and
        incorporated herein by reference.</p>
        <p style="font: 10pt Times New Roman,serif; margin: 0pt 0.25pt 0pt 0; text-align: justify; text-indent: 0.25pt"></p></td></tr>
</table>







<p style="font: 10pt Times New Roman,serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; width: 0.35in"><span style="font-size: 10pt">(2)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Draft Registration Statement on Form S-1 (Registration No. 377-01354) submitted to the SEC on July 26, 2016 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(3)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on March 17, 2023 and incorporated herein by reference. </span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(4)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on February 17, 2021 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">(5)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 10-Q (File No. 000-55710) filed with the SEC on February 4, 2022 and incorporated herein by reference.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify; width: 0.35in"><span style="font-size: 10pt">(6)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Registration Statement on Form S-4 (Registration No. 333-268227) filed with the SEC on November 7, 2022 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(7)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Registration Statement on Form S-3 (File No. 333-271268) filed with the SEC on April 14, 2023 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(8)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to Elk Creek Resources Corp.&#8217;s (f/k/a GX Acquisition Corp. II) Current Report on Form 8-K (File No. 001-40226) filed with the SEC on March 22, 2021 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(9)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on January 27, 2023 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(10)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on February 24, 2023 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">(11)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on September 1, 2023 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">(12)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on December 20, 2023 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">(13)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on April 12, 2024 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">(14)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on June 24, 2024 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">(15)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on November 13, 2017 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">(16)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 000-55710) filed with the SEC on September 16, 2020 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(17)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 000-55710) filed with the SEC on September 8, 2021 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(18)</span></td>
    <td>
        <p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">Previously filed as an exhibit to the Company&#8217;s
        Post-Effective Amendment No. 1 to the Registration Statement on Form S-3 on Form S-1 (File No. 333-271268) filed with the SEC on
        August 22, 2023 and incorporated herein by reference.</p>
        <p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&#160;</p></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">(19)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Registration Statement on Form S-1 (Registration No. 333-213451) filed with the SEC on September 2, 2016 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(20)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to Amendment No. 1 to the Company&#8217;s Annual Report on Form 10-K/A (File No. 000-55710) filed with the SEC on October 31, 2022 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">(21)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 000-55710) filed with the SEC on August 29, 2017 and incorporated herein by reference.</span></td></tr>
</table>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify; width: 36px">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(22)</span></td>
    <td>
        <p style="font: 10pt Times New Roman,serif; margin: 0pt 0.25pt 0pt 0; text-align: justify; text-indent: 0.25pt">Previously filed
        as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on January 22, 2024 and
        incorporated herein by reference.</p>
        <p style="font: 10pt Times New Roman,serif; margin: 0pt 0.25pt 0pt 0; text-align: justify; text-indent: 0.25pt"></p></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(23)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on May 3, 2024 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(24)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on September 11, 2024 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(25)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 000-55710) filed with the SEC on September 6, 2022 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">(26)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-size: 10pt">Submitted Electronically Herewith. Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Balance Sheets at June 30, 2024 and June 30, 2023, (ii) the Consolidated Statements of Operations and Comprehensive Loss for the years ended June 30, 2024 and 2023, (iii) the Consolidated Statements of Cash Flows for the years ended June 30, 2024 and 2023, (iv) the Consolidated Statements of Shareholders&#8217; Equity (Deficit) and Redeemable Noncontrolling Interest for the years ended June 30, 2024 and 2023, (v) the Notes to the Consolidated Financial Statements.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman,serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in">ITEM&#160;16.</td><td><span style="font-size: 10pt"><span id="a068"></span>FORM 10&#8211;K SUMMARY</span>&#160;</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0">None.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><span id="a069"></span>SIGNATURES</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 2.75pt; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 2.75pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 10pt">NIOCORP DEVELOPMENTS LTD.</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 52%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 4%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 44%; font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif"><span style="font-size: 10pt">/s/ Neal Shah</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman,serif; margin: 0pt 0">Neal Shah&#160;</p>
        <p style="font: 10pt Times New Roman,serif; margin: 0pt 0"></p>
        <p style="font: 10pt Times New Roman,serif; margin: 0pt 0">Chief Financial Officer&#160;</p>
        <p style="font: 10pt Times New Roman,serif; margin: 0pt 0"></p></td></tr>
</table>
<p style="font: 10pt Times New Roman,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0">September 20, 2024</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 2.75pt; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant
and in the capacities indicated on September 20, 2024.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 2.75pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-size: 10pt"><b>Signature</b></span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif; text-align: center"><span style="font-size: 10pt"><b>Title</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif"><span style="font-size: 10pt">/s/ Mark A. Smith</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 10pt">President, Chief Executive Officer (Principal</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Mark A. Smith</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Executive Officer and Authorized U.S. Representative)</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 10pt">and Chairman of the Board of Directors</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif"><span style="font-size: 10pt">/s/ Neal Shah</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Chief Financial Officer (Principal Financial and</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Neal Shah</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Accounting Officer)</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>
        <p style="border-bottom: black 1pt solid; font: 10pt Times New Roman,serif; margin: 0pt 0">/s/ Michael Morris</p>
        </td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Michael Morris</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>
        <p style="border-bottom: black 1pt solid; font: 10pt Times New Roman,serif; margin: 0pt 0">/s/ David C. Beling</p>
        </td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">David C. Beling</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font-family: Times New Roman,serif"><span style="font-size: 10pt">/s/ Nilsa Guerrero-Mahon</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Nilsa Guerrero-Mahon</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font-family: Times New Roman,serif"><span style="font-size: 10pt">/s/ Dean C. Kehler</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Dean C. Kehler</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; font-family: Times New Roman,serif"><span style="font-size: 10pt">/s/ Michael G. Maselli</span></td>
    <td style="vertical-align: top; width: 1%; font-family: Times New Roman,serif">&#160;</td>
    <td style="vertical-align: top; width: 66%; font-family: Times New Roman,serif"><span style="font-size: 10pt">Director</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; font-family: Times New Roman,serif"><span style="font-size: 10pt">Michael G. Maselli</span></td>
    <td style="vertical-align: top; font-family: Times New Roman,serif">&#160;</td>
    <td style="vertical-align: top; font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font-family: Times New Roman,serif"><span style="font-size: 10pt">/s/ Peter Oliver</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><span style="font-size: 10pt">Peter Oliver</span></td>
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
</table>






<p style="font: 10pt Times New Roman,serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></p></div>

    <!-- Field: /Page -->








</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>2
<FILENAME>n2574_x219ex4-5.htm
<DESCRIPTION>FORM OF LIND CONTINGENT CONSENT WARRANTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THE SECURITIES REPRESENTED HEREBY AND
THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED (THE &ldquo;U.S. SECURITIES ACT&rdquo;) OR U.S. STATE SECURITIES LAWS. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES,
AGREES FOR THE BENEFIT OF THE CORPORATION THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED, DIRECTLY
OR INDIRECTLY, ONLY (A) TO THE CORPORATION; (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH REGULATION S UNDER THE U.S. SECURITIES
ACT AND IN COMPLIANCE WITH APPLICABLE LOCAL LAWS AND REGULATIONS; (C) PURSUANT TO THE EXEMPTIONS FROM REGISTRATION UNDER THE U.S.
SECURITIES ACT PROVIDED BY (I) RULE 144 THEREUNDER, IF AVAILABLE OR (II) RULE 144A THEREUNDER, IF AVAILABLE, AND, IN BOTH CASES,
IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OF THE UNITED STATES, OR (D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION
UNDER THE U.S. SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS OF THE UNITED STATES AND, IN THE CASE OF CLAUSES (C)(I) OR
(D) ABOVE, OR IF OTHERWISE REQUIRED BY THE CORPORATION, THE SELLER HAS FURNISHED TO THE CORPORATION AN OPINION OF COUNSEL OF RECOGNIZED
STANDING IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE CORPORATION TO SUCH EFFECT. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIS WARRANT AND THE SECURITIES ISSUABLE
UPON EXERCISE HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT, OR THE SECURITIES LAWS OF ANY STATE
OF THE UNITED STATES. THIS WARRANT MAY NOT BE EXERCISED IN THE UNITED STATES OR BY OR ON BEHALF OF, OR FOR THE ACCOUNT OR BENEFIT
OF, A U.S. PERSON OR A PERSON IN THE UNITED STATES UNLESS THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED
UNDER THE U.S. SECURITIES ACT AND THE APPLICABLE SECURITIES LEGISLATION OF ANY SUCH STATE OR AN EXEMPTION FROM SUCH REGISTRATION
REQUIREMENTS IS AVAILABLE. &ldquo;UNITED STATES&rdquo; AND &ldquo;U.S. PERSON&rdquo; ARE AS DEFINED IN REGULATION S UNDER THE U.S.
SECURITIES ACT.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>THIS WARRANT CERTIFICATE IS VOID IF NOT
EXERCISED ON OR BEFORE</B><BR>
<B>5PM (NEW YORK TIME) ON SEPTEMBER 17, 2028. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THIS WARRANT IS TRANSFERABLE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANT CERTIFICATE</B><BR>
<B>NIOCORP DEVELOPMENTS LTD.</B><BR>
<B>SEPTEMBER 17, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 51%; text-align: left; text-indent: -3.25in; padding-left: 3.25in"><B>Warrant Certificate No. LW#2-2024</B></TD>
    <TD STYLE="width: 49%; text-align: left"><B>2,816,742 WARRANTS (the &ldquo;Warrants&rdquo;), each Warrant entitling the holder
    to acquire, subject to adjustment, one Common Share of NioCorp Developments Ltd.</B></TD></TR>
</TABLE>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in; text-indent: -3.25in">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THIS IS TO CERTIFY THAT, for value received,
Lind Global Asset Management III, LLC (the &ldquo;<B>Holder</B>&rdquo;) is entitled to subscribe for and purchase up to <B>2,816,742</B>
fully paid and non-assessable Common Shares (as subject to adjustment hereunder, the &ldquo;<B>Warrant Shares</B>&rdquo;) of NioCorp
Developments Ltd. (the &ldquo;<B>Corporation</B>&rdquo;) at a purchase price (the &ldquo;<B>Exercise Price</B>&rdquo;) of <B>US$2.308</B>
per Warrant Share until 5:00 (New York time) on September 17, 2028 (the &ldquo;<B>Expiry Time</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrants are exercisable at any time
and from time to time after the date of this Warrant Certificate up to the Expiry Time, in whole or in part, subject, however,
to the provisions and upon the terms and conditions hereinafter set out.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All references herein to dollar amounts
are to the lawful money of the United States of America, unless specified otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">1.</FONT></TD><TD STYLE="text-align: justify">Interpretation</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this Warrant Certificate, unless the
context otherwise requires, the following expressions have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">&ldquo;<B>Business Day</B>&rdquo; means any day of the year (i) other than a Saturday, Sunday or
a statutory holiday in New York, New York, Vancouver, British Columbia or Toronto, Ontario, and (ii) on which the Exchange is open
for business;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">&ldquo;<B>Common Shares</B>&rdquo; means common shares in the share capital of the Corporation;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">&ldquo;<B>Current Market Price</B>&rdquo; means on any given date the volume weighted average trading
price on the Exchange (or, if the Common Shares are not listed and posted for trading on the Exchange, such other stock exchange
or over-the-counter market on which the Common Shares may be listed or quoted) for the 20 Trading Days ending three Trading Days
prior to the relevant date;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">&ldquo;<B>Exchange</B>&rdquo; means The Nasdaq Stock Market LLC, or such other stock exchange on
which the Common Shares are listed or quoted;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">&ldquo;<B>Trading Day</B>&rdquo; means a day on which not less than a round lot of Common Shares
has traded on the Exchange;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">&ldquo;<B>U.S. Person</B>&rdquo; means a &ldquo;U.S. person&rdquo; as such term is defined in Rule
902(k) of Regulation S under the U.S. Securities Act;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">&ldquo;<B>U.S. Securities Act</B>&rdquo; means the United States Securities Act of 1933, as amended;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">&ldquo;<B>VWAP</B>&rdquo; means the volume weighted average trading price of the Common Shares
on the Exchange over the relevant time period; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">&ldquo;<B>Warrant Certificate</B>&rdquo; means this certificate representing the Warrants.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify">Exercise of Warrants.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Warrants may be exercised in whole or in part from time to time in the sole discretion of the
Holder by delivery to the Corporation at its principal office in Colorado of a written notice of exercise in the form attached
as Schedule A hereto prior to the Expiry Time specifying the number of Warrant Shares with respect to which the Warrants are then
being exercised and accompanied by payment in full of the purchase price for the Warrant Shares then being purchased and the original
copy of this Warrant Certificate. In the event that the Holder subscribes for and purchases less than the full number of Warrant
Shares entitled to be subscribed for and purchased under this Warrant Certificate prior to the Expiry Time, the Corporation shall
issue a new certificate to the Holder in the same form as this Warrant Certificate with appropriate changes, such certificate </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">                                                                                                                                                                                                                                                                                                                                                                                                                              <TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">to
be delivered by courier to the Holder concurrently with the delivery by courier to the Holder of the certificates representing
the Warrant Shares acquired on exercise.</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Upon due exercise of the Warrants by the Holder, the Warrant Shares so subscribed for shall be
deemed to have been issued as fully paid and non-assessable shares and the person to whom such Warrant Shares are to be issued
shall be deemed to have become the holder of record of such Warrant Shares on the date of exercise unless the transfer books of
the Corporation shall be closed on such date, in which case the Warrant Shares so subscribed for shall be deemed to have been issued
and such person shall be deemed to have become the holder of record of such Warrant Shares on the date on which such transfer books
were reopened and such Warrant Shares shall be issued at the Exercise Price in effect on the date of exercise.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Notwithstanding the partial exercise of the Warrants by the Holder, the Warrants may be exercised
at any time (and from time to time) prior to the Expiry Time for all or any part of the Warrant Shares which, prior to such time,
have not been issued to the Holder. The Holder will be deemed to have represented and warranted its compliance with the re-sale
and transfer restrictions set forth in Section 19(b) below upon the exercise of any Warrants in the United States or to, or for
the account or benefit of, any U.S. Person.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">When the transfer books of the Corporation have been opened for three (3) Business Days after the
due exercise or partial exercise of the Warrants, the Corporation shall use its reasonable best efforts to cause a certificate
evidencing the number of Warrant Shares so subscribed for to be delivered by courier to the person in whose name such Warrant Shares
are to be issued (as specified in the notice of exercise) at the address specified in the notice of exercise, within five (5) Business
Days thereafter or shall cause the Warrant Shares to be entered into a direct registration or other electronic book-entry system
if no certificates are issued, provided that, if no certificates are issued, such Warrant Shares may be issued with a restricted
CUSIP.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">The Warrants and the Warrant Shares have not been registered under the U.S. Securities Act. The
Warrants may not be exercised within the United States or by or on behalf of a U.S. Person unless registered or exempt from the
registration requirements thereunder.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">Subject to the terms hereof, this Warrant Certificate may be transferred, subject to the terms
set forth in the Transfer Form attached hereto. No transfer of this Warrant Certificate shall be effective unless this Warrant
Certificate is accompanied by a duly executed Transfer Form or other instrument of transfer in such form as the Corporation may
from time to time prescribe, together with such evidence of the genuineness of each endorsement, execution and authorization and
of other matters as may be required by the Corporation, and delivered to the Corporation. No transfer of this Warrant Certificate
shall be made if, in the opinion of counsel to the Corporation, such transfer would result in the violation of any applicable securities
laws. Subject to the foregoing, the Corporation shall issue and mail, as soon as practicable, and in any event within five (5)
Business Days of the receipt by the Corporation of this Warrant Certificate and the Transfer Form, a new Warrant Certificate (with
or without legends as determined by the Corporation) registered in the name of the transferee or as the transferee may direct and
shall take all other necessary actions to effect the transfer as directed.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">3.</FONT></TD><TD STYLE="text-align: justify">Rights of Holder Before Exercise of Warrants</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Holder shall not have any rights whatsoever
as a shareholder in respect of the Warrant Shares until the Warrants are exercised, in whole or in part, and payment for the Warrant
Shares thereby purchased has been made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">4.</FONT></TD><TD STYLE="text-align: justify">Adjustments to Number or Kind of Securities Issuable on Exercise</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">If, at any time prior to the Expiry Time, there occurs:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">a reclassification or redesignation of the Common Shares or any other capital reorganization other
than a Common Share Reorganization (as defined below); or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">a consolidation, merger or amalgamation of the Corporation with or into any other corporation or
entity or an arrangement with any other corporation or entity which results in the cancellation, reclassification or redesignation
of the Common Shares or a change or conversion of the Common Shares into other shares or securities or the holders of the Common
Shares becoming entitled to receive shares or other securities of the other corporation or entity, or the transfer of all or substantially
all of the assets of the Corporation to another corporation or entity or the Corporation being controlled (within the meaning of
the Income Tax Act (Canada)) by another corporation or entity;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(any such event being herein
called a &ldquo;<B>Capital Reorganization</B>&rdquo;), then, immediately upon the effective time of such Capital Reorganization
and at all times thereafter, a Holder who exercises its right to subscribe for Warrant Shares shall be entitled to be issued and
receive and shall accept for the same aggregate consideration, upon such exercise, in lieu of the number of Warrant Shares to which
it was theretofore entitled upon exercise of the Warrants, the kind and aggregate number of shares or other securities or property
of the Corporation or of the corporation or other entity resulting from such Capital Reorganization or any other corporation that
the Holder would have been entitled to be issued and receive upon such Capital Reorganization if, immediately prior to the effective
time thereof, it had been the registered holder of the number of Warrant Shares to which it was theretofore entitled upon exercise
of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">If necessary as a result of any Capital Reorganization, appropriate adjustments shall be made in
the application of the provisions of this section with respect to the rights and interest thereafter of the Holder to the end that
the provisions set forth in this section shall thereafter correspondingly be made applicable as nearly as may reasonably be practicable
in relation to any shares or other securities or property thereafter issuable and deliverable upon the exercise of the Warrants.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">If at any time after the date hereof and prior to the Expiry Time any adjustment or readjustment
in the Exercise Price shall occur pursuant to the provisions of subsection 5(a), then the number of Warrant Shares issuable upon
the subsequent exercise of the Warrants shall be simultaneously adjusted or readjusted, as the case may be, by multiplying the
number of Warrant Shares issuable upon the exercise of the Warrants immediately prior to such adjustment or readjustment by a fraction
which shall be the reciprocal of the fraction employed in the adjustment or readjustment of the Exercise Price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">5.</FONT></TD><TD STYLE="text-align: justify">Adjustment of Exercise Price</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">If, at any time prior to the Expiry Time, the Corporation shall:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">subdivide the outstanding Common Shares into a greater number of shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">consolidate the outstanding Common Shares into a lesser number of shares; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">make a distribution (other than a distribution referred to in subsections 4(b) or 4(c) of this
Warrant Certificate) to the holders of all or substantially all of the Common Shares payable in Common Shares or securities exchangeable
for or convertible into Common Shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(any such event being herein
called a &ldquo;<B>Common Share Reorganization</B>&rdquo;), then the Exercise Price shall be adjusted, effective immediately after
the effective date or record date at which holders of Common Shares are determined for the purposes of the Common Share Reorganization,
by multiplying the Exercise Price in effect immediately prior to such effective date or record date by a fraction of which:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">A.</TD><TD STYLE="text-align: justify">the numerator shall be the number of Common Shares outstanding on such effective date or record
date before giving effect to such Common Share Reorganization; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">B.</TD><TD STYLE="text-align: justify">the denominator shall be the number of Common Shares outstanding immediately after giving effect
to such Common Shares Reorganization, including, without limitation, in the case of a distribution of securities exchangeable for
or convertible into Common Shares, the number of Common Shares </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
                                                           <TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify">that would have been outstanding if such securities had been exchanged
for or converted into Common Shares on such date.</TD></TR>
</TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">To the extent that any adjustment
in the Exercise Price occurs pursuant to this subsection (a) as a result of the fixing by the Corporation of a record date for
the distribution of securities exchangeable for or convertible into Common Shares, the Exercise Price shall be readjusted immediately
after the expiration of any relevant exchange or conversion right to the Exercise Price which would then be in effect based upon
the number of Common Shares actually issued and remaining issuable pursuant to such exchangeable or convertible securities after
such expiration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">If, at any time prior to the Expiry Time, the Corporation shall fix a record date for the issue
to the holders of all or substantially all of the Common Shares of rights, options or warrants under which such holders are entitled,
during a period expiring not more than 45 days after the record date for such issue (which period is herein called the &ldquo;<B>Rights
Period</B>&rdquo;), to subscribe for or purchase Common Shares or securities exchangeable for or convertible into Common Shares
at a price per share to the holder (or, in the case of securities exchangeable for or convertible into Common Shares, at an exchange
or conversion price per share) of less than 95% of the Current Market Price of the Common Shares on such record date (any such
event being herein called a &ldquo;<B>Rights Offering</B>&rdquo;), the Exercise Price shall be adjusted, effective immediately
after the record date, to a price determined by multiplying the Exercise Price in effect on such date by a fraction of which:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the numerator shall be the aggregate of:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">the number of Common Shares outstanding on the record date for the Rights Offering; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">the number determined by dividing:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(I)</TD><TD STYLE="text-align: justify">either</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">(x)</TD><TD STYLE="text-align: justify">the product of the number of Common Shares offered for issue during the Rights Period upon exercise
of the rights, warrants or options under the Rights Offering and the price at which such Common Shares are offered; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">(y)</TD><TD STYLE="text-align: justify">the product of the exchange or conversion price of the securities so offered and the number of
Common Shares for or into which the securities so offered pursuant to the Rights Offering are exchangeable or convertible;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">as the case may be, by;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(II)</TD><TD STYLE="text-align: justify">the Current Market Price of the Common Shares as of the record date for the Rights Offering; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the denominator shall be the aggregate of the number of Common Shares outstanding on such record
date and the number of Common Shares offered pursuant to such Rights Offering (or the number of Common Shares into which the securities
so offered may be exchanged or converted).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If by the terms of the rights, options
or warrants referred to in this subsection (b), there is more than one purchase, conversion or exchange price per Common Share,
the aggregate price of the total number of additional Common Shares offered for subscription or purchase, or the aggregate conversion
or exchange price of the convertible securities so offered, shall be calculated for purposes of the adjustment on the basis of
the lowest purchase, conversion or exchange price per Common Share, as the case may be. Any Common Shares owned by or held for
the account of the Corporation or any subsidiary of the Corporation shall be deemed not to be outstanding for the purpose of any
such computation. To the extent that any adjustment in the Exercise Price occurs pursuant to this subsection (b) as a result </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">of
the fixing by the Corporation of a record date or the distribution of rights, options or warrants referred to in this subsection
(b), the Exercise Price shall be readjusted immediately after the expiration of any relevant exchange, conversion or exercise right
to the Exercise Price which would then be in effect based upon the number of Common Shares actually issued and remaining issuable
after such expiration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">If, at any time prior to the Expiry Time, the Corporation shall issue or distribute to the holders
of all or substantially all of the Common Shares:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Common Shares or other securities of the Corporation including, without limitation, rights, options
or warrants to acquire Common Shares or securities exchangeable for or convertible into Common Shares or any property or asset
of the Corporation, (other than rights, options or warrants pursuant to which holders of Common Shares are entitled, during a period
expiring not more than 45 days after the record date for such issue, to subscribe for or purchase Common Shares at a price per
share (or in the case of securities exchangeable for or convertible into Common Shares at an exchange or conversion price per share
at the date of issue of such securities) of at least 95% of the Current Market Price of the Common Shares on such record date),
and including, without limitation, evidences of indebtedness, or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">any property or other assets including, without limitation, cash;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">and such issuance or distribution
does not constitute a Rights Offering or a Common Share Reorganization (any such issuance or distribution being herein called a
&ldquo;<B>Special Distribution</B>&rdquo;), then the Exercise Price shall be adjusted, effective immediately after the record date
at which the holders of Common Shares are determined for purposes of the Special Distribution, to a price determined by multiplying
the Exercise Price in effect on the record date of the Special Distribution by a fraction of which:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">the numerator shall be the difference between:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(I)</TD><TD STYLE="text-align: justify">the product of the number of Common Shares outstanding on the record date and the Current Market
Price of the Common Shares on the record date; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(II)</TD><TD STYLE="text-align: justify">the fair market value to the holders of Common Shares, as determined by the board of directors
of the Corporation acting reasonably, of the securities, rights, options, warrants, evidences of indebtedness or other assets issued
or distributed in the Special Distribution; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">the denominator shall be the product of the number of Common Shares outstanding on the record date
and the Current Market Price of the Common Shares on the record date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Any Common Shares owned by or
held for the account of the Corporation or any subsidiary shall be deemed not to be outstanding for the purpose of such computation.
To the extent that any adjustment in the Exercise Price occurs pursuant to this subsection (c) as a result of the fixing by the
Corporation of a record date for the distribution of exchangeable or convertible securities or rights, options or warrants referred
to in this subsection (c), the Exercise Price shall be readjusted immediately after the expiration of any relevant exchange, conversion
or exercise right to the Exercise Price which would then be in effect if the fair market value had been determined on the basis
of the number of Common Shares issued and remaining issuable pursuant to such exchangeable or convertible securities immediately
after such expiration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">6.</FONT></TD><TD STYLE="text-align: justify">Adjustment Rules</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Subject to the other provisions of this section 6, any adjustment made pursuant to sections 4 or
5 are cumulative and shall be made successively whenever any event referred to in either of such sections shall occur.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">In any case where an adjustment shall become effective immediately after a record date for an event
referred to herein, the Corporation may defer, until the occurrence of such event:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">issuing to the Holder, by reason of the adjustment required by such event, the additional Warrant
Shares issuable upon exercise of the Warrants after such record date and before the occurrence of such event; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">delivering to the Holder any distributions declared with respect to such additional Warrant Shares
after the exercise of the Warrants and before such event;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">provided, however, that the Corporation
shall deliver to the Holder an appropriate instrument evidencing the Holder&rsquo;s right, upon the occurrence of the event requiring
the adjustment, to an adjustment in the Exercise Price or the number of Warrant Shares issuable upon exercise of the Warrants and
to such distributions declared with respect to any such additional Warrant Shares issuable on the exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">No adjustment in the Exercise Price shall be required unless the adjustment would result in a change
of at least 1% in the Exercise Price then in effect and no adjustment shall be made in the number of Warrant Shares issuable on
the exercise of the Warrants unless it would result in a change of at least one one-hundredth of a Warrant Share, provided, however,
that any adjustments which, except for the provisions of this subsection (c) would otherwise have been required to be made, shall
be carried forward and taken into account in any subsequent adjustment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">No adjustment in the Exercise Price or in the number or kind of securities issuable on exercise
of the Warrants shall be made in respect of any event described in sections 4 or 5 if the Holder is entitled to participate in
such event on the same terms mutatis mutandis as if the Holder had exercised the Warrants prior to or on the effective date or
record date, as the case may be, of such event.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">If the Corporation shall set a record date to determine shareholders for the purpose of entitling
them to receive any dividend or distribution or any subscription or purchase rights and shall, thereafter and before the distribution
to such shareholders of any such dividend, distribution or subscription or purchase rights, legally abandon its plan to pay or
deliver such dividend, distribution or subscription or purchase rights, no adjustment in the Exercise Price or the number of Warrant
Shares issuable upon exercise of these Warrants shall be required by reason of the setting of such record date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">In the absence of a resolution of the directors of the Corporation fixing a record date for a stock
dividend or other distribution comprising a Common Share Reorganization, a Rights Offering or a Special Distribution, the Corporation
shall be deemed to have fixed as the record date therefor the effective date of such event.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">The Corporation will not, whether pursuant to an adjustment under sections 4 and 5 or any other
circumstances, be obligated to issue any fraction of a Warrant Share on any exercise or partial exercise of the Warrants. If any
fractional interest in a Warrant Share would, except for the provisions of this section 5(g), be issuable upon the exercise or
partial exercise of the Warrants, the number of Warrant Shares issuable shall be rounded down to the nearest whole number.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">In the event of any question arising with respect to the adjustments provided for in sections 4
or 5, such question shall conclusively be determined by a firm of reputable chartered accountants appointed by the Corporation,
which accountants may be the Corporation&rsquo;s auditors. Such accountants shall have access to all necessary records of the Corporation
and such determination shall be binding upon the Corporation and the Holder.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">7.</FONT></TD><TD STYLE="text-align: justify">Proceedings Prior to Action Requiring Adjustment</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">As a condition precedent to the taking of any action that would require an adjustment pursuant
to sections 4 or 5, the Corporation shall take or cause to be taken all such action as, in the opinion of counsel of the </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">                                                                                                                                                                                                                                                                                                                                                                                                                              <TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">Corporation,
may be necessary in order that the Holder shall be entitled to receive, upon exercise of the Warrants, the shares or other securities
or property provided for under the provisions hereof.</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Adjustments to the Exercise Price or the number of Warrant Shares purchasable pursuant to this
Warrant Certificate may be subject to the prior approval of the Exchange.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">8.</FONT></TD><TD STYLE="text-align: justify">Notice</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At least twenty-one days prior to any record
date or effective date, as the case may be, for any event which requires or might require an adjustment in any of the rights of
the Holder under this Warrant Certificate, including the Exercise Price and the number of Warrant Shares that are purchasable under
this Warrant Certificate, the Corporation will deliver to the Holder, at the Holder&rsquo;s registered address, a certificate of
the Corporation specifying the particulars of such event and, if determinable, the required adjustment and the calculation of such
adjustment. In case any adjustment has been given that is not then determinable, the Corporation will promptly after such adjustment
is determinable deliver to the Holder, at the Holder&rsquo;s registered address, a certificate providing the calculation of such
adjustment. The Corporation hereby covenants and agrees that the register of transfers and share transfer books for the Warrant
Shares will be open, and that the Corporation will not take any action that might deprive the Holder of the opportunity of exercising
the rights of subscription contained in this Warrant Certificate, during such twenty-one day period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">9.</FONT></TD><TD STYLE="text-align: justify">Replacement</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon receipt of evidence satisfactory to
the Corporation of the loss, theft, destruction or mutilation of this Warrant Certificate and, if requested by the Corporation,
upon delivery of a bond of indemnity satisfactory to the Corporation (or, in the case of mutilation, upon surrender of this Warrant
Certificate), the Corporation will issue to the Holder a replacement certificate (containing the same terms and conditions as this
Warrant Certificate).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">10.</FONT></TD><TD STYLE="text-align: justify">Covenants</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation covenants with the Holder
that so long as any obligations of the Corporation under this Warrant Certificate remain outstanding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">it will use its reasonable best efforts to at all times maintain its existence; will carry on and
conduct its business in a prudent manner in accordance with industry standards and good business practice, and will keep or cause
to be kept proper books of account in accordance with generally accepted accounting practice, subject to the completion of a Capital
Reorganization in accordance with subsection 10(g) below;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">it will cause the certificates evidencing the Warrant Shares, from time to time, subscribed and
paid for, upon the exercise of the Warrants, to be duly issued and delivered in accordance with the conditions hereof or cause
such Warrant Shares to be entered into a direct registration or other electronic book-entry system if no certificates are issued,
provided that, if no certificates are issued, such Warrant Shares may be issued with a restricted CUSIP;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">all Warrant Shares which shall be issued upon exercise of the Warrants and payment of the Exercise
Price shall be fully paid and non-assessable shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">it will reserve and keep available a sufficient number of Warrant Shares for the purpose of enabling
it to satisfy its obligation to issue Warrant Shares upon the exercise of the Warrants;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">it will maintain the listing of the Common Shares on the Exchange and the status of the Corporation
as a reporting issuer not in default and otherwise remain in full compliance with the periodic reporting and other substantive
requirements under the securities legislation of each of the provinces of British Columbia, Alberta, Saskatchewan, Ontario and
New Brunswick until the Expiry Time unless the Corporation shall become merged into, or amalgamated with, or otherwise acquired
by, another issuer and the shareholders of the Corporation shall receive cash from or publicly traded shares of such other issuer;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">except as required by law, it will not close its transfer books or take any other action which
might deprive the Holder of the opportunity of exercising its right to subscribe for Warrant Shares pursuant to the Warrant during
the period of twenty-one days after the giving of a notice required by section 8 or unduly restrict such opportunity;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">it shall not complete or facilitate a Capital Reorganization if the effect of such Capital Reorganization
is that:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">all or substantially all of its assets become the property of, or are under the control of, or
it is controlled (within the meaning of the Income Tax Act (Canada)) by, any other person (an &ldquo;<B>Acquiring Person</B>&rdquo;);
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">holders of Common Shares receive any other security in replacement of, or in addition to, their
Common Shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">unless, at or prior to or contemporaneously
with the effective time of such Capital Reorganization, the Corporation and the Acquiring Person shall have executed such instruments
and done such things as the Corporation, acting reasonably, considers necessary or advisable to establish that upon the consummation
of such transaction:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">the Acquiring Person will have assumed all the covenants and obligations of the Corporation under
this Warrant Certificate, and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">the Warrant and the terms set forth in this Warrant Certificate will be a valid and binding obligation
of the Acquiring Person entitling the Holder, as against the Acquiring Person, to all the rights of the Holder under this Warrant
Certificate.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Acquiring Person shall possess,
and from time to time may exercise, each and every right and power of the Corporation under this Warrant in the name of the Corporation
or otherwise and any act or proceeding by any provision hereof required to be done or performed by any director or officer of the
Corporation may be done and performed with like force and effect by the like directors or officers of the Acquiring Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">generally it will well and truly perform and carry out all of the acts or things to be done by
it as provided by this Warrant Certificate.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">11.</FONT></TD><TD STYLE="text-align: justify">Representations and Warranties</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation represents and warrants
to the Holder that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">it has obtained all required corporate authorization for creation and issue of the Warrants and
the performance of its obligations in connection with the Warrants and has provided for the issuance, subject only to receipt by
the Corporation of the Exercise Price, of the Warrant Shares which Warrant Shares, when issued, will be issued as fully paid and
non-assessable shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">it has obtained all regulatory approvals (including, without limitation, the approvals of the Exchange)
necessary or desirable for the issuance of the Warrants, the Warrant Shares to the Holder and the Warrant Shares, when issued,
will be listed and posted for trading on the Exchange;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">it is a &ldquo;reporting issuer&rdquo; not in default under the applicable securities legislation
of the provinces of British Columbia, Alberta, Saskatchewan, Ontario and New Brunswick;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">the execution, delivery and performance by the Corporation of this Warrant Certificate will not
violate any provision of the constating documents of the Corporation or any material contract to which the Corporation is a party
or by which the Corporation is bound, nor will it create an event of default thereunder; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">this Warrant Certificate is a valid and enforceable obligation of the Corporation, enforceable
in accordance with the provisions of this Warrant Certificate.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">12.</FONT></TD><TD STYLE="text-align: justify">Time of the Essence</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time shall be of the essence of this Warrant
Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">13.</FONT></TD><TD STYLE="text-align: justify">Governing Law</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Warrant Certificate shall be governed
by and construed in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein.
The Holder irrevocably attorn to the exclusive jurisdiction of the courts of the Province of British Columbia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">14.</FONT></TD><TD STYLE="text-align: justify">Headings</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The division of this Warrant Certificate
into sections and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation
of this Warrant Certificate. The section headings in this Warrant Certificate are not intended to be full or accurate descriptions
of the text to which they refer and shall not be considered part of this Warrant Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">15.</FONT></TD><TD STYLE="text-align: justify">Number and Gender</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this Warrant Certificate, words (including,
without limitation, defined terms) in the singular include the plural and vice-versa and words in one gender include all genders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">16.</FONT></TD><TD STYLE="text-align: justify">Invalidity</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any provision of this Warrant Certificate
is determined to be invalid or unenforceable by a court of competent jurisdiction from which no further appeal lies or is taken,
that provision shall be deemed to be severed herefrom, and the remaining provisions of this Warrant Certificate shall not be affected
thereby and shall remain valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">17.</FONT></TD><TD STYLE="text-align: justify">Amendment</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Warrant Certificate may only be amended,
supplemented or otherwise modified by a written agreement signed by the Corporation and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">18.</FONT></TD><TD STYLE="text-align: justify">Further Assurances</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation shall do such acts and
shall execute such documents and will cause the doing of acts and will cause the execution of such further documents as are within
its power in order to give full effect to the provisions of this Warrant Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">19.</FONT></TD><TD STYLE="text-align: justify">Hold Periods, Legends and Re-sale Restrictions</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Holder understands and acknowledges
that, until such time as the Warrant Shares are no longer restricted securities pursuant to Rule 144(a)(3) under the U.S. Securities
Act, the Warrant Shares may not be offered or sold or otherwise transferred, directly or indirectly, in the United States or to,
or for the account or benefit of a U.S. Person, and it will not deposit any of the Warrant Shares with Cede &amp; Co. or any successor
thereto, nor will it transfer or sell any Warrant Shares over the facilities of the Exchange and it will also cause any nominee
holding the Warrant Shares on its behalf to comply with the foregoing re-sale and transfer restrictions. In addition, if the Warrants
are exercised in the United States or by or on behalf of a U.S. Person, the Holder exercising such Warrants will be deemed to have
represented to the Corporation that the Holder has implemented appropriate internal controls and procedures to ensure that the
Warrant Shares shall be properly identified in its records as restricted securities under the U.S. Securities Act that are subject
to the re-sale and transfer restrictions set forth herein notwithstanding the absence of a U.S. restrictive </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">legend or a definitive
physical certificate, as contemplated by the parties and in reliance on the foregoing representation of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">20.</FONT></TD><TD STYLE="text-align: justify">Successors and Assignment</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to compliance with all applicable
securities legislation and the approval of the Exchange (if required in the circumstances), this Warrant Certificate and the rights
evidenced by this Warrant Certificate may be transferred or assigned at the discretion of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Warrant Certificate shall enure to
the benefit of and be binding upon the Corporation, the Holder and their successors. Reference in this Warrant Certificate to a
&ldquo;successor&rdquo; of any body corporate shall be construed so as to include, but not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">any amalgamated or other corporation of which such body corporate or any of its successors is one
of the amalgamating or merging corporations;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">any corporation resulting from any court approved arrangement of which such body corporate or any
of its successors is a party;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">any corporation resulting from the continuance of such body corporate or any successor of it under
the laws of another jurisdiction of incorporation; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">any successor (determined as aforesaid or in any similar or comparable procedure under the laws
of any other jurisdiction) of any corporation referred to in clause (a), (b) or (c).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[INTENTIONALLY LEFT BLANK]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF the Corporation has
caused this Warrant Certificate to be executed by its duly authorized officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NIOCORP DEVELOPMENTS LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%">Per:</TD><TD STYLE="width: 46%; border-bottom: Black 1pt solid">/s/ Neal S. Shah</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>                                                                        <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>Neal S. Shah</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>Chief Financial Officer</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE &ldquo;A&rdquo;<BR>
<BR>
WARRANT EXERCISE FORM</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO:&nbsp;NIOCORP DEVELOPMENTS LTD. (the &ldquo;<B>Corporation</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the provisions of a
warrant certificate dated September 17, 2024 between the undersigned and the Corporation (the &ldquo;Warrant Certificate&rdquo;),
the undersigned hereby exercises the Warrants, as indicated below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 33%; text-align: justify"># of Warrant Shares Purchased</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 33%; text-align: justify">Exercise Price/Share</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: justify">Total Price</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">$</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">$</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalized terms used but not otherwise
defined herein have the meanings given to such terms in the Warrant Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the exercise of the
Warrant Certificate, the undersigned represents as follows: (Please check the <B><U>ONE</U></B> box applicable):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned hereby certifies
that (i) at the time of exercise, it is not a U.S. Person and did not execute this Warrant Exercise Form while within the United
States; (ii) it is not exercising any of the Warrants represented by the Warrant Certificate by or on behalf of any U.S. Person
or any person who is within the United States; (iii) no &ldquo;directed selling efforts&rdquo; (as defined in Regulation S under
the United States Securities Act of 1933, as amended (the &ldquo;U.S. Securities Act&rdquo;)) have been engaged in by the undersigned
or on the undersigned&rsquo;s behalf; and (iv) has in all other respects complied with the terms of an Off-Shore Transaction in
compliance with Regulation S under the U.S. Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned holder (i) acquired
the Warrants as a part of a private placement offering in the United States; (ii) is exercising the Warrants solely for its own
account or for the benefit of a U.S. Person or a person in the United States for whose account such holder acquired the Warrants
in the private placement offering and for whose account such holders exercises sole investment discretion; (iii) was and is, and
any beneficial purchaser for whose account such holder acquired the Warrant and is exercising the Warrants was and is, an &ldquo;accredited
investor&rdquo; within the meaning of Rule 501(a) of Regulation D under the U.S. Securities Act both on the date the Warrants
were purchased and on the date hereof; and (iv) the representations and warranties made by the holder or any beneficial purchaser,
as the case may be, to the Corporation in connection with the acquisition of the Warrants pursuant to the private placement remain
true and correct on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned is delivering
a written opinion of U.S. counsel to the effect that the Warrant Shares to be delivered upon exercise hereof have been registered
under the U.S. Securities Act or are exempt from registration thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Notes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Warrant
Shares will not be registered or delivered to an address in the United States unless Box 2 or 3 above is checked and the undersigned,
upon exercise, will be deemed to have represented and warranted that it will comply with the re-sale and transfer restrictions
set forth in Section 19(b) of the Warrant Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
Box 3 above is checked, holders are encouraged to consult with the Corporation in advance to determine that the legal opinion tendered
in connection with the exercise will be satisfactory in form and substance to the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
terms &ldquo;United States&rdquo;, &ldquo;U.S. Person&rdquo; and &ldquo;Off-Shore Transaction&rdquo; have the meaning ascribed
thereto pursuant to Regulation S under the U.S. Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To pay for that portion of the Warrants
being exercised, the undersigned encloses a certified cheque or bank draft in United States currency made payable to the Corporation
in the amount of $_______.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby directs that the
Warrant Shares be issued as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center">NAME(S) IN FULL</TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center">ADDRESS(ES)</TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center">NUMBER OF <BR>
WARRANT SHARES</TD></TR>
<TR STYLE="vertical-align: top; background-color: #C6D9F1">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #C6D9F1">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The certificate(s) issued representing
the Warrant Shares or related entry into a direct registration or other electronic book-entry system to which the undersigned is
entitled following this exercise is to be in the name indicated below and, if issued, certificate(s) are to be forwarded to the
undersigned at the address set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 7%">Name:</TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Address:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the Warrant Exercise Form indicates
that Warrant Shares are to be issued to a person or persons other than the registered holder of the Warrant Certificate, the signature
on this Warrant Exercise Form must be guaranteed by a Canadian chartered bank, or eligible guarantor institution with membership
in an approved signature guarantee medallion program. The guarantor must affix a stamp bearing the actual words &ldquo;Signature
Guaranteed&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated this __________________________ day
of _________________, 20___</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; text-decoration: none">
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-decoration: none; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="width: 48%; text-decoration: none; text-align: justify">Medallion Signature Guarantee Stamp of Holder</TD><TD STYLE="width: 4%; text-decoration: none">&nbsp;</TD>
    <TD STYLE="width: 48%; text-decoration: none; text-align: justify">Signature of Holder</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-decoration: none; text-align: justify">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-decoration: none; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-decoration: none; text-align: justify">Witness</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">Signature of Holder</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-decoration: none; text-align: justify">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-decoration: none; text-align: justify">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">Name of Holder</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">Name of Authorized Representative</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">Address of Holder</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>TRANSFER FORM</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the undersigned (the
&ldquo;<B>Transferor</B>&rdquo;) hereby sells, assigns and transfers unto ________________________________, (the &ldquo;<B>Transferee</B>&rdquo;)
(include name and address of the transferee) ____________________ (number of Warrants) Warrants exercisable for common shares of
NioCorp Developments Ltd. (the &ldquo;<B>Corporation</B>&rdquo;) registered in the name of the undersigned on the register of the
Corporation maintained therefor, and hereby irrevocably appoints the Corporate Secretary of the Corporation as the attorney of
the undersigned to transfer the said securities on the books maintained by the Corporation with full power of substitution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalized terms not defined herein have
the meaning set out in the attached Warrant Certificate dated September 17, 2024 (the &ldquo;Warrant Certificate&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DATED this _______ day of ___________________,
20___.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; text-decoration: none">
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-decoration: none; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="width: 48%; text-decoration: none; text-align: justify">Medallion Signature Guarantee Stamp of Holder</TD><TD STYLE="width: 4%; text-decoration: none">&nbsp;</TD>
    <TD STYLE="width: 48%; text-decoration: none; text-align: justify">Signature of Transferor</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-decoration: none; text-align: justify">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-decoration: none; text-align: justify">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">Name of Transferor</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">Name of Authorized Representative</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD STYLE="text-align: justify; text-decoration: none">&nbsp;</TD><TD STYLE="text-decoration: none">&nbsp;</TD>
    <TD STYLE="text-decoration: none; text-align: justify">Address of Holder</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THE UNDERSIGNED HERBY CERTIFIES AND
DECLARES</B> that the Warrants are not being offered, sold, pledged or transferred to, or for the account or benefit of, a &ldquo;U.S.
person&rdquo; (as defined in Regulation S under the United States Securities Act of 1933, as amended (the &ldquo;<B>U.S. Securities
Act</B>&rdquo;)) or a person within the United States unless registered under the U.S. Securities Act and any applicable state
securities laws or unless an exemption from such registration requirements is available, and an opinion of counsel confirming same,
in form and substance acceptable to the Corporation and its counsel, or such other evidence as the Corporation may require, has
been delivered to the Corporation. The undersigned Transferor understands and agrees that it shall bear all costs associated with
(i) obtaining any legal opinion tendered to the Corporation and (ii) the issuance of any new Warrant Certificate and any applicable
transfer fees thereto, in connection with the transfer of Warrants in the United States or to, or for the account or benefit of,
U.S. Persons (as such term is defined in Regulation S under the U.S. Securities Act) pursuant to an exemption from the registration
requirements of the U.S. Securities Act and is encouraged to consult with the Corporation in advance to determine that the legal
opinion tendered in connection with such transfer will be satisfactory in form and substance to the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">It is understood that the Corporation may require additional
evidence necessary to verify the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DATED this _______ day of ___________________, 20___.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 48%">Witness</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 48%">Signature of Transferee</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Name of Transferee</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Name of Authorized Representative</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Address of Transferee</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note:<BR>
The signature of the Transferor must correspond with the name written upon the face of this Warrant Certificate in every particular
without any changes whatsoever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.29
<SEQUENCE>3
<FILENAME>n2574_x219ex4-29.htm
<DESCRIPTION>CONSENT AND WAIVER, DATED AS OF SEPTEMBER 4, 2024, BETWEEN NIOCORP DEVELOPMENTS LTD. AND YA II PN, LTD.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 4.29</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>CONSENT AND WAIVER</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>THIS CONSENT AND
WAIVER </B>(this &ldquo;<U>Consent and Waiver</U>&rdquo;), dated as of September 4, 2024 to the Note (as defined below) is between
<B>NIOCORP DEVELOPMENTS LTD.</B>, a company organized under the laws of the Province of British Columbia, Canada, with principal
executive offices located at 7000 South Yosemite Street, Suite 115, Centennial, Colorado 80112 (the &ldquo;<U>Company</U>&rdquo;),
and <B>YA II PN, LTD.</B>, a Cayman Islands exempt limited partnership (the &ldquo;<U>Holder</U>&rdquo;). Capitalized terms used
herein and not otherwise defined have the meanings set forth for such terms in the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, reference
is made to that certain Unsecured Convertible Note, dated as of April 12, 2024 (the &ldquo;<U>Note</U>&rdquo;), between the Company
and the Holder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the
Note was originally issued pursuant to the Securities Purchase Agreement, dated April 11, 2024, between the Company, the Holder
and Lind Global Fund II LP;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, pursuant
to Section (1)(c) of the Note, any Payment Date and the amount payable to the Holder on any such Payment Date may be modified from
time to time upon the mutual written consent of the Company and the Holder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, pursuant
to the terms of the Note (as unmodified), the Company is obligated to make payment of $1,285,200 (the &ldquo;<U>September Payment
Amount</U>&rdquo;) in respect of the Payment Date on September 1, 2024 (the &ldquo;<U>September Payment Date</U>&rdquo;) because
the Equity Conditions have not been satisfied as of the last Trading Date prior to the September Payment Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the
Company and the Holder desire to modify the Company&rsquo;s payment obligation with respect of the September Payment Date by decreasing
the amount payable on the September Payment Date and deferring the due date of the remainder of the September Payment Amount until
December 1, 2024 (the &ldquo;<U>December Payment Date</U>&rdquo;) as set forth herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the
Company and the Holder desire to modify the maximum Offset Amount in respect of the December Payment Date as set forth herein;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the
Holder desires to prospectively waive any term in the Note that would otherwise be triggered upon a failure to pay to the Holder
the full September Payment Amount on the September Payment Date, including, but not limited to, (i) the occurrence of an Event
of Default under Section (2)(a)(i) of the Note (the &ldquo;<U>Event of Default Provision</U>&rdquo;), (ii) an increase to the Interest
Rate pursuant to Section (1)(b) of the Note (the &ldquo;<U>Interest Rate Provision</U>&rdquo;) and (iii) the Holder&rsquo;s right
to accelerate, at the Holder&rsquo;s election, all amounts owing in respect of the Note pursuant to Section (2)(b) of the Note
(the &ldquo;<U>Acceleration Provision</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>,
in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Company and the Holder hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Pursuant to Section (1)(c) of the Note, the Company and the Holder hereby consent to the modification of Company&rsquo;s
payment obligation in respect of the September Payment Date as follows: (i) the amount payable on the September Payment Date is
$285,200; and (ii) the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">remainder of the
September Payment Amount, equal to $1,000,000, will be due and payable on December 1, 2024, which will be due and payable on such
date in addition to any payment of Amortization Principal Amount, plus the Payment Premium in respect of such Amortization Principal
Amount, plus accrued and unpaid Interest under the Note, if any, as of the Payment Date on December 1, 2024, that the Company
may be obligated to make in respect of such Payment Date on December 1, 2024 pursuant to the terms of the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company and the Holder hereby consent that in respect of the December Payment Date the Offset Amount shall not exceed
$2,512,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Holder hereby prospectively waives any term in the Note that would otherwise be triggered upon a failure to pay to the
Holder the remainder of the September Payment Amount, equal to $1,000,000, on the September Payment Date, including, but not limited
to, (i) the Event of Default Provision, (ii) the Interest Rate Provision and (iii) the Acceleration Provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as described in Sections 1, 2 and 3 of this Consent and Waiver, the terms of the Note attached hereto as <U>Exhibit
A</U> are unchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This Consent and Waiver may be executed in two or more counterparts, each of which shall for all purposes be deemed to be
an original and all of which shall constitute the same document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0"><I>[remainder
of page intentionally left blank]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Holder and the Company have caused their respective signature page to this Consent and Waiver to be duly executed as of the
date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in"><B>COMPANY:</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in"><B>NIOCORP DEVELOPMENTS LTD.</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%; padding-bottom: 1pt; text-indent: 0in">By:</TD>
    <TD STYLE="width: 45%; text-align: left; padding-bottom: 1pt; border-bottom: Black 1pt solid">/s/ Mark A Smith</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Name:</TD>
    <TD STYLE="text-align: left">Mark A Smith</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Title:</TD>
    <TD STYLE="text-align: left">NioCorp President &amp; CEO</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page to Consent and Waiver
to the Unsecured Convertible Note]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>HOLDER:</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 40%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: left"><B>YA II PN, LTD.</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>By:</TD><TD COLSPAN="2">Yorkville Advisors Global, LP</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Its:</TD><TD COLSPAN="2">Investment Manager</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>By:</TD>
    <TD STYLE="text-align: left">Yorkville Advisors Global II, LLC</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>Its:</TD>
    <TD STYLE="text-align: left">General Partner</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">By:</TD>
    <TD STYLE="text-align: left; padding-bottom: 1pt; border-bottom: Black 1pt solid">/s/ Michael Rosselli</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>Name:</TD>
    <TD STYLE="text-align: left">Michael Rosselli&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>Title:</TD>
    <TD>Partner</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature Page to Consent and Waiver
to the Unsecured Convertible Note]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><U>Yorkville Note</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.30
<SEQUENCE>4
<FILENAME>n2574_x219ex4-30.htm
<DESCRIPTION>CONSENT AND WAIVER, DATED AS OF SEPTEMBER 4, 2024, BETWEEN NIOCORP DEVELOPMENTS LTD. AND LIND GLOBALFUND II LP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 4.30</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>CONSENT AND WAIVER</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>THIS CONSENT AND
WAIVER </B>(this &ldquo;<U>Consent and Waiver</U>&rdquo;), dated as of September 4, 2024 to the Note (as defined below) is between
<B>NIOCORP DEVELOPMENTS LTD.</B>, a company organized under the laws of the Province of British Columbia, Canada, with principal
executive offices located at 7000 South Yosemite Street, Suite 115, Centennial, Colorado 80112 (the &ldquo;<U>Company</U>&rdquo;),
and <B>LIND GLOBAL FUND II LP</B>, a Delaware limited partnership (the &ldquo;<U>Holder</U>&rdquo;). Capitalized terms used herein
and not otherwise defined have the meanings set forth for such terms in the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, reference
is made to that certain Unsecured Convertible Note, dated as of April 12, 2024 (the &ldquo;<U>Note</U>&rdquo;), between the Company
and the Holder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the
Note was originally issued pursuant to the Securities Purchase Agreement, dated April 11, 2024, between the Company, the Holder
and YA II PN, Ltd.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, pursuant
to Section (1)(c) of the Note, any Payment Date and the amount payable to the Holder on any such Payment Date may be modified from
time to time upon the mutual written consent of the Company and the Holder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, pursuant
to the terms of the Note (as unmodified), the Company is obligated to make payment of $226,800 (the &ldquo;<U>September Payment
Amount</U>&rdquo;) in respect of the Payment Date on September 1, 2024 (the &ldquo;<U>September Payment Date</U>&rdquo;) because
the Equity Conditions have not been satisfied as of the last Trading Date prior to the September Payment Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the
Company and the Holder desire to modify the Company&rsquo;s payment obligation with respect of the September Payment Date by decreasing
the amount payable on the September Payment Date and deferring the due date of the remainder of the September Payment Amount until
December 1, 2024 (the &ldquo;<U>December Payment Date</U>&rdquo;) as set forth herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the
Company and the Holder desire to modify the maximum Offset Amount in respect of the December Payment Date as set forth herein;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the
Holder desires to prospectively waive any term in the Note that would otherwise be triggered upon a failure to pay to the Holder
the full September Payment Amount on the September Payment Date, including, but not limited to, (i) the occurrence of an Event
of Default under Section (2)(a)(i) of the Note (the &ldquo;<U>Event of Default Provision</U>&rdquo;), (ii) an increase to the Interest
Rate pursuant to Section (1)(b) of the Note (the &ldquo;<U>Interest Rate Provision</U>&rdquo;) and (iii) the Holder&rsquo;s right
to accelerate, at the Holder&rsquo;s election, all amounts owing in respect of the Note pursuant to Section (2)(b) of the Note
(the &ldquo;<U>Acceleration Provision</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>,
in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Company and the Holder hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Pursuant to Section (1)(c) of the Note, the Company and the Holder hereby consent to the modification of Company&rsquo;s
payment obligation in respect of the September Payment Date as follows: (i) the amount payable on the September Payment Date is
$50,324; and (ii) the </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">remainder of the September Payment Amount, equal to $176,476, will be due and payable on December 1, 2024,
which will be due and payable on such date in addition to any payment of Amortization Principal Amount, plus the Payment Premium
in respect of such Amortization Principal Amount, plus accrued and unpaid Interest under the Note, if any, as of the Payment Date
on December 1, 2024, that the Company may be obligated to make in respect of such Payment Date on December 1, 2024 pursuant to
the terms of the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company and the Holder hereby consent that in respect of the December Payment Date the Offset Amount shall not exceed
$2,512,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Holder hereby prospectively waives any term in the Note that would otherwise be triggered upon a failure to pay to the
Holder the remainder of the September Payment Amount, equal to $176,476, on the September Payment Date, including, but not limited
to, (i) the Event of Default Provision, (ii) the Interest Rate Provision and (iii) the Acceleration Provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as described in Sections 1, 2 and 3 of this Consent and Waiver, the terms of the Note attached hereto as <U>Exhibit
A</U> are unchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This Consent and Waiver may be executed in two or more counterparts, each of which shall for all purposes be deemed to be
an original and all of which shall constitute the same document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0"><I>[remainder
of page intentionally left blank]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Holder and the Company have caused their respective signature page to this Consent and Waiver to be duly executed as of the
date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in"><B>COMPANY:</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in"><B>NIOCORP DEVELOPMENTS LTD.</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%; padding-bottom: 1pt; text-indent: 0in">By:</TD>
    <TD STYLE="width: 45%; text-align: left; padding-bottom: 1pt; border-bottom: Black 1pt solid">/s/ Mark A. Smith</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Name:</TD>
    <TD STYLE="text-align: left">Mark A. Smith</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Title:</TD>
    <TD STYLE="text-align: left">NioCorp President &amp; CEO</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature Page
to Consent and Waiver to the Unsecured Convertible Note]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in"><B>HOLDER:</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in"><B>LIND GLOBAL FUND II LP</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%; text-indent: 0in">By:</TD>
    <TD STYLE="width: 45%; text-align: left">Lind Global Partners II LLC</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Its:</TD>
    <TD STYLE="text-align: left">General Partner</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-indent: 0in">By:</TD>
    <TD STYLE="text-align: left; padding-bottom: 1pt; border-bottom: Black 1pt solid">/s/ Jeff Easton</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Name:</TD>
    <TD STYLE="text-align: left">Jeff Easton</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Title:</TD>
    <TD STYLE="text-align: left">Managing Member</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature Page
to Consent and Waiver to the Unsecured Convertible Note]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><U>Lind Note</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.33
<SEQUENCE>5
<FILENAME>n2574_x219ex4-33.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.33</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>DESCRIPTION
OF Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The authorized capital of NioCorp Developments
Ltd., a British Columbia corporation (the &ldquo;Company&rdquo;), consists of an unlimited number of common shares, without par
value, of the Company (the &ldquo;Common Shares&rdquo;). The holders of Common Shares are entitled to receive notice of and attend
all meetings of shareholders, with each Common Share held entitling the holder to one (1) vote on any resolution to be passed at
such shareholder meetings. The holders of Common Shares are entitled to dividends if, as and when declared by the Company&rsquo;s
Board of Directors. The Common Shares are entitled, upon liquidation, dissolution, or winding up of the Company, to receive the
remaining assets of the Company available for distribution to shareholders. There are no pre-emptive, conversion, or redemption
rights attached to the Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Exchange Controls</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There are no governmental laws, decrees,
or regulations in Canada that restrict the export or import of capital, including foreign exchange controls, or that affect the
remittance of dividends, interest or other payments to non-resident holders of the securities of the Company, other than as discussed
below and Canadian withholding tax. See &ldquo;&mdash;<I>Certain Canadian Federal Income Tax Considerations for U.S. Residents</I>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Competition Act</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Limitations on the ability to acquire and
hold Common Shares may be imposed by the Competition Act (Canada). This legislation permits the Commissioner of Competition of
Canada (the &ldquo;Commissioner&rdquo;) to review any acquisition of a significant interest in the Company. This legislation grants
the Commissioner jurisdiction to challenge such an acquisition before the Canadian Competition Tribunal if the Commissioner believes
that it would, or would be likely to, result in a substantial lessening or prevention of competition in any market in Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Investment Canada Act</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Investment Canada Act subjects an acquisition
of control of a company by a non-Canadian to government review if the enterprise value (or in some cases, asset value) of such
company, as calculated pursuant to the legislation, exceeds a threshold amount. A reviewable acquisition may not proceed unless
the relevant minister is satisfied that the investment is likely to result in a net benefit to Canada. Under the national-security-review
regime in the Investment Canada Act, review on a discretionary basis may also be undertaken by the federal government in respect
of a broad range of investments by a non-Canadian. No financial threshold applies to a national security review. The relevant test
is whether such investment by a non-Canadian could be &ldquo;injurious to national security.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Certain Canadian Federal Income Tax Considerations for
U.S. Residents</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following generally summarizes certain
Canadian federal income tax consequences generally applicable under the <I>Income Tax Act</I> (Canada) and the regulations enacted
thereunder (collectively, the &ldquo;Canadian Tax Act&rdquo;) and the <I>Canada-United States Tax Convention (1980)</I> (the &ldquo;Convention&rdquo;)
to the holding and disposition of Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">Comment is restricted
to holders of Common Shares each of whom, at all material times for the purposes of the Canadian Tax Act and the Convention, (i)
is resident solely in the United States for tax purposes, (ii) is a &ldquo;qualifying person&rdquo; under and entitled to the benefits
of the Convention, (iii) holds all Common Shares as capital property, (iv) holds no Common Shares that are &ldquo;taxable Canadian
property&rdquo; (as defined in the Canadian Tax Act) of the holder, (v) deals at arm&rsquo;s-length with and is not affiliated
with the Company, (vi) does not and is not deemed to use or hold any Common Shares in a business carried on in Canada, (vii) is
not an insurer that carries on business in Canada and elsewhere, (viii) is not an &ldquo;authorized foreign bank&rdquo; (as defined
in the Canadian Tax Act), and (ix) has not entered into a &ldquo;derivative forward agreement&rdquo; (as defined in the Canadian
Tax Act) with respect to the Common Shares (each such holder, a &ldquo;U.S. Resident Holder&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">Certain U.S.-resident
entities that are fiscally transparent for United States federal income tax purposes (including limited liability companies) may
not in all circumstances be entitled to the benefits of the Convention. Members of or holders of an interest in such an entity
that holds Common Shares should consult their own tax advisers regarding the extent, if any, to which the benefits of the Convention
will apply to the entity in respect of its Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">Generally, a
U.S. Resident Holder&rsquo;s Common Shares will be considered to be capital property of such holder provided that the U.S. Resident
Holder is not a trader or dealer in securities, did not acquire, hold, or dispose of the Common Shares in one or more transactions
considered to be an adventure or concern in the nature of trade (i.e., speculation), and does not hold the Common Shares in the
course of carrying on a business.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">This summary
is based on the current provisions of the Canadian Tax Act and the Convention in effect as of the date prior to the date hereof,
all specific proposals to amend the Canadian Tax Act and Convention publicly announced by or on behalf of the Minister of Finance
(Canada) prior to the date hereof, and the current published administrative policies and assessing practices of the Canada Revenue
Agency (the &ldquo;CRA&rdquo;). It is assumed that all such amendments will be enacted as currently proposed, and that there will
be no other material change to any applicable law or administrative policy or assessing practice, whether by way of judicial, legislative
or governmental decision or action, although no assurance can be given in these respects. This summary is not exhaustive of all
possible Canadian federal income tax considerations. Except as otherwise expressly provided, this summary does not take into account
any provincial, territorial, or foreign tax considerations, which may differ materially from those set out herein. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><B>This
summary is of a general nature only, is not exhaustive of all possible Canadian federal income tax considerations and is not intended
to be and should not be construed as legal or tax advice to any particular U.S. Resident Holder. U.S. Resident Holders are urged
to consult their own tax advisers for advice with respect to their particular circumstances. The discussion below is qualified
accordingly.</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">Generally, a
U.S. Resident Holder&rsquo;s Common Shares will not constitute &ldquo;taxable Canadian property&rdquo; of such holder at a particular
time at which the Common Shares are listed on a &ldquo;designated stock exchange&rdquo; (which currently includes The Nasdaq Stock
Market LLC (&ldquo;Nasdaq&rdquo;)) unless, at any time during the 60-month period that ends at the particular time both of the
following conditions are concurrently met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 13.5pt">1.</TD><TD STYLE="text-align: justify; padding-right: 1.45pt">25% or more of the issued shares of any class of the capital stock of the
Company were owned by or belonged to one or any combination of:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31.5pt"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify; padding-right: 1.25pt">the U.S. Resident Holder,</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31.5pt"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify; padding-right: 1.5pt">persons with whom the U.S. Resident Holder did not deal at arm&rsquo;s length,
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31.5pt"></TD><TD STYLE="width: 18pt">(c)</TD><TD STYLE="text-align: justify; padding-right: 1.45pt">partnerships in which the U.S. Resident Holder or a person referred to in
clause (b) holds a membership interest directly or indirectly through one or more partnerships, and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 13.5pt">2.</TD><TD STYLE="text-align: justify; padding-right: 1.5pt">more than 50% of the fair market value of the Common Shares was derived directly
or indirectly from, one or any combination of, real or immovable property situated in Canada, &ldquo;Canadian resource properties&rdquo;
(as defined in the Canadian Tax Act), &ldquo;timber resource properties&rdquo; (as defined in the Canadian Tax Act), or options
in respect of, or interests in any of the foregoing, whether or not the property exists.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Common Shares may also be deemed to be
&ldquo;taxable Canadian property&rdquo; in certain circumstances set out in the Canadian Tax Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">A U.S. Resident
Holder who disposes or is deemed to dispose of one or more Common Shares generally should not thereby incur any liability for Canadian
federal income tax in respect of any capital gain arising as a consequence of the disposition.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in">A U.S. Resident
Holder to whom the Company pays or credits or is deemed to pay or credit a dividend on such holder&rsquo;s Common Shares will be
subject to Canadian withholding tax, and the Company will be required to withhold the tax from the dividend and remit it to the
CRA for the holder&rsquo;s account. The rate of withholding tax under the Canadian Tax Act is 25% of the gross amount of the dividend,
but should generally be reduced under the Convention to 15% (or, if the U.S. Resident Holder is a company which is the beneficial
owner of at least 10% of the voting stock of the Company, 5%) of the gross amount of the dividend. For this purpose, a company
that is a resident of the United States for purposes of the Canadian Tax Act and the Convention and is entitled to the benefits
of the Convention shall </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0">be considered to own the voting stock of the Company owned by an entity that is considered fiscally transparent
under the laws of the United States and that is not a resident of Canada, in proportion to such company&rsquo;s ownership interest
in that entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">From time to time, the Company has outstanding
Common Share purchase warrants, with each Common Share purchase warrant exercisable for one Common Share. The exercise price per
Common Share and the number of Common Shares issuable upon exercise of Common Share purchase warrants is subject to adjustment
upon the occurrence of certain events, including, but not limited to, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the subdivision or re-division of the outstanding Common Shares into a greater number of Common Shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the reduction, combination or consolidation of the outstanding Common Shares into a lesser number of Common Shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the issuance of Common Shares or securities exchangeable for, or convertible into, Common Shares to all or substantially all
of the holders of Common Shares by way of stock dividend or other distribution (other than a distribution of Common Shares upon
the exercise of Common Share purchase warrants or any outstanding options);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the reorganization of the Company or the consolidation or merger or amalgamation of the Company with or into another corporate
body; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>a reclassification or other similar change to the outstanding Common Shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company will issue the Common Shares
issuable upon exercise of Common Share purchase warrants within five business days following its receipt of notice of exercise
and payment of the exercise price, subject to surrender of the Common Share purchase warrants. Prior to the exercise of any Common
Share purchase warrants, holders of the Common Share purchase warrants will not have any of the rights of holders of the Common
Shares issuable upon exercise, including the right to vote or to receive any payments of dividends on the Common Shares issuable
upon exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NioCorp Assumed Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On March 17, 2023 (the &ldquo;Closing Date&rdquo;),
the Company closed a series of transactions (the &ldquo;GXII Transaction&rdquo;) pursuant to the Business Combination Agreement,
dated as of September 25, 2022 (the &ldquo;Business Combination Agreement&rdquo;), by and among the Company, GX Acquisition Corp.
II, a Delaware corporation (&ldquo;GXII&rdquo;), and Big Red Merger Sub Ltd., a Delaware corporation and a direct, wholly owned
subsidiary of the Company. In connection with the closing of the GXII Transaction (the &ldquo;Closing&rdquo;), pursuant to the
Business Combination Agreement, the Company assumed GXII&rsquo;s obligations under the Warrant Agreement, dated as of March 17,
2021 (the &ldquo;GXII Warrant Agreement&rdquo;), by and between GXII and Continental Stock Transfer &amp; Trust Company (&ldquo;CST&rdquo;),
as warrant agent, and each share purchase warrant of GXII thereunder (the &ldquo;GXII Warrants&rdquo;) that was issued and outstanding
immediately prior to the Closing Date was converted into one Common Share purchase warrant (the &ldquo;NioCorp Assumed Warrants&rdquo;)
pursuant to the GXII Warrant Agreement, as amended by an Assignment, Assumption and Amendment Agreement, dated the Closing Date
(the GXII Warrant Agreement, as so amended, the &ldquo;NioCorp Assumed Warrant Agreement&rdquo;), among the Company, GXII, CST,
as existing warrant agent, and Computershare Inc. and its affiliate Computershare Trust Company, N.A, together as successor warrant
agent (the &ldquo;NioCorp Assumed Warrant Agent&rdquo;). In connection with the Closing, NioCorp issued (a) 9,999,959 public NioCorp
Assumed Warrants in respect of the GXII Warrants that were publicly traded prior to the Closing and (b) 5,666,667 NioCorp Assumed
Warrants to GX Sponsor II LLC (the &ldquo;Sponsor&rdquo;) in respect of the GXII Warrants that it held prior to the Closing, which
NioCorp Assumed Warrants were subsequently distributed by the Sponsor to its members in connection with the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Both the public NioCorp Assumed Warrants
and the NioCorp Assumed Warrants issued to the Sponsor are subject to the terms of the NioCorp Assumed Warrant Agreement and are
identical, with certain exceptions applicable to the NioCorp Assumed Warrants issued to the Sponsor for so long as such NioCorp
Assumed Warrants are held by the Sponsor, its members, or their respective affiliates and other permitted transferees. In accordance
with the NioCorp Assumed Warrant Agreement, any NioCorp Assumed Warrants issued to the Sponsor that are held </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">by someone other than
the Sponsor, its members, or their respective affiliates and other permitted transferees, are treated as public NioCorp Assumed
Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each NioCorp Assumed Warrant is exercisable
on and after April 16, 2023 until its expiration for 1.11829212 Common Shares at a price of $11.50 per 1.11829212 Common Shares
(subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the like). Under the terms of
NioCorp Assumed Warrant Agreement, for so long as the NioCorp Assumed Warrants issued to the Sponsor are held by the Sponsor, its
members, or their respective affiliates and other permitted transferees, such holders have the right to elect to exercise those
NioCorp Assumed Warrants on a cashless basis. For such NioCorp Assumed Warrants exercised on a cashless basis after the Closing,
the holder will be entitled to pay the exercise price for those NioCorp Assumed Warrants by surrendering all or portion of the
cash and/or Common Shares (valued at their fair market value) into which those NioCorp Assumed Warrants are exercisable as shall
be elected by the holder. For this purpose, Common Shares so surrendered will be deemed to have a &ldquo;fair market value&rdquo;
equal to the average reported last sale price of the Common Shares for the 10 trading days ending on the third trading day prior
to the date of exercise of the applicable NioCorp Assumed Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The NioCorp Assumed Warrants will expire
at 5:00 p.m., New York City time, on March 17, 2028 or earlier upon redemption or liquidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company will not be obligated to deliver
any Common Shares pursuant to the exercise of a NioCorp Assumed Warrant and will have no obligation to settle such exercise unless
a registration statement under the Securities Act with respect to the Common Shares underlying the NioCorp Assumed Warrants is
then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations described below
with respect to registration. No NioCorp Assumed Warrant will be exercisable and the Company will not be obligated to issue Common
Shares upon exercise of a NioCorp Assumed Warrant unless Common Shares issuable upon such exercise have been registered, qualified
or deemed to be exempt under the securities laws of the state of residence of the registered holder of the NioCorp Assumed Warrants.
In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a NioCorp Assumed
Warrant, the holder of such NioCorp Assumed Warrant will not be entitled to exercise such NioCorp Assumed Warrant and such NioCorp
Assumed Warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any NioCorp
Assumed Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The NioCorp Assumed Warrants, and the underlying
Common Shares issuable upon the exercise thereof, were registered under the Securities Act pursuant to the Company&rsquo;s registration
statement on Form S-4, originally filed on November 7, 2022, as subsequently amended, which was declared effective by the SEC on
February 8, 2023. The ongoing registered offering of the Common Shares underlying the NioCorp Assumed Warrants is being conducted
pursuant to the Company&rsquo;s registration statement on Form S-3, originally filed on April 14, 2023, as subsequently post-effectively
amended to convert such registration statement to Form S-1, which was declared effective on October 30, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company will have the right to call
the public NioCorp Assumed Warrants for redemption at any time following the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 22.5pt">&#9679;</TD><TD>in whole and not in part;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 22.5pt">&#9679;</TD><TD>at a price of $0.01 per NioCorp Assumed Warrant;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 22.5pt">&#9679;</TD><TD>upon not less than 30 days&rsquo; prior written notice of redemption (the &ldquo;30-day redemption period&rdquo;) to each public
NioCorp Assumed Warrant holder;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 22.5pt">&#9679;</TD><TD>if, and only if, the reported last sale price of the Common Shares equals or exceeds approximately $16.10 per share (subject
to certain adjustments) for any 20 trading days within a 30-trading day period commencing once the NioCorp Assumed Warrants become
exercisable and ending three business days before the Company sends the notice of redemption to the public NioCorp Assumed Warrant
holders; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 22.5pt">&#9679;</TD><TD>if there is an effective registration statement covering the Common Shares issuable upon exercise of the NioCorp Assumed Warrants,
and a current prospectus relating thereto, available throughout the 30-day redemption period.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The NioCorp Assumed Warrants issued to
the Sponsor are not redeemable by the Company for so long as such NioCorp Assumed Warrants are held by the Sponsor, its members,
or their respective affiliates or other permitted transferees. In addition, the Company may not exercise its redemption right if
the issuance of Common Shares upon exercise of the NioCorp Assumed Warrants is not exempt from registration or qualification under
applicable state blue sky laws or the Company is unable to effect such registration or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Company calls the public NioCorp
Assumed Warrants for redemption as described above, the Company will have the option to require any holder that wishes to exercise
its public NioCorp Assumed Warrant to do so on a &ldquo;cashless basis.&rdquo; In determining whether to require all holders to
exercise their public NioCorp Assumed Warrants on a &ldquo;cashless basis,&rdquo; the Company will consider, among other factors,
its cash position, the number of NioCorp Assumed Warrants that are outstanding and the dilutive effect on the Company&rsquo;s shareholders
of issuing the maximum number of Common Shares issuable upon the exercise of the NioCorp Assumed Warrants. If the Company takes
advantage of this option, all holders of public NioCorp Assumed Warrants would pay the exercise price by surrendering their NioCorp
Assumed Warrants for that number of Common Shares equal to the quotient obtained by dividing (x) the product of the number of Common
Shares underlying the public NioCorp Assumed Warrants, multiplied by the difference between the exercise price of the NioCorp Assumed
Warrants and the &ldquo;fair market value&rdquo; (defined below) by (y) the fair market value. The &ldquo;fair market value&rdquo;
shall mean the average reported last sale price of the Common Shares for the 10 trading days ending on the third trading day prior
to the date on which the notice of redemption is sent to the holders of public NioCorp Assumed Warrants. If the Company takes advantage
of this option, the notice of redemption will contain the information necessary to calculate the number of Common Shares to be
received upon exercise of the NioCorp Assumed Warrants, including the &ldquo;fair market value&rdquo; in such case. Requiring a
cashless exercise in this manner will reduce the number of Common Shares to be issued and thereby lessen the dilutive effect of
a redemption of the public NioCorp Assumed Warrants. If the Company calls the public NioCorp Assumed Warrants for redemption and
does not take advantage of this option, the Sponsor, its members, and their respective affiliates and other permitted transferees
would still be entitled to exercise their NioCorp Assumed Warrants for cash or on a cashless basis using the same formula described
above that other NioCorp Assumed Warrant holders would have been required to use had all NioCorp Assumed Warrant holders been required
to exercise their NioCorp Assumed Warrants on a cashless basis, as described in more detail below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A holder of a NioCorp Assumed Warrant may
notify the Company in writing in the event it elects to be subject to a requirement that such holder will not have the right to
exercise such NioCorp Assumed Warrant, to the extent that after giving effect to such exercise, such holder (together with such
holder&rsquo;s affiliates), to the NioCorp Assumed Warrant Agent&rsquo;s actual knowledge, would beneficially own in excess of
4.9% or 9.8% (or such other amount as a holder may specify) of the Common Shares outstanding immediately after giving effect to
such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The NioCorp Assumed Warrants have certain
anti-dilution and adjustments rights upon certain events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The NioCorp Assumed Warrants may be exercised
upon surrender of the certificate representing such NioCorp Assumed Warrants on or prior to the expiration date at the offices
of the NioCorp Assumed Warrant Agent, with the exercise form on the reverse side of such certificate completed and executed as
indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by certified or official
bank check payable to the order of the NioCorp Assumed Warrant Agent or by wire transfer, for the number of NioCorp Assumed Warrants
being exercised. The NioCorp Assumed Warrant holders will not have the rights or privileges of holders of Common Shares or any
attendant voting rights until they exercise their NioCorp Assumed Warrants and receive Common Shares. After the issuance of Common
Shares upon exercise of the NioCorp Assumed Warrants, each holder will be entitled to one (1) vote for each Common Share held of
record on all matters to be voted on by NioCorp shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If, upon exercise of the NioCorp Assumed
Warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to
the nearest whole number of Common Shares to be issued to the NioCorp Assumed Warrant holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The NioCorp Assumed Warrants were issued
in registered form under the NioCorp Assumed Warrant Agreement. The NioCorp Assumed Warrant Agreement may be amended by the parties
thereto without the consent of any registered holder (i) for the purpose of curing any ambiguity, or curing, correcting or supplementing
any mistake, or adding or changing any other provisions with respect to matters or questions arising under NioCorp </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">Assumed Warrant
Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest of the
registered holders of the NioCorp Assumed Warrants, and (ii) to provide for the delivery of such kind and amount of Common Shares
or other securities or property (including cash) receivable upon a reclassification, reorganization, merger or consolidation, or
upon a dissolution following any such sale or transfer, that the holder of NioCorp Assumed Warrants would have received if such
holder had exercised his, her or its NioCorp Assumed Warrants immediately prior to such event. All other modifications or amendments,
including any amendment to increase the warrant price or shorten the exercise period, shall require the vote or written consent
of the registered holders of a majority of the then outstanding public NioCorp Assumed Warrants. Any amendment solely to the NioCorp
Assumed Warrants issued to the Sponsor and that are held by the Sponsor, its members, or their respective affiliates or other permitted
transferees, shall require the vote or written consent of a majority of the holders of the then outstanding NioCorp Assumed Warrants
issued to the Sponsor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Notes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 12, 2024, the Company issued and
sold to the YA II PN, Ltd. (&ldquo;Yorkville&rdquo;) and Lind Global Fund II LP (&ldquo;Lind II&rdquo;), in a private placement
(the &ldquo;April 2024 Private Placement&rdquo;), $8.0 million aggregate principal amount of unsecured notes (the &ldquo;Notes&rdquo;),
pursuant to a Securities Purchase Agreement, dated April 11, 2024 (the &ldquo;Purchase Agreement&rdquo;), between the Company and
each of Yorkville and Lind II, as purchasers (in such capacity, the &ldquo;Purchasers&rdquo;). Pursuant to the terms of the Notes,
subject to certain exceptions as described below, on the first day of each calendar month, beginning on June 1, 2024 (excluding
August 2024) (a &ldquo;Payment Date&rdquo;), the Company will be required to repay a portion of the outstanding balance of all
of the Notes, on a pro-rata basis, in an amount equal to the sum of (i) $1.4 million of principal (or the outstanding principal
if less than such amount) in the aggregate among all of the outstanding Notes, plus (ii) 8.0% of the principal amount being paid
(the &ldquo;Payment Premium&rdquo;), and (iii) accrued and unpaid interest, if any, as of the Payment Date. The Company is required
to make payments on each Payment Date until the entire outstanding principal is repaid, but will not have an obligation to make
a payment on a Payment Date if the Equity Conditions (as defined below) are satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Purchase Agreement, the
Purchasers advanced an aggregate of $6.96 million to the Company in consideration of the issuance by the Company to the Purchasers
of $8.0 million aggregate principal amount of Notes and Warrants (the &ldquo;April 2024 Warrants&rdquo;) to purchase up to 615,385
Common Shares (the &ldquo;April 2024 Warrant Shares&rdquo;). Each April 2024 Warrant is exercisable for one Common Share for cash
or, if at any time there is no effective registration statement registering, or no current prospectus available for, the resale
of the underlying Common Shares, on a cashless basis at the option of the holder, at a price per Common Share of $3.25 (the &ldquo;April
2024 Exercise Price&rdquo;), subject to adjustment for recapitalizations, stock splits, reverse stock splits or similar events,
and expires April 12, 2027.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to certain limitations, including
those as described below, contained within the Notes, holders of the Notes will be entitled to convert the principal amount of,
accrued and unpaid interest, if any, and any Payment Premium that has become due and payable on each Note, from time to time over
their term, into a number of Common Shares equal to the quotient of the amount being converted divided by the fixed conversion
price of $2.75 per Common Share (the &ldquo;Fixed Conversion Price&rdquo;) up to a maximum of 3,141,817 Common Shares (together
with the April 2024 Warrant Shares, the &ldquo;Underlying Shares&rdquo;). The terms of the Notes restrict the conversion of the
Notes by a holder if such a conversion or exercise would cause such holder to exceed certain beneficial ownership thresholds in
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Notes are the unsecured obligations
of the Company and will mature on December 31, 2024. The Notes will incur a simple interest rate obligation of 0.0% per annum (which
will increase to 18.0% per annum upon the occurrence of an event of default). The outstanding principal amount of, accrued and
unpaid interest, if any, on, and the Payment Premium, if any, on the Notes must be paid by the Company in cash when the same becomes
due and payable under the terms of the Notes at their stated maturity, upon their redemption or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As mentioned above, the Company is required
to make payments on each Payment Date until the entire outstanding principal is repaid, but will not have an obligation to make
a payment on a Payment Date if the Equity Conditions are satisfied. The &ldquo;Equity Conditions&rdquo; means (i) on each of the
five consecutive trading days prior a Payment Date (the &ldquo;Measuring Period&rdquo;) a registration statement registering the
resale by the Purchasers of the Underlying Shares under the Securities Act (the &ldquo;Underlying Shares Registration Statement&rdquo;)
is effective and </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">available for the resale by the Purchasers of all Underlying Shares, (ii) the Company has no knowledge of any
fact that would cause the Underlying Shares Registration Statement not to be effective and available for the resale of the Underlying
Shares, (iii) on each day during the Measuring Period, the Common Shares are designated for quotation on Nasdaq, or on such other
market or exchange on which the Common Shares are then listed or traded to the extent such other market or exchange is the principal
U.S. trading market for the Common Shares (the &ldquo;Principal U.S. Market&rdquo;), and have not been suspended from trading nor
have delisting or suspension of trading been threatened or pending, (iv) during the Measuring Period, an event of default has not
occurred, (v) on each trading day during the Measuring Period, the daily U.S. dollar volume-weighted average price for a Common
Share on the Principal U.S. Market as reported by Bloomberg Financial Markets is greater than 120% of the Fixed Conversion Price,
(vi) on each trading day during the Measuring Period the average daily volume traded exceeded $500,000, and (vii) there is no limitation
on conversion under the terms of Notes. In addition, any Payment Date and the amount payable to the holder of a Note on any such
Payment Date may be modified from time to time upon mutual written consent of the Company and such holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the terms of the Notes, to
the extent a holder is a party to the Standby Equity Purchase Agreement, dated January 26, 2023 (the &ldquo;Yorkville Equity Facility
Financing Agreement&rdquo;), between the Company and Yorkville, under which Yorkville agreed to purchase up to $65.0 million of
Common Shares over a three-year period, at the Company&rsquo;s discretion and subject to certain restrictions (the &ldquo;Yorkville
Equity Facility Financing&rdquo;), for so long as any amount remains outstanding under such holder&rsquo;s Note, the amount of
cash received by the Company as payment from such holder in respect of an Advance (as defined in the Yorkville Equity Facility
Financing Agreement) is subject to a right of offset, exercisable in such holder&rsquo;s sole discretion, against an equal amount
of principal, accrued and unpaid interest, if any, and other amounts that have become due and payable under the Note, not to exceed
$1.512 million in any calendar month.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Notes may also be redeemed at the Company&rsquo;s
option at any time and from time to time over their term at a redemption price equal to the principal amount being redeemed, plus
the Payment Premium, plus accrued and unpaid interest, if any, as of the redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Notes contain events of default customary
for instruments of their type (with customary grace periods, as applicable) and provide that, upon the occurrence of an event of
default arising from certain events of bankruptcy or insolvency with respect to the Company, all outstanding Notes will become
due and payable immediately without further action or notice. If any other type of event of default occurs and is continuing, then
any holder may declare all of its Notes to be due and payable immediately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to a global guaranty agreement,
dated as of April 11, 2024, among Elk Creek Resources Corp. (&ldquo;ECRC&rdquo;) and 0896800 B.C. Ltd. (together with ECRC, the
&ldquo;Guarantors&rdquo;), the Guarantors guaranteed the full, prompt and unconditional payment when due (whether at maturity,
by acceleration or otherwise), and the performance of all liabilities, agreements and other obligations of the Company to the Purchasers
contained in the Notes and the Purchase Agreement, to the extent such liabilities, agreements and obligations are payable in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp;</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>6
<FILENAME>n2574_x219ex19-1.htm
<DESCRIPTION>NIOCORP DEVELOPMENTS LTD. INSIDER TRADING POLICY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
19.1</B></FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NIOCORP
DEVELOPMENTS LTD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INSIDER
TRADING POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Adopted
Effective as of March 17, 2023, Revised March 28, 2024)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PURPOSE
OF THE POLICY</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Insider Trading Policy (the &ldquo;<B><I>Policy</I></B>&rdquo;) provides guidelines with respect to transactions in the securities
of NioCorp Developments Ltd. (the &ldquo;<B><I>Company</I></B>&rdquo;) and the handling of confidential information about the
Company and the companies with which the Company does business. The Company&rsquo;s Board of Directors (the &ldquo;<B><I>Board</I></B>&rdquo;)
has adopted this Policy to promote compliance with Canadian securities laws and U.S. federal and state securities laws that prohibit
certain persons who are aware of Material Nonpublic Information (as defined below) about a company from: (A) trading in securities
of that company; or (B) providing (or &ldquo;<B><I>tipping</I></B>&rdquo;) Material Nonpublic Information or making recommendations
based on Material Nonpublic Information to other persons who may trade on the basis of that information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>APPLICABILITY
OF THE POLICY</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transactions
Subject to the Policy</U>. This Policy applies to transactions in the Company&rsquo;s securities (collectively referred to as
&ldquo;<B><I>Company Securities</I></B>&rdquo;), including the Company&rsquo;s common stock, warrants, units, options to purchase
common stock, stock appreciation rights, restricted stock units, and any other types of securities that the Company may issue,
including (but not limited to) preferred stock, non-convertible debt securities such as senior notes and convertible debt securities,
as well as derivative securities that are not issued by the Company, such as exchange-traded put or call options or swaps relating
to Company Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, when a person who is subject to this Policy, in connection with working for the Company, becomes aware of Material Nonpublic
Information of a company with which the Company does business, including customers and suppliers, this Policy also applies equally
to transactions in the securities of such other company. Each person who is subject to this Policy must treat Material Nonpublic
Information of the Company&rsquo;s business partners, customers and suppliers with the same care required with respect to Company&rsquo;s
Material Nonpublic Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Persons
Subject to the Policy</U>. This Policy applies to all members of the Board and all officers and employees of the Company and its
subsidiaries. The Company may also determine from time to time that other persons will be subject to this Policy, such as contractors
or consultants who have access to Material Nonpublic Information and certain shareholders of the Company (collectively, all such
persons are referred to as &ldquo;<B><I>Company Persons</I></B>&rdquo;). This Policy also applies to family members, other members
of a person&rsquo;s household and entities controlled by a person covered by this Policy, as described more fully below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transactions
by Family Members and Others</U>. This Policy applies to family members who reside with a Company Person (including a spouse,
a child, a child away at college, stepchildren, grandchildren, parents, stepparents, grandparents, siblings and in-laws), anyone
else who lives in a Company Person&rsquo;s household, and any family members who do not live in a Company Person&rsquo;s household
but whose transactions in Company Securities are directed by a Company Person or are subject to a Company Person&rsquo;s influence
or control, such as parents or children who consult with a Company Person before they trade in Company Securities (collectively
referred to as &ldquo;<B><I>Family Members</I></B>&rdquo;). Company Persons are responsible for the transactions of these other
persons and therefore should make them aware of the need to confer with such Company Persons before they trade in Company Securities,
and Company Persons must treat all such transactions for the purposes of this Policy and applicable securities laws as if the
transactions were for such Company Person&rsquo;s own account. This Policy does not, however, apply to personal securities transactions
of Family Members where the purchase or sale decision is made by a third party not controlled by, influenced by or related to
a Company Person or his or her Family Members.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transactions
by Entities that a Company Person Influences or Controls</U>. This Policy applies to any entities that a Company Person influences
or controls, including any corporations, partnerships or trusts (collectively referred to as &ldquo;<B><I>Controlled Entities</I></B>&rdquo;
and, together with Company Persons and Family Members, &ldquo;<B><I>Insiders</I></B>&rdquo;), and transactions by these Controlled
Entities must be treated for the purposes of this Policy and applicable securities laws as if they were for the Company Person&rsquo;s
own account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>DEFINITION
OF MATERIAL NONPUBLIC INFORMATION</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>When
Information is Considered Material</U>. Information is considered &ldquo;material&rdquo; if a reasonable investor would consider
that information important in making a decision to buy, hold or sell securities. Any information that could be expected to affect
Company&rsquo;s stock price, whether it is positive or negative, should be considered material. There is no bright-line standard
for assessing materiality; rather, materiality is based on an assessment of all of the facts and circumstances, and is often evaluated
by enforcement authorities with the benefit of hindsight. While it is not possible to define all categories of material information,
some examples of information that ordinarily would be regarded as material are:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial
                                         condition or results;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unpublished
                                         projections regarding future earnings or losses, other earnings guidance, changes to
                                         previously announced earnings guidance or the decision to suspend earnings guidance;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         gain or loss of a significant contract, customer, supplier, or finance source;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pending
                                         or proposed mergers, acquisitions, dispositions, restructurings, tender offers, joint
                                         ventures, partnerships or spin-offs;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                         developments regarding the Elk Creek Project or other projects;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                         developments relating to resource estimates and reserve estimates;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                         developments relating to our properties and facilities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">creation
                                         of, change in, or termination of a dividend policy, the declaration of a stock split,
                                         an offering of additional securities or the establishment of a repurchase program for
                                         Company securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">financing
                                         transactions not in the ordinary course of business;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         significant change in management;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                         raw material shortages or discoveries;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                         pending or threatened litigation or government investigations;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         significant disruption in operations or loss (including environmental- or safety-related
                                         incidents), potential loss, breach or unauthorized access of property or assets, including
                                         as a result of a cybersecurity incident, cyber attack or otherwise;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">impacts
                                         to the business regarding significant health- or safety-related developments, such as
                                         a pandemic;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                         bank borrowings or other financing transactions out of the ordinary course;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">extraordinary
                                         items for accounting purposes;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         change in auditors or notification that the auditor&rsquo;s reports may no longer be
                                         relied upon; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">impending
                                         defaults on indebtedness, bankruptcy, or the existence of severe liquidity problems.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>When
Information is Considered Public</U>. Information that has not been disclosed to the public is generally considered to be nonpublic
information. To establish that the information has been disclosed to the public, it may be necessary to demonstrate that the information
has been widely disseminated. Information generally would be considered widely disseminated if it has been disclosed through a
press release, newswire services, a broadcast on widely-available radio or television programs, published in a widely-available
newspaper, magazine or news website, on the Company&rsquo;s external website or public disclosure documents filed with applicable
Canadian securities regulators or the U.S. Securities and Exchange Commission (the &ldquo;<B><I>SEC</I></B>&rdquo;) that are available
on the SEC&rsquo;s website. By contrast, information would likely not be considered widely disseminated if it is available only
to our employees, or if it is only available to a select group of analysts, brokers and institutional investors. The circulation
of rumors, even if accurate and reported in the media, does not constitute effective widespread dissemination. As a general rule,
information should not be considered fully absorbed by the marketplace until after the second full business day after the day
on which the information is released. If, for example, the Company were to make an announcement after the commencement of trading
on a</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monday,
Insiders must not trade in Company Securities until Thursday (assuming all such days are business days on which the Company&rsquo;s
stock is trading). Depending on the particular circumstances, the Company may determine that a longer or shorter period should
apply to the release of specific Material Nonpublic Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>STATEMENT
OF THE POLICY</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Prohibition
Against Insider Trading</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
                                         Transactions on the Basis of Material Nonpublic Information</U>. No Insider may, directly
                                         or indirectly through third parties, buy, sell, or otherwise engage in any transactions
                                         in Company Securities if such Insider possesses Material Nonpublic Information. The only
                                         exceptions to this prohibition are described below under &ldquo;Permitted
Transactions.&rdquo;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
                                         Recommendations on the Basis of Material Nonpublic Information</U>. No Insider may make
                                         recommendations or express opinions about trading in Company Securities if such Insider
                                         possesses Material Nonpublic Information.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
                                         Tipping of Material Nonpublic Information</U>. No Insider may, directly or indirectly,
                                         disclose (&ldquo;<B><I>tip</I></B>&rdquo;) Material Nonpublic Information to any person
                                         within the Company whose jobs do not require them to have that information, or outside
                                         of the Company to other persons, including, but not limited to, family, friends, business
                                         associates, investors and expert consulting firms, unless any such disclosure is made
                                         in accordance with the Company&rsquo;s policies regarding the protection or authorized
                                         external disclosure of information about the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insiders
may be liable for tipping Material Nonpublic Information to any third party (a &ldquo;<B><I>Tippee</I></B>&rdquo;). Tippees
inherit an insider&rsquo;s duties and may be liable for trading on Material Nonpublic Information illegally tipped to them by
an Insider. Tippees can obtain Material Nonpublic Information by receiving overt tips from others or through, among other
things, conversations at social, business or other gatherings. Therefore, Insiders must keep all Material Nonpublic
Information relating to the Company strictly confidential (as further described below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
                                         Assistance</U>. No Insider may assist anyone engaged in the activities described in sections
                                         (i)-(iii) above.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Maintaining
                                         Confidentiality of Material Nonpublic Information</U>. All Material Nonpublic Information
                                         relating to the Company is the property of the Company and the Company has the sole and
                                         exclusive right to determine how and when to disclose such information to the public.
                                         Unless specifically authorized by the Company, no Insider should publicly disclose Material
                                         Nonpublic Information and all such information must be kept strictly confidential.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Transactions
that may be necessary or justifiable for independent reasons (such as the need to raise money for an emergency expenditure), or
small transactions, are not excepted from this Policy. Securities laws do not recognize any mitigating circumstances, and, in
any event, even the appearance of an improper transaction must be avoided to preserve the Company&rsquo;s reputation for adhering
to the highest standards of conduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Other
Prohibited Transactions in Company Securities</U>. The Company has also determined that there is a heightened legal risk and the
appearance of improper or inappropriate conduct if Insiders engage in certain types of other transactions. Therefore, the following
rules are applicable to Insiders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Short
                                         Sales</U>. Short sales of Company Securities (i.e., the sale of a security that the seller
                                         does not own) may evidence an expectation on the part of the seller that the securities
                                         will decline in value, and therefore have the potential to signal to the market that
                                         the seller lacks confidence in the Company&rsquo;s prospects. In addition, short sales
                                         may reduce a seller&rsquo;s incentive to seek to improve the Company&rsquo;s performance.
                                         For these reasons, short sales of Company Securities are prohibited. In addition, Section
                                         16(c) of the Securities
Exchange Act of 1934, as amended (the &ldquo;<B><I>Exchange Act</I></B>&rdquo;) prohibits officers and directors from engaging
in short sales of Company securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Publicly-Traded
                                         Options</U>. Given the relatively short term of publicly-traded options, transactions
                                         in options may create the appearance that an Insider is trading based on Material
Nonpublic Information and focus an Insider&rsquo;s attention on short-term performance at the expense of the Company&rsquo;s long-term
objectives. Accordingly, transactions in put options, call options or other derivative securities, on an exchange or in any other
organized market, are prohibited by this Policy.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Hedging
                                         Transactions</U>. Hedging or monetization transactions can be accomplished through a
                                         number of possible mechanisms, including through the use of financial instruments such
                                         as prepaid variable forwards, equity swaps, short sale instruments, puts, collars and
                                         exchange funds or through other transactions that hedge or offset, or are designed to
                                         hedge or offset, any decrease in the market value of Company Securities. Such hedging
                                         transactions may permit an Insider to continue to own Company Securities obtained through
                                         employee benefit plans or otherwise, but without the full risks and rewards of ownership.
                                         When that occurs, Insiders may no longer have the same objectives as the Company&rsquo;s
                                         other shareholders. Accordingly, hedging transactions by any Insider, or any of their
                                         designees, are prohibited under this Policy.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Margin
                                         Accounts and Pledged Securities</U>. Securities held in a margin account or pledged as
                                         collateral for a margin loan may be sold by the broker without the customer&rsquo;s consent
                                         if the customer fails to meet a margin call. Similarly, securities pledged, hypothecated
                                         or otherwise used as collateral for a loan may be sold in foreclosure if the borrower
                                         defaults on the loan. A margin sale or foreclosure sale may occur at a time when the
                                         owner is aware of Material Nonpublic Information or otherwise is not permitted to trade
                                         in Company Securities. For these reasons, Insiders are prohibited from pledging, hypothecating
                                         or otherwise using Company Securities as</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">collateral
for a loan or other form of indebtedness, including, without limitation, holding Company Securities in a margin account as collateral
for a margin loan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Standing
                                         and Limit Orders</U>. Standing and limit orders (except standing and limit orders under
                                         approved Trading Plans, as described below) create heightened risks for insider trading
                                         violations similar to the use of margin accounts. There is no control over the timing
                                         of purchases or sales that result from standing instructions to a broker, and as a result,
                                         the broker could execute a transaction when an Insider is in possession of Material Nonpublic
                                         Information. The Company therefore discourages placing standing or limit orders on Company
                                         Securities. If an Insider determines that they must use a standing order or limit order,
                                         the order should be limited to short duration and should otherwise comply with the guidelines
                                         outlined below.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Permitted
Transactions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transactions
                                         Under Company Plans</U>. This Policy does not apply to transactions with the Company
                                         involving Company Securities, except as specifically noted.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock
                                         Options</U>. This Policy does not apply to the exercise of employee stock options (where
                                         no shares of stock are sold to fund the exercise), or when shares are withheld by the
                                         Company for the Company Person&rsquo;s payment of withholding taxes or the applicable
                                         exercise price upon exercise (if authorized by the Company). This Policy does apply,
                                         however, to any sale of stock as part of a broker-assisted cashless exercise of an option,
                                         any other market sale of stock for the purpose of generating the cash needed to pay the
                                         exercise price of an option or related withholding taxes, or any market sale of stock
                                         following exercise.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
                                         Stock and Restricted Stock Units</U>. This Policy does not apply to the vesting of restricted
                                         stock and restricted stock units under the Company&rsquo;s equity plans, or when related
                                         shares or units are withheld by the Company for the Company Person to pay withholding
                                         taxes upon vesting (if authorized by the Company). This Policy does apply, however, to
                                         any market sale of stock upon vesting.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Employee
                                         Stock Purchase and Savings Plan and Deferred Compensation Plans, if Adopted</U><I>.</I>
                                         This Policy will not apply to purchases of Company Securities in, if adopted, a Company
                                         employee stock purchase plan, 401(k) plan, or deferred compensation plan or other similar
                                         employee benefit plans resulting from a Company
Person&rsquo;s periodic contribution of money to the plan pursuant to his or her payroll deduction election. This Policy
will apply, if adopted, however, to certain elections a Company Person may make under these plans, including: (a)&nbsp;an
election to increase or decrease the percentage of his or her periodic contributions that will be allocated to his or her
Company stock fund; (b) an election to switch an existing account balance into or out of a Company Person&rsquo;s Company
stock fund; (c) an election to borrow money against a</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 1.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Company
Person&rsquo;s plan account if the loan will result in a liquidation of some or all of his or her Company stock fund; (d) an election
to withdraw money from a Company Person&rsquo;s plan account if the withdrawal will result in a liquidation of some or all of
his or her Company stock fund; and (e) an election to pre-pay a plan loan if the pre-payment will result in allocation of loan
proceeds to a Company Person&rsquo;s Company stock fund.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Dividend
                                         Reinvestment Plan, if Adopted</U><I>.</I> This Policy will not apply to purchases of
                                         Company Securities, if adopted, under the Company&rsquo;s (or a broker-sponsored) dividend
                                         reinvestment plan resulting from a Company Person&rsquo;s
reinvestment of dividends paid on Company Securities. This Policy will apply, if adopted, however, to voluntary purchases of Company
Securities resulting from additional contributions a Company Person chooses to make to the dividend reinvestment plan, and to
a Company Person&rsquo;s election to participate in the plan or increase his or her level of participation in the plan. This Policy
will also apply, if adopted, to a Company Person&rsquo;s sale of any Company Securities pursuant to the plan.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Other
                                         Similar Transactions</U><I>.</I> Any other purchase of Company Securities from the Company
                                         or sales of Company Securities to the Company are not subject to this Policy.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Gifts</U><I>.
                                         </I>Bona fide gifts of Company Securities to a family member, charitable organization,
                                         or any other person (including a transfer to a family trust) are not transactions subject
                                         to this Policy, unless the person making the gift has reason to believe that the recipient
                                         intends to sell the Company Securities while the person making the gift is aware of Material
                                         Nonpublic Information, or the person making the gift is subject to the trading restrictions
                                         specified below under the heading &ldquo;Additional Procedures&rdquo; and the sales by
                                         the recipient of the Company
Securities occur during a Black Out Period (as defined below). However, whether a gift is a bona fide gift will depend on the
circumstances surrounding each gift, including, but not limited to, the donor&rsquo;s relationship with the recipient and the
nature of the tax benefit to the donor.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mutual
                                         Funds</U><I>.</I> Transactions in a mutual fund or other collective investment vehicle
                                         (e.g., hedge fund or exchange traded fund) that is invested in Company Securities and
                                         (1) is publicly traded and widely held, (2) is broad based and diversified, and (3) has
                                         investment discretion for fund investments exercised by an independent third party are
                                         not transactions subject to this Policy. Insiders should consult with the General Counsel
                                         or CEO if they have questions regarding whether a specific fund is considered &ldquo;broad-based
                                         and diversified.&rdquo;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ADDITIONAL
PROCEDURES</U></B>. The Company has established additional procedures, applicable only to certain persons (as described below),
in order to assist in the administration of this Policy, to facilitate compliance with laws prohibiting insider trading while
in possession of Material Nonpublic Information, and to avoid the appearance of any impropriety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Pre-Clearance
Procedures</U>. Certain designated persons may not engage in any transaction in Company Securities, including gifts involving
the transfer of Company Securities, without first obtaining pre-clearance of the transaction from the Company by contacting either
the Chief Financial Officer or the General Counsel (the &ldquo;<B><I>Pre-Clearance Procedures</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following persons (the &ldquo;<B><I>Covered Persons</I></B>&rdquo;) are subject to the Company&rsquo;s Pre-Clearance
Procedures:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">directors;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">executive
                                         officers;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">members
                                         of the Company&rsquo;s legal department;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">employees
                                         who are serving in executive management;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         individuals reporting directly to the Company&rsquo;s Chief Financial Officer;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">employees
                                         who are involved in the preparation of financial statements as determined by the Company&rsquo;s
                                         Chief Financial Officer;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">employees
                                         with knowledge of consolidated financial performance forecasts as determined by the Company&rsquo;s
                                         Chief Financial Officer;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designated
                                         Corporate Communications professionals;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">anyone
                                         who has access to, or is in possession of, material nonpublic information in connection
                                         with working for any of the foregoing persons, departments or offices;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
                                         persons designated by the Chief Executive Officer (the &ldquo;<B><I>CEO</I></B>&rdquo;),
                                         Chief Financial Officer or General Counsel; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Family
                                         Members and Controlled Entities of any persons described above.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
request for pre-clearance to trade in Company Securities should be submitted in writing to the General Counsel or CEO (or other
designated attorneys) at least one business day in advance of the proposed transaction. When a request for pre-clearance is made,
the requestor should confirm in the request that he or she (1) has reviewed this Policy and (2) is not aware of any Material Nonpublic
Information about the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is under no obligation to approve a transaction submitted for pre-clearance and may determine not to permit the transaction.
If the General Counsel or CEO, as applicable, does not respond to a request for pre-clearance, the request will be deemed to have
been denied. If a person seeks pre-clearance and permission to engage in the transaction is denied or not responded to, then he
or she must refrain from initiating any transaction in Company Securities, and must not inform any other person of the restriction.
If permission to engage in the transaction is granted, then the transaction must be initiated</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">within
five business days of receipt of pre-clearance, unless an exception is granted or the person becomes aware of Material Nonpublic
Information before the trade is executed, in which case the preclearance is void and the trade must not be completed. If transactions
are not effected within the time limit, pre-clearance must be requested and approved in writing again.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Quarterly
Blackout Periods</U>. Except with the prior written approval of the General Counsel, CFO or CEO, Covered Persons may not conduct
any transactions involving Company Securities (other than as specified by this Policy) during certain <I>&ldquo;<B>Blackout Periods</B></I>.&rdquo;
Quarterly Blackout Periods begin on the 22<SUP>nd</SUP> day of the last month of each fiscal quarter (September 22<SUP>nd</SUP>,
December 22<SUP>nd</SUP>, March 22<SUP>nd</SUP>, and June 22<SUP>nd</SUP>) and end at the beginning of the third business day
following the date of the public release of the Company&rsquo;s earnings results for that quarter. In other words, these persons
may only conduct transactions in Company Securities during the &ldquo;<B><I>Window Period</I></B>&rdquo; beginning on the third
business day following the public release of Company&rsquo;s quarterly earnings and ending on September 21<SUP>st</SUP> , December
21<SUP>st</SUP> , March 21<SUP>st</SUP> or June 21<SUP>st</SUP> (as applicable) of the next fiscal quarter. For example, if the
quarterly earnings were released after trading commenced on a Monday, the Window Period would begin on Thursday, giving the marketplace
at least two full business days, Tuesday and Wednesday, to fully absorb the earnings release (assuming all of such days are business
days on which the Company&rsquo;s stock is trading).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Event-Specific
Blackout Periods</U>. From time to time, an event may occur or information may exist that is material to the Company and is known
by only certain directors, officers and/or employees. So long as the event or information remains material and nonpublic, certain
persons designated by the CEO, Chief Financial Officer or General Counsel may not engage in any transaction in Company Securities
during such Event-Specific Blackout Period. In addition, the Company&rsquo;s financial results may be sufficiently material in
a particular fiscal quarter that, in the judgment of the CEO, Chief Financial Officer or General Counsel, designated persons should
refrain from trading in Company Securities even sooner than the typical Blackout Period described above. In either situation,
the CEO, Chief Financial Officer or General Counsel may notify these persons that they must not engage in transactions in Company
Securities, without disclosing the reason for the restriction. The existence of an event-specific trading restriction period or
extension of a Blackout Period will not be announced to the Company as a whole, and must not be communicated to any other person.
Exceptions will not be granted during an event-specific trading restriction period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exceptions</U>.
Blackout Periods do not apply to those transactions to which this Policy does not apply, as described above under the heading
&ldquo;Permitted Transactions.&rdquo; Further, the requirements for Pre-Clearance Procedures and Blackout Periods do not apply
to transactions conducted pursuant to approved Trading Plans, as described below under the heading &ldquo;Automatic Trading Plans.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AUTOMATIC
TRADING PLANS</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Company
Securities may be purchased or sold without regard to certain insider trading restrictions if such a transaction is made pursuant
to a pre-arranged written trading plan designed in accordance with Rule 10b5-1(c) of the Exchange Act that is also an &ldquo;automatic
plan&rdquo; as set forth in the Securities Act (British Columbia) (&ldquo;<B><I>Trading Plan</I></B>&rdquo;). To comply with this
Policy, Trading Plans must be approved by the General Counsel or CEO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Trading Plans must be entered into at a time when (i) the person entering into the plan is not aware of Material Nonpublic
Information and (ii) a Blackout Period is not in effect. Any Trading Plan must be submitted to the General Counsel or CEO for
approval five business days prior to the entry into the Trading Plan. Subsequent modifications to any Trading Plan must also be
pre-approved by the General Counsel or CEO. Once a Trading Plan is approved, no further pre-approval of transactions conducted
pursuant to the Trading Plan is required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SECTION
16 REPORTS AND <I>NI 55-104</I></U></B>. Certain Company Persons, including directors, officers designated as such for SEC reporting
purposes by the Board and certain shareholders of the Company (collectively, &ldquo;<B><I>Section 16 Reporting Persons</I></B>&rdquo;),
are required to file reports with the SEC that disclose such Company Person&rsquo;s trading and other transactions relating to
Company Securities (&ldquo;<B><I>Section 16 Reports</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CEO&rsquo;s office and the General Counsel&rsquo;s office will assist Section 16 Reporting Persons that are directors and officers
in preparing and filing the required Section 16 Reports; however, such Section 16 Reporting Persons retain responsibility for
the filing and accuracy of Section 16 Reports. To ensure compliance with all reporting requirements, such Section 16 Reporting
Persons must, on the date of any trade, provide the CEO&rsquo;s office and the General Counsel&rsquo;s office with all information
relating to the trade that is necessary to properly prepare a Form 4 or other Section 16 Report. Such Section 16 Reporting Persons
must also execute a Form 4 or other Section 16 Report (either individually or through a duly authorized power of attorney) within
a sufficient amount of time to allow the CEO&rsquo;s office and the General Counsel&rsquo;s office to electronically file the
Form 4 via the SEC&rsquo;s Electronic Data Gathering, Analysis, and Retrieval system before the end of the second business day
following the trade.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Reporting
Insiders&rdquo; within the meaning of National Instrument 55-104 &ndash; <I>Insider Reporting Requirements and Exemptions</I>
(including members of the Board, executive officers and significant shareholders) are required under applicable Canadian securities
legislation to report their trades of Company Securities on the System for Electronic Disclosure by Insiders, commonly known as
&ldquo;SEDI&rdquo; in Canada. These reports are required within five days of the trade. In addition, a Reporting Insider is required
to file an insider trading report within 10 days after becoming a Reporting Insider, disclosing such person&rsquo;s beneficial
ownership of, or control or direction over Company Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>POST-TERMINATION
TRANSACTIONS</U></B>. This Policy continues to apply to transactions in Company Securities even after termination of service to,
or employment with, the Company. If an individual is in possession of Material Nonpublic Information when his or her service or
employment terminates, that individual may not trade in Company Securities until that information has become public or is no longer
material, as determined by the General Counsel or CEO. To facilitate the General Counsel&rsquo;s or CEO&rsquo;s determination,
such an individual may not trade in</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Company
Securities without first obtaining pre-clearance of the transaction from the General Counsel or CEO, in accordance with the pre-clearance
procedures set forth in &ldquo;Additional Procedures&mdash;Pre-Clearance Procedures&rdquo; above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INDIVIDUAL
RESPONSIBILITY</U></B>. Insiders have ethical and legal obligations to maintain the confidentiality of information about the Company
and to not engage in transactions in Company Securities while in possession of Material Nonpublic Information. Each Company Person
is individually responsible for making sure that he or she complies with this Policy, and that any of his or her Family Members
or Controlled Entities also comply with this Policy. In all cases, the ultimate responsibility for determining whether an individual
is in possession of Material Nonpublic Information rests with that individual, and any action on the part of Company, the General
Counsel, CEO or any other employee or director pursuant to this Policy (or otherwise) does not in any way constitute legal advice
or insulate an individual from liability under applicable securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>VIOLATIONS</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Consequences
of Violations</U>. The purchase or sale of securities while aware of Material Nonpublic Information, or the disclosure of Material
Nonpublic Information to others who then trade in Company Securities, is prohibited by U.S. federal and state laws and applicable
Canadian laws. Insider trading violations are pursued vigorously by the SEC, the U.S. Department of Justice and state enforcement
authorities. Punishment for insider trading violations is severe, and could include significant fines and imprisonment. While
the regulatory authorities concentrate their efforts on individuals who trade, or who tip inside information to others who trade,
the U.S. federal securities laws also impose potential liability on companies and other &ldquo;controlling persons&rdquo; if they
fail to take reasonable steps to prevent insider trading by company personnel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, an individual&rsquo;s failure to comply with this Policy may subject the individual to discipline by Company, including
dismissal for cause, whether or not the individual&rsquo;s failure to comply results in a violation of law. Needless to say, a
violation of law, or even an SEC investigation that does not result in prosecution, can tarnish a person&rsquo;s reputation and
irreparably damage a career.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reporting
of Violations</U>. Any Insider who violates this Policy, any U.S. federal or state or applicable Canadian law governing insider
trading, or knows of any such violation by any Insider, must report the violation immediately to the General Counsel and CEO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>7
<FILENAME>n2574_x219ex21-1.htm
<DESCRIPTION>SUBSIDIARIES OF NIOCORP DEVELOPMENTS LTD.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List
of Subsidiaries of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: #D9D9D9; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 32%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></P></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 34%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>State/Province
                                         of </B><BR>
                                         <B>Formation</B></FONT></P></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ownership</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800
    B.C. Ltd. (&ldquo;0896800&rdquo;)</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">British
    Columbia</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp. </FONT></TD>
    <TD STYLE="padding-bottom: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">79.7%<SUP>(1)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    Technologies Limited</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    Kingdom</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                         100% of Class A common stock owned by 0896800, and 4,282,116 Vested Shares and 3,391,596
                                         Earnout Shares (each as defined below) held by third parties, and outstanding as of June
                                         30, 2024.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>n2574_x219ex23-1.htm
<DESCRIPTION>CONSENT OF DELOITTE & TOUCHE LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: Black">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: fuchsia"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-size: 10pt">We consent to the incorporation by reference
in Registration Statement Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541, and 333-271266 on Form S-1, No. 333-280176 on
Form S-3 and No. </FONT>333-222313 <FONT STYLE="font-size: 10pt">on Form S-8 of our report dated September 20, 2024, relating to the financial
statements of NioCorp Developments Ltd. appearing in this Annual Report on Form 10-K for the year ended June 30, 2024.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><I>/s/ DELOITTE &amp; TOUCHE LLP</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.2pt 0 0">Denver, Colorado</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.2pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">September <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">20,
2024</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: fuchsia"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>9
<FILENAME>n2574_x219ex23-2.htm
<DESCRIPTION>CONSENT OF BDO USA, P.C.
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><B>Exhibit 23.2</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><U>Consent of Independent Registered
Public Accounting Firm</U></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 0; text-align: justify; color: fuchsia">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 0; text-align: justify">We hereby consent to the incorporation by reference
in the Registration Statements on Form S-1 (No. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541, and 333-271266), Form S-3
(No. 333-280176) and Form S-8 (No. 333-222313) of NioCorp Developments Ltd. (the Company) of our report dated October 6, 2023, relating
to the consolidated financial statements, which appears in this Annual Report on Form 10-K. Our report contains an explanatory paragraph
regarding the Company&#8217;s ability to continue as a going concern.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">/s/ BDO USA, P.C.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Spokane, WA</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 0; text-align: justify">September 20, 2024</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 0; text-align: justify; color: fuchsia">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>10
<FILENAME>n2574_x219ex23-3.htm
<DESCRIPTION>CONSENT OF DAHROUGE GEOLOGICAL CONSULTING USA LTD.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.3</B></FONT></P>

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="n2574ex2303img001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. hereby consents to the public filing of Sections 1.1 to 1.5, 1.9 to 1.11, 2 to 6, 7.1 to 7.2, 8,
9.2, 9.3, 16, 18 to 21, 22.1, 22.3, 22.9 to 22.12, 23.1.1, and 23.1.9 (the &ldquo;Covered Sections&rdquo;) of the Technical Report
Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the
&ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2024
(the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s
Registration Statement on Form S-1 (Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266),
Registration Statement on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313)
(collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately
represents the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20<SUP>th</SUP> day of September 2024 at Centennial, Colorado.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Trevor Mills</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trevor Mills, P.G., SME-RM</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Geologist / US Operations Manager</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge Geological Consulting USA Ltd.</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; margin-left: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.4
<SEQUENCE>11
<FILENAME>n2574_x219ex23-4.htm
<DESCRIPTION>CONSENT OF UNDERSTOOD MINERAL RESOURCES LTD.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.4</B>&nbsp;</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: left"><IMG SRC="n2574ex2304img001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Understood
Mineral Resources Ltd. hereby consents to the public filing of Sections 1.6, 9.1, 11 and 22.2 (the &ldquo;Covered Sections&rdquo;)
of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date
of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June 30, 2024 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Understood
Mineral Resources Ltd. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration
Statement on Form S-1 (Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration
Statement on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Understood
Mineral Resources Ltd. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Understood
Mineral Resources Ltd. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Understood
Mineral Resources Ltd. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately
represents the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20<SUP>th</SUP> day of September, 2024 at 22 Middleton Crescent, Saskatoon, Saskatchewan, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Matt Batty</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matt
    Batty, P.Geo</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owner
    and Geostatistican</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Understood
    Mineral Resources Ltd.</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.5
<SEQUENCE>12
<FILENAME>n2574_x219ex23-5.htm
<DESCRIPTION>CONSENT OF OPTIMIZE GROUP INC.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.5</B></FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: left"><IMG SRC="n2574ex2305img001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF QUALIFIED PERSON</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
Group Inc. hereby consents to the public filing of Sections 1.7, 12, 13.3 to 13.5, 15.7, 22.5 and 23.1.4 (the &ldquo;Covered Sections&rdquo;)
of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date
of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June 30, 2024 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
Group Inc. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement
on Form S-1 (Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement
on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
Group Inc. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo;
(as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with
the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
Group Inc. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference
in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
Group Inc. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents
the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20th day of September, 2024 at Toronto, Ontario, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Gavin Clow</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gavin Clow, P.Eng.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining Manager - Canada</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize Group Inc.</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.6
<SEQUENCE>13
<FILENAME>n2574_x219ex23-6.htm
<DESCRIPTION>CONSENT OF TETRA TECH
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.6</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"><IMG SRC="n2574ex2306img001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tetra
Tech hereby consents to the public filing of Sections 14.5, 15.1.1, 15.1.2, 15.2 to 15.4, 22.7 and 23.1.6 (the &ldquo;Covered
Sections&rdquo;) of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with
an Effective Date of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K
for the fiscal year ended June 30, 2024 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tetra
Tech also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on
Form S-1 (Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement
on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tetra
Tech also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo;
(as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with
the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tetra
Tech also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in
the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tetra
Tech certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20th day of September, 2024 at Salt Lake City, Utah.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ David R. Winters</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David R. Winters, SE, PE</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Project Manager and Senior Principal Engineer
    <BR>
Tetra Tech</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.7
<SEQUENCE>14
<FILENAME>n2574_x219ex23-7.htm
<DESCRIPTION>CONSENT OF ADRIAN BROWN CONSULTANTS INC.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.7</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"><IMG SRC="n2574ex2307img001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. hereby consents to the public filing of Sections 7.4.1, 7.4.2 and 13.2 (the &ldquo;Covered Sections&rdquo;)
of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date
of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June 30, 2024 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration
Statement on Form S-1 (Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration
Statement on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately
represents the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20<SUP>th</SUP> day of September 2024 at Denver, Colorado, USA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Adrian Brown</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian Brown, P.E.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Engineer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian Brown Consultants Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><IMG SRC="n2574ex2307img002.jpg" ALT=""></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.8
<SEQUENCE>15
<FILENAME>n2574_x219ex23-8.htm
<DESCRIPTION>CONSENT OF MAGEMI MINING INC.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.8</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"><IMG SRC="n2574ex2308img001.jpg" ALT=""></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. hereby consents to the public filing of Sections 10.1, 14.1.1, 14.2.1, 14.3.1, and 14.4.1 (the &ldquo;Covered Sections&rdquo;)
of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date
of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June 30, 2024 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement
on Form S-1 (Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement
on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo;
(as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with
the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference
in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents
the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20<SUP>th</SUP> day of September 2024 at North York, Ontario, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Georgi Doundarov</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Georgi Doundarov, M.SC, P.Eng., PMP, CCP</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi Mining Inc.</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.9
<SEQUENCE>16
<FILENAME>n2574_x219ex23-9.htm
<DESCRIPTION>CONSENT OF L3 PROCESS DEVELOPMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.9</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"><IMG SRC="n2574ex2309img001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development hereby consents to the public filing of Sections 10.2, 10.2.1 to 10.2.3, 14.1.2, 14.1.4, 14.2.2, 14.2.4, 14.3.2,
14.3.4, 14.4.2, 14.4.4, 22.4, 22.6, 23.1.2, and 23.1.5 (the &ldquo;Covered Sections&rdquo;) of the Technical Report Summary titled
&ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the &ldquo;Technical
Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (the &ldquo;Form
10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration
Statement on Form S-1 (Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration
Statement on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents
the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20<SUP>th</SUP> day of September 2024 at Salt Lake City.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Eric Larochelle</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric Larochelle Ing.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Owner - CEO</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3 Process Development</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.10
<SEQUENCE>17
<FILENAME>n2574_x219ex23-10.htm
<DESCRIPTION>CONSENT OF OLSSON
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.10</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"><IMG SRC="n2574ex2310img001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olsson
hereby consents to the public filing of Sections 1.8, 17, 22.8 and 23.1.7 (the &ldquo;Covered Sections&rdquo;) of the Technical
Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022
(the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30,
2024 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olsson
also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on Form
S-1 (Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement on Form
S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively, the &ldquo;Registration
Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olsson
also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo; (as
defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the
Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olsson
also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the
Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olsson
certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20<SUP>th</SUP> day of September, 2024 at Omaha, Nebraska.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brian Osborn</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Osborn</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice President</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olsson</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.11
<SEQUENCE>18
<FILENAME>n2574_x219ex23-11.htm
<DESCRIPTION>CONSENT OF A2GC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.11</B></FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: left"><IMG SRC="n2574ex2311img001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
hereby consents to the public filing of Sections 7.3, 13.1 and 23.1.3 (the &ldquo;Covered Sections&rdquo;) of the Technical Report
Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the
&ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2024
(the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statements on Form
S-1 (Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement on Form
S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively, the &ldquo;Registration
Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo; (as
defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the
Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the
Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20th day of September 2024 in Montreal, Quebec, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Patrick Andrieux</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick Andrieux, Ph.D., P.Eng., Eng.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Engineer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.12
<SEQUENCE>19
<FILENAME>n2574_x219ex23-12.htm
<DESCRIPTION>CONSENT OF METALLURGY CONCEPT SOLUTIONS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.12</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><IMG SRC="n2574ex2312img001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC hereby consents to the public filing of Sections 10.3, 14.1.3, 14.2.3, 14.3.3, and 14.4.3 (the &ldquo;Covered
Sections&rdquo;) of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with
an Effective Date of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K
for the fiscal year ended June 30, 2024 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration
Statement on Form S-1 (Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration
Statement on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately
represents the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20<SUP>th</SUP> day of September, 2024 at 50 St-Louis #103, Valleyfield, QC, Canada J6T 1M6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sylvain Harton</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sylvain Harton, P. Eng.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Metallurgist Engineer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy Concept Solutions LLC</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.13
<SEQUENCE>20
<FILENAME>n2574_x219ex23-13.htm
<DESCRIPTION>CONSENT OF SCOTT HONAN, M.SC., SME-RM, NIOCORP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.13</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><IMG SRC="n2574ex2313img001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Scott Honan, M.Sc., SME-RM, consent to the public filing of Sections 13.7.5, 13.7.6, 13.7.7, 13.7.8, 13.7.15, 15.5, 15.6 and 22.7.1
(the &ldquo;Covered Sections&rdquo;) of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project,
Nebraska&rdquo; with an Effective Date of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual
Report on Form 10-K for the fiscal year ended June 30, 2024 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on Form S-1
(Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement on Form
S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively, the &ldquo;Registration
Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the use of and references to my name, including my status as an expert or &ldquo;qualified person&rdquo; (as defined
in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K,
the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the Registration
Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
certify that I have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20<SUP>th</SUP> day of September 2024 at Centennial, Colorado, USA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Scott Honan</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott Honan, M.Sc., SME-RM</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp Developments Ltd.</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.14
<SEQUENCE>21
<FILENAME>n2574_x219ex23-14.htm
<DESCRIPTION>CONSENT OF EVERETT BIRD, P.E., CEMENTATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.14</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><IMG SRC="n2574ex2314img001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cementation
hereby consents to the public filing of Sections 13.7.1, 13.7.2, 13.7.3, 13.7.4, 13.7.12, 13.7.9, 13.7.10, 13.7.11, 13.7.13, 13.7.14,
15.1.3, 15.1.4 and 23.1.8 (the &ldquo;Covered Sections&rdquo;) of the Technical Report Summary titled &ldquo;Technical Report
Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;)
as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (the &ldquo;Form 10-K&rdquo;) of NioCorp
Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cementation
also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statements on Form
S-1 (Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement on Form
S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively, the &ldquo;Registration
Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cementation also consents to
the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo; (as defined in Subpart
1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K, the Registration
Statements and the Technical Report Summary.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cementation
also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the
Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cementation
certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20<SUP>th</SUP> day of September, 2024 at Salt Lake City, Utah.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Everett Bird</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Everett Bird, PE</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Engineering Manager</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cementation</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.15
<SEQUENCE>22
<FILENAME>n2574_x219ex23-15.htm
<DESCRIPTION>CONSENT OF MAHMOOD KHWAJA, P.E., CDM SMITH
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.15</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><IMG SRC="n2574ex2315img001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Mahmood Khwaja, P.E., consent to the public filing of Section 15.8 (the &ldquo;Covered Section&rdquo;) of the Technical Report
Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the
&ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2024
(the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the incorporation by reference of the Covered Section in the Company&rsquo;s Registration Statement on Form S-1
(Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement on Form
S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively, the &ldquo;Registration
Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the use of and references to my name, including my status as an expert or &ldquo;qualified person&rdquo; (as defined
in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K,
the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to any extracts from or a summary of the Covered Section in the Form 10-K and incorporated by reference in the Registration
Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
certify that I have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20th day of September 2024 at Boston, Massachusetts, USA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mahmood Khwaja</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mahmood Khwaja, PE</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice President / Senior Geotechnical Engineer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technical Services Unit &#9474; ISG</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDM Smith</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><IMG SRC="n2574ex2315img002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.16
<SEQUENCE>23
<FILENAME>n2574_x219ex23-16.htm
<DESCRIPTION>CONSENT OF WYNAND MARX, M.ENG., BBE CONSULTING
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.16</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex2316img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Wynand Marx, M.Eng., consent to the public filing of Section 13.6 (the &ldquo;Covered Section&rdquo;) of the Technical Report
Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the
&ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2024
(the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the incorporation by reference of the Covered Section in the Company&rsquo;s Registration Statement on Form S-1
(Registration Nos. 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement on Form
S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively, the &ldquo;Registration
Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the use of and references to my name, including my status as an expert or &ldquo;qualified person&rdquo; (as defined
in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K,
the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to any extracts from or a summary of the Covered Section in the Form 10-K and incorporated by reference in the Registration
Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
certify that I have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 20<SUP>th</SUP> day of September 2024 at Johannesburg, South Africa.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="text-align: justify; width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
                            Wynand Marx</FONT></TD>
</TR>                                                                           <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Wynand
Marx, M.Eng.</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief
Operating Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">BBE
Consulting</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>24
<FILENAME>n2574_x219ex31-1.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Mark A. Smith, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this Annual Report on Form 10-K of NioCorp Developments Ltd.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make&nbsp;the&nbsp;statements made, in light of&nbsp;the&nbsp;circumstances under which such statements were made, not misleading
with respect to&nbsp;the&nbsp;period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge,&nbsp;the&nbsp;financial statements, and other financial information included in this report, fairly present
in all material respects the&nbsp;financial condition, results of operations and cash flows of&nbsp;the&nbsp;registrant as of,
and for,&nbsp;the&nbsp;periods presented in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;The&nbsp;registrant's
other&nbsp;certifying&nbsp;officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for&nbsp;the&nbsp;registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to&nbsp;the&nbsp;registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during&nbsp;the&nbsp;period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding&nbsp;the&nbsp;reliability of financial reporting and&nbsp;the&nbsp;preparation
of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Evaluated&nbsp;the&nbsp;effectiveness of&nbsp;the&nbsp;registrant's disclosure controls and procedures and presented in this report
our conclusions about&nbsp;the effectiveness of&nbsp;the&nbsp;disclosure controls and procedures, as of&nbsp;the&nbsp;end of&nbsp;the&nbsp;period
covered by this report based on such evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Disclosed in this report any change in&nbsp;the&nbsp;registrant's internal control over financial reporting that occurred during&nbsp;the&nbsp;registrant's
most recent fiscal quarter (the&nbsp;registrant's fourth fiscal quarter in&nbsp;the&nbsp;case of an annual report) that has materially
affected, or is reasonably likely to materially affect,&nbsp;the&nbsp;registrant's internal control over financial reporting;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&nbsp;The&nbsp;registrant's
other&nbsp;certifying&nbsp;officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to&nbsp;the&nbsp;registrant's auditors and&nbsp;the&nbsp;audit committee of&nbsp;the&nbsp;registrant's board of directors
(or persons performing&nbsp;the&nbsp;equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All significant deficiencies and material weaknesses in&nbsp;the&nbsp;design or operation of internal control over financial reporting
which are reasonably likely to adversely affect&nbsp;the&nbsp;registrant's ability to record, process, summarize and report financial
information; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in&nbsp;the&nbsp;registrant's
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 54%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
September 20, 2024</FONT></P></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Mark A. Smith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark A. Smith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
        Executive Officer)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>25
<FILENAME>n2574_x219ex31-2.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Neal Shah, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this Annual Report on Form 10-K of NioCorp Developments Ltd.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make&nbsp;the&nbsp;statements made, in light of&nbsp;the&nbsp;circumstances under which such statements were made, not misleading
with respect to&nbsp;the&nbsp;period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge,&nbsp;the&nbsp;financial statements, and other financial information included in this report, fairly present
in all material respects the&nbsp;financial condition, results of operations and cash flows of&nbsp;the&nbsp;registrant as of,
and for,&nbsp;the&nbsp;periods presented in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;The&nbsp;registrant's
other&nbsp;certifying&nbsp;officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for&nbsp;the&nbsp;registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to&nbsp;the&nbsp;registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during&nbsp;the&nbsp;period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding&nbsp;the&nbsp;reliability of financial reporting and&nbsp;the&nbsp;preparation
of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Evaluated&nbsp;the&nbsp;effectiveness of&nbsp;the&nbsp;registrant's disclosure controls and procedures and presented in this report
our conclusions about&nbsp;the effectiveness of&nbsp;the&nbsp;disclosure controls and procedures, as of&nbsp;the&nbsp;end of&nbsp;the&nbsp;period
covered by this report based on such evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Disclosed in this report any change in&nbsp;the&nbsp;registrant's internal control over financial reporting that occurred during&nbsp;the&nbsp;registrant's
most recent fiscal quarter (the&nbsp;registrant's fourth fiscal quarter in&nbsp;the&nbsp;case of an annual report) that has materially
affected, or is reasonably likely to materially affect,&nbsp;the&nbsp;registrant's internal control over financial reporting;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&nbsp;The&nbsp;registrant's
other&nbsp;certifying&nbsp;officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to&nbsp;the&nbsp;registrant's auditors and&nbsp;the&nbsp;audit committee of&nbsp;the&nbsp;registrant's board of directors
(or persons performing&nbsp;the&nbsp;equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All significant deficiencies and material weaknesses in&nbsp;the&nbsp;design or operation of internal control over financial reporting
which are reasonably likely to adversely affect&nbsp;the&nbsp;registrant's ability to record, process, summarize and report financial
information; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in&nbsp;the&nbsp;registrant's
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 54%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
September 20, 2024</FONT></P></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Neal Shah</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal Shah</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
        Financial and Accounting Officer)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>26
<FILENAME>n2574_x219ex32-1.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report on Form 10-K of NioCorp Developments Ltd. (the &quot;Company&quot;), for the year ended June
30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &quot;Report&quot;), I, Mark Smith, Chief
Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 54%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
September 20, 2024</FONT></P></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Mark A. Smith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark A. Smith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
Executive Officer)</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>27
<FILENAME>n2574_x219ex32-2.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report on Form 10-K of NioCorp Developments Ltd. (the &quot;Company&quot;), for the year ended June
30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &quot;Report&quot;), I, Neal Shah, Chief
Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 54%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
September 20, 2024</FONT></P></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Neal Shah</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal Shah</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
Financial and Accounting Officer)</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>28
<FILENAME>n2574_x219ex97-1.htm
<DESCRIPTION>COMPENSATION CLAWBACK POLICY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
97.1</B></FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NIOCORP
DEVELOPMENTS LTD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Clawback Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effective
November 9, 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purpose</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required pursuant to the listing standards of the Nasdaq Stock Market LLC (the &ldquo;<B><I>Stock Exchange</I></B>&rdquo;), Section
10D of the Securities Exchange Act of 1934, as amended (the &ldquo;<B><I>Exchange Act</I></B>&rdquo;), and Rule 10D-1 under the
Exchange Act, the Board of Directors (the &ldquo;<B><I>Board</I></B>&rdquo;) of NioCorp Developments Ltd. (the &ldquo;<B><I>Company</I></B>&rdquo;)
has adopted this Compensation Clawback Policy (the &ldquo;<B><I>Policy</I></B>&rdquo;) to empower the Company to recover Covered
Compensation (as defined below) erroneously awarded to a Covered Officer (as defined below) in the event of an Accounting Restatement
(as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything in this Policy to the contrary, at all times, this Policy remains subject to interpretation and operation in accordance
with the final rules and regulations promulgated by the U.S. Securities and Exchange Commission (the &ldquo;<B><I>SEC</I></B>&rdquo;),
the final listing standards adopted by the Stock Exchange, and any applicable SEC or Stock Exchange guidance or interpretations
issued from time to time regarding such Covered Compensation recovery requirements (collectively, the &ldquo;<B><I>Final Guidance</I></B>&rdquo;).
Questions regarding this Policy should be directed to the Company&rsquo;s Chief Financial Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Policy
Statement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
a Clawback Exception (as defined below) applies, the Company will recover reasonably promptly from each Covered Officer the Covered
Compensation Received (as defined below) by such Covered Officer in the event that the Company is required to prepare an accounting
restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws,
including any required accounting restatement to correct an error in previously issued financial statements that is material to
the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the
current period or left uncorrected in the current period (each, an &ldquo;<B><I>Accounting Restatement</I></B>&rdquo;). If a Clawback
Exception applies with respect to a Covered Officer, the Company may forgo such recovery under this Policy from such Covered Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Covered
Officers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Policy, &ldquo;<B><I>Covered Officer</I></B>&rdquo; is defined as any current or former &ldquo;Section 16 officer&rdquo;
of the Company within the meaning of Rule 16a-1(f) under the Exchange Act, as determined by the Board. Covered Officers include,
at a minimum, &ldquo;executive officers&rdquo; as defined in Rule 3b-7 under the Exchange Act and identified under Item 401(b)
of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Covered
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Policy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Covered
                                         Compensation</I></B>&rdquo; is defined as the amount of Incentive-Based Compensation
                                         (as defined below) Received during the applicable Recovery Period (as defined below)
                                         that exceeds the amount of Incentive-Based Compensation that otherwise would have been
                                         Received during such Recovery Period had it been determined based on the relevant restated
                                         amounts, and computed without regard to any taxes paid. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive-Based
Compensation Received by a Covered Officer will only qualify as Covered Compensation if: (i) it is Received on or after October
2, 2023; (ii) it is Received after such Covered Officer begins service as a Covered Officer; (iii) such Covered Officer served
as a Covered Officer at any time during the performance period for such Incentive-Based Compensation; and (iv) it is Received
while the Company has a class of securities listed on a national securities exchange or a national securities association.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Incentive-Based Compensation based on stock price or total shareholder return, where the amount of erroneously awarded Covered
Compensation is not subject to mathematical recalculation directly from the information in an Accounting Restatement, the amount
of such Incentive-Based Compensation that is deemed to be Covered Compensation will be based on a reasonable estimate of the effect
of the Accounting Restatement on the stock price or total shareholder return upon which the Incentive-Based Compensation was Received,
and the Company will maintain and provide to the Stock Exchange documentation of the determination of such reasonable estimate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Incentive-Based
                                         Compensation</I></B>&rdquo; is defined as any compensation that is granted, earned, or
                                         vested based wholly or in part upon the attainment of a Financial Reporting Measure (as
                                         defined below). For purposes of clarity, Incentive-Based Compensation includes compensation
                                         that is in any plan, other than tax-qualified retirement plans, including long term disability,
                                         life insurance, and supplemental executive retirement plans, and any other compensation
                                         that is based on such Incentive-Based Compensation, such as earnings accrued on notional
                                         amounts of Incentive-Based Compensation contributed to such plans. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Financial
                                         Reporting Measure</I></B>&rdquo; is defined as a measure that is determined and presented
                                         in accordance with the accounting principles used in preparing the Company&rsquo;s financial
                                         statements, and any measures that are derived wholly or in part from such measures. Stock
                                         price and total shareholder return are also Financial Reporting Measures. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive-Based
                                         Compensation is deemed &ldquo;<B><I>Received</I></B>&rdquo; in the Company&rsquo;s fiscal
                                         period during
which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or
grant of the Incentive-Based </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation occurs after the end of that period.</FONT></TD></TR>
</TABLE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Recovery
Period</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Policy, the applicable &ldquo;<B><I>Recovery Period</I></B>&rdquo; is defined as the three completed fiscal years
immediately preceding the Trigger Date (as defined below) and, if applicable, any transition period resulting from a change in
the Company&rsquo;s fiscal year within or immediately following those three completed fiscal years (provided, however, that if
a transition period between the last day of the Company&rsquo;s previous fiscal year end and the first day of its new fiscal year
comprises a period of nine to 12 months, such period would be deemed to be a completed fiscal year).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Policy, the &ldquo;<B><I>Trigger Date</I></B>&rdquo; as of which the Company is required to prepare an Accounting
Restatement is the earlier to occur of: (i) the date that the Board, or officers authorized to take action if Board action is
not required, concludes, or reasonably should have concluded, that the Company is required to prepare the Accounting Restatement
or (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare the Accounting Restatement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clawback
Exceptions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to recover all Covered Compensation Received by a Covered Officer in the event of an Accounting Restatement
unless (i) one of the following conditions are met and (ii) the Committee has made a determination that recovery would be impracticable
in accordance with Rule 10D-1 under the Exchange Act (under such circumstances, a &ldquo;<B><I>Clawback Exception</I></B>&rdquo;
applies):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         direct expense paid to a third party to assist in enforcing this Policy would exceed
                                         the amount to be recovered (and the Company has already made a reasonable attempt to
                                         recover such erroneously awarded Covered Compensation from such Covered Officer, has
                                         documented such reasonable attempt(s) to recover, and has provided such documentation
                                         to the Stock Exchange);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recovery
                                         would violate home country law that was adopted prior to November 28, 2022 (and the Company
                                         has already obtained an opinion of home country counsel, acceptable to the Stock Exchange,
                                         that recovery would result in such a violation, and provided such opinion to the Stock
                                         Exchange); or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recovery
                                         would likely cause an otherwise tax-qualified retirement plan, under which benefits are
                                         broadly available to employees of the Company, to fail to meet the requirements of Section
                                         401(a)(13) or Section 411(a) of the Internal Revenue Code of 1986, as amended, and regulations
                                         thereunder. For purposes of clarity, this Clawback Exception only applies to tax-qualified
                                         retirement plans and does not apply to other plans, including long term disability, life
                                         insurance, and supplemental executive  </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">retirement plans, or any other compensation that
                                         is based on Incentive-Based Compensation in such plans, such as earnings accrued on notional
                                         amounts of Incentive-Based Compensation contributed to such plans. </FONT></TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prohibitions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is prohibited from paying or reimbursing the cost of insurance for, or indemnifying, any Covered Officer against the loss
of erroneously awarded Covered Compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Administration
and Interpretation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board will administer this Policy in accordance with the Final Guidance, and will have full and exclusive authority and discretion
to supplement, amend, repeal, interpret, terminate, construe, modify, replace and/or enforce (in whole or in part) this Policy,
including the authority to correct any defect, supply any omission or reconcile any ambiguity, inconsistency or conflict in the
Policy, subject to the Final Guidance. The Board will review the Policy from time to time and will have full and exclusive authority
to take any action it deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board will have the authority to offset any compensation or benefit amounts that become due to the applicable Covered Officers
to the extent permissible under Section 409A of the Internal Revenue Code of 1986, as amended, and as it deems necessary or desirable
to recover any Covered Compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Covered Officer, upon being so designated or assuming such position, is required to execute and deliver to the Company&rsquo;s
Chief Financial Officer an acknowledgment of and consent to this Policy, in a form reasonably acceptable to and provided by the
Company from time to time, (i) acknowledging and consenting to be bound by the terms of this Policy, (ii) agreeing to fully cooperate
with the Company in connection with any of such Covered Officer&rsquo;s obligations to the Company pursuant to this Policy, and
(iii) agreeing that the Company may enforce its rights under this Policy through any and all reasonable means permitted under
applicable law as it deems necessary or desirable under this Policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy, and any recovery of Covered Compensation by the Company pursuant to this Policy that is required to be disclosed in the
Company&rsquo;s filings with the SEC, will be disclosed as required by the Securities Act of 1933, as amended, the Exchange Act,
and related rules and regulations, including the Final Guidance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>NIOCORP
DEVELOPMENTS LTD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Clawback Policy Acknowledgment and Consent</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby acknowledges that he or she has received and reviewed a copy of the Compensation Clawback Policy (the &ldquo;<B><I>Policy</I></B>&rdquo;)
of NioCorp Developments Ltd. (the &ldquo;<B><I>Company</I></B>&rdquo;), effective as of November 9, 2023, as adopted by the Company&rsquo;s
Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to such Policy, the undersigned hereby:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acknowledges
                                         that he or she has been designated as (or assumed the position of) a &ldquo;Covered Officer&rdquo;
                                         as defined in the Policy;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acknowledges
                                         and consents to the Policy;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acknowledges
                                         and consents to be bound by the terms of the Policy;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">agrees
                                         to fully cooperate with the Company in connection with any of the undersigned&rsquo;s
                                         obligations to the Company pursuant to the Policy; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">agrees
                                         that the Company may enforce its rights under the Policy through any and all reasonable
                                         means permitted under applicable law as the Company deems necessary or desirable under
                                         the Policy.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 40%"></TD><TD STYLE="text-align: justify; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACKNOWLEDGED
AND AGREED:</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 80%">                                                                                                                                     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 40%"></TD><TD STYLE="text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 75%">                                                                                                                                     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 40%"></TD><TD STYLE="text-align: justify; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>[Compensation
Clawback Policy Acknowledgment and Consent]</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>29
<FILENAME>niobf-20240630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9qw5o7xRiXgen8uEZ3ZcSa+EGaOdz511yZlBtWl+HTkqTygiOMzX7y+Gz9z2kQAF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:niobf="http://niocorp.com/20240630" elementFormDefault="qualified" targetNamespace="http://niocorp.com/20240630">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://niocorp.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" id="StatementsOfOperationsAndComprehensiveLoss">
          <link:definition>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000005 - Statement - Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest" id="StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest">
          <link:definition>00000006 - Statement - Consolidated Statements of Shareholders' Equity (Deficit) and Redeemable Noncontrolling Interest</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DescriptionOfBusiness" id="DescriptionOfBusiness">
          <link:definition>00000007 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BasisOfPreparation" id="BasisOfPreparation">
          <link:definition>00000008 - Disclosure - BASIS OF PREPARATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
          <link:definition>00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GoingConcernIssues" id="GoingConcernIssues">
          <link:definition>00000010 - Disclosure - GOING CONCERN ISSUES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GxiiTransaction" id="GxiiTransaction">
          <link:definition>00000011 - Disclosure - 2023 GXII TRANSACTION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LandAndBuildingsNet" id="LandAndBuildingsNet">
          <link:definition>00000012 - Disclosure - LAND AND BUILDINGS, NET</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/MineralProperties" id="MineralProperties">
          <link:definition>00000013 - Disclosure - MINERAL PROPERTIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
          <link:definition>00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebt" id="ConvertibleDebt">
          <link:definition>00000015 - Disclosure - CONVERTIBLE DEBT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" id="ClassBCommonStockOfEcrc">
          <link:definition>00000016 - Disclosure - CLASS B COMMON STOCK OF ECRC</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonShares" id="CommonShares">
          <link:definition>00000017 - Disclosure - COMMON SHARES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" id="RelatedPartyTransactionsAndBalances">
          <link:definition>00000018 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ExplorationExpenditures" id="ExplorationExpenditures">
          <link:definition>00000019 - Disclosure - EXPLORATION EXPENDITURES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/Leases" id="Leases">
          <link:definition>00000020 - Disclosure - LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000021 - Disclosure - INCOME TAXES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FairValueMeasurements" id="FairValueMeasurements">
          <link:definition>00000022 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000023 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
          <link:definition>00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BasisOfPreparationTables" id="BasisOfPreparationTables">
          <link:definition>00000025 - Disclosure - BASIS OF PREPARATION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
          <link:definition>00000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GxiiTransactionTables" id="GxiiTransactionTables">
          <link:definition>00000027 - Disclosure - 2023 GXII TRANSACTION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LandAndBuildingsNetTables" id="LandAndBuildingsNetTables">
          <link:definition>00000028 - Disclosure - LAND AND BUILDINGS, NET (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
          <link:definition>00000029 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtTables" id="ConvertibleDebtTables">
          <link:definition>00000030 - Disclosure - CONVERTIBLE DEBT (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" id="ClassBCommonStockOfEcrcTables">
          <link:definition>00000031 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesTables" id="CommonSharesTables">
          <link:definition>00000032 - Disclosure - COMMON SHARES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" id="RelatedPartyTransactionsAndBalancesTables">
          <link:definition>00000033 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ExplorationExpendituresTables" id="ExplorationExpendituresTables">
          <link:definition>00000034 - Disclosure - EXPLORATION EXPENDITURES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LeasesTables" id="LeasesTables">
          <link:definition>00000035 - Disclosure - LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>00000036 - Disclosure - INCOME TAXES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
          <link:definition>00000037 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" id="TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details">
          <link:definition>00000038 - Disclosure - These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" id="DescriptionOfBusinessDetailsNarrative">
          <link:definition>00000039 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails" id="CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails">
          <link:definition>00000040 - Disclosure - The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attr (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" id="ScheduleOfExcludedFromDilutiveSecuritiesDetails">
          <link:definition>00000041 - Disclosure - Schedule of excluded from the dilutive securities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" id="SignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" id="GoingConcernIssuesDetailsNarrative">
          <link:definition>00000043 - Disclosure - GOING CONCERN ISSUES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details" id="FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details">
          <link:definition>00000044 - Disclosure - The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails" id="NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails">
          <link:definition>00000045 - Disclosure - The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GxiiTransactionDetailsNarrative" id="GxiiTransactionDetailsNarrative">
          <link:definition>00000046 - Disclosure - 2023 GXII TRANSACTION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfPropertiesDetails" id="ScheduleOfPropertiesDetails">
          <link:definition>00000047 - Disclosure - Schedule of properties (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" id="ScheduleOfAccountPayableAndAccruedLiabilitiesDetails">
          <link:definition>00000048 - Disclosure - Schedule of account payable and accrued liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" id="ScheduleOfConvertibleDebtDetails">
          <link:definition>00000049 - Disclosure - Schedule of convertible debt (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" id="ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails">
          <link:definition>00000050 - Disclosure - Changes in the Lind III Convertible Security are as follows (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails" id="FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails">
          <link:definition>00000051 - Disclosure - The following table summarizes the components of the initial loss and final loss on extinguishment: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" id="ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails">
          <link:definition>00000052 - Disclosure - The change in the fair value of the Contingent Consent Warrants is presented below: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails" id="ScheduleOfValuationDateAndProbabilityCalculatedDetails">
          <link:definition>00000053 - Disclosure - Schedule of valuation date and the probability calculated (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" id="ChangesInConvertibleDebenturesAreAsFollowsDetails">
          <link:definition>00000054 - Disclosure - Changes in the Convertible Debentures are as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" id="FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details">
          <link:definition>00000055 - Disclosure - The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails" id="FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails">
          <link:definition>00000056 - Disclosure - The following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details" id="FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details">
          <link:definition>00000057 - Disclosure - The following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details" id="FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details">
          <link:definition>00000058 - Disclosure - The following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants. (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details" id="FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details">
          <link:definition>00000059 - Disclosure - The following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June 30, 2024. (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" id="ConvertibleDebtDetailsNarrative">
          <link:definition>00000060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" id="FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details">
          <link:definition>00000061 - Disclosure - The following table discloses the primary inputs into the Monte Carlo models. (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details" id="FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details">
          <link:definition>00000062 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2024: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" id="ClassBCommonStockOfEcrcDetailsNarrative">
          <link:definition>00000063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfStockOptionDetails" id="ScheduleOfStockOptionDetails">
          <link:definition>00000064 - Disclosure - Schedule of stock option (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" id="FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails">
          <link:definition>00000065 - Disclosure - The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" id="WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details">
          <link:definition>00000066 - Disclosure - Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" id="AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails">
          <link:definition>00000067 - Disclosure - At June 30, 2024, the Company has outstanding exercisable warrants, as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" id="CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails">
          <link:definition>00000068 - Disclosure - The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" id="ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails">
          <link:definition>00000069 - Disclosure - The change in the Private Warrants liability is presented below: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" id="ScheduleOfExpensesAsOtherOperatingCostsDetails">
          <link:definition>00000070 - Disclosure - Schedule of expenses as other operating costs (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" id="CommonSharesDetailsNarrative">
          <link:definition>00000071 - Disclosure - COMMON SHARES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" id="ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails">
          <link:definition>00000072 - Disclosure - Changes in the Smith Credit Agreement principal balance are as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" id="RelatedPartyTransactionsAndBalancesDetailsNarrative">
          <link:definition>00000073 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" id="ScheduleOfExplorationExpendituresDetails">
          <link:definition>00000074 - Disclosure - Schedule of exploration expenditures (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" id="CompanyIncurredLeaseCostsAsFollowsDetails">
          <link:definition>00000075 - Disclosure - The Company incurred lease costs as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details" id="MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details">
          <link:definition>00000076 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2024: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
          <link:definition>00000077 - Disclosure - LEASES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails" id="DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails">
          <link:definition>00000078 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" id="FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails">
          <link:definition>00000079 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" id="DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails">
          <link:definition>00000080 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" id="ChangesInValuationAllowanceAreAsFollowsDetails">
          <link:definition>00000081 - Disclosure - Changes in the valuation allowance are as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" id="ScheduleOfCumulativeNetOperatingLossesDetails">
          <link:definition>00000082 - Disclosure - Schedule of cumulative net operating losses (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>00000083 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" id="ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails">
          <link:definition>00000084 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>00000085 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20240630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20240630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20240630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20240630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="niobf_CommonSharesWithoutParValueMember" name="CommonSharesWithoutParValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" name="WarrantsEachExercisableFor1.11829212CommonSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_RedeemableNoncontrollingInterestMember" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_Entity0896800BCLtdMember" name="Entity0896800BCLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ElkCreekResourcesCorpMember" name="ElkCreekResourcesCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ElkCreekResourcesCorpECRCMember" name="ElkCreekResourcesCorpECRCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_NioCorpTechnologiesLimitedMember" name="NioCorpTechnologiesLimitedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantAgreementMember" name="WarrantAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LegacyNioCorpShareholdersMember" name="LegacyNioCorpShareholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GXIIClassAShareholdersMember" name="GXIIClassAShareholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_OtherMember" name="OtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleConvertibleSecurityMember" name="YorkvilleConvertibleSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ConvertibleSecurityMember" name="ConvertibleSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_April2024ConvertibleSecurityMember" name="April2024ConvertibleSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LindIIIConvertibleSecurityMember" name="LindIIIConvertibleSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" name="YorkvilleConvertibleDebtFinancingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ProbabilityOfIssuanceMember" name="ProbabilityOfIssuanceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MonteCarloModelMember" name="MonteCarloModelMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutMember" name="EarnoutMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_BlackScholesMember" name="BlackScholesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_KingdonCapitalManagementLLCMember" name="KingdonCapitalManagementLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleEquityFacilityFinancingAgreementMember" name="YorkvilleEquityFacilityFinancingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GXIIPublicWarrantsMember" name="GXIIPublicWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GXIIPrivateWarrantsMember" name="GXIIPrivateWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice9.70Member" name="ExercisePrice9.70Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice8.94Member" name="ExercisePrice8.94Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice4.60Member" name="ExercisePrice4.60Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice3.54Member" name="ExercisePrice3.54Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice2.20Member" name="ExercisePrice2.20Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice3.25Member" name="ExercisePrice3.25Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice11.50Member" name="ExercisePrice11.50Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GeneralSecurityAgreementMember" name="GeneralSecurityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_NonRevolvingCreditFacilityAgreementMember" name="NonRevolvingCreditFacilityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MarkSmithMember" name="MarkSmithMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FeasibilityStudyAndEngineeringMember" name="FeasibilityStudyAndEngineeringMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FieldManagementAndOtherMember" name="FieldManagementAndOtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MetallurgicalMember" name="MetallurgicalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GeologistsAndFieldStaffMember" name="GeologistsAndFieldStaffMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CorporateOfficeMember" name="CorporateOfficeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LindConsentWarrantIssuanceMember" name="LindConsentWarrantIssuanceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutLiabilityAtFairValue" name="EarnoutLiabilityAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExplorationExpenditures" name="ExplorationExpenditures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfEarnoutLiability" name="ChangeInFairValueOfEarnoutLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfWarrantLiability" name="ChangeInFairValueOfWarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfConvertibleNotes" name="ChangeInFairValueOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ProfitLoss1" name="ProfitLoss1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarningsLossPerShareBasicAndDiluted" name="EarningsLossPerShareBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" name="TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AssumptionOfEarnoutLiability" name="AssumptionOfEarnoutLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfEarnoutShareLiability" name="ChangeInFairValueOfEarnoutShareLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AssumptionOfPrivateAndPublicWarrants" name="AssumptionOfPrivateAndPublicWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInValuationOfWarrantLiabilities" name="ChangeInValuationOfWarrantLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfConvertibleNote" name="ChangeInFairValueOfConvertibleNote" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LossesOnExtinguishmentOfDebt" name="LossesOnExtinguishmentOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FairValueOfCommitmentSharesIssued" name="FairValueOfCommitmentSharesIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ForeignCurrencyTransactionGainLossBeforeTax1" name="ForeignCurrencyTransactionGainLossBeforeTax1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_OtheroperatingGainsLosses" name="OtheroperatingGainsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ConversionsOfDebtForCommonShares" name="ConversionsOfDebtForCommonShares" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_RecognitionOfOperatingLeaseLiabilities" name="RecognitionOfOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ValueOfWarrantsIssued" name="ValueOfWarrantsIssued" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CommonSharesIssuedInTheGXIITransaction" name="CommonSharesIssuedInTheGXIITransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CommonSharesIssuedInTheGXIITransactionShares" name="CommonSharesIssuedInTheGXIITransactionShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SharesIssuedUnderTheYorkvilleEquityFacility" name="SharesIssuedUnderTheYorkvilleEquityFacility" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" name="SharesIssuedUnderTheYorkvilleEquityFacilityShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_RedeemableNoncontrollingInterest" name="RedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrivatePlacementValue" name="PrivatePlacementValue" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrivatePlacementShares" name="PrivatePlacementShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureClassBCommonStockOfEcrcAbstract" name="DisclosureClassBCommonStockOfEcrcAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" name="ScheduleOfClassBCommonStockOfECRCTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureExplorationExpendituresAbstract" name="DisclosureExplorationExpendituresAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExplorationExpendituresDisclosuresTextBlock" name="ExplorationExpendituresDisclosuresTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureLeasesAbstract" name="DisclosureLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DevelopmentStageIssuerPolicyTextBlock" name="DevelopmentStageIssuerPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MineralPropertiesPolicyTextBlock" name="MineralPropertiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ConvertibleDebtCarriedatFairValueTextBlock" name="ConvertibleDebtCarriedatFairValueTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantsPolicyTextBlock" name="WarrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutSharesPolicy" name="EarnoutSharesPolicy" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ReverseStockSplitPolicyTextBlock" name="ReverseStockSplitPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_RedeemableNoncontrollingInterestPolicyTextBlock" name="RedeemableNoncontrollingInterestPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" name="ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" name="ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfWarrantValuationTableTextblock" name="ScheduleOfWarrantValuationTableTextblock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" name="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock" name="ShareholdersEquityAndShareBasedWarrantsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" name="ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" name="ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" name="ScheduleOfOutstandingExercisableWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" name="ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfExplorationExpendituresTableTextBlock" name="ScheduleOfExplorationExpendituresTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_IncorporationStateCountryName" name="IncorporationStateCountryName" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WorkingCapitalDeficit" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CashAndCashEquivalentsAtCarryingValue1" name="CashAndCashEquivalentsAtCarryingValue1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" name="BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutSharesAssumedAtFairValue" name="EarnoutSharesAssumedAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MinimumConsentPaymentAtInception" name="MinimumConsentPaymentAtInception" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ASC470LossOnExtinguishment" name="ASC470LossOnExtinguishment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AdditionalConsentPaymentbooked" name="AdditionalConsentPaymentbooked" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInValuationOfWarrants" name="ChangeInValuationOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrincipalAndAccruedInterestConverted" name="PrincipalAndAccruedInterestConverted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ContractualInterest" name="ContractualInterest" nillable="true" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ImpliedDiscountRate" name="ImpliedDiscountRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValue" name="ChangeInFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_TransactionCost" name="TransactionCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" name="StockIssuedDuringPeriodSharesStockOptionsExercise" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" name="StockIssuedDuringPeriodSharesStockOptionsExercise1" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" name="ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DebtMaturityPeriod" name="DebtMaturityPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DescriptionOfEarnOutShares" name="DescriptionOfEarnOutShares" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleFinancingWarrants" name="YorkvilleFinancingWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" name="ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GxiiWarrants" name="GxiiWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" name="ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExpired" name="ClassOfWarrantOrRightExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceExpired" name="ClassOfWarrantOrRightExercisePriceExpired" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightGranted" name="ClassOfWarrantOrRightGranted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceGranted" name="ClassOfWarrantOrRightExercisePriceGranted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangesInFairValueOfInitialValuation" name="ChangesInFairValueOfInitialValuation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleCashFee" name="YorkvilleCashFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SaleOfStockPricePerShare1" name="SaleOfStockPricePerShare1" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AmountsAdvanced" name="AmountsAdvanced" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LineOfCreditFacilityPrepaymentFee" name="LineOfCreditFacilityPrepaymentFee" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EstablishmentFeesPayable" name="EstablishmentFeesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CostCentreAxis" name="CostCentreAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="niobf_CostCentreDomain" name="CostCentreDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FixedRentExpense" name="FixedRentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_TotalLeasePayments" name="TotalLeasePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LessAmountOfPaymentsRepresentingInterest" name="LessAmountOfPaymentsRepresentingInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LessCurrentPortionOfOperatingLeaseLiability" name="LessCurrentPortionOfOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_OperatingLeasesLiabilityNoncurrent" name="OperatingLeasesLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DiscountRate" name="DiscountRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutSharesLiability" name="EarnoutSharesLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantLiability" name="WarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GxiiTransactionCosts" name="GxiiTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ConvertibleNoteValuation" name="ConvertibleNoteValuation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EffectOfLegislativeChanges" name="EffectOfLegislativeChanges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsMineralInterest" name="DeferredTaxAssetsMineralInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" name="DeferredTaxAssetsStartupAndOorganizationalCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" name="DeferredTaxAssetsResearchAndDevelopmentCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsShareIssuanceCosts" name="DeferredTaxAssetsShareIssuanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CapitalLossesAvailableForFuturePeriods" name="CapitalLossesAvailableForFuturePeriods" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsValuationAllowanceAdditions" name="DeferredTaxAssetsValuationAllowanceAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CapitalLossCaryforward" name="CapitalLossCaryforward" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" name="AvailableForSaleSecuritiesEquitySecuritiesOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceExercised" name="ClassOfWarrantOrRightExercisePriceExercised" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice11.00Member" name="ExercisePrice11.00Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_InterestExpenseAssociatedWithConvertibleDebenturesTextBlock" name="InterestExpenseAssociatedWithConvertibleDebenturesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>30
<FILENAME>niobf-20240630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://niocorp.com/role/Cover" xlink:href="niobf-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheets" xlink:href="niobf-20240630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:href="niobf-20240630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="niobf-20240630.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfCashFlows" xlink:href="niobf-20240630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest" xlink:href="niobf-20240630.xsd#StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusiness" xlink:href="niobf-20240630.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPreparation" xlink:href="niobf-20240630.xsd#BasisOfPreparation" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPolicies" xlink:href="niobf-20240630.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernIssues" xlink:href="niobf-20240630.xsd#GoingConcernIssues" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransaction" xlink:href="niobf-20240630.xsd#GxiiTransaction" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNet" xlink:href="niobf-20240630.xsd#LandAndBuildingsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MineralProperties" xlink:href="niobf-20240630.xsd#MineralProperties" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="niobf-20240630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebt" xlink:href="niobf-20240630.xsd#ConvertibleDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:href="niobf-20240630.xsd#ClassBCommonStockOfEcrc" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonShares" xlink:href="niobf-20240630.xsd#CommonShares" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:href="niobf-20240630.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpenditures" xlink:href="niobf-20240630.xsd#ExplorationExpenditures" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/Leases" xlink:href="niobf-20240630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxes" xlink:href="niobf-20240630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurements" xlink:href="niobf-20240630.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEvents" xlink:href="niobf-20240630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:href="niobf-20240630.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPreparationTables" xlink:href="niobf-20240630.xsd#BasisOfPreparationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:href="niobf-20240630.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransactionTables" xlink:href="niobf-20240630.xsd#GxiiTransactionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:href="niobf-20240630.xsd#LandAndBuildingsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="niobf-20240630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebtTables" xlink:href="niobf-20240630.xsd#ConvertibleDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:href="niobf-20240630.xsd#ClassBCommonStockOfEcrcTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesTables" xlink:href="niobf-20240630.xsd#CommonSharesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:href="niobf-20240630.xsd#RelatedPartyTransactionsAndBalancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpendituresTables" xlink:href="niobf-20240630.xsd#ExplorationExpendituresTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesTables" xlink:href="niobf-20240630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxesTables" xlink:href="niobf-20240630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurementsTables" xlink:href="niobf-20240630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" xlink:href="niobf-20240630.xsd#TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="niobf-20240630.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails" xlink:href="niobf-20240630.xsd#CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:href="niobf-20240630.xsd#ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="niobf-20240630.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:href="niobf-20240630.xsd#GoingConcernIssuesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details" xlink:href="niobf-20240630.xsd#FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails" xlink:href="niobf-20240630.xsd#NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransactionDetailsNarrative" xlink:href="niobf-20240630.xsd#GxiiTransactionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:href="niobf-20240630.xsd#ScheduleOfPropertiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:href="niobf-20240630.xsd#ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" xlink:href="niobf-20240630.xsd#ScheduleOfConvertibleDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:href="niobf-20240630.xsd#ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails" xlink:href="niobf-20240630.xsd#FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:href="niobf-20240630.xsd#ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails" xlink:href="niobf-20240630.xsd#ScheduleOfValuationDateAndProbabilityCalculatedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:href="niobf-20240630.xsd#ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:href="niobf-20240630.xsd#FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails" xlink:href="niobf-20240630.xsd#FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details" xlink:href="niobf-20240630.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details" xlink:href="niobf-20240630.xsd#FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details" xlink:href="niobf-20240630.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:href="niobf-20240630.xsd#ConvertibleDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:href="niobf-20240630.xsd#FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details" xlink:href="niobf-20240630.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:href="niobf-20240630.xsd#ClassBCommonStockOfEcrcDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:href="niobf-20240630.xsd#ScheduleOfStockOptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:href="niobf-20240630.xsd#FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:href="niobf-20240630.xsd#WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:href="niobf-20240630.xsd#AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:href="niobf-20240630.xsd#CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:href="niobf-20240630.xsd#ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:href="niobf-20240630.xsd#ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:href="niobf-20240630.xsd#CommonSharesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:href="niobf-20240630.xsd#ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:href="niobf-20240630.xsd#RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:href="niobf-20240630.xsd#ScheduleOfExplorationExpendituresDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:href="niobf-20240630.xsd#CompanyIncurredLeaseCostsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details" xlink:href="niobf-20240630.xsd#MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesDetailsNarrative" xlink:href="niobf-20240630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails" xlink:href="niobf-20240630.xsd#DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:href="niobf-20240630.xsd#FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:href="niobf-20240630.xsd#DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:href="niobf-20240630.xsd#ChangesInValuationAllowanceAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:href="niobf-20240630.xsd#ScheduleOfCumulativeNetOperatingLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:href="niobf-20240630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:href="niobf-20240630.xsd#ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:href="niobf-20240630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssets" xlink:label="loc_us-gaapDepositsAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDepositsAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:label="loc_us-gaapLongTermInvestmentsAndReceivablesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapLongTermInvestmentsAndReceivablesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:label="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutLiabilityAtFairValue" xlink:label="loc_niobfEarnoutLiabilityAtFairValue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_niobfEarnoutLiabilityAtFairValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExplorationExpenditures" xlink:label="loc_niobfExplorationExpenditures" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_niobfExplorationExpenditures" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:label="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfEarnoutLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutLiability" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_niobfChangeInFairValueOfEarnoutLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfWarrantLiability" xlink:label="loc_niobfChangeInFairValueOfWarrantLiability" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_niobfChangeInFairValueOfWarrantLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfConvertibleNotes" xlink:label="loc_niobfChangeInFairValueOfConvertibleNotes" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_niobfChangeInFairValueOfConvertibleNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAmount" xlink:label="loc_us-gaapExtinguishmentOfDebtAmount" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapExtinguishmentOfDebtAmount" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ProfitLoss1" xlink:label="loc_niobfProfitLoss1" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfProfitLoss1" xlink:to="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfProfitLoss1" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_niobfProfitLoss1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" xlink:label="loc_us-gaapOciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" xlink:to="loc_us-gaapOciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AssumptionOfEarnoutLiability" xlink:label="loc_niobfAssumptionOfEarnoutLiability" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfAssumptionOfEarnoutLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutShareLiability" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfChangeInFairValueOfEarnoutShareLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AssumptionOfPrivateAndPublicWarrants" xlink:label="loc_niobfAssumptionOfPrivateAndPublicWarrants" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfAssumptionOfPrivateAndPublicWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInValuationOfWarrantLiabilities" xlink:label="loc_niobfChangeInValuationOfWarrantLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfChangeInValuationOfWarrantLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfConvertibleNote" xlink:label="loc_niobfChangeInFairValueOfConvertibleNote" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfChangeInFairValueOfConvertibleNote" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LossesOnExtinguishmentOfDebt" xlink:label="loc_niobfLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FairValueOfCommitmentSharesIssued" xlink:label="loc_niobfFairValueOfCommitmentSharesIssued" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfFairValueOfCommitmentSharesIssued" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ForeignCurrencyTransactionGainLossBeforeTax1" xlink:label="loc_niobfForeignCurrencyTransactionGainLossBeforeTax1" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfForeignCurrencyTransactionGainLossBeforeTax1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaapOperatingLeaseImpairmentLoss" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseImpairmentLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_OtheroperatingGainsLosses" xlink:label="loc_niobfOtheroperatingGainsLosses" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfOtheroperatingGainsLosses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfAssumptionOfEarnoutLiability" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfChangeInFairValueOfEarnoutShareLiability" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfAssumptionOfPrivateAndPublicWarrants" xlink:type="arc" weight="1" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfChangeInValuationOfWarrantLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfChangeInFairValueOfConvertibleNote" xlink:type="arc" weight="1" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" weight="1" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfForeignCurrencyTransactionGainLossBeforeTax1" xlink:type="arc" weight="1" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseImpairmentLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfOtheroperatingGainsLosses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfProductiveAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfProductiveAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest" xlink:title="00000006 - Statement - Consolidated Statements of Shareholders&apos; Equity (Deficit) and Redeemable Noncontrolling Interest" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparation" xlink:title="00000008 - Disclosure - BASIS OF PREPARATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssues" xlink:title="00000010 - Disclosure - GOING CONCERN ISSUES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransaction" xlink:title="00000011 - Disclosure - 2023 GXII TRANSACTION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNet" xlink:title="00000012 - Disclosure - LAND AND BUILDINGS, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralProperties" xlink:title="00000013 - Disclosure - MINERAL PROPERTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebt" xlink:title="00000015 - Disclosure - CONVERTIBLE DEBT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:title="00000016 - Disclosure - CLASS B COMMON STOCK OF ECRC" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonShares" xlink:title="00000017 - Disclosure - COMMON SHARES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000018 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpenditures" xlink:title="00000019 - Disclosure - EXPLORATION EXPENDITURES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Leases" xlink:title="00000020 - Disclosure - LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurements" xlink:title="00000022 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparationTables" xlink:title="00000025 - Disclosure - BASIS OF PREPARATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransactionTables" xlink:title="00000027 - Disclosure - 2023 GXII TRANSACTION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:title="00000028 - Disclosure - LAND AND BUILDINGS, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000029 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtTables" xlink:title="00000030 - Disclosure - CONVERTIBLE DEBT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:title="00000031 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesTables" xlink:title="00000032 - Disclosure - COMMON SHARES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:title="00000033 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpendituresTables" xlink:title="00000034 - Disclosure - EXPLORATION EXPENDITURES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesTables" xlink:title="00000035 - Disclosure - LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesTables" xlink:title="00000036 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurementsTables" xlink:title="00000037 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" xlink:title="00000038 - Disclosure - These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="00000039 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails" xlink:title="00000040 - Disclosure - The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attr (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:title="00000041 - Disclosure - Schedule of excluded from the dilutive securities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:title="00000043 - Disclosure - GOING CONCERN ISSUES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details" xlink:title="00000044 - Disclosure - The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails" xlink:title="00000045 - Disclosure - The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransactionDetailsNarrative" xlink:title="00000046 - Disclosure - 2023 GXII TRANSACTION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:title="00000047 - Disclosure - Schedule of properties (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:title="00000048 - Disclosure - Schedule of account payable and accrued liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" xlink:title="00000049 - Disclosure - Schedule of convertible debt (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:title="00000050 - Disclosure - Changes in the Lind III Convertible Security are as follows (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails" xlink:title="00000051 - Disclosure - The following table summarizes the components of the initial loss and final loss on extinguishment: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:title="00000052 - Disclosure - The change in the fair value of the Contingent Consent Warrants is presented below: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails" xlink:title="00000053 - Disclosure - Schedule of valuation date and the probability calculated (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:title="00000054 - Disclosure - Changes in the Convertible Debentures are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:title="00000055 - Disclosure - The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails" xlink:title="00000056 - Disclosure - The following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details" xlink:title="00000057 - Disclosure - The following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details" xlink:title="00000058 - Disclosure - The following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details" xlink:title="00000059 - Disclosure - The following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June 30, 2024. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:title="00000060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:title="00000061 - Disclosure - The following table discloses the primary inputs into the Monte Carlo models. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details" xlink:title="00000062 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2024: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:title="00000063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:title="00000064 - Disclosure - Schedule of stock option (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:title="00000065 - Disclosure - The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:title="00000066 - Disclosure - Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:title="00000067 - Disclosure - At June 30, 2024, the Company has outstanding exercisable warrants, as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:title="00000068 - Disclosure - The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:title="00000069 - Disclosure - The change in the Private Warrants liability is presented below: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:title="00000070 - Disclosure - Schedule of expenses as other operating costs (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:title="00000071 - Disclosure - COMMON SHARES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:title="00000072 - Disclosure - Changes in the Smith Credit Agreement principal balance are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:title="00000073 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:title="00000074 - Disclosure - Schedule of exploration expenditures (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:title="00000075 - Disclosure - The Company incurred lease costs as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details" xlink:title="00000076 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2024: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_TotalLeasePayments" xlink:label="loc_niobfTotalLeasePayments" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfTotalLeasePayments" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfTotalLeasePayments" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfTotalLeasePayments" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesDetailsNarrative" xlink:title="00000077 - Disclosure - LEASES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails" xlink:title="00000078 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:title="00000079 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:title="00000080 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsMineralInterest" xlink:label="loc_niobfDeferredTaxAssetsMineralInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsMineralInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:label="loc_niobfDeferredTaxAssetsStartupAndOorganizationalCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsStartupAndOorganizationalCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:label="loc_niobfDeferredTaxAssetsResearchAndDevelopmentCosts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsResearchAndDevelopmentCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:label="loc_niobfDeferredTaxAssetsShareIssuanceCosts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsShareIssuanceCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CapitalLossesAvailableForFuturePeriods" xlink:label="loc_niobfCapitalLossesAvailableForFuturePeriods" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfCapitalLossesAvailableForFuturePeriods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:title="00000081 - Disclosure - Changes in the valuation allowance are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:title="00000082 - Disclosure - Schedule of cumulative net operating losses (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000083 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:title="00000084 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000085 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>31
<FILENAME>niobf-20240630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://niocorp.com/role/Cover" xlink:href="niobf-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheets" xlink:href="niobf-20240630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:href="niobf-20240630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="niobf-20240630.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfCashFlows" xlink:href="niobf-20240630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest" xlink:href="niobf-20240630.xsd#StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusiness" xlink:href="niobf-20240630.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPreparation" xlink:href="niobf-20240630.xsd#BasisOfPreparation" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPolicies" xlink:href="niobf-20240630.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernIssues" xlink:href="niobf-20240630.xsd#GoingConcernIssues" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransaction" xlink:href="niobf-20240630.xsd#GxiiTransaction" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNet" xlink:href="niobf-20240630.xsd#LandAndBuildingsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MineralProperties" xlink:href="niobf-20240630.xsd#MineralProperties" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="niobf-20240630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebt" xlink:href="niobf-20240630.xsd#ConvertibleDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:href="niobf-20240630.xsd#ClassBCommonStockOfEcrc" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonShares" xlink:href="niobf-20240630.xsd#CommonShares" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:href="niobf-20240630.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpenditures" xlink:href="niobf-20240630.xsd#ExplorationExpenditures" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/Leases" xlink:href="niobf-20240630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxes" xlink:href="niobf-20240630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurements" xlink:href="niobf-20240630.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEvents" xlink:href="niobf-20240630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:href="niobf-20240630.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPreparationTables" xlink:href="niobf-20240630.xsd#BasisOfPreparationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:href="niobf-20240630.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransactionTables" xlink:href="niobf-20240630.xsd#GxiiTransactionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:href="niobf-20240630.xsd#LandAndBuildingsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="niobf-20240630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebtTables" xlink:href="niobf-20240630.xsd#ConvertibleDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:href="niobf-20240630.xsd#ClassBCommonStockOfEcrcTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesTables" xlink:href="niobf-20240630.xsd#CommonSharesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:href="niobf-20240630.xsd#RelatedPartyTransactionsAndBalancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpendituresTables" xlink:href="niobf-20240630.xsd#ExplorationExpendituresTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesTables" xlink:href="niobf-20240630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxesTables" xlink:href="niobf-20240630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurementsTables" xlink:href="niobf-20240630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" xlink:href="niobf-20240630.xsd#TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="niobf-20240630.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails" xlink:href="niobf-20240630.xsd#CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:href="niobf-20240630.xsd#ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="niobf-20240630.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:href="niobf-20240630.xsd#GoingConcernIssuesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details" xlink:href="niobf-20240630.xsd#FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails" xlink:href="niobf-20240630.xsd#NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransactionDetailsNarrative" xlink:href="niobf-20240630.xsd#GxiiTransactionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:href="niobf-20240630.xsd#ScheduleOfPropertiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:href="niobf-20240630.xsd#ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" xlink:href="niobf-20240630.xsd#ScheduleOfConvertibleDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:href="niobf-20240630.xsd#ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails" xlink:href="niobf-20240630.xsd#FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:href="niobf-20240630.xsd#ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails" xlink:href="niobf-20240630.xsd#ScheduleOfValuationDateAndProbabilityCalculatedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:href="niobf-20240630.xsd#ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:href="niobf-20240630.xsd#FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails" xlink:href="niobf-20240630.xsd#FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details" xlink:href="niobf-20240630.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details" xlink:href="niobf-20240630.xsd#FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details" xlink:href="niobf-20240630.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:href="niobf-20240630.xsd#ConvertibleDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:href="niobf-20240630.xsd#FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details" xlink:href="niobf-20240630.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:href="niobf-20240630.xsd#ClassBCommonStockOfEcrcDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:href="niobf-20240630.xsd#ScheduleOfStockOptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:href="niobf-20240630.xsd#FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:href="niobf-20240630.xsd#WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:href="niobf-20240630.xsd#AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:href="niobf-20240630.xsd#CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:href="niobf-20240630.xsd#ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:href="niobf-20240630.xsd#ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:href="niobf-20240630.xsd#CommonSharesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:href="niobf-20240630.xsd#ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:href="niobf-20240630.xsd#RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:href="niobf-20240630.xsd#ScheduleOfExplorationExpendituresDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:href="niobf-20240630.xsd#CompanyIncurredLeaseCostsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details" xlink:href="niobf-20240630.xsd#MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesDetailsNarrative" xlink:href="niobf-20240630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails" xlink:href="niobf-20240630.xsd#DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:href="niobf-20240630.xsd#FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:href="niobf-20240630.xsd#DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:href="niobf-20240630.xsd#ChangesInValuationAllowanceAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:href="niobf-20240630.xsd#ScheduleOfCumulativeNetOperatingLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:href="niobf-20240630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:href="niobf-20240630.xsd#ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:href="niobf-20240630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CommonSharesWithoutParValueMember" xlink:label="loc_niobfCommonSharesWithoutParValueMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfCommonSharesWithoutParValueMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:label="loc_niobfWarrantsEachExercisableFor1.11829212CommonSharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfWarrantsEachExercisableFor1.11829212CommonSharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_60" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_60" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_60" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_60" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_60" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_60" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_60" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_60" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_60" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_60" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_60" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_60" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_60" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_60" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_60" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_60" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_60" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_60" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_60" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName_60" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation_60" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId_60" xlink:type="arc" order="60" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest" xlink:title="00000006 - Statement - Consolidated Statements of Shareholders&apos; Equity (Deficit) and Redeemable Noncontrolling Interest">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_RedeemableNoncontrollingInterestMember" xlink:label="loc_niobfRedeemableNoncontrollingInterestMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfRedeemableNoncontrollingInterestMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CommonSharesIssuedInTheGXIITransaction" xlink:label="loc_niobfCommonSharesIssuedInTheGXIITransaction_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfCommonSharesIssuedInTheGXIITransaction_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CommonSharesIssuedInTheGXIITransactionShares" xlink:label="loc_niobfCommonSharesIssuedInTheGXIITransactionShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfCommonSharesIssuedInTheGXIITransactionShares_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:label="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacility_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacility_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:label="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacilityShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacilityShares_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_RedeemableNoncontrollingInterest" xlink:label="loc_niobfRedeemableNoncontrollingInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfRedeemableNoncontrollingInterest_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_PrivatePlacementValue" xlink:label="loc_niobfPrivatePlacementValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementValue_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_PrivatePlacementShares" xlink:label="loc_niobfPrivatePlacementShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementShares_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" xlink:type="arc" order="25" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparation" xlink:title="00000008 - Disclosure - BASIS OF PREPARATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssues" xlink:title="00000010 - Disclosure - GOING CONCERN ISSUES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransaction" xlink:title="00000011 - Disclosure - 2023 GXII TRANSACTION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNet" xlink:title="00000012 - Disclosure - LAND AND BUILDINGS, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralProperties" xlink:title="00000013 - Disclosure - MINERAL PROPERTIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebt" xlink:title="00000015 - Disclosure - CONVERTIBLE DEBT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:title="00000016 - Disclosure - CLASS B COMMON STOCK OF ECRC" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonShares" xlink:title="00000017 - Disclosure - COMMON SHARES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000018 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpenditures" xlink:title="00000019 - Disclosure - EXPLORATION EXPENDITURES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/Leases" xlink:title="00000020 - Disclosure - LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurements" xlink:title="00000022 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparationTables" xlink:title="00000025 - Disclosure - BASIS OF PREPARATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransactionTables" xlink:title="00000027 - Disclosure - 2023 GXII TRANSACTION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:title="00000028 - Disclosure - LAND AND BUILDINGS, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000029 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtTables" xlink:title="00000030 - Disclosure - CONVERTIBLE DEBT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:title="00000031 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesTables" xlink:title="00000032 - Disclosure - COMMON SHARES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:title="00000033 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpendituresTables" xlink:title="00000034 - Disclosure - EXPLORATION EXPENDITURES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesTables" xlink:title="00000035 - Disclosure - LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesTables" xlink:title="00000036 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurementsTables" xlink:title="00000037 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" xlink:title="00000038 - Disclosure - These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_Entity0896800BCLtdMember" xlink:label="loc_niobfEntity0896800BCLtdMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfEntity0896800BCLtdMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ElkCreekResourcesCorpMember" xlink:label="loc_niobfElkCreekResourcesCorpMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfElkCreekResourcesCorpMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ElkCreekResourcesCorpECRCMember" xlink:label="loc_niobfElkCreekResourcesCorpECRCMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfElkCreekResourcesCorpECRCMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_NioCorpTechnologiesLimitedMember" xlink:label="loc_niobfNioCorpTechnologiesLimitedMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfNioCorpTechnologiesLimitedMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_IncorporationStateCountryName" xlink:label="loc_niobfIncorporationStateCountryName_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_niobfIncorporationStateCountryName_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent_150" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="00000039 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails" xlink:title="00000040 - Disclosure - The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attr (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:title="00000041 - Disclosure - Schedule of excluded from the dilutive securities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:title="00000043 - Disclosure - GOING CONCERN ISSUES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details" xlink:title="00000044 - Disclosure - The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails" xlink:title="00000045 - Disclosure - The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapOffsettingAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LegacyNioCorpShareholdersMember" xlink:label="loc_niobfLegacyNioCorpShareholdersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfLegacyNioCorpShareholdersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GXIIClassAShareholdersMember" xlink:label="loc_niobfGXIIClassAShareholdersMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIClassAShareholdersMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_OtherMember" xlink:label="loc_niobfOtherMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfOtherMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_90" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransactionDetailsNarrative" xlink:title="00000046 - Disclosure - 2023 GXII TRANSACTION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_WarrantAgreementMember" xlink:label="loc_niobfWarrantAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfWarrantAgreementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:title="00000047 - Disclosure - Schedule of properties (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember" xlink:label="loc_us-gaapLandMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapLandMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapBuildingMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="loc_us-gaapPropertyPlantAndEquipmentOther_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentOther_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:title="00000048 - Disclosure - Schedule of account payable and accrued liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" xlink:title="00000049 - Disclosure - Schedule of convertible debt (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleConvertibleSecurityMember" xlink:label="loc_niobfYorkvilleConvertibleSecurityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfYorkvilleConvertibleSecurityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ConvertibleSecurityMember" xlink:label="loc_niobfConvertibleSecurityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfConvertibleSecurityMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_April2024ConvertibleSecurityMember" xlink:label="loc_niobfApril2024ConvertibleSecurityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfApril2024ConvertibleSecurityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtCurrent_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtNoncurrent_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:title="00000050 - Disclosure - Changes in the Lind III Convertible Security are as follows (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ConvertibleSecurityMember" xlink:label="loc_niobfConvertibleSecurityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_niobfConvertibleSecurityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtNoncurrent_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAmount" xlink:label="loc_us-gaapExtinguishmentOfDebtAmount_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapExtinguishmentOfDebtAmount_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConversionOfStockAmountIssued1_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAccretionExpense_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:label="loc_us-gaapPaymentsToAcquireHeldToMaturitySecurities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapPaymentsToAcquireHeldToMaturitySecurities_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtCurrent_40" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails" xlink:title="00000051 - Disclosure - The following table summarizes the components of the initial loss and final loss on extinguishment: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:title="00000052 - Disclosure - The change in the fair value of the Contingent Consent Warrants is presented below: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails" xlink:title="00000053 - Disclosure - Schedule of valuation date and the probability calculated (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ProbabilityOfIssuanceMember" xlink:label="loc_niobfProbabilityOfIssuanceMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_niobfProbabilityOfIssuanceMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_130" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:title="00000054 - Disclosure - Changes in the Convertible Debentures are as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:title="00000055 - Disclosure - The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails" xlink:title="00000056 - Disclosure - The following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MonteCarloModelMember" xlink:label="loc_niobfMonteCarloModelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_niobfMonteCarloModelMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ImpliedDiscountRate" xlink:label="loc_niobfImpliedDiscountRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_niobfImpliedDiscountRate_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details" xlink:title="00000057 - Disclosure - The following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details" xlink:title="00000058 - Disclosure - The following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_BlackScholesMember" xlink:label="loc_niobfBlackScholesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_niobfBlackScholesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details" xlink:title="00000059 - Disclosure - The following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June 30, 2024. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:title="00000060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LindIIIConvertibleSecurityMember" xlink:label="loc_niobfLindIIIConvertibleSecurityMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfLindIIIConvertibleSecurityMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LindIIIConvertibleSecurityMember" xlink:label="loc_niobfLindIIIConvertibleSecurityMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_niobfLindIIIConvertibleSecurityMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaapUnsecuredDebtMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapUnsecuredDebtMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRate" xlink:label="loc_us-gaapInvestmentInterestRate_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapInvestmentInterestRate_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaapOtherCommitment_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapOtherCommitment_290" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromInterestReceived" xlink:label="loc_us-gaapProceedsFromInterestReceived_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromInterestReceived_290" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTerm" xlink:label="loc_us-gaapLongTermDebtTerm_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtTerm_290" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionDescription" xlink:label="loc_us-gaapDebtConversionDescription_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtConversionDescription_290" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonUnitIssued" xlink:label="loc_us-gaapCommonUnitIssued_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapCommonUnitIssued_290" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:label="loc_us-gaapAcceleratedShareRepurchasesFinalPricePaidPerShare_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapAcceleratedShareRepurchasesFinalPricePaidPerShare_290" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_290" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_290" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_290" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntermediateLifePlantsUsefulLife" xlink:label="loc_us-gaapIntermediateLifePlantsUsefulLife_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapIntermediateLifePlantsUsefulLife_290" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapConvertibleDebtCurrent_290" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_TransactionCost" xlink:label="loc_niobfTransactionCost_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfTransactionCost_290" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:label="loc_us-gaapLineOfCreditFacilityCommitmentFeeAmount_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCommitmentFeeAmount_290" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_290" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise_290" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_290" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentTerms" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentTerms_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentTerms_290" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_290" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaapDebtInstrumentRedemptionPricePercentage_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentRedemptionPricePercentage_290" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise1_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise1_290" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaapLossContingencyAccrualAtCarryingValue_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLossContingencyAccrualAtCarryingValue_290" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingLiability" xlink:label="loc_us-gaapServicingLiability_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapServicingLiability_290" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_290" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_290" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:label="loc_niobfShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_290" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DebtMaturityPeriod" xlink:label="loc_niobfDebtMaturityPeriod_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfDebtMaturityPeriod_290" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_290" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:label="loc_us-gaapOptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapOptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_290" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_290" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_290" xlink:type="arc" order="31" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:title="00000061 - Disclosure - The following table discloses the primary inputs into the Monte Carlo models. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details" xlink:title="00000062 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2024: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAmount_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAmount_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAdditions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAdditions_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:title="00000063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DescriptionOfEarnOutShares" xlink:label="loc_niobfDescriptionOfEarnOutShares_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfDescriptionOfEarnOutShares_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:title="00000064 - Disclosure - Schedule of stock option (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:title="00000065 - Disclosure - The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:title="00000066 - Disclosure - Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:title="00000067 - Disclosure - At June 30, 2024, the Company has outstanding exercisable warrants, as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice9.70Member" xlink:label="loc_niobfExercisePrice9.70Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice9.70Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice8.94Member" xlink:label="loc_niobfExercisePrice8.94Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice8.94Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice4.60Member" xlink:label="loc_niobfExercisePrice4.60Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice4.60Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice3.54Member" xlink:label="loc_niobfExercisePrice3.54Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.54Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice2.20Member" xlink:label="loc_niobfExercisePrice2.20Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.20Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice3.25Member" xlink:label="loc_niobfExercisePrice3.25Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.25Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice11.50Member" xlink:label="loc_niobfExercisePrice11.50Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice11.50Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CAD" xlink:label="loc_currencyCAD_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_100" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:title="00000068 - Disclosure - The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharePrice_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:title="00000069 - Disclosure - The change in the Private Warrants liability is presented below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoteWarrantMember" xlink:label="loc_us-gaapNoteWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapNoteWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="loc_niobfChangesInFairValueOfInitialValuation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="loc_us-gaapServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:title="00000070 - Disclosure - Schedule of expenses as other operating costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleCashFee" xlink:label="loc_niobfYorkvilleCashFee_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_niobfYorkvilleCashFee_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOtherCostAndExpenseOperating_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses_20" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:title="00000071 - Disclosure - COMMON SHARES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CAD" xlink:label="loc_currencyCAD_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_KingdonCapitalManagementLLCMember" xlink:label="loc_niobfKingdonCapitalManagementLLCMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_niobfKingdonCapitalManagementLLCMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleEquityFacilityFinancingAgreementMember" xlink:label="loc_niobfYorkvilleEquityFacilityFinancingAgreementMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleEquityFacilityFinancingAgreementMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GXIIPublicWarrantsMember" xlink:label="loc_niobfGXIIPublicWarrantsMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPublicWarrantsMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GXIIPrivateWarrantsMember" xlink:label="loc_niobfGXIIPrivateWarrantsMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPrivateWarrantsMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_240" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_240" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_240" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SaleOfStockPricePerShare1" xlink:label="loc_niobfSaleOfStockPricePerShare1_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfSaleOfStockPricePerShare1_240" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaapProceedsFromOtherEquity_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromOtherEquity_240" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_240" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_240" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" xlink:label="loc_niobfShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_240" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_240" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_240" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOtherCostAndExpenseOperating_240" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses_240" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction_240" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNewIssuance" xlink:label="loc_us-gaapConversionOfStockNewIssuance_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockNewIssuance_240" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_240" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensation_240" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_240" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees_240" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:title="00000072 - Disclosure - Changes in the Smith Credit Agreement principal balance are as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:title="00000073 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GeneralSecurityAgreementMember" xlink:label="loc_niobfGeneralSecurityAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfGeneralSecurityAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_NonRevolvingCreditFacilityAgreementMember" xlink:label="loc_niobfNonRevolvingCreditFacilityAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfNonRevolvingCreditFacilityAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtChiefExecutiveOfficerMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MarkSmithMember" xlink:label="loc_niobfMarkSmithMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_niobfMarkSmithMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="loc_us-gaapRelatedPartyTransactionRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionRate_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LineOfCreditFacilityPrepaymentFee" xlink:label="loc_niobfLineOfCreditFacilityPrepaymentFee_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfLineOfCreditFacilityPrepaymentFee_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLongTermLineOfCredit_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EstablishmentFeesPayable" xlink:label="loc_niobfEstablishmentFeesPayable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfEstablishmentFeesPayable_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:title="00000074 - Disclosure - Schedule of exploration expenditures (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CostCentreAxis" xlink:label="loc_niobfCostCentreAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_niobfCostCentreAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CostCentreDomain" xlink:label="loc_niobfCostCentreDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_niobfCostCentreAxis" xlink:to="loc_niobfCostCentreDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CostCentreDomain" xlink:label="loc_niobfCostCentreDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_niobfCostCentreAxis" xlink:to="loc_niobfCostCentreDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FeasibilityStudyAndEngineeringMember" xlink:label="loc_niobfFeasibilityStudyAndEngineeringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFeasibilityStudyAndEngineeringMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FieldManagementAndOtherMember" xlink:label="loc_niobfFieldManagementAndOtherMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFieldManagementAndOtherMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MetallurgicalMember" xlink:label="loc_niobfMetallurgicalMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfMetallurgicalMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GeologistsAndFieldStaffMember" xlink:label="loc_niobfGeologistsAndFieldStaffMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfGeologistsAndFieldStaffMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExplorationExpense" xlink:label="loc_us-gaapExplorationExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapExplorationExpense_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:title="00000075 - Disclosure - The Company incurred lease costs as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details" xlink:title="00000076 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2024: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesDetailsNarrative" xlink:title="00000077 - Disclosure - LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CorporateOfficeMember" xlink:label="loc_niobfCorporateOfficeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_niobfCorporateOfficeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaapLesseeOperatingLeaseOptionToExtend_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseOptionToExtend_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DiscountRate" xlink:label="loc_niobfDiscountRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_niobfDiscountRate_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRemainingLeaseTerm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseRemainingLeaseTerm_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOperatingLeasePayments_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails" xlink:title="00000078 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:title="00000079 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:title="00000080 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:title="00000081 - Disclosure - Changes in the valuation allowance are as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:title="00000082 - Disclosure - Schedule of cumulative net operating losses (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000083 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CAD" xlink:label="loc_currencyCAD_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CapitalLossCaryforward" xlink:label="loc_niobfCapitalLossCaryforward_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_niobfCapitalLossCaryforward_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:title="00000084 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:label="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapNotesPayable_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapFinancialLiabilitiesFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFinancialLiabilitiesFairValueDisclosure_90" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000085 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MarkSmithMember" xlink:label="loc_niobfMarkSmithMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_niobfMarkSmithMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LindConsentWarrantIssuanceMember" xlink:label="loc_niobfLindConsentWarrantIssuanceMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfLindConsentWarrantIssuanceMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventDescription" xlink:label="loc_us-gaapSubsequentEventDescription_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventDescription_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIssuedPrincipal" xlink:label="loc_us-gaapDebtInstrumentIssuedPrincipal_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuedPrincipal_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:label="loc_us-gaapDebtInstrumentIncreaseDecreaseOtherNet_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseDecreaseOtherNet_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="loc_us-gaapLineOfCreditFacilityFairValueOfAmountOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityFairValueOfAmountOutstanding_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:label="loc_us-gaapLongTermDebtPercentageBearingVariableInterestRate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLongTermDebtPercentageBearingVariableInterestRate_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyExpenseRatioIncludingIncentiveFee" xlink:label="loc_us-gaapInvestmentCompanyExpenseRatioIncludingIncentiveFee_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapInvestmentCompanyExpenseRatioIncludingIncentiveFee_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_80" xlink:type="arc" order="8" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>32
<FILENAME>niobf-20240630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CommonSharesWithoutParValueMember" xlink:label="niobf_CommonSharesWithoutParValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesWithoutParValueMember" xlink:to="niobf_CommonSharesWithoutParValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CommonSharesWithoutParValueMember_lbl" xml:lang="en-US">Common Shares, without par value [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:label="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:to="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember_lbl" xml:lang="en-US">Warrants, each exercisable for 1.11829212 Common Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_RedeemableNoncontrollingInterestMember" xlink:label="niobf_RedeemableNoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterestMember" xlink:to="niobf_RedeemableNoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_RedeemableNoncontrollingInterestMember_lbl" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_Entity0896800BCLtdMember" xlink:label="niobf_Entity0896800BCLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_Entity0896800BCLtdMember" xlink:to="niobf_Entity0896800BCLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_Entity0896800BCLtdMember_lbl" xml:lang="en-US">Entity 0896800 B C Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ElkCreekResourcesCorpMember" xlink:label="niobf_ElkCreekResourcesCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ElkCreekResourcesCorpMember" xlink:to="niobf_ElkCreekResourcesCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ElkCreekResourcesCorpMember_lbl" xml:lang="en-US">Elk Creek Resources Corp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ElkCreekResourcesCorpECRCMember" xlink:label="niobf_ElkCreekResourcesCorpECRCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ElkCreekResourcesCorpECRCMember" xlink:to="niobf_ElkCreekResourcesCorpECRCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ElkCreekResourcesCorpECRCMember_lbl" xml:lang="en-US">Elk Creek Resources Corp ECRC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_NioCorpTechnologiesLimitedMember" xlink:label="niobf_NioCorpTechnologiesLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NioCorpTechnologiesLimitedMember" xlink:to="niobf_NioCorpTechnologiesLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_NioCorpTechnologiesLimitedMember_lbl" xml:lang="en-US">Nio Corp Technologies Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_WarrantAgreementMember" xlink:label="niobf_WarrantAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantAgreementMember" xlink:to="niobf_WarrantAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantAgreementMember_lbl" xml:lang="en-US">Warrant Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LegacyNioCorpShareholdersMember" xlink:label="niobf_LegacyNioCorpShareholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LegacyNioCorpShareholdersMember" xlink:to="niobf_LegacyNioCorpShareholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LegacyNioCorpShareholdersMember_lbl" xml:lang="en-US">Legacy Nio Corp Shareholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GXIIClassAShareholdersMember" xlink:label="niobf_GXIIClassAShareholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIClassAShareholdersMember" xlink:to="niobf_GXIIClassAShareholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GXIIClassAShareholdersMember_lbl" xml:lang="en-US">GXII Class A Shareholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_OtherMember" xlink:label="niobf_OtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtherMember" xlink:to="niobf_OtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_OtherMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandMember" xlink:to="us-gaap_LandMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandMember_lbl" xml:lang="en-US">Land [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleConvertibleSecurityMember" xlink:label="niobf_YorkvilleConvertibleSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleSecurityMember" xlink:to="niobf_YorkvilleConvertibleSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleConvertibleSecurityMember_lbl" xml:lang="en-US">Yorkville Convertible Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ConvertibleSecurityMember" xlink:label="niobf_ConvertibleSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleSecurityMember" xlink:to="niobf_ConvertibleSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ConvertibleSecurityMember_lbl" xml:lang="en-US">Convertible Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_April2024ConvertibleSecurityMember" xlink:label="niobf_April2024ConvertibleSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_April2024ConvertibleSecurityMember" xlink:to="niobf_April2024ConvertibleSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_April2024ConvertibleSecurityMember_lbl" xml:lang="en-US">April 2024 Convertible Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LindIIIConvertibleSecurityMember" xlink:label="niobf_LindIIIConvertibleSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindIIIConvertibleSecurityMember" xlink:to="niobf_LindIIIConvertibleSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LindIIIConvertibleSecurityMember_lbl" xml:lang="en-US">Lind I I I Convertible Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember" xlink:label="us-gaap_UnsecuredDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebtMember" xlink:to="us-gaap_UnsecuredDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnsecuredDebtMember_lbl" xml:lang="en-US">Unsecured Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:to="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_lbl" xml:lang="en-US">Yorkville Convertible Debt Financing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ProbabilityOfIssuanceMember" xlink:label="niobf_ProbabilityOfIssuanceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ProbabilityOfIssuanceMember" xlink:to="niobf_ProbabilityOfIssuanceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ProbabilityOfIssuanceMember_lbl" xml:lang="en-US">Probability of Issuance [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US">Measurement Input, Exercise Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MonteCarloModelMember" xlink:label="niobf_MonteCarloModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MonteCarloModelMember" xlink:to="niobf_MonteCarloModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_MonteCarloModelMember_lbl" xml:lang="en-US">Monte Carlo Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="niobf_EarnoutMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutMember" xlink:to="niobf_EarnoutMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutMember_lbl" xml:lang="en-US">Earnout [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_BlackScholesMember" xlink:label="niobf_BlackScholesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_BlackScholesMember" xlink:to="niobf_BlackScholesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_BlackScholesMember_lbl" xml:lang="en-US">Black Scholes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xml:lang="en-US">Valuation Technique, Option Pricing Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CAD" xlink:label="currency_CAD" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_CAD" xlink:to="currency_CAD_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_CAD_lbl" xml:lang="en-US">Canada, Dollars</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_KingdonCapitalManagementLLCMember" xlink:label="niobf_KingdonCapitalManagementLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_KingdonCapitalManagementLLCMember" xlink:to="niobf_KingdonCapitalManagementLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_KingdonCapitalManagementLLCMember_lbl" xml:lang="en-US">Kingdon Capital Management LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleEquityFacilityFinancingAgreementMember" xlink:label="niobf_YorkvilleEquityFacilityFinancingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleEquityFacilityFinancingAgreementMember" xlink:to="niobf_YorkvilleEquityFacilityFinancingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleEquityFacilityFinancingAgreementMember_lbl" xml:lang="en-US">Yorkville Equity Facility Financing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GXIIPublicWarrantsMember" xlink:label="niobf_GXIIPublicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPublicWarrantsMember" xlink:to="niobf_GXIIPublicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GXIIPublicWarrantsMember_lbl" xml:lang="en-US">GXII Public Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GXIIPrivateWarrantsMember" xlink:label="niobf_GXIIPrivateWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPrivateWarrantsMember" xlink:to="niobf_GXIIPrivateWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GXIIPrivateWarrantsMember_lbl" xml:lang="en-US">GXII Private Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice9.70Member" xlink:label="niobf_ExercisePrice9.70Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice9.70Member" xlink:to="niobf_ExercisePrice9.70Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice9.70Member_lbl" xml:lang="en-US">Exercise Price 9.70 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice8.94Member" xlink:label="niobf_ExercisePrice8.94Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice8.94Member" xlink:to="niobf_ExercisePrice8.94Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice8.94Member_lbl" xml:lang="en-US">Exercise Price8.94 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice4.60Member" xlink:label="niobf_ExercisePrice4.60Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice4.60Member" xlink:to="niobf_ExercisePrice4.60Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice4.60Member_lbl" xml:lang="en-US">Exercise Price4.60 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice3.54Member" xlink:label="niobf_ExercisePrice3.54Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice3.54Member" xlink:to="niobf_ExercisePrice3.54Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice3.54Member_lbl" xml:lang="en-US">Exercise Price3.54 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice2.20Member" xlink:label="niobf_ExercisePrice2.20Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice2.20Member" xlink:to="niobf_ExercisePrice2.20Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice2.20Member_lbl" xml:lang="en-US">Exercise Price2.20 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice3.25Member" xlink:label="niobf_ExercisePrice3.25Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice3.25Member" xlink:to="niobf_ExercisePrice3.25Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice3.25Member_lbl" xml:lang="en-US">Exercise Price3.25 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice11.50Member" xlink:label="niobf_ExercisePrice11.50Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice11.50Member" xlink:to="niobf_ExercisePrice11.50Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice11.50Member_lbl" xml:lang="en-US">Exercise Price11.50 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoteWarrantMember" xlink:label="us-gaap_NoteWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoteWarrantMember" xlink:to="us-gaap_NoteWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoteWarrantMember_lbl" xml:lang="en-US">Note Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GeneralSecurityAgreementMember" xlink:label="niobf_GeneralSecurityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeneralSecurityAgreementMember" xlink:to="niobf_GeneralSecurityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GeneralSecurityAgreementMember_lbl" xml:lang="en-US">General Security Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_NonRevolvingCreditFacilityAgreementMember" xlink:label="niobf_NonRevolvingCreditFacilityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NonRevolvingCreditFacilityAgreementMember" xlink:to="niobf_NonRevolvingCreditFacilityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_NonRevolvingCreditFacilityAgreementMember_lbl" xml:lang="en-US">Non Revolving Credit Facility Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MarkSmithMember" xlink:label="niobf_MarkSmithMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MarkSmithMember" xlink:to="niobf_MarkSmithMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_MarkSmithMember_lbl" xml:lang="en-US">Mark Smith [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CostCentreAxis" xlink:label="niobf_CostCentreAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CostCentreAxis" xlink:to="niobf_CostCentreAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CostCentreAxis_lbl" xml:lang="en-US">Cost Centre [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FeasibilityStudyAndEngineeringMember" xlink:label="niobf_FeasibilityStudyAndEngineeringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FeasibilityStudyAndEngineeringMember" xlink:to="niobf_FeasibilityStudyAndEngineeringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FeasibilityStudyAndEngineeringMember_lbl" xml:lang="en-US">Feasibility Study and Engineering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FieldManagementAndOtherMember" xlink:label="niobf_FieldManagementAndOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FieldManagementAndOtherMember" xlink:to="niobf_FieldManagementAndOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FieldManagementAndOtherMember_lbl" xml:lang="en-US">Field Management and Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MetallurgicalMember" xlink:label="niobf_MetallurgicalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MetallurgicalMember" xlink:to="niobf_MetallurgicalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_MetallurgicalMember_lbl" xml:lang="en-US">Metallurgical [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GeologistsAndFieldStaffMember" xlink:label="niobf_GeologistsAndFieldStaffMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeologistsAndFieldStaffMember" xlink:to="niobf_GeologistsAndFieldStaffMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GeologistsAndFieldStaffMember_lbl" xml:lang="en-US">Geologists and Field Staff [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CorporateOfficeMember" xlink:label="niobf_CorporateOfficeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CorporateOfficeMember" xlink:to="niobf_CorporateOfficeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CorporateOfficeMember_lbl" xml:lang="en-US">Corporate Office [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LindConsentWarrantIssuanceMember" xlink:label="niobf_LindConsentWarrantIssuanceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindConsentWarrantIssuanceMember" xlink:to="niobf_LindConsentWarrantIssuanceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LindConsentWarrantIssuanceMember_lbl" xml:lang="en-US">Lind Consent Warrant Issuance [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssets" xlink:label="us-gaap_DepositsAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssets" xlink:to="us-gaap_DepositsAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssets_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:label="us-gaap_LongTermInvestmentsAndReceivablesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:to="us-gaap_LongTermInvestmentsAndReceivablesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermInvestmentsAndReceivablesNet_lbl" xml:lang="en-US">Investment in equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Land and buildings, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:label="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:to="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties_lbl" xml:lang="en-US">Mineral properties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Warrant liabilities, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl" xml:lang="en-US">Convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleDebtNoncurrent_lbl" xml:lang="en-US">Convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Warrant liabilities, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutLiabilityAtFairValue" xlink:label="niobf_EarnoutLiabilityAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutLiabilityAtFairValue" xlink:to="niobf_EarnoutLiabilityAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutLiabilityAtFairValue_lbl" xml:lang="en-US">Earnout liability, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, no par value, unlimited shares authorized; 38,062,647 and 31,202,131 shares outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders&#8217; equity(deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, redeemable noncontrolling interest, and shareholders&#8217; equity (deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:label="us-gaap_CommonStockSharesAuthorizedUnlimited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:to="us-gaap_CommonStockSharesAuthorizedUnlimited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorizedUnlimited_lbl" xml:lang="en-US">Common stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US">Employee related costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExplorationExpenditures" xlink:label="niobf_ExplorationExpenditures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpenditures" xlink:to="niobf_ExplorationExpenditures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExplorationExpenditures_lbl" xml:lang="en-US">Exploration expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherGeneralExpense" xlink:label="us-gaap_OtherGeneralExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralExpense" xlink:to="us-gaap_OtherGeneralExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralExpense_lbl" xml:lang="en-US">Other operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfEarnoutLiability" xlink:label="niobf_ChangeInFairValueOfEarnoutLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ChangeInFairValueOfEarnoutLiability_lbl" xml:lang="en-US">Change in fair value of earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfWarrantLiability" xlink:label="niobf_ChangeInFairValueOfWarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfWarrantLiability" xlink:to="niobf_ChangeInFairValueOfWarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ChangeInFairValueOfWarrantLiability_lbl" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfConvertibleNotes" xlink:label="niobf_ChangeInFairValueOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNotes" xlink:to="niobf_ChangeInFairValueOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ChangeInFairValueOfConvertibleNotes_lbl" xml:lang="en-US">Change in fair value of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAmount" xlink:label="us-gaap_ExtinguishmentOfDebtAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAmount" xlink:to="us-gaap_ExtinguishmentOfDebtAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtAmount_lbl" xml:lang="en-US">Loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign exchange loss (gain)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other gains</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_lbl" xml:lang="en-US">Loss on equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ProfitLoss1" xlink:label="niobf_ProfitLoss1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ProfitLoss1" xlink:to="niobf_ProfitLoss1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="niobf_ProfitLoss1_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net loss attributable to redeemable noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net loss attributable to the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Other comprehensive loss:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Other comprehensive gain:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Reporting currency translation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Total comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" xlink:to="us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest_lbl" xml:lang="en-US">Comprehensive loss attributable to redeemable noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:to="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_lbl" xml:lang="en-US">Comprehensive loss attributable to the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarningsLossPerShareBasicAndDiluted" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarningsLossPerShareBasicAndDiluted" xlink:to="niobf_EarningsLossPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per common share, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments for:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AssumptionOfEarnoutLiability" xlink:label="niobf_AssumptionOfEarnoutLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AssumptionOfEarnoutLiability" xlink:to="niobf_AssumptionOfEarnoutLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AssumptionOfEarnoutLiability_lbl" xml:lang="en-US">Initial valuation of earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutShareLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability_lbl" xml:lang="en-US">Change in valuation of earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AssumptionOfPrivateAndPublicWarrants" xlink:label="niobf_AssumptionOfPrivateAndPublicWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AssumptionOfPrivateAndPublicWarrants" xlink:to="niobf_AssumptionOfPrivateAndPublicWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AssumptionOfPrivateAndPublicWarrants_lbl" xml:lang="en-US">Initial valuation of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInValuationOfWarrantLiabilities" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrantLiabilities" xlink:to="niobf_ChangeInValuationOfWarrantLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities_lbl" xml:lang="en-US">Change in valuation of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfConvertibleNote" xlink:label="niobf_ChangeInFairValueOfConvertibleNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNote" xlink:to="niobf_ChangeInFairValueOfConvertibleNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfConvertibleNote_lbl" xml:lang="en-US">Change in fair value of convertible note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionExpense" xlink:label="us-gaap_AccretionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpense" xlink:to="us-gaap_AccretionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionExpense_lbl" xml:lang="en-US">Accretion of convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LossesOnExtinguishmentOfDebt" xlink:label="niobf_LossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LossesOnExtinguishmentOfDebt" xlink:to="niobf_LossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_LossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FairValueOfCommitmentSharesIssued" xlink:label="niobf_FairValueOfCommitmentSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueOfCommitmentSharesIssued" xlink:to="niobf_FairValueOfCommitmentSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FairValueOfCommitmentSharesIssued_lbl" xml:lang="en-US">Yorkville share issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ForeignCurrencyTransactionGainLossBeforeTax1" xlink:label="niobf_ForeignCurrencyTransactionGainLossBeforeTax1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ForeignCurrencyTransactionGainLossBeforeTax1" xlink:to="niobf_ForeignCurrencyTransactionGainLossBeforeTax1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ForeignCurrencyTransactionGainLossBeforeTax1_lbl" xml:lang="en-US">Foreign exchange loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xml:lang="en-US">Unrealized loss on equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl" xml:lang="en-US">Noncash lease activity</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_OtheroperatingGainsLosses" xlink:label="niobf_OtheroperatingGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtheroperatingGainsLosses" xlink:to="niobf_OtheroperatingGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_OtheroperatingGainsLosses_lbl" xml:lang="en-US">Other gains</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities, Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in working capital items:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xml:lang="en-US">Proceeds from sale of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Issuance of debt, net of costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of capital stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Related party debt draws</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Related party debt repayments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Debt repayments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Share issue costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Exchange rate effect on cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Change in cash and cash equivalents during period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Amounts paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-cash investing and financing transactions:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ConversionsOfDebtForCommonShares" xlink:label="niobf_ConversionsOfDebtForCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConversionsOfDebtForCommonShares" xlink:to="niobf_ConversionsOfDebtForCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ConversionsOfDebtForCommonShares_lbl" xml:lang="en-US">Conversion of debt for common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_RecognitionOfOperatingLeaseLiabilities" xlink:label="niobf_RecognitionOfOperatingLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RecognitionOfOperatingLeaseLiabilities" xlink:to="niobf_RecognitionOfOperatingLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_RecognitionOfOperatingLeaseLiabilities_lbl" xml:lang="en-US">Recognition of operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ValueOfWarrantsIssued" xlink:label="niobf_ValueOfWarrantsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ValueOfWarrantsIssued" xlink:to="niobf_ValueOfWarrantsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ValueOfWarrantsIssued_lbl" xml:lang="en-US">Value of warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Beginning balance (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Fair value of warrants granted</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CommonSharesIssuedInTheGXIITransaction" xlink:label="niobf_CommonSharesIssuedInTheGXIITransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesIssuedInTheGXIITransaction" xlink:to="niobf_CommonSharesIssuedInTheGXIITransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CommonSharesIssuedInTheGXIITransaction_lbl" xml:lang="en-US">Common Shares issued in the GXII Transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CommonSharesIssuedInTheGXIITransactionShares" xlink:label="niobf_CommonSharesIssuedInTheGXIITransactionShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesIssuedInTheGXIITransactionShares" xlink:to="niobf_CommonSharesIssuedInTheGXIITransactionShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CommonSharesIssuedInTheGXIITransactionShares_lbl" xml:lang="en-US">Common Shares issued in the GXII Transaction (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Commitment shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Commitment shares issued (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US">Registered direct offering &#8211; May 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Registered direct offering May 2023 (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacility" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:to="niobf_SharesIssuedUnderTheYorkvilleEquityFacility_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacility_lbl" xml:lang="en-US">Yorkville equity facility draws</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:to="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares_lbl" xml:lang="en-US">Shares issued under the Yorkville equity facility (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_lbl" xml:lang="en-US">Debt conversions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Debt conversions (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Share issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_RedeemableNoncontrollingInterest" xlink:label="niobf_RedeemableNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterest" xlink:to="niobf_RedeemableNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_RedeemableNoncontrollingInterest_lbl" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Reporting currency presentation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Loss for the year</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_PrivatePlacementValue" xlink:label="niobf_PrivatePlacementValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementValue" xlink:to="niobf_PrivatePlacementValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrivatePlacementValue_lbl" xml:lang="en-US">Private placements</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_PrivatePlacementShares" xlink:label="niobf_PrivatePlacementShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementShares" xlink:to="niobf_PrivatePlacementShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrivatePlacementShares_lbl" xml:lang="en-US">Private placement (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl" xml:lang="en-US">Option liability valuations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Exchange of Class B shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Exchange of Class B shares (in shares)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Ending balance (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccounting" xlink:label="us-gaap_BasisOfAccounting" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccounting_lbl" xml:lang="en-US">BASIS OF PREPARATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">GOING CONCERN ISSUES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">2023 GXII TRANSACTION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">LAND AND BUILDINGS, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ExtractiveIndustriesAbstract" xlink:label="srt_ExtractiveIndustriesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ExtractiveIndustriesAbstract" xlink:to="srt_ExtractiveIndustriesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ExtractiveIndustriesAbstract_lbl" xml:lang="en-US">Extractive Industries [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MineralIndustriesDisclosuresTextBlock" xlink:label="us-gaap_MineralIndustriesDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MineralIndustriesDisclosuresTextBlock" xlink:to="us-gaap_MineralIndustriesDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MineralIndustriesDisclosuresTextBlock_lbl" xml:lang="en-US">MINERAL PROPERTIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">CONVERTIBLE DEBT</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="niobf_DisclosureClassBCommonStockOfEcrcAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:to="niobf_DisclosureClassBCommonStockOfEcrcAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureClassBCommonStockOfEcrcAbstract_lbl" xml:lang="en-US">Class B Common Stock Of Ecrc</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:label="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:to="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock_lbl" xml:lang="en-US">CLASS B COMMON STOCK OF ECRC</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">COMMON SHARES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS AND BALANCES</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="niobf_DisclosureExplorationExpendituresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureExplorationExpendituresAbstract" xlink:to="niobf_DisclosureExplorationExpendituresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureExplorationExpendituresAbstract_lbl" xml:lang="en-US">Exploration Expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:label="niobf_ExplorationExpendituresDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:to="niobf_ExplorationExpendituresDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExplorationExpendituresDisclosuresTextBlock_lbl" xml:lang="en-US">EXPLORATION EXPENDITURES</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="niobf_DisclosureLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureLeasesAbstract" xlink:to="niobf_DisclosureLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureLeasesAbstract_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DevelopmentStageIssuerPolicyTextBlock" xlink:label="niobf_DevelopmentStageIssuerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DevelopmentStageIssuerPolicyTextBlock" xlink:to="niobf_DevelopmentStageIssuerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DevelopmentStageIssuerPolicyTextBlock_lbl" xml:lang="en-US">Development Stage Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MineralPropertiesPolicyTextBlock" xlink:label="niobf_MineralPropertiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MineralPropertiesPolicyTextBlock" xlink:to="niobf_MineralPropertiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_MineralPropertiesPolicyTextBlock_lbl" xml:lang="en-US">Mineral Properties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ConvertibleDebtCarriedatFairValueTextBlock" xlink:label="niobf_ConvertibleDebtCarriedatFairValueTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleDebtCarriedatFairValueTextBlock" xlink:to="niobf_ConvertibleDebtCarriedatFairValueTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ConvertibleDebtCarriedatFairValueTextBlock_lbl" xml:lang="en-US">Convertible Debt Carriedat Fair Value [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_WarrantsPolicyTextBlock" xlink:label="niobf_WarrantsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsPolicyTextBlock" xlink:to="niobf_WarrantsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantsPolicyTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutSharesPolicy" xlink:label="niobf_EarnoutSharesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesPolicy" xlink:to="niobf_EarnoutSharesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutSharesPolicy_lbl" xml:lang="en-US">Earnout Shares Policy</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetRetirementObligationsPolicy" xlink:label="us-gaap_AssetRetirementObligationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationsPolicy" xlink:to="us-gaap_AssetRetirementObligationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationsPolicy_lbl" xml:lang="en-US">Asset Retirement Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ReverseStockSplitPolicyTextBlock" xlink:label="niobf_ReverseStockSplitPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ReverseStockSplitPolicyTextBlock" xlink:to="niobf_ReverseStockSplitPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ReverseStockSplitPolicyTextBlock_lbl" xml:lang="en-US">Reverse Stock Split</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:label="niobf_RedeemableNoncontrollingInterestPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:to="niobf_RedeemableNoncontrollingInterestPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_RedeemableNoncontrollingInterestPolicyTextBlock_lbl" xml:lang="en-US">Redeemable Noncontrolling Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Per Share Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_lbl" xml:lang="en-US">These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_lbl" xml:lang="en-US">Schedule of excluded from the dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl" xml:lang="en-US">The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_lbl" xml:lang="en-US">The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of properties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of account payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:to="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_lbl" xml:lang="en-US">Schedule of convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" xlink:to="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_lbl" xml:lang="en-US">Changes in the Lind III Convertible Security are as follows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:label="us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:to="us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock_lbl" xml:lang="en-US">The following table summarizes the components of the initial loss and final loss on extinguishment:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfWarrantValuationTableTextblock" xlink:label="niobf_ScheduleOfWarrantValuationTableTextblock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfWarrantValuationTableTextblock" xlink:to="niobf_ScheduleOfWarrantValuationTableTextblock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfWarrantValuationTableTextblock_lbl" xml:lang="en-US">The change in the fair value of the Contingent Consent Warrants is presented below:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" xlink:label="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" xlink:to="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_lbl" xml:lang="en-US">Schedule of valuation date and the probability calculated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xml:lang="en-US">Changes in the Convertible Debentures are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:to="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_lbl" xml:lang="en-US">The following table discloses the components of interest expense associated with the Convertible Debentures.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:label="us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:to="us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_lbl" xml:lang="en-US">The following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_lbl" xml:lang="en-US">The following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock" xlink:label="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock" xlink:to="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock_lbl" xml:lang="en-US">The following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xml:lang="en-US">The following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June 30, 2024.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:label="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:to="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_lbl" xml:lang="en-US">The following table discloses the primary inputs into the Monte Carlo models.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:label="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:to="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_lbl" xml:lang="en-US">The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2024:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xml:lang="en-US">Schedule of stock option</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">The following table summarizes the weighted average information and assumptions used to determine option costs:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:label="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_lbl" xml:lang="en-US">At June 30, 2024, the Company has outstanding exercisable warrants, as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_lbl" xml:lang="en-US">The change in the Private Warrants liability is presented below:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:label="us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:to="us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_lbl" xml:lang="en-US">Schedule of expenses as other operating costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">Changes in the Smith Credit Agreement principal balance are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:label="niobf_ScheduleOfExplorationExpendituresTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:to="niobf_ScheduleOfExplorationExpendituresTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfExplorationExpendituresTableTextBlock_lbl" xml:lang="en-US">Schedule of exploration expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">The Company incurred lease costs as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">The maturity of lease liabilities is as follows at June 30, 2024:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Domestic and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">The following table is a reconciliation of income taxes at statutory rates:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xml:lang="en-US">Changes in the valuation allowance are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xml:lang="en-US">Schedule of cumulative net operating losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xml:lang="en-US">Schedule of fair values determined by level 3 inputs are unobservable data</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_IncorporationStateCountryName" xlink:label="niobf_IncorporationStateCountryName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncorporationStateCountryName" xlink:to="niobf_IncorporationStateCountryName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_IncorporationStateCountryName_lbl" xml:lang="en-US">Country of incorporation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US">Percentage of ownership</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of reportable segments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Adjust: net loss attributable to noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss available to participating securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net loss attributable to vested shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:label="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:to="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_lbl" xml:lang="en-US">Net loss attributed to common shareholders - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average shares outstanding basic and diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarningsLossPerShareBasicAndDiluted" xlink:to="niobf_EarningsLossPerShareBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted_2_lbl" xml:lang="en-US">Loss per common share outstanding basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" xlink:label="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" xlink:to="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions_lbl" xml:lang="en-US">Options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xml:lang="en-US">Convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DilutiveSecurities" xlink:label="us-gaap_DilutiveSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DilutiveSecurities" xlink:to="us-gaap_DilutiveSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DilutiveSecurities_lbl" xml:lang="en-US">Total potentially dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xml:lang="en-US">Accrued exploration stage expense</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_WorkingCapitalDeficit" xlink:label="niobf_WorkingCapitalDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WorkingCapitalDeficit" xlink:to="niobf_WorkingCapitalDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WorkingCapitalDeficit_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CashAndCashEquivalentsAtCarryingValue1" xlink:label="niobf_CashAndCashEquivalentsAtCarryingValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CashAndCashEquivalentsAtCarryingValue1" xlink:to="niobf_CashAndCashEquivalentsAtCarryingValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CashAndCashEquivalentsAtCarryingValue1_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_lbl" xml:lang="en-US">Gross cash proceeds, net of transaction costs incurred by GXII</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xml:lang="en-US">Less:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Net liabilities assumed</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" xlink:label="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" xlink:to="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_lbl" xml:lang="en-US">Yorkville Equity Facility Financing Agreement &#8211; cash costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_lbl" xml:lang="en-US">Transaction costs expensed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_lbl" xml:lang="en-US">Non-cash costs associated with the 2023 Transactions:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_lbl" xml:lang="en-US">Private Warrants assumed at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutSharesAssumedAtFairValue" xlink:label="niobf_EarnoutSharesAssumedAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesAssumedAtFairValue" xlink:to="niobf_EarnoutSharesAssumedAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutSharesAssumedAtFairValue_lbl" xml:lang="en-US">Earnout Shares assumed at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_lbl" xml:lang="en-US">Yorkville Equity Facility Financing Agreement &#8211; shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xml:lang="en-US">&#160;Total transaction related losses incurred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable" xlink:label="us-gaap_OffsettingAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsTable" xlink:to="us-gaap_OffsettingAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsTable_lbl" xml:lang="en-US">Offsetting Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="us-gaap_OffsettingAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsLineItems" xlink:to="us-gaap_OffsettingAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsLineItems_lbl" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_4_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl" xml:lang="en-US">Number of shares, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xml:lang="en-US">Post reverse stock split shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xml:lang="en-US">Convertible shares issued upon conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xml:lang="en-US">Number of shares purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="us-gaap_PropertyPlantAndEquipmentOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentOther" xlink:to="us-gaap_PropertyPlantAndEquipmentOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentOther_lbl" xml:lang="en-US">Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Accounts payable, trade</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Trade payable accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Environmental accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Loan origination fees payable to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Total accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleDebtCurrent_2_lbl" xml:lang="en-US">Convertibled debt, current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtNoncurrent_2_lbl" xml:lang="en-US">Convertible debt, noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ConvertibleDebtNoncurrent_3_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAmount" xlink:to="us-gaap_ExtinguishmentOfDebtAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ExtinguishmentOfDebtAmount_2_lbl" xml:lang="en-US">Fair value increase due to debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="us-gaap_ConversionOfStockAmountIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl" xml:lang="en-US">Conversions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpense" xlink:to="us-gaap_AccretionExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccretionExpense_2_lbl" xml:lang="en-US">Accretion expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" xml:lang="en-US">Payment at maturity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ConvertibleDebtCurrent_3_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MinimumConsentPaymentAtInception" xlink:label="niobf_MinimumConsentPaymentAtInception" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MinimumConsentPaymentAtInception" xlink:to="niobf_MinimumConsentPaymentAtInception_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_MinimumConsentPaymentAtInception_lbl" xml:lang="en-US">Minimum Consent Payment at inception</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ASC470LossOnExtinguishment" xlink:label="niobf_ASC470LossOnExtinguishment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ASC470LossOnExtinguishment" xlink:to="niobf_ASC470LossOnExtinguishment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ASC470LossOnExtinguishment_lbl" xml:lang="en-US">Loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl" xml:lang="en-US">Initial fair value of Contingent Consent Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_lbl" xml:lang="en-US">Initial loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AdditionalConsentPaymentbooked" xlink:label="niobf_AdditionalConsentPaymentbooked" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AdditionalConsentPaymentbooked" xlink:to="niobf_AdditionalConsentPaymentbooked_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AdditionalConsentPaymentbooked_lbl" xml:lang="en-US">Additional Consent Payment booked</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnRestructuringOfDebt" xlink:label="us-gaap_GainsLossesOnRestructuringOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnRestructuringOfDebt" xlink:to="us-gaap_GainsLossesOnRestructuringOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnRestructuringOfDebt_lbl" xml:lang="en-US">Total loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Initial valuation, at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInValuationOfWarrants" xlink:label="niobf_ChangeInValuationOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrants" xlink:to="niobf_ChangeInValuationOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInValuationOfWarrants_lbl" xml:lang="en-US">Change in valuation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_2_lbl" xml:lang="en-US">Valuation, at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Probability of issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ConvertibleDebt_lbl" xml:lang="en-US">Balance, June 30, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:label="us-gaap_AccretionExpenseIncludingAssetRetirementObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:to="us-gaap_AccretionExpenseIncludingAssetRetirementObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionExpenseIncludingAssetRetirementObligations_lbl" xml:lang="en-US">Accretion expense</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_PrincipalAndAccruedInterestConverted" xlink:label="niobf_PrincipalAndAccruedInterestConverted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrincipalAndAccruedInterestConverted" xlink:to="niobf_PrincipalAndAccruedInterestConverted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_PrincipalAndAccruedInterestConverted_lbl" xml:lang="en-US">Principal and accrued interest converted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ConvertibleDebt_2_lbl" xml:lang="en-US">Balance, June 30, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xml:lang="en-US">Add: uamortized debt issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount_lbl" xml:lang="en-US">Balance, June 30, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ContractualInterest" xlink:label="niobf_ContractualInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ContractualInterest" xlink:to="niobf_ContractualInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ContractualInterest_lbl" xml:lang="en-US">Contractual interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Amortization of discount and issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndDebtExpense" xlink:label="us-gaap_InterestAndDebtExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDebtExpense" xlink:to="us-gaap_InterestAndDebtExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndDebtExpense_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Closing common share price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:to="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_lbl" xml:lang="en-US">Term (expiry)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Weighted average of the equity volatility and implied volatility of the public warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ImpliedDiscountRate" xlink:label="niobf_ImpliedDiscountRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ImpliedDiscountRate" xlink:to="niobf_ImpliedDiscountRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ImpliedDiscountRate_lbl" xml:lang="en-US">Implied discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueHedgeAssetsAtFairValue" xlink:label="us-gaap_FairValueHedgeAssetsAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueHedgeAssetsAtFairValue" xlink:to="us-gaap_FairValueHedgeAssetsAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueHedgeAssetsAtFairValue_lbl" xml:lang="en-US">Fair value, April 12, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Principal payments</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValue" xlink:label="niobf_ChangeInFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValue" xlink:to="niobf_ChangeInFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ChangeInFairValue_lbl" xml:lang="en-US">Change in fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueHedgeAssetsAtFairValue" xlink:to="us-gaap_FairValueHedgeAssetsAtFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueHedgeAssetsAtFairValue_2_lbl" xml:lang="en-US">Balance, June 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" xlink:label="us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" xlink:to="us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_lbl" xml:lang="en-US">Remaining principal balance, June 30, 2024</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Closing Common Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Term (years)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_2_lbl" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xml:lang="en-US">Face value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRate" xlink:label="us-gaap_InvestmentInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInterestRate_lbl" xml:lang="en-US">Investment Interest Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitment" xlink:label="us-gaap_OtherCommitment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitment" xlink:to="us-gaap_OtherCommitment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitment_lbl" xml:lang="en-US">Commitment fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromInterestReceived" xlink:label="us-gaap_ProceedsFromInterestReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromInterestReceived" xlink:to="us-gaap_ProceedsFromInterestReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromInterestReceived_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTerm" xlink:label="us-gaap_LongTermDebtTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTerm" xlink:to="us-gaap_LongTermDebtTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTerm_lbl" xml:lang="en-US">Long term debt duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionDescription" xlink:label="us-gaap_DebtConversionDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionDescription" xlink:to="us-gaap_DebtConversionDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionDescription_lbl" xml:lang="en-US">Debt Conversion, Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonUnitIssued" xlink:label="us-gaap_CommonUnitIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssued" xlink:to="us-gaap_CommonUnitIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonUnitIssued_lbl" xml:lang="en-US">Common share purchase warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:label="us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:to="us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_lbl" xml:lang="en-US">Exercisable at a price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntermediateLifePlantsUsefulLife" xlink:label="us-gaap_IntermediateLifePlantsUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntermediateLifePlantsUsefulLife" xlink:to="us-gaap_IntermediateLifePlantsUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntermediateLifePlantsUsefulLife_lbl" xml:lang="en-US">Expected life</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebtCurrent_4_lbl" xml:lang="en-US">Convertible debt liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_TransactionCost" xlink:label="niobf_TransactionCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TransactionCost" xlink:to="niobf_TransactionCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_TransactionCost_lbl" xml:lang="en-US">Transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl" xml:lang="en-US">Commitment fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:to="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise_lbl" xml:lang="en-US">Issuance of the convertible debentures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Aggregate exercise price, per shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentTerms" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentTerms" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentTerms_lbl" xml:lang="en-US">Debt term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Interest rate obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xml:lang="en-US">Principal percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:to="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1_lbl" xml:lang="en-US">Issuance of the convertible debentures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xml:lang="en-US">Contingent liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingLiability" xlink:label="us-gaap_ServicingLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiability" xlink:to="us-gaap_ServicingLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ServicingLiability_lbl" xml:lang="en-US">Contingent liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_3_lbl" xml:lang="en-US">Warrant liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_2_lbl" xml:lang="en-US">Fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:label="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:to="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_lbl" xml:lang="en-US">Fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DebtMaturityPeriod" xlink:label="niobf_DebtMaturityPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DebtMaturityPeriod" xlink:to="niobf_DebtMaturityPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_DebtMaturityPeriod_lbl" xml:lang="en-US">Expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xml:lang="en-US">Transaction loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:label="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:to="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_lbl" xml:lang="en-US">Option Contract Indexed to Equity, Settlement, Number of Shares, Effect of Change in Fair Value of Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_lbl" xml:lang="en-US">Fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Transaction loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_lbl" xml:lang="en-US">Implied volatility of public warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAmount" xlink:to="us-gaap_ServicingLiabilityAtFairValueAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount_lbl" xml:lang="en-US">Fair value at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:label="us-gaap_ServicingLiabilityAtFairValueAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:to="us-gaap_ServicingLiabilityAtFairValueAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServicingLiabilityAtFairValueAdditions_lbl" xml:lang="en-US">Change in fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAmount" xlink:to="us-gaap_ServicingLiabilityAtFairValueAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount_2_lbl" xml:lang="en-US">Fair value at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares, issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_5_lbl" xml:lang="en-US">Common stock, shares, outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Earnout shares</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DescriptionOfEarnOutShares" xlink:label="niobf_DescriptionOfEarnOutShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DescriptionOfEarnOutShares" xlink:to="niobf_DescriptionOfEarnOutShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DescriptionOfEarnOutShares_lbl" xml:lang="en-US">Description of earnout shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted, in shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted, per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Cancelled/expired, in shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Cancelled/expired, per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Cancelled/expired, in shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Cancelled/expired, per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Weighted average remaining contractual life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Fair value per option granted during the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected option life in years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Balance at beginning average price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleFinancingWarrants" xlink:label="niobf_YorkvilleFinancingWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleFinancingWarrants" xlink:to="niobf_YorkvilleFinancingWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleFinancingWarrants_lbl" xml:lang="en-US">Yorkville financing warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_lbl" xml:lang="en-US">Yorkville financing warrants average price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GxiiWarrants" xlink:label="niobf_GxiiWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GxiiWarrants" xlink:to="niobf_GxiiWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GxiiWarrants_lbl" xml:lang="en-US">GXII warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_lbl" xml:lang="en-US">GXII warrant average price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightExpired" xlink:label="niobf_ClassOfWarrantOrRightExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExpired" xlink:to="niobf_ClassOfWarrantOrRightExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExpired_lbl" xml:lang="en-US">Class of Warrant or Right Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired_lbl" xml:lang="en-US">Cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightGranted" xlink:label="niobf_ClassOfWarrantOrRightGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightGranted" xlink:to="niobf_ClassOfWarrantOrRightGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightGranted_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceGranted_lbl" xml:lang="en-US">Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2_lbl" xml:lang="en-US">Balance at ending average price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Number of share outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xml:lang="en-US">Expiry date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="srt_PlatformOperatorCryptoAssetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetTable" xlink:to="srt_PlatformOperatorCryptoAssetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetTable_lbl" xml:lang="en-US">Platform Operator, Crypto-Asset [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="srt_PlatformOperatorCryptoAssetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetLineItems" xlink:to="srt_PlatformOperatorCryptoAssetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetLineItems_lbl" xml:lang="en-US">Platform Operator, Crypto-Asset [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Stock price on valuation date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_3_lbl" xml:lang="en-US">Strike price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk free rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xml:lang="en-US">Expected warrant life in years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="niobf_ChangesInFairValueOfInitialValuation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="niobf_ChangesInFairValueOfInitialValuation_lbl" xml:lang="en-US">Initial valuation, at begining</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:to="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_lbl" xml:lang="en-US">Change in valuation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="niobf_ChangesInFairValueOfInitialValuation_2_lbl" xml:lang="en-US">Initial valuation, at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleCashFee" xlink:label="niobf_YorkvilleCashFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleCashFee" xlink:to="niobf_YorkvilleCashFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleCashFee_lbl" xml:lang="en-US">Yorkville Cash Fee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Fair value of Commitment Shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="us-gaap_OtherCostAndExpenseOperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostAndExpenseOperating" xlink:to="us-gaap_OtherCostAndExpenseOperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostAndExpenseOperating_lbl" xml:lang="en-US">Legal and other related costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Costs expensed to other operating expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Shares issue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Price per unit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Gross proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SaleOfStockPricePerShare1" xlink:label="niobf_SaleOfStockPricePerShare1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SaleOfStockPricePerShare1" xlink:to="niobf_SaleOfStockPricePerShare1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SaleOfStockPricePerShare1_lbl" xml:lang="en-US">Shares price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="us-gaap_ProceedsFromOtherEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromOtherEquity" xlink:to="us-gaap_ProceedsFromOtherEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl" xml:lang="en-US">Proceeds from equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3_lbl" xml:lang="en-US">Expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" xlink:label="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" xlink:to="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_lbl" xml:lang="en-US">Expected dividend rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xml:lang="en-US">Units issue and sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostAndExpenseOperating" xlink:to="us-gaap_OtherCostAndExpenseOperating_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCostAndExpenseOperating_2_lbl" xml:lang="en-US">Other operating expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingCostsAndExpenses_2_lbl" xml:lang="en-US">Employee related costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xml:lang="en-US">Description of stock transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNewIssuance" xlink:label="us-gaap_ConversionOfStockNewIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockNewIssuance" xlink:to="us-gaap_ConversionOfStockNewIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockNewIssuance_lbl" xml:lang="en-US">Conversion of Stock, New Issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xml:lang="en-US">Outstanding stock options vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share based compensation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_3_lbl" xml:lang="en-US">Warrants traded prior to the closing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:to="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xml:lang="en-US">Description of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDepositLiabilities" xlink:label="us-gaap_RelatedPartyDepositLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDepositLiabilities" xlink:to="us-gaap_RelatedPartyDepositLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_RelatedPartyDepositLiabilities_lbl" xml:lang="en-US">Related Party Deposit Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AmountsAdvanced" xlink:label="niobf_AmountsAdvanced" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AmountsAdvanced" xlink:to="niobf_AmountsAdvanced_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AmountsAdvanced_lbl" xml:lang="en-US">Amounts advanced</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Repayments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDepositLiabilities" xlink:to="us-gaap_RelatedPartyDepositLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_RelatedPartyDepositLiabilities_2_lbl" xml:lang="en-US">Related Party Deposit Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="us-gaap_RelatedPartyTransactionRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionRate" xlink:to="us-gaap_RelatedPartyTransactionRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionRate_lbl" xml:lang="en-US">Interest at a rate</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LineOfCreditFacilityPrepaymentFee" xlink:label="niobf_LineOfCreditFacilityPrepaymentFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LineOfCreditFacilityPrepaymentFee" xlink:to="niobf_LineOfCreditFacilityPrepaymentFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LineOfCreditFacilityPrepaymentFee_lbl" xml:lang="en-US">Prepayment fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLineOfCredit" xlink:label="us-gaap_LongTermLineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xml:lang="en-US">Principal amount outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EstablishmentFeesPayable" xlink:label="niobf_EstablishmentFeesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EstablishmentFeesPayable" xlink:to="niobf_EstablishmentFeesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EstablishmentFeesPayable_lbl" xml:lang="en-US">Establishment fees payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued Liabilities, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExplorationExpense" xlink:label="us-gaap_ExplorationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExplorationExpense" xlink:to="us-gaap_ExplorationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ExplorationExpense_lbl" xml:lang="en-US">Exploration expenditures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureLeasesAbstract" xlink:to="niobf_DisclosureLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_DisclosureLeasesAbstract_2_lbl" xml:lang="en-US">Company Incurred Lease Costs As Follows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US">&#160;&#160;Operating Lease Cost:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FixedRentExpense" xlink:label="niobf_FixedRentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FixedRentExpense" xlink:to="niobf_FixedRentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FixedRentExpense_lbl" xml:lang="en-US">&#160;&#160;Fixed rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableLeaseCost_lbl" xml:lang="en-US">&#160;&#160;Variable rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xml:lang="en-US">&#160;&#160;Short term lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SubleaseIncome_lbl" xml:lang="en-US">&#160;&#160;Sublease income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">&#160;&#160;Net lease cost &#8211; other operating expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureLeasesAbstract" xlink:to="niobf_DisclosureLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="niobf_DisclosureLeasesAbstract_3_lbl" xml:lang="en-US">Maturity Of Lease Liabilities Is As Follows At June 30 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_TotalLeasePayments" xlink:label="niobf_TotalLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TotalLeasePayments" xlink:to="niobf_TotalLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_TotalLeasePayments_lbl" xml:lang="en-US">Total lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LessAmountOfPaymentsRepresentingInterest" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessAmountOfPaymentsRepresentingInterest" xlink:to="niobf_LessAmountOfPaymentsRepresentingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest_lbl" xml:lang="en-US">Less amount of payments representing interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Present value of lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LessCurrentPortionOfOperatingLeaseLiability" xlink:label="niobf_LessCurrentPortionOfOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessCurrentPortionOfOperatingLeaseLiability" xlink:to="niobf_LessCurrentPortionOfOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_LessCurrentPortionOfOperatingLeaseLiability_lbl" xml:lang="en-US">Less current portion of operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_OperatingLeasesLiabilityNoncurrent" xlink:label="niobf_OperatingLeasesLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OperatingLeasesLiabilityNoncurrent" xlink:to="niobf_OperatingLeasesLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_OperatingLeasesLiabilityNoncurrent_lbl" xml:lang="en-US">Noncurrent operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xml:lang="en-US">Other lease description</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DiscountRate" xlink:label="niobf_DiscountRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DiscountRate" xlink:to="niobf_DiscountRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DiscountRate_lbl" xml:lang="en-US">Discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xml:lang="en-US">Remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Cash payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Combined Canadian federal and provincial statutory income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income tax benefit at statutory tax rates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign rate differential</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutSharesLiability" xlink:label="niobf_EarnoutSharesLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesLiability" xlink:to="niobf_EarnoutSharesLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutSharesLiability_lbl" xml:lang="en-US">Earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_WarrantLiability" xlink:label="niobf_WarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantLiability" xlink:to="niobf_WarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantLiability_lbl" xml:lang="en-US">Warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GxiiTransactionCosts" xlink:label="niobf_GxiiTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GxiiTransactionCosts" xlink:to="niobf_GxiiTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GxiiTransactionCosts_lbl" xml:lang="en-US">GXII transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xml:lang="en-US">Share based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetRetirementObligationAccretionExpense" xlink:label="us-gaap_AssetRetirementObligationAccretionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationAccretionExpense" xlink:to="us-gaap_AssetRetirementObligationAccretionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AssetRetirementObligationAccretionExpense_lbl" xml:lang="en-US">Accretion expense</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ConvertibleNoteValuation" xlink:label="niobf_ConvertibleNoteValuation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleNoteValuation" xlink:to="niobf_ConvertibleNoteValuation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ConvertibleNoteValuation_lbl" xml:lang="en-US">Convertible note valuation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtGainLossIncomeTax" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax_lbl" xml:lang="en-US">Loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EffectOfLegislativeChanges" xlink:label="niobf_EffectOfLegislativeChanges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EffectOfLegislativeChanges" xlink:to="niobf_EffectOfLegislativeChanges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EffectOfLegislativeChanges_lbl" xml:lang="en-US">Capital loss rate differential</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Change in estimates related to prior years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating losses available for future periods</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsMineralInterest" xlink:label="niobf_DeferredTaxAssetsMineralInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsMineralInterest" xlink:to="niobf_DeferredTaxAssetsMineralInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsMineralInterest_lbl" xml:lang="en-US">Mineral interests</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:label="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:to="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts_lbl" xml:lang="en-US">Startup and organizational costs</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:label="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:to="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts_lbl" xml:lang="en-US">Research and development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:label="niobf_DeferredTaxAssetsShareIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:to="niobf_DeferredTaxAssetsShareIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsShareIssuanceCosts_lbl" xml:lang="en-US">Share issuance/financing costs</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CapitalLossesAvailableForFuturePeriods" xlink:label="niobf_CapitalLossesAvailableForFuturePeriods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CapitalLossesAvailableForFuturePeriods" xlink:to="niobf_CapitalLossesAvailableForFuturePeriods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CapitalLossesAvailableForFuturePeriods_lbl" xml:lang="en-US">Capital losses available for future periods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">&#160;Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Valuation allowance, beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:label="niobf_DeferredTaxAssetsValuationAllowanceAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:to="niobf_DeferredTaxAssetsValuationAllowanceAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_DeferredTaxAssetsValuationAllowanceAdditions_lbl" xml:lang="en-US">Current year additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsIncurredDevelopmentCosts" xlink:label="us-gaap_CostsIncurredDevelopmentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsIncurredDevelopmentCosts" xlink:to="us-gaap_CostsIncurredDevelopmentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostsIncurredDevelopmentCosts_lbl" xml:lang="en-US">Startup and organizational costs acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_3_lbl" xml:lang="en-US">Valuation allowance, end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US">Federal income tax payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_4_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOtherLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards_lbl" xml:lang="en-US">Tax losses incurred</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CapitalLossCaryforward" xlink:label="niobf_CapitalLossCaryforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CapitalLossCaryforward" xlink:to="niobf_CapitalLossCaryforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CapitalLossCaryforward_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:to="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_3_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventDescription" xlink:label="us-gaap_SubsequentEventDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventDescription" xlink:to="us-gaap_SubsequentEventDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventDescription_lbl" xml:lang="en-US">Subsequent event description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIssuedPrincipal" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuedPrincipal" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal_lbl" xml:lang="en-US">Aggregate principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:label="us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:to="us-gaap_DebtInstrumentIncreaseDecreaseOtherNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseDecreaseOtherNet_lbl" xml:lang="en-US">Increased the amounts due</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_lbl" xml:lang="en-US">Line of credit facility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingVariableInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:to="us-gaap_LongTermDebtPercentageBearingVariableInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtPercentageBearingVariableInterestRate_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyExpenseRatioIncludingIncentiveFee" xlink:label="us-gaap_InvestmentCompanyExpenseRatioIncludingIncentiveFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyExpenseRatioIncludingIncentiveFee" xlink:to="us-gaap_InvestmentCompanyExpenseRatioIncludingIncentiveFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyExpenseRatioIncludingIncentiveFee_lbl" xml:lang="en-US">Establishment fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Number of share issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xml:lang="en-US">Warrants issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:to="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember_doc" xml:lang="en-US">The element represents  warrants each exercisable for1.11829212 common shares member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesWithoutParValueMember" xlink:to="niobf_CommonSharesWithoutParValueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CommonSharesWithoutParValueMember_doc" xml:lang="en-US">The element represents common shares without par value member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncorporationStateCountryName" xlink:to="niobf_IncorporationStateCountryName_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_IncorporationStateCountryName_doc" xml:lang="en-US">The element represents incorporation state country name.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_Entity0896800BCLtdMember" xlink:to="niobf_Entity0896800BCLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_Entity0896800BCLtdMember_doc" xml:lang="en-US">The element represents entity 0896800 b c ltd member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ElkCreekResourcesCorpMember" xlink:to="niobf_ElkCreekResourcesCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ElkCreekResourcesCorpMember_doc" xml:lang="en-US">The element represents elk creek resources corp member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ElkCreekResourcesCorpECRCMember" xlink:to="niobf_ElkCreekResourcesCorpECRCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ElkCreekResourcesCorpECRCMember_doc" xml:lang="en-US">The element represents elk creek resources corp ecrc member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NioCorpTechnologiesLimitedMember" xlink:to="niobf_NioCorpTechnologiesLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_NioCorpTechnologiesLimitedMember_doc" xml:lang="en-US">The element represents  nio corp technologies limited member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DevelopmentStageIssuerPolicyTextBlock" xlink:to="niobf_DevelopmentStageIssuerPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DevelopmentStageIssuerPolicyTextBlock_doc" xml:lang="en-US">The element represents  development stage issuer policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MineralPropertiesPolicyTextBlock" xlink:to="niobf_MineralPropertiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MineralPropertiesPolicyTextBlock_doc" xml:lang="en-US">The element represents  mineral properties policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsPolicyTextBlock" xlink:to="niobf_WarrantsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantsPolicyTextBlock_doc" xml:lang="en-US">The element represents  warrants policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleDebtCarriedatFairValueTextBlock" xlink:to="niobf_ConvertibleDebtCarriedatFairValueTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ConvertibleDebtCarriedatFairValueTextBlock_doc" xml:lang="en-US">The element represents  convertible debt carriedat fair value text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesPolicy" xlink:to="niobf_EarnoutSharesPolicy_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutSharesPolicy_doc" xml:lang="en-US">The element represents  earnout shares policy.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ReverseStockSplitPolicyTextBlock" xlink:to="niobf_ReverseStockSplitPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ReverseStockSplitPolicyTextBlock_doc" xml:lang="en-US">The element represents  reverse stock split policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:to="niobf_RedeemableNoncontrollingInterestPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_RedeemableNoncontrollingInterestPolicyTextBlock_doc" xml:lang="en-US">The element represents  redeemable noncontrolling interest policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarningsLossPerShareBasicAndDiluted" xlink:to="niobf_EarningsLossPerShareBasicAndDiluted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted_doc" xml:lang="en-US">The element represents earnings loss per share basic and diluted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CashAndCashEquivalentsAtCarryingValue1" xlink:to="niobf_CashAndCashEquivalentsAtCarryingValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CashAndCashEquivalentsAtCarryingValue1_doc" xml:lang="en-US">The element represents cash and cash equivalents at carrying value1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantAgreementMember" xlink:to="niobf_WarrantAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantAgreementMember_doc" xml:lang="en-US">The element represents warrant agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" xlink:to="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_doc" xml:lang="en-US">The element represents business combination separately recognized transactions additional disclosures acquisition cash costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesAssumedAtFairValue" xlink:to="niobf_EarnoutSharesAssumedAtFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutSharesAssumedAtFairValue_doc" xml:lang="en-US">The element represents earnout shares assumed at fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LegacyNioCorpShareholdersMember" xlink:to="niobf_LegacyNioCorpShareholdersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LegacyNioCorpShareholdersMember_doc" xml:lang="en-US">The element represents legacy nio corp shareholders member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIClassAShareholdersMember" xlink:to="niobf_GXIIClassAShareholdersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GXIIClassAShareholdersMember_doc" xml:lang="en-US">The element represents gxii class a shareholders member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtherMember" xlink:to="niobf_OtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_OtherMember_doc" xml:lang="en-US">The element represents other member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleSecurityMember" xlink:to="niobf_ConvertibleSecurityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ConvertibleSecurityMember_doc" xml:lang="en-US">The element represents convertible security member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindIIIConvertibleSecurityMember" xlink:to="niobf_LindIIIConvertibleSecurityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LindIIIConvertibleSecurityMember_doc" xml:lang="en-US">The element represents lind i i i convertible security member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TransactionCost" xlink:to="niobf_TransactionCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_TransactionCost_doc" xml:lang="en-US">The element represents transaction cost.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" xlink:to="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_doc" xml:lang="en-US">The element represents  schedule of changes in lind iii convertible security one text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MinimumConsentPaymentAtInception" xlink:to="niobf_MinimumConsentPaymentAtInception_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MinimumConsentPaymentAtInception_doc" xml:lang="en-US">The element represents minimum consent payment at inception.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ASC470LossOnExtinguishment" xlink:to="niobf_ASC470LossOnExtinguishment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ASC470LossOnExtinguishment_doc" xml:lang="en-US">The element represents as c470 loss on extinguishment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AdditionalConsentPaymentbooked" xlink:to="niobf_AdditionalConsentPaymentbooked_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AdditionalConsentPaymentbooked_doc" xml:lang="en-US">The element represents additional consent paymentbooked.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfWarrantValuationTableTextblock" xlink:to="niobf_ScheduleOfWarrantValuationTableTextblock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfWarrantValuationTableTextblock_doc" xml:lang="en-US">The element represents  schedule of changes in lind iii convertible security one text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrants" xlink:to="niobf_ChangeInValuationOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInValuationOfWarrants_doc" xml:lang="en-US">The element represents change in valuation of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" xlink:to="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_doc" xml:lang="en-US">The element represents  fair value assets and liabilities measured on recurring and nonrecurring monte carlo techniques table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ProbabilityOfIssuanceMember" xlink:to="niobf_ProbabilityOfIssuanceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ProbabilityOfIssuanceMember_doc" xml:lang="en-US">The element represents probability of issuance member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:to="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_doc" xml:lang="en-US">The element represents yorkville convertible debt financing agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:to="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise_doc" xml:lang="en-US">The element represents stock issued during period shares stock options exercise.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:to="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1_doc" xml:lang="en-US">The element represents stock issued during period shares stock options exercise1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:to="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_doc" xml:lang="en-US">The element represents share based goods and nonemployee services transaction valuation method expected dividend yield rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DebtMaturityPeriod" xlink:to="niobf_DebtMaturityPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DebtMaturityPeriod_doc" xml:lang="en-US">The element represents debt maturity period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrincipalAndAccruedInterestConverted" xlink:to="niobf_PrincipalAndAccruedInterestConverted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrincipalAndAccruedInterestConverted_doc" xml:lang="en-US">The element represents principal and accrued interest converted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:to="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock_doc" xml:lang="en-US">The element represents  schedule of class b common stock of e c r c table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutMember" xlink:to="niobf_EarnoutMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutMember_doc" xml:lang="en-US">The element represents earnout member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DescriptionOfEarnOutShares" xlink:to="niobf_DescriptionOfEarnOutShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DescriptionOfEarnOutShares_doc" xml:lang="en-US">The element represents description of earn out shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:to="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_doc" xml:lang="en-US">The element represents  schedule of primary inputs into the monte carlo models table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:to="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_doc" xml:lang="en-US">The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:to="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_doc" xml:lang="en-US">The element represents  schedule ofsummary of the changes in the fair value of the earnout share liability table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SaleOfStockPricePerShare1" xlink:to="niobf_SaleOfStockPricePerShare1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SaleOfStockPricePerShare1_doc" xml:lang="en-US">The element represents sale of stock price per share 1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" xlink:to="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_doc" xml:lang="en-US">The element represents share based compensation arrangement by share based payment award fair value assumptions expected volatilityrate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleFinancingWarrants" xlink:to="niobf_YorkvilleFinancingWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleFinancingWarrants_doc" xml:lang="en-US">The element represents yorkville financing warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GxiiWarrants" xlink:to="niobf_GxiiWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GxiiWarrants_doc" xml:lang="en-US">The element represents gxii warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExpired" xlink:to="niobf_ClassOfWarrantOrRightExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExpired_doc" xml:lang="en-US">The element represents class of warrant or right expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightGranted" xlink:to="niobf_ClassOfWarrantOrRightGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightGranted_doc" xml:lang="en-US">The element represents class of warrant or right granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_doc" xml:lang="en-US">The element represents class of warrant or right exercise price warrants yorkville financing warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_doc" xml:lang="en-US">The element represents class of warrant or right exercise price warrants gxii warrants.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised_doc" xml:lang="en-US">The element represents class of warrant or right exercise price exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceGranted_doc" xml:lang="en-US">The element represents class of warrant or right exercise price granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired_doc" xml:lang="en-US">The element represents class of warrant or right exercise price expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_doc" xml:lang="en-US">The element represents  schedule of outstanding exercisable warrants table text block.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice11.00Member" xlink:label="niobf_ExercisePrice11.00Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice11.00Member" xlink:to="niobf_ExercisePrice11.00Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice11.00Member_doc" xml:lang="en-US">The element represents exercise price 11.00 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice9.70Member" xlink:to="niobf_ExercisePrice9.70Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice9.70Member_doc" xml:lang="en-US">The element represents exercise price 9.70 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice8.94Member" xlink:to="niobf_ExercisePrice8.94Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice8.94Member_doc" xml:lang="en-US">The element represents  exercise price8.94 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice4.60Member" xlink:to="niobf_ExercisePrice4.60Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice4.60Member_doc" xml:lang="en-US">The element represents  exercise price4.60 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice3.54Member" xlink:to="niobf_ExercisePrice3.54Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice3.54Member_doc" xml:lang="en-US">The element represents  exercise price3.54 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice2.20Member" xlink:to="niobf_ExercisePrice2.20Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice2.20Member_doc" xml:lang="en-US">The element represents  exercise price2.20 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice3.25Member" xlink:to="niobf_ExercisePrice3.25Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice3.25Member_doc" xml:lang="en-US">The element represents  exercise price3.25 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice11.50Member" xlink:to="niobf_ExercisePrice11.50Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice11.50Member_doc" xml:lang="en-US">The element represents exercise price 11.50 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPublicWarrantsMember" xlink:to="niobf_GXIIPublicWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GXIIPublicWarrantsMember_doc" xml:lang="en-US">The element represents gxii public warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPrivateWarrantsMember" xlink:to="niobf_GXIIPrivateWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GXIIPrivateWarrantsMember_doc" xml:lang="en-US">The element represents gxii private warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_doc" xml:lang="en-US">The element represents schedule of changes in the fair value of the private warrants table textblock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangesInFairValueOfInitialValuation_doc" xml:lang="en-US">The element represents changes in fair value of initial valuation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleCashFee" xlink:to="niobf_YorkvilleCashFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleCashFee_doc" xml:lang="en-US">The element represents yorkville cash fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeneralSecurityAgreementMember" xlink:to="niobf_GeneralSecurityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GeneralSecurityAgreementMember_doc" xml:lang="en-US">The element represents general security agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LineOfCreditFacilityPrepaymentFee" xlink:to="niobf_LineOfCreditFacilityPrepaymentFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LineOfCreditFacilityPrepaymentFee_doc" xml:lang="en-US">The element represents line of credit facility prepayment fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NonRevolvingCreditFacilityAgreementMember" xlink:to="niobf_NonRevolvingCreditFacilityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_NonRevolvingCreditFacilityAgreementMember_doc" xml:lang="en-US">The element represents non revolving credit facility agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MarkSmithMember" xlink:to="niobf_MarkSmithMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MarkSmithMember_doc" xml:lang="en-US">The element represents mark smith member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EstablishmentFeesPayable" xlink:to="niobf_EstablishmentFeesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EstablishmentFeesPayable_doc" xml:lang="en-US">The element represents establishment fees payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AmountsAdvanced" xlink:to="niobf_AmountsAdvanced_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AmountsAdvanced_doc" xml:lang="en-US">The element represents amounts advanced.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:to="niobf_ExplorationExpendituresDisclosuresTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExplorationExpendituresDisclosuresTextBlock_doc" xml:lang="en-US">The element represents  exploration expenditures disclosures text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:to="niobf_ScheduleOfExplorationExpendituresTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfExplorationExpendituresTableTextBlock_doc" xml:lang="en-US">The element represents  schedule of exploration expenditures table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CostCentreAxis" xlink:to="niobf_CostCentreAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CostCentreAxis_doc" xml:lang="en-US">The element represents  cost centre axis.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FeasibilityStudyAndEngineeringMember" xlink:to="niobf_FeasibilityStudyAndEngineeringMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FeasibilityStudyAndEngineeringMember_doc" xml:lang="en-US">The element represents feasibility study and engineering member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FieldManagementAndOtherMember" xlink:to="niobf_FieldManagementAndOtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FieldManagementAndOtherMember_doc" xml:lang="en-US">The element represents field management and other member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeologistsAndFieldStaffMember" xlink:to="niobf_GeologistsAndFieldStaffMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GeologistsAndFieldStaffMember_doc" xml:lang="en-US">The element represents geologists and field staff member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MetallurgicalMember" xlink:to="niobf_MetallurgicalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MetallurgicalMember_doc" xml:lang="en-US">The element represents metallurgical member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CorporateOfficeMember" xlink:to="niobf_CorporateOfficeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CorporateOfficeMember_doc" xml:lang="en-US">The element represents corporate office member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DiscountRate" xlink:to="niobf_DiscountRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DiscountRate_doc" xml:lang="en-US">The element represents discount rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FixedRentExpense" xlink:to="niobf_FixedRentExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FixedRentExpense_doc" xml:lang="en-US">The element represents fixed rent expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessAmountOfPaymentsRepresentingInterest" xlink:to="niobf_LessAmountOfPaymentsRepresentingInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest_doc" xml:lang="en-US">The element represents less amount of payments representing interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesLiability" xlink:to="niobf_EarnoutSharesLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutSharesLiability_doc" xml:lang="en-US">The element represents earnout shares liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantLiability" xlink:to="niobf_WarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantLiability_doc" xml:lang="en-US">The element represents warrant liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GxiiTransactionCosts" xlink:to="niobf_GxiiTransactionCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GxiiTransactionCosts_doc" xml:lang="en-US">The element represents gxii transaction costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EffectOfLegislativeChanges" xlink:to="niobf_EffectOfLegislativeChanges_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EffectOfLegislativeChanges_doc" xml:lang="en-US">The element represents effect of legislative changes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleNoteValuation" xlink:to="niobf_ConvertibleNoteValuation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ConvertibleNoteValuation_doc" xml:lang="en-US">The element represents  convertible note valuation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsMineralInterest" xlink:to="niobf_DeferredTaxAssetsMineralInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsMineralInterest_doc" xml:lang="en-US">The element represents deferred tax assets mineral interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:to="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts_doc" xml:lang="en-US">The element represents deferred tax assets startup and oorganizational costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:to="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts_doc" xml:lang="en-US">The element represents deferred tax assets research and development costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:to="niobf_DeferredTaxAssetsShareIssuanceCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsShareIssuanceCosts_doc" xml:lang="en-US">The element represents deferred tax assets share issuance costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CapitalLossesAvailableForFuturePeriods" xlink:to="niobf_CapitalLossesAvailableForFuturePeriods_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CapitalLossesAvailableForFuturePeriods_doc" xml:lang="en-US">The element represents capital losses available for future periods.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:to="niobf_DeferredTaxAssetsValuationAllowanceAdditions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsValuationAllowanceAdditions_doc" xml:lang="en-US">The element represents deferred tax assets valuation allowance additions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CapitalLossCaryforward" xlink:to="niobf_CapitalLossCaryforward_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CapitalLossCaryforward_doc" xml:lang="en-US">The element represents Capital Loss Caryforward.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_InterestExpenseAssociatedWithConvertibleDebenturesTextBlock" xlink:label="niobf_InterestExpenseAssociatedWithConvertibleDebenturesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_InterestExpenseAssociatedWithConvertibleDebenturesTextBlock" xlink:to="niobf_InterestExpenseAssociatedWithConvertibleDebenturesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_InterestExpenseAssociatedWithConvertibleDebenturesTextBlock_doc" xml:lang="en-US">The element represents interest expense associated with convertible debentures text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ContractualInterest" xlink:to="niobf_ContractualInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ContractualInterest_doc" xml:lang="en-US">The element represents contractual interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MonteCarloModelMember" xlink:to="niobf_MonteCarloModelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MonteCarloModelMember_doc" xml:lang="en-US">The element represents monte carlo model member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ImpliedDiscountRate" xlink:to="niobf_ImpliedDiscountRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ImpliedDiscountRate_doc" xml:lang="en-US">The element represents implied discount rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock" xlink:to="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock_doc" xml:lang="en-US">The element represents shareholders equity and share based warrants text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_BlackScholesMember" xlink:to="niobf_BlackScholesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_BlackScholesMember_doc" xml:lang="en-US">The element represents black scholes member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutLiabilityAtFairValue" xlink:to="niobf_EarnoutLiabilityAtFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutLiabilityAtFairValue_doc" xml:lang="en-US">The element represents earnout liability at fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpenditures" xlink:to="niobf_ExplorationExpenditures_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExplorationExpenditures_doc" xml:lang="en-US">The element represents exploration expenditures.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfEarnoutLiability_doc" xml:lang="en-US">The element represents change in fair value of earnout liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfWarrantLiability" xlink:to="niobf_ChangeInFairValueOfWarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfWarrantLiability_doc" xml:lang="en-US">The element represents change in fair value of warrant liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNotes" xlink:to="niobf_ChangeInFairValueOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfConvertibleNotes_doc" xml:lang="en-US">The element represents change in fair value of convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_doc" xml:lang="en-US">The element represents income loss from continuing operations before income taxes extraordinary items noncontrolling interest1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ProfitLoss1" xlink:to="niobf_ProfitLoss1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ProfitLoss1_doc" xml:lang="en-US">The element represents profit loss1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_doc" xml:lang="en-US">The element represents total weighted average number of share outstanding basic and diluted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AssumptionOfEarnoutLiability" xlink:to="niobf_AssumptionOfEarnoutLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AssumptionOfEarnoutLiability_doc" xml:lang="en-US">The element represents assumption of earnout liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutShareLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability_doc" xml:lang="en-US">The element represents change in fair value of earnout share liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AssumptionOfPrivateAndPublicWarrants" xlink:to="niobf_AssumptionOfPrivateAndPublicWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AssumptionOfPrivateAndPublicWarrants_doc" xml:lang="en-US">The element represents assumption of private and public warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrantLiabilities" xlink:to="niobf_ChangeInValuationOfWarrantLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities_doc" xml:lang="en-US">The element represents change in valuation of warrant liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNote" xlink:to="niobf_ChangeInFairValueOfConvertibleNote_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfConvertibleNote_doc" xml:lang="en-US">The element represents change in fair value of convertible note.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LossesOnExtinguishmentOfDebt" xlink:to="niobf_LossesOnExtinguishmentOfDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LossesOnExtinguishmentOfDebt_doc" xml:lang="en-US">The element represents losses on extinguishment of debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ForeignCurrencyTransactionGainLossBeforeTax1" xlink:to="niobf_ForeignCurrencyTransactionGainLossBeforeTax1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ForeignCurrencyTransactionGainLossBeforeTax1_doc" xml:lang="en-US">The element represents foreign currency transaction gain loss before tax1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtheroperatingGainsLosses" xlink:to="niobf_OtheroperatingGainsLosses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_OtheroperatingGainsLosses_doc" xml:lang="en-US">The element represents otheroperating gains losses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConversionsOfDebtForCommonShares" xlink:to="niobf_ConversionsOfDebtForCommonShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ConversionsOfDebtForCommonShares_doc" xml:lang="en-US">The element represents conversions of debt for common shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RecognitionOfOperatingLeaseLiabilities" xlink:to="niobf_RecognitionOfOperatingLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_RecognitionOfOperatingLeaseLiabilities_doc" xml:lang="en-US">The element represents recognition of operating lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ValueOfWarrantsIssued" xlink:to="niobf_ValueOfWarrantsIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ValueOfWarrantsIssued_doc" xml:lang="en-US">The element represents value of warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesIssuedInTheGXIITransaction" xlink:to="niobf_CommonSharesIssuedInTheGXIITransaction_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CommonSharesIssuedInTheGXIITransaction_doc" xml:lang="en-US">The element represents common shares issued in the g x i i transaction.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesIssuedInTheGXIITransactionShares" xlink:to="niobf_CommonSharesIssuedInTheGXIITransactionShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CommonSharesIssuedInTheGXIITransactionShares_doc" xml:lang="en-US">The element represents common shares issued in the g x i i transaction shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:to="niobf_SharesIssuedUnderTheYorkvilleEquityFacility_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacility_doc" xml:lang="en-US">The element represents shares issued under the yorkville equity facility.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:to="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares_doc" xml:lang="en-US">The element represents shares issued under the yorkville equity facility shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterest" xlink:to="niobf_RedeemableNoncontrollingInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_RedeemableNoncontrollingInterest_doc" xml:lang="en-US">The element represents redeemable noncontrolling interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementValue" xlink:to="niobf_PrivatePlacementValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrivatePlacementValue_doc" xml:lang="en-US">The element represents private placement value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:to="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_doc" xml:lang="en-US">The element represents available for sale securities equity securities other.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementShares" xlink:to="niobf_PrivatePlacementShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrivatePlacementShares_doc" xml:lang="en-US">The element represents private placement shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:to="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_doc" xml:lang="en-US">The element represents schedule of changes in lind iii convertible security text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValue" xlink:to="niobf_ChangeInFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValue_doc" xml:lang="en-US">The element represents change in fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessCurrentPortionOfOperatingLeaseLiability" xlink:to="niobf_LessCurrentPortionOfOperatingLeaseLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LessCurrentPortionOfOperatingLeaseLiability_doc" xml:lang="en-US">The element represents less current portion of operating lease liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OperatingLeasesLiabilityNoncurrent" xlink:to="niobf_OperatingLeasesLiabilityNoncurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_OperatingLeasesLiabilityNoncurrent_doc" xml:lang="en-US">The element represents operating leases liability noncurrent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueOfCommitmentSharesIssued" xlink:to="niobf_FairValueOfCommitmentSharesIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FairValueOfCommitmentSharesIssued_doc" xml:lang="en-US">The element represents fair value of commitment shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TotalLeasePayments" xlink:to="niobf_TotalLeasePayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_TotalLeasePayments_doc" xml:lang="en-US">The element represents total lease payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WorkingCapitalDeficit" xlink:to="niobf_WorkingCapitalDeficit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WorkingCapitalDeficit_doc" xml:lang="en-US">The element represents working capital deficit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleSecurityMember" xlink:to="niobf_YorkvilleConvertibleSecurityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleConvertibleSecurityMember_doc" xml:lang="en-US">The element represents yorkville convertible security.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_April2024ConvertibleSecurityMember" xlink:to="niobf_April2024ConvertibleSecurityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_April2024ConvertibleSecurityMember_doc" xml:lang="en-US">The element represents april 2024 convertible security.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindConsentWarrantIssuanceMember" xlink:to="niobf_LindConsentWarrantIssuanceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LindConsentWarrantIssuanceMember_doc" xml:lang="en-US">The element represents lind consent warrant issuance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_KingdonCapitalManagementLLCMember" xlink:to="niobf_KingdonCapitalManagementLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_KingdonCapitalManagementLLCMember_doc" xml:lang="en-US">The element represents kingdon capital management llc.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleEquityFacilityFinancingAgreementMember" xlink:to="niobf_YorkvilleEquityFacilityFinancingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleEquityFacilityFinancingAgreementMember_doc" xml:lang="en-US">The element represents yorkville equity facility financing agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfEarnoutLiability_3_lbl" xml:lang="en-US">Change In Fair Value Of Earnout Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfWarrantLiability" xlink:to="niobf_ChangeInFairValueOfWarrantLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfWarrantLiability_3_lbl" xml:lang="en-US">Change In Fair Value Of Warrant Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNotes" xlink:to="niobf_ChangeInFairValueOfConvertibleNotes_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfConvertibleNotes_3_lbl" xml:lang="en-US">Change In Fair Value Of Convertible Notes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_2_lbl" xml:lang="en-US">Other Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_2_lbl" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_3_lbl" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ProfitLoss1" xlink:to="niobf_ProfitLoss1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ProfitLoss1_3_lbl" xml:lang="en-US">Profit Loss1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_3_lbl" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:to="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_2_lbl" xml:lang="en-US">OCI, Equity Method Investment, before Tax, Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LossesOnExtinguishmentOfDebt" xlink:to="niobf_LossesOnExtinguishmentOfDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LossesOnExtinguishmentOfDebt_3_lbl" xml:lang="en-US">Losses On Extinguishment Of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtheroperatingGainsLosses" xlink:to="niobf_OtheroperatingGainsLosses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_OtheroperatingGainsLosses_3_lbl" xml:lang="en-US">Otheroperating Gains Losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xml:lang="en-US">Repayments of Related Party Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_2_lbl" xml:lang="en-US">Repayments of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterest" xlink:to="niobf_RedeemableNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_RedeemableNoncontrollingInterest_3_lbl" xml:lang="en-US">Redeemable Noncontrolling Interest [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_2_lbl" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend_2_lbl" xml:lang="en-US">Stock Issued During Period, Value, Stock Dividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_2_lbl" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_2_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ASC470LossOnExtinguishment" xlink:to="niobf_ASC470LossOnExtinguishment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ASC470LossOnExtinguishment_3_lbl" xml:lang="en-US">AS C470 Loss on Extinguishment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_3_lbl" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebt_3_lbl" xml:lang="en-US">Convertible Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrincipalAndAccruedInterestConverted" xlink:to="niobf_PrincipalAndAccruedInterestConverted_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrincipalAndAccruedInterestConverted_3_lbl" xml:lang="en-US">Principal and Accrued Interest Converted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount_2_lbl" xml:lang="en-US">Investment Owned, Balance, Principal Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueHedgeAssetsAtFairValue" xlink:to="us-gaap_FairValueHedgeAssetsAtFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueHedgeAssetsAtFairValue_3_lbl" xml:lang="en-US">Fair Value Hedge Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_2_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValue" xlink:to="niobf_ChangeInFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValue_3_lbl" xml:lang="en-US">Change In Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_4_lbl" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromInterestReceived" xlink:to="us-gaap_ProceedsFromInterestReceived_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromInterestReceived_2_lbl" xml:lang="en-US">Proceeds from Interest Received</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_2_lbl" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:to="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1_3_lbl" xml:lang="en-US">Stock Issued During Period Shares Stock Options Exercise1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiability" xlink:to="us-gaap_ServicingLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServicingLiability_2_lbl" xml:lang="en-US">Servicing Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:to="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_3_lbl" xml:lang="en-US">Share-Based Goods and Nonemployee Services Transaction Valuation Method Expected Dividend Yield Rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DebtMaturityPeriod" xlink:to="niobf_DebtMaturityPeriod_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DebtMaturityPeriod_3_lbl" xml:lang="en-US">Debt Maturity Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_2_lbl" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAmount" xlink:to="us-gaap_ServicingLiabilityAtFairValueAmount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount_3_lbl" xml:lang="en-US">Servicing Liability at Fair Value, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_3_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceGranted_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceGranted_3_lbl" xml:lang="en-US">Class of Warrant or Right Exercise Price Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangesInFairValueOfInitialValuation_4_lbl" xml:lang="en-US">Changes in Fair Value of initial Valuation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:to="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_2_lbl" xml:lang="en-US">Servicing Asset at Fair Value, Changes in Fair Value Resulting from Changes in Valuation Inputs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDepositLiabilities" xlink:to="us-gaap_RelatedPartyDepositLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDepositLiabilities_3_lbl" xml:lang="en-US">Related Party Deposit Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExplorationExpense" xlink:to="us-gaap_ExplorationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExplorationExpense_2_lbl" xml:lang="en-US">Exploration Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubleaseIncome_2_lbl" xml:lang="en-US">Sublease Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessAmountOfPaymentsRepresentingInterest" xlink:to="niobf_LessAmountOfPaymentsRepresentingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest_3_lbl" xml:lang="en-US">Less Amount of Payments Representing Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessCurrentPortionOfOperatingLeaseLiability" xlink:to="niobf_LessCurrentPortionOfOperatingLeaseLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LessCurrentPortionOfOperatingLeaseLiability_3_lbl" xml:lang="en-US">Less Current Portion Of Operating Lease Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationAccretionExpense" xlink:to="us-gaap_AssetRetirementObligationAccretionExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationAccretionExpense_2_lbl" xml:lang="en-US">Asset Retirement Obligation, Accretion Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleNoteValuation" xlink:to="niobf_ConvertibleNoteValuation_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ConvertibleNoteValuation_3_lbl" xml:lang="en-US">Convertible Note Valuation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax_2_lbl" xml:lang="en-US">Extinguishment of Debt, Gain (Loss), Income Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_2_lbl" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:to="niobf_DeferredTaxAssetsValuationAllowanceAdditions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsValuationAllowanceAdditions_3_lbl" xml:lang="en-US">Deferred Tax Assets Valuation Allowance Additions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsIncurredDevelopmentCosts" xlink:to="us-gaap_CostsIncurredDevelopmentCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsIncurredDevelopmentCosts_2_lbl" xml:lang="en-US">Costs Incurred, Development Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_2_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:to="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_3_lbl" xml:lang="en-US">Available For Sale Securities Equity Securities Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_2_lbl" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_2_lbl" xml:lang="en-US">Warrants Not Settleable in Cash, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_2_lbl" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>33
<FILENAME>niobf-20240630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://niocorp.com/role/Cover" xlink:href="niobf-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheets" xlink:href="niobf-20240630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:href="niobf-20240630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="niobf-20240630.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfCashFlows" xlink:href="niobf-20240630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest" xlink:href="niobf-20240630.xsd#StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusiness" xlink:href="niobf-20240630.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPreparation" xlink:href="niobf-20240630.xsd#BasisOfPreparation" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPolicies" xlink:href="niobf-20240630.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernIssues" xlink:href="niobf-20240630.xsd#GoingConcernIssues" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransaction" xlink:href="niobf-20240630.xsd#GxiiTransaction" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNet" xlink:href="niobf-20240630.xsd#LandAndBuildingsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MineralProperties" xlink:href="niobf-20240630.xsd#MineralProperties" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="niobf-20240630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebt" xlink:href="niobf-20240630.xsd#ConvertibleDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:href="niobf-20240630.xsd#ClassBCommonStockOfEcrc" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonShares" xlink:href="niobf-20240630.xsd#CommonShares" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:href="niobf-20240630.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpenditures" xlink:href="niobf-20240630.xsd#ExplorationExpenditures" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/Leases" xlink:href="niobf-20240630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxes" xlink:href="niobf-20240630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurements" xlink:href="niobf-20240630.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEvents" xlink:href="niobf-20240630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:href="niobf-20240630.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPreparationTables" xlink:href="niobf-20240630.xsd#BasisOfPreparationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:href="niobf-20240630.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransactionTables" xlink:href="niobf-20240630.xsd#GxiiTransactionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:href="niobf-20240630.xsd#LandAndBuildingsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="niobf-20240630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebtTables" xlink:href="niobf-20240630.xsd#ConvertibleDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:href="niobf-20240630.xsd#ClassBCommonStockOfEcrcTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesTables" xlink:href="niobf-20240630.xsd#CommonSharesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:href="niobf-20240630.xsd#RelatedPartyTransactionsAndBalancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpendituresTables" xlink:href="niobf-20240630.xsd#ExplorationExpendituresTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesTables" xlink:href="niobf-20240630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxesTables" xlink:href="niobf-20240630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurementsTables" xlink:href="niobf-20240630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" xlink:href="niobf-20240630.xsd#TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="niobf-20240630.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails" xlink:href="niobf-20240630.xsd#CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:href="niobf-20240630.xsd#ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="niobf-20240630.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:href="niobf-20240630.xsd#GoingConcernIssuesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details" xlink:href="niobf-20240630.xsd#FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails" xlink:href="niobf-20240630.xsd#NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransactionDetailsNarrative" xlink:href="niobf-20240630.xsd#GxiiTransactionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:href="niobf-20240630.xsd#ScheduleOfPropertiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:href="niobf-20240630.xsd#ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" xlink:href="niobf-20240630.xsd#ScheduleOfConvertibleDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:href="niobf-20240630.xsd#ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails" xlink:href="niobf-20240630.xsd#FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:href="niobf-20240630.xsd#ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails" xlink:href="niobf-20240630.xsd#ScheduleOfValuationDateAndProbabilityCalculatedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:href="niobf-20240630.xsd#ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:href="niobf-20240630.xsd#FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails" xlink:href="niobf-20240630.xsd#FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details" xlink:href="niobf-20240630.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details" xlink:href="niobf-20240630.xsd#FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details" xlink:href="niobf-20240630.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:href="niobf-20240630.xsd#ConvertibleDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:href="niobf-20240630.xsd#FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details" xlink:href="niobf-20240630.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:href="niobf-20240630.xsd#ClassBCommonStockOfEcrcDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:href="niobf-20240630.xsd#ScheduleOfStockOptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:href="niobf-20240630.xsd#FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:href="niobf-20240630.xsd#WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:href="niobf-20240630.xsd#AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:href="niobf-20240630.xsd#CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:href="niobf-20240630.xsd#ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:href="niobf-20240630.xsd#ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:href="niobf-20240630.xsd#CommonSharesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:href="niobf-20240630.xsd#ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:href="niobf-20240630.xsd#RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:href="niobf-20240630.xsd#ScheduleOfExplorationExpendituresDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:href="niobf-20240630.xsd#CompanyIncurredLeaseCostsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details" xlink:href="niobf-20240630.xsd#MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesDetailsNarrative" xlink:href="niobf-20240630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails" xlink:href="niobf-20240630.xsd#DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:href="niobf-20240630.xsd#FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:href="niobf-20240630.xsd#DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:href="niobf-20240630.xsd#ChangesInValuationAllowanceAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:href="niobf-20240630.xsd#ScheduleOfCumulativeNetOperatingLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:href="niobf-20240630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:href="niobf-20240630.xsd#ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:href="niobf-20240630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CommonSharesWithoutParValueMember" xlink:label="loc_niobfCommonSharesWithoutParValueMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfCommonSharesWithoutParValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:label="loc_niobfWarrantsEachExercisableFor1.11829212CommonSharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfWarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssets" xlink:label="loc_us-gaapDepositsAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapDepositsAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:label="loc_us-gaapLongTermInvestmentsAndReceivablesNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapLongTermInvestmentsAndReceivablesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:label="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutLiabilityAtFairValue" xlink:label="loc_niobfEarnoutLiabilityAtFairValue" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_niobfEarnoutLiabilityAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:label="loc_us-gaapCommonStockSharesAuthorizedUnlimited" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorizedUnlimited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExplorationExpenditures" xlink:label="loc_niobfExplorationExpenditures" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_niobfExplorationExpenditures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfEarnoutLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_niobfChangeInFairValueOfEarnoutLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfWarrantLiability" xlink:label="loc_niobfChangeInFairValueOfWarrantLiability" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_niobfChangeInFairValueOfWarrantLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfConvertibleNotes" xlink:label="loc_niobfChangeInFairValueOfConvertibleNotes" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_niobfChangeInFairValueOfConvertibleNotes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAmount" xlink:label="loc_us-gaapExtinguishmentOfDebtAmount" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapExtinguishmentOfDebtAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:label="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ProfitLoss1" xlink:label="loc_niobfProfitLoss1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_niobfProfitLoss1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" xlink:label="loc_us-gaapOciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarningsLossPerShareBasicAndDiluted" xlink:label="loc_niobfEarningsLossPerShareBasicAndDiluted" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:to="loc_niobfEarningsLossPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_niobfTotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:to="loc_niobfTotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AssumptionOfEarnoutLiability" xlink:label="loc_niobfAssumptionOfEarnoutLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfAssumptionOfEarnoutLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutShareLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfChangeInFairValueOfEarnoutShareLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AssumptionOfPrivateAndPublicWarrants" xlink:label="loc_niobfAssumptionOfPrivateAndPublicWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfAssumptionOfPrivateAndPublicWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInValuationOfWarrantLiabilities" xlink:label="loc_niobfChangeInValuationOfWarrantLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfChangeInValuationOfWarrantLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValueOfConvertibleNote" xlink:label="loc_niobfChangeInFairValueOfConvertibleNote" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfChangeInFairValueOfConvertibleNote" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LossesOnExtinguishmentOfDebt" xlink:label="loc_niobfLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FairValueOfCommitmentSharesIssued" xlink:label="loc_niobfFairValueOfCommitmentSharesIssued" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfFairValueOfCommitmentSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ForeignCurrencyTransactionGainLossBeforeTax1" xlink:label="loc_niobfForeignCurrencyTransactionGainLossBeforeTax1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfForeignCurrencyTransactionGainLossBeforeTax1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaapOperatingLeaseImpairmentLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseImpairmentLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_OtheroperatingGainsLosses" xlink:label="loc_niobfOtheroperatingGainsLosses" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfOtheroperatingGainsLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfProductiveAssets" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ConversionsOfDebtForCommonShares" xlink:label="loc_niobfConversionsOfDebtForCommonShares" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_niobfConversionsOfDebtForCommonShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_RecognitionOfOperatingLeaseLiabilities" xlink:label="loc_niobfRecognitionOfOperatingLeaseLiabilities" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_niobfRecognitionOfOperatingLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ValueOfWarrantsIssued" xlink:label="loc_niobfValueOfWarrantsIssued" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_niobfValueOfWarrantsIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest" xlink:title="00000006 - Statement - Consolidated Statements of Shareholders&apos; Equity (Deficit) and Redeemable Noncontrolling Interest">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_RedeemableNoncontrollingInterestMember" xlink:label="loc_niobfRedeemableNoncontrollingInterestMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_niobfRedeemableNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CommonSharesIssuedInTheGXIITransaction" xlink:label="loc_niobfCommonSharesIssuedInTheGXIITransaction" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfCommonSharesIssuedInTheGXIITransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CommonSharesIssuedInTheGXIITransactionShares" xlink:label="loc_niobfCommonSharesIssuedInTheGXIITransactionShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfCommonSharesIssuedInTheGXIITransactionShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:label="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacility" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacility" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:label="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacilityShares" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_RedeemableNoncontrollingInterest" xlink:label="loc_niobfRedeemableNoncontrollingInterest" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfRedeemableNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_PrivatePlacementValue" xlink:label="loc_niobfPrivatePlacementValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_PrivatePlacementShares" xlink:label="loc_niobfPrivatePlacementShares" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparation" xlink:title="00000008 - Disclosure - BASIS OF PREPARATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccounting" xlink:label="loc_us-gaapBasisOfAccounting" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapBasisOfAccounting" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssues" xlink:title="00000010 - Disclosure - GOING CONCERN ISSUES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransaction" xlink:title="00000011 - Disclosure - 2023 GXII TRANSACTION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNet" xlink:title="00000012 - Disclosure - LAND AND BUILDINGS, NET">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralProperties" xlink:title="00000013 - Disclosure - MINERAL PROPERTIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ExtractiveIndustriesAbstract" xlink:label="loc_srtExtractiveIndustriesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MineralIndustriesDisclosuresTextBlock" xlink:label="loc_us-gaapMineralIndustriesDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtExtractiveIndustriesAbstract" xlink:to="loc_us-gaapMineralIndustriesDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebt" xlink:title="00000015 - Disclosure - CONVERTIBLE DEBT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:title="00000016 - Disclosure - CLASS B COMMON STOCK OF ECRC">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:label="loc_niobfScheduleOfClassBCommonStockOfECRCTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_niobfScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonShares" xlink:title="00000017 - Disclosure - COMMON SHARES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapShareholdersEquityAndShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000018 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpenditures" xlink:title="00000019 - Disclosure - EXPLORATION EXPENDITURES">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="loc_niobfDisclosureExplorationExpendituresAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:label="loc_niobfExplorationExpendituresDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureExplorationExpendituresAbstract" xlink:to="loc_niobfExplorationExpendituresDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Leases" xlink:title="00000020 - Disclosure - LEASES">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurements" xlink:title="00000022 - Disclosure - FAIR VALUE MEASUREMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaapFairValueMeasurementInputsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DevelopmentStageIssuerPolicyTextBlock" xlink:label="loc_niobfDevelopmentStageIssuerPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfDevelopmentStageIssuerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MineralPropertiesPolicyTextBlock" xlink:label="loc_niobfMineralPropertiesPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfMineralPropertiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ConvertibleDebtCarriedatFairValueTextBlock" xlink:label="loc_niobfConvertibleDebtCarriedatFairValueTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfConvertibleDebtCarriedatFairValueTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_WarrantsPolicyTextBlock" xlink:label="loc_niobfWarrantsPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfWarrantsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutSharesPolicy" xlink:label="loc_niobfEarnoutSharesPolicy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfEarnoutSharesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetRetirementObligationsPolicy" xlink:label="loc_us-gaapAssetRetirementObligationsPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAssetRetirementObligationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ReverseStockSplitPolicyTextBlock" xlink:label="loc_niobfReverseStockSplitPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfReverseStockSplitPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:label="loc_niobfRedeemableNoncontrollingInterestPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfRedeemableNoncontrollingInterestPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparationTables" xlink:title="00000025 - Disclosure - BASIS OF PREPARATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransactionTables" xlink:title="00000027 - Disclosure - 2023 GXII TRANSACTION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:label="loc_srtScheduleOfCondensedFinancialStatementsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_srtScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:title="00000028 - Disclosure - LAND AND BUILDINGS, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000029 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtTables" xlink:title="00000030 - Disclosure - CONVERTIBLE DEBT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:label="loc_niobfScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" xlink:label="loc_niobfScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:label="loc_us-gaapScheduleOfExtinguishmentOfDebtTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfExtinguishmentOfDebtTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfWarrantValuationTableTextblock" xlink:label="loc_niobfScheduleOfWarrantValuationTableTextblock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfScheduleOfWarrantValuationTableTextblock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" xlink:label="loc_niobfFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="loc_us-gaapConvertibleDebtTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleDebtTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:label="loc_us-gaapScheduleOfOtherNonoperatingExpenseByComponentTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:label="loc_us-gaapScheduleOfInterestRateDerivativesTableTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInterestRateDerivativesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock" xlink:label="loc_niobfShareholdersEquityAndShareBasedWarrantsTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfShareholdersEquityAndShareBasedWarrantsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:title="00000031 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:label="loc_niobfScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_niobfScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:label="loc_niobfScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_niobfScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesTables" xlink:title="00000032 - Disclosure - COMMON SHARES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:label="loc_niobfScheduleOfOutstandingExercisableWarrantsTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:label="loc_niobfScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:label="loc_us-gaapScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:title="00000033 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpendituresTables" xlink:title="00000034 - Disclosure - EXPLORATION EXPENDITURES (Tables)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="loc_niobfDisclosureExplorationExpendituresAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:label="loc_niobfScheduleOfExplorationExpendituresTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureExplorationExpendituresAbstract" xlink:to="loc_niobfScheduleOfExplorationExpendituresTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesTables" xlink:title="00000035 - Disclosure - LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesTables" xlink:title="00000036 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="loc_us-gaapSummaryOfValuationAllowanceTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapSummaryOfValuationAllowanceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:label="loc_us-gaapSummaryOfOperatingLossCarryforwardsTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapSummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurementsTables" xlink:title="00000037 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="loc_us-gaapFairValueByBalanceSheetGroupingTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" xlink:title="00000038 - Disclosure - These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_Entity0896800BCLtdMember" xlink:label="loc_niobfEntity0896800BCLtdMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfEntity0896800BCLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ElkCreekResourcesCorpMember" xlink:label="loc_niobfElkCreekResourcesCorpMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfElkCreekResourcesCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ElkCreekResourcesCorpECRCMember" xlink:label="loc_niobfElkCreekResourcesCorpECRCMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfElkCreekResourcesCorpECRCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_NioCorpTechnologiesLimitedMember" xlink:label="loc_niobfNioCorpTechnologiesLimitedMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfNioCorpTechnologiesLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_IncorporationStateCountryName" xlink:label="loc_niobfIncorporationStateCountryName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_niobfIncorporationStateCountryName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="00000039 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaapNumberOfReportableSegments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNumberOfReportableSegments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails" xlink:title="00000040 - Disclosure - The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attr (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:label="loc_us-gaapNetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarningsLossPerShareBasicAndDiluted" xlink:label="loc_niobfEarningsLossPerShareBasicAndDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfEarningsLossPerShareBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:title="00000041 - Disclosure - Schedule of excluded from the dilutive securities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToWrittenPutOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToWrittenPutOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DilutiveSecurities" xlink:label="loc_us-gaapDilutiveSecurities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDilutiveSecurities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:title="00000043 - Disclosure - GOING CONCERN ISSUES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_WorkingCapitalDeficit" xlink:label="loc_niobfWorkingCapitalDeficit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_niobfWorkingCapitalDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CashAndCashEquivalentsAtCarryingValue1" xlink:label="loc_niobfCashAndCashEquivalentsAtCarryingValue1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_niobfCashAndCashEquivalentsAtCarryingValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfDebt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details" xlink:title="00000044 - Disclosure - The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" xlink:label="loc_niobfBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_niobfBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutSharesAssumedAtFairValue" xlink:label="loc_niobfEarnoutSharesAssumedAtFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_niobfEarnoutSharesAssumedAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails" xlink:title="00000045 - Disclosure - The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapOffsettingAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapOffsettingAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LegacyNioCorpShareholdersMember" xlink:label="loc_niobfLegacyNioCorpShareholdersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfLegacyNioCorpShareholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GXIIClassAShareholdersMember" xlink:label="loc_niobfGXIIClassAShareholdersMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIClassAShareholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_OtherMember" xlink:label="loc_niobfOtherMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransactionDetailsNarrative" xlink:title="00000046 - Disclosure - 2023 GXII TRANSACTION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_WarrantAgreementMember" xlink:label="loc_niobfWarrantAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfWarrantAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:title="00000047 - Disclosure - Schedule of properties (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember" xlink:label="loc_us-gaapLandMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapLandMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="loc_us-gaapPropertyPlantAndEquipmentOther" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:title="00000048 - Disclosure - Schedule of account payable and accrued liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" xlink:title="00000049 - Disclosure - Schedule of convertible debt (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleConvertibleSecurityMember" xlink:label="loc_niobfYorkvilleConvertibleSecurityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfYorkvilleConvertibleSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ConvertibleSecurityMember" xlink:label="loc_niobfConvertibleSecurityMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfConvertibleSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_April2024ConvertibleSecurityMember" xlink:label="loc_niobfApril2024ConvertibleSecurityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfApril2024ConvertibleSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:title="00000050 - Disclosure - Changes in the Lind III Convertible Security are as follows (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ConvertibleSecurityMember" xlink:label="loc_niobfConvertibleSecurityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_niobfConvertibleSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAmount" xlink:label="loc_us-gaapExtinguishmentOfDebtAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapExtinguishmentOfDebtAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConversionOfStockAmountIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:label="loc_us-gaapPaymentsToAcquireHeldToMaturitySecurities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapPaymentsToAcquireHeldToMaturitySecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails" xlink:title="00000051 - Disclosure - The following table summarizes the components of the initial loss and final loss on extinguishment: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MinimumConsentPaymentAtInception" xlink:label="loc_niobfMinimumConsentPaymentAtInception" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfMinimumConsentPaymentAtInception" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ASC470LossOnExtinguishment" xlink:label="loc_niobfASC470LossOnExtinguishment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfASC470LossOnExtinguishment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="loc_us-gaapAdjustmentOfWarrantsGrantedForServices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapAdjustmentOfWarrantsGrantedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AdditionalConsentPaymentbooked" xlink:label="loc_niobfAdditionalConsentPaymentbooked" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfAdditionalConsentPaymentbooked" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnRestructuringOfDebt" xlink:label="loc_us-gaapGainsLossesOnRestructuringOfDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapGainsLossesOnRestructuringOfDebt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:title="00000052 - Disclosure - The change in the fair value of the Contingent Consent Warrants is presented below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInValuationOfWarrants" xlink:label="loc_niobfChangeInValuationOfWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfChangeInValuationOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails" xlink:title="00000053 - Disclosure - Schedule of valuation date and the probability calculated (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ProbabilityOfIssuanceMember" xlink:label="loc_niobfProbabilityOfIssuanceMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_niobfProbabilityOfIssuanceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:title="00000054 - Disclosure - Changes in the Convertible Debentures are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:label="loc_us-gaapAccretionExpenseIncludingAssetRetirementObligations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapAccretionExpenseIncludingAssetRetirementObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_PrincipalAndAccruedInterestConverted" xlink:label="loc_niobfPrincipalAndAccruedInterestConverted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfPrincipalAndAccruedInterestConverted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleDebt_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapPaymentsOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:label="loc_us-gaapInvestmentOwnedBalancePrincipalAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapInvestmentOwnedBalancePrincipalAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:title="00000055 - Disclosure - The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ContractualInterest" xlink:label="loc_niobfContractualInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfContractualInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndDebtExpense" xlink:label="loc_us-gaapInterestAndDebtExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapInterestAndDebtExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails" xlink:title="00000056 - Disclosure - The following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MonteCarloModelMember" xlink:label="loc_niobfMonteCarloModelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_niobfMonteCarloModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ImpliedDiscountRate" xlink:label="loc_niobfImpliedDiscountRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_niobfImpliedDiscountRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details" xlink:title="00000057 - Disclosure - The following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueHedgeAssetsAtFairValue" xlink:label="loc_us-gaapFairValueHedgeAssetsAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapFairValueHedgeAssetsAtFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangeInFairValue" xlink:label="loc_niobfChangeInFairValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfChangeInFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueHedgeAssetsAtFairValue" xlink:label="loc_us-gaapFairValueHedgeAssetsAtFairValue_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapFairValueHedgeAssetsAtFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" xlink:label="loc_us-gaapProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details" xlink:title="00000058 - Disclosure - The following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_BlackScholesMember" xlink:label="loc_niobfBlackScholesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_niobfBlackScholesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details" xlink:title="00000059 - Disclosure - The following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June 30, 2024. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:title="00000060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LindIIIConvertibleSecurityMember" xlink:label="loc_niobfLindIIIConvertibleSecurityMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfLindIIIConvertibleSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LindIIIConvertibleSecurityMember" xlink:label="loc_niobfLindIIIConvertibleSecurityMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_niobfLindIIIConvertibleSecurityMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaapUnsecuredDebtMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapUnsecuredDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRate" xlink:label="loc_us-gaapInvestmentInterestRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapInvestmentInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaapOtherCommitment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapOtherCommitment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromInterestReceived" xlink:label="loc_us-gaapProceedsFromInterestReceived" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromInterestReceived" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTerm" xlink:label="loc_us-gaapLongTermDebtTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionDescription" xlink:label="loc_us-gaapDebtConversionDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtConversionDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonUnitIssued" xlink:label="loc_us-gaapCommonUnitIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapCommonUnitIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:label="loc_us-gaapAcceleratedShareRepurchasesFinalPricePaidPerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapAcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntermediateLifePlantsUsefulLife" xlink:label="loc_us-gaapIntermediateLifePlantsUsefulLife" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapIntermediateLifePlantsUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_TransactionCost" xlink:label="loc_niobfTransactionCost" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfTransactionCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:label="loc_us-gaapLineOfCreditFacilityCommitmentFeeAmount" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentTerms" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentTerms" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaapDebtInstrumentRedemptionPricePercentage" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentRedemptionPricePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise1" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaapLossContingencyAccrualAtCarryingValue" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLossContingencyAccrualAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingLiability" xlink:label="loc_us-gaapServicingLiability" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapServicingLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:label="loc_niobfShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DebtMaturityPeriod" xlink:label="loc_niobfDebtMaturityPeriod" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfDebtMaturityPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:label="loc_us-gaapOptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapOptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:title="00000061 - Disclosure - The following table discloses the primary inputs into the Monte Carlo models. (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details" xlink:title="00000062 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2024: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAdditions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAdditions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAmount_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAmount_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:title="00000063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DescriptionOfEarnOutShares" xlink:label="loc_niobfDescriptionOfEarnOutShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfDescriptionOfEarnOutShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:title="00000064 - Disclosure - Schedule of stock option (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:title="00000065 - Disclosure - The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:title="00000066 - Disclosure - Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleFinancingWarrants" xlink:label="loc_niobfYorkvilleFinancingWarrants" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfYorkvilleFinancingWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GxiiWarrants" xlink:label="loc_niobfGxiiWarrants" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfGxiiWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightExpired" xlink:label="loc_niobfClassOfWarrantOrRightExpired" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceExpired" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightGranted" xlink:label="loc_niobfClassOfWarrantOrRightGranted" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceGranted" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceGranted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:title="00000067 - Disclosure - At June 30, 2024, the Company has outstanding exercisable warrants, as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice9.70Member" xlink:label="loc_niobfExercisePrice9.70Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice9.70Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice8.94Member" xlink:label="loc_niobfExercisePrice8.94Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice8.94Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice4.60Member" xlink:label="loc_niobfExercisePrice4.60Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice4.60Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice3.54Member" xlink:label="loc_niobfExercisePrice3.54Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.54Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice2.20Member" xlink:label="loc_niobfExercisePrice2.20Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.20Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice3.25Member" xlink:label="loc_niobfExercisePrice3.25Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.25Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ExercisePrice11.50Member" xlink:label="loc_niobfExercisePrice11.50Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice11.50Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_srtCurrencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CAD" xlink:label="loc_currencyCAD" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:title="00000068 - Disclosure - The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_srtPlatformOperatorCryptoAssetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:title="00000069 - Disclosure - The change in the Private Warrants liability is presented below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoteWarrantMember" xlink:label="loc_us-gaapNoteWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapNoteWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="loc_niobfChangesInFairValueOfInitialValuation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="loc_us-gaapServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="loc_niobfChangesInFairValueOfInitialValuation_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:title="00000070 - Disclosure - Schedule of expenses as other operating costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleCashFee" xlink:label="loc_niobfYorkvilleCashFee" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_niobfYorkvilleCashFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOtherCostAndExpenseOperating" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:title="00000071 - Disclosure - COMMON SHARES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtCurrencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CAD" xlink:label="loc_currencyCAD" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_KingdonCapitalManagementLLCMember" xlink:label="loc_niobfKingdonCapitalManagementLLCMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_niobfKingdonCapitalManagementLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_YorkvilleEquityFacilityFinancingAgreementMember" xlink:label="loc_niobfYorkvilleEquityFacilityFinancingAgreementMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleEquityFacilityFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GXIIPublicWarrantsMember" xlink:label="loc_niobfGXIIPublicWarrantsMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GXIIPrivateWarrantsMember" xlink:label="loc_niobfGXIIPrivateWarrantsMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPrivateWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_SaleOfStockPricePerShare1" xlink:label="loc_niobfSaleOfStockPricePerShare1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfSaleOfStockPricePerShare1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaapProceedsFromOtherEquity" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromOtherEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" xlink:label="loc_niobfShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOtherCostAndExpenseOperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNewIssuance" xlink:label="loc_us-gaapConversionOfStockNewIssuance" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockNewIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:title="00000072 - Disclosure - Changes in the Smith Credit Agreement principal balance are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDepositLiabilities" xlink:label="loc_us-gaapRelatedPartyDepositLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyDepositLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AmountsAdvanced" xlink:label="loc_niobfAmountsAdvanced" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_niobfAmountsAdvanced" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDepositLiabilities" xlink:label="loc_us-gaapRelatedPartyDepositLiabilities_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyDepositLiabilities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:title="00000073 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GeneralSecurityAgreementMember" xlink:label="loc_niobfGeneralSecurityAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfGeneralSecurityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_NonRevolvingCreditFacilityAgreementMember" xlink:label="loc_niobfNonRevolvingCreditFacilityAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfNonRevolvingCreditFacilityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MarkSmithMember" xlink:label="loc_niobfMarkSmithMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_niobfMarkSmithMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="loc_us-gaapRelatedPartyTransactionRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LineOfCreditFacilityPrepaymentFee" xlink:label="loc_niobfLineOfCreditFacilityPrepaymentFee" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfLineOfCreditFacilityPrepaymentFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLongTermLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EstablishmentFeesPayable" xlink:label="loc_niobfEstablishmentFeesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfEstablishmentFeesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:title="00000074 - Disclosure - Schedule of exploration expenditures (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="loc_niobfDisclosureExplorationExpendituresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureExplorationExpendituresAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CostCentreAxis" xlink:label="loc_niobfCostCentreAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_niobfCostCentreAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CostCentreDomain" xlink:label="loc_niobfCostCentreDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreAxis" xlink:to="loc_niobfCostCentreDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FeasibilityStudyAndEngineeringMember" xlink:label="loc_niobfFeasibilityStudyAndEngineeringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFeasibilityStudyAndEngineeringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FieldManagementAndOtherMember" xlink:label="loc_niobfFieldManagementAndOtherMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFieldManagementAndOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MetallurgicalMember" xlink:label="loc_niobfMetallurgicalMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfMetallurgicalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GeologistsAndFieldStaffMember" xlink:label="loc_niobfGeologistsAndFieldStaffMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfGeologistsAndFieldStaffMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExplorationExpense" xlink:label="loc_us-gaapExplorationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapExplorationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:title="00000075 - Disclosure - The Company incurred lease costs as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract" xlink:label="loc_us-gaapLeaseCostAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCostAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_FixedRentExpense" xlink:label="loc_niobfFixedRentExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfFixedRentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaapVariableLeaseCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapVariableLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaapShortTermLeaseCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapShortTermLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="loc_us-gaapSubleaseIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapSubleaseIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCost" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details" xlink:title="00000076 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2024: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_TotalLeasePayments" xlink:label="loc_niobfTotalLeasePayments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfTotalLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LessAmountOfPaymentsRepresentingInterest" xlink:label="loc_niobfLessAmountOfPaymentsRepresentingInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfLessAmountOfPaymentsRepresentingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LessCurrentPortionOfOperatingLeaseLiability" xlink:label="loc_niobfLessCurrentPortionOfOperatingLeaseLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfLessCurrentPortionOfOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_OperatingLeasesLiabilityNoncurrent" xlink:label="loc_niobfOperatingLeasesLiabilityNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfOperatingLeasesLiabilityNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesDetailsNarrative" xlink:title="00000077 - Disclosure - LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CorporateOfficeMember" xlink:label="loc_niobfCorporateOfficeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_niobfCorporateOfficeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaapLesseeOperatingLeaseOptionToExtend" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseOptionToExtend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DiscountRate" xlink:label="loc_niobfDiscountRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_niobfDiscountRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRemainingLeaseTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails" xlink:title="00000078 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:title="00000079 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EarnoutSharesLiability" xlink:label="loc_niobfEarnoutSharesLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfEarnoutSharesLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_WarrantLiability" xlink:label="loc_niobfWarrantLiability" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfWarrantLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_GxiiTransactionCosts" xlink:label="loc_niobfGxiiTransactionCosts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfGxiiTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetRetirementObligationAccretionExpense" xlink:label="loc_us-gaapAssetRetirementObligationAccretionExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapAssetRetirementObligationAccretionExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_ConvertibleNoteValuation" xlink:label="loc_niobfConvertibleNoteValuation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfConvertibleNoteValuation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtGainLossIncomeTax" xlink:label="loc_us-gaapExtinguishmentOfDebtGainLossIncomeTax" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapExtinguishmentOfDebtGainLossIncomeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_EffectOfLegislativeChanges" xlink:label="loc_niobfEffectOfLegislativeChanges" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfEffectOfLegislativeChanges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:title="00000080 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsMineralInterest" xlink:label="loc_niobfDeferredTaxAssetsMineralInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsMineralInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:label="loc_niobfDeferredTaxAssetsStartupAndOorganizationalCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsStartupAndOorganizationalCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:label="loc_niobfDeferredTaxAssetsResearchAndDevelopmentCosts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsResearchAndDevelopmentCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:label="loc_niobfDeferredTaxAssetsShareIssuanceCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsShareIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CapitalLossesAvailableForFuturePeriods" xlink:label="loc_niobfCapitalLossesAvailableForFuturePeriods" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfCapitalLossesAvailableForFuturePeriods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:title="00000081 - Disclosure - Changes in the valuation allowance are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:label="loc_niobfDeferredTaxAssetsValuationAllowanceAdditions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsValuationAllowanceAdditions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsIncurredDevelopmentCosts" xlink:label="loc_us-gaapCostsIncurredDevelopmentCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCostsIncurredDevelopmentCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:title="00000082 - Disclosure - Schedule of cumulative net operating losses (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000083 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtCurrencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CAD" xlink:label="loc_currencyCAD" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_CapitalLossCaryforward" xlink:label="loc_niobfCapitalLossCaryforward" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_niobfCapitalLossCaryforward" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:title="00000084 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:label="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapFinancialLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFinancialLiabilitiesFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000085 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_MarkSmithMember" xlink:label="loc_niobfMarkSmithMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_niobfMarkSmithMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240630.xsd#niobf_LindConsentWarrantIssuanceMember" xlink:label="loc_niobfLindConsentWarrantIssuanceMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfLindConsentWarrantIssuanceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventDescription" xlink:label="loc_us-gaapSubsequentEventDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIssuedPrincipal" xlink:label="loc_us-gaapDebtInstrumentIssuedPrincipal" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuedPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:label="loc_us-gaapDebtInstrumentIncreaseDecreaseOtherNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseDecreaseOtherNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="loc_us-gaapLineOfCreditFacilityFairValueOfAmountOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:label="loc_us-gaapLongTermDebtPercentageBearingVariableInterestRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLongTermDebtPercentageBearingVariableInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyExpenseRatioIncludingIncentiveFee" xlink:label="loc_us-gaapInvestmentCompanyExpenseRatioIncludingIncentiveFee" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapInvestmentCompanyExpenseRatioIncludingIncentiveFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>n257410kimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 4@+0 P$1  (1 0,1 ?_$ +X  0 !!0$!
M       ' 00%!@@# @$!  (# 0                $& P0% A   0," @<"
M" @)" <)      $" P0%$0<A$M.5!E87,1-!42*RLW0V-V&Q,G(C<Q0U<8&1
MH9+#-!5UT4)28C.35 C!\:*#E+06@M)#4R0E52<8$0$  0,!! 8'" (" P
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M45K41,6JQ?S''YGI+<5_N[G<Y3J[LME+DFG,=<
M
M     ,5Q9[+W?U.?T;@.<(X)W1/G8UW=PJW7D3L:KL5;^75 Z'X+O[+YP_35
MN/TZ-[JI;XI&:'?I?*_&!;YD>Q5S^:STK0-2R/\ V:[?.@^*0#TX@NW#?#O$
M,\E)']NXAJY421TFF.G1^'9\.'B_UXHPVQ=Q=+6MTED7S=TI%KJVDH*9]55S
M-@IX],DDBX(AE;+6'9K\%M<K?M;UPT8I%(J?$ ZL<%_XJ3^YD_D SEFXCL]Z
M@?+;:EM0V/#O&IBCFJO9K-7!4QP(D<XYW:,QKBG]2#T+2W<JC^/"F\U_?F'2
M]L3_ -OIOJF>:A4[]ZW8_A:WFK:KA=>![A0VZ!U15R]UW<+,-9VK,QRX8X>!
M#9T62VS+$W;FKS#'=?BF+=[3LBN%>(K#4W=]VH)*)L[($A[S#RM37UODJO9B
M;O-=5CRW1PRT>3Z:_'$\4-RON:G!5CK'T5=<$^UQZ)(8F/E5B^)RL16HOP8F
MGBT.7)%8C8W\O,,5DTF=K%]=LO/\7-_<2_R&>.59_P!/MA@_M\'ZO9*]M.<'
M =TJXZ2GN*1SRN1D;)HY(]9SM"(CG-1NE?A,.7E^:R*S#)BYGAOFD2V&_<26
MBPT*5UUJ6TU(KTC256N<FLY%5$P8CE\!@Q8+LD\-L5EM9<]N.WBNG8P*YO9>
MI$LO[YBU=;4PU)=;'1_-U=;#X<,#9_K<]:<,M7^SP4KQ+ZQ9@\*7ZM6BM-P9
M55+6+*Z-K)&X,:J(J^6UO](P9=+DQQ6Z*,V'6XLDTMFKXES,X%AE?#->J9DL
M;E9(Q7+BCFK@J=GC/4:/-.V+9H\3S##$TFZ*OCJCP!_\Y2_I+_(/]+-^BY/]
MA@_7:N:','@ROG;3TEYI))WK@R/O$1SE7Q(N&)YNTN6(K-LQ#U9K<5TTBZ)E
ML*=A@;0
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M].W2^-KE^,J.HMBW)=$=%T^*YZ6ZN*V?\8\%^86<
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MY3Y>U2^;>8N=(\)>RMF]1IO0M*SJ_P!V_P":?%:]'^S9\MO@RIKMD
M                              :KU8RLYRL>\J/: .K&5G.5CWE1[0!U
M8RLYRL>\J/: .K&5G.5CWE1[0!U8RLYRL>\J/: .K&5G.5CWE1[0!U8RLYRL
M>\J/: .K&5G.5CWE1[0!U8RLYRL>\J/: .K&5G.5CWE1[0!U8RLYRL>\J/:
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M#%>QS)&(]N'PMT_B V[([]FN_P ZG^*0#4^-_>'6>L1>:P"0LY/92+UN/S)
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M]Y4>T =6,K.<K'O*CV@#JQE9SE8]Y4>T =6,K.<K'O*CV@#JQE9SE8]Y4>T
M=6,K.<K'O*CV@#JQE9SE8]Y4>T =6,K.<K'O*CV@#JQE9SE8]Y4>T =6,K.<
MK'O*CV@#JQE9SE8]Y4>T =6,K.<K'O*CV@#JQE9SE8]Y4>T =6,K.<K'O*CV
M@#JQE9SE8]Y4>T =6,K.<K'O*CV@#JQE9SE8]Y4>T =6,K.<K'O*CV@#JQE9
MSE8]Y4>T =6,K.<K'O*CV@#JQE9SE8]Y4>T =6,K.<K'O*CV@#JQE9SE8]Y4
M>T =6,K.<K'O*CV@#JQE9SE8]Y4>T =6,K.<K'O*CV@#JQE9SE8]Y4>T VH
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MWH6E9U?[M_S3XK9H_P!FSY8\&5-=L
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MM)!31IJQP1MC8U/ UC4:B?F*SDOFZZ9GIE:L5G#9%O5$/4\,@
M
M    !</"!3R0&LWQH Q;VX@/)%0Q;XT 8L[<4T]A%8#%OC0D-9O;B@!<,!4W
MJ*B'FD=)6>A31XT_**]J*=BF+?"J:?A)X:D=BN#? $BZOP8B8B=YMZ# (IV&
M"8B8ZTQ475\.'P"D"GA0BLHV*KV$R.5^%%5<U:-5[5NB^E4NFIC^/=7J4G3>
M8MIUNJ$3#L*5$=2[=ZJ8XZ4)HE]$@
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M)G4<[8DN:N618WHU&]XNG%4+9J,UDZ>8KMHJ>GPWQGC9L=0M*BN2I(
M
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M^Q(%'3MAI884[(FM8GXDP.;?MNF7<PQPV1"X1J8)HTH0R<,*X(@2
M
M           *.^2IYN3#X\1ZDC?*O@)E(IXN%?".A"G\HA,B>$]$GB(G>B!Q
MXZ9(43M/4(Z'TI$;DPIX!=T]Z7RG:HC>B=\##)<]2^S&\=*CQ<]0JGR2(1+Y
M\![M1.]'_&OMOP_]8WTANX?AESM1\5OS?:D)II=+H6OHE(
7                           #_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>n257410kimg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!( %Q P$1  (1 0,1 ?_$ +4   (" P$!
M       %! 8! @,'" $! 0$! 0$               $" P0%$  " 0,# 0,$
M"PP$"P4%"0$! @,1! 4 $@8A,4$342(4!V%Q@3*RD].4%546D4)2TB-4M#5U
M%S=7H6(S<['!T7*"DD-3)'0VH[-$)0BB8S34E>'"@\-D165&)U81 0$  @("
M @$%  (#       !$0(2 R$3,01!46$B,A1Q!9$C,__:  P# 0 "$0,1 #\
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M^\?G'\N<O\XL/E] ?O'YQ_+G+_.+#Y?0'[R.<?RYR_SBP^7T!^\CG'\N<O\
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MG.AH>[R:!_PZ]YM=37?VDLXK2%!$+3PR"SDAC(6H[C\'IW&HZCKH+5TT!0:
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MA5+YW9!2Z5V61127S0-M#VTK7KV:"Y<8FS<^(AES<2PY%MQEB0 !5WG94!G
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M*TE)1V$^:#45J= VOO4I!;8B:[ON2O'F[<QO:\HF5A<1A&J5G9IMLL9Z *:
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MKE0A+-"A)V@L!V]@.@M51H#0&@XWH4VLP8T4HP)\@I[.@3\":5N%8(RKMD]
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M>7%7UQ9279N(;J)8W0P^!&O:74]-A'45U1P3F$CW!MX\%EWF5%E9%M"2$<D
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MU WA2*0499%.U@1TIUT">S$T?.I(V93&<3"54#J"L\@/6O6M=!WYC;K)'C)
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MPD:"NX>RL;?U@9F""W6,>@6,I<+M\YI+E&"GL/FHM= QQF$Q#7&04VD1V7-
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M$\&Q.-LFBA:;TN5FFN,AXC"XEF>A>1W!%:L*[?>^Q30<<%C4/)<M=74C75S
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MQG6^FM%?&3;X$$1ZB:+S0S*W97KH&F;L6>7$P^ERK(MR:2 H'8^#)UZK3I[
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MDOTBRT%MT%1]4?\ #'C/[/@^ -!+Y/D9;#*XB6&RGOY"9U6WM@F_J@ZUD>-
M![+:#:.[YG<++*EE:6BFO@17$SM**=\GA*R"OD5C[>@BQ<,&5$5WRHID+Y/.
MCMXRZ6MNU"/R*5!+4-"[><?8'30<6XA#9Y:),'>3XR1;9]H#&>(_E$]]%,7'
M^J5/LZ!'PKBW(RF6PN3SSSXRPOGC6*"+T>:1)$2?:\V]V5"92*)M-/OM!:4]
M7O%A.TTEHTY= A2>::=-HK]Y*[K]]Y-!);$8S&?1MMC[6*T@%UTB@18U_LI.
MY0!H&\TT,$32RL$B0%G=J   5)).@K5G/##S+*SNX%O<6N.CB-:AI"]Q3H/*
M"-!*Y9QS#Y;$W*7MA%=OX3>$60,X:G3:WO@?:.@7I?2\7EC2_NC-QV8A(+^=
MZO:OV>'/(WOHV[%=C4'HQ-1H.N%O+:^Y1G9K&YCEB\.P_*Q,LBF@E)%5)'9H
M',30G,S#PP)E@B+35ZE2[T6GL$$^[H&%1H.5U_\ #R_YC?X#H.6+_5MJ3WQ)
M\$:!'Q"[G]&GC:)Y$;)90&8;=L82]E"@U->M>E- KYSD\Y#R/"V.%D@M[V[A
MO"]U<1F9(XHS"6*QJT>YBQ4"IIVZZZ:SYKIKK,90]OK./_\ 8K$#]FG_ .8U
M<Z&=2_*9+F-G-;C(\OQEI(26MUFLQ%N(&TT!NEW>^TSHO+1MBY.<K&UM9<JQ
MTWA%G=4L Y4O(Q-:7/X88>YIG0Y:.0EYE/G1LY9C'RMK"\1MEL5,B1R,C,2@
MN=PZHNF=#EHEW%AZP;B>WN)<_8&:U8O _P!&]5+*5;KZ1W@]=,Z&=76*X]8L
MQD6+DV/<Q-LD"XZI5J [6I<=#0C3.AG5T*^LVG_45C_]-/\ \QIG0Y:*Y';<
MCQMW=6>9M;[DK7U;B._Q]Q+81^(WFO'/'Z0D2 *!M*CJ.ZO75X2_!QE18\YR
M'C<$]HUUC>.B_NGGMK*!),E?,' 58XXE\($A4 !VMK<ZHW-(UNN'\XY);&?)
M7%Y!8$I67*RCQ'#.!5,?:^%"G;_M6;_-UJ]FNJW:1>N)^IO@_')!=06*761'
M4WURJO(#_44 )'_H*-<=_L;;.=[JG+&EORV\LX)7BN+RR1XI2K2A6622K>=N
M44W= :#7E^=FKYT2_ OQE+B.VN%%[Z/9F6>1*JRK)-N\P$4+"OM:Z.!;/-R&
MUYED(+"SM9H;JSM[E);J=X 'B9XG'F135H-IKTT$ALSR6V>P&5LK!K>]N4MB
MUK<22;=X9E?\I#&#U4:"'S'!9*TR#<OPMXL%Y9VX]/LIJ""\@MRSA'D-?"*I
M++M8=Y%>@TQ;\)X,N$+QN?&KE,-:BT-^JSW4/7>LDH\8K(*D;P9>NK=;^26?
MA8FACDZLH;R5%=<]M)?EJ5@6\8I11T%!T[O)IPAFL>AV^S9X2;.W;04K[6IZ
MYC&#E63;1%@Q5=R^]-!4>UJ\)^AFL"UB!8A%J_OC0=?;TX0S6PA2H-!4"@-.
MP:UQB.@U1&R?ZNNO[F3X)T'/"_JBR_Y>+X T"#(?Q0PO[(R7Z39:"V:"H^J/
M^&/&?V=!\ :"3RG+PXK*8FYEM[BX0F=?#M89+B3J@Z[(PS4]G01H_65AG?:<
M=F$_K/BKX#[OA: ;UH\80T:+)@^3Z*R'R&@A2^L3C29Q;F66[CM_12E6L;T>
M<9 >SP?(-!#L_6!QJ/E\LMK<2C'Y"V,MW)):W,:K<P,D<="\:^_C8U_S= V/
MK6X4+OPSDXA!LW>,1)[ZM-NW;7LZUT&+OUA\+N+BP\++0G9/O<DE:+X3BO4#
MO.@F7'K']7Z$QSYVR0D=4>5!4'V#H*_CO6)P<\QRC'.V7HK6=D(&,R;#(CW&
M_::]H!6N@=9/UC\*6PG>#/V/C+&QC GC)W =.E=!V/.?5_<Q-%)FL=+&1YZ/
M/$5/MAC305..]]7=YRG,33YV.V5DM1";7(-:1% C#;2&5%=@VXD^R-!LL?JZ
M7)&2/ESCHIF5\M.04J]%5_'%*$^S_3H)*+ZO4)9.93*_B&1'^F'8J#]X%>1E
M*^V-!F[N^'FV<1<ZF60=0WTA YZ?>[75E(/M:#:RS?%UL+9FYTT>V)*IZ38]
M/-'0_DN[0(N,YSBL-A="XYY+:$Y'(%$%Q9C<K7DK*_G0M[]3NT'"WR.+NO6#
MBS:<H/(56UOVVL\#> A-O0'P43MH>IUUU_JZZ_UJ^0W$$J;HG5U[*J01_1KD
MY*;S/BV6RG(\5D\>T!]"@GAEAEGEMR?%DA;<#$K[@/"ZJ?+H%?'_ %=<@Q/+
M4S1OXVLR)$GLE9PK"2>YF#]@JR>.H%>GOO8U1BY]7^>;Z3L[6[LXDN9KFY@O
MPKKD%],F61D,J^\55!4%>T4'2FH(MYZL.7-+D1:YMUMIY5-M"UQ,-T*O58G.
MURFQ0%##=7OT,G'#^%YWC^=OLC?907EG>(NZ-W>J21Q1)XO4!6:3PVWD^Q3O
MT,KXK @'NT%*Y;E)QG[7$O=7]MCY+5[BX^BK22ZN7(D"!=T:2F):'WVWW==]
M;B9==?$R .)6EC$<'Q[+B^CN[:X>\DQUWZ2_A3*TA>:9-[5CW#M[]<KV6L7>
MG=]R=\G83VTF$S,DHD$UL38O %V,&059Z$@CMUEDW/.+L/L7B^98=F\0P!>O
M^=.- O;D.?3/27R<2RLD#VZ0@AK%3579JG=<CIYVL2><NEV_CAK;YWFT.4NK
MJ3B5Y.DRK'$PGL(RJ(SLH8>D/6F_MUMS<[N_Y[+R&'(1\2+V8M);66*6^M5)
M,CQN#12XH-A!T$;DF-YGFL=;XQ.+VMM:6T]O/ RY0Q%/!D5B!X,%5JNY?-/?
MH(^4X;RG)6,]@^"L8H)T:,3',WLCJ".VC6Q!]H]-=>KLX;9<^W3E,%7#>+\V
M]7,D]_D-F0P4M!>P64DL\L( Z3B-T3<%I1PGG4Z]::]/V?L]?9K,3#S]/1OI
M?G+U[&Y/'Y&SBO+"X2YM9ANBGB8,C#V"->%[$G<-!G0&@- : T$;)_JZZ_N9
M/@G0<\+^J++_ )>+X T""_\ XH87]D9+])LM!;-!4?5'_#'C/[/@^ - XR-#
MG\1[5S\!= VH/)H,;1H#:-!F@\F@U*H.T: HAT&IAA)J5!/E(!T!X$'X"_<&
M@/ @_ 7[@T!Z/ >V-3[@T&/1;?\ W:_ZHT!Z+;_[M/\ 5&@SZ/;_ .Z3_5&@
M/1K?_=)_JC0'HT [(U_U1H#T>#_=K]P:#SOUA6X?E>&AC"I)<X[*PQ$T4&1E
M@HM?<)UVZ_.M==/ZU2,-ZL>186SL(\5E&M9WA+9-8BD,/I$5J([<>'&J[U\4
M5=CU;OUSXUCC4"7!>M WC6D5S*EUZ*[PSRR&8HC2V@DC]+VQ^?*8IV4#WH/=
MTHX5.-3,CP_UE7N+N;2ZOI+B66UA2.6.\\% R*A>-D6/SG:16/B5'0^YIQJ8
MJR7F-Y1!RJ\R./M4>&_QT%FMP\P5H)HGE8N4(.^GB@].VFG"F*1V7'O6?&UH
MUQ>2R01REI+<7M) VR >(\WA-OBWI,?"V_?#R='"F*62<*]:5YX[Y"Z$CEKO
MT6$73-&GI%J\2UW[@RB7::'I3N'9IQOZ&*:IQCUER7CK-E)(;1YP9GCN:;X?
M2-R^"H0>#LM_,8#WQZ^SIQOZ&*LWJ_CR<')[&TRTXN,M;8()?2;MY+^D* S'
MI[[:>O?KIM/XNMF-7J( IV:XN3-!Y- 4&@*#0%!H"@T!0: H-!@J#W:"HY+@
M]Q;WDF3XI>+ALC,=US 4,MC<$]K36X*4?^O&RMY:CIH(5SP'+VULN3L<U>W/
M*(#XHGN;F;T2=NUX7M%;P(XG'FC:E5Z&I/:%HXQG8L[@K++1(T2WD2R&)NK(
MQZ,AIWJP(T#30&@- :"-D_U==?W,GP3H.>%_5%C_ ,O%\ :!!?\ \4,+^R,E
M^DV6@MF@\HQF1O\ '>H;!W5A<^B7*6%F$GJHIN*@^^!KT/8HW>306S"W5U=Q
M\6NKM_$NIK5WGDHHW.T*%C125ZGR:"UZ T!H#0+\W/>0V$K6:[[D[5B%*C<S
M 5/L"O77#[&VTU_C\MZ26^2J3+9:VQ,4QMWGOI)"DD80T4@FO9][TZ'7G]O9
M-)X\NEUUMQ^$V3(Y$92.W2WK;&@DE(;H2K,:'LZ4 ]W6_=OG&/#%UF'"/-9
MPY"1[1QZ,Q6W4(]7%: T-"?9IK,[]_/A>$\,',Y46^.?T1O$NF N$"N?#!/]
M'NZ>_?$\+PU/U[->V?#BSJ@T!H#0&@- JSO&<+G;=+?*VD=W%$XDB#CJCCL9
M&%&4^T=:UVPLV)_W5\'^KO\ MI_E-:]M;YC]UG!_J[_MI_E-3VU.='[K>#_5
MW_;3_CZ>VG,?NLX/]7?]M/\ *:>VG,?NMX/]7'XZ?\?5]M.8_=;P?ZN_[:?\
M?3V['-G]UO!_J[_MI_Q]/;4YF>"XEQ_ F8XJRCMGN"#/(*L[[?>[G8LQIW==
M9VVM-MK3G661H#0&@- : T!H#0&@IN;Y-F;GD\''N,O:O<1Q2S9>XG26:.UI
MM$,;>$R /+N)"EJT%= XXAQUN/X2+'-<-=2!Y9I9B @,EQ*TTFQ![Q-\AVKW
M#0.M : T!H(V3_5UU_<R?!.@\_Y'F\S87W#[?'WGH\5TL:W,'Y,^*E8E("MU
M[&/6H'^E0:!Y??Q/PO['R7Z39:"VZ#R2SNYK3_T_X:>&$7#KC[.D)C6;=4J*
M;7!4>V0:>30.<'=75B.,3Y"XM;7%FR81JZM ZRM"A*DNVT+VA5I706_[4<;^
MM;3X^/\ &T!]J.-_6MI\?'^-H#[4<;^M;3X^/\;0'VHXW]:VGQ\?XV@P>3<:
M/_[K:?'Q_C:#4\GXP.IRMF!_?Q?C:F!M]I>-?6MI\?'^-JC'VFXU]:VGQ\?X
MVI@9^TW&?K2S^/C_ !M7 S]J.-?6MI\?'^-H#[4<;^M;3X^/\;0'VHXW]:VG
MQ\?XV@P.5\9+;?I:SW 5IX\5:=E??:#/VHXW]:VGQ\?XV@/M1QOZUM/CX_QM
M ?:CC?UK:?'Q_C: ^U'&OK6T^/C_ !M ?:CC7UK:?'Q_C: /)^-_6EI\?'^-
MH,+RKC+"JY6S(\HGB_&T&?M1QKZTM/CX_P ;0'VHXU]:VGQ\?XV@/M1QKZUM
M/CX_QM ?:CC?UK:?'Q_C:#'VHXU]:6GQ\?XV@PW*^,KU;+68!( )GB[3T'WV
M@V^U'&_K6T^/C_&T!]J.-_6MI\?'^-H#[4<;^M;3X^/\;0'VHXW]:VGQ\?XV
M@/M1QOZUM/CX_P ;0'VHXW]:VGQ\?XV@U^U?&-VSZ6L]PZD>/%6A_P!+V-!M
M]J.-_6MI\?'^-H%G)/6!QO#86ZR8O(KST5"_HUO+&\KGL 4;O*>OD[= OX/?
M8?&XF1LAD\>N0O[FXO[I89T**]S(9-@8FK;%(6O?306/[4<:^M;3X^/\;0'V
MHXW]:VGQ\?XV@/M1QOZUM/CX_P ;08'*N,M6F6LS0T-)XNT?Z6@S]J.-_6MI
M\?'^-H(V3Y-QUL?<JF4M"QB< >-&:DJ>[=H//L]+G5FX;:WL4%RT[I66WMB1
M$BF$J^YS(ZMY=M/+W:"WWHIZSL+^Q\E^DV6@MV@\XX=CKK(>I? 6]K!:W-S]
M'6SQ07RL]NY0!MKA2IZT[=!<N-XV2RP-A9W"J);>!(W1:%58* 57V%[!H&7@
MQ?@+]P: \&+\!?N#0'@Q?@+]P: \&+\!?N#01,K)):X^XN+6T-W<11L\5LFU
M6D<"JJ"U *G0>?Q<BYM>2VT.4XSX5L7\2;8')62$*\2A@6[9PO6E*'^J3H).
M&Y/SZZREO;WG'DMK)Y422X*N/,()9J%CL\VA%>RFWM/0/0A#%3WB_<&@/!B_
M 7[@T!X,7X"_<&@/!B_ 7[@T%8YEE>08P6IPF,6_\0R>DC8[%%"^:P"4'OC4
MBM2.@J=!5QG>9H[Y+[,5S3&.VDA'B>&+9-TAHU2"WB;J-[GDJ%EX9E>39*2\
M^G,4F/CA$0MFH09&8,9#M):@IM/;TK0]1H+5X,7X"_<&@/!B_ 7[@T!X,7X"
M_<&@PT40%=B_<&@\\RW*N?P9*Z@L^."6SBFD2&8JYW1JH"R5#"M6;=M ZCH.
MH- X#D7-;)C;XWC.^PC0.K.KEFE9#+*H)(Z;V('3NIU)% ON#:ZN,3:SY"W2
M"]DB5KB$#HKD5(H:T]JN@G>#%^ OW!H#P8OP%^X- >#%^ OW!H(68,]OCKF:
MSA66ZCB=H(BN[<X4E10%:U/LZ"A7&7YA>7 L\KQY6M8)C*LL*R /+;4>#::G
MH9D7J>U3_5)T$K"\EYY=9BWM;W );6#NHENBC*:;26-"S;*BA%>SWO;V!Z (
M8OP%^X- >#%^ OW!H#P8OP%^X- >#%^ OW!H*GS7,\FQEQ91X+#C(I,)#=2;
M6;P]H 0T4BO5JD=X'305Y,MROQKC)#C/_GS[+?;Y_@+%$Q\.I)\[<TTHWCV"
M>G:#WB&;Y9DK^1,SAEQ]JL6])""&+EO-'G$_>U!'E%?O@-!</ B_ 7[@T&?!
MB_ 7[@T&/!B_ 7[@T 88J>\7[@T%#Y#R7F]GFKJUQ?'A>6$7AF&Y(8!ZJ6D6
MH/:.[I3I3J3T!:N?YI8^#'C.->*EPIN+YW5U NI9&,JI4^:I((Z^][>SM"\\
M9GR-[AX;G*VBVE[)O+P!2**'(2H:I!*T-- U,,1^\7[@T%7Y?Q_(9&_Q4UG;
M6<RP3J+F:X4^/%'O5]]N]=M:I0J5ZZ#6]J/6=A0?J?)?I-EH+;H/+N,8GUU<
M?X_882VM^/SV^.A2WBFEGO [*@H"P$=*Z!IZ1Z\OS+CGQ][\EH#TGUY?F7'/
MG%[\EH#TGUY?F7'/G%[\EH#TGUY?F7'/G%[\EH#TGUY?F7'/G%[\EH W'KQ/
M;9<;^/O?D]!KXWKQ_,N-_'WOR>@R)_7C^9<;^/O?DM!GTGUY?F7'/G%[\EH#
MTGUY?F7'/G%[\EH#TGUY?F7'/G%[\EH#TGUY?F7'/G%[\EH,&?UX_F7&_C[W
MY/08\;UX_F/&_C[WY/09$_KQ'_@N-_'WOR6@SZ3Z\OS+CGSB]^2T!Z3Z\OS+
MCGSB]^2T!Z3Z\OS+CGSB]^2T ;CUY?F7'/G%[\EH,&?UX_F7&_C[WY+0'C^O
M'\RXY\XO?DM!D7'KR'99<<^/O?DM >D^O+\RXY\XO?DM >D^O+\RXY\XO?DM
M >D^O+\RXY\XO?DM >D>O+\RXY\?>_)Z#!G]>/YCQOX^]^3T!X_KQ[[+C?Q]
M[\GH,^D^O+\RXY\XO?DM >D^O+\RXY\XO?DM >D^O+\RXY\XO?DM >D^O+\R
MXY\XO?DM!@S^O$_^"XW\?>_): $_KQ_,N-_'WOR>@!/Z\?S+C?Q][\GH,^D^
MO+\RXY\XO?DM >D^O+\RXY\XO?DM >D^O+\RXY\XO?DM >D^O+\RXY\XO?DM
M!@S^O'\RXW\?>_): \;UX_F/&_C[WY+09%QZ\1V67'/C[WY+0'I/KR_,N.?.
M+WY+0!N/7D?_  7&_C[WY+0;8#$>L*XYC;YODR8N&WM+&XM(8\=)/(S/<2P2
..$MXR+T'@=V@O770?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>n257410kimg003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg003.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!P@+( P$1  (1 0,1 ?_$ ,4   (# 0$!
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M\#4]_&<WM_'\R#<WS0)_SZ?_ *Q_WT? U9SQG-[?Q_-4<[S1)!SIQ_\ $?\
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M=1I2#=]G*/YW!?M+CL/^N4?MKF\3U3VIZ7H_3OU;>Q?02]ZM;W/E#MMCL?\
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M95@+,RI%D6,[B8]2B#4'XFC(P=Q0[QF1VN7-Q<6(%&1@OEA5D\YO=;#3M\Z
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M_;G,2X?!)"H53)+(OJD790;'3YU&U;:;8<OR#I)R\SAK[/#0$GK1!M<F\+:
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M6N<S9Y<B=GU7^Y'456&=J4ED2(><FW:PJ2R\LC2Q&21SO!L N@_111DS$ZE
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MWYM%&\M:,:%A?OI4X&&2^0,KDS*@_ AMYFO8D_53@CH(\A)\.$A@=CL H%K
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M4K1D'X?*@;3I7Q#D&2.:&1H1";Q3"UQXMJ.U PU"N4N9ZF3F!Q*=ZJY 8MN
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M(3R.,J<J="[?KH 3&X ))UZ&F$J K7^.M $:3<"HZ&@*(C!_AWH"SHJ#<U
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MPTH\)<[;7%G5US#/ZC)-=)-M=NOJ_@5''O+"CJZ!;6ZFUQVN*[WEX1_*9O\
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M4#@5/&3%KW'VT#@5?CS:YL/'0@4%88P50-Z)D4R,/)8ZZ48*'(<CU@$C4R2
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M\M$JCK175\3!O!S%R-X4FRV)!^-)4YF384DBZV7O4K\SG>8*+RK'6WE(H9;
MM(1?;I=MVO3I:@XI,X 8@ZM;4Z #KVH+:F\!KS1DV)O8>'F%N_SH*]3&R5C2
M9D0W()OTZ@VJ_,PO61RBV^Q\.E$.EC]56%K>)H-( &M[_"@)L*"> H(7^(T'
M(@T'A-M+T'A9;WZT! '^_0FUO^Q+?Z5\;8_\LG^4*Y/&?IU]N>EW_3/U[>Q?
M0U/>0B;W-EM;SVC!/P](4_#^=?U3]WR^QC0JI/37KI6SSM/.9QWC&7 K#=^(
MIL/@PZTY%J%V8%G&I:Y^WK3:2)4%A24L$Z6ZT@6S "X!:UAK_O4T[0J)51O
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M1>WFN=+=116N4)*)/. VT]+FVGB12$H@L+?II++98=YPL=@;7W'6U!6%)O2
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M@C0,2!Z:1LKOM/8"Q.E%QA4KEQ<Q;U;<!:Y[5A>M62V9<XKGL1<5S>(_;O\
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M!53M-Z WO93W]T\<?_?)_E"N3Q75/:GI>C],_7M[%]#7]V[?](,@F_2/0?\
M1K6GA/.W^H?N^7V.>=8\?+$Z JLNKD]V'A717GZWIJ>1Q P$P0MYVVMVM84F
M=O21,;*2.@I-,+74=[DT!.[: ?#K0>53(DINI# >%!92 HZ4!-M=30%MPUL;
M_"G %J&MNU/8]30! "%(7J=;_*@*]"0Q%J!'@JV-M;U4%CP ':QJBPAHS>_[
M32*ZC8S6:^G3K4U.#(,9T;05*IL%DCU%C4*&6,E@3T!_;0?$%&VT-)8$FUV
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M-QN>,!F(\/,0-:$;;-'W%QD>$CR29*2R!_P;$-9&%]I([BE6?64!Y-\;C\O
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MHH<JFWF!*GY41!4,T<DABT)7RW\1WJX#X.ZW;04&D"Q^%!5ZPH";&W2D$;:
M]:G@.@]BC_\ :N._Z9/\H5Q>-ZM?;GI>G]+_ '+[%_&+?V@X?J^ZLL[;!DC\
M]^XC72U7X7SK^H3_ &^7V.;_ "SJT2L"07 8ZV%S:^GSKHG6\Z>=I/F9^-G3
M%D_.1LWGC?06&@V^%%:2G(<OA9GLT4N.YMHZ^6_S(I+DR-/Q2-")\*42(;FR
MV)N.H-J#PRLAII'101&U_P 1NX \*&>U#R9(8%:1WT%_*>YOI:AGDN,X,P#1
MLI^(O]E,9-KY;BVM&&FJ))XDD"$V9M=!I2H-\;"DF1(SR+H+QBXZ#KI2.&LI
MU*%1IK_NM3A[5I8H'Y>/72U1L-6+G./SDMM3N[UIKU"@GI3) &E >5"[*FGF
M(%^MKT"]2),6"*9\?$7;"I-I[$;V\0#VO4UST7$R5DC\PLRDJP.G3O2:\NBJ
M26NO?M0U9_-PR228]E)(W%B 3H!\*$[*XV5.48-"[6-DVJU_D:FQ*X@Y'D)X
MXFQVBA!OJ#U'C506'N+2?B^3M/&=D]D$@%E7N/OH/6-;G6#>E8@#PHG6IC@V
MU)K0+>?P/W5-4JX)4@W^1[?92B-EY0C\='!>VP&1);W#7!N"#3K&];=X.%H>
M.@CMJ 6M?^E4UT:5K%#M'W^%1A> G0^I$"!YF %S87\;FJUB;2N+/C.OI"5?
M44G<NX$Z&U.PXNT;!B>NXZ#P%+B,ES.+ZO'S*%\X%X[==P(-'$5UZ"4;2H4W
MK9A -U^M]]JY^??]W+_R_!U>'G^CF?X@1E;:VN#H"*Z;.EQR]!H7:",]2K7U
MN+7I8%K3U;<#8C6]+7H7M,R*V7^4Y4,0&XY49$8ZV"/<_IKQ^;9.?+;)T>F,
M_'\K;;@X9;B>:?:4CXW.D-Q$!V\SJOZR*<\3RYFYU[W#P<WJX-NZAY6-+B.$
MGLK%0Z[65A8_WI-7RN;Q:L=MMIMTD]S3DJ#Y"WTCN!\ZU\Q;7-'8DN2.@%K?
M*G#NH"D!PU^AO]U#"BS(%<D=#9A\C031]L?][C_HIO\ LVKF\=^W[OXM.5U_
MY3\6BUS&%47+*/-X:"O0Y-_ICZ'Q'[FWWT%,38PN>G>M,L150H=RV/Q.M&5X
M"SLXXZC:-SR7M?M:@K<+X4V^(.2?48>86[_*C!0:1K,H(M\Z,G=C28ZRQ#4K
MUU'>A<Z8JW'8[KM8L>_6C P$.$PVZ;OO%/I'#%_Y)AH+DMK\11,CA@<F#C11
MR-&S$[&[BLN?/Z+]S7PE_P!D^]EID1M97&TC0:=11X?]O7[I^#+Q7[NWM7\0
M<B-A(7"74ZZ=-:V<X"J0P('FZ%?&_P : C+CE3#R R%$,;&^NXV\37/S?U:N
MKD?HW]GT5R7K/Z>RUT)O8V;_ 'Z[8\R]4_BJ64J5*!OG3&4JZKHHVC[*"27N
MO7:U[@@7O0!8V;TRHD4N#>S#;]QI'%3+L(;8=+W%KG]%*J%9A)$K@==>FHO2
MB*!?S&K2A@": @7O1DCW$Q;YBW]&]JFJC796'?[:BPK!8681]>AH:Z+22DW%
M!;+1'_,,U0+^5&(\ "=:<+#(@P\G)8NJE8R0-Y_W:U2M=#>7@K#C'8I_#(61
MMM]?C:C+6ZL21XHVD)4I/. I7P0$'[[BDSV@$S>2X/?0548[1FL=TNI*_$4\
MG(*'E1@!(_SZBC)BC*F U*FW337]%&08A7)F7>J!E!LVW]M&0=_EV7M#+M*D
M7O<Z5/$,"'CI@+[@1X@&CB& VPI=2-5'7J+??1QJFK5]BNO^E?'J""1,EQ?^
MZ%<OBNF3VIZ7H?3?W-O8OH;?N_&F?W#D,L;E;1ZA21?TUTZ5?AKUMOJ%_P!O
ME]C DP<N2>!5@D>TJW.QK=?E6SSY9TBY.%FO,[^A*"3?1&[_ &545F/+@YEU
M!AEV@W-T:BB['O;V+RD<\F"<9C%(VZ HC EB;D6M6>^\UF;U)VYLUF;U#\A[
M5Y8YL>0O'3O&S R(L;'PO]FM9?-\K..*,]_%<J7&4Y/L7(FR#D-Q^0VI9(_3
M;:I^ M4SQO)]:,_F>5VDHO:GN!,A)3QDQ]%_4C4Q.0UB/*>E/YWD^M$_-<KM
M*9O!<MBS,9\.:)&8B-G0J#WTO\ZZ=.9KMG'FQ_-MR^;K<]/5C^9(\-R&0?2&
M.]F==;=A]M.GQR]30D]M3^FV-&)% \IFC6SJ#J?&I.;P*+V;R6-*)X%R9E
M7U 3W[V%J<I7;+H,?C>1&,GJ8[J=O=3XU%F6DV8N5P',RR2.N*YNQ(M;I]]7
M*5V"3@^9(L<5]/E^^JA<0J\#S!%_RCV^:_OH'$A. Y<3"V*P'S'[Z63NRXX;
ME(8F1L5E3^$>7]]*L=H67C.4]8!\<HC"R[BJ^;PZTBG0;BX7DE-]B@]@73]A
M--OE:.$8V5?+R<>,J#Y1("=.O2G@KO#2\[Q9:T.1&[6ZH0-/F;"EA/Q(S_\
M2C+)F]7'B54)$1,Z:Z]P/&C";S,DI^;SLA?-'C(^X&,+(K6V]2;MK>C X^AZ
M7D^9]<3R9,$2#15)BVD'X7TM\Z)"XR_(YN3EG'6+*C&R0NJ^K&@9@+6O]M67
M%3&+A<K'N'YTQ[CN9O55B3X=.E36FMHOY;F$!*9P?=>ZEET^1HBMA^,DYV'#
M$"X\64@N$ED=;C4_MI6ID/XN5SR/&9\2..)/K9&5KCP J6D$R?<Y@0,(D!+$
M#>RQ]OE5IVW8!S,_D.5CFEF@*%_ZE9@0-+@U4B+M6>S.C/(LL+2EKI^*I&IO
MUMVHL*;-CB^?SH@JY4T$@W7/XGFM\ZGA7-VU-S'&/YGR(]RCZ=XT_11PJVYL
MPSVSN.ESRRY<;#TP@L;G1MQKC\3+QZ[3JUR[/"<[7X>VEO3MA>3^5JA9<FUN
MI('[#2^-MZNW\OS5>3IZ^O\ /\DXTW&O(8UR0[-_ HU^P$T?'V]7;^7YB<G3
MU]/Y_D)/F\4DKF3,9!].RW2GKSML_IV_E^9? F?UZ?S_ "6BS..B5S^:W*?J
M=@1^NB<S%S=-O+^*M=++^O3^?Y('-<2S;?S<8%PI8D>6_P ZPVVMULX-O+^*
M^3I-=\W?3'\?R3R*>W,G++CGL$"P$2[I=VQ1;4!/[FN7DZ\S68NFW\OS?+<S
MG<W:YX;_ "5C@]O(-R\]A&VA-Y!;[UK3BYGJ;_R_,KM?4V_E^:ZGV^ 0/<&"
M ?[J3_V:J;[_ /M[_P OS*\W;U-OY?F$V-PP-_Y_@[?[]_\ V:7Q-_\ V]_Y
M?FSNVWJ[>7\5VAX8H@_GF 2-"=[=.P^FCXF_J;_R_,N.^?7;R_BT^ @XN//W
MQ\KB3R+'+:&)R7-XVZ @5CXK;;?E]&NW1CL[?O:^&VNW,FF+T[>E<93*@41F
MP !^)M71IXG&L_IVZOL_-]KS/ V[6\6O7]OY(_,M8>1B?$U7S?\ ;M_+\T?_
M !_]^G\_R1^9:W]6U_E1\W_;M_+\Q\A?7T[[^1+)$DF1ZFT!;6VF]3?&R7'#
MM_+\SGTO;;-FVG],SUW\A8)9HXPI%K="-?UU7S7]NW\OS$\!F3^K7^?Y).1D
M%P7)=5! #?&CYO\ MV_E^:+X&>OIWW\CF)RNQ=ICW6/\-^E'S?\ ;M_+\SG@
MYZ^G??R$'+ '6%K?.B>*_MV_E^:ODYZ^G??R7'-&UA"2/"]'S=]7;^7YE\GK
MZ^G??R1_-)I388Y/P%$\9?5V_E^9Z^#US^O7^?Y!Y&5*R,# R @C7M4[^(NT
MQ-=NIIIX6:;<5VUZ_M_)G'$>8AO51; 6%C>NGP^9I)?-'F>+Q\2V7.;G^:IQ
MRLEAE(21VOVZ5NYE?1=9 6E3QN;BF,FY\V/+PEP\J>,8Z @NH8LH((OTUKGY
MW1=;]OXNGP]_IWG]M_"N0/&<:I*KRV.P'3RR]/\ %KLCS+?Y(_EO'?\ ^4A_
MQ9?W52<H/&\9_P#Y2+_$D_=0)4_RSCB-.3CT_N)/W4'E4\?BAA;D(2O<E9+_
M *J19>/'HJ 09V.[$ZHP9 ?M;2BP^(1N*GB"13#TD4?UK7VF^IM;K\+5(XE6
MX_C;C_/@IMJ/2DZU64U0X6"&V#.O<7OZ;_MM1DEQQN$8RRYP8?"-SK4Y5@]A
M8F#B*H><@N;ZQL.NE$J]8;,$-P#+<>.TT4['@(?I29=H/FNC U)RX6>+&  ]
M;S'^Y/[Z,)O2:Q,:*+%S9#D"PA\RA3>U^M.+DP2PLKC_ %DDDE_#&JAMVAM3
M5-X+F3X9QF4Y09))49A9AN.X4#;=S>?%@OG2LDY";KA0A/V7-J&-N41<=#E*
MWIRD(O5BI!O0)'GX2% 6$Q;2WT?[]"IJO%Q>-%,LOKA@%W%&C-C^FC)85R<?
M!=/3.U&5M72-M1U\:,C"<:""%MRY#];V,9(_71DL'(IH&NIF&^WE!C(O^FDO
M"D>*%EWR9+N+W5%4[10!IL:#(#+^;:-6'F01$]?CNH3<G/9?%<?B^Z^/D@S!
M+(DR 1B,K>[#O?M7-XF]$]J>EZ'TO]>WL7T-+W?GY2<_EQQRNJQB)@+D*+QK
M>K\/YVOU#]WR^QGX7(<AZT<BY$NK;EL3TK=YW:6?/Y&XMERV_OSX?"J@P')G
M9X6[94H!ZDR-I;[:*>#GL^3D9?<V$YR)FQ]S@EY"0UU;I7%XZXY.WW.;QD_U
M;?<W<O.RUB2V1*MQ>X=N_P!OPKCUTDQ>AAIX?6V7!S$S,UH$8SRFX_IM^^JO
M+F?,+R=,WH,C+R6&D\EQIJ[?OI?"E[!\OIV$>;X^'-XR#\T9)3'DR%3O;0^F
MH\:OPG+X>9M/LU_]2_#:\OCVF/-K_P"IDX_L^;(Q<G-QL*67"Q%WY60 Q6($
M7\YW"VFM>I,WH>AP:3J&P/9?(-AKR.-QLS8LK& 9*;F5F9@BI<GZMYM1=3X8
MI^7R,%GP<H-'-BLT4L;DAU92;JWQ%1PB2(=QL-S="-+D_K-.14D66(0QKM %
MU%R?$_.F+(&,6-LORKYF5?*+ZG=;X=::<0SR&'E<=ER8F7$<?(B($L,FC*2+
MBX^1H/$"L"M]MS2/$76(VW-8 =?]QH3=8'/!&ZE38_$]O ZT#AC)Q9^>R<2;
M*Q%W00.L,F2RA8XV>^S<P[L%-JJ1%#/M3F.;C:/VYA9'*-"?_J$N,ADVNP\J
MLW12VNEZKA3C+G,_#GXV>?C<@-CY<#".?'F!1U( .UT8*RFQJ;$W4K+-.92J
MH)$;:V\CQ\*,%-6U%P'/)PTG-?D96XI9/2?-,?X(8D#;O^9HPN:LW*<.OJ3(
MOX8T)%Q]W>KD5PP.)6D:R*M]0IMW-NE%3B9=*C(%101NMJ1W/VU%:3#RR;"S
M,P,?4WL+ '4WJ,&Z_P!I^TO=')<+!G8_%3RXV1N?'E6/<K+N(N"#TI\*I(/B
M<%S6:\T>!@3Y,F,Q7(6%&;:RFQ4[1:]^U'"?0XG+X/WG[AYW*P,7B<I\CC[[
M\,1D31 FUY$ZB]ZN:L-H6R?;7N#V]G8QYO R<)Y=QACFC9=]A:R ?6=>U5PI
ML!YCVA[MX7"AR^3XG*PL23:B9$T3(FYA?KK8Z=#:CA+#(1S'*P6ZK>V]C<V'
M]$4@\<AF,CR,0H:Z1WL6![F]!6R=8^%E@.-Q+"Q)VBX'PO\ "E;@M9I;U'H^
M0QV/E?:2-"1IUHXOM;=71.IYL^(RK+%.(\A!M5A8?K%3Q?:,V]@$_(3PY221
M3^K*]W)TM8Z4YM]J+I.PI/R&0Y>-Y6DMH4']SUO5<7VI^']@2RD/9@%!-PHN
M;6U'?K1Q?:/A_8L9CZ\C6)+-9"1J!X&ET=E7Q?:)M1HV7:"==Q(%/H[*,_:4
MEA54W1Q@$6 ;YT='92M^TS$08MI4;^][4NCLJ<_:NB0^L>UP"@/2]/H^T\2^
M=K^W 8^<QF L65U:YT-T;PK'GV?#VZ6WA-^+F28\[N 2%M?2PM]U9\N[<,QV
M1T^(UU^)M]]_%0$DVO5?U,L:K$=!UH_J+&H$]]Z7\:X_$[;S?7^/H>GX"ZS3
MF>S^;S'6U=LXGF;37:3^*  0:?\ 4+K]AWVSQF/R&;/%.TJQ0P29#"!4:1ME
MO*OJ-&G?NU5K-JGA^QJ\K[,Y7%RLA<2)\G$A*A92 K&Z(Y&U2U]GJA6*W%_M
MIW3<\?8G&]E<JN0$Y%?R2[X$%RK%O6G6$A=I.J7-Z.#<\?8-'[2Y:'E<C&QT
M]>.-GCQY=\=I!ZKQ)T8J&9HR-M[W!I_#V%Z/,=R/:4+%(I,F57AC]7E (@?3
M1L=LA1%YO,VU"#>VM/X.PXM:S.:]L\-QF/G?F,J8<CB3C%CC,2"*9[;F],J[
M. D95F++I<5&VEG6-9/,P$1(T"PV:P\M];GQO645T!RQ.T9#%5)&KLPOM/6J
M+H*S8?I)?5HW4[6'2W2N;Q'5/:GXNGP\_5[&WX.8R>,9$,D9+GN@&MJZL]/<
M\RZ]9 &QUN+>-:)2&OUOUHAS"Y #&QTM3/H>W&@D;F^?SUH*X.8F:[1+BS/>
M$?1?^$]K5-$PABL4I62.\@T(/?XBE#H>V%VD+B[L JV%@OC070MC9AP#M"W2
M0 VTT8&XZT6'*<>5LJ83@7W:V%NW46%)4:LD<4FU@;/;Z:%6%]NT,6JL$'*;
MA"#<CZJ5A5I8\D0AR(W-O5QI!;QL+TC\SF&;?M_XH_;1AF([$;;,/3C.^3O9
MAT%Z>%7J97GFD/>[: ?$T)D;6'C-!"5ZR'5_"]"XMD3J@-R-]OI!OK0N6 S3
M+)#N ^D6-)D"Q&Z]N@O]M I>56+'SG[+Z4$H RVLVX]KWH6/!/,ATW(3_$#=
M?NH$$GR'E.TOZ8(NUA:Y^% M:GL8C_2[C@IN/634_P!\*Y?$]4]J>EW_ $S]
M>WL7T-'WO$9/<64M]&]+</@(UK7POG:_4-?]OE]A+! 5U4'Z5=@ >P4VK?#S
MI.LJ(Y7DVHH]+;YG)M:PTIGDMD2\-%(&FE:9U8@1BY /?06HBN*8:'M3F<F;
MW3@1P0J,9I&%VO?Z&\-!7#]1_9V^YP^/W_T[?<8_/YTZA7V$#2R@W%NU9==D
M^QGU62=@R<IE8K>9M"- .E3*B2-''Y^ _P!8C ][>-#34QR/.X*<3CS/N$;Y
M,B V!U$2&CPTGQ=ONU_'9IX?:_%V^[7\=G<_V8YV!E>V.4Q]V_#Y#,Q>.R--
M=F6&ATOWNPKV-:[]KET(XI,'VG)[:<K/%QF?QN/+W5GGEBGD)^9FM59B7+\M
MA\;Q'#\OF8O&8<F1%[GEP\<Y$1E5(-A8IMW+?Z=->]+H/!Y/;G$Q\G[@3#PS
M)/C<E# N+%B_GS'C20B2PB,L.U6DW+OOI2Q P>5GQ..X+/EX_CXD=^;;!A.;
M#ZDD,'H-(R[-UMP86&XFC$#;Y+VS^3]K<KD9G'P19O&OQXP<G&QY(D(DD02$
M2N[&>X;5MH53TIR0FK/PV#F^[?=,C\>T^2<_%BCRC!^:B4-C)>-XU='4-?ZP
M#;QHZ X1."R/],7X:V)+D#-]#TD,HQ;WW;"Q)DV@6!UO>LKUJCN,;VQB--[?
M;DN,B3(R.5GQ,@+C/BQ/ F/*Z_A.\C,-T>CMJ:UX8ECQ8/MSD<!9N0P\?C\>
M'W#_ "\S0@PD8K[]J.Q/4L "U'##L<Y[\P^=XS^SCF&GXB#AB>7Q(<98HC$&
MBC>11H6;?92+/WN>MJ&=*_V/8_,S>T^1Q(^-R>1XF3/CEG;B<PX?(13[!9V4
M-&)(F&NK=?A3UI1TONSV7B\EF>_,=B?</N&/C,"? ]=8FRX7O*&BM"$3?M4'
M0=QK3L5ADYWMGB>"RN<9^%PSF\3[2P<Q()HMR)GEV5W8 BYW#S:ZT= Q \2+
MD?='M3V-Q<>#Q<DF?R')2M!-$T&/;&(DT$)NNG7;JQHZ#D;LG]GWMW(F]HGF
M.(BQ\WD)\Z#+QUB? BR'ABDDQXS$SNR E18EMS#YT= K%]E^S\CD_<. ?>/M
MG$X8RX>6_&PPH\$F7DX[QFSXQE&BJY(^G=XFB291CI8O]IN#QN >'.+QF3QV
M?/'*V>\^+^2CFVE=CQP>K+MZMN\WV5GO.PK7.<S![7CX&/\ *<K+D\Q*$.7@
MOBM'%"&OO(F+$-;ITI0Y7USVOAY$WM#VRT?#<SG(O'$>OQV9^6@4C(ELC)N6
M[_'PM5R-)2J</[SS/8N+QO ^M#R&-RF6>?QL:;T\E9B1Z.]]ZLP4'S6:Q-/
M9$$V3Q?+^^,WW5DY&?DX_'X47(MQLPQIE;UX@J"9 @#I<!S?7QI39-CI,'.X
M_(YWV-D[?5]E*,J;C.0S9Y,C+&8X4-'DM)_5^FXT\Q!^RM,E8X?W-Q']JG&\
M1[AR/<&4T/$Y<J+/'G3(XR93(2JXJGUMOCY=NE1<HKY>R(55KAMOU$7K.U(7
MIQKK(MV.JCQ'VTE0Q@1F25%8:"[,!:VG:G+A<M:@Q(W\Q4 #44\Y5D.7&Q6
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MC\)HY6D#@D+M(^=,:]9R5;J5ZM0TK$Y#,D0O# =C"Q>4]!\OC0RV(;BH""Y
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M/F0:BE*Q.1=7>.0@V9-OE/<$@UIKU)VO2"DTDD!@B%L?U-Q9]#<#6P^-!-K
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M]:0RT/*QV _3V^54<"@MY@.[$_>:32%^7'J0B)3YF;2WRJHCF0GB^IA1R1$
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M@LM?V?(']S<?;4+-'K_ABN7Q/5/:GI>A]._7M[%] GOE9?\ 2?)*J;!8]?\
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M;?*U&"6GFC4'?ITU^-&!D2.5" 30,B&53U&GA0"TLO([V].4)$-0H47MX7-
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MHL+F]SXGXVH3#R1(Q)"#MK4U<%6, V8]:1X"GBC8&.1=R>&M PA$5 =H"@^
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MU-EV68V%B+&F9#$R(I("K:.K%1XD V!H$$2+:-+%"=;>%5"L)18[KFS3NNU
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M0\N;YWV[[9PLGW=RG*_GN0_E7*XV)!'%/$DCK/$IL[[.QUZ=!:IX"7P_[/\
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M?J>U%I966]R.U(91OL+#K>@PIX6FDWB1UTV[5-A0>$28:B (@ "@V/>_C3+
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M?G29&OVVE3?K3521QL:64@1>B64 ,-5/B3\Z985&'CPF58W$VP#SKTN1K]U
M4!N-!N^'A0<HH4!&+&Q/:@]E0EGOV-(+[+=1K021&68#KNTM0<#EBVR%".G4
M4 N8EZ@:TR#DATO_ !=Q0,-WV&NWW5QNO_+)I_A"N/Q75/:GI>E]-_7M[%]#
M=]Z&0<OD@ C<\5B/A#J/TUIX?SJ^I?N^7V.=7>6%K%ET!\*UP\_6]:TC,%,1
M/E/U4X+2\P((N="+@_"JB*+Q^#+GYL6*KB-Y397:Y (%^VM;<O2[62)M;/\
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M#^-:Y?$]4]J>EZ7T_P#5M[%]#WOY3^<F)8!?44GJ&_J470B_C6GA?.CZE?\
M;Y?8YDY-E(U4?P@=?MK9YTO6 Y9HV2([6;5G;74:VZ]*#RA6RD5&?:Z_\HR
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M5DPLKZ GG7ZC=;'Y:UOAP37K+MCYFEX' OT)3]]&!PF1BY$*F1RJHHNYW"C
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M85A;8FP-IN%SU[T<40R^ YSV3[:]RXV?PRYF5'(,N+D<C(CBB*0Y*V40Q[I
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M9@[[; ')8SD;6ERH"1UU$@)KB\;U:^W/2]'Z?^K;V+Z&/[X:WN/)7KI'I_\
M#6M/#3K1]0G^WR^QA#SP3&QUGQ+FW7R97A77'GSSO=1I>W?0Z4=/89?).YXT
MZZ[@/D/C2Q4V%I)1!/'-;:>NT7%R>UJ,42-/#C#!%-T1B !_?'O]].086@;U
M8PY7:23IKV-J+*> <R*0-&Z,%)W*-P[_ 'TL7L*E5#1H%)5BA%F [TL4]:C
M,:9"Z&0N2[R&YM8]+4^$5H\FQ?'PI4C"M*^2K;0;':T87]!-5PY3@@CY?J;O
M2O&5ZWL;_*INJM>@<2S,A)B8$>-+A:!IZN\W0Z=/C1PD,[R!6(0DJK,!_>J3
MV^5'"J%E=WEG-K>8 Z'L*+KAEL-&K.44W # ]^U+I["D:L",,>Q&BM<GOTI7
M+:.@B)DA1@.H![5,UIKMN&4OC^4Q2=.Q5M*TV++*YWC9&5<K"/IS)]833</B
M!6:=G*J[L6T.Y?J!TM5QE:*=H&XD=OTTTY QY5>-I>@:1OO&E457$[>HR_2
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MZCW"O^3P_P#3W6CW#]YX_P#I_P"VE[@]YX?^G_LJI_@7O*]__+]+W%>\M_\
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6U_4OT?W7A\:WY77.KT,]^J_=?O?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>n257410kimg004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg004.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!F@&# P$1  (1 0,1 ?_$ -H   $% 0$!
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M,=<5;33:$*;4ZA;CQ"K\%"_RP.8X[2MJE>)"I<JX&0H H H H H H H H H
MH H H H H H H H H H H H H H H H H H H H H H H H H H H H H H
MH H H H H" = .^8M_\ RR1_>&:EQ_2O^HOID&]).^6#VGCV<*AT %M)Y\?_
M &WK(/="=6KMH#V@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@
M"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@*W,E,1]\1"ZJVK&R
M0FP*B;2&>X&ID?TS^>/TLP]9,_:L'^$K^C7_ +-0S(?:L'^$K^C<_P!F@#[5
M@_PE?T;G^S0'GVI'^2V\L=BDLN$?<30":\[ 0LH7YB%@:BE3:@0GOXCEPYUL
MH-@X_:+%\/&HZ@2BR2=0'/3WV]%'%F:':,Y!<*0@.J*DAQ(#2S=!Y*%AQ''G
M6'%T,-4/%;@QR202L%*M!!;4+*/R>7/T5G"S-#IO-0W02TEUQ()25(:6H CF
M+I!XUAIIT,#CWES^S._&W_MU@![R[_9G/C;_ -N@&YS40!)X66;(/F,V)XBP
M\?>"*RXNE3-#I.6CJ-DIU'5HL%LDZOX/M\Z86*'CF8C-MN.+&EMHD.**VK)(
MY@G7SK.!B@DO<.-0E2EN(2E"4K62ZP E*O9)^<X ]AK*MRX#"570<?:*"E*@
MVHI5;2=35C<7%O'VBM!I.1E63:R>8)'C:X@<_EUMA8.EY%"$I6MLI0OV%%38
M!X%7#Q]P)K"BV*"7VW#TJ5<:4JT*5YC-@H=A.OG6<+X#-!3[4:M?0;:_+OK:
M]L\D^WS]%8H^ Q0XD9)2#I#:$+"=:@\ZEL! YJ\.O[U$GP&:#%W<S33OE..P
MD.<;H,L BUKW^;X>T/CK96I/8*'*=U,JY+BWU!('O"@;JL >+7(ZA8\JV=F2
M%!<9MPN!L>ZE94I 0)/'4BY4+>7?AI-:.$N 4$E[F;0I:5+B H3J4/>CRO;^
M;X_!6WE2X!049SRGE*2T8BU)L5 2K\%6L?H^W4/CK#MRX!05;RCK@04N1 '#
M9L![7J/\4V3>M6FA0\7EE(4TA;\4*>"E,C4?&$D!13WV*A6RA)ZD*#=O<L9P
M HEQ?$H) )6DW(N+A0%KWYUEV9K8*"S&9]X<2VQ(BNN*UV2A9)^;-E\NXUK@
M>N@PNE=@.9A3:UH<>CI4V0%@E? GX/C[J*#%&+,S);SKC3:F%.,FS@\8M?ES
M''UUAQ:,#@(G$7+K0/:/+4;?#K%8 :)O\\W_ $:O^)0!Y<W^>;_HU?\ $H#W
MRYO\\W_1J_XE 'ESOYYO^C5_Q* \TS0;%YOX&U?Z7#0":WEMJT+EMI41J"2D
M V! OQ5RN0*RHL4$T36UA!1D&5APV;*0DZCW)LKC6<+,T.T/*6$%$QM7F7#=
MDI.HCGI\7&UJQ1F&(2YZF4J0F6T9 L V0D6*N6KQ7MQIA8'6.F(DQD*+B%O!
M*2\$6\*BFY!%R1ZC1J@H.ZP H H H H"K963 8WG$]\D(CH5C9&A:UA'$2&3
MX2>VID?TS^>/TLP]9*Q\UCP4MN36%%0NAP+190^/@:AF1U]JXO\ MC'](C\-
M 'VKB_[8Q_2(_#0"J9$5:0I#J%)/(A0(^X: BY^'QTR2J0X\4K4A+9TJ3[(#
M@MQ![7;_  "ND+K1G$*,8A+*E+:?4GS$@.!*&PA5KZ2 $\/:[*>88JZE#Q>_
M-O2NHG_I^EN:9V.BKC+?46T-K0A"'=6MM270;!(X 5FLG%NFA;=A*N6$H8JK
M27<[=B@K*77$A97VIX(=*U+1Q':IU7'G3S72A'KL(:#NV.RS(1%9D3)"WE!M
M3B0@.*X DK T!*1;@.([J[RL-T%#B=U.QT5\-%E1L%!8OXDN)6I.@I )Y)N2
MF];V\A)HRH#/)]34^1',)"BZZ"2E U**_&@( 6E(/BTFX//@:WM[O>+Q&5$C
M8692Y&9FK4X$M+677"AL) ;!"4I\QK05%//Y7#LXFND[5*Q7$9H-\KU(QF+Q
MP2E;RF(3Y=+9;TJ$9A.K0A2DI\:AWFX[36L\LU5O70Z6[+FZ(@=K;CPN[<8O
M+8IV5CXR);@\F04NN>?I"]:-#B> "T>-=@+&YI"<J4E&CX]&O[:#>]:P-:<2
MXBP1</C7Y+C2LJ0IY;:6U.,+T^\A3;CJ!9: =7E)\5@#<VY5FY=G2M-1QKP&
M;1NLV,S,]K%P5Y!#^2D!O4ZB,6QY@*5)"?,X#BGY7 <*Q9N2?K6II<-'VEC/
M(1C%O'%\Z+DF9)>=<==?&E#R9BR6D,M 76"K45H6$I0E5P .(YC@JI4E&*KJ
M7+J*^$=FVHP@9A&6@B/'GMRCYCBAY*D+0EPLZBFZ-1!439(LKQ<?%QK$+EMZ
M8T9TN69P]:+CRJA(!6=2U(4RA8<;F6#Z&V5J"%O$W5:RE.%9!"E*Y<N%*P5.
M0YQ6(KG_ *U[>R.6QV'QYERW,O-:2M\*" EUXM,^(*0"JVG5PY=YJ"KC<FE&
MM(\E%I)SR"MPQ2DEUFJHVMEW50QI+:0TZV\5A"DC4XXL7!))3XT@"]%FHT?*
M5J=!(;?Q_O:XJO>#(B>6R74MH2TMW4T_[11I/("RE7T\+$6H\Q*FPSB)!W$X
M_')3':?D-K<0O6VCW<Z$$H4YJNBQYBW;W5R\V4M:77Z3"=3*,9UIP6:ZA1<!
M#QLQ;>1FEEQ^1(2V4.DN(<LRAM84@!P\"L7[>5=8V\P[>/"O+PZR;/+VXPKY
MGB]TV<;.B)>+[<AUMU2E.A20W9+JDI3K0DH(2=+:1W<.7$U'68="#C.T;1A(
M0$I>=N"Q97@%A'Y >'DH<%7K'YEC$1[X$">PQ!6XIUI08D):0U=:=(=0G0$J
M/ *)*@D>NNL?$G4S4S;*[^PK6^HNTLPS+9R:&PX9RWVV&&UNLJ?TZ $V3J5I
MN57[S76'FX9245Y:I5[-FTEPRRP53K+@VETCP5NQD*QKCZH[@\IO2F.4%)>#
MFA6E("]37BOR[+VN*PYKBZ2-*J=&B+1O%S&=6,7LI['/.')1W)2YKCC>E.MM
MQQQ!0AA(6$J1IOK[1W5QDKEQ.22P1VG96[?EMXO%P&AKP,-U:EZG$"ZM"4E(
M"=:=*]/ ^TGA]ZU<5==")%Z!&7A7#DF)+*W= /SJ4K\L>%22@62$Z@!JYWK=
M7-&DV3(C<6:B;6P!F9J>F#%6M+<EQ9?>4XXL?[M3>I36K2KDGXJTE.*>DZ6;
M3FZ)5%XL7(9"'$FQ)1=B28[:M8><3YC2UI<1IN 4J\JZ=7 _Z.D9Q-)+#*AW
M W6MLMX]V-(?EL#RGG])2A2D$(4H+4$I-U&MI6*Z4S&&H[F[LBQ2$EE;KF@K
M4E"F^&E+B[7*@.3*JT5AL83Q&[6%<XK[:>'C4$:>/+DH\3V#MK+R[6T4%\CC
M)<F<9#2TI08ZFDDFQ2LZO%["C\KL4*UA))4,%7WQDML8AB&,U-;QKDA8;AL)
M2ZXVI27$K4DEILJ&I)L01;C6T;^ [6X2DM&D>0L5'A+6I&18*M<=1N^E 6&=
M.K4D).CV3P2>-^-;ROXMAR<M#*Z]OG"P]_Q-L*9DOLAIQTYA#P3&3K0\X6U:
M $WNK3S'&U<G<=-!(5F+MXL2KP;2?E2MK,H<\S+ ..D.)\H^<$Z7$N:=02L\
M5('M&L>:]!&K4L6!B>7$1(\U3OO#;2@5 >%(1X4BP' 7K6<Z@E:U,!0!0!0!
M0&9=2TA6Z\4#Q'N$K\_'J9']._ZD?ID8>LJCS9;\(]D\14-&1+S".!-_3?[]
M =:^_EW&@&SB7M2BFQ2>7H%@*V5 ='6 JP.HCPD6[N7&]- %F<E)+BD-R39"
M0 @.'P]G('A6'0S3:1&06]!FQMP-DIF1'+NR$V\TH<3Y:O&+*OXC;C4S*2QU
MMO5+N,3FW0L[.X\^6DG[1D\1<'SE\OCJ')-,)C)]V2XTI*7"%*TA2A9*B$J"
MN*@ >8KJKSH9J0K^>R2<TRU)>TM1E%+3JQJT!04;B_AXE1XV[:Z6KDVJG3%0
M4ERY+$!4O&R_+<96%H?95I4#=)5Q2!S-N!X45Z=UX*T^U.\*Y36CJ!NC((PT
MEQY7G!E5K2+.W6L$*4CS KRU'S#<HM6KE<3HJ\QI.[&O 0.5Q4'*I@YB8GS%
MM/@+"B5 %3MU%5K:N*1P(KLL4KFFF+#HZB1'.RC&D7H$\&U&P+IPT!K2RB0M
ML(X+\*O"1X@;\*E7\S>:C*B]5?NZ.XCPVJI:$93/-K:5'46E,K"T+(:20H)T
M"UARM^'G5=+,R>+XAB*3]BXK%[@]X3%0U-#I>2M ^4Z.) Y=M67GW;EG16E*
M=<7W&JDZE@DA4A&0Q\A"5-,QU@DI)"DV) L218ZCV5 \<EXFZ.1TC/"ZK61&
M#81%E,185HS9?#GS/S9NO2+^ IXD)'&NSRS46UH1EYB<O6=2\ZG4A:5.+5YB
M@M=R>*AR)]509-O14YXFG5%"=9:Q^7/E-)9]UD!:%) 04IU7!!3Q' BKG*VJ
MQQU]=.)B<I-86]6DO:LL\'TLB:H.VN&O-6#;GROQX"J5*AG6J@E4G7J4ZH@D
M%8UJ/$<N?,\N/HK9R,#=_,YEK)1H<=U?D70[;4JZ2@FY3QX6 K,$]9O!HK2D
M,8[>#<J.VAF2F4E]MY 2AP*D("7%!20#=7:;\JM\MBEEM>A1>@XN;DZ\YH;6
MYMPMFZ<B_<BQU+*A_P!J]4E:FYR]NW=A4"WDG0.WV>_U5LJ&4-!N/="UZESY
M 45!PJ&BX5I"=0L.>GA6[EHT"E=!2]]P&]RYZ K,,^=)#08:E<6UE 5>RB@I
MUD=A5WFI^7O-VIV_8>GHH^XWC-P:G'9H+AB<QG\+!AX_'R5HAX]L-1&BEM:4
M)"0D>TFY\(M\)JO;,.;FVWK(W<69R[N;PNZ)SA=GX-XB(_9*-+<BR'$J#>C4
ME:18W[S4O*S;4K:]I=FGN.3+N>I&XDI-D1C8$CYM7.WX]0$C81/4[<^O26HW
M"_#RU\2!V>.LRI05H5;J7GIFZ=KG%Y5#2HI?:>^92MM04A5@+E1X'40:[922
MC+PK%6+U\AO&4H/%%DS&WKN*+#8C1'$Q(L9M++#"6TJ2A#:=*0->M9X)YDUH
MZ.3V&'-MMO6QH]G\@XXIQ;4=;JUDN*,9DDE0!)XHYDULFUM,+05S);OSDJ<I
ME3[;T!"O*::+#!0&Q;4E(+?(\:8FMM#920^&Y0ET.MJ<:6D@@MA*.(-[^$BM
M7>EJK4U9V_NZ0^[YCLB2M9 &HK)/#TE5<T8(23D&LCDTKD:U1F!VWNIQ7,DW
MOPKLX)05=9M"<HMT>ADL<S"3=14H)%R?">7.N23<E0U&&'R,=:GY;WA=DK\(
ML2 A/A2+U(S$5!J/ 81.M +)[4Z2:BF3<,'^IH/_ "[7YL5D#V@"@"@"@"@,
MBZD9W'#J%C\2ITIF-XMYY2%"R0AQ]O2=?+_<J[:M+>6F\GYB7A\V.WB9I7Q$
M*],BJ:2?:;=05H<18BZ1>W/G5<K;-JC),A*G"TI!2H%2%7MP6GVD\#67!I:0
M=#5J4 ; '@+7[+USJ9/=*_X7W/\ KH#RSA[1\7_70$1'8]TSCS941[VWK0HC
MFJ]U)_TUVPIPT&*DB_$2^PXRZHE#B2E5K<C\%<H3PO$MAD98%R2J(N.ZL^;$
M<4ROD> ]GLJ9G84:DM4])JB50ATFVLW[.7X*A&Q%R,8Y)R,YA;B=99:T$V-E
M"^D\N^I5N6%1X&W_  AO2-8+7F[<D-H< 4$N^8FU[* ^YP KM<AAO+W6X]QK
MB=!ECFW)DAN,G4EDI1(<43<%24@"Z;=JJ[YJW&"Q<R[>\1FQ;*I<C&4RX"&I
M:"\SIMI#S=E'X[7KEE$YT:]:+T\AB:T".G5N",^+@2DH>!N#Q(L>(]*:D7+=
M;,E[DFN:IC:6;RT@\%$_#_U52ZCH5O<3):RL205$)5IN>=O+5?X[*JXW<\4)
M1X#G/6/)2W1(R8/SC@C_ #BN">&C@?NU%C:K&-??,[2)BE+67B+N4H5Y2B3V
M6 !^]4RZ\5N2X)/L1A:RZ(=:='A<U>I0JE:TG0K.;B%>6EH2+A<3SAQ[4<^?
M<$5<96=+*7NS]!S>L>0&D2,E'DG45JB(<U$GVB2@GG4+,VU"J^(Z)LF0CCS/
MQFHC,D<\D_;T<7-O)7VGTUWBZ6Y<J--I%;K:4S-CR4?*3I4+\_+6"/RJL-V:
M827VV^DUD6<%!&I*B4GB"%'B#57<CADUP,W1RH\K"_?<GE6ADX6EX\EA X>R
M/PDTJZ IV0=<D36I2EDL.NZ6%JX'2@@$V[*O,MEZ0<?A[4<ZT9=$-:3](I5N
M^W'[E43]6AT9QD8K4G'OLE-RMLZ?Q@+I^[4BQ<P7$UP_L,2TG.'?;E8R._S*
MD643SU)X*[>\5G-V\-QH(>%">P?=/X:X(R1.YAIP[ND '4BQ_P!<5)R:K<7(
M^QF'K%H3#K,-+3RPMT:M3G GB2>9ORJ/=UOE-FZC;*+:8A*(>6Y)60VRV"D
MK6;"^D"NMFUCGAV:S60RE8Y+$G'QD^T^5I4JP%E)2";?#72$*QN<1ACPX1=_
M"X+>D5#J;(8Y."]$CZ]04XM0;:2+W*E<OO5)R]O'-+9%&&QS%VZI#*0XZ KF
MJPOQ/$\37.[*LF9H)9;%,M1T-(<47Y3B6F[VL ?:-NX 5WR<*SJ_5CI,,GHF
M"Q[3026KD #B3PMZJC3DY2;9D>^4VTT4MI"$@'@*U!LV#_4T#_EVOR!0#V@"
M@"@"@"@,RZD(2-W8I8'B^SY(U=O!]BIL)-9=I/1YD?ID:O74KICLD@E )"=
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M6(R^/!.AOL D_*;/FHTCO2K2:[Y.XU:;6M-=YB:'>Q\@F7@&6[_.Q/F'$'F
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M.'>K3QJ7F98(J"V:9<IJN$F)ITQ5]W ?= J'2AL1E <N>PKU&@-CP?ZF@?\
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M<)X?0JJUMY6;R+N+U?,CV,U;TDV=Z87YE33JGVGX3N1:?;&IM33"D)6D*O\
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MUN4NJWD5<]J%</*VX]5:GT&PPTRE#;20AM"0E"4\$@)%@!5PE14/)R=746H
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M@I+/BY>*[9^"HBT9E\<>QKTEI=\637PS[4_08IN2.8G6C"PO9;8W9'4VW<D
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MG2WS^@V% -6AYU'5#(4 WF_1)^M:_.IH!P* Y>^B7^*?O4 AC/U;%^I;_)%
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M[ @*L-!XGG>O7;XK.%F][UM1YXI>D\]%437&63I?+5*7NATH*$_;LUM(-R/
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ML^\1&H3*'F-105 .NJ "ARKV?^-OS8W[#EAC.,?XBON1PQC<7O/N])K^T,=
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M*6YC3C7?INO^+;ASJ%NB^EFKF4N/\.['HE%K"^[G&8MXLK"Y[498>ION(?\
M>4FIR.X=K9O#26W$M8TY"&X#J#@]X;*- XA1\=[>BO0[JO\ Y2S<5Q>&4XVY
M?+)TEU%?:M>;*.'7K7,6+H:U$5O>%DF'B^_EMK"=/=4LK)E.9-8=!)/-)38]
MYX]M5=S=[R>4E:>F:OZ7P^#74[YS.?F+BEJ26A&E=86BK8,UPD)\AZ([Q%[Z
M9+8M\-Z\[G?Y,GP:27NK]1%>]5=*:*MM_',9/HAEF' DK6R]*Y$)#[3:7TGA
M_!6D5#R2QY>7'B)V\)^5G(-^SA[2_P"PL@N=LS#2E*4M3D5L+6LW6I21I45'
MO)%3LK*MN+*S>-IV[\X\#)Y2@*D$,R!G'.Y7HYN::IQULY!4K)AQU(%TM*#Y
MTI3:P7Y9^.JNQ;_"N/ADWU%_F+BCFK27L*"ZQSU0D*=Z9[?SB$(?=QTK'S6U
M6!;#I;+22?:X!;HKK=O366Q0=,271H9SR-B#SKMR6BLUT5)SHF'4].\;YB=!
M/FD"Q L7%<1?LK.0E6Q7CEVG'?*IF&N!171%(YZF2&)TK;^UR3JR\WS)*0K3
M_5XP"E\E(5Q4I-B.[OM6,_''2W[[[#.ZJP<[R_XXZ.<:%LY7K:%BRH^W\6$G
MO#\@D]W:VX.'H]=;S\5Y+8E4RG@R+7OS70OVE,WAM0[AZS)V^XXI&+E/0LUD
MV1>SK41A:$(5<VTJ<;TD<>=^%3]VYG\OF+DMLK=(\KV\QI>6/(0DO9N-<QO=
MTCCR[ZYZ%R%4S'.N^>?=<A;=CV,>R9V3)O?07 TRF_*VLJ41WA-5>];GA<%K
M/1_X_EUYCNOAPKE?[*DGFW?LKJ1LO)%/S&1A.8YU?AX* 2IH<;'FZ23Z/36]
MV6"=J7)'IH<<OX[%^UMQ8ONXFS2994F)((X$-J(([P#5BU1%+!>(SS]W:/-1
MTUBR95C[ZX7V5:BI11Y:&R5D_*UMJJ+DHTB_F?:RRWOHNI<$(?2C3:F%6% %
M -YOT2?K6OSJ: <"@.7OHE_BG[U (8S]6Q?J6_R10#F@"@"@"@"@(%S_ #S%
M_P ,D?WAFI<?TS^>/TLP]9/5$,A0#.'^FS_K$?FD4 \H#+')8W7UL3C[)?PV
MR8GO#A'B3]JS/ @+OPU-LA118<#?C5JH>1DW+5*ZU'_;'2^O"<]<J<!J2185
M4HZ'M9 4 4 F3VV^&M6JZ-AAUV&<]$9[\S#[D4_:[&X<BPC2+>!!1:_IXU-S
MF3AEY1C#5*,9?>CB?6=+F8E=:<MFCHT'6Z9'V!U+P>7+93#RS*L=+>%M(<0N
M[>N_?KO?N2?AHLW)PNQDO:T?;I+;(P5W+7+>V/C77B[$1&XE/[:Z\X#,(T^X
M;MAKP\P&_A?CGS&E>T "KPI'HO87XUZS++S\I<AMM4FN32GW%"]:95-UPEP_
MWA<*FS@:EY2/*;4YR5JB%!*#8>$*;(]=ZIMUPI=O_P!-%Y>NXLC;7NS:[S0]
MQ*:QG5_;DW2$(RL.1"<<X<5M$*0/7=P<3Z*K\P\-Z#X?#]NDURJQY:Y'@:EZ
M>PH_5D37U=15,NJ0XW%QV/;"/#=N4N-K!([/$J_H-=,O?\G-NY7U<'-I),;+
MN96W;2]:4WT(6_=WRKCDGR'4J;7*Q,)P(4 GA$;1%!MSX^6;=]B:DY^ZI;QN
MRBU*$_$FM6EZ>AZ"/>M2_(PQ>M&37-K[R#_>0B.3=Y8V,T$E;IA!(7[)X2SQ
MX&I.ZG)9B;3H_*D:PDHY6LM7F+N+;MF6Q,W5M"4Z@!C*X)R ZVX M+GNNL*N
MJW$JU))!Y"J.Q<DKMN;?B<:-\>ON)N;CAMW[:7JW,2Y*T[RD]4]EX6/O+#[7
MVTE$5C;^%EY%49Q3KJ6T)=+ZAK<4LZG+*[>%[UZ?-7)YC=]YR>*YBCJXM14[
MKFK>9@VO"_22'0?#/X/JG-B+NWCI6"3*PS2U CW=^0AQ:6Q?DE[S. J??SZS
M>ZK5RGC4_%]UZR-FK/E7Y0X&;/U+B*E; S[22D*$)YQ)6+I!:27!PL?X%>6S
M*K:EP4)&2GAOP?Q(A.D<)B1TX;01X)ID!P*\2;%19X ]FE X5%W9"EE+E+#?
MS_NWQ*/97O%>BQ?;V%&@R=0D8Q^1#>2M)2L*;=5<*'?QXUTR,O!3@9PWJ\5[
M%[R3+%O+)C&;3S&1&L*BPWG4EO@O4&S;3?MORJ1=G2#:X&0\I!3NPB]LEULB
M,!BUCIBQC@E.N1CEH"5'4"7VS[1-^>OC7++1_"2X>\D9RY_<M\#["M10SG^@
M;B7TA(:QSBD7\=E0B5MKXVXW:"JY65CR].!4Z"9>GY.>Q+WJ_>_U++TF=2[T
M]P[B>UMP#U!Y=JVW=&EB*Y>TX;Y=<U/_ &OIBB,CJ^V>KK[J4ZH^W8@82OL#
M[XU* \7$%*[&PYIMS%:RK._\BZW7T",O+R/Q7)]44O2<]*7O?8FX=T2E +RN
M1>6A\D6]T8&AD7N19*>'.U;Y5XG*?Q4&\E@\NWL45TLSOIQE\ME.I+.^YBE"
M!NJ7.@8YD( "8L)"41RI7*ZN/$<?":L]\V%E[UJ/M84I<K;EV-&,BW<RMR&Q
M/%Z>P^@I#K;+#CSS@:9;!6MQ1"4I2D7))/  "N-452X3%7H;F1V9NK>4QLMN
MYN7'$$N<Q";EM); O>W!('P7JDN+%:N7'MK3D/59>6"_:L+V=?S-/TEEZN)2
MUL?$YAM(4_B9D*0VL:;@*(:(NH<B7$_<[JE9I?A*7NT?VZ"#NV:>9E'9/%'I
MT%\DY"(K!/9!+B51#&6^'4>));T:]0MS%N-3,58U*F$&II<96>B20GI?@4@
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MZ#?4E/*V=.G2=;;W%+C](]V[9D65D]GHE891<X^9' *([I";6!:4 /57J/\
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M*:"5J.9"@"@&\WZ)/UK7YU- .!0'+WT2_P 4_>H!#&?JV+]2W^2* <T 4 4
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M))UP 4 4 WF_1)^M:_.IH!P* Y>^B7^*?O4 AC/U;%^I;_)% .: * * * *
MH.6WO@L;U2B8F:\6'_L=Y]3RP$LI;4\E5U+)%OH%=G=5M;R<Y9&5Q:O,BNIF
MK>DF).^L8VII<4"?#>8>>:EQG&EI48X)6@)U:N8"=5M(40">-5\;+9LV=8C>
M2,AD1"5#=CJU/,J<66RD28]BZSX5*/A2;ZN1K$K3BJU!+PC_ %V?]8C\TBN0
M'M % % % % % % % % >*%TD4#/G3=4UW'9F5,86&Y$7+SW6G"+@+2^T0H^@
M6N?17F<W)J<I+7YG8CVV1A&=N,7JE:ITO2360F1,9UMP&XTCRV]R8MAIUQ/A
M2?,44Z24ZDK-_+/Q5=2WA<C"-O\ X[FGGU%'8W?&<+OOVZ]"TC/I/#3D]V9N
M-(4 TC&+A:0.;;JP3JX][AJKW=%RO2_W]I9;XE@L0>WP/]UEBW'C\AA]F;=Z
M?>\'(3\R^(;LA*=']4;6''UV5KX!"@GAV<:L+EO!;5OAT+DJ55F[&[=E>IX8
MJO/3TF1IB2,7O%B,BQ^SIQQ[#1)<0AM$E1"$ZN8&@FJ2<7&[A?LR/40ECL8M
MLHL^KI,=$F*]&< 4AYM3:TD7!"TD&X^&O5254>!C*C1\];%S*D[WZ>H=</A@
MY& M1\96?-)3WZ024V[K5*W?+#NN:?\ W)=9:;TM8\U)KW%+]U5'^8>;:ZD2
MLH@CR(NY(*9$L<FVUQ7&W4D]Q6SI/JKS5S^=-O9*/\1;9=/\NH\-N?;;+]N9
MN0_U4VDT%A++$>:^00+E5D< ?2$U,OMNY;7/^ZRHRD:9>Z^%)?O1#K>PTKIU
M-<<)LR_$5:]@=<E#1"O19RNF>_E2XD:;IEAS,:;6D5C$91>-Z>[HVO,="W<6
MTN.T\I) <CSK)0JR;\3YU^9YBH5J;A;G;UX57F999FQYEVU=7MRZXDAT79=Q
MN7W%AW5))3[G.2$"R/ZVP'56!\0\2^5S:NF[K?EMQXEV&F^YJY&,N!S7[S[C
M5ARX59M'GZZ3YP_>"E*R6Y4,.K6F-@TH6T1<)\]32G57-B/&A2 /4>/=5YG/
M.%R44JIQPOG::^D]3N;)IV8S;IXJKD6A_42G1B0_GNH,[(26T 8/&QX3:VKZ
M 5@--)[/]VTM1!OQ7Z*G;OL_VT;S]KPI?#';TU1#WW=C"X[<=3DY/ED]"["X
M[&D(@=0MZX=;B4H6^B>VCQ7(>2'5K!/"P+P!_!4?+QP79Q?M4?:1LW^)E;3^
M:/TG?3+_ .XLWFM[24I/O+RH.*(O=,-GV3_[RX)]-;97Q3E-\W(;;PK9M1L?
M[GRLT@)%JGU*BE2@=;L:EW9R,DD?/X>6Q+:.G5P*_)4#W)L[J)]%0-XQK9=-
M:TEON6:CF4GJEH8IO;*-.Q]HK(),[+PE-FUK$MK7Q%^ZL9N>*,'\<>TUR%NE
MRXN"W<["^BIY5F>=>A_^*LW^-$M_\ZS5CN=?W,5Q]QI<U&@,BR!Z0/O57&YW
M0!0!0#>;]$GZUK\ZF@' H#E[Z)?XI^]0"&,_5L7ZEO\ )% .: * * * * KK
MS+9WW%7H3Y@QDCQVX_I#(Y_#4R+?Y5K_ -(]C-6M)*2,-C9+ZI+\5EV2IHL*
M=6@%1:5>[9)'%/B/#TU%4FC:AY%P>*BO!^+$98>"2@.-MI2K22"1<"_$CC6)
M3D] .H7Z;/\ K$?FD5@#V@"@"@"@"@"@"@"@"@/%7TFW.@, Q<+[5W0VG)!+
M[$_,96.\@@<4:FTK!%K6*5VJ@P5N.NIW3UDKN&RL.AQM1?2R!WG[X<!AG2K1
M+VQ,E8J0\5>,AM06UX>/#2PZGX.?&N>8;\JFV$J=.HDY3"KTI>Q=@I=%<1:O
MW?VPO.9ITN%UUIAIL.$@WU:?,U=YUM]M=-T4<Y2VT[2-_D=8VX1XW7F5-!:]
MHQ$;BZ@9S=3MI$''J^S,.M2@L)+0L^ML#@ 5ZK*^4#5C!8[KG[,='.4MZ7EY
M>-OVIK%+GU+J3Y&C)NK<"5A^H<Z0-3(D3XTV*[=/)R,I*UIL/DN)4./=55O&
M+C<;VM=_[#T&YKF.RJZDZ<U$?2F*EIF8V),1Q1)9;=!O?@XD*''MYU?6IXE%
M\*/'WH.,VGL=.L^6<HY,V_UK@PG"IMN#D)+S(&DN%$EY+P\7+QM:;#LY5)A%
MQW=<T:LQ!\W@+VT_,<'[UF:YZS+ON""G[&WCD2H P=Q,R5#2+K2F0MD-W];Q
M->?S*Q1N-<*?43<E.ERPGJ<'V_L+XAQJ=U:CN(;)7%Q*%K*K61YBG/9[S\Z
M:F2FI9F*7LQ951BXY)_%-=_H)[?L0R=DYUHJ" J!(.HB]BEHJO;X*F7HXH-<
M17966&[%_$NU&.[FA1V,9L_*^\&*QEX[&,R"4N! 4(RDJ:6H$$6LDZC;F$U1
M3@W:MS6MZ'R'J<NZ7KUIZ</BCR\72:!.>:Q?6#&N#P(SN+7'!3H 4Y%65A2K
MV5["DI_DCLJREHOQ?LR]!2VXNYE)\-N2ES-T+Y(DHCL+D.JT,LH4MU1Y!*1<
MD^H5-KH*I)MGS9N6-)7MC'Y%I7F9;<N2F+*R 2EO2IMSP^,D(\Q2/1<510M2
ME!W%Z\I:.-:>YU/80NI7?*]BW;H^*6A]L:&B_N]0(:-C_:3(;5(R3_F/O) "
MSY;:$)"SI"N0N >_TU8Y"4O+2;U2>C@TUIW\Y3[\GBOU2UPASNBJR$ZQHRS.
M]XD?%(7[SN/''&^!1!4$O?.#N%TN!//MOV5%SL9J46O6<6B5N?RY698_5A)2
MY/M0U[;>#CX3"PL9&0E+,5I+=TBVI0'B60.U2N)JTM0PP2*+,7G=FYO6WU;"
M4 X5T.1![XPZ\SM#+XMLV=EQ76V56U6<*#Y:@+BY"[&M)I-:3I:N8)*7 9ZT
M\G)[;Z9O.IN/M&.+6(L66'4#XBBJU4\FVML9Q70RZDG#,WZ>Y/HE1]C->JU*
M$S_K>N*K84B'(6IL3Y4.,VM("K+,EMP7!(_F_CKIE[]RU<QVX^8X[-9VR]F-
MR6%M+E+ZR24#LX#A7&+KI>LY.AW6Q@* * ;S?HD_6M?G4T X% <O?1+_ !3]
MZ@$,9^K8OU+?Y(H!S0!0!0!0!0$"Y_GF+_ADC^\,U+C^F?SQ^EF'K)ZHAD*
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M\CPM:J=&YU63(4 4 WF_1)^M:_.IH!P* Y>^B7^*?O4 AC/U;%^I;_)% .:
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MAF;@O/YW'(8:^4M7G7LE/,FW'A5SN-+S9-^S"3[#G<V&E(-Q5,=%J/: * *
M;S?HD_6M?G4T X% <O?1+_%/WJ 0QGZMB_4M_DB@'- % % % % 0+G^>8O\
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M4:G<9-BRA8&X 7Y2E73Q%DNDD]U=,^F[;ILT]!#W5-*\D]4O#][01G0E./\
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M^>8O^&2/[PS4N/Z9_/'Z68>LGJB&0H!G#_39_P!8C\TB@'E % % % % % %
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MSQ^EF'K)ZHAD* 90_P!-G_6H_-(H!YJ'?0!>@"]#)Z#0P!Y4!X32@/: * *
M#RH#R_963!G?6",93.VHM]/G9EE!5SMJ9=%[7'?5;O%Z(_-'M+K<SI*X^"W+
ML9HB>56)3'+S33S:FG4A;:P4K0H7!218@CN-&-IF$;&X_&=9X4& RF-$9Q*
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M9*)C*_>'YRG8H80RH^4_Y25M'RD..%.DI<5K(^.]<XZR5=?A2+\.5="*% %
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MZ/\ C<JQ5CRCZ@K8MPH H H H H H H H H H H H H H H H H H H H H
MH H H H H H H H H H H H H H H H H H#-^MOZKP/ZP_6['ZL^D]A?M^B
M@*SDO\PR?T7V\M^D\_8'TW\;^:_[ORZ 0B?IN2_1_H%_1_H_T68]G_I[5 7W
M9/ZQS'T'/_X;E^L,AS_T>B@,\WQ^HV.?Z.O]1?K'](1R_P#X;^9]%J V+9W^
M4<+]-^@Q_P!)^F^B3])_&[Z!&4]>/UKC_P!$Y*_1_P!8?(^D_B?P?AK#.-XI
G>U/\SM?0_I"/TW]&^D3[?^CT5@CV]9](?_)_H?\ T_\ <5DEG__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>n257410kimg004a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg004a.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ #0!G P$1  (1 0,1 ?_$ )0   (# 0$
M      4& P0'  $! 0$! 0$               (# 0 $$   ! 0% @4$ 04
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K!S*F4D%7L "A( 3=1QS.EV:MN[#;PZN*R$HYR<F2.M^E>ZU.,X<,9"C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>n257410kimg004b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg004b.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ &0&H P$1  (1 0,1 ?_$ *(  0 # 0$! 0
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M*BRY[^=+5LZ1&;9T)"!224D<>9" '$DQT(A59,>U5].<GF3PS&K_ !;FU*@
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M$;J7-OAC8;M S':ZB0,9'I(!SF6-:J^\=TM/S_F$(R Z[J>%E] YDWA%MHT
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MC]DF?+8(G;>4_L-'[),^6P1.V\I_8:/V29\M@B=MY3^PT?LDSY;!%&>GY0.
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M6TP1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$7G7)<#:4C<E
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MVJ J^'\$=FN.0=A^'Q:3^>FV9J!:IG=2S?\ 9]V]N0O1]YL^VWI(O1Q[M2E
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MS&FYK<UP':JK[?1)41D^7=LV\4[D':)4M2Q<5&!<D>3&2&_IQU>XS>LD=O\
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)!$P1,$3!%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>n257410kimg005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg005.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!#@)T P$1  (1 0,1 ?_$ ,D  0$  @,! 0$!
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M\VYKXJ\?,?G3A;KNY>J,R<@>B713J3W<(=X-IYMS7Q5X^8_.G"W7=R]49DY
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M[::T+0:<*DS;'B@&K364UQ3,RS@*B6.SN?:@;Y)Q07\E_P ][&6>+BHX$O\
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M PK)JRX,:JV4P@.LF!-"Z4T_$GT!?;L;K%9NXVNSE>3N>)&/VNVD>4VJ<6'
M\E4H3.I""DD@E&XQXXLX'P0R5P[9!FS(N)<'+,>_FZFZYWIK2YTMX:!$T&I>
MF3. B6NAU+M:=O;IDL/*5X\2-H(05'S!J [G3+;43I$;AY<8;>C\',=^JRZ0
M+'A1PBC&QPOBLWPMG=*%_NS5@A+VQJ)NUX#6O+'67$ &%<:LN#&O-E,@'63
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M /;$?ICSI,E/E@%WVA%5[5"K2B)1$HB41*(E$2B)1$HB41*(O(Y_R]?]GO\
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M);B@HG%#S@B6&2)YF,3.1?(,7/R9<[Q+<YMDD-="(!(C&%!Z_2O'2)K21 D
MPB*L2R D[\Z2KL1.>?$7:Z 52%V4MDVR[9+(2DT331;KD4LRF"2WU96"5,@"
M:VM^GE\B!7/R#GL# 61?$3$3"^4#=;P)@E%CMH10(&*\V4VU8LFT<$%CJ ?$
MFU<V%6)-*->1&@E-YERJ_P"+F(\E9\L[)OSK:)8G8,ORJ^8E'(K!F[B8; ;D
M@E;*"CC_ '(/F1!,KV"MCE><VZ3I0%H&):"1 ]F)( /28+U\F8P"(,81ZHF
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M2!++F:B0^2".24\F=B"H* #0<B6H&,0NU@" IEK7R[>6>&&=TZ]L +ICZ?\
MD<<,>.*K+YP )<ZGI*R#R&:-=&.J'=UB#@^H\3>=X_6.=>;6;I.RE.0S1KHQ
MU0[NL0<'TXF\[Q^L<Z;6;I.RE.0S1KHQU0[NL0<'TXF\[Q^L<Z;6;I.RE.0S
M1KHQU0[NL0<'TXF\[Q^L<Z;6;I.RE>6+ELUU_P#:N]SON#A7W1<I_KGW6>ZQ
MC>[CUQ[H?3?6OL/ZB]F?67IO]]Y_T7SOG?S^UVORUVMM-\DVEIVTVE<3&O&M
MUM_ 6HFU:KCTKT:>"#_2^UB_C3]X66:^.?F?_>3_ +G]MB^J\M_PF>GXBMK=
M<!;THB411;;=R/B>\BCHPX6^OMYXCQ$SI/8[_.Y%\F.^EARFI(%4(M(FL;8"
MITAI;6C4\NE20M\LE5()J(X%K8IAFNGY9./*QS1A!E[0M<W[30+/:]TEP:3@
M) />"S\0T7GAB"'600<!C&CK@(](CB748=\12$I%AR/)J>ZDAQ*@25#&KLLH
M" L.D!RO7)1VCC=2DIKQ\&TF^EB+JHYB"0DFO,X$0#0JD 2-F0P0P2HN5K+S
MR>\R;R^[2@9CV3)K"0(-A*=9+HDP B17"$0*RHR[W+?+$QW9!:TXSVA$""^Y
ML>(]JNY)D5(CPE%EE<1V[!SBC]ZX.8DHM:1B\\GG,C- %,42((J>AW-.9OAH
MY3-0,@8J:P<#(ENV;M<&_C^37]EV%XV;N\\.;"ENS@3$8:#$P% $312@O<@S
M-G:%0@<=JKUT=="RXR-K8==+7<;A5'NS$$PRT@LYGHGEG26<!=L--<E&4(E9
MKB454F4+%[$G6[8?7B@5K8=H(ZFFB^7ER OEEGFW"\RYC6-:XAQ@VB$2&M>1
M#H#VGJ(.%6-GRW DD"%)IJ$2!E(.18Z4_$BT51QEP!1V>BXN,W<7'FJAV5C(
M]PPV6J#HS\&)^CDA;*H$=J)40-R"%//X-VV-\U*Y7#\ZKF\FYHZ!;(F=J$*-
M(1;U6OLQ[WV8J!OEV%;VT>RO)AQ85:A4T6/%BQTD9 .$S@ )HH;*C!F"QHL8
M#Q% ,EAPLLPAP!PL[989XWOCEC>U[7O:]<P@@P-!"T5TA?O7B]2B)1%+VI/T
M?2)]J+;[[SLK5OYA_P!S/Z$G^VU42.X???\ $54-8%>L";1SJ3UDUZER?C[<
M,N\I%#,4G>,V"BH61#"Y8AYO'!/#5SA<T53?/B"VM<80//$/'RWOC?R5KN-U
M-^ODNZ!UDS' 1A&'HPJJ?-V,ITTB-D1@L6M+;(=(:+F?6RS=C."6RG+C6;#4
M/MJ<DJ<!7JYG)=4M[,IR:U&:BJUW-A8H!D43B@!\X?#&$SP#QQ+YWOHF<O#I
MC95R<^:\@DQ8660(4DDD0QDP ]*@V?!I=.#6B( [48G%56O[6?$,TB0,R."O
MLW$Q3!08A63PS7M&$.0)Q\=-*A J[UE2+!#)Z ABJ2&=*>?/"E\<3A,<O?R#
M B88^-Y1S-\;,B90^S5]JB@"LF!!HP$&HH;W=A6]M4?1C7/)F\>I2NNMEM$I
MW8UUQWD$<^AIYLT=31!+N-..+#92E,11(E &^YG0D)XQI+2%#,JJ*1<.XA8N
M+AY,KQ=ROF#6N>93[+28X:J"1"L F!(B :RO1>9!( <(G],IP"M<"B;Y:RO]
M.)G8>EV.)/$'=L'( X"<[RZ.'ZEGJ0"$?,MV(QI1(W#<R4KJPYD!-R(V%+J:
MD3$3PQ\#..=@Y.Y5?9)(O,M[.R\U1IEMM.!A40(1C4#&$%X+U)</Y;@ZEN'2
M, >G] NG3!XE&J45M-XN4E*;+>IF/WI&[9>"2F.8FF8I:(\MB(ZUQ>+Z*+*D
M!9(<#5A]WR&#[2&4X0T FF0+DC(A<R*'C5EWY+?Y\QK#+<T/:X@D1B1+=,#8
M5@O#>R#"(I$0HS+Y(8TD.!((CZ7!I/4":<BR&;W:U[P3FP["$EL8U'2KA*UW
M,\#[FQ0C+),1 BDUIWIZRTU1/"<(*JBECN&:@4,A$S2>!F&,('? 7#RU#EE\
MBZ66.VPL0$(VK9@($40. B(-2D;S*@' BQ3$QJA71].)=XD;:K7>(S:@0DB6
MVBTE%+=;>89M-4C8^2E[;.YFKL@M1H%$\J6,'5%RN9GMH\=3R)? 4R=Q+WP!
MPS%RPPRJDW"^7@ R9;G-+2Z(JL@AI/0 2 34,*F^?*ET/< 8P])$0/2$AG:K
M7/8@X?(0?,;&E RFM]%=1JS15\%,')O+PQLH1529H/#$JHE@5(@.2.>CYBY)
MR@#F4-V!,XW"LO-POES -ZEN8"2*1"D8.C&(UBD1"2Y\F=_U.#J(T*@*QJU*
M(I>U5_\ 'IE^U%L9_F>N5NO_ 'Y?]"7\(5,FIWON^DJH:PJY*(E$7PJ:@$DI
MJ@J#A&QP$TB;4!@"!48\>&")EQ# @1(D6P$,'#8F =[!A!XY9B9WMCC:][VJ
M31:<&BLE>$P$5K.A+Q'E+8=E&5B)M;G<[WH=O"BFVVRA2$R%YIDVE/+7=SR;
M*O*TGM[)7;\6+K)0F.=L[D7(%4/(QTVE %_6%U8EF)VKSR9MSFV;Q.:V6+8)
M+7 Q80TAK3 N#BX6#0" XF%DK'*O9FMBQA+J*(B$' FDX(0I&"BN(55POL\R
M95U^/[#+X%XL:S54)G19&L[UE%'2V2J:^2(^HOE8Z([$LV8;ZRSDERQRJ#DE
MD 2Q<\E8A&NR%YRX>&&\W&;(O8N;/YDQP86P!BX3&M<R@T@D.$16#0KY<YKY
M6U/9:(QC@LD@TXJ#3B4; >*FTS\717*A6%GJBI\CR+L2U#+9?ZRGLAY(;?UQ
MV (Z_..Y5!,IRB.MS"ZEI;(J".QLKDSPY; ^$(;",$<@QNB>0S!/F2#-:2QD
MLQ:+0)F2]H*<#  07TB,*(&C/QK2QK[) )=0:#V76<IP-Z\2V"P_*A>8D%P.
M]'1AB#. ?+K:S'71CP1JS^0&>?LW#S[(%@@ \2+>67:G*821G84R&II!8JIA
M"^9/!AA\B\2#=WB6XQF607#1)IL]8!$:H$EM86J6_: N'=B0.F&'+5T4X5EB
MLZL2B)1$HBB77'])[+_:HE/_  #3KZGRO_5W;^D/I*^2_F3_ ',[K'PA4Q6Y
M<-*(E$4:29NHP(DVXAC5%ZH"\G&9Q9"JOM:4>T7S8Z:\P7!BB->.'()Y+#HJ
MP_[ECF".:%RL5-J0 2=C?TPX4#%T,N[IDAT]I'9-(PPPGT8<JL;++I9F# :O
M:N#8&^L2.9OJKO>YQ BIKHQ)Z#GC;I>*<,KXF6KLD_\ 6A,*@MXJ2Q4#MWL\
M6-CBD8E_/&#IU0"3P013/D[?KKL\&RV+G&%0QM#O4#3E7IE.!@*3]45Q9SQ*
M=3TV24UE*<IM%.:ZQ%PLEI\DFUS$)OA>JY(7XQ=Z"X2>1.Q]FBQ^X$#()P'%
M?T(JB&!L"YZY8:]L;^BYSRRT&FU:A#T1'7'!"O O=A,LQ@8QA#T1692>UT-E
MBTHF7D^66T,8E*S2Y79YUTEE7!*C>!U0BF2(_EH0J4!LC$6R(IE_61?/MBD<
MQL<,LL[W\M5["9V;()M0AUNJ'I4-FZB )C#UU+K3AWVTZ:SG7&4N[!Q^2=K<
M55UOJK=Q/'#JN&Z6SD#=>9A,D0)&AE5\IA8P&:%0REAU:Q#/$W8O<M>PM>BZ
MWAP#@PV3]&/JZ:EZ)4PB(!@J8:#N:\@--L/MD+Z2ZV8]&^CNMI.A!/ *:&XV
MTX4\NK(:ZCJ)7,0L?2U9,-A#@#!Y7P$"$QRM>]KU2YKFN+7"#@8$*!!!@:"%
MV.O%XE$2B*6=??I9WE^U*T?N3Z>U=-[DOW#\;E8_NL]W]HJIJI5:Q!L(SER1
M(#G"/VR" 8<CZB"2V<WP#1@,H6&7'.S%I$203!L7R!%0!#YX.V8F7YN&-[WO
M^2U62G!DUKC4' ^M280'@FH$+6O)_AX.(#1](AN*W)-!Y]FLM6U*4V@^MF)$
MFQ-=[?AMVM1Q2''#$3]LG!/4*-(-R)Q,^"$G"H ;67<P2J<KA^K+]LOK9>QQ
M.T>&V>U AH$(@P)LV2<L16*5>V<-K:="%,( "NJJ!]JDUO>%2^%9K[ G7/$Q
M-5/NC57;-EZZMZ:5W7ERN"(Y8F0]G@V!$%%A"*(TA.&E%4N$84A;M8H=+I!A
M;/VP5C%SAG&UYOK0YMEU >TNA:I KK))]-<!0IF> 1 _:$81I ZS$^G(LK3'
MX<SA2S3X9<):TQ.8(OF$(,C[7J6$HTPF?EH_)K*=CV<DB2:FIADN3<Z>?4'0
MY23R"56>$>6G0Y25RZQB "$6/57+O8(#ICW1#B7"DVP0(#U0@: *L2BV<*"Y
MQH)B-(8O934*ETU0\,*446,8\*1]&<;MV35&'-MF;.3B2%%N)"V_%Z3-E8-E
M*)2[O<Q<((^]RB,V&0J7*9G!3 :+;'$L#YK 2V%2%\87FV266FD=$&D&&*OT
MKW;-),281$/0""NO[,^'3L7*K0FU@LJ$V 4EES2!OZ^U?;@Z^6ND*T_17LK'
M.Q;<AG71;.I]LY4!":@DJLM&42JV &V41/CPF<2QC P2> 5E)O<IA:YSCLP&
M"S ]DM+278J8$B%)M4X5ZR<QI#B39 ;1B((B<6 ]-*RZI:%RR\E964F%"+$U
M:CEP2RQ#Y.#4E?9>2,U_9;4;::$GE-!@C'6 S2Q4GXY)?;"5B6(Y"J1I$;!8
MZ<P ,9YE"]8O4MH@YQ>\-/:IIBYI IIH@3UF"CM6@4DN="OT@PIZCE7"FM+]
ME9O((:9+<$M5K-5+COPHHA<K/<<B,UYEGRCZA[=K\K;$'3I%$$/(X[$7(^6L
ML4HD;$R.+1;+, V4+""9%K>\1)EF,MQ+HS3&!$+38-],:\2]VC&TM,3%YJQB
M 6>M8="#^ONQ33E!K1='$?HI=^>(-[2'V6"WD@\/&4W3$PWO C4L51RY841L
MI:6VA1P4C#R$T0Q:_8"#S%ROE5.O6UE%CG$F#*\8!#CU].%0F3;;+)))@W*!
M2MO%85G2B*8X%^E3=C[3C4^YIJ15TWN2_</QN4W]UON^TJG*I4$HB41*(O-Q
M_P#6?LDLHX]A&@:07"V4B)5:7Q3D\F\$[:N3XIW&86QIHQKN=0E125-18T=#
M2)/@(LE)V#1*%G$[D[+--#Q1<503K\9)!KH),.SW06%O:TCW<= --,%MV[!A
MHIA14""*<9JQU+:UIRQ9EB1%<;<=,?+S:CQ]2Y([UCQD.*54]_KNMT96:\?I
M[7C975A%QSXN$=WOI/<:^"42%112VT75@TX(QF 7"\F&\.ES""""\- )A"T:
M8GT" I%,(K/-+7&(/: $:*SC^CK70V-J:-AI&5;,X1(G2UL"MXR!L1(S+)/L
M=NW<NSLLI3P4'NUBTFI:P@7+-@<J_#[#\[<U9-$9-[I@@0J9E<KG)T__ /HC
M+=9E4-!A]D0@8>BUCC36I&9_-BTP955@'1Z^M?!K'"VV,)SN;:CA<!I>@/%,
M<C@5U\(.,D]CNYUO!HQ.X%Y:36\2Q$F!%E%2V,.R(HYA&,_9,@R3J4G%<LQB
MA<$G[.F2)DJT!_-],0 3Z(6;/3&)28Z6]L1W_3T^B$(=,5LXK&J$HB41*(O(
MY_R]?]GO^C%=S\"_]/:NA^'?>]JWE>"#_2^UB_C3]X66:^0_F?\ WD_[G]MB
M^K\M_P )GI^(K:W7 6]*(E$6O^:-%B4SOK8Q]'GZ8:R]*K&UG+Q"Z4!'P]KX
M&F/6%PS4[&++Z"HF3F156-@+LJ%_.)V00)8ZG%3B><N.34!PJZ]VYH;M*DR@
MRTR6Z9;!-$QDT,#F'%0VNL$@B! 669=MHY[B8$AL#A:6DD'U^S"I>B;PO)+@
MDIK6Z8^FIC*\I:P1%J;&;7L\F NB,!X90!JW*^K[X,KQ%)=Y==0_;=&E0552
MC)0<8PC&"5@!L3I<R/C?=>.>2+T9TN=*>)$^9-<8.%H;2:R:V$1 V2R!!KC&
M@@*AER?*L.8X6V-:!$4&RTM.'#&(Q=*XIG^%C,#3(2PRLI_C95C_ &:6F8Z-
MA1O<\NICS <!+8N6MEI&M#AT&2C:4UD)VN:85)&1"JF"IB-9/"+F<!CHX>80
MLIG/;O,,N;L7B=(#A+[8+8;-DMMOLQ) 8"XB%HQ$ %XVY3&AS;8L/A:HIC:+
MC"FB,2!&KI7-7\,J8T$@]6ZQ9WCDFW9BC)H1E*N;GBQQJZT338TVQV;V=:!Y
M@#)DBHQ$H<7 -H55 5/6(1K$#U>6.E[97N(5RCYW=GN:^;*>7RWES8. ':E2
MY1M1::MD'"$*R#C7O!S!$-<(. !B,3G.$*?^1!RK*J3X=2BF(;*1[26C9W:6
MM_B.P5D-@T3&&)I3WRFJ)Y9(NP(/UWE<N''X,<#DC9?RY"*F9_SN(I>V&6&>
M=W. Y[G6#VIUW?7@D,>R%7VK41BAA5@NA  M5,F-JTR#'T0]*V)1JTQ6#'+
M8HQ[!3&9;*:K3%4@P,BP:@*W$(@CB'L"V8H^1? WD3N);"^>=\+9>3M7\GEK
MCSYFVG/F@0M.)AUF*UL;88&X@ NZU4I)1$HBE[4GZ/I$^U%M]]YV5JW\P_[F
M?T)/]MJHD=P^^_XBJAK KU.>W,#Y[/ZTS-K[@MD6Y>662HL[);4TFZZGIX:B
M(!<44ZC6-$O61;((*^&8/G<+9VR\E[^2MO+[WP-]EWN!=LW1@##UX%3/E;:2
MZ55:$%.6R?AX1G)#-BI*@AL1O ZO#\Y%YV2T9DH#@BMGOE;$BB3(75TAW*$
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MBA$Y<[8NI%/T;N=7&9/;,O$F;,8UTQ[;;VN<'S+,!2R!9+LDM:1 N,2(1:<
MN<YK"UCFM)#08 @$-C&HQ#G1@2#0!132K%$U#7) @%GZT2RIQNSXE;;?:X%V
MYJVWGM#&*4X(TD=&=D8%F@*H/EV@); 2$-NDP5%'- '/6)X.^=QL2N616_.\
MP9)O;K[=P]UX<33-+7Q#FD.C!HBXDF!$(#!&E7[ OE"2^ E@#NQ%1B(4FCH7
M6(JT8<<-ZTRC!;>F1Q.YU2)/LVRPBRK(1HTX'3%Z=.LT.=WK*RP3AP,\,FRH
MSV \CPA!4MV03;QRS41@P@#(H&,[QS1EYOLN]/EM;+9)8PM;0'%C  '8VEP$
M1@90*0"O&78RY+I0<2XN)B:Q:)-'2 :\=*Y[673QQZ\S5([O)O!)]UJJB*;9
M8[,1<G'@9$;P[B3%1@)#I3E(\.W4HEKZS4NS/:>"9AEYU!&SR,7"SMB%4+[S
M%E\NS)9:=N""YQA7 AQ$*3M";;X_:JBO9-W,J87 ]B$ /HC[HH$,"ONN2M24
M1*(E$42ZX_I/9?[5$I_X!IU]3Y7_ *N[?TA])7R7\R?[F=UCX0J8K<N&E$2B
M*+IQTS:6PDFNUS2&JBCLAX:VG('-M]*#,);I1%RTFI$FMR36H[P#7G6\ZV2N
MHA4ZCF0 +&D]6*%S@0N.86-JT2[PZ4P!G>#[715"!&(X>A6-F%C0!6'1]2B=
MA>%E*+';<3J)G8QNO*8H<!1G$DO1P1@8*MA[24E;5RWL:I++S:*,[B619"=2
M9+)Q)S+D#00B8H8AJ)>XE@,"F6AU]8YSA8(ENHA&H60V@PP0CTU*TSVDGL]D
M]/0![%^IOPU=@!7%L2\2D]0\6<&Y$;27&T_!&(9<A]):I.4E0T5-J\-@YR2"
M("8:+$P*D RRS8T775BPJH:L7QRLGW<9*@QMET)9!;37#'1A.*H4=*;=D&B!
M@T@BG%C7X2AX64F*[3F)I13.C);1*<HIW9@9V#/R.7"[S2-&FW2FQE0HJ-TP
ME/UMY"OEB!LL0IF*=L.24/6/I%PPLBOF#1E]8'-<]I):YCA PI;'H-!BC9[8
M@N!H+37A"JQHZ3G&Q(T9/S-\)9NS V_V-VC,$L&V,".JEYVB23HO*-8,WDJ"
M6*GVYC( 8XAZ^&>)D$I<*P0?;MEC2Z\18YL*Y;6ZI!]BK,V+2(5M R$%4'JO
M"YK7/6V"X%.N !UFX>BQE1R9<I5/$22RZ,TT(FC9J@"8*;/BD CN13MX@Y#"
MW#M?R=K+R>6J9TS:SG380M.)RJ#W6WEV,K/E5J*41*(I9U]^EG>7[4K1^Y/I
M[5TWN2_</QN5C^ZSW?VBJFJE5I1$HB41:.]7?%-E":X0TY5I CU@L'8697=$
MF,P,$K@X33:QB.=]4)FV8A^7XC$-+_K,1MO8"/2R9GD='4<4Q835Y($N,.1P
M-WZ,ZY,ES)@:29308'I:X-(/5') X5JF2&M<Z!)8 8=8(!!_3$58VCV[^&TL
M?PI=]1N]8GEF3M9(VV*+)KC0$Q&9\A-MQI+:+/)V1/Z$]7LMEVBW7BXRI>Q)
MQ735X FI)XXA?,$T$8$HO-VV#W62'2VO+>D8@:!3#%16JILK9DP(+0XCJZ_J
M7%G9BVZF>3MD$;6,[KRT&;K$^B$1CD)J8LAO=PS?*N,6,"7' G)[C9DJ1X0A
M)E)R9)J8C JAA'>)P=1P-'/0;%0 03WHER);&&=;+GB-! @(D808F@F$1UXO
M;,MK6F9$EPC1@$88J:NA51K?-:/LCK]"FP" DGD!'FF+6+)Q! 4Q@3*B@!/1
MMIR_="/FBV.)4V<1A#V1808*WF1<PKYX>7#*UZHG2S)FNE&DM<1D5;VECRPU
M@P6:JK44HB41*(IC@7Z5-V/M.-3[FFI%73>Y+]P_&Y3?W6^[[2J<JE02B)1$
MHBT*MOQ89(63C490-X 7Y;GMK,I:C9A(!9U8*6K;K>6V$):N*<7[5D?;U5/N
MQXQL9GLBJJ8:=9F&CAINJJ;B3*]LJ>OTS<6 %W;$MI,31V@&ET6T4 V8"NL'
MH6HW=HIILBOIH)B.N'2ME<&2K,DI-'8IB+:A&:5/D RRY80-/=-9#I$B5<<(
M\:1S+[!?&,9F9($=Q5&,,B7D7UHBV=P@^)\ T$"I=BX8ML<UDMCF.%K9.;&$
M1&L@B,(5@TP]"I>UK2"(V"(]-9%?HQ*&+[;[^ Q=*$AH*##$RH*+L [H9C9Z
MQ3K#/JA=QD(FC28LY!=1J)&[/<ENU6;+FV;9"1&J(KE54J7*Y#FULP".G7*W
MST["ZVVL)<TE@)!<W"1 1L@=TEQ$,0K5NSE6@#$&$3$C"1"F&*GU*\-=MF$N
M<'3(*6.XHY2CB<>$]A(S3W0E*,HFF<T\BK4>\GKZ2&L9GLV0KROZQ2T \ GA
MIY])3RBF$:'#500P,TV29;08'I,*(FD#KA2>FC JGLL@&GKP=615M5"K2B)1
M$HB\CG_+U_V>_P"C%=S\"_\ 3VKH?AWWO:MY7@@_TOM8OXT_>%EFOD/YG_WD
M_P"Y_;8OJ_+?\)GI^(K:W7 6]*(E$2B)1$HB41*(E$2B)1$HBE[4GZ/I$^U%
MM]]YV5JW\P_[F?T)/]MJHD=P^^_XBJAK KTHB41*(E$2B)1$HB41*(E$2B*7
MM5?_ !Z9?M1;&?YGKE;K_P!^7_0E_"%3)J=[[OI*J&L*N2B)1$HB41*(E$2B
M)1$HB41*(HEUQ_2>R_VJ)3_P#3KZGRO_ %=V_I#Z2ODOYD_W,[K'PA4Q6Y<-
M*(E$2B)1$HB41*(E$2B)1$HBEG7WZ6=Y?M2M'[D^GM73>Y+]P_&Y6/[K/=_:
M*J:J56E$2B)1%K]*>&MKD2 T;S+B/X)=\/\ CY+BR&G8$X$HNX72PDF'S,-%
MFY+>95N@)+S)8HX^*J'YDH0R)K8=QRERX!@V6,:C>YIVM4)IB1TQC1BQ=2MV
MS^W5!YB<L:%@IV>'"GQQ$#9:3$#<6VZTRHR96ML7)>U1^'7 B0E Z+Z%=7%:
M2"G16RVN_7=V&XE9 F'9@K&,U!-3C(HX@1'(J9M;>R^87.A+!)<;,:7=-)(%
M)JAAQJ8GESB3V03$PC2<OT+/RAHHD'Q5I78<[[+:Y^])J,I'G)I14](V4BTF
MJ#38:'')1P.%SR-%DC.UN2/[!M\BA'70SU-MJZ@33RP@@]S)8H9 J%Y(@'-8
M^R3 D&B)C4"!"-,""%#:X"&NA5&-&' 11T&*X^(=1@X4VES>L8QZT&%$27$B
M-%R>;!7&\X5(PRVDPXC9<=1^U$8:,DQ[QZD,_./C(A@"[L5$LUAYHQ< <T>R
MQ1DR?M)-EY)F6H^DDDDTP,8XHY*?73+4N#B2Z,?ICAIR?7L)K*J4HB41*(IC
M@7Z5-V/M.-3[FFI%73>Y+]P_&Y3?W6^[[2J<JE02B)1$HBU_'_#MC-?'=JF\
M98G=[NA2!;I:-GLYW(Q3CQ@8)H2RU)P;)F-5LO')01P+B=)L>MH^85'O@[U-
M7";:<44S!TH$("-J%[>(!K6AN$",'1!;33B)JA")A!6[9PH  &'IHA]&*"SE
M#NN!.&L\S:7*LJ.M87W@^Y#E):=PL="'9F?3X3VVB@N1^ MR.FXGIPK';C23
MTM!*-P% 3RJ>6#"' -=C'*U<R=M*VM   $(T 1H%.&-,8J+GVL JHZ%]K$UY
M0HMUF;^L<=O%\-Q$:D4!14@2-8^DFI.*6P0,D060!E?%&*H9B139H414%.V3
ML"N2J)D-8M;#^ZKQTTOG&<\ DNC#!U=6#J0O+GVS",8]"Q['.D\5Q3-&$N,=
M3<R*ED$NQ5NQ26NW0H_;"I>)8:@GUPD"!H&#R\V7BF!6XF%TX95%2P<PC!KT
M?(R+@(#-]X>^7LW0)QX327=5;B:HKUTUSFV3E])/TDJQ*SJM*(E$2B+R.?\
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M$KPMY+.HTR2<[HR83DV4?K!TXDQHR$J'FZ:<C&VA*[*3/L9M,>CQQ*662JP
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MQ/V%2W(F*3 D"*)!1HU6E>8&6:+$<B"TS&"1?ATVI"ECAC').;IX</.^>18
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M@LF%-6]56-#F,1A[XA^S?S!*?>+M-;*<&7>?+F$1:+6S:QL &M:T1L1H$!&
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M@X %I!&!PB,/=)C @"^5/$Q\!W"P.:>@T&/2*,L,"LBN:M"41*(E$4O:J_\
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M-*)1S)H!$VVP6Y<T*.L)ED\10],MYO9/Y81-;)NCGS)KK46N9LWLL@$ES22
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M><DR7)VO+8E!2CY%:R0Y]==8E.)4Q_OAHSA#L_LR5-D$)0FEWF)<,-E[PF0
M((P9Y,L03%M? "4+W5,<RFT7QC6AC&O+(Q@YT8 @M(;0(4&NFD"BA7B>  T
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MM-V4KS:/TCE3E=UGZ=H*^$; X?IMIVF[*4VC](Y5,D"ZUZZ&Y4W7+FX"A4T
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M*(E$2B)1$HB41*(I2UR=D]))K88DP889#T;>&S,FYEUY<F@RRE <P(3;&1L
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MQ3%37Q(<Z;$DG!S4T"S?=!@!W(*Z<<_M7B6+B6 LGA%[FBS,E2&,:Z4]K8Q
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M1%-@FF>GXS,78X&U3UM&CQT.,F\7,PQH-C$5F.)VIP0H">Z%UKB-?)$5G$0
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M*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$70-._T3/_ -J&5_\
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M7L'WN-!OYA:</=?$,U7_ +J;*3O!D=F3G3\03\&O8/O<:#?S"TX>Z^(9JO\
MW4V4G>#([,O-#S ;._\ LV^];D+D_P!]/+!ZIY6_??K1[:^I/=5Z'[5>\OWH
M>YKT'T'_ +OT7UWZ;YO\SS7G?S:Z^RD^3V-JW9V^]!T*ZH0CZENL,X&S;%FU
'7 X\4(K_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>n257410kimg006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg006.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!#0)8 P$1  (1 0,1 ?_$ -<  0 " @(# 0
M       %!P8( P0! @D* 0$  @,! 0$!             0(#! 4&!P@)$
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MQ$>\B#\CW_\ #'8?W9QF.)^'XB/>1!^1[_\ ACL/[LXS'$_#\1'O(@_(]_\
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M\1)RU?M#E$G @RD>>&.R46 HJKH.DRJ&$B!.K'MEAU4CW2YLF5D)9OW<G_\
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MI] *:Y1V=8TH-7:6PH#6M6)Q;G-X]L)7AFLA* HX1&-K3/ZD8'<@I_X=J)R
M<0$Y>--<KL]Q3M=97]4]-UG4@ +14]K9)\"RHRUC^=_H7K*NCIH7=Q8?Y>D5
M\O>?,NJH 4?S%6N1G _+6&<_2I,SN;V/18*,C9)]<JBU2GVRBU6,]LL.T1LY
MP;_6$4H)59X4LL*Y3%ZOU?M1$# (<>(9@W+;-6NT*I;;KI:SR_!B%4GP\0#C
MQQ)I"6<7+ :Y<*7_ )0<X.3X9!STSXB5%RA;YD>9GE[H>ZY:M,Z@_N2EK*M7
MH^37F&C M=N=AJZ IR#AFP67,Z0A2K'XI% AU!*'$  P]/;U1K)K,#DWZ&IL
M'_NG9UJKV4>\(;"H/0D $@$XE;AY7<M[0'5=3?OUPW]X4V% Y'L+ 9(&0#X$
M^,V5S3D1B(Q$8B5=+?SJH']+MO\ \6:/R/;+#\A^8_WR0V-M?6^HHIA.;-N<
M#2(B4E"PL=(6!Z1BV>2QV3R1*P;J' >T<F8QZZO5#IZB1A_)GG?4OJ[TSZ-T
MZ]_U3O:^AI6V^4CW-Q5K"K.$!/BW%&;'N4STOI;T9ZK];[EO;O26AL]PWJ:?
M-=*4+LM8=4YL!X+S=%S[V ]LUZN//IRN5:LR\_';6JUS?1K;MFM7JLHW?3\R
ML*A"%:QS<XI)&5X&$PB<Q2%*41$<^<=Y_<']I^U=LN[AK=XT]V^I,K118&ML
M.?RHIP"?;U(&!XSZ=V+]M_W@[QW:CMNUV;<T->U\-L;%;)34,$\G89./9T!)
M)Z"9 WYVN5!PW;N/?QKUO]8017[!U-I(.D.V3*IV+E Q>N@Y2ZW543-\XAP$
MH](#G1K^^OV@LK6S_J'MJ\E!P;0",C."/$$>!!Z@]#.9;^W[[T56M5_TYW-N
M+$96HE3@XRI\"I\01T(P1T,AI+FWKP[0IU+K4?$S51N.OE]AP6P'=JC(6)N,
M<DG*&4CM>B] K2S2T<$<4[M R[<Z22X' !(0Y@][VCU!VWOO8]SU%VBQ=KME
M&KY])J/([*&OS%LJ'MI9@:?,Z\;1@C&"?F_>O3_=?3W>*>P=YILU>ZOL^3:M
MJE118+%K-5OM6[BWFJF,-7^4ER%E(47XA;>U:'V1NE[289JG4IJOLZU&MK@@
MDUL45/6RO4=_)/G<LR8N8=&B6R;5CII<R)FI7+%;L%%"=4P^EMUBE6D%>L[&
MW:B')Q6JVE_)N#'KY=ZHQJY!7..H$Y&FOZO=V*.+I71K;-A!7-@?5I>^W7('
MTFX(*V/ LH%]>3G,L""YM+GL)O1&&M]<1+VWRZVW9"V14S9@+7VU5U'/=R7%
M@K-LCFCAC*QERMCUN>%=&(5%XP0=' >LGFENV_H]6[N94GMU'::MRP'Z;:WV
M"3KTE#TRU=&XS$'IY59Z"T2M85F379D_5V[XHKXGDKHNN+[K01[:6NU*;4\:
M[=CBV2AS&4/G.M=I_P#3[X^U5%4U'F$JS&[U>2F;ZP0AAAI0E:48UME**L$V
MDCL/ZK/*.C18&3%1NU$$CJ*J%)G1V=&S7[KM]FR&WM.@.5'C8S'8'](>+)4:
M:Q>WBGZBI@I4,1@NM-%!V&7^D-NZ@MGZ4;78*PL/\GG'G^G)^EO*MY%<#.>Z
MMYNXC8<5N"=D*9,U2(T SDXG:[E^Y:NSQ&RZZI*KV:C1*37K>-@B(-BUD2O2
MB5%=K+L^H'6,J5/E[.WKZ_IX^I<DZ#@>4.G-RJ#]0K#/TFC8;]*3X/=5?Q^A
M S;RZUS>H!Z;4#]>,L_]U:K&!T[ ?YALT![^(^JE0JO]38'<B>:![$4R$NNW
M-;35&0O1(9UK.MUQV38ETMS>7AG=C7CPK%;;*/VLS78!H+N0*':())=<2J&[
M,W'>[A3_ *5MMVS>('<J7M%P7ZJZQ2!YMAL'3RJVRK.0 2 5R&$TM*U>YZR]
MS[?]?:;$0UN?I9C<ZIKKP/7GL<E-:#J">#\6Z2&7Y^^7 JJH,)NVSS5,CL$Y
M2O4.TS$2Z=QD$G9YF+:2#./.@O*0-=,=Z^0 >LV014$_ 2"&84'F.5& O/ 8
M]%90U:FU6/0U*;:BUGY0'4^!F90UBJ:P69E0X'5@UC6)54P]EMEE-E:)XLZ%
M9/Q7.WR[3$A--6]P>H1T*SM+LUI?U^98U"5/2F,;)VB/@+$X:$834K$1\PU5
M4;(&,J8JY>J!C<0"72RNAKW5@%"$*1]=@LN_3H:U\7!OQ5E?YF7/1@9/%N:*
M1]+8Y-_+46J:X"UO"MC4ECX/\M;Y_*9XB^<_2\Y,,ZK&+VQ.[.RSQW--EJA-
MQ%AKK>"AFL^I)VN->MTG$)#O(F0:N4'!@."K=RFH =4W'-;>L;4T=K='$KJZ
M=U[DG"IY+75M6Y_E<6Z]M97!(="/:N9U!5L[5&MDYV-FJJO R;/.\KB]7L=.
M-R-RSC!/M5@*^B/B#Z>3CI)W=8NX5$L<-"9M)5S KGK5QF+YKYELAK'4>764
M;EEU6%;67=*E5*@<6K4RQ0$IB<=[=KKT[KZK6*>1M;%3!QQ8+JD"ZXKU_HH6
M0,P)(\RO(^L3!J.VWKZVS2.=.SHU;*LO5,77/157DX_J.R'B/ E;%SFI\;J5
M.TU^\U>NW2IRC6<J]M@XNR5V99'%1G*PDTR0D8N1:G$ $S=XR<$4(/ /FF#+
M;FIL:&W9H[:E-JEV1U/B&4X(_@1*:VS3MT+LT'-3C(_V$'X@]"/81,%UI^\>
M[OZM)_\ E7J_-43:;P'R_P!YEM9,I&(C$2J]G?K>L/ZH1'\/6G(,NOM^4M3)
ME)"6;]W)_P#P:3_8EL21XCYR$UI_+C7_ /HFJ?Y$PQ!\3\YFV)$8B,1&(C$1
MB(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(GY]9/3=HV=LSXA^P]1BD3F Y
M:^;BC[BT^Y1_6)*3A=/5GO1KQV=+BJ:*V)5_K$>JB("!ECI&X (<<Q=OW/\
M0O3O:_4ZH;-?7[KWBK:K'_/T;-S&Q7XX+5C^O5XD65]!EIV.]ZE/=^\OZ=V'
M\H[?I_MIIM)QY&TAO;7N\,@<P*[,%<ULW(X$H2D[*A]Q<C&Q=JM8YS"QU_\
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MH^1.F<X=.>VV;]/7]8^I>W%JDV=_6TK*64@):^J[_J]>H]%(2RQMA%!^I<<
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M/J36O(WR:5*W7:.K4OMV<V!1]4Q,VH\"5M]A0V%?9!.": *"J@RZ<8S.=4'
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M 1U (TOVI\-OE[OY(8E5BPU+XM4=*/5*/'M 5FNW(0B*<@>2,Z_NFG5,8@$
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M%:RE42 "I*EG%&!I(%4RE "F[7K% . #BC_+$G7_ *9;.>/TYSXYQCQ]OO\
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M"=?*NQ.$.FB1,H$*W[,"@4.'#@&6+N=@[9).VPP7S]9'N+>)'7PS*A%&O^E
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MM,.J]1J079:KI2T2I;T:]]01D3/%JZ5^+],J;=P3K&$ 3 Q@#K=(".&\&@V
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M\Q*WZU"P5.!6^?J9,+W_ /VW5[FJLBW+HLU=@*VJ-Z^NA/H'(J*WM4\K> L
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MSAQ$XMB%$Q!5'<V*+=7=H[)L%5[X[/S #-2B54&^XAE'(M41Y0#*J6-E_,1
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M4!('E8 =,O7-R5=ZC)!R2@JM0KYV'9="?_VBE(&1FM:NE399^HUV!2[D?/\
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MTWCS"36I#1M7B$8&^;6LYTF]3U[!1,NJ_<G7."99"743F%31D8F(\>L<H"H
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M3JE* FX%ZI"HFR^(C$1B(Q$8B:F[CY94K+/$VMI^;'5VZHT#+(V"-(*,-;
M@%/%W".1**+Q)VF4$Q<=F=0"\ 4*J3YN(G5U!S-*RMB)J/>,&76.YFA>Q39O
M#@E6KJ!!$J<C4Y-0PMU#/2EZQ&_:&$X\>R,80,F1$V\Q$8B,1&(C$1B(Q$8B
M,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$2J
M]G?K>L/ZH1'\/6G(,NOM^4M3)E)"6;]W)_\ P:3_ &);$D>(^<A-:?RXU_\
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M'+),/KCHNNV"Q:C7<.).W:7G)>+>KPZ:A^T=/J$Y9RDH[ Z11$_9B03B <%
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M.]::_P"=V/T^(COO3O6FO^=V/T^(COM3A_\ [37_ #LQ^GQ$&N]-('$]JKQ
M_.>88%#_ +S+@&!UZ"/#QD4^VIK*,2%:1V'2&"0#U14>6F$;$ W5,;@)EGI
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M)Q$ 'K_^@OJW7('>=SLW;P1G-^V@Q_\ XQ9_9-,?<?LERENWT;^T?=5KL?\
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M0'E<^,#SE;DVC+4AGR\4S=#R3C91]!U*@N)2BR-8,P.9<',U8IEU9V#B(1;
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M7M?:=M'U8I&Z:,-2)G;S@_9)(HI@=9TSM)U3&*!?[Q4X]8W6,8W$3#GQ;O\
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MG>DON5ZQMU_L3Z<[#ZOI[?IUKL;W<K[M)N=A8HE&N==WNHK XFZPIFP-77E
M&.EZ;_:;O_;+TOK[?W[[YW?TUL;^U9^GU.W45;J\*PO(W;"V^77<_+D*D#X0
MJSD.2HW0D?AA<ZUC:-PFN9+;CI55(2O49SF9O\T3J&5*X3;]BJT6;ID:K<3=
M4IE4Q/P$O#AT^.WOOY^Y9ZU;TYZ5^V/;;N0)\S5OV<#C@K_3_3?5_P!\,>G3
M!SF=75^U_P"UBJQU[OW_ .XF]7@@&NZC7!ZY#8=+SCW*0.O7IX3N&^#KL>6=
M)KVU?3=U."ZKGM;O<]X3O5552 BIA,C*-7'66$@"8P&ZYC '$PE#AG*_]</W
MPH..AW3T%I*5Q_E^W;*=!U'0L_RQX?#/6;Q]"?LK(SM=L]=;; Y'G;VLQZ]/
M$!/G[_\ 9,TJWP?W\&Z<+&J?*HU!1 2D6"*W#9S@IVY%"%!G9K*HQ1(4 'YY
M2B8> %$#%$V<M_NC^^+N=C#NOK7LE.N02HU](Y#'ICK76>(&<$NQR!T]HW%[
M!^RW013V_P!(=_NNZ ^?N)@@>WI8XY$XSA5&">H\)<T1\-"VL6:B!)GEFBEA
M5,=)=IRQ:VL:I2J%*57Y]MKDBB'7*3@!!1.4@<1+U3#QSA7]Q_=?OTLFU]R=
MJBTX :B@A@!UZ9<+GWY0Y'MG2_U']J>M:K:WV[%U0'46[;J,_P#@;EC_ ,8^
M4M>'Y(-U1#5JE&<RU9K9D.R,"-5Y:=+P:"!VX"FW!!6(@8E0Y&Z7 $P$I0)_
MR@'RYYK:](??SN2@]S^Y?=;;.I.=/6;J?'J2"<^W/MG5U_N%]@NW.1V[[;:"
MUX &>X;?@/#H2P&/A[)G*7*ES$=LW,YYX]D T2$ 5:16O:I"$.GTB8J8,)(K
M=)0QAX]<43B/Y<Y@^U7W.MV%MW?7W=+*@?J"Z>LA(]P(8@'XE3-O_P!8OM57
M2U>K]NNT+8? ON;%F#\0U>2/@&$[R?*!L95VJXD^<7F!=IK H)T6<HVB_P"]
M.)>!B=BJJW13*''YA$BAT]'#AFVOV?\ 4#6FS9]8^HF5LY"O4G7WC"$ ? */
MX3"WWQ]+)0M6GZ%],HRXP6K:SH/8<X8GXEC\<R&>\@$//,5XRW<QO,W:8]<W
M$T?*;1D7<<8!Z3 LPDDY-JMQ'Y/F@ </DS4K^PE/7S_57K%B3TQW.U<?V'_=
M,MO[B#D'6]'^BT&.N>UTL3_'Z?\ ?.I&_#4T;&BFJ2V[;4=)<13<A9:^@JF;
MB/5,F=&I$7(8 X=/7$1X9]-]/^DK^Q5^1?W;NO<=4#'#<;6M'\676KL;_P 5
MC3Y7ZD];:_J"X[.MV7L_;-PG/F:2[-+#Y*=IZ5_\-2_V"57?_AQ69VZ\94W;
MS^?%$P?58;8#^SMTDVX"43-C2T!+G67Z_ ?D00#C^4/ES1]0_;#T1ZGL%W==
M-O/7P:J_8HP#XCC3:B'^*GX3I^FOO%]Q?2=1U^T=P!UCXI=1KW@GV'E;4UF1
M_P ?\)\7_BQNK7\/SEUDM[6#EAEIR0@W1D#S%"L=@ML):G[L$63%2TRKM2:6
MU_7(XHBNY<..W<"BG\PH]7JF^8]S_:_]LNX=VU.XUU75Z]5I?80V6V/M?3Q1
M&N>PM6@."W%2[ !0Z#K/J?;?W:_=+1[-N=NO?7MW;JU36M%==::OU9=UH5.-
MKL.B\F"*224>;%?!WD>6WG,T?$;#WEJ1K3;9=&D19*E5=B3%IJUI[ R9T)5!
M@@G*PT;9ZVH_0!:.>$2*HX:GXJ)]!@+B[!^V/[==L[CO'NNC1O\ :[+ULU2]
MFPM]((^NFWA8M5J*P!J?'(J2M@)&3D]1_NM^Y/=>U]O'9M_8[=WFJEJMP5UZ
MSZ][ _T[ZO,K>VJQER+:\\ V&K8 \1]XF')]RP,BG,TTM1C%7 IA,NP5? (<
M.@4A>.7 )%$!_P"3@ Y](H^SGVMU\^5V'MO7WTJWX<LX_AB?,MC[Y_=W:QYW
MJ#N/T^'&P+^/$+G^.9ES;EQY?VO#L=):JZ" 0.VH-8<_-#APX_68Q7B;H^7Y
M1_/G43[:_;NO\O8>S_QT]<_[:S.+;]U/N9=^?U!WGQSTW-A?_+8/PF4Q^J=7
M1((!%:VH,8#4!!J$?3JZS!L @("" -HY,$0$##_9X?+G9U?2_IK254TNW:-*
M)^4)KU(%_P"$*@Q_"<;9]9>K]TL=SNO<KB_YN>S>W+Y\G.?XS*VL)#,"@1C$
M1C,A3]J4K5@U;E!3H_O *BD0 /\ -#I^7HSK5ZNM2,4UH@SGHH'7W]!.-=O[
MVP>6Q=;8<8^IV;I[NI/3X23S/-2,1&(C$1B(Q$8B,1&(C$1B)5>SOUO6']4(
MC^'K3D&77V_*6IDRDA+-^[D__@TG^Q+8DCQ'SD)K3^7&O_\ 1-4_R)AB#XGY
MS-L2(Q$8B,1&(C$2+G'JD;"S$BB9 BS"+D'J1G/6^K%4:M%ER&<=42F[ #)@
M)^ @/5XYCNNJUZFV+SBFM2S'W*HR3_ "9M>BW:O35H'*^QPJCWLQ  _B3/Q#
M\M/,U\7.2^)YMNU7.V4]'E_OJ,;#T.:7E3EK;UW)J.$*G&P23YH;K.$3J&)*
MH/TD&<<CV)FJ@*&[5?B_]<^D+.V4^H%[AH#LN\M24V!EQ8;#QJ1!_B>:7^G#
M $/D/@3V"?;3UW_K>UZ7N[=O+W3MHMLV49&(I2L<K+#CZ&3C]0*9+K@KDS[?
M;'TK\6&VJ?5T;157+%P"G;*)[1&OF:E$X\$$V5?B8<BI!+T]*PB(=!AST%G?
M>R=N*^=V/U!W)RF<4;';->M6_NLUU_F=?'*H1CXSC:_IW6W'^OU#VG3H#8)?
M4[C;81[645T\/AAF'X352?\ AV?$>GG",A(SM1;/TU3B+V%EZV_?G*/$4RN'
M-G>R0N"%X_F ./$<V$^Z^GVH-_IGVLOWV*CC^O[]K^/\Q(U^.!XXP6]F0)U*
MOMIZ-W\#N7W)LU.IS^E['<>G\H!N8Y/OR!\)+QG(S\2B!%1RXOUG50^HBR,A
M3Y[5E.E!ZZJ9B*%E:[#DDE"I!U@$.('$#<>N'5X#RMS]P_W-TV)[%]FO2:4*
MX*FWO=MMA'@04\IESG'@Q  \.L[.I]D_LELL%[C]U_4C6%2"%[+76H/OY^;G
M\0#U\9E1>2OFAF$G+O9+3G$M+T4DBG)#<Y<M&,EP:I)]5;Q<1N#?ZP<Y#<$R
MI" ?-'KF-QRVI^ZO[]ZM!Q]KO2E#*S$"JRB[Z2,XY6JKELY^&,8]PML_MV_;
MYL7CR_N9WVQ6 !-FM97US[JW9>.,=?'QG;B^2&-ZS@;=RC<VMT(HX1>%"S<U
M\A81%=(#%,"@+M(L!*J0W QN)E!^0! ,J/WA_N*/AZ$T]7"X'Z9--?'W\C[/
M9CI[Q*M^V#[#*,)]Q//);)\^O:Q_#BY_CF=Z+Y1N6Q@NH$C\(O:$J)G+E9=Z
MZMK^1>++*#\HF&T,$'*1E0$_6-\X>L)A$PCG%?\ >_\ N7:S@_IKU-72HX_T
MET\=.@XYZ8/SQC&!.B?VC?8'R^=7K7TRUQZ_U/U0\?'.,G/^_P 9:M;UAR[T
M\Z"$5\(F_M2->U3XKP,#/J$*X#^]$#3$^](Y/P'YHG4'J_\ *(9R=W]X7WYW
MW)W/3?K4Y(SQ.NOA[N#J/P(!]LW];]JOV?UJA^D]9>C>@..0O/C[RU;-_83[
MI::=STO  DS_ /\ 5?<&G!$J9"KZ6U&Z4% !'@)E5G+A13Y1XB8PF'//['[J
M/NF+/\SZ=]>*Y.?\1?QP-G'X3IT?M=]!75\M?U?Z&9!T_P"9^'76EI)<T&M*
MJ1(Z')GMBO@XZA2 RT]7FG7,U*42$XL! !^K 8.K^0/R9J[G[A^XX5NX=D]7
M'EG'/7=NOM_YA]_7WS8U/VVTW%ET?4WI)N.,\=D#I[/&L>[I[IEI^?O7L4Q(
MZD=/[[ATSB0JJ9M72QRI+J%'@D)V8*D4-P)\I>(='RYR[_W ^G]77&SO]I]1
MU)T!SH7'!/LRN<_PZ3:K_;3ZDV=@Z^EWOTU<>I&.X5#('MPV"/X]9Z)_$9T8
M#8[B0JV[8TJ95#+?6=0VXR*2) XF66<D9"V32 O$3"8P 4 Z>&:J_N6^WPK-
MEVMWVL#J<]MVL #VD\, ?QZ3(_[6?N(;15K;GI^TG ''N>MDD^P*7Y$_ #K[
M)JAH;GAUA&;!VV-5Y=$E)&S6)1SKIMIS7-=C+A/U5%$"NV]L<-2QBRKE=TQ)
M)"*IC%(HZ5*<0[(IC>8]/_N[[IZL[GW'M/=*.\=UU:]CEVO7I#W6?IU3@0Z6
M6<4;*^8#TXBPH<"OK[KU1^SS3].]F[9W/M^]VKM>Q^EX]UOV6%=7ZEGY ULB
M$NHY&K'\WEJX!+D#:X.9OFBM0F)K_DPM\>/%,$W&U+9$5!L<BAC#V@"R3E#&
M J1>(AQ  ,( (\!XYZH?<_[J]X5E].>B-VFP$=>X;-6LIS[1Q\PG _MP">N9
MX7_TD^T'9\-ZF]>Z-HZY';M:W988]GU&O'7^S/3/2> 6^(W;S<4FG+WJ)$X'
MXI2"DY?'1 ZGS>HXCUVZ)3F,/Y4C  A_[<@O^Y/O*!JT]-]E/7*N;MP_P9"B
M_'P,DI^UCL?1W]3]\<>U!5IJ?_"X8X_\0GG_ --W-E:2F->><R<A"K  .(O7
M%%K\?'F*)RBHFB\?HIRJ("4. &[01+^;);[:_=SNV+.]^MMC7)QRKTM.A*R,
M]0&LS8/<#GI[H_\ 57[+=G/'T]Z#U]@K^6S>V[G?PZ$HA-9^(QUG,C\/Z@R1
MTW-^VYO_ & ZZPG=)S&SYEO$.S&*<#%-#H"=!!$3GZP$3.4I3?\ MRZ_M[]/
M;-PV>^]X]1]PNSEA9OVK4_0CK4F !USA2!F4?]S'J744U>F^R>F>V4^"FKM]
M36KX?\UNI/3&6!)$L"L<BG*?4U2.8S3%97>$#A];EC2,LH?I PBHD^>K-!,)
MB\>()ATYW^T_87[0]EL%VEV+3-^/S6![2?;U%C,N?X3S/=_W%?>CO:&G<[_N
M+0?Y:^%8'R*(&_\ BFP$#K7756$IJU0J;7SE$H@I#5F%C5>L02B4PJLV2*AC
ME$H#UA$1XAGT7M_IST]VC_\ 2M#3UO\ \*BNO^/T*.O3QGS/N7JOU1W@8[MW
M+?VE]UNQ;8/P9R,=3TF;9V9P(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1,;L
M=-J%P3:(VVJUNTHL%%%F*5C@XR;39K+$!-95H23:NBMU%4R@4QB  F . ]&<
MSN?9.S=Z5$[SJ:NVE9)4755VA21@E0ZM@D="1C(G5[5W[OG8G=^R;NWIO8 '
M-%UE18 Y 8ULO( ]0#G!G7KM"HU07=.:E2ZG5W+Y)-!ZXKM<AX1=V@B<RB*+
MI6,9ME'"22AS&*4XB!1$1#I',7;/3W8.RN]O9]'3U+;  QIIKJ+ 9(#%%4D
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M^E<_3XB.XU3\BM_TKGZ?$1W&J?D5O^E<_3XB.XU3\BM_TKGZ?$1W&J?D5O\
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MX(2%I"CS+75^+%02+A:/UNOK;*M1SUV:T$CBH<8H ?P6^P@V,QS333Q-H#$
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M ] @ A^8>G$1P ./  #C\O\ V_\ '$3SB(Q$8B,1&(C$1B(Q$8B,1/ @ _*
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MU#^FC,&5 R(5V1S!,\8B,1*KV=^MZP_JA$?P]:<@RZ^WY2U,F4D)9OW<G_\
M!I/]B6Q)'B/G(36G\N-?_P"B:I_D3#$'Q/SF;8D1B(Q$8B,1&(C$1B(Q$8B,
M1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(
MQ$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(
MC$1B(Q$8B,1*KV=^MZP_JA$?P]:<@RZ^WY2U,F4D-8DSJU^<23*)U%(B2(0A
M?E,<S-8I2A_VB(XDCQF.:L<(NM8ZZ<MU 507HM2524+Q #D/ 1YBCP, &*/
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MWB/>@V]2MC^R3C[1C,<#[Q'O0;>I6Q_9)Q]HQF.!]XCWH-O4K8_LDX^T8S'
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:1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>n2574ex2303img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2303img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 40#( P$1  (1 0,1 ?_$ .D   $$ P # 0
M      D !P@*!08+ @,$ 0$  0,% 0                (#" $$!08'"1
M  8" 0(# @,."1D)     0(#! 4&!P@) !$2$Q05"B$B%C%!42.TMA=W&'BX
M&3DZ,G/55I8WA[<X<8&1L=%2DC.STR0T5#5UM7:FUE>7IWD:>J'!0D/4539'
M6!$  @$# @($!@H-"08'     0(# !$$$@4A!C%!$P=187&!(C*1H;%"<C.S
M%#05P=%28B-SDW0U%C8W"(*RXE.C)%1U%^'20].T&/!C);4F=CC_V@ , P$
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MF\@6 \,U9C+W*:)#M?622_C>.C($,JH<P=^B-F>#(#$D!Y!Q\%NCR4'@RV\
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M6<CBVM/91LF8IBLW\@PJ,A+QT<Y-V(L9 B*XIF$$UDCB4Y>N_K!KD./&8OG
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MKN&.KKZ:T[E67!R.0^;I]L4)MKSY;1+;3IB,1,8T^]LI MU=%1''^$#RC?Y
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M2B*'2XM8 ,HL+:KL>H5)Q)>6H-]/,?SZ#M\W&2!!VL>AA&9)=2F]R2";\;6
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MOGM)9:/+P+?)N.[U&PD.E#2J)K%8L@Y%@+U-!5F+I)62?P]?]C @"H>,#F<
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GU6D'IK]Z*I2Z**7112Z**7112Z**7112Z**7112Z**7112Z**__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>n2574ex2304img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2304img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !8 5(# 2(  A$! Q$!_\0
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MAVN%T=)[FREO$_NQF25XW?'\+  UO]6CMSASG[V9^2F[L#U[<FOS#_X-^_\
M@M3K/_!173]?^&'Q1MXM*^,GP^AWW31QFW_MRV5O)DE>(_ZNXB?:KJ/^>BGU
MKX>_X.#_ (;^*_VEO^"_'PV^$^A^/-9\%P^.- TG2Q<6UU,(+5WGN?WC1(Z[
MC_\ 6K.&%?/R2#FTN?T.AP_I^=-$F#SC/H*_"L_\&AOQ5!_Y.WUW_P  ;O\
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M74FVWLY7B=UA65^#:W'WHST60E?XB!W7_!E./+^&_P"T%_V'-,_]%SU]2_\
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M ,$R_"?B#QM\0M1M?$/QG\<*(M3N(I#-'H]OGS6MTE/+N\F'D?N0H[5\2_\
M!?+PW\5_AA_P75^'7QG\"?"?Q1\0;3P+H6DWL4=K83O97=Q!/<N8FEB!(."O
MYUM"M'V_N"Y/</16_9=_X+&9_P"2J> ?_!K;_P#QBOTY_P"">7AOXT>"OV./
M#VF?'_5-/USXKP)>'6+VQE66&4-/*\ #*JK\L1C4\=17Y??\1)_[8.?^3)]3
M_P"_>I?_ !JON7_@D+_P4/\ BW_P4*^'_CB_^*7P=F^$%UX=N8H+"WE6XSJ4
M<D;LS@3*I.UE ./6L,0I\OO**+B?A1_P2"_X*)_%+_@GO\<OCE=?"WX,7OQB
MN/%&H"/4$M%N6.E+#<7/EY\E3]_>W_?->\?M(_\ !<G]I[_@K=%J/[*OA#X,
M:#X'\5^.7?3M4LY[F1;]8$7S)4(N-HAPJ[F;!;9R!7T'_P &I'P#\??!7]HK
M]I:Y\7^$/$_A:TUJYLVL)-2L)+:*[VW-VS[-P&<!E_[Z%=?_ ,'(7_!*KQ7X
MH\0>'?VK/@-;7]O\7? EY;-JUKI$9^U:K%$V+>[C5>7FA.%9>=\;'.0O/5.K
M2]L8\LN4^R/^"5G_  3$TG]@K_@G/9?!3Q%)9>(;C6X[R3Q6\"E;:]GNP5F1
M0>=BQ[8P>X3-?F=X]_X-QOVJO^">WQ8U?Q5^QY\6V71[R7S$TN;4FL+X1 G$
M,H8-#<8' 9@#Q7Z3?LK?M:?%?]O/_@FA?ZYX?\/2?#'X\+I4^ER6GBC398+:
MSU<1G;.@(!>%_ED4CH6P?NFOSB^&?_!9G]O'_@FC;OX'_:#^ ?B'XJ_8G,=I
MXAMX96N+A1ZSVZ-',O7YB :Y*3K<TM2Y<IM_L;?\'!?[1?[+7[6_AKX)_MD>
M ETZ;Q'=0:?;ZTMB+*\MO-;R8[AU4F*>)GQN9#D9-?N@I!7([\_6OYW;WPQ^
MT-_P<;_\%%?A1XNU_P"#FH?"CX1?#.YC^T7NHV\D9\A+A)YD+RA6DFD*!$5%
MVJ,G/6OZ(8T$<:J.B@ 5E72N7$_!3_@GO_RMZ?''_KAJW_HNVK]3?^"RD.K2
M?\$K?CVNB)<-J!\&Z@%6#[[(82),?\ W?E7YP_L)_L^^//#?_!U+\9/&FH^#
M?$EEX2OX]46UUNXL'2QGW)!LV2XVG=AL<]J_:KQ%H%GXLT2]TS4+>*[T^_A:
MWN()1N2:)@0P/J"":JM/WXR"&Q^2'_!FUJNAS_\ !.'QG;6#0'7K;QO.=548
M\Q4:UM_(SWV$!\?1Z_7]5YZ5_//\4?V"_P!J/_@W?_:XU[XG_LZ:-?\ Q(^#
M/B-W>ZTF")KD1VV\LMK>0+\^Z($^7.@)P<'O7:>._P#@Y/\ VL?VE_#,?@SX
M.?LN>)?#_CC6E-O_ &E-8W=W]D<_Q0QO&B9]Y&P*VKT75GSPD1"5O=9QOPR$
M>K?\'E^J2>"OGLXM9N_[4-H08R4T8K=^9CIB;(/^W[U8_:^N=/TK_@\2\$7'
MC(.-&>_T;^RVNSMC60Z=BW\OU7[7S_OU]E?\&_?_  15UO\ 8,37_B]\7[E=
M4^-WQ C?[3&9?M!T2WDD$LJ/+_'<2OAI"./D4#^*K'_!PA_P13U7_@HSH'AW
MXF?"V:.P^,_P_B\JTW2_9AJ]FC-*D*R#[DZ2Y:-^WF-STJ_K$/:V\K"Y/</T
M[9<9X[YK\F?^#P>XT6/_ ()>:-'J7V<ZE/XULWTU6/[W(AG\UD_X 3GZBOGG
MX6?\'&?[6_[)?AW_ (07XV_LR>*/%/C#1HQ!'J4-C=6DUT0-JF=8T>-S\OWT
M/.>E<AX:_8S_ &J_^#CC]J?P]XY^/FA7OPF^!GAV57L]-DA:V A8@F"TBD^>
M6:3@-.X&T=.PK&A1=.?/.0Y^]L?5,UKK5G_P:%%=<\];[_A6>^,RCYC;--F
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MIT&PN/A':VZ7OQ%\)3>(-*G8:G<EXX%C4B.;: 3GDK7V!^W ]CX@_P""'OQ
M3PVNF7VFWGPRG%@- L6M[&X1K;I;08!2(C[J8W!>.M5[!>Z'.?5G@SXI^'/B
M+%,_AWQ%HOB!+<A)6TS4(KL1'W\MCM/UJWXA\4Z?X9@CDU._M+&":=((Y+N9
M8D:5WVQQ@L0"S.0%7J>*_-C_ ()\_"#5? 7_  5,*^)/AWX(^".H:-\.(Y-,
MTOP1!,VG?$&WG: 2W,\I1(Q+9/$J",IYI^T%B2#5K_@L)X=\8_MX?'G2O@GX
M/\%^)?%VC_#W2)/%VNRZ7J4.E-8ZU<131:(PFG9%8P.L\[(I/_+//:E[-<P<
MY^F%Q<+!$97V1JB;V=S@(/>JFB:_;>(-,CO;"]MK^RG0203V\BR0R#U5U)##
MZ5\]?LB?M%:Q^U+_ ,$_(_$7B/3;S2/&UKHUYHOB?3KB-H6L]8LUDM[M ",E
M3*C%7&0RLI%>)?\ !"/]LCX9^)OV(?A'\*+#Q/ ?B+X?\-!=2T-[6:.YM6B=
MO,1BR 9^8=#46*/O#Q!XFLO"FCRZCJ=_::9I]JF^:YNYUB@C7U9V( _&J/A+
MXD^'_B+8M<>']>T?Q!!$_E2S:;>QW:QGW,;$ _6OEC_@O'HLVL_\$G/BQ9VM
ML]_=W%K9I%!L:1IV^W0$H0H).1N!P.F:\9_X)L_"#4_A_P#\%0?B5_PDO@WP
MI\&=3TSP596EAX2\&QS-HOBNSEF\P:PTA1(VFC=&@V!0Z_-NR"#51A%PYB.?
MWS[^\6?'/P9X)U8Z?KOB_P +:-?A1(UM?ZM!;2HI^ZVQV!Q6YJ&M65CH[:G+
MJ%I;Z=%'Y[73RJ($CQ]\N2%48_BS7XV?MR:IX?\ "W_!83XU77B?5_@AX?L;
MW0_#J6]Q\2O!%SKT5ZJ12F1+)T4K&RDIYG3.Z/T-?=O_  5#\*^#OB7_ ,$U
MM9TS6_$>I>%?"-_#IUQ'J^E:+-J%O;(EQ!+"9[6(;FM&8(LB' \IF!ISIQ]T
M?.?3/@CXB:%\3-'&I>'];TG7K!OD%YI]['=0D_[T9(#>U1>(/BWX9\&Z[9:3
MK'B7P_I6JZE_QY65WJ44%S=_[D;L&;\!7QC_ ,$3OB=:^+-&^*>F:?X0^'MA
MI.B:O:-'XN\!Z3<:5X=\82S0!W>&UF5?*EAPJ2>6/+W$8/6OF_QJ?@1X)\1_
MM/:+^T]X6U?6_C1XF\4:C+H$EUI=Q>ZCK.CRG&BQZ'/&K"'RX]BXB*,LJN9"
M0:/9^\',C]<M9UFVT'3I;V^NXK2UMU:2>>=UCBA0?>+.Q 5>.IJO=^)[%;NR
MM?[0LQ<ZD#)91&90UVJ@%FC7.6"@JQQG@U\<^.O@Q\3_ !S_ ,$$]8\#>+[:
M_P!8^+-U\*9+&^MG<3WMQ?BSRL3L.&F+84G^][UYE\"_VD_"G[:W[:G[*,OP
MZ;4M;3X4^$]9E\7--IES:KX;::RM;:."9I54";S%==G+84FER!SGZ#>+_B]X
M7^'LL$/B'Q+H&@278/D)J>H16CSX^\5$C#</I6MI^K17]HES;31S17"+)#)&
M0T4H8?)M9<A@?45^</\ P5"^'OB+XA_\%$/"EQX:^$?@7XRW>D?"+7[M-%\6
MAX[&1A>V>/(D$;J;EA\BJ=ORN^"*]5_X)?\ AG4=%_X)":!8^"M>NM4\3:AH
M6HSZ6;I);?\ LB_G>:0:>BS#?&EM*WE*'SM6(<XH]G'E#G1]76_QA\*7/B^?
MP]!XH\.W'B2T!,VE1:E"][%C[VZ(-O';C%3>,OBMX=^'=O$?$?B+0?#\5P2D
M3ZG?1VHGQ][;YC#=U'3UK\W/^"9WB3]E.RM/@[X<U3P=<6W[36E3%M;;4M!O
M&\1V^O\ E.+ZYO;K;ED:3S"#(YCPZ;0.,7_^"[D]AI'[47[.6H:O=_#C2M,M
M[3Q+'+?^.?#DVNZ- S1V6Q6AB4XD;#;"1QM;%.-/WN4=S]'_  IXLTKQ[HL&
MJ:)J6GZQITV]8[NPN%GBDVDJVUU)5L,N.#53PU\4?#'C34+RRT+Q%H&LWNF/
MY5Y;V%_%<26I])$1B5/'0UX3^R_K/A#QI_P3Q5?#VK:&_AV71-0MKN_\!:1)
MIEMOV2":6QMB!(C@Y*X&2<&OCC_@BQXH\+^$?VHK/P)X1M? 7Q#L[+P9(H\?
M^'_"UUH&MZ5#!/"D5IKL4BB.6[G#,3(&:0/')D $4O9_$(_4_7_$%OX8T\W5
M]>VUE:1$;IKF0)&-QVKEV( RQ6K%YJ<.G6S7$UPD4$2&1Y9'"HJK]YF)Z 5\
MI_\ !;IRG_!,GXCN5E81?V=/*(XVD8(FH6S/A5!9OD#=!V->F_LZ?M??"?\
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M'I_/S?7[R<'(HHHKF/4&"! N-BXZXQ08$:/:47:>",<&GT4 ->%)% 95(!!
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M3$I!^4?-UXZT"-0 -HXQCCICI3J* "BBB@!IC4C[H_*A8U7H!^5%%  (P#G
M].E<YX]^%GAOXH:0]AXAT/2-:LR-ICO;9)@I]@P.***J,Y1=XNS#I8\(U/\
MX).?!'4-1%W#X4FTF8=/[-U">!1^ 8"K.@_\$L_@SHFJ?;?^$8N-0G;J;^_G
MG!_!F-%%=_\ ;./Y+>VE]YXU?A_+JD[SHQ?R/</ _P +O#WPVTM;/0]%TW2+
M:/I':6ZPK^2@5T*Q*AX4#\***X9U)S?--W9Z=##4J$.2C%17DK"[1Z4@C"]A
M^5%%0;#J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>n2574ex2305img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2305img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !A /L# 2(  A$! Q$!_\0
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MNIZ[:V32-EHXS 25_ YH ]!D_P"#HO\ 98BG93J'C>0J2@9="<QO[@[J</\
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M%?[/'@/QWJLNHZ[X,\*ZSJ<R[9+R^TFWGG<#IEV3)Q_2@#X=;_@Z0_9:P?\
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M_@EM^PD?&.E"#X%?&%[B2[55&H^'O$?V8,2 /.W+MV?7CUXK]/M(^&F@^'/
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M\6]:T@1_%KQ-"_A;1]2,LS>=B)I"GEC]V,11D>81GC'- 'Q1X8Y_X.UO$_\
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MSPQXPT^.RUWQ]\8-?TO[3#=/8W_BZYEMKAHI%D59!W4,H./:OIMNE?+^M?\
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MRXC++M(VL5;C_>4T :'ACPQI_@WP_9:1I-G!I^F:;"EM:V\"[([>-!A44>@
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MI\%6/P]@\.:3?:]965GH$?AZPE$B,]E%%J!OX9%#)@O',< $8*  @]:L6?[
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MO"GAOP):^%[2^UM=)L_#.J^$[>&2=)&BL+^0,^7*DED"JJ;LC ^;)YKZ!HH
MXWX4?#P_"WX?:-X=6_N=0AT:".VBGECCCDD12  5B55&!CD#GO79444 %%%%
M !1110 AZ4T_ZNBBET#J.'2EHHI@%%%% !1110 4444 %%%% !1110 4444
;%%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>n2574ex2306img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2306img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !( .\# 2(  A$! Q$!_\0
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M'_#IK]GS_HF7A_\ []5S_P#"/_+/\#JY,X_FA^)PO_#]O]F/_HH</_@%/_\
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M>ZU]FY^B_P <_P!JOP+^S+\.QXF\:Z]9Z'I3@&%I7^><E<@(O7..U?*>E_\
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MR/M7]C3_ (*,?#[]N3Q'XDTOP7<7LMQX9DVW0GC*  -MX_$5]"H?O?6OQO\
M^#7B]?4?BC\8+F2 VTMPL,\L)ZQ,\C$H?I7[(E<K^->;G^7PP6,E0AT2/4R'
M&3Q>$A7GW9^6_P#P:_\ /[/7Q _[#7_LM?J2H_>?A7Y;?\&O_P#R;U\0/^PU
M_P"RU^I*G#'Z5T<5?\C6L9<-?\BVD?D5_P '5 V^!/AGC_G\N/\ T&OFW_@D
MO\&_%'[0'[ W[0_A'P9(X\37RVK6P$IA& ,G##!Z5]:?\'+GP;\8?&'PE\.8
M/"WAW5==-M<W$EQ]BA,A@^3OBL?_ (-M?@/XP^%VC?%.#Q/X=UC07U"*%(#?
M0F/S?E(XS7U^"Q].CP^E&2YO^"?(8O"5:V>M2C[O_ /R%\(?"?Q!XE^,]KX.
MTY2?%,VH?88D$N/])W;#\W7.:^R#_P $//VM  YBN.H/_(;?_P"*KYW^+=_X
MA_9 _;_U;4KO3C;:YX7\327\4%RA076V7>C _P!TCO7V?\<O^#FCXD^,;O2[
M?X>^&=/T'$0%PEXOVB6[G/\ "@%?19E4S"<:<\'"#A8^?P$,#2E..*G-3/UY
M^!_@S5_AW^QYH^A:VQ;6-+\.&UNRS^9F58B#ENYKX=_X-LC_ ,4U\<?^QOD_
M]GKZ\_8X\;>._B1^Q#8:_P#$J"*U\5ZOID]Q<011[#$C*=BE?7%?(?\ P;9C
M_BF_CC_V-\G_ +/7YM1O]1Q?-W7YGZ)/_?<)Z/\ (_3YN":_-;_@I7_P3U^)
MO[1G_!1CX8^/_#&F65QX:\-B#[9.\H5UV2;CQ7Z5;\FD*JPZ?_7KQ,!CYX6?
MMJ9[N.P<,5#V<CB/CQX/N_&_P(\4Z+IZ+)J&J:1/:P!C]YWCV@?GBOR-_8S_
M &.?VW_V%='US2O WAWPJ;+5[PW4HN[@,2?45^TX04X*D7(KHP.;5</2G2BE
MRS[G+C\II8FK"I-_ ?.W_!/74/CKJ7PWU3_A>]AHUCKHO<6*6#;E,..2U?-'
M_!6S_@GY\2OVJ/VQ?A/XN\':=:7FB^%Y8WO9))=I3$@8X_ 5^D#!1SC\:0 8
MX_E6>'S*>'Q'UBFO>-J^6PK8=8>?PHY[QCHLVK?#;4[& !KNZTR2WC!/5S$5
MQ^=?GK_P1L_X)E^-OV>O!WQBT#XJZ-81:5XWE\J" 2"7S8SO^8^A^;]*_2QU
M /04S<OE'CZU&'S*M1I3HT_M?H/$9=2K5(U:GV3\T/\ @D_^PM\9_P#@GQ^U
M#X]T6ZL+:Z^%NN>?<:?.+D'9.I)A^7MD84UY]\&_^"+?BO\ :C_;%^('C[]H
M2RFM--U"X>328K*\Q(/FPHR.<;:_7#:O' .?:A[5?;).<UW/B/%<]2M#XY1Y
M3SUP]A^2%%_"I<Q^2O[=W_!O99:3X#T?6?@*NHS>,M(U!)G74=28B6(?,N">
MX8"OTE_96'BR3X!>%HO'=DECXL@L8X=0CC?<GF*-I.??%>D*-HQBFD$'C _K
M7)B\VQ&(HQI8CWK'=A<KI8>JZE'2YS7Q>\/W'BOX6>(M.LE5KO4--GMX5)P&
M=HV5<GZD5\/_ /!"?]A/X@?L4>%_'\/CVPM+)M=U!)[4Q2[RZKD<_G7Z$,!L
MZ5'A=G"].*QI8ZI3P\L-'[1I6P$*F(CB9?9/SK_X+K?L(?%#]LR;X>7/PWTZ
MSU&Y\,W,D\HGF"(AW KG/N!7,^ /$7_!0O0M3T2PG\/^"DT>TE@@G^9=Q@7"
MMCG^[FOTV49SD?B*<(L#J?QKOI9Y.&%6%J4XRBMG;8X)Y-">)^M4YN,NQ^?'
M_!4G_@D/K/[6WB'0_B;\/=8B\,?%;1((_,D4[(KXJ 1\W\+*W0UXYI?@_P#X
M*0^(M&'@^;4-#TFWV"U.MR,A<I]W=D<DXYK]:EC!CQU[4T)Y3]./K6F'XAKP
MH^PJ4X3BMG):KT)JY%2E5]O";A)[I'Y<?\%(?^"9OQE^.GPO^!.DZ=)'XOUS
MP0 =>U2:?86D+*S$ ]1Q7Z-3>%KR3X+S:1LC_M!]&-IM!POF&$K@'ZUV1;O@
M>M (=,8&#VQ7%5S:K4C&G+:+N==+**-.4IQZH_.'_@A[_P $_P#XF?L=?$GX
MF:IX]T^"QA\1RJ;%HY@S2?.S'./:OTAQGO2I& .@]O:FL?FK#'8R>+JNM5W9
MT8#!1PM+V5/8_+G_ (-?^/V>?B!_V&__ &6OU#D;>>^#W%?BS_P3Y_:7@_X(
MS?M1>//@]\6(KO2?#6M:A]JTS6I(6,( X5L]#&?7K7Z-)_P5C_9\$:D_$[PZ
MO_;Q7O<18/$8C&SQ-&#E"?5'SW#^.H4,%##5I\LX]SZ->!)/O*I^HIJ0+%G:
M%7/7"]:^=_\ A[/^SW_T4_PY_P!_:3_A[+^SW_T4WP[_ -_J\7^S<9;^'+[F
M>[_:.$O?VD2]^U=_P3:^$/[:5V+GQSX6L[K58UV+?0'RKDJ.S,.2/K7$_L_?
M\$6/@#^SCXI@UO2/"$5[JEL=T,NH/YZQGUVMD9KJ/^'LO[/)'_)3_#O_ '^H
M_P"'LO[/..?B=X=_[^UV4_[6A3]BE/E^9QR_LN=7VK<.8]R\;1B+P+JZJ NR
MRE"A1C;B,XQ7YN?\&VH_XIKXX_\ 8X/_ .SUZ5^VM_P7 ^#OPG^"^L)X2\26
M_C#Q1J5I);:=8:>3(9)'7 8_3-5O^#?O]F?Q#\$OV5=5\2>*;>;3]8^(>JMK
M+6\JE9(XS]W<O8GTKKITZN&RVLL0N7G<=SCJ5Z.)S&DZ7O<E]C] ,48I:*^<
M/J!,48S2T4 &.*3%+10 =:38,=*6B@!,48S2T4 )BC%+10 4FWVI:* $"@=A
M^5&VEHH 0+@4;1Z"EHH 3%&W%+10 4F*6B@#RG]H?]COX;_M6:,EEX[\*Z9K
MT<7^JDEAQ-'])!\P_ UX6_\ P0@_9E;_ )D"'_P.F_\ BJ**TI9GB::Y83:1
MRULMPU1WG%!_PX@_9D_Z)_'_ .!TW_Q5'_#B']F3_HG\?_@=-_\ %445M_;&
M,_Y^/[S/^R<)_(@/_!"']F0_\T_C_P# Z;_XJE_X<0_LR?\ 1/XO_ Z;_P"*
MHHH_MC&_\_']X?V1A-^1'2?"K_@CM^SW\'_%<.MZ/\.],^WVQ!B>X=[I4(Z8
M#DBOIZWL(K.%8XXTC1>%"K@****PKXFK6_B2N;4<)2HZTXV)Z***@Z HHHH
F**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>n2574ex2307img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2307img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !: )X# 2(  A$! Q$!_\0
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MBB@ HHHH **** "BB@F@#PW]J_\ ;*T;]D_2+&;4M&U;6[K4'^6&SBPD,?\
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M_D**O3?VN/V1?$7BC]C;P+\/O!VGQ7M_X;NK6=TDN(HE_=6LJO+NE_Z:R?\
MCU?7-% 'PW^T)^QS\0?''['7PH\(Z7I-M=:]X4_Y"5N;^.)8?W7_ #TKZE_9
CR\)WWP]^ '@[1=6M_*U+2=(M;*YA$GG;)(XE4\UW]% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>n2574ex2307img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2307img002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ ?0"" P$1  (1 0,1 ?_$ 'X   (" P$!
M       &!0<#! @! @$!                     !   00! P,# 04%!04)
M     @$#! 4& !$2(1,',2(4,D%1814(<8$C,Q:10F)3)%*B0S07H;%R@H-$
M-39&$0$                     _]H # ,!  (1 Q$ /P#JG0&@- :" O\
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MIT'6P=;5" T0A).J*B]=!]:"O?.67.X[@[P17QCV5J:0H3ANHQL1HJDHN$A
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MVJM"K8?4GUN'Q300.%1ZW+<+LL%NY4N.6.FMNQ^5N-J^ZP*%WH@JTG:0EWZ
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+T&QH#0&@- :#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>n2574ex2308img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2308img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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MX'(K7+L^P>-FX4IZF&:9!CL!&,\1"R>QTL73\:=38SD'ZTZO=U6YXP449HH
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MJ]73+.2:23;'&I;<W3&.I^@%:X?&4JM-U*>R.>OA*]"HJ56.K//?VM/CM8_
M/X3:EJ]QB2\\LQV-ONP;F=N$7\/O?\!K\E=4^(.KW/CJ37/MLTNK?:/M@NLY
M7S =WF?G_.OJ3]L34)/VIIM6\67GB2W\-^!_#LITO1WE0R+JMQ]YR@'W<X"[
MO]GVKX[N2?F"LK $G//.?FYS]:_%./,VKUL1"-/2,7=,_??#;(\+3PU2=;64
ME9K^OQ/UD_91_:NTSXT_ :/Q%J%Q':WVGQF+5$/_ "Q=44EOQ4JW_ J_/_\
M;6_:)N/VA/BS=7T,Y71;&4PV$6[$7EKD;_JQ)/T(KC/@A'XF\4:[)X/\/W4D
M+>,2EA-'C,3H&W.SC^ZH&3_L[ZV?VC_V:M0^"L]C*-6M_$.A:D6%MJELNU1*
MKN'C;_:7 S[FN3-,_P =F.61A;W(K5]V=>1\.Y9E.=RE4E[TOACV/,V@(N.>
MOKG(;W'M6EHFH7&B:M#<VLS6]U"1+"X_A=3D/_P#K_P*J49(NE99-RNI^;UQ
MUKV_X2?L6ZU\4?A[;:_9ZIIMCJ%^6.DZ3<#;)J2IM9F5MZ].>,=J^*RS!XC$
M5E'#+WEJ?>9YF.$PN';QKLI:6/OC]B7]I*'X]?":&::1?[<TU!#?0L?F9@!^
M\_X$"#^->V!\CYL_+7YL_#KPSJW[ ?Q"T?Q VNV.N>']0NCI&N-"FW[%(AQL
M;YFRPR&SGH@XK[G^*GQD7P'\(_\ A*+'39O$-JB1S210-M=[=C\T@_O8'S$>
ME?T-PQFE26%]GBU:4-S^7^)\IA2QGM<"[PG\)Z- ?E/UHK&^'GC*P\>^$[/6
M--N%NK'4$$T,BGAE(';MCICU%%?64ZD9Q4HO0^7E%Q?++<^3/^"F'Q8U_4E'
M@GP_HFNWUK<*LVIW%G:/)O SMB5A\H(/+ ]F'K76_L-?L[0_L]?"F;Q)K%O'
M#KVKP?:;DK!N:T@5=WE #G;P2?\ :(KZ8O;2.>8,Z(QQQD4TJL2#<N.PPO%?
M/RX?A5QSQE9W?V?(]S^WZD< LOHQLKW?]X_,_P"(.A^./VU?VE@LFC:YI^CS
M7 @@FNK&1(;.U0_>&[C>V3GWK]#OA?\ #>P^&?@:ST'385AL[&'R$X 9^!\Q
MQZG-=!#9QI*6"QC//3%3\+_L_2M,KR&&$JSKS=Y2>K%FW$$\;3ITH0Y(05K?
MJ?!W_!2/]DFXTOQ+'X]\+Z7>W3WAV:G;V$323>:/NR@#NV%0^Q%>S?LL^/IO
MVE_V>+KP_P"+]+OK>\MK;[#?)?6QB-TH0 3 'J#D<^H-?05PJ_-YLBLO0!AD
M#_.#7->&OB[X9USP]J.K:?J5O)8Z8\D5U(HPMNT?WPWT_K7/')\/0QDL0YVY
MEK'OYG7//J^(P4,-./.Z;7++MY'YV>&M$\7?L*_M/O'%HNK7FGQR^4\EO9RS
MQ7=F[<-A>,J/QX%?67QXT/7OVE/%6@^#;2SU73_!,T4>J:UJ31/"MU&""EJA
M+JZN2.0!C!'O7J4OQ\\&2S>&Y&U*W;_A+)&ATEPN5NF7J!7:;H4VM'Y:]1]W
MH?7]*SR[)X4:<Z5.K>#=[=O(K,L]K8FI"O4IVJ)6OW\_D?,_Q._8ET_P"/\
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M\MVN8;<089HE.&;^8_"OE<;PO7Q%!QDXJ[ZMGUN6\5X;#5XSI*;MOHM3XO\
MV8=+T/P#\(=:U;3/&GA#2?'FNJME;/JFH)_Q++;/S;E.1YC%6[= *T/B9JGB
M[XD>%9M%U7XL?"N^T>0QE;875M&8O3D0@Y/7KWK[<B_8A^%.>/ _A^3MEK=2
M0.W7VI\G[$'PJD?+>!_#YXQS;+1'A&M#"K"JUK=&S6IQI@Y8MXI1DW>^JB[>
MA^7?PR^'VB^(OB8NE:_XBTK3=)T]R;Z^-Q&L=PBG.R(G[S/@#Z5[W'^T3H?A
MFXN/B1;W>FRZ];HNA^%M%\X,-)M%)+S3(O0LH/Z5]DP_L._"@J<>!O#O7M;"
MDE_8=^%9E3;X'T&,>UN*Y\OX+Q>"UH\M_.]_Z1MFG'&!Q\U[:,VK>7S^\^/'
M^(7@/Q'J]P]QJ=C;^&/BK"&UO2Q/^^T._.3YX3^%'DR=Q_I7K/\ P3_^-UK>
M#5/A?J^H:?J<FB^8NFW,-QYD5];C *@^N,_G7M3_ +$OPK%O\O@W0UYZ_9@:
MTO"G[)_P[\%:Y:ZGI/A71[/4+7YH9XH=K(3UKVL'DF84L0JU3EL]SY[&YWEM
M:@Z-)33W6VAPGP3\.:Y\ /B_JG@VWL+J_P# >JDZCI%VB;H],)YDMW/]TD;A
M[N:*]]@M]N>5V@\8]**^NI83V:Y8['RE3&>T?-*+N7*.M%%=AS!0!BBB@##^
M(.KKX?\ "U]?-]VU@>4G_=4M_2OSI\%^,=6^'WP3\0>%5E5M2^(T5A<:2A_Y
M;"_D:.5?P09_&OT*^,/@MOB+\/=8T-;IK)M6LWM?.5<F,."I_/->2S_L0Z/>
M>,?A[K$MY(W_  @5@EDD*Q@K=&-0BEOQ!-?)Y_EN)Q%2-6ATT^\^HR',L-AH
M25?K^FJ/$?@WX^U+2/!7P?T5+B$_9=7U/2I7>".0_P"C^;MVEE)4A!C/M4/P
MY_:(^)\/A_P7XKU3Q3;7FE^(/$JZ#+I;V, _=M*4#B50&+Y!&.F *]JTG]AZ
M/1O$=GJ,>O7$D.F^(+W7$@-N"K&X14,:MN&U4VENG.XBH],_83@TOX8>%?#O
M]OS,WA?Q&GB#[5]GV?:BLLDOE;-_&?,Q^%>/3RO,XVCY'IU,RRR3<N[[=SR/
M0?C!X[DL='T_P[K5MH]QK'CK4=+EN4TRW9FC3(!9/XF']X\D #M6U!^T-\2/
M#?AOQ#X8N-:M]1\2VOBN#PW9:J]K'& +@;M[1CY>,-C/>O2/#W[$4>B:MX?N
MVUV9VT;Q)=>( /L@7S#/C]UR3C&W[WO[5S/[0O[/%MX#\'^,=8FM=<\00^(=
M;M]7>/2XQ]LTAD3:)8@/]:5ZD>E74P>/IT^>3EYV?Z&<<9@:E7DC%:[77F7/
M@[XI^(7@S]INU\(>*O%4?B33YM"?41.U@D+NRW"+@[..-W4\U2_:(U6?P[^U
M]I-Y;3+!-IW@O4I828TD"LK<'GGM7,_L1^%]0\3?M(7'B.;4_%FO:?9:";*7
M5-;M?LS32F5"B+'VPH;\2:]O^)W[.4?Q1^*L/B;^T'M3'X=N=&6#RM__ !\?
MQD^HST]JZ<+3Q&(P/NW^+2^YABJF'P^-2=OAUMM]QX5\&?CK\3H)OAGK.N^)
M+/5=)\<3265Q:?V?'%Y!"2,C*X_B)4#'L*['X=:C\7/CEGQ;I'C"QT+0I+^6
M"UT:7389(W@CD*YDD/S;R0W XX%=;X4_8X_X1_PW\-K(Z]/<-\/Y?,++!QJ)
M";=I_NC'&:RE_8X\2:!XN;_A'?B-K6A^%Y+U[Z728[=)&1F?>R1RMR%)./SJ
MJ.#Q].:]HVUV3,YXS!SNJ:BGW:O_ $SZ*TP2+:QB5MT@ #$#&3@9XJT>E</X
M/\%:SHGCS7-4N_$%Q?6&I+"EII\D*JE@RC!.5^]GCG_"NTB^XWU/;&*^NP][
M:GRU2U]!R?=IU-3I3JVCL0%%%%4 4444 %%%% !1110 4444 %,F177YAFBB
E@%N,M8%@W!5"\YXJ:BBDMBI;A1113)"BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>n2574ex2309img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2309img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !E 5\# 2(  A$! Q$!_\0
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MM],U1);C[.\6_;L_C_X!7IO_  0V_P""AWBGX.?M!:/\)?$VI75WX)\5W/\
M9]O#=R?\@6\_Y9>5_<1Y?D=/[TE?2YIP7AEAZF(RRO[3DW/*PW$%3VM.&*I\
MG.?NWUI,$#M7C?Q[_;O^$O[+-W;6/CSQWHV@WT\?FI:2.\MRR?W_ "XU>2J-
MA_P4-^#6H_!O4/'EOX^T2^\*:+(D5_?6F^X^QN[[$WQ(F]/F_O)7PL,!B90Y
M_9NQ]%];H\W+SGN)SCC%"$]Z\K_9U_;%^'/[5VE:C>?#WQ19^)K;2)4BO#;Q
M2Q_9W?YD7]ZB=A7+V'_!2GX):G\8_P#A7]KX\T^Z\7?VE_91TV*TN'=;OS?*
MV;]FS=O_ -JL_J.(YI0]G+W2O;T?CYSWLX<XKD?BS\;/"?P&\-IKGC/7]+\,
MZ2\R6ZW6HW"P1;W^ZF3_ !<5Y-\3?^"HGP&^$GC2?P]KGQ.\/VFKVS^5/ AE
MN%M7_N2/$CHG_ J^9O\ @X!^(^@?%?\ X)L:+KOAK6K#7]'O?%%G+!?Z?.D\
M$@^SW/W72O1RW):U;%T:.(A.$9LY<7F,*=&=2'V3[N^$?QZ\%_M!:'/J7@KQ
M/H_BC3[6;[//-IUTD\4;_P!PE:[-_P!V..*_,3_@W"\6Z=X)_8N^(&K:O?V>
MF:=9>(VEGNKN8(D2?9XN7<U]:^#_ /@J/\ OB1XT3PWI/Q1\,3:O++Y42O*\
M"3/_ +$KHL;_ / 6J\UR.KA\;6P^'C.<("PF94JE&%6I[O,?1&<T9Q[5XE^T
M%^WQ\(OV3/$=II/C_P 86?A[4[^W^V002VMQ*TT6_9O_ '2/_$E<-I'_  6%
M_9NUOQ%;Z5%\4=$%U>?ZMY8[B*W_ ._KIY:?]]5Q4<KQE6G[2G2GR_X3IGC,
M/"?).9]2@;AS2]%P*\>^/_[<'PM_9@TO1;WQUXPL-#M/$*N^FS^5+<)>!/+W
M;/*1_P#GJG_?5>:O_P %I/V:8KFTB/Q.TQVO_NL+*[V1_P"_^Z^3_@5/#Y;C
M*\.>G2G;T%/&X>'NSF?562WO0?E/W<5\U_$O_@K-^SY\*-3MK74_B9H#3W*(
MZ?V>TNHA4?[N\VZ2;*]A^$7QP\)_'[P-;>(_"6OZ9KVBW7,5U:2B1/Q]&^M9
MUL#BJ,/:5*<K#AC*$I\D9G:8Q1BOG'Q1_P %6_V>/!WC1]!U'XJ>&H]3A?RF
M\MI9X(W_ +OG(AB_\?KK?C#^W-\*O@+X%T;Q1XJ\9Z78^'?$4GE:9?1"6\@O
M6_V&A1\T?V?BER_NI^_Y#^N4?YSUQ%\L@+TIP.,Y.17S-I'_  5Z_9MUAK:&
M+XK^'5-XWE)YPFBVG_;WI\G_  /%?-G_  7M_;@A^&OP8\+Z-\/_ (AZAHGC
M+4+VWU7_ (DMU+%+=:8\5RJ2^<GR/%YB_P!^N_!\/XRMBX89P<>?NF<M?,\/
M3I2JJ5S],0]'8U^77_!%+_@IOX>N_@^OA?XH?$N_U7Q_KWB9K;3;?4WN[RZF
M22*W2*)'V/\ \M?-_CK]1,YS7-FF65L!B)8?$=#; XV&*I^TIG\IG[1__)P_
MCS_L/ZA_Z42UQ]O"]Y=1P0)))/(_E)''_P M'KL/VE?^3B/'G_8P:A_Z42U[
MM_P2;_9TC^+?QZF\4ZE;^;H?@'9=?-_RTNW_ ./?_OU]^OW?Q"XVPW"G"V)S
M[%?#2AS?XI_97S=D?F61916S/,Z>"I?:F?>_[$_[/2?LO_LZ:+X>=(SK#I]M
MUEO^>E[+_K?^^/\ 5?\ ;*O'/^"O7[38^&?P;MO!.E3^7KGCC_CX\O\ UL.G
MI_K?^_OW/^_M?66MZ[:>&/#UWJ^HW"6VG65M+<W$[_\ +-$^_7XG_M1?'BZ_
M:6^.FM^+;KS(X-0?RM.MY/\ EULD_P!5%7^77T8^"L9XD>(5;C'._>I4I^TE
M_>G+X8_+?T2/Z1\1<YIY!D4,JP/QR]WY?:_KS//J***_V&5TK(_E0*^Y?^#=
MT_\ &RK3/^Q=U/\ ]I5\-5]5_P#!&G]HWP=^RM^V]:^+_'.KPZ!H4>B7UF]U
M+"[Y=VBV?<6O XJHU*N5UZ=*/V#TLGJ<F,A.9^W?[6?@GX#7GBKPKXM^,T'@
M1-4T)Y?[ NO$EQ%&L)^1W\I)7V.WRI7S5^U5_P %AOA]\0?C!\.OA/\ "W6H
M?%M]XG\8:9;ZOJMG_P >-C:1W<4DJ)+_ ,M97V;?DKY,_P""^/[=?PJ_;4\+
M_#*#X<>*+;Q-/X=O=0EOTCM+A&MTEBBV;M\7^Q7Q+^R+XTTOX8_M5?#CQ%KE
MU]BT?0?$NGWM_<;-_P!EMTE_>RU^8Y'P0ZV7+&XKGYXW]S[SZK'<0*.(^KT/
M_ C^AC_@I/\ MS0?L _LU3^.7TC^W;Z34+?3+"R^T?9TEN)=VW>_9/D>N1_8
M&\8:+KW[+>M_M$GPM%8>(_B7:S>*]:M['_2;B1+>+RHK='_C_=6Z_P# W:OB
MG_@N3_P4=^#?[7O[*FB^'?AYXRM?$.KP>([6^E@CM+A&BA\J7]Y\\7^VM<!_
MP1]_X+,Z-^R#X#'PS^)D-^WA6"=[C1]7M8_M+Z=YO[R6WE3^YOW/\G]ZO+H\
M+5WD7UBE3E[7G]Y?W#IGG$/KWLIS]T_0_P#X)T?\% M$_P""KGP:\;'4O 5S
MH>GZ=>?V1=6-]+]LM]0MY4W8W[%7[ORNG\-?D!^WM;W_ (U_;;M/@E9ZFMIX
M9^'VH6_@GPZD[_NK&WW_ .ME_P"!O\\O_3*OT@_:$_X+Z? ;X)_#>[3X4_\
M%8>(KI'EM;.QTN6QL8YW_CN)72+_ ,<W/7RI\>/^"37Q%_:]^!/@'X[_  _\
MC7O$_B_0[?4O$6G23);W%U=_\M;BWW_N_G_N5Z7#-..7XF6*Q<?8TIZ0Y_YS
MFS.V*I1I49<\H?$>I6G_  0!C_9T^.'ACQ-:?$:34]"\.VTFN7]HD?V'5KJ:
MU3?LM]DGW'?9\_\ !7YS:7\8]-^+GQ_UCQE\5=-\1^./[8=[N[M],U3["\CO
M_MO$_E115]G_ +''_!/;]K[X@?M3^$/$OBZ^\5^$K?PA*D7]L>(-1^U-':?\
MM;>*)Y9=^]/DV?ZJNQ_:%_X(D_&K]G']H2^\;?L[ZO$=.U!Y9(;=-0BLKO34
M?_EW_>_NWBKV<OSG#T,54HX[$PJ2E#XOA_\ )CBQ&$K5(<]"ERQ/CW]A7QIJ
M?A?]NO1X/ BZSX=TKQ?>/X>2WO)_-ECM[Q-FQW2*+?Y6_P W[G_+*N%N_ E[
M^RC\5]7TCXC_  [L?$<5E</I\UK=7%Q;1;TE_>RV]Q;RI_[/7ZH?L#_\$Y?V
MFO!^N^/_ !/X_P#B2GAS5_&VD/9%,IJMY%>[/*M[O=_JD\K_ &*^2_&G_!-#
M]L;]GBX\1^%=#LM9\3>&_$;RB\DTZ_2\L=4W_P#+66*7[DG_ $U\K?7;A,_P
ME3'3I^VA;W?M?^W?U\CFJ9=7C1C/EF2_"CX=>#?VA_\ @E1\0]'^$=CJ%EX\
MT'7K3Q!XIL]2N$DNKZQB\WRHHW_Y:QIO_P"_BR_[%?)WAOQ'X5\'^&)_#7C?
MX=R_VG]HW_VS;WEQ8ZG8I_UR?_1G_P"^/^!U]Z?"3_@@Q\:;']D7Q7#_ ,)7
M:>%?%_BM[?[3X95TEMKVTB^=(KBX3[C^;\_R_)\E>.^)/^";/[97Q8L]&\!^
M(O"^NZEH^D7&;*XU+4;>6WLOX/\ CX\W[G_3*MLNS/ QGB81Q,>3G_F_JY5?
M!XSDA^Z/V;_8!UOP#XC_ &0/ ]Q\+X6M/!7V )902C;<0NC;9%F_Z:[U??\
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M'_P3?_=%%%'UNM_,'L*?8/\ AU(O_0]'_P $W_W13O\ AU0O_0]'_P $Y_\
MDBBBCZY6_F#V%/L?=G_!,[_@B%X$^&NJ6'Q'\3:U/XTU329_-TZRDLOLMC:R
M1?<D,?F.';_>K]/(T"+C%%%?S]Q3C:^(S"HZTKV;1]_D=*$<-'E1)1117SY[
M04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>n2574ex2310img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2310img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  Z ,(# 2(  A$! Q$!_\0
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M^/=U21!'N7^+YGW5XWK?[7?Q/O;=X'\=>(O)*<[)EB_\?1=W_CU97P*_9?\
M%'[2/BF*TTRSN+:TG=I;O5[B%S:Q>OS8^9J]CB3Q.GQ-A?[(R;#SO4T=_P M
M']]S@QN)J58>SI+<^E/^"1?P_P!3UP^+/'^K37%Y+>[=(M)YY&E9UB.]_F/;
M=LKXM^)FN:SI_P 1/%MA!?ZE#83:W>[[=)V6*3=.W\*U^Q/P9^$FD_!'X;Z;
MX<T>$1VFGP["VW#3.?ONW^T[?,:_+7XD?#LS?$GQ)(Z?\Q:Z?[G_ $W:O.\2
M<KIY'P_EV!E'5-W];*Y.+P=1481B]3]*OV>]?LO"?[+/@.XU*[M["V3P]IZM
M)<2B)4_T>/\ B:I9?"/@/X\V$UY92:3J;[_*:]L)E\V-_O?>7/S?6O/O&GP;
MU+XB_L:^$[#36D%]H^D6=TEM\W^E;+=1L*C^+^[7R3X=^./C#X#>*)?[-N[O
M2[C?FYLKA&6*5E_OH5KZ+BOC.& J87+\YP"JX.I36K5W>ROY:?>>U[1T8(V?
MV^?V!=<^'^FZIX^M/$W]NZ3IV-]I=IY%U8H\NU51E^5U5G_V?^!53_X)*_&W
M4_"WQT3P:\UQ)HFOVDSI;[V\JWN$'F[U7[J[E5]U<C^T/^V#X\^.ND_V1JU]
M';Z5)\CVE@GD176&W#S-S,QVM7L'_!*_]EW5K'X@S^/-7L)["SL+>2VTP7$;
MQ&Z=^&F&X?="[UKY?(:V$Q/$M"7"]*4**M?LEU^5NA\WR*ICU5H)^9]G>+?B
M5X,-Z=#UG5]$^T7!\HV-W<(6D/\ =V,:\U^//[$.G?$OPU-:^'=;N_!US-U>
MVC6>"16X*LC8;YO9J\*_;&^$6N> /B'JFKI;W%WI6KW#WL=VB.XAW-NV.?X=
MN?EKC]+_ ."A?Q*\':1]DBOK'44C^[->P^;-C_?5O_9:]+...<JQ69U\OXOR
MU?NW[DN6[TZW;ZZ-6/HJU6$8N$GHSYU^,7P9US]E[XO2Z1=7D']LZ)Y5Y:WN
MGN5^\-T3I]UEK[:^('CG5_VE_P#@GKX>\5WEM(=1TZZ\R]1/XS$T]L[_ /LY
MKXZN;#QC^TU\2GE_XF/B;7=1<1//Y!E\O^$;MB_*BU^IGP$_9YL/@_\ L^:;
MX%G,>I6T=L\5ZSCBZ:4LTA_X$S5AP3DE?.5F.%P<90PM6#4>;O\ 9^[J>#E=
M"7M9J-^0^0?V%OC38?"7XMW$>JW*6FDZW;_9VEE?;%;RH=R,?9ONU^@UK>1W
MD DC9'0\@KS7YO\ [4?[(6M? O7S+86UYK?AV?/D7*P&5K=?^>4NU?\ OFN!
MTO\ :G^(GA;3(K33?&FNVUI FU(O.64(%[#>K-7+P9QWC.#(3R'.J$N6#?*U
M;KZM*W5'IQQ/LO<F?H]^T7^T%HO[.OPYO=;U>X0$1LMI:J_[^]F[1H#7Y0?#
M^T\0?&OXCZ5X634M1CB\3ZEY4EO%.VV-7?<[8_V5WM6IXN\:>+/CUKEN-2U'
M7_%-XFX6\;.\[1[OO!$56Q_P%:^UOV OV%/^%0"/QAXKMH)O$D\2/8V^QB=+
M1E^;=N_Y:GI_LUVU\9BN/\YHPIT'##TM=?QONK]%8X:O/C*J4/A1YM_P61UN
M]\)^._AI/IUW<6=PEGJ""6)V5L;[5?X:O_\ !&_7-0\4>(OB)=ZG>7%_=&'3
MAYLK[FVYN:N?\%@_#?\ ;'B3P"^W_4V]ZG_?1@_PJW_P2$\-GP_>^.G*;?,6
MR_\ '?/KM<Z4?$SD4=;K_P!(12H5?K]_L'W!7P!_P4;U3[+^T=Y?_/32;;=_
MWU+7WYV;_=K\X?\ @J5JYM/VHU3_ *@MM_Z,GKZSQXH.MPURO_GY']3T\74]
MG"Y]$?\ !,:]-[\)=:<_]!5O_0%KZ<4Y-?)O_!)BZDN_@AK;NLG[S6&PS^T$
M5?6$;9%?7>%]/V?#&$@_Y?\ ,THU/:4U(?1117Z":#7_ -6:Y[QA\.=$\?Z>
MMMK6E:;JL ;>L=[;+.@;V#5T*_<J-NHKFK4*51>SJQYEYA:YYI!^Q_\ #&P?
M>O@+PI\OW4;3(F7_ +Y/RUW^C:-:Z%81VUG;6]M!%]R.&-41/HHJV_6I<_O*
MQP^5X3#ROAZ<8^B2$DD,D3,=<C?? [P?J]^]U=>&="N;B9F=YIK")Y)&/.=V
MVNP4_-3ZK$X*A725>"E;NAE:.U$,00=%^[FN;\9_"'PQ\0L-KN@Z+J[1IL5K
MVS2=E'U:NMIC<-3K82E67LZL5)>:N.YY[HO[,7PZ\,WB75CX)\,6]S&=Z2II
MD.^,C^ZQ7BN_C@"CBD4_-3ZFA@Z&&]RC",5Y*WY"Y%'8KW-I%>P-'(B/&_!4
M]&!K@=5_93^'.J3^;)X(\*L_K_9D7]%KT4?ZRES4XO+,)B?]XIQEZJXK1ENC
MG_"'PTT'X=6;0:'H^E:1&YRZ65JD"O\ 7:M="B_)3Z;)751HTZ,?9THV0^EB
M*>-9DV.G#]:\^U_]E7X=>)KEY[WP9X<N)Y&WO)]@C#2-_M86O2*ADKFQ678;
M$^[B*<9KS5PY5+1G)>"?@GX4^&UP\N@^&]%TB5_O26MI%$9![L%W5UGV;ZTJ
M'FI ?EJL+0I4X>SHP45Y H*.QS7CGX7>'?B/!"NN:/IFJ);_ '/M5NLOE_[I
M/2CP)\+O#WPVLYH=!TC3]*CN'WRK:0"+S&'K72$_**5.E2LKPOM_K?LX^T_F
MLK_> TCBN&^(O[//@OXLZI#>^(O#.DZM=0)Y4<MQ;JSQKZ9]*[M^E0S]!4XV
MC1K0]EB(*:\P<5):F%X"^&^B_#+0(=,T+3;/2-.AW%+6TB$42$]?NUT@IB=J
7:O4UUT:%.E&-*DK)"LHZ(FHHHK89_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>n2574ex2311img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2311img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" ![ &$# 2(  A$! Q$!_\0
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M'6],DU.=K"-'G%G&QWJNYA\S;7('=4;V!^)3^Q+X.W'=XC\41'^Z+*# ]O\
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M^*3A;ZXW$6]L>WS8)/\ LIDU],7FIOJ6H37DS[[BY;SIB1Q*_11[*!V%>O\
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M!8HI)((.2!P.3SD=ZQ?!?C+PYXJDO$\.ZEHFI-:[3<MIMQ#((R<A ^PG&0&
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$4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>n2574ex2312img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2312img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" "3 , # 2(  A$! Q$!_\0
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MW7V3-KSS2_?KCJ8@#QC]D#_@EQ\$/V+EMKGP[X3M];\1P_?\0:]Y=[?22?\
M3/\ Y9Q_]LZB_8;UAYO%'QX=Y[F23_A9%Y_K)/,\K]W'_JZ]TLY_-ECKP/\
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M+EGJ3PUN:/XD?S8_GKD_/JY9WG[VI,SY._X*6_\ !/S6[?QG'^T?\ 6D\/\
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M*+2W\O0_%%Q_S[2?_&Y/WG_32O9IYCSGB5,MA"9]*:]_P6>_9W\-W7D6NO\
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MR_\ \%%/CO\ $GX\?$;?X_>YLO#=K'Y=GINFR2?V'+_T\_\ 3223_II_J_\
M5U]V?MU>#YX=+\-^,8((Y(]+D_L[5/\ KWD_U<G_ '\_]&5X_P#V;8ZQ81IL
M\N.__=R02?O(I?\ IGY=?$XW$U,#B)PA\$S['!4J>+IPJ?;@>6?\$T_&&A_"
MS]FGQY>ZQ8VTGAC6?'%GX8U#]W^[BCU"VCMZ](\">"?#G[,G[+_Q$^"^E746
MOZA:^"]8\:>)-6\N3S/+DDDMK>/_ +9VT?E_]LZYKQ)^R7X9UG0;RQ?0++^R
M]4N([B\L--O+BRMKJ2/_ %<DD<<GER25S\W['VCS:I>7SWWQ#_M"_M_[.O+O
M_A++C[3?V_\ S[22?\M(_P#IG)7I4L^PGL_WASU,IKU*@?&SP?\ '/XA>//
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M]S=6<8\O]W)_US_Y9VW_ '\K@O GQ<^&G[!WB _"']C?PE<_'S]HKQ'FSO\
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M!* /^$@T@?V=JF?4RQ_ZS_MH'K\^/%G_  ;)_'/]DC49=2_97_:?US1[2/\
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MX1_X7^$[;39[M-FHZQ<XN=4U0CG]_/CIG^ 83@8%?1@Z4M=AS!1110 4444
M%%%% !1110 4444 %%%% !65J6@V/B4/:ZA96=];@?ZN>!9%_(BBB@#RWQU_
MP3_^!?Q#LC+K?P=^&6I2[<[Y_#-F6_/R\UQ-Q_P1<_9.NY=\G[/GPL9O7^PH
M?\*** ':=_P1H_92TVZ+P?L^_"F-AW'A^#_XFN\\)?L-?!;X9:<9/#_PD^&V
MCR8SOM?#5G&WYB.BB@#U73M%M-'M/(M+:&UA_N1($'Z5:HHH **** "BBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>n2574ex2313img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2313img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !] 10# 2(  A$! Q$!_\0
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M[J_CQC_@$>/X(^?>OTR\9_\ (FZQ_P!>DO\ Z+-?@[-_KJ L?M'^Q%_R:5X
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MZ"OZ$/\ @JY_RCU^)W_8,C_]'QU_/>_5OH*_H7PB_P"15B/\?_MB/YM\9/\
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M._/42G[TOA^9]WP]FO%"I8JKF\+<D/<]V/Q''?\ $0G\%O\ H#>/?_ "W_\
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M^CXZ_GO?JWT%?T(?\%7/^4>OQ._[!D?_ */CK^>]^K?05_0OA%_R*L1_C_\
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MR_Y1X>&?^PAJ'_I3)77XF_\ (@I_XX?^D&/A9_R4=?\ PS_]*1]@G[HKP?\
MX*7?\F%_%?\ [%ZX_I7O!^Z*\'_X*7?\F%_%?_L7KC^E?A>1_P#(RH?XX?\
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M%]Y87\$D%Q"^I/Y<J2#&S\J^1P_A%F$*D)NM"W_;W^1]=B?&7 5*4Z:H3_\
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M<T >+0_\$\_@W$^__A"+'_@5S<?_ !RO3? ?P[T'X8Z$NF^'M(L-&L%Y$%I
M(D_(5N9S1NH 9G>AR/P]:\>^,/[#WPG^/6I_;_%?@30=3U.3_67?V;R[B3_?
MDCV.X^IKV(4ASG@XK2AB*]"?/0FX/RT.7$X.AB(<F(@IKS/F[_AT7^SO_P!$
MTT__ ,#[O_X[1_PZ+_9W_P"B::?_ .!]W_\ ':^D".>OZ4N/?]*]/_6'-?\
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M2O!O^"F<JQ?L'?%$OT_L*;^E>\OQ7S]_P5#_ .3 OBC_ -@<_P#HR.NO(/\
MD98?_KY#_P!*1EQ!_P BS$?X)_\ I+/YZ81ND)],5_03\9OV"OAY^VA\-/!#
M>-;"[GFT338Q:36TYMY%62./S$R/78*_GWMQ@M^%?TZ?"Q2OPX\.Y/']FP''
M_;-*_:?%G%U\*\)B,//DG[Y^&>$."H8I8O#XB'/#W3Y/'_!!SX"'C['XE_\
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HSF*J>VKSKR^TS] R["QPN$IT(_9BB<"EI!TI:P.X**** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>n2574ex2314img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2314img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  < *X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]^7D(DVC;
M^)Y[]O\ Z]?+W[2G_!67X>?LL?M-^'?A+XET;QU+XL\6+$=(%AHOGVU_O?9\
MDF\=&!R,<#'K7:_MH_\ !07X5_L%>$K35OB7XHM=#346,=C: &6[O6'7RXEY
M('>ORH_;=_;!^$?[3'_!3#]FCXJZ?XY\;Z6]G'#)H]O'X8$HL$EE'E;LGGSI
M-ZDY^55Z<YKZ?(,AGC'*I7A+V:C)II;M+8RJR:6A^X%K-]IA1]K(2 =K#!'?
M!]Z)) K\D#W-?+'[+/\ P6'^!/[5_P 8+_X?^%_%,EMXOLKF>V33=3MC;37C
MQ2-&[19X<!E;/0_ABO(_^#C7]M_Q/^QM^P_%'X.N;C3?$/CG4ET>.]@;$UI;
MA2T[(>BO@J ?<\5YN$R3%8C'4\"UR2F[*_8'4<8<Q]GWG[2?P_T[Q)_8UQXY
M\'V^K"3RS92:S;I<;O3RRVXGVQ7:6]T)5X;=S]X*<'C(P:_$W]GO_@V/\,?'
M']B71_&.K>.?$K?%GQ1I,>LP7KW&ZSAG<>9#&P.9"IW98AP<MP0!BOJ7]E/Q
MA\1_^"+W_!.CQ/J7[2_B72?%&G>$)@-!DTRZ:>YN(G4!;9V=%^;S V#SA6Y)
MQ7LYCP[@(-PR[$^TJJ7(X-6;?>/=+N*-1O?8_1%"=OS=?:G5^24__!PK\8_A
MQX,\._%;Q[^SR-#^!?BFZCAL]6AU/?J$<;G E9,D$<$X"CZUZK_P46_X+RK^
MQGX\^$]IX5\%)X^T/XI:3'JMG=1W)AG99)Q$D<:8^9CZ>N*R?!N:*O"A&*;E
M>S4DUINK[)KJA^VA:Y^C%%?D!IG_  <D_%3P[\>M8^&OBO\ 9TU"U\<7J*WA
MG0;6X?[=<LXWQB<$D?ZOYCM"U[5_P3$_X+B:M^UU\</'?PR^*?@2'X<^-/!%
MK-?W$<,K/"D,)_>B3<Q*E%*DG.#N[8HQ'!N;4*3K3I^ZE?1IZ=TK["6(@W8_
M16BORLUS_@OQ\5?C9K?C;5_@#\"5\<?#GX<SR1:SK6HW_D2S!%9F,,89>2 "
M%YX8'O7HWBO_ (+W:)??\$P;G]H7PEX5^WWVF:K#HVI^';VZ\N6PN&8;U9L#
M.$R0?<>E95.$<UIJ+G2M=I;JZ;V372_F4JL6?H;4%U<>3(.8QG'WC^?Z9K\=
M?B#_ ,',WQ3\$^!O!_Q!D_9XGL_AEK^R-]5OKMXS>2]76W;A1@9*[@V[! KR
M+_@X]_:]\??$CQG\%[[0]&UCPUX"NX1J_AO7K34G1_$3SPVTC120IM*>5D#Y
ML@[R:]'#<!9E5Q,,-5M'F3:=T_AZ;[^0O;0M<_>J"0NG2FRR;>3C ZYXP*^"
M_BO_ ,%1?BS^SM^QWX#U[4/V??$NH?%'QC/+:IX;L2]U::9'%@"XNKB-2(T=
M"C*#S\Q':N ^"G_!;SXJ^'_VS_#OP4^.OP=TWP?XE\86GVC2'T;43<*2ZL85
M<,S8+E2O;!!KRZ7">8U*<JE%*25];J]H[NU]D*>(A$_2]KZ-)'4R(6098 C*
MCKTSGI62WQ(T%?%7]A?VUI(UG ;[!]I3[5C:7_U>=WW>>E?@!\(/VP?C[!_P
M7=\2:U!\/-9U'QE<,\-YX$_MR3R=/A,2*9MI;8,(Q?'N*^N[CXB^ 5_X.3K?
M1I/ EVGCXZ1O/B :PWDQ_P#$K9F'D?=.!QG'4UZF,X)JX27)4E>]/VFEO\_Q
M".(B]3]8 2>3^(':GJ,"ORT^+O\ P7X^(/CSXX^,_"O[./P3E^*6E?#IG_M[
M5Y)R(FVM_P L@K+@$!B&.<[3QQ7H7PY_X+S:+\7?^";7Q!^-N@^%7'B7X:[8
MM9\,W=SM,$C2*@;S!_RS.20?8UYE3A+,X1C.<-6TK75US?#==+]+E>W@^I^A
M5%?C/XG_ .#FCXLGX":1\3=&_9[V^!EG:UU?6[RZ<V?G>9L5(&4CU3DY!)-?
MJ7^QQ^TQIW[8G[-/A+XE:5;/96/BNR%W';2-N>W.2K(3WPRMS@<8K',^',?E
M]*-;$PM%NVZ>O9VV8U.+=D?FW^VC\)/$?@G]M3XD>/\ Q9I1UR[T^&QN?!;W
MUHM_%I>E/?Q1ZA+!$PV&548GD' .2"!7MO[<WBJX_9"MOA9XNTR30_$W@Q/$
MT4FM!/#EE-,VC&$81&2+Y&$CJRE-I/Z5]N^.OA'X?^)=S:R:WI\=\]BLT<#.
M3F)9HS'*![,AP0>.!WYKC[;]BCX:VGAJ#1E\.AM-MO(,=N]W,Z+Y(41<%R/E
M"@?ASFNR.?<RI*M>RT:3LFB)Q9^;WCWX/:U^U-\'=&^*-QHVD:5\2=9^+%LW
MP_32=.BL[K3-.BN/WF^2-0T@D@4^8S$X..E?5_\ P6K_ .">E[_P4>_8WO/"
M^A2QV_BW1+@:OHYD8B*>6,$-"Q[;P< ^H':OI+PC^SUX1\"VOA^'2](CM8_"
MD=Q%I8$C-]D%P=TV,D\N<Y/N<8KL%LDB!P.IR?PZ?E@5SU>)*RQ5+%8;W73;
MMUT[?<4J:DK,_";P-_P46_;7^!'[+J_ 7_A0'BB;Q=I]C_86F^);:QG8VD&W
M:'79E)'4<"08"]U.*],UO_@D?^T5\7_^"+/B3PIX_P#%FN>*?BWJ^LVOBBTT
MK5]2:\^PI;@@6:L_ 9@69AC&2 ,'.?V/>V&T\OR<YW'_ "/PH6W$:DCJQR3Z
MUZU?CENHJF"PT*4N93DUJV_5ZI=TC-8=7W/YOO"_[-'_  E_PL\,_#D_LC_'
M#7/BC;21VFJIJWB"[CT!R-R&=1O\N-0IW?+@9' KZ;_X*"?L!>/- _:Q_8LT
MSPKX US4O#WP\LM/MM4GT]9KZUTC;J"LZ/*=W 4G+$^G:OVF: %3RWYT- -O
M?GWK2OQ[B:E2,Z<$DN;2]]9*S=_R704<*K69^1GQ^_9D^(>M?\',OP^^(%EX
M-\27/@:SM+47&N0V<ILH66PD1E:7&,!FYS[5SO[,_P"Q=\0=8_X+N_M&:KK7
MA#Q+H_@CQMH6O:19Z[/9N+*7[48$79*<;L@$@X/-?LLL"[,=O3M35ME9B?FY
MX*Y^4CZ=*YO]=<3[#V,J:M[)4EKV=^;U#ZK'<_F\^&7[$&K_ +%%[XW\#_%G
M]GSXT^/-5DOY!X=U3PCJMY!INH(Z[%640G:>!U;)P1GC&/H7XH_\$\_&7A3_
M ((6^+](T'X,:OX4\3^-O$UIJW_"*6-S<:G>)"C* \@;+*Q^;(SZ'O7[@^2/
M>FBU5&+ 88CYB  6]S^5=V*X_P 36J0JJDE)2C)ZMIN.VG0%AHH_&O\ X*,_
MLN_$GQU_P;X_ ?P-HW@;Q-K'C'1+G19+_1X+&1KNV,<,X<NF,C!<52_X+.?L
M6?%/XJ?L%?LIWGA7P7KVO:C\-K.!=8TJVMI&O+9FM[5?F7&3AHW!S7[0FW7S
M>_/)P>M(MJJDGDGGD^]<N#XWQ.'G1FZ<7[.I.IUU<]UZ(%AHVLS\3_\ @J+\
M5_VCOVH_V??@7XMTOX=?%KP/X EED@\8>&-'E=-97R9/+WR%0K!2@W1@Y&2<
M@UY'\(_V0M>B_P""JGP.\=> ?V?_ (Q>"?AI9W5I+>7GB6.XO+NXD#$R7-PY
M9VC5MW3(QMS@ U_07)9J5/+?YX_'\:4VX'(+ DY)S6N&XZK8;"K#4*$5?GBW
M=[3W]7YLA85-:GXH?'_X>?&/]BK_ (+Z:_\ &K2_@WXT^(_A'Q''#!;R:)"S
MC$UM%"[-*$^41LI)SGC [5Z#>_LS_$*__P"#EM/B&?!?B"/P1)HHCDUT:>YL
MHV;2C&8_,*XSO('7JIK];!:J .O';/O4BVX5<<]21[9S_C7%+C*NU']U'F5)
MTKZ_#O?U-/JT4C\*?V;K#XW?\$*?C1\9O",/P0\4?%/PU\0YVFT+6-%B\V+<
M/-,'F,H;@+,0T9P<C/&:=^SI_P $Q_BY\-?^"1/[2>L>(/".JP^./C$+6>P\
M+VT,DEU!#%,KC,8'WB&*[3V0>M?NBUFFQA\QR1G<=W\Z<(!CN.<G'?BNQ\=U
MTU-48\\I0E*6NOL[<JMT\Q+#11^,>N?LI?$N;_@V%L?A^/ OB?\ X3O[9#+)
MH/V*3[<BC5!)S%MR/DQ7WO\ \$3?AUKWPF_X)B?"KP_XGTC4-"US3M/E2ZL;
MV-HY[=C<2L RMR."*^HS;JI/J1@GN:EC38M>1F/$^(QV$EAJL4E*HZEUW:M;
(T-(45%W1_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>n2574ex2315img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2315img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  ? $4# 2(  A$! Q$!_\0
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M/^\MY(Y/^F?ER5T/P$U3]I/XWZE\6/&GQE\7:SX0T'4_#6M1Z/X"U#48[/\
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M?_\ !/SXP?$'_@DI^SWX"T?PK'?>*?!EP\VLV7]J648M/W5R/]8[^6_W_P"
MU[ZJY33KTX^Y4YZD^><U'X;?GY_YGB*.:U*=1ISAR0AR0/&OVE?^"C_[8_PI
MT[P#\7M8\0Z9X=\)_$6!]2T#0[*VMY++R8L?)<))'YN9(W$F?-_C'I7M_P 7
M_P#@H?\ $+4_^"IGP0\-V+>'[+PSX]L_"^H7=K)HUK<7,/VY#))''>.GF^F,
M=.V*3_@I?^P%\7/C-^P/^S1X2\.>%4U#7O ^C_9M<LVU2RB^R2"RMHC^\D<1
MORDG^KK-\8?L!?%S5_\ @HU\ /&<'A.&3PYX-TCPA:ZS>G5+,?8I+54$W[LR
M>9)L/3RQSVS7FR638G#PG.G#:M_]H=/+F4*WL_?G_!_^V/%/^"9.C?$S5/\
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I1^5+?7#1#_A(-.X7SGQ_R\45W_V1PW4]]J%W_>.+^T,_A[B<]/[I_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>n2574ex2315img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2315img002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ ?@"" P$1  (1 0,1 ?_$ 'L   $$ P$
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MV4GC:NSG:/6QQ$-**C+2(FY=G[ZZ %7%2@-7:+^/N3-FB96CXG"#J.#'&,B
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JVWUZM*[O702=O_'=L/X_I=M4MO0V[*U]WT\*[N>@<Z!:!:!:!:!:#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>n2574ex2316img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2316img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ /P$  P$1  (1 0,1 ?_$ +\   $#!0$! 0
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M%/6H;:/A[A76L0E1,?0;MUXL5OE5J5ZBDRD"<Y 9Q,J^W,<2-B]Q:]W2_A1
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M%4P%:^[X19Q6<:^F.H85CHLH*0KR'8:H"D]P[2ZXEPL@U\.OCJ@G+LBI<>U
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$B"/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283868864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 20, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NioCorp
Developments Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001512228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1262185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">A1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000
                                         South Yosemite Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Centennial<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(720)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">334-7066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,660,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">DELOITTE & TOUCHE
LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Denver, Colorado&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=niobf_CommonSharesWithoutParValueMember', window );">Common Shares, without par value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Shares, without par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember', window );">Warrants, each exercisable for 1.11829212 Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants,
    each exercisable for 1.11829212 Common Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NIOBW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=niobf_CommonSharesWithoutParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=niobf_CommonSharesWithoutParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724286005104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,012<span></span>
</td>
<td class="nump">$ 2,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">916<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,928<span></span>
</td>
<td class="nump">3,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAndReceivablesNet', window );">Investment in equity securities</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Land and buildings, net</a></td>
<td class="nump">837<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties', window );">Mineral properties</a></td>
<td class="nump">16,085<span></span>
</td>
<td class="nump">16,085<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">20,070<span></span>
</td>
<td class="nump">20,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,843<span></span>
</td>
<td class="nump">3,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Warrant liabilities, at fair value</a></td>
<td class="nump">2,365<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible debt</a></td>
<td class="nump">7,660<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">11,964<span></span>
</td>
<td class="nump">3,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Warrant liabilities, at fair value</a></td>
<td class="nump">1,651<span></span>
</td>
<td class="nump">4,989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarnoutLiabilityAtFairValue', window );">Earnout liability, at fair value</a></td>
<td class="nump">3,817<span></span>
</td>
<td class="nump">10,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">17,536<span></span>
</td>
<td class="nump">29,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">1,534<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; EQUITY (DEFICIT)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, no par value, unlimited shares authorized; 38,062,647 and 31,202,131 shares outstanding, respectively</a></td>
<td class="nump">163,823<span></span>
</td>
<td class="nump">140,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(161,912)<span></span>
</td>
<td class="num">(150,477)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(911)<span></span>
</td>
<td class="num">(911)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity(deficit)</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="num">(10,967)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interest, and shareholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 20,070<span></span>
</td>
<td class="nump">$ 20,930<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarnoutLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnout liability at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarnoutLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized costs of unproven properties that include fee ownership or a lease, concession, or other interest representing the right to extract oil or gas subject to such terms as may be imposed by the conveyance of that interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 932<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//932/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482274/932-235-50-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 235<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482274/932-235-50-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestmentsAndReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestmentsAndReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (12)(c)<br> -Section S99<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph 14<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph 15<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (16)(c)<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285738240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorizedUnlimited', window );">Common stock, authorized</a></td>
<td class="text">Unlimited<span></span>
</td>
<td class="text">Unlimited<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">38,062,647<span></span>
</td>
<td class="nump">31,202,131<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorizedUnlimited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the number of common shares permitted to be issued by an entity's charter and bylaws is unlimited. The acceptable value is "Unlimited".</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorizedUnlimited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:authorizedUnlimitedItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285357632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Employee related costs</a></td>
<td class="nump">$ 3,509<span></span>
</td>
<td class="nump">$ 2,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">3,533<span></span>
</td>
<td class="nump">2,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ExplorationExpenditures', window );">Exploration expenditures</a></td>
<td class="nump">2,552<span></span>
</td>
<td class="nump">5,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other operating expenses</a></td>
<td class="nump">4,163<span></span>
</td>
<td class="nump">27,158<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">13,757<span></span>
</td>
<td class="nump">37,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfEarnoutLiability', window );">Change in fair value of earnout shares liability</a></td>
<td class="num">(6,704)<span></span>
</td>
<td class="num">(2,674)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfWarrantLiability', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(1,875)<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfConvertibleNotes', window );">Change in fair value of convertible notes</a></td>
<td class="nump">2,542<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Loss on debt extinguishment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">4,490<span></span>
</td>
<td class="nump">2,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange loss (gain)</a></td>
<td class="num">(31)<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other gains</a></td>
<td class="num">(147)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Loss on equity securities</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1', window );">Loss before income taxes</a></td>
<td class="num">(12,037)<span></span>
</td>
<td class="num">(40,612)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(139)<span></span>
</td>
<td class="num">(304)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ProfitLoss1', window );">Net loss</a></td>
<td class="num">(11,898)<span></span>
</td>
<td class="num">(40,308)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to redeemable noncontrolling interest</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss attributable to the Company</a></td>
<td class="num">(11,435)<span></span>
</td>
<td class="num">(40,080)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,898)<span></span>
</td>
<td class="num">(40,308)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive gain:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Reporting currency translation</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">(11,898)<span></span>
</td>
<td class="num">(40,226)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest', window );">Comprehensive loss attributable to redeemable noncontrolling interest</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentBeforeTaxParent', window );">Comprehensive loss attributable to the Company</a></td>
<td class="num">$ (11,435)<span></span>
</td>
<td class="num">$ (39,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarningsLossPerShareBasicAndDiluted', window );">Loss per common share, basic and diluted</a></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (1.34)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares outstanding</a></td>
<td class="nump">34,320,024<span></span>
</td>
<td class="nump">28,705,840<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfEarnoutLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of earnout liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfEarnoutLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarningsLossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnings loss per share basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarningsLossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ExplorationExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents exploration expenditures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ExplorationExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents income loss from continuing operations before income taxes extraordinary items noncontrolling interest1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ProfitLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents profit loss1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ProfitLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents total weighted average number of share outstanding basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481725/323-10-35-18<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481725/323-10-35-18<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481839/830-10-45-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482014/830-20-35-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general expenses not normally included in Other Operating Costs and Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284754704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="num">$ (11,898)<span></span>
</td>
<td class="num">$ (40,308)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AssumptionOfEarnoutLiability', window );">Initial valuation of earnout shares liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">13,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfEarnoutShareLiability', window );">Change in valuation of earnout shares liability</a></td>
<td class="num">(6,704)<span></span>
</td>
<td class="num">(2,674)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AssumptionOfPrivateAndPublicWarrants', window );">Initial valuation of warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInValuationOfWarrantLiabilities', window );">Change in valuation of warrant liabilities</a></td>
<td class="num">(1,875)<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfConvertibleNote', window );">Change in fair value of convertible note</a></td>
<td class="nump">2,542<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion of convertible debt</a></td>
<td class="nump">4,490<span></span>
</td>
<td class="nump">2,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">2,881<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_LossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueOfCommitmentSharesIssued', window );">Yorkville share issuances</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ForeignCurrencyTransactionGainLossBeforeTax1', window );">Foreign exchange loss</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on equity securities</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Noncash lease activity</a></td>
<td class="nump">20<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_OtheroperatingGainsLosses', window );">Other gains</a></td>
<td class="num">(148)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities, Total</a></td>
<td class="num">(10,580)<span></span>
</td>
<td class="num">(19,171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in working capital items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">469<span></span>
</td>
<td class="num">(985)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(1,621)<span></span>
</td>
<td class="nump">2,861<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(11,732)<span></span>
</td>
<td class="num">(17,295)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from sale of assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Issuance of debt, net of costs</a></td>
<td class="nump">6,935<span></span>
</td>
<td class="nump">14,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of capital stock</a></td>
<td class="nump">6,185<span></span>
</td>
<td class="nump">2,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Related party debt draws</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Related party debt repayments</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(3,130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="num">(1,512)<span></span>
</td>
<td class="num">(515)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(205)<span></span>
</td>
<td class="num">(204)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">11,403<span></span>
</td>
<td class="nump">14,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Exchange rate effect on cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(302)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash and cash equivalents during period</a></td>
<td class="num">(329)<span></span>
</td>
<td class="num">(2,939)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">2,341<span></span>
</td>
<td class="nump">5,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">2,012<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Amounts paid for interest</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing and financing transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ConversionsOfDebtForCommonShares', window );">Conversion of debt for common shares</a></td>
<td class="text">14,479<span></span>
</td>
<td class="text">5,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_RecognitionOfOperatingLeaseLiabilities', window );">Recognition of operating lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ValueOfWarrantsIssued', window );">Value of warrants issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text">3,337<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AssumptionOfEarnoutLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents assumption of earnout liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AssumptionOfEarnoutLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AssumptionOfPrivateAndPublicWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents assumption of private and public warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AssumptionOfPrivateAndPublicWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfEarnoutShareLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of earnout share liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfEarnoutShareLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInValuationOfWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in valuation of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInValuationOfWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ConversionsOfDebtForCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents conversions of debt for common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ConversionsOfDebtForCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FairValueOfCommitmentSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fair value of commitment shares issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FairValueOfCommitmentSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ForeignCurrencyTransactionGainLossBeforeTax1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents foreign currency transaction gain loss before tax1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ForeignCurrencyTransactionGainLossBeforeTax1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_LossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents losses on extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_LossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_OtheroperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents otheroperating gains losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_OtheroperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_RecognitionOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents recognition of operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_RecognitionOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ValueOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents value of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ValueOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481639/420-10-35-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479365/842-20-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284416416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity (Deficit) and Redeemable Noncontrolling Interest - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Redeemable Noncontrolling Interest [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2022</a></td>
<td class="nump">$ 129,055<span></span>
</td>
<td class="num">$ (110,397)<span></span>
</td>
<td class="num">$ (993)<span></span>
</td>
<td class="nump">$ 17,665<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="nump">27,667,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="nump">265,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants granted</a></td>
<td class="nump">$ 3,338<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,338<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CommonSharesIssuedInTheGXIITransaction', window );">Common Shares issued in the GXII Transaction</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CommonSharesIssuedInTheGXIITransactionShares', window );">Common Shares issued in the GXII Transaction (in shares)</a></td>
<td class="nump">1,753,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Commitment shares issued</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Commitment shares issued (in shares)</a></td>
<td class="nump">81,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Registered direct offering &#8211; May 2023</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Registered direct offering May 2023 (in shares)</a></td>
<td class="nump">314,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacility', window );">Yorkville equity facility draws</a></td>
<td class="nump">$ 501<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares', window );">Shares issued under the Yorkville equity facility (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Debt conversions</a></td>
<td class="nump">$ 5,604<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,604<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Debt conversions (in shares)</a></td>
<td class="nump">1,020,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share issuance costs</a></td>
<td class="num">$ (204)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_RedeemableNoncontrollingInterest', window );">Redeemable noncontrolling interest</a></td>
<td class="num">(2,328)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,328)<span></span>
</td>
<td class="nump">2,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Share-based compensation</a></td>
<td class="nump">1,794<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,794<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Reporting currency presentation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(40,080)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(40,080)<span></span>
</td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2023</a></td>
<td class="nump">$ 140,421<span></span>
</td>
<td class="num">(150,477)<span></span>
</td>
<td class="num">(911)<span></span>
</td>
<td class="num">$ (10,967)<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="nump">31,202,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,202,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="nump">7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacility', window );">Yorkville equity facility draws</a></td>
<td class="nump">$ 3,398<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,398<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares', window );">Shares issued under the Yorkville equity facility (in shares)</a></td>
<td class="nump">1,358,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Debt conversions</a></td>
<td class="nump">$ 14,479<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,479<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Debt conversions (in shares)</a></td>
<td class="nump">4,232,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share issuance costs</a></td>
<td class="num">$ (204)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Share-based compensation</a></td>
<td class="nump">2,779<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,779<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (11,435)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (11,435)<span></span>
</td>
<td class="num">$ (463)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrivatePlacementValue', window );">Private placements</a></td>
<td class="nump">2,995,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,995,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrivatePlacementShares', window );">Private placement (in shares)</a></td>
<td class="nump">978,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockDividend', window );">Option liability valuations</a></td>
<td class="num">$ (148)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (148)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Exchange of Class B shares</a></td>
<td class="nump">$ 103<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Exchange of Class B shares (in shares)</a></td>
<td class="nump">283,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2024</a></td>
<td class="nump">$ 163,823<span></span>
</td>
<td class="num">$ (161,912)<span></span>
</td>
<td class="num">$ (911)<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,534<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2024</a></td>
<td class="nump">38,062,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,062,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CommonSharesIssuedInTheGXIITransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents common shares issued in the g x i i transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CommonSharesIssuedInTheGXIITransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CommonSharesIssuedInTheGXIITransactionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents common shares issued in the g x i i transaction shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CommonSharesIssuedInTheGXIITransactionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PrivatePlacementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents private placement shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PrivatePlacementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PrivatePlacementValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents private placement value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PrivatePlacementValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_RedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_RedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents shares issued under the yorkville equity facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SharesIssuedUnderTheYorkvilleEquityFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents shares issued under the yorkville equity facility shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued to shareholders as a dividend during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285734976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--NatureOfOperations_zD6PtwSAtQel" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_821_zW6VRr1DoiE">DESCRIPTION
                                         OF BUSINESS</span></span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd. (the &#8220;Company&#8221; or &#8220;NioCorp&#8221;) was incorporated on February 27, 1987, under the laws of
the Province of British Columbia and currently operates in <span id="xdx_90F_eus-gaap--NumberOfReportableSegments_dxL_uNUMBER_c20230701__20240630_zJc3cWKtp6z2" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0549">one</span></span> reportable operating segment consisting of exploration and development
of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property (the &#8220;Elk Creek Project&#8221;)
located in southeastern Nebraska.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed in Notes 5, 9, 10, and 11, on March 17, 2023 (the &#8220;Closing Date&#8221;), the Company closed the GXII Transaction
(as defined below) with GX Acquisition Corp. II (&#8220;GXII&#8221;), pursuant to the Business Combination Agreement, dated September
25, 2022 (the &#8220;Business Combination Agreement&#8221;), among the Company, GXII and Big Red Merger Sub Ltd (the &#8220;Closing&#8221;).
At the Closing, the Company also closed convertible debt financings (the &#8220;Yorkville Convertible Debt Financing&#8221;) with
YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (together with YA II PN, Ltd., &#8220;Yorkville&#8221;),
and the standby equity purchase facility with Yorkville (the &#8220;Yorkville Equity Facility Financing&#8221; and, together with
the Yorkville Convertible Debt Financing, the &#8220;Yorkville Financings&#8221;) became effective. The transactions contemplated
by the Business Combination Agreement, including the GXII Transaction, the Yorkville Financings and the Reverse Stock Split (as
defined below), are referred to, collectively, as the &#8220;2023 Transactions.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
GXII Transaction was accounted for as an equity raise transaction in accordance with generally accepted accounting principles
of the United States of America (&#8220;U.S. GAAP&#8221;). Under this method of accounting, GXII is treated as the &#8220;acquired&#8221;
company for financial reporting purposes. Accordingly, the GXII Transaction is treated as the equivalent of NioCorp issuing common
shares, no par value, of the Company (&#8220;Common Shares&#8221;) for the assets and liabilities of GXII. The net assets of GXII
are stated at historical cost, with no goodwill or other intangible assets recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 4, these matters raise substantial doubt about the Company&#8217;s
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing and maintaining continued support from its shareholders and creditors.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284288608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">BASIS OF PREPARATION</a></td>
<td class="text"><p id="xdx_802_eus-gaap--BasisOfAccounting_zsQVKD3gUrj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82D_z5hzFCKjEWSc">BASIS
                                         OF PREPARATION</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
                                         of Preparation and Consolidation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements have been prepared in conformity with U.S. GAAP and the rules and regulations of the U.S. Securities
and Exchange Commission. The consolidated financial statements include the consolidated accounts of the Company and its wholly
owned subsidiaries with all significant intercompany transactions eliminated. Certain transactions include reference to Canadian
dollars (&#8220;C$&#8221;) where applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zf69pR31uxh6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; width: 97%; border-collapse: collapse">
<tr>
    <td colspan="2" rowspan="2" style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiary</span></td>
    <td rowspan="2" style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction
    of incorporation</span></td>
    <td>&#160;</td>
    <td colspan="3" style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    at June 30,</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="border-top: Black 1pt solid; width: 28%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800 BC Ltd. (&#8220;0896800&#8221;)</span></td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="border-top: Black 1pt solid; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zjCmO2yFTGz4" title="Country of incorporation"><span id="xdx_903_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zLkrTedR6Li4" title="Country of incorporation">British
    Columbia, Canada</span></span></span></td>
    <td style="width: 1%">&#160;</td>
    <td id="xdx_98D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_z8rt1hY4BU3k" style="border-top: Black 1pt solid; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td style="width: 1%">&#160;</td>
    <td id="xdx_98E_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zaMVCXvGfrKf" style="border-top: Black 1pt solid; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zThpzWj8ANz1" title="Country of incorporation"><span id="xdx_909_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_z64JqIVxOu5i" title="Country of incorporation">Nebraska,
    USA</span></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zWG4d2e4K7Ck" title="Percentage of ownership">100</span>% </span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp. (&#8220;ECRC&#8221;)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zOzbwCizq231" title="Country of incorporation"><span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zvuBARcqoNpk" title="Country of incorporation">Delaware,
    USA</span></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zw7RJNX49Ww2" title="Percentage of ownership">79.7</span>%<sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zi1J736PuuGf" title="Percentage of ownership">79.1</span>%<sup>(1)</sup></span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    Technologies Limited</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zIJCeRfSoK58" title="Country of incorporation"><span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zc2xV3GIE6R7" title="Country of incorporation">United
    Kingdom</span></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zqOqhWwkifdi" title="Percentage of ownership">100</span>%</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span id="xdx_F09_zSzo3oHuagfl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F1C_zdZyBZKB7Z3f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents 100% of Class A common stock owned by 0896800, and 4,282,116 and 4,565,808 Vested Shares and 3,391,596 and 3,391,596
Earnout Shares (each as defined below) held by third parties, and outstanding as of June 30, 2024 and 2023, respectively.</span></td></tr></table>

<p id="xdx_8A1_zBJ4Q2TIiE0k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
                                         of Estimates</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the consolidated financial statements, and the reported amounts of expenses during the reporting period. The Company regularly
evaluates estimates and assumptions related to the valuation of mineral properties, deferred income tax asset valuations, convertible
debt valuations, earnout valuation, derivative liabilities, warrant liabilities, and share-based compensation. The Company bases
its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable
under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results
experienced by the Company may differ materially and adversely from the Company&#8217;s estimates. To the extent there are material
differences between estimates and the actual results, future results of operations will be affected.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285097328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zt4CN23jWZra" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_820_zPeyYA2MXzB8">SIGNIFICANT
                                         ACCOUNTING POLICIES</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_ecustom--DevelopmentStageIssuerPolicyTextBlock_z6Ky6LyWq3Wg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zOxMMr2INzx4">Development
                                         Stage Issuer</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#8220;S-K 1300&#8221;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#8217;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#8217;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.</span></p>

<p id="xdx_85E_zBYenB0qbRz5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zyKcv3ZE804d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
                                         and Cash Equivalents</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90
days or less, and money market funds. The Company maintains the majority of its cash balances with two financial institutions.
Accounts at banks in the United States (&#8220;U.S.&#8221;) are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;)
up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance Corporation (&#8220;CDIC&#8221;) up
to C$100. At June 30, 2024, the Company had $1,406 and $0 in excess of the FDIC and CDIC insured limits, respectively.</span></p>

<p id="xdx_85F_zyACynnHwCae" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zFpeUIPaGY17" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_863_zlLDdyLwxws8">Foreign
                                         Currency Translation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Functional
and reporting currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
included in the financial statements of each of the Company&#8217;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#8220;the functional currency&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency for these consolidated financial statements is U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in functional currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to March 17, 2023, the Company&#8217;s functional currency was the Canadian dollar. The Company re-assessed its functional currency
and determined that on March 17, 2023, its functional currency changed from the Canadian dollar to the U.S. dollar based on significant
changes in economic facts and circumstances in our organization. The change in functional currency was accounted for prospectively
from March 17, 2023 and prior-period consolidated financial statements were not restated for the change in functional currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
both monetary and non-monetary assets and liabilities, translated balances as of March 17, 2023 became the new accounting basis.
The exchange rate on the date of change became the historical rate at which non-monetary assets and liabilities were translated
in subsequent periods. There was no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded
cumulative translation adjustments were not reversed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency for the Company&#8217;s Canadian subsidiary, 0896800 BC Ltd., which has no independent operations from its
parent, also changed from the Canadian dollar to the U.S. dollar. The functional currency for Elk Creek Resources Corp. remains
as the U.S. dollar.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transactions
in foreign currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation
to reporting currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
gains and losses from the application of the U.S. dollar as the reporting currency for all periods prior to March 17, 2023 (when
the Canadian dollar was the functional currency) are included as part of cumulative currency translation adjustment, which is
reported as a component of shareholders&#8217; equity under accumulated other comprehensive loss.</span></p>

<p id="xdx_853_zu1ogsAIjjoj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_ecustom--MineralPropertiesPolicyTextBlock_z871pBas3l0e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zFugxpbaTuvl">Mineral
                                         Properties</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of Common Shares issued as consideration. Properties acquired under option agreements,
whereby payments are made at the sole discretion of the Company, are capitalized as mineral property acquisition costs at such
time as the payments are made. Exploration costs are expensed as incurred. When it is determined that a mining deposit can be
economically and legally extracted or produced based on established proven and probable reserves under S-K 1300, and the Company&#8217;s
board of directors (the &#8220;Board&#8221;) has approved the commencement of formal development activities, development costs
related to such reserves and incurred after such board approval will be considered for capitalization. The establishment of proven
and probable reserves is based on results of feasibility studies, which indicate whether a property is economically feasible.
Upon commencement of commercial production, capitalized costs will be amortized over their estimated useful lives or units of
production, whichever is a more reliable measure. Capitalized amounts relating to a property that is abandoned or otherwise considered
uneconomic for the foreseeable future are written off.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#8217;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was no impairment recorded to mineral properties as of
June 30, 2024 or 2023, respectively.</span></p>

<p id="xdx_85C_zosz9HQMWyZ3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBC9mEc6STt1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zEaiVHlVtH27">Long
                                         Lived Assets</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was no impairment recorded to long-lived assets as of June 30, 2024 or 2023, respectively.</span></p>

<p id="xdx_851_zRDcCnhtaOr4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zw3U6fHn81tj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_z26z4m9B3eV7">Leases</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Accounting Standards Codification (&#8220;ASC&#8221;) 842, <i>Leases</i>, we determine if a contractual arrangement is, or contains,
a lease at the inception date. Right-of-use (&#8220;ROU&#8221;) assets and liabilities related to operating leases are separately
reported in the consolidated balance sheets. The Company currently has no finance leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.</span></p>

<p id="xdx_852_zMZ3v4YoUK2f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_ecustom--ConvertibleDebtCarriedatFairValueTextBlock_zFf3LGmktr5j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
                                         Debt Carried at Fair Value</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With regard to the Company&#8217;s debt related to the convertible promissory notes issued in April 2024 (as further discussed in
Note 9), the Company has elected to account for these notes at fair value per the provisions of ASC Topic 815, <i>Derivatives
and Hedging</i> (&#8220;ASC 815&#8221;). Under ASC 815-15-25, an election can be taken at the inception of a financial instrument
to account for the instrument at fair value. The notes were recorded at fair value at inception and assessed quarterly thereafter
using a Monte Carlo simulation methodology which incorporates multiple conversion scenarios. All changes in fair value subsequent
to the initial recording, excluding the impact of the change in fair value related to the Company&#8217;s own credit risk, are
recorded as a component of non-operating income/expense, within Change in fair value of convertible debt in the consolidated statements
of operations. Changes in fair value related to the Company&#8217;s own credit risk, if any, are recorded through other comprehensive loss.</span></p>

<p id="xdx_856_z8PrHWApeFwb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_ecustom--WarrantsPolicyTextBlock_zVzXuHVnB1jg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_zFBuDFHSSjra">Warrants</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
apply relevant accounting guidance for warrants to purchase our stock based on the nature of the relationship with the counterparty.
For warrants issued to investors or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC
480, <i>Distinguishing Liabilities from Equity</i>, and ASC 815, to assist in the determination of whether the warrants should
be classified as liabilities or equity. The fair value of warrants is estimated using Black Scholes modeling or Monte Carlo modeling,
depending on the settlement features embedded in the warrant. Inputs under both models include inputs such as NioCorp&#8217;s
Common Share price, the risk-free interest rate, the expected term, the volatility, and the dividend rate. Warrants that are determined
to require liability classifications are measured at fair value upon issuance and are subsequently remeasured to their then fair
value at each subsequent reporting period with changes in fair value recorded in current earnings. Warrants that are determined
to require equity classifications measured at fair value upon issuance and are not subsequently remeasured unless they are required
to be reclassified.</span></p>

<p id="xdx_85F_zqVQtxg8taF9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_ecustom--EarnoutSharesPolicy_zXvZc6JpFmed" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
                                         Shares</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The Earnout Shares
are measured at fair value upon issuance and subsequently remeasured at each reporting period using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#8217;s Common Share price, the risk-free interest rate, the expected term, the weighted
average of historical Common Share volatility and implied volatility underlying the Company&#8217;s Public Warrants, the dividend
rate, the conversion price, and the number of Earnout Shares outstanding. Assumptions used in the model are subjective and require
significant judgment.</span>&#160;</p>

<p id="xdx_857_zOo0ojmXRhib" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>



















<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zeSl7pShaLzl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zymGassAsrg2">Financial
                                         Instruments</span></span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, receivables, equity securities, accounts payable and
accrued liabilities, notes payable, convertible debt, and the related party loan. It is management&#8217;s opinion that the Company
is not exposed to significant interest, currency or credit risks arising from its financial instruments. The fair values of these
instruments approximate their carrying value unless otherwise noted.</span></p>

<p id="xdx_852_zTwingViNPT2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_ziM19jf9lqHl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zxxEgvrMFbk">Concentration
                                         of Credit Risk</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver, British Columbia and Santa Clara, California.
As part of its cash management process, the Company regularly monitors the relative credit standing of these institutions.</span></p>

<p id="xdx_853_zXx6f6rixo32" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--AssetRetirementObligationsPolicy_ze2r2G0Eiqnb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zLzHOWeAYgJ3">Asset
                                         Retirement Obligation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $<span id="xdx_908_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20240630_zOV4XPJ3gpjc">48</span> as an accrued liability related to
estimated obligations as of June 30, 2024 (2023 - $<span id="xdx_900_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20230630_zaXUsPjc7Ke4" title="Accrued exploration stage expense">48</span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss
in the period an estimate is revised.</span></p>

<p id="xdx_85F_zhmYRDK7YtY6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zCv3nwIbVBba" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zgf1SsEh0XDb">Income
                                         Taxes</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, <i>&#8220;Income Taxes &#8211; Recognition.&#8221;
</i>Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#8220;more likely than not&#8221; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#8220;Income Taxes &#8211; Disclosure,&#8221;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2024 and 2023, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.</span></p>

<p id="xdx_853_zHPq2BRxIFqh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_ecustom--ReverseStockSplitPolicyTextBlock_zcryDoHkjpUg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zixf7ipR0xk5">Reverse
                                         Stock Split</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2023, the Company effected a reverse stock split (the &#8220;Reverse Stock Split&#8221;) on the basis of one (1) post-Reverse
Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding, with any fractional
shares resulting from the Reverse Stock Split rounded down to the nearest whole share. Immediately after the Reverse Stock Split,
there were 30,000,442 Common Shares issued and outstanding. All references to share and per share amounts (excluding authorized
shares) in the consolidated financial statements and accompanying notes have been retroactively restated to reflect the Reverse
Stock Split.</span></p>

<p id="xdx_85B_zMeiKcNYisq6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zZYz7a3R8b5l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_z98S5JPclJ1a">Redeemable
                                         Noncontrolling Interest</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#8217;s control and is reported in the mezzanine section between total liabilities
and shareholders&#8217; deficit, as temporary equity in the Company&#8217;s consolidated balance sheets. The Company&#8217;s non-controlling
interest is redeemable at fair value, and no adjustment to the earnings per share numerator is required because redemption at
fair value is not considered an economic distribution different from other common stockholders.&#160;</span></p>

<p id="xdx_854_zevX8FbQDsyi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>



















<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_z8mz8hNA0fja" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_z61ows0CsP4a">Basic
                                         and Diluted Per Share Disclosure</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average number
of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout Shares (each as defined
in Note 10), to be participating securities, requiring the use of the two-class method. Diluted earnings (loss) per share represents
net earnings (loss) attributable to common shareholders divided by the weighted average number of Common Shares outstanding, inclusive
of the dilutive impact of all potentially dilutive securities outstanding during the period, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z4oXpvuz7yij" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zmPdZGo8Jldb" style="width: 12%; text-align: right" title="Net loss::XDX::-11898"><span style="-sec-ix-hidden: xdx2ixbrl0652">(11,898</span></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230630_zZ8ZK7ESqopj" style="width: 12%; text-align: right" title="Net loss">(40,308</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Adjust: &#160;Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20230701__20240630_ztoS73kIOKx3" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::463"><span style="-sec-ix-hidden: xdx2ixbrl0656">458</span></td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zORNxPZyMr5f" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::228"><span style="-sec-ix-hidden: xdx2ixbrl0658">(251</span></td><td style="padding-bottom: 1pt; text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net loss available to participating securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zOIH99mkHtGl" style="text-align: right" title="Net loss available to participating securities">(11,440</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zS9EcMMR2GMc" style="text-align: right" title="Net loss available to participating securities">(40,057</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Net loss attributable to Vested Shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zqM20nkHogYb" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares">967</td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zbdm4thPBHWk" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares">1,528</td><td style="padding-bottom: 1pt; text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zg6rjKR1gZY5" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">(10,473</td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_zXsSreWXTDt5" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">(38,529</td><td style="padding-bottom: 2pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_znEa4o0ILxi4" style="text-align: right" title="Weighted average shares outstanding basic and diluted">34,320,024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zVCao1x4Trsc" style="text-align: right" title="Weighted average shares outstanding basic and diluted">28,705,840</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Loss per Common Share outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20240630_z6niy4YWEVQ" style="text-align: right" title="Loss per common share outstanding basic and diluted">(0.31</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_zxQjh92qxab4" style="text-align: right" title="Loss per common share outstanding basic and diluted">(1.34</td><td style="text-align: left">)</td></tr>
</table>

<p id="xdx_8A6_zoFmaRWAIf1b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following shares underlying options, warrants, and outstanding convertible debt were antidilutive due to a net loss in the periods
presented and, therefore, were excluded from the dilutive securities computation for the years ended June 30, 2024 and 2023, as
indicated below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zBrtvXc7lCd2" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; visibility: hidden"><span id="xdx_8B8_zZeo1Pcp509">Schedule of excluded from the dilutive securities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; border-collapse: collapse; width: 91%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded potentially dilutive securities <sup id="xdx_F69_zLunV1ebYId4">(1)(2)</sup>:</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; padding-left: 0.25in; text-indent: -0.125in">Options</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zvapHnoAM9w6" style="width: 12%; text-align: right" title="Options">2,495,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zWphhe01Uuyi" style="width: 12%; text-align: right" title="Options">1,541,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_z2ofRW7Lmgk" style="text-align: right" title="Warrants">18,563,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zBJov0ZymEgi" style="text-align: right" title="Warrants">18,816,304</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Convertible debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zlzyJMRW9Uj5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,849,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_zYJcZ1sPSRk5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,871,660</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Total potentially dilutive securities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_zaGrLyZ7nwpf" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities">23,908,061</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zfyvgekKOY25" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities">23,229,464</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify"><span id="xdx_F02_zLNq355T4bGf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F15_zGoQRZD8Ae11" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span id="xdx_F0C_ztq3eT2kaFPj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span id="xdx_F1B_z7xqga9FTee9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;</span></td></tr>
</table>

<p id="xdx_8A3_zqXUp5Ok9Uw2" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="margin-top: 0; margin-bottom: 0"></p>

<p id="xdx_855_zGTaXDfAX5Ml" style="margin-top: 0; margin-bottom: 0"></p>

<p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zNUCQi67FfWd" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                    <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)</span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zCtXI4XN2huk">Share
                                         Based Compensation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants stock options to directors, officers, employees, and business advisors. Option terms and vesting conditions are
at the discretion of the Board. Prior to March 31, 2023, the option exercise price was equal to the closing market price on The
Toronto Stock Exchange (the &#8220;TSX&#8221;) on the day preceding the date of grant. Effective March 21, 2023, the option exercise
price is equal to the closing market price on the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) on the day preceding the date
of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of stock options using the Black-Scholes option pricing model. The Company recognizes forfeitures
as they occur.&#160;</span></p>

<p id="xdx_85D_zyHZ54Jr96Di" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>



















<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zxAhxkbPKgP9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">r)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_zloV9IAt35fk">Recent
                                         Accounting Standards</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Not Effective</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, <i>Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures</i>, which is intended to improve reportable segment disclosure requirements, primarily through
enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses
that are regularly provided to the chief operating decision maker and included within segment profit and loss. The amendments
are effective for the Company&#8217;s annual periods beginning July 1, 2024, and interim periods beginning July 1, 2025, with
early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. The
Company has evaluated the ASU and has determined that implementation will have limited impact on the Company&#8217;s disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>, which includes
amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation
categories and income taxes paid by jurisdiction. The amendments are effective for the Company&#8217;s annual periods beginning
June 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively. The Company is currently
evaluating the ASU to determine its impact on the Company&#8217;s disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#8217;s consolidated financial statements upon adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_853_zG1Q0u67xNt2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368423984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOING CONCERN ISSUES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">GOING CONCERN ISSUES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zD3Y051Eptji" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82A_zNS4kjR0vWpa">GOING
                                         CONCERN ISSUES</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred a net loss of $<span id="xdx_907_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zGFZ4HE3dWui" title="Net loss::XDX::-11898"><span style="-sec-ix-hidden: xdx2ixbrl0712">11,435</span></span> for the year ended June 30, 2024 (2023 - $<span id="xdx_90B_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230630_zWXvkh5dWsPe" title="::XDX::-40308"><span style="-sec-ix-hidden: xdx2ixbrl0713">40,080</span></span>) and had a working capital deficit of
$<span id="xdx_905_ecustom--WorkingCapitalDeficit_pn3n3_c20230701__20240630_zmhiPMfjOad9" title="Working capital deficit">9,036</span> and an accumulated deficit of $<span id="xdx_901_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20240630_zoaMe1B4oPR3" title="Accumulated deficit">161,912</span> as of June 30, 2024. As a development stage issuer, the Company has not yet commenced
its mining operations and accordingly does not generate any revenue. As of June 30, 2024, the Company had cash of $<span id="xdx_905_ecustom--CashAndCashEquivalentsAtCarryingValue1_pn3n3_c20230701__20240630_zexyJvPSKJid" title="Cash">2,012</span>, which
will not be sufficient to fund normal operations or the repayment of the April 2024 Notes for the next twelve months. These conditions
and events raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>






<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to these conditions and events, the Company plans to obtain additional financing. Subject to the conditions discussed
in Note 11d, NioCorp expects to have access to up to $<span id="xdx_90B_eus-gaap--ProceedsFromRepaymentsOfDebt_pn3n3_c20230701__20240630_znLqm2vKB2Ua" title="Net proceeds">59,269</span> in net proceeds from the Standby Equity Purchase Agreement, dated
January 26, 2023 (the &#8220;Yorkville Equity Facility Financing Agreement&#8221;), between the Company and YA II PN, Ltd., an
investment fund managed by Yorkville Advisors Global, LP (&#8220;Yorkville&#8221;), through April 1, 2026. In addition, the Company
may pursue additional sources of financing, and while it has been successful in doing so in the past, there can be no assurance
it will be able to do so in the future. Other than the potential issuance of Common Shares under the Yorkville Equity Facility
Financing Agreement, the Company did not have any further funding commitments or arrangements for additional financing as of June
30, 2024. The Company&#8217;s plans to obtain additional financing have not been finalized, are subject to market conditions,
and are not within the Company&#8217;s control and therefore cannot be deemed probable. Further, the Company will be required
to raise additional funds for the construction and commencement of operations. As a result, the Company has concluded that management&#8217;s
plans do not alleviate substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></p>













<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285378272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2023 GXII TRANSACTION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">2023 GXII TRANSACTION</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_zMqEPDRef7V9" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82F_z9wu9DvZZi79">2023
                                                                                                                                              GXII                                          TRANSACTION</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the following transactions (collectively, the &#8220;GXII Transaction&#8221;) occurred
on the Closing Date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.625in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a
    result of a series of transactions, GXII became an indirect, majority-owned subsidiary of NioCorp and changed its name to
    &#8220;Elk Creek Resources Corp&#8221; (&#8220;ECRC&#8221;).</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the
    parent company of the merged entity, NioCorp issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFgBUZOKQRb1" title="Post reverse stock split shares">1,753,821</span> post-Reverse Stock Split Common Shares in exchange for all of
    the Class A shares of GXII issued and outstanding immediately prior to the Closing, including 83,770 Common Shares issued
    to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory services.</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    of the Class B shares of GXII issued and outstanding immediately prior to the Closing (after giving effect to the surrender
    of certain Class B shares of GXII in accordance with the Sponsor Support Agreement, dated September 25, 2022 (the &#8220;Sponsor
    Support Agreement&#8221;), among GX Sponsor II LLC (the &#8220;Sponsor&#8221;), GXII, NioCorp and the other persons party
    thereto) were converted into <span id="xdx_908_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_uShares_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zuxE9VyS3UE3" title="Convertible shares issued upon conversion">7,957,404</span> shares of Class B common stock of GXII (now known as ECRC) as the surviving entity
    of the mergers that occurred on the Closing Date as part of the GXII Transaction. Pursuant to the Business Combination Agreement,
    the Sponsor Support Agreement and the Exchange Agreement, dated as of March 17, 2023 (as amended, supplemented or otherwise
    modified, the &#8220;Exchange Agreement&#8221;), by and among NioCorp, ECRC and the Sponsor, after the Closing, the shares
    of Class B common stock of ECRC are exchangeable into Common Shares on a one-for-one basis, subject to certain equitable adjustments,
    under certain conditions. See Note 10 for additional information regarding the Class B common stock of ECRC.</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    assumed GXII&#8217;s obligations under the agreement (the &#8220;GXII Warrant Agreement&#8221;) governing the GXII share purchase
    warrants (the &#8220;GXII Warrants&#8221;) and issued an aggregate of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember_zJQNuttuZSSh" title="Number of shares purchase">15,666,626</span> warrants (the &#8220;NioCorp Assumed Warrants&#8221;)
    to purchase up to an aggregate of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkxt8uhfFemh" title="Number of shares purchase">17,519,864</span> Common Shares. See Note 11c for additional information regarding the NioCorp
    Assumed Warrants. </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p id="xdx_897_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zKUVvNELzpWg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the distribution of funds to GXII redeeming shareholders and prior to paying transaction costs incurred by GXII, $15,676 became
available to the Company. <span id="xdx_8B5_zTrPe6YC7z0a">The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements
of Operations and Comprehensive Loss for the year ended June 30, 2023:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td id="xdx_497_20240630_zDLUSx4h8pj3" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_pn3n3_zi1H2eW1ntTi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 79%; text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Gross cash proceeds, net of transaction costs incurred by GXII</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,168</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zmURVwpgdLe8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Cash costs associated with the 2023 Transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_zNLMqDZy6U37" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net liabilities assumed</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">392</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_iI_pn3n3_zabKhGg8SDZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Yorkville Equity Facility Financing Agreement &#8211; cash costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,996</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_iI_pn3n3_zgg3OYDVUrzd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Transaction costs expensed</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,715</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_pn3n3_zA4xcJ5lWgtl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Non-cash costs associated with the 2023 Transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_iI_pn3n3_z3WnogewIok8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Private Warrants assumed at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,987</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--EarnoutSharesAssumedAtFairValue_iI_pn3n3_zuyWFtL9oZ09" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Earnout Shares assumed at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,195</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_pn3n3_znImeCHUfwpi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Yorkville Equity Facility Financing Agreement &#8211; shares issued</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">650</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pn3n3_zWeKgiDlfUgl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">&#160;Total transaction related losses incurred</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">23,767</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_zppruokwxdna" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>



















<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p id="xdx_891_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_zC7xeqbOOV0j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zxM4hW8dTdzj">The
number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Common Shares</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Percentage</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Legacy NioCorp Shareholders</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zWOIlnILdPP5" style="width: 12%; text-align: right" title="Common stock, shares outstanding">28,246,621</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zW4jrfzTP7ue" title="Number of shares, percentage">93.90</span></td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former GXII Class A Shareholders<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zOkXCQtlUpi4" style="text-align: right">1,753,821</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zjbTVwksDMg" title="Number of shares, percentage">5.83</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<sup>(2)</sup></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--OtherMember_fKDIp_z6u5pI41BQMa" style="border-bottom: Black 1pt solid; text-align: right">81,213</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--OtherMember_fKDIp_z5IF8MmrkA0h" title="Number of shares, percentage">0.27</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Total Common Shares Outstanding Upon Completion of 2023 Transactions</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_dxL_uShares_c20240630_zAmY6gSaz2Jf" style="border-bottom: Black 2pt solid; text-align: right" title="Common stock, shares outstanding::XDX::38062647"><span style="-sec-ix-hidden: xdx2ixbrl0782">30,081,655</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; text-align: right"><span id="xdx_908_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630_zS4TL18wCk9j" title="Number of shares, percentage">100</span></td><td style="padding-bottom: 2pt; text-align: left">%</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span id="xdx_F0F_zeKfNxmYnfgg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_zf9p9PT20DCa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span id="xdx_F0F_zSrKWsF1MpYe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_zGgsi7nrWCx7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.</span></td></tr>
</table>
<p id="xdx_8A1_zcfdafWdovXl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the GXII Transaction, the Company also closed the Yorkville Convertible Debt Financing and the Yorkville Equity
Facility Financing, as discussed in Notes 9 and 11d.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368418240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LAND AND BUILDINGS, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">LAND AND BUILDINGS, NET</a></td>
<td class="text"><p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z6gENgu6aRng" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_827_zMRmoXbiTvc8">LAND
                                         AND BUILDINGS, NET</span></span></td></tr></table>

<p id="xdx_89F_eus-gaap--PropertyPlantAndEquipmentTextBlock_zsf5VlsY2OS6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zjH7iNtlzLg1" style="display: none; visibility: hidden">Schedule of properties</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="22" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Depreciation</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Depreciation</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%">Land</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zdsre1YFxA19" style="width: 9%; text-align: right" title="Cost">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_z8IUo9bs8WCa" style="width: 9%; text-align: right" title="Accumulated depreciation">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_ze0jotrhr99" style="width: 9%; text-align: right" title="Net">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zgzb5HDz3Gv5" style="width: 9%; text-align: right" title="Cost">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zPDF3VqB2a11" style="width: 9%; text-align: right" title="Accumulated depreciation">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zcM9L3E1goE8" style="width: 9%; text-align: right" title="Net">807</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Buildings and other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zIruABl0K3Vd" style="border-bottom: Black 1pt solid; text-align: right">41</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zK2z9QutyQH9" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">11</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zXXhxMlWSw7j" style="border-bottom: Black 1pt solid; text-align: right">30</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zecxZ01MMXsk" style="border-bottom: Black 1pt solid; text-align: right">41</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zxcPsPXvzPvi" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">9</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_ztpKRWIFA8Rf" style="border-bottom: Black 1pt solid; text-align: right">32</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630_zTFX7EcRu9ei" style="border-bottom: Black 2pt solid; text-align: right">848</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630_zyi03axIe7R8" style="border-bottom: Black 2pt solid; text-align: right">11</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630_zSD4lpbEdZd6" style="border-bottom: Black 2pt solid; text-align: right">837</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630_zl74fad9yrjh" style="border-bottom: Black 2pt solid; text-align: right">848</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630_zV0lmdm7Fp4k" style="border-bottom: Black 2pt solid; text-align: right">9</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630_zMxKOpXKn491" style="border-bottom: Black 2pt solid; text-align: right">839</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A5_zu8iSU907OHf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285849872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MINERAL PROPERTIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ExtractiveIndustriesAbstract', window );"><strong>Extractive Industries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MineralIndustriesDisclosuresTextBlock', window );">MINERAL PROPERTIES</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--MineralIndustriesDisclosuresTextBlock_zdHNZcuWRo51" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82C_zwlrceSJtaL">MINERAL
                                         PROPERTIES</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
properties consist of original acquisition costs and purchased mineral rights related to the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the land and mineral rights currently owned by the Company, the property interests of Elk Creek include eight prepaid
mineral exploration option-to-purchase agreements and include a pre-determined buyout for permanent ownership of the mineral and/or
surface rights. Terms of the agreements require no further significant payments, and the Company may negotiate lease extensions
or elect to purchase the mineral and/or surface rights any time. Agreements that allow for the purchase of mineral rights contain
provisions whereby the landowners would retain a 2% net smelter return.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ExtractiveIndustriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ExtractiveIndustriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MineralIndustriesDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for mineral industries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 930<br> -SubTopic 715<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482467/930-715-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 930<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//930/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 932<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//932/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MineralIndustriesDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368423984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zD93zpi8CChd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_820_zJYXNHkCrH5e">ACCOUNTS
                                         PAYABLE AND ACCRUED LIABILITIES</span></span></td></tr></table>

<p id="xdx_89C_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zUzytk9bw3B5" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; visibility: hidden"><span id="xdx_8BE_zOLTfAnTn5S7">Schedule of account payable and accrued liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_498_20240630_z0efgPplLRZ6" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49F_20230630_ztm9nDAsd6ke" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zEzHFlCkCtdj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-left: 5pt">Accounts payable, trade</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,417</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,990</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_zQP2rw5TezS1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Trade payable accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,324</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zSiuC12OJN7h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Income taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zzpM6NFCfkoh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Environmental accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zn7w7eYXPj3g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt">Loan origination fees payable to related party</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_ziNEuC5jSt1d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 5pt">Total accounts payable and accrued liabilities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">1,843</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">3,491</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A3_zlT2aGd9kVua" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285731376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">CONVERTIBLE DEBT</a></td>
<td class="text"><p id="xdx_809_eus-gaap--LongTermDebtTextBlock_z2WMKBOT1zW4" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_823_z9E9m23ZRkd7">CONVERTIBLE
                                         DEBT</span></span></td></tr></table>

<p id="xdx_891_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_znt2ASmxe8F3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"><span id="xdx_8B2_zuddybIb4Vbi">Schedule
of convertible debt</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Current Portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-left: 0.25in">Yorkville convertible debentures:</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleSecurityMember_z4al58ZIKgad" style="width: 10%; text-align: right" title="Convertibled debt, current">571</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zm6prukscnK8" style="width: 10%; text-align: right" title="Convertibled debt, current"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in">April 2024 notes</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zlWSwZHZYha8" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current">7,089</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zA3WMLa7U3Ok" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Total Current Portion</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zqhajbNKEC34" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current">7,660</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zPkuDigqFcJ" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Noncurrent Portion &#8211; Yorkville convertible debenture</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zyU1pL7QKcPe" style="border-bottom: Black 2pt solid; text-align: right" title="Convertible debt, noncurrent"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zH3wR4pfycCb" style="border-bottom: Black 2pt solid; text-align: right" title="Convertible debt, noncurrent">10,561</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AC_zjjKW2eKpPoc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Lind
III Convertible Security</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 16, 2021, the Company issued to Lind Global Asset Management III, LLC (&#8220;Lind&#8221;), an entity managed by The
Lind Partners, the convertible security (the &#8220;Lind III Convertible Security&#8221;) pursuant to the Convertible Security
Funding Agreement, dated February 16, 2021, as amended by Amendment #1 to the Convertible Security Funding Agreement, dated December
2, 2021, between the Company and Lind (as amended, the &#8220;Lind III Agreement&#8221;). The Lind III Convertible Security had
a face value of $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pn3n3_c20210216__20210219_ztalY4bPS2p6" title="Face value">11,700</span> (representing $10,000 in funding plus an implied <span id="xdx_90E_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20210219_z3ADXCANTKxi">8.5</span>% interest rate per annum for the term of the Lind
III Convertible Security). After deducting a $<span id="xdx_902_eus-gaap--OtherCommitment_iI_pn3n3_c20210219_zhnpdhlI2OZk" title="Commitment fee">350</span> commitment fee as set forth in the Lind III Agreement, NioCorp received net
proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromInterestReceived_pn3n3_c20210216__20210219_zLVcmKMSYo6e" title="Net proceeds">9,650</span> from the funding of the Lind III Convertible Security. The Company used a portion of the proceeds from the
funding of the Lind III Convertible Security to purchase a key land parcel associated with the Company&#8217;s Elk Creek Project,
with the remainder spent for general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Lind III Convertible Security had a term of (i) <span id="xdx_905_eus-gaap--LongTermDebtTerm_iI_dxL_c20230630_zTHMjVeU5fs8" title="Long term debt duration::XDX::P24M"><span style="-sec-ix-hidden: xdx2ixbrl0875">24</span></span> months or (ii) 30 calendar days after the date on which the face value of the
Lind III Convertible Security is nil due to such amount having been fully converted and/or fully repaid (including with any applicable
premium) in accordance with the terms of the Lind III Agreement, whichever is earlier.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--DebtConversionDescription_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zdjDo22Y0aqf">Pursuant
to the Lind III Agreement, Lind was entitled to convert the Lind III Convertible Security into Common Shares in monthly installments
over its term at a price per Common Share equal to 85% of the volume-weighted average price Common Shares on the TSX for the five
trading days immediately preceding to the date on which Lind provides notice to the Company of its election to convert. The Lind
III Agreement provided that Common Shares issuable upon conversion, together with the number of Common Shares issued upon exercise
of Warrants, shall not exceed 4,358,800 Common Shares.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 19, 2021, in connection with the funding and issuance of the Lind III Convertible Security, the Company issued <span id="xdx_90A_eus-gaap--CommonUnitIssued_iI_uShares_c20210219_zOJHsBsos0K5" title="Common share purchase warrants">855,800</span>
Common Share purchase warrants, exercisable at a price per Common Share of C$<span id="xdx_907_eus-gaap--AcceleratedShareRepurchasesFinalPricePaidPerShare_uCADPShares_c20230701__20240630_zVye1cz2NWVl" title="Exercisable at a price per share">9.70</span>, expiring February 19, 2025 (the &#8220;Lind
III Warrants&#8221;), to Lind pursuant to the Lind III Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company identified embedded derivatives in the Lind III Convertible Security that were evaluated to be immaterial at both the
closing date and at June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocated the net proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pn3n3_uUSD_c20230701__20240630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_zzJNZYejqTJ1">9,477</span> from the Lind III Convertible Security as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,712
    was allocated to Common Stock, representing the fair value of the Lind III Warrants based on the Black Scholes pricing model
    using a risk-free interest rate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_ziJ3vqAv1Lu3" title="Risk-free interest rate">0.40</span>%, an expected dividend yield of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zqAFBIPanAZ4" title="Expected dividend yield">0</span>%, a volatility of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_ztVBm41AMT41" title="Volatility">51.60</span>%, and an expected life of
    <span id="xdx_907_eus-gaap--IntermediateLifePlantsUsefulLife_iI_dxL_c20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zUAtHjSa5Iw9" title="Expected life::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0889">4.0</span></span> years. </span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_z0opgOtbN14l" title="Convertible debt liabilit">7,938</span> was allocated
to the convertible debt liability. Transaction costs of $<span id="xdx_90C_ecustom--TransactionCost_pn3n3_uUSD_c20230701__20240630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_z1h87Ma9HVfe" title="Transaction costs">173</span>, in addition to a commitment fee of $<span id="xdx_900_eus-gaap--LineOfCreditFacilityCommitmentFeeAmount_pn3n3_c20210217__20210219_z21sULxUbHqd" title="Commitment fee">350</span>, were recognized as a direct
deduction from the debt liability, resulting in a net opening balance of $7,765. This balance was accreted up to the face value
of the Lind III Convertible Security at maturity using the effective interest method and recorded as non-cash interest expense
in the consolidated
statement of operations and comprehensive loss.</span></td></tr>
</table>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"></p>

<p id="xdx_895_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_z1i0WPYFDhT9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zhg0BZ2GTAlh">Changes
in the Lind III Convertible Security are as follows</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ending <br/>
June 30, 2023</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
    balance</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_znePfQEwOtqi" style="width: 10%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,169</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value increase due to debt extinguishment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_ztsEgdWtpGJj" style="text-align: right" title="Fair value increase due to debt extinguishment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversions</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"></td>
    <td id="xdx_98E_eus-gaap--ConversionOfStockAmountIssued1_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zC9ggsIYxk2" style="text-align: right" title="Conversions">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,950</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion
    expense</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zynamc468rZ5" style="text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    at maturity</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"></td>
    <td id="xdx_989_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zutaLWwXJZkh" style="border-bottom: Black 1pt solid; text-align: right" title="Payment at maturity"><span style="font: 10pt Times New Roman, Times, Serif">(</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">515</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June
    30, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zt6CCQWihBv3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0916">-</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p id="xdx_8A2_zlMYM4oQCMol" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 25, 2022, the Company and Lind entered into the Waiver and Consent Agreement, dated September 25, 2022, between the
Company and Lind (the &#8220;Lind Consent&#8221;), which included the following principal terms: (i) the consent of Lind to the
GXII Transaction disclosed in Note 5 and Yorkville Financings disclosed below and in Note 11d, including all actions taken by
NioCorp as set out in the Business Combination Agreement to permit the completion of the 2023 Transactions; (ii) the consent of
Lind to NioCorp&#8217;s expected cross-listing to the Nasdaq and the consolidation of the Common Shares in order to meet the minimum
listing requirements thereof; (iii) the waiver of Lind of its participation right for up to 15% of the total offering in the Yorkville
Equity Facility Financing; and (iv) the waiver of Lind of certain restrictive covenants in the Lind III Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As consideration for entering into the
Lind Consent, Lind received, amongst other things: (i) the right to receive a payment of $500, which would have been reduced to
$200 if the 2023 Transactions had not been consummated on or before April 30, 2023 (collectively, the &#8220;Consent Payment&#8221;);
(ii) an extension of its existing participation rights under the Lind III Agreement in future financings of NioCorp for a further
two-year period, subject to certain exceptions as well as an extension of such participation rights beyond the additional two-year
period if Yorkville or any affiliate is a party to any such applicable transaction; and (iii) the right to receive additional Warrants
(the &#8220;Contingent Consent Warrants&#8221;) if on the date that is 18 months following the Closing Date, the closing trading
price of the Common Shares on the TSX or such other stock exchange on which such shares may then be listed, is less than C$10.00
(on a post-Reverse Stock Split basis), subject to adjustments. The number of Contingent Consent Warrants to be issued, if any,
is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate as reported by Bloomberg,
LP) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date of issuance, unless otherwise
agreed. Further, the number of Contingent Consent Warrants issued will be proportionately adjusted based on the percentage of Warrants
currently held by Lind that are exercised, if any, prior to the issuance of any Contingent Consent Warrants. The Lind Consent was
signed as an amendment to the existing Lind III Agreement.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
determined that the Lind Consent should be evaluated using ASC 470, which requires an evaluation of the contract amendment under
debt modification guidance. The Company performed a comparison of the discounted cash flows of the Lind III Convertible Security
pursuant to the existing Lind III Agreement and pursuant to the Lind III Agreement as amended by the Lind Consent and determined
that a debt extinguishment loss of $201 had occurred. Further, ASC 470 requires that the minimum estimated Consent Payment of
$200 also be included in the calculation of the initial loss on debt extinguishment. The Company also evaluated the Contingent
Consent Warrant feature included in the Lind Consent and determined that the Contingent Consent Warrants meet the criteria to
be considered separate, freestanding instruments, should be accounted for as a liability under ASC 480, and should be booked at
fair value on the date of the Lind Consent, with subsequent changes in valuation recorded as a non-operating gain or loss in the
consolidated statement of operations and comprehensive loss. <span>The following table summarizes the components of the initial loss
and final loss on extinguishment:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p id="xdx_897_eus-gaap--ScheduleOfExtinguishmentOfDebtTextBlock_z5sVttqay9U8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">&#160;<span id="xdx_8BC_zCpNCSkq0uk1">The following table summarizes the components of the initial loss and final loss on extinguishment:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Component
    of loss</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20230701__20240630_zuwKBTzqeyhe" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--MinimumConsentPaymentAtInception_pn3n3_z0lvL9KTt57k" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 77%; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum
    Consent Payment at inception</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--ASC470LossOnExtinguishment_pn3n3_zUh8DOXqOWIk" style="vertical-align: bottom">
    <td style="text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on debt extinguishment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--AdjustmentOfWarrantsGrantedForServices_pn3n3_zVOTyhwsJj76" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; width: 77%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    fair value of Contingent Consent Warrants</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,221</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_pn3n3_zAI1LwFFQNHl" style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    loss on debt extinguishment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,622</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--AdditionalConsentPaymentbooked_pn3n3_zJow2YPMqar3" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    Consent Payment booked<sup id="xdx_F4F_zp1q7smy2gme">(1)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--GainsLossesOnRestructuringOfDebt_pn3n3_zJTCgIi1gapg" style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    loss on debt extinguishment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,922</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify"><span id="xdx_F02_zkh2PLuTpzb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F10_zhOm4ESnSM54" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.</span></td></tr>
</table>


<p id="xdx_8AA_zLWtklORCwk4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>



















<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<p id="xdx_89C_ecustom--ScheduleOfWarrantValuationTableTextblock_zhE2hs07LbYc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zUGu0r4iMI85">The
change in the fair value of the Contingent Consent Warrants is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 37%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    valuation, September 25, 2022</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iS_c20220701__20230630_zQIK8izaqrz6" style="width: 10%; text-align: right" title="Initial valuation, at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,221</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_ecustom--ChangeInValuationOfWarrants_c20220701__20230630_zEMPS1TodF55" style="border-bottom: black 1pt solid; text-align: right" title="Change in valuation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    at June 30, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iE_c20220701__20230630_zPAsfAyTEG52" style="text-align: right" title="Valuation, at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,710</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ChangeInValuationOfWarrants_c20230701__20240630_zf3RqufC5qwc" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    at June 30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iE_c20230701__20240630_zUJWpt80Idq6" style="border-bottom: black 1.5pt solid; text-align: right" title="Valuation, at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,365</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p id="xdx_8AC_ziatf9pxJRjb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contingent Consent Warrants are classified as a Level 3 financial instrument and were valued utilizing a Monte Carlo simulation
pricing model, which calculates multiple potential outcomes for future share prices based on historic volatility of the Common
Shares to determine the probability of issuance at 18 months following the applicable valuation date and to determine the value
of the Contingent Consent Warrants. The following table discloses the primary inputs into the Monte Carlo model at each valuation
date, and the probability of issuance calculated by the model.</span></p>

<p id="xdx_892_ecustom--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_zSUmcTMTX2Ac" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; visibility: hidden"><span id="xdx_8BA_zBUzmwMhlFg3">Schedule of valuation date and the probability calculated</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto">
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
    Valuation Input</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></p></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></p></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&#160;25,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="background-color: #CCECFF">
    <td style="vertical-align: bottom; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    price on valuation date</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zmA2MRDKFa6b" style="vertical-align: bottom; width: 10%; text-align: right" title="Share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.73</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zxaoQRZH10k3" style="vertical-align: bottom; width: 10%; text-align: right" title="Share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zfbGiT624Uak" style="vertical-align: bottom; width: 10%; text-align: right" title="Share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.82</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_z8DzHiw5SFZ5" style="vertical-align: bottom; text-align: right" title="Volatility"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.0</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zmTiN5M68p39" style="vertical-align: bottom; text-align: right" title="Volatility"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.0</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zfGp98M0egGa" style="vertical-align: bottom; text-align: right" title="Volatility"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62.4</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="background-color: #CCECFF">
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    free rate</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zD3RKNi7vBcd" style="vertical-align: bottom; text-align: right" title="Risk free rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.40</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zxLbhvVnRKpf" style="vertical-align: bottom; text-align: right" title="Risk free rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_z7RRe4dMVIHe" style="vertical-align: bottom; text-align: right" title="Risk free rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.93</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Probability
    of issuance</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_z5dUA5BPSK76" style="vertical-align: bottom; text-align: right" title="Probability of issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.0</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zxbvx5XAiIQj" style="vertical-align: bottom; text-align: right" title="Probability of issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.8</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zd04jufot4vl" style="vertical-align: bottom; text-align: right" title="Probability of issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59.4</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>
<p id="xdx_8A2_zFc2oTm3AVrl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
on debt extinguishment is presented as a non-operating expense in the Company&#8217;s consolidated statements of operations and
comprehensive loss. This accounting also resulted in a decrease in the amount of accretion to be recognized over the remaining
life of the Lind III Convertible Security through February 2023. Accretion expenses are disclosed as a part of interest expense,
which is not included as a component of operating costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Yorkville
Convertible Debentures</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the GXII Transaction, on January 26, 2023, NioCorp entered into definitive agreements with respect to the Yorkville
Financings, including a Securities Purchase Agreement, dated January 26, 2023 (as amended the &#8220;Yorkville Convertible Debt
Financing Agreement&#8221;), between the Company and Yorkville, and a Standby Equity Purchase Agreement, dated January 26, 2023
(the &#8220;Yorkville Equity Facility Financing Agreement&#8221;), between the Company and Yorkville.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Yorkville Convertible Debt Financing Agreement, at the Closing, Yorkville advanced a total amount of $15,360 to NioCorp
in consideration of the issuance by NioCorp to Yorkville of (i) $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240630__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zH70YXD2Nwpc" title="Aggregate principal amount">16,000</span> aggregate principal amount of unsecured convertible debentures
(the &#8220;Convertible Debentures&#8221;) and (ii) Common Share purchase warrants, exercisable for up to <span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zjQF16gscUL" title="Number of shares purchase">1,789,267</span> Common Shares
for cash or, if at any time there is no effective registration statement registering, or no current prospectus available for,
the resale of the underlying Common Shares, on a cashless basis, at the option of the holder, at a price per Common Share of approximately
$<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zIDjSTqPvsA8" title="Number of shares purchase">8.9422</span>, subject to adjustment to give effect to any stock dividend, stock split, reverse stock split or similar transaction (the
&#8220;Financing Warrants&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Convertible Debenture issued under the Yorkville Convertible Debt Financing Agreement is an unsecured obligation of NioCorp, has
an <span id="xdx_906_eus-gaap--LongTermDebtMaturitiesRepaymentTerms_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zT6JJlmFCzy6" title="Debt term">18-month</span> term from the Closing Date, which may be extended for one six-month period in certain circumstances at the option
of NioCorp, and incurs a simple interest rate obligation of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MinimumMember_zoF428AtYo9a" title="Interest rate obligation">5.0</span>% per annum (which will increase to <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MaximumMember_zbHcDWkUUXu7" title="Interest rate obligation">15.0</span>% per annum upon the occurrence
of an event of default). The outstanding principal amount of, accrued and unpaid interest, if any, on, and premium, if any, on
the Convertible Debentures must be paid by NioCorp in cash when the same becomes due and payable under the terms of the Convertible
Debentures at their stated maturity, upon their redemption or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations contained within the Yorkville Convertible Debt Financing Agreement and the Convertible Debentures, including
those as described below, holders of the Convertible Debentures will be entitled to convert the principal amount of, and accrued
and unpaid interest, if any, on each Convertible Debenture, in whole or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">in part, from time to time over their term, into a number
of Common Shares equal to the quotient of the principal amount and accrued and unpaid interest, if any, being converted divided
by the Conversion Price. The &#8220;Conversion Price&#8221; means, as of any Conversion Date (as defined below) or other date
of determination, the greater of (i) 90% of the average of the daily U.S. dollar volume-weighted average price of the Common Shares
on the principal U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading
days immediately preceding the date on which the holder exercises its conversion right in accordance with the requirements of
the Yorkville Convertible Debt Financing Agreement (the &#8220;Conversion Date&#8221;) or other date of determination, but not
lower than the Floor Price (as defined below), and (ii) the five-day volume-weighted average price of the Common Shares on the
TSX (or on the principal U.S. market if the majority of the trading volume and value of the Common Shares occurred on Nasdaq during
the relevant period) for the five consecutive trading days immediately prior to the Conversion Date or other date of determination
less the maximum applicable discount allowed by TSX. The &#8220;Floor Price&#8221; means a price of $2.1435 per share, which is
equal to the lesser of (a) 30% of the average of the daily volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
preceding the Debenture Closing and (b) 30% of the average of the volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
following the Debenture Closing, subject to certain adjustments to give effect to any stock dividend, stock split, reverse stock
split, recapitalization or similar event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Convertible Debentures restrict the number of Convertible Debentures that may be converted during each calendar month
by Yorkville at a Conversion Price below a fixed price equal to approximately $8.9422 (i.e., the quotient of $10.00 divided by
1.11829212 (being the number of Common Shares that were exchanged for each share of GXII at the Closing, after giving effect to
the Reverse Stock Split)), subject to adjustment to give effect to any stock dividend, stock split, reverse stock split, recapitalization
or similar event. The Convertible Debentures are subject to customary anti-dilution adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Convertible Debentures restrict the conversion of Convertible Debentures by Yorkville if such a conversion would
cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or such a conversion would cause the aggregate number
of Common Shares issued pursuant to the Yorkville Convertible Debt Financing Agreement to exceed the thresholds for issuance of
Common Shares under the rules of Nasdaq, unless prior shareholder approval is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Convertible Debentures, following certain trigger events, and until a subsequent cure event, NioCorp will
be required to redeem $1,125 aggregate principal amount of Convertible Debentures (the &#8220;Triggered Principal Amount&#8221;)
each month by making cash payments to the Investors, on a pro rata basis, in an amount equal to the Triggered Principal Amount,
plus accrued and unpaid interest thereon, if any, plus a redemption premium of 7% of the Triggered Principal Amount. Such monthly
prepayments under the terms of the Convertible Debentures are triggered (i) at the time when NioCorp has issued 95% of the total
amount of Common Shares pursuant to the Yorkville Convertible Debt Financing that it may issue under applicable Nasdaq rules or
(ii) when NioCorp has delayed or suspended the effectiveness or use of the Convertible Debt Financing Registration Statement for
more than 20 consecutive calendar days, and such monthly prepayment obligations will continue until, with respect to (i) above,
shareholder approval is obtained or, with respect to (ii) above, the Investors may once again resell Common Shares under the Convertible
Debt Financing Registration Statement, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Debentures may also be redeemed at NioCorp&#8217;s option at any time and from time to time over their term at a redemption
price equal to <span id="xdx_901_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zDNf4iIPaZB2" title="Principal percentage">110</span>% of the principal amount being redeemed, plus accrued and unpaid interest, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with the issuance of the Convertible Debentures, NioCorp issued to Yorkville <span id="xdx_90D_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zdABP6yjf5e5" title="Issuance of the convertible debentures">1,789,267</span>
Financing Warrants at an exercise price of approximately $<span id="xdx_902_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise1_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zPQ4aqM8ohn3" title="Issuance of the convertible debentures">8.9422</span>
per Common Share (the &#8220;Financing Warrant Exercise Price&#8221;), subject to adjustment to
give effect to any stock dividend, stock split, reverse stock split recapitalization or similar event. The Financing Warrants
are exercisable, in whole or in part, but not in increments of less than $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__srt--RangeAxis__srt--MaximumMember_zxMkrK1VDK33" title="Aggregate exercise price, per shares">50</span> aggregate Financing Warrant Exercise Price (unless
the remaining aggregate Financing Warrant Exercise Price is less than $50), beginning on May 4, 2023, and may be exercised at
any time prior to their expiration. Holders of the Financing Warrants may exercise their Financing Warrants, at their election,
by paying the Financing Warrant Exercise Price in</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">cash or, if at any time there is no effective registration statement registering,
or no current prospectus available for, the resale of the underlying Common Shares, on a cashless exercise basis. 1/12th of the
Financing Warrants will expire on each of the first 12 monthly anniversaries of the date that is six months following the Closing
Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>











<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Financing Warrants have customary anti-dilution adjustments. The terms of the Financing Warrants restrict the exercise of Financing
Warrants by Yorkville if such an exercise would cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or
such an exercise would cause the aggregate number of Common Shares issued pursuant to the Yorkville Convertible Debt Financing
Agreement to exceed the thresholds for issuance of Common Shares under the rules of the Nasdaq, unless prior shareholder approval
is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Financing Warrants were originally recorded as a $<span id="xdx_903_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_pn3n3_c20230126__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIelF8H5emV1" title="Contingent liability">2,704</span> contingent liability on January 26, 2023, and were subsequently marked
to market of $<span id="xdx_90E_eus-gaap--ServicingLiability_iI_pn3n3_c20230316__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxjptlUhgbc" title="Contingent liability">3,337</span> through March 16, 2023. The change in fair value during this period resulted in a loss of $<span id="xdx_90E_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_dxL_c20220701__20230630_zKbOOHaCibTl" title="Fair value of warrant liability::XDX::3338"><span style="-sec-ix-hidden: xdx2ixbrl1016">633</span></span>, which was
booked to change in fair value of warrant liability in the consolidated statement of operations and comprehensive loss. The Financing
Warrants were reclassified to shareholders equity on March 17, 2023, in connection with the closing of the Convertible Debentures
as noted below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocated the net proceeds of $15,360 from the Convertible Debentures as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zwBEgamIuQT" title="Fair value">2,704</span>
    was booked to Common Shares, representing the initial fair value of the Financing Warrant tranches on January 26, 2023 based
    on the Black Scholes pricing model using a risk-free interest rate <span style="color: #353535">of <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_z4VF79aiO6Sd" title="Fair value">4.33</span>%, an expected dividend
    yield of <span id="xdx_90C_ecustom--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_pid_dp_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z8lyEiMtiEPk" title="Fair value">0</span>%, a volatility of <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zbSZWcFbtsgd" title="Fair value">64.6</span>%, and an expected life of <span id="xdx_901_ecustom--DebtMaturityPeriod_dxL_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MinimumMember_zIztXPQML6kk" title="Expected life::XDX::P6M"><span style="-sec-ix-hidden: xdx2ixbrl1026">6</span></span> months to <span id="xdx_90F_ecustom--DebtMaturityPeriod_dxL_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MaximumMember_zVvscG6PK5a" title="Expected life::XDX::P18M"><span style="-sec-ix-hidden: xdx2ixbrl1028">18</span></span> months</span>. </span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90E_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zTPSIZJhPmje" title="Convertible debt liability">12,656</span>
    was booked to the convertible debt liability. In addition, transaction costs of $<span id="xdx_907_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zGZCHj3EqGz2" title="Transaction costs">503</span> were recognized as a direct deduction
    from the debt liability, resulting in a net opening balance of $12,153 at an effective interest rate of 29.9%. This balance
    will be accreted to face value of the Convertible Debentures at maturity plus the conversion premium, using the effective
    interest method and recorded as interest expense in the consolidated statement of operations and comprehensive loss.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p id="xdx_89A_eus-gaap--ConvertibleDebtTableTextBlock_zCZIt9LXAG1b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_ziH8btiidYhl">Changes
in the Convertible Debentures are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 2%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opening balance,
    March 17, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230315__20230630_zmxNCG0LTaxa" style="text-align: right" title="Opening balance, March 17, 2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,153</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion expense</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230315__20230630_z7wTzvPSLpPe" style="text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,962</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal and accrued
    interest converted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: left"></td>
    <td id="xdx_98B_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230315__20230630_zCfSSCzz9So1" style="border-bottom: black 1pt solid; text-align: right" title="Principal and accrued interest converted"><span style="font: 10pt Times New Roman, Times, Serif">(</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,554</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30,
    2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230701__20240630_zPQTp9SJcDme" style="text-align: right" title="Balance, June 30, 2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,561</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion expense</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230701__20240630_zDYYc4CSjGa3" style="text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,489</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal and accrued
    interest converted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_987_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230701__20240630_zICELzkeyOA" style="border-bottom: black 1pt solid; text-align: right" title="Principal and accrued interest converted"><span style="font: 10pt Times New Roman, Times, Serif">(</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,479</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30,
    2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--ConvertibleDebt_iE_pn3n3_c20230701__20240630_zPFMd0apsUA3" style="text-align: right" title="Balance, June 30, 2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">571</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Less: Unamortized
    debt issuance costs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_98E_eus-gaap--PaymentsOfFinancingCosts_pn3n3_dxL_c20230701__20240630_z329JUk6wQ66" style="border-bottom: black 1pt solid; text-align: right" title="Add: uamortized debt issuance costs::XDX::0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1050">(</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining principal
    balance, June 30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iE_pn3n3_c20230701__20240630_z89uW0w9kQQl" style="border-bottom: black 1.5pt solid; text-align: right" title="Balance, June 30, 2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">550</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p id="xdx_8AA_zY2YhXXZfl11" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p id="xdx_898_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_zWJVatfuywXk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
conversion, the portion of remaining unamortized issuance costs associated with the conversion are recognized as a component of
interest expense. <span id="xdx_8BF_zvWjZ9Y2PN97">The following table discloses the components of interest expense associated with the Convertible Debentures.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ending June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Component of Interest Expense</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: justify">Contractual &#160;interest</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--ContractualInterest_c20230701__20240630_zNFOoCJrv9K" style="width: 14%; text-align: right" title="Contractual interest">279</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--ContractualInterest_c20220701__20230630_zvrniZHfvDw8" style="width: 14%; text-align: right" title="Contractual interest">225</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Amortization of discount and issuance costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AmortizationOfFinancingCosts_c20230701__20240630_zq65XXL4La31" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs">4,210</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AmortizationOfFinancingCosts_c20220701__20230630_zE9KM6YtcXGb" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs">1,737</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--InterestAndDebtExpense_c20230701__20240630_zad4crZ0IL64" style="border-bottom: Black 2pt solid; text-align: right" title="Total">4,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--InterestAndDebtExpense_c20220701__20230630_zfgz1HD72KHf" style="border-bottom: Black 2pt solid; text-align: right" title="Total">1,962</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AD_z9LaIIKzUr3a" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>









<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Debentures contain events of default customary for instruments of their type (with customary grace periods, as applicable)
and provide that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to NioCorp, all outstanding Convertible Debentures will become due and payable immediately without further action or notice. If
any other type of event of default occurs and is continuing, then any holder may declare all of its Convertible Debentures to
be due and payable immediately. The Company</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">obtained a waiver from Yorkville with respect to any acceleration rights it may have
under the Convertible Debentures in connection with the restatements of the Company&#8217;s consolidated financial statements for the
periods ended September 30, 2022 and December 31, 2022 and the delay in filing the Company&#8217;s Quarterly Report on Form 10-Q for
the quarterly period ended March 31, 2023. The Yorkville Convertible Debt Financing Agreement also contains certain covenants
that, among other things, limit NioCorp&#8217;s ability to use the proceeds from the Yorkville Convertible Debt Financing to repay
related party debt or to enter into any variable rate transaction other than with Yorkville, subject to certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the Company&#8217;s closing Common Share price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z5kz1rz5fw47">1.73</span> as of June 30, 2024, conversion of the remaining Convertible Debenture
principal balance of $552, including accrued interest, would require the issuance of approximately 257,000 Common Shares.
For each $0.10 change in the fair value of one Common Share, the total shares the Company would be obligated to issue would change
by approximately <span id="xdx_90E_eus-gaap--OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_iI_c20240630_ziyBVOVqCHaa">11,500</span> shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2024, the Company and Yorkville entered into a make-whole payment agreement under which Yorkville agreed to convert the
remaining principal and outstanding accrued interest of $554 remaining under the Convertible Debenture into Common Shares in exchange
for a $95 make-whole payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">April
2024 Notes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2024, the Company issued and sold to Yorkville and Lind Global Fund II LP (together with Yorkville, the &#8220;April
2024 Purchasers&#8221;), $8,000 aggregate principal amount of unsecured notes (the &#8220;April 2024 Notes&#8221;), pursuant to
a securities purchase agreement, dated April 11, 2024 (the &#8220;April 2024 Purchase Agreement&#8221;), between the Company and
each of the April 2024 Purchasers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also issued to the April 2024 Purchasers, in proportion to the aggregate principal amount of April 2024 Notes issued to
each April 2024 Purchaser, Warrants (the &#8220;April 2024 Warrants&#8221;) to purchase up to 615,385 Common Shares (the &#8220;April
2024 Warrants Shares&#8221;), which are equal to 25% of the aggregate principal amount of April 2024 Notes issued to the April
2024 Purchasers divided by the exercise price of $3.25, subject to any adjustment to give effect to any stock dividend, stock
split or recapitalization. The April 2024 Warrants expire on April 12, 2027.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the April 2024 Purchase Agreement, the April 2024 Purchasers advanced an aggregate of $6,935 to the Company in consideration
of the issuance by the Company to the April 2024 Purchasers of $8,000 aggregate principal amount of the April 2024 Notes and April
2024 Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the April 2024 Notes, subject to certain exceptions, on the first day of each calendar month, beginning on June 1,
2024 (excluding August 2024) (the &#8220;Payment Date&#8221;), the Company will be required to repay a portion of the outstanding
balance of all of the April 2024 Notes, on a pro-rata basis, in an amount equal to the sum of (i) $1,400 of principal (or the
outstanding principal if less than such amount) in the aggregate among all of the outstanding Notes, plus (ii) 8.0% of the principal
amount being paid (the &#8220;Payment Premium&#8221;), and (iii) accrued and unpaid interest, if any, as of the Payment Date.
The Company is required to make payments on each Payment Date until the entire outstanding principal is repaid but will not have
an obligation to make a payment on a Payment Date if certain equity conditions (the &#8220;Equity Conditions&#8221;) are satisfied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations contained within the April 2024 Notes, holders of the April 2024 Notes will be entitled to convert the
principal amount of, accrued and unpaid interest, if any, and any Payment Premium that has become due and payable on each April
2024 Note, from time to time over their term, into a number of Common Shares equal to the quotient of the amount being converted
divided by a fixed conversion price of $2.75 per Common Share up to a maximum of 3,141,817 Common Shares (together with the April
2024 Warrant Shares, the &#8220;April 2024 Underlying Shares&#8221;). The terms of the April 2024 Notes restrict the conversion
of the April 2024 Notes by a holder if such a conversion would cause such holder to exceed certain ownership thresholds in the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
noted above, the Company is required to make payments on each Payment Date until the entire outstanding principal is repaid,
but will not have an obligation to make a payment on a Payment Date if the Equity Conditions are satisfied (a &#8220;deferred
payment&#8221;). The Equity Conditions means (i) on each of the five consecutive trading days prior a Payment Date (the
&#8220;Measuring Period&#8221;) the Underlying Shares Registration Statement (as defined below) is effective</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">and available
for the resale by the Purchasers of all Underlying Shares, (ii) the Company has no knowledge of any fact that would cause the
Underlying Shares Registration Statement not to be effective and available for the resale of the Underlying Shares, (iii) on
each day during the Measuring Period, the Common Shares are designated for quotation on Nasdaq, or on such other market or
exchange on which the Common Shares are then listed or traded to the extent such other market or exchange is the principal
U.S. trading market for the Common Shares (the &#8220;Principal U.S. Market&#8221;), and have not been suspended from trading
nor have delisting or suspension of trading been threatened or pending, (iv) during the Measuring Period, an event of default
has not occurred, (v) on each trading day during the Measuring Period, the daily U.S. dollar volume-weighted average price
(&#8220;VWAP&#8221;) for a Common Share on the Principal U.S. Market as reported by Bloomberg Financial Markets is greater
than 120% of the Conversion Price, (vi) on each trading day during the Measuring Period the average daily volume traded
exceeded $500, and (vii) there is no limitation on conversion under the terms of Notes. Deferred payments, if any, that are
not subsequently converted into Common Shares by the holders of the April 2024 Notes will require repayment by
the Company upon maturity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes are the unsecured obligations of the Company and will mature on December 31, 2024. The April 2024 Notes will
incur a simple interest rate obligation of 0.0% per annum (which will increase to 18.0% per annum upon the occurrence of an event
of default). The outstanding principal amount, accrued and unpaid interest, if any, and the Payment Premium, if any, on the April
2024 Notes must be paid by NioCorp in cash when the same becomes due and payable under the terms of the April 2024 Notes at their
stated maturity, upon their redemption, or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes may also be redeemed at the Company&#8217;s option at any time and from time to time over their term at a redemption
price equal to the principal amount being redeemed, plus the Payment Premium, plus accrued and unpaid interest, if any, as of
the redemption date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes contain events of default customary for instruments of their type (with customer grace periods, as applicable)
and provide that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to the company, all outstanding April 2024 Notes will become due and payable immediately without further action or notice. If
any other type of event of default occurs and is continuing, then any holder may declare all of its April 2024 Notes to be due
and payable immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Purchase Agreement contains customary representations, warranties, conditions and indemnification obligations by each
party. The representations, warranties and covenants contained in the April 2024 Purchase Agreement were made only for purposes
of the April 2024 Purchase Agreement and as of specific dates, were solely for the benefit of the parties to such agreement and
are subject to certain important limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Purchase Agreement also contains certain covenants that, among other things, limit NioCorp&#8217;s ability to use the
proceeds from the April 2024 Purchase Agreement to repay related party debt or to enter into any variable rate transaction other
than with Yorkville, subject to certain exceptions, and to distribute proceeds from the April 2024 Purchase Agreement to subsidiaries
other than ECRC and 0896800 B.C. Ltd. (together with ECRC, the &#8220;Guarantors&#8221;), upon the entry by the Guarantors into
a global guaranty agreement, dated as of April 11, 2024, among the Guarantors in favor of the Purchasers (the &#8220;Guaranty Agreement&#8221;).
Pursuant to the Guaranty Agreement, the Guarantors guaranteed the full, prompt and unconditional payment when due (whether at
maturity , by acceleration or otherwise), and the performance of all liabilities, agreements and other obligations of NioCorp
to the April 2024 Purchasers contained in the April 2024 Notes, the April 2024 Warrants and the April 2024 Purchase Agreement,
to the extent such liabilities, agreements and obligations are payable in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the Company&#8217;s analysis of the criteria contained in ASC 815, the Company determined that April 2024 Warrants met the
definition of a&#160;derivative liability, as any warrant exercise that could cause the holder to exceed 19.9% ownership of NioCorp
Common Shares would require shareholder approval. As such, the April 2024 Warrants were recognized as warrant liabilities on the
consolidated balance sheet and were measured at their inception date fair value and subsequently remeasured at each reporting
period with changes being recorded as a non-operating gain or loss in the consolidated statement of operations and comprehensive
loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company elected to value the April 2024 Notes at fair value in accordance with ASC 815-15-25. The fair value of the April 2024
Notes was estimated using a Monte Carlo simulation pricing model and the April 2024 Notes were</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">classified as Level 3 instruments.
The Company incurred transaction costs totaling $<span id="xdx_90E_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zarXN1Tl7me" title="Transaction loss">474</span> in connection with the issuance of the April 2024 Notes and due to the fair
value election noted above, these costs were expensed at closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Components
and initial valuations associated with the April 2024 Notes were comprised of the following amounts:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_902_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240401__20240430_zo5PWB31vEwk" title="Warrant liabilities">902</span>
    was recorded to warrant liabilities, representing the initial fair value of the April 2024 Warrants based on the assumptions
    outlined below.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_903_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_pn3n3_c20240401__20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zZNfCdGpUTM7" title="Fair value">10,315</span> was recorded
    to the April 2024 Notes, representing the fair value based on the assumptions outlined below. The Company also recognized
    an opening transaction loss of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pn3n3_c20240401__20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zqEHBE2MnU2d" title="Transaction loss">4,256</span>, representing the difference between the fair value of the April 2024 Notes, including
    the fair value of the variable conversion features embedded therein, and cash received in the transaction.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p id="xdx_89A_eus-gaap--ScheduleOfInterestRateDerivativesTableTextBlock_zHNvXdAmOAT3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zfUrMHRhCZu5">The
following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left">Key Valuation Input</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">June 30,&#160; <br/>2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">April 12,&#160; <br/>2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98C_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhqSFnTS9d7e" style="width: 21%; text-align: center" title="Closing common share price">$1.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98F_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zmBICTXydg34" style="width: 21%; text-align: center" title="Closing common share price">$3.11</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zaJ72QA4j4Ce" title="Term (expiry)">December 31, 2024</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zADAFpNQqTH9" title="Term (expiry)">December 31, 2024</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted average of the equity volatility and implied volatility of the public warrants</td><td>&#160;</td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zBICEfh0rBGg" style="text-align: center" title="Weighted average of the equity volatility and implied volatility of the public warrants">80%</td><td style="text-align: left"></td><td>&#160;</td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIUl1VeCkHje" style="text-align: center" title="Weighted average of the equity volatility and implied volatility of the public warrants">66.0%</td><td style="text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zdy5tTkY5Qdb" style="text-align: center" title="Risk-free rate">5.33%</td><td style="text-align: left"></td><td>&#160;</td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zqR3GtXVGbL4" style="text-align: center" title="Risk-free rate">5.26%</td><td style="text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Implied discount rate</td><td>&#160;</td>
    <td id="xdx_982_ecustom--ImpliedDiscountRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zyuehdXX7kk3" style="text-align: center" title="Implied discount rate">15.0%</td><td style="text-align: left"></td><td>&#160;</td>
    <td id="xdx_984_ecustom--ImpliedDiscountRate_pid_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z4V10XbqMFRl" style="text-align: center" title="Implied discount rate">15.0%</td><td style="text-align: left"></td></tr>
</table>

<p id="xdx_8AB_z6XJa1PWXF9e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p id="xdx_890_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_zJ9Smiw7Z0uf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zpAR7ydiCVOb">The
following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 47%; text-align: justify">Fair value, April 12, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20230701__20240630_z2jv5DxV4aAj" style="width: 10%; text-align: right" title="Fair value, April 12, 2024">10,315</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Principal payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20230701__20240630_zJI5vBB9C5pf" style="text-align: right" title="Principal payments">(1,512</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Change in fair value</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--ChangeInFairValue_iN_di_c20230701__20240630_zx4TGDsCPam" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">(1,714</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2pt">Balance, June 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_c20230701__20240630_zHeWpD3PZia7" style="border-bottom: Black 2pt solid; text-align: right" title="Balance, June 30, 2024">7,089</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Remaining principal balance, June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_c20230701__20240630_zjHqglcvRBN3" style="text-align: right" title="Remaining principal balance, June 30, 2024">7,128</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A1_zmFHIGoaU1j8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify">&#160;</p>

<p id="xdx_89F_ecustom--ShareholdersEquityAndShareBasedWarrantsTextBlock_zh3qMPNxLzI3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zQEb40a2NLt7">The
following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,&#160; <br/>2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">April 12,&#160; <br/>2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zPmCPTpX0pW3" style="width: 15%; text-align: right" title="Closing Common Share price">1.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z20QFBugWrD5" style="width: 15%; text-align: right" title="Closing Common Share price">3.24</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFsziBESTP1e" style="text-align: right" title="Term (years)">2.78</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQd3COrPHMv7" style="text-align: right" title="Term (years)">3.0</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFipjWoRMIF9" style="text-align: right" title="Expected volatility">66.34</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwkJ8FX3AS7l" style="text-align: right" title="Expected volatility">62.39</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zURmgUpQIT27" style="text-align: right" title="Risk-free rate">4.57</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZymoChGO0h6" style="text-align: right" title="Risk-free rate">4.77</td><td style="text-align: left">%</td></tr>
</table>

<p id="xdx_8A6_zSvcJIS5Y6s5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p id="xdx_89C_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_z5JKzlucfzUh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zrCdDv1tM1Nh">The
following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June
30, 2024.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 47%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of April 12, 2024</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z0iuzQNGBL5" style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">902</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_988_eus-gaap--FairValueAdjustmentOfWarrants_iN_pn3n3_di_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z3qby1HDA9Jj" style="border-bottom: black 1pt solid; text-align: right">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">604</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of June 30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zRvILZ43JrPb" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">298</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p id="xdx_8AD_zdO0PJW0XbP6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284274368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract', window );"><strong>Class B Common Stock Of Ecrc</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock', window );">CLASS B COMMON STOCK OF ECRC</a></td>
<td class="text"><p id="xdx_800_ecustom--ScheduleOfClassBCommonStockOfECRCTableTextBlock_zzNEzJKKYE82" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>









<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</span></td><td id="xdx_825_z2mAKcvliIuj" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLASS
                                         B COMMON STOCK OF ECRC</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the Sponsor Support Agreement, and the Exchange Agreement, after the Closing, the GXII
founders have the right to exchange shares of Class B common stock of ECRC for Common Shares on a one-for-one basis, subject to
certain equitable adjustments, under certain conditions. All <span style="color: #353535"><span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zTqmkU1m8Oz1" title="Common stock, shares, issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zyGs29QzoyI2" title="Common stock, shares, outstanding">7,957,404</span></span> shares of Class B common stock
of ECRC that were issued in connection with the Closing were issued and outstanding as of</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="color: #353535">June 30, 2023. </span>Of the issued
and outstanding shares of Class B common stock of ECRC, <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zeziB1rUy7t4" title="Earnout shares">4,565,808</span> shares (the &#8220;Vested Shares&#8221;)&#8201;were vested
as of the Closing Date and are exchangeable at any time, and from time to time, until the tenth anniversary of the Closing Date
(the &#8220;Ten-Year Anniversary&#8221;) and <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTH8QWiKpXu7" title="Earnout shares">3,391,596</span> shares (the &#8220;Earnout Shares&#8221;) are exchangeable until the Ten-Year
Anniversary, subject to certain vesting conditions. Under certain circumstances, and subject to certain exceptions, NioCorp may
instead settle all or a portion of any exchange pursuant to the terms of the Exchange Agreement in cash, in lieu of Common Shares,
based on a volume-weighted average price of Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2024 and May 16, 2024, 243,692 Vested Shares and 40,000 Vested Shares, respectively, were exchanged for an equivalent
number of Common Shares. This exchange resulted in a change in the Company&#8217;s ownership interest in ECRC and was accounted
for as an equity transaction in accordance with ASC 810-10-45-23, with no gain or loss recognized. Accordingly, the carrying amount
of the noncontrolling interest was adjusted to reflect the change in the Company&#8217;s ownership interest with a corresponding
offset booked to equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the shares of Class B common stock of ECRC are subject to the Amended and Restated Registration Rights Agreement, dated as
of March 17, 2023 (the &#8220;Registration Rights and Lock-up Agreement&#8221;), among NioCorp, GXII, the Sponsor, the pre-Closing
directors and officers of NioCorp and the other parties thereto, including the members of the Sponsor. Pursuant to Registration
Rights and Lock-up Agreement, all shares of Class B common Stock of ECRC (including the Vested Shares and the Released Earnout
Shares) are subject to certain &#8220;lock-up&#8221; restrictions on transfer beginning upon the Closing and ending upon the earlier
of (i) one year after the Closing and (ii) the date on which the trading price of Common Shares exceeds certain thresholds or
the date on which NioCorp completes a transaction that results in all of NioCorp&#8217;s shareholders having the right to exchange
their Common Shares for cash, securities or other property. Both Vested Shares and Released Earnout Shares may be exchanged by
the holders into Common Shares at any time. Under the Exchange Agreement, all Vested Shares and Earnout Shares must be exchanged
for Common Shares by the Ten-Year Anniversary except for Released Earnout Shares that have been vested for a period of fewer than
twenty-four months as of the Ten-Year Anniversary. Such Released Earnout Shares will be forfeited if not exchanged for Common
Shares by the date that is twenty-four months after the vesting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Vested
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the exchange of Vested Shares are contingently redeemable at the option of the noncontrolling interest shareholders, the Company
classifies the carrying amount of the redeemable noncontrolling interest in the mezzanine section on the consolidated balance
sheet, which is presented above the equity section and below liabilities. Adjustments to the carrying value of the redeemable noncontrolling interest associated with redemptions are recorded by reclassifying the proportionate amount of mezzanine equity to permanent equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Earnout
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--DescriptionOfEarnOutShares_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_ze2DrMfIJODg" title="Description of earnout shares">The
Earnout Shares vest (the &#8220;Released Earnout Shares&#8221;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement.</span> These shares will be forfeited if the market
share price milestones or an acceleration event is not reached prior to the Ten-Year Anniversary. At such time that the Earnout
Shares shall become vested, and therefore, become Released Earnout Shares, the shares will be transferred to the redeemable noncontrolling
interest in the mezzanine section of the Consolidated Balance Sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Earnout Shares were classified as a liability due to failure to meet the equity classification criteria under ASC 815-40, as Level
3 instruments under the fair value hierarchy and are considered a financial liability under ASC 480, Distinguishing Liabilities
from Equity. The Earnout Shares were measured at fair value on the Closing Date with subsequent changes in fair value recorded
in earnings. The Earnout Shares were valued utilizing a Monte Carlo simulation pricing model. The following table discloses the
primary inputs into the Monte Carlo models.</span></p>





















<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p id="xdx_89C_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zDefajNB1qE" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zmVlM2iqUTHk" style="display: none; visibility: hidden">The following table discloses the primary inputs into the Monte Carlo models.</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left">Key Valuation Input</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>
2023</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">March 17, <br/>
2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: left">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJv4vq5K4bTb" style="width: 13%; text-align: center" title="Closing common share price">$1.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJydUB0JDn5k" style="width: 13%; text-align: center" title="Closing common share price">$5.03</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_981_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zjcDHDNjyqr3" style="width: 13%; text-align: center" title="Closing common share price">$7.00</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlN1m5Fe2Jm8" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zW1FZ1Te9q55" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zLuZFFoxgCEa" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zu1umMnDVy6a" title="Implied volatility of public warrants">65.0</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zCKwC7xnccL2" title="Implied volatility of public warrants">33.5</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zw3II2SHIbH8" title="Implied volatility of public warrants">19.5</span>%</td><td style="text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zPFG7rb1vSrb" title="Risk-free rate">4.35</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTZ1viASsVS8" title="Risk-free rate">3.83</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zOOGRta5PSok" title="Risk-free rate">3.39</span>%</td><td style="text-align: left"></td></tr>
</table>

<p id="xdx_8AF_z4GaHVg2OTEi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z9eWTOTSPLte" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zNWKTfXspJW4">The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 47%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of March 17, 2023</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230315__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zw5yyEtakKkc" style="width: 10%; text-align: right" title="Fair value at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,195</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20230315__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z437Lf6iNWm7" style="border-bottom: black 1pt solid; text-align: right" title="Change in fair value">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,674</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of June 30, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zMQCqvLOjN0c" style="text-align: right" title="Fair value at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,521</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_987_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zL4LH2VZupBd" style="border-bottom: black 1pt solid; text-align: right" title="Change in fair value">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,704</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of June 30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zGe47ofFlYRh" style="border-bottom: black 1.5pt solid; text-align: right" title="Fair value at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,817</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p id="xdx_8AE_zrItpNfeQrrd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureClassBCommonStockOfEcrcAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  schedule of class b common stock of e c r c table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724382883888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">COMMON SHARES</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_z6HNmwl1pUEf" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</span></td><td id="xdx_821_zE1qMkJmXF2l" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMON
                                         SHARES</span></td></tr></table>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuances</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal
Year 2024 Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 1, 2023, the Company closed a non-brokered private placement (the &#8220;September 2023 Private Placement&#8221;) of
units of the Company (the &#8220;September 2023 Units&#8221;). A total of <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230830__20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zA7YiU6lOAkf" title="Shares issue">250,000</span> September 2023 Units were issued at a price
per September 2023 Unit of $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zzge53SsQWwh" title="Price per unit">4.00</span>, for total gross proceeds to the Company of $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20230830__20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_z6CFZ3WVVRvh" title="Gross proceeds">1,000</span>. Each September 2023 Unit consists of one
Common Share and one Warrant (&#8220;September 2023 Warrant&#8221;). Each September 2023 Warrant entitles the holder to acquire
one Common Share at a price of $<span id="xdx_90E_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zXB5cVt35Lze" title="Shares price">4.60</span> at any time prior to September 1, 2025. Proceeds of the September 2023 Private Placement
will be used for continued advancement of the Elk Creek Project and for working capital and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
September 2023 Warrants were classified as an equity instrument and accordingly, the net proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930_zm232uZKM6nf">962</span> were allocated based
on the relative fair values of the Common Shares and the September 2023 Warrants on the date of issuance. The amount allocated
to the fair value of the September 2023 Warrants was $<span id="xdx_904_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpCaj6U5T0g1">254</span> and the balance of the proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztcC797dXS9c">708</span> was allocated to the Common
Shares. The fair value of the September 2023 Warrants issued was computed using the Black Scholes pricing model using the following
assumptions: an expected life of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmL4yKo4V1K9" title="Expected life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1229">2.0</span></span> years, a risk-free interest rate of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrzudoLdJ8i2" title="Risk-free rate">4.85</span>%, an expected volatility of <span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uPure_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJ6syQxiY3J1" title="Expected volatility">71.63</span>%, and an expected
dividend rate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrsFszMVX2n1" title="Expected dividend rate">0</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2023, the Company closed a non-brokered private placement (the &#8220;December 2023 Private Placement&#8221;) of
<span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zvqVeAdD0gL8" title="Shares issue">413,432</span> units of the Company (the &#8220;December 2023 Units&#8221;). Each December 2023 Unit consists of one Common Share and
one Warrant (&#8220;December 2023 Warrant&#8221;). Each December 2023 Warrant entitles the holder to acquire one Common Share
at a price of $<span id="xdx_903_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zn1oBfdpF6og" title="Shares price">3.54</span> at any time until December 22, 2025. <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zOCReH2wGVTc" title="Units issue and sold">274,587</span> of the December 2023 Units were issued and sold to certain accredited
investors, who are not affiliated with the Company but with whom the Company had a pre-existing relationship, at a price of $<span id="xdx_906_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_ziziWDmkS82" title="Shares price">3.08</span>
per December 2023 Unit, and <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__srt--TitleOfIndividualAxis__srt--DirectorMember_zxzxscOG9kHc" title="Units issue and sold">138,845</span> of the December 2023 Units were issued and sold to certain officers and directors of the Company
(the &#8220;Insider Investors&#8221;), at a price of $<span id="xdx_909_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__srt--TitleOfIndividualAxis__srt--DirectorMember_zN8E7lQG4wA5" title="Shares price">3.205</span> per December 2023 Unit. The price per December 2023 Unit paid by the
Insider Investors included $0.125 per December 2023 Warrant underlying each December 2023 Unit purchased by the Insider Investors
which allowed the Insider Investors to participate in the December 2023 Private Placement in accordance with the rules of Nasdaq.
The Company received aggregate gross proceeds from the December 2023 Private Placement of approximately $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zIwH0dvqb8C" title="Gross proceeds">1,290</span>. Proceeds of the
December 2023 Private Placement will be used for continued advancement of the Elk Creek Project and for working capital and general
corporate purposes. The Company recorded a non-cash expense of $<span id="xdx_90C_eus-gaap--OtherCostAndExpenseOperating_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbU1WvBc5pMd" title="Other operating expenses">92</span> and $<span id="xdx_90F_eus-gaap--OperatingCostsAndExpenses_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z80GviyR3sFd" title="Employee related costs">10</span> to other operating expense and employee related costs,
respectively, representing the excess of fair value of the December 2023 Units over the purchase price paid by Insider Investors.</span></p>





















<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
December 2023 Warrants were classified as an equity instrument and accordingly, the estimated net proceeds of $1,241 were allocated
based on the relative fair values of the Common Shares and the December 2023 Warrants on the date of issuance. The amount allocated
to the fair value of the December 2023 Warrants was $<span id="xdx_908_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVIdjTUGMow" title="Proceeds from equity">264</span> and the balance of the proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze4zM8VnzkE" title="Proceeds from equity">977</span> was allocated to the Common Shares.
The fair value of the December 2023 Warrants issued was computed using the Black Scholes pricing model using the following assumptions:
an expected life of <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zicL57i0zUog" title="Expected life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1266">2.0</span></span> years, a risk-free interest rate of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrlPhIYkDDta" title="Risk-free rate">4.33</span>%, an expected volatility of <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uPure_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvJVRb30H41a" title="Expected volatility">54.8</span>%, and an expected dividend rate
of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpo4b9gKhX5d" title="Expected dividend rate">0</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 24, 2024, <span id="xdx_90E_eus-gaap--SaleOfStockDescriptionOfTransaction_c20240623__20240624__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_znrjaRmmEF18" title="Description of stock transaction">the Company closed a non-brokered private placement (the &#8220;June 2024 Private Placement&#8221;) of units of
the Company (the &#8220;June 2024 Units&#8221;). A total of 315,000 June 2024 Units were issued at a price per June 2024 Unit
of $1.91, for total gross proceeds to the Company of $<span id="xdx_903_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240623__20240624__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_za58kwM0qHt7" title="Proceeds from equity">602</span>. Each June 2024 Unit consists of one Common Share and one Warrant (&#8220;June
2024 Warrant&#8221;). Each June 2024 Warrant entitles the holder to acquire one Common Share at a price of $2.20 at any time prior
to June 24, 2026. Proceeds of the June 2024 Private Placement will be used for continued advancement of the Elk Creek Project
and for working capital and general corporate purposes.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
June 2024 Warrants were classified as an equity instrument and accordingly, the net proceeds of $602 were allocated based on the
relative fair values of the Common Shares and the June 2024 Warrants on the date of issuance. The amount allocated to the fair
value of the June 2024 Warrants was $<span id="xdx_90E_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYNadUl6HeZh" title="Proceeds from equity">161</span> and the balance of the proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEsilUOwKh69" title="Proceeds from equity">441</span> was allocated to Common Shares. The fair value
of the June 2024 Warrants issued was computed using the Black Scholes pricing model using the following assumptions: an expected
life of <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zM52UVP5Y9d3" title="Expected life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1282">2.0</span></span> years, a risk-free interest rate of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z28LnKRE7yVg" title="Risk-free rate">4.73</span>%, an expected volatility of <span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uPure_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZhpJwDOWXwe" title="Expected volatility">73.92</span>%, and an expected dividend rate of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSPSuv7Vip8i" title="Expected dividend rate">0</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal
Year 2023 Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the Common Shares issued in connection with the GXII Transaction, as discussed in Note 5, the following Common Share
issuances occurred during fiscal year 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 28, 2023, <span id="xdx_90F_eus-gaap--ConversionOfStockNewIssuance_c20230427__20230428__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--KingdonCapitalManagementLLCMember_zg605uNWs6y2">the Company closed a registered direct offering and issued 314,465 Common Shares for $2,000, before deducting
share issuance costs of $172. The Common Shares were sold pursuant to a securities purchase agreement, dated April 26, 2023, between
the Company and a fund managed by Kingdon Capital Management, LLC.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 9, 2023, <span id="xdx_90C_eus-gaap--ConversionOfStockNewIssuance_c20230608__20230609__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleEquityFacilityFinancingAgreementMember_zjKwF4ksuwzf">the Company issued 100,000 Common Shares under the Yorkville Equity Facility Financing Agreement (discussed below)
in exchange for $488 in cash proceeds. The Company recorded a non-cash operating expense of $13 which represented the difference
between the proceeds received and the fair value of the Common Shares issued based on Nasdaq closing price per Common Share on
the issuance date.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
                                         Options</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2024, the Company&#8217;s shareholders voted to approve an amendment and restatement of its long-term incentive plan
(the &#8220;2017 Amended Long-Term Incentive Plan&#8221;) and the granting of incentive securities thereunder until January 19,
2027. Under the 2017 Amended Long-Term Incentive Plan, the Board may, in its discretion from time to time, grant options and share
units (in the form of restricted share units and performance share units) to directors, employees and certain other service providers
(as defined in the 2017 Amended Long-Term Incentive Plan) of the Company and affiliated entities selected by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to adjustment as described in the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares that may be reserved
for issuance to participants under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, may not exceed 10% of the issued and outstanding Common Shares from time to time, and the Common
Shares reserved for issuance upon settlement of share units will not exceed 5% of the issued and outstanding Common Shares from
time to time. The 2017 Amended Long-Term Incentive Plan limits the maximum number of Common Shares issued to insiders (as defined
under TSX rules for this purpose) within any 1-year period, or issuable to insiders at any time, in the aggregate, under all security-based
compensation arrangements (including the 2017 Amended Long-Term</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Incentive Plan) to 10% of the then issued and outstanding Common
Shares. The 2017 Amended Long-Term Incentive Plan also limits the aggregate number of Common Shares that may be reserved for issuance
to any one participant under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation arrangements
of the Company, to 5% of the then issued and outstanding Common Shares (on a non-diluted basis). Subject to the adjustment provisions
of the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares actually issued or transferred by the Company
upon the exercise of incentive stock options will be limited as described above.</span></p>













<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has power over the granting, amendment, administration, or settlement of any award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
option transactions are summarized as follows:</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_zWGZKuGVAEe2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_z0jy0iletlJc" style="display: none; visibility: hidden">Schedule of stock option</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Number of Options</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Exercise Price</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Aggregate Intrinsic Value</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Remaining Contractual Life</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2023</span></td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230701__20240630_zye0TeAXrv1b" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Beginning balance">1,541,500</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20230701__20240630_zqAAL9m57Goh" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Beginning balance">7.19</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Granted</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230701__20240630_zUeNkdqhxVWd" style="text-align: right" title="Granted, in shares">1,625,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zwKafKcDrL35" style="text-align: right" title="Granted, per share">2.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Exercised</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230701__20240630_zWX5btsMY8Zb" style="text-align: right" title="Cancelled/expired, in shares">(7,800</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zd1ix0BCB8Yg" style="text-align: right" title="Cancelled/expired, per share">3.95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Cancelled/expired</span></td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230701__20240630_zYPoYl8DeWhh" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, in shares">(663,200</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zkovxxki1jm2" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, per share">5.88</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20230701__20240630_zb2buhWzOMM3" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">2,495,500</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20230701__20240630_zWtr5uPr8tR6" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">4.78</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">-</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20230701__20240630_zyNXfsZgVxv2" title="Weighted average remaining contractual life::XDX::P3Y5M9D"><span style="-sec-ix-hidden: xdx2ixbrl1322">3.44</span></span> years</span></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AB_zq5LTkXk7RSl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_pid_dp_uPure_c20230701__20240630_zkgY6nZaXhe6" title="Outstanding stock options vested">100</span>% of the outstanding stock options were fully vested. The total intrinsic value of options exercised during
the year ended June 30, 2024 <span style="background-color: white">was immaterial, and as of June 30, 2024, </span>there were
no unrecognized compensation costs related to unvested share-based compensation arrangements granted. The Company recognized share-based
compensation expense of $<span id="xdx_906_eus-gaap--ShareBasedCompensation_pn3n3_dxL_c20230701__20240630_zuzaPTNtLga5" title="Share based compensation expense::XDX::2881"><span style="-sec-ix-hidden: xdx2ixbrl1326">2,779</span></span> and $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_pn3n3_c20220701__20230630_zJmibczMz0tc" title="Share based compensation expense">1,794</span> for the years ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z2kBH6g6jsd2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the weighted average information and assumptions used to determine option costs:&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 70%; margin-left: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_491_20230701__20240630_zJT66EgqTjpc" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_492_20220701__20230630_zMJX0iLpVci" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 4pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">Year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 4pt">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">2023</td><td>&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_za4ZZCglBnD3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-left: 4pt">Fair value per option granted during the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 10%; text-align: right">$1.71</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 10%; text-align: right">$3.09</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_zKro84PDHlkd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 4pt">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.30</td><td style="text-align: left">%</td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zf36kUWNMGyg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 4pt">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_zS7Liq7OcSJl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 4pt">Expected stock price volatility (historical basis)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63.6</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 4pt">Expected option life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630_zUuwWwGG7Rlg" style="text-align: right" title="Expected option life in years::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1344">5.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220701__20230630_zh9CTGbFc9Pl" style="text-align: right" title="Expected option life in years::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1346">3.0</span></td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A4_zVO1iM18sgtj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to January 1, 2024, the Company concluded that under ASU 718, <i>Compensation &#8211; Stock Compensation (Topic 718)</i>, Options
previously issued on December 31, 2021, May 30, 2022, and March 27, 2023, which included a C$ strike price should remain equity-classified
as management determined that the Options qualified for an exemption from liability classification as the Options were denominated
in a currency in which a substantial portion of the Company&#8217;s equity securities traded. Effective January 1, 2024, the Company
determined that due to historically decreasing trading volume on the TSX, this exemption no longer applied and accordingly, these
Options were classified as a liability based on their fair values on that date. The Company recorded a mark-to-market gain of
$147 in other operating expenses related to these option liabilities for the year ended June 30, 2024. The associated liability
related to these Canadian-denominated Options was nil at June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Board approved a modification to Options previously issued on March 27, 2023, with dual strike prices of $6.95
and C$9.52, under which the option to exercise in C$ was removed. No other terms or conditions were amended by the Board. Based
on this amendment, the Company re-classified these Options to equity on March 28, 2024, based on their fair value on that date.</span></p>





















<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zajsKuOKR16b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
transactions are summarized as follows. <span id="xdx_8BC_zyqEmpR0lZz1">Weighted average exercise prices related to Canadian dollar denominated warrants were
converted to U.S. dollars using end of period foreign currency exchange rates.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0"></p>
                                   <p style="margin-top: 0; margin-bottom: 0"></p></td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Warrants</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Exercise Price</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Balance, June 30, 2022</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20220701__20230630_z8XckUuBZlg4" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Beginning balance">1,851,622</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20220701__20230630_zlPFz7KFYO25" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Balance at beginning average price">8.99</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Granted:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Yorkville financing warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--YorkvilleFinancingWarrants_pid_uShares_c20220701__20230630_zsM2GDSooiDh" style="text-align: right" title="Yorkville financing warrants">1,789,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_pid_uUSDPShares_c20220701__20230630_zuRZJAtK8XX7" style="text-align: right" title="Yorkville financing warrants average price">8.94</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">GXII warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--GxiiWarrants_pid_uShares_c20220701__20230630_zHMJkushqd4a" style="text-align: right" title="GXII warrants">15,666,626</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_pid_uUSDPShares_c20220701__20230630_zJ7RdbGA8fG" style="text-align: right" title="GXII warrant average price">11.50</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20220701__20230630_zwtkNzObpjxd" style="border-bottom: Black 1pt solid; text-align: right">(491,211</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20220701__20230630_z9twSZGNm2y1" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled">11.67</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20230701__20240630_zurKJrQeN0hh" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance">18,816,304</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20230701__20240630_zjTCrM0X5K51" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at beginning average price">10.98</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20230701__20240630_z0W5fkGoigqf" style="text-align: right" title="Granted">1,593,817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20230701__20240630_zPvax70AxKZh" style="text-align: right" title="Granted">3.33</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20230701__20240630_z3hKFny45BZb" style="border-bottom: Black 1pt solid; text-align: right">(1,846,560</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20230701__20240630_zcw1PQYD0wEb" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled">8.67</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Balance, June 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20230701__20240630_zpRUOUmiGBv8" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">18,563,561</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iE_pid_uUSDPShares_c20230701__20240630_zE325rBL0CJ7" style="border-bottom: Black 2pt solid; text-align: right" title="Balance at ending average price">10.53</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_z7veq4cSjdr8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89E_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zfZlJxw1mQ28" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zpt6fAXGWFI7">At
June 30, 2024, the Company has outstanding exercisable warrants, as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
    Date</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zoXC4JVPcOGg" style="width: 16%; text-align: right" title="Number of share outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">855,800</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zGpJ8aCGpI45" title="Exercise price">9.70</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zeHof6GKu6p" style="width: 60%; text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-02-19"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1393">February
    19, 2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zDEglaeylwUe" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">447,318</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zOMzWTH7SnI3" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$8.94</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zhUsGKRWEASg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zdGPamuZW8j" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.60</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_z2x4fRJLJVIj" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-09-01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1401">September
    1, 2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zYi3g4pIj88e" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">413,432</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zntLCYZYgUF1" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3.54</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zSP9E4t43nVc" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-12-22"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1406">December
    22, 2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zIJjZwTBQP0d" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">315,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zQIyFNHSsqQb" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zE506OVXL2qa" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-06-24"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1411">June
    24, 2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_z6HnfquTlHxc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">615,385</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zFf6iyBUoy03" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3.25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zpbNSKQf8iMl" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2027-04-12"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1416">April
    12, 2027</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z9oNsluQzth" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,666,626</span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z0pvMgx2Hztl" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$11.50</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zJ17oOr84gIc" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2028-03-17"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1421">March
    17, 2028</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630_zjf9tMeF7pac" style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,563,561</span></td><td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; padding-right: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 2.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span id="xdx_F0F_zHWjoLgb5ZYh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: left"><span id="xdx_F1E_zX2isN3oIiNc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expires
    in 3 equal monthly tranches on July 17, 2024, August 17, 2024, and September 17, 2024.</span></td></tr>
</table>
<p id="xdx_8A5_zwecu1KHXiVc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Closing, pursuant to the Business Combination Agreement, the Company assumed the GXII Warrant Agreement and
each GXII Warrant thereunder that was issued and outstanding immediately prior to the Closing Date was converted into one NioCorp
Assumed Warrant pursuant to the GXII Warrant Agreement, as amended by an Assignment, Assumption and Amendment Agreement, dated
March 17, 2023, among the Company, GXII, Continental Stock Transfer &amp; Trust Company, as the existing warrant agent, and Computershare
Inc. and its affiliate, Computershare Trust Company, N.A, together as the successor warrant agent (the &#8220;NioCorp Assumed
Warrant Agreement&#8221;). In connection with the Closing, NioCorp issued (a) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--GXIIPublicWarrantsMember_z1SYUjMrhvBf" title="Warrants traded prior to the closing">9,999,959</span> public NioCorp Assumed Warrants (the &#8220;Public
Warrants&#8221;) in respect of the GXII Warrants that were publicly traded prior to the Closing and (b) <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--GXIIPrivateWarrantsMember_z7lUvDhskIcl" title="Warrants traded prior to the closing">5,666,667</span> NioCorp Assumed
Warrants (the &#8220;Private Warrants&#8221;) to the Sponsor in respect of the GXII Warrants that it held prior to the Closing,
which NioCorp Assumed Warrants were subsequently distributed by the Sponsor to its members in connection with the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zi7DUScxqMG7" title="Description of warrants">Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like).</span> No fractional shares will be issued upon exercise of any NioCorp Assumed Warrants, and fractional shares that would otherwise
be due to the exercising holder will be rounded down to the nearest whole Common Share. In no event will the Company be required
to net cash settle any NioCorp Assumed Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Public
Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may elect to redeem the Public Warrants subject to certain conditions, in whole and not in part, at a price of $0.01 per
Public Warrant if (i) 30 days&#8217; prior written notice of redemption is provided to the holders, </span><span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20230701__20240630_zsbTlpE3ms8g" title="Description of warrants">(ii)
the last reported sale price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span title="Description of warrants">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span title="Description of warrants"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span title="Description of warrants">within a 30-trading day period ending
on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders</span> and <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
there is an effective registration statement covering the Common Shares issuable upon exercise of the Public Warrants, and a current
prospectus relating thereto, available through the redemption date. Upon issuance of a redemption notice by the Company, the warrant
holders will have until the redemption date to exercise for cash, or, at the Company&#8217;s election, on a cashless basis. The
Public Warrants are not precluded from equity classification and are accounted for as such on the date of issuance, and each balance
sheet date thereafter. Because the 2023 Transactions resulted in an excess of liabilities over assets acquired, no value was ascribed
to the Public Warrants.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Warrants </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants: (i) will be exercisable either for cash or on a cashless basis at the holder&#8217;s option and (ii) will not
be redeemable by the Company, in either case as long as the Private Warrants are held by the Sponsor, its members or any of their
permitted transferees (as prescribed in the NioCorp Assumed Warrant Agreement). In accordance with the NioCorp Assumed Warrant
Agreement, any Private Warrants that are held by someone other than the Sponsor, its members or any of their permitted transferees
are treated as Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the Private Warrants assumed in the 2023 Transactions in accordance with the guidance contained in ASC 815-40.
Such guidance provides that because the Private Warrants do not meet the criteria for equity treatment thereunder, each Private
Warrant must be recorded as a liability. This liability is carried as a component of Warrant Liabilities on the consolidated balance
sheet and is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be
adjusted to its current fair value, with the change in fair value recognized in the consolidated statement of operations and comprehensive
loss. The Company will reassess the classification at each balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zHgR48wJZmoa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zLLrOhG6vMfk">The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a
Black Scholes model with the following assumptions:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 17, 2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 31%; text-align: justify">Stock price on valuation date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1Z5rDZjdkV4" style="width: 10%; text-align: right" title="Stock price on valuation date">1.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFE6f8V4pHcc" style="width: 10%; text-align: right" title="Stock price on valuation date">5.03</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKti9c2iZ2ub" style="width: 10%; text-align: right" title="Stock price on valuation date">7.00</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zOtZwGvw2vs9" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWcBARjHuf42" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhgD62xwvIt6" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4ENW3fVdG78" title="Implied volatility of public warrants">69.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zCWPeAEkl5yl" title="Implied volatility of public warrants">33.5</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeImYtHqK0Mf" title="Implied volatility of public warrants">19.5</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXiirYGbXKZb" title="Risk free rate">4.45</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFq3HWAZU19c" title="Risk free rate">4.18</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zMKev04i1UE2" title="Risk free rate">3.47</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zcsificTC6ej" title="Dividend yield">0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDKPV2q7L2Wl" title="Dividend yield">0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zvsYn0LvsLYd" title="Dividend yield">0</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected warrant life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zcG5EAX3qLbj" title="Expected warrant life in years::XDX::P3Y8M12D"><span style="-sec-ix-hidden: xdx2ixbrl1472">3.7</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjMLr3IZqMDe" title="Expected warrant life in years::XDX::P4Y8M12D"><span style="-sec-ix-hidden: xdx2ixbrl1474">4.7</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znJ3gJPKi7ci" title="Expected warrant life in years::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1476">5.0</span></span></td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_zlDiwfsl7V6j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in">&#160;</p>

<p id="xdx_89B_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zbDEDzsTxw83" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zN3GUDOwHwG3">The
change in the Private Warrants liability is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%">Initial valuation, March 17, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230315__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_ze4dEjbfLz13" style="width: 10%; text-align: right" title="Initial valuation, at begining">2,987</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in valuation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230315__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zAkWZjJgEmzl" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation">292</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Valuation at June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zN4GuycS7h48" style="text-align: right" title="Initial valuation, at begining">3,279</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in valuation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zXXIPqLb19rj" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation">(1,926</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Valuation at June 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zNiq6OhMP5qk" style="border-bottom: Black 2pt solid; text-align: right" title="Initial valuation, at ending">1,353</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A7_zVzwu0rhjBTa" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
                                         Equity Facility Financing</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrent
with the closing of the GXII Transaction, the Yorkville Equity Facility Financing became effective. Pursuant to the
Yorkville Equity Facility Financing Agreement, Yorkville committed to purchase up to $65,000 of Common Shares (the
&#8220;Commitment Amount&#8221;), at NioCorp&#8217;s direction from time to time for a period commencing upon the Closing
Date and ending on the earliest of (i) the first day of the month next following the 36-month anniversary of the Closing,
(ii) the date on which Yorkville shall have made payment of the full Commitment Amount and (iii) the date that the Yorkville
Equity Facility Financing Agreement otherwise terminates in accordance with its terms (the &#8220;Commitment Period&#8221;), subject to certain limitations and the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">satisfaction
of the conditions in the Yorkville Equity Facility Financing Agreement. The Common Shares that may be sold pursuant to the Yorkville
Equity Facility Financing Agreement would be purchased by Yorkville at a purchase price equal to 97% of the daily volume-weighted
average price of the Common Shares on Nasdaq or such other principal U.S. market for the Common Shares if the Common Shares are
ever listed or traded on the New York Stock Exchange or the NYSE American as reported by Bloomberg Financial Markets (or, if not
available, a similar service provider of national recognized standing) during the applicable pricing period, which is a period
during a single trading day or a period of three consecutive trading days, at the Company&#8217;s option and subject to certain
restrictions, in each case, defined based on when an Advance Notice (as defined in the Yorkville Equity Facility Financing Agreement)
is submitted, subject to certain limitations.</span></p>













<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Yorkville Equity Facility Financing Agreement, NioCorp issued 81,213 of Common Shares (the &#8220;Commitment
Shares&#8221;) valued at $650 to Yorkville as consideration for its irrevocable commitment to purchase Common Shares under the
Yorkville Equity Facility Financing Agreement. On June 9, 2023, NioCorp issued and sold 100,000 Common Shares to Yorkville under
the Yorkville Equity Facility Financing Agreement. Additionally, NioCorp is required to pay Yorkville an aggregate fee of $1,500
in cash (the &#8220;Cash Fee&#8221;), including $500 that NioCorp paid on the Closing Date and an additional $250 NioCorp was
paid as of June 30, 2023. NioCorp will pay the remaining $750 balance in installments over a 12-month period following the Closing
Date, provided that it will have the right to prepay without penalty all or part of the remaining installments of the Cash Fee
at any time. In addition, legal and other costs of $496 were incurred in connection with the Yorkville Equity Facility Financing
and were expensed on the effective date. The following amounts related to the Yorkville Equity Facility Financing Agreement were
expensed as other operating costs during the year ended June 30, 2023:</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_z3ASikrYjJu1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zzt2wXsBEeM6" style="display: none; visibility: hidden">Schedule of expenses as other operating costs</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zeU06pPLzlEi" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_ecustom--YorkvilleCashFee_zCo8eoTA9VL9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%; text-align: justify">Yorkville Cash Fee</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zMxZ7zqa5Uci" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Fair value of Commitment Shares issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--OtherCostAndExpenseOperating_z0jMHASx6W26" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Legal and other related costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">496</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--OperatingCostsAndExpenses_z85GnfZNKj0e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2pt">Costs expensed to other operating expense</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">2,646</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A4_zBQ86SNeRFa6" style="margin-top: 0; margin-bottom: 0"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285863152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS AND BALANCES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS AND BALANCES</a></td>
<td class="text"><p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4eKlHaWxKOf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</span></td><td id="xdx_829_z8tIyz7Feacf" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RELATED
                                         PARTY TRANSACTIONS AND BALANCES</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was party to a non-revolving credit facility agreement (the &#8220;Smith Credit Facility&#8221;) with Mark Smith, Chief
Executive Officer, President, and Executive Chairman of NioCorp, which expired on June 30, 2023. The Smith Credit Facility bore
interest at a rate of <span id="xdx_903_eus-gaap--RelatedPartyTransactionRate_pid_dp_uPure_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zFLs49Ru3Er6" title="Interest at a rate">10</span>% and drawdowns from the Smith Credit Facility were subject to a <span id="xdx_904_ecustom--LineOfCreditFacilityPrepaymentFee_pid_dp_uPure_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zdoV39mhXN3d" title="Prepayment fee">2.5</span>% establishment fee. Amounts outstanding
under the Smith Credit Facility were secured by all of the Company&#8217;s assets pursuant to a general security agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_898_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zi0DW29dRwp2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zbYcDYi02tPc">Changes
in the Smith Credit Agreement principal balance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the year ending June 30,2023</span></td>
    <td style="text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 57%; background-color: #CCEEFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
    balance</span></td>
    <td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20220701__20230630_zvLcTJ5yFCRl" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td>
    <td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Amounts
    advanced</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_ecustom--AmountsAdvanced_pn3n3_c20220701__20230630_zGvahmC47mrb" style="vertical-align: bottom; text-align: right" title="Amounts advanced"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,130</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom; background-color: #CCECFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Repayments</span></td>
    <td style="vertical-align: bottom; background-color: #CCECFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: #CCECFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_984_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20220701__20230630_zFkN7hObNvhd" style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: #CCECFF; text-align: right" title="Repayments">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,130</span></td>
    <td style="vertical-align: bottom; background-color: #CCECFF; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance,
    end of period</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20220701__20230630_z2ENjS0AcD5j" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1520">-</span></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
</table>
<p id="xdx_8AA_zUbKMvpONWhf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 22, 2023, the Company repaid Mr. Smith $<span id="xdx_901_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230322__us-gaap--TypeOfArrangementAxis__custom--NonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zdbedpl4zKKb" title="Credit agreement">1,841</span> of principal borrowed under the Smith Credit Facility. This repayment was
made out of funds transferred to the Company from the GXII trust account on the Closing Date. The Company repaid the remaining
principal balance of $<span id="xdx_907_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_z3kHivj0Nai7" title="Principal amount outstanding">1,289</span> on May 31, 2023. Accounts payable and accrued liabilities as of June 30, 2024 includes $<span id="xdx_907_ecustom--EstablishmentFeesPayable_pn3n3_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_zK1bq0V0XkW5" title="Establishment fees payable">28</span> of origination
fees payable under the Smith Credit Agreement. During fiscal year 2023 the Company paid a total of $<span id="xdx_900_eus-gaap--AccruedLiabilitiesCurrent_iI_pn3n3_c20230630_zsKcCa1LoaJh">183</span>, representing accrued
interest on the Smith Credit Agreement.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724375706448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EXPLORATION EXPENDITURES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureExplorationExpendituresAbstract', window );"><strong>Exploration Expenditures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ExplorationExpendituresDisclosuresTextBlock', window );">EXPLORATION EXPENDITURES</a></td>
<td class="text"><p id="xdx_808_ecustom--ExplorationExpendituresDisclosuresTextBlock_zAPlN4B9j978" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</span></td><td id="xdx_82C_zxLiF2y2jxa1" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPLORATION
                                         EXPENDITURES</span></td></tr></table>

<p id="xdx_893_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zrUmCPvNDG57" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zEW02sgRxMqk" style="display: none; visibility: hidden">Schedule of exploration expenditures</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td><td colspan="6" style="padding-bottom: 1pt; text-align: center">For the year ended <br/>
June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td><td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-left: 5.4pt">&#160;Feasibility study and engineering</td>
    <td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td>
    <td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_z0TgLiCc3Xya" style="width: 10%; text-align: right">353</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zZw16AZyDUGh" style="width: 10%; text-align: right">410</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">&#160;Field management and other</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td>
    <td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_ztJXK1DHfYU1" style="text-align: right">503</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zjIM2zz2poy4" style="text-align: right">738</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">&#160;Metallurgical</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td>
    <td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--MetallurgicalMember_zwIzBzW08n1b" style="text-align: right">1,678</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--MetallurgicalMember_zVKXQvCj98Cb" style="text-align: right">4,174</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">&#160;Geologists and field staff</td>
    <td>&#160;</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z29Ug68eIXCh" style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z4lMg6XsyCeh" style="border-bottom: Black 1pt solid; text-align: right">26</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; padding-left: 5.4pt">&#160;Total</td>
    <td>&#160;</td><td style="border-bottom: Black 2pt solid; text-align: left">$</td>
    <td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630_znMH3N4wvcZ" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures">2,552</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630_zpJ67NrBhQeh" style="border-bottom: Black 2pt solid; text-align: right">5,348</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A3_zwFN6yUj2lnk" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureExplorationExpendituresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureExplorationExpendituresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ExplorationExpendituresDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  exploration expenditures disclosures text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ExplorationExpendituresDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368383184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--LesseeOperatingLeasesTextBlock_zGxsbcstybTa" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</span></td><td id="xdx_826_zq6vjV7Y0CU4" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEASES</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
February 2023, the Company entered into a <span id="xdx_90F_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20230701__20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CorporateOfficeMember_zsLN8BflOW15" title="Other lease description">39-month corporate office lease extension and recognized a corresponding ROU asset and
lease liability of $198 associated with this extension, based on a discount rate of <span id="xdx_90D_ecustom--DiscountRate_dp_uPure_c20230701__20240630_zR36QQLX1Tmd" title="Discount rate">16</span>%.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024 and 2023, the Company had one corporate office lease with a remaining lease term of <span id="xdx_907_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20240630_zzCUMc7n15Bj" title="Remaining lease term::XDX::P2Y7M6D"><span style="-sec-ix-hidden: xdx2ixbrl1556">2.6</span></span> years and <span id="xdx_903_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20230630_zUEDHhLfWTKb" title="Remaining lease term::XDX::P3Y7M6D"><span style="-sec-ix-hidden: xdx2ixbrl1558">3.6</span></span> years,
respectively. During the year ended June 30, 2024 and 2023, operating cash flows included cash payments of $<span id="xdx_905_eus-gaap--OperatingLeasePayments_c20230701__20240630_zyu7tCP0eKd7" title="Cash payment">71</span> and $<span id="xdx_900_eus-gaap--OperatingLeasePayments_c20220701__20230630_zSm28HK1LF29" title="Cash payment">93</span>, respectively
related to the measurement of lease liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zFMDPesBUyD4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zZwNhVP7znVa">The
Company incurred lease costs as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49A_20230701__20240630_zdpHnoiu8ZHk" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_494_20220701__20230630_zfGHLIRpd2B2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_ztcs0JNenlYa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;Operating Lease Cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--FixedRentExpense_z8wiWrFQMm9a" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-left: 0.125in">&#160;&#160;Fixed rent expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">90</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">83</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--VariableLeaseCost_zYilEpcHe0me" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">&#160;&#160;Variable rent expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">&#160;&#160;Short term lease cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_zMx8rbZIbR35" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">&#160;&#160;Sublease income</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(32</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zVDNB18iZSb3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">&#160;&#160;Net lease cost &#8211; other operating expense</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">81</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">73</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AD_zHKUfcwJmSg2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zIBH6df4xrIb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zIL0QupF7Sh">The
maturity of lease liabilities is as follows at June 30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt; padding-left: 10pt"></td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20240630_zVO867MS1l3i" style="border-bottom: Black 1pt solid; text-align: center">&#160;Fiscal Year Lease Maturities</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zOLwY093Fgn2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%; text-align: left; padding-left: 0.125in">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">96</td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_znOgn2YDFFx7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">98</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzI5d_z6iGPLc1xjm7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">2027</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">50</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_409_ecustom--TotalLeasePayments_iI_pn3n3_mtLOLLPzI5d_zHxp79pTNTA5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">244</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_ecustom--LessAmountOfPaymentsRepresentingInterest_iNI_pn3n3_di_zB2RmiaocxGb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less amount of payments representing interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_z7RPNTFnrOh5" style="vertical-align: bottom; background-color: White">
    <td>Present value of lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_402_ecustom--LessCurrentPortionOfOperatingLeaseLiability_iNI_pn3n3_di_zRkoiw9xk6U9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less current portion of operating lease liability</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(95</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_409_ecustom--OperatingLeasesLiabilityNoncurrent_iI_pn3n3_z8eJ9hvacpNd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Noncurrent operating lease liability</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">105</td><td style="text-align: left; padding-bottom: 2pt">&#160;</td></tr>
</table>

<p id="xdx_8A5_z3Su5hebItt" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368265120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zMXvECizM2db" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</span></td><td id="xdx_82D_z6W5ECWpJsb2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCOME
                                         TAXES</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_z9bgB1OQuWef" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_z2BFpEQH5sRh">Domestic
and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows:</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; padding-left: 5pt">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z57vaDVMMEd6" style="width: 10%; text-align: right" title="Total">8,319</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_znIGbYlP5VUj" style="width: 10%; text-align: right" title="Total">34,606</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zjd2vsIFj6Xi" style="text-align: right" title="Total">3,679</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zWVpHypcitNa" style="text-align: right" title="Total">6,006</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt">United Kingdom</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zzAPDkmYszX2" style="border-bottom: Black 1pt solid; text-align: right" title="Total">39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zcE2d0hva516" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl1616">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt; padding-left: 5pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zfJxujeMcwoe" style="border-bottom: Black 2pt solid; text-align: right" title="Total">12,037</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zHNyoDRvRkii" style="border-bottom: Black 2pt solid; text-align: right" title="Total">40,612</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AF_z6gUo2qyACbf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>


















<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p id="xdx_896_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zQKS2yZlaJyk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zKmOYbnYfTne">The
following table is a reconciliation of income taxes at statutory rates:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_495_20230701__20240630_zkoJDe5peD99" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_494_20220701__20230630_zcURCFmpWzj5" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_zLcapFBp6554" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left; padding-left: 5pt">Loss before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">12,037</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">40,612</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_z4Aj6nOFUsbk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Combined Canadian federal and provincial statutory income tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_z0kWdi5AgPzc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Income tax benefit at statutory tax rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,965</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_zgmSZqkdF78l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Foreign rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(62</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(131</td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--EarnoutSharesLiability_zvAOBQaeeGK" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5pt">Earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,810</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,841</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40A_ecustom--WarrantLiability_z13vU622ux3c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">506</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,518</td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--GxiiTransactionCosts_zY0iqsfhNwX7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">GXII transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1648">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(925</td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zVXkJ8u5iGy1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt">Share based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(747</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(412</td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--AssetRetirementObligationAccretionExpense_iN_di_zMM7wzlve5oe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,138</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(496</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_ecustom--ConvertibleNoteValuation_iN_di_zzNlctPWi7hc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Convertible note valuation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(607</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1658">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--ExtinguishmentOfDebtGainLossIncomeTax_zyMdhRxpNHHf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1660">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(54</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40D_ecustom--EffectOfLegislativeChanges_zvRSKnwWjus" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Capital loss rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1663">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_zNTU5WJBgTx8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Change in estimates related to prior years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(160</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_zuHweNmP1zfb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt">Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zRe8hs5irF0b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,718</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,341</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 5pt">Income tax benefit</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20230701__20240630_zHg9FOUnnAz1" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit::XDX::-139"><span style="-sec-ix-hidden: xdx2ixbrl1675">139</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20220701__20230630_z1ZhZermPT97" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit::XDX::-304"><span style="-sec-ix-hidden: xdx2ixbrl1677">304</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A5_zdEoOZ2VSwl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax benefit for the year ends June 30, 2024 and 2023 were derived solely from our U.S. operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z8sr4ADEJGdf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zFluBkuRj1Tf">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_491_20240630_zcsLRmqQm5X7" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_495_20230630_zjZzn2nJl5Ll" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzakr_zHHYB11mTGj5" style="vertical-align: bottom; background-color: White">
    <td style="width: 54%; text-align: left; padding-left: 0.25in">Net operating losses available for future periods</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">14,177</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">11,893</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zxQyGBDpziZ8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Mineral interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,438</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,477</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_z12T6eRhe5Pa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Startup and organizational costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,987</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,132</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zQ0ysepiv2D3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Research and development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,419</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,060</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zuIAc0JPPD21" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in">Share issuance/financing costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">635</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">446</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zM7WHQZtgW6j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Capital losses available for future periods</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">419</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzakr_zPHUuuadLk09" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.25in">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">69</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iI_mtDTAGzakr_maDTALNz97R_zH8FslKJJ5z8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,181</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,463</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNz97R_zGnLV8BaggNf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">&#160;Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(28,181</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(25,463</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNz97R_zKvv3YhPtfs9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Net deferred tax assets</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AF_zAEXbRBhj7s5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p id="xdx_895_eus-gaap--SummaryOfValuationAllowanceTextBlock_znJg9a2MUMp" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zlgJc4C0A8Y">Changes
in the valuation allowance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left">Valuation allowance, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20230701__20240630_zy8O1HuJiqMl" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year">(25,463</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20220701__20230630_zpQNsLKSooqe" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year">(18,948</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Current year additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20230701__20240630_z8oKQuFi0Bk3" style="text-align: right" title="Current year additions">(2,718</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20220701__20230630_z85LpOCidlBc" style="text-align: right" title="Current year additions">(4,341</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Startup and organizational costs acquired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20230701__20240630_z0bO8mMe3TD3" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired"><span style="-sec-ix-hidden: xdx2ixbrl1721">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20220701__20230630_zzoiCwC6VpGf" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired">(2,174</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Valuation allowance, end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20230701__20240630_zmbFKoM7NRxj" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year">(28,181</td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20220701__20230630_zRbdcmhhLzKe" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year">(25,463</td><td style="padding-bottom: 2pt; text-align: left">)</td></tr>
</table>

<p id="xdx_8A1_zOdriCJbK0Bg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>









<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acquired a federal income tax payable of $<span id="xdx_90C_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_pn3n3_c20230701__20240630_zYjQPwyq48I3" title="Federal income tax payable">443</span> in connection with the GXII Transaction. As a result of a post-transaction
loss at ECRC, partial releases of the valuation allowance attributed to the reduction of the acquired federal income tax payable
of $139 and $304 were recorded as an income tax benefit in the consolidated statement of operations and comprehensive loss for
the year ended June 30, 2024 and 2023, respectively. The Company establishes a valuation allowance against future income tax assets
if, based on available information, it is more likely than not that all of the assets will not be realized. The valuation allowance
of $<span id="xdx_90E_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pn3n3_c20240630_zwtwN4vSnHe" title="Valuation allowance">28,181</span> at June 30, 2024, relates mainly to net</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">operating loss carryforwards in Canada and mineral interests due to deferred
exploration expenditures in the United States, where the utilization of such attributes is not more likely than not.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the following cumulative net operating losses for Canadian and U.S. income tax purposes and these carryforwards will
generally expire between 2028 and 2044. As a result of the Tax Cuts and Jobs Act of 2017, U.S. tax losses incurred for our tax
years ending on and after June 30, 2019, totaling $<span id="xdx_900_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_c20190630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zd3Ac0dpWetc" title="Tax losses incurred">3,924</span>, have no expiration.</span></p>

<p id="xdx_896_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zcb4TTHIh5xb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zUlCkb3Tqdy1" style="display: none; visibility: hidden">Schedule of cumulative net operating losses</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 4pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-left: 4pt">Jurisdiction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; padding-left: 4pt">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zFYEneDdpFnc" style="width: 10%; text-align: right" title="Total">47,623</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z9aOqr2g4Un1" style="width: 10%; text-align: right" title="Total">40,267</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 4pt">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_z9HoM3kIozy7" style="text-align: right" title="Total">4,905</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zjMnTpQKmzl" style="text-align: right" title="Total">3,491</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 4pt">United Kingdom</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zaGPbrYeEioc" style="border-bottom: Black 1pt solid; text-align: right" title="Total">39</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zFqvrzdgQatb" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl1753">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt; padding-left: 4pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630_zurE3MeGlGec" style="border-bottom: Black 2pt solid; text-align: right" title="Total">52,567</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630_zQtPWQ385yo5" style="border-bottom: Black 2pt solid; text-align: right" title="Total">43,758</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A7_zoygixFsPxV1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company has a Canadian capital loss carryforward of $<span id="xdx_907_ecustom--CapitalLossCaryforward_iI_c20240630__srt--CurrencyAxis__currency--CAD_zsIFwOVeDd3e" title="Capital loss carryforward">3,388</span> as of June 30, 2024, which has no expiration date and
can be used to offset future capital gains, and U.S. state net operating loss carryforwards of $<span id="xdx_909_ecustom--CapitalLossCaryforward_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zGKTfiJ2enU" title="Net operating loss carryforwards">7,018</span> as of June 30, 2024 which
generally expire between 2031 and 2044.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At June 30, 2024 and 2023, we had no undistributed earnings of foreign subsidiaries that would be subject to income tax upon distribution to Canada from a foreign subsidiary. As such, as of June 30, 2024 and 2023, we did not provide for deferred taxes on any such earnings of our foreign subsidiaries.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no unrecognized tax benefits as of June 30, 2024 or 2023. The Company recognizes interest accrued related to unrecognized
tax benefits and penalties in its income tax provision. The Company has not recognized any interest or penalties in the fiscal
years presented in these consolidated financial statements. The Company is subject to income tax in the U.S. federal jurisdiction,
the United Kingdom, and Canada. Certain years remain subject to examination but there are currently no ongoing exams in any taxing
jurisdictions.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285545728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_z6kSW9bwKGYb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_828_zhdaTYuH8g9h">FAIR VALUE MEASUREMENTS</span> </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures the fair value of financial assets and liabilities based on U.S. GAAP guidance which defines fair value, establishes
a framework for measuring fair value, and expands disclosures about fair value measurements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies financial assets and liabilities as held-for-trading, available-for-sale, held-to-maturity, loans and receivables,
or other financial liabilities depending on their nature. Financial assets and financial liabilities are recognized at fair value
on their initial recognition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and liabilities classified as held-for-trading are measured at fair value, with gains and losses recognized in net income.
Financial assets classified as held-to-maturity, loans and receivables, and financial liabilities other than those classified
as held-for-trading are measured at amortized cost, using the effective interest method of amortization. Financial assets classified
as available-for-sale, including investments in equity securities, are measured at fair value, with unrealized gains and losses
being recognized in income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments including receivables, accounts payable and accrued liabilities, and related party loans are carried at amortized
cost, which management believes approximates fair value due to the short-term nature of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of June 30, 2024, and 2023, respectively, and indicate the fair value hierarchy of the valuation techniques the Company utilized
to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active
markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable, such as quoted
prices, interest rates, and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the financial
instrument and include situations where there is little, if any, market activity for the instrument.</span></p>






















<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p id="xdx_89A_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zqR1VBqKFzgc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B4_ztZC8PdC0OQi" style="display: none; visibility: hidden">Schedule of fair values determined by level 3 inputs are unobservable data</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630_zHfnRgmMcD5k" style="width: 9%; text-align: right" title="Cash and cash equivalents">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyRxZhHo8qo8" style="width: 9%; text-align: right">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuDVZt1TPtDh" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1776">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zN369ejReXih" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1777">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630_zOIyZjI5NWh5" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqe2eCldhxH8" style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQ4l33XBWen" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1781">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zihji5P0r9K6" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1782">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240630_zvcKadMnfjh7" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents">2,016</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zeI8BTDUYdN4" style="border-bottom: Black 2pt solid; text-align: right">2,016</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzvUB5OU6Ip4" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1786">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoeVxg1XDiUg" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1787">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Cash and cash equivalents">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">April 2024 notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--NotesPayable_iI_c20240630_zuYPO2SS3pS7" style="text-align: right" title="Cash and cash equivalents">7,089</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayable_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0beG8D1zJu1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1790">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPpARldt2JD1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1791">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqDGw7MQKQmc" style="text-align: right">7,089</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630_zcECAf2SJC42" style="text-align: right" title="Cash and cash equivalents">3,817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zuniSErcRgH8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1795">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1QuLWobF3Pg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1796">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zRpHCnxP2JZd" style="text-align: right">3,817</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630_zvCFGjvx2cca" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents">4,016</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMAd9oqQPJV4" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1800">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSL8Gmr1BLkg" style="border-bottom: Black 1pt solid; text-align: right">1,651</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkpM0PKAKxhc" style="border-bottom: Black 1pt solid; text-align: right">2,365</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630_zTzQMwOS31Eg" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents">14,922</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zf6BSJcdfyqb" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1805">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfKOJWWtknL9" style="border-bottom: Black 2pt solid; text-align: right">1,651</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zR1PuZxqKHR4" style="border-bottom: Black 2pt solid; text-align: right">13,271</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630_zjKL33g94I7c" style="width: 9%; text-align: right">2,341</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z016rH6Konm5" style="width: 9%; text-align: right">2,341</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLnMX4mSWxud" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1810">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbU94EDQpM84" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1811">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630_zesl4AemIP5f" style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZoSGIGJ00H8" style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPoMcCvmtIPk" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1814">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z6q6OpuNSPm1" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1815">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20230630_zmdeNUGbcMhe" style="border-bottom: Black 2pt solid; text-align: right">2,350</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ztxdhphe9fXg" style="border-bottom: Black 2pt solid; text-align: right">2,350</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zk2To6FAGcQi" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0ojJd3792ii" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630_z8xu1VMvKUS3" style="text-align: right">10,521</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpcoCm9ZFpuf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1821">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKDHPxK7uY1i" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1822">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zte778YsURXj" style="text-align: right">10,521</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630_zEfg3D4LhXyf" style="border-bottom: Black 1pt solid; text-align: right">4,989</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zN7hMLfrEA44" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1825">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zo58gZJhjfmf" style="border-bottom: Black 1pt solid; text-align: right">3,279</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYb5UcoqWp1i" style="border-bottom: Black 1pt solid; text-align: right">1,710</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630_zgFQkBE7jSZ8" style="border-bottom: Black 2pt solid; text-align: right">15,510</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6MWMm3HZeZ2" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1829">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zp8Ki3EXr6A4" style="border-bottom: Black 2pt solid; text-align: right">3,279</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zSLNZntZD21i" style="border-bottom: Black 2pt solid; text-align: right">12,231</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A2_zZ4z7AS8qs52" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
<span style="color: #353535">Yorkville Convertible Debt Financing </span>discussed in Note 9 was initially recorded at fair value,
which represented a nonrecurring fair value measurement using a Level 3 input. At June 30, 2024, the estimated fair value of this
instrument approximated carrying value given that the instrument was issued in March 2023 and has a short time period until maturity.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//820/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285731376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zCjkZIUAAiy6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</span></td><td style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_82F_zCq3f7wrP0b3">SUBSEQUENT
                                         EVENTS</span> </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Yorkville
Consents</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SubsequentEventDescription_c20240902__20240904__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyuGoKceutHh" title="Subsequent event description">On
September 4, 2024, NioCorp entered into (i) a consent and waiver (the &#8220;Yorkville Consent&#8221;) to the April 2024 Note
issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together with the
Yorkville Consent, the &#8220;Consents&#8221;) to the April 2024 Note issued and sold to Lind Global Fund II LP pursuant to
the April 2024 Purchase Agreement. The Consents, among other things, reduced the amounts due to the April 2024 Purchasers
on September 1, 2024 by an aggregate of $<span id="xdx_90C_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20240830__20240901__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrPFfZLz1xr2" title="Aggregate principal amount">1,176</span> to an aggregate of $<span id="xdx_90A_eus-gaap--DebtInstrumentIncreaseDecreaseOtherNet_pn5n6_c20240830__20240901__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zs7Hvk4DJPK1" title="Increased the amounts due">336</span>, increased the amounts due to the April 2024 Purchasers on December 1, 2024 by an aggregate of $<span id="xdx_907_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20241129__20241201__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zkSGqnsT48Ul" title="Aggregate principal amount">1,176</span>, and prospectively waived any term of the April 2024 Notes that would otherwise be triggered upon a failure of
the Company to pay to the April 2024 Purchasers the remainder of the amount due on September 1, 2024. Except as modified by
the Consents, the terms of the April 2024 Notes as previously disclosed are unchanged.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Smith
Loan Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2024, the Company and Mark Smith entered into a Loan Agreement (the &#8220;Smith Loan Agreement&#8221;) pursuant
to which Mr. Smith agreed to make available to the Company a non-revolving, multiple draw credit facility of up to $<span id="xdx_90D_eus-gaap--LineOfCreditFacilityFairValueOfAmountOutstanding_iI_c20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPCxwh2lKd51" title="Line of credit facility">2,000</span>
(the &#8220;Loan&#8221;). The Loan is non-revolving and amounts paid back under the terms of the Smith Loan Agreement do not again
become available for drawdowns at the request of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will pay interest to Mr. Smith on amounts outstanding under the Loan and on any overdue interest at a rate equal to <span id="xdx_906_eus-gaap--LongTermDebtPercentageBearingVariableInterestRate_iI_pid_dp_uPure_c20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPfkxf2b6hih" title="Interest rate">10</span>%
per annum, calculated monthly in arrears, through to the date of repayment of the Loan. Mr. Smith</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">will also receive an
establishment fee equal to <span id="xdx_90C_eus-gaap--InvestmentCompanyExpenseRatioIncludingIncentiveFee_pid_dp_uPure_c20240909__20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdF9V3V2kD2i" title="Establishment fee">2.5</span>%
of the amount of any drawdown payable at the time of the drawdown as consideration of the advancement of such drawdown. Any
outstanding balance on the Loan, including accrued interest, shall be immediately due and payable by the Company on the
earlier of the date of expiration of the Smith Loan Agreement on June 30, 2025 and the occurrence of an event of default (the &#8220;Due Date&#8221;). The Company can repay the Loan at any time without notice and
without penalty, but any amount of principal or interest repaid by the Company prior to the Due Date will be subject to an
early payment fee of 2.5% of the value of any such payment. Amounts outstanding under the Smith Loan Agreement are secured by all of the Company&#8217;s assets pursuant to a general
security agreement between the Company and Mr. Smith, dated September 11, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lind
Consent Warrant Issuance</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 17, 2024, the Company&#8217;s Common Share price was below the threshold price set forth in the Lind Consent,
and accordingly, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20240916__20240917__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_ztWGhcl6704j" title="Number of share issued">2,816,742</span> Contingent Consent Warrants to Lind. Each Contingent Consent Warrant is
exercisable for one Common Share at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240917__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zZjnyfVO80tc" title="Exercise price">2.308</span> and may be exercised at any time prior
to their expiration on September 17, 2028. The number of Contingent Consent Warrants issued was based on $<span id="xdx_904_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20240916__20240917__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zmFZvJcF4Ujj" title="Warrants issued">5,000</span> divided by
the five-day volume weighted average price of the Common Shares on September 16, 2024.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283631296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DevelopmentStageIssuerPolicyTextBlock', window );">Development Stage Issuer</a></td>
<td class="text"><p id="xdx_84B_ecustom--DevelopmentStageIssuerPolicyTextBlock_z6Ky6LyWq3Wg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zOxMMr2INzx4">Development
                                         Stage Issuer</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#8220;S-K 1300&#8221;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#8217;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#8217;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zyKcv3ZE804d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
                                         and Cash Equivalents</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90
days or less, and money market funds. The Company maintains the majority of its cash balances with two financial institutions.
Accounts at banks in the United States (&#8220;U.S.&#8221;) are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;)
up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance Corporation (&#8220;CDIC&#8221;) up
to C$100. At June 30, 2024, the Company had $1,406 and $0 in excess of the FDIC and CDIC insured limits, respectively.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><p id="xdx_849_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zFpeUIPaGY17" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_863_zlLDdyLwxws8">Foreign
                                         Currency Translation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Functional
and reporting currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
included in the financial statements of each of the Company&#8217;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#8220;the functional currency&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency for these consolidated financial statements is U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in functional currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to March 17, 2023, the Company&#8217;s functional currency was the Canadian dollar. The Company re-assessed its functional currency
and determined that on March 17, 2023, its functional currency changed from the Canadian dollar to the U.S. dollar based on significant
changes in economic facts and circumstances in our organization. The change in functional currency was accounted for prospectively
from March 17, 2023 and prior-period consolidated financial statements were not restated for the change in functional currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
both monetary and non-monetary assets and liabilities, translated balances as of March 17, 2023 became the new accounting basis.
The exchange rate on the date of change became the historical rate at which non-monetary assets and liabilities were translated
in subsequent periods. There was no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded
cumulative translation adjustments were not reversed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency for the Company&#8217;s Canadian subsidiary, 0896800 BC Ltd., which has no independent operations from its
parent, also changed from the Canadian dollar to the U.S. dollar. The functional currency for Elk Creek Resources Corp. remains
as the U.S. dollar.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transactions
in foreign currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation
to reporting currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
gains and losses from the application of the U.S. dollar as the reporting currency for all periods prior to March 17, 2023 (when
the Canadian dollar was the functional currency) are included as part of cumulative currency translation adjustment, which is
reported as a component of shareholders&#8217; equity under accumulated other comprehensive loss.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_MineralPropertiesPolicyTextBlock', window );">Mineral Properties</a></td>
<td class="text"><p id="xdx_84F_ecustom--MineralPropertiesPolicyTextBlock_z871pBas3l0e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zFugxpbaTuvl">Mineral
                                         Properties</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of Common Shares issued as consideration. Properties acquired under option agreements,
whereby payments are made at the sole discretion of the Company, are capitalized as mineral property acquisition costs at such
time as the payments are made. Exploration costs are expensed as incurred. When it is determined that a mining deposit can be
economically and legally extracted or produced based on established proven and probable reserves under S-K 1300, and the Company&#8217;s
board of directors (the &#8220;Board&#8221;) has approved the commencement of formal development activities, development costs
related to such reserves and incurred after such board approval will be considered for capitalization. The establishment of proven
and probable reserves is based on results of feasibility studies, which indicate whether a property is economically feasible.
Upon commencement of commercial production, capitalized costs will be amortized over their estimated useful lives or units of
production, whichever is a more reliable measure. Capitalized amounts relating to a property that is abandoned or otherwise considered
uneconomic for the foreseeable future are written off.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#8217;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was no impairment recorded to mineral properties as of
June 30, 2024 or 2023, respectively.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long Lived Assets</a></td>
<td class="text"><p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBC9mEc6STt1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zEaiVHlVtH27">Long
                                         Lived Assets</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>













<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was no impairment recorded to long-lived assets as of June 30, 2024 or 2023, respectively.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zw3U6fHn81tj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_z26z4m9B3eV7">Leases</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Accounting Standards Codification (&#8220;ASC&#8221;) 842, <i>Leases</i>, we determine if a contractual arrangement is, or contains,
a lease at the inception date. Right-of-use (&#8220;ROU&#8221;) assets and liabilities related to operating leases are separately
reported in the consolidated balance sheets. The Company currently has no finance leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ConvertibleDebtCarriedatFairValueTextBlock', window );">Convertible Debt Carriedat Fair Value [Text Block]</a></td>
<td class="text"><p id="xdx_84B_ecustom--ConvertibleDebtCarriedatFairValueTextBlock_zFf3LGmktr5j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
                                         Debt Carried at Fair Value</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With regard to the Company&#8217;s debt related to the convertible promissory notes issued in April 2024 (as further discussed in
Note 9), the Company has elected to account for these notes at fair value per the provisions of ASC Topic 815, <i>Derivatives
and Hedging</i> (&#8220;ASC 815&#8221;). Under ASC 815-15-25, an election can be taken at the inception of a financial instrument
to account for the instrument at fair value. The notes were recorded at fair value at inception and assessed quarterly thereafter
using a Monte Carlo simulation methodology which incorporates multiple conversion scenarios. All changes in fair value subsequent
to the initial recording, excluding the impact of the change in fair value related to the Company&#8217;s own credit risk, are
recorded as a component of non-operating income/expense, within Change in fair value of convertible debt in the consolidated statements
of operations. Changes in fair value related to the Company&#8217;s own credit risk, if any, are recorded through other comprehensive loss.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_WarrantsPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><p id="xdx_84D_ecustom--WarrantsPolicyTextBlock_zVzXuHVnB1jg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_zFBuDFHSSjra">Warrants</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
apply relevant accounting guidance for warrants to purchase our stock based on the nature of the relationship with the counterparty.
For warrants issued to investors or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC
480, <i>Distinguishing Liabilities from Equity</i>, and ASC 815, to assist in the determination of whether the warrants should
be classified as liabilities or equity. The fair value of warrants is estimated using Black Scholes modeling or Monte Carlo modeling,
depending on the settlement features embedded in the warrant. Inputs under both models include inputs such as NioCorp&#8217;s
Common Share price, the risk-free interest rate, the expected term, the volatility, and the dividend rate. Warrants that are determined
to require liability classifications are measured at fair value upon issuance and are subsequently remeasured to their then fair
value at each subsequent reporting period with changes in fair value recorded in current earnings. Warrants that are determined
to require equity classifications measured at fair value upon issuance and are not subsequently remeasured unless they are required
to be reclassified.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarnoutSharesPolicy', window );">Earnout Shares Policy</a></td>
<td class="text"><p id="xdx_844_ecustom--EarnoutSharesPolicy_zXvZc6JpFmed" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
                                         Shares</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The Earnout Shares
are measured at fair value upon issuance and subsequently remeasured at each reporting period using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#8217;s Common Share price, the risk-free interest rate, the expected term, the weighted
average of historical Common Share volatility and implied volatility underlying the Company&#8217;s Public Warrants, the dividend
rate, the conversion price, and the number of Earnout Shares outstanding. Assumptions used in the model are subjective and require
significant judgment.</span>&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Financial Instruments</a></td>
<td class="text"><p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zeSl7pShaLzl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zymGassAsrg2">Financial
                                         Instruments</span></span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, receivables, equity securities, accounts payable and
accrued liabilities, notes payable, convertible debt, and the related party loan. It is management&#8217;s opinion that the Company
is not exposed to significant interest, currency or credit risks arising from its financial instruments. The fair values of these
instruments approximate their carrying value unless otherwise noted.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_ziM19jf9lqHl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zxxEgvrMFbk">Concentration
                                         of Credit Risk</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver, British Columbia and Santa Clara, California.
As part of its cash management process, the Company regularly monitors the relative credit standing of these institutions.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationsPolicy', window );">Asset Retirement Obligation</a></td>
<td class="text"><p id="xdx_845_eus-gaap--AssetRetirementObligationsPolicy_ze2r2G0Eiqnb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zLzHOWeAYgJ3">Asset
                                         Retirement Obligation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $<span id="xdx_908_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20240630_zOV4XPJ3gpjc">48</span> as an accrued liability related to
estimated obligations as of June 30, 2024 (2023 - $<span id="xdx_900_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20230630_zaXUsPjc7Ke4" title="Accrued exploration stage expense">48</span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss
in the period an estimate is revised.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zCv3nwIbVBba" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zgf1SsEh0XDb">Income
                                         Taxes</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, <i>&#8220;Income Taxes &#8211; Recognition.&#8221;
</i>Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#8220;more likely than not&#8221; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#8220;Income Taxes &#8211; Disclosure,&#8221;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2024 and 2023, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ReverseStockSplitPolicyTextBlock', window );">Reverse Stock Split</a></td>
<td class="text"><p id="xdx_84A_ecustom--ReverseStockSplitPolicyTextBlock_zcryDoHkjpUg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zixf7ipR0xk5">Reverse
                                         Stock Split</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2023, the Company effected a reverse stock split (the &#8220;Reverse Stock Split&#8221;) on the basis of one (1) post-Reverse
Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding, with any fractional
shares resulting from the Reverse Stock Split rounded down to the nearest whole share. Immediately after the Reverse Stock Split,
there were 30,000,442 Common Shares issued and outstanding. All references to share and per share amounts (excluding authorized
shares) in the consolidated financial statements and accompanying notes have been retroactively restated to reflect the Reverse
Stock Split.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_RedeemableNoncontrollingInterestPolicyTextBlock', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text"><p id="xdx_849_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zZYz7a3R8b5l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_z98S5JPclJ1a">Redeemable
                                         Noncontrolling Interest</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#8217;s control and is reported in the mezzanine section between total liabilities
and shareholders&#8217; deficit, as temporary equity in the Company&#8217;s consolidated balance sheets. The Company&#8217;s non-controlling
interest is redeemable at fair value, and no adjustment to the earnings per share numerator is required because redemption at
fair value is not considered an economic distribution different from other common stockholders.&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Per Share Disclosure</a></td>
<td class="text"><p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_z8mz8hNA0fja" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_z61ows0CsP4a">Basic
                                         and Diluted Per Share Disclosure</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average number
of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout Shares (each as defined
in Note 10), to be participating securities, requiring the use of the two-class method. Diluted earnings (loss) per share represents
net earnings (loss) attributable to common shareholders divided by the weighted average number of Common Shares outstanding, inclusive
of the dilutive impact of all potentially dilutive securities outstanding during the period, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z4oXpvuz7yij" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zmPdZGo8Jldb" style="width: 12%; text-align: right" title="Net loss::XDX::-11898"><span style="-sec-ix-hidden: xdx2ixbrl0652">(11,898</span></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230630_zZ8ZK7ESqopj" style="width: 12%; text-align: right" title="Net loss">(40,308</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Adjust: &#160;Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20230701__20240630_ztoS73kIOKx3" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::463"><span style="-sec-ix-hidden: xdx2ixbrl0656">458</span></td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zORNxPZyMr5f" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::228"><span style="-sec-ix-hidden: xdx2ixbrl0658">(251</span></td><td style="padding-bottom: 1pt; text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net loss available to participating securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zOIH99mkHtGl" style="text-align: right" title="Net loss available to participating securities">(11,440</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zS9EcMMR2GMc" style="text-align: right" title="Net loss available to participating securities">(40,057</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Net loss attributable to Vested Shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zqM20nkHogYb" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares">967</td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zbdm4thPBHWk" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares">1,528</td><td style="padding-bottom: 1pt; text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zg6rjKR1gZY5" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">(10,473</td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_zXsSreWXTDt5" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">(38,529</td><td style="padding-bottom: 2pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_znEa4o0ILxi4" style="text-align: right" title="Weighted average shares outstanding basic and diluted">34,320,024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zVCao1x4Trsc" style="text-align: right" title="Weighted average shares outstanding basic and diluted">28,705,840</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Loss per Common Share outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20240630_z6niy4YWEVQ" style="text-align: right" title="Loss per common share outstanding basic and diluted">(0.31</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_zxQjh92qxab4" style="text-align: right" title="Loss per common share outstanding basic and diluted">(1.34</td><td style="text-align: left">)</td></tr>
</table>

<p id="xdx_8A6_zoFmaRWAIf1b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following shares underlying options, warrants, and outstanding convertible debt were antidilutive due to a net loss in the periods
presented and, therefore, were excluded from the dilutive securities computation for the years ended June 30, 2024 and 2023, as
indicated below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zBrtvXc7lCd2" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; visibility: hidden"><span id="xdx_8B8_zZeo1Pcp509">Schedule of excluded from the dilutive securities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; border-collapse: collapse; width: 91%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded potentially dilutive securities <sup id="xdx_F69_zLunV1ebYId4">(1)(2)</sup>:</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; padding-left: 0.25in; text-indent: -0.125in">Options</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zvapHnoAM9w6" style="width: 12%; text-align: right" title="Options">2,495,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zWphhe01Uuyi" style="width: 12%; text-align: right" title="Options">1,541,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_z2ofRW7Lmgk" style="text-align: right" title="Warrants">18,563,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zBJov0ZymEgi" style="text-align: right" title="Warrants">18,816,304</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Convertible debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zlzyJMRW9Uj5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,849,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_zYJcZ1sPSRk5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,871,660</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Total potentially dilutive securities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_zaGrLyZ7nwpf" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities">23,908,061</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zfyvgekKOY25" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities">23,229,464</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify"><span id="xdx_F02_zLNq355T4bGf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F15_zGoQRZD8Ae11" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span id="xdx_F0C_ztq3eT2kaFPj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span id="xdx_F1B_z7xqga9FTee9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;</span></td></tr>
</table>

<p id="xdx_8A3_zqXUp5Ok9Uw2" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="margin-top: 0; margin-bottom: 0"></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share Based Compensation</a></td>
<td class="text"><p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zNUCQi67FfWd" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                    <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)</span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zCtXI4XN2huk">Share
                                         Based Compensation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants stock options to directors, officers, employees, and business advisors. Option terms and vesting conditions are
at the discretion of the Board. Prior to March 31, 2023, the option exercise price was equal to the closing market price on The
Toronto Stock Exchange (the &#8220;TSX&#8221;) on the day preceding the date of grant. Effective March 21, 2023, the option exercise
price is equal to the closing market price on the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) on the day preceding the date
of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of stock options using the Black-Scholes option pricing model. The Company recognizes forfeitures
as they occur.&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zxAhxkbPKgP9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">r)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_zloV9IAt35fk">Recent
                                         Accounting Standards</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Not Effective</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, <i>Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures</i>, which is intended to improve reportable segment disclosure requirements, primarily through
enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses
that are regularly provided to the chief operating decision maker and included within segment profit and loss. The amendments
are effective for the Company&#8217;s annual periods beginning July 1, 2024, and interim periods beginning July 1, 2025, with
early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. The
Company has evaluated the ASU and has determined that implementation will have limited impact on the Company&#8217;s disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>, which includes
amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation
categories and income taxes paid by jurisdiction. The amendments are effective for the Company&#8217;s annual periods beginning
June 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively. The Company is currently
evaluating the ASU to determine its impact on the Company&#8217;s disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#8217;s consolidated financial statements upon adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ConvertibleDebtCarriedatFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  convertible debt carriedat fair value text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ConvertibleDebtCarriedatFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DevelopmentStageIssuerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  development stage issuer policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DevelopmentStageIssuerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarnoutSharesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  earnout shares policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarnoutSharesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_MineralPropertiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  mineral properties policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_MineralPropertiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_RedeemableNoncontrollingInterestPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  redeemable noncontrolling interest policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_RedeemableNoncontrollingInterestPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ReverseStockSplitPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  reverse stock split policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ReverseStockSplitPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_WarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  warrants policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_WarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal obligation associated with retirement of long-lived asset that results from acquisition, construction, or development or from normal operation of long-lived asset. Excludes environmental remediation liability from improper or other-than-normal operation of long-lived asset, obligation arising in connection with leased property that meets definition of lease payments or variable lease payments and from plan to sell or otherwise dispose of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//410-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284275280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated.</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zf69pR31uxh6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; width: 97%; border-collapse: collapse">
<tr>
    <td colspan="2" rowspan="2" style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiary</span></td>
    <td rowspan="2" style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction
    of incorporation</span></td>
    <td>&#160;</td>
    <td colspan="3" style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    at June 30,</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="border-top: Black 1pt solid; width: 28%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800 BC Ltd. (&#8220;0896800&#8221;)</span></td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="border-top: Black 1pt solid; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zjCmO2yFTGz4" title="Country of incorporation"><span id="xdx_903_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zLkrTedR6Li4" title="Country of incorporation">British
    Columbia, Canada</span></span></span></td>
    <td style="width: 1%">&#160;</td>
    <td id="xdx_98D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_z8rt1hY4BU3k" style="border-top: Black 1pt solid; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td style="width: 1%">&#160;</td>
    <td id="xdx_98E_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zaMVCXvGfrKf" style="border-top: Black 1pt solid; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zThpzWj8ANz1" title="Country of incorporation"><span id="xdx_909_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_z64JqIVxOu5i" title="Country of incorporation">Nebraska,
    USA</span></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zWG4d2e4K7Ck" title="Percentage of ownership">100</span>% </span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp. (&#8220;ECRC&#8221;)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zOzbwCizq231" title="Country of incorporation"><span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zvuBARcqoNpk" title="Country of incorporation">Delaware,
    USA</span></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zw7RJNX49Ww2" title="Percentage of ownership">79.7</span>%<sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zi1J736PuuGf" title="Percentage of ownership">79.1</span>%<sup>(1)</sup></span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    Technologies Limited</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zIJCeRfSoK58" title="Country of incorporation"><span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zc2xV3GIE6R7" title="Country of incorporation">United
    Kingdom</span></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zqOqhWwkifdi" title="Percentage of ownership">100</span>%</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span id="xdx_F09_zSzo3oHuagfl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F1C_zdZyBZKB7Z3f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents 100% of Class A common stock owned by 0896800, and 4,282,116 and 4,565,808 Vested Shares and 3,391,596 and 3,391,596
Earnout Shares (each as defined below) held by third parties, and outstanding as of June 30, 2024 and 2023, respectively.</span></td></tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4M<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284277184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders:</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z4oXpvuz7yij" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zmPdZGo8Jldb" style="width: 12%; text-align: right" title="Net loss::XDX::-11898"><span style="-sec-ix-hidden: xdx2ixbrl0652">(11,898</span></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230630_zZ8ZK7ESqopj" style="width: 12%; text-align: right" title="Net loss">(40,308</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Adjust: &#160;Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20230701__20240630_ztoS73kIOKx3" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::463"><span style="-sec-ix-hidden: xdx2ixbrl0656">458</span></td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zORNxPZyMr5f" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::228"><span style="-sec-ix-hidden: xdx2ixbrl0658">(251</span></td><td style="padding-bottom: 1pt; text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net loss available to participating securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zOIH99mkHtGl" style="text-align: right" title="Net loss available to participating securities">(11,440</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zS9EcMMR2GMc" style="text-align: right" title="Net loss available to participating securities">(40,057</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Net loss attributable to Vested Shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zqM20nkHogYb" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares">967</td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zbdm4thPBHWk" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares">1,528</td><td style="padding-bottom: 1pt; text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zg6rjKR1gZY5" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">(10,473</td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_zXsSreWXTDt5" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">(38,529</td><td style="padding-bottom: 2pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_znEa4o0ILxi4" style="text-align: right" title="Weighted average shares outstanding basic and diluted">34,320,024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zVCao1x4Trsc" style="text-align: right" title="Weighted average shares outstanding basic and diluted">28,705,840</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Loss per Common Share outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20240630_z6niy4YWEVQ" style="text-align: right" title="Loss per common share outstanding basic and diluted">(0.31</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_zxQjh92qxab4" style="text-align: right" title="Loss per common share outstanding basic and diluted">(1.34</td><td style="text-align: left">)</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock', window );">Schedule of excluded from the dilutive securities</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zBrtvXc7lCd2" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; visibility: hidden"><span id="xdx_8B8_zZeo1Pcp509">Schedule of excluded from the dilutive securities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; border-collapse: collapse; width: 91%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded potentially dilutive securities <sup id="xdx_F69_zLunV1ebYId4">(1)(2)</sup>:</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; padding-left: 0.25in; text-indent: -0.125in">Options</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zvapHnoAM9w6" style="width: 12%; text-align: right" title="Options">2,495,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zWphhe01Uuyi" style="width: 12%; text-align: right" title="Options">1,541,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_z2ofRW7Lmgk" style="text-align: right" title="Warrants">18,563,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zBJov0ZymEgi" style="text-align: right" title="Warrants">18,816,304</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Convertible debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zlzyJMRW9Uj5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,849,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_zYJcZ1sPSRk5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,871,660</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Total potentially dilutive securities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_zaGrLyZ7nwpf" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities">23,908,061</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zfyvgekKOY25" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities">23,229,464</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify"><span id="xdx_F02_zLNq355T4bGf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F15_zGoQRZD8Ae11" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span id="xdx_F0C_ztq3eT2kaFPj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span id="xdx_F1B_z7xqga9FTee9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368281808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2023 GXII TRANSACTION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedFinancialStatementsTableTextBlock', window );">The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023:</a></td>
<td class="text"><p id="xdx_897_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zKUVvNELzpWg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the distribution of funds to GXII redeeming shareholders and prior to paying transaction costs incurred by GXII, $15,676 became
available to the Company. <span id="xdx_8B5_zTrPe6YC7z0a">The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements
of Operations and Comprehensive Loss for the year ended June 30, 2023:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td id="xdx_497_20240630_zDLUSx4h8pj3" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_pn3n3_zi1H2eW1ntTi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 79%; text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Gross cash proceeds, net of transaction costs incurred by GXII</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,168</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zmURVwpgdLe8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Cash costs associated with the 2023 Transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_zNLMqDZy6U37" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net liabilities assumed</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">392</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_iI_pn3n3_zabKhGg8SDZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Yorkville Equity Facility Financing Agreement &#8211; cash costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,996</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_iI_pn3n3_zgg3OYDVUrzd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Transaction costs expensed</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,715</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_pn3n3_zA4xcJ5lWgtl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Non-cash costs associated with the 2023 Transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_iI_pn3n3_z3WnogewIok8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Private Warrants assumed at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,987</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--EarnoutSharesAssumedAtFairValue_iI_pn3n3_zuyWFtL9oZ09" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Earnout Shares assumed at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,195</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_pn3n3_znImeCHUfwpi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Yorkville Equity Facility Financing Agreement &#8211; shares issued</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">650</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pn3n3_zWeKgiDlfUgl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">&#160;Total transaction related losses incurred</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">23,767</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock', window );">The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows</a></td>
<td class="text"><p id="xdx_891_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_zC7xeqbOOV0j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zxM4hW8dTdzj">The
number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Common Shares</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Percentage</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Legacy NioCorp Shareholders</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zWOIlnILdPP5" style="width: 12%; text-align: right" title="Common stock, shares outstanding">28,246,621</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zW4jrfzTP7ue" title="Number of shares, percentage">93.90</span></td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former GXII Class A Shareholders<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zOkXCQtlUpi4" style="text-align: right">1,753,821</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zjbTVwksDMg" title="Number of shares, percentage">5.83</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<sup>(2)</sup></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--OtherMember_fKDIp_z6u5pI41BQMa" style="border-bottom: Black 1pt solid; text-align: right">81,213</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--OtherMember_fKDIp_z5IF8MmrkA0h" title="Number of shares, percentage">0.27</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Total Common Shares Outstanding Upon Completion of 2023 Transactions</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_dxL_uShares_c20240630_zAmY6gSaz2Jf" style="border-bottom: Black 2pt solid; text-align: right" title="Common stock, shares outstanding::XDX::38062647"><span style="-sec-ix-hidden: xdx2ixbrl0782">30,081,655</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; text-align: right"><span id="xdx_908_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630_zS4TL18wCk9j" title="Number of shares, percentage">100</span></td><td style="padding-bottom: 2pt; text-align: left">%</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span id="xdx_F0F_zeKfNxmYnfgg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_zf9p9PT20DCa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span id="xdx_F0F_zSrKWsF1MpYe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_zGgsi7nrWCx7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.</span></td></tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedFinancialStatementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedFinancialStatementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724375705632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LAND AND BUILDINGS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of properties</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--PropertyPlantAndEquipmentTextBlock_zsf5VlsY2OS6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zjH7iNtlzLg1" style="display: none; visibility: hidden">Schedule of properties</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="22" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Depreciation</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Depreciation</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%">Land</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zdsre1YFxA19" style="width: 9%; text-align: right" title="Cost">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_z8IUo9bs8WCa" style="width: 9%; text-align: right" title="Accumulated depreciation">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_ze0jotrhr99" style="width: 9%; text-align: right" title="Net">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zgzb5HDz3Gv5" style="width: 9%; text-align: right" title="Cost">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zPDF3VqB2a11" style="width: 9%; text-align: right" title="Accumulated depreciation">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zcM9L3E1goE8" style="width: 9%; text-align: right" title="Net">807</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Buildings and other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zIruABl0K3Vd" style="border-bottom: Black 1pt solid; text-align: right">41</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zK2z9QutyQH9" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">11</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zXXhxMlWSw7j" style="border-bottom: Black 1pt solid; text-align: right">30</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zecxZ01MMXsk" style="border-bottom: Black 1pt solid; text-align: right">41</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zxcPsPXvzPvi" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">9</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_ztpKRWIFA8Rf" style="border-bottom: Black 1pt solid; text-align: right">32</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630_zTFX7EcRu9ei" style="border-bottom: Black 2pt solid; text-align: right">848</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630_zyi03axIe7R8" style="border-bottom: Black 2pt solid; text-align: right">11</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630_zSD4lpbEdZd6" style="border-bottom: Black 2pt solid; text-align: right">837</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630_zl74fad9yrjh" style="border-bottom: Black 2pt solid; text-align: right">848</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630_zV0lmdm7Fp4k" style="border-bottom: Black 2pt solid; text-align: right">9</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630_zMxKOpXKn491" style="border-bottom: Black 2pt solid; text-align: right">839</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368421168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of account payable and accrued liabilities</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zUzytk9bw3B5" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; visibility: hidden"><span id="xdx_8BE_zOLTfAnTn5S7">Schedule of account payable and accrued liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_498_20240630_z0efgPplLRZ6" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49F_20230630_ztm9nDAsd6ke" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zEzHFlCkCtdj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-left: 5pt">Accounts payable, trade</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,417</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,990</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_zQP2rw5TezS1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Trade payable accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,324</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zSiuC12OJN7h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Income taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zzpM6NFCfkoh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Environmental accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zn7w7eYXPj3g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt">Loan origination fees payable to related party</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_ziNEuC5jSt1d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 5pt">Total accounts payable and accrued liabilities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">1,843</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">3,491</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283866032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock', window );">Schedule of convertible debt</a></td>
<td class="text"><p id="xdx_891_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_znt2ASmxe8F3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"><span id="xdx_8B2_zuddybIb4Vbi">Schedule
of convertible debt</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Current Portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-left: 0.25in">Yorkville convertible debentures:</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleSecurityMember_z4al58ZIKgad" style="width: 10%; text-align: right" title="Convertibled debt, current">571</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zm6prukscnK8" style="width: 10%; text-align: right" title="Convertibled debt, current"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in">April 2024 notes</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zlWSwZHZYha8" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current">7,089</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zA3WMLa7U3Ok" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Total Current Portion</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zqhajbNKEC34" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current">7,660</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zPkuDigqFcJ" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Noncurrent Portion &#8211; Yorkville convertible debenture</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zyU1pL7QKcPe" style="border-bottom: Black 2pt solid; text-align: right" title="Convertible debt, noncurrent"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zH3wR4pfycCb" style="border-bottom: Black 2pt solid; text-align: right" title="Convertible debt, noncurrent">10,561</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock', window );">Changes in the Lind III Convertible Security are as follows</a></td>
<td class="text"><p id="xdx_895_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_z1i0WPYFDhT9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zhg0BZ2GTAlh">Changes
in the Lind III Convertible Security are as follows</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ending <br/>
June 30, 2023</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
    balance</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_znePfQEwOtqi" style="width: 10%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,169</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value increase due to debt extinguishment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_ztsEgdWtpGJj" style="text-align: right" title="Fair value increase due to debt extinguishment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversions</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"></td>
    <td id="xdx_98E_eus-gaap--ConversionOfStockAmountIssued1_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zC9ggsIYxk2" style="text-align: right" title="Conversions">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,950</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion
    expense</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zynamc468rZ5" style="text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    at maturity</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"></td>
    <td id="xdx_989_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zutaLWwXJZkh" style="border-bottom: Black 1pt solid; text-align: right" title="Payment at maturity"><span style="font: 10pt Times New Roman, Times, Serif">(</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">515</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June
    30, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zt6CCQWihBv3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0916">-</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock', window );">The following table summarizes the components of the initial loss and final loss on extinguishment:</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfExtinguishmentOfDebtTextBlock_z5sVttqay9U8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">&#160;<span id="xdx_8BC_zCpNCSkq0uk1">The following table summarizes the components of the initial loss and final loss on extinguishment:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Component
    of loss</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20230701__20240630_zuwKBTzqeyhe" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--MinimumConsentPaymentAtInception_pn3n3_z0lvL9KTt57k" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 77%; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum
    Consent Payment at inception</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--ASC470LossOnExtinguishment_pn3n3_zUh8DOXqOWIk" style="vertical-align: bottom">
    <td style="text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on debt extinguishment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--AdjustmentOfWarrantsGrantedForServices_pn3n3_zVOTyhwsJj76" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; width: 77%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    fair value of Contingent Consent Warrants</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,221</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_pn3n3_zAI1LwFFQNHl" style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    loss on debt extinguishment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,622</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--AdditionalConsentPaymentbooked_pn3n3_zJow2YPMqar3" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    Consent Payment booked<sup id="xdx_F4F_zp1q7smy2gme">(1)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--GainsLossesOnRestructuringOfDebt_pn3n3_zJTCgIi1gapg" style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    loss on debt extinguishment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,922</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify"><span id="xdx_F02_zkh2PLuTpzb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F10_zhOm4ESnSM54" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.</span></td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfWarrantValuationTableTextblock', window );">The change in the fair value of the Contingent Consent Warrants is presented below:</a></td>
<td class="text"><p id="xdx_89C_ecustom--ScheduleOfWarrantValuationTableTextblock_zhE2hs07LbYc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zUGu0r4iMI85">The
change in the fair value of the Contingent Consent Warrants is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 37%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    valuation, September 25, 2022</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iS_c20220701__20230630_zQIK8izaqrz6" style="width: 10%; text-align: right" title="Initial valuation, at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,221</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_ecustom--ChangeInValuationOfWarrants_c20220701__20230630_zEMPS1TodF55" style="border-bottom: black 1pt solid; text-align: right" title="Change in valuation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    at June 30, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iE_c20220701__20230630_zPAsfAyTEG52" style="text-align: right" title="Valuation, at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,710</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ChangeInValuationOfWarrants_c20230701__20240630_zf3RqufC5qwc" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    at June 30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iE_c20230701__20240630_zUJWpt80Idq6" style="border-bottom: black 1.5pt solid; text-align: right" title="Valuation, at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,365</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock', window );">Schedule of valuation date and the probability calculated</a></td>
<td class="text"><p id="xdx_892_ecustom--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_zSUmcTMTX2Ac" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; visibility: hidden"><span id="xdx_8BA_zBUzmwMhlFg3">Schedule of valuation date and the probability calculated</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto">
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
    Valuation Input</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></p></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></p></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&#160;25,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="background-color: #CCECFF">
    <td style="vertical-align: bottom; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    price on valuation date</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zmA2MRDKFa6b" style="vertical-align: bottom; width: 10%; text-align: right" title="Share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.73</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zxaoQRZH10k3" style="vertical-align: bottom; width: 10%; text-align: right" title="Share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zfbGiT624Uak" style="vertical-align: bottom; width: 10%; text-align: right" title="Share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.82</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_z8DzHiw5SFZ5" style="vertical-align: bottom; text-align: right" title="Volatility"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.0</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zmTiN5M68p39" style="vertical-align: bottom; text-align: right" title="Volatility"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.0</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zfGp98M0egGa" style="vertical-align: bottom; text-align: right" title="Volatility"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62.4</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="background-color: #CCECFF">
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    free rate</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zD3RKNi7vBcd" style="vertical-align: bottom; text-align: right" title="Risk free rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.40</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zxLbhvVnRKpf" style="vertical-align: bottom; text-align: right" title="Risk free rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_z7RRe4dMVIHe" style="vertical-align: bottom; text-align: right" title="Risk free rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.93</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Probability
    of issuance</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_z5dUA5BPSK76" style="vertical-align: bottom; text-align: right" title="Probability of issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.0</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zxbvx5XAiIQj" style="vertical-align: bottom; text-align: right" title="Probability of issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.8</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zd04jufot4vl" style="vertical-align: bottom; text-align: right" title="Probability of issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59.4</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Changes in the Convertible Debentures are as follows:</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ConvertibleDebtTableTextBlock_zCZIt9LXAG1b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_ziH8btiidYhl">Changes
in the Convertible Debentures are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 2%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opening balance,
    March 17, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230315__20230630_zmxNCG0LTaxa" style="text-align: right" title="Opening balance, March 17, 2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,153</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion expense</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230315__20230630_z7wTzvPSLpPe" style="text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,962</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal and accrued
    interest converted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: left"></td>
    <td id="xdx_98B_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230315__20230630_zCfSSCzz9So1" style="border-bottom: black 1pt solid; text-align: right" title="Principal and accrued interest converted"><span style="font: 10pt Times New Roman, Times, Serif">(</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,554</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30,
    2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230701__20240630_zPQTp9SJcDme" style="text-align: right" title="Balance, June 30, 2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,561</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion expense</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230701__20240630_zDYYc4CSjGa3" style="text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,489</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal and accrued
    interest converted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_987_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230701__20240630_zICELzkeyOA" style="border-bottom: black 1pt solid; text-align: right" title="Principal and accrued interest converted"><span style="font: 10pt Times New Roman, Times, Serif">(</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,479</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30,
    2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--ConvertibleDebt_iE_pn3n3_c20230701__20240630_zPFMd0apsUA3" style="text-align: right" title="Balance, June 30, 2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">571</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Less: Unamortized
    debt issuance costs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_98E_eus-gaap--PaymentsOfFinancingCosts_pn3n3_dxL_c20230701__20240630_z329JUk6wQ66" style="border-bottom: black 1pt solid; text-align: right" title="Add: uamortized debt issuance costs::XDX::0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1050">(</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining principal
    balance, June 30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iE_pn3n3_c20230701__20240630_z89uW0w9kQQl" style="border-bottom: black 1.5pt solid; text-align: right" title="Balance, June 30, 2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">550</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock', window );">The following table discloses the components of interest expense associated with the Convertible Debentures.</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_zWJVatfuywXk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
conversion, the portion of remaining unamortized issuance costs associated with the conversion are recognized as a component of
interest expense. <span id="xdx_8BF_zvWjZ9Y2PN97">The following table discloses the components of interest expense associated with the Convertible Debentures.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ending June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Component of Interest Expense</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: justify">Contractual &#160;interest</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--ContractualInterest_c20230701__20240630_zNFOoCJrv9K" style="width: 14%; text-align: right" title="Contractual interest">279</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--ContractualInterest_c20220701__20230630_zvrniZHfvDw8" style="width: 14%; text-align: right" title="Contractual interest">225</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Amortization of discount and issuance costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AmortizationOfFinancingCosts_c20230701__20240630_zq65XXL4La31" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs">4,210</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AmortizationOfFinancingCosts_c20220701__20230630_zE9KM6YtcXGb" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs">1,737</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--InterestAndDebtExpense_c20230701__20240630_zad4crZ0IL64" style="border-bottom: Black 2pt solid; text-align: right" title="Total">4,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--InterestAndDebtExpense_c20220701__20230630_zfgz1HD72KHf" style="border-bottom: Black 2pt solid; text-align: right" title="Total">1,962</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock', window );">The following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes:</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfInterestRateDerivativesTableTextBlock_zHNvXdAmOAT3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zfUrMHRhCZu5">The
following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left">Key Valuation Input</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">June 30,&#160; <br/>2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">April 12,&#160; <br/>2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98C_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhqSFnTS9d7e" style="width: 21%; text-align: center" title="Closing common share price">$1.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98F_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zmBICTXydg34" style="width: 21%; text-align: center" title="Closing common share price">$3.11</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zaJ72QA4j4Ce" title="Term (expiry)">December 31, 2024</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zADAFpNQqTH9" title="Term (expiry)">December 31, 2024</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted average of the equity volatility and implied volatility of the public warrants</td><td>&#160;</td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zBICEfh0rBGg" style="text-align: center" title="Weighted average of the equity volatility and implied volatility of the public warrants">80%</td><td style="text-align: left"></td><td>&#160;</td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIUl1VeCkHje" style="text-align: center" title="Weighted average of the equity volatility and implied volatility of the public warrants">66.0%</td><td style="text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zdy5tTkY5Qdb" style="text-align: center" title="Risk-free rate">5.33%</td><td style="text-align: left"></td><td>&#160;</td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zqR3GtXVGbL4" style="text-align: center" title="Risk-free rate">5.26%</td><td style="text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Implied discount rate</td><td>&#160;</td>
    <td id="xdx_982_ecustom--ImpliedDiscountRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zyuehdXX7kk3" style="text-align: center" title="Implied discount rate">15.0%</td><td style="text-align: left"></td><td>&#160;</td>
    <td id="xdx_984_ecustom--ImpliedDiscountRate_pid_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z4V10XbqMFRl" style="text-align: center" title="Implied discount rate">15.0%</td><td style="text-align: left"></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">The following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024:</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_zJ9Smiw7Z0uf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zpAR7ydiCVOb">The
following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 47%; text-align: justify">Fair value, April 12, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20230701__20240630_z2jv5DxV4aAj" style="width: 10%; text-align: right" title="Fair value, April 12, 2024">10,315</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Principal payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20230701__20240630_zJI5vBB9C5pf" style="text-align: right" title="Principal payments">(1,512</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Change in fair value</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--ChangeInFairValue_iN_di_c20230701__20240630_zx4TGDsCPam" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">(1,714</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2pt">Balance, June 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_c20230701__20240630_zHeWpD3PZia7" style="border-bottom: Black 2pt solid; text-align: right" title="Balance, June 30, 2024">7,089</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Remaining principal balance, June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_c20230701__20240630_zjHqglcvRBN3" style="text-align: right" title="Remaining principal balance, June 30, 2024">7,128</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock', window );">The following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants.</a></td>
<td class="text"><p id="xdx_89F_ecustom--ShareholdersEquityAndShareBasedWarrantsTextBlock_zh3qMPNxLzI3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zQEb40a2NLt7">The
following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,&#160; <br/>2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">April 12,&#160; <br/>2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zPmCPTpX0pW3" style="width: 15%; text-align: right" title="Closing Common Share price">1.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z20QFBugWrD5" style="width: 15%; text-align: right" title="Closing Common Share price">3.24</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFsziBESTP1e" style="text-align: right" title="Term (years)">2.78</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQd3COrPHMv7" style="text-align: right" title="Term (years)">3.0</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFipjWoRMIF9" style="text-align: right" title="Expected volatility">66.34</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwkJ8FX3AS7l" style="text-align: right" title="Expected volatility">62.39</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zURmgUpQIT27" style="text-align: right" title="Risk-free rate">4.57</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZymoChGO0h6" style="text-align: right" title="Risk-free rate">4.77</td><td style="text-align: left">%</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">The following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June 30, 2024.</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_z5JKzlucfzUh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zrCdDv1tM1Nh">The
following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June
30, 2024.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 47%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of April 12, 2024</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z0iuzQNGBL5" style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">902</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_988_eus-gaap--FairValueAdjustmentOfWarrants_iN_pn3n3_di_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z3qby1HDA9Jj" style="border-bottom: black 1pt solid; text-align: right">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">604</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of June 30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zRvILZ43JrPb" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">298</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  fair value assets and liabilities measured on recurring and nonrecurring monte carlo techniques table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  schedule of changes in lind iii convertible security one text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of changes in lind iii convertible security text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfWarrantValuationTableTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  schedule of changes in lind iii convertible security one text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfWarrantValuationTableTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents shareholders equity and share based warrants text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (b)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of debt extinguished which may include, amount of gain (loss), the income tax effect and the per share amount of the aggregate gain (loss), net of the related income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481244/470-50-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the detailed components of other nonoperating expenses. This disclosure may include methodology, assumptions and amounts for : (a) losses on securities (net of profits) and (b) miscellaneous income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724382885776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract', window );"><strong>Class B Common Stock Of Ecrc</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock', window );">The following table discloses the primary inputs into the Monte Carlo models.</a></td>
<td class="text"><p id="xdx_89C_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zDefajNB1qE" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zmVlM2iqUTHk" style="display: none; visibility: hidden">The following table discloses the primary inputs into the Monte Carlo models.</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left">Key Valuation Input</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>
2023</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">March 17, <br/>
2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: left">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJv4vq5K4bTb" style="width: 13%; text-align: center" title="Closing common share price">$1.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJydUB0JDn5k" style="width: 13%; text-align: center" title="Closing common share price">$5.03</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_981_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zjcDHDNjyqr3" style="width: 13%; text-align: center" title="Closing common share price">$7.00</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; vertical-align: top">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlN1m5Fe2Jm8" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zW1FZ1Te9q55" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zLuZFFoxgCEa" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zu1umMnDVy6a" title="Implied volatility of public warrants">65.0</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zCKwC7xnccL2" title="Implied volatility of public warrants">33.5</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zw3II2SHIbH8" title="Implied volatility of public warrants">19.5</span>%</td><td style="text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zPFG7rb1vSrb" title="Risk-free rate">4.35</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTZ1viASsVS8" title="Risk-free rate">3.83</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zOOGRta5PSok" title="Risk-free rate">3.39</span>%</td><td style="text-align: left"></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock', window );">The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2024:</a></td>
<td class="text"><p id="xdx_891_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z9eWTOTSPLte" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zNWKTfXspJW4">The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 47%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of March 17, 2023</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230315__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zw5yyEtakKkc" style="width: 10%; text-align: right" title="Fair value at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,195</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20230315__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z437Lf6iNWm7" style="border-bottom: black 1pt solid; text-align: right" title="Change in fair value">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,674</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of June 30, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zMQCqvLOjN0c" style="text-align: right" title="Fair value at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,521</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_987_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zL4LH2VZupBd" style="border-bottom: black 1pt solid; text-align: right" title="Change in fair value">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,704</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of June 30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zGe47ofFlYRh" style="border-bottom: black 1.5pt solid; text-align: right" title="Fair value at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,817</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureClassBCommonStockOfEcrcAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  schedule of primary inputs into the monte carlo models table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  schedule ofsummary of the changes in the fair value of the earnout share liability table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283119696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Schedule of stock option</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_zWGZKuGVAEe2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_z0jy0iletlJc" style="display: none; visibility: hidden">Schedule of stock option</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Number of Options</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Exercise Price</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Aggregate Intrinsic Value</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Remaining Contractual Life</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2023</span></td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230701__20240630_zye0TeAXrv1b" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Beginning balance">1,541,500</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20230701__20240630_zqAAL9m57Goh" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Beginning balance">7.19</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Granted</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230701__20240630_zUeNkdqhxVWd" style="text-align: right" title="Granted, in shares">1,625,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zwKafKcDrL35" style="text-align: right" title="Granted, per share">2.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Exercised</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230701__20240630_zWX5btsMY8Zb" style="text-align: right" title="Cancelled/expired, in shares">(7,800</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zd1ix0BCB8Yg" style="text-align: right" title="Cancelled/expired, per share">3.95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Cancelled/expired</span></td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230701__20240630_zYPoYl8DeWhh" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, in shares">(663,200</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zkovxxki1jm2" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, per share">5.88</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20230701__20240630_zb2buhWzOMM3" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">2,495,500</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20230701__20240630_zWtr5uPr8tR6" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">4.78</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">-</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20230701__20240630_zyNXfsZgVxv2" title="Weighted average remaining contractual life::XDX::P3Y5M9D"><span style="-sec-ix-hidden: xdx2ixbrl1322">3.44</span></span> years</span></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">The following table summarizes the weighted average information and assumptions used to determine option costs:</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z2kBH6g6jsd2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the weighted average information and assumptions used to determine option costs:&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 70%; margin-left: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_491_20230701__20240630_zJT66EgqTjpc" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_492_20220701__20230630_zMJX0iLpVci" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 4pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">Year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 4pt">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">2023</td><td>&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_za4ZZCglBnD3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-left: 4pt">Fair value per option granted during the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 10%; text-align: right">$1.71</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 10%; text-align: right">$3.09</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_zKro84PDHlkd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 4pt">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.30</td><td style="text-align: left">%</td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zf36kUWNMGyg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 4pt">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_zS7Liq7OcSJl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 4pt">Expected stock price volatility (historical basis)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63.6</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 4pt">Expected option life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630_zUuwWwGG7Rlg" style="text-align: right" title="Expected option life in years::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1344">5.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220701__20230630_zh9CTGbFc9Pl" style="text-align: right" title="Expected option life in years::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1346">3.0</span></td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates.</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zajsKuOKR16b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
transactions are summarized as follows. <span id="xdx_8BC_zyqEmpR0lZz1">Weighted average exercise prices related to Canadian dollar denominated warrants were
converted to U.S. dollars using end of period foreign currency exchange rates.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0"></p>
                                   <p style="margin-top: 0; margin-bottom: 0"></p></td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Warrants</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Exercise Price</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Balance, June 30, 2022</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20220701__20230630_z8XckUuBZlg4" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Beginning balance">1,851,622</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20220701__20230630_zlPFz7KFYO25" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Balance at beginning average price">8.99</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Granted:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Yorkville financing warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--YorkvilleFinancingWarrants_pid_uShares_c20220701__20230630_zsM2GDSooiDh" style="text-align: right" title="Yorkville financing warrants">1,789,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_pid_uUSDPShares_c20220701__20230630_zuRZJAtK8XX7" style="text-align: right" title="Yorkville financing warrants average price">8.94</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">GXII warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--GxiiWarrants_pid_uShares_c20220701__20230630_zHMJkushqd4a" style="text-align: right" title="GXII warrants">15,666,626</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_pid_uUSDPShares_c20220701__20230630_zJ7RdbGA8fG" style="text-align: right" title="GXII warrant average price">11.50</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20220701__20230630_zwtkNzObpjxd" style="border-bottom: Black 1pt solid; text-align: right">(491,211</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20220701__20230630_z9twSZGNm2y1" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled">11.67</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20230701__20240630_zurKJrQeN0hh" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance">18,816,304</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20230701__20240630_zjTCrM0X5K51" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at beginning average price">10.98</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20230701__20240630_z0W5fkGoigqf" style="text-align: right" title="Granted">1,593,817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20230701__20240630_zPvax70AxKZh" style="text-align: right" title="Granted">3.33</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20230701__20240630_z3hKFny45BZb" style="border-bottom: Black 1pt solid; text-align: right">(1,846,560</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20230701__20240630_zcw1PQYD0wEb" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled">8.67</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in">Balance, June 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20230701__20240630_zpRUOUmiGBv8" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">18,563,561</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iE_pid_uUSDPShares_c20230701__20240630_zE325rBL0CJ7" style="border-bottom: Black 2pt solid; text-align: right" title="Balance at ending average price">10.53</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock', window );">At June 30, 2024, the Company has outstanding exercisable warrants, as follows:</a></td>
<td class="text"><p id="xdx_89E_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zfZlJxw1mQ28" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zpt6fAXGWFI7">At
June 30, 2024, the Company has outstanding exercisable warrants, as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
    Date</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zoXC4JVPcOGg" style="width: 16%; text-align: right" title="Number of share outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">855,800</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zGpJ8aCGpI45" title="Exercise price">9.70</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zeHof6GKu6p" style="width: 60%; text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-02-19"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1393">February
    19, 2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zDEglaeylwUe" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">447,318</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zOMzWTH7SnI3" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$8.94</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zhUsGKRWEASg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zdGPamuZW8j" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.60</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_z2x4fRJLJVIj" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-09-01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1401">September
    1, 2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zYi3g4pIj88e" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">413,432</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zntLCYZYgUF1" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3.54</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zSP9E4t43nVc" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-12-22"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1406">December
    22, 2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zIJjZwTBQP0d" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">315,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zQIyFNHSsqQb" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zE506OVXL2qa" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-06-24"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1411">June
    24, 2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_z6HnfquTlHxc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">615,385</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zFf6iyBUoy03" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3.25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zpbNSKQf8iMl" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2027-04-12"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1416">April
    12, 2027</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z9oNsluQzth" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,666,626</span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z0pvMgx2Hztl" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$11.50</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zJ17oOr84gIc" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2028-03-17"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1421">March
    17, 2028</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630_zjf9tMeF7pac" style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,563,561</span></td><td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; padding-right: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 2.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span id="xdx_F0F_zHWjoLgb5ZYh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: left"><span id="xdx_F1E_zX2isN3oIiNc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expires
    in 3 equal monthly tranches on July 17, 2024, August 17, 2024, and September 17, 2024.</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions:</a></td>
<td class="text"><p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zHgR48wJZmoa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zLLrOhG6vMfk">The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a
Black Scholes model with the following assumptions:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 17, 2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 31%; text-align: justify">Stock price on valuation date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1Z5rDZjdkV4" style="width: 10%; text-align: right" title="Stock price on valuation date">1.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFE6f8V4pHcc" style="width: 10%; text-align: right" title="Stock price on valuation date">5.03</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKti9c2iZ2ub" style="width: 10%; text-align: right" title="Stock price on valuation date">7.00</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zOtZwGvw2vs9" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWcBARjHuf42" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhgD62xwvIt6" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4ENW3fVdG78" title="Implied volatility of public warrants">69.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zCWPeAEkl5yl" title="Implied volatility of public warrants">33.5</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeImYtHqK0Mf" title="Implied volatility of public warrants">19.5</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXiirYGbXKZb" title="Risk free rate">4.45</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFq3HWAZU19c" title="Risk free rate">4.18</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zMKev04i1UE2" title="Risk free rate">3.47</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zcsificTC6ej" title="Dividend yield">0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDKPV2q7L2Wl" title="Dividend yield">0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zvsYn0LvsLYd" title="Dividend yield">0</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected warrant life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zcG5EAX3qLbj" title="Expected warrant life in years::XDX::P3Y8M12D"><span style="-sec-ix-hidden: xdx2ixbrl1472">3.7</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjMLr3IZqMDe" title="Expected warrant life in years::XDX::P4Y8M12D"><span style="-sec-ix-hidden: xdx2ixbrl1474">4.7</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znJ3gJPKi7ci" title="Expected warrant life in years::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1476">5.0</span></span></td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock', window );">The change in the Private Warrants liability is presented below:</a></td>
<td class="text"><p id="xdx_89B_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zbDEDzsTxw83" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zN3GUDOwHwG3">The
change in the Private Warrants liability is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%">Initial valuation, March 17, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230315__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_ze4dEjbfLz13" style="width: 10%; text-align: right" title="Initial valuation, at begining">2,987</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in valuation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230315__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zAkWZjJgEmzl" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation">292</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Valuation at June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zN4GuycS7h48" style="text-align: right" title="Initial valuation, at begining">3,279</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in valuation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zXXIPqLb19rj" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation">(1,926</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Valuation at June 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zNiq6OhMP5qk" style="border-bottom: Black 2pt solid; text-align: right" title="Initial valuation, at ending">1,353</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock', window );">Schedule of expenses as other operating costs</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_z3ASikrYjJu1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zzt2wXsBEeM6" style="display: none; visibility: hidden">Schedule of expenses as other operating costs</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zeU06pPLzlEi" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_ecustom--YorkvilleCashFee_zCo8eoTA9VL9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%; text-align: justify">Yorkville Cash Fee</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zMxZ7zqa5Uci" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Fair value of Commitment Shares issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--OtherCostAndExpenseOperating_z0jMHASx6W26" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Legal and other related costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">496</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--OperatingCostsAndExpenses_z85GnfZNKj0e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2pt">Costs expensed to other operating expense</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">2,646</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of changes in the fair value of the private warrants table textblock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  schedule of outstanding exercisable warrants table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724286079552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS AND BALANCES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Changes in the Smith Credit Agreement principal balance are as follows:</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zi0DW29dRwp2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zbYcDYi02tPc">Changes
in the Smith Credit Agreement principal balance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the year ending June 30,2023</span></td>
    <td style="text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 57%; background-color: #CCEEFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
    balance</span></td>
    <td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20220701__20230630_zvLcTJ5yFCRl" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td>
    <td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Amounts
    advanced</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_ecustom--AmountsAdvanced_pn3n3_c20220701__20230630_zGvahmC47mrb" style="vertical-align: bottom; text-align: right" title="Amounts advanced"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,130</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom; background-color: #CCECFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Repayments</span></td>
    <td style="vertical-align: bottom; background-color: #CCECFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: #CCECFF"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_984_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20220701__20230630_zFkN7hObNvhd" style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: #CCECFF; text-align: right" title="Repayments">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,130</span></td>
    <td style="vertical-align: bottom; background-color: #CCECFF; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    </tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance,
    end of period</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20220701__20230630_z2ENjS0AcD5j" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1520">-</span></span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285767792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EXPLORATION EXPENDITURES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureExplorationExpendituresAbstract', window );"><strong>Exploration Expenditures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfExplorationExpendituresTableTextBlock', window );">Schedule of exploration expenditures</a></td>
<td class="text"><p id="xdx_893_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zrUmCPvNDG57" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zEW02sgRxMqk" style="display: none; visibility: hidden">Schedule of exploration expenditures</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td><td colspan="6" style="padding-bottom: 1pt; text-align: center">For the year ended <br/>
June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td><td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-left: 5.4pt">&#160;Feasibility study and engineering</td>
    <td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td>
    <td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_z0TgLiCc3Xya" style="width: 10%; text-align: right">353</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zZw16AZyDUGh" style="width: 10%; text-align: right">410</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">&#160;Field management and other</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td>
    <td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_ztJXK1DHfYU1" style="text-align: right">503</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zjIM2zz2poy4" style="text-align: right">738</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">&#160;Metallurgical</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td>
    <td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--MetallurgicalMember_zwIzBzW08n1b" style="text-align: right">1,678</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--MetallurgicalMember_zVKXQvCj98Cb" style="text-align: right">4,174</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">&#160;Geologists and field staff</td>
    <td>&#160;</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z29Ug68eIXCh" style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z4lMg6XsyCeh" style="border-bottom: Black 1pt solid; text-align: right">26</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; padding-left: 5.4pt">&#160;Total</td>
    <td>&#160;</td><td style="border-bottom: Black 2pt solid; text-align: left">$</td>
    <td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630_znMH3N4wvcZ" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures">2,552</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630_zpJ67NrBhQeh" style="border-bottom: Black 2pt solid; text-align: right">5,348</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureExplorationExpendituresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureExplorationExpendituresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfExplorationExpendituresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  schedule of exploration expenditures table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfExplorationExpendituresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284275280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">The Company incurred lease costs as follows:</a></td>
<td class="text"><p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zFMDPesBUyD4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zZwNhVP7znVa">The
Company incurred lease costs as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49A_20230701__20240630_zdpHnoiu8ZHk" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_494_20220701__20230630_zfGHLIRpd2B2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_ztcs0JNenlYa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;Operating Lease Cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--FixedRentExpense_z8wiWrFQMm9a" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-left: 0.125in">&#160;&#160;Fixed rent expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">90</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">83</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--VariableLeaseCost_zYilEpcHe0me" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">&#160;&#160;Variable rent expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">&#160;&#160;Short term lease cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_zMx8rbZIbR35" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">&#160;&#160;Sublease income</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(32</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zVDNB18iZSb3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">&#160;&#160;Net lease cost &#8211; other operating expense</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">81</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">73</td><td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">The maturity of lease liabilities is as follows at June 30, 2024:</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zIBH6df4xrIb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zIL0QupF7Sh">The
maturity of lease liabilities is as follows at June 30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt; padding-left: 10pt"></td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20240630_zVO867MS1l3i" style="border-bottom: Black 1pt solid; text-align: center">&#160;Fiscal Year Lease Maturities</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zOLwY093Fgn2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%; text-align: left; padding-left: 0.125in">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">96</td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_znOgn2YDFFx7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">98</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzI5d_z6iGPLc1xjm7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">2027</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">50</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_409_ecustom--TotalLeasePayments_iI_pn3n3_mtLOLLPzI5d_zHxp79pTNTA5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">244</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_ecustom--LessAmountOfPaymentsRepresentingInterest_iNI_pn3n3_di_zB2RmiaocxGb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less amount of payments representing interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_z7RPNTFnrOh5" style="vertical-align: bottom; background-color: White">
    <td>Present value of lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_402_ecustom--LessCurrentPortionOfOperatingLeaseLiability_iNI_pn3n3_di_zRkoiw9xk6U9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less current portion of operating lease liability</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(95</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_409_ecustom--OperatingLeasesLiabilityNoncurrent_iI_pn3n3_z8eJ9hvacpNd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Noncurrent operating lease liability</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">105</td><td style="text-align: left; padding-bottom: 2pt">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724286078064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Domestic and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows:</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_z9bgB1OQuWef" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_z2BFpEQH5sRh">Domestic
and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows:</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; padding-left: 5pt">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z57vaDVMMEd6" style="width: 10%; text-align: right" title="Total">8,319</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_znIGbYlP5VUj" style="width: 10%; text-align: right" title="Total">34,606</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zjd2vsIFj6Xi" style="text-align: right" title="Total">3,679</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zWVpHypcitNa" style="text-align: right" title="Total">6,006</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt">United Kingdom</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zzAPDkmYszX2" style="border-bottom: Black 1pt solid; text-align: right" title="Total">39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zcE2d0hva516" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl1616">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt; padding-left: 5pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zfJxujeMcwoe" style="border-bottom: Black 2pt solid; text-align: right" title="Total">12,037</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zHNyoDRvRkii" style="border-bottom: Black 2pt solid; text-align: right" title="Total">40,612</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">The following table is a reconciliation of income taxes at statutory rates:</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zQKS2yZlaJyk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zKmOYbnYfTne">The
following table is a reconciliation of income taxes at statutory rates:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_495_20230701__20240630_zkoJDe5peD99" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_494_20220701__20230630_zcURCFmpWzj5" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_zLcapFBp6554" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left; padding-left: 5pt">Loss before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">12,037</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">40,612</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_z4Aj6nOFUsbk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Combined Canadian federal and provincial statutory income tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_z0kWdi5AgPzc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Income tax benefit at statutory tax rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,965</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_zgmSZqkdF78l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Foreign rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(62</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(131</td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--EarnoutSharesLiability_zvAOBQaeeGK" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5pt">Earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,810</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,841</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40A_ecustom--WarrantLiability_z13vU622ux3c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">506</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,518</td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--GxiiTransactionCosts_zY0iqsfhNwX7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">GXII transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1648">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(925</td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zVXkJ8u5iGy1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt">Share based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(747</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(412</td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--AssetRetirementObligationAccretionExpense_iN_di_zMM7wzlve5oe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,138</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(496</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_ecustom--ConvertibleNoteValuation_iN_di_zzNlctPWi7hc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Convertible note valuation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(607</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1658">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--ExtinguishmentOfDebtGainLossIncomeTax_zyMdhRxpNHHf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1660">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(54</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40D_ecustom--EffectOfLegislativeChanges_zvRSKnwWjus" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Capital loss rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1663">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_zNTU5WJBgTx8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Change in estimates related to prior years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(160</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_zuHweNmP1zfb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt">Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zRe8hs5irF0b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,718</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,341</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 5pt">Income tax benefit</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20230701__20240630_zHg9FOUnnAz1" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit::XDX::-139"><span style="-sec-ix-hidden: xdx2ixbrl1675">139</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20220701__20230630_z1ZhZermPT97" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit::XDX::-304"><span style="-sec-ix-hidden: xdx2ixbrl1677">304</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z8sr4ADEJGdf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zFluBkuRj1Tf">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_491_20240630_zcsLRmqQm5X7" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_495_20230630_zjZzn2nJl5Ll" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzakr_zHHYB11mTGj5" style="vertical-align: bottom; background-color: White">
    <td style="width: 54%; text-align: left; padding-left: 0.25in">Net operating losses available for future periods</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">14,177</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">11,893</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zxQyGBDpziZ8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Mineral interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,438</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,477</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_z12T6eRhe5Pa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Startup and organizational costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,987</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,132</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zQ0ysepiv2D3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Research and development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,419</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,060</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zuIAc0JPPD21" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in">Share issuance/financing costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">635</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">446</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zM7WHQZtgW6j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Capital losses available for future periods</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">419</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzakr_zPHUuuadLk09" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.25in">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">69</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iI_mtDTAGzakr_maDTALNz97R_zH8FslKJJ5z8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,181</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,463</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNz97R_zGnLV8BaggNf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">&#160;Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(28,181</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(25,463</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNz97R_zKvv3YhPtfs9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Net deferred tax assets</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Changes in the valuation allowance are as follows:</a></td>
<td class="text"><p id="xdx_895_eus-gaap--SummaryOfValuationAllowanceTextBlock_znJg9a2MUMp" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zlgJc4C0A8Y">Changes
in the valuation allowance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left">Valuation allowance, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20230701__20240630_zy8O1HuJiqMl" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year">(25,463</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20220701__20230630_zpQNsLKSooqe" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year">(18,948</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Current year additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20230701__20240630_z8oKQuFi0Bk3" style="text-align: right" title="Current year additions">(2,718</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20220701__20230630_z85LpOCidlBc" style="text-align: right" title="Current year additions">(4,341</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Startup and organizational costs acquired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20230701__20240630_z0bO8mMe3TD3" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired"><span style="-sec-ix-hidden: xdx2ixbrl1721">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20220701__20230630_zzoiCwC6VpGf" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired">(2,174</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Valuation allowance, end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20230701__20240630_zmbFKoM7NRxj" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year">(28,181</td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20220701__20230630_zRbdcmhhLzKe" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year">(25,463</td><td style="padding-bottom: 2pt; text-align: left">)</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Schedule of cumulative net operating losses</a></td>
<td class="text"><p id="xdx_896_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zcb4TTHIh5xb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zUlCkb3Tqdy1" style="display: none; visibility: hidden">Schedule of cumulative net operating losses</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 4pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-left: 4pt">Jurisdiction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; padding-left: 4pt">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zFYEneDdpFnc" style="width: 10%; text-align: right" title="Total">47,623</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z9aOqr2g4Un1" style="width: 10%; text-align: right" title="Total">40,267</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 4pt">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_z9HoM3kIozy7" style="text-align: right" title="Total">4,905</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zjMnTpQKmzl" style="text-align: right" title="Total">3,491</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 4pt">United Kingdom</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zaGPbrYeEioc" style="border-bottom: Black 1pt solid; text-align: right" title="Total">39</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zFqvrzdgQatb" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl1753">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt; padding-left: 4pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630_zurE3MeGlGec" style="border-bottom: Black 2pt solid; text-align: right" title="Total">52,567</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630_zQtPWQ385yo5" style="border-bottom: Black 2pt solid; text-align: right" title="Total">43,758</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368260688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of fair values determined by level 3 inputs are unobservable data</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zqR1VBqKFzgc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B4_ztZC8PdC0OQi" style="display: none; visibility: hidden">Schedule of fair values determined by level 3 inputs are unobservable data</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630_zHfnRgmMcD5k" style="width: 9%; text-align: right" title="Cash and cash equivalents">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyRxZhHo8qo8" style="width: 9%; text-align: right">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuDVZt1TPtDh" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1776">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zN369ejReXih" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1777">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630_zOIyZjI5NWh5" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqe2eCldhxH8" style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQ4l33XBWen" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1781">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zihji5P0r9K6" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1782">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240630_zvcKadMnfjh7" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents">2,016</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zeI8BTDUYdN4" style="border-bottom: Black 2pt solid; text-align: right">2,016</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzvUB5OU6Ip4" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1786">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoeVxg1XDiUg" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1787">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Cash and cash equivalents">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">April 2024 notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--NotesPayable_iI_c20240630_zuYPO2SS3pS7" style="text-align: right" title="Cash and cash equivalents">7,089</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayable_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0beG8D1zJu1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1790">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPpARldt2JD1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1791">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqDGw7MQKQmc" style="text-align: right">7,089</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630_zcECAf2SJC42" style="text-align: right" title="Cash and cash equivalents">3,817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zuniSErcRgH8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1795">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1QuLWobF3Pg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1796">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zRpHCnxP2JZd" style="text-align: right">3,817</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630_zvCFGjvx2cca" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents">4,016</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMAd9oqQPJV4" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1800">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSL8Gmr1BLkg" style="border-bottom: Black 1pt solid; text-align: right">1,651</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkpM0PKAKxhc" style="border-bottom: Black 1pt solid; text-align: right">2,365</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630_zTzQMwOS31Eg" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents">14,922</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zf6BSJcdfyqb" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1805">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfKOJWWtknL9" style="border-bottom: Black 2pt solid; text-align: right">1,651</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zR1PuZxqKHR4" style="border-bottom: Black 2pt solid; text-align: right">13,271</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630_zjKL33g94I7c" style="width: 9%; text-align: right">2,341</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z016rH6Konm5" style="width: 9%; text-align: right">2,341</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLnMX4mSWxud" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1810">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbU94EDQpM84" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1811">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630_zesl4AemIP5f" style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZoSGIGJ00H8" style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPoMcCvmtIPk" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1814">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z6q6OpuNSPm1" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1815">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20230630_zmdeNUGbcMhe" style="border-bottom: Black 2pt solid; text-align: right">2,350</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ztxdhphe9fXg" style="border-bottom: Black 2pt solid; text-align: right">2,350</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zk2To6FAGcQi" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0ojJd3792ii" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630_z8xu1VMvKUS3" style="text-align: right">10,521</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpcoCm9ZFpuf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1821">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKDHPxK7uY1i" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1822">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zte778YsURXj" style="text-align: right">10,521</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630_zEfg3D4LhXyf" style="border-bottom: Black 1pt solid; text-align: right">4,989</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zN7hMLfrEA44" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1825">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zo58gZJhjfmf" style="border-bottom: Black 1pt solid; text-align: right">3,279</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYb5UcoqWp1i" style="border-bottom: Black 1pt solid; text-align: right">1,710</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630_zgFQkBE7jSZ8" style="border-bottom: Black 2pt solid; text-align: right">15,510</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6MWMm3HZeZ2" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1829">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zp8Ki3EXr6A4" style="border-bottom: Black 2pt solid; text-align: right">3,279</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zSLNZntZD21i" style="border-bottom: Black 2pt solid; text-align: right">12,231</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285712192">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=niobf_Entity0896800BCLtdMember', window );">Entity 0896800 B C Ltd [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncorporationStateCountryName', window );">Country of incorporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">British
    Columbia, Canada<span></span>
</td>
<td class="text">British
    Columbia, Canada<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=niobf_ElkCreekResourcesCorpMember', window );">Elk Creek Resources Corp [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncorporationStateCountryName', window );">Country of incorporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Nebraska,
    USA<span></span>
</td>
<td class="text">Nebraska,
    USA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=niobf_ElkCreekResourcesCorpECRCMember', window );">Elk Creek Resources Corp ECRC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncorporationStateCountryName', window );">Country of incorporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Delaware,
    USA<span></span>
</td>
<td class="text">Delaware,
    USA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">79.70%<span></span>
</td>
<td class="nump">79.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=niobf_NioCorpTechnologiesLimitedMember', window );">Nio Corp Technologies Limited [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncorporationStateCountryName', window );">Country of incorporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">United
    Kingdom<span></span>
</td>
<td class="text">United
    Kingdom<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents 100% of Class A common stock owned by 0896800, and 4,282,116 and 4,565,808 Vested Shares and 3,391,596 and 3,391,596
Earnout Shares (each as defined below) held by third parties, and outstanding as of June 30, 2024 and 2023, respectively.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_IncorporationStateCountryName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents incorporation state country name.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_IncorporationStateCountryName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=niobf_Entity0896800BCLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=niobf_Entity0896800BCLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=niobf_ElkCreekResourcesCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=niobf_ElkCreekResourcesCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=niobf_ElkCreekResourcesCorpECRCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=niobf_ElkCreekResourcesCorpECRCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=niobf_NioCorpTechnologiesLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=niobf_NioCorpTechnologiesLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285381728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>N</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284115472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attr (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,898)<span></span>
</td>
<td class="num">$ (40,308)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Adjust: net loss attributable to noncontrolling interest</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to participating securities</a></td>
<td class="num">(11,440)<span></span>
</td>
<td class="num">(40,057)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Net loss attributable to vested shares</a></td>
<td class="nump">967<span></span>
</td>
<td class="nump">1,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic', window );">Net loss attributed to common shareholders - basic and diluted</a></td>
<td class="num">$ (10,473)<span></span>
</td>
<td class="num">$ (38,529)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding basic and diluted</a></td>
<td class="nump">34,320,024<span></span>
</td>
<td class="nump">28,705,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarningsLossPerShareBasicAndDiluted', window );">Loss per common share outstanding basic and diluted</a></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (1.34)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarningsLossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnings loss per share basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarningsLossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368248688">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of excluded from the dilutive securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions', window );">Options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">2,495,500<span></span>
</td>
<td class="nump">1,541,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">18,563,561<span></span>
</td>
<td class="nump">18,816,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Convertible debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">2,849,000<span></span>
</td>
<td class="nump">2,871,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecurities', window );">Total potentially dilutive securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">$ 23,908,061<span></span>
</td>
<td class="nump">$ 23,229,464<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-26<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of outstanding written put options using the reverse treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 35<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-35<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-36<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284444880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued exploration stage expense</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283283440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOING CONCERN ISSUES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,898)<span></span>
</td>
<td class="num">$ (40,308)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="nump">9,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">161,912<span></span>
</td>
<td class="nump">$ 150,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CashAndCashEquivalentsAtCarryingValue1', window );">Cash</a></td>
<td class="nump">2,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfDebt', window );">Net proceeds</a></td>
<td class="nump">$ 59,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CashAndCashEquivalentsAtCarryingValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents cash and cash equivalents at carrying value1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CashAndCashEquivalentsAtCarryingValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents working capital deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285106640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023: (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts', window );">Gross cash proceeds, net of transaction costs incurred by GXII</a></td>
<td class="nump">$ 2,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net liabilities assumed</a></td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts', window );">Yorkville Equity Facility Financing Agreement &#8211; cash costs</a></td>
<td class="nump">1,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed', window );">Transaction costs expensed</a></td>
<td class="nump">6,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Private Warrants assumed at fair value</a></td>
<td class="nump">2,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarnoutSharesAssumedAtFairValue', window );">Earnout Shares assumed at fair value</a></td>
<td class="nump">13,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities', window );">Yorkville Equity Facility Financing Agreement &#8211; shares issued</a></td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">&#160;Total transaction related losses incurred</a></td>
<td class="nump">$ 23,767<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents business combination separately recognized transactions additional disclosures acquisition cash costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarnoutSharesAssumedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnout shares assumed at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarnoutSharesAssumedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease obligation assumed in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities assumed (as defined) which have been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of any issuance related costs which have not been expensed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724286109856">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">38,062,647<span></span>
</td>
<td class="nump">31,202,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Number of shares, percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_LegacyNioCorpShareholdersMember', window );">Legacy Nio Corp Shareholders [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,246,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Number of shares, percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">93.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_GXIIClassAShareholdersMember', window );">GXII Class A Shareholders [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,753,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Number of shares, percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_OtherMember', window );">Other [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">81,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Number of shares, percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0.27%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_LegacyNioCorpShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_LegacyNioCorpShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_GXIIClassAShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_GXIIClassAShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368310448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2023 GXII TRANSACTION (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_WarrantAgreementMember', window );">Warrant Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Number of shares purchase</a></td>
<td class="nump">15,666,626<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible shares issued upon conversion</a></td>
<td class="nump">7,957,404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Post reverse stock split shares</a></td>
<td class="nump">1,753,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Number of shares purchase</a></td>
<td class="nump">17,519,864<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_WarrantAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_WarrantAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284512784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of properties (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Cost</a></td>
<td class="nump">$ 848<span></span>
</td>
<td class="nump">$ 848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net</a></td>
<td class="nump">837<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LandMember', window );">Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Cost</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Cost</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283648672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of account payable and accrued liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable, trade</a></td>
<td class="nump">$ 1,417<span></span>
</td>
<td class="nump">$ 1,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Trade payable accruals</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">1,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Income taxes payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Environmental accruals</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure', window );">Loan origination fees payable to related party</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued liabilities</a></td>
<td class="nump">$ 1,843<span></span>
</td>
<td class="nump">$ 3,491<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of trade and related party payables and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284773520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of convertible debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertibled debt, current</a></td>
<td class="nump">$ 7,660<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible debt, noncurrent</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,561<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=niobf_YorkvilleConvertibleSecurityMember', window );">Yorkville Convertible Security [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertibled debt, current</a></td>
<td class="nump">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=niobf_ConvertibleSecurityMember', window );">Convertible Security [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertibled debt, current</a></td>
<td class="nump">7,660<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible debt, noncurrent</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,561<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=niobf_April2024ConvertibleSecurityMember', window );">April 2024 Convertible Security [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertibled debt, current</a></td>
<td class="nump">$ 7,089<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=niobf_YorkvilleConvertibleSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=niobf_YorkvilleConvertibleSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=niobf_ConvertibleSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=niobf_ConvertibleSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=niobf_April2024ConvertibleSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=niobf_April2024ConvertibleSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724286410896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in the Lind III Convertible Security are as follows (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Beginning balance</a></td>
<td class="nump">$ 10,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Fair value increase due to debt extinguishment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion expense</a></td>
<td class="nump">4,490<span></span>
</td>
<td class="nump">2,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Ending balance</a></td>
<td class="nump">$ 7,660<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=niobf_ConvertibleSecurityMember', window );">Convertible Security [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Fair value increase due to debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Payment at maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481639/420-10-35-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=niobf_ConvertibleSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=niobf_ConvertibleSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285341072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table summarizes the components of the initial loss and final loss on extinguishment: (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_MinimumConsentPaymentAtInception', window );">Minimum Consent Payment at inception</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ASC470LossOnExtinguishment', window );">Loss on debt extinguishment</a></td>
<td class="nump">201<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentOfWarrantsGrantedForServices', window );">Initial fair value of Contingent Consent Warrants</a></td>
<td class="nump">1,221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost', window );">Initial loss on debt extinguishment</a></td>
<td class="nump">1,622<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AdditionalConsentPaymentbooked', window );">Additional Consent Payment booked</a></td>
<td class="nump">300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnRestructuringOfDebt', window );">Total loss on debt extinguishment</a></td>
<td class="nump">$ 1,922<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ASC470LossOnExtinguishment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents as c470 loss on extinguishment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ASC470LossOnExtinguishment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AdditionalConsentPaymentbooked">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents additional consent paymentbooked.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AdditionalConsentPaymentbooked</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_MinimumConsentPaymentAtInception">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents minimum consent payment at inception.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_MinimumConsentPaymentAtInception</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentOfWarrantsGrantedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment for noncash service expenses paid for by granting of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentOfWarrantsGrantedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnRestructuringOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 60<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481408/470-60-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnRestructuringOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285640864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The change in the fair value of the Contingent Consent Warrants is presented below: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Initial valuation, at beginning</a></td>
<td class="nump">$ 1,710<span></span>
</td>
<td class="nump">$ 1,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInValuationOfWarrants', window );">Change in valuation</a></td>
<td class="nump">655<span></span>
</td>
<td class="nump">489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Valuation, at ending</a></td>
<td class="nump">$ 2,365<span></span>
</td>
<td class="nump">$ 1,710<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInValuationOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in valuation of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInValuationOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283176960">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Schedule of valuation date and the probability calculated (Details)<br></strong></div></th>
<th class="th" colspan="2">
<div>Jun. 30, 2024 </div>
<div>N </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>N </div>
<div>$ / shares</div>
</th>
<th class="th" colspan="2">
<div>Jun. 30, 2023 </div>
<div>N </div>
<div>$ / shares</div>
</th>
<th class="th" colspan="2">
<div>Sep. 25, 2022 </div>
<div>N </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Share price | (per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 7.82<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Probability of issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.680<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.680<span></span>
</td>
<td class="nump">0.630<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.624<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Probability of issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.0440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0440<span></span>
</td>
<td class="nump">0.0411<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0393<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=niobf_ProbabilityOfIssuanceMember', window );">Probability of Issuance [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Probability of issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1.000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.000<span></span>
</td>
<td class="nump">0.808<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.594<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Expires
    in 3 equal monthly tranches on July 17, 2024, August 17, 2024, and September 17, 2024.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=niobf_ProbabilityOfIssuanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=niobf_ProbabilityOfIssuanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284131296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in the Convertible Debentures are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Balance, June 30, 2023</a></td>
<td class="nump">$ 12,153<span></span>
</td>
<td class="nump">$ 10,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpenseIncludingAssetRetirementObligations', window );">Accretion expense</a></td>
<td class="nump">1,962<span></span>
</td>
<td class="nump">4,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrincipalAndAccruedInterestConverted', window );">Principal and accrued interest converted</a></td>
<td class="nump">3,554<span></span>
</td>
<td class="nump">14,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Balance, June 30, 2023</a></td>
<td class="nump">$ 10,561<span></span>
</td>
<td class="nump">571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Add: uamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalancePrincipalAmount', window );">Balance, June 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PrincipalAndAccruedInterestConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents principal and accrued interest converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PrincipalAndAccruedInterestConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpenseIncludingAssetRetirementObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense, which includes, but is not limited to, accretion expense from asset retirement obligations, environmental remediation obligations, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481879/410-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpenseIncludingAssetRetirementObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalancePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of investment owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalancePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285137584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table discloses the components of interest expense associated with the Convertible Debentures. (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ContractualInterest', window );">Contractual interest</a></td>
<td class="nump">$ 279<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of discount and issuance costs</a></td>
<td class="nump">4,210<span></span>
</td>
<td class="nump">1,737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Total</a></td>
<td class="nump">$ 4,489<span></span>
</td>
<td class="nump">$ 1,962<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ContractualInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents contractual interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ContractualInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 835<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283753744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes: (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 12, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Weighted average of the equity volatility and implied volatility of the public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
<td class="nump">63.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member] | Monte Carlo Model [Member] | Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 3.11<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2', window );">Term (expiry)</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Weighted average of the equity volatility and implied volatility of the public warrants</a></td>
<td class="nump">66.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">5.26%<span></span>
</td>
<td class="nump">5.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ImpliedDiscountRate', window );">Implied discount rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ImpliedDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents implied discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ImpliedDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=niobf_MonteCarloModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=niobf_MonteCarloModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368281024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024: (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeAssetsAtFairValue', window );">Fair value, April 12, 2024</a></td>
<td class="nump">$ 10,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Principal payments</a></td>
<td class="num">(1,512)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValue', window );">Change in fair value</a></td>
<td class="num">(1,714)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeAssetsAtFairValue', window );">Balance, June 30, 2024</a></td>
<td class="nump">7,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment', window );">Remaining principal balance, June 30, 2024</a></td>
<td class="nump">$ 7,128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative assets designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from repayments of the balance excluding interest (principal) on loans receivable and leases held for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284554352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants. (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 12, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 5 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
<td class="nump">63.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member] | Black Scholes [Member] | Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing Common Share price</a></td>
<td class="nump">$ 3.24<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Term (years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">2 years 9 months 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">62.39%<span></span>
</td>
<td class="nump">66.34%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">4.77%<span></span>
</td>
<td class="nump">4.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=niobf_BlackScholesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=niobf_BlackScholesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283911024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June 30, 2024. (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="num">$ (902)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,338)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,817<span></span>
</td>
<td class="nump">$ 10,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember', window );">Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724276612816">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Details Narrative)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 19, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 19, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>N </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th" colspan="2">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>N </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>N </div>
<div>$ / shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>N </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 16, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 26, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th" colspan="2">
<div>Sep. 25, 2022 </div>
<div>N </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Face value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Investment Interest Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Commitment fee</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromInterestReceived', window );">Net proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Long term debt duration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">24 months<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonUnitIssued', window );">Common share purchase warrants | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">855,800<span></span>
</td>
<td class="nump">855,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Exercisable at a price per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9.70<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible debt liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,660<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,660<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 7,660<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Commitment fee</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3,338<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare', window );">Option Contract Indexed to Equity, Settlement, Number of Shares, Effect of Change in Fair Value of Share | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized', window );">Fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Transaction loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value | N</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0411<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0393<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value | N</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.680<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.680<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.680<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.630<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.624<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Aggregate exercise price, per shares | (per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.82<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Aggregate exercise price, per shares | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Contingent liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiability', window );">Contingent liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible debt liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,656<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,656<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12,656<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,704<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,704<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,704<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Principal percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1', window );">Issuance of the convertible debentures | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8.9422<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 503<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.33<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.33<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4.33<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate', window );">Fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value | N</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">64.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate obligation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DebtMaturityPeriod', window );">Expected life</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate obligation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DebtMaturityPeriod', window );">Expected life</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Warrant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodSharesStockOptionsExercise', window );">Issuance of the convertible debentures | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,789,267<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Aggregate exercise price, per shares | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.9422<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.9422<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8.9422<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentTerms', window );">Debt term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18-month<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt [Member] | Yorkville Convertible Debt Financing Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=niobf_LindIIIConvertibleSecurityMember', window );">Lind I I I Convertible Security [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Face value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,477<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible debt liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,938<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,938<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 7,938<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_TransactionCost', window );">Transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=niobf_LindIIIConvertibleSecurityMember', window );">Lind I I I Convertible Security [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionDescription', window );">Debt Conversion, Description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pursuant
to the Lind III Agreement, Lind was entitled to convert the Lind III Convertible Security into Common Shares in monthly installments
over its term at a price per Common Share equal to 85% of the volume-weighted average price Common Shares on the TSX for the five
trading days immediately preceding to the date on which Lind provides notice to the Company of its election to convert. The Lind
III Agreement provided that Common Shares issuable upon conversion, together with the number of Common Shares issued upon exercise
of Warrants, shall not exceed 4,358,800 Common Shares.<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Volatility</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.60%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntermediateLifePlantsUsefulLife', window );">Expected life</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">4 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="18"></td></tr>
<tr><td colspan="18"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Expires
    in 3 equal monthly tranches on July 17, 2024, August 17, 2024, and September 17, 2024.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DebtMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents debt maturity period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DebtMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents share based goods and nonemployee services transaction valuation method expected dividend yield rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodSharesStockOptionsExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period shares stock options exercise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodSharesStockOptionsExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period shares stock options exercise1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_TransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents transaction cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_TransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481138/505-30-25-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expenses and losses recorded for each transaction with the acquiree that was recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonUnitIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common units issued of limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonUnitIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -SubTopic 470<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntermediateLifePlantsUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of intermediate-life plants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 905<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482211/905-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntermediateLifePlantsUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of timing of required repayments, sinking fund requirements, and other redeemable securities at fixed or determinable prices and dates in the five years immediately following the date of the latest balance sheet presented in the financial statements, and the amount thereafter to fully repay the principal of long-term debt. These disclosures may be made either on an individual debt or security basis, by type of debt or security basis, or on a combined basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in number of shares that would be issued upon settlement from change in fair value of share for option contract indexed to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInterestReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest received on loans and other debt instruments during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInterestReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of servicing liabilities that are subsequently measured at fair value and servicing liabilities that are subsequently measured using the amortization method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481260/860-50-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=niobf_LindIIIConvertibleSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=niobf_LindIIIConvertibleSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=niobf_LindIIIConvertibleSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=niobf_LindIIIConvertibleSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724276860848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table discloses the primary inputs into the Monte Carlo models. (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 17, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Implied volatility of public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
<td class="nump">63.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member] | Valuation Technique, Option Pricing Model [Member] | Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 7.00<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2', window );">Term (expiry)</a></td>
<td class="text">Mar. 17,  2033<span></span>
</td>
<td class="text">Mar. 17,  2033<span></span>
</td>
<td class="text">Mar. 17,  2033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Implied volatility of public warrants</a></td>
<td class="nump">19.50%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">33.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">3.39%<span></span>
</td>
<td class="nump">4.35%<span></span>
</td>
<td class="nump">3.83%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285733952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2024: (Details) - Earnout [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiabilityAtFairValueAmount', window );">Fair value at beginning</a></td>
<td class="nump">$ 13,195<span></span>
</td>
<td class="nump">$ 10,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiabilityAtFairValueAdditions', window );">Change in fair value</a></td>
<td class="nump">2,674<span></span>
</td>
<td class="nump">6,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiabilityAtFairValueAmount', window );">Fair value at ending</a></td>
<td class="nump">$ 10,521<span></span>
</td>
<td class="nump">$ 3,817<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingLiabilityAtFairValueAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of new servicing liabilities, that are subsequently measured at fair value, acquired or created during the current period through assumptions of servicing obligations and servicing obligations that result from transfers of financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481229/860-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingLiabilityAtFairValueAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingLiabilityAtFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of a liability representing servicing arrangements under which the estimated future revenue from contractually specified servicing fees, late charges, and other ancillary revenues are not expected to adequately compensate the servicer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481229/860-50-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481260/860-50-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481260/860-50-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481260/860-50-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingLiabilityAtFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283575280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="nump">38,062,647<span></span>
</td>
<td class="nump">31,202,131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember', window );">Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Earnout shares</a></td>
<td class="nump">3,391,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DescriptionOfEarnOutShares', window );">Description of earnout shares</a></td>
<td class="text">The
Earnout Shares vest (the &#8220;Released Earnout Shares&#8221;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,957,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,957,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Earnout shares</a></td>
<td class="nump">4,565,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DescriptionOfEarnOutShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents description of earn out shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DescriptionOfEarnOutShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724282986304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of stock option (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance | shares</a></td>
<td class="nump">1,541,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance | $ / shares</a></td>
<td class="nump">$ 7.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted, in shares | shares</a></td>
<td class="nump">1,625,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, per share | $ / shares</a></td>
<td class="nump">$ 2.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Cancelled/expired, in shares | shares</a></td>
<td class="num">(7,800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Cancelled/expired, per share | $ / shares</a></td>
<td class="nump">$ 3.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled/expired, in shares | shares</a></td>
<td class="num">(663,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled/expired, per share | $ / shares</a></td>
<td class="nump">$ 5.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance | shares</a></td>
<td class="nump">2,495,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance | $ / shares</a></td>
<td class="nump">$ 4.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life</a></td>
<td class="text">3 years 5 months 9 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368168896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table summarizes the weighted average information and assumptions used to determine option costs: (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value per option granted during the period</a></td>
<td class="nump">$ 1.71<span></span>
</td>
<td class="nump">$ 3.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Weighted average of the equity volatility and implied volatility of the public warrants</a></td>
<td class="nump">63.20%<span></span>
</td>
<td class="nump">63.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option life in years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283006256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance</a></td>
<td class="nump">18,816,304<span></span>
</td>
<td class="nump">1,851,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Balance at beginning average price</a></td>
<td class="nump">$ 10.98<span></span>
</td>
<td class="nump">$ 8.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_YorkvilleFinancingWarrants', window );">Yorkville financing warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,789,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants', window );">Yorkville financing warrants average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_GxiiWarrants', window );">GXII warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,666,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants', window );">GXII warrant average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExpired', window );">Class of Warrant or Right Expired</a></td>
<td class="num">(1,846,560)<span></span>
</td>
<td class="num">(491,211)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceExpired', window );">Cancelled</a></td>
<td class="nump">$ 8.67<span></span>
</td>
<td class="nump">$ 11.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightGranted', window );">Granted</a></td>
<td class="nump">1,593,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceGranted', window );">Granted</a></td>
<td class="nump">$ 3.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending balance</a></td>
<td class="nump">18,563,561<span></span>
</td>
<td class="nump">18,816,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Balance at ending average price</a></td>
<td class="nump">$ 10.53<span></span>
</td>
<td class="nump">$ 10.98<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price warrants gxii warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price warrants yorkville financing warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_GxiiWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents gxii warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_GxiiWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_YorkvilleFinancingWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents yorkville financing warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_YorkvilleFinancingWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283019664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>At June 30, 2024, the Company has outstanding exercisable warrants, as follows: (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="nump">18,563,561<span></span>
</td>
<td class="nump">18,563,561<span></span>
</td>
<td class="nump">18,816,304<span></span>
</td>
<td class="nump">1,851,622<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice9.70Member', window );">Exercise Price 9.70 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="nump">855,800<span></span>
</td>
<td class="nump">855,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Feb. 19,  2025<span></span>
</td>
<td class="text">Feb. 19,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice9.70Member', window );">Exercise Price 9.70 [Member] | Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice8.94Member', window );">Exercise Price8.94 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="nump">447,318<span></span>
</td>
<td class="nump">447,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 8.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice4.60Member', window );">Exercise Price4.60 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 4.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.54Member', window );">Exercise Price3.54 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="nump">413,432<span></span>
</td>
<td class="nump">413,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 3.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Dec. 22,  2025<span></span>
</td>
<td class="text">Dec. 22,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.20Member', window );">Exercise Price2.20 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="nump">315,000<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 2.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Jun. 24,  2025<span></span>
</td>
<td class="text">Jun. 24,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.25Member', window );">Exercise Price3.25 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="nump">615,385<span></span>
</td>
<td class="nump">615,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Apr. 12,  2027<span></span>
</td>
<td class="text">Apr. 12,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.50Member', window );">Exercise Price11.50 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="nump">15,666,626<span></span>
</td>
<td class="nump">15,666,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Mar. 17,  2028<span></span>
</td>
<td class="text">Mar. 17,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice9.70Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice9.70Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice8.94Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice8.94Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice4.60Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice4.60Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.54Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.54Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.20Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.20Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.25Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.25Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.50Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.50Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724282982080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 17, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto-Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Implied volatility of public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
<td class="nump">63.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected warrant life in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto-Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Stock price on valuation date</a></td>
<td class="nump">$ 7.00<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Strike price</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Implied volatility of public warrants</a></td>
<td class="nump">19.50%<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">33.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free rate</a></td>
<td class="nump">3.47%<span></span>
</td>
<td class="nump">4.45%<span></span>
</td>
<td class="nump">4.18%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected warrant life in years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_PlatformOperatorCryptoAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section FF<br> -Subsection Q2<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_PlatformOperatorCryptoAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285708128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The change in the Private Warrants liability is presented below: (Details) - Note Warrant [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangesInFairValueOfInitialValuation', window );">Initial valuation, at begining</a></td>
<td class="nump">$ 2,987<span></span>
</td>
<td class="nump">$ 3,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs', window );">Change in valuation</a></td>
<td class="nump">292<span></span>
</td>
<td class="num">(1,926)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangesInFairValueOfInitialValuation', window );">Initial valuation, at ending</a></td>
<td class="nump">$ 3,279<span></span>
</td>
<td class="nump">$ 1,353<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangesInFairValueOfInitialValuation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents changes in fair value of initial valuation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangesInFairValueOfInitialValuation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in fair value from changes in the inputs used to calculate the fair value of contract to service financial assets under which the benefits of servicing are expected to more than adequately compensate the servicer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(4)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481229/860-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283075776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of expenses as other operating costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Fair value of Commitment Shares issued</a></td>
<td class="num">$ (204)<span></span>
</td>
<td class="num">$ (204)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_YorkvilleCashFee', window );">Yorkville Cash Fee</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Fair value of Commitment Shares issued</a></td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Legal and other related costs</a></td>
<td class="nump">496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Costs expensed to other operating expense</a></td>
<td class="nump">$ 2,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_YorkvilleCashFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents yorkville cash fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_YorkvilleCashFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724274658736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 24, 2024</div></th>
<th class="th"><div>Sep. 02, 2023</div></th>
<th class="th"><div>Jun. 09, 2023</div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Outstanding stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,881<span></span>
</td>
<td class="nump">$ 1,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees', window );">Description of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(ii)
the last reported sale price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_GXIIPublicWarrantsMember', window );">GXII Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Warrants traded prior to the closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,999,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_GXIIPrivateWarrantsMember', window );">GXII Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Warrants traded prior to the closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleEquityFacilityFinancingAgreementMember', window );">Yorkville Equity Facility Financing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockNewIssuance', window );">Conversion of Stock, New Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company issued 100,000 Common Shares under the Yorkville Equity Facility Financing Agreement (discussed below)
in exchange for $488 in cash proceeds. The Company recorded a non-cash operating expense of $13 which represented the difference
between the proceeds received and the fair value of the Common Shares issued based on Nasdaq closing price per Common Share on
the issuance date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=niobf_KingdonCapitalManagementLLCMember', window );">Kingdon Capital Management LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockNewIssuance', window );">Conversion of Stock, New Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company closed a registered direct offering and issued 314,465 Common Shares for $2,000, before deducting
share issuance costs of $172. The Common Shares were sold pursuant to a securities purchase agreement, dated April 26, 2023, between
the Company and a fund managed by Kingdon Capital Management, LLC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.73%<span></span>
</td>
<td class="nump">4.85%<span></span>
</td>
<td class="nump">4.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.92%<span></span>
</td>
<td class="nump">71.63%<span></span>
</td>
<td class="nump">54.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees', window );">Description of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 441<span></span>
</td>
<td class="nump">$ 708<span></span>
</td>
<td class="nump">$ 977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Units issue and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Warrants traded prior to the closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Employee related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from equity</a></td>
<td class="nump">$ 602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">Description of stock transaction</a></td>
<td class="text">the Company closed a non-brokered private placement (the &#8220;June 2024 Private Placement&#8221;) of units of
the Company (the &#8220;June 2024 Units&#8221;). A total of 315,000 June 2024 Units were issued at a price per June 2024 Unit
of $1.91, for total gross proceeds to the Company of $602. Each June 2024 Unit consists of one Common Share and one Warrant (&#8220;June
2024 Warrant&#8221;). Each June 2024 Warrant entitles the holder to acquire one Common Share at a price of $2.20 at any time prior
to June 24, 2026. Proceeds of the June 2024 Private Placement will be used for continued advancement of the Elk Creek Project
and for working capital and general corporate purposes.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">413,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SaleOfStockPricePerShare1', window );">Shares price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Canada, Dollars | Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SaleOfStockPricePerShare1', window );">Shares price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Units issue and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Canada, Dollars | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SaleOfStockPricePerShare1', window );">Shares price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Units issue and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SaleOfStockPricePerShare1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents sale of stock price per share 1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SaleOfStockPricePerShare1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents share based compensation arrangement by share based payment award fair value assumptions expected volatilityrate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reason for issuing warrant or right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockNewIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the new financial instrument issued in a noncash (or part noncash) conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockNewIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_GXIIPublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_GXIIPublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_GXIIPrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_GXIIPrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleEquityFacilityFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleEquityFacilityFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=niobf_KingdonCapitalManagementLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=niobf_KingdonCapitalManagementLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724282630624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in the Smith Credit Agreement principal balance are as follows: (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyDepositLiabilities', window );">Related Party Deposit Liabilities</a></td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AmountsAdvanced', window );">Amounts advanced</a></td>
<td class="nump">1,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Repayments</a></td>
<td class="nump">3,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyDepositLiabilities', window );">Related Party Deposit Liabilities</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AmountsAdvanced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents amounts advanced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AmountsAdvanced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyDepositLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deposits held by the entity for a related party (entity, shareholder, employee).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyDepositLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724282577264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Mar. 22, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=niobf_MarkSmithMember', window );">Mark Smith [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EstablishmentFeesPayable', window );">Establishment fees payable</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_GeneralSecurityAgreementMember', window );">General Security Agreement [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Interest at a rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_LineOfCreditFacilityPrepaymentFee', window );">Prepayment fee</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_NonRevolvingCreditFacilityAgreementMember', window );">Non Revolving Credit Facility Agreement [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,841<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EstablishmentFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents establishment fees payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EstablishmentFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_LineOfCreditFacilityPrepaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents line of credit facility prepayment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_LineOfCreditFacilityPrepaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481573/470-10-45-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481573/470-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=niobf_MarkSmithMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=niobf_MarkSmithMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_GeneralSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_GeneralSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_NonRevolvingCreditFacilityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_NonRevolvingCreditFacilityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724284783952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of exploration expenditures (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">$ 2,552<span></span>
</td>
<td class="nump">$ 5,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_FeasibilityStudyAndEngineeringMember', window );">Feasibility Study and Engineering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">353<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_FieldManagementAndOtherMember', window );">Field Management and Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">503<span></span>
</td>
<td class="nump">738<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_MetallurgicalMember', window );">Metallurgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">4,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_GeologistsAndFieldStaffMember', window );">Geologists and Field Staff [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExplorationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exploration expenses (including prospecting) related to oil and gas producing entities and would be included in operating expenses of that entity. Costs incurred in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: (i) Costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or "G&amp;G" costs. (ii) Costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, and the maintenance of land and lease records. (iii) Dry hole contributions and bottom hole contributions. (iv) Costs of drilling and equipping exploratory wells. (v) Costs of drilling exploratory-type stratigraphic test wells.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482274/932-235-50-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExplorationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_FeasibilityStudyAndEngineeringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_FeasibilityStudyAndEngineeringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_FieldManagementAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_FieldManagementAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_MetallurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_MetallurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_GeologistsAndFieldStaffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_GeologistsAndFieldStaffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724368346448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company incurred lease costs as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>&#160;&#160;Operating Lease Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FixedRentExpense', window );">&#160;&#160;Fixed rent expense</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">&#160;&#160;Variable rent expense</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">&#160;&#160;Short term lease cost</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">&#160;&#160;Sublease income</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">&#160;&#160;Net lease cost &#8211; other operating expense</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FixedRentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fixed rent expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FixedRentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724382006848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The maturity of lease liabilities is as follows at June 30, 2024: (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">$ 96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_TotalLeasePayments', window );">Total lease payments</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_LessAmountOfPaymentsRepresentingInterest', window );">Less amount of payments representing interest</a></td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease payments</a></td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_LessCurrentPortionOfOperatingLeaseLiability', window );">Less current portion of operating lease liability</a></td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_OperatingLeasesLiabilityNoncurrent', window );">Noncurrent operating lease liability</a></td>
<td class="nump">$ 105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_LessAmountOfPaymentsRepresentingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents less amount of payments representing interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_LessAmountOfPaymentsRepresentingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_LessCurrentPortionOfOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents less current portion of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_LessCurrentPortionOfOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_OperatingLeasesLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents operating leases liability noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_OperatingLeasesLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_TotalLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents total lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_TotalLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285854704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DiscountRate', window );">Discount rate</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">3 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash payment</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=niobf_CorporateOfficeMember', window );">Corporate Office [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Other lease description</a></td>
<td class="text">39-month corporate office lease extension and recognized a corresponding ROU asset and
lease liability of $198 associated with this extension, based on a discount rate of 16%.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=niobf_CorporateOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=niobf_CorporateOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283412432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Domestic and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Total</a></td>
<td class="nump">$ 12,037<span></span>
</td>
<td class="nump">$ 40,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Total</a></td>
<td class="nump">8,319<span></span>
</td>
<td class="nump">34,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Total</a></td>
<td class="nump">3,679<span></span>
</td>
<td class="nump">6,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Total</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283165936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table is a reconciliation of income taxes at statutory rates: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax', window );">Loss before income taxes</a></td>
<td class="nump">$ 12,037<span></span>
</td>
<td class="nump">$ 40,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Combined Canadian federal and provincial statutory income tax rate</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit at statutory tax rates</a></td>
<td class="nump">$ 3,250<span></span>
</td>
<td class="nump">$ 10,965<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(131)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarnoutSharesLiability', window );">Earnout shares liability</a></td>
<td class="nump">1,810<span></span>
</td>
<td class="num">(2,841)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_WarrantLiability', window );">Warrant liability</a></td>
<td class="nump">506<span></span>
</td>
<td class="num">(1,518)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_GxiiTransactionCosts', window );">GXII transaction costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(925)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Share based compensation</a></td>
<td class="num">(747)<span></span>
</td>
<td class="num">(412)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationAccretionExpense', window );">Accretion expense</a></td>
<td class="num">(1,138)<span></span>
</td>
<td class="num">(496)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ConvertibleNoteValuation', window );">Convertible note valuation</a></td>
<td class="num">(607)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossIncomeTax', window );">Loss on debt extinguishment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EffectOfLegislativeChanges', window );">Capital loss rate differential</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Change in estimates related to prior years</a></td>
<td class="num">(160)<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(2,718)<span></span>
</td>
<td class="num">(4,341)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">$ (139)<span></span>
</td>
<td class="num">$ (304)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ConvertibleNoteValuation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents  convertible note valuation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ConvertibleNoteValuation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarnoutSharesLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnout shares liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarnoutSharesLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EffectOfLegislativeChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents effect of legislative changes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EffectOfLegislativeChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_GxiiTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents gxii transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_GxiiTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationAccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481879/410-20-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481850/410-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationAccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -SubTopic 740<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480887/718-740-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtGainLossIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current period income tax expense or benefit pertaining to a gain (loss) on an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtGainLossIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285101888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses available for future periods</a></td>
<td class="nump">$ 14,177<span></span>
</td>
<td class="nump">$ 11,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsMineralInterest', window );">Mineral interests</a></td>
<td class="nump">9,438<span></span>
</td>
<td class="nump">9,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsStartupAndOorganizationalCosts', window );">Startup and organizational costs</a></td>
<td class="nump">1,987<span></span>
</td>
<td class="nump">2,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsResearchAndDevelopmentCosts', window );">Research and development costs</a></td>
<td class="nump">1,419<span></span>
</td>
<td class="nump">1,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsShareIssuanceCosts', window );">Share issuance/financing costs</a></td>
<td class="nump">635<span></span>
</td>
<td class="nump">446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CapitalLossesAvailableForFuturePeriods', window );">Capital losses available for future periods</a></td>
<td class="nump">456<span></span>
</td>
<td class="nump">419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">28,181<span></span>
</td>
<td class="nump">25,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">&#160;Valuation allowance</a></td>
<td class="num">(28,181)<span></span>
</td>
<td class="num">(25,463)<span></span>
</td>
<td class="num">$ (18,948)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CapitalLossesAvailableForFuturePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents capital losses available for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CapitalLossesAvailableForFuturePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsMineralInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets mineral interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsMineralInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsShareIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets share issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsShareIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsStartupAndOorganizationalCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets startup and oorganizational costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsStartupAndOorganizationalCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283602400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in the valuation allowance are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance, beginning of year</a></td>
<td class="num">$ (25,463)<span></span>
</td>
<td class="num">$ (18,948)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsValuationAllowanceAdditions', window );">Current year additions</a></td>
<td class="num">(2,718)<span></span>
</td>
<td class="num">(4,341)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsIncurredDevelopmentCosts', window );">Startup and organizational costs acquired</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,174)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance, end of year</a></td>
<td class="num">$ (28,181)<span></span>
</td>
<td class="num">$ (25,463)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsValuationAllowanceAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets valuation allowance additions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsValuationAllowanceAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsIncurredDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Development costs incurred, including capitalized costs and costs charged to expense, in oil and gas activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 235<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482274/932-235-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsIncurredDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285008848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of cumulative net operating losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Total</a></td>
<td class="nump">$ 52,567<span></span>
</td>
<td class="nump">$ 43,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Total</a></td>
<td class="nump">47,623<span></span>
</td>
<td class="nump">40,267<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Total</a></td>
<td class="nump">4,905<span></span>
</td>
<td class="nump">3,491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Total</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283064032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Federal income tax payable</a></td>
<td class="nump">$ 443,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">28,181,000<span></span>
</td>
<td class="nump">$ 25,463,000<span></span>
</td>
<td class="nump">$ 18,948,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CAD', window );">Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CapitalLossCaryforward', window );">Net operating loss carryforwards</a></td>
<td class="nump">3,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOtherLossCarryforwards', window );">Tax losses incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,924,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CapitalLossCaryforward', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 7,018,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CapitalLossCaryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents Capital Loss Caryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CapitalLossCaryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOtherLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOtherLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724283745200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of fair values determined by level 3 inputs are unobservable data (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,012<span></span>
</td>
<td class="nump">$ 2,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Cash and cash equivalents</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">2,016<span></span>
</td>
<td class="nump">2,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Cash and cash equivalents</a></td>
<td class="nump">7,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">3,817<span></span>
</td>
<td class="nump">10,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">4,016<span></span>
</td>
<td class="nump">4,989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">14,922<span></span>
</td>
<td class="nump">15,510<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">2,012<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Cash and cash equivalents</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">2,016<span></span>
</td>
<td class="nump">2,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">1,651<span></span>
</td>
<td class="nump">3,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">1,651<span></span>
</td>
<td class="nump">3,279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Cash and cash equivalents</a></td>
<td class="nump">7,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">3,817<span></span>
</td>
<td class="nump">10,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">2,365<span></span>
</td>
<td class="nump">1,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 13,271<span></span>
</td>
<td class="nump">$ 12,231<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents available for sale securities equity securities other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AvailableForSaleSecuritiesEquitySecuritiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of warrants not settleable in cash classified as equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsNotSettleableInCashFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45724285005840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 01, 2024</div></th>
<th class="th"><div>Sep. 17, 2024</div></th>
<th class="th"><div>Sep. 11, 2024</div></th>
<th class="th"><div>Sep. 04, 2024</div></th>
<th class="th"><div>Sep. 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventDescription', window );">Subsequent event description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On
September 4, 2024, NioCorp entered into (i) a consent and waiver (the &#8220;Yorkville Consent&#8221;) to the April 2024 Note
issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together with the
Yorkville Consent, the &#8220;Consents&#8221;) to the April 2024 Note issued and sold to Lind Global Fund II LP pursuant to
the April 2024 Purchase Agreement. The Consents, among other things, reduced the amounts due to the April 2024 Purchasers
on September 1, 2024 by an aggregate of $1,176 to an aggregate of $336, increased the amounts due to the April 2024 Purchasers on December 1, 2024 by an aggregate of $1,176, and prospectively waived any term of the April 2024 Notes that would otherwise be triggered upon a failure of
the Company to pay to the April 2024 Purchasers the remainder of the amount due on September 1, 2024. Except as modified by
the Consents, the terms of the April 2024 Notes as previously disclosed are unchanged.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Aggregate principal amount</a></td>
<td class="nump">$ 1,176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,176,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet', window );">Increased the amounts due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 336,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Lind Consent Warrant Issuance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of share issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,816,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Mark Smith [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingVariableInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyExpenseRatioIncludingIncentiveFee', window );">Establishment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in debt instruments, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseDecreaseOtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuedPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuedPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyExpenseRatioIncludingIncentiveFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage, after deduction of fee waiver and incentive fee, of expense to average net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyExpenseRatioIncludingIncentiveFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_LindConsentWarrantIssuanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_LindConsentWarrantIssuanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=niobf_MarkSmithMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=niobf_MarkSmithMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>144
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M$GLPYH3,P9V0J8*Y@0A)7)%"9X0^*7S]6,;51[86H%%G8$JM"K#T!C9>T!<
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M<<W,=\9('%FH7>@EC*_MCONM>.*D@CD19]H+P)G*/JD@=@K V2 Z30W]SJY
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M3.C[3@^*94P4#IC8F54Y%80]\M$^8%/ZJ#E<!1D(\N1K]WH1B32# .G&B=#
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M^B1[>GIQ>(-DZRE'.)Z0.0D#J.7YF0CC[ *+O@ =K\,P?=.^5%_VK<T=AJ$
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MF@V_7%L#:$<7X/ME@[3OW] &P^]Z_?)_4$L#!!0    (  F1-%E.07JXR@(
M .0%   9    >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;(U436_;, R]YU<0
M7K&3$3O.QYHN"=!D[98!38-FW0[##HK-Q%IMR9/DI-VO'R4[7@JT02^V2(J/
MCZ3(T5ZJ!YTB&GC,,Z''7FI,<1$$.DXQ9[HM"Q1DV4B5,T.BV@:Z4,@2YY1G
M012&@R!G7'B3D=,MU60D2Y-Q@4L%NLQSIIZFF,G]V.MX!\4=WZ;&*H+)J&!;
M7*&Y+Y:*I*!!27B.0G,I0.%F[%UV+J8]>]]=^,YQKX_.8#-92_E@A7DR]D)+
M"#.,C45@]-OA#+/, A&-/S6FUX2TCL?G _JURYUR63.-,YG]X(E)Q]ZY!PEN
M6)F9.[G_@G4^?8L7RTR[+^SKNZ$'<:F-S&MG8I!S4?W98UV'MSA$M4/D>%>!
M',M/S+#)2,D]*'N;T.S!I>J\B1P7MBDKH\C*R<],/M_.%Y]A=KN87=TM8+Y:
MW5^M1H$A9&L/XAIE6J%$KZ!T(KB1PJ0:KD2"R7. @"@UO*(#KVET$O%K*=K0
M#7V(PJAW J_;Y-EU>(-7\&[5E@G^E]FGX,-,"BTSGK#J98@$E@HU"E,IY :N
MN6 BYBR#%2F1GJ'1\/-RK8VBA_3KI1)5!+HO$[##=:$+%N/8*VPLM4-O\OY=
M9Q!^/)%>KTFO=PK]S6T\C=)K@P-J/0>";RFV9C(OF'@"+N)2*4R @:"=D4FM
M;;W.H-/Q>]T^]$(_/ ]AZ(?= 70&'7](CR/R0_K.18LR+ZCV"$:"2:D,$$N1
M<%MU[?J .UMIWQKA$++(&%G)0ZX-K1E@2>5!S=E4;1+;-JS*]6\:]1KY&#?A
MFB9)8](BYX4T2%P3'Q9<SJ0J !\+\G,!4K9#6A0Q:B>6A?V>07_H1X/A2VT*
MCB8O1[5U^T53\%*8:@@;;;/"+JO)_7^]VG\W3&TYL<UP0ZYA^T/? U7ME$HP
MLG!SO):&MH([IK2&4=D+9-](2JT6;(!FL4_^ 5!+ P04    "  )D319 S-3
M3M0&  "L#P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6R=5]ERXS86
M?>=7H-29+KN*D41J]U8E*YV.ISINE^TL4U/S )&0A&D28 !0:LW7YUQPL>R6
M7<F\2!1UEW.W<X&+G39?[$8(Q[[FF;*7G8USQ5FO9Y.-R+GMZD(H_+/2)N<.
M/\VZ9PLC>.J5\JP7]_OC7LZEZEQ=^'=WYNI"ERZ32MP99LL\YV9_+3*]N^Q$
MG>;%O5QO'+WH75T4?"T>A/NEN#/XU6NMI#(7RDJMF!&KR\X\.KL>DKP7^%6*
MG3UX9A3)4NLO].,FO>ST"9#(1.+( L?75BQ$EI$AP/BCMMEI79+BX7-C_4<?
M.V)9<BL6.OM-IFYSV9EV6"I6O,S<O=[]).IX1F0OT9GUGVQ7R8Z&'9:4UNF\
M5@:"7*KJFW^M\W"@,.V_HA#7"K''73GR*'_@CE]=&+UCAJ1AC1Y\J%X;X*2B
MHCPX@W\E]-Q5W(\'[./O-S?L\7Y^^S!?/-Y\OKWH.9@F@5Y2F[FNS,2OF(EB
M]K-6;F/9!Y6*]+F!'C"UP.(&V'7\IL5_EJK+!OV0 >'P#7N#-M"!MS=^Q=YU
M:?'&6K;0^5(J7O6$2MG<6O3^//FCE%;ZM_^>+ZTSZ)?_'$M$Y69PW W-T)DM
M>"(N.Q@2*\Q6=*[>OXO&_?,W@ABV00S?LO[7J_6VF5&7LCH(7EIB=Z6Q)5<N
M<)JYC6!'DS9?&R$PER[T,BN=8;*E6C/D3%GNI\VR$W2F'[VMR/:5Y/MWTSCN
MGU=>GV3]Z^C\E.DD*8T1:0 G)+_(M"6[:&QQ%KQ_-QM/9N>H%^,!4HNQ8WK%
M.$.2I;#T? @@K/*T% G/!0K-I$JE : 0X_-?;:3;?Z]W2J3@HZ65J00ED8U;
MJ1?:%+XUD@U7:TA(9YDB,TX'=1 ?LB]L@3Q\8??"ZM(D@I)DBCH8=M+(+>X7
M38#=PQ@08%!P@S2R1.<%5]X[A9T+0T[Q#S"&+2!I;8G743@9#<)I'#T9R[*@
M5EUD',6Z9G8#RSXE/@FU*H4$7K8.#Y17F><"<3L4B!5&:L/JLC>)/^$K)PQ;
MRRW]$JL5TM?(6"H59MV0[T08AP7PJG]BWT2;E*M$@.#<QIMX*% G>'THBT(;
M=]A8*5"E[$$43N1+0(A'G@AB=G+02+5^\(U^D_"0\5P#^<??6U] \^G3XIB9
M)R7"'#YK!)+6^#"L$,92>Z-T;A_0*^'T*=OA&W546R2"&D8A2Y-P-IJ$P_ZP
MK51M,D"22J3>.R*WT>0<R5IF<LVKX2DIL=XK;V)Z!MEG]3=NT.]'PF9K#1S*
MCR1TO+"O""O0J!OLL&!7Z=I7K=K6&,7?-A#PP!M@"BIN- K'XW$XCL<LFH2C
M:!9.QT,VIZ:AU+!4@D?ELO2T ?D5XK+40-X3)AVX":4'M]$9@K;>7]N-!=^_
M8!9DV0*W5!57L.6^KM=WA&8RKB<^X%LN,[[,1-O4U91UV>-STO(RU9E$_D_X
MP60X-%!";3.2+RF+<:@GOD=;Z^BA3-9]Z_#E#=!P?$;/U'6EV @'HJ5SS5:P
M3QH#L])5L?>"&T9#E3*L/]&LO\%9,,]U"5K^:$@\X7:#%.E$B!0\IX1[07ZO
MY(A]Q^(P&D^#3Z#TLV!!9BI)-*1.I,?>3J??-0<Q0^,6GC+)ES+#HA1>S??Q
M8!8'_\+A:RM!^>P#-JG;LQ]Y0G)XP.)0">6Z[53?<1%H,GG"$(6SV3AX_"8*
M\14'4 LOXW 2C8);K;Y/_C;R.R.WU+1-=[?0N6,K+@W;\JR$9CB;3H(/W"CP
M)'NH6.RX:#0(H]GH_PR[YL=ZK,:C?O"H'<^>U="(S(<%+K;BH)@HXB"<C"?4
MQX$J/3VB_&@K<%V#^2\P_L$(;#QW^1EH1O5H'BN:X[;6M<%SIW<":U YG.71
M86N>[%L.?3@<\'@:QD-BC8C-!MU9G_TCH ,VPO!-6NV0^7.=D^CT:?.Q47<Z
M@-9GS\@G\2F;1F$<#5B_&T_POLKE<VR?#[+P"PC?CV$FFG"_#16SUX?9\6C$
MHCYA) @W*LG*5-A@BA),^L>3#D:X?KSY&/I%@]4GOE;G"#_F370O-J3;H+ND
M0]$3 5I(*<FT8B0" 0?ZYB%UGFXE=M4^H).EQ*&C&U#\]\(?-HEP"))T7J&&
M=0);N*=(Y1<3N]68@RA*3QN\3\OF;S5S%]D(T#:JOE^UX_>2+,-#^@5S6LT2
M-+5(7_A<5.M3$A__();NP&FS@U\"#+X%&%+JL'AP=[)/ 5LV\T80=_?8.;QW
M<(/RYR^Z)X)IB76KRU3[MKV*SJL;V)-X=8_]F9NU1 -E8@75?G<RZC!3W0VK
M'TX7_CZVU ZW._^XP75:&!+ _RL-P/4/<M!>T*_^!%!+ P04    "  )D319
ML*Z7Y8L"  "T!0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6R55-]S
MVC ,?N>OT&6[/77D!Y32#KB#TFW=M1Q7UNUAMP>3".*K8V>V4]K_?K(#&;U1
M=GM((LG2IT^1I<%&Z0>3(UIX*H0TPR"WMKP(0Y/F6##35B5*.EDI73!+JEZ'
MIM3(,A]4B#")HEY8,"Z#T<#;YGHT4)457.)<@ZF*@NGG"0JU&09QL#/<\75N
MG2$<#4JVQ@7:^W*N20L;E(P7* U7$C2NAL$XOIATG;]W^,9Q8_9D<)4LE7IP
MRG4V#")'" 6FUB$P^CSB)0KA@(C&KRUFT*1T@?OR#OVCKYUJ63*#ETI\YYG-
MAT$_@ Q7K!+V3FT^X[:>4X>7*F'\&S:U;Y<RII6QJM@&DUYP67_9T_8_[ 7T
MHU<"DFU XGG7B3S+*;-L--!J ]IY$YH3?*D^FLAQZ9JRL)I..<79T<UX-@7W
M3.ZO;Z;7LT^+$YA=?1V$EL"=2YAN@28U4/(*4)S K9(V-W E,\Q> H3$JJ&6
M[*A-DJ.(7RK9ADYT DF4=(_@=9I2.QZO]PK>7--5UO;Y!.:"20M,9G#UJ^(E
MW3$+/\9+8S5=DI^':J^1.X>1W>!<F)*E. QH,@SJ1PQ&[][$O>C#$=[=AG?W
M&/K_M.@HT&&:O3:X!*V_$\""-D!6"02U@K+^>1Q-:VR<@;J#KCLMUQW7HD[K
M4AD+XS2MBDHPBQE,D?*DG/GYF]&&^:='Z\9UY2WTHS-ZOV^D%WIK4G&1<;DV
MOH?*YJBA&T,<$R$GG$,G:9%KMT\!9"6QXU&\X=SKYW"H->'>)!6HUWY?&$A5
M)6T]5(VU64GC>A+_N-?[[);I-9<&!*XH-&J?G0:@ZQU1*U:5?BZ7RM*4>S&G
MM8K:.=#Y2BF[4UR"9E&/?@-02P,$%     @ "9$T6</R#&1M P  <P<  !D
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M&O72:3WS \;1+R#284M!QGT^'IO]=)O7:0S@#9[9X.:$G5YOR;:+DPGXO&1
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MDWF,57ZDZTF <7Q:+YST<4YC=4H^@+%K1J#V&*^^(@3OO9#OWLGWE_*T>5V
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M>0KCZ=[0E_45* W-?];8&>: A=\3TS3CIGFM66XY8(;4#QTI '#>RMYJ@9%
MF@ZSP91$SA]6$BEK>UO021C,0'CPFY/:J8:'OM]TWR8[[X N9Z-HBC/;\FP5
M@6&51[D_HB:="BJ4SEZ-7+N#"\4U_5QMIN),'^<ON0CCWWYECED_J&,NLCKF
MRW(D_$ @*1OB0^_NRE0F#^J_KFMQ9)?@IZ*Y?H^CU&:!A&&?%*D*-EU3H  \
M]KH^S;3>O0(H^<:DB;LB07$S+^QV/IW4M.>ZU??"?FN] ]6K8<823[&,OJJ-
MM*NCK2[/CC&XI[]3]/=W/DBXF%4" ;:4A3/06&T:"&J-3%N8[?&-G]TLZ-'&
MSX;*V^R7\%R=Z>[P,D9^Y]5RWKU;B[U\9'N^X,EI$,["8!4N.TZ_<]54UTK;
M8D(_XOC)%1^:&*$G$=]1A8&>!C'T/'%$YP*&&QITCIR^U0]WD_%#&?C* 4"\
M240@V(W]"MR_STH$HF,FY%>9"9RR8P2:FU^>1D:XL=HI;&D4A^9=(2S0[CC<
M$H@^IE,C.M8?QIG_%K%HMH2FXP<5E=P@=4FY H=I8>R.V@U5?GNZE8'!KC1'
M-L-4V(1IC],%-@V0FC (W5QG^L#UKQH%08.3Y?)SEM^"E;NREQ#L(E)X;)EJ
M5G3$@Q>%ZL"'BP86(EL+T1+I)YLDQU$'0B>OPZ\M KL#_-Y!/&RD\)Z$R!S3
M1CNG<[F9+?AP.ZYW<8CN2,P+T;T\I'\:2@?R_2&4.0%U<F$#W013]4[@;MY(
M[*E OS?2Z.71'LD&&FDV%'-O9!.3T&ZU%_BXW@9V*;I'/(.9Z,%8F>N:;".$
M:>XRQ&TXHJ4N>NX6D =.R =\B])1N?7DEP4K:&5[F&&<&[>)O<UZOTH\LF=?
MF)M,?_[EY:7=UYQ0:3@SC>M[^?V8KE60NSY_( C.AA,'0=N-E<B&Y-%\8(>N
M%^GW,&LU%>Q_@%2^'HIPZXVV&;9EP,$MG-]S;#TM0^021_*U-M?6^3@\9.Y)
M02?F]8FE=UZIK2?)I:W>@W"<=H'2M<AL[H1O!:G>8>[.X_Q*-SSDO=U[ *J=
M_>:3U#CUGN^PP%[X5N9ZUHG2'<4BP;M_L6\NP=O=VG<<-@Y>C3%0.=!=?(#O
MY*F^T@LGMW<-8O_)JOG</24>X;:@]JG].(#1X2.@KQ_5:.C;./?4PG?,DSU&
MNGA/#X4E[FP<)@^PQX4ZMBB6C/9* ^BR@Z '.MJZDJX8/ LJ4L16,5Q=+"F\
M3I_ GG# 6XD&M&>H_:@OT_VO:D%J.)4FKC<DZ0BX5TCWM2>VXE=]ML1V)L:V
M<:;#G#^VX(FMVO_[ZYV5+H$SPUHUSZ%P]/].M;.S D:"0+LX5N<41]..7NG,
MZH6];C;26;9;C@@3Q(U>KH&OYP1MS-SU4KX!!ZN"GE10W8LMWI&A]44XYIY'
MEW3H)AQZED$-0?I*DY15^U 7!VR-Z(DJ>P8@&$WZAOJ$"Z+MA23BT*!T2H^+
M8W%+ESO)B7</LD0X-O6'%>W3 5K#P0\!AL%(VTNV/$1D]Y0\Y3]?\A3=DN=Q
MDFRV\P^J=8K'USH#>ZD(1DX)A-!]E=M[EX%P*8']@^V,PJN[OKGX<$$SC%?K
M!=Y:_6IT,9+OJWC43J?@DXVLR9_K"'4\]TMOUCS"M+#E-/1R3Q*G1"2ON/!W
MQ5_<=:MFK+/-VID1?F=(B$%O\L)F0EUX>]HE]Z[G\GMQV6HI[#X;M&?5I)L^
MPEV=IGA;']CI2KL\:U*\VXD(?J!9!O#%O(TJ8:]B#B@CY+=@^'CAS+N\A>^U
M\W/LYAHQLF;>91)42*:96B#4W#!PM$QRS%SI_&CK4W>GD*;U>'E(](2[1Y?B
M+8+*^L8],+XSG0%6#]N(*0)IW)6)A73V8K?&2O$.ME4X;V;(VI?']2UZS_?%
M"7.Q!P/OR+OFW=WWQF@#BRPZ,VF+@#3\MM4?VTG]A>O1^JF7^/-DV@R ."]C
M0IN^YE2Z9!AY/RQ.<A?-UCY#MR<O<V*YT<MCJD'\=Y3LU5%["CDMN$T*[WXT
MZK3V+NCB0PQ>Q(=GP]WK%-ER\(QY"-V,PTA/WWAGT.NCKKH;N'<'67WLJCMA
MK[JSQ7?Z.PN<W>$5#<43WJ)[SL9KQ3R'_TWFNG>R<XV9&U9H3(A_+L/>YV@N
MQN^_IZMYBW[?+M9CJLZ=8>;&, ]\MRI1F3Y=[CM&;H.D0STX[8F<+6?2MF+R
M=7_F;CY[[U-_(^H D2B:A"X*TXE<VVW*D4VCU7D]GOA-S>-@&LZQ27.^('D^
MZGHN ZNZMW/5^NIX7)!)P;2I?XX79\F^B[.HT<V6Y<7%<+_3"5^,-1V%H?B$
M@=\IU?7OSKI)ANXGXI=VMDLS4-?GO+O62$A[")S@X>X5;(<:K/;6V(M2KL9/
MY6(Q&O,E7.?N$J[Y:#I]"O^=+)Z*=WHXVSQ+3^#],$_U?_OD42KF>W5-9PGI
M;ZE96^\NOZSNV3A:?W:M=F&\C\COK+9-ZV_M6)Y@3/,U*Y'7+F[K*J=A, \G
M\DS?[<=0QE)UBO?^];:GFY'I;T3U=8++P4[P91!.5E^ORO07-\[-7]QXD#+;
M]H@_0I_-36_3$>@G:S0*ISR3D]%R!1^/Q5_,78!=-06EF\[X"KCI6G;4;S::
M+^D.N"7^\Z]4KU]:KO-N2-7L'7DC7]7T7PAI@&2G;VC"W&61OD+)Q1CUJ3-$
M6TDFZY7L^X-MS[P_I;=7Q17]P4!$B4 8_U4]^ZG]FX0O^4_QN<?Y#QK^$!57
M&.>E:@>OCD?+^1-N.#:_5/F!_C#?)J\@@*<?KQ5$P@4^ -_O<MBB^A><P/ZE
MQN__!U!+ P04    "  )D319@JZPW 0)  !W%@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6R56&MSV[82_<Y?@5$S'6>&UEM^)+9G;-6Y-[=)G;'3
M]-Z/$ E):$B"!4 KRJ^_9Q<D];#L-C,>F02!Q=G=LP_@8F7L5[=4RHMO>5:X
MR\[2^_)-K^>2I<JEZYI2%?@R-S:7'J]VT7.E53+E17G6&_;[)[U<ZJ)S=<%C
MG^S5A:E\I@OUR0I7Y;FTZQN5F=5E9]!I!N[U8NEIH'=U4<J%>E#^]_*3Q5NO
ME9+J7!5.FT)8-;_L7 _>W(QI/D_XHM7*;3T+TF1FS%=Z>9]>=OH$2&4J\21!
MXM^CFJHL(T& \5<ML]-N20NWGQOI[UAWZ#*33DU-]H=._?*R<]81J9K+*O/W
M9O5O5>LS(7F)R1S_BE68.SSOB*1RWN3U8B#(=1'^RV^U';86G/6?63"L%PP9
M=]B(4?XBO;RZL&8E+,V&-'I@57DUP.F"G/+@+;YJK/-7TP_7#P_B1DSO/GZ\
M^TT\?+Z;_BKNWHG;Z?WTHN>Q \WK);6TFR!M^(RTP5!\-(5?.G%;I"K=%= #
MM!;?L,%W,WQ1XG^JHBM&_5@,^\/Q"_)&K;XCEG?RG+Z9=([T-7D.4CQXDWP5
M=W-QF]CDD+Y!VNBP-(J8-ZZ4B;KL("2<LH^J<_7S3X.3_ML7L(Y;K..7I/^P
M;UZ4=ACKH-\5O$UT>!OQJ;*NDH6/O!%^J<1-Y2 7)H0!9[J0'%K7"ZL4(M7'
M/.>A-(4S5CQ496FLW_XLBY2GW'Y+EK)8J)UO<Z\L?YUF!KLL@K1__??]^VAN
M*A#*.K&4CXJ'+86; "K5B')+";V$F8O&R4EPLF,G8YPU0B)KO5^O0'+ CSK&
MIV/\IS#7+D:BFOV)Y(%-HD19CPPGU%^5]G*6*2'3/Q&=A!PS&9QH)B6F2#49
MQG7%=9:)T_A\<AJ/^V,!-JN&S:.N&,>3DTE\UC\3HWAT/H@GYR?BKHC>J9FM
MD"'%\"SPGLWV4:[%X"0,X'<\BD_.A^*+<EZEC28T;]R/^_W^[H<8^=.5BC-@
MMH[%2EG5&BYED\B@W*/,H%)45/D,&I$MMTW5%9^7VFU,CB%D/TC09,)Z$,_L
M1).7LEC__-/9<'#Z%E9>%7#@4I>8 $<#'LUDEQ#LE03\)(&?(2]B1*X!Y=?"
M6UDX&3(Y;8:9-I5%HI O_5)</TS%V:!_C+_QY'@XBL-P8<2"/ )IH)0#WL0L
M"OU=I? ,BP#-R" $.)'6KO$N9$XH(BA/PX4IX%!O39;1QQ8\ V820'_P$-4D
M8[:0J!^U!*.%!8TE1Q%_B@4 S!W*,I6TL$6P!9.J0?</28])6W3FE=?@+G(T
M&_\>&"3I<:\6VL'6;&>NT&X[1%.>)!WM_E':9"D&IX',XHADDHK#_MM#4FB;
M#X!T7)4;B3Q_\/9U3#:'<7_39FIL&7/0[R23\(+$=5PGARC5\*8W-HB&K71"
M"0+(:BEMLC'XL:*4UFN8BEZ4-S&,GV05&9HGY8H8S^NWMNVV"9#,MJU7]))>
MT =Q_ZQO'G9\<[0+Y&E$T^@]^A@T'ZFXE;9 <Q6%[Z_W/=ODH-H364!6VYGB
MU5O-4<1ICZ-J#N/,H%E1$(2J-,5V$F8$B@FY^::DS;2R1(,C_9IRIUAC[&D*
MY]5'&G-HD.A#VZZ6&M2A$0!@R250J2?IAA*-4JEKM?)+C"Y-AB%CHZ<B&\_#
MSF6F/-EO)W/XI?1UTG*<1N"E#6': &7'T39UQ6E<\Z3F$ 2]7TXH=R72+5%
M5%)9S:S#6$U#BX;:4A3?8." M_<]W7S+D?]GVUE[MF8+-#B12\P>$BB+O",\
MNNBN^)UKU+/%%Y9XBF4? I+=#H;H:3&=K7F/SZHX_A]1XAJT>@0^JF?DSM*S
M@9[3DCW$17ZF5"$> R0N!P)VTX9"7<S5BG611>17P+]&Z:ZLR$/O*=LH/H2B
MB[X$5'D.P$K#$M 16\Z5YMHV1PWP>^4R*!WM*LUD9 U0) \!:\.#]")6T8IN
M;?A&V+5CO[9%%KKL>08A3R4) K!%M@:C4_@QM"6A )F2^?XW)6R;Y_%VJ8H2
M2EAZ7N?+_=+8R-W:][DMZA*8J^_?)?*+HI@(T,*'A-)LID-AF<F,2GK$QYFX
MCFF8DOO5@DO/S-3]7]T7-.*(K3,Z8HI,RYG...I0*3==6E/W6EW0ZE3J!U2!
M14RB&2B7:UJ2ER&7DDNHN; I!R8]!PNNF]Q!<8]F&+.))!L[;BS3=#J&B)[+
M J#;BK^;]=&%J6B/M\2HO2)\D.!-R67/K+BGD!DG29SW'9]PTY#H9;+4BG,?
MCNM?54V7D*JC7&?8$(F?8TV64.^;QB$9[:5X-1AVT8%"BYW<P#[:GSDY-'._
M7<66"+G:?TU,1ULQ'5-^#:"W>J_:BY0/<$Z'B=.&CMRO9X'130[L'K(J-\IM
M,*3<D[8,6XL4! *LN=199?DQIXN4+7XV:Y/0#"4H!\ABLCXQA+9U<HR>G41_
M4- W&@$ERG056%NU:1N[V)JT<(RE]FL=;!KR@=.821@%=(4[-?RZ@;K9<'R&
MW7[1G( JC3X45OBP"9IH;DTN;FOB?:9Z<< F.;A5\6Y^&]A>[_ +<9V#!2V*
M@TF(T\%!7'^W5C;1$]$I"QMBN7M^>UX#GGJ _LYNY(L'[(S.Q BG\RH+%B>Z
M,H=-JK(@<([(-BL.3 [X5+L$@$.NB[" KJ< KZQ\759)IVWY+,S] VGB!Z1%
MOZJU^ +% O#WM&)S8FP?VKX[:JR\$V2ADWHUZ)Z.Q"M$%WY/$6/19^04<:2^
ME=JN7^\T[Z/1RZ_1>S131/Y'0S9E-B'F/U6S3"?B#Z13240]P69B-.I.Q."\
M.T%[[+X>SQ%;PA()QMW11(RZ9R/\C,XYU/8-A[,.-T]\$JHO"9OTO,69O5"H
M)^R19,-[*M8T@?O3<.(A4T;-G=*;Z#H<]]Y!9A1DA@9B[X#S2@Q&\>!\$DU#
MZ[=+WR,QC$].Q^+U4SD[AWXQZ,>3X> Y(2?Q:?]OA8R!912?#4[%H4NFWM9E
M8*[L@J\\T4*3DN%>L!UM;U6OPV7B9GJXDH4%<"R -=4<2_O=TTDG],#-BS<E
M7RW.C/<FY\>EDD@T- '?Y\;XYH4V:.^:K_X/4$L#!!0    (  F1-%F8$]JO
MP14  !\^   9    >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;+U;:W/;QM7^
MOK]B1U4RT@P$$>#=MQE9L5NGCN.)G*:9=]X/2V!)H@8!!@!%J[^^SSF["RPH
M2K':M!]LD<!>SI[[>?;PQ;ZL/M=KK1OY99,7]<N3==-LGUU>ULE:;U0=EEM=
MX,VRK#:JP==J=5EO*ZU2GK3)+^/!8'*Y45EQ\NH%/_M8O7I1[IH\*_3'2M:[
MS495=Z]U7NY?GD0G[L%/V6K=T(/+5R^V:J5O=//S]F.%;Y?M*FFVT46=E86L
M]/+ER57T[/6(QO. OV5Z7WN?)9UD49:?Z<N[].7)@ C2N4X:6D'ASZV^UGE.
M"X&,W^R:)^V6--'_[%9_RV?'61:JUM=E_DN6-NN7)[,3F>JEVN7-3^7^+]J>
M9TSK)65>\_]R;\9&&)SLZJ;<V,F@8),5YJ_Z8OG@39@-'I@0VPDQTVTV8BJ_
M4XUZ]:(J][*BT5B-/O!1>3:(RPH2RDU3X6V&><VKZQ]_^.''#_+F+U<_O;EY
M<=E@27IQF=CIK\WT^('I42Q_*(MF7<LW1:K3_@*7H*4E*'8$O8X?7?'[71'*
MX2"0\2 >/;+>L#W@D->;/+#>F]]V67,G_^]J43<5=.#_CQW2+#$\O@39Q;-Z
MJQ+]\@2*7^OJ5I^\^O9/T63P_!$"1RV!H\=6_WT)/#K].'%1%$JSKC#K"G4N
MW]7U3A6)KN7;K$Y4+G[5JF(V>Z]^+,2-WC9ZL]"5C%@*PT V:RVOR\U6%7<R
MR<M:IU+)HBPN%E7Y65?XNJVR6]5HN<U!"HRVD6<TZ=L_S>)X\+Q;DM:3'^W@
MCVXP#XN>G\MR*79%UM3XT-OTD<5^IO%N@5!>R:9L5$X+Q.-!,!@,Y"C$?Y']
M.!G(3VLM#A;Y1565*K#O'J?!$55=9\N,CEE+54AME"@KH$,[/ITJ\"Y)RBK-
MBE5^9UA4P(ENJS+1.N43G,KY) 89(SD=S&0<TOZSL9Q&X60H!\3K[W1BJ8C_
M*%YW2_XNJT?1,!@-8SD,06(\'07CV11?0&LTG 6ST1A?XL$8O(OG SF/9628
MU]_BC^&=KIL,3A;3[G$1VX\BL[K*\S*A48)<<2KAUVERI7-%WETN55;)6Y7O
MM*]"&PR[62N8!^]-3Q\X@ETO)99A?F;M(J1C2[4I=T1^2T-3\NAN4[?G0PP"
M1TYE/!G)^71J]6$XE&-HA5$'.#\MXY%Q?O^Y*ICER, ?4P/I+$X\9''=.@\;
MVS :LX4=C#5B(SX2\6 >D9R 8#"G/U2PJ,,YG YR#;OPJBKKNM,&RW!'(YO8
M9!"S4G:K_9>,F3;J*Z'TE5 \70F/D/PD!92> HJ> AYC!BM?-(GD"-9DE&\Z
ME--A",,>',:$H1<3WA5"I6G&650G >\\5KQ9(9.R*&R^M<^:-8_]\]_?O9.?
M0$2M^$U <DBQW:ZNS:P/)4X[-FQ?ECC='G+H[2&REIHR2785Z7ZZJVC8D@F7
M=X[P9V1(5]"R7,:S1YUJI5=9W; =I5D%LL&]I>9%24+V5,-H%(PFXX,CDXJ>
MQJ3Q@5QH?(/,=+K# 8N5J&E,*SLPI6ZL)YO&1I+]Q5BKZC*'/>\JFM00GY6L
M-8X*OF,(7B1K:)M4JTJS!0>L)*FT1YVXHRYTL]>ZZ!DS*[A<[O!GHPHDVU#=
M._E7T)J"BFNUS<C8?N!79NWW[Z_#UB/-C['1LB<:F"#;/Q%V@H'3\%^1E-]F
M>:ZES<3>JB3+^4-6@#W$[2MW)GG6Z<6""H9S ?707W#T8J4-TT>S&6N:JM>M
M?;9,9<H@2IARZRQY)*J82I%PL!H*FEH;>0SE?ITE:TSAY*E@HR+[RT@3-*0G
M+#_Y<>L/L(6&J:>M*=^/ 4=-I'48'U2=JM]8%XFHSBGZTS"0Q=AJ$DD\%(MS
M>=.4R6?QXY;LB9.V[U6Q0U$EH_F1X$$..YH^KR4KYAJ*IJM:WI;6A:@MS@6_
M!=^H((6T]8D@O,&._)V<$;0X+XO5!6QF QDD>$[^#L&G$'Z\B ?15%[14MC@
M/<WX1#/>M3,0AHHV CD6KLA/$3-HJW:H9P,85&FC67"#4'KOT *'GH8()$[O
MOHH&PZ77I:K(,.#XH5AT2M+"2K,;6U;E1B(UT>SZ\#<PA$*C#/.)?.:KS5S/
MLL(Z,FR'HQ 3(5WBM?$+9AA-@[RYK";1>N_.:2OCD<JJ#J3>;//R3MO D>BJ
M0;$M2V*'I(2?50<2S$BLXHR\JUZB3&#?^M6\.#_,N=EI+)<P5O8S-)3%8$IJ
MXT):]H7R9K?X!YY34J32?Z!R-6I$Q("9V>*)Y!C1J!5<PXJ"8;'CA HT]@VK
M62.K@.S@+Z2M?U)!CJ(U&A"T5563)=F6 ^'NR3I2KC0SFT,:HF_+>U;-NPMC
MU0GX!L^B2"T$1UWC3 ^+F8#)+<J&')MF%_J-&^(2);"^W#6POB(]#(7U,95T
M-F0&"CO0\4/V^+';8JE:-TW>6K:OF'LX:Y^Z\=.)$SYQQC=_%:MEGFV(!-IL
MH[YDF]WF0;E;8K )$CG6?.EIOC!"_G3S=UGM<ANOFW7&@72+^'_.PH1"DJ9'
M%YP]P!RS,@VD8]8BU[WU*7W%:,-QJ\NM@@96KT@]^HHA?,60/<6 KTCR'7/Q
M"78*FCR5P;_B<=%8=7B*(%1>E[XT_CT[[.D=.P9*VI%0>/;X/S'''M?%H3F"
ML/$3V.E.?$;K<H:19OG.E@-9?=ZZ0I<L>^Z0W30!FBT5?Z@S1(*] T/:Y(R4
MGA)OY#)5Y[#MP04[ JZ]O^@JR4Q.Y$5>RC':,,=N ;)EI3"U5.?8U0+Y ^N7
M,,$4J:K<EGNB\=9*UX7WH$LR\#'=9$5&R)RI#,KJP#-Q(-J; ,,YCZ''',O4
M$S@VI<^,*F?_-*29*J)^)F^2-=+RG(_F'TA\:%GHLJA?&,&EC!HD(Q&6;QQ;
M/G)V=M6R_UV!B ZOD,B_<<9W;^9/FO!PHS(%PXX0BWR?+<$?E9,U!*9$LT#G
M4$;!>(1_2*1/Y32,YN+/Q"X*#L$D-I5U',[GPM&4RK-I,,/3<XD";BRN:5%D
MV>DE\MN,A'TVF0R#F$>,P]GL^,8C&0>C^=ANC()PAC\76'(TDE>LH[W1 :7[
M7$EF&P)KJDSE)O@HCG('@^-@.IWC!-/YB'6CJ^T:=JZMS(R3V3LV*LO&K#"W
M#FS!O EF6&GM:N/]4TW9*'R^%:RIMIZ90M98E:-*F .#W>)MEZY3TFVGKBS/
M;67)&3_'! (FII$\'8:#N?@IJS]?+%&Q@#ZJ'NM&5J05HS >RV_ N^% ?@-!
M;4V6E&:4F('ZNTRCPL,[V7MOM-(4 +<E00A<'9TA6"']RZBV-7Y%3H9AC-GX
M,_$7L,3GT"Z*2A3*:HA\0$@>J6Y9D>MM<^6CX%+)<8B+'^5<\M7-SW(:H82^
M]CTIUQ+1<V.-_5=GG\HM; )SSJDD^4&A9'4U^,A/M6W!007:ID2IA4,Z<,$9
M(\JQVZS<U9XO*Z1=<>K*40X *9D6I=B?M>&B16O(*DAIKD_GX3AVX=F4>T2*
M<R1EY_[ O>M35N]*;XC 4'XH;70A+:O)/X%7!@NQ=;NROKN?#;_FR,_^%4F'
MY_%\ME?ZPD.G\ 8T. 807:9@[@[>LM+'G:#(?O%9&!&:2C$Y[_ ?^T%\G><,
M.Z?FK+%ED^4RXUW&".%]5)HA;T@Q&W8'?2]AD_QZ[Z-QR(4*+&>G_1S>A'8*
M&317YQ1RE\[L"%?)5K!I0GR*Y*Z# LCBZE!TIWO<>1_W?C&L838F#QO#[<W(
MOUJW"__1XA;+%J=HCP*7-IL'\61*DT:"$:[NY3B83"98="*C*!P/R%*-1Q[-
MHP#& X^,%Y/I@[%@%LRB23 <C.!NP_G,BP7C^1#O"*0?#KMU<8K1)!A/R-?/
M'EQX1 N/$13&DX@6'@_E52,.7+:OGA3$_?3'*@"[;G?:P(^V+J@ZW@L3.)G.
M._$=1"9FXS&'+=C9/)P.Y%N]J,@O"0M<C,5H- V&$>(0L19G.Q?N'N>4;V_:
MFQL1N1GV&N.4[S$<]B[LE<I8.&@Z#F.#3PL+L8_%!*^&LS%-A?-F*$U$9MY4
M>((\94D:.Q21<4 ST?%3@$YS3ET39#4DXX5?VM#E*'P8&1TR$<9WO]_A@5T#
M=%SM5L@.O0?DM+P[./L\)!CV&+QZ;2"DH(<=LB<BB])U3?)<D#'2M*L./NS5
M^A19+?;%VFP-RX/F0);0"FZH]][#9-CO<&YP/'M&RJ!3PA)P_"V%I19,MB 8
M*0@OT#D)1-B2*X8/67E=5EMQ90EU^Q\>^CCQK*6>HX:GPD+P+.;E59M7,-%7
M+0AV=0"VVI@6M1%(0<"K?C5!% 2<]X'[!>&J)E1^LHFX_%9MML_QE:3>SE*U
MS<01]3U7@YS?D$^!#&-19E0&;$*!$!J8FL D!],$_5&'NWP(K[SZR>Y9[Q*X
M\QKRZ&W:NP&R[)>6_>(>A[L[H7?';P%:-75+62TY4^=R'LSG^#>>2VMQ<*QO
MH&KB8-M6L(Q%Y39M-'BF4X"*X@!C/@XQC\(HFL7S.(H/JZ6&KX-Z8<W PFSL
M6W(Q#\T]J[L:KZOO#,Y@,KIZBSP._M%\<UD@'E2ZK%:JR/[)%LD/$H/ NT<.
MSA$YDAJP].-ND6=)%^PHEW:62R4W W)$":(!Q,%\,'.Z\._1ZQ#$+I-A.&,/
M1FK>FM ?/* J/? O[8@W@W 0,6OZ&\AL*<\R%",#6,I=;1%G:^=[E.4-RFJL
M:Y<A0JW%9;4#+]O[+(M0!U@Q.V<$'%E20R!]R5ZA5KDGKOM@._M>3M8,AE6;
MC/,+7S##^YQ&DS!B 5ODBY C(T4+6O1$*/X#$4H6(:])TD( 0BA@=TAL:D$H
M\.W">^'R'\V>4]@R'4.1/"^<6^=QOA\UEX:%E^,Z):F);'.K>4P$=KXS?W=!
M .X;]O-E%MO*<JFYC<K>G9FR77:W! F5^UGG$@\ .TX=&';P(8<CZFJ+2IOX
M-0+2JZG<V=FTTVY1Z:;$T%N5Y0:M6U?E;K6V/0'M^3@9EC]ORZ)#00E;\,=8
MQO0ADL#GBW!\82ADC;387D,<V:U75I#PZ1**X VVIV-7,ZY/+9 ,*]'XG*3,
MM9^!5@Y-FC273!6UDJW>&!FV98.K+!*O?J9R)4GH$MGJN2+' &5YX-K9B(&C
M_L*DE,*T"IHSD@#4$L$&]0X, "6YA;20Q'[RRPS(?Y>;>&Y<+@4<V@A!:T'U
M+MTK,%($FC4=+<$AP-, ![25#24&R@).KO/B@".AZW/HNTK7_. >/F-/Y0 M
M/ZO5&0=&)S#R($>DX41H]*&58-EE$.2W6B!=++1US+S'H8;1!:?9-N'[77/'
MYH+S(>TLPS4!"7:=&VAU37I%><"&<T;V?+8_@@M$L26(I.&JRV8A=)M$7H^N
M/?NW,P_%W#;4FQAO^B78E-H8_\!4X>=A(.O>F3AS] ]6EQM-69\MO5'R??59
MY=&S"EJ]@;9:Z/*>XO@AU9J(NS0X)@1[P/9"ZU#AL^,,6NVRU+8$%!2"S1)7
M-]=R%HTO1H-0W) UML-L8+0<6G@V=H^DM&1?L"'KI $0*N-S? CK$I@![*>[
MM#TPYGU@.')#>2,KKKM+QZE;<[TCAL$0VN\4'Q),=5TVC+Z7A05QW:+O?6LW
MK$M(HGF6VG8:W\>8'@P_<:GTQ4:K>E?9BJ3IN2;9N:90_D(LY[?LW_HS>V[=
M.X1U":)-!>CV![RU4<C#68).IA:0@!P]&(;8MBH84\F.'+1WK6Y;$US20)RK
M])KZGF^1 9;U07<#$PE!PE'6QD<<>OI'V.*K>0L]U<<47+[7MSJ7L=<GY5^=
M>F==9Z ?N;:Y,>[Z^ Z&&7Q'B=>Y0C)UDU"V61/^I_..F1U"[&&]S\1?]1U#
M[>: [PI4. ?01A]!Z9=IXL:#6#'_MEV)P]@I*H3I$'_&X6#(\/M@@"D=H$@C
MN"(X^"O>;9 @XJ0>; MY'H;IR3PDT'<X# D>CN;TAT%DR2"RQ8Y']'(41C.&
MD$=3C/GN*'+<1X\[)?;1WV$X)3"?46 2>:>C1WU'SXR[1ACNP'DFKKCK# 4G
M#!?5;,N]X(#-U-H8S&=3<=WNUG$:-93H)*B: X$-@W@Z/SKQ+ KF\42>/SQ[
M1/((AN.A2,^[=B/Q<+L1:G.75W96;#$(FX[>[UEKOK*7B9ST1G>9,E5O/8A"
M/*DC*O VA6=PD<TK;W=;^GHZ,1C7O2M!JN*%K>*O>0&#;+!07=7.6:F-WFT^
M8SI0CO; F-S152E$ES9TMU>*MMQGT,_X!0,"N1M'5<%R:O9_E(RQ[6=5W7!5
M8X7 X)DL])?&\POT8CBY,.]448#%54T7&ZX2M#B#X!SL?EG4L1.EG\OC-RJE
M2^D[YY*9G!W>WN.82^_\M3DX]_3C$>7K #5.;O94()@;+$*TCR4.? ?/MP\^
M(N-1]I'%T,GR2*G/M[8'E2G=VM1+H]_N-MJ[W+#.XDG:>JRYT6\,N-?C^'2N
M[<L=Y8BZ-0!.&#LJ#5SAC,/X;X/%8KOYM+WG3U$SWI'G1FB[<#>/PMUU/ (N
M=,U[A!-P\<19*J84U-*0FVN-C:H^ZZ9-(0]JX:-=P946FFJ@/./DPUS>IUV7
M^P>]YX-:0/&-NPNQ6WSX]>8-89=T9UA(OL2R> D8]#HO2\J75XZIW.]))%(C
M Z742ZY5VEHZH/Y3: U=YQPVF1%C#)ZL<C_5<5#ON7^#JK8(D@F7/L15[G:T
MC3;&(JF@LH^$G4=;%RLJZ#U,Q'<Y+!F*GI16Z63'F(2/K#Q89WM5VGT[$:Y9
MKP7%.).BPBQHF^K:R[<]M8H0E)S>LK5^,!#"D0:\)QG1N3!9K_'UOV?.77QQ
M1;&]J5P^?>=[X.R,[JN&QX/*?4=D^XS:QD[.^[CK']%I0/1[9LHH/S=6F:#.
MK4)0Q@R!^;8T^I)T/LZ/> ^T&C\ML%)WL^QW-Q\<GE6$'-;Q%N?><9@(\6_X
MRRO;6$]=.SX%,"N#@)CVQ9Z'*[Q.H*6VD#6U< C7%]V3#SUXJW47'[JFLU/J
M^V '[7;>JJSU-[U[&<:/L'-+KSR-(50W;Z]JP7/O-X(,PVX4U2YT&@.9N2:9
MTRE6<N4*M>"BY !#;/,DPT(RBFW,;Z^&_8S 3S<"#T^FHV6-A]CUKPC@(=4=
M1]D2%<56XU@0%+>450Q_.S/J:.W39OVX9;'P.@0-2&*Y%<@<XLK-E9C!>MK?
M!(SF$_LCF<+^L.&!WU%\A69QPP,O9KO<6UEVR&U;"/K%UL8 'MZ5_I-UV=SO
MM_N2'O!)N\Y[<V8O--S=[]&Q/^'PV[;LDO6#2[H*I2/7"80K S*,M[WV?"]W
MZG>3PDV)]P>2<CPQU$-:**#I4WO2IKQ'EON- 55$D]%$'ON9Z*7WHUT$[17_
M-)F\(HYB?K_;/FU__7QE?O3;#3<_G48@7T$OH61+3!V$T_&)47+WI2FW_!/@
M1=DTY88_KC52BXH&X/VR+!OWA39H?Q/^ZE]02P,$%     @ "9$T6?)UT(IG
M P  '0<  !D   !X;"]W;W)K<VAE971S+W-H965T,3@N>&ULI95MC]HX$,??
MYU.,TJIJI90\P.[174 *+-7UU&41T#M5IWMAD@FQ-K%SMH'EV]_8 ;IWVJ4O
M3H(DMF=^\Y^)/1GLI7K4):*!I[H2>NB7QC0W8:BS$FNF.[)!02N%5#4S-%2;
M4#<*6>Z<ZBI,HN@ZK!D7_FC@YN9J-)!;4W&!<P5Z6]=,'<98R?W0C_W3Q()O
M2F,GPM&@81M<HOG6S!6-PC,EYS4*S:4 A<703^.;<<_:.X/?.>[ULV>PF:RE
M?+2#+_G0CZP@K# SEL#HML,)5I4%D8R_CTS_'-(Z/G\^T3^[W"F7-=,XD=4?
M/#?ET._[D&/!MI59R/VO>,SGRO(R66EWA7UKVXM\R+;:R/KH3 IJ+MH[>SK6
MX9E#_S6'Y.B0.-UM(*?RCADV&BBY!V6MB68?7*K.F\1Q85_*TBA:Y>1G1HOI
MUW0UO8-YNEA]A]4BG2W3R>K+PVP)Z>P.QNG7=#:9+@>AH6#6)<R.X'$+3EX!
MQPG<2V%*#5.18_YO0$@JSU*3D]1Q<I'XVU9TH!L%D$1)[P*O>TZ]ZWC7KZ6.
M%3.8PYPI<X"58D(SMU4T_)FNM5$T^NNEQ%ML]V6L/44WNF$9#GTZ)AK5#OW1
MNS?Q=71[073O++IWB?Y_WM=E<)QTX CW?@*'58G>1-8-$P?8,PV-JZ"1P$!(
M\5'A3E8[+C:0*<RY@8)EO.)DPC8*D8ZT@?>F1'CWII\DT>VRYJ:$26O[^6CK
MUN+;#W0>:/&>J4=P=@%,2HZ%-WW";&M/-#P4!<]0!3"G<O.<Z $PD<,/BTG)
M.)U@ ;* &9<3J9H ]B7/2L"GAE-@H 9!^PM/^ZO;L4G"B\I@+15Z7!BD> 88
M_4#13K+T.(*D<V4#B@UJ,@+S7TQZKD&CN,AXPRKJ*Q43&0)3]-=0R(J:I;[Q
MJ/$XP &9 A2YK>E)IE7IC7'#A:!I[X1X"TD019&7UG(KC/98OK/S.<1!W(V\
M!3;L8*-K> ]=.P4?O''K&W@4PF;1H.(R)]1'>! >U9X*E21M80(GZ/3V%>%X
M#O>J<TSR+<7I]V*Z)OU/D/0A[G=?VO;ALY95H]JXQJPALZ+;[G6>/??^M&UY
M/\S;#P?IHR)HJ+ @UZCSRY4/JFW&[<#(QC7 M3343MUC2=\O5-: U@LIS6E@
M YR_B*-_ %!+ P04    "  )D319 3][ZYT"  "M!0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6R55-MN&C$0?><K1MNJ3XB]<5,*2"&7-E63($C:
MOIK=6;#BM:GM#>'O._;"EDH$J2_KL3USYHQGSXRV2K^8-:*%MU)(,P[6UFXN
MPM!D:RR9Z:@-2KHIE"Z9I:U>A6:CD>4^J!1A$D7]L&1<!I.1/YOIR4A55G")
M,PVF*DNF=U,4:CL.XN!P,.>KM74'X62T82M<H'W>S#3MP@8EYR5*PY4$C<4X
MN(POIEWG[QU^<-R:(QM<)4NE7MSF+A\'D2.$ C/K$!@MKWB%0C@@HO%[CQDT
M*5W@L7U O_6U4RU+9O!*B9\\M^MQ, P@QX)5PL[5]BONZ^DYO$P)X[^PK7V3
M7@!99:PJ]\'$H.2R7MG;_AV. H;1.P')/B#QO.M$GN4ULVPRTFH+VGD3FC-\
MJ3Z:R''IFK*PFFXYQ=G)S:_9]\?YY=/=XP.0??-P???T/+]9C$)+Z,XGS/9(
MTQHI>0<I3N!>2;LV<"-SS/\%"(E6PRTY<)LF9Q&_5;(#:=2&)$JZ9_#2IM;4
MX_7?J_5M(Y1F_F\@&V7.;:71G*JU1DI/(SFE7)@-RW <D!0,ZE<,)I\^Q/WH
M\QF>W89G]QSZ?_7D+-)IGG':@:,4K>,4L"#5YY5 4 7@T7OAT7NU2 ]@UP@[
M9!K0=;OE6N3ZE+9ND1F^Y(+;'1A;Y3M@,B>O%7%#S>4*/D+:2^G;C:/6+4>1
MTP\M:0*0UJUW5@2NH1>E,$B'K7NT3(A*KWC&!,3M_F (W78\Z+:^H!)JQ8TU
M/JSP6,:RHH!X"$F_]:0HE#(E[5XOH;773KM#.-6B\$A")>J5'Q0&,E5)6ZNI
M.6UFT64MP;_N]2"[9T15&A!84&C4&9#T=3T<ZHU5&R_(I;(D;V^N:9ZB=@YT
M7RAE#QN7H)G0DS]02P,$%     @ "9$T68Q1X8FY P  -@@  !D   !X;"]W
M;W)K<VAE971S+W-H965T,C N>&UL?59M;]LV$/ZN7W%0@R(%,NO-=NS4-I!D
M*;:A68.X[;"/M'2VB$JD2E*QO5^_(VG+SA;[@R6*O.>YYXY'GB=KJ7[H$M'
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M&["^5'@/Z6[H@/TGM\N_ %!+ P04    "  )D3193_&&YRT&  #[#P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6RM5]MNXS80?==7$&Y1M(#BB^Q<
MFP1PLMDVQ6ZQV.P%1=$'6J(M=BG2(2DG[M?W#"G;<M;.ID 1.)0HSLR9,Q>2
MYP_&?G&E$)X]5DJ[BT[I_?RLUW-Y*2KNNF8N-+Y,C:VXQZN=]=S<"EX$H4KU
MLG[_J%=QJ3N7YV'NG;T\-[574HMWEKFZJKA=7@EE'BXZ@\YJXKV<E9XF>I?G
M<SX3=\)_G+^S>.NMM12R$MI)HYD5TXO.>'!V-:+U8<$G*1Y<ZYF1)Q-COM#+
M;7'1Z1,@H43N20/'L!#70BE2!!CWC<[.VB0)MI]7VE\'W^'+A#MQ;=1G6?CR
MHG/28868\EKY]^;A5]'X<TCZ<J-<^,\>XMKAJ,/RVGE3-<) 4$D=1_[8\- 2
M..GO$<@:@2S@CH8"RE?<\\MS:QZ8I=701@_!U2 -<%)34.Z\Q5<).7_Y>GS[
MGGT:O_EXP][>C.\^OK]Y>_/[A[OSGH=R6M++&T5745&V1]$@8V^-]J5C-[H0
MQ;:"'E"MH64K:%?9LQI_JW67#?LIR_K9Z!E]P[6KPZ#O:)^K7%KVB:M:L%?2
MY<JXV@K'_AQ/G+?(CK]V.1U5#G>KI(HY<W.>BXL.2L()NQ"=RQ^^&QSU?WX&
M\&@->/2<]O\2FV<5[88Y..JR/1;8AU(DUZ::<[UDE>"1*%\*-B4.%X%#,V53
MJ;G.)5>,.R>\8UP73$D^D4IZ"1&JEX*A^#YV[[KLE_'X'9O5LH"08 ^ES$LJ
M((!U+<4I$\[SB9)(:I=P-K6\$E3:#"VH02/U;$N"[(I'P"T<*UJQY1/TH3;H
MQAET%;2R+3=S!1_DE%!_TRWN6"E4<0! !TB= G" 8<&E FX1IAU7P!56>7.
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MLP^LNF;M94B1!(P5@IA"-\<)#YQO]';9K68SH:%<I:UYMQ$IV&3)WB NB@T
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MV<(Q^H%VV:&3C"J+X..H-LN$450-*5*IDW) XD27F]R'=(%[*DGWV-?G]@R
M+TQK5Y37QH4SQ1\R.GHFHRX'\>C,N'GAZBEGFKI5<])>,P-S=]-[!9N3Z[EK
MBWK7T".#WA$4#RYKUJY5MNT7./HL395VL1&;IV74-%K2.8F'G=$@(2K]Z 2.
M72:>.W9[>W=B@7KI;WY#9P,EH;X>V]7V<7%>WZD[\?IE0M6[Y-* P 6I1MW1
M<0BZONWKB56EOV'GRM)][8<Y/9!0.P':7R@Z*IJ),] ^N:;? 5!+ P04
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MYB/:(.G;*7R3X3<J^H9YKO@+$+D5/)7R.Z#W7);?23" 6<W:+A H-"1,: &
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MWCI8/[)XD)6]F(V2C[9--$O/KL_3\\D$Y?=LBJ\2WX.>@OA=G,+_4WQY-;T
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M^'Y10;ADW^ &_B=87_T/4$L#!!0    (  F1-%E_WK>=X0,  '\(   9
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M3VK0S<6U65A5^<OB3%FZ>OK'@N[ZJ)T!O9\K8KI9N -V_SV,_@)02P,$%
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MVKJQ-E.0CBG(L<*9P?X<[4_0_NB$D)Q69<D+32]EB5E%_@LY=RLRD-O2 8/
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M5,$41@V6^;UEE_ZHQC\WE4,"UR:^ZX<C^H+!T\#HBU_0]_Y+P]6>_'V^E$H
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M<112O1O43QB.W[Q*>O&[(ZPZ+:O.,?3Q0X%PK<J*R15PF==:XPR$HPJY,M8
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M"\44U#]-BGD!;1(ZUPN:PD4'LXP&]02=R6^_1(/P]R:V+8'5N/<K[GV'/CC
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M#)A-U::/N1D8N7"=O:DT1A;N,0>:@;(+\/U,2K,=V VJ;O+D/U!+ P04
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MA+;#?KYT29V \<L"W-1=FH;G, L:EPMW$*1OWXRFT:<3Y4V&\B:GV--56V\
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MJD.7#?6%IFSOMY O,16 H(6BM,YZZ@WQLF66$\FRHNO,F50]K!@FZB\#<;U
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M-!!\A839K=',P!K32FOZE)E[OU-"OZ5:3HWN$T!LD3V"0'R*QCS+]&7<)42
M1%3*!<2(L!AICY%*#RB;(9IE$%.B(%VC*4^UYYA5I8$BSJS_V!O5<&;-]_P
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MC[7(IH["M;7*6X/^_#MPAZP15.0*KQ,&^\9XC\(*;RHK7%]:?=45NJA/!K4
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MY$KQS X3()J_V:#?3[FV3C$Q!Y2=Q]'_4$L#!!0    (  F1-%F@Z_,,_0(
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M5EUOFS 4_2L6JZ96VLIG$MH1I#;5M$WK5#7K]C#MP8&;Q*K!S#9)]^]G Z%
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MGL0FW@;\)+"1.V-DG,PY?S*3NVSD>$804$B58<#Z;PT3H-00:1E_:TZGV=(
M=\=;]B_6N_8RQQ(FG/XBF5J-G-A!&2QP2=4]WWR%VD_/\*6<2ON+-G6LYZ"T
ME(KG-5@KR FK_O%SG8<=@!^=  0U('@K(*P!H35:*;.V;K'"R5#P#1(F6K.9
M@<V-16LWA)FW.%-"/R4:IY*9+HNLI(#X0J<TY253J, O>*Z7,,O,FB@A0Y3@
M.:%$$9#H_!84)E1^0!_1X^P6G9]]0&>(,/2PXJ74*#ETE=9F=G#36L=-I2,X
MH>-;R2Y1Z%V@P NB%OCD[?!P'^[JC#1I"9JT!):O?X)O6J5 VAR,30XPE>CW
M>"Z5T)7WI\U@Q1BV,YK3>"T+G,+(T<=-@EB#D[Q_Y_>]3VUV_Q/9GOFP,1]V
ML2?CJ@[DMA ND#:=09OGBBBR1.;"6"=^Y ^&[GK72TO0U977!.UIC!J-4:?&
M!Z/HM5+K-]0FL>+I[>P>]KP#A<<Q?FC*L$UAKU'8ZU1XQU*> U+X&9I,MNGK
M9&E_TZBM8GK''CR_W4*_L=#OM/"9K8G@3%_:"M/.)/>/-H_B@QQWANS)&S3R
M!IWROG/,$!=D21BV/6$!KZE&BNLN0['2EU>!A7IIDSTXTA0<RNX,V9,=-[+C
M[M+E=3;W#MFIV[9-=GQ\H.(H/!!^'!1&5X<%X>YT#M.U?V"ALRD1A86&>9<#
M;5Q4G;":*%[89C+G2K<F.USICP<0)D _7W"NMA/3GYK/D>0?4$L#!!0    (
M  F1-%EBV@ST) ,  "X/   9    >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM
M;*V784_;,!"&_XJ5H0DD('':IBUK(T'1-*8A(0J;)K0/;G-M+!([L]T6_OWL
M)*0)E"AE^=+:B>^U'_LNOAMMN'B4(8!"3W'$Y-@*E4K.;%O.0XB)/.4),/UF
MP45,E.Z*I2T3 21(C>+(=AW'LV-"F>6/TF<WPA_QE8HH@QN!Y"J.B7B^@(AO
MQA:V7A[<TF6HS /;'R5D"5-0]\F-T#V[4 EH#$Q2SI" Q=@ZQV<3W#4&Z8B?
M%#:RU$8&9<;YH^E<!6/+,2N"".;*2!#]MX8)1)%1TNOXFXM:Q9S&L-Q^4?^:
MPFN8&9$PX=$O&JAP; TL%,""K")URS??( ?J&;TYCV3ZBS;96*]KH?E**A[G
MQGH%,679/WG*-Z)D@-\S<',#MZE!)S?HI*#9RE*L2Z*(/Q)\@X09K=5,(]V;
MU%K34&:.<:J$?DNUG?*GVB^"502(+]"<LS4(16>Z&\!,H<-+4(1&\@B=H/OI
M)3H\.$('B#)T%_*5)"R0(UOI11@I>YY/>)%-Z+XSX?<5.T4=YQBYCMO=83YI
M;MZIFML:O>!W"WXWU?/>XP^Y4"=W(&)T:9 ??N@!Z$I!+/_L@LO4.KO53,R=
MR83,86SIH)(@UF#YGS]AS_FR"[4EL0IXIP#OU*G[D^UA!^EI'VMW$P*8VH6=
M:753+?-E6/M]SW-&]KJ,4SOA;AQ40](M2+I-27(0QED-2ZU:HV5FN)E.K[0G
MV.EYN-B4"DRO@.G5POS6'[TUC31*&6L*FH>J9_1P#?$,Q$[7K!7>US5;$JOL
M@5?L@==J3'IM@K<D5@'O%^#]%F.R_\;_>GW\*B1KY_L@S:"@&32.RT8.7"NW
M[SFV)%8A'Q;DPU8=>-@F>$MB%7#L;-,)IT47SL5Z]?=*_93[7RRXE!SA5J^6
M>KD][I9<J.'E@K?9#J[-*?SS1- H3;WVOU_JI?=UT[;4JANQS7YPI]40Q1](
M;FK@6U*KPF\3)MPX8VH2I-VWR9\S&+X.TO]/JS(:NU3,F$KRFH@E91)%L-#*
MSFE?!X7(BK.LHWB2UC<SKG2UE#9#7="", /T^P7GZJ5C2J:B1/;_ 5!+ P04
M    "  )D319348K:Z@#   /#P  &0   'AL+W=O<FMS:&5E=',O<VAE970U
M,"YX;6RUEU%OVS80Q[\*H15#"ZR1*%MRG-D"8F=%/2Q 4+?;0[$'6CI;1"72
M(RD[^?8C*46V8YF-5^_%%BG>G_<CQ>/=:,O%-YD#*/18%DR.O5RI]8WORS2'
MDL@KO@:FWRRY*(G23;'RY5H R:Q16?AA$,1^22CSDI'M>Q#)B%>JH P>!))5
M61+Q-(&";\<>]IX[/M%5KDR'GXS69 5S4%_6#T*W_%8EHR4P23E# I9C[Q;?
M3'%D#.R(/RELY=XS,B@+SK^9QBP;>X'Q" I(E9$@^F\#4R@*HZ3]^*<1]=HY
MC>'^\[/Z!PNO819$PI07?]%,Y6/OVD,9+$E5J$]\^Q$:(.M@R@MI?]&V&1MX
M**VDXF5CK#TH*:O_R6.S$'L&.#YA$#8&X4N#_@F#7F/0LZ"U9Q;KCBB2C 3?
M(F%&:S7S8-?&6FL:RLPVSI70;ZFV4\DT)VP%$E&&5 [H#\HR-)O-T)2S#0A%
M%P6@.:25H.H)$0&(2+3DA=Y]B=[>@2*TD._0>_1E?H?>OGF'WABESSFO)&&9
M'/E*^VAF\M/&GTGM3WC"'QRB>\Y4+M%O+(/L4,#7<"UA^$PX"9V*OU?L"O6"
M7U 8A/T.AZ:O-^\YW.FU"]ZS>O$)O7G.A7K_&42)[F"AT%>]Y(!F"DKY=]=R
MU6J];C5SR&_DFJ0P]O0IEB VX"4__X3CX-<NU N)'8#W6_"^2SV9P(HR1ME*
M'[N"L!2Z:&N)OI4P$6B3X""*\<C?[&,X)_J/&%&+$3DQ/A JT(84%>@O/=61
M4P+*=$-Q'3WT?L*CTHP5E;D.=JJ+T:G?[3WJVLSH>*V&8=@NU0%=W-+%3KK;
M5"/9^ J/^J:0G9M42T1[$_?[P^#%'AT/"G$TZ/9NT'HW<'JG0\)WOI_!T9H,
MXOBE:\Y)7K4!!]Y?M]Y?.[WO#*E?[Z%<@.@\^DZY<X_^A<0.R(<M^?"B,6]X
M2? +B1V XV!WO08_'O7<&N<"-VJ'1R\>=A\]O)<HX/\Y\+DG.!L3'V,&^ 1E
MN*,,7W%(39+:G;PXK<]&"(\0\# *3C#L,@SLO,=?%\3=&F>3](Y(AM$)CEW"
M@-T9PP-Y,I\2(DIGO,K&RTZ2"Z4##4G_B"3"IU!V20-V9PW?O[G< F=3_'B2
M49/Z>Z5%"6)E*RZ)4EXQ5>?@;6];U=W:6N9%_\14>[9DV<G4I>(]$3I&2E3
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M7<PP'75[S+<-JVI_4FZ5Q7/7OY9X-0+M)N!XH90]-MP'^LM6^@]02P,$%
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MGH2M'1NQ6MU^U4:NCXIRZZ/VS,ZKC[+;95BEG_IE/_5/-:&[@#\BEX$<P;$
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M;"]W;W)K<VAE971S+W-H965T-38N>&ULS5AK;]LV%/TK%]HPM$!JO?Q(,MM
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M!OK!(8H2M6@HOK)%VYPK70+:ST27]2B,@1Y?<*ZV#3-!]8^"R;]02P,$%
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MTW6&3%>'R%;C_+UW0ZI7;EW-I&:BFJ6_SKKIG:[>WZUG-%&&:BZJ>:CFHUJ
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M#'8GBK/01FU4<X[;!?>XQ3QTVWQ4"U M1+6(TN2*K"-J/?5$<>K97-4KMZY
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M)%H7QZZKH@1SIIJB0$XK,R%SIFDHYZXJ)++8.N69&WA>Q\U9RIW1P,Y=R=%
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MIM[/?B;4GJ,T!K0^$T)O!B9 U?"/?@!02P,$%     @ "9$T6?>H3JHJ P
M0PH  !D   !X;"]W;W)K<VAE971S+W-H965T-C0N>&ULM99=;YLP%(;_BL6F
M:9.Z\$V2+D%JVNY+JE2UVGHQ[<*%D\2JL:EMDD;:CY\-A*0*T/2B-P&#SWL>
MOP['9[+FXD$N 11ZRBB34VNI5'YJVS)90H;E@.? ])LY%QE6>B@6MLP%X+0,
MRJCM.4YD9Y@P*YZ4SZY%/.&%HH3!M4"RR#(L-C.@?#VU7&O[X(8LELH\L.-)
MCA=P"^I7?BWTR&Y44I(!DX0S)& ^M<[<TYD;F(!RQF\":[EWC\Q2[CE_,(,?
MZ=1R#!%02)21P/JR@G.@U"AICL=:U&IRFL#]^ZWZUW+Q>C'W6,(YIW<D5<NI
M-;)0"G-<4'7#U]^A7E!H]!).9?F+UM7<(+!04DC%LSI8$V2$55?\5!NQ%^![
M'0%>'>"5W%6BDO("*QQ/!%\C869K-7-3+K6,UG"$F5VY54*_)3I.Q;=ZF]."
M N)SI),E#XCGI5T?+T!A0N6GB:UT'C/;3FK-6:7I=6BZ'KKB3"TENF0II,\%
M; W84'I;RIG7J_BS8 /D.R?(<[P O4<VDDLL0-:7G@Q^XX-?9H@Z,EP^%D1M
MT)^S>ZF$_JO\;5MV)>&W2YCOYU3F.(&II3\0"6(%5OSAG1LY7WH @P8PZ%./
M9[ @C!&VT']"BED"Z%_KZBO22BLLM<R'N8K=,'!#QYG8JQ:(L($(7PVQVXTV
MD$ION <R'+CC=HJHH8AZ*;X)S!2D)XBP[?^@SXOHT(O(TU9T>#%L*(;'4>0@
MJNPOFC$\,,,;C#O,&#48HUZ,<[,-E$)JPU-.Q/&VC YL^3P<=9DR;FC&KZ4Y
MWI[Q@3W^8!RV [G.KL Y;V-0K?O,H2CRO2Z/W+V:Z[Z=2[7VODWA8#3J8/)V
M3%XODR[5QQ:76FG?&"\8AYW5Q=T58;>WA!Y"O&"%?V!%,!AV6;&KM&Y_J;TK
MCW)($5Z!T*V)[CY,?V/($GVNF>.AP!11,H=6JGYU'VT "XE"E%6'Y!BE>--Z
MAME[YWH&8E%V+U)#%$Q51WSSM.F0SJJ^8#>]:J^NL-"E6R(*<QWJ#(9Z]T35
ML50#Q?.R2[CG2O<<Y>U2=WD@S 3]?LZYV@Y,@J9OC/\#4$L#!!0    (  F1
M-%EO9]XI. ,  /\(   9    >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;*U6
M;6^;,!#^*Q:;IDU: X&\-4N0VK35-JE2U6[KAVD?G' $JP93VR3-?OW.AC"2
M$=0/^Y+XY9['SYW/=\RV0CZI!$"3EY1G:NXD6N=3UU6K!%*J>B*'#'=B(5.J
M<2K7KLHET,B"4N[ZGC=R4\HR)YS9M3L9SD2A.<O@3A)5I"F5NTO@8CMW^LY^
MX9ZM$VT6W'"6TS4\@/Z>WTF<N35+Q%+(%!,9D1#/G8O^=#$Q]M;@!X.M:HR)
M\60IQ).9?(GFCF<$ 8>5-@P4_S:P ,X-$<IXKCB=^D@#;([W[#?6=_1E214L
M!']DD4[FSL0A$<2TX/I>;#]#Y<_0\*T$5_:7;"M;SR&K0FF15F!4D+*L_*<O
M51P:@/[H!,"O /XQ8' "$%2 P#I:*K-N75%-PYD46R*--;*9@8V-1:,W+#.W
M^* E[C+$Z?!; B06'"^396NBZ9)#=:/L-RBB<7MK0P$1H1N0>+.$967VV&O(
M<%TA(C=310J%AEI@)#5(U M$V!VR$DJK*7E_!9HRKCZ0,_*6N$0E5(*:N1I]
M,8K<5:7[LM3MG]#=]\FMR'2BR'46071(X&(0ZDCX^TA<^IV,7XNL1P+O(_$]
M?] B:/%Z>- A)Z@O)K!\HQ-\U\\%TSOR\V*IM,1D_]46HY(B:*<P!6"J<KJ"
MN8,O7('<@!.^>],?>9_:_/M/9 ?>#FIO!UWLX0UEDFPH+X#D(/<YLY8T,XD7
M%=)F9V)WF8C:8E$>,+8'F-JU"?N]<7_F;IH^_FL4]+SSVNA ^[#6/NS4?L_4
MTUDLP3P,3'I0FDBJH4UC273>.-[K>0-_>*2RU2P(VF6.:IFC3IG7+SF63A--
MMF$1X+O=,>"MH2R))LWSCQ1V61RH&]?JQIWJ'H^+C(CM?4/Y##:"8[WA9F@J
M#DMSSM"XL5S9Y\62LQ794FERI[6PC%NB.PK\(P_;K4;M7DYJ+R>ONX,JP3F+
M3=:0'5#9JK6;;G@2N.@&!FW TB.WT4M2D&O;8A66[R+393&M5^LN?F&;U]'Z
M)7;WLAG_I2D_#6ZI7#/L%1QBI/1Z8\QW6;;;<J)%;CO64FCL?W:8X!<*2&.
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MPR/3)%EY>Q5HL7#V.!7:F*T;YN8Z1&D3S/I,&%>K [M!<\$F?P!02P,$%
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MJ;F)/^>\]?P#K39&T=0>T C"AEX17H929?K(8]@]8RFH. REN5":!Z7Y4%H
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MZI=?KK4!KIY\Z#4)2G.A- ]*\Z&T $H+H;0(2HM1-+6G- D+IO%* :X)S5R
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M5OL"W%UNY+2OP=WEVFM.1-"]B%$TU3V;- 53OQC ^C+\6&1))47%3A^%YB1
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MNZ*H5E]$!2(16^[.Y?\!4$L#!!0    (  F1-%GP;/$UG0(  (8&   9
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MR]Q^*% [!_M^K10=#$?0?'J2GU!+ P04    "  )D319')P8'%T$  #\&
M&0   'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6RUF6MOXD84AO_*D;NJ=J5M
M?.$2D@*2@[UMJH1%P+:J5OTPV <8Q?;0F0$2J3^^XPL&9XUWD292%&PS[S,S
M[['/^ S]/>-/8HTHX3F.$C$PUE)N;DU3!&N,B;AB&TS4-TO&8R+5*5^98L.1
MA)DHCDS'LKIF3&AB#/O9M0D?]ME61C3!"0>QC6/"7^XP8ON!81N'"U.Z6LOT
M@CGL;\@*9RB_;"9<G9DE):0Q)H*R!#@N!X9KW_IV)Q5D+?ZDN!<GQY!.9<'8
M4WIR'PX,*QT11AC(%$'4QPY'&$4I28WCWP)JE'VFPM/C _U3-GDUF041.&+1
M7S24ZX'1,R#$)=E&<LKVOV,QH6R  8M$]A_V15O+@& K)(L+L1I!3)/\DSP7
M1IP([.X9@5,(G->"]AE!JQ"T7@M:9P3M0M#^T1XZA2";NIG//3/.(Y(,^YSM
M@:>M%2T]R-S/U,HOFJ0WRDQR]2U5.CF<^@_NW/=@XD[G?\-\ZHYG[FA^_WD\
M W?LP9W[X(Y'_@S>>R@)C02,"><D#>X'^ 6^S#QX_^X#O .:P'S-MH(DH>B;
M4HTLY9M!,8J[?!3.F5'8#CRR1*X%^$F(815@JBF5\W(.\[IS&HE_;),K:%D?
MP;&<=LV 1C\N;]7(O6;Y(WF!EGU6[7]/S:_ <>KD%2]:98Q;&:][+L88$8DA
M3 B7+S#G)!$D?TR_/JBF<"\Q%O_412WGMNJY:0Z[%1L2X,!024H@WZ$Q_/DG
MNVO]6N>X3IBG$^9K@E6"TRZ#TVZB#]T@X%L5G =*%C2BDJ+X"*,MYYC(NI T
MTBX-20YK9[!T2=D-[9ZZXW:G3NOLT-<$JSC=*9WN-#JM'JLGF,54KN'K(\8+
MY+7W?"/D4H-UPCR=,%\3K!*);AF)[ALEI*[.X.B$>3IAOB98)3C797"N&Q^3
M":=)0#<D A*S;2)!O5X*J=9UFJSJ0M)(NS0D.F'>];?9S>G=5-.;KZG'BM6]
MTNI>H]6^\G414;%6;]X2EH@"-N1%7<(ZHWO?3,?I52<S:NSN4OMTPGQ-L(K-
M-Z7--XTV_X8)<G4_SS#8<JHRCKOBB)GGAX4 _H/1FN(2_&?5*'V]A<_+)0V0
M-ZX5C?U>>N_KA'DZ8;XF6"5XMG6L4*PW6BT*L*;X:*5Y6FF^+EHU1"=%I-WX
MA-TG$A57 E%_H.K#V@160'HG&<RZLE^EL.:>+G99)\W71:NZ[!Q==KZS,J-:
M'@YK1:W#.>"FXK#E=%Y[W-C/Q1[KI/FZ:%6/CZ6RW5CL#<<JK4QQQZ*=>MV!
M$<>02OA$@K0TT[AP-(_BXLRDM;362O-UT:KQ/%;7=ONM%@^ME;96FJ>5YNNB
M54-T+,OMYKK\TH*C&7=Q8+26Z%II?D&K[L^TCRMF;KAYLOL;(U]EV^X"@M3+
M?".XO%IN[;O9AK9Y;)[_+O!(^(HF B)<*JEU=:T&P/.M]OQ$LDVVE[Q@4K(X
M.UPC"9&G#=3W2\;DX23MH/S!8_@_4$L#!!0    (  F1-%F\FDH3(0,  $T+
M   9    >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;*U6:V_:,!3]*U963:VT
M-6]".T J?>PAH55EW3Y,^V#();'JV,QVH/WWLQU(PRM:);X0V[GW^)Q[L'-[
M2RZ>9 Z@T'-!F>P[N5+S2]>5TQP*+,_Y')A^,^.BP$I/1>;*N0"<VJ2"NH'G
M==P"$^8,>G;M7@QZO%24,+@72)9%@<7+$"A?]AW?62\\D"Q79L$=].8X@S&H
MQ_F]T#.W1DE) 4P2SI" 6=^Y\B^O?9M@(WX26,K&&!DI$\Z?S.1KVG<\PP@H
M3)6!P/JQ@&N@U"!I'G]7H$Z]ITELCM?H=U:\%C/!$JXY_452E?>=KH-2F.&2
MJ@>^_ (K0;'!FW(J[2]:5K%)X*!I*14O5LF:04%8]<3/JT(T$OS.@81@E1!L
M)T0'$L)50FB%5LRLK!NL\* G^!()$ZW1S,#6QF9K-809&\=*Z+=$YZG!6/\O
MTI("XC,$SW/*!;;EU6-@*5&E (E.;T!A0N49^H@>QS?H].0,G2#"T(^<EQ*S
M5/9<I<D82'>ZVGA8;1P<V-@/T(@SE4MTRU)(-P%<K:*6$JRE#(-6Q&\E.T>A
M]P$%7A#M(73]_^EA"YVPKFQH\<(#>+<'JKFO5!529)',P5L,@C@.>NZB27\W
M* ZC;AVT03*J24:M).\ 2S(AE*@7-%9E^H*TF]J13,>!("Q#OT=03$#\V4>[
M%=M<0)=RCJ?0=_0-(T$LP!F\?^=WO$_[W#D2V$89XKH,\=&\JI#BA@UA'&Y9
MM1L3^=Y^ISHUQ4Z[4P1HBD:8Z<M57Z/*&O5=Y2!:+6H%?:M%1P+;T)_4^I.C
M693LE#_VMBW:C4G" X>I6U/LME(<Z5N2TE)D9(IIJRNM.&]UY4A@&Y(O:LD7
M1W/E8J?B?B?I;MFR&Q3Y2;3?%]][_<AYK30_ Z<\(U))>VRJLS16>#9KM:D=
M]:T^'0MMLP:-#[U_-*M64,UOC;_MU)Z8H+-EE-MH3 H0F>W7))KRDJGJPUZO
MUCWAE>V$MM:'IE>T#<\K3-5HCK ^;TPB"C,-Z9TG^K\CJMZMFB@^M^W/A"O=
M3-EAKOM=$"9 OY]QKM83LT'=00_^ 5!+ P04    "  )D319A[/(J.H"
M"0  &0   'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6RMEFMOVC 4AO^*E595
M*ZW-#0*E$*G05=NT;E5IN\\F.1"KB9W9#M!_/]L)*87 +NQ+$COGO'[.F\0G
M_07C+R(!D&B9I50,K$3*O&?;(DH@P^*"Y4#5G2GC&99JR&>VR#G@V"1EJ>TY
M3F!GF% K[)NY>Q[V62%30N&>(U%D&>:O0TC98F"YUFKB@<P2J2?LL)_C&8Q!
M/N7W7(WL6B4F&5!!&$4<I@/KVNV-NCK>!#P36(BU:Z0KF3#VH@>?XX'E:"!(
M(9): :O3'$:0IEI(8?RL-*UZ29VX?KU2OS6UJUHF6,"(I3](+).!U;50#%-<
MI/*!+3Y!54];ZT4L%>:(%E6L8Z&H$))E5;(BR @MSWA9^;"6X 8[$KPJP=M,
M:.U(\*L$WQ1:DIFR;K#$89^S!>(Z6JGI"^.-R5;5$*J?XEAR=9>H/!D^)H!&
M+,LQ?46$1@7G$*,4E#$H8D(*A 6:LE0];-%#IS<@,4G%&3I'3^,;='I\AHY5
M&GI,6"$PC47?E@I*2]M1!3 L ;P= *Z'[AB5B4 ?:0SQ>P%;55.7Y*U*&GI[
M%;\4] +YS@?D.5ZK 6CTY^G^'AR_=M@W>D&SGOX,>R+'$0PL]9T)X'.PPI,C
M-W"NRN/W'#B6A,[05^/[2/G>:S*R7,?_^W6:3/A/8N\L:=66M/Y5O3S>DJ5Z
M#3E0B6"I-BP!37Z4B[3,(GJWFH>73M^>KU>Y'=+UZY!W[.V:O7T8^S/F!$]2
M^"U^N4Y[C<UM;> WA.S #VK\X##\<<*X1!)XMK8--.$'6VR7&_3;$:[33-^I
MZ3L'TA>3DEKM92QKM+VS177N>QOD33$[C._6Z-W#T+^IEOWF.#HYZGJN>X68
M3( C5N\1>UZH[O;+[FX4MAW2V:S+7FLF&?"9Z;%"0154EIMP/5NW\6O3O3;F
MAZJ]E]WX3:;\-[C#?$:H4.5.E:1ST5%.\[+?E@/)<M.R)DRJ!F@N$_6+ EP'
MJ/M3QN1JH!>H?WK"7U!+ P04    "  )D319V@JW1+T"  "O!P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970W-BYX;6R5E6UOVC 0Q[^*E553*VU-""0\+$1:
M6TW;U$VH#]MK Q=BU;$SVX'R[7=V0DI'H-H;L!/?__\[.W=.-E(]Z1S D.>"
M"SWU<F/*B>_K10X%U9>R!(%O,JD*:G"J5KXN%="E"RJX'P9![!>4"2]-W+.9
M2A-9&<X$S!3155%0M;T"+C=3K^?M'MRQ56[L S]-2KJ">S"/Y4SAS&]5EJP
MH9D41$$V]3[W)E>]P :X%;\8;/3>F-A4YE(^V<FWY=0++!%P6!@K0?%O#=?
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M;6_:,!#^*Z>LFEJI;5X(@3&(5.BF=5*EJK3=AVD?3'(0JXE-;0?:_?K93LB
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M@*LU-<*"C;!Q<!3Q:\DNH>.=0^ %80NAR=^[=X[0Z31Q[EB\Z #>#4MX@?!
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MOSO&CM7CCG$ U-1;6QEQ:'?L6'WTG@[4U*M-$W)HFNQ8??2>#M34JPT8<FC
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M+*/CL5/!&,M;',.?VQNF#1A8'(CTO%SCJXU7R/XZP-9T7X5@,\4K$9LIGFM
MW'D#1I*X5QN+ PQL%;#:@?CN.%!3;DX4P:IBVK =C"-)@B%0B^X:C6,D.S%\
MW>N#[9(H2A(W IA;011A".Q&',$4@ 8,B2+S'-QY'@7KYU2P^4_TZ!=02P,$
M%     @ "9$T69>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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M_R>,:KV6N1BK?%>)NMG'48O2 =9F([>FQVI>B8M>K.Z%=I_'OD%:[#];8Z%
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MM=.R^>XBNB<L)6^_%]&))F:A(;&%#F=ISX>X@"=70_2.9F(!C54E3"/S=M_
MMF#M7MN>KK:J=C>'0TQ,0,-76 9).[<S+7)5YQ 3$]"06$!CL1;MB+%#QP;6
M@C[:"52+=2GRIK.3,,($-*(64'=F?]I!XB["4.<C3$ CZB,AN .[JW9E.W18
M;=].=;_Z,<($-"(64/=D^I>A#C$Q 8U.**"G34W#"M$(7<$I<X0):$0LH%]N
M&>R&%&)B AJU CIK7VP^?BC$6M:BF-JW,/9ZSLM\KIG[Y5KJ>\' W>BZWI5E
M;*_-ZHGBQ>'[:X?OWGW\%U!+ P04    "  )D319(!6^$(0"   F,@  &@
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=I-;J- $(;AJU@<(.VNZJKN
MC.*L9I/M*!= 3OM'L8T%C":Y_5C.PO[0+&83\:U0@RC>#8\0\/2K'MIQWYV&
MW?X\+#Z.A].P:G;C>/X1PK#>U6,[/'3G>KH<V73]L1TORWX;SNWZO=W6(,NE
MA_Y^1O/\=#]S\?IYKO\SL=ML]NOZLUO_/M;3^(_!X4_7OP^[6L=F\=KVVSJN
MFO!QN.T>PG43'RZ3F\7+VZKI7]YB$^8.$@B2^8,4@G3^H 1!:?X@@R";/\@A
MR.</RA"4YP\J$%3F#WJ$H,?Y@^(295P2)$VP)M Z(M>1P.N(8$<"L2.2'0G,
MCHAV)% [(MN1P.V(<$<"N2/2'0GLCHAW)-!;4&\AT%M0;R'06R8/VP1Z"^HM
M!'H+ZBT$>@OJ+01Z"^HM!'H+ZBT$>@OJ+01Z"^HM!'HKZJT$>BOJK01Z*^JM
M!'KKY&4)@=Z*>BN!WHIZ*X'>BGHK@=Z*>BN!WHIZ*X'>BGHK@=X)]4X$>B?4
M.Q'HG5#O1*!W0KT3@=YI\K*;0.^$>B<"O1/JG0CT3JAW(M [H=Z)0.^$>B<"
MO0WU-@*]#?4V KT-]38"O0WU-@*]#?4V KUM\K&20&]#O8U ;T.]C4!O0[V-
M0&]#O8U ;T>]G4!O1[V=0&]'O9U ;T>]G4!O1[V=0&]'O9U ;Y_\;$*@MZ/>
M3J"WH]Y.H+>CWDZ@=T:],X'>&?7.!'IGU#L3Z)U1[TR@=T:],X'>&?7.!'IG
MU#L3Z)TG/PL2Z)U1[TR@=T:],X'>!?4N!'H7U+L0Z%U0[T*@=T&]"X'>!?4N
M!'H7U+M\I][#^'FHPZWG:XW7_TZJQ\NY]7;YZ_)KY^2&NN(<[BN&Y[]02P,$
M%     @ "9$T68ENS'XK @  NS   !,   !;0V]N=&5N=%]4>7!E<UTN>&UL
MS=M-;MLP$(;AJQC:!I8L4J34(LZF[;;-HA=@)3H6K#^03.K<OI2<!&B1&@E<
MH._&@DUROA$'>':^_OXX6;\Z]MW@M\D^A.ECEOEZ;WOCTW&R0US9C:XW(7YU
M=]EDZH.YLYG8;'16CT.P0UB'N49R<_W9[LQ]%U9?CO%GWX[#-G&V\\GJTVGC
MG+5-S#1U;6U"7,\>AN:/E/530AI/+GO\OIW\5=R09*\FS"M_#W@Z]^W!.M<V
M=G5K7/AJ^K@K.W:9#X^=]>GY$J_T..YV;6V;L;[OXY'43\Z:QN^M#7V7GHI>
MG4\.\8;MZ3._.'\I<RXP[KQUX^3CQ)Q]?]SS2.;3ZRD6LBZTYU_Q)3&6OOC]
M[#SMQC9OS([7^W-TAV4>/EL>E]_Q[S-^J?_./@2D#PGIHX#TH2!]:$@?):2/
M"M+'!T@?^8;2"$74G$)J3C$UIZ":4U3-*:SF%%=S"JPY159!D5509!44605%
M5D&155!D%119!45609%54&25%%DE159)D5529)44625%5DF155)DE119)476
M@B)K09&UH,A:4&0M*+(6%%D+BJP%1=:"(FM!D5519%44615%5D6155%D5119
M%45619%54615%%DU159-D5539-44635%5DV155-DU119-45639&UI,A:4F0M
M*;*6%%E+BJPE1=:2(FM)D;6DR%I29*THLE8462N*K!5%UHHB:_4_9?TQCH=_
M'+\\T]ZTPW-^MOQGX>874$L! A0#%     @ "9$T60=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  )
MD319XY^N6^X    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    "  )D319F5R<(Q &  "<)P  $P
M@ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  F1-%F2[S(?
M\0<  #8V   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    "  )D319@9@V$.T%  "5&0  &
M@($T$   >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ "9$T
M6>#B.F>W @  10<  !@              ("!5Q8  'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    (  F1-%GUT="6W04  )$8   8
M      " @409  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M"  )D3196![H/# (   U)@  &               @(%7'P  >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ "9$T6<#>>S?+"   AD$  !@
M             ("!O2<  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    (  F1-%ETB%",: 8  ($.   8              " @;XP  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    "  )D319'G;=Z4T&  !4
M#@  &               @(%<-P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ "9$T6:(LO.4B&P  XTL  !@              ("!WST
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (  F1-%E.07JX
MR@(  .0%   9              " @3=9  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ "9$T60,S4T[4!@  K \  !D
M ("!.%P  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    "  )
MD319L*Z7Y8L"  "T!0  &0              @(%#8P  >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (  F1-%G#\@QD;0,  ','   9
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M970Q-RYX;6Q02P$"% ,4    "  )D319\G70BF<#   =!P  &0
M    @(%LK0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M  F1-%D!/WOKG0(  *T%   9              " @0JQ  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ "9$T68Q1X8FY P  -@@  !D
M             ("!WK,  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    "  )D319)\]_:"P(  !^$P  &0              @('.MP  >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (  F1-%E/\8;G+08
M /L/   9              " @3'   !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ "9$T61],%&8S!   ?@D  !D              ("!
ME<8  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  )D319
MJ(D8T(<<  ".50  &0              @('_R@  >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    (  F1-%E_WK>=X0,  '\(   9
M      " @;WG  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ "9$T65O*'YP!!0  < P  !D              ("!U>L  'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    "  )D319@G9(D?H$  !)#
M&0              @($-\0  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    (  F1-%EI,Z\_C0(  *(%   9              " @3[V  !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ "9$T6=L8RN3)
M @  *@8  !D              ("! OD  'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    "  )D319;/?N?#L(   +'   &0
M@($"_   >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (  F1
M-%D6T8 ^90,  (<(   9              " @70$ 0!X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ "9$T64E#',E8!P  =!0  !D
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M=#,V+GAM;%!+ 0(4 Q0    (  F1-%E4T-H]0P,  -4'   9
M  " @2T? 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @
M"9$T6;WIJ+0>!0  618  !D              ("!IR(! 'AL+W=O<FMS:&5E
M=',O<VAE970S."YX;6Q02P$"% ,4    "  )D319SF _@5$"  #8!   &0
M            @('\)P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4
M Q0    (  F1-%GFU9/XZ@,  #<+   9              " @80J 0!X;"]W
M;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ "9$T6:OKQ=D !
M#0L  !D              ("!I2X! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX
M;6Q02P$"% ,4    "  )D319KE0L@D0"   >!0  &0              @('<
M,@$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (  F1-%F2
MQ=6^"0,  ,,(   9              " @5<U 0!X;"]W;W)K<VAE971S+W-H
M965T-#,N>&UL4$L! A0#%     @ "9$T68E-5W^- P  L@D  !D
M     ("!ES@! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  F1-%EBV@ST) ,  "X/   9              "
M@9Q* 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ "9$T
M64U&*VNH P  #P\  !D              ("!]TT! 'AL+W=O<FMS:&5E=',O
M<VAE970U,"YX;6Q02P$"% ,4    "  )D319D?-IT'<#  !X"0  &0
M        @('640$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0
M   (  F1-%E4R')=P0(  "H'   9              " @815 0!X;"]W;W)K
M<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ "9$T6<N4C>B3!   4AD
M !D              ("!?%@! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q0
M2P$"% ,4    "  )D319!(GS+A@#  "$"0  &0              @(%&70$
M>&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (  F1-%GG7U[+
MW0(  $$'   9              " @95@ 0!X;"]W;W)K<VAE971S+W-H965T
M-34N>&UL4$L! A0#%     @ "9$T66&X5"P,!   <1   !D
M ("!J6,! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    "  )
MD3190))GX]@"   C!P  &0              @('L9P$ >&PO=V]R:W-H965T
M<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    (  F1-%F"#U$L_ ,  #00   9
M          " @?MJ 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#
M%     @ "9$T68'$[H6: P  ]0X  !D              ("!+F\! 'AL+W=O
M<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    "  )D319(>OF,O@5  "S
M0@$ &0              @('_<@$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM
M;%!+ 0(4 Q0    (  F1-%DC^4&2TP,  (L.   9              " @2Z)
M 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ "9$T67AK
M4<(" P  R@<  !D              ("!.(T! 'AL+W=O<FMS:&5E=',O<VAE
M970V,BYX;6Q02P$"% ,4    "  )D319@LNT(+L#  #\"P  &0
M    @(%QD $ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    (
M  F1-%GWJ$ZJ*@,  $,*   9              " @6.4 0!X;"]W;W)K<VAE
M971S+W-H965T-C0N>&UL4$L! A0#%     @ "9$T66]GWBDX P  _P@  !D
M             ("!Q)<! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"
M% ,4    "  )D319'GN_?/$#  !)#@  &0              @($SFP$ >&PO
M=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    (  F1-%D6F3I);08
M  T^   9              " @5N? 0!X;"]W;W)K<VAE971S+W-H965T-C<N
M>&UL4$L! A0#%     @ "9$T64$"-79;!   0A$  !D              ("!
M_Z4! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    "  )D319
MT.PTHLT"  !L!P  &0              @(&1J@$ >&PO=V]R:W-H965T<R]S
M:&5E=#8Y+GAM;%!+ 0(4 Q0    (  F1-%E W^"Y1@,  $X+   9
M      " @96M 0!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%
M  @ "9$T69# -J(_$   ++,  !D              ("!$K$! 'AL+W=O<FMS
M:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    "  )D319\&SQ-9T"  "&!@
M&0              @(&(P0$ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+
M 0(4 Q0    (  F1-%D<G!@<700  /P8   9              " @5S$ 0!X
M;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ "9$T6;R:2A,A
M P  30L  !D              ("!\,@! 'AL+W=O<FMS:&5E=',O<VAE970W
M-"YX;6Q02P$"% ,4    "  )D319A[/(J.H"    "0  &0
M@(%(S $ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    (  F1
M-%G:"K=$O0(  *\'   9              " @6G/ 0!X;"]W;W)K<VAE971S
M+W-H965T-S8N>&UL4$L! A0#%     @ "9$T622A1[5; P  P@H  !D
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M=#@Q+GAM;%!+ 0(4 Q0    (  F1-%DWME\R'@,   8-   9
M  " @?OE 0!X;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @
M"9$T64<:&\2Y P  HA,  !D              ("!4.D! 'AL+W=O<FMS:&5E
M=',O<VAE970X,RYX;6Q02P$"% ,4    "  )D319:?DY4.<$  "R(0  &0
M            @(% [0$ >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4
M Q0    (  F1-%G==0IMV@4  &8A   9              " @5[R 0!X;"]W
M;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @ "9$T6="U)71D P
MEA8   T              ( !;_@! 'AL+W-T>6QE<RYX;6Q02P$"% ,4
M"  )D319EXJ[',     3 @  "P              @ '^^P$ 7W)E;',O+G)E
M;'-02P$"% ,4    "  )D319C'!LX$$'  #_-P  #P              @ 'G
M_ $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ "9$T62 5OA"$ @  )C(
M !H              ( !500" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ "9$T68ENS'XK @  NS   !,              ( !$0<"
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %T 70""&0  ;0D"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>200</ContextCount>
  <ElementCount>426</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>72</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Shareholders' Equity (Deficit) and Redeemable Noncontrolling Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity (Deficit) and Redeemable Noncontrolling Interest</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DescriptionOfBusiness</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - BASIS OF PREPARATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BasisOfPreparation</Role>
      <ShortName>BASIS OF PREPARATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SignificantAccountingPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - GOING CONCERN ISSUES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GoingConcernIssues</Role>
      <ShortName>GOING CONCERN ISSUES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - 2023 GXII TRANSACTION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GxiiTransaction</Role>
      <ShortName>2023 GXII TRANSACTION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - LAND AND BUILDINGS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LandAndBuildingsNet</Role>
      <ShortName>LAND AND BUILDINGS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - MINERAL PROPERTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/MineralProperties</Role>
      <ShortName>MINERAL PROPERTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - CONVERTIBLE DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebt</Role>
      <ShortName>CONVERTIBLE DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - CLASS B COMMON STOCK OF ECRC</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrc</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - COMMON SHARES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonShares</Role>
      <ShortName>COMMON SHARES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RelatedPartyTransactionsAndBalances</Role>
      <ShortName>RELATED PARTY TRANSACTIONS AND BALANCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - EXPLORATION EXPENDITURES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ExplorationExpenditures</Role>
      <ShortName>EXPLORATION EXPENDITURES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FairValueMeasurements</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - BASIS OF PREPARATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BasisOfPreparationTables</Role>
      <ShortName>BASIS OF PREPARATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/BasisOfPreparation</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - 2023 GXII TRANSACTION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GxiiTransactionTables</Role>
      <ShortName>2023 GXII TRANSACTION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/GxiiTransaction</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - LAND AND BUILDINGS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LandAndBuildingsNetTables</Role>
      <ShortName>LAND AND BUILDINGS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/LandAndBuildingsNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - CONVERTIBLE DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtTables</Role>
      <ShortName>CONVERTIBLE DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebt</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrcTables</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/ClassBCommonStockOfEcrc</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - COMMON SHARES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesTables</Role>
      <ShortName>COMMON SHARES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonShares</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables</Role>
      <ShortName>RELATED PARTY TRANSACTIONS AND BALANCES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/RelatedPartyTransactionsAndBalances</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - EXPLORATION EXPENDITURES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ExplorationExpendituresTables</Role>
      <ShortName>EXPLORATION EXPENDITURES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/ExplorationExpenditures</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LeasesTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/Leases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/FairValueMeasurements</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details</Role>
      <ShortName>These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/DescriptionOfBusiness</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company???s basic and diluted net loss per share attr (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails</Role>
      <ShortName>The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company???s basic and diluted net loss per share attr (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Schedule of excluded from the dilutive securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails</Role>
      <ShortName>Schedule of excluded from the dilutive securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - GOING CONCERN ISSUES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GoingConcernIssuesDetailsNarrative</Role>
      <ShortName>GOING CONCERN ISSUES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/GoingConcernIssues</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details</Role>
      <ShortName>The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails</Role>
      <ShortName>The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - 2023 GXII TRANSACTION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GxiiTransactionDetailsNarrative</Role>
      <ShortName>2023 GXII TRANSACTION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/GxiiTransactionTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Schedule of properties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfPropertiesDetails</Role>
      <ShortName>Schedule of properties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Schedule of account payable and accrued liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Schedule of account payable and accrued liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Schedule of convertible debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfConvertibleDebtDetails</Role>
      <ShortName>Schedule of convertible debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Changes in the Lind III Convertible Security are as follows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails</Role>
      <ShortName>Changes in the Lind III Convertible Security are as follows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - The following table summarizes the components of the initial loss and final loss on extinguishment: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails</Role>
      <ShortName>The following table summarizes the components of the initial loss and final loss on extinguishment: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - The change in the fair value of the Contingent Consent Warrants is presented below: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails</Role>
      <ShortName>The change in the fair value of the Contingent Consent Warrants is presented below: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Schedule of valuation date and the probability calculated (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails</Role>
      <ShortName>Schedule of valuation date and the probability calculated (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Changes in the Convertible Debentures are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails</Role>
      <ShortName>Changes in the Convertible Debentures are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details</Role>
      <ShortName>The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - The following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes: (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails</Role>
      <ShortName>The following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - The following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024: (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details</Role>
      <ShortName>The following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - The following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details</Role>
      <ShortName>The following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - The following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June 30, 2024. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details</Role>
      <ShortName>The following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June 30, 2024. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtDetailsNarrative</Role>
      <ShortName>CONVERTIBLE DEBT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebtTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - The following table discloses the primary inputs into the Monte Carlo models. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details</Role>
      <ShortName>The following table discloses the primary inputs into the Monte Carlo models. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2024: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details</Role>
      <ShortName>The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2024: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ClassBCommonStockOfEcrcTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Schedule of stock option (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfStockOptionDetails</Role>
      <ShortName>Schedule of stock option (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails</Role>
      <ShortName>The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details</Role>
      <ShortName>Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - At June 30, 2024, the Company has outstanding exercisable warrants, as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails</Role>
      <ShortName>At June 30, 2024, the Company has outstanding exercisable warrants, as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails</Role>
      <ShortName>The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - The change in the Private Warrants liability is presented below: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails</Role>
      <ShortName>The change in the Private Warrants liability is presented below: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - Schedule of expenses as other operating costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails</Role>
      <ShortName>Schedule of expenses as other operating costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - COMMON SHARES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetailsNarrative</Role>
      <ShortName>COMMON SHARES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - Changes in the Smith Credit Agreement principal balance are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails</Role>
      <ShortName>Changes in the Smith Credit Agreement principal balance are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - Schedule of exploration expenditures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails</Role>
      <ShortName>Schedule of exploration expenditures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - The Company incurred lease costs as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails</Role>
      <ShortName>The Company incurred lease costs as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2024: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details</Role>
      <ShortName>The maturity of lease liabilities is as follows at June 30, 2024: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - LEASES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LeasesDetailsNarrative</Role>
      <ShortName>LEASES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/LeasesTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails</Role>
      <ShortName>Domestic and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails</Role>
      <ShortName>The following table is a reconciliation of income taxes at statutory rates: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails</Role>
      <ShortName>Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - Changes in the valuation allowance are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails</Role>
      <ShortName>Changes in the valuation allowance are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - Schedule of cumulative net operating losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails</Role>
      <ShortName>Schedule of cumulative net operating losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/IncomeTaxesTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>00000084 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails</Role>
      <ShortName>Schedule of fair values determined by level 3 inputs are unobservable data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="n2574_x219-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>00000085 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/SubsequentEvents</ParentRole>
      <Position>85</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="n2574_x219-10k.htm">n2574_x219-10k.htm</File>
    <File>niobf-20240630.xsd</File>
    <File>niobf-20240630_cal.xml</File>
    <File>niobf-20240630_def.xml</File>
    <File>niobf-20240630_lab.xml</File>
    <File>niobf-20240630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>n257410kimg001.jpg</File>
    <File>n257410kimg002.jpg</File>
    <File>n257410kimg003.jpg</File>
    <File>n257410kimg004.jpg</File>
    <File>n257410kimg004a.jpg</File>
    <File>n257410kimg004b.jpg</File>
    <File>n257410kimg005.jpg</File>
    <File>n257410kimg006.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2023</BaseTaxonomy>
    <BaseTaxonomy items="744">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>151
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "n2574_x219-10k.htm": {
   "nsprefix": "niobf",
   "nsuri": "http://niocorp.com/20240630",
   "dts": {
    "inline": {
     "local": [
      "n2574_x219-10k.htm"
     ]
    },
    "schema": {
     "local": [
      "niobf-20240630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "niobf-20240630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "niobf-20240630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "niobf-20240630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "niobf-20240630_pre.xml"
     ]
    }
   },
   "keyStandard": 325,
   "keyCustom": 101,
   "axisStandard": 25,
   "axisCustom": 1,
   "memberStandard": 30,
   "memberCustom": 40,
   "hidden": {
    "total": 163,
    "http://fasb.org/us-gaap/2023": 123,
    "http://niocorp.com/20240630": 33,
    "http://xbrl.sec.gov/dei/2023": 7
   },
   "contextCount": 200,
   "entityCount": 1,
   "segmentCount": 72,
   "elementCount": 648,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 744,
    "http://xbrl.sec.gov/dei/2023": 40,
    "http://fasb.org/srt/2023": 1
   },
   "report": {
    "R1": {
     "role": "http://niocorp.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://niocorp.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://niocorp.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
     "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LaborAndRelatedExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LaborAndRelatedExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://niocorp.com/role/StatementsOfCashFlows",
     "longName": "00000005 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2022-07-012023-06-30",
      "name": "niobf:AssumptionOfEarnoutLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-012023-06-30",
      "name": "niobf:AssumptionOfEarnoutLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest",
     "longName": "00000006 - Statement - Consolidated Statements of Shareholders' Equity (Deficit) and Redeemable Noncontrolling Interest",
     "shortName": "Consolidated Statements of Shareholders' Equity (Deficit) and Redeemable Noncontrolling Interest",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://niocorp.com/role/DescriptionOfBusiness",
     "longName": "00000007 - Disclosure - DESCRIPTION OF BUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://niocorp.com/role/BasisOfPreparation",
     "longName": "00000008 - Disclosure - BASIS OF PREPARATION",
     "shortName": "BASIS OF PREPARATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:BasisOfAccounting",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:BasisOfAccounting",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://niocorp.com/role/SignificantAccountingPolicies",
     "longName": "00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://niocorp.com/role/GoingConcernIssues",
     "longName": "00000010 - Disclosure - GOING CONCERN ISSUES",
     "shortName": "GOING CONCERN ISSUES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://niocorp.com/role/GxiiTransaction",
     "longName": "00000011 - Disclosure - 2023 GXII TRANSACTION",
     "shortName": "2023 GXII TRANSACTION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://niocorp.com/role/LandAndBuildingsNet",
     "longName": "00000012 - Disclosure - LAND AND BUILDINGS, NET",
     "shortName": "LAND AND BUILDINGS, NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://niocorp.com/role/MineralProperties",
     "longName": "00000013 - Disclosure - MINERAL PROPERTIES",
     "shortName": "MINERAL PROPERTIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:MineralIndustriesDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:MineralIndustriesDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://niocorp.com/role/AccountsPayableAndAccruedLiabilities",
     "longName": "00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://niocorp.com/role/ConvertibleDebt",
     "longName": "00000015 - Disclosure - CONVERTIBLE DEBT",
     "shortName": "CONVERTIBLE DEBT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrc",
     "longName": "00000016 - Disclosure - CLASS B COMMON STOCK OF ECRC",
     "shortName": "CLASS B COMMON STOCK OF ECRC",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://niocorp.com/role/CommonShares",
     "longName": "00000017 - Disclosure - COMMON SHARES",
     "shortName": "COMMON SHARES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://niocorp.com/role/RelatedPartyTransactionsAndBalances",
     "longName": "00000018 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES",
     "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://niocorp.com/role/ExplorationExpenditures",
     "longName": "00000019 - Disclosure - EXPLORATION EXPENDITURES",
     "shortName": "EXPLORATION EXPENDITURES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:ExplorationExpendituresDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:ExplorationExpendituresDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://niocorp.com/role/Leases",
     "longName": "00000020 - Disclosure - LEASES",
     "shortName": "LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://niocorp.com/role/IncomeTaxes",
     "longName": "00000021 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://niocorp.com/role/FairValueMeasurements",
     "longName": "00000022 - Disclosure - FAIR VALUE MEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://niocorp.com/role/SubsequentEvents",
     "longName": "00000023 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://niocorp.com/role/SignificantAccountingPoliciesPolicies",
     "longName": "00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:DevelopmentStageIssuerPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:DevelopmentStageIssuerPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://niocorp.com/role/BasisOfPreparationTables",
     "longName": "00000025 - Disclosure - BASIS OF PREPARATION (Tables)",
     "shortName": "BASIS OF PREPARATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://niocorp.com/role/SignificantAccountingPoliciesTables",
     "longName": "00000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://niocorp.com/role/GxiiTransactionTables",
     "longName": "00000027 - Disclosure - 2023 GXII TRANSACTION (Tables)",
     "shortName": "2023 GXII TRANSACTION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://niocorp.com/role/LandAndBuildingsNetTables",
     "longName": "00000028 - Disclosure - LAND AND BUILDINGS, NET (Tables)",
     "shortName": "LAND AND BUILDINGS, NET (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables",
     "longName": "00000029 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://niocorp.com/role/ConvertibleDebtTables",
     "longName": "00000030 - Disclosure - CONVERTIBLE DEBT (Tables)",
     "shortName": "CONVERTIBLE DEBT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrcTables",
     "longName": "00000031 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)",
     "shortName": "CLASS B COMMON STOCK OF ECRC (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://niocorp.com/role/CommonSharesTables",
     "longName": "00000032 - Disclosure - COMMON SHARES (Tables)",
     "shortName": "COMMON SHARES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables",
     "longName": "00000033 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)",
     "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://niocorp.com/role/ExplorationExpendituresTables",
     "longName": "00000034 - Disclosure - EXPLORATION EXPENDITURES (Tables)",
     "shortName": "EXPLORATION EXPENDITURES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://niocorp.com/role/LeasesTables",
     "longName": "00000035 - Disclosure - LEASES (Tables)",
     "shortName": "LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://niocorp.com/role/IncomeTaxesTables",
     "longName": "00000036 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://niocorp.com/role/FairValueMeasurementsTables",
     "longName": "00000037 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details",
     "longName": "00000038 - Disclosure - These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)",
     "shortName": "These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_Entity0896800BCLtdMember",
      "name": "niobf:IncorporationStateCountryName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_Entity0896800BCLtdMember",
      "name": "niobf:IncorporationStateCountryName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative",
     "longName": "00000039 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)",
     "shortName": "DESCRIPTION OF BUSINESS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R40": {
     "role": "http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails",
     "longName": "00000040 - Disclosure - The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company\u2019s basic and diluted net loss per share attr (Details)",
     "shortName": "The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company\u2019s basic and diluted net loss per share attr (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails",
     "longName": "00000041 - Disclosure - Schedule of excluded from the dilutive securities (Details)",
     "shortName": "Schedule of excluded from the dilutive securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:AccruedLiabilitiesAndOtherLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AssetRetirementObligationsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:AccruedLiabilitiesAndOtherLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AssetRetirementObligationsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative",
     "longName": "00000043 - Disclosure - GOING CONCERN ISSUES (Details Narrative)",
     "shortName": "GOING CONCERN ISSUES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:WorkingCapitalDeficit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:WorkingCapitalDeficit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details",
     "longName": "00000044 - Disclosure - The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023: (Details)",
     "shortName": "The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails",
     "longName": "00000045 - Disclosure - The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows (Details)",
     "shortName": "The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://niocorp.com/role/GxiiTransactionDetailsNarrative",
     "longName": "00000046 - Disclosure - 2023 GXII TRANSACTION (Details Narrative)",
     "shortName": "2023 GXII TRANSACTION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_WarrantAgreementMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_WarrantAgreementMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://niocorp.com/role/ScheduleOfPropertiesDetails",
     "longName": "00000047 - Disclosure - Schedule of properties (Details)",
     "shortName": "Schedule of properties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentOther",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentOther",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails",
     "longName": "00000048 - Disclosure - Schedule of account payable and accrued liabilities (Details)",
     "shortName": "Schedule of account payable and accrued liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails",
     "longName": "00000049 - Disclosure - Schedule of convertible debt (Details)",
     "shortName": "Schedule of convertible debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ConvertibleDebtCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_custom_YorkvilleConvertibleSecurityMember",
      "name": "us-gaap:ConvertibleDebtCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
     "longName": "00000050 - Disclosure - Changes in the Lind III Convertible Security are as follows (Details)",
     "shortName": "Changes in the Lind III Convertible Security are as follows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:ConvertibleDebtNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30_custom_ConvertibleSecurityMember",
      "name": "us-gaap:ConvertibleDebtNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails",
     "longName": "00000051 - Disclosure - The following table summarizes the components of the initial loss and final loss on extinguishment: (Details)",
     "shortName": "The following table summarizes the components of the initial loss and final loss on extinguishment: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:MinimumConsentPaymentAtInception",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:MinimumConsentPaymentAtInception",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails",
     "longName": "00000052 - Disclosure - The change in the fair value of the Contingent Consent Warrants is presented below: (Details)",
     "shortName": "The change in the fair value of the Contingent Consent Warrants is presented below: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfWarrantValuationTableTextblock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfWarrantValuationTableTextblock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails",
     "longName": "00000053 - Disclosure - Schedule of valuation date and the probability calculated (Details)",
     "shortName": "Schedule of valuation date and the probability calculated (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_MeasurementInputSharePriceMember",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_custom_ProbabilityOfIssuanceMember",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "NUMBER",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails",
     "longName": "00000054 - Disclosure - Changes in the Convertible Debentures are as follows: (Details)",
     "shortName": "Changes in the Convertible Debentures are as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "AsOf2023-03-14",
      "name": "us-gaap:ConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-03-14",
      "name": "us-gaap:ConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details",
     "longName": "00000055 - Disclosure - The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)",
     "shortName": "The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:ContractualInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:ContractualInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
     "longName": "00000056 - Disclosure - The following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes: (Details)",
     "shortName": "The following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details",
     "longName": "00000057 - Disclosure - The following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024: (Details)",
     "shortName": "The following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:FairValueHedgeAssetsAtFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:FairValueHedgeAssetsAtFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
     "longName": "00000058 - Disclosure - The following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants. (Details)",
     "shortName": "The following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ShareholdersEquityAndShareBasedWarrantsTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details",
     "longName": "00000059 - Disclosure - The following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June 30, 2024. (Details)",
     "shortName": "The following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June 30, 2024. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "From2024-04-012024-04-30",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-10_custom_EarnoutMember",
      "name": "us-gaap:OtherLiabilitiesFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
     "longName": "00000060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)",
     "shortName": "CONVERTIBLE DEBT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "From2021-02-162021-02-19",
      "name": "us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-02-162021-02-19",
      "name": "us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
     "longName": "00000061 - Disclosure - The following table discloses the primary inputs into the Monte Carlo models. (Details)",
     "shortName": "The following table discloses the primary inputs into the Monte Carlo models. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details",
     "longName": "00000062 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2024: (Details)",
     "shortName": "The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2024: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "AsOf2023-03-14_custom_EarnoutMember",
      "name": "us-gaap:ServicingLiabilityAtFairValueAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock",
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-03-14_custom_EarnoutMember",
      "name": "us-gaap:ServicingLiabilityAtFairValueAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock",
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
     "longName": "00000063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)",
     "shortName": "CLASS B COMMON STOCK OF ECRC (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_EarnoutMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://niocorp.com/role/ScheduleOfStockOptionDetails",
     "longName": "00000064 - Disclosure - Schedule of stock option (Details)",
     "shortName": "Schedule of stock option (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails",
     "longName": "00000065 - Disclosure - The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)",
     "shortName": "The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details",
     "longName": "00000066 - Disclosure - Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)",
     "shortName": "Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
     "longName": "00000067 - Disclosure - At June 30, 2024, the Company has outstanding exercisable warrants, as follows: (Details)",
     "shortName": "At June 30, 2024, the Company has outstanding exercisable warrants, as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_currency_CAD_custom_ExercisePrice9.70Member",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "CADPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
     "longName": "00000068 - Disclosure - The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)",
     "shortName": "The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails",
     "longName": "00000069 - Disclosure - The change in the Private Warrants liability is presented below: (Details)",
     "shortName": "The change in the Private Warrants liability is presented below: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "AsOf2023-03-14_us-gaap_NoteWarrantMember",
      "name": "niobf:ChangesInFairValueOfInitialValuation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-03-14_us-gaap_NoteWarrantMember",
      "name": "niobf:ChangesInFairValueOfInitialValuation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails",
     "longName": "00000070 - Disclosure - Schedule of expenses as other operating costs (Details)",
     "shortName": "Schedule of expenses as other operating costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember",
      "name": "niobf:YorkvilleCashFee",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://niocorp.com/role/CommonSharesDetailsNarrative",
     "longName": "00000071 - Disclosure - COMMON SHARES (Details Narrative)",
     "shortName": "COMMON SHARES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2023-09-012023-09-30",
      "name": "us-gaap:ProceedsFromOtherEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-09-012023-09-30",
      "name": "us-gaap:ProceedsFromOtherEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails",
     "longName": "00000072 - Disclosure - Changes in the Smith Credit Agreement principal balance are as follows: (Details)",
     "shortName": "Changes in the Smith Credit Agreement principal balance are as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:RelatedPartyDepositLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:RelatedPartyDepositLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
     "longName": "00000073 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:AccruedLiabilitiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:AccruedLiabilitiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
     "longName": "00000074 - Disclosure - Schedule of exploration expenditures (Details)",
     "shortName": "Schedule of exploration expenditures (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ExplorationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ExplorationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails",
     "longName": "00000075 - Disclosure - The Company incurred lease costs as follows: (Details)",
     "shortName": "The Company incurred lease costs as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:FixedRentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:FixedRentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details",
     "longName": "00000076 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2024: (Details)",
     "shortName": "The maturity of lease liabilities is as follows at June 30, 2024: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://niocorp.com/role/LeasesDetailsNarrative",
     "longName": "00000077 - Disclosure - LEASES (Details Narrative)",
     "shortName": "LEASES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:DiscountRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "us-gaap:LesseeOperatingLeaseOptionToExtend",
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:DiscountRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "us-gaap:LesseeOperatingLeaseOptionToExtend",
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails",
     "longName": "00000078 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows: (Details)",
     "shortName": "Domestic and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails",
     "longName": "00000079 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)",
     "shortName": "The following table is a reconciliation of income taxes at statutory rates: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails",
     "longName": "00000080 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)",
     "shortName": "Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails",
     "longName": "00000081 - Disclosure - Changes in the valuation allowance are as follows: (Details)",
     "shortName": "Changes in the valuation allowance are as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "niobf:DeferredTaxAssetsValuationAllowanceAdditions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails",
     "longName": "00000082 - Disclosure - Schedule of cumulative net operating losses (Details)",
     "shortName": "Schedule of cumulative net operating losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
     "longName": "00000083 - Disclosure - INCOME TAXES (Details Narrative)",
     "shortName": "INCOME TAXES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails",
     "longName": "00000084 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)",
     "shortName": "Schedule of fair values determined by level 3 inputs are unobservable data (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://niocorp.com/role/SubsequentEventsDetailsNarrative",
     "longName": "00000085 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "From2024-09-022024-09-04_us-gaap_SubsequentEventMember",
      "name": "us-gaap:SubsequentEventDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-09-022024-09-04_us-gaap_SubsequentEventMember",
      "name": "us-gaap:SubsequentEventDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x219-10k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "niobf_ASC470LossOnExtinguishment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ASC470LossOnExtinguishment",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss on debt extinguishment",
        "documentation": "The element represents as c470 loss on extinguishment.",
        "label": "AS C470 Loss on Extinguishment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercisable at a price per share",
        "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time."
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total accounts payable and accrued liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan origination fees payable to related party",
        "documentation": "Fair value portion of trade and related party payables and accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued liabilities",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r703"
     ]
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable, trade",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26"
     ]
    },
    "us-gaap_AccretionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccretionExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion of convertible debt",
        "verboseLabel": "Accretion expense",
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations."
       }
      }
     },
     "auth_ref": [
      "r686",
      "r782"
     ]
    },
    "us-gaap_AccretionExpenseIncludingAssetRetirementObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccretionExpenseIncludingAssetRetirementObligations",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion expense",
        "documentation": "Amount of accretion expense, which includes, but is not limited to, accretion expense from asset retirement obligations, environmental remediation obligations, and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued exploration stage expense",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Environmental accruals",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated depreciation",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r188",
      "r539"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive loss",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r129",
      "r193",
      "r536",
      "r562",
      "r563"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r16",
      "r42",
      "r418",
      "r421",
      "r468",
      "r558",
      "r559",
      "r751",
      "r752",
      "r753",
      "r764",
      "r765",
      "r766"
     ]
    },
    "niobf_AdditionalConsentPaymentbooked": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "AdditionalConsentPaymentbooked",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Consent Payment booked",
        "documentation": "The element represents additional consent paymentbooked."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentOfWarrantsGrantedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentOfWarrantsGrantedForServices",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial fair value of Contingent Consent Warrants",
        "documentation": "Adjustment for noncash service expenses paid for by granting of warrants."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities, Total",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities",
        "documentation": "The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for:"
       }
      }
     },
     "auth_ref": []
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of discount and issuance costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r343",
      "r454",
      "r757"
     ]
    },
    "niobf_AmountsAdvanced": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "AmountsAdvanced",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts advanced",
        "documentation": "The element represents amounts advanced."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "niobf_April2024ConvertibleSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "April2024ConvertibleSecurityMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April 2024 Convertible Security [Member]",
        "documentation": "The element represents april 2024 convertible security."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_AssetRetirementObligationAccretionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetRetirementObligationAccretionExpense",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accretion expense",
        "label": "Asset Retirement Obligation, Accretion Expense",
        "documentation": "Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r306"
     ]
    },
    "us-gaap_AssetRetirementObligationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetRetirementObligationsPolicy",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Retirement Obligation",
        "documentation": "Disclosure of accounting policy for legal obligation associated with retirement of long-lived asset that results from acquisition, construction, or development or from normal operation of long-lived asset. Excludes environmental remediation liability from improper or other-than-normal operation of long-lived asset, obligation arising in connection with leased property that meets definition of lease payments or variable lease payments and from plan to sell or otherwise dispose of a long-lived asset."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r189",
      "r218",
      "r250",
      "r254",
      "r256",
      "r291",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r410",
      "r415",
      "r436",
      "r533",
      "r613",
      "r703",
      "r716",
      "r785",
      "r786",
      "r807"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r195",
      "r218",
      "r291",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r410",
      "r415",
      "r436",
      "r703",
      "r785",
      "r786",
      "r807"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_AssumptionOfEarnoutLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "AssumptionOfEarnoutLiability",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial valuation of earnout shares liability",
        "documentation": "The element represents assumption of earnout liability."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_AssumptionOfPrivateAndPublicWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "AssumptionOfPrivateAndPublicWarrants",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial valuation of warrant liabilities",
        "documentation": "The element represents assumption of private and public warrants."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r728",
      "r730",
      "r731"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r728",
      "r730",
      "r731"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r728",
      "r730",
      "r731"
     ]
    },
    "niobf_AvailableForSaleSecuritiesEquitySecuritiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "AvailableForSaleSecuritiesEquitySecuritiesOther",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "The element represents available for sale securities equity securities other.",
        "label": "Available For Sale Securities Equity Securities Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccounting": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccounting",
     "presentation": [
      "http://niocorp.com/role/BasisOfPreparation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BASIS OF PREPARATION",
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "niobf_BlackScholesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "BlackScholesMember",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Black Scholes [Member]",
        "documentation": "The element represents black scholes member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r697",
      "r698"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r86",
      "r406",
      "r697",
      "r698"
     ]
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction loss",
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/GxiiTransaction"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2023 GXII TRANSACTION",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r407"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Warrants assumed at fair value",
        "documentation": "Amount of lease obligation assumed in business combination."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Equity Facility Financing Agreement \u2013 shares issued",
        "documentation": "The amount of financial liabilities assumed (as defined) which have been recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total transaction related losses incurred",
        "documentation": "Amount of liabilities assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net liabilities assumed",
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash costs associated with the 2023 Transactions:",
        "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Equity Facility Financing Agreement \u2013 cash costs",
        "documentation": "The element represents business combination separately recognized transactions additional disclosures acquisition cash costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross cash proceeds, net of transaction costs incurred by GXII",
        "documentation": "For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction costs expensed",
        "documentation": "For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of any issuance related costs which have not been expensed."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value",
        "label": "Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized",
        "documentation": "The expenses and losses recorded for each transaction with the acquiree that was recognized separately from the acquisition of assets and assumptions of liabilities in the business combination."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows",
        "documentation": "Tabular disclosure of transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "currency_CAD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "CAD",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada, Dollars"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CapitalLossCaryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "CapitalLossCaryforward",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating loss carryforwards",
        "documentation": "The element represents Capital Loss Caryforward."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CapitalLossesAvailableForFuturePeriods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "CapitalLossesAvailableForFuturePeriods",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital losses available for future periods",
        "documentation": "The element represents capital losses available for future periods."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedCostsMineralInterestsInUnprovedProperties",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral properties",
        "documentation": "Capitalized costs of unproven properties that include fee ownership or a lease, concession, or other interest representing the right to extract oil or gas subject to such terms as may be imposed by the conveyance of that interest."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r162",
      "r163"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r186",
      "r677"
     ]
    },
    "niobf_CashAndCashEquivalentsAtCarryingValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "CashAndCashEquivalentsAtCarryingValue1",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "documentation": "The element represents cash and cash equivalents at carrying value1."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r136",
      "r216"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Change in cash and cash equivalents during period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r136"
     ]
    },
    "niobf_ChangeInFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ChangeInFairValue",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value",
        "documentation": "The element represents change in fair value.",
        "label": "Change In Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfConvertibleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ChangeInFairValueOfConvertibleNote",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of convertible note",
        "documentation": "The element represents change in fair value of convertible note."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ChangeInFairValueOfConvertibleNotes",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of convertible notes",
        "documentation": "The element represents change in fair value of convertible notes.",
        "label": "Change In Fair Value Of Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfEarnoutLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ChangeInFairValueOfEarnoutLiability",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of earnout shares liability",
        "documentation": "The element represents change in fair value of earnout liability.",
        "label": "Change In Fair Value Of Earnout Liability"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfEarnoutShareLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ChangeInFairValueOfEarnoutShareLiability",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation of earnout shares liability",
        "documentation": "The element represents change in fair value of earnout share liability."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ChangeInFairValueOfWarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of warrant liabilities",
        "documentation": "The element represents change in fair value of warrant liability.",
        "label": "Change In Fair Value Of Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInValuationOfWarrantLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ChangeInValuationOfWarrantLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation of warrant liabilities",
        "documentation": "The element represents change in valuation of warrant liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInValuationOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ChangeInValuationOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation",
        "documentation": "The element represents change in valuation of warrants."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangesInFairValueOfInitialValuation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ChangesInFairValueOfInitialValuation",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Initial valuation, at begining",
        "periodEndLabel": "Initial valuation, at ending",
        "documentation": "The element represents changes in fair value of initial valuation.",
        "label": "Changes in Fair Value of initial Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "documentation": "Person with designation of chief executive officer."
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/Cover",
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r190",
      "r191",
      "r192",
      "r218",
      "r236",
      "r240",
      "r245",
      "r246",
      "r248",
      "r249",
      "r291",
      "r319",
      "r321",
      "r322",
      "r323",
      "r326",
      "r327",
      "r345",
      "r346",
      "r347",
      "r348",
      "r351",
      "r436",
      "r566",
      "r567",
      "r568",
      "r569",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r601",
      "r622",
      "r647",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r737",
      "r758",
      "r768"
     ]
    },
    "niobf_ClassOfWarrantOrRightExercisePriceExpired": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ClassOfWarrantOrRightExercisePriceExpired",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancelled",
        "documentation": "The element represents class of warrant or right exercise price expired."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExercisePriceGranted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ClassOfWarrantOrRightExercisePriceGranted",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted",
        "documentation": "The element represents class of warrant or right exercise price granted.",
        "label": "Class of Warrant or Right Exercise Price Granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price",
        "verboseLabel": "Aggregate exercise price, per shares",
        "terseLabel": "Exercise price",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII warrant average price",
        "documentation": "The element represents class of warrant or right exercise price warrants gxii warrants."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville financing warrants average price",
        "documentation": "The element represents class of warrant or right exercise price warrants yorkville financing warrants."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExpired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ClassOfWarrantOrRightExpired",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right Expired",
        "documentation": "The element represents class of warrant or right expired."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ClassOfWarrantOrRightGranted",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted",
        "documentation": "The element represents class of warrant or right granted."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Number of share outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of warrants",
        "documentation": "Description of reason for issuing warrant or right."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r111",
      "r534",
      "r600"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "niobf_CommonSharesIssuedInTheGXIITransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "CommonSharesIssuedInTheGXIITransaction",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares issued in the GXII Transaction",
        "documentation": "The element represents common shares issued in the g x i i transaction."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CommonSharesIssuedInTheGXIITransactionShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "CommonSharesIssuedInTheGXIITransactionShares",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares issued in the GXII Transaction (in shares)",
        "documentation": "The element represents common shares issued in the g x i i transaction shares."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CommonSharesWithoutParValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "CommonSharesWithoutParValueMember",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares, without par value [Member]",
        "documentation": "The element represents common shares without par value member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r706",
      "r707",
      "r708",
      "r710",
      "r711",
      "r712",
      "r713",
      "r764",
      "r765",
      "r794",
      "r818",
      "r824"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://niocorp.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "us-gaap_CommonStockSharesAuthorizedUnlimited": {
     "xbrltype": "authorizedUnlimitedItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorizedUnlimited",
     "presentation": [
      "http://niocorp.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, authorized",
        "documentation": "Indicates that the number of common shares permitted to be issued by an entity's charter and bylaws is unlimited. The acceptable value is \"Unlimited\"."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares, issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://niocorp.com/role/BalanceSheetsParenthetical",
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails",
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, outstanding",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "verboseLabel": "Common stock, shares outstanding",
        "terseLabel": "Common stock, shares, outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r122",
      "r601",
      "r619",
      "r824",
      "r825"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, no par value, unlimited shares authorized; 38,062,647 and 31,202,131 shares outstanding, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r535",
      "r703"
     ]
    },
    "us-gaap_CommonUnitIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonUnitIssued",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common share purchase warrants",
        "documentation": "Number of common units issued of limited liability company (LLC)."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OciEquityMethodInvestmentBeforeTaxParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r200",
      "r202",
      "r209",
      "r530",
      "r547"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss attributable to vested shares",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r91",
      "r95",
      "r200",
      "r202",
      "r208",
      "r529",
      "r546"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r173"
     ]
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r96"
     ]
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "presentation": [
      "http://niocorp.com/role/BasisOfPreparationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated.",
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r96"
     ]
    },
    "niobf_ContractualInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ContractualInterest",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual interest",
        "documentation": "The element represents contractual interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockAmountIssued1",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversions",
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r53"
     ]
    },
    "us-gaap_ConversionOfStockNewIssuance": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockNewIssuance",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, New Issuance",
        "documentation": "A description of the new financial instrument issued in a noncash (or part noncash) conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r53"
     ]
    },
    "niobf_ConversionsOfDebtForCommonShares": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ConversionsOfDebtForCommonShares",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of debt for common shares",
        "documentation": "The element represents conversions of debt for common shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, June 30, 2023",
        "periodEndLabel": "Balance, June 30, 2023",
        "label": "Convertible Debt",
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r167",
      "r816"
     ]
    },
    "niobf_ConvertibleDebtCarriedatFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ConvertibleDebtCarriedatFairValueTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt Carriedat Fair Value [Text Block]",
        "documentation": "The element represents  convertible debt carriedat fair value text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible debt",
        "verboseLabel": "Convertibled debt, current",
        "periodEndLabel": "Ending balance",
        "terseLabel": "Convertible debt liability",
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible debt",
        "label": "Convertible debt, noncurrent",
        "periodStartLabel": "Beginning balance",
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in the Convertible Debentures are as follows:",
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ConvertibleNoteValuation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ConvertibleNoteValuation",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Convertible note valuation",
        "documentation": "The element represents  convertible note valuation.",
        "label": "Convertible Note Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible shares issued upon conversion",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r71",
      "r121",
      "r147",
      "r349"
     ]
    },
    "niobf_ConvertibleSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ConvertibleSecurityMember",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Security [Member]",
        "documentation": "The element represents convertible security member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CorporateOfficeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "CorporateOfficeMember",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate Office [Member]",
        "documentation": "The element represents corporate office member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CostCentreAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "CostCentreAxis",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost Centre [Axis]",
        "documentation": "The element represents  cost centre axis."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CostCentreDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "CostCentreDomain",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "auth_ref": []
    },
    "us-gaap_CostsIncurredDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsIncurredDevelopmentCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Startup and organizational costs acquired",
        "label": "Costs Incurred, Development Costs",
        "documentation": "Development costs incurred, including capitalized costs and costs charged to expense, in oil and gas activities."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "documentation": "Information by currency."
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionDescription",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Description",
        "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r119",
      "r120",
      "r165",
      "r167",
      "r221",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r455",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r759"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r104",
      "r328",
      "r455",
      "r688",
      "r689"
     ]
    },
    "us-gaap_DebtInstrumentIncreaseDecreaseOtherNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentIncreaseDecreaseOtherNet",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increased the amounts due",
        "documentation": "Amount of increase (decrease) in debt instruments, classified as other."
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate obligation",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r102",
      "r340"
     ]
    },
    "us-gaap_DebtInstrumentIssuedPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentIssuedPrincipal",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate principal amount",
        "documentation": "Amount of principal of debt issued."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r455",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r759"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r221",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r455",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r759"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal payments",
        "label": "Debt Instrument, Periodic Payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r113"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r71",
      "r72",
      "r101",
      "r102",
      "r104",
      "r112",
      "r146",
      "r148",
      "r221",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r455",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r759"
     ]
    },
    "niobf_DebtMaturityPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "DebtMaturityPeriod",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected life",
        "documentation": "The element represents debt maturity period.",
        "label": "Debt Maturity Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]",
        "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total deferred tax assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r393"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r792"
     ]
    },
    "niobf_DeferredTaxAssetsMineralInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "DeferredTaxAssetsMineralInterest",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral interests",
        "documentation": "The element represents deferred tax assets mineral interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating losses available for future periods",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r793"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r793"
     ]
    },
    "us-gaap_DeferredTaxAssetsOtherLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOtherLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax losses incurred",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r793"
     ]
    },
    "niobf_DeferredTaxAssetsResearchAndDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "DeferredTaxAssetsResearchAndDevelopmentCosts",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development costs",
        "documentation": "The element represents deferred tax assets research and development costs."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DeferredTaxAssetsShareIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "DeferredTaxAssetsShareIssuanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issuance/financing costs",
        "documentation": "The element represents deferred tax assets share issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DeferredTaxAssetsStartupAndOorganizationalCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "DeferredTaxAssetsStartupAndOorganizationalCosts",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Startup and organizational costs",
        "documentation": "The element represents deferred tax assets startup and oorganizational costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails",
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "negatedPeriodStartLabel": "Valuation allowance, beginning of year",
        "negatedPeriodEndLabel": "Valuation allowance, end of year",
        "label": "Valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "niobf_DeferredTaxAssetsValuationAllowanceAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "DeferredTaxAssetsValuationAllowanceAdditions",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Current year additions",
        "documentation": "The element represents deferred tax assets valuation allowance additions.",
        "label": "Deferred Tax Assets Valuation Allowance Additions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepositsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositsAssets",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future."
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r59"
     ]
    },
    "niobf_DescriptionOfEarnOutShares": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "DescriptionOfEarnOutShares",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of earnout shares",
        "documentation": "The element represents description of earn out shares."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DevelopmentStageIssuerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "DevelopmentStageIssuerPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Development Stage Issuer",
        "documentation": "The element represents  development stage issuer policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DilutiveSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DilutiveSecurities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total potentially dilutive securities",
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "DirectorMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "documentation": "Person serving on board of directors."
       }
      }
     },
     "auth_ref": [
      "r771",
      "r820"
     ]
    },
    "niobf_DisclosureClassBCommonStockOfEcrcAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "DisclosureClassBCommonStockOfEcrcAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Common Stock Of Ecrc"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DisclosureExplorationExpendituresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "DisclosureExplorationExpendituresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Exploration Expenditures"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DisclosureLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "DisclosureLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "verboseLabel": "Company Incurred Lease Costs As Follows",
        "terseLabel": "Maturity Of Lease Liabilities Is As Follows At June 30 2024"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss before income taxes",
        "documentation": "Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r116",
      "r117"
     ]
    },
    "niobf_DiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "DiscountRate",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount rate",
        "documentation": "The element represents discount rate."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r728",
      "r730",
      "r731"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r717"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r732"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Authority [Member]",
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarningsLossPerShareBasicAndDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "EarningsLossPerShareBasicAndDiluted",
     "presentation": [
      "http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per common share, basic and diluted",
        "verboseLabel": "Loss per common share outstanding basic and diluted",
        "documentation": "The element represents earnings loss per share basic and diluted."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and Diluted Per Share Disclosure",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r57"
     ]
    },
    "niobf_EarnoutLiabilityAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "EarnoutLiabilityAtFairValue",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout liability, at fair value",
        "documentation": "The element represents earnout liability at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarnoutMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "EarnoutMember",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout [Member]",
        "documentation": "The element represents earnout member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarnoutSharesAssumedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "EarnoutSharesAssumedAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout Shares assumed at fair value",
        "documentation": "The element represents earnout shares assumed at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarnoutSharesLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "EarnoutSharesLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout shares liability",
        "documentation": "The element represents earnout shares liability."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarnoutSharesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "EarnoutSharesPolicy",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout Shares Policy",
        "documentation": "The element represents  earnout shares policy."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange rate effect on cash and cash equivalents",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r444"
     ]
    },
    "niobf_EffectOfLegislativeChanges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "EffectOfLegislativeChanges",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital loss rate differential",
        "documentation": "The element represents effect of legislative changes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Canadian federal and provincial statutory income tax rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r389",
      "r402"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share based compensation",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r739",
      "r791"
     ]
    },
    "niobf_ElkCreekResourcesCorpECRCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ElkCreekResourcesCorpECRCMember",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elk Creek Resources Corp ECRC [Member]",
        "documentation": "The element represents elk creek resources corp ecrc member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ElkCreekResourcesCorpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ElkCreekResourcesCorpMember",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elk Creek Resources Corp [Member]",
        "documentation": "The element represents elk creek resources corp member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_Entity0896800BCLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "Entity0896800BCLtdMember",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity 0896800 B C Ltd [Member]",
        "documentation": "The element represents entity 0896800 b c ltd member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r723"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r734"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r181",
      "r204",
      "r205",
      "r206",
      "r222",
      "r223",
      "r224",
      "r226",
      "r231",
      "r233",
      "r247",
      "r292",
      "r293",
      "r353",
      "r378",
      "r379",
      "r380",
      "r398",
      "r399",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r425",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r468",
      "r558",
      "r559",
      "r560",
      "r577",
      "r647"
     ]
    },
    "niobf_EstablishmentFeesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "EstablishmentFeesPayable",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Establishment fees payable",
        "documentation": "The element represents establishment fees payable."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice11.50Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ExercisePrice11.50Member",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price11.50 [Member]",
        "documentation": "The element represents exercise price 11.50 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice2.20Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ExercisePrice2.20Member",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price2.20 [Member]",
        "documentation": "The element represents  exercise price2.20 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice3.25Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ExercisePrice3.25Member",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price3.25 [Member]",
        "documentation": "The element represents  exercise price3.25 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice3.54Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ExercisePrice3.54Member",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price3.54 [Member]",
        "documentation": "The element represents  exercise price3.54 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice4.60Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ExercisePrice4.60Member",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price4.60 [Member]",
        "documentation": "The element represents  exercise price4.60 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice8.94Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ExercisePrice8.94Member",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price8.94 [Member]",
        "documentation": "The element represents  exercise price8.94 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice9.70Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ExercisePrice9.70Member",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 9.70 [Member]",
        "documentation": "The element represents exercise price 9.70 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExplorationExpenditures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ExplorationExpenditures",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exploration expenditures",
        "documentation": "The element represents exploration expenditures."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExplorationExpendituresDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ExplorationExpendituresDisclosuresTextBlock",
     "presentation": [
      "http://niocorp.com/role/ExplorationExpenditures"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EXPLORATION EXPENDITURES",
        "documentation": "The element represents  exploration expenditures disclosures text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExplorationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ExplorationExpense",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exploration expenditures",
        "label": "Exploration Expense",
        "documentation": "Exploration expenses (including prospecting) related to oil and gas producing entities and would be included in operating expenses of that entity. Costs incurred in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: (i) Costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or \"G&amp;G\" costs. (ii) Costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, and the maintenance of land and lease records. (iii) Dry hole contributions and bottom hole contributions. (iv) Costs of drilling and equipping exploratory wells. (v) Costs of drilling exploratory-type stratigraphic test wells."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ExtinguishmentOfDebtAmount",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on debt extinguishment",
        "verboseLabel": "Fair value increase due to debt extinguishment",
        "documentation": "Gross amount of debt extinguished."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExtinguishmentOfDebtGainLossIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ExtinguishmentOfDebtGainLossIncomeTax",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss on debt extinguishment",
        "label": "Extinguishment of Debt, Gain (Loss), Income Tax",
        "documentation": "Current period income tax expense or benefit pertaining to a gain (loss) on an extinguishment of debt."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "srt_ExtractiveIndustriesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ExtractiveIndustriesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Extractive Industries [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details",
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of warrants granted",
        "negatedLabel": "Fair Value Adjustment of Warrants",
        "verboseLabel": "Warrant liabilities",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r9"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r429",
      "r433"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r429",
      "r433"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions:",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of valuation date and the probability calculated",
        "documentation": "The element represents  fair value assets and liabilities measured on recurring and nonrecurring monte carlo techniques table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "presentation": [
      "http://niocorp.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair values determined by level 3 inputs are unobservable data",
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r429",
      "r481",
      "r482",
      "r483",
      "r688",
      "r689",
      "r694",
      "r695",
      "r696"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r429",
      "r431",
      "r432",
      "r434"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueHedgeAssetsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueHedgeAssetsAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value, April 12, 2024",
        "periodEndLabel": "Balance, June 30, 2024",
        "label": "Fair Value Hedge Assets",
        "documentation": "Fair value of all derivative assets designated as fair value hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r355",
      "r360",
      "r429",
      "r481",
      "r694",
      "r695",
      "r696"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r355",
      "r360",
      "r429",
      "r482",
      "r688",
      "r689",
      "r694",
      "r695",
      "r696"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r429",
      "r483",
      "r688",
      "r689",
      "r694",
      "r695",
      "r696"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FAIR VALUE MEASUREMENTS",
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r481",
      "r482",
      "r483",
      "r688",
      "r689",
      "r694",
      "r695",
      "r696"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r434"
     ]
    },
    "niobf_FairValueOfCommitmentSharesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "FairValueOfCommitmentSharesIssued",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville share issuances",
        "documentation": "The element represents fair value of commitment shares issued"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r22"
     ]
    },
    "niobf_FeasibilityStudyAndEngineeringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "FeasibilityStudyAndEngineeringMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Feasibility Study and Engineering [Member]",
        "documentation": "The element represents feasibility study and engineering member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal income tax payable",
        "documentation": "Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r388"
     ]
    },
    "niobf_FieldManagementAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "FieldManagementAndOtherMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Field Management and Other [Member]",
        "documentation": "The element represents field management and other member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r344",
      "r350",
      "r424",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r545",
      "r685",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r774",
      "r775",
      "r776",
      "r777"
     ]
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Financial Liabilities Fair Value Disclosure",
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_FixedRentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "FixedRentExpense",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed rent expense",
        "documentation": "The element represents fixed rent expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Tax Authority [Member]",
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign exchange loss (gain)",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r438",
      "r440",
      "r442",
      "r443",
      "r644"
     ]
    },
    "niobf_ForeignCurrencyTransactionGainLossBeforeTax1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax1",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign exchange loss",
        "documentation": "The element represents foreign currency transaction gain loss before tax1."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Translation",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "niobf_GXIIClassAShareholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "GXIIClassAShareholdersMember",
     "presentation": [
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII Class A Shareholders [Member]",
        "documentation": "The element represents gxii class a shareholders member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GXIIPrivateWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "GXIIPrivateWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII Private Warrants [Member]",
        "documentation": "The element represents gxii private warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GXIIPublicWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "GXIIPublicWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII Public Warrants [Member]",
        "documentation": "The element represents gxii public warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial loss on debt extinguishment",
        "documentation": "Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r65"
     ]
    },
    "us-gaap_GainsLossesOnRestructuringOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainsLossesOnRestructuringOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total loss on debt extinguishment",
        "documentation": "For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "niobf_GeneralSecurityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "GeneralSecurityAgreementMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Security Agreement [Member]",
        "documentation": "The element represents general security agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GeologistsAndFieldStaffMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "GeologistsAndFieldStaffMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geologists and Field Staff [Member]",
        "documentation": "The element represents geologists and field staff member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GxiiTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "GxiiTransactionCosts",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII transaction costs",
        "documentation": "The element represents gxii transaction costs."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GxiiWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "GxiiWarrants",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII warrants",
        "documentation": "The element represents gxii warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r143"
     ]
    },
    "niobf_ImpliedDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ImpliedDiscountRate",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Implied discount rate",
        "documentation": "The element represents implied discount rate."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_ProfitLoss1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income taxes",
        "documentation": "The element represents income loss from continuing operations before income taxes extraordinary items noncontrolling interest1.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r218",
      "r225",
      "r250",
      "r253",
      "r255",
      "r257",
      "r291",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r426",
      "r436",
      "r541",
      "r683",
      "r785"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r385",
      "r390",
      "r391",
      "r396",
      "r400",
      "r403",
      "r404",
      "r405",
      "r571"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_ProfitLoss1",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax benefit",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r177",
      "r232",
      "r233",
      "r252",
      "r388",
      "r401",
      "r550"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r386",
      "r387",
      "r391",
      "r392",
      "r395",
      "r397",
      "r565"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign rate differential",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax benefit at statutory tax rates",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in estimates related to prior years",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "niobf_IncorporationStateCountryName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "IncorporationStateCountryName",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country of incorporation",
        "documentation": "The element represents incorporation state country name."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in working capital items:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r239",
      "r246"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible debt",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r242",
      "r246"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToWrittenPutOptions",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of outstanding written put options using the reverse treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r246",
      "r680",
      "r681"
     ]
    },
    "us-gaap_InterestAndDebtExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestAndDebtExpense",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r170",
      "r207",
      "r251",
      "r453",
      "r631",
      "r714",
      "r821"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r214",
      "r215"
     ]
    },
    "us-gaap_IntermediateLifePlantsUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntermediateLifePlantsUsefulLife",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life",
        "documentation": "Useful life of intermediate-life plants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "us-gaap_InvestmentCompanyExpenseRatioIncludingIncentiveFee": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyExpenseRatioIncludingIncentiveFee",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Establishment fee",
        "documentation": "Percentage, after deduction of fee waiver and incentive fee, of expense to average net assets."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "us-gaap_InvestmentInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentInterestRate",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Interest Rate",
        "documentation": "Rate of interest on investment."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r654",
      "r656",
      "r657",
      "r658",
      "r659",
      "r662",
      "r663",
      "r708",
      "r772",
      "r773"
     ]
    },
    "us-gaap_InvestmentOwnedBalancePrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentOwnedBalancePrincipalAmount",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance, June 30, 2023",
        "label": "Investment Owned, Balance, Principal Amount",
        "documentation": "Amount of principal of investment owned."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r590",
      "r655",
      "r661",
      "r664",
      "r708"
     ]
    },
    "us-gaap_InvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestorMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investor [Member]",
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value."
       }
      }
     },
     "auth_ref": [
      "r803",
      "r804"
     ]
    },
    "niobf_KingdonCapitalManagementLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "KingdonCapitalManagementLLCMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Kingdon Capital Management LLC [Member]",
        "documentation": "The element represents kingdon capital management llc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee related costs",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "us-gaap_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LandMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land [Member]",
        "documentation": "Part of earth's surface not covered by water."
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net lease cost \u2013 other operating expense",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r702"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostAbstract",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Cost:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Company incurred lease costs as follows:",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r801"
     ]
    },
    "niobf_LegacyNioCorpShareholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "LegacyNioCorpShareholdersMember",
     "presentation": [
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legacy Nio Corp Shareholders [Member]",
        "documentation": "The element represents legacy nio corp shareholders member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_LessAmountOfPaymentsRepresentingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "LessAmountOfPaymentsRepresentingInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less amount of payments representing interest",
        "documentation": "The element represents less amount of payments representing interest.",
        "label": "Less Amount of Payments Representing Interest"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_LessCurrentPortionOfOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "LessCurrentPortionOfOperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less current portion of operating lease liability",
        "documentation": "The element represents less current portion of operating lease liability.",
        "label": "Less Current Portion Of Operating Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The maturity of lease liabilities is as follows at June 30, 2024:",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details": {
       "parentTag": "niobf_TotalLeasePayments",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details": {
       "parentTag": "niobf_TotalLeasePayments",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details": {
       "parentTag": "niobf_TotalLeasePayments",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other lease description",
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining lease term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://niocorp.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r218",
      "r291",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r411",
      "r415",
      "r416",
      "r436",
      "r599",
      "r682",
      "r716",
      "r785",
      "r807",
      "r808"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, redeemable noncontrolling interest, and shareholders\u2019 equity (deficit)",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r168",
      "r538",
      "r703",
      "r760",
      "r778",
      "r797"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r185",
      "r218",
      "r291",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r411",
      "r415",
      "r416",
      "r436",
      "r703",
      "r785",
      "r807",
      "r808"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_LindConsentWarrantIssuanceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "LindConsentWarrantIssuanceMember",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lind Consent Warrant Issuance [Member]",
        "documentation": "The element represents lind consent warrant issuance."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_LindIIIConvertibleSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "LindIIIConvertibleSecurityMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lind I I I Convertible Security [Member]",
        "documentation": "The element represents lind i i i convertible security member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitment fee",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of credit facility",
        "documentation": "Fair value of the amount outstanding under the credit facility."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "niobf_LineOfCreditFacilityPrepaymentFee": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "LineOfCreditFacilityPrepaymentFee",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayment fee",
        "documentation": "The element represents line of credit facility prepayment fee."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentTerms",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt term",
        "documentation": "Disclosure of timing of required repayments, sinking fund requirements, and other redeemable securities at fixed or determinable prices and dates in the five years immediately following the date of the latest balance sheet presented in the financial statements, and the amount thereafter to fully repay the principal of long-term debt. These disclosures may be made either on an individual debt or security basis, by type of debt or security basis, or on a combined basis."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r71"
     ]
    },
    "us-gaap_LongTermDebtPercentageBearingVariableInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtPercentageBearingVariableInterestRate",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate",
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_LongTermDebtTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtTerm",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long term debt duration",
        "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONVERTIBLE DEBT",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_LongTermInvestmentsAndReceivablesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermInvestmentsAndReceivablesNet",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in equity securities",
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value."
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "us-gaap_LongTermLineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermLineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal amount outstanding",
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r61",
      "r62"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r63"
     ]
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingencyAccrualAtCarryingValue",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent liability",
        "documentation": "Amount of loss contingency liability."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r738"
     ]
    },
    "niobf_LossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "LossesOnExtinguishmentOfDebt",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss on debt extinguishment",
        "documentation": "The element represents losses on extinguishment of debt.",
        "label": "Losses On Extinguishment Of Debt"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_MarkSmithMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "MarkSmithMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mark Smith [Member]",
        "documentation": "The element represents mark smith member."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r318",
      "r362",
      "r512",
      "r557",
      "r591",
      "r592",
      "r653",
      "r656",
      "r659",
      "r660",
      "r662",
      "r674",
      "r675",
      "r684",
      "r692",
      "r699",
      "r705",
      "r787",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814"
     ]
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExercisePriceMember",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Exercise Price [Member]",
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Share Price [Member]",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_MetallurgicalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "MetallurgicalMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Metallurgical [Member]",
        "documentation": "The element represents metallurgical member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MineralIndustriesDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MineralIndustriesDisclosuresTextBlock",
     "presentation": [
      "http://niocorp.com/role/MineralProperties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MINERAL PROPERTIES",
        "documentation": "The entire disclosure for mineral industries."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r514",
      "r515"
     ]
    },
    "niobf_MineralPropertiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "MineralPropertiesPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral Properties",
        "documentation": "The element represents  mineral properties policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_MinimumConsentPaymentAtInception": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "MinimumConsentPaymentAtInception",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossAndFinalLossOnExtinguishmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum Consent Payment at inception",
        "documentation": "The element represents minimum consent payment at inception."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r318",
      "r362",
      "r512",
      "r557",
      "r591",
      "r592",
      "r653",
      "r656",
      "r659",
      "r660",
      "r662",
      "r674",
      "r675",
      "r684",
      "r692",
      "r699",
      "r705",
      "r787",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814"
     ]
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of ownership",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_MonteCarloModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "MonteCarloModelMember",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Monte Carlo Model [Member]",
        "documentation": "The element represents monte carlo model member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://niocorp.com/role/DescriptionOfBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r178"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r213"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r213"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r137",
      "r138"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails",
      "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative",
      "http://niocorp.com/role/StatementsOfCashFlows",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss",
        "verboseLabel": "Net loss for the period",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r138",
      "r169",
      "r183",
      "r199",
      "r201",
      "r206",
      "r218",
      "r225",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r243",
      "r250",
      "r253",
      "r255",
      "r257",
      "r291",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r426",
      "r436",
      "r544",
      "r621",
      "r645",
      "r646",
      "r683",
      "r714",
      "r785"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss attributable to redeemable noncontrolling interest",
        "verboseLabel": "Adjust: net loss attributable to noncontrolling interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r160",
      "r199",
      "r201",
      "r232",
      "r233",
      "r543",
      "r753"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss available to participating securities",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r227",
      "r228",
      "r229",
      "r230",
      "r234",
      "r235",
      "r244",
      "r246",
      "r250",
      "r253",
      "r255",
      "r257",
      "r683"
     ]
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss attributed to common shareholders - basic and diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r246"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Standards",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_NioCorpTechnologiesLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "NioCorpTechnologiesLimitedMember",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nio Corp Technologies Limited [Member]",
        "documentation": "The element represents  nio corp technologies limited member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_NonRevolvingCreditFacilityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "NonRevolvingCreditFacilityAgreementMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Revolving Credit Facility Agreement [Member]",
        "documentation": "The element represents non revolving credit facility agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash investing and financing transactions:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoteWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoteWarrantMember",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Warrant [Member]",
        "documentation": "A note that entitles the holder to buy stock of the company at a specified price, which is much higher than the stock price at the time of issue."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Notes Payable",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r167",
      "r816"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of reportable segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OciEquityMethodInvestmentBeforeTaxParent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive loss attributable to redeemable noncontrolling interest",
        "documentation": "Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r409",
      "r414"
     ]
    },
    "us-gaap_OciEquityMethodInvestmentBeforeTaxParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OciEquityMethodInvestmentBeforeTaxParent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Comprehensive loss attributable to the Company",
        "label": "OCI, Equity Method Investment, before Tax, Parent",
        "documentation": "Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r409",
      "r414"
     ]
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsLineItems",
     "presentation": [
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offsetting Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsTable",
     "presentation": [
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offsetting Assets [Table]",
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r128"
     ]
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs expensed to other operating expense",
        "verboseLabel": "Employee related costs",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash lease activity",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Present value of lease payments",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liability",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash payment",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r466"
     ]
    },
    "niobf_OperatingLeasesLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "OperatingLeasesLiabilityNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncurrent operating lease liability",
        "documentation": "The element represents operating leases liability noncurrent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option Contract Indexed to Equity, Settlement, Number of Shares, Effect of Change in Fair Value of Share",
        "documentation": "Increase (decrease) in number of shares that would be issued upon settlement from change in fair value of share for option contract indexed to equity."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payable accruals",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_OtherCommitment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitment",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitment fee",
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive loss:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting currency translation",
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r129",
      "r439",
      "r441",
      "r445"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on equity securities",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r197",
      "r198"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting currency presentation",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive gain:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCostAndExpenseOperating",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal and other related costs",
        "verboseLabel": "Other operating expenses",
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r549"
     ]
    },
    "us-gaap_OtherGeneralExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherGeneralExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other operating expenses",
        "documentation": "Amount of general expenses not normally included in Other Operating Costs and Expenses."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other gains",
        "label": "Other Income",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r623",
      "r665",
      "r666",
      "r667"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liabilities, at fair value",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r703"
     ]
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Other Liabilities, Fair Value Disclosure",
        "periodEndLabel": "Other Liabilities, Fair Value Disclosure",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Other Liabilities, Fair Value Disclosure",
        "documentation": "Fair value portion of other liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrant liabilities, at fair value",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "niobf_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "OtherMember",
     "presentation": [
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other [Member]",
        "documentation": "The element represents other member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "niobf_OtheroperatingGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "OtheroperatingGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other gains",
        "documentation": "The element represents otheroperating gains losses.",
        "label": "Otheroperating Gains Losses"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfFinancingCosts",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Add: uamortized debt issuance costs",
        "documentation": "The cash outflow for loan and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share issue costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment at maturity",
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r259"
     ]
    },
    "srt_PlatformOperatorCryptoAssetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "PlatformOperatorCryptoAssetLineItems",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto-Asset [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "srt_PlatformOperatorCryptoAssetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "PlatformOperatorCryptoAssetTable",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto-Asset [Table]",
        "documentation": "Disclosure of information about crypto-asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r302",
      "r303",
      "r678"
     ]
    },
    "niobf_PrincipalAndAccruedInterestConverted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "PrincipalAndAccruedInterestConverted",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal and accrued interest converted",
        "documentation": "The element represents principal and accrued interest converted.",
        "label": "Principal and Accrued Interest Converted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PrivatePlacementShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "PrivatePlacementShares",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private placement (in shares)",
        "documentation": "The element represents private placement shares."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PrivatePlacementValue": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "PrivatePlacementValue",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private placements",
        "documentation": "The element represents private placement value."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ProbabilityOfIssuanceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ProbabilityOfIssuanceMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Probability of Issuance [Member]",
        "documentation": "The element represents probability of issuance member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of debt, net of costs",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_ProceedsFromInterestReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromInterestReceived",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net proceeds",
        "label": "Proceeds from Interest Received",
        "documentation": "Interest received on loans and other debt instruments during the current period."
       }
      }
     },
     "auth_ref": [
      "r756"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of capital stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Face value",
        "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromOtherEquity",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from equity",
        "documentation": "Amount of cash inflow from the issuance of equity classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024NotesForYearEndedJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining principal balance, June 30, 2024",
        "documentation": "The cash inflow from repayments of the balance excluding interest (principal) on loans receivable and leases held for investment purposes."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party debt draws",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRepaymentsOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds",
        "documentation": "The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments",
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of assets",
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r513",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r676",
      "r693",
      "r704",
      "r740",
      "r783",
      "r784",
      "r788",
      "r817"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r513",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r676",
      "r693",
      "r704",
      "r740",
      "r783",
      "r784",
      "r788",
      "r817"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r714",
      "r822",
      "r823"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net loss attributable to the Company",
        "negatedLabel": "Loss for the year",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r199",
      "r201",
      "r212",
      "r218",
      "r225",
      "r232",
      "r233",
      "r250",
      "r253",
      "r255",
      "r257",
      "r291",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r409",
      "r412",
      "r413",
      "r426",
      "r436",
      "r531",
      "r542",
      "r576",
      "r621",
      "r645",
      "r646",
      "r683",
      "r700",
      "r701",
      "r715",
      "r753",
      "r785"
     ]
    },
    "niobf_ProfitLoss1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ProfitLoss1",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net loss",
        "documentation": "The element represents profit loss1",
        "label": "Profit Loss1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LAND AND BUILDINGS, NET",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r174",
      "r175",
      "r176"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land and buildings, net",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r187",
      "r540"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r532",
      "r540",
      "r703"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentOther",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of properties",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r318",
      "r354",
      "r362",
      "r374",
      "r375",
      "r376",
      "r484",
      "r512",
      "r557",
      "r591",
      "r592",
      "r653",
      "r656",
      "r659",
      "r660",
      "r662",
      "r674",
      "r675",
      "r684",
      "r692",
      "r699",
      "r705",
      "r708",
      "r781",
      "r787",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r318",
      "r354",
      "r362",
      "r374",
      "r375",
      "r376",
      "r484",
      "r512",
      "r557",
      "r591",
      "r592",
      "r653",
      "r656",
      "r659",
      "r660",
      "r662",
      "r674",
      "r675",
      "r684",
      "r692",
      "r699",
      "r705",
      "r708",
      "r781",
      "r787",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814"
     ]
    },
    "niobf_RecognitionOfOperatingLeaseLiabilities": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "RecognitionOfOperatingLeaseLiabilities",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognition of operating lease liabilities",
        "documentation": "The element represents recognition of operating lease liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_RedeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "RedeemableNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Redeemable noncontrolling interest",
        "documentation": "The element represents redeemable noncontrolling interest.",
        "label": "Redeemable Noncontrolling Interest [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable noncontrolling interest",
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r68",
      "r69",
      "r70"
     ]
    },
    "niobf_RedeemableNoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "RedeemableNoncontrollingInterestMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Noncontrolling Interest [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_RedeemableNoncontrollingInterestPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "RedeemableNoncontrollingInterestPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Noncontrolling Interest",
        "documentation": "The element represents  redeemable noncontrolling interest policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDepositLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDepositLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Related Party Deposit Liabilities",
        "periodEndLabel": "Related Party Deposit Liabilities",
        "label": "Related Party Deposit Liabilities",
        "documentation": "Amount of deposits held by the entity for a related party (entity, shareholder, employee)."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r472",
      "r473",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r618",
      "r620",
      "r652"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r626",
      "r627",
      "r630"
     ]
    },
    "us-gaap_RelatedPartyTransactionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionRate",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest at a rate",
        "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r472",
      "r473",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r618",
      "r620",
      "r652",
      "r806"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalances"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS AND BALANCES",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r470",
      "r471",
      "r473",
      "r474",
      "r572",
      "r573",
      "r574",
      "r628",
      "r629",
      "r630",
      "r650",
      "r651"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Debt repayments",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r755"
     ]
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Related party debt repayments",
        "label": "Repayments of Related Party Debt",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r149",
      "r537",
      "r561",
      "r563",
      "r570",
      "r602",
      "r703"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r222",
      "r223",
      "r224",
      "r226",
      "r231",
      "r233",
      "r292",
      "r293",
      "r378",
      "r379",
      "r380",
      "r398",
      "r399",
      "r417",
      "r419",
      "r420",
      "r422",
      "r425",
      "r558",
      "r560",
      "r577",
      "r824"
     ]
    },
    "niobf_ReverseStockSplitPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ReverseStockSplitPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Stock Split",
        "documentation": "The element represents  reverse stock split policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross proceeds",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockDescriptionOfTransaction": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockDescriptionOfTransaction",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of stock transaction",
        "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r92",
      "r159"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issue",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Price per unit",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_SaleOfStockPricePerShare1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "SaleOfStockPricePerShare1",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares price",
        "documentation": "The element represents sale of stock price per share 1."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of account payable and accrued liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r86",
      "r406"
     ]
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024:",
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in the Lind III Convertible Security are as follows",
        "documentation": "The element represents  schedule of changes in lind iii convertible security one text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of convertible debt",
        "documentation": "The element represents schedule of changes in lind iii convertible security text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The change in the Private Warrants liability is presented below:",
        "documentation": "The element represents schedule of changes in the fair value of the private warrants table textblock."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ScheduleOfClassBCommonStockOfECRCTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CLASS B COMMON STOCK OF ECRC",
        "documentation": "The element represents  schedule of class b common stock of e c r c table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "srt_ScheduleOfCondensedFinancialStatementsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfCondensedFinancialStatementsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss for the year ended June 30, 2023:",
        "documentation": "Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r748",
      "r763"
     ]
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June 30, 2024.",
        "documentation": "Tabular disclosure of derivative liabilities at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company\u2019s basic and diluted net loss per share attributable to common shareholders:",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of excluded from the dilutive securities",
        "documentation": "Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r58",
      "r767"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table is a reconciliation of income taxes at statutory rates:",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "niobf_ScheduleOfExplorationExpendituresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ScheduleOfExplorationExpendituresTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ExplorationExpendituresTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of exploration expenditures",
        "documentation": "The element represents  schedule of exploration expenditures table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfExtinguishmentOfDebtTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table summarizes the components of the initial loss and final loss on extinguishment:",
        "documentation": "Tabular disclosure of debt extinguished which may include, amount of gain (loss), the income tax effect and the per share amount of the aggregate gain (loss), net of the related income tax."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows:",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r761"
     ]
    },
    "us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInterestRateDerivativesTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes:",
        "documentation": "Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherNonoperatingExpenseByComponentTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table discloses the components of interest expense associated with the Convertible Debentures.",
        "documentation": "Tabular disclosure of the detailed components of other nonoperating expenses. This disclosure may include methodology, assumptions and amounts for : (a) losses on securities (net of profits) and (b) miscellaneous income deductions."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of expenses as other operating costs",
        "documentation": "Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ScheduleOfOutstandingExercisableWarrantsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At June 30, 2024, the Company has outstanding exercisable warrants, as follows:",
        "documentation": "The element represents  schedule of outstanding exercisable warrants table text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table discloses the primary inputs into the Monte Carlo models.",
        "documentation": "The element represents  schedule of primary inputs into the monte carlo models table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r626",
      "r627",
      "r630"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in the Smith Credit Agreement principal balance are as follows:",
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table summarizes the weighted average information and assumptions used to determine option costs:",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Short-Term Debt [Table]",
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock option",
        "documentation": "Tabular disclosure of the change in stock options."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates.",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "niobf_ScheduleOfWarrantValuationTableTextblock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ScheduleOfWarrantValuationTableTextblock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The change in the fair value of the Contingent Consent Warrants is presented below:",
        "documentation": "The element represents  schedule of changes in lind iii convertible security one text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2024:",
        "documentation": "The element represents  schedule ofsummary of the changes in the fair value of the earnout share liability table text block."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in valuation",
        "label": "Servicing Asset at Fair Value, Changes in Fair Value Resulting from Changes in Valuation Inputs",
        "documentation": "Amount of increase (decrease) in fair value from changes in the inputs used to calculate the fair value of contract to service financial assets under which the benefits of servicing are expected to more than adequately compensate the servicer."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "us-gaap_ServicingLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ServicingLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contingent liability",
        "label": "Servicing Liability",
        "documentation": "Aggregate amount of servicing liabilities that are subsequently measured at fair value and servicing liabilities that are subsequently measured using the amortization method."
       }
      }
     },
     "auth_ref": [
      "r495"
     ]
    },
    "us-gaap_ServicingLiabilityAtFairValueAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ServicingLiabilityAtFairValueAdditions",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value",
        "documentation": "The value of new servicing liabilities, that are subsequently measured at fair value, acquired or created during the current period through assumptions of servicing obligations and servicing obligations that result from transfers of financial assets."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_ServicingLiabilityAtFairValueAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ServicingLiabilityAtFairValueAmount",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value at beginning",
        "periodEndLabel": "Fair value at ending",
        "label": "Servicing Liability at Fair Value, Amount",
        "documentation": "Fair value of a liability representing servicing arrangements under which the estimated future revenue from contractually specified servicing fees, late charges, and other ancillary revenues are not expected to adequately compensate the servicer."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r494",
      "r495",
      "r496"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation",
        "verboseLabel": "Share based compensation expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock price on valuation date",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected dividend yield",
        "verboseLabel": "Dividend yield",
        "terseLabel": "Expected dividend rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average of the equity volatility and implied volatility of the public warrants",
        "verboseLabel": "Expected volatility",
        "terseLabel": "Implied volatility of public warrants",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility",
        "documentation": "The element represents share based compensation arrangement by share based payment award fair value assumptions expected volatilityrate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volatility",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free rate",
        "verboseLabel": "Risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free rate",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled/expired, in shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted, in shares",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r367"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value per option granted during the period",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r366"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r366"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding stock options vested",
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares purchase",
        "documentation": "Number of shares purchased for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancelled/expired, per share",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cancelled/expired, per share",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted, per share",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r367"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364",
      "r371",
      "r372",
      "r373",
      "r374",
      "r377",
      "r381",
      "r382",
      "r383",
      "r384"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value",
        "documentation": "The element represents share based goods and nonemployee services transaction valuation method expected dividend yield rate.",
        "label": "Share-Based Goods and Nonemployee Services Transaction Valuation Method Expected Dividend Yield Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing common share price",
        "verboseLabel": "Closing Common Share price",
        "terseLabel": "Strike price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected option life in years",
        "verboseLabel": "Expected warrant life in years",
        "terseLabel": "Expected life",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2": {
     "xbrltype": "dateItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term (expiry)",
        "documentation": "The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term (years)",
        "verboseLabel": "Weighted average remaining contractual life",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning average price",
        "periodEndLabel": "Balance at ending average price",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonShares"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMON SHARES",
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r152"
     ]
    },
    "niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ShareholdersEquityAndShareBasedWarrantsTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants.",
        "documentation": "The element represents shareholders equity and share based warrants text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_SharesIssuedUnderTheYorkvilleEquityFacility": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "SharesIssuedUnderTheYorkvilleEquityFacility",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville equity facility draws",
        "documentation": "The element represents shares issued under the yorkville equity facility."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "SharesIssuedUnderTheYorkvilleEquityFacilityShares",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued under the Yorkville equity facility (in shares)",
        "documentation": "The element represents shares issued under the yorkville equity facility shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short term lease cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r702"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r217"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r727"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302024And2023AreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/Cover",
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r190",
      "r191",
      "r192",
      "r218",
      "r236",
      "r240",
      "r245",
      "r246",
      "r248",
      "r249",
      "r291",
      "r319",
      "r321",
      "r322",
      "r323",
      "r326",
      "r327",
      "r345",
      "r346",
      "r347",
      "r348",
      "r351",
      "r436",
      "r566",
      "r567",
      "r568",
      "r569",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r601",
      "r622",
      "r647",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r737",
      "r758",
      "r768"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r40",
      "r181",
      "r204",
      "r205",
      "r206",
      "r222",
      "r223",
      "r224",
      "r226",
      "r231",
      "r233",
      "r247",
      "r292",
      "r293",
      "r353",
      "r378",
      "r379",
      "r380",
      "r398",
      "r399",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r425",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r468",
      "r558",
      "r559",
      "r560",
      "r577",
      "r647"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/Cover",
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
      "http://niocorp.com/role/ScheduleOfPropertiesDetails",
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r247",
      "r513",
      "r564",
      "r588",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r601",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r620",
      "r624",
      "r625",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r647",
      "r709"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/Cover",
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
      "http://niocorp.com/role/ScheduleOfPropertiesDetails",
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r247",
      "r513",
      "r564",
      "r588",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r601",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r620",
      "r624",
      "r625",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r647",
      "r709"
     ]
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants issued",
        "documentation": "Value of preferred stock and warrants for common stock issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversions (in shares)",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r39",
      "r71",
      "r149",
      "r338"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered direct offering May 2023 (in shares)",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r71",
      "r121",
      "r122",
      "r149"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange of Class B shares (in shares)",
        "verboseLabel": "Earnout shares",
        "terseLabel": "Warrants traded prior to the closing",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share issued",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r121",
      "r122",
      "r149",
      "r566",
      "r647",
      "r669"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitment shares issued (in shares)",
        "verboseLabel": "Units issue and sold",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesReverseStockSplits",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post reverse stock split shares",
        "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "niobf_StockIssuedDuringPeriodSharesStockOptionsExercise": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercise",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of the convertible debentures",
        "documentation": "The element represents stock issued during period shares stock options exercise."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercise1",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of the convertible debentures",
        "documentation": "The element represents stock issued during period shares stock options exercise1.",
        "label": "Stock Issued During Period Shares Stock Options Exercise1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails",
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options (in shares)",
        "negatedLabel": "Cancelled/expired, in shares",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r121",
      "r122",
      "r149",
      "r368"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Transaction loss",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r40",
      "r149"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversions",
        "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered direct offering \u2013 May 2023",
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r40",
      "r149"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange of Class B shares",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails",
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issuance costs",
        "verboseLabel": "Fair value of Commitment Shares issued",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r121",
      "r122",
      "r149",
      "r577",
      "r647",
      "r669",
      "r715"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitment shares issued",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueStockDividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockDividend",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Option liability valuations",
        "label": "Stock Issued During Period, Value, Stock Dividend",
        "documentation": "Value of stock issued to shareholders as a dividend during the period."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r40",
      "r149"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r40",
      "r149"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total shareholders\u2019 equity(deficit)",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r124",
      "r125",
      "r140",
      "r603",
      "r619",
      "r648",
      "r649",
      "r703",
      "r716",
      "r760",
      "r778",
      "r797",
      "r824"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS\u2019 EQUITY (DEFICIT)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityDeficitAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, value",
        "periodEndLabel": "Ending balance, value",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r90",
      "r93",
      "r181",
      "r182",
      "r205",
      "r222",
      "r223",
      "r224",
      "r226",
      "r231",
      "r292",
      "r293",
      "r353",
      "r378",
      "r379",
      "r380",
      "r398",
      "r399",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r425",
      "r446",
      "r447",
      "r451",
      "r468",
      "r559",
      "r560",
      "r575",
      "r603",
      "r619",
      "r648",
      "r649",
      "r673",
      "r715",
      "r760",
      "r778",
      "r797",
      "r824"
     ]
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sublease income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r702"
     ]
    },
    "us-gaap_SubsequentEventDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventDescription",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent event description",
        "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r476"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r476"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r476"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r476"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r476"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://niocorp.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r475",
      "r477"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
     "presentation": [
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares, percentage",
        "documentation": "Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "documentation": "Different names of stock transactions and the different attributes of each transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "presentation": [
      "http://niocorp.com/role/GoingConcernIssues"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GOING CONCERN ISSUES",
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of cumulative net operating losses",
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in the valuation allowance are as follows:",
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r166",
      "r815"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": [
      "r771",
      "r805"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_TotalLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "TotalLeasePayments",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total lease payments",
        "documentation": "The element represents total lease payments."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average common shares outstanding",
        "documentation": "The element represents total weighted average number of share outstanding basic and diluted."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_TransactionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "TransactionCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction costs",
        "documentation": "The element represents transaction cost."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransactionDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r679"
     ]
    },
    "us-gaap_TransactionTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransactionTypeAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOf2023TransactionsWereAsFollowsDetails",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Type [Axis]",
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r679"
     ]
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfApril2024WarrantLiabilityForYearEndedJune302024.Details",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r344",
      "r350",
      "r424",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r545",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r774",
      "r775",
      "r776",
      "r777"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized loss on equity securities",
        "label": "Unrealized Gain (Loss) on Investments",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForBlack-scholesModelUsedInValuingApril2024Warrants.Details",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsForMonteCarloModelUsedInValuingApril2024NotesDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ValuationTechniqueOptionPricingModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueOptionPricingModelMember",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Technique, Option Pricing Model [Member]",
        "documentation": "Valuation technique calculating price of option."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "niobf_ValueOfWarrantsIssued": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "ValueOfWarrantsIssued",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of warrants issued",
        "documentation": "The element represents value of warrants issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable rent expense",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r464",
      "r702"
     ]
    },
    "niobf_WarrantAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "WarrantAgreementMember",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Agreement [Member]",
        "documentation": "The element represents warrant agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_WarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "WarrantLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liability",
        "documentation": "The element represents warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r706",
      "r707",
      "r710",
      "r711",
      "r712",
      "r713"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Initial valuation, at beginning",
        "periodEndLabel": "Valuation, at ending",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "presentation": [
      "http://niocorp.com/role/AtJune302024CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiry date",
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Probability of issuance",
        "verboseLabel": "Fair value",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "WarrantsEachExercisableFor1.11829212CommonSharesMember",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each exercisable for 1.11829212 Common Shares [Member]",
        "documentation": "The element represents  warrants each exercisable for1.11829212 common shares member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsNotSettleableInCashFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsNotSettleableInCashFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Warrants Not Settleable in Cash, Fair Value Disclosure",
        "documentation": "Fair value portion of warrants not settleable in cash classified as equity."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "niobf_WarrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "WarrantsPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants",
        "documentation": "The element represents  warrants policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://niocorp.com/role/CompanyUtilizesWeightedAverageMethodToDetermineImpactOfChangesInParticipatingSecurityOnCalculationOfLossPerShare.FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttrDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding basic and diluted",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r246"
     ]
    },
    "niobf_WorkingCapitalDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "WorkingCapitalDeficit",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital deficit",
        "documentation": "The element represents working capital deficit."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r735"
     ]
    },
    "niobf_YorkvilleCashFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "YorkvilleCashFee",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Cash Fee",
        "documentation": "The element represents yorkville cash fee."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_YorkvilleConvertibleDebtFinancingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "YorkvilleConvertibleDebtFinancingAgreementMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Convertible Debt Financing Agreement [Member]",
        "documentation": "The element represents yorkville convertible debt financing agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_YorkvilleConvertibleSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "YorkvilleConvertibleSecurityMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Convertible Security [Member]",
        "documentation": "The element represents yorkville convertible security."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_YorkvilleEquityFacilityFinancingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "YorkvilleEquityFacilityFinancingAgreementMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Equity Facility Financing Agreement [Member]",
        "documentation": "The element represents yorkville equity facility financing agreement."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_YorkvilleFinancingWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240630",
     "localname": "YorkvilleFinancingWarrants",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville financing warrants",
        "documentation": "The element represents yorkville financing warrants."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a-c)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "835",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "60",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481408/470-60-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1B"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "e",
   "SubTopic": "470",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-13"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-14"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481244/470-50-50-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Section": "S99",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4M"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "855",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-14"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-18"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3A"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205-40/tableOfContent"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481138/505-30-25-5"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//820/tableOfContent"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "932",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//932/tableOfContent"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-13"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "FF",
   "Subsection": "Q2",
   "Publisher": "SEC"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-26"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481725/323-10-35-18"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//410-20/tableOfContent"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481879/410-20-45-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481850/410-20-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481260/860-50-45-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481260/860-50-45-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481260/860-50-45-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "905",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482211/905-360-50-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "930",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//930/tableOfContent"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "930",
   "SubTopic": "715",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482467/930-715-50-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-23"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "35",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-35"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-36"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481639/420-10-35-4"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10"
  },
  "r739": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "SubTopic": "740",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480887/718-740-35-2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r741": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r742": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r743": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r744": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r745": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r746": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r747": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r748": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r749": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r752": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r753": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r754": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r755": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r756": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-16"
  },
  "r757": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r758": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r764": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r765": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r766": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r767": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r768": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r769": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r771": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r772": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r773": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r774": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r775": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r776": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r777": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r778": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r779": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r780": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481879/410-20-45-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r782": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r784": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r786": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r787": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r788": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r789": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r790": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479365/842-20-25-6"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-14"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>152
<FILENAME>0001539497-24-001980-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001539497-24-001980-xbrl.zip
M4$L#!!0    (  F1-%G>FC[$GQ@  $4=   2    ;C(U-S0Q,&MI;6<P,#$N
M:G!GY79Y.%M[VVY0JJ:6&%KC+M46-5:H(710LRH1J4;8YHIYB)GL3H8H=J@I
M1+M14Y FYBBJ06JN(10-15%C4&-K.-[W.]_PUWN^LZ_SQSG7N=>U_KG7=3WK
M^:UUW_?S''\^_@HX9VIH8@A@804 7$\NP/$*@-\ Y>(5#F !G (  +HGU!J
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M'*^<)_BNJ:2%/JV+>-V&>TL%>E//=*>6P0TBF?X4'^RM'U1:9RBGY1&.;,:
MB\@Q!FJ_'#CX=V9C/$A<YYBI>5\E3W(K:;[EE1+$$6>,#2\[?8U1ZEIV)''
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MU1$HYHQ)^PO>%_AREF2YV0.&HV0\TQ2D=$[)7MBAI]1_H#B1:D@SLA[P]S/
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M9M1'+3FQ>,>S"#;,OYP<F.Q;T?2$,XY?T+U9T>=O7*GD3]Q)&D9#M"9OVG
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MKZM<&W\2#MMB#'.X)QHR'U;^T/KJJN&4-7^QZ8H:011IXIV@Z4NK"J(OJG-
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M_5672%N,54[5&KW2TPG G/S]9'+WJ&9&W7JZU,?>;Z<BR._H)<>D3Q;(,SM
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MQ]TQ;HC),4T'"Y$<V:P"\3'E"M&=DO3<@53V-$M/-"Q,MGY6$?43\=",(RV
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M_<FOZ54V@#_-Z8L#E@W4,?<THTPIR(&S+8U\(!W?=^725?C+86M$+?07GT&
M)YZL2J+N+*$N!%,"4WP>%DI']%G[XFV4^;1WJ,J][)$5G_8942#V1JW<)NR+
M)$BNE-*6(+HIQ;73M!$^?I4HF9U>23F;HC-[]#$")-_5$B/ICWO)8FD94HB_
MX;_-(%Q[V]X: :JZK9)OF14JNGRW;!U-+5G/WJ;?;<96-TIGI3JVK 6V1ILE
M:=15059 0Q*VVFRGFX2TFS&FMC:(::J"7#S!FU3+O0IK=%7UC=GP(!T]O/LF
MPN)1HZ$@O- 1U?*Y/(Z#@%T5Y_]5VE='Q=4L^TYP)\'=W2%8L#"X! ONP75P
MEP2'X.XRN#L,#@GN#,$],$!P#1;LY<OYSCOGOG?>77>M]U_MZ:Y=]>O>TU)5
M77VHX%93(X)%Q.ALQ1FQ,]S6!DA:9?3!=K+C[U4X]4P=7&%W<"@(H4A)F/.Y
M+U7/=G _5N#R"X=WC&B1Y^$?:QDOST!^W\]TX/OS![;6$&K2D$*S8D2VMV0Y
MY>9,MC(I:\N-CL%'/8. ;O'1?5=?6V(]!:).Q-300$TTH9\G0FWIH\Z0G+<T
M7Z-<!4I7TGM/5NDDH;ZRZMFV[L=ID2Y&U*,UE]YDUX3,_/RLD@S*I);P@W(<
M^(D> :W")"KH'WO?ENH>;J3T07Y-N$^-M+S(%?G)SW]G1C_I0\LWD&E>W*'F
M;$^']&;.@XTGF)3>8U:["=/A:L3@L2T/6YUY6,I-14I"F(6.]A=SQ79H8KBH
M)VC/T@O-8!YUG8D<@J2N13?>=)^)]@S@B[S $O!W_#CBGY$X1?_3O*Q$<.X=
MAD?#[-7*#-![H#/1K-H\::-3K7&FH1@HA*J'Q>F*(Y?0J+9=,R!:$E2JVS&R
M597:P!@=&89W=./VXZW& (6(6\VF"KO[FW&_&E8PWWRQC#L0')/T:.C^.)Z'
ML/=FT\>4[=/.UBV\>-!_=<%YRW"R^D9>809W-V2O&$B;6$'46HH5@J>#M?./
M5%62@!^(?3<*;^>!BXK>(O"NK6"K'#/# =5XH69KK*#^/)O*'UG\QA_DL&^5
M S9&@O-&]'@\*7'$/[Z NG:*9,J9QQ*!DMMYJKI?!Q7%AF!C[%'O7-Y%VZO)
ML)FT=;>;X.=4N4+V*5+HDLCQ-;S'A^JLN8>.O2E8T6U,KR$S$SC?M.67\!IQ
M)IJ(IA1R,[%.O3/]D@F^R:1VB[SG278D<HB!9LZIGQ+%P._L\1+ON;V\$,O!
M3ZZ.B7S#R:Q3F!))37>U*L[8"%Q^HR.3RT<@ V;!5IH]0KC>>WF>FM*8#6Y&
MPPA1)*8 FM@K^7]S@\?8)B8]E6YF>.-0F#4HC-9DA&>[!\_S<MWF$&QY1]JD
M-&%!A2=<<8ZF/JJXSR"AK"UFZR>7.(H<NIE)3(<!3:"SG7._&>K07Q@:993T
MYBMRUOD:]4F(WSU$$5]\[8='CU'UH]# ^VA]R[,[8FX(!+^N3::MOCG1 @FS
M)HK75F9S\TG=!>NDL"$3]=H^Z6)LV)%MSL).CD[BWGA"ETY]844(>7!P7"X1
M157$7RTH0%I:B,2;ESCH@/A!!:LGT2.F N4R#9("99A8HBSA3CM/\R[PII5[
M%VHJG!\_&UO0O-^>R98AT;K;4!L%0LPR--]*ZO/U=?DVF/(B6"0RU[JTWM ,
MU"-KZ-/#IS)NZNVAGF7VXS6I0.*@AQJFF7^\(HI__EJHCC* C;"[O3$E5R]-
M7LO/@>)BLUAQOC,W26B48%=PVG:E<SN@U+ *]=H]%]6W_AQ7/7S3OCAQ\QL1
M* HY'@%M7)IY2Z&__MJ7M5J)5J#%L>^=%0[,<][&U=T$XUOC2%O&"TR(#+S+
M_8R"&^_L)NY:RT'R W:T4%GBA Y5@48=F&*8*L]3.\08])YJBU_PQ"ZS(PBE
MI+DI;"Z# V^41CY50D_PJS0OB_SI8>7 YZ[1A:@^77FR'MFN &G7-M-&0&%+
MMBU&"G*UNZ#TM;UD^H2%L_>[YHD^B6HK*X<2P>NV3/Z,-&\M>!/AKE-C1YV\
MI07'O1+8&Z5KRE38O-T;!W90-0]V>$I0;Z)LPN]I64(G)$:-RDGHFE,Y><$J
M9T_^,"JT*SR&'K;2&O#N_GN6[<TKU293DL+\DUG<>J.&V^*K(P]4IVDC16>^
M)C5%4H;=H*)6.G4SEA-UHPDX3MV,<===)T&+]GBE^->TU9D9I6>V0:J!^'MZ
MHK#&):@/$G.!X/TG1+I8:I*(;Q86\4P P.BZDYC>'GT. GK6"[XM T+:OAB8
M)N5"L?XSP,KHXV2N-OLAA-K/P)1W2-$*UK.C2S8,9B;E#Q07'C8J-:B=?1(<
M,QHW:$Z*[%\L.Q\3KF!UL$%!:)$0NI=L5'_(&WR7UC*I4F 80=B*9K=4T^I2
M?06VIC5_!F@;?OK+J8^&3+--_ [T#,!N:FSGZO.K+SI_0>I(F8BWO.YI1M$,
MOP:&"G<_,6[^%2_\)\Z&0C/<.VG6""")IGRALS2T.4(R6L2MEUA%Y$9N)ZE"
M#>6*77YBNNU_G>5J2ALMDT"7$'\5 D5&;T9>#P+?N5&$H<"_JQ0.*S#!9DX=
M@K&3'%R;8+"*HY:S#=5KRFI9GL"7SW%I#MD[U'#L3IGG<ZVO 5(A)YY\S66
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ME.1IL?#9([$\TMWI[]MWJ8IRL:%B(H\+9C2J5,[]<@KU"$;T,)-T36RU6=C
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MSLJ/S):9N6;FVO=DW2_S+VL +$59!5D #"P 8/GZ ;S\ 6"_]P0Z^ !@ /
M $#L570,P)"R=+:P EAVO4I@7I8 80!$>'AX!'A$! 3$-XBO7U1D1$1D5#04
M%%04%#0LM'\#"PT#$PL3 PT7%P\/%Y>,E)24C/+_#!@D)"1T-'0B+"PB$GQL
M?!+*_]?QT@7 1H;I@1V"@\$&P&+#P&'#O/0!^@$ 6#@8&!C _QEP\#"P"(@
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MPF]J1O_31,A*,=+<UNV&&S4;1 ];1%OCZ;HC[%Y?:/)Q_R"H2->C[N2D"<W
M$ZHB,CZ4RQ6!GP;)F=R9J:@@0S<TYH0H?HF\[8^C'8X<>9E%?I9G$,1;AL+!
M55Y%<M,_\E93D\K2?$N5"KO/&ZW$*R^;![#/WY?BR>!_;ELZE%"UZA$M.:_
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M"RUB-N49IS"!J5S@Z=C3C]9"3,><"'TMDM/OR^T.%O25:A7*"[@S[.*$6*6
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MB50M-$V\,=C:R0 SK;A8NC$/GZO;3L/8_QR^04[0!<CL:SX)V]H=7"Z]]7P
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M.8&Y^2D \Y+W ["^[S/(AJ='/B\HMEFP(?L!H)PXZS,>;J!6>?NETS>]75Q
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M:2V_YGY9D^X2.C.C;466#_T9JA/$*_(PT8.4U?MOMJX"T^#":%FPR[IGX5H
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M&*:J/F(A^V*;N?4!CGWDK/1&Y+..KR.8HQ8@NY]-D-^S94_%NL7U-#VTM$P
M ]UX&.AI)>MO=L3QTNG6E,LY"^%#0_4T4)*<&<.1+XJX"B6D_1&5[%5 RZ"Y
MG\E?\%;"U_R/D7)= 6A\Y,G(UE^B$=OG%]018MYJ^</;H\N@=*L#;*Z?/P&?
M +'7+I;I>\8<@Q[_@QI,2A%8]YC([VZZ^1B=MZT.)TU+!./[CFU/SS^><PG5
M,LCB"8KR6Q%!-O=KZ.!6;[SDMW8S24Q,TJ'X8_;E24JK3:L)%)+.K*;-_K4J
MAVKK%EZ.VD%=X/K;6C_F+$PL1B07AK:)1ASQ/GE9?CA2(AY#3YB\]31*\*8I
MO&"BGXA(3\K(,.B2\DA]0.J&\V#S;(X@+XX:3ZBM;,VN?LUBCR@$=\2_GU?,
MG1"^VK2)NT4X',= -X2X0H;CV$%N23#RO>/Q]&EX/>MC[#%^PD+HJ[E\-"'_
M!M+<U^.;6M.T R^?3\!2RY:.UL?'?JB$6@)V7JX@J5Y54$Z3I4\]/;'$T<DX
M)$09L/749BLFH^U]:6*OMY"&Y3"68<0NR-2-K4;BP)FIS(W/U+Z+R5EV!Q-=
M<)6I#5-.X@9]('Z\0FR"\%)I%#A,_@TTI^NV\0YSM%L(&+H4L,#O2UYN?9WC
M4N%,!,Z(QBY?-V0_:L ]KG>]*%]_8_/>RN#FSO!FD5L)<DV'\89((7>2-C'8
M?4D!,S(/[S_;Y<A/SJ<'YY?$%Q&7;_!-L6V>N6Q0)M>L<"_N^/8=?P(XXA/A
M863_H7JIN38?V/\MX#QZ*?H$N&T-7%%WY\,;[T%MS[?(G.]DU_+T=7$C6 C!
MEGKK9;*A!"PYX]&B/?P4VBXG)'BCIIMIG@,(L&.J^O(HD;Q1D47_5EC;MO6M
M$@31ELM Y!5^ 4^USWWC[/$/@=" 4O5GGA6'T""V<NDB+DT-,"'60K13"+HK
MKX4.$E-9I%Q\+0NE%NK1B%CWF($8M!UY\)G6L:!S(>L/*M-8%48/R.DL$!*>
MST</KN9?1(GG"?""5W)+.1!SP$3# VXWQ+L"D?Q]N>2&1GXVV;Y8AQ4/C+"D
M$&KB5L8N7A6@0&'KGR;OT& =M1)SV3_BJA.B1 I]82N4D'K^N?E+8N"/G2-5
M,3$CGA_/,IH]F/<7?P)5F;O'757>*&W>/6<%G%27Y+H5<_*)< EHVLR_6L_]
MG?6_M4K_Q[P)^S_F#<[CFW;,!?<D6Q,M/_\X#]& SGS_/Z]:\M&G>X1YA%%;
M&V=E08_QLF2XG6[B-^M&/^^3U4^]1J\LAP>(EW(FK>GTK+526Q7KALCVF6S1
MR2#I^E6N+5,\_6YTX89TK1%")CGPZ*5:NE% X>%<0=:&1-,4=L>[-KRN45TT
M4@_>?&146Z0T8Y[. W0D2EV@TC++^6I0R%Z4W=E0#3[BSVV1- &M#PXE:GQP
MIW4@$!>2U!T556AUE:%]KNJ!8"K\:2$?\MR;J"'D*.F[K0=24))DT:9IHQ;M
MQ[A13S4>8E]HUY1E\)QEPJ#<PEUQJVU$P)=5*]VS:A(9/T9=J#E@AB\IJ'UX
MZ;7B3X(J+QI#T&Y=0U0]UF*.@OHR->>&MWM1:0"BMY*B5R!BG&@Q;L6H+1HO
MZE?(*6H1K2R\1T&XOVOV!.VU;OKM"@S^&HV7=<YCUY.,5+H>I^H^8F=K&PP^
MP,?C+4R<906[1LK,^\6X].PL[\+]GAZ%)TY.!:YLY#+L+RIVWGK*MVB-#BX^
M+8^V6PAC8\989(NZFR]9N (F;J"+AF>#G"[?'<\;T?A\TP2OT[+"7<6+1_6;
M+*_5UT$Q-CK($DY"F+3'V>NNFNV;++?3379'*<4R.WR7U=[5%Z302@.?%O3F
MJS5;MA\F].OA8$9S*'&"$5-=WTDG8[99AQY%5*$\,X*G6C9YW\&LX^*8[^ N
MX 7Z2JO=^?#)\X\8Y'";&^Z>_].983$]I_,7/3&&A'KA1NE\0TK,U,6UCQHO
MSYL^7? 63@@RR;H$A=/%4]BLEK3.?WXW&9'O*]IBMEZ11D,FH<.8B]'V+ML=
M*0[GX(#D12>YB,UP?%F,W);76C9D^JH=_IH93_JJ:30.4<L^A:^V=1K^-S?#
M,C_6LR3X,W>/=6L!#DL<$Y!4?;JT_Y%^]_SXGN5[%Y[^A5XB#*S+U^+;,CY
M! SV)"7?3?38-#=NM4/Z-N.*?K_0<(&U_H;J)'=[PXS^$_?K\[%80(V0GN?
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M]S(KR#%^3I/5Y[3<R)*+9)60'KXR4\9_U_.[W>7 MMGQ8.06-'%PZCS_)^Y
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MMX\CXSN*I",,^1%CSAYK><0: G2@EOT[VQ8)7EZ_AVX\VQ96ZZCYEF+'Y/%
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M>SY)*6&B8<YM2;[>T=ITZAFPJ])WMQIA.4I$+W]DLFII4A'!S,_S*J> 76+
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MLR[+IJ-DZ6*0./+4#@K >]5\N\N=/#Z9.9IPX<2^\8TW?'>!/*^^W;[KZGX
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MG@TV!I7T4'QP2S.7DWHTC(6@-0ET#MT:_K[^^$XU#.(7-00K9(R O#JB&LF
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M:59<%FMB4LQT,(5GH[X@DY<ETS1NBCDCL+PZ8NE8"MII_Q$=9IWDZD$( VF
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M-!0'G3LC!T084;CF7&KPJ:B#L+./(1O\\>%5_F=_[J!IPG8K+-JIW8^->2\
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MTC!Q<B3U>5ZJM2^K69+BI,S!?*..-K'/<ACNFC:E&B*,!$IT&\F2(??O5$A
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MW^XPEC\>/51>W#2IPI'%3#X" (\ E'Q1A]8ML,$=TL$3C<NBNY=7W)ZA,W!
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MX*Z!X.YNP=V=8#>_[[OOOKK_W%>O[N[=_^P^I\ZI[K-JK=55^W7A=1V IZP
M5  @( ( EO\NP.LQ /^#NX6=%P !@ P  ,3_E4X!.#*6CN96 ,O.?Q6$UV5
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MZ3V-[P?NTJ7J&EE[S(BZ,)^@DH1GOH>MZUI< [[;,IH-CK\"KX!:C9'PI:J
MD,K]E5> =:#D[+<GI@"%O4=^M!Q;Q0>NMNJ%@IH-&F=^1+NQ3MDATEVZS[9L
M6K;(+!W?=[JS['\N"#_G]9Y?%!\BYPVR:%!>WRU/*I)8AW\9DW$JH!7-*P@G
M0%(1DMG.->MQWM-W=GLWBTO<]'Z0D: *5(Y,,L.9?^GE>JWK5,LOZBB /:$"
M=.\)!FF'I?Q$W^6.]YPC!T]T;JT9OXR<]?UY= ^DOCR[M9$4? 4L_Z3(G)$F
M\#2P'I"T$&3Y7G5Q%\S!S0WEDRO8R2]>9)MQ_U)EQ'CX@MLX]D,_=ROM^VC#
M5A2YT9?XS<BE&J5=C/FQVJ!(#!ZG+0THFP,=FRRH/O$(P,1^"WP8 ]R2#S5R
M(V'H3#C?1F*"?BY%ZD!8M'2%2$DN;B,GP")DNJIEV9\3MNR^4[Z80$*_P;8U
M0F!V]C"L6R+M!;0@/5P:)^:JO(6?J<M.UR5ZY*!R3+T?H\'A9J(/<TZ_D/B)
M'C7AGV0:.KC_+MV.,S[Z/A-'2B(1"2<D@G#BE_"JLFQQ15,ZI7<K<3K:/^0@
MI+\Q61GE/TO>JHK?H_@Y#(@RO'OX13UQ?V1EJ_XY=^BK%OMV4^,, 5H;*T5I
M)S67BVAH'/OB8B(1*5DC5E#U*<Q*65HZJ1_$K<VU\R<LR5!8)5 #Z)-6QP8&
M;2*&'&K<Y0_=OCC&_3;R JT3$=F(%R47U)ES :LU""I_ZU;_E5R5VRH3<UDG
M(G9D/0I"X?Z T&W=Z6.:_Z1EN58/SI7KW4D.Y0_M(&);A_$*T+P%(LA+W+(3
MUX1D%[ *.;KT.2%&./LJ8P"@!2M14:$(=G^RK!;3%U@Y^VS6*%7LE2*/(N<M
M<RUS,@0_<6\9KGOOOVO1^RSR0\O.D-);5'L1X3/TG&7]_K'X9^_;6CZFMJ,8
MP4*B+>8QW+?U#ZZ4?N[A)-$XB"SX+D?2MW%<"G]PJO41\ARO1E\!"I7WR0@[
MHR]>'?NSKP""P+OAC*>K@$GX"Q/ R[4CV_&O0$#/3_%I?@K2C'L*O;_&_PZV
M%P0NN], Q2]F+$#Z+-U![-*,6)/7BSPI4!]"9$FF[[18$Y]4?,<\M&70-3)Q
M@LMFAD)(H9?FM)J85!SK[6L,L>TE"Z/C]DY3CD^#D"%V"LK*1S;;7IBN@$.#
MYD3-&?MDH[X;_6;C03;JRLN(EQ^DSE<H9A4K^V^@(I9#DQ!B]@C_,-*+$L<D
MY-KI*^+3)6VP-!0J7H_OQ4V-2%B6^<Z)$S5LSQ%I<X<C3EKAQ@456RM^LMU\
M!32\?Z:7P@;XP:->%OJOOS_Q(Y8D$(,QY8I!ZO1$Z(]A@5$YX?T?$TMPQ$'U
M=%Q9[.HU2,$K,B<>KP! 17S+9*9LM#G!4')##LBW)W!=F0)=I[(@D+![Z;CH
MAWD%#)>T0_"Z(B_@X*]1NHU%7@7O'TT(=CFZ+-5L>3W3A#V!,()!6:9186BC
M&?M.2&XD'/A5S(.5@\V])Q1Z6Q1,Q0&:[/$HF77>4Q>8"O$^IOMYNG!<2X=O
MD, KNZ8!46.D%:X )%;Q(Q<8!6Z*P=O*A&3D(E;5^N5]^0TTJS3T.R*XF6S5
M@N,QMC,2,^9N+PF^# 6.L\S,/."/,+*V[#/"D$"13U_0$<!*DES,ZU?K=CX^
M[9L79)H,9M:@;6OK<C7DNOI48U9[1M3?&,J^?77$1%</QF+"Z0=BVF5Z^.G8
ME^U*?>87O]F,ALP)=Z86'95#K GALD0%17VY:PYBJG;BM3J.)C@IQ\TM]&AV
M#N+<)WT\7)$>NI*\3$WB:2C<S7L'6',Q."R!6(HQ'HA]N_&9)4"%N#B%CH9O
M/G-5 D4$FYSX3O?SVTU3-05L.PTI,UM8TV=TJDV'*"F![E[ "WTD5P>=C%0;
MY6G-OC94"$79PLC(;;637KS< QM"NUK>>WNO0!@0XTH8A^W!& VS-R/1O[X$
MUJVXI#].][:WS=EWOYG9,C7+>?X3N<:E-6=*_+"TR6>XIB$)03*3'@"'X<=Z
M*93I;>FA<4ODO:+U4C2M-7Y*,$-_]DK^KG#N=@F6K#'G(5N+ )ZV:B)G)2D-
M*7D/MY&WA8);L[733=[64+$2B@UH)I0W-)PB[?-?"BM;=*.>5=V:Y T#9#;E
MG>%0#A0UN4Q=^N970+F/#T-*O]G%KG$C[Y6A\A],= SWS6E)V@)$.'BV.]6K
MF'W+!:Q0%\=$DN@ZP.'4R\8T9UN\M/A5YPV8JX#_R)$XA(U!*Y;3F "H'D.+
M-6F=KSBD6R1#UWCQ<MM4>O>-GB5ET)TKEXMK557JA @L'E@#]1/GE"^^(BCL
M%HY <Q9^<M&B*MH6;,1KA^2OCH40A(J4[E?O<BVO&K<MJAB:^"=AS R]SP+_
MMFX))47 I7@/V;9.,?;_$-*@<<!--\P;-D<42"F.V?OHI:>_/"+F>5[)@U-C
M?WF[A?F0S>.VV#?V/37J9,"]41LF2A2_FGB8F'PDJXP.G%I2_(ICK*IH$"Z+
MPU<'>:LDK6SJL5YMY8D2XB_MZ<7JI'-$DV:!3WV/QU+50]Q49*AA+FLHIV?H
M%JZ1A< NCAC!CD'=<D1#X,ZG)3AT=LQA=,@]-<+'E9E.@4,V[-?P%N)04W2]
MCR"H!@,WZSR.NH=GA($T30UAIJ,90*=A3F*UFO4E$X;?1M7Q979QI6+?AAR5
M+9*)4K^E$\-H>;1,.2Z/VRLX<.RB"F+8BQ2^USF2OL_2[STNJAX7=M%<26ZN
M$%Y+/H+T4\K(OE725TXH_/NHZ.Z<V.PLPEBE"%XT:MQIC.KM_&+7V>UN:UJ$
MQUV. 53"F,OBF.Y\!&[<E1OKS,LRF@:1>>KA ",XRU<!3X>@#DY/[<0@RY!#
M@.V>]ZKQ9,$B+X.S=1[$'B$M/?O'>]VZ1J;>U+5_'SJ@5<L[>:Z<?3LGLBYY
M,SL)EJ'F$*%MRFD<)DL)K&8B-0?&+M6'9_X3A'.I^(7K1/"A%G<GJ?T#LIXI
ME3?%7Y'<RVO6)!:F:%(Z+[,#@,I$!7BAK%PR;$*:Y3#S%JWW8?G-K36<( (#
MHXHO'""-PGNP2E3]4.#V$%S>K#KD@J(^U#7R$;RQI:&0+=[,>B'QK:'F\@1"
M1#JPQ328:<E?!T,530<R]W*(MIEVQ0T=:Y2;,4+?$/M=)"Z_#:.+GIF[J%#2
M=Z# 4*D0A#'UE .9"H?""C+PY)OF)CL"3QP($B<+O+"(J0GF"BSUV>>I%,Y@
M"&99HO6,C/NWZLC90EM&0R]<X2Q<;RK:?SE5W3VI5A5:_AH ]ZN9X2+WJ=6)
M;T , :JGY>+]%'HLSM,R= 91C5$$E:A3_MKE94.45[R=P@<X+$.23FJI!+M9
M,ASBVD$GY/WIU_AP4&]0Q$[/AS@!M<=N""LQPH:28BA]IQ-IN8UHL&[].R($
MZ7]I;:*BI'O4B]3C$U(YWO]/"XJ]%/BGO?4>RA]->6)8%)>74_C0UB5,&*#Z
M\HPP]^O%I"_0?M-T)B^#*-LTZ#.'E;2;>R <J3@.@^1TI^]Z B5M$,C-ACTH
M*"N-CD.#:T/KJ4OU9AJ,'V\T8=VW@IV8ED#96D/HR)_;\V![$<7^PN @P,?&
MZ=YPH]+4L[N*)286)VD(?%10QW?RW;F\/Z1,^LC,Z[?(S5\ ZR(JIU,F4?ZN
M'-Q4#/"*/*P4)2O!?/%AS)SF OJH:":#IN'D=2@H%%'WGE!JP9.*E K5TJSW
M&B#C9DYI[3;[#JX^79+P15THDAO468ERM(F:2*_(?;U<<N8,<T<@OY@BGS::
M/Y5:+Y-,IYQ^;-4.F4WI"K&MGN;=2MXL'-JS#Q\!BU57(B!!>V6&"G',S7U[
MZ^ZQ,)FDB<7<B0V7F@J<Z%LY0<V%/ZKV#QD5Q5C[$KR1SR$*G2U.$^130XQ<
M5;%8Y_ NQ>\4YR5Z5T+IT<7M.H\M8M_/ETH-\9/'!1N@5/(PWJHZSK!$V6 W
M+'V7QHT]G:F1P<W[,/JD6VX.TB:)C?<:,Q,'7AS2#VJQC#@F]59[J\TV\F!E
M]]X[\A+1% PZ$'Y\_X"L]O3[.0PV1C9!1BP"^=C\10UQ%U/F_6VWZ/.6<DL%
M[!#YY!Y]W>A%7Y$K*4&'=OH7Q&Q&1N>*<<X9(T/\U!^9[3:@JY*94)@:EZEY
M\+R+9[$+RZR&Y?*D5C9SEJ:L>TKU@^L.?XK?G+0A43P>*$L/F>B"$AV>65[:
M3^7GMFGNDJ1O-%O0#N<\]^.,*,59VJ@4^+R<PW&QS@YE)YLKQ=#.\DX^_,Y(
M'&,KKLCM.\XM&;DXT+GZ-&95EOS%>?53@IL81+E%&:-9G9H$L1;Y)N-W7EW!
M^]@U[*'8);+$-*!?8SQ!.&(!+5,O"B.2NT?&)=RW@<VJ?E_3&X?;0:UM-VQN
M=X4KHXC^>:!ZIB;W%6![ S3,R&QO_6JFP;6=A=2X>':C.Q2F,>$@,5%_:/R
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MJU?&X*GBI:U?LG$JP_T&PZ.!0@2/I;R(K6.(\1@8U)5- 6GD_==T=V:ZR?*
M126*QE.Y6]A%WE..U +].SG/2,87G_X;WHF>.:_JNDD] %Y'3,W1)*"H1T2W
M9;:^497MU']_>5)8MZN"-I=1X:DMD-7[_7AFQ)V'AC9N-Z_'9HG3%=MB*:W[
M2UR$TDBW3#0)FT*DI7/*]RKMO^X4,^._*VGN'/X;P(LTJ :? 91>*J"H*-2-
M9#4L!5_"POB<@2_)HA7SL,SL/L[_Y-]T;#(JPQ3M\"S=383;?#$,?R3)>*'/
M_&V<BBCMJ(;J6U%-]5N^J;!;9.958W&%K(GJI_*Y&]/\G--1_62N/^[^XT5[
MP1)/6%RS'/7>XUO16!+3 ?B?FHT<JM1\?R[!9%%OD^HPQ<#K/A>9./4VMU>3
M>)?94J\.75/SEDQOS89?Z/58.@@#[[;YJ$S!HE9R(THRD[.1&-7\W?Q[B*VP
ML'RR8V!6^O'G+9DA_8*$S/?1KZ$_*0T'.M\_@W3(Q&*Y>D?^#4(%[J5Z9["^
M0W52=30"LQ=(Y-VX]A0']1,C^0/&@UG8C:IY#>UYYKH!0AO)2(_36I#'DB^7
MX\@#(']ERR= \XJA?K>J1/WST*A9<X.@(FVN#'V/6LW'JY>PWU;>A2-;8!I=
M^C^]VP7RO:!O'Q\ DZ4V^D,(D<]_M<^^^$[MFP\4,HCD+>TZ@ PK%9!9F_04
M:^'^;&S8YOZ167BZ5-R:&+)ZCWWES>A;Z\5VLJ9:#.W0P5O>:-_5,REIW?IY
M#:XW<3VG>'A!%J-/4'T=H</>WG*^5X9.5GU;O'OHU)60J69^,%3I)'%-.4*S
M<7.]<K/5,BG.X#P=LE6>MEBC-M19=";0$!QW3*98F=,S"S/" @!2R:PLET6P
M9JK9#[3;^_9J\SKF.+:N,,P%7@T8AWD8R_'>6"\)J0)CJN;:LNO\!T-Y*1%7
M7.X\[(BB9[Q/EHH2AA1H^[7L$MR^"5:M8[B8AWWK2G.5QHUBO%A@Z3Y/LT(/
M0WC1Y!$3M(Z).\"#7XSK=DB1N!SM&@)\6K1U.K6I- E4# J6(?UT&1+HH4ZK
M>E+!@)2'O5;E+N[_-E[,N);3Q'@N6Y@H?S<O#@N E;Z#S#(JDW  GX4[AQ>]
MS,NGGN%K-".%&6YQXRRF=$P<R)R'("U:YMV5O2KY*,T(L7@D/'\QOE ;\8!]
M]P^ ^X[-"MO36';+?^9@7VN4\^W4!0H,.-I"^NMC(X\P(H;GB39*,A;;!DP.
M*>1'*Y]?] I.=4\*M_%RJ2'?AO2&!V\:OUE\I\((E/*\0,BW6.R1H>Z%EVL2
MRJJ5VS#0"+,&-SFV>V+J^;O<P?H7!,'?AMK;)>P +=I,#.H!"TGJU/#\ B8R
M>(A:^WBHX,"Z4-M"VX3FDTI$] - Q3$ ;MY+S_ROI65[9XX47L5:LV1=I]O)
M](J(;RF/C40PJ",<C%6%T)RU-DT]_V1^V;A:K.U;QJG'$>U8*NHJ?^"ULXQT
M&O!B!F+6^>QJ4D']?H(CF,^&7I\":<Y4T02=U^D%O>$/>  6-.!XJ"T4Y+"R
M.G^V5F[3:M%_V'WJF>[>4*3?C(T]%6PPDGL94!SZ5=5_LK1AK<BFG"RG1\M7
M"J)571Z:40Q\)7\GM%,-F0EI%)@B=UVP;;K\D(<IV.+$&3^8K%_PM+BX?=G7
MU;Z.O&#U*DF1T 58*RO#NY]@Z!(P"P54VSYW/>TGU1-&.(Z$.0[,,6?DN8K5
M*QHXV:&=Z31L))&[D7S;]K^Q+J_Y\<3R@[,;2(8G;A1<6RX2713C4E' N*&4
M\&OOMZ&^?-O=I:_$1C,\'NG,9* )F+I'3"+M;#^.+\\+5HCDN-6L.9-)>(W[
M[6953_^Z$L]ZSSP,JF&PI=R2,[*C^NFBX6!3G3:?S'IRC>,+&$O?4!Y[[0N8
MMQIBV('?;AN_>.RU=I"ANYS:*$83?*=%NJUU&R'&_W\"9;0? $+M_P7 =TO_
MC;\IHG(?SZ+&WG0IO5ZZ3Q3=P;_*4L)C?.S%#ODIL./326>AYE#($#D.<X"8
M$5)*WN#PI:%QB0Y!$G PI.@65#'W$6$5#]30TDC-3!I>S[=&)8GP\'"1XI&_
M-0E[YI?)F0CO,GKTZB8@?P=%L;YZ5H.(,LSSCT%';=RUUL[-/  :S"J(LGD?
M389G],%E7U6D&P(==P^)'P %4,>0B=<A.57.%8K[O\OF,/:N_7X8/6@85^X1
MY7ZA6SPEQ6Q4>BH[C6]??:S/ ^"QE@WM%C26O66IO*[S<K?TF_&=)D8F 8ZK
MU9_[HR@\;-C\QI9EW.!1:"_'*6R%BX:VEL^KW@%)6E9D2])0'_ES<NJ10%N>
M)?WLS['D&F$!L>[VB&>C&5OPGZ)\0KW6T$=V&E33^4V'<S^7\G=9RWNI$-N+
M6?7JSLEGMN_VDY%34._ J/#N%0141;Q\&I[P'O=/]BN1^K'Q]9HO[5OF#M]/
M9==LUFR08?7<@^;)G]MX49.N/RF.H:6WKQX],O3Q)YB"F0HX7:J%FZ4H'* <
M.!<CC=QB8)RLH7&N0;8&0]PQQ3RNEA_1XG,B'U=%[>SA,&ONMV<OA"W6+C*1
M@\MS_$'UCD07MD%3P E=<9R1+^8A?WW^[-%3FR3YM<TJ'Q_<M,0X+M(5&</@
M!-+-R2,&OZT/2I2OXCR*V'$N%3AS>D,)? IZ;K7)[(@N]OK!TB[+F4.0SD&E
M"WJI/I[;+L,XQ88O,YK016BA4"=MKT!DJO%EY-IEJ'X^+W? Z@E^E8U=37Q0
MR?-D;/5G KVS<UWKQY/#1_ ;D95=<S8U'@,\;":2]4^7>V##%!=*,;C5(:@6
M4<$,LT85O?O4\[('S?5ZBHUO_G2J=H-(+FXW93DD^S.D19F2#.)_5!FEXR@2
MG&-D#1'.*UL@,[)$G+HSUX[:4+BDA[P(NR>YP+O;4]$)1NAS(_KJ];_-B3()
M4\VZTJDZW&Z^.9>^\176LU[LZY9ALNQ&FEBC2Z.]5;A9/8A<S$+0>KZC=['7
MW9IQ$%@%XU9T)E5,FO_=](=_-,U2.OB9L^\9C0D)-ES+L1^S)Q#34<3I.%JN
MEAY8[E.L:LVDEVO ;U6@P'L$&P_<'K>LBLQ:TM.6?SZRKE!!.Y=^1D*0680;
M']>01)SV&(!EP:QS8!?#M':W(&4_JT[<N!A=*>VDSJHEE?.-,P4Z&UN+.6/D
MVFQXLBOLTUG7'NSXH3PGT"E7W!S?2JH@NFCQT+5. *M;D=!F:618M5JPL,3M
M #J%=5]!L@UN[#+,"J5LIU-A%AU(O#%EL36-=Q5EOHYW0V>;>)]-2S;P*IW?
M?V/1OTH.ZEI>@,.L&%F>IK<SVK[DQ*J\QH%@DGPX2?48P+RD5+P!;#U1C@Y0
M]9)V6&O1"2AR3JZ]+VBD"%-^]+2*EHN'@H'"=)/)F'D@_,!+XTA^#-FQ.CE!
M.25( C]QUV:78E;K/W"N.5!8%4XE-D.S(13%BZ0#^YSV2H<?OS-A^FP1"H9(
M>5&E,0>&T/J4V!<41VW@-C:&)(X)60>6HR<GP:80<3)[I@4.QAK!;-QMT6>2
M\UK]G:PLC4*<D>XRV0\ ZFX&;OM=N"!>)C*U(..P#(?7<S4PRFI4^]?)5=@Z
M^*@\<<PM*RHDJ#I=8V#V[\OW\].TB<[[6I4:/M0=>5>](5)29E&Y6?'UK+F\
M_"[5XPRS'[=X/H@P\->G=2C$[7XQJHYR/?RLACE-^5;9_4?:)G",S('@HNK"
MH3]>V(K0TVGDF2+C7^/'7E:\FU%G11[VGY[\$+.Y&&(_4IQ/>]/A411TQGHO
M^U]NB_\>=+YA\TS1?P#XR=X?]LN%;:7^I<Z.<^G>_F7(^-SZ 2"?>O;K=ICQ
M1?0C,9M,LW'R::-W;*PR3O8M'E^RW&/*--5$/H11VF;3'Y,:X5)I/*,0_-$8
MDK_L^2-:^?Q X %0Y3$2.7R%8VY;!:-%[YE_;:VA?]:W '6<I2?'[7]K;GL(
MM6@_5\NN?B14A9^[A)[:<;JP(YA8G[VV2"[G#_MPG?)G8_^RE3\E>2-3$2N\
M;;=P?4$.]4S6OKKEQWY3<<\"]Z7":&8&0K7ZWIRY88(KQU:+0RZC[A7[W+YD
M+(_;7,W'"%[SU6P#M>GV6#+(666!YS-Q&?"JJ?0M1#W3WA3S]%I(N(P6/B;Q
M.1^+PU:0_0.@WME'JK%+]RPZZJN8$%Y,FSIJ8/,/VRM2P0H(AHK<JHH(45F$
MO<.KH!3C-)V*UZ=(;=0-&G1MDLB_L5,\*F:__0><_GRBO1,KO/X$,959!5-*
M[Q?"G@P4%%2&E5[]S.:/>]OG1_TZV\?PZ%6__EI>ME2;UW8,,?"K1H%6T...
MEON$Q'M%H@J'??8K&D2<2L7<8#L*T^Y[?ZVS.D"+SV!EOI<ZFD>ATYF7:1,]
MR[0KMT]4J\:'(FII,*&*='UF<2]HVU?!4EEY%:K!EZWNEU2'W^NVV3 ]F7[:
M5F"TOC2UHZ:\1I)KD+/Z_HM$C[@><K7U1*%@5E,LZ'!%^6(=&%OF(;"'^4>V
MYW=T_7_!$FO-+LGVIV074J/GCQ4<OWY!BEB20+/U_[7"ZL&Q;ATJR=IN6&HQ
MR$4GESW'NI-,RUOWO&%= ;B+_0G1QR'5WSV)^,F='D>7MS8ZT$PV!,3F36FX
MO9P7BB1K4E=6F8FJ^&;,8T^E*EZ7P935]E-R$'2QK0YTTR]@\@ XCF6Y6*&^
MW<P/2LT+(](UY3"9 #(\ +)$XN,+U^E7ZV)BI\ 6; ;E[Z1SC2B?IB/V1V0C
ME?AL@ MF#2K\)?M G$B3V/%I3=DYE\5LXIZ9=.LMNN?(^I_.*QJT<QF&L-7J
M3U./AE?JI%/$:?3>.V!%Q7C[3F6CAY.?>7CL"Y(8WEF1[7S:+@5)>/UV:?]Q
ML9\1; "BOIPE>;)EK\NCEG'[[?*1*]V6>C'ZI,;H=7\NI:7R=1BL+BTWJG:A
M#%%[WW(V&+R"*8[]FB6,_" (\=N&!$:_5HV5+ICTS@*":G(:$=<U_KP"+D43
MN>#5O9X"L5SYLAXK_@9.;)TQ6K:=5V(4C]\"Q2(]E-E!]T&JQ+ZO82USI@4(
MV6,2YQH@-O@!,'$+_805K1Z/IWVL!.^V,"[.JBUQAPWXG',")/PYVB$:3Y;R
M&]>7ES,NZ^7VVM\91"%V="2SJ@3C=CYI#-"JB5JLC-&04@AO*S^I$OXU*$-]
M.N%\6<)X*)WEI#:O )OAA\6;&-V[30XN-[/)_<@["L_516H_UA(#0</R5+HA
M"9#DAMR_5V[D)P*.$0N<6DQ=AL>M[[N4Z') L]K?'I'5:K+C>6'E#1@M,=LD
MC*C#QBQGCFL20D("]-PJ>7=MPJ:&%.]Z'>_%"N0\\M>%QLY64,R,@B:ITXBL
M;[RT 7*3LWQO9R7V94^4V]>R7(A4V&=:ZS*T_LEWJ['04)N>.Y:U%>(=[>$K
MDN*1XA@,<*ZS,<F.0&14RUBG$"]ZI\CGL+06 G,QTK&<=?LVTQ/$:K#J;O/I
M!VSHBZL8T1/G9LG4(K,3=!H%UA-44X!GH,<9P(_KS%P7;74L!5C_SU+G#]O;
M$]);3ID+/U-MSR_W3G<LK>.**I]IQ+C\K\T? (4RZQ%B0FE8C['=]GFJYX=[
M-RBJ%J60XW^JHM<3>5+H\ BZB&>848[%'=C3)F^M/M,(<%<96LR%$6/^Z)JO
M1A?&&K4OP+-[CE@*W["D)3-]:(V1FX^O\CA!GM$NA?4TFWVK'L-WRE^Q3N,2
M CP 3@9V'P O.^^AV^,'FT4/ #5/^8J$\2MA.FHQV]?TB/W?7M&Q7%QT'R>'
M6:8T)+PH=B.?6<^C8/5OA3U4!#[*#,O'PF.)VP\^7>N\^O(IPFNGPQ97#/]"
M34!$C1]3ZD&?MY\;4)WMLRT@\Q7-J[=N: !\ ! EN(6&.(;O+#/4E;805ZJR
M@L$?@9*1D6*CR>SI#+T\/,J0'JNM$N'D$(LF5F#LGF=P9FM:YP/ "=TAJLQ3
M61T)W7E.N&7-F*U-%9XF&F1F2WEF5,\ UD7]N[JU#P '&3.ULNE@T3.YVFL!
MKJT(?-2PN%P>Y,_S15_L0VY<MK(U*?,5/WEJQGUSET-*P]FU,L,/6H2[@W(.
MIC CT^$H"W5XRRO**N;;4(URC%GO5"?I38 C*G7EU-+A;ML!G#@ACRS[?II)
M'ASKM:JIC AAJNB6+[+DJ;Q5U:K_+J<<.:$V(13_Q%4"M5J;>9JY>C<7.F#A
MD2G]VRAI?/YM#0E%B(#0IJ\"7VL04RG46W?(H]=DMR3]0,OA9";_;-/EM "Q
M6ZE^8+Q)LU^_/Z!// ;;I-RAZ2/Q-+(7?AIGV6F&GR+CRS"WSJ#%3D7#-+@=
M6N*=YRCT .#2U[0OEJ/P,"ZYY_XT #_>[[8&%X_$3ZXR7^1UB*0UTC['R#-'
M8OOP4XJ1(\GX;KF#"\QH'3?"D(4;VL"M!P#3/#J;S?J"Y;TS%GWK1E81UIC'
M8N")_?V2^JRGBMPSU6@+,T?2X1Y215OVU;H*0;;S3%*^UMQW&P0J<;LLU6$L
M;QY;OL6\.N!=46;M;^B)[22IQV89JWJ=X#WQ2JK)[F95>!(Z@5<XD_&.MKNK
M=N>WQHU%(9#6'Q>LO*+#.I>CK[R4"[W+Q:Y.[!8_Y+G6W>41J&"2\.IQ'!YT
M&:I($%!UVB\"JX8!+^4;W<+<U;\-.UI,^#3,#9NQND8-\V[2^?QQ=;8@QE__
M>@(EZ;'7O6[XZ;#[$JMTT"G%L42GB9E/L_% 2WDC$!'U5TJ9NT-30)<5BJJC
M9&14G*G0DN6E_9V6^%-O8&SMN$#^[[:C)&;>!&C$?HTR#QJ3 _6)%CC55%PU
M_JYFM:@/-!JN0G0[X]YT S8_;.O)^!4[Y">-U=CLIZIQ[ B+;#>N3@<] ,HW
MU$CJP2E^@NQ\';:."H;<7+3<2 DW$9*EJ;3GX7S6KS#+%K;SY@8Q?X "$P2*
M45*"@4EWI\-5Q%]P)K*;6F0*IQQ%VORK/_"N&_)^\FDSUP;$1E:BQQC?6.*T
MX*VH4^RBL5C-9^SA"NO_!-QIBKTZ&4<R16*H7V(.^<<I0P;?6\SK'T?390F!
M(7ZUM)_?85]6(&OOMH-5F]0),TO+\8=*@$P^!NF\UF&IO&9*F%6?K)+4-X+,
M(0UC+$RN\ !>SK<GM3PN?R.VV 2Q+7!JJC@N(PDH]>J;H)#BY8%LIS!"L^DS
M9F:SIP0N/;?[9G_K-LHBA#D@DHWC,CW]?<KW,?:MC&B;@_Y9N7G1GO):FGE$
MOC.4Z)$8;^(I^'J\62#AT>\T?M=-U&7N@=)+ U&U]NO8!P"=$NY_\BBPZ&4<
M#9;LX514GZUX*GXYCWU1@A@ 0<Z@(S[5UDW9M6G![?%YJ"*0.:!D70IFF6,Z
M'^E ==#Q)17WDP2:I=^"C9N[Z%E0$1LK3E0!(AOHF_JM99R')_\ !':JY-)W
M4O_T_Q>>&L]5QQAP5^?KM?1D1&SI)6P%?;."?%I^I<'E4&1V=1>XCK74.!T'
M83&FCO-^L6]O_\I %'(B1]+&" #Y/XWRSOTDO/H.J1\ 3;RZE]*"QRBU&D\I
MJ^L:D<3O[";'1'=HP%=''Z%=GL<?#"L(%PUG7]R=Y&.90$ B,9YTZG&8!(S#
M<M*<M5SOU/8UV@&9@NKUCQ+D0+19>F+H9C:+0R0? %K0!EP#8ZNN'IA9VZHR
M-EU6HJ]X@ET=42+5P:OFQZYF$Y;?BCOV_/^5T+3).%=AI&\6'N^X3:3'H+<!
MA8A_8=!Y)K%($JG]8I%I"6%YW?[*AO 8ECTI\LEM;1R?BP,UN==9;M3K&_S9
M)5I-J 7#]#11^XB8R^8RW?6?3OJ[&6'E7&#CALTQ%I@[3/Z$YMROK[4;FYDY
M<%@E0UP@/-P7,5=#_()QQQ*HYO+6"HP<;1?H#C/XQR*Y7G;%:I.2I=F/Q;3?
MI:]=5WULB=CY4,CE&5!O*6/.0-IW1%N\4[NW_OY<3D9]CX<*)0,3Q'OCG58D
M7^1( 3BAA.\=FE:I65Y"VYQQ+MH*$E.)T(-Y;A<WPTQQR0IMAG05!_AD/CU4
M!LKB2KAU:8_]0>>>*U;](3>X&@9\G9>!-Q&M;V<1)_NG"?>#G6(+R6^MB/G\
M9U#$R)_YZG%*RSA3CH-*=FC:"E_GD#F7=;AI5?!>+[9V MD^\$ R>0*X=]ET
M)+YU?A:%VF;KD :/S_0;'$VQB.C$D+.R?RR-U@'Q8EG34%4@$24N&FKE%TG"
MX!Z"H*7BJA$5-<V@J-RZ@/O"C1R9A6-KC?/H=3EAKQ LSF&+KZ<7T,6UW]&(
MCI40I]UU79Q485%"#VUU]L"&41W@_)ZIV5.4'_6OJP;AU=U=OIF9F=RCE>*A
M^!!V*G&,0@G3"[4,L=%R>5_IY*I76CF="G$5/ =7U0?JTQK-+L#/5OU)G3":
M?28R:(<,5U1;?=K6<F_ZZT/E-:.\1 \L_X"K2U2SPO>WL1I(([>J!P""+4 ^
M55QW1#WXN!,(2?_Y?!M73'3\+4%L[)P!P2UCL<!"M<_/ R VIFHTE]U*%?H]
MT3%C/*^VYJ+90%AZQ_NV<&2"6S2;A(6S@^LB9/9-CS=ARI_V5+,PP@AM_-\K
M'=?03+VICL:BB3#'/_](V2;LKOL!<"24<1;$()>DMZNF.4XA5\3.%:ZED.8+
M!,/:P5#9VO<_?T\D]@BLN'&YMQ>?^ +QMEI+,3&,6F%_H(:;^>HJG?I&,-)<
MP0U'")491JJ78Z^M"$LQAC@]&[1GS>#;?GFXHG2,KVX$NH1%C73I;(RF,ZLM
M5W9PV*VX:!INNAXE;35QS0UE2J3@S@:AV^MRB3(M[]RKFJ"6UJKV)E6# ^3[
M?+:<&>.9I^G%^$-U+NCHKEKO0H=Q8_%.ME6Z;H=[5^_9O67Q,[KQ@(*:@B(I
M^X#VJ5Y@OCI0_3@[,[MF4.[,+IM2N(?Q&+*<\@"X9\VWPEM5#-^H\X3APIBW
MI!][Z-IP!'=74K;OO4B%2_C^"*_2++<86*HL1/)4A4CT3%O:>10:7RL[-U2
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MH<Y1CL6>F@-E0;-4R2$>.Z,)5?HNMSSS->JXM1O,1!DKE#]PG#76N=TA;*0
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MU;WBZ!I4X"S$*D)64B.^Y?BDD$'7".U0?!1J"3"S9G9H'T^RG.A:*=MZ[QS
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M6O9P-GY^NPBO.*5R,@\T'+6+[**<^(?C&TMVMP=\VAUL-W,5*AWN9Z7@MRY
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ML>7&LE)]&]QD14M90X9,!Q8%"\QWGCXC-1^*42W-*<#(2,=Q=U*9YOC5C>E
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MD5 (/#:P39C@%5>I+S_",_&YM=@]83XW%E8QH$9KX&*IHBW'0@-SD,!_';N
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MM1B18O+>A9@0+Z*$?U9OT\P'S%B7DSFQ/)2$+_:]9#@JV:5,#EZI>D9LP,I
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M(>'Q=6-CCD4OG#0KF"OB# VM<H&'?2^VPQBY.TNQ5-?NU?^[:_[7]M_? T3
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MIQR+F7N7MG_M&CI(7SKQ%U!+ P04    "  )D319Z\-9<C87  #2&   $P
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MT<=@0YM]2+I?-9DM6\DFA#!K;D:/$>U@=2$,S\8.) I6<4Y^W^'BT,YSNV
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M%**4\3?N67_[UYJ-_U_QW?_FF26T<4.ULD9/'C\JK]$5((T_E)^QHLTM IA
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M#W K:&88G>Z*!IMPYL;<B#6C>Y&16<M@HMY9@@=YJN%@5RD:=>M3ZC3^?[A
M8)>L]I>XJLSL$K'N*HPGD?E)][7PM/=Y@J"F?[L>#7FYR)!0UMD73[*D,JK=
M3N#341S$9;4^UIE:,@&9N='M9-CT ^=%\7/",\VA7Z_G^5PFATX/DL1(WZ)7
MD0)-&I4$_F1TF F]>-#Y'IS9N:"4(   <V-0MGI(<:<=?>99N_B])L_P#;@W
M-BX.LJ"GU-]I\<!."5%,N0@ULY&266 4T:.56\48+,DOH9^\)M1 HY4(+^[
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M@F"\DH.::)>*E_>I>AVU1X_5<ONAWEESQDYEJ!(7((,,A%9=!SV4!S[!^;#
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MYJG^XC^00 EM\3B/CPD^U$\1G 6-V>)VA*O9RP.9Z'B3LJS4QI\/&C\3:"4
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M27XC-G81.A8%YS,>T'RU:T3CHK3Y\*[M:PR4-H66TU%N_:C:7D3MPO5!:OT
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M^*)?]B_PU_#]G[!9U?;_>R#^'Q^:3D^/PW0A._N9)=NW%^;$UME-NM;6/FS
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M=7[^RQ)717>Y/JOV+'>Q<Y#DT/R7Y1"+&[[Z,2+QO[+=TK ]*$3V#G6O<Z'
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M%$YI%BK:R/DDF_D8@^BM#*%SJVJ7^CJU!8_"HJ*M*G?&O(;5QQ: BG=YEC7
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MD>-_HN@FQY8EB50)ROWWF/4V.YD3GT4ICIQ=K9+RZ-7-O%?J$UF\-G2]AC@
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M8#N\!ETD\:4.^EBCY-611_YT>N/)=V^375?AGN'2,@+ORNYX$_,??6@=]D2
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MU:J>%;\)B@-RU!M+EZ]E5=]G]8HUM*Q)6D: 8M>R:]VA@:^! M49<&=\_=-
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MQ5UL7N4OK@, X['A3*'XY#+,QY3A0(XYK&8NB[\*%/U;U"([:?S?@)4PL]^
MA \G_:66#>99;?'_&TX!*[$/_K.?I,]_OK(+>\"O_6$I\1L@]?[\1<S(Z]^
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M]A?N.HE2LQ:A)7?N3K1!0XYZU5X5OX@N: E%C]R__.S>$:M0]8V"@< +A*]
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M6$ G8%1Y.$I[W"TSX1[ 1G\/,-G1/T!H-&$_U@F8?WKB&GR$.;CSM/W<^Q[
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MLY/VOWSSW\.8!HBXQO6/''YGY2#1*^)C(EI;@S_ O#6SHEL@/VC/B5Y!.9.
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M\GGLA:444=5$C@:N)FX/-@JW1G<M)S&(23QE,][/7C539W:JO#IJJ1!\9 S
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M9!X),Y#">Z&Q!VG).U%I9H 3%*_GO'[5M),21,=H49!;9R$ >E9]=86FIZZ
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M1!AVN)R("%\M;)$ #T:4,FEX3MXL?CA$"5XYO&>BF?H&;D7()@#&1X1(!&$
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MJAG8R;(ME*X#BNL? *6=X^+;%3^WIFL;B$U,9F6E84ES/')P*ZT-SN:B^'Y
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MPJLK&])@K QL:=>]%N39TO^$4Y!6B1XE6? 08QDP^B^>VN@,I#,B$WDYUNH
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MVSN21H6L[WI'CM<V\SH)=@+XV?N<3KFLG]A(J[$.N Y/3@M"0ER]5NLS%X,
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MBTQ,6K)E/L]2%E7E&HK_D"'L<+Q0\9YZ$$%R>3QEBH# IU^<7)2&@JTJH4L
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M[>P.S8U>;YTDU_6@D\#]-V01Y[N%*\UK%^"K=-?%I8>D-4162(HJWB?\5(\
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M#!6P<'7387J)$!:[ G,J5$,\;Z#=2TT;LWHZ)$@4BF94+*S:"C6E-#F\0S*
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MYR+6RE+#VFP=&2&]*J0!<<[QRCOXQ<G2F% ":::)+9#%.L_8J59.,#$&FKO
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MH\<"OUT8_6 YYI"1:UO CXN72Y='8C)K:-I3<),?=&W<<#Z#<LNLNL8XR..
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M/)!PO__NB:7Z$'H2G(0008+]9U]X7EX.3O]EF743B4A<@'$L*.5]NJGZH%^
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MIO8# K)[90Z%#=MM+"'7]BN-:WZ9@:?K_+'08H?GG/X.#>D,*^>]@J]: :=
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MEM?$? DIV3<, + *([3J!NO,KO;@&/ACR^2'MZ8!K=&PN(]+]\9-Q 9T0U!
MTKEYU<@S0!W.LA-SNHQ5UC34< P_SOQT<P=M4%,Z5-0\^>$YQ<11D6V@2EW!
M_5TQ1,;;LH)<"/-+R38-D-O]!-U[&VA@ZG1RF:\]GXLQ%3Z,?<?7/OT7+EB%
M;KY-MK=$P'UZU$W!B7%;6B.TJX*X#^+VA8$DN93/X[9E:CJM53+U^#:,Y@5W
M&)*8"%F,[)ELN)*5G@VHL?!@2(GZVE4^['5OX$^F._JL]!YZP+SK 9?)_8!
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MGEL/A2YQWCBMP]HW^K^SA2U"&&GL^22)#@D2YSP@L.Q'@*4H F^-E;=IWV1
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MJLBE1S"YLRF$BZ@E=JC0O5>19''3;;P$+QL)"(2RCS 48Y,A@9JR,UZT\+5
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M< # V8>B0,+RW-_C.Y9. =6*7/U_-G6T]A9^0GYDC/9G2WL0%"^2'7_DSPX
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ML9B@(6G9 ^J$&*.8=Z4'-V1-'/A8MC77]O^2@?_\>>AT\F]02P,$%     @
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M;\P^/I^\\2!V]F*$$YV%AODE=IP'AB*/@S>(VI>A 5*J*N0*R*>*A6)XK0\
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MO:0=IPE+:+GCYMSWY[WOI.U?6'90^[YMV[UI>J\-+:;CQP>V[^_/^T#H/07
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M9"<1OBC9A4^[K=*M+G2B/K?5OJE3.Z6TK:"TR2TY"#+;$:TJ)9B48+:18'9
MGTI))R6=[2"= ]&D4H)+"6X+"6Y;=2CH(+]W!+*MB)B07I+.GB_$E%M*=WD'
MZ'ZCQ8521.R1FC\>#%TW!P/3J.O$MB]V?X?] J-\0G?=MF.JSU'99W+">Q?1
M]JZ"FFYZJEK-5WPQY?V'BXT5/"G>LY.*W]T0?\5GL4!.ZLS< BU\^O?3-NL@
M]/-M2E%+:2REL3VGL4T4EREE"R<IC:4T=L T5@K=C+QM/M&4VE)JVW5JVV)]
M;FH]QI1&4QH]6!K=K@J8<6F7J=2:TNAAT^B2V;MA63>1*K68>[UWI+.MB/C0
MM/=TEW>([C=:G3I%Q#[8" .Z/X4.Q$]GV7P08@K'\ O@Z%XG:N@ZJ">\Z0&O
MA7BJURYW>?/;;L=F&B/6J$UT&NM#CU^!M0@C>'US7:ZDZ-1;UZ^PKA_)?DY#
M<)N7_2!N$F4_*3 /#YA1+AB&6")<\,RW$)WM=-&?LR54^[.D5?OHXJ;7?'^T
MC+E+(!&1;)P+'@Q0)N:<@F4^IULJ&QR$;+#%/B=?:"T4LZ5""LS# F9$:.4(
M^(C0@SG YC_;-%ZH[9C6'IRMNXS!12;:HCI,0KL'/C=Z ('2)BKZ3>R+4?B;
MZ,RCVYSRZA5Y=4H^*?FD)TJ4)& +GRZ91=64'':!'+"+!^;@W)J&QEZ8YA)=
M](5?17<R/3!6/3!2ZDBI8]_/@Q31A\L:WX5,:NQ/01*48JEFBR7_I_)T8_\^
M<YRD? '[S?8D>!9'=+&<,*)3MK<U;$_NQQ:RO1GE25(?9PJ6L"!5SA9/_)].
MO?#+WYC1TTRC3H;,(?H-,4B/K_;U=7WWL;.(;4Y$:;Z['!\I>N$.+NHZQ[U.
M%%: ]5/_IS,/5C]-Z_F%Z3H55'M%5'XGGHR1-7JUGD7W1/"Z<&UF4-NNJ3!5
MFR' PHA:<"4^$E^XE8OB"S=]D_J?Q->//YO->[<#*R0E!'OW@13B4./72DZ;
M;JH(SH\6H7<<#ESBYIOB95:=SG &XUGN)+_[&&GWB44OB$TUE)OA6YXAR3^U
M:Z[3-RWV#]4>#8U:7'26*9,Z01DILAXM8O0B&)NR6A]DO-[$]1X2*R$OS/X!
M9X..\Q2;F^!CI[FS\N["<=-8"5;K$+%2SE5WF'5M&BO!:ATB5DJY2LI7YL9*
ML%J'B)5BKICRE;FQ$JS6(6*EE"M64JS,SU>\U3I$K!0*N4K*6.8&2VBY]ATM
MGB?TBC +"T-17J+*OJ8O5"_N/F+\:5V,_!]_A5Z(I?9'?))1Y^B,9=A7)(S7
M9DR1L*5(V'C=ZA0)VXN$CZJNG&)BFS"QQ9ZC=VL ITC:6B3M6*7:%$E;BZ2M
MKJ?JX>?6]+W_NX^:.0++)^;[H6+,1HNKIEN^!=%SVUMI-87'AW.$C[JI--WR
M5&^981]-X;%OYL]W0V&I ;*VWJ:J:\'(QZ+/>5V!>I_1;N,-GG#8"ZQCEZET
M#XH,8)#L7;>&FR]R.B(1LS.7Y5V4+#*.19)2>#C>].U(F=N$ E0L>DB_-8T6
M?3'U%V;TZA;5F./E7J2@%Z"?>X52_$]J>,4D"D@'2*Y@11B)Y!MB/;<'S.GO
M/AX7S\@;F_S';7EEP\51TLW_T,W?XO/N/<A<46*S#F?D;<?51C5#:Q@]9E#H
MR^CM+HX$)NJF[=3A72L2Z3+/G%/XS/9AI?#93OALJ^-J"O=A5->"S'E8R3NG
MO\NR]$S<S)ILRF_FXS<I8#X:,+O%86ZH0W3=M7I,)?I^PB1FBBDWF8N;I.!(
M.<<,Z[>IFSUF.S8P7LZ*VP[I=O<3)C,GFW*3N;A)"I@/!\QN<9BZ:0U-"SH3
MANK=!4I0K].$=7)&F&^$XBJ6L1IB<Q>C\;(SL7-/&<V<(>BF15G/J)LND.5H
M]W'3-%1S0!_(FTQA&[\#(VZ^*5;F##)/L9*>1W/R%5X_%?CVM0G*PK]=B]D:
MXVZ7_8?-.U-/N<U\W"9%T-8A:,=XT"4LLNTP]6 .K-@)I_QF/GZ3HB7E+6,1
M486S%",?C)$@&,K;#'])-E)L<Q<W=RMO$MYX$9:45O<RTV!:R9W4-K&W>YW:
MH;9FKQ,OFY/:D;;1"O"1U)XB8,L0L(G26:DDMRV2W,8Y?ESEE<+N[_DZ"M 4
M]IOSSX.$4HJ$T#+L*Q+F*6^6\H0MX D;EP52GK"E/"'Q:C/ =,ZR^:+_4U!R
M#"MPT+]=&'CCA>Y+29'0A(* MRD/?+#K1N[,HHX^W,/D''W0P2G@T>^JD,)E
M>^!R&N(4"\"ED"1<"H5L\4S\5$SALDUPX3NS(%SX'B;F&!9X+$PKE;&_V$F^
MEL)^(3FJ-"%DDA:0SE)TINA<7HI;E,]&,)V(% <=5/V?3F:#UT/\-3.T.FP\
M?"'K[C5MVR7&/F3&) 2K188PXP[H]U;^8^%=J"X![P2+9Z>@3D&]JD2QKIM+
M7(,);#ZV)Z+>!I38KD7/F6V6BX63K_"(UY3W5:1];"N^<7&_V+3VY2KQ9Y;L
M (9V']^)QEX OA,+BF_>N@-J$<><A,[\<Q\?7DR;H1XOJ6$.F/%.G^^NQWBG
M,<UZ7X>G__XRWD,7LW=I"#\NN4>WCS<7C=:TYF65R"7;KM<2WG\_A'*/]O\[
M>_MJH8B,TG*?#94NB%\MVK5!$ .6".= Y:1PK#BF_,PT'<-T*'Y^FC_^,F\3
MI56;J)X68YNHGITHD5]/YV^QO/86JVMO\73=+9[EU][BVG?F;.T[<[;NG3DY
MJ<2V>'):F;^)D]6;B,?'"2!QWB9.XP&Q0!-GQ?A1G)4*<S=1B=WR0KE8FK^)
MV#U>K(G8B2S41#5V.1=K(I:@%FMB]>6LKKZ<U=67\V3UY3Q9?3E/5E_.D_>6
M\PMOPS9=2Z4V?,(_Z%.BH3KQ_0L<XN='1T??AXKMC'10W;H@R7]5"OFAHSR
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MY5#*?)M8'0+-9N_>=#I"7"N?"A7E,=?.U7/*2;&*^?6?D7J#66+@XM'0[>C
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MY_SZ8M[PSA782AU^\,A!'#BFD%54W;2YY@@M8FE0E2H\: OEV>"IF/2KG/(
M_(DJK_C7[+!LF22&+XM,L3O7X9HJ=(Q+/63:DRN^X6M>SI\5,5OB>7!S]<_9
MKW^4V?MK/JN/V$T _G.6+8Z'457GW(3F[55H\46/Q^>ETTRUFL\4R^6)3? B
MK"1^;?Z&8@:#Q*5NTZ$C:*<HKS7>AYB!;2\B^KUS?GE7?[QIW#ZTCYJW];O6
M_5VK]M"X5"Y^*JW&5:/5N*TWE,D+O[9]8AL[0<;N] 38KEFMN#6=(S(< E=%
M,^<FB"+Q*<5=[S<KPK"8!A/&!!/*/]M%BAME@QMH/+T6>2,7&Z[S0'NH75PW
MCNZNE/K=[0,>;'MY>G5,$/^W;N //$82=) Z2IV&8^_@'.(OGTWH)NP(+2_G
MXY]D/_&7Y:TA[O-L_!9LT5]$7,A6BKEBN$B)"!EA1O!)*$1D/$*N*E@C4?H6
M:A?_1?+Y\:L6%V%RLV/;V]Q!J=PP Y60RR#<>MS93-84^5@87S\>/3/W4DW;
MU_5AGZTIBG(3F-PT#HN)X?"&.F@U;/SMLA>B1]CFN@"XS:![24$W%72EY$#'
M#&H176E1FUHOZ$DT-/S%="V5I@!, 2@ 6$X,@"(I4QUQX/F.FA9:L0\+?>FA
M.QU^E<3@UV+VLX+&;].RE;8[ !UCE.)N=W"W%,+R//TF#+!J8@"[K[4>E.9!
M0:JPTXA*EI.=) :TYD/C1A@M"KG)N%+EXK'=O&VTVRD2=Q2)Y6C1U\6 >"*=
M-V$HGB8'10Q=U5SN]TWQEN)-X.TL,;S]RFR0WW!YE$OZ0G5S&(ZS]A*N4B2F
M2.1(+.030Z*'->5NB&G$B5B1MQEVE11VTV&7G L#0T"IPW@8M _!NFEH"3DR
MMAF"U12"TR&8G/>B/E+U S/9I4B;@;3D7!8-U33, 5-!UAMB!JFATH."W4D*
MN^FP2\Y1\0/SAPRN6 0U15/@I< 3P$O.1?&K"Z\H=3)D#M$/"G!G*>"F RXY
ME\65:;T22\M>F^8SAD3Y-S4=EGB7HF\&^I+S8]1>"--YF&73$)E(AW;.%O;)
M>+=F!UHA0:]%X$"KQ7G06LWV;\I5K?YPUSHP+]H^X7'MG# YMP;&IMB@;.B\
MYJUC*G>N=:#>C&**P*D(+";GSIA H R2QUB]D*?ML+"8JL$SL)B<CV,"BZE!
MII@>S#.@F)RO(_9@OJ2=PV*$Q5**ONGH2\[_,8$^#'(1U3\448?CL&!8WB,8
MKEE;+B;G#D%M62E<2$7Y\;;5:-]=_]ZX5-H/M2O,NKZY$5G7AP3%?1(-UPW%
MY!PD HIU"<7ZSXM&J]VH/[::#S]3^*7P$_!+SET2V V+$;.A<M^ZNV^T'IJ-
M ^."IRD,I\)P$_D?I2@,KQL_:M<(QGJC<=F\_7%8:"SO4Y36NM&X"6=*.8K&
MF^9M0VG7KAH//Y7+9KM^?==^;!T8A]QQ3*XGY[*8G.-$Y%P>5M+ECF,J43Y7
M2LY#$O"YRAB?J[5^:SPH5W<MI=7XT6P_M&JW#[*T;YNKQW>W2N,_CZ"D9.")
M:UYNL_UP5__MU[OKRT8+&GAX $4FH]1N+Y5FN_T(G]T_MNJ_UMJ-MG)W)5]6
MI*IS:%+F7N%]W=;'4G)N&%'[^&!C<U+8S8)=<BZ77TU=H]9A6;93K,W"6G(.
MEDN&%X<96HJV%&T>VI)SI+2#6YQJKM,W+?B.7X&G-&V\HD:ERB._ZJLA;GRH
MA^[)4>YU<F#IG2E,9\$T.2?+O6NI?6)3?G>3A&((NO(J.7D738K(%)$2D<GY
M75H4JSXK;:(+4#X:H1OP F@>%A;WR06X=BPFYWSQ"U=BQ7/+U%/4I:CS4)><
MDZ4.BT,8YH8:1&/PX!75>#7?IJ&: ZH\D#<$I,TTKQ@-EROQ&EBL\8M*SH'E
M].T54M=M)4_.(1-8R:LQF57?V7FKT6ZT?F]<?O_"S@\+D&FPQ%1 EC?AMCF)
M >1-[;;VHX'QB[[#!EW5C^UV\^Z6^V/@@>N?[2;WPUPU;VNW]6;M&J^:N6P^
M>,\ IA^O'_@C& =4PR\.S$>3IE!/EPO*"=YH(NI8RQMX^/U1/%;\RK]7&Q.X
M9(DZHZ?<4XM[<PZMDDZ*SUGX3#!_AMJN+BZ2/] ZB2GR9B$O.=?.-?O;91K:
M+I$#RIHZ!WK?227-'IR!P01O/"%V7[G2S=<QW?RPP)<:S6> +SDW3L-X89;)
MLZ8/K)A8BKA9B$NKB:7P^T#X)5A.3%5-U^!J;JABR8%A;Y^LWFO'7H+^&?1
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MM!_O[Z_Y[[763^6R]E#;(E[E@^A?&^%;^Q1:L&[=-MDB= *D9UXANE]KMS]
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M >.K!(A_4R0]JZ:NDZ$-P_%^6C9V?)SW GVL<B3*P1;+_PIX/3\,OBJ57#D
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M$>48%,]%$"_XCV?A(5>9-<J0<R+.CB9[E[)V, 6/\4V7$6P9\8="N8R\BA7
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MG5@>XP^#%]SS^5U,I2I\@(^@9^K:V @RPF,1V5\Q :P1+$H" J^R*9\^WBB
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M7A2)8?>B1@(0F_0Y>%J$8GM&)LQ^3T6#*'D]L+LP(]K'0NT/80ZBL7FN>?)
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MX/QGY#-C?22?QJ=<'!NO@X1^,17D'OC4H_4C44W"MPQ-+K>L$&_:--2U9-W
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M+E8J5316')#6[L=_Z-4;"5VM>7UH4);565R=41VUDW3XS<CUI1Q3!I;LGW1
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M_[QX\?+EJU=70 7P\.'?KQU/^JLY2:<<"E38&8D6SKLT5W,E-?Y[:VNS[LP
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M.MIO7_+>3.<EC/L$PP*_8D-ID]V%8_&O,M?&6_^ MV35XJ[>RRM6ROC37=C
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M^[A2TX(XMCLJXGV7YL6I6>$(+;:&5[:_"OX>,=,=M:J0<3I4ES]DQ505B+6
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MU *N+^.8B\$&&Z>F]C&?S+@J30,&G8EPN]J_31!>8)G/L?_B*L[ 8\RV*6#
M#&]W%$[(<5R$HZB(247]%F>CN)J)X@"2->FP4J\@%@ V?-6102TT$,0F[MD+
MBY=,OYF3Y/2"/TE'],)SVFEI3,LA8KD19>C&ENIK22=)O@95> :72)Y5Y_1
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MJ=)IR1>Z$-JWM\1S$R#X(*4[<E2QV>':S:;CGR0F/9?C&L_F%8ZN]"2NA.0
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M._;":0'KX&A6W)D%!9J()F XN,KUZ0N/-SRK4O&HBU7:EEL"7"- X%7_M&Y
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M^N$Y1! BW(;F$]D\17S!)167J3A(\SR^8-!TLFL$ND_C@3E[H&D6GID)!Q*
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M"^-@WYNKY5 !5Z$XLD^>P<F@7>=/S3$5!JL^8]9"DPN32; &0)N<%%:'&B,
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MJE=!!;>RJL^ZKN74/;/ZOFST:<Z+I+$ZLYP431-N4<F@EIRDQUIGHZD+8E"
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M83K>T2ZGX[V>HMB$VGOM/7T#PJD-$LR[R[*3\>H#*0JT!6B[5#5AL&0$CL-
MI^G-W/_4#YM--H3O\!5XJT-98633I^\&B:CK;]+T'A2ZH #EPO2\G))$X1<&
ML)#X,1&.5I3F>KE5;RY<'(0WEKK<P)LGL "\(MT!;4XY%Y,D<D9< B(B(4WE
M$SEN1H=1F5,\5=V0\0OU,?AG&.,!AV-#>=+;1.JOV-B9J#P-ZM'U$/P7B<H5
MRO5+PVS75Y_KJO@GH M%\/7 $54DL4='KP+5\.4X]&1,\;J9X+ B\5R^%1M0
M/&%8RUDN'A@50.9D,J16C(Y(8WF5M@-A=>^6BLO(C7#U55W1C-.&GU"U?V3!
MP-]5"AJ8FV"<A(-84,=88AH#FE#%!I0R@D\Z/.H#DZ(U0S8*I8$9IS6M#?."
M,!KBC:LR4[P8/7P3IM9K%^$S ?^:JD/#JTRRFE6L>2^7*$CE=(#4(,O&A1,A
M$(Q-I4L=R*P"GSN860L-X^SAPD5$[?);WA$?)!'=,*86G]I"_J59_+=PH0'O
MH73;0C6;/M?"+S-0(Z&N7,, S0&*/*2GEQF'Z@#S1*GW@0;Q5C=:?\G]O'9<
MX"H$A4.*\3MZ=YM)DGDM=&Q7,%B[L'1,Q@C8^S;F(\Z^DU^KC_ 3J(+(<XP
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M3.[G10ZKYHTNJ=1^HEU]"CKH^&LN!T8U(%$%A9$'/Z4:.2!EB8<X"?VIB$=
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MXR4)'P+ZQE3;1]XY_OA4V<%D_F+TDN9]6MXHU4ZTBU(3P1#O"-BWX#<\-R/
MV9<OIZEK =^EKD6A0%-+3XZ5]%)GM[$3H#0?F>904:<D;A(_^)A"5TX2190J
MX8 ^ $JJY0JB8O@&H_O%:\)V4Z$]!LK\@$DV[Y4_(GZ S9NF48Y%1-F+&KH(
MP^FJ7@L4"+*BSGN93%1:(?#_D4H -]]3NF,D;CUQISG?P%I8 (#S,>61&(7>
MJ7=2S^7V#1)@=,J !+4FHA#;W@K\@9N@G:XO-:F%!IK9\*M%T*H 6@;MKT9
MQ*1PO0!+[>MT=EISN20'=):/<+C4U55#/^Q3:T1ZX6WH8S491LL0GS6]@!9
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MH^57UW?[>-7NH/2CBVRPIIP;3X[8GO3QG'Q5&SW5E=998;=.-)F=N"+KRP-
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M8;%3PY(=,DE*WM>BZ@7:BNO"IG?/Z;FSL'W19N82AT' AV*Q-$L=L@IL1$V
M*0JI\I/)847(9"T)^[^1>S*G22I%9>\J2&2M9D6H[!0^XWAOMSQE+21,36_5
MIK0JBK.J:+WO?(J&WBID5G&Y9:EI@S94,4^@TH1".KK2.ZBDBCZN"*D_04.G
MW&&ULB6N9;1R'L%/;GK3CSZLT%!D?IT51+PE9>LOSR+WRJFTF",K((5X;S(9
M5Y!6JB+VGJ!3*TU<N?K52N^CD@*T*DRQLH?^0-G65E+9DX<P/3#A:^WSF?3W
M:JK%,XAW\0W7@F$:AX4^?&K=9J/5SBX9TPO%3J.UWAOF[U%X*X)RCE%9A)?6
M8>.HM_E9;?O5P8CYU"+$(L0BQ"+$(L0BQ"+$(F0'$%*>F:Z[YC/T5<R[!+2Y
M(%&]5 3;.:@?],HQ"_;IJ&HVNB^ JF;CZ,%YE15 U,O05/OXL-X^/+*X6@)7
MK<-FO=LLQZ#8LN.JW3@NQTSFLB.J56\>MNJM(XNM9;#5[;3JA\<=BZLE<'78
M;%BB6DI6U7N'EJ26LD#K!X>':W&;=NX6IGC;D'I4^N.U5[7$W%^R7LA2M?6K
MK%]E_2KK5U4!5]:OLGZ5]:NL7U4%1%F_ZKE^E>F:\NQ$O74">^+[M8$W3"*A
MN]:B#Z=Z34=BX&-?$>P>$PF?4TL9[CA)Q)VI:2N3-2Q3[9SD@QVNU]MTX^7Z
M9]A.327NU+2)8<)_)4#7@^DZP5RIA]/?"0 R\( 1)R*2>LC03!LG;.B3\A^V
M;?HV@;_#BNPW8+@).P\<U5+>_&;YY4?87#M8T$FJ!)VA+&]:WGQ5WIQE0> \
M->TD#%(69:[ GNAU]0^<#J;:?SI<CO8'?GC'QJ$K?);$GN_]&\AUE7;LC /]
M\"&0?Q+OAX.!;I4([-EL +;?/=0('HXZ'N$[L(D\]FEO'34_C.W<%<O*N\C*
MJ?8$3IAA:V7(YN:M^%/&21\"I_>G;"RP>2G-.P!H1'#K16$P!F>"^RO,5IC@
M;(<X!B*O,U\,X5D</>$+^!_^@V.CL#HX2(X7[D_ 32)"J^LA2O2,%PPB+N,H
M<6(PX4'JW H_G" 8*P !ID4(@BM"*U_<XB!#3\K$]B"V0F$WA8(3!N'8<PHC
MU1*IG&)7#%"CS]H 14VLAJ( &#YH>OF39:,2L5%IN:A7>BXZ"0)P2Y=G)/!@
M4\W*]KZ$7]^;,7_8Q#O2>O?_#NO=7C,WL1,G%W[@L!;&CR(].XE-!8_PZ^67
M'R2^GUO0:C/+AEO!AN>!AQ//5E!H:-6AV3KP;L4^,M(<'_X?.ZSWFO=PX=U(
M!+/<M/SJX!Y'..)3N)8#+0=N!0=^I<F"*\ZNUH,K_N_@';O#\.IDXGO*I@3?
M$L *)T*-U,L[<5EDJ?,NC0&#TPF4-5UEW@:^O,Z.LW=(M')=>$OZ)2[=4S\(
MBZZDY5O+MSO)MQ$P"1RAIS3B,7 'S2 UK.L%S ^#X2@$"LWQ[T&[T<.Y]$QZ
MJ#+A/SS2WV_A+(T-#1G0&U'W]CR)PY1Z#QX<.Y ^J1,!\-&GC2+8S,@!M8<.
M[F$N9:&[*&.A.YNPL &^H!9%$1_CJ-E*#29H/0./]/,U8_%_<!1PI3#8+ATE
M_@'NS2P*=ZHRH3RGD=.7IZ&,2Y']519N[[8;G7)DA)>'7MY^B D+-*Y\NQLR
ME ?IWZ/0$5(:1JTR2:Z=25O-@\9AL\HHJ0276BW[G//X$Q,,"$M?.8ZOPI +
M.9+GQ<O]*I/Q^CG[H'%0CL3]\A"25;^O@/1K[OFPIIQAX"J3YMJ9M=UHEJ/0
MM#QD8Y5PN<[C&R; $9:*6K?*9+MV/H8U#JN,D$KPL6761Y'^FZ#L.\(3&LHG
M+J#? Y[E6*Q290I=.\L>-8ZMZEV-9>?K- O7;/.7;$\&;M&-VL__;W^???:$
M[_[$OH,Q^1%^^G<B IQ1W>M\9'3% %MA^_OZ,%WO=N8TB\?5SHXKOY&#!?>%
M!Q2#7\=%Y*(9Z LO)W/;-1O]R*ZG$]CC2<3[GO.17?"Q4,BX"'';W7;^J0_F
M,?P*4?CS!\#(/&XF\/Q^/Q+\9K\O!F$$K^3^'9_*E=&2*T+-3K"X;AX^!)Q.
MJU;52][:'"\0U6=;W^9[X"?8U5LB*"_#*?=C3\@/N<S?7T-0N-\C,?:2<?EO
M.<NCACO=K<66-:NW ^F9#XRWO=(&G//(.6BTR]'4JCST8F-8Y3H/TRLRE[!1
MDJ:196%BP%#K^*!QV*XZ9C9#/3,,O:8<+,NYC^)^8<,&D\X!?X]#=N&%?3"Y
M@:^#6Q%)+RS'<+ZEV^B^EMH^;AR4(P%DS9C: !6^LSK\U<] LSGA26=VL4M5
MAC M!1F7A;&/VHU..=H\EX=XUL/ EDM7Y%+/L7=.A0:8I=&YY:&8MQ]NAE:]
MOOHQ7'O*N&[GC&NK9A\J<V@V.O8"V:K9I1&=KW'</.=N@^K-5S.N>;S'-A0H
MY4L5K48N!8^O\QBN'.OK/H:CXTZCM<SU<6DQ8I5P=1&M&30.V94S'Z7NZ+;"
M)0M+EX5S6[U.HVM]81MG+ML9I&IW&RSH=4]OZ36:EF>7LI;ORY5>=U:T;00V
M"[%M"/T<,$GNK3!S(=<)>J:Y,S7*9&\IY@T\PB[Z]0<-I;<D8."7*S1HQQJ7
M-/YAWH/N/;RFH63X'(BJ<6 R"0.&\VDG@H;4ZM[Q\$;N3Z60*W33#2.&;3Q-
M#U#$P<Q F+9M%&CEPV[*!QSM$LKX'B[4@V%P6 2VLP:VT4P$/U+SU?[S/X[:
M[>9'3+S:'_)8U.F#UL?E0:"Y+D'(D/AQ?>XS-[P+]F4<"3XFZ+ 1[]^)%PE7
MS84B8''$5 H,0#P0410&N?O-I?[LT3@,'YOF@UB<,CD*X7T.H,&3L=[S0>\=
M2$I$5:?W#L3F^SKC..V"!YC7Y'KA#\\5J7CQ5F@Q/ GOP.!"$356?4RE __%
MM\:1?JT7Y']E!9455-LAJ)XUN4J/>3/CI+Z$7].Q4+V#3J-Y\('Z@5MNL=RR
M'=QB)B0NSS)JE"(R"BBF6P]'H[J@ZCP?_I+./DV'H?Z8J/E02ML6E/]-$-[!
M0T.QT@P+:M6-&]=S-%"5[N&$UD@%OMZ3NIN$,=CV'LVC,LW@<$#5*'0EV^M/
MX35>Y.Y/>!1/L]&2*TVIDJ#*WUM!8 7!=@B"KU[606*I/^F\U>)(5$_.C$0E
MPWK@!3QPD!_5E$?L]Q\EH&@'L8@*8Y-7&-*F1 SJ9]X/;T6=W8T\<,?UE&:)
MMC06_R@_9(+KH.Y6,QZIY@6)4"821SX>-XY;"*JW0@  MHICG<FF!_D#DHVG
ML_&8,^+!T!H*5CYLB7Q8T?^_Y< % 6A>"I,YX1CXWL/*^6(08$$@3L:)B[_3
MO"EXY'N"YO/\1:;$"DI:11>4!'I@)3<D/AYQG.;. C'D),Z48#/6BA9W6SBO
M8 9J#T2FYZP _/VSYW\"O$9C$(;+I!T4GB9B=H438@.C$)8@"\\''?7FE]-P
M#':;!_97#42YUEOL4L@PB9#@T/[+?4JC2],=O\S&-WD^*\,'$NO>1#+ZT".N
MV(1L \:+1(U&A 2A5HD2(T_(46?^#3N-A+C!5"?D[;PW3F>)<UAGQ[K+!6'V
M;AT_=(@NU "APOMK][X?2669!3J-K3F2Y25 /_3=U^6&L_P,X1H>UE6(1F0U
MH-\$+[\.S9S4@F3<!R4,;'$CIGI&LY*TA3G/ &S:KUE'UO'O4NG6OA"@\1%(
M\K:9F;PU)PAPPO.8#'6RZ&N!4%S=!S4^GOCT3K2V)?P.U#.%(KB#YB):O"!>
M*-T GQAS#^#RS&U#. G1\)B7/!*G\26^6#.?EX?%K3,P _%1XQ# >9XST#I:
MMW56"5?@SY'GK^ *H&T=" S"@=7F3TE/^^)'G7@2HX_!D U5_TKXUES((?>J
M7\8B-Q0>'HK"9#A:Y29RR@;"U8I_F/@\#J,I S$5..ER$M[+8VPI<!I&$Q!J
M0PS_HZRCWZ&7L$=2!'Q^!YR7U>*5?UR=G)[IN*247M^?*KGW_>0]^3=3Y0HM
MD$NYF8/Z2E7%&E:,EWJ$.GQ!&'DHJ<WLQ0'POJ_\,@=L)QQI.B6YZ044%E:N
MCR=O\,<<)6B,DG85+^R"Z\O7@C9GWT/0TE-VXIC4"R\-&L^AH<%.8BW!P5@#
M5 #5B!6R1?!1\AJ %/H"W,E;<^!W0JDF0VDN_7;,_P+59(@F1WS<41?9J)!6
MP0%J.NW TA%2+V5X$]BM?CQ">DZ-8VV\ND("^Z(![(=.>ESF'=FQK7#5Q5-J
M5WO/W8L7MRI1T89]U)NO.Z+6!LBL3JR(3CS-<?4*NDF)-<W..6T$4)UX$?M.
M_,@&43BF'U[%>D3\A>A'7-YP$_/&>+HG94)Z\VF"$20,N;QM\GB;*FJ6 P(D
MDA-Y?03.]XT]+2<Z]L_AAV(,(*!\7$$PFIVE*% NN;$!1JEHUA(0+^=A*;JR
M@U^KVP029ZX8TQF@"[\\ /1VBE2J?"&Z43@Y^>^K!OL&9S !BX6U>BJ9KU[
M%P^",('G7+4\/:A/9?GE/PF\@B3U#IO+:4C"PQD814-8R;WUI,:&69W6!''M
MA2XXNT#;(B#4KWS\<\H6\ZQ:AQ]E_NRY"N#@;%<19<?3%PY/I"@ -N*KZ"01
MZ^!J:I>Y8N %GCENG056U)DXA#;_;U"2&%T>>$I1KGR#I()!.K\,C"4D!J)O
MM?F,MZPNM+K0ZL(EPD5+<V#$72_D2H68JU/)P#, <882&30-V*+*W,Z4A9&S
M,^+S=X'6-$K.Y0'X/8$=X4YN/;P[V-,"Y^+3[[]?:8GPOLZ^#0:840YK7"+
M?CA$:M,+-MBO6@XJ>>*MX)WYX&6AUX%Y,NB9&34TXA&HP="Y,2DN.H2UP  8
M)Z#_?:P4UC]%U;#")7;@^(F+Y\OC1+G@WQPGB2)\U67N>+[JXU%:D!!4\"ER
M[H078$KIBL(8%=XXC"@D(- -XA-,,!+WW!70A1"XI+]&(7?9E1-.!/NBZ$:9
M+EHA+0\ IC11B/(NC&YP]W02:J.A]OTY&3QY5RSG'2K-T6ZVNE916$5A%<6C
M8'X*G61LPE$KF6WBA\ZBQTP"O!:>N8<  U%)H[2>8$','R2O,N[0WN0K!;5
M'".?D] B+04+ CP)%4)I=:4CE6$2YZQ) EKG)"XG)395/OC05)6NG:J"4U4Z
ME9VJLM')*H4I)U;=6'53$75SE40#ODH2VQV:O&"4@GX((V41YD7]HP)>79!C
M;,8%C4$76D^*$N*]#;R=:X4F&7H]Z6U)0?%]S2[@KZ8R%F-ZVO=N!!CV<][#
M2@GO& O)7^JOHKXV,2EL35?U5@Y9.53:^,B=B'UD8)>,7'4/6*QO^2N)/.EZ
MCG:]262AC) @?T@,W%%J7( EI +%$/-7RK(G,Q=$E\[;F:8@$5@1]U#>L('
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MQ9[@,J9;(C,J%'%7[+7V!7 3I0K\OM7UN_35]9Y9_.KW$[-PH_8IZQD]@..
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MD<>Q1T:C1M4_X$N-C9=-OC5W=4/#OY(@UW4Q3*+[ )'HB:EZ*U,6!IX8=2
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M1.&/:?%W[->01^Z^6:GX'3X3$G['()4 -!Z(,-'0-=CU2$B#6U<XH,VD0NY
MR;AI7L8Y.1FGOO__V?O6IK:1;>WO^A5Z<V:?DU0)QG>;S)Y4.0829@@P0)*9
M^4+)5ALKR)(CR8#Y]6^OU1>U9-F6A8P->-<Y>P>PI;ZL^^W1Q=^K=&$VI0=*
MAKHUQI# +Y7J;HN^U7'@H'&<6+X;U.X&=F^@]QP/UD8_^\7TZ<_EIH$?CAVZ
M=PO'Z>B40^F6U:.@R\)#3"R\1KG"I[]T3;=GT]]3TKZE-R%.E3*##<\(-#A(
MG/&\T\4S@L.@I(,7R8YYZG[EP^"<;3Q@QW8)):J 6JC4;*4KQ>L-2*AW)XS\
MDLNSZ9GW0HV>WR_EW9)ZGF#CAH@MS"F;OAJO&VG)I^L)QO0<*5F-?#*TQT.D
M4X]N$\@$#]P;^Y2. R;S7&H8!9;Y<W=-DB"R?+0G-VV*D>*Y96"QKU_V[<69
M1_:'@^'(\2:$"'&D,:[GDCR2+VDRA7'SE""ABQ-?A6\"E[CC81=41I]J#102
MNDTE,'L*X2L 4:/A:])XS>0B0IEX.$(EA(RK2!1X'>-!>%T71:TY#@>>3S=N
MR;?I@>F8_D2N--!1:FE=TJ/>ADZ8:7%+]#;=GZ.7F>S:+=:*6#L!K,(ZS,U4
MA9*U@DBK:A6VX4AS,CJ?EN(+M*=!=4;?X<;GG>?? #%2Q314E3%^7$/]2!\!
MCW-(2)! +7)+C=(1C!H#*H5?[9,AY8N0K5D_<X05 W\+QMT G=Q06%U,H\SZ
M'GW=+9S-1*/F!]5G 7"$3W4MOI#2MN=3'H>GF]8M:AQX4DAZ Q=",_@70I6]
M-[1[] ?3F0"#>(R71]2H=H$_I4*#I0S-:Y>$].,^&-YTXZ"M[FV+!!I=S8GM
M=3Q_]+__TZJ4F[]1;4J7Z1*TCJPQY=2 &DYD5S]RY3,9OT4V"+\O+F*F;#58
M&#]AE =T WT;*B$T?DR7<G/G9$2WKU^,AT,0 ,PZX'OC*1&Y3KJ&BGY(7VTS
MD C](AQ;$S1!X.,'SHW>\0FYT<]\[P<E!X-)$;08Z/NI.)5VTL5!!]YR04;4
M=P%AV, M5G8IM0HVM#^DW2;;+!5^A,M 11R/V'MUK_N#R2O^04%MEB9H*.W)
MDI@"G7((H]U#TO7'<##PBA7)N_6)AA<K\"@!]BFCHWFI]0E)4>'+"[EIU1Z9
ML&:OYXU=%(!]IKREGZ#QIT_;KCT)RF)2%X\:P(&JNAUR31_,R#WY[1X5'R#0
MJ<4]=BU6XD278C*:!R(_I.)7O]@I(\5?[%2Y  BV-)QA5^IVQ,K+S=UFP;D?
MUH0=1)$<G45RF,$&MXJ"7%))FDRF:H;GM%<:X7FB$UF90&)TMS9YQ.>43\TH
MGQ&4F:"X\@GU? .ZJ"!!!\HS$DH_\;R8-J>_&#MA "; %[I$2DJF[WA*\&#H
M601DQ*Y^RN(0!K?.F-_/"3!:(Q5"])DCS[4"\7X1P%"^ X(.(P]LQ=J,0,8J
MY-(Z+_VU47(2TR87";^UW^'G%,7ZG3TWT-_"'T#L54J_=3Q4M?2Y&OTG/%]^
M#C]1_@V>8X:QPA[SFMJF+)0)WC;\XY@>E?[)\;KT1>T ?.LOU+Z_9H[!T=&1
MH1\?=_2W_*WP:?GX,:5[O4?\T*0:GCH';,'!K+C@=Y-J9A;@$BMNPWK@389N
MX0%$QG"ESJQA@\KR\(X0-[X1^A!<N7HD\ MQ&&*1&%NT**.- V[TG% %H>]%
M+H*+F5!\NQ)$#.DOAGAI/'R-WSVC7HP.9W)$_ZJW=*J[B-=GP<.WMOU.FWG#
MW.E@L0.TAL1M%;=";<X*9T4KXYIU>L%GOGT+-I:D029/(SN02U:FKU&RBL ,
MA'M!S-$[&X*?@P*0?K%'A%,4A5K0C?0I$7+&86\/X,(%F>M),J>$@58?BQM1
M&Y :$O <I OQX9#XPY48?%O!^G2"-0EC$J0)UBC$AS^A+T"=",?Q>C(\HCR6
M<Y?"D,!V,E<!M-JCA&93TJ)"-/JBD0PMIK*[B =0=]KV+.Y+_S&FYD"U9&R5
M_3/;E,VZ;-*1 =)H$;T1Z?^B:-+;D7M\$5*%8?H6%!U8Z/<@@0HEV[[H2!U[
MZ8WLGEYKE@QMG[[;F YQ1:S!9V%,E%!ZJHX$M0X"4G[Q@G]1O)7%J$Q*T#T2
M<>$OY?)N4Z:OWLHMPXY^*9>4U!;P O?)1\XXP/C_<.0 +[5VZ_^1O4@ZNN\C
M- K<\5!PC09"6S#RW 6_TT=C/QCS""<S$*8_I1_RQ4R9&S*T56:QMS)PMV8.
M&;]2%=F&?^(M_T\YURMB#/'<."*=J^>5HY6WY6ATV_72JRU'*XI L[QZ/4HG
M]V+W28^[-D+6S/=L(DG$@A!)"2Y%S>I\'6W*D]A]8H'V>-DU]?4Y5LO+-%XD
M"H-$8+ _Z(]*!(CHO^+Y@;Y6-2.U5NB^QCZ1VEZ\/E9 M(V!/<--"8,X<\LY
MI;>$A0P95^Z4R? ])8>#SGDGM37M&WT.Q(<PJ,OC!QJ/]^O>G<O,-460OD)"
MZGJ.M?S.'B%AY\M6]E?;^OV-6:I5WPCQ>FS_'-L6M9DQ+=<Q1W:(.?C &_L]
M98S?YFST11=1?R?:P+P%/J(L>DM<*MA92:M:1@U1W;[O#44Q \1&7,;?+@85
M^5=8+A:J)3UT?PQ,?7CNM9=X&+ZR"[8/LT.(I7'V#4P'O4WXXM2,1^!Q:A'#
MWT<\,#FB+@2S7HPT9QB^!.XPO"-@=A2Y)W[/#O M5!6!!WM+M%->A@9$J81F
MZ4_"XX80ZH1**M.E&_P.'C*D?K >V=-1H[DA!$3'80#^/>PX_:%WL'7J#=\2
M%J$7"])DU-.&NHPQWQ5\N6<& QU+=XC%KR(8TYL07X6G4N>;2<,>78P^=ATH
M\X$O0]3!P:U3>KNATA:#L.AMPRFK\=D 2I9-AVISJ+UE;V.),U&:S,^./8(N
MF)@8R!7K+5CL;JRL?28[.<+$S%0JIL-#\SS&DE)SK[HD/G5<*(M8J*GCE AA
MH=9N541^T /I4_7OW04OMK^"V250B4]_VZ/'^/N;TAO\F3<MXL]+[U9,$"Z5
M_O.;SN,D/7J4YBB@RQ'_>I-SJL&LKM<%?:G=_!,M1 <G-I_2K^S6ZNHP)#D7
M@O^^2-\OO>]KGP0]WT:)7-R @_5-4Z$4 ;_]_4WES49='@NF%7QW[2'$SI/7
M]H@I'UGYX;G2>Y&3,3:*QI\O#;_]I50JO2N0AM-A0@]6 Q/*U5.K_)]-(W4Q
MU@8M$VFKH(W\Z>^C(YU:ID$HJE.IA=*G5TO7.A&U]KRID#6 ]7QT)JA'JC89
M)AK?J!<"3WX26(KJLN>]J5)D/HK%&C?YRQ/LK_XXKED!%&2YT5JI*DT33W>/
M';NYF8(G[I>#Y_2/Y]_<4I>()$/BH7[(\BYJJKA8+?VLA<3KV\2JY_/7C%:]
M^>2<7H ALIF\CD;&XC[X2  <L!CFH=ECE8U;_M]NX@GY_VW9V-MK%#4;<PVJ
M?N;\T%4P.6M*Q45G]0J>NXN]WM#1J]CDJEF\833+]:=G\0)U_%,R.2,3]M_I
M%OQ4.N1%\WB^F9.;Z:VO;8<K9O&642W74AA\>CSEYF;77E):]7) M"DIH4/K
M*!6?K&2.VQ)Z0+ ?%,KD/#^$2G4.FQ6H@\U,W2>F-:'4%0Z@P($-S1F/=L1L
M)UX&Q>8[B?HG.\ !63W>#P"]+G=JXR"DY>UPS'_JV_XPB,:8);JI9<L*_1C]
M8T@/8%<_'/O0GQTK6;!#?6 &^C7=JJN)78J9$E/S+^C.AE"H,* L 6%7WX,I
M&+HY]+! 3%V?F+Y%-P4]!R;NFX^S",1J>U#3 16#0S.DEV,Z@0996+*M.UC%
M3K*\[\V']2WX4BD8DMU<6M3-A90*<VYLK*(65)K%.T_P%G^(H;O$]'>P006>
MYE R)N+G'@[6"3VMQXK:<#B?'F]IE.Q&GVGYYIUN>7>N:*)<*FI@0%^:';**
M;Y^P$3ETU<$8)[_ D!W>FZL[]I"N)RI%8G56H1WTN2<#/7;\LU$?[Z[^?4!<
MW;PU;0?4C+'\&C5^;-@"Y(U  HY=^"Q(*YQ.XTSH[4._,>-NB*ZXHK)$/:ZA
M!PUY,$#0F>SJGVT0%" 'G(G!OH4RB<UBI,_$TC*Y<BV!;Q .J"%[/4BI(<.*
M)K8OD(>LW U'(=$CQ &4%M98L<8,>EA4A-/]*94UB=D4L#8-=X3#C'#T&=0Z
M \7$JVR@FHZ/$: 2T:%B8?GSAB_S_EX3,^9T0W?$TE@'6EJ_(Z-1><I4]5"1
M^L@5R'E02F&@AH6!0+(FZA9ZM*SQ88*MEI3PX)!V];:#-86,-.('!"6'CUN<
MAB5O@@P#&$[%QC* # F6F9JXU1VKV\FIJ_TQIJ13WF.=LG$J /D573KFZ3$$
M"Q*%KOZ&[-P-//H7D> U)64R)F L'3TA&HG JT>Q ]$G0RH,F0$"+#[B,]"H
MC/?'['VL@Q$*X.KUJM%L-/6(RV8V0GCQ:DN@>W+/.XB!.$W]E[VZ42J5M.FM
MO" 3YT41:S2S@@^TI10+ V!8W:R@([4L.!)-<I8!M35L2L@OZ(XW:">K,F.#
M1R[T5)W^%Q$/"*"D'3$]1 -'"N*<*V:@#*@\&4!C!/LKV  PU7$@/"=U+(8A
MA)GG T$F-2WK']<J1JO<,)JURMPI'+S+?%<_@$KPV9]D%C66CV,!+>IBE\1W
M!O:!&Q7$RRKS7RJ[U5(+5PTV2C>JXK?8=R;,JJ!? #?6>\)+?/Y#CW.\<EX/
M>&7; PX]X.5GV@/^I.2D,L^FLDYF ?'F Q6BML]TN<D<ZQ0)WV(^%YN K;&V
MV9G2E8_R0%EO\DEVO]2561OT.FTKZG[L4\=IQZ(B\M9SQN!F$8A%@Y2$,.2U
MTKC#!3Z5O1HW1N.+;<@Y-:LXJ5<F-3<AL(9I$/:OYI*C2MLXV"LVORAN,0Q,
MWJ/&='5$GFAGX$!L,'=Y8$RW2-_NV<Q[VHL^;<2:SI7G537U><FGP6?H2B-D
M!3>VU.JN?A&-RZ8/GK,/SF[5ZIY1J9<2_!'Y=\N%1)).'EUL0YV5<^U#]W.L
ML6I7CSL6Y5FN\!?3O]$OAG8X,/3.P"9]_>">],8XJ/Z4P4@8^AE=O6T1@8(B
M/] 9F+8_-#'^QR/Y1LREUDSL=U2<:'66$+Y6/X8/I,RB8(ZV# !R[U:E#==S
M=WQ"!=4MWB9]J0V3MMA)[NIM5Q-3O"!2BH'2Z K27HZ44*V"_XP24\Z\3H@V
M?IJ[,DFCQMX"#"QI+O9))@H[X6]JQH=^GL51)S+>!I,19H?;V!QR>A0"-B::
M8CP:TW\%Q86A'L'NA6KE-<Y%_DXT%L.?GH2)W;*L(9EY'6P$@4R">3"L@#!'
M90S1FUB@- KOLK9?.;Y>"6!3D:&9(T#[L2%7Y4PH\3<4ZF==N:HLJA?L_;_@
MB=2;I74?ZT(J* <8P8]"11IO6P&XH0E2(T,QHHX]2SHI&%:LV5[8>51OA0-*
M=((R8TA*(@$2HSX,Q*LYK^X4 9<5Q05CV_ E!LZ^95,3XQ^O-C&6"9X_,%8D
MZV!&\H!0FP%Q)>C1#+&[/ GBH+$F?AR5+-2J2R#+!C/;4*,PM H5-F,J!<VQ
MF_ALHR!"[!*+P-<:0I(G@G53-R"& B@=1#,E_2Q%Q9>$V0RY+FKOVQ!I5J8S
MT=>G#[^?@36A%!1 ]0";]#2$*=1 !K,&\Q[\??0%KLX1@P@Y1@B*/"WH43$9
M#62-;D+<%D0XA7'$IT_)Q\.CJ29/4E%EFHJ 2 2M]KTX\I?&\+BB,H@LUPX>
M41)E9&C^\'!<'YL8 R@JMF538C)P\DRZC.<)7(VE".@R8!QB-,H"-?H84+L
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M>T[*;*TI;T+9A")+?HY-'^92L,GC<E1PE<.,H@D)"MX'V\B-S>]E,IX!I;F
M;R32\L$82]WBMP+Q28M:2]>8C>2%IRD^\ZDK@$[KAC8=>Y;GCR A9\?,(F7N
MWB7_%1@Z=!$,51&0GM1UR-!N;#UT5Q;:HJ@J5/=8,T&2026K"X\[HI_K,15R
M"7&0BP&UNI17 R?:?3M^70(;41& S)!%Z@TIH;J)*:+<9?Y!^0N10^,^LZA3
M3[C,;,0M8IZGNN$XDX__=MIM%98D8SE0@GC75)A3]0H%L#NAM\-^ TY(H */
MBJ<*D,\^#&)3C4^X$Y$^D0YZTL%1(4#%D7$S09,N3A#21P93UQJ_3E8BG1!
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MA#?+WHMQ(8&O1/_)"$Z M@4*$*I*RZP,E+@)!%$L4#$1S$@EY1C'ZVF0K%.
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MZWJL2[@P-YZ+#RC:EJ,M F'DNV#9JV88M_>^[E[L\HX:U[3,-#N(%^";]Q
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M+& /,%6&$1]53<H69&D<S EUX=/?5MY!&PM V5@:&W]/G34VJIXZ2XZ#M>,
MJRG!!!$B4Z#B"%290(1DQ*:XYDN]A""*CID.G#J;$ZU1N:&J->$1IQLSH7E#
M7!9GNAMX#A]\P>QG>+0!:EM9#U?1Z53!YKMJ3.>R*=P!Q!^Q9S:^FO0'@$)V
M53-C^FX\#@D O3/L*E^!E4O%T%3T$>Y)=,UKZ$14?M//(<D"A\0^4S5@5#>.
MZ6[,(^+7(<X '3E-F.O[&!O%B7(,>>"EG\2IRZ/9Y8J:A>0>J0;<!O8\6/@X
MZ']$C37I&:FC_"FK@^,$2%VN;);7__'\FUO;X1":QS;]KT^LPAR'NJL]\[+M
M[I>642J5X/^UMP*8/4'R ID]YO7C*)X(63B>"F">3!! 2_Z=G##!^(#G1<4S
M</D<;T2[-F])[$/,9X1H'L0MQCX5ZM1U&X_@QT:Y;E1;=5;5Z?(QVFJB.("I
MA3A=2&GBK^Y6U"9^E/OB"!T'XO>(]>I2XNRQ$0'5,KLK&6R3.\(4#KD?V>P;
ML:MMO@+QJ :AI.+@,1IM(;E"MY/R&1@?A[E99K+$X!3@Y"&;11R&#4%OG^%6
M2 I*X%G8KI8,SRHQX@L9^>L@UAQ7^&_;%YUW>HN2E4Y%UKXL$6;O_TPLL"5
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MF#8?7FSA<N(3/Q%K+!50C*,S]OOH!OF :>,#[;%A72@] (H+\=GYZ$>.,R;
MQQ N1$HJ'.^U#,A7:B<T"_YIV4&_Y%=G07_I^:"_4A5*/N@O46W^1-!?6[Z>
M(5L1?$Q;*?C8]NQGR-2 :(L%J>F+861SL- DPP^70T33TA'1U#;8!<M['$B:
M]GB0-%U,@D:\K,@?R :9IA4+F::.I5@",DU;!V3:EBUG.*\+0=OT%8*V:5E
MVW05M"V;",F&X*8MC^"F%XO@IF5&<!, %$4#N&G+ K@)X5DP@)NV'@"WK5A(
M6S35I=I,"#G]D1!R&=R7N?R9Q)/35XDGIRW&D]-3\.06[C$KN)R6!UPN92)M
M3G"YQ19;%J0Y?5FDN<WGD&?)UM0!^C7X5?NX?ZI_O6@;^MEN9W?K #V9I95:
MB!/%/7@Y#H8+*J5R'>07A(BWK/$4Z>>1=V.ZQ( !K0,J&$,(#3RK'3SAL4=E
M+L_A8$Y[H=>EQD2#95RVU_H(1-/:MN8,:LZJK[7F[.61NQ;#-9;?FZY7C5'8
M-"T]OL!U;@.%_)U#^N'[8HO_J%FXL$JI,"-QG;N,%0A698&@6DJC?>0%&A=0
MH)%21*,PUOG8(3N"N51.5\D-=I*U169:D.(7F!0M1U)4W1L\3.G(BC@(9 '_
M;U48Q!:]SHO,\BZ\-?TE4-];'LZB%(8A F\<4/<=@R489;<\QS%]^@!R#]48
M'&:(DJ3Y[KEO/8XA_QB)NO@+JUETQDY*T9E2+7V\*I?+5R.WZE:O'O;;9Z7&
MX.,?_>.]-WHP'M)E3_"#[Z-J/7TG7M 7ET(YFC1CUVF.0^\WG8L4J*PR1P'=
MJ?A7>DLG8GNR[V*'YLP63G;^;[CA$?5L3EM@D7#B;9;*CTM^6WY<''IMKZ[T
M^Y2_[8_^N#NL_F$-WBS[Q(WZ>+2]SA4V-N'V]JSO%_4?G_;^JF7=7>*TL>OS
M"2^5DAKPT^]O&G,7',<P$T_\=7W+K;Q)*.2X9Z/H9/5-R#IO/K!6.O::;(]Y
MVL55'[,X>2.20DN5*S(.=JY-<[2S ^.9PJ#=#7 X^Y7]\>JA=E=WNHVO_8=:
M]<W\>Z2RBK[YVO?&K@7RRO/ILJ^[;RNEFE&IMHQ*O?YN^JY1AC.03WB00_?-
MI;70:M@]SD_#QJSX>WVGM%MF3>7MBXN#RXMECS[E:.>PW:J>FW(;'Z=NH\-J
MN&*7<G 2?K2^UVSGJ)GC4KX/[) 4?Q-\H2_F*O:4J^B8P:#M6O _!S_']JWI
M@*_5#CNF[T.Q(897KNQ2^>AJ:+8[#]5/PZN'?T_*SL/QEW_ORS<K81VN_YN@
M_J>=E^3=59MS+P^JE&7U-XGVF)0VPNCXSUQ%*3\UO;(W'WZ9]<S*?U*%'N_\
M/?3YR'G6PLOOYGVFJWD3ZQ=N!Z?]63W"=<I1;";6[V_L^_"].QY:7FB1GCTT
MG3<Z_T?P^YL=D(?T)NE2Z+_&KLV>_?5BGXIIHU2NB'9BL>X/,X\R[9#BM/H"
M3[^:>OJM0DZ_6BL7=_HIHJ&FB(8S*!VVK8/[$7$#PH5@4A0,)OO#3^'%V&F9
MQ0GLV3PO; &,,RPG"/AV$*W!#7AA&.*S9;'_ES%IYM%Y#M-H/IVFWE)VJ= H
M%4"7>^7&0JI\[ &^\,M)%1J-<@&74S:JK?J*KR=%DNS/LO= @EQ2$1)R$4)E
MR</M%_/JX5N[^V__Z]_6QWW[J0SRQ<;%7,/PT@NAEHSW(IBXRV6#"?/H<6EZ
MBQWT$D*@6HARVJNT%M+98]A\C<>6SIZU HZM:C0KBZ7GTNS7G&*_$\_MI7A<
M/R]&][WCO<]AL[8Y'A==ZTXO@]?U>,)8_,$GI-(\BTFY^P/E[O<)MGX&C :D
M]<8DKG-Z/#Z_/-W_:UA9B<1=SD 32UVK*(B?UQ(B=*\(6;!83V^D_,QP:*D"
MM%F$\?GH0TOAH$.%@XX]]_J2^,,C]Y;PKCKJ%YZ3'J%.8=<AP0D)$WQU6.EU
M+D)S\-<?UT_A%&5CKVC]4!4,@9!PHG31K)6 LIQQ=EYL5@H@J]KS9,7<)YG.
MH$48AGO%\Z?J7+!A(^28F $YAR,Z[7\-"(JB!%N6W#V;M">][]Y*M-UC&107
MO^/U=V"&\ 8X$W,.=@E>K!?APK861[TVDAN7/<)T)FP4X9U55^!D',:BA=!X
M'T[.')-Z&*X%05,LW/KD>T'2\#QH.\W1WYU:;^1LCH(\QJY5^O_=L>W ]P)#
M=\FJ'9!% :1YI[H$&Q81?FY5F\^3#7.<8CHG%F'DMZHK4(@?8RF]D1W2+S\0
MJ^,%8?#%QM$Z1WP64G#D?G6A%8I8_%RH]9?@3W+0\1J=GGUQNYI0W$H"_'R?
MT.;%=_6L8\=YKC&[0&@5$EIN&*65QY9?^_6E2J)6$2[.DUQ?IMADE!-@\L?Z
MXZ-E'G_[Z^3;:LM %LNA2IH<RI 4B-OOR8"8\O2Y^>Y%_2L9DN#+/&*)8/D2
MDJ:(*'FE9)2:I7RD.O>\'BEI-O<NTL5&$=X8O8N]ZJKO(EN%Y>.M#SSF:0XO
MSV7QC4T&;-1B%L55.7P1U7NQA-2XUAI4;<OY01J;DY Z/FI_/#H^NCPZF%^1
MN;WVM&NOI%][6@'HSW;KY^%=^>'[YR<K BB\%G1+!&E$T%*M/C9%)#@S)Q"4
M3M26'7<>W*.?5P^''<\Y#DFC>M??G"B16#K]VH1-AV+(6?Z86!*2+7<^9<ID
M6-XD2#W:[.;:7A$A_[+1JE6?.%;TI$>7:EWM%5,/4MM[;+1[ ?>=0M'CM!Q.
MLE]W6'&;WL_Z^3_=C<R7?$_@(-H(,!PJJ*-K#3K...4E.+&0N+]1;6QN58':
M'[D3D-Z.?;_#0+;>ZY1N*_9]UW?H233??-A)8"(68HQT(CC:?=(-9S!"O=9N
M'53V#YM'>1AA17I(63HEA>YZTQ3IY[@$J1<16&\:C<9BMW2S2;U<*A5(ZFJC
MS^F(#\C&9*202Y,9)'_9FNS]]6_UHO*3/)\$@-PB?23=8P20^ZP#R?,O+C./
ME4M%A(SWMH7^15U2F@E9+A5A?3<7VX^%Q_2K<UU\&=_G\H4*FH?[3V=7#Z/P
MTVFG'?[INC_6%.C/4>C_:"^OJ%JO_,9EN51(74[9V&L\UT*Y;(>7SJ5%6.95
MH]Y8W$JY-"/6TQEQ1O5_4/IY^MFT'_ZY+#])!?BVZG]E\;6]V7Y-=/G2SF/B
M]^]#Z_;''_5O)U]?KV.3T3 OE_,:YIOADT4TD%W.E0NI,BA10;>"B%9[3D1K
M)L$/[OJ#AZ/KRO?&:N3=*XMI+2"J5,NC7$24M&PTZL^T)GC),TQGS"*LMYJQ
MUUI!*6+EBO3& >6@G9T#TW>]<2C=H79X2.E8&2G"1I*-Z7(B%KT;'E=NSGO6
M'_7-T4E\(U%$81.8TK6];O_]G#->@B>+F U2-5KE9U8@G.\(TUFRB IKT)65
M%>C*ZN) X$R5Z9GD1\D+AT,SCXN^#06N/LJ41PM7BFB]+)<6.__;<&#FBTJ5
M*Y5B"K57?5'90X)1+!#E"Y4S[8N#A]/]+U</#\/^I^:D]W#0S&.=/W$T< .C
M@$NP?R%5'DVC_NBVL@T]M71>+*24><]H[CW63EK ;@AB*+M_.XA;>TW<GM+I
M$W'=Z./Y4?MK\.,?>UT^\?R*NV@O'"%>V<T&AN8V:C$I=-)1Z.2<6(0,H=@)
M5!/#Q'/HX8HNE0.<$B!&WK419&R:@ XJAYWJOW__:_Y1H-A^)-5$.]/=V-88
M!B#=VUK%3YZ#7T*Z%U%.4:;"_9GF=@H[W50M4"W"=*X8Y=)CBU46) $N0J]W
M,Z &#_$#MN-8ZJ?<O_]W].W.6978+][NNOC</C_X?'J\?W!^P7'*](._OAY=
M_J._W3\X/.H<7;[;0!F\48M96! W''HN4DYL\B\5]7]97Z\>@OW)Q_*?MW\>
M?]W;G.@<6S1]&EVUH4>H*K"]O=BL$&5[9Z9_ZB/@@84[/2/^!8!<7-E'5R/;
MNK(\C$N>X2^#JUXTS-]I?KF\+_TX^>>P^48/[1"V$%_"R.1Q0?VM[0HL#8 (
M93@:[]Y\2"ZR4]@B^4C^+]97\^O?1_Y?7\OY%[D@O[1PF=DU5C4>/8,\',C5
M.^J3!L15A>K1R6%<EO+-KVJYJ2J@5GK\<ETO1?Q/_8+G&_%_HBN;IO)&.@&Q
ME[7'X<#SH17YJ^O80P!PO[+NCSF]-$OE*P6KHGTROOFW<C#9^WX]@W),^;CW
M[__>__O]>_G4:<+.O:Z*7!>GZ //_''QX_C'Q?=N[G4M3O/6*DM\MO;FPUB\
M(GY5B8M#C@J4!?XV=8%[\P[J=!P*-&W!^N-IP73:^UF]^]OZRZKW9YR0%SUG
M"7Z96D-VOJYEK92)\XG@$6I<E!H5HU%+\Y?9T8)+F%'D9SI+3FW7P^.A=QC<
M!QVRAK-,%SI9,PPSSK)LT"<;Y6I:?B%&ILK.#$2O9L#J3J;@^0KK&>*FR1+*
MI9!:MT;5:%6>NJGI*<\NW=DIHM2-ZDNCMHJ\UF$LEA&:MDLLR.;!\*9VKS<>
MCAW0\OND;_?L,&G,>DWG_L"J??OK^JFGW&1N-10[H >-6U@Q%;U=Y%<O.N+L
M3%G/YT4#P#S]W31WEHV]#,@4TV>S:H]Q-4>:RJOU?*FB64=:ITS;S!.H?C>3
M7VOQ'F"Q4RR) 0!RGPR(&U!=<^3VO"$Y]@*85WG:OS3OD\P[O&NVRD>=O\X:
MFPX\H;(QXDW0"U6VJCMTEQN>[5Q Q$M>Y1)"(E^::@9%[Y57T1B128"\[+M+
MET;YDF7KN+L4256>&TB5.6PNC=1LR)?Z:/QSO_QO;T6M<[G&6*6*K0Q);O0(
M^-9%R)6-CG[++9)-)__YU#]]M4L(IT),8Z.4(0_P0HMH%HBFC)>3+GWR533.
MLH5*QEYCL2E4I ":43W3=JTYXBB20EWSV_%#KS;^]WL>*;0)$_1B)?#^PG2N
M@9&@V?)*GQ)8R1ZEYSR4;Q&%+"'5BL@=;\?U%7=+J>*M$-BV)QSD]RM"EG]8
M$F^],/ATL: 9R.\KQ:Z/'Y! ?2YN;Y<#HID]<"E-%\H9J( ,(=?@PV@J%(_7
M.!79]$- LZ8V?D" SB)T]SY.J;?!W!, \$$<<'ZC3BK+^V==^?_;V=$/;>)8
M[_4S\YK\1C_]<TS<'CW-9OTW'8.C]/GZS@X7*)9]FY4/U!TW4G;<@-LJY"BG
MCRGM>.G+E.V*C?ZF7TY&=(]MG\JBWF_Z"950[#!./-AVHZ9^ZU?Q-?@3G.)_
M?Z4G,GTV(_K]G:Y/S)N=+J&"B3[2=.[,2;#TL;"_\@V(2XR_5UT?+!QO:\.(
MM$A1M9:=,4E>W+[^V_UP8GL=SQ]I^^26.-Z(E70>A];N?W_M?GB1.XX2D]U2
MJ?9&;+*C2%_M0LI<$,^\<X!^ .W96#1&/\9(8?*L%'8X'SMD1["$RI_39GJ&
MXWKS(47\X1>F/!MU\_ P@4%<*BF SL#!_+]5%HXM>K/N/INJ@8O>9 K.MHNW
MY)Z26A!0@\!VJ9G@C0-*@4B47W<O=D6%D*&1^QZ!FQ\P$\.*:H9T2M'FNV=^
M#C.MQ,7V*MLQFKI4,S@.]RQ_?T.M=?B9/K@G?A:>?K7T\:I<KO)6V(>JT_E4
M_=SR_3'D),=#^I8)?I!J<"$H]!U=E2#ZDA+DS?(WPGF_!R0P"BB3BW\E.'WQ
MQ.XHJ) S+RXT;MK'9?1DKW*55MIT=O3]\O#VV_WG,"IYS?KLC?IXM-'V55JM
MU,_QZ85?/_[\[7,EZT:3-Y)M /MRUTFI!GCK]S>-N:LZ]'QP4_0),7W]OUW_
MUP_$M2B=_S%VB5XM&86L-]^Q3&\E.N < 5 @S>6"B$^[N.IC%K=@.)'LD>3H
MZ/$I\ ='EP>?Z\ZP:F] %B53U#)J.29\0QM8_KU1BTDAD)(:]38IM2%X)68G
M.9E K/MJ:)X>/(S<+U</IYV_SX/SZ\IA/0^$\8PX-]=IC=I_LE#%@M$1PY'C
M30C1?;8-RIS!-#",T*+_F:L>Y*<RA2_%I^O_R1.J3#W\>(#RT/>&+$#9W"F5
M0V]62+E11/U=U:B7%D\KF7M"Z33ZG(^^PHY^9I2XH G2&<H>,Q_\ KSR,]_K
M4R>$OL)T#@EK5U78O?1W+;PA]4[ESZ<>1I&-V]7EZWVRYM;PY&'F9-\B)IM0
M]JT^T^+93*>XB!,+R:H9]4<#X:9# \B!3?=463'O$<6.98=C?XH)*TW_+_?;
MJ7EYL4'HK<K2F0'&U[X6TN%SA=)/,Q\7-HN8 T(IJ/[8F:,;?Y0+6+$0=/BZ
M4:VU5MN^B]5XGPBB1J;;OL.#P\;-P>G'8[?UC"8S806LE\M9VM@RLI2[RLGE
M14P8J1GEQF)=^T)KRHJYJ$4RI! <Q:91KB\6(H7/93J8%X3!4K*K8<AES# X
M.C[LG#Y4+OZY>M@+OGZS_ZP?_#W9G#D?K%8LGSA9F<4X=:HYA4$14QG+5:-9
M?V9C&9<[QT6\6HC[TC1JY17,Z]B/;._.P'2OR9$K9T^>]I.#*8$Y3ZXLF]H
M"EN.&^6J>?OO[<=>;2-]8K8Q2"I& U,A447X4%7>=;K4B,;B&[*8G9GA$O+Q
M<JN(@KV&T<PP<7%C>MP>=Z0+V+H0 /N*T6@^XD#G.],I&^?CO1<P]$&KU*\$
M%ZWJ7AZ&7M60E1E<?#<]L7S#J"UYZ#D9N"!<S&8>-+Y5,_ J3G01_Q;:'E:F
MZOFQP\J65L\*PL()U-RF<_-QX^_#ROZP;E[GB9:M3SWW%!P.+"G>+!I,'GY.
MKLZ7(9E!A16C7MO<\%K&J3:M(L$VFXJO>7 /IOS8#@90JW3:!U22:*1DW-4\
M/I\<__S[SV_-OS8(^AF*IW1*F8!*0QU-=3>;<G=[SPRD9C9-Y-$I>X4,-3?V
M*BO Y?JH<(*<0ZF&=57ROWX8GWR[V/OSWUS(YZO7&6(#(MRR5AI*G&8^1;!7
M1%:@9M3V-A>!]M&'N(C[BK"0*T;UT2/%%[3S'WH^H=]DJ'^]R24U90/VGD^F
M[8*0_X@M+'SHR+1%9YXT/O_;.*S>UZ\W1SGQ75&.[#&##L:*Z&^OZ9;6/.)F
MB?/.R;N%U!?ER:ROQR\KZF 7\7.QMG%Y!6S=3.9+V<"2&6&5?V^KGZ]_5BXK
MF^F(L<PH,.R:(BBQ)!D[R9P,60@64NK0QW5SY"./;A'+%3*X/4^=U=R(9IS'
M9DP(:M^:M@.M+U0L7="579#>V&>][M:/<8 (#@L4:^7&#49?N\[-7[T-G^DE
M7$$^6R*0>WW^V?$BKC>7V*B4"IU?MSC.^GHK(%9VQ_/E&_UUH4'?IZ^=Z$0!
MX>C88.\,8V=,)4C4?\>.BGV.'A@)#NY#WZ1+LEW3GQR%9!BDXU.4115&)!N'
MYMGQ@WGWQ]7#I\-O?WJ3\[.'<1XAN7*X'I2,; : ;N/6]1#VOLZDT"JO*J>H
M*S;[43%*U6=D+:WI5A8)IWQNY(P[J96,QF,&TBX,(?)#X0&;C\0E?5M$TH6L
M."A=5D;[[O#@9L/MJ2,I*:CLP)ULN))=X ?,N)Z<PJ+867;5Q6U4KVX*ZC+W
MM4B,Y'-^9]Q6=240J[-E3#LR<*#OQ0Y!/J,]<G*)_EK(90L:)'^<E:\>/@X^
M#2Z(>W]VL:XQZG,-DA,29AZQO"I5IQQE/A%0+B2S539:>WFZ%M9J)BPZNP7L
M6"ZB3HPJ\VKI$2>WH J;DJCBA(6A;W?'.$7DTDNW;R(UCQSX[X-_]F ?CX[;
MUH;K><&,NJGL4@^]# ,^-US!S-<O2]]P3C%11 JNMFT>6>4E+I)7A6 ,5];0
M5_(QT<;-A';"=$!YU;P?CL.'EKT_64W%^A/-*9XIS&!X38<-Y$R>^O,8-KS
M6HYN-Z>8*F1R>MFH57,&>><>8'Y79L/O99'D*:+=B%I*I=8J9@HG+:E5F#EX
MRM-"H#Q7"FSL>)V-6LR"FIQ960F9D:"$&<0R$M17/_-\(*ZX)CXS?7I!L5E2
M0=L;7/QU>='XO)J(^0IF2<V "7J_@3>[48M9 *00L^!X-WWGZ.3T\J']<WCU
M4!]\OVSW?_P8_]'=F ;7QX4OII3.\DHE=F;Y]'VEV+3?$X<QGN0,%^CF2J%
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MW )58_M-B4'Y>5/*@T>!?S=3V-0[_0!@JQQM!T'Q\#I\0$QX^H9"Z%@\_.)
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M>THKY7/]<1TLO4T3Q10.R1MKZE@&=*7N'?INC<^A^K27]H[3C385>IUD1F>
MEAD+T-T,U#?N2.&#;@^D-$,G!Q$5S>N?7D+?&(INH-=S&9@,FXX4PA%'1*<&
MNEZ7 JMB3!$N!-O'RBQ6*6Q%/BC%8MX6!GHU.F46O+V)B;7I:5\7V'0&V5<B
M%%R04U;F8UR!%6UA_Y(7)4^Q!U$?TU$>K!R+#<[R%TW1D6:V 6Y[1]*4L:_L
MB\^*B":KB$F+?4/WW,$4W4-PXSR.#I>USRKM8HBI(98^:;J%OB:;[>=,"9RY
MO)TX^Z#; Q<B!6OHTLB1A=8/$@TXT/O>+R*+1=-L4  KOW1C1JQ1+D2&?/*M
M1<=(#OW#/6F%X$'JCM;><0)#BTK@P^]D^N^V0WN^!_FJ'.D7@/&9>19CZ8S(
MO>6C),?<).UHLGA5*@N<P>>0\32=S^UU%@;\3%-. ^\Y- <GXQ6QW)(V63_+
MMHNSA098AZF.W,&7J;D/#+ FK6U\I]D+.Z;;0,]A.;/K.<2>P\JG[CD4&^-'
MS?IU61)?JIGN.GL.:XUQ5OM]H5=^&T^%!;H;D^PYQ*3W55WY7KPH7YOY+>DY
M/&R,GRQU\/KPPQJVI:UH.CQIC"_-NROYY_% SC=W38?!)MVCT?7#[?7YL'"S
M:SK<(HV-$9(HM\7Q'L)NH>MIN;.J1FDA-&<DS4VZ+K/ %,T;C^SKHW &%J?Z
M%!@F#;+>U)=Q[9@7-FT37I%0&+S4()A5-5/<J?4_<1(081IEEQOCMYNGH7A;
MD,[>-C2B]WU,N:GL\]&"]?X<'0T&L6S,GQ0)"AQ!3Y)I>$#R!=9I<Y<%O"A,
M"8W3V#QPD!.=YVP9^4DKZ"0&^A5-IV'1/[[N0+B<XPF",-'Y)#MA\@I]/9%>
M])?ZI!.K3LU8M37AWM)?PG_8L^(YW.%WPM<])SAEL$:VDQ -!IS)#BW\H(_5
M,;+&"R&\1 NKB*45)?"!G7OY0;?GR"9V[1BH_2,3B?XSF"!]UR[@8VB=JNIP
MN)<K]2G)'ZQAY^$B%F@5)J+BPI=AEVBI*!/$"8-'B(V_@[P)'Z25^Q@*\P)%
MD4SN18P<\TDQ4UYKMHGB&6PQD#6L )H:MUU=!;? Y-89+6>S1KQK0&KQ5V+8
MF\IS_#Y\AV@F[7B>%!6SBI%RC;$MZAVS>O;\K&_*T/DLQ4C%3&B^QB7K<;]Q
M6]QG5QSYYKW,^V9C7"Z)_4/)S*F9;:@9V]4K+42,\C;4*X%3<V)WWOI-Z<X>
MJ'O?.,W%KU?RJ'-7I;3-JM:Y6 ZU,6)M7";MBP&I9UK!AB%-5@S2LFC^0^53
M[2<^CPH0Q*!BP;+'\!%4H_@05'KR@5 -?\/1EBE:Q>QTQTEN;Q35M))B.-71
MB-]!DTLUAD?)D2)IQQQ5E(%''/AHD3>I82T1U9!ZG[VD8Q".B9*B(^Z;(]#:
M(PYX0=$D9.+X Z:N,GP6@_A-#QXFF=P]K">$9Q)QR/AP[$Y+67!=CNDRL80#
MX=C7-L:_B$UL#*N%OLL[YP=Z[!;6KX0S[1+ORG/+U5M 3DV2<E+@+AB'2CKT
MWT"$B(B+AH3!N^-85HQEU#'CW%05LTODF9U@3CLC[S?T$&A"0:944Y<,F=;3
M4WI#L),O^#E>K76(?W8+N3'*!,8@OE?FJ;M>#[,-3JL8!0=6I_38I0._IX>:
M\H'3T)Y!=_VT+Y*?L""U+8PQX@?8>MDBX$T.0HBOTQ.-3I<L?+4#[M$YBV7G
MEXH^/[A+]]!]X"1M<"T5WLAG6L"K%,.&V9# LMB=@%Q(;4#)(T-X6N#&V6-4
M[)?LZ]K$,4YID/03.Z-)%R"EAZ8W_AZV1*.)P,0.^ K6\Y&VK8*GC#O3#0K'
MC-M)^9].=X%I4UPMT*U.?6GTKE6W-/  #'0?PW$0(WJ)O'O1MVD&FH.-CW#$
MNL9(FIK'0\7T7UG*UKR2$!X,Q3"#20A].<>(008<&HIE$90%[9WO_4&WQRH%
M6TBI3D^L@Z0E&<8("8DJ'C,:H8J)62?*;2/_N-3CLF^34*$+R@-?PTB/2Q^@
M-UYXX$>]8IVP2,5II^H'_PDRP[#V[3X3H)%\2?WDM,#IUI14\H\*W()Z,^U2
M/#P(PT\=6*,_^I8*@G.9_C4=^-.)^/I_=,-=#T4VPP_3AF0J!MB9",C*P)BP
M>R>R"!N!#7I]X%Y[,SM]&OV0D"5]#<E<UOCJ-_NV 2H,U_5 !%9V%KPT%$D4
MP,DVHJX-GZ2 \E$,NB&T55#:I!2-0<I3%6],5()QH4KO2T?L*86ORGL6RG<@
MBB%M:G=ZRVAS>U1Q&54C6(0#RX2+]LZ ]T1CP(+5X3@]T;Q+.BWX:MCP$U1G
MT\HPVYR^\;3001K47&W(&KH#L&"I0)>ZK^L<M39B\S.L,@]CC>TKHJ3.Z[7V
MFY.\=+M%'.VBR[Q)#L^@;ULI^E>XVSJ>CO]%&,F@IH^K3;@X1GP :D>V57W(
M6^'P! +TP!;*OZ&#^NU(+B@;B!/L>C=YP5Z*E_Z<M:?84E8W8A7^)_B7@TM6
M&8GRR'I0N'@%[4Q;I5/HEGGDB2$;5[TZ)4C4U#/\B(1H$D0>A\0+D9Q-4$6&
M9T'-7C=*Y%Q6*A:A^[D8E3J\9B I*M/0S&3W<Q.7&12X?1^#8R,?^A^%C..
M$I294TJ4$.8&J\ %-FI]C8HKYPR8PT _&RH'\YVF<X 4TW%2--"2N%00.QX6
M'@D='S>(5FN,=7-<^?[S\F'T.[<%T9F/%40KA#OZSMS;O#:.%!-4@:1>MR]
MT5S U<A5FI"9'5K+^IKYEGE<8WQ8J_2.6\7ZG25NP8WNXFT+T2W9AGC;86-\
M+"F_OJN_K._9TMXWI+CXP39*FP(CSEVX;9N=#+S7?71XY13+%:?]F?8H*XW.
M.4'E9IN3**HLL3Q0R)!'&"(L6<?D1"/6M<Q24^U9;M&XZI9YT]2PUSC@+F*W
MHA'AZ5^D+)K"=LUQVN''U;J+'NQWKC#KK[JG(3BG,?E!N!*3&EYP)&A$N(V
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M,V&'I+DK&=AVE1ZE>WC%GPM<J8Z<B)L9*-@$U>=3;*A'9^A[?^<CCE\Q>4D
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ML%SO)Z*:P>\FFD SZ5PFJA%T\2M=GL<?NHI%9LML?)/'R3XYLR![5VE"[:O
M2,VYVPEO2@OF3A4W][VD[%U"WK*S#<E\C[XST^B[ZMO*G1Y=<3)/N%AZO91[
M.;L^?\MY/=#\Y+0%SXP+HWPQMY3:650Z%8&F"],D4R3]3!SZ/UMRQ?D$KWA"
MU%W?7KW=_!Y=&H5V4E><S98W<L5E$++9@KCJ':_3)DG.#O'!9^& KRFQIYFF
M^-3P\53*.YI*><YB[G06,JK[LO_4\0\ *H3$RO79]TJE]_+=.E4GU&N\?4;Z
M$DLHWOG[B%3-D7$8OW(N9I)4SF!EY?.9N<IYAI&5$#T<)T(/$S*H7CEN75[>
M9D\O6Q^3'N:8:L7E8%6FFVJ90FEY:EBK?38AY)8WT:8:98$P_A:98K4 L*L/
M^X#1%^SGNGTGO2V@M2.EY^ME-J.]?-<[3Y,>W\19#=A9L3KVE;3R3"9:<;M+
M"MDDT&\JQ?FL]+',Q=):R'!":#?E7M[JWAQ^?WCYU&0X3[87$R!",5W(SG>^
MM]^B=5:675W8LYZ8J&SF_F0B8MY)99?AONPL[HL*-56G64=(234=@0IL6-6U
MBY(S:6WX]CG7BNX4C>?S6['S^ZDPG0$7.L;9C#GE/):PLI8_CR4513E1:SR3
MSI=R"W-K-I);)^.@[T.[4\.DB=#NA/)X-.L&>7B\.[+^<-J=HUU*B?J1(-0+
MV4K"E+M9=\)1)N),;7)$L'E!PUZ(KXFXP-.]R_D?C'K@%BUFN\-?#^&R"7.R
M_LM!<9EJ%B04_? ;ULZZJFQ95[2"ZKK-?-)K;W%<$BIRPV9_B];EVK&4US-G
M%V^*!S8:9^O3Q>#"MO-".UI.#Y?BQD'.KDY\LHLM <17/IW+9M(T3;YP\"-!
M_O,HXB0QBIC0D+]JDBZ^Y>\,L_5Q*6*>=HOKP$?30[:<+F4*Z?)2H=%D1. J
M*FRFW+MPJJH"J ]KE'I11F$F.#8>B_MP75,*_!A-@Z%Q,TO2%35EE']Z./[U
MTR5K=Z]^4V]YHIYBS;%F_AC[6%*VQ8T#4%J.--!N',+.'.3$S47[HVY>7/WF
M)R3:V\_G;B7[^B8U\Q_JZN<)L;C.98R+%P]RR^BV@"7N=4[,:+BM%AMC_:0G
MW3Y4S]KB%DPR"0SR_D0M%'08DUMYR_6U;R*[SB:BIX6A.W\]!&0S,?F0P>'
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M,V"\]R[)D94DFD_3F>FDP:-?*=?C;(+_:V-AM8(D 2YWV];0+X5%J/YKYIK
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M=!454\[4%Z;((*9-2;QMJW@C,O4Q3-V=OR*9%A^W NZKAGZ5IH,[8MH&5A&
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M6JTI#M'/AFYR&!56/P,"D2IK\!- P-.2+*3TKJ[*Z$C0TE3'Y>]+HU"F"<C
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MH']9YC<&)AC<"<'9"3X/%V_3+97I&+II;FNJ:?G M$YD4Y$?Z6*#J:F^"4Q
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M0Z[T7%Y6!L!T1@R#Q$ZK7:NUQD<WUH-V>EY_?E@:?/HLP<'^20Q07OT *$>
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M'=2]/",&7IO)=V2]"83CO9-N06V>R7]V<SX<(T<'#-UISI<8&+O:Y68&!O,
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MT29ZAF[+<OSD#GLIL$8.S@.FI7<>W.:'&?9WP1QJ*HV!&:0C#U7P]'C&'8L
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MH*@E,+"HWHW>49/2 DRL;5N,5,#M8!>@L,>Z"Q7H#BN[81]Z\H%!84DN*]!
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M^I<9TTOZ[(SJGYX-3VN?@T$/Q+!W,6A&V,5D?4,&W7KX^]MO-[YU5I9U:[\
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MJ/&(/9$C&R!G@V.MJ"9HG=2Q8QLZ-/[CB%?TB5MX_5>C,PGYI!HCXH^BW[6
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MN;J<\8]KQ?_GZ(CH"+S(_2*NF3'_'WCYFP9T"?^+J%?_(U#>#BR7.#HR1B<
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M5[\';"&CXO>@ _*K?:\EK*T.M)S3E2[=GW$OMW<GE_+2T3?J#%;@^\NXYCK
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M0)P>@EK95BJ.]H/-\69,F\8[=L37)(\R(8CH?Q(^<@<5X[;"V:1J_&,BW^P
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MGL\;\XO:XV,UUM4'*+J$A)#%_E*1S.9M7D 9^<W1V(WH2CW+/%3C/)Z=;4M
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M(*'RPN,5K/%T^P"P!!&J,J/_Q+3]U6ZO=CP2KQY(NT =A3<!B4,X,PZ(145
MJ[*49;1D77?[?%_O$;-4'#'K/J%OO^FZ ;W%FF\@9/0*8P,\_)QJXDXZ$#,9
M^ U@0LYD/%/HYNH.#[F#'\SA+YM=""L,8U:OP4_(K(#**@WL*T&UWY&W$2H9
M@A-4W. 2-&FT99?HM(S/HLFBH9,=]1NZ\N=/]Y&\G=K]VBWGJ\*[")QO2F?1
MEN.ZY5'#-?T\+#S?L+!F)/QED](^D]QLJ+FU]AW(B^O"<\) UN&#6!DQ'..
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M&9K  GYDN,Z-^5P1AAIB]%L9NB;@2PK@/6=D-PX&MZ6X&MI\(L,Z&CS4S/J
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M0J8GGU(B9%$C3H.KVG3L_*>]@B@!4<VD!SM?KR1OPXZT'ZK18L*HYG:=0TL
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M8/JD: [G0+]_?#VO:67A9$5FIV-\"!^M"CP!5@&QCG7MU\C/^CS3Z:9RNKQ
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M:O/X11*[GG""XSE&"8)V2!,B0N46==4\!??W@>1>0!*;BFNA U8<T@#/R"1
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MH[N+S^S J:1)G?51<QH;IUJ;T:/JGIS,=YC+P'4;U\PI#MLVE6K>%1/)G)F
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M'GIS&QW&XN,P2'J@P8V"1ZCE1<F>&.+[P\^KTN?]GQ^/'MKV8@7(QH3 &T!
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MDD42PW:9;_<+F)2-:'K=)EQF:=^J[UT<?A(KJL 3K:7^'2+\'Q9:,RL*?')
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M/C@X.D[(R:M96_53'0/LQHUA3O9R8?A0.;0LA28,^%+I;6XEJN2YF9)5JIS
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MR *S :C10?PZ\AJB\*? GGS;^[Z#,&5 _9FB%1/^1D4KR#N&](I-,)901 K
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M,DX*V'WAX*W<B9SIKU P!BK>,BT>3OQ;]];B&*M+<4&U?A\+.\=QT@(KZ[1
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M"/\VPW;S=;FX52A7JH7R]O:;87XQ_BMEDW+!R;8WMY#O9UN7TX?3!TC!.2N
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M<BJ%T(289_!5AW<<M&)&:!F$7<VBV)AXL+FT-EZD0H#57O$!87 9JMXD9KZ
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M!\%^3:!<\";?'C4GA!_[C+<%IY;I#H*^HWS"'Y/4SWUA[ HH8-;"5N?4Z80
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M[?:(& 59C'TAZ3+ O3([@<USE500'W;*Q< T.6;UZ+.<(TQD:((%P\?E16(
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M<14/0O$@G2H>9.=D6]9XD$0/K!DUFLA4]8A<+"#U%--7LI>4OYFX=W1?^O9
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M#X33"8AOI-][U)$(S7[;10:/_A]]XCW XLA=!$].^" $PM);1LMJX?J#*3#
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M#/3AU,??:>WB]-_ZWE@J<%+G;.!A27[2:.@'=&C$*X:>I,XDUO5+>B "!!"
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M2H\JK%1860<KE4JV\KVN%S)'\/Q&I5=5>E6E5SVK7I5UQIZJ;;S$,DTD^;S
ME=IVJ].OO;?*B]K,SO8I0D?P9UKB3"O:[1R/9PA'C+L\TQ)5Z(\*()Y,?72(
M4<0,1O58=;.CGXRYBR$U7SPXC#?<'^MG+IY<S Y"57K=<N +VCQ49V1?SXA5
MCC/RF;O<QZ0*T6T-SP&[N_/Y'>:=N9&'.YU2AJ?*OY\-^X)C-&%(/O:$(NA$
M!%GNDR47X-UQ>$76+X"%Z1[]*6//'H_Z#),!%P:N)3*/*4@0$]\P-TYD' /0
MOZ@G9"T+O*-(U.I3!G0"6LH1#P&-Q"C@_^*B;SYG.!LME&H7\#!T:(51?0?
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M/TZ\,^KTD>H4OVB\S_\Z.]-$KV8<5+JCG#C9;&9\2C^R6B21;#>=$$XW-\M
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M1GO!URFYKU&ABH@,TZ:_D-=6LVMTN]U:&[2?GTWZHU/#]!I2*2A"WJK5S?3
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M>?,I+1:30>9.H;!UGW33+?#%&4_X[]3TH)W D23M!<N2#AC>?& 8 E8;".*
M!5S+PJEP-0.@3P:CB*I]B3>#):^62B2A[=KNU-%VS<UJ.@>=/:'UU:'_P\/K
M;!_UGIS$GC;E\_JC164T!F]*O?MW27>8IOXHTN1#KW2D)MTD^?GJ\3YZB?*"
M?R*<A3)\BNK[#F5&G:P>?&7?C8!BMDIZ"Z]",GFL8I$)OHCDBM4/X%5BF=&'
MBZG=P23!(19*N!Z,^!!KU)F*R.,YP+;PJ>RA:.XR1IX<>H/O3_-DP<X%&Y_
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MRQ\QVX<WE'SZX#%_B']\!#$Y"#W_A3K-% =G&]]_[="2*#2Y+>IF&G/#Q)=
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MZ,F+(J0V>,<=IA-)<6MOFB40VS)+XF"3W*H:.M>$=@PG-!ZYZ3.=AJI8I^M
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M9%4QD.- C@,YMF>$@HLR1N]-DD!6(*G1,0K&ORH6Y)B5T1^5-MJZD&-MV(-
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MH8,#&0AM(+2!T#[=K*ZC-A(L4>I4PNCJ)#UK] .4<?87'K.B4(B:80AM-LW
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MN_YR8_'2-OLEK? (P9V Y;0:0I.I^%1.:G##/1HWG#Y\Z+EK0$#G?1 -IXW
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MQ:?,P_AYU(_;#RN<A\_WZ>B>Q0EY.;L3G3RT7*K/%*SD+>R(':+T#@'IV&W
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MS!\#E_B7GI>>S'L0*G*$UZ#7"(0<% M\RVZ:E;;!FE@I!$F9@+(CX5N"*+$
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MIK1W:"+<V8]'V]_9TV]]#IO+9]_Z?*]A'.V[TTJ![;1NXZ%X0[@_$N7(Q.+
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M@YM!>NE.39%<6;[][%*%*@T\A=Q/ \=)*3S@U3(?#QF/X!<(\(,:$#K#966
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MWX-.K]]W1^W.Z>#34<DJ)>>C=K>;G[\X"-?,US.SU?J]"1,A?2HK9A GD4)
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MB@3PUU#LK:%8+%^U6Y^)MI 1=.@U#44T2WZ_GO8KWYE^%A&^P%OY@]G^XLY
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M%<EU6E&]:G1/U?TY,U;-G6UZB9O>]?X'4$L#!!0    (  F1-%E3:Y!->@4
M %H=   5    ;C(U-S1?>#(Q.65X,C,M,3,N:'1M[5EM;]I($/Z.Q'^80[JJ
MD7@U(4F#$XD :;DCP&%R4C\N]AJV,;ON[CH-]^MOUB\$4DB3$SJU2?B [?7L
M[#/C9UZ\MC]-KOKG^9S]J=OJX!',SY[T)OWNN5U)CGBWDMZV+X:=S^!,/O>[
M9P5?<'T*M6JH8<(65,& ?H.Q6!!>3 :*X%#)_ ).Q*FC;-Z"R!GC)2W"4Z@V
M(;V<"JW% D<*Y_;E<#!97Z7DDP4+EJ>/K].$6%:Q?V@"JW#^CD]5V+0K1B':
M,WH<R5,-^AYS$S2]TR42L!D_!<EF<[U/,^R+\^[=G$V9SN>L>KE6MRL7YT^U
MZN?Q[Q8DO:N/X(S;9P5N-8X/Z9U5K]798E:MULI?PED!6OW)66&OKOSYO9;0
M<"H"[SE<3("'^GOH9BRFIY:$*U]('(S"D$J7*+K)7)=R3>4^;6T/!TYW,,GG
MAI?PUW6KW[OL=3LPZHZ=X>!U>.!)3WN_9J:V?(F49OXR'63<HV:I:KG!^#X-
M[!7S.<=%$/!)<"-_57;<,LI?=4OCJR*X@BM<&;0 /:<01M. N>"S@/$9"!_U
MNIJA#-3JY>-RHY@<C]+C<7H\28\U(] H)_]'0+@'EF7&\[GW1OV[P/L:B69;
MW%))O97R=S(>/C +&K$)=>><N22 ,0V%U.!$"_3G$C33 <Y+U>P2*T(WN(&V
MI/0&1E)\P570"P,ZE43=D'0Q^,;T'!%"U_<-C%L*':*I@?!'Q"G4JT6PJI8%
MZ\!WK;@R@"BCDB;U('-JB_.(!/E<.D=PN$26XP,J_8D/3,8R/E-&[9(2"13)
MX&V@.-Q L9J][K<!$VTA0^C06QJ(<($/54%?>V78]/PB)'R%M_R"F?_R0SN?
M(X$2#T.8<1=Y("0QH073)4CJ8[1QEV;A]3#\<$HZGI)#&7(HY/B,*9TJ<C1&
MAV'5BK].R83UAM! J#+4Z_62=?SAT/I03,^KC4,K.Z]91R?I>>.P4:NMR=3B
MA+$2.SHH_@ "IK92'1Y"2!&<5&O'1P>QRA\:<K)+B65ZG@-X[XH@2+)$@.EE
M+:#6IR&<3+=ZB[ 78."."(M4'$J&6:O84N;F8@F<+&C1Q& 0>::$XI!"4D1J
M51JPLT'JR8Q 7[$T,)]A..(-)7A6GMZCO$=]QJF7SV& .M$T)#BS5J]6S>I(
MO"A(&8UU))1B$04SI)]G8M[ O"X[91/CD62:417C[=ZY<\)G<:POF%(X_<#
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MO4P]_>OCO9?L"AH2&QY;M69\Q5B?&/S?'%DQ7T:33Z7)%]5_ 5!+ P04
M"  )D319.T5HA:\%   X'P  %0   &XR-3<T7W@R,3EE>#(S+3$T+FAT;>U9
M66_;.!!^-^#_,&M@BP3P)1])&BL&G-AIL^LZWLA9H(^T1-EL9%(EJ1S]]3O4
MX2N.FQ1&T4V:AU"BR.$WPYEOAJ;]<?2IW\[G[(^]3A=;,'_VZ&+4[[7M2M+B
MUTKZV3Z]['X&9_2YWSLI^(+K8["JH881FU$% WH'5V)&>#'I*()#)?,+.!&G
M#K-Y,R(GC)>T"(^AVH+T=2RT%C/L*;3M\\O!:'F5DD]F+'@XWKY."^*QBGVC
M":Q"^QT?J[!E5XQ U&>X'<ES%7J,N06:WNL2"=B$'X-DDZG>I1KV:;MW/V5C
MIO.Y6KUL->S*:?NY6OTZ]MV Y.+3!W"NSDX*O-8\;-#[6MUJL-FD6K7*7\))
M 3K]T4EAIZ;\5:VVC"5QQ+$(O)=X8P(]U(_!F[[80;4D7/E"8F<4AE2Z1-%5
MWW4IUU3N4MNSRX'3&XSRN<MS^.>ZT[\XO^AU8=B[<BX'3^[&J[+ =Z+DQ;3S
M##537;Y$2C/_(>UDW*-FJ6JYR?A.MYC.4##13/!\;DHE'3^ *[C"3@5:@)Y2
M"*-QP%SP6<#X!(2/PEPS08%5+Q^6K6+2UM*VGK:-M+6R#^^SCFKVD$VULCE6
MHYC/6<VR%4LQ;0,(]\!09_D(]@R<=X'W-1*M,W&+<+TYF'<R[MXW ,VP$76G
MG+DD@"L:"JG!B69H] ?03 <X+Q6S/BR?2\<5H1?<P)FD] :&4GS!98IHV+$D
MZH:DB\$=TU,$"#W?-S!N*72)I@;"7Q&G4$=-:]5:;07X4\ R!?(YHHQ,FN2-
M;!<ZG$>+.8+#.88"[F+I;]Q5&0_QF3)B'RB10-%CO!44C144\]G+=ALP<29D
MF,]UZ2T-1#B+W:"OO?*:Z6<AX7/ Y5<<'V^+ $B@Q*/P9]Q%GQ R'@/(#Y+Z
M&'G<I5FHK8<B3DG[4S]1QD\4^NZ$*9T*<G!1FCA8ZLP8>B4+]E9&#80J0[U>
M+]4.WS=JR"#)<[79J&7/5NW@*'UN-IJ&4^9CK)@\YL,.]HM/8%B&4'\$(45P
M5+4.#_9CD=NE@%,Z>DI(#>ND^C[LN2(($LH(D&J6@FMY&L*96^EWM+T"!7]$
M-;6L4@Q]_=2R%?Q2@,-Z?.=SQO$B%4>R\>MY:,?1+R()G,QHT7! $'EQ^L<^
MA>(BS%%IFL):#%U?9@[\%=,4\QGR 7Y0@F>Y<@_'>]1G'+\@03C1."0FWUKU
M:M6LCXX?!6E$85(+I9A%P03=WS.D8X!>EYVR(9E(,LVHBA'W[MTIX9.8;&9,
M*9R^;_ :-7G"1TF6-@+F22^)N*="+1:\K88H_\P-7!PS?LE8>-[O"*\XIE\]
M:6TO$3#!(P=@%+GX[F/0&BH@H-)J^SLEPJ*(-3&W*#62H%]4&LGP?.ZI$F*Y
M/.UB&1P(%4GZ.V>^ @57W,_%7&.2"[K>E&BXHS E>.J2E"2,O=A[&%.3K_#4
MND@@:4&:\CO.Q^.53Y@,DB[B8FI!EPJ,YX62ICX>U\#FAX<4P[RZ777IWT[V
M/U;0P<6HA_2&;N#%]*.G3.&QV7:NAVT]M2NFQ4\/R0\@(1+/F,KT8(V>Y)!
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MD4 QD-X-+0[+I5WW%>R[CILR,10R@A&]HH&(0@R,@HGVZK<\'T:$%_K6GP5
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M2I7N_[N S:N[?6WQ^:T>Z#]02P,$%     @ "9$T69?5D;/J!0  YB$  !0
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M"VY31NM,)%%7)-L,;IF>(4#H!H&!<4.A0S1-(/P5<PIU&Y6P'><>\L=VS#4
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M((IJ"+\EG$*CCD;4;?L>\ET:5P80B48#S7)GYLD>Y\EZ2,3A'-F,'Z+ROEA
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M4SS3:D/YFM$^5_C'#%DSQY_Y>6A^;/HO4$L#!!0    (  F1-%DOC%HHE 4
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MVJ<*_YPA:^:<-#TX3<]7_P502P,$%     @ "9$T60N4.O)E!P  QBD  !0
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M1K/E<YE&X!UN)2S*-(CS$-8!JDHB&\"FU/&<90 "+-5K!/DX7F*W (AA&QS
M&@DEF6]0LSQ&*ZP,!>BX08WS*N!FPJ)8S<PZCK482V,UQY+B]!@EC+K [=6H
M/1Q-Z>=:( >2Y4-"Y+M3[^UP/5L_FWK-H:V@(Z\SP"K^6D61Q+UC<^(0,&!<
M"P<D8$*.8D$)9@+P'<723-#--4M MT2Y=!U*$\3*Y.A'1*Q5[,&4:16($+?A
MP#$@$PJ@T8.A_R68\'0L6!=T=I_'B+7]EC?;Y\?"N]$^#_V5OY0D$5./8AJ
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M'F4'YMNO[O'^VZQ=NCWC(>#ID#9_Y[O;_+D#TK!<1HTE@Q'I5A&\)#."W@L
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M!F"*CFBCV>*Y3"/P#K<2%F4:Q'D(ZP!5)9$-8%/J>,8R  &6ZC6"?!POL%L
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MJ42]J;CG='\HIL4;3_53ZSI_KJD>?_X%4$L#!!0    (  F1-%D<^82', 0
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M2JU6T_^@Q ,J8)EJ"[UIS0LWZZ=*G!-NZ((;3N62KMHP(SFFY,<Y,?RL;62
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M=[W!5:M'WKZ']]TNZ0T3-;09+):&L&:.<C@DH*'R62AG/%B?Y@:L=A6S,U!
MP!48"RH0S-&3))+P=L9"QGTC@R\4$3!2..>2I;#-*"@'Q_<8Z-^?2B*9(A,1
M@E;@-Y&1/8M'Y'Z*_-DA[/R@'O;QIG/7:8T,7B&;@&+!&HL%L'>/.LRX!1B5
MS4)%05/OP<?L* 0-@[N!BRENN49WJP[6 FMU2;46>]<:U-A^U3ECY])(Q/9F
MX,4+QC(.HJ+?!QQ01+&@P],<50Q9C_O4=1<0FF2$GA6%,J(0_^)(-D*<(*"
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M).9 !T!ZW>\-94F^Y7KH=>_P](O'[NE;':Z,?RY#IS+]9S;^!U!+ P04
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M9$LD4!BPABA@-9J->P!KK 2R<"$25(H9QMR)DWL%110P$97^3 .)(-R&*2$
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M*:@R))!,9A)8J@CVS%!+@ O>N35UZWZ0NV5;FW:K(W7C>'_]GG.D;O<;QLU
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M@B3;SMVH4D$B^]+Y/"JSLMG0T6IDK4;VF!I9101;6RI?7S,CCT@=,$XT: 0
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MQ)Z")Z+B.*/C5#VGYDL@,WWMYH*[L/9SZB37;V &.:'-] 9WO,#;<]3=@*6
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ME* ?'/,!L/%BP?.^C*K"5F"./K+L$YGE#AD#N%;0$[DQXOQ<O2 .*,YY.BI
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M/H.C$7!/)[8MLG.F;%0Q>3X93_2"4F=NLRT@@(Y.9]0WF%W/JJ^'A.ZRDN%
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M!_-"/="FSI(7-*VH/R>M*U#)5;#Y798J/=!J.I@;ZUV<^CSISSR4P,E?+=A
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MD6+4*[* AOT2W,P5#+'"WB/VH\7I@U35.E;+,KPKA):U*]H^+41QSTF/JD+
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MN^GN.%\OEW3)IC-LY*<71X4S&%VUX4H9T>F6WQW4K_CH//H#V>$HH"/L;^L
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M)6.L$2IP%J?RGG(SWE;QVC+;[XM3,1Z02DIO<XP<3:18UV7L:"Q]NHFFCR:
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MV!>/M\2A*05G4^W\)O;(^M*E]UM"L.6G%$L]X;3[:D%2J2S=%Z0!B^@<BM.
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M9G*^R?\BUB7JM/&:%8OZLC3HS7J>1-E.5E56CWZQA\CYF)FK:1P&CLDZ1@L
M&JIMQ"L(#F7;W6XY76E]!/,"R\CER?[G?8]07,^WOWO!DXN#H;WR(MN_M@,[
M#O%P=344.RM**SZ<&BOX.@QP;=C=9D::@>L&/"YS(7;+VN9% Z9E.45?I=[
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ML/@L=Z]+OH?_/%)5GW[S_P%02P,$%     @ "9$T69]0K&8+F   C$T( !8
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M&NJ^MB?XI._DY0$&B/K.3;C/RB"9!%[4= [[&D][XZV>^S=-QGD\[4T+FK/
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MSCY_*CU4*:)6$Q'5^5G5I(*X^'47E_O+(&0!/--2A=BVX2%3R#CS%(E"[!H
MPL9IJ/5I0G@SJ&YGUBPAQ@HH-[N') ZK;!1#U4_4PFXKGY@ =ZN>J"2!T&D
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M@^"&!E2?"^PWE*W1VW>_>_A]4X[;\>>_SN[S(")3XMU^\Y EFNQ32BE7)#!
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MJ!#V5U?C5%UP98HQE$9C]+PS; )8*<R\5J47%-JXSUH;_:/6/ZXW,867BZ+
M93' P+Z02ZZI 8JLZDJ X8\2EC1,W=U=W-\!84&UOK<B@R3KGA,:N#(U>H+
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MAA[VZ'?T>2A.?X_:0ICM,T\0BT'WWCV)'3F=2<XQ_U_A!9T%VYA '*[::]V
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M,$N%<7BE+2)!FQ-U3?3)Q-\T .&>#:]0=A/$M+RDYCU(4FXO*B@A=F\@=$3
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M7J]%U7HMQ67O62@HRSQ^V/%G$.-"GM&X$/(W_@2XQU??^G3/T^:R%+K3>_Q
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MZ"W2G*830=&.K>IH)T*XTZ1WGT6LZ\7"UKAY/&RM7Z_"5LE]".*0 ?*XH-,
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M2N<I3 /%:<L83]NH1^W,;L];K+94K?#V/\_/G6Z,821>;.* JXS%G4S%'W%
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MY]7^A,0.KB$C3JM'PWAL4IF_SDX'< -]#.PYNIV'\]6AE8(DZ>\LU>CA]\1
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M"%MAM?M&6:OI:Y@V12'ROU]F>7U6.F*EK&D!7C3%1/S2.6"0I^1S'NG:CN$
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MZ/;NF5[6N\]D";#/ED8!K6N-H^5+T?)DN$I:C7HDHX[3L#ON'?-%M"P]1JM
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M&YZ89F^>AG[##4#DI#5J.=5.5A1HFV<AQM%\R3-UW:>?!WY0VMVVP"#D=G]
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MPZSBM":J!?A.0CJ#/!BR68"4#X-KE>9^S0DB:JC6\TZSR9XN<9!"\M_!(^F
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M?X_H,@! CRX*W%YS9O!K]/OJ\DMQOL-_QT%^_R73,GID*VY'ATDF=L>044T
M&FFFX.[SFY#F#Z^+J.29.O]E0CM@R2J:.9FNM)'725@!N8*R?WQ5E+TDK_$(
M[X0W Y6PHI%3^4K;>)5T%8 KV/HOLVTMWF=ED#!D-2"EUZ,2<[>]J ?9>H^R
MC'<># #K?V<F6+GS-C'LAX5.$6[RRQNK=8WK%F^)Z>2_"%GK*"YU9(^ULL-
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MD)="_X>6=7L.$GH;KGFM-"LRF:&);;JM4WM]I_O58\WJ[%W;*D/;D!H+7%G
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MP+"H,*RD$0EN5Q D]B8KJV('OLCP<)XF=P5D1=LZ$QR-R+RN:XP'_+9#S(
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M!_NR40X9FX,@/7E3.@@H(8:6T\5 TML =83/[3"/6531Y'=6/;63+W.$5C_
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M'WXVC@\-M(%8D69[$C1"!28T!BN2_Z,1Y.>@"DKXB>^JDKT8JNQ0&43U&IY
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M=CK7AJA2&-9G;,4+2%WDY4+YR1CM(U4I#>M#BK $T\]/2OKY25,_P_J2/.R
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M(M;T#ZQ3:?D7I9%\>1KD8ZJ"=^H(G;[@#<@+<#OS*"S2BGS->Q#'2UQ65/E
MKY2&?!$\-1RJTGGJT**^=,)P\(Q5ZT!*]$3J<K"@I1D">;1\[9A$+V/B#EZD
MK#;RC_?J<F9^;/5H4O0B:1,?UI]8)KN=QRX;;"^_;)CZZR#<IBR5%\5274!5
M<@:+Y':X5M&D#K@YEE<>G=N85CH6I5C5!JIR9[AL24U2MW>CK"$.SA!:&)8@
M<[BH]=U"4['N5@I7F.I+J#)QL AMEYM+70H-5RF"7;!%M"U9&B^\"<+L>H:]
MRVQA45H:03I/N3#/8(>F-I$#+00'Y@Q-GG_R<5I#I/H.1Z$NB^IL52X-%P4]
MBDMZ1!J,5]5^ZI(GX9S!JIP8+NAX%">$)#"KI"O;P)O (_2,TC+6UVB-'1PS
MX]=%:&NS\B["\N:5*K _JE>!+7_\?]N[(/I/*X7!^DL&Q7]8MN]:!T"L*B16
M 0IT%5EVVU"AHU8Y6=%T(+\@!VY%Z:Z 1#9.MG4;FV!H.T3.F;K-7\.H7'($
MF!=DXR.F?A3X41IK&$\J$L4C?@G\\K,-8 :D D1K[ 0^U6*C%ZS"B_9IY\B6
M=DQ*%82!KKNJ8%T'6QL+:EAPAAO&$)&PU:^8VA$J%?P$:VZ49[?=(5KY7A"9
M; Z%+ES=A1-<C,%#$0L4$Z% ;MZ80L80WGACZCUK<$6,.SAK1HZ3;!.6A\;K
M4"'CEL82T&6?NS!0FT(#QB+$7A&749F3KC8;NNRO%H^T,#-DRS7=@N+6NK7?
MBVYWM;[6-^8,;/@>#1.Q3X*>__WMP0Y(@Z2E9C]*1E#++&-.7IDLJ"!_]APN
M$DR16VXPRH)_[&\S5LT\FKR@T,%1:Q"TO'?TEC+F$%?2"UW(9,81T80\E>A^
M."Q<"[J=P[$L5B 4.(^+,JR'8DV'P#V?G9)IQEAO,LXIH3_@A>OA#C$5GZF_
MVJ!/_YI.2Q53^=>N:K.A^RW(F:&%CA$\D5V(ZZP!W4*A5_[T>R$^J(W"_.AN
M-DDV%;I90B\V2(4,IC(LLZ([<:PR%[HG0C\VQ5GPC$G7(75FMG[PL<BFT%P&
MO%-"+[N/2Q]3N9H*X/%LY:X#W@*AGRTZ&&.YEDOY:'[P"9'(Z?Q[$'Y^QIZ'
MTHC4C>T(6^UI+0'>S4#1<.E %Q-X)#8Q.RP$WJJ@?WZ=D;59U@>E2C:'1NOW
MB+B>I9+)QQ^4BI\![W/0^T&J15]3I:9YC+2BU</!RUD7O+=!_P>QD(*F"@(3
M[WOTA?VEHUHH30?O?M#+=F_0 ^R^N^M-MP&] !0/9.4\Z',NOUQI5C!R7?:.
MP/;H>ZJIG]4C;N\R6 [P+Q"Q3R(<$_42/F,'I1);>ID@2& Y%0#F] 60*8 3
M\^2LY9>7%42[;/"[L8U\E_WDI=POZ,V,I97]PA?7H;X'WO) 63J'I3BX-3(/
M@S66-,<JCP%O/J#,N"9FD!6QN(9'U@1^[MD.0XO9/3QK@S,8O,B_HHDAQ'4P
MTZ[^57'(A3?:G,KX>C0^H^ )^]LUI@4O_&/2B Y+@->_[R]_J$Z7LR[O)\(V
M_34Y6C-#KJ,OW+(,>*'\7J2!2Q]3]W8YTGL,6[GKF%/)_J@0EN&,-3Z+7*-N
MTW U\4^<2/YJ"C3UGTBN(PZ L3=%3 9B\HEK,ERCR GQ+BW><95$A"@E]ZQ2
M8.$GZUOK&D>.%T1)B.@/D^5X,9VOIK-[:W9C73TLI_>3Y1*F)L(L?+)]_&]&
MDT/IA]3QGY?H-5MG!35L[U 40EXSH:?E@8I!V3'A6%&<A8#/1[1MK.*F'6K+
M]LK:>A4H+FG@ZZ5<V1&.:%LM1,AD5R*FE8WY<WUC7HV6TR7=DO/%9#Y:C.@.
MO>Q*TW9EQMZLT:;P5&T9^HKW))<P\%MRB9]\O,:.[<<'\.8$>:=\H5W9G1_K
MNW,Y_70_O9F.1_<K:S0>SQ[N5]/[3]9\=CL=3R= QV<3&_GN$\T!<HM$[%D1
M5E]YPKY0JO.!-Y^<67771HLN\-OL4T";T1+_"H5^+=V@O+?>O:WOK4\SNI7&
ML_OQ9'%O39?+!Z@-=3GY1+5_'ZDG%1.@KH/D,1X]!DE<YKG*5M58XQ6?E?JD
M-&!WOV#<]K2LLK7?U;<VE2*+OGJR5HO1_7(TAK-J<S]Y'&P?"<<R5K*FMR,G
M37K *B6L==<!LE.;4!X8H[!35><#[])N3*V;KEJT@M^*MS9!T7>O$D(96I^H
M7,*ZLAW?U[?C[>C^VJ+_?_4PO;TFI^[RK];]9 6S(>=A0/SW>#_WJ(7CNS1\
MNZ/J4[X'%::"Y8&T Z:U^?16 =Z"RFQL)I9HDPI^[]T131':7@8\SW]\]Z&^
M\^ZF]Y/%Z-::+V;SR6+5K\L8A7%).,E/!\$D/_PQ>6%\8#E7;D)[5 @=13)%
M/ -F:V64/P!TH*^*EZ@X'6HS28G>NH>T: *_>3(W-IK;>WH;1T]JQPD3Y+:5
M'*_LI^_K^RF+P2RM^>CWT=7MA)UJY)>+A\FU=3L=74UOISWO,IUC($4PRC&T
M/07O4#@)K-2@E&%:)UOG!:$/.3E#FS4(CR$=_&;E=9"O[,L?ZOMR/+O_E9YO
M=$M>3ZZ 3$L*\ $L^=;CC8?9=;>!_[1"X99"I;"G.,.!=XR8!;7-(L38@*W@
MV5%T5<HMF*TGSJ&D<W5+_-C8$K>CY=*Z(EOC[FYV;RU7L_$_Z3W?9+P8=]H>
MW!3=PV<Y$ MV EM!8X&>GWH[&^0F'IJMVSY,",7JC8LV0_H:6G<9J$VB2^WJ
MKNF&JS&[J:T94&4+-9)6\JWSRV@!9=*I]NDPI"%'HU,+,4 .K[_RQN<J(7OM
ME8 /'K6V'1WI [][%HC5M9[;85Q^*44MTRO;H^WK.9NJD7"RF-R.5L1;FH\6
MJ]_+\?EE&B(<W8[NQU#;C8NF= /*9T)5U&^'2\M_TEH$>".JLK!1?5^;3O"[
M<O*R\X(TW8O\DTS$-$.-LQ,;R263?\UO9VG&%_WWY/YZNGKH>M(I6(<<:-6M
M0^D"_5J'G,\I!@#9&EI+&&(5*K*I8A5V(!7\[F%M!]LWR_M&MLCM9+0<;FND
MH*COA/IXH(@!BB*$JFT<58P[V3Q#-D([4^HQ!"4:P M[^NY]9;_P)+Z11#&]
M)_[/Q%J-_@5EC14PZP35A).@.EXW0%+8)>)9P%:6 FL:W:_E1(#?)D6Q\3NR
MD0F(U3)DE0W32'.X&4T7UJ^CVX>)=4=."V)*W4WN5T![IT"D= ;+-X]X%G#Y
M^Q)+IOXNB?5\&,UE@/>7"OMX=?)UZ 2_XVA6(OHS(:M-GOF;K9'9L'RX6D[^
M^X%L,&OR*]PVJT.OT%&7.P,NP;8,CV(^+6<*\+:1L:,E(U:(NP';0Y2.+WQ-
M\KZ1O2!Y36+])5_O/[[BAR5\;PT](R]@N6++V'Y*2SF$[*M[:2! <?+9/!;1
M08J[E4[\2-V.-B/?I?^AL?=GVZ-;7LZ_;+[B=.A>>-KO?;3( LY$?M&VJ%JU
M39VQ1RP)W>Q.F]E'DV^P.E^-#%=%Q2J?!]V%3E.IJA("?"M.MSOB<;!V7"$Q
M,W9!9'NS-<VIN<7/*'T-H;X+NZT&W7Y.>P,>0S1PCJ>QSC3$J<Q8X23H)G3:
M_%,@ 62)6D'+M$I:Y=@.0XQ<.RZ"!E)%J[,"=#L[396K3YS!CL&\KZ'BZ<<=
M#MVP3I,#$K0'(_?$#OT@R<ILIA_G7N6V#87N+J=)9@&ZX(=+L=E*3YNG/D$F
MV1X<$H7PKG@Z=&\Y?8M=ARS@3&0/R?TXS018X.CSF!Q^.*;_$GC6HDG@+>3T
M'6HY#<#YQ.S,!8IQ>DTP>_3P4]GO$\3;I#/!F\-I<TR5&N!L*^Y0U=TJ[@SP
MUG#ZOI,$^P';R]#N1&DEY^7.P[&B=2:?!][O3=. 4*4$6*<?9<YH+@/>@$V;
M49WH!*[AJ(5*BTO,4<BL5&5%)YT(WBI-6]\IT@*<9^WM?=+./B/?G3)S"#_3
MK@9R^Z+38N#]TO2KK'6G&3B_[]&7$KYA0%Q*/VU7D4&JO&GU5P+OQZ;-Z:[4
M@D\]:-:496_[.-D&C3?9;95EK;^D2P E&%P*[0E=]P/ -,R]VMC^;QMB-NQG
M7WSDTEP9[&([W,_9/J&_#*,-WN4FQ62]1DY,!&9,)CZQ9JXJU^K#?O85E_,[
M"</@M9"X'JE (35>Q$O3GT!UDQ')3\?;@L7S\+KU2D\3AXC]-?:2&+G2E_6Y
MH=1UP;-)I3H644.L0C[\&=Q7^_0)/JL;<!3G)0N>70K6D:2#U]&U*JTBK=PH
MLM!:JQ58%[^"HJV2XGRE,AX!X;-/'-$6"T2JI,E2W58ZZP*NG;$V1%6W8+],
M?3SD[;.FR_]&;CD[4/6X[F%I:/4]5''?;B2&5^XM=7]%"KY1\(-3_1=8Q7]5
M98"/*?YKCM+NO>2O@9M-I7ZC:/<UBGRH5BR%WHZOI'3IP2Y0YJ26*]1E5>AM
MJUW$M \BPF_E6E:I8-=^:%0;J=<S!=Z=H(5-5:HWI@',*669.\6X1/HE<I(0
MQ_*4@*ZKG47!TZ,P'#BE0PNLF:]5CE-W06C?8RANMI$-W TMA;U>:+2,N%8;
MEG^W5BQ!K+P ]#L]K:K$FF0YP;[,LO-I&O+A&I@"\JBV#67SH5_H==IU:D09
MC#M%7GCZ9(Q81B63**L XL[\!54 M%<]&7 ?^&'^XUW@QVALAUZP0L[&QW\F
M"M8H^_()/@S]JD]#'D[&!G!MW6;.JMWOBZ9!/P#4TLQ*) !GU$%%S>(-"HFX
M!7EU.E:;,4+L.FD7^&J1H:[K03\"['CH=B&:03S/DSL6=DR$-,3/-DTC[!!I
M4%P(^J%A1RYKD<D@]A:V?NE=&(UKIL>//I?UUH-^[MB1V5V(-IQ9+:X!G[^$
ME7NYVNM OWW4,;,[$LF@G7K0*B6+<%1Z4ZZ]5W57!'\ZV7&[=J.< 0'?]G8J
MHL!OH^BNJ&O/<4'@5]V^9Q[BK1WNTW*7Y&P/5AMT\*WN A=YBN[M<6L:4KGZ
MN,8^W8EY@EA4E&PI<+,U :HXU\F_2T<[^:E<Z"!7(GM= >CQ4V!QY5X%HW?:
M&Z"S2UVA1(JZ4>RYTAL*^'KNS)I$%?*42B![\Q8M L^["<(O=M@A-5QQH;-H
M$=6-.@89OHU^5B,*=AF;(F9.'+!DN]-*,.S[.] W?KI"T2-Q39(9BD#%W[L/
M8I2[>;-P@9\V:J6INR\)?4G813WHD^P$)MJ,F(VQ[;LL=HI"!T=4_ J?7=,*
MTUL-^BI1S,2C4#-DTQYYX\4>%1\N3=4O'[/OG^CST%>02LK@I*PX9?Y/PZ>8
MLXA09QW2>6'HZTDM=7(D^< U2^T.KNBI-0XBEK;=P^6EUIK0%YB:!D%7HL$[
MX0K-946^>:,WC&*+66"O_?7UFCW((@]"?2]/=:7S[#K;E6+P>Y;3\5.T3QO]
M:'@-: >_Z#BW3K3EE% ^V34,(L5E#+G.Z-*1MB/)X#=6UD%4L(\:E9;2WK2#
M[YIS;5)+H*#6D.K9PYU@R&Y0;$LKQ!K<UF]KFUM<%MW9<?H&19EC'18SY4JN
M<Y=A17+!:[12ZV&16FO4:RHW( :VU5]+)^)R B0%[@JM@Q = "7_B6)6;"CK
M%-4E;[33PF?7S[@G4H)KXI*AQ.K!X><#$C0[EA:K\!VB:*JO7)3EH<NJT)=R
MQTA#=RH:) I%M"C*Q9O@D<>2D(_66-F<.FI1Z#NY8P2A,PWAY2#/\SG<)7M>
M\(4&XE08KC0;^J*N V<UJ&(."P\V8Q!%M+/5?IWFD:@U>M99!?K.[ B6:E )
MWIYN:_0NM*P;-?=N1M.%]>OH]F%BW4U&RX?%Y(ZV4 <VLE5ZW@LNA%MG =^1
M7^VS"XSE!J'X4Q@D.R)D.M?<TA6 #6<5IO&NK16I [_C5AM$HREYO>766G]$
M^WB)B_**->GY;_OLX4I>B1FCZ!9'9/[4OPGHX4'1I5ON#3E*V),T)YW$N07[
MQ7XFI@/R)Q[>TJIRR'USC6(;>YR-WZC%QA"QG!(FUCI'Q8H*7"R<(F/%&V39
M&496L&8_9WA9MN^RGZ,2=I;'T"/SV9_6.9)6S+"T")KD;P<\K;B$*%OQ,4/5
MVA!<K4>"K(4.V%I_R?"]%)#_.@K(4['ATVO 3\K4:D,U#:)=SZY^?$J\\LNR
MUR.,Y!!!4T+;Z+0"6?JL&4(Y^$8_@:"6B%K$$/H55DD!Y@+(T0MN$R@RIC;D
M*V-^DP"EJ!\ GZZ#K8U]":?R0<"\:M*.3]L<Y(.?T'.+99_8I/NW/W_\\>>W
M;Z_&M[%[A[:/*&RA9-JCF#L>+"K<1JZ6E ,9IH-ET$X\VF,6?5Z@*$A"8CR/
MB?<BH;)H"EC6JRJAY?B>EM;T=78'>I>G@976.(;F3;P'H_L]#N@7699ZX 5/
MS)7>8N(4B@DOGP?7"%>1]*JH#T9[&E@-=UD.%?,OQC0B$.[O[6V;=\9F228!
MAZU.XA]4N*A$1/![@SOL!S27)$>SP'N.0MJ2TGY"5QE)^%Z0UB+0=[TGE80N
M!#(E"'J-(B?$NS3<D/>WR,)Q]_1E";WT;H]#-JK27T^6X\5TSC)_9S?6U<-R
M>C]9+HOPGE4L> GT&1?HNT_HJ4-3UHDZ8X'=)7IBD/$1%LUYQ3T:Y:2"W]=9
M//\AQA[^-XI^0_3A,')'SR@D>N@.Q9O 705D8Z)P2_4:&>W$I==F],D"=O".
MW9\>"DZ/;<])O(QR]%HU[VGVIGKUL41Q=$.(LZ%P)#FI,Z"B6N\[JEM+2XWB
M.!1=@'S?**R_*EU@)!G&[*KB2X:V9:=X6UN&N!4'EINCS@9BAC^]#'%2"M#+
M#MO:E:E@11D9K""]"'$.Q* S"3B1M4.A%3&",*AJ=R46?=%)?DD(DZYPH$[M
M(N9__Z^?W[_[Z3\CZY'2BEVBN"FU+!_%M6]9-B$9]"W*ZVAU260QS3B@$BG0
M?-5AY]:6LA5+<#.U A75 O@Q8=MF%=P'Y _$KB;;B6"96UB*_%%;"MID/8Z)
M.N0J,9H@N49AB-S;E(1<5!@>1(D^!A%B8\T0DF>B\%*42^6OLOH9[)11%1&%
MA:#3%H\4$&52@>L!>@2&:(/\J$BX):C,UBO[Y3BM</3"T/F-VB+0$RG!1:(B
MRC>$+,2F)V1("*Q9EA_-J6F(>*G@K(XV..8#T/F2QVF)XTD++BHU5R=WUM)J
M@*7B/!*!T%P&NJ:(-ML[D6FX"YBL17;9#ZQYB=Q+&)6IT%4_U-FCCM,@QMR)
MPQ3E!]TL.=&E&HBA2 ZL+.Y J"6,!S3J+>>K4I\:9>M:E"?,PW:SU7-_GF8X
M7GSG?MY3IGGKME>NP%HU-'XC%"<2,D_BK+0A'\.NZYV;-WX<W< /7"7PQ[;G
M98 3'9;7K#J2][Q%S\Z5[X&$9^W4J^'/&C5%+)),FQ <3H=CQ4BP\-DY_3V1
M\JS%J6D_\"6D;>S9N?E\A.%OHI;XR<=K[- V[0V\E&Z:OV_4:5]./]U/;Z;C
MT?TJ[X4^O?]DS6>WTS%K>V[*C?/K,.R:[;G) <0J$Y9^)41(9?JYF6U:5('?
MAY\"5D#2=U#H3Z,H4=U\C4*,GV9TKXUG]^/)XMZ:+I</)NVX2X['*[O<'#23
M8XA[4&Z0Z[<@_$SWH+W#Q#J[1N10Q-R*:YS!T*[-(-P0(6R(D[N@ZLU';AZ9
M(\H_V2:LNB>?D=EDE;G0?L:0NTR==OI>Q\?T<//1$UWN&*^#NVW'=K0A5*#_
MH<6;GVV/X1RSBA($'_;J_1UO'ZO.AO8YAMO8>O0#W^GS,' 0<ME5V +MTH8L
M4>HG\_>X>!;TI>"0NUN%7O#6;RT]D96(H6F"$P]E\'YZP;A4H8&6 7*H3F'1
MDJ*RPH$L17V9-!Y7N6EG5ZE!^#NRPPF%\1^)CSZ\I:(FO,AHU%)N32$L8&>W
M&2A#(,\?_/2OZ=0JX6'9.2(TZS'-,"P5BCC@0Q<X8,0R#BLX610IFKO(%MD3
MU"Q&?XLB9WUX^U>+XO<WZ*N4/(>=P/Y(ZTND0LYZ:8P<HGXBS'XE-?1UUX%1
M5BU0+LD>)$Q$WIZ6IWLBVY[(<+GRB.LRT(F-52KN<D")UI<5. ?#?1'8S^@F
M.#5E.#0_P$_'%@0/:$U=0F:\QE1/9=UK*![$B*MVL6%-S*J1DR[[L=\/0WM6
M0\G?$.QY56)XCTXD=NQ#T(Z><6)6(O]@D9<AU#)Q9WA')?OHL-^$=A>/$Z,3
M$,A<1=4)21JQIR74&';W09R5G&W+BNO9%.%_&=JK-<IBDS'(1$E4T=F?@L#]
M@CVOW40@Z^DFX9\:#NC,7,@#]TCFG:O,MJ*;72RP+ANS1P\_L>5.8_GQO@V=
MEFR<,2AFTJ#IYT$29ZE2*2BCN"AI*TH]%TY3Y.]/9O)7#<=7J"J*(+A2>LOP
M7P8K(V6JFA QZ%5)XLD%L(O<??QJY,[(Q*[\Z58YW9<E>%$<2B^YIEN" 69^
M37$;1N^"Z'U2>OE'1;GLZ/Q&K,%1E X6/\%I="^D-U<^ XS>*Z6@62EL%F;
ML1NFX ">A0_PE2^]-FEI\QS*_)Z+PEJ^YXJL+XA6PHBRN>!O>KZNBZC9>DT
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M(<LE*T'[%0R; EBY2\$;#_U8;;D)PGB%PBT%4/EA6MLL,VYDQ'SA/C9K0\B
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MI2*88HPY-J 6D5+LK.6!-AZ)YO9>'.6KCC+&E!N0ZVUT.6M&IS=$I;K2.BI
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MYCE:]?$297#4RM"=*+NHB1Y(J55J(OL+_9]'X@>0W_S_4$L! A0#%     @
M"9$T6=Z:/L2?&   11T  !(              ( !     &XR-3<T,3!K:6UG
M,# Q+FIP9U!+ 0(4 Q0    (  F1-%G',OG+^GH  &"    2
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M,3!K:6UG,# T8BYJ<&=02P$"% ,4    "  )D3194V.AJ'CF  "T) $ $@
M            @ $_M@( ;C(U-S0Q,&MI;6<P,#4N:G!G4$L! A0#%     @
M"9$T65)9LFN*T0  9?   !(              ( !YYP# &XR-3<T,3!K:6UG
M,# V+FIP9U!+ 0(4 Q0    (  F1-%F&H %O C<$ "-W)P 2
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M2P$"% ,4    "  )D319?,;Z!UD%  !;'   %0              @ $9X@@
M;C(U-S1?>#(Q.65X,C,M,3 N:'1M4$L! A0#%     @ "9$T62S7PEQQ!0
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M-S1?>#(Q.65X,C,M,38N:'1M4$L! A0#%     @ "9$T655A@SC" @  J0<
M !0              ( !Z0D) &XR-3<T7W@R,3EE>#(S+3(N:'1M4$L! A0#
M%     @ "9$T69?5D;/J!0  YB$  !0              ( !W0P) &XR-3<T
M7W@R,3EE>#(S+3,N:'1M4$L! A0#%     @ "9$T690M-?R?!0  S1\  !0
M             ( !^1() &XR-3<T7W@R,3EE>#(S+30N:'1M4$L! A0#%
M  @ "9$T6<:QXRZ.!0  /R   !0              ( !RA@) &XR-3<T7W@R
M,3EE>#(S+34N:'1M4$L! A0#%     @ "9$T65(\AQ.+!0  H!L  !0
M         ( !BAX) &XR-3<T7W@R,3EE>#(S+38N:'1M4$L! A0#%     @
M"9$T62RD-$V/!0  LQT  !0              ( !1R0) &XR-3<T7W@R,3EE
M>#(S+3<N:'1M4$L! A0#%     @ "9$T673E^^=X!0  /QT  !0
M     ( !""H) &XR-3<T7W@R,3EE>#(S+3@N:'1M4$L! A0#%     @ "9$T
M62^,6BB4!0  :!T  !0              ( !LB\) &XR-3<T7W@R,3EE>#(S
M+3DN:'1M4$L! A0#%     @ "9$T60N4.O)E!P  QBD  !0
M ( !>#4) &XR-3<T7W@R,3EE>#,Q+3$N:'1M4$L! A0#%     @ "9$T66$#
M-<IE!P  PRD  !0              ( !#ST) &XR-3<T7W@R,3EE>#,Q+3(N
M:'1M4$L! A0#%     @ "9$T629F,XDJ!   !14  !0              ( !
MID0) &XR-3<T7W@R,3EE>#,R+3$N:'1M4$L! A0#%     @ "9$T61SYA(<P
M!   $14  !0              ( ! DD) &XR-3<T7W@R,3EE>#,R+3(N:'1M
M4$L! A0#%     @ "9$T62ZQ*6]<"P  E40  !0              ( !9$T)
M &XR-3<T7W@R,3EE>#0M,CDN:'1M4$L! A0#%     @ "9$T69I2C-S]"@
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M>#(Q.65X.3<M,2YH=&U02P$"% ,4    "  )D319U44X$*<>  "--@$ $@
M            @ $NY D ;FEO8F8M,C R-# V,S N>'-D4$L! A0#%     @
M"9$T6;31G)J'(   \$8! !8              ( !!0,* &YI;V)F+3(P,C0P
M-C,P7V-A;"YX;6Q02P$"% ,4    "  )D319]!DJ1L)*  !^100 %@
M        @ ' (PH ;FEO8F8M,C R-# V,S!?9&5F+GAM;%!+ 0(4 Q0    (
M  F1-%F?4*QF"Y@  (Q-"  6              "  ;9N"@!N:6]B9BTR,#(T
M,#8S,%]L86(N>&UL4$L! A0#%     @ "9$T6=DBK@2F;   B9L& !8
M         ( !]08+ &YI;V)F+3(P,C0P-C,P7W!R92YX;6Q02P4&     "D
,*0"."@  SW,+

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>n2574_x219-10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:currency="http://xbrl.sec.gov/currency/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:niobf="http://niocorp.com/20240630"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="niobf-20240630.xsd" xlink:type="simple"/>
    <context id="From2023-07-01to2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_CommonSharesWithoutParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:CommonSharesWithoutParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:WarrantsEachExercisableFor1.11829212CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-09-20</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_Entity0896800BCLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_Entity0896800BCLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_Entity0896800BCLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_Entity0896800BCLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ElkCreekResourcesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ElkCreekResourcesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ElkCreekResourcesCorpECRCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpECRCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ElkCreekResourcesCorpECRCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ElkCreekResourcesCorpECRCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_NioCorpTechnologiesLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:NioCorpTechnologiesLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_NioCorpTechnologiesLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:NioCorpTechnologiesLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_NioCorpTechnologiesLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:NioCorpTechnologiesLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_WarrantAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:WarrantAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_LegacyNioCorpShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LegacyNioCorpShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_LegacyNioCorpShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LegacyNioCorpShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_GXIIClassAShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIClassAShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_GXIIClassAShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIClassAShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_YorkvilleConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:YorkvilleConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_April2024ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:April2024ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_April2024ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:April2024ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2021-02-162021-02-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2021-02-16</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="AsOf2021-02-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2021-02-19</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember7263812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_LindIIIConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_LindIIIConvertibleSecurityMember7263843">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2021-02-172021-02-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2021-02-17</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_UnsecuredDebtMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-01-26_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-26</instant>
        </period>
    </context>
    <context id="AsOf2023-03-16_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-16</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="From2024-04-012024-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-04-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ConvertibleSecurityMember7264156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-25_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-25_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-25_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ProbabilityOfIssuanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">niobf:ProbabilityOfIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ProbabilityOfIssuanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">niobf:ProbabilityOfIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-25_custom_ProbabilityOfIssuanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">niobf:ProbabilityOfIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="From2023-03-152023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:MonteCarloModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:MonteCarloModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-12</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:MonteCarloModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:MonteCarloModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-12</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-12</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-12</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-10_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-10</instant>
        </period>
    </context>
    <context id="From2024-04-112024-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-17</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-17</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="From2023-03-152023-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-08-302023-09-02_us-gaap_PrivatePlacementMember_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-30</startDate>
            <endDate>2023-09-02</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-02_us-gaap_PrivatePlacementMember_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-02</instant>
        </period>
    </context>
    <context id="From2023-09-012023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_currency_CAD_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-06-232024-06-24_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-23</startDate>
            <endDate>2024-06-24</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-06-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-272023-04-28_custom_KingdonCapitalManagementLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:KingdonCapitalManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-27</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="From2023-06-082023-06-09_custom_YorkvilleEquityFacilityFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleEquityFacilityFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-08</startDate>
            <endDate>2023-06-09</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_GXIIPublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_GXIIPrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ExercisePrice9.70Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice9.70Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_currency_CAD_custom_ExercisePrice9.70Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice9.70Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ExercisePrice8.94Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice8.94Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ExercisePrice4.60Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice4.60Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ExercisePrice3.54Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.54Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ExercisePrice2.20Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ExercisePrice3.25Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ExercisePrice11.50Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.50Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-17</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-17_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-17</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-14_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="From2023-03-152023-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:GeneralSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-22_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:NonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-22</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_custom_MarkSmithMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_MarkSmithMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_FeasibilityStudyAndEngineeringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_FeasibilityStudyAndEngineeringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_FieldManagementAndOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_FieldManagementAndOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_MetallurgicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:MetallurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_MetallurgicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:MetallurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_GeologistsAndFieldStaffMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_GeologistsAndFieldStaffMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_CorporateOfficeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">niobf:CorporateOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2024-09-022024-09-04_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-02</startDate>
            <endDate>2024-09-04</endDate>
        </period>
    </context>
    <context id="From2024-08-302024-09-01_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-30</startDate>
            <endDate>2024-09-01</endDate>
        </period>
    </context>
    <context id="From2024-11-292024-12-01_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-29</startDate>
            <endDate>2024-12-01</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_MarkSmithMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="From2024-09-092024-09-11_custom_MarkSmithMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-09</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="From2024-09-162024-09-17_us-gaap_SubsequentEventMember_custom_LindConsentWarrantIssuanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LindConsentWarrantIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-16</startDate>
            <endDate>2024-09-17</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-17_us-gaap_SubsequentEventMember_custom_LindConsentWarrantIssuanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LindConsentWarrantIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-17</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="NUMBER">
        <measure>niobf:N</measure>
    </unit>
    <unit id="CADPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-07-01to2024-06-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2023-07-01to2024-06-30" id="Fact000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentPeriodEndDate contextRef="From2023-07-01to2024-06-30" id="Fact000005">2024-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2023-07-01to2024-06-30" id="Fact000006">2024</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-07-01to2024-06-30" id="Fact000007">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="From2023-07-01to2024-06-30" id="Fact000008">0001512228</dei:EntityCentralIndexKey>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0022">A1</dei:EntityIncorporationStateCountryCode>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0097"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0100"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0111"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0142">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0144">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <niobf:ChangeInFairValueOfConvertibleNotes
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0187"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0189"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0228"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AssumptionOfEarnoutLiability
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0255"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AssumptionOfPrivateAndPublicWarrants
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0261"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ChangeInFairValueOfConvertibleNote
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0268"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:LossesOnExtinguishmentOfDebt
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0276"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ForeignCurrencyTransactionGainLossBeforeTax1
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0282"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0315"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0318"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0330"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0345"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0360"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:RecognitionOfOperatingLeaseLiabilities
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0369"
      xsi:nil="true"/>
    <niobf:ValueOfWarrantsIssued
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0372"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0387"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:CommonSharesIssuedInTheGXIITransaction
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:CommonSharesIssuedInTheGXIITransaction
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0398"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:CommonSharesIssuedInTheGXIITransaction
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0399"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:CommonSharesIssuedInTheGXIITransaction
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:CommonSharesIssuedInTheGXIITransaction
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0406"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0407"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0409"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0414"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0422"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0423"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0425"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0430"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0431"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0433"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0438"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0439"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0441"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:RedeemableNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0444"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:RedeemableNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0445"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0450"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0451"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0453"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0459"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0463"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0475"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0476"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0478"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0479"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:PrivatePlacementValue
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0484"
      unitRef="Shares"
      xsi:nil="true"/>
    <niobf:PrivatePlacementValue
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0485"
      unitRef="Shares"
      xsi:nil="true"/>
    <niobf:PrivatePlacementValue
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0487"
      unitRef="Shares"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0492"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0493"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0495"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0500"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0501"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0508"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0509"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0514"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0515"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0517"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0521"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0528"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0529"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0531"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0533"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0535"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NumberOfReportableSegments
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="xdx2ixbrl0549"
      unitRef="NUMBER">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="xdx2ixbrl0652"
      unitRef="USD">-11898000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="xdx2ixbrl0656"
      unitRef="USD">463000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="xdx2ixbrl0658"
      unitRef="USD">228000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="xdx2ixbrl0712"
      unitRef="USD">-11898000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="xdx2ixbrl0713"
      unitRef="USD">-40308000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="xdx2ixbrl0782"
      unitRef="Shares">38062647</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0830"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember"
      id="xdx2ixbrl0854"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-06-30_custom_April2024ConvertibleSecurityMember"
      id="xdx2ixbrl0858"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember"
      id="xdx2ixbrl0862"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2024-06-30_custom_ConvertibleSecurityMember"
      id="xdx2ixbrl0864"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtTerm contextRef="AsOf2023-06-30" id="xdx2ixbrl0875">P24M</us-gaap:LongTermDebtTerm>
    <us-gaap:IntermediateLifePlantsUsefulLife
      contextRef="AsOf2024-06-30_custom_LindIIIConvertibleSecurityMember"
      id="xdx2ixbrl0889">P4Y</us-gaap:IntermediateLifePlantsUsefulLife>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember7264156"
      id="xdx2ixbrl0916"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="xdx2ixbrl1016"
      unitRef="USD">3338000</us-gaap:FairValueAdjustmentOfWarrants>
    <niobf:DebtMaturityPeriod
      contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MinimumMember"
      id="xdx2ixbrl1026">P6M</niobf:DebtMaturityPeriod>
    <niobf:DebtMaturityPeriod
      contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MaximumMember"
      id="xdx2ixbrl1028">P18M</niobf:DebtMaturityPeriod>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="xdx2ixbrl1050"
      unitRef="USD">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember"
      id="xdx2ixbrl1229">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember"
      id="xdx2ixbrl1266">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember"
      id="xdx2ixbrl1282">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl1322">P3Y5M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="xdx2ixbrl1326"
      unitRef="USD">2881000</us-gaap:ShareBasedCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl1344">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1346">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-06-30_custom_ExercisePrice9.70Member"
      id="xdx2ixbrl1393">2025-02-19</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-06-30_custom_ExercisePrice4.60Member"
      id="xdx2ixbrl1401">2025-09-01</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-06-30_custom_ExercisePrice3.54Member"
      id="xdx2ixbrl1406">2025-12-22</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-06-30_custom_ExercisePrice2.20Member"
      id="xdx2ixbrl1411">2025-06-24</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-06-30_custom_ExercisePrice3.25Member"
      id="xdx2ixbrl1416">2027-04-12</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-06-30_custom_ExercisePrice11.50Member"
      id="xdx2ixbrl1421">2028-03-17</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1472">P3Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1474">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-03-152023-03-17_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1476">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:RelatedPartyDepositLiabilities
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl1520"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="AsOf2024-06-30" id="xdx2ixbrl1556">P2Y7M6D</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="AsOf2023-06-30" id="xdx2ixbrl1558">P3Y7M6D</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_us-gaap_DomesticCountryMember"
      id="xdx2ixbrl1616"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:GxiiTransactionCosts
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl1648"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ConvertibleNoteValuation
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl1658"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ExtinguishmentOfDebtGainLossIncomeTax
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl1660"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:EffectOfLegislativeChanges
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl1663"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="xdx2ixbrl1675"
      unitRef="USD">-139000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="xdx2ixbrl1677"
      unitRef="USD">-304000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl1708"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl1709"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostsIncurredDevelopmentCosts
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl1721"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-06-30_us-gaap_DomesticCountryMember"
      id="xdx2ixbrl1753"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1776"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1777"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1781"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1782"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1786"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1787"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1790"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1791"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1795"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1796"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1800"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1805"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1810"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1811"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1814"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1815"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1818"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1819"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1821"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1822"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1825"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1829"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2023-07-01to2024-06-30" id="Fact000016">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2023-07-01to2024-06-30" id="Fact000017">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2023-07-01to2024-06-30" id="Fact000018">2024-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2023-07-01to2024-06-30" id="Fact000019">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2023-07-01to2024-06-30" id="Fact000020">001-41655</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2023-07-01to2024-06-30" id="Fact000021">NioCorp Developments Ltd.</dei:EntityRegistrantName>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-07-01to2024-06-30" id="Fact000023">98-1262185</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-07-01to2024-06-30" id="Fact000024">7000                                          South Yosemite Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-07-01to2024-06-30" id="Fact000025">Suite 115</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-07-01to2024-06-30" id="Fact000026">Centennial</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-07-01to2024-06-30" id="Fact000027">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-07-01to2024-06-30" id="Fact000028">80112</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-07-01to2024-06-30" id="Fact000029">(720)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-07-01to2024-06-30" id="Fact000030">334-7066</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="From2023-07-012024-06-30_custom_CommonSharesWithoutParValueMember"
      id="Fact000031">Common     Shares, without par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2023-07-012024-06-30_custom_CommonSharesWithoutParValueMember"
      id="Fact000032">NB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2023-07-012024-06-30_custom_CommonSharesWithoutParValueMember"
      id="Fact000033">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2023-07-012024-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember"
      id="Fact000034">Warrants,     each exercisable for 1.11829212 Common Shares</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2023-07-012024-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember"
      id="Fact000035">NIOBW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2023-07-012024-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember"
      id="Fact000036">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2023-07-01to2024-06-30" id="Fact000037">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2023-07-01to2024-06-30" id="Fact000038">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2023-07-01to2024-06-30" id="Fact000039">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2023-07-01to2024-06-30" id="Fact000040">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2023-07-01to2024-06-30" id="Fact000041">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2023-07-01to2024-06-30" id="Fact000042">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-07-01to2024-06-30" id="Fact000043">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2023-07-01to2024-06-30" id="Fact000044">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000045"
      unitRef="USD">100600000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-09-20"
      decimals="INF"
      id="Fact000046"
      unitRef="Shares">38660244</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName contextRef="From2023-07-01to2024-06-30" id="Fact000047">DELOITTE &amp; TOUCHE LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2023-07-01to2024-06-30" id="Fact000048">Denver, Colorado</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="From2023-07-01to2024-06-30" id="Fact000049">34</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000057"
      unitRef="USD">2012000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000058"
      unitRef="USD">2341000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000060"
      unitRef="USD">916000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000061"
      unitRef="USD">1385000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000063"
      unitRef="USD">2928000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000064"
      unitRef="USD">3726000</us-gaap:AssetsCurrent>
    <us-gaap:DepositsAssets
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000069"
      unitRef="USD">35000</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000070"
      unitRef="USD">35000</us-gaap:DepositsAssets>
    <us-gaap:LongTermInvestmentsAndReceivablesNet
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000072"
      unitRef="USD">4000</us-gaap:LongTermInvestmentsAndReceivablesNet>
    <us-gaap:LongTermInvestmentsAndReceivablesNet
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000073"
      unitRef="USD">9000</us-gaap:LongTermInvestmentsAndReceivablesNet>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000075"
      unitRef="USD">181000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000076"
      unitRef="USD">236000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000078"
      unitRef="USD">837000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000079"
      unitRef="USD">839000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000081"
      unitRef="USD">16085000</us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties>
    <us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000082"
      unitRef="USD">16085000</us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties>
    <us-gaap:Assets
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000084"
      unitRef="USD">20070000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000085"
      unitRef="USD">20930000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000093"
      unitRef="USD">1843000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000094"
      unitRef="USD">3491000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000096"
      unitRef="USD">2365000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000099"
      unitRef="USD">7660000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000102"
      unitRef="USD">96000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000103"
      unitRef="USD">71000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000105"
      unitRef="USD">11964000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000106"
      unitRef="USD">3562000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000112"
      unitRef="USD">10561000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000114"
      unitRef="USD">1651000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000115"
      unitRef="USD">4989000</us-gaap:OtherLiabilitiesNoncurrent>
    <niobf:EarnoutLiabilityAtFairValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000117"
      unitRef="USD">3817000</niobf:EarnoutLiabilityAtFairValue>
    <niobf:EarnoutLiabilityAtFairValue
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000118"
      unitRef="USD">10521000</niobf:EarnoutLiabilityAtFairValue>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000120"
      unitRef="USD">104000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000121"
      unitRef="USD">164000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000123"
      unitRef="USD">17536000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000124"
      unitRef="USD">29797000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000129"
      unitRef="USD">1534000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000130"
      unitRef="USD">2100000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000138"
      unitRef="USDPShares">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact000140"
      unitRef="USDPShares">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000146"
      unitRef="Shares">38062647</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact000148"
      unitRef="Shares">31202131</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000135"
      unitRef="USD">163823000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000136"
      unitRef="USD">140421000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000150"
      unitRef="USD">-161912000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000151"
      unitRef="USD">-150477000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000153"
      unitRef="USD">-911000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000154"
      unitRef="USD">-911000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000156"
      unitRef="USD">1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000157"
      unitRef="USD">-10967000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000159"
      unitRef="USD">20070000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000160"
      unitRef="USD">20930000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000165"
      unitRef="USD">3509000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000166"
      unitRef="USD">2323000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000168"
      unitRef="USD">3533000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000169"
      unitRef="USD">2581000</us-gaap:ProfessionalFees>
    <niobf:ExplorationExpenditures
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000171"
      unitRef="USD">2552000</niobf:ExplorationExpenditures>
    <niobf:ExplorationExpenditures
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000172"
      unitRef="USD">5348000</niobf:ExplorationExpenditures>
    <us-gaap:OtherGeneralExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000174"
      unitRef="USD">4163000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000175"
      unitRef="USD">27158000</us-gaap:OtherGeneralExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000177"
      unitRef="USD">13757000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000178"
      unitRef="USD">37410000</us-gaap:OperatingExpenses>
    <niobf:ChangeInFairValueOfEarnoutLiability
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000180"
      unitRef="USD">6704000</niobf:ChangeInFairValueOfEarnoutLiability>
    <niobf:ChangeInFairValueOfEarnoutLiability
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000181"
      unitRef="USD">2674000</niobf:ChangeInFairValueOfEarnoutLiability>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000183"
      unitRef="USD">1875000</niobf:ChangeInFairValueOfWarrantLiability>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000184"
      unitRef="USD">-1414000</niobf:ChangeInFairValueOfWarrantLiability>
    <niobf:ChangeInFairValueOfConvertibleNotes
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000186"
      unitRef="USD">-2542000</niobf:ChangeInFairValueOfConvertibleNotes>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000190"
      unitRef="USD">1922000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:InterestExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000192"
      unitRef="USD">4490000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000193"
      unitRef="USD">2336000</us-gaap:InterestExpense>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000195"
      unitRef="USD">31000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000196"
      unitRef="USD">-216000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:OtherIncome
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000198"
      unitRef="USD">147000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000199"
      unitRef="USD">13000</us-gaap:OtherIncome>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000201"
      unitRef="USD">-5000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000202"
      unitRef="USD">-1000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000204"
      unitRef="USD">-12037000</niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1>
    <niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000205"
      unitRef="USD">-40612000</niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000207"
      unitRef="USD">-139000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000208"
      unitRef="USD">-304000</us-gaap:IncomeTaxExpenseBenefit>
    <niobf:ProfitLoss1
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000210"
      unitRef="USD">11898000</niobf:ProfitLoss1>
    <niobf:ProfitLoss1
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000211"
      unitRef="USD">40308000</niobf:ProfitLoss1>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000213"
      unitRef="USD">463000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000214"
      unitRef="USD">228000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000216"
      unitRef="USD">11435000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000217"
      unitRef="USD">40080000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000222"
      unitRef="USD">-11898000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000223"
      unitRef="USD">-40308000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000229"
      unitRef="USD">-82000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000231"
      unitRef="USD">11898000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000232"
      unitRef="USD">40226000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000234"
      unitRef="USD">463000</us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000235"
      unitRef="USD">228000</us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000237"
      unitRef="USD">11435000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000238"
      unitRef="USD">39998000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000240"
      unitRef="USDPShares">-0.31</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000241"
      unitRef="USDPShares">-1.34</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000243"
      unitRef="Shares">34320024</niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000244"
      unitRef="Shares">28705840</niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000249"
      unitRef="USD">-11898000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000250"
      unitRef="USD">-40308000</us-gaap:NetIncomeLoss>
    <niobf:AssumptionOfEarnoutLiability
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000256"
      unitRef="USD">13195000</niobf:AssumptionOfEarnoutLiability>
    <niobf:ChangeInFairValueOfEarnoutShareLiability
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000258"
      unitRef="USD">-6704000</niobf:ChangeInFairValueOfEarnoutShareLiability>
    <niobf:ChangeInFairValueOfEarnoutShareLiability
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000259"
      unitRef="USD">-2674000</niobf:ChangeInFairValueOfEarnoutShareLiability>
    <niobf:AssumptionOfPrivateAndPublicWarrants
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000262"
      unitRef="USD">2987000</niobf:AssumptionOfPrivateAndPublicWarrants>
    <niobf:ChangeInValuationOfWarrantLiabilities
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000264"
      unitRef="USD">-1875000</niobf:ChangeInValuationOfWarrantLiabilities>
    <niobf:ChangeInValuationOfWarrantLiabilities
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000265"
      unitRef="USD">1414000</niobf:ChangeInValuationOfWarrantLiabilities>
    <niobf:ChangeInFairValueOfConvertibleNote
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000267"
      unitRef="USD">2542000</niobf:ChangeInFairValueOfConvertibleNote>
    <us-gaap:AccretionExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000270"
      unitRef="USD">4490000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000271"
      unitRef="USD">2157000</us-gaap:AccretionExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000273"
      unitRef="USD">2881000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000274"
      unitRef="USD">1794000</us-gaap:ShareBasedCompensation>
    <niobf:LossesOnExtinguishmentOfDebt
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000277"
      unitRef="USD">1422000</niobf:LossesOnExtinguishmentOfDebt>
    <niobf:FairValueOfCommitmentSharesIssued
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000279"
      unitRef="USD">105000</niobf:FairValueOfCommitmentSharesIssued>
    <niobf:FairValueOfCommitmentSharesIssued
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000280"
      unitRef="USD">663000</niobf:FairValueOfCommitmentSharesIssued>
    <niobf:ForeignCurrencyTransactionGainLossBeforeTax1
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000283"
      unitRef="USD">200000</niobf:ForeignCurrencyTransactionGainLossBeforeTax1>
    <us-gaap:Depreciation
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000285"
      unitRef="USD">2000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000286"
      unitRef="USD">3000</us-gaap:Depreciation>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000288"
      unitRef="USD">-5000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000289"
      unitRef="USD">-1000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000291"
      unitRef="USD">20000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000292"
      unitRef="USD">-12000</us-gaap:OperatingLeaseImpairmentLoss>
    <niobf:OtheroperatingGainsLosses
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000294"
      unitRef="USD">148000</niobf:OtheroperatingGainsLosses>
    <niobf:OtheroperatingGainsLosses
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000295"
      unitRef="USD">13000</niobf:OtheroperatingGainsLosses>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000297"
      unitRef="USD">-10580000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000298"
      unitRef="USD">-19171000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000303"
      unitRef="USD">-469000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000304"
      unitRef="USD">985000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000306"
      unitRef="USD">-1621000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000307"
      unitRef="USD">2861000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000309"
      unitRef="USD">-11732000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000310"
      unitRef="USD">-17295000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000316"
      unitRef="USD">21000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000319"
      unitRef="USD">21000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000324"
      unitRef="USD">6935000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000325"
      unitRef="USD">14857000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000327"
      unitRef="USD">6185000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000328"
      unitRef="USD">2499000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000331"
      unitRef="USD">1130000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000334"
      unitRef="USD">3130000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000336"
      unitRef="USD">1512000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000337"
      unitRef="USD">515000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000339"
      unitRef="USD">205000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000340"
      unitRef="USD">204000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000342"
      unitRef="USD">11403000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000343"
      unitRef="USD">14637000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000346"
      unitRef="USD">-302000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000348"
      unitRef="USD">-329000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000349"
      unitRef="USD">-2939000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000351"
      unitRef="USD">2341000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-06-30"
      decimals="-3"
      id="Fact000352"
      unitRef="USD">5280000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000354"
      unitRef="USD">2012000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000355"
      unitRef="USD">2341000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000361"
      unitRef="USD">264000</us-gaap:InterestPaidNet>
    <niobf:ConversionsOfDebtForCommonShares contextRef="From2023-07-01to2024-06-30" id="Fact000366">14,479</niobf:ConversionsOfDebtForCommonShares>
    <niobf:ConversionsOfDebtForCommonShares contextRef="From2022-07-012023-06-30" id="Fact000367">5,175</niobf:ConversionsOfDebtForCommonShares>
    <niobf:RecognitionOfOperatingLeaseLiabilities contextRef="From2022-07-012023-06-30" id="Fact000370">199</niobf:RecognitionOfOperatingLeaseLiabilities>
    <niobf:ValueOfWarrantsIssued contextRef="From2022-07-012023-06-30" id="Fact000373">3,337</niobf:ValueOfWarrantsIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000381"
      unitRef="Shares">27667060</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000375"
      unitRef="USD">129055000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000376"
      unitRef="USD">-110397000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000377"
      unitRef="USD">-993000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30"
      decimals="-3"
      id="Fact000378"
      unitRef="USD">17665000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000389"
      unitRef="Shares">265138</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000383"
      unitRef="USD">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000386"
      unitRef="USD">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000391"
      unitRef="USD">3338000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000394"
      unitRef="USD">3338000</us-gaap:FairValueAdjustmentOfWarrants>
    <niobf:CommonSharesIssuedInTheGXIITransactionShares
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000403"
      unitRef="Shares">1753821</niobf:CommonSharesIssuedInTheGXIITransactionShares>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000411"
      unitRef="Shares">81213</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000405"
      unitRef="USD">650000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000408"
      unitRef="USD">650000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000419"
      unitRef="Shares">314465</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000413"
      unitRef="USD">2000000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000416"
      unitRef="USD">2000000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000427"
      unitRef="Shares">100000</niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000421"
      unitRef="USD">501000</niobf:SharesIssuedUnderTheYorkvilleEquityFacility>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000424"
      unitRef="USD">501000</niobf:SharesIssuedUnderTheYorkvilleEquityFacility>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000435"
      unitRef="Shares">1020434</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000429"
      unitRef="USD">5604000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000432"
      unitRef="USD">5604000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000437"
      unitRef="USD">-204000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000440"
      unitRef="USD">-204000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <niobf:RedeemableNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000443"
      unitRef="USD">-2328000</niobf:RedeemableNoncontrollingInterest>
    <niobf:RedeemableNoncontrollingInterest
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000446"
      unitRef="USD">-2328000</niobf:RedeemableNoncontrollingInterest>
    <niobf:RedeemableNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000447"
      unitRef="USD">2328000</niobf:RedeemableNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000449"
      unitRef="USD">1794000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000452"
      unitRef="USD">1794000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000457"
      unitRef="USD">82000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000458"
      unitRef="USD">82000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000462"
      unitRef="USD">40080000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000464"
      unitRef="USD">40080000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000465"
      unitRef="USD">228000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000473"
      unitRef="Shares">31202131</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000467"
      unitRef="USD">140421000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000468"
      unitRef="USD">-150477000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000469"
      unitRef="USD">-911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000470"
      unitRef="USD">-10967000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000471"
      unitRef="USD">2100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000481"
      unitRef="Shares">7800</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <niobf:PrivatePlacementShares
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000489"
      unitRef="Shares">978432</niobf:PrivatePlacementShares>
    <niobf:PrivatePlacementValue
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000483"
      unitRef="Shares">2995000</niobf:PrivatePlacementValue>
    <niobf:PrivatePlacementValue
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000486"
      unitRef="Shares">2995000</niobf:PrivatePlacementValue>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000497"
      unitRef="Shares">1358000</niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000491"
      unitRef="USD">3398000</niobf:SharesIssuedUnderTheYorkvilleEquityFacility>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000494"
      unitRef="USD">3398000</niobf:SharesIssuedUnderTheYorkvilleEquityFacility>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000505"
      unitRef="Shares">4232592</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000499"
      unitRef="USD">14479000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000502"
      unitRef="USD">14479000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000507"
      unitRef="USD">-204000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000510"
      unitRef="USD">-204000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000513"
      unitRef="USD">148000</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000516"
      unitRef="USD">148000</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000525"
      unitRef="Shares">283692</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000519"
      unitRef="USD">103000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000522"
      unitRef="USD">103000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000523"
      unitRef="USD">-103000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000527"
      unitRef="USD">2779000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000530"
      unitRef="USD">2779000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000534"
      unitRef="USD">11435000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000536"
      unitRef="USD">11435000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000537"
      unitRef="USD">463000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000545"
      unitRef="Shares">38062647</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000539"
      unitRef="USD">163823000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000540"
      unitRef="USD">-161912000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000541"
      unitRef="USD">-911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000542"
      unitRef="USD">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000543"
      unitRef="USD">1534000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NatureOfOperations contextRef="From2023-07-01to2024-06-30" id="Fact000547">&lt;p id="xdx_80F_eus-gaap--NatureOfOperations_zD6PtwSAtQel" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_821_zW6VRr1DoiE"&gt;DESCRIPTION
                                         OF BUSINESS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NioCorp
Developments Ltd. (the &#x201c;Company&#x201d; or &#x201c;NioCorp&#x201d;) was incorporated on February 27, 1987, under the laws of
the Province of British Columbia and currently operates in &lt;span id="xdx_90F_eus-gaap--NumberOfReportableSegments_dxL_uNUMBER_c20230701__20240630_zJc3cWKtp6z2" title="Number of reportable segments::XDX::1"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0549"&gt;one&lt;/span&gt;&lt;/span&gt; reportable operating segment consisting of exploration and development
of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property (the &#x201c;Elk Creek Project&#x201d;)
located in southeastern Nebraska.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
further discussed in Notes 5, 9, 10, and 11, on March 17, 2023 (the &#x201c;Closing Date&#x201d;), the Company closed the GXII Transaction
(as defined below) with GX Acquisition Corp. II (&#x201c;GXII&#x201d;), pursuant to the Business Combination Agreement, dated September
25, 2022 (the &#x201c;Business Combination Agreement&#x201d;), among the Company, GXII and Big Red Merger Sub Ltd (the &#x201c;Closing&#x201d;).
At the Closing, the Company also closed convertible debt financings (the &#x201c;Yorkville Convertible Debt Financing&#x201d;) with
YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (together with YA II PN, Ltd., &#x201c;Yorkville&#x201d;),
and the standby equity purchase facility with Yorkville (the &#x201c;Yorkville Equity Facility Financing&#x201d; and, together with
the Yorkville Convertible Debt Financing, the &#x201c;Yorkville Financings&#x201d;) became effective. The transactions contemplated
by the Business Combination Agreement, including the GXII Transaction, the Yorkville Financings and the Reverse Stock Split (as
defined below), are referred to, collectively, as the &#x201c;2023 Transactions.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
GXII Transaction was accounted for as an equity raise transaction in accordance with generally accepted accounting principles
of the United States of America (&#x201c;U.S. GAAP&#x201d;). Under this method of accounting, GXII is treated as the &#x201c;acquired&#x201d;
company for financial reporting purposes. Accordingly, the GXII Transaction is treated as the equivalent of NioCorp issuing common
shares, no par value, of the Company (&#x201c;Common Shares&#x201d;) for the assets and liabilities of GXII. The net assets of GXII
are stated at historical cost, with no goodwill or other intangible assets recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 4, these matters raise substantial doubt about the Company&#x2019;s
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing and maintaining continued support from its shareholders and creditors.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
    <us-gaap:BasisOfAccounting contextRef="From2023-07-01to2024-06-30" id="Fact000551">&lt;p id="xdx_802_eus-gaap--BasisOfAccounting_zsQVKD3gUrj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82D_z5hzFCKjEWSc"&gt;BASIS
                                         OF PREPARATION&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basis
                                         of Preparation and Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
consolidated financial statements have been prepared in conformity with U.S. GAAP and the rules and regulations of the U.S. Securities
and Exchange Commission. The consolidated financial statements include the consolidated accounts of the Company and its wholly
owned subsidiaries with all significant intercompany transactions eliminated. Certain transactions include reference to Canadian
dollars (&#x201c;C$&#x201d;) where applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zf69pR31uxh6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; width: 97%; border-collapse: collapse"&gt;
&lt;tr&gt;
    &lt;td colspan="2" rowspan="2" style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td rowspan="2" style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Jurisdiction
    of incorporation&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ownership
    at June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td style="border-top: Black 1pt solid; width: 28%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0896800 BC Ltd. (&#x201c;0896800&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; width: 22%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zjCmO2yFTGz4" title="Country of incorporation"&gt;&lt;span id="xdx_903_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zLkrTedR6Li4" title="Country of incorporation"&gt;British
    Columbia, Canada&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_z8rt1hY4BU3k" style="border-top: Black 1pt solid; width: 16%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zaMVCXvGfrKf" style="border-top: Black 1pt solid; width: 16%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Elk
    Creek Resources Corp.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zThpzWj8ANz1" title="Country of incorporation"&gt;&lt;span id="xdx_909_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_z64JqIVxOu5i" title="Country of incorporation"&gt;Nebraska,
    USA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zWG4d2e4K7Ck" title="Percentage of ownership"&gt;100&lt;/span&gt;% &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Elk
    Creek Resources Corp. (&#x201c;ECRC&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zOzbwCizq231" title="Country of incorporation"&gt;&lt;span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zvuBARcqoNpk" title="Country of incorporation"&gt;Delaware,
    USA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zw7RJNX49Ww2" title="Percentage of ownership"&gt;79.7&lt;/span&gt;%&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zi1J736PuuGf" title="Percentage of ownership"&gt;79.1&lt;/span&gt;%&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NioCorp
    Technologies Limited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zIJCeRfSoK58" title="Country of incorporation"&gt;&lt;span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zc2xV3GIE6R7" title="Country of incorporation"&gt;United
    Kingdom&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zqOqhWwkifdi" title="Percentage of ownership"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span id="xdx_F09_zSzo3oHuagfl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zdZyBZKB7Z3f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents 100% of Class A common stock owned by 0896800, and 4,282,116 and 4,565,808 Vested Shares and 3,391,596 and 3,391,596
Earnout Shares (each as defined below) held by third parties, and outstanding as of June 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A1_zBJ4Q2TIiE0k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Use
                                         of Estimates&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the consolidated financial statements, and the reported amounts of expenses during the reporting period. The Company regularly
evaluates estimates and assumptions related to the valuation of mineral properties, deferred income tax asset valuations, convertible
debt valuations, earnout valuation, derivative liabilities, warrant liabilities, and share-based compensation. The Company bases
its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable
under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results
experienced by the Company may differ materially and adversely from the Company&#x2019;s estimates. To the extent there are material
differences between estimates and the actual results, future results of operations will be affected.&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccounting>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000553">&lt;p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zf69pR31uxh6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; width: 97%; border-collapse: collapse"&gt;
&lt;tr&gt;
    &lt;td colspan="2" rowspan="2" style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td rowspan="2" style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Jurisdiction
    of incorporation&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ownership
    at June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td style="border-top: Black 1pt solid; width: 28%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0896800 BC Ltd. (&#x201c;0896800&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; width: 22%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zjCmO2yFTGz4" title="Country of incorporation"&gt;&lt;span id="xdx_903_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zLkrTedR6Li4" title="Country of incorporation"&gt;British
    Columbia, Canada&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_z8rt1hY4BU3k" style="border-top: Black 1pt solid; width: 16%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zaMVCXvGfrKf" style="border-top: Black 1pt solid; width: 16%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Elk
    Creek Resources Corp.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zThpzWj8ANz1" title="Country of incorporation"&gt;&lt;span id="xdx_909_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_z64JqIVxOu5i" title="Country of incorporation"&gt;Nebraska,
    USA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zWG4d2e4K7Ck" title="Percentage of ownership"&gt;100&lt;/span&gt;% &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Elk
    Creek Resources Corp. (&#x201c;ECRC&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zOzbwCizq231" title="Country of incorporation"&gt;&lt;span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zvuBARcqoNpk" title="Country of incorporation"&gt;Delaware,
    USA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zw7RJNX49Ww2" title="Percentage of ownership"&gt;79.7&lt;/span&gt;%&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zi1J736PuuGf" title="Percentage of ownership"&gt;79.1&lt;/span&gt;%&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NioCorp
    Technologies Limited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--IncorporationStateCountryName_c20230701__20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zIJCeRfSoK58" title="Country of incorporation"&gt;&lt;span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zc2xV3GIE6R7" title="Country of incorporation"&gt;United
    Kingdom&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zqOqhWwkifdi" title="Percentage of ownership"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span id="xdx_F09_zSzo3oHuagfl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zdZyBZKB7Z3f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents 100% of Class A common stock owned by 0896800, and 4,282,116 and 4,565,808 Vested Shares and 3,391,596 and 3,391,596
Earnout Shares (each as defined below) held by third parties, and outstanding as of June 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <niobf:IncorporationStateCountryName
      contextRef="From2023-07-012024-06-30_custom_Entity0896800BCLtdMember"
      id="Fact000555">British
    Columbia, Canada</niobf:IncorporationStateCountryName>
    <niobf:IncorporationStateCountryName
      contextRef="From2022-07-012023-06-30_custom_Entity0896800BCLtdMember"
      id="Fact000557">British
    Columbia, Canada</niobf:IncorporationStateCountryName>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2024-06-30_custom_Entity0896800BCLtdMember"
      decimals="INF"
      id="Fact000558"
      unitRef="Pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2023-06-30_custom_Entity0896800BCLtdMember"
      decimals="INF"
      id="Fact000559"
      unitRef="Pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <niobf:IncorporationStateCountryName
      contextRef="From2023-07-012024-06-30_custom_ElkCreekResourcesCorpMember"
      id="Fact000561">Nebraska,
    USA</niobf:IncorporationStateCountryName>
    <niobf:IncorporationStateCountryName
      contextRef="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpMember"
      id="Fact000563">Nebraska,
    USA</niobf:IncorporationStateCountryName>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2023-06-30_custom_ElkCreekResourcesCorpMember"
      decimals="INF"
      id="Fact000565"
      unitRef="Pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <niobf:IncorporationStateCountryName
      contextRef="From2023-07-012024-06-30_custom_ElkCreekResourcesCorpECRCMember"
      id="Fact000567">Delaware,
    USA</niobf:IncorporationStateCountryName>
    <niobf:IncorporationStateCountryName
      contextRef="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpECRCMember"
      id="Fact000569">Delaware,
    USA</niobf:IncorporationStateCountryName>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2024-06-30_custom_ElkCreekResourcesCorpECRCMember"
      decimals="INF"
      id="Fact000571"
      unitRef="Pure">0.797</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2023-06-30_custom_ElkCreekResourcesCorpECRCMember"
      decimals="INF"
      id="Fact000573"
      unitRef="Pure">0.791</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <niobf:IncorporationStateCountryName
      contextRef="From2023-07-012024-06-30_custom_NioCorpTechnologiesLimitedMember"
      id="Fact000575">United
    Kingdom</niobf:IncorporationStateCountryName>
    <niobf:IncorporationStateCountryName
      contextRef="From2022-07-012023-06-30_custom_NioCorpTechnologiesLimitedMember"
      id="Fact000577">United
    Kingdom</niobf:IncorporationStateCountryName>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2024-06-30_custom_NioCorpTechnologiesLimitedMember"
      decimals="INF"
      id="Fact000579"
      unitRef="Pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000588">&lt;p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zt4CN23jWZra" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_820_zPeyYA2MXzB8"&gt;SIGNIFICANT
                                         ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--DevelopmentStageIssuerPolicyTextBlock_z6Ky6LyWq3Wg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zOxMMr2INzx4"&gt;Development
                                         Stage Issuer&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#x201c;S-K 1300&#x201d;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#x2019;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#x2019;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85E_zBYenB0qbRz5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zyKcv3ZE804d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
                                         and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90
days or less, and money market funds. The Company maintains the majority of its cash balances with two financial institutions.
Accounts at banks in the United States (&#x201c;U.S.&#x201d;) are insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;)
up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance Corporation (&#x201c;CDIC&#x201d;) up
to C$100. At June 30, 2024, the Company had $1,406 and $0 in excess of the FDIC and CDIC insured limits, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85F_zyACynnHwCae" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zFpeUIPaGY17" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_863_zlLDdyLwxws8"&gt;Foreign
                                         Currency Translation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Functional
and reporting currency&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Items
included in the financial statements of each of the Company&#x2019;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#x201c;the functional currency&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
reporting currency for these consolidated financial statements is U.S. dollars.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Change
in functional currency&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to March 17, 2023, the Company&#x2019;s functional currency was the Canadian dollar. The Company re-assessed its functional currency
and determined that on March 17, 2023, its functional currency changed from the Canadian dollar to the U.S. dollar based on significant
changes in economic facts and circumstances in our organization. The change in functional currency was accounted for prospectively
from March 17, 2023 and prior-period consolidated financial statements were not restated for the change in functional currency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
both monetary and non-monetary assets and liabilities, translated balances as of March 17, 2023 became the new accounting basis.
The exchange rate on the date of change became the historical rate at which non-monetary assets and liabilities were translated
in subsequent periods. There was no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded
cumulative translation adjustments were not reversed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
functional currency for the Company&#x2019;s Canadian subsidiary, 0896800 BC Ltd., which has no independent operations from its
parent, also changed from the Canadian dollar to the U.S. dollar. The functional currency for Elk Creek Resources Corp. remains
as the U.S. dollar.&lt;/span&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Transactions
in foreign currency&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Translation
to reporting currency&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Translation
gains and losses from the application of the U.S. dollar as the reporting currency for all periods prior to March 17, 2023 (when
the Canadian dollar was the functional currency) are included as part of cumulative currency translation adjustment, which is
reported as a component of shareholders&#x2019; equity under accumulated other comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_853_zu1ogsAIjjoj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_ecustom--MineralPropertiesPolicyTextBlock_z871pBas3l0e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zFugxpbaTuvl"&gt;Mineral
                                         Properties&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of Common Shares issued as consideration. Properties acquired under option agreements,
whereby payments are made at the sole discretion of the Company, are capitalized as mineral property acquisition costs at such
time as the payments are made. Exploration costs are expensed as incurred. When it is determined that a mining deposit can be
economically and legally extracted or produced based on established proven and probable reserves under S-K 1300, and the Company&#x2019;s
board of directors (the &#x201c;Board&#x201d;) has approved the commencement of formal development activities, development costs
related to such reserves and incurred after such board approval will be considered for capitalization. The establishment of proven
and probable reserves is based on results of feasibility studies, which indicate whether a property is economically feasible.
Upon commencement of commercial production, capitalized costs will be amortized over their estimated useful lives or units of
production, whichever is a more reliable measure. Capitalized amounts relating to a property that is abandoned or otherwise considered
uneconomic for the foreseeable future are written off.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#x2019;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was no impairment recorded to mineral properties as of
June 30, 2024 or 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85C_zosz9HQMWyZ3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBC9mEc6STt1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86B_zEaiVHlVtH27"&gt;Long
                                         Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was no impairment recorded to long-lived assets as of June 30, 2024 or 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_zRDcCnhtaOr4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zw3U6fHn81tj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_864_z26z4m9B3eV7"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, &lt;i&gt;Leases&lt;/i&gt;, we determine if a contractual arrangement is, or contains,
a lease at the inception date. Right-of-use (&#x201c;ROU&#x201d;) assets and liabilities related to operating leases are separately
reported in the consolidated balance sheets. The Company currently has no finance leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_852_zMZ3v4YoUK2f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--ConvertibleDebtCarriedatFairValueTextBlock_zFf3LGmktr5j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;g)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
                                         Debt Carried at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With regard to the Company&#x2019;s debt related to the convertible promissory notes issued in April 2024 (as further discussed in
Note 9), the Company has elected to account for these notes at fair value per the provisions of ASC Topic 815, &lt;i&gt;Derivatives
and Hedging&lt;/i&gt; (&#x201c;ASC 815&#x201d;). Under ASC 815-15-25, an election can be taken at the inception of a financial instrument
to account for the instrument at fair value. The notes were recorded at fair value at inception and assessed quarterly thereafter
using a Monte Carlo simulation methodology which incorporates multiple conversion scenarios. All changes in fair value subsequent
to the initial recording, excluding the impact of the change in fair value related to the Company&#x2019;s own credit risk, are
recorded as a component of non-operating income/expense, within Change in fair value of convertible debt in the consolidated statements
of operations. Changes in fair value related to the Company&#x2019;s own credit risk, if any, are recorded through other comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_856_z8PrHWApeFwb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--WarrantsPolicyTextBlock_zVzXuHVnB1jg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;h)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86F_zFBuDFHSSjra"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
apply relevant accounting guidance for warrants to purchase our stock based on the nature of the relationship with the counterparty.
For warrants issued to investors or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC
480, &lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt;, and ASC 815, to assist in the determination of whether the warrants should
be classified as liabilities or equity. The fair value of warrants is estimated using Black Scholes modeling or Monte Carlo modeling,
depending on the settlement features embedded in the warrant. Inputs under both models include inputs such as NioCorp&#x2019;s
Common Share price, the risk-free interest rate, the expected term, the volatility, and the dividend rate. Warrants that are determined
to require liability classifications are measured at fair value upon issuance and are subsequently remeasured to their then fair
value at each subsequent reporting period with changes in fair value recorded in current earnings. Warrants that are determined
to require equity classifications measured at fair value upon issuance and are not subsequently remeasured unless they are required
to be reclassified.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85F_zqVQtxg8taF9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--EarnoutSharesPolicy_zXvZc6JpFmed" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
                                         Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The Earnout Shares
are measured at fair value upon issuance and subsequently remeasured at each reporting period using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#x2019;s Common Share price, the risk-free interest rate, the expected term, the weighted
average of historical Common Share volatility and implied volatility underlying the Company&#x2019;s Public Warrants, the dividend
rate, the conversion price, and the number of Earnout Shares outstanding. Assumptions used in the model are subjective and require
significant judgment.&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_857_zOo0ojmXRhib" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;



















&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zeSl7pShaLzl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;j)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_866_zymGassAsrg2"&gt;Financial
                                         Instruments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of cash and cash equivalents, receivables, equity securities, accounts payable and
accrued liabilities, notes payable, convertible debt, and the related party loan. It is management&#x2019;s opinion that the Company
is not exposed to significant interest, currency or credit risks arising from its financial instruments. The fair values of these
instruments approximate their carrying value unless otherwise noted.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_852_zTwingViNPT2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_ziM19jf9lqHl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;k)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zxxEgvrMFbk"&gt;Concentration
                                         of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver, British Columbia and Santa Clara, California.
As part of its cash management process, the Company regularly monitors the relative credit standing of these institutions.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_853_zXx6f6rixo32" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--AssetRetirementObligationsPolicy_ze2r2G0Eiqnb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;l)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zLzHOWeAYgJ3"&gt;Asset
                                         Retirement Obligation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $&lt;span id="xdx_908_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20240630_zOV4XPJ3gpjc"&gt;48&lt;/span&gt; as an accrued liability related to
estimated obligations as of June 30, 2024 (2023 - $&lt;span id="xdx_900_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20230630_zaXUsPjc7Ke4" title="Accrued exploration stage expense"&gt;48&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss
in the period an estimate is revised.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85F_zhmYRDK7YtY6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zCv3nwIbVBba" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;m)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_861_zgf1SsEh0XDb"&gt;Income
                                         Taxes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, &lt;i&gt;&#x201c;Income Taxes &#x2013; Recognition.&#x201d;
&lt;/i&gt;Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#x201c;more likely than not&#x201d; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#x201c;Income Taxes &#x2013; Disclosure,&#x201d;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2024 and 2023, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_853_zHPq2BRxIFqh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--ReverseStockSplitPolicyTextBlock_zcryDoHkjpUg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;n)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zixf7ipR0xk5"&gt;Reverse
                                         Stock Split&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 17, 2023, the Company effected a reverse stock split (the &#x201c;Reverse Stock Split&#x201d;) on the basis of one (1) post-Reverse
Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding, with any fractional
shares resulting from the Reverse Stock Split rounded down to the nearest whole share. Immediately after the Reverse Stock Split,
there were 30,000,442 Common Shares issued and outstanding. All references to share and per share amounts (excluding authorized
shares) in the consolidated financial statements and accompanying notes have been retroactively restated to reflect the Reverse
Stock Split.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85B_zMeiKcNYisq6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zZYz7a3R8b5l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;o)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86B_z98S5JPclJ1a"&gt;Redeemable
                                         Noncontrolling Interest&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#x2019;s control and is reported in the mezzanine section between total liabilities
and shareholders&#x2019; deficit, as temporary equity in the Company&#x2019;s consolidated balance sheets. The Company&#x2019;s non-controlling
interest is redeemable at fair value, and no adjustment to the earnings per share numerator is required because redemption at
fair value is not considered an economic distribution different from other common stockholders.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_854_zevX8FbQDsyi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;



















&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_z8mz8hNA0fja" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;p)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_864_z61ows0CsP4a"&gt;Basic
                                         and Diluted Per Share Disclosure&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average number
of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout Shares (each as defined
in Note 10), to be participating securities, requiring the use of the two-class method. Diluted earnings (loss) per share represents
net earnings (loss) attributable to common shareholders divided by the weighted average number of Common Shares outstanding, inclusive
of the dilutive impact of all potentially dilutive securities outstanding during the period, as applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z4oXpvuz7yij" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share
attributable to common shareholders:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zmPdZGo8Jldb" style="width: 12%; text-align: right" title="Net loss::XDX::-11898"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0652"&gt;(11,898&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230630_zZ8ZK7ESqopj" style="width: 12%; text-align: right" title="Net loss"&gt;(40,308&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Adjust: &#160;Net loss attributable to noncontrolling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20230701__20240630_ztoS73kIOKx3" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::463"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0656"&gt;458&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zORNxPZyMr5f" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::228"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0658"&gt;(251&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Net loss available to participating securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zOIH99mkHtGl" style="text-align: right" title="Net loss available to participating securities"&gt;(11,440&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zS9EcMMR2GMc" style="text-align: right" title="Net loss available to participating securities"&gt;(40,057&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Net loss attributable to Vested Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zqM20nkHogYb" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares"&gt;967&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zbdm4thPBHWk" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares"&gt;1,528&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Net loss attributed to common shareholders - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zg6rjKR1gZY5" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;(10,473&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_zXsSreWXTDt5" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;(38,529&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Weighted average shares outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_znEa4o0ILxi4" style="text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;34,320,024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zVCao1x4Trsc" style="text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;28,705,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Loss per Common Share outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20240630_z6niy4YWEVQ" style="text-align: right" title="Loss per common share outstanding basic and diluted"&gt;(0.31&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_zxQjh92qxab4" style="text-align: right" title="Loss per common share outstanding basic and diluted"&gt;(1.34&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_zoFmaRWAIf1b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following shares underlying options, warrants, and outstanding convertible debt were antidilutive due to a net loss in the periods
presented and, therefore, were excluded from the dilutive securities computation for the years ended June 30, 2024 and 2023, as
indicated below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zBrtvXc7lCd2" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; visibility: hidden"&gt;&lt;span id="xdx_8B8_zZeo1Pcp509"&gt;Schedule of excluded from the dilutive securities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; border-collapse: collapse; width: 91%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Excluded potentially dilutive securities &lt;sup id="xdx_F69_zLunV1ebYId4"&gt;(1)(2)&lt;/sup&gt;:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; padding-left: 0.25in; text-indent: -0.125in"&gt;Options&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zvapHnoAM9w6" style="width: 12%; text-align: right" title="Options"&gt;2,495,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zWphhe01Uuyi" style="width: 12%; text-align: right" title="Options"&gt;1,541,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_z2ofRW7Lmgk" style="text-align: right" title="Warrants"&gt;18,563,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zBJov0ZymEgi" style="text-align: right" title="Warrants"&gt;18,816,304&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zlzyJMRW9Uj5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;2,849,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_zYJcZ1sPSRk5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;2,871,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Total potentially dilutive securities&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_zaGrLyZ7nwpf" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities"&gt;23,908,061&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zfyvgekKOY25" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities"&gt;23,229,464&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: justify"&gt;&lt;span id="xdx_F02_zLNq355T4bGf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_zGoQRZD8Ae11" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F0C_ztq3eT2kaFPj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_z7xqga9FTee9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zqXUp5Ok9Uw2" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p id="xdx_855_zGTaXDfAX5Ml" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zNUCQi67FfWd" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;
                                                    &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;q)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_861_zCtXI4XN2huk"&gt;Share
                                         Based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company grants stock options to directors, officers, employees, and business advisors. Option terms and vesting conditions are
at the discretion of the Board. Prior to March 31, 2023, the option exercise price was equal to the closing market price on The
Toronto Stock Exchange (the &#x201c;TSX&#x201d;) on the day preceding the date of grant. Effective March 21, 2023, the option exercise
price is equal to the closing market price on the Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;) on the day preceding the date
of the grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates the fair value of stock options using the Black-Scholes option pricing model. The Company recognizes forfeitures
as they occur.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zyHZ54Jr96Di" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;



















&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zxAhxkbPKgP9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;r)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86F_zloV9IAt35fk"&gt;Recent
                                         Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Issued
and Not Effective&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, &lt;i&gt;Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures&lt;/i&gt;, which is intended to improve reportable segment disclosure requirements, primarily through
enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses
that are regularly provided to the chief operating decision maker and included within segment profit and loss. The amendments
are effective for the Company&#x2019;s annual periods beginning July 1, 2024, and interim periods beginning July 1, 2025, with
early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. The
Company has evaluated the ASU and has determined that implementation will have limited impact on the Company&#x2019;s disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/i&gt;, which includes
amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation
categories and income taxes paid by jurisdiction. The amendments are effective for the Company&#x2019;s annual periods beginning
June 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively. The Company is currently
evaluating the ASU to determine its impact on the Company&#x2019;s disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#x2019;s consolidated financial statements upon adoption.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_853_zG1Q0u67xNt2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <niobf:DevelopmentStageIssuerPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000590">&lt;p id="xdx_84B_ecustom--DevelopmentStageIssuerPolicyTextBlock_z6Ky6LyWq3Wg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zOxMMr2INzx4"&gt;Development
                                         Stage Issuer&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#x201c;S-K 1300&#x201d;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#x2019;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#x2019;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.&lt;/span&gt;&lt;/p&gt;

</niobf:DevelopmentStageIssuerPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000592">&lt;p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zyKcv3ZE804d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
                                         and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90
days or less, and money market funds. The Company maintains the majority of its cash balances with two financial institutions.
Accounts at banks in the United States (&#x201c;U.S.&#x201d;) are insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;)
up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance Corporation (&#x201c;CDIC&#x201d;) up
to C$100. At June 30, 2024, the Company had $1,406 and $0 in excess of the FDIC and CDIC insured limits, respectively.&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000594">&lt;p id="xdx_849_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zFpeUIPaGY17" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_863_zlLDdyLwxws8"&gt;Foreign
                                         Currency Translation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Functional
and reporting currency&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Items
included in the financial statements of each of the Company&#x2019;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#x201c;the functional currency&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
reporting currency for these consolidated financial statements is U.S. dollars.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Change
in functional currency&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to March 17, 2023, the Company&#x2019;s functional currency was the Canadian dollar. The Company re-assessed its functional currency
and determined that on March 17, 2023, its functional currency changed from the Canadian dollar to the U.S. dollar based on significant
changes in economic facts and circumstances in our organization. The change in functional currency was accounted for prospectively
from March 17, 2023 and prior-period consolidated financial statements were not restated for the change in functional currency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
both monetary and non-monetary assets and liabilities, translated balances as of March 17, 2023 became the new accounting basis.
The exchange rate on the date of change became the historical rate at which non-monetary assets and liabilities were translated
in subsequent periods. There was no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded
cumulative translation adjustments were not reversed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
functional currency for the Company&#x2019;s Canadian subsidiary, 0896800 BC Ltd., which has no independent operations from its
parent, also changed from the Canadian dollar to the U.S. dollar. The functional currency for Elk Creek Resources Corp. remains
as the U.S. dollar.&lt;/span&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Transactions
in foreign currency&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Translation
to reporting currency&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Translation
gains and losses from the application of the U.S. dollar as the reporting currency for all periods prior to March 17, 2023 (when
the Canadian dollar was the functional currency) are included as part of cumulative currency translation adjustment, which is
reported as a component of shareholders&#x2019; equity under accumulated other comprehensive loss.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <niobf:MineralPropertiesPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000603">&lt;p id="xdx_84F_ecustom--MineralPropertiesPolicyTextBlock_z871pBas3l0e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zFugxpbaTuvl"&gt;Mineral
                                         Properties&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of Common Shares issued as consideration. Properties acquired under option agreements,
whereby payments are made at the sole discretion of the Company, are capitalized as mineral property acquisition costs at such
time as the payments are made. Exploration costs are expensed as incurred. When it is determined that a mining deposit can be
economically and legally extracted or produced based on established proven and probable reserves under S-K 1300, and the Company&#x2019;s
board of directors (the &#x201c;Board&#x201d;) has approved the commencement of formal development activities, development costs
related to such reserves and incurred after such board approval will be considered for capitalization. The establishment of proven
and probable reserves is based on results of feasibility studies, which indicate whether a property is economically feasible.
Upon commencement of commercial production, capitalized costs will be amortized over their estimated useful lives or units of
production, whichever is a more reliable measure. Capitalized amounts relating to a property that is abandoned or otherwise considered
uneconomic for the foreseeable future are written off.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#x2019;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was no impairment recorded to mineral properties as of
June 30, 2024 or 2023, respectively.&lt;/span&gt;&lt;/p&gt;

</niobf:MineralPropertiesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000605">&lt;p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBC9mEc6STt1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86B_zEaiVHlVtH27"&gt;Long
                                         Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was no impairment recorded to long-lived assets as of June 30, 2024 or 2023, respectively.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000613">&lt;p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zw3U6fHn81tj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_864_z26z4m9B3eV7"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, &lt;i&gt;Leases&lt;/i&gt;, we determine if a contractual arrangement is, or contains,
a lease at the inception date. Right-of-use (&#x201c;ROU&#x201d;) assets and liabilities related to operating leases are separately
reported in the consolidated balance sheets. The Company currently has no finance leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <niobf:ConvertibleDebtCarriedatFairValueTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000615">&lt;p id="xdx_84B_ecustom--ConvertibleDebtCarriedatFairValueTextBlock_zFf3LGmktr5j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;g)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
                                         Debt Carried at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With regard to the Company&#x2019;s debt related to the convertible promissory notes issued in April 2024 (as further discussed in
Note 9), the Company has elected to account for these notes at fair value per the provisions of ASC Topic 815, &lt;i&gt;Derivatives
and Hedging&lt;/i&gt; (&#x201c;ASC 815&#x201d;). Under ASC 815-15-25, an election can be taken at the inception of a financial instrument
to account for the instrument at fair value. The notes were recorded at fair value at inception and assessed quarterly thereafter
using a Monte Carlo simulation methodology which incorporates multiple conversion scenarios. All changes in fair value subsequent
to the initial recording, excluding the impact of the change in fair value related to the Company&#x2019;s own credit risk, are
recorded as a component of non-operating income/expense, within Change in fair value of convertible debt in the consolidated statements
of operations. Changes in fair value related to the Company&#x2019;s own credit risk, if any, are recorded through other comprehensive loss.&lt;/span&gt;&lt;/p&gt;

</niobf:ConvertibleDebtCarriedatFairValueTextBlock>
    <niobf:WarrantsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000617">&lt;p id="xdx_84D_ecustom--WarrantsPolicyTextBlock_zVzXuHVnB1jg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;h)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86F_zFBuDFHSSjra"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
apply relevant accounting guidance for warrants to purchase our stock based on the nature of the relationship with the counterparty.
For warrants issued to investors or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC
480, &lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt;, and ASC 815, to assist in the determination of whether the warrants should
be classified as liabilities or equity. The fair value of warrants is estimated using Black Scholes modeling or Monte Carlo modeling,
depending on the settlement features embedded in the warrant. Inputs under both models include inputs such as NioCorp&#x2019;s
Common Share price, the risk-free interest rate, the expected term, the volatility, and the dividend rate. Warrants that are determined
to require liability classifications are measured at fair value upon issuance and are subsequently remeasured to their then fair
value at each subsequent reporting period with changes in fair value recorded in current earnings. Warrants that are determined
to require equity classifications measured at fair value upon issuance and are not subsequently remeasured unless they are required
to be reclassified.&lt;/span&gt;&lt;/p&gt;

</niobf:WarrantsPolicyTextBlock>
    <niobf:EarnoutSharesPolicy contextRef="From2023-07-01to2024-06-30" id="Fact000619">&lt;p id="xdx_844_ecustom--EarnoutSharesPolicy_zXvZc6JpFmed" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
                                         Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The Earnout Shares
are measured at fair value upon issuance and subsequently remeasured at each reporting period using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#x2019;s Common Share price, the risk-free interest rate, the expected term, the weighted
average of historical Common Share volatility and implied volatility underlying the Company&#x2019;s Public Warrants, the dividend
rate, the conversion price, and the number of Earnout Shares outstanding. Assumptions used in the model are subjective and require
significant judgment.&lt;/span&gt;&#160;&lt;/p&gt;

</niobf:EarnoutSharesPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-07-01to2024-06-30" id="Fact000627">&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zeSl7pShaLzl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;j)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_866_zymGassAsrg2"&gt;Financial
                                         Instruments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of cash and cash equivalents, receivables, equity securities, accounts payable and
accrued liabilities, notes payable, convertible debt, and the related party loan. It is management&#x2019;s opinion that the Company
is not exposed to significant interest, currency or credit risks arising from its financial instruments. The fair values of these
instruments approximate their carrying value unless otherwise noted.&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2023-07-01to2024-06-30" id="Fact000629">&lt;p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_ziM19jf9lqHl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;k)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zxxEgvrMFbk"&gt;Concentration
                                         of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver, British Columbia and Santa Clara, California.
As part of its cash management process, the Company regularly monitors the relative credit standing of these institutions.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:AssetRetirementObligationsPolicy contextRef="From2023-07-01to2024-06-30" id="Fact000631">&lt;p id="xdx_845_eus-gaap--AssetRetirementObligationsPolicy_ze2r2G0Eiqnb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;l)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zLzHOWeAYgJ3"&gt;Asset
                                         Retirement Obligation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $&lt;span id="xdx_908_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20240630_zOV4XPJ3gpjc"&gt;48&lt;/span&gt; as an accrued liability related to
estimated obligations as of June 30, 2024 (2023 - $&lt;span id="xdx_900_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20230630_zaXUsPjc7Ke4" title="Accrued exploration stage expense"&gt;48&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss
in the period an estimate is revised.&lt;/span&gt;&lt;/p&gt;

</us-gaap:AssetRetirementObligationsPolicy>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000632"
      unitRef="USD">48000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000634"
      unitRef="USD">48000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000636">&lt;p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zCv3nwIbVBba" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;m)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_861_zgf1SsEh0XDb"&gt;Income
                                         Taxes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, &lt;i&gt;&#x201c;Income Taxes &#x2013; Recognition.&#x201d;
&lt;/i&gt;Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#x201c;more likely than not&#x201d; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#x201c;Income Taxes &#x2013; Disclosure,&#x201d;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2024 and 2023, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <niobf:ReverseStockSplitPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000638">&lt;p id="xdx_84A_ecustom--ReverseStockSplitPolicyTextBlock_zcryDoHkjpUg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;n)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zixf7ipR0xk5"&gt;Reverse
                                         Stock Split&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 17, 2023, the Company effected a reverse stock split (the &#x201c;Reverse Stock Split&#x201d;) on the basis of one (1) post-Reverse
Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding, with any fractional
shares resulting from the Reverse Stock Split rounded down to the nearest whole share. Immediately after the Reverse Stock Split,
there were 30,000,442 Common Shares issued and outstanding. All references to share and per share amounts (excluding authorized
shares) in the consolidated financial statements and accompanying notes have been retroactively restated to reflect the Reverse
Stock Split.&lt;/span&gt;&lt;/p&gt;

</niobf:ReverseStockSplitPolicyTextBlock>
    <niobf:RedeemableNoncontrollingInterestPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000640">&lt;p id="xdx_849_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zZYz7a3R8b5l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;o)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86B_z98S5JPclJ1a"&gt;Redeemable
                                         Noncontrolling Interest&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#x2019;s control and is reported in the mezzanine section between total liabilities
and shareholders&#x2019; deficit, as temporary equity in the Company&#x2019;s consolidated balance sheets. The Company&#x2019;s non-controlling
interest is redeemable at fair value, and no adjustment to the earnings per share numerator is required because redemption at
fair value is not considered an economic distribution different from other common stockholders.&#160;&lt;/span&gt;&lt;/p&gt;

</niobf:RedeemableNoncontrollingInterestPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000648">&lt;p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_z8mz8hNA0fja" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;p)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_864_z61ows0CsP4a"&gt;Basic
                                         and Diluted Per Share Disclosure&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average number
of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout Shares (each as defined
in Note 10), to be participating securities, requiring the use of the two-class method. Diluted earnings (loss) per share represents
net earnings (loss) attributable to common shareholders divided by the weighted average number of Common Shares outstanding, inclusive
of the dilutive impact of all potentially dilutive securities outstanding during the period, as applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z4oXpvuz7yij" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share
attributable to common shareholders:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zmPdZGo8Jldb" style="width: 12%; text-align: right" title="Net loss::XDX::-11898"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0652"&gt;(11,898&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230630_zZ8ZK7ESqopj" style="width: 12%; text-align: right" title="Net loss"&gt;(40,308&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Adjust: &#160;Net loss attributable to noncontrolling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20230701__20240630_ztoS73kIOKx3" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::463"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0656"&gt;458&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zORNxPZyMr5f" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::228"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0658"&gt;(251&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Net loss available to participating securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zOIH99mkHtGl" style="text-align: right" title="Net loss available to participating securities"&gt;(11,440&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zS9EcMMR2GMc" style="text-align: right" title="Net loss available to participating securities"&gt;(40,057&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Net loss attributable to Vested Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zqM20nkHogYb" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares"&gt;967&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zbdm4thPBHWk" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares"&gt;1,528&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Net loss attributed to common shareholders - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zg6rjKR1gZY5" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;(10,473&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_zXsSreWXTDt5" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;(38,529&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Weighted average shares outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_znEa4o0ILxi4" style="text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;34,320,024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zVCao1x4Trsc" style="text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;28,705,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Loss per Common Share outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20240630_z6niy4YWEVQ" style="text-align: right" title="Loss per common share outstanding basic and diluted"&gt;(0.31&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_zxQjh92qxab4" style="text-align: right" title="Loss per common share outstanding basic and diluted"&gt;(1.34&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_zoFmaRWAIf1b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following shares underlying options, warrants, and outstanding convertible debt were antidilutive due to a net loss in the periods
presented and, therefore, were excluded from the dilutive securities computation for the years ended June 30, 2024 and 2023, as
indicated below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zBrtvXc7lCd2" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; visibility: hidden"&gt;&lt;span id="xdx_8B8_zZeo1Pcp509"&gt;Schedule of excluded from the dilutive securities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; border-collapse: collapse; width: 91%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Excluded potentially dilutive securities &lt;sup id="xdx_F69_zLunV1ebYId4"&gt;(1)(2)&lt;/sup&gt;:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; padding-left: 0.25in; text-indent: -0.125in"&gt;Options&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zvapHnoAM9w6" style="width: 12%; text-align: right" title="Options"&gt;2,495,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zWphhe01Uuyi" style="width: 12%; text-align: right" title="Options"&gt;1,541,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_z2ofRW7Lmgk" style="text-align: right" title="Warrants"&gt;18,563,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zBJov0ZymEgi" style="text-align: right" title="Warrants"&gt;18,816,304&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zlzyJMRW9Uj5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;2,849,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_zYJcZ1sPSRk5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;2,871,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Total potentially dilutive securities&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_zaGrLyZ7nwpf" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities"&gt;23,908,061&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zfyvgekKOY25" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities"&gt;23,229,464&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: justify"&gt;&lt;span id="xdx_F02_zLNq355T4bGf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_zGoQRZD8Ae11" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F0C_ztq3eT2kaFPj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_z7xqga9FTee9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zqXUp5Ok9Uw2" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000650">&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z4oXpvuz7yij" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share
attributable to common shareholders:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zmPdZGo8Jldb" style="width: 12%; text-align: right" title="Net loss::XDX::-11898"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0652"&gt;(11,898&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230630_zZ8ZK7ESqopj" style="width: 12%; text-align: right" title="Net loss"&gt;(40,308&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Adjust: &#160;Net loss attributable to noncontrolling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20230701__20240630_ztoS73kIOKx3" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::463"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0656"&gt;458&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zORNxPZyMr5f" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::228"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0658"&gt;(251&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Net loss available to participating securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zOIH99mkHtGl" style="text-align: right" title="Net loss available to participating securities"&gt;(11,440&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zS9EcMMR2GMc" style="text-align: right" title="Net loss available to participating securities"&gt;(40,057&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Net loss attributable to Vested Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zqM20nkHogYb" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares"&gt;967&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zbdm4thPBHWk" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares"&gt;1,528&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Net loss attributed to common shareholders - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zg6rjKR1gZY5" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;(10,473&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_zXsSreWXTDt5" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;(38,529&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Weighted average shares outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_znEa4o0ILxi4" style="text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;34,320,024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zVCao1x4Trsc" style="text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;28,705,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Loss per Common Share outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20240630_z6niy4YWEVQ" style="text-align: right" title="Loss per common share outstanding basic and diluted"&gt;(0.31&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_zxQjh92qxab4" style="text-align: right" title="Loss per common share outstanding basic and diluted"&gt;(1.34&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000654"
      unitRef="USD">-40308000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000660"
      unitRef="USD">-11440000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000662"
      unitRef="USD">-40057000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000664"
      unitRef="USD">967000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000666"
      unitRef="USD">1528000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000668"
      unitRef="USD">-10473000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000670"
      unitRef="USD">-38529000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000672"
      unitRef="Shares">34320024</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000674"
      unitRef="Shares">28705840</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000676"
      unitRef="USDPShares">-0.31</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000678"
      unitRef="USDPShares">-1.34</niobf:EarningsLossPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000680">&lt;p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zBrtvXc7lCd2" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; visibility: hidden"&gt;&lt;span id="xdx_8B8_zZeo1Pcp509"&gt;Schedule of excluded from the dilutive securities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; border-collapse: collapse; width: 91%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Excluded potentially dilutive securities &lt;sup id="xdx_F69_zLunV1ebYId4"&gt;(1)(2)&lt;/sup&gt;:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; padding-left: 0.25in; text-indent: -0.125in"&gt;Options&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zvapHnoAM9w6" style="width: 12%; text-align: right" title="Options"&gt;2,495,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zWphhe01Uuyi" style="width: 12%; text-align: right" title="Options"&gt;1,541,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_z2ofRW7Lmgk" style="text-align: right" title="Warrants"&gt;18,563,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zBJov0ZymEgi" style="text-align: right" title="Warrants"&gt;18,816,304&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zlzyJMRW9Uj5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;2,849,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_zYJcZ1sPSRk5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;2,871,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Total potentially dilutive securities&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_zaGrLyZ7nwpf" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities"&gt;23,908,061&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zfyvgekKOY25" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities"&gt;23,229,464&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: justify"&gt;&lt;span id="xdx_F02_zLNq355T4bGf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_zGoQRZD8Ae11" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F0C_ztq3eT2kaFPj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_z7xqga9FTee9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000682"
      unitRef="Shares">2495500</us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions>
    <us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000684"
      unitRef="Shares">1541500</us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000686"
      unitRef="Shares">18563561</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000688"
      unitRef="Shares">18816304</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000690"
      unitRef="Shares">2849000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000692"
      unitRef="Shares">2871660</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000694"
      unitRef="USD">23908061000</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000696"
      unitRef="USD">23229464000</us-gaap:DilutiveSecurities>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2023-07-01to2024-06-30" id="Fact000700">&lt;p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zNUCQi67FfWd" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;
                                                    &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;q)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_861_zCtXI4XN2huk"&gt;Share
                                         Based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company grants stock options to directors, officers, employees, and business advisors. Option terms and vesting conditions are
at the discretion of the Board. Prior to March 31, 2023, the option exercise price was equal to the closing market price on The
Toronto Stock Exchange (the &#x201c;TSX&#x201d;) on the day preceding the date of grant. Effective March 21, 2023, the option exercise
price is equal to the closing market price on the Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;) on the day preceding the date
of the grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates the fair value of stock options using the Black-Scholes option pricing model. The Company recognizes forfeitures
as they occur.&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000708">&lt;p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zxAhxkbPKgP9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;r)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86F_zloV9IAt35fk"&gt;Recent
                                         Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Issued
and Not Effective&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, &lt;i&gt;Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures&lt;/i&gt;, which is intended to improve reportable segment disclosure requirements, primarily through
enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses
that are regularly provided to the chief operating decision maker and included within segment profit and loss. The amendments
are effective for the Company&#x2019;s annual periods beginning July 1, 2024, and interim periods beginning July 1, 2025, with
early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. The
Company has evaluated the ASU and has determined that implementation will have limited impact on the Company&#x2019;s disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/i&gt;, which includes
amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation
categories and income taxes paid by jurisdiction. The amendments are effective for the Company&#x2019;s annual periods beginning
June 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively. The Company is currently
evaluating the ASU to determine its impact on the Company&#x2019;s disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#x2019;s consolidated financial statements upon adoption.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000710">&lt;p id="xdx_803_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zD3Y051Eptji" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82A_zNS4kjR0vWpa"&gt;GOING
                                         CONCERN ISSUES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company incurred a net loss of $&lt;span id="xdx_907_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zGFZ4HE3dWui" title="Net loss::XDX::-11898"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0712"&gt;11,435&lt;/span&gt;&lt;/span&gt; for the year ended June 30, 2024 (2023 - $&lt;span id="xdx_90B_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230630_zWXvkh5dWsPe" title="::XDX::-40308"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0713"&gt;40,080&lt;/span&gt;&lt;/span&gt;) and had a working capital deficit of
$&lt;span id="xdx_905_ecustom--WorkingCapitalDeficit_pn3n3_c20230701__20240630_zmhiPMfjOad9" title="Working capital deficit"&gt;9,036&lt;/span&gt; and an accumulated deficit of $&lt;span id="xdx_901_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20240630_zoaMe1B4oPR3" title="Accumulated deficit"&gt;161,912&lt;/span&gt; as of June 30, 2024. As a development stage issuer, the Company has not yet commenced
its mining operations and accordingly does not generate any revenue. As of June 30, 2024, the Company had cash of $&lt;span id="xdx_905_ecustom--CashAndCashEquivalentsAtCarryingValue1_pn3n3_c20230701__20240630_zexyJvPSKJid" title="Cash"&gt;2,012&lt;/span&gt;, which
will not be sufficient to fund normal operations or the repayment of the April 2024 Notes for the next twelve months. These conditions
and events raise substantial doubt about the Company&#x2019;s ability to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
response to these conditions and events, the Company plans to obtain additional financing. Subject to the conditions discussed
in Note 11d, NioCorp expects to have access to up to $&lt;span id="xdx_90B_eus-gaap--ProceedsFromRepaymentsOfDebt_pn3n3_c20230701__20240630_znLqm2vKB2Ua" title="Net proceeds"&gt;59,269&lt;/span&gt; in net proceeds from the Standby Equity Purchase Agreement, dated
January 26, 2023 (the &#x201c;Yorkville Equity Facility Financing Agreement&#x201d;), between the Company and YA II PN, Ltd., an
investment fund managed by Yorkville Advisors Global, LP (&#x201c;Yorkville&#x201d;), through April 1, 2026. In addition, the Company
may pursue additional sources of financing, and while it has been successful in doing so in the past, there can be no assurance
it will be able to do so in the future. Other than the potential issuance of Common Shares under the Yorkville Equity Facility
Financing Agreement, the Company did not have any further funding commitments or arrangements for additional financing as of June
30, 2024. The Company&#x2019;s plans to obtain additional financing have not been finalized, are subject to market conditions,
and are not within the Company&#x2019;s control and therefore cannot be deemed probable. Further, the Company will be required
to raise additional funds for the construction and commencement of operations. As a result, the Company has concluded that management&#x2019;s
plans do not alleviate substantial doubt about the Company&#x2019;s ability to continue as a going concern.&lt;/span&gt;&lt;/p&gt;













</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <niobf:WorkingCapitalDeficit
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000715"
      unitRef="USD">9036000</niobf:WorkingCapitalDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000717"
      unitRef="USD">-161912000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <niobf:CashAndCashEquivalentsAtCarryingValue1
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000719"
      unitRef="USD">2012000</niobf:CashAndCashEquivalentsAtCarryingValue1>
    <us-gaap:ProceedsFromRepaymentsOfDebt
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000728"
      unitRef="USD">59269000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000732">&lt;p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_zMqEPDRef7V9" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82F_z9wu9DvZZi79"&gt;2023
                                                                                                                                              GXII                                          TRANSACTION&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Business Combination Agreement, the following transactions (collectively, the &#x201c;GXII Transaction&#x201d;) occurred
on the Closing Date:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.625in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As a
    result of a series of transactions, GXII became an indirect, majority-owned subsidiary of NioCorp and changed its name to
    &#x201c;Elk Creek Resources Corp&#x201d; (&#x201c;ECRC&#x201d;).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As the
    parent company of the merged entity, NioCorp issued &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFgBUZOKQRb1" title="Post reverse stock split shares"&gt;1,753,821&lt;/span&gt; post-Reverse Stock Split Common Shares in exchange for all of
    the Class A shares of GXII issued and outstanding immediately prior to the Closing, including 83,770 Common Shares issued
    to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory services.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
    of the Class B shares of GXII issued and outstanding immediately prior to the Closing (after giving effect to the surrender
    of certain Class B shares of GXII in accordance with the Sponsor Support Agreement, dated September 25, 2022 (the &#x201c;Sponsor
    Support Agreement&#x201d;), among GX Sponsor II LLC (the &#x201c;Sponsor&#x201d;), GXII, NioCorp and the other persons party
    thereto) were converted into &lt;span id="xdx_908_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_uShares_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zuxE9VyS3UE3" title="Convertible shares issued upon conversion"&gt;7,957,404&lt;/span&gt; shares of Class B common stock of GXII (now known as ECRC) as the surviving entity
    of the mergers that occurred on the Closing Date as part of the GXII Transaction. Pursuant to the Business Combination Agreement,
    the Sponsor Support Agreement and the Exchange Agreement, dated as of March 17, 2023 (as amended, supplemented or otherwise
    modified, the &#x201c;Exchange Agreement&#x201d;), by and among NioCorp, ECRC and the Sponsor, after the Closing, the shares
    of Class B common stock of ECRC are exchangeable into Common Shares on a one-for-one basis, subject to certain equitable adjustments,
    under certain conditions. See Note 10 for additional information regarding the Class B common stock of ECRC.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NioCorp
    assumed GXII&#x2019;s obligations under the agreement (the &#x201c;GXII Warrant Agreement&#x201d;) governing the GXII share purchase
    warrants (the &#x201c;GXII Warrants&#x201d;) and issued an aggregate of &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember_zJQNuttuZSSh" title="Number of shares purchase"&gt;15,666,626&lt;/span&gt; warrants (the &#x201c;NioCorp Assumed Warrants&#x201d;)
    to purchase up to an aggregate of &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkxt8uhfFemh" title="Number of shares purchase"&gt;17,519,864&lt;/span&gt; Common Shares. See Note 11c for additional information regarding the NioCorp
    Assumed Warrants. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zKUVvNELzpWg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;After
the distribution of funds to GXII redeeming shareholders and prior to paying transaction costs incurred by GXII, $15,676 became
available to the Company. &lt;span id="xdx_8B5_zTrPe6YC7z0a"&gt;The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements
of Operations and Comprehensive Loss for the year ended June 30, 2023:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240630_zDLUSx4h8pj3" style="border-bottom: Black 1pt solid; text-align: right"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_pn3n3_zi1H2eW1ntTi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 79%; text-align: justify; padding-left: 0.125in; text-indent: -0.125in"&gt;Gross cash proceeds, net of transaction costs incurred by GXII&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,168&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zmURVwpgdLe8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash costs associated with the 2023 Transactions:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_zNLMqDZy6U37" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Net liabilities assumed&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_iI_pn3n3_zabKhGg8SDZh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Yorkville Equity Facility Financing Agreement &#x2013; cash costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,996&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_iI_pn3n3_zgg3OYDVUrzd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Transaction costs expensed&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,715&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_pn3n3_zA4xcJ5lWgtl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"&gt;Non-cash costs associated with the 2023 Transactions:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_iI_pn3n3_z3WnogewIok8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Private Warrants assumed at fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,987&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--EarnoutSharesAssumedAtFairValue_iI_pn3n3_zuyWFtL9oZ09" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Earnout Shares assumed at fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_pn3n3_znImeCHUfwpi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Yorkville Equity Facility Financing Agreement &#x2013; shares issued&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;650&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pn3n3_zWeKgiDlfUgl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;Total transaction related losses incurred&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;23,767&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zppruokwxdna" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;



















&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p id="xdx_891_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_zC7xeqbOOV0j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zxM4hW8dTdzj"&gt;The
number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows&lt;/span&gt;:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Common Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Percentage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Legacy NioCorp Shareholders&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zWOIlnILdPP5" style="width: 12%; text-align: right" title="Common stock, shares outstanding"&gt;28,246,621&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zW4jrfzTP7ue" title="Number of shares, percentage"&gt;93.90&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Former GXII Class A Shareholders&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zOkXCQtlUpi4" style="text-align: right"&gt;1,753,821&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zjbTVwksDMg" title="Number of shares, percentage"&gt;5.83&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--OtherMember_fKDIp_z6u5pI41BQMa" style="border-bottom: Black 1pt solid; text-align: right"&gt;81,213&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--OtherMember_fKDIp_z5IF8MmrkA0h" title="Number of shares, percentage"&gt;0.27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Total Common Shares Outstanding Upon Completion of 2023 Transactions&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_dxL_uShares_c20240630_zAmY6gSaz2Jf" style="border-bottom: Black 2pt solid; text-align: right" title="Common stock, shares outstanding::XDX::38062647"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0782"&gt;30,081,655&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630_zS4TL18wCk9j" title="Number of shares, percentage"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span id="xdx_F0F_zeKfNxmYnfgg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zf9p9PT20DCa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_F0F_zSrKWsF1MpYe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zGgsi7nrWCx7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A1_zcfdafWdovXl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the GXII Transaction, the Company also closed the Yorkville Convertible Debt Financing and the Yorkville Equity
Facility Financing, as discussed in Notes 9 and 11d.&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000734"
      unitRef="Shares">1753821</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000736"
      unitRef="Shares">7957404</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2023-07-012024-06-30_custom_WarrantAgreementMember"
      decimals="INF"
      id="Fact000738"
      unitRef="Shares">15666626</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000740"
      unitRef="Shares">17519864</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <srt:ScheduleOfCondensedFinancialStatementsTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000742">&lt;p id="xdx_897_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zKUVvNELzpWg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;After
the distribution of funds to GXII redeeming shareholders and prior to paying transaction costs incurred by GXII, $15,676 became
available to the Company. &lt;span id="xdx_8B5_zTrPe6YC7z0a"&gt;The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements
of Operations and Comprehensive Loss for the year ended June 30, 2023:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240630_zDLUSx4h8pj3" style="border-bottom: Black 1pt solid; text-align: right"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_pn3n3_zi1H2eW1ntTi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 79%; text-align: justify; padding-left: 0.125in; text-indent: -0.125in"&gt;Gross cash proceeds, net of transaction costs incurred by GXII&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,168&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zmURVwpgdLe8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash costs associated with the 2023 Transactions:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_zNLMqDZy6U37" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Net liabilities assumed&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_iI_pn3n3_zabKhGg8SDZh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Yorkville Equity Facility Financing Agreement &#x2013; cash costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,996&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_iI_pn3n3_zgg3OYDVUrzd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Transaction costs expensed&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,715&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_pn3n3_zA4xcJ5lWgtl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"&gt;Non-cash costs associated with the 2023 Transactions:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_iI_pn3n3_z3WnogewIok8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Private Warrants assumed at fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,987&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--EarnoutSharesAssumedAtFairValue_iI_pn3n3_zuyWFtL9oZ09" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"&gt;Earnout Shares assumed at fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_pn3n3_znImeCHUfwpi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Yorkville Equity Facility Financing Agreement &#x2013; shares issued&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;650&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pn3n3_zWeKgiDlfUgl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;Total transaction related losses incurred&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;23,767&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</srt:ScheduleOfCondensedFinancialStatementsTableTextBlock>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000744"
      unitRef="USD">2168000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000748"
      unitRef="USD">392000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <niobf:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000750"
      unitRef="USD">1996000</niobf:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000752"
      unitRef="USD">6715000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000756"
      unitRef="USD">2987000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <niobf:EarnoutSharesAssumedAtFairValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000758"
      unitRef="USD">13195000</niobf:EarnoutSharesAssumedAtFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000760"
      unitRef="USD">650000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000762"
      unitRef="USD">23767000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000770">&lt;p id="xdx_891_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_zC7xeqbOOV0j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zxM4hW8dTdzj"&gt;The
number of Common Shares issued and outstanding immediately following the consummation of the 2023 Transactions were as follows&lt;/span&gt;:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 94%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Common Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Percentage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Legacy NioCorp Shareholders&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zWOIlnILdPP5" style="width: 12%; text-align: right" title="Common stock, shares outstanding"&gt;28,246,621&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zW4jrfzTP7ue" title="Number of shares, percentage"&gt;93.90&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Former GXII Class A Shareholders&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zOkXCQtlUpi4" style="text-align: right"&gt;1,753,821&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zjbTVwksDMg" title="Number of shares, percentage"&gt;5.83&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630__us-gaap--TransactionTypeAxis__custom--OtherMember_fKDIp_z6u5pI41BQMa" style="border-bottom: Black 1pt solid; text-align: right"&gt;81,213&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--OtherMember_fKDIp_z5IF8MmrkA0h" title="Number of shares, percentage"&gt;0.27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Total Common Shares Outstanding Upon Completion of 2023 Transactions&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iI_pid_dxL_uShares_c20240630_zAmY6gSaz2Jf" style="border-bottom: Black 2pt solid; text-align: right" title="Common stock, shares outstanding::XDX::38062647"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0782"&gt;30,081,655&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20230701__20240630_zS4TL18wCk9j" title="Number of shares, percentage"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span id="xdx_F0F_zeKfNxmYnfgg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zf9p9PT20DCa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_F0F_zSrKWsF1MpYe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zGgsi7nrWCx7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_custom_LegacyNioCorpShareholdersMember"
      decimals="INF"
      id="Fact000772"
      unitRef="Shares">28246621</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="From2023-07-012024-06-30_custom_LegacyNioCorpShareholdersMember"
      decimals="INF"
      id="Fact000774"
      unitRef="Pure">0.9390</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_custom_GXIIClassAShareholdersMember"
      decimals="INF"
      id="Fact000775"
      unitRef="Shares">1753821</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="From2023-07-012024-06-30_custom_GXIIClassAShareholdersMember"
      decimals="INF"
      id="Fact000777"
      unitRef="Pure">0.0583</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_custom_OtherMember"
      decimals="INF"
      id="Fact000778"
      unitRef="Shares">81213</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="From2023-07-012024-06-30_custom_OtherMember"
      decimals="INF"
      id="Fact000780"
      unitRef="Pure">0.0027</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000784"
      unitRef="Pure">1</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000788">&lt;p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z6gENgu6aRng" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_827_zMRmoXbiTvc8"&gt;LAND
                                         AND BUILDINGS, NET&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89F_eus-gaap--PropertyPlantAndEquipmentTextBlock_zsf5VlsY2OS6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zjH7iNtlzLg1" style="display: none; visibility: hidden"&gt;Schedule of properties&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 13%"&gt;Land&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zdsre1YFxA19" style="width: 9%; text-align: right" title="Cost"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_z8IUo9bs8WCa" style="width: 9%; text-align: right" title="Accumulated depreciation"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_ze0jotrhr99" style="width: 9%; text-align: right" title="Net"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zgzb5HDz3Gv5" style="width: 9%; text-align: right" title="Cost"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zPDF3VqB2a11" style="width: 9%; text-align: right" title="Accumulated depreciation"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zcM9L3E1goE8" style="width: 9%; text-align: right" title="Net"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Buildings and other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zIruABl0K3Vd" style="border-bottom: Black 1pt solid; text-align: right"&gt;41&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zK2z9QutyQH9" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;11&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zXXhxMlWSw7j" style="border-bottom: Black 1pt solid; text-align: right"&gt;30&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zecxZ01MMXsk" style="border-bottom: Black 1pt solid; text-align: right"&gt;41&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zxcPsPXvzPvi" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;9&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_ztpKRWIFA8Rf" style="border-bottom: Black 1pt solid; text-align: right"&gt;32&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630_zTFX7EcRu9ei" style="border-bottom: Black 2pt solid; text-align: right"&gt;848&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630_zyi03axIe7R8" style="border-bottom: Black 2pt solid; text-align: right"&gt;11&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630_zSD4lpbEdZd6" style="border-bottom: Black 2pt solid; text-align: right"&gt;837&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630_zl74fad9yrjh" style="border-bottom: Black 2pt solid; text-align: right"&gt;848&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630_zV0lmdm7Fp4k" style="border-bottom: Black 2pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630_zMxKOpXKn491" style="border-bottom: Black 2pt solid; text-align: right"&gt;839&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_zu8iSU907OHf" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000790">&lt;p id="xdx_89F_eus-gaap--PropertyPlantAndEquipmentTextBlock_zsf5VlsY2OS6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zjH7iNtlzLg1" style="display: none; visibility: hidden"&gt;Schedule of properties&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 13%"&gt;Land&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zdsre1YFxA19" style="width: 9%; text-align: right" title="Cost"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_z8IUo9bs8WCa" style="width: 9%; text-align: right" title="Accumulated depreciation"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_ze0jotrhr99" style="width: 9%; text-align: right" title="Net"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zgzb5HDz3Gv5" style="width: 9%; text-align: right" title="Cost"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zPDF3VqB2a11" style="width: 9%; text-align: right" title="Accumulated depreciation"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zcM9L3E1goE8" style="width: 9%; text-align: right" title="Net"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Buildings and other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zIruABl0K3Vd" style="border-bottom: Black 1pt solid; text-align: right"&gt;41&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zK2z9QutyQH9" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;11&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zXXhxMlWSw7j" style="border-bottom: Black 1pt solid; text-align: right"&gt;30&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zecxZ01MMXsk" style="border-bottom: Black 1pt solid; text-align: right"&gt;41&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zxcPsPXvzPvi" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;9&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_ztpKRWIFA8Rf" style="border-bottom: Black 1pt solid; text-align: right"&gt;32&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630_zTFX7EcRu9ei" style="border-bottom: Black 2pt solid; text-align: right"&gt;848&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630_zyi03axIe7R8" style="border-bottom: Black 2pt solid; text-align: right"&gt;11&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630_zSD4lpbEdZd6" style="border-bottom: Black 2pt solid; text-align: right"&gt;837&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630_zl74fad9yrjh" style="border-bottom: Black 2pt solid; text-align: right"&gt;848&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630_zV0lmdm7Fp4k" style="border-bottom: Black 2pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630_zMxKOpXKn491" style="border-bottom: Black 2pt solid; text-align: right"&gt;839&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2024-06-30_us-gaap_LandMember"
      decimals="-3"
      id="Fact000792"
      unitRef="USD">807000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-06-30_us-gaap_LandMember"
      decimals="-3"
      id="Fact000794"
      unitRef="USD">-0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30_us-gaap_LandMember"
      decimals="-3"
      id="Fact000796"
      unitRef="USD">807000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2023-06-30_us-gaap_LandMember"
      decimals="-3"
      id="Fact000798"
      unitRef="USD">807000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_us-gaap_LandMember"
      decimals="-3"
      id="Fact000800"
      unitRef="USD">-0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-06-30_us-gaap_LandMember"
      decimals="-3"
      id="Fact000802"
      unitRef="USD">807000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2024-06-30_us-gaap_BuildingMember"
      decimals="-3"
      id="Fact000803"
      unitRef="USD">41000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-06-30_us-gaap_BuildingMember"
      decimals="-3"
      id="Fact000805"
      unitRef="USD">11000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30_us-gaap_BuildingMember"
      decimals="-3"
      id="Fact000806"
      unitRef="USD">30000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2023-06-30_us-gaap_BuildingMember"
      decimals="-3"
      id="Fact000807"
      unitRef="USD">41000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_us-gaap_BuildingMember"
      decimals="-3"
      id="Fact000809"
      unitRef="USD">9000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-06-30_us-gaap_BuildingMember"
      decimals="-3"
      id="Fact000810"
      unitRef="USD">32000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000811"
      unitRef="USD">848000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000812"
      unitRef="USD">11000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000813"
      unitRef="USD">837000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000814"
      unitRef="USD">848000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000815"
      unitRef="USD">9000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000816"
      unitRef="USD">839000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:MineralIndustriesDisclosuresTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000818">&lt;p id="xdx_80D_eus-gaap--MineralIndustriesDisclosuresTextBlock_zdHNZcuWRo51" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82C_zwlrceSJtaL"&gt;MINERAL
                                         PROPERTIES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mineral
properties consist of original acquisition costs and purchased mineral rights related to the Elk Creek Project.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition to the land and mineral rights currently owned by the Company, the property interests of Elk Creek include eight prepaid
mineral exploration option-to-purchase agreements and include a pre-determined buyout for permanent ownership of the mineral and/or
surface rights. Terms of the agreements require no further significant payments, and the Company may negotiate lease extensions
or elect to purchase the mineral and/or surface rights any time. Agreements that allow for the purchase of mineral rights contain
provisions whereby the landowners would retain a 2% net smelter return.&lt;/span&gt;&lt;/p&gt;

</us-gaap:MineralIndustriesDisclosuresTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000820">&lt;p id="xdx_803_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zD93zpi8CChd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_820_zJYXNHkCrH5e"&gt;ACCOUNTS
                                         PAYABLE AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zUzytk9bw3B5" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; visibility: hidden"&gt;&lt;span id="xdx_8BE_zOLTfAnTn5S7"&gt;Schedule of account payable and accrued liabilities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20240630_z0efgPplLRZ6" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20230630_ztm9nDAsd6ke" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zEzHFlCkCtdj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 5pt"&gt;Accounts payable, trade&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,417&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,990&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_zQP2rw5TezS1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Trade payable accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,324&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zSiuC12OJN7h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Income taxes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0830"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zzpM6NFCfkoh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Environmental accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zn7w7eYXPj3g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt"&gt;Loan origination fees payable to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_ziNEuC5jSt1d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 5pt"&gt;Total accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;1,843&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;3,491&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zlT2aGd9kVua" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000822">&lt;p id="xdx_89C_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zUzytk9bw3B5" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; visibility: hidden"&gt;&lt;span id="xdx_8BE_zOLTfAnTn5S7"&gt;Schedule of account payable and accrued liabilities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20240630_z0efgPplLRZ6" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20230630_ztm9nDAsd6ke" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zEzHFlCkCtdj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 5pt"&gt;Accounts payable, trade&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,417&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,990&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_zQP2rw5TezS1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Trade payable accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,324&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zSiuC12OJN7h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Income taxes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0830"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zzpM6NFCfkoh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Environmental accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zn7w7eYXPj3g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt"&gt;Loan origination fees payable to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_ziNEuC5jSt1d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 5pt"&gt;Total accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;1,843&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;3,491&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000824"
      unitRef="USD">1417000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000825"
      unitRef="USD">1990000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000827"
      unitRef="USD">350000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000828"
      unitRef="USD">1324000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000831"
      unitRef="USD">101000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000833"
      unitRef="USD">48000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000834"
      unitRef="USD">48000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000836"
      unitRef="USD">28000</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000837"
      unitRef="USD">28000</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000839"
      unitRef="USD">1843000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000840"
      unitRef="USD">3491000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000848">&lt;p id="xdx_809_eus-gaap--LongTermDebtTextBlock_z2WMKBOT1zW4" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_823_z9E9m23ZRkd7"&gt;CONVERTIBLE
                                         DEBT&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_znt2ASmxe8F3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;&lt;span id="xdx_8B2_zuddybIb4Vbi"&gt;Schedule
of convertible debt&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Current Portion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 0.25in"&gt;Yorkville convertible debentures:&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleSecurityMember_z4al58ZIKgad" style="width: 10%; text-align: right" title="Convertibled debt, current"&gt;571&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zm6prukscnK8" style="width: 10%; text-align: right" title="Convertibled debt, current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0854"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in"&gt;April 2024 notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zlWSwZHZYha8" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current"&gt;7,089&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zA3WMLa7U3Ok" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Total Current Portion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zqhajbNKEC34" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current"&gt;7,660&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zPkuDigqFcJ" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0862"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in"&gt;Noncurrent Portion &#x2013; Yorkville convertible debenture&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zyU1pL7QKcPe" style="border-bottom: Black 2pt solid; text-align: right" title="Convertible debt, noncurrent"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0864"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zH3wR4pfycCb" style="border-bottom: Black 2pt solid; text-align: right" title="Convertible debt, noncurrent"&gt;10,561&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AC_zjjKW2eKpPoc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Lind
III Convertible Security&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 16, 2021, the Company issued to Lind Global Asset Management III, LLC (&#x201c;Lind&#x201d;), an entity managed by The
Lind Partners, the convertible security (the &#x201c;Lind III Convertible Security&#x201d;) pursuant to the Convertible Security
Funding Agreement, dated February 16, 2021, as amended by Amendment #1 to the Convertible Security Funding Agreement, dated December
2, 2021, between the Company and Lind (as amended, the &#x201c;Lind III Agreement&#x201d;). The Lind III Convertible Security had
a face value of $&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pn3n3_c20210216__20210219_ztalY4bPS2p6" title="Face value"&gt;11,700&lt;/span&gt; (representing $10,000 in funding plus an implied &lt;span id="xdx_90E_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20210219_z3ADXCANTKxi"&gt;8.5&lt;/span&gt;% interest rate per annum for the term of the Lind
III Convertible Security). After deducting a $&lt;span id="xdx_902_eus-gaap--OtherCommitment_iI_pn3n3_c20210219_zhnpdhlI2OZk" title="Commitment fee"&gt;350&lt;/span&gt; commitment fee as set forth in the Lind III Agreement, NioCorp received net
proceeds of $&lt;span id="xdx_907_eus-gaap--ProceedsFromInterestReceived_pn3n3_c20210216__20210219_zLVcmKMSYo6e" title="Net proceeds"&gt;9,650&lt;/span&gt; from the funding of the Lind III Convertible Security. The Company used a portion of the proceeds from the
funding of the Lind III Convertible Security to purchase a key land parcel associated with the Company&#x2019;s Elk Creek Project,
with the remainder spent for general corporate purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Lind III Convertible Security had a term of (i) &lt;span id="xdx_905_eus-gaap--LongTermDebtTerm_iI_dxL_c20230630_zTHMjVeU5fs8" title="Long term debt duration::XDX::P24M"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0875"&gt;24&lt;/span&gt;&lt;/span&gt; months or (ii) 30 calendar days after the date on which the face value of the
Lind III Convertible Security is nil due to such amount having been fully converted and/or fully repaid (including with any applicable
premium) in accordance with the terms of the Lind III Agreement, whichever is earlier.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--DebtConversionDescription_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zdjDo22Y0aqf"&gt;Pursuant
to the Lind III Agreement, Lind was entitled to convert the Lind III Convertible Security into Common Shares in monthly installments
over its term at a price per Common Share equal to 85% of the volume-weighted average price Common Shares on the TSX for the five
trading days immediately preceding to the date on which Lind provides notice to the Company of its election to convert. The Lind
III Agreement provided that Common Shares issuable upon conversion, together with the number of Common Shares issued upon exercise
of Warrants, shall not exceed 4,358,800 Common Shares.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 19, 2021, in connection with the funding and issuance of the Lind III Convertible Security, the Company issued &lt;span id="xdx_90A_eus-gaap--CommonUnitIssued_iI_uShares_c20210219_zOJHsBsos0K5" title="Common share purchase warrants"&gt;855,800&lt;/span&gt;
Common Share purchase warrants, exercisable at a price per Common Share of C$&lt;span id="xdx_907_eus-gaap--AcceleratedShareRepurchasesFinalPricePaidPerShare_uCADPShares_c20230701__20240630_zVye1cz2NWVl" title="Exercisable at a price per share"&gt;9.70&lt;/span&gt;, expiring February 19, 2025 (the &#x201c;Lind
III Warrants&#x201d;), to Lind pursuant to the Lind III Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company identified embedded derivatives in the Lind III Convertible Security that were evaluated to be immaterial at both the
closing date and at June 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company allocated the net proceeds of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pn3n3_uUSD_c20230701__20240630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_zzJNZYejqTJ1"&gt;9,477&lt;/span&gt; from the Lind III Convertible Security as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 94%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$1,712
    was allocated to Common Stock, representing the fair value of the Lind III Warrants based on the Black Scholes pricing model
    using a risk-free interest rate of &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_ziJ3vqAv1Lu3" title="Risk-free interest rate"&gt;0.40&lt;/span&gt;%, an expected dividend yield of &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zqAFBIPanAZ4" title="Expected dividend yield"&gt;0&lt;/span&gt;%, a volatility of &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_ztVBm41AMT41" title="Volatility"&gt;51.60&lt;/span&gt;%, and an expected life of
    &lt;span id="xdx_907_eus-gaap--IntermediateLifePlantsUsefulLife_iI_dxL_c20240630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zUAtHjSa5Iw9" title="Expected life::XDX::P4Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0889"&gt;4.0&lt;/span&gt;&lt;/span&gt; years. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90F_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_z0opgOtbN14l" title="Convertible debt liabilit"&gt;7,938&lt;/span&gt; was allocated
to the convertible debt liability. Transaction costs of $&lt;span id="xdx_90C_ecustom--TransactionCost_pn3n3_uUSD_c20230701__20240630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_z1h87Ma9HVfe" title="Transaction costs"&gt;173&lt;/span&gt;, in addition to a commitment fee of $&lt;span id="xdx_900_eus-gaap--LineOfCreditFacilityCommitmentFeeAmount_pn3n3_c20210217__20210219_z21sULxUbHqd" title="Commitment fee"&gt;350&lt;/span&gt;, were recognized as a direct
deduction from the debt liability, resulting in a net opening balance of $7,765. This balance was accreted up to the face value
of the Lind III Convertible Security at maturity using the effective interest method and recorded as non-cash interest expense
in the consolidated
statement of operations and comprehensive loss.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_z1i0WPYFDhT9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_zhg0BZ2GTAlh"&gt;Changes
in the Lind III Convertible Security are as follows&lt;/span&gt;:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; border-collapse: collapse; width: 70%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the year ending &lt;br/&gt;
June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 44%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beginning
    balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_znePfQEwOtqi" style="width: 10%; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,169&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value increase due to debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_ztsEgdWtpGJj" style="text-align: right" title="Fair value increase due to debt extinguishment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;201&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Conversions&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ConversionOfStockAmountIssued1_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zC9ggsIYxk2" style="text-align: right" title="Conversions"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,950&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accretion
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zynamc468rZ5" style="text-align: right" title="Accretion expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;95&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payment
    at maturity&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zutaLWwXJZkh" style="border-bottom: Black 1pt solid; text-align: right" title="Payment at maturity"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;515&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June
    30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zt6CCQWihBv3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0916"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A2_zlMYM4oQCMol" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 25, 2022, the Company and Lind entered into the Waiver and Consent Agreement, dated September 25, 2022, between the
Company and Lind (the &#x201c;Lind Consent&#x201d;), which included the following principal terms: (i) the consent of Lind to the
GXII Transaction disclosed in Note 5 and Yorkville Financings disclosed below and in Note 11d, including all actions taken by
NioCorp as set out in the Business Combination Agreement to permit the completion of the 2023 Transactions; (ii) the consent of
Lind to NioCorp&#x2019;s expected cross-listing to the Nasdaq and the consolidation of the Common Shares in order to meet the minimum
listing requirements thereof; (iii) the waiver of Lind of its participation right for up to 15% of the total offering in the Yorkville
Equity Facility Financing; and (iv) the waiver of Lind of certain restrictive covenants in the Lind III Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;As consideration for entering into the
Lind Consent, Lind received, amongst other things: (i) the right to receive a payment of $500, which would have been reduced to
$200 if the 2023 Transactions had not been consummated on or before April 30, 2023 (collectively, the &#x201c;Consent Payment&#x201d;);
(ii) an extension of its existing participation rights under the Lind III Agreement in future financings of NioCorp for a further
two-year period, subject to certain exceptions as well as an extension of such participation rights beyond the additional two-year
period if Yorkville or any affiliate is a party to any such applicable transaction; and (iii) the right to receive additional Warrants
(the &#x201c;Contingent Consent Warrants&#x201d;) if on the date that is 18 months following the Closing Date, the closing trading
price of the Common Shares on the TSX or such other stock exchange on which such shares may then be listed, is less than C$10.00
(on a post-Reverse Stock Split basis), subject to adjustments. The number of Contingent Consent Warrants to be issued, if any,
is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate as reported by Bloomberg,
LP) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date of issuance, unless otherwise
agreed. Further, the number of Contingent Consent Warrants issued will be proportionately adjusted based on the percentage of Warrants
currently held by Lind that are exercised, if any, prior to the issuance of any Contingent Consent Warrants. The Lind Consent was
signed as an amendment to the existing Lind III Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
determined that the Lind Consent should be evaluated using ASC 470, which requires an evaluation of the contract amendment under
debt modification guidance. The Company performed a comparison of the discounted cash flows of the Lind III Convertible Security
pursuant to the existing Lind III Agreement and pursuant to the Lind III Agreement as amended by the Lind Consent and determined
that a debt extinguishment loss of $201 had occurred. Further, ASC 470 requires that the minimum estimated Consent Payment of
$200 also be included in the calculation of the initial loss on debt extinguishment. The Company also evaluated the Contingent
Consent Warrant feature included in the Lind Consent and determined that the Contingent Consent Warrants meet the criteria to
be considered separate, freestanding instruments, should be accounted for as a liability under ASC 480, and should be booked at
fair value on the date of the Lind Consent, with subsequent changes in valuation recorded as a non-operating gain or loss in the
consolidated statement of operations and comprehensive loss. &lt;span&gt;The following table summarizes the components of the initial loss
and final loss on extinguishment:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfExtinguishmentOfDebtTextBlock_z5sVttqay9U8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;&#160;&lt;span id="xdx_8BC_zCpNCSkq0uk1"&gt;The following table summarizes the components of the initial loss and final loss on extinguishment:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Component
    of loss&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230701__20240630_zuwKBTzqeyhe" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--MinimumConsentPaymentAtInception_pn3n3_z0lvL9KTt57k" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 77%; text-align: justify; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Minimum
    Consent Payment at inception&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;200&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--ASC470LossOnExtinguishment_pn3n3_zUh8DOXqOWIk" style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;201&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--AdjustmentOfWarrantsGrantedForServices_pn3n3_zVOTyhwsJj76" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify; width: 77%; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    fair value of Contingent Consent Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,221&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_pn3n3_zAI1LwFFQNHl" style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,622&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--AdditionalConsentPaymentbooked_pn3n3_zJow2YPMqar3" style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additional
    Consent Payment booked&lt;sup id="xdx_F4F_zp1q7smy2gme"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;300&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--GainsLossesOnRestructuringOfDebt_pn3n3_zJTCgIi1gapg" style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,922&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: justify"&gt;&lt;span id="xdx_F02_zkh2PLuTpzb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_zhOm4ESnSM54" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AA_zLWtklORCwk4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;



















&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_89C_ecustom--ScheduleOfWarrantValuationTableTextblock_zhE2hs07LbYc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zUGu0r4iMI85"&gt;The
change in the fair value of the Contingent Consent Warrants is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 37%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    valuation, September 25, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iS_c20220701__20230630_zQIK8izaqrz6" style="width: 10%; text-align: right" title="Initial valuation, at beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,221&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ChangeInValuationOfWarrants_c20220701__20230630_zEMPS1TodF55" style="border-bottom: black 1pt solid; text-align: right" title="Change in valuation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;489&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    at June 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iE_c20220701__20230630_zPAsfAyTEG52" style="text-align: right" title="Valuation, at ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,710&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ChangeInValuationOfWarrants_c20230701__20240630_zf3RqufC5qwc" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;655&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    at June 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iE_c20230701__20240630_zUJWpt80Idq6" style="border-bottom: black 1.5pt solid; text-align: right" title="Valuation, at ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,365&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8AC_ziatf9pxJRjb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Contingent Consent Warrants are classified as a Level 3 financial instrument and were valued utilizing a Monte Carlo simulation
pricing model, which calculates multiple potential outcomes for future share prices based on historic volatility of the Common
Shares to determine the probability of issuance at 18 months following the applicable valuation date and to determine the value
of the Contingent Consent Warrants. The following table discloses the primary inputs into the Monte Carlo model at each valuation
date, and the probability of issuance calculated by the model.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_zSUmcTMTX2Ac" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; visibility: hidden"&gt;&lt;span id="xdx_8BA_zBUzmwMhlFg3"&gt;Schedule of valuation date and the probability calculated&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key
    Valuation Input&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
30,&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
30,&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September&#160;25,&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCECFF"&gt;
    &lt;td style="vertical-align: bottom; width: 46%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    price on valuation date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zmA2MRDKFa6b" style="vertical-align: bottom; width: 10%; text-align: right" title="Share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.73&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zxaoQRZH10k3" style="vertical-align: bottom; width: 10%; text-align: right" title="Share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.03&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zfbGiT624Uak" style="vertical-align: bottom; width: 10%; text-align: right" title="Share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.82&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Volatility&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_z8DzHiw5SFZ5" style="vertical-align: bottom; text-align: right" title="Volatility"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;68.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zmTiN5M68p39" style="vertical-align: bottom; text-align: right" title="Volatility"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zfGp98M0egGa" style="vertical-align: bottom; text-align: right" title="Volatility"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;62.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCECFF"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk
    free rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zD3RKNi7vBcd" style="vertical-align: bottom; text-align: right" title="Risk free rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.40&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zxLbhvVnRKpf" style="vertical-align: bottom; text-align: right" title="Risk free rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.11&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_z7RRe4dMVIHe" style="vertical-align: bottom; text-align: right" title="Risk free rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Probability
    of issuance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_z5dUA5BPSK76" style="vertical-align: bottom; text-align: right" title="Probability of issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zxbvx5XAiIQj" style="vertical-align: bottom; text-align: right" title="Probability of issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;80.8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zd04jufot4vl" style="vertical-align: bottom; text-align: right" title="Probability of issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;59.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A2_zFc2oTm3AVrl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
on debt extinguishment is presented as a non-operating expense in the Company&#x2019;s consolidated statements of operations and
comprehensive loss. This accounting also resulted in a decrease in the amount of accretion to be recognized over the remaining
life of the Lind III Convertible Security through February 2023. Accretion expenses are disclosed as a part of interest expense,
which is not included as a component of operating costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Yorkville
Convertible Debentures&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the GXII Transaction, on January 26, 2023, NioCorp entered into definitive agreements with respect to the Yorkville
Financings, including a Securities Purchase Agreement, dated January 26, 2023 (as amended the &#x201c;Yorkville Convertible Debt
Financing Agreement&#x201d;), between the Company and Yorkville, and a Standby Equity Purchase Agreement, dated January 26, 2023
(the &#x201c;Yorkville Equity Facility Financing Agreement&#x201d;), between the Company and Yorkville.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Yorkville Convertible Debt Financing Agreement, at the Closing, Yorkville advanced a total amount of $15,360 to NioCorp
in consideration of the issuance by NioCorp to Yorkville of (i) $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240630__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zH70YXD2Nwpc" title="Aggregate principal amount"&gt;16,000&lt;/span&gt; aggregate principal amount of unsecured convertible debentures
(the &#x201c;Convertible Debentures&#x201d;) and (ii) Common Share purchase warrants, exercisable for up to &lt;span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zjQF16gscUL" title="Number of shares purchase"&gt;1,789,267&lt;/span&gt; Common Shares
for cash or, if at any time there is no effective registration statement registering, or no current prospectus available for,
the resale of the underlying Common Shares, on a cashless basis, at the option of the holder, at a price per Common Share of approximately
$&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zIDjSTqPvsA8" title="Number of shares purchase"&gt;8.9422&lt;/span&gt;, subject to adjustment to give effect to any stock dividend, stock split, reverse stock split or similar transaction (the
&#x201c;Financing Warrants&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
Convertible Debenture issued under the Yorkville Convertible Debt Financing Agreement is an unsecured obligation of NioCorp, has
an &lt;span id="xdx_906_eus-gaap--LongTermDebtMaturitiesRepaymentTerms_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zT6JJlmFCzy6" title="Debt term"&gt;18-month&lt;/span&gt; term from the Closing Date, which may be extended for one six-month period in certain circumstances at the option
of NioCorp, and incurs a simple interest rate obligation of &lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MinimumMember_zoF428AtYo9a" title="Interest rate obligation"&gt;5.0&lt;/span&gt;% per annum (which will increase to &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MaximumMember_zbHcDWkUUXu7" title="Interest rate obligation"&gt;15.0&lt;/span&gt;% per annum upon the occurrence
of an event of default). The outstanding principal amount of, accrued and unpaid interest, if any, on, and premium, if any, on
the Convertible Debentures must be paid by NioCorp in cash when the same becomes due and payable under the terms of the Convertible
Debentures at their stated maturity, upon their redemption or otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to certain limitations contained within the Yorkville Convertible Debt Financing Agreement and the Convertible Debentures, including
those as described below, holders of the Convertible Debentures will be entitled to convert the principal amount of, and accrued
and unpaid interest, if any, on each Convertible Debenture, in whole or&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;in part, from time to time over their term, into a number
of Common Shares equal to the quotient of the principal amount and accrued and unpaid interest, if any, being converted divided
by the Conversion Price. The &#x201c;Conversion Price&#x201d; means, as of any Conversion Date (as defined below) or other date
of determination, the greater of (i) 90% of the average of the daily U.S. dollar volume-weighted average price of the Common Shares
on the principal U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading
days immediately preceding the date on which the holder exercises its conversion right in accordance with the requirements of
the Yorkville Convertible Debt Financing Agreement (the &#x201c;Conversion Date&#x201d;) or other date of determination, but not
lower than the Floor Price (as defined below), and (ii) the five-day volume-weighted average price of the Common Shares on the
TSX (or on the principal U.S. market if the majority of the trading volume and value of the Common Shares occurred on Nasdaq during
the relevant period) for the five consecutive trading days immediately prior to the Conversion Date or other date of determination
less the maximum applicable discount allowed by TSX. The &#x201c;Floor Price&#x201d; means a price of $2.1435 per share, which is
equal to the lesser of (a) 30% of the average of the daily volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
preceding the Debenture Closing and (b) 30% of the average of the volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
following the Debenture Closing, subject to certain adjustments to give effect to any stock dividend, stock split, reverse stock
split, recapitalization or similar event.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms of the Convertible Debentures restrict the number of Convertible Debentures that may be converted during each calendar month
by Yorkville at a Conversion Price below a fixed price equal to approximately $8.9422 (i.e., the quotient of $10.00 divided by
1.11829212 (being the number of Common Shares that were exchanged for each share of GXII at the Closing, after giving effect to
the Reverse Stock Split)), subject to adjustment to give effect to any stock dividend, stock split, reverse stock split, recapitalization
or similar event. The Convertible Debentures are subject to customary anti-dilution adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms of the Convertible Debentures restrict the conversion of Convertible Debentures by Yorkville if such a conversion would
cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or such a conversion would cause the aggregate number
of Common Shares issued pursuant to the Yorkville Convertible Debt Financing Agreement to exceed the thresholds for issuance of
Common Shares under the rules of Nasdaq, unless prior shareholder approval is obtained.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the Convertible Debentures, following certain trigger events, and until a subsequent cure event, NioCorp will
be required to redeem $1,125 aggregate principal amount of Convertible Debentures (the &#x201c;Triggered Principal Amount&#x201d;)
each month by making cash payments to the Investors, on a pro rata basis, in an amount equal to the Triggered Principal Amount,
plus accrued and unpaid interest thereon, if any, plus a redemption premium of 7% of the Triggered Principal Amount. Such monthly
prepayments under the terms of the Convertible Debentures are triggered (i) at the time when NioCorp has issued 95% of the total
amount of Common Shares pursuant to the Yorkville Convertible Debt Financing that it may issue under applicable Nasdaq rules or
(ii) when NioCorp has delayed or suspended the effectiveness or use of the Convertible Debt Financing Registration Statement for
more than 20 consecutive calendar days, and such monthly prepayment obligations will continue until, with respect to (i) above,
shareholder approval is obtained or, with respect to (ii) above, the Investors may once again resell Common Shares under the Convertible
Debt Financing Registration Statement, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Convertible Debentures may also be redeemed at NioCorp&#x2019;s option at any time and from time to time over their term at a redemption
price equal to &lt;span id="xdx_901_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zDNf4iIPaZB2" title="Principal percentage"&gt;110&lt;/span&gt;% of the principal amount being redeemed, plus accrued and unpaid interest, if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
conjunction with the issuance of the Convertible Debentures, NioCorp issued to Yorkville &lt;span id="xdx_90D_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zdABP6yjf5e5" title="Issuance of the convertible debentures"&gt;1,789,267&lt;/span&gt;
Financing Warrants at an exercise price of approximately $&lt;span id="xdx_902_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise1_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zPQ4aqM8ohn3" title="Issuance of the convertible debentures"&gt;8.9422&lt;/span&gt;
per Common Share (the &#x201c;Financing Warrant Exercise Price&#x201d;), subject to adjustment to
give effect to any stock dividend, stock split, reverse stock split recapitalization or similar event. The Financing Warrants
are exercisable, in whole or in part, but not in increments of less than $&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__srt--RangeAxis__srt--MaximumMember_zxMkrK1VDK33" title="Aggregate exercise price, per shares"&gt;50&lt;/span&gt; aggregate Financing Warrant Exercise Price (unless
the remaining aggregate Financing Warrant Exercise Price is less than $50), beginning on May 4, 2023, and may be exercised at
any time prior to their expiration. Holders of the Financing Warrants may exercise their Financing Warrants, at their election,
by paying the Financing Warrant Exercise Price in&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;cash or, if at any time there is no effective registration statement registering,
or no current prospectus available for, the resale of the underlying Common Shares, on a cashless exercise basis. 1/12th of the
Financing Warrants will expire on each of the first 12 monthly anniversaries of the date that is six months following the Closing
Date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Financing Warrants have customary anti-dilution adjustments. The terms of the Financing Warrants restrict the exercise of Financing
Warrants by Yorkville if such an exercise would cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or
such an exercise would cause the aggregate number of Common Shares issued pursuant to the Yorkville Convertible Debt Financing
Agreement to exceed the thresholds for issuance of Common Shares under the rules of the Nasdaq, unless prior shareholder approval
is obtained.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Financing Warrants were originally recorded as a $&lt;span id="xdx_903_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_pn3n3_c20230126__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIelF8H5emV1" title="Contingent liability"&gt;2,704&lt;/span&gt; contingent liability on January 26, 2023, and were subsequently marked
to market of $&lt;span id="xdx_90E_eus-gaap--ServicingLiability_iI_pn3n3_c20230316__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxjptlUhgbc" title="Contingent liability"&gt;3,337&lt;/span&gt; through March 16, 2023. The change in fair value during this period resulted in a loss of $&lt;span id="xdx_90E_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_dxL_c20220701__20230630_zKbOOHaCibTl" title="Fair value of warrant liability::XDX::3338"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1016"&gt;633&lt;/span&gt;&lt;/span&gt;, which was
booked to change in fair value of warrant liability in the consolidated statement of operations and comprehensive loss. The Financing
Warrants were reclassified to shareholders equity on March 17, 2023, in connection with the closing of the Convertible Debentures
as noted below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company allocated the net proceeds of $15,360 from the Convertible Debentures as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zwBEgamIuQT" title="Fair value"&gt;2,704&lt;/span&gt;
    was booked to Common Shares, representing the initial fair value of the Financing Warrant tranches on January 26, 2023 based
    on the Black Scholes pricing model using a risk-free interest rate &lt;span style="color: #353535"&gt;of &lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_z4VF79aiO6Sd" title="Fair value"&gt;4.33&lt;/span&gt;%, an expected dividend
    yield of &lt;span id="xdx_90C_ecustom--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_pid_dp_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z8lyEiMtiEPk" title="Fair value"&gt;0&lt;/span&gt;%, a volatility of &lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zbSZWcFbtsgd" title="Fair value"&gt;64.6&lt;/span&gt;%, and an expected life of &lt;span id="xdx_901_ecustom--DebtMaturityPeriod_dxL_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MinimumMember_zIztXPQML6kk" title="Expected life::XDX::P6M"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1026"&gt;6&lt;/span&gt;&lt;/span&gt; months to &lt;span id="xdx_90F_ecustom--DebtMaturityPeriod_dxL_c20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MaximumMember_zVvscG6PK5a" title="Expected life::XDX::P18M"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1028"&gt;18&lt;/span&gt;&lt;/span&gt; months&lt;/span&gt;. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90E_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zTPSIZJhPmje" title="Convertible debt liability"&gt;12,656&lt;/span&gt;
    was booked to the convertible debt liability. In addition, transaction costs of $&lt;span id="xdx_907_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zGZCHj3EqGz2" title="Transaction costs"&gt;503&lt;/span&gt; were recognized as a direct deduction
    from the debt liability, resulting in a net opening balance of $12,153 at an effective interest rate of 29.9%. This balance
    will be accreted to face value of the Convertible Debentures at maturity plus the conversion premium, using the effective
    interest method and recorded as interest expense in the consolidated statement of operations and comprehensive loss.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ConvertibleDebtTableTextBlock_zCZIt9LXAG1b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_ziH8btiidYhl"&gt;Changes
in the Convertible Debentures are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 46%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 2%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Opening balance,
    March 17, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230315__20230630_zmxNCG0LTaxa" style="text-align: right" title="Opening balance, March 17, 2023"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,153&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accretion expense&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230315__20230630_z7wTzvPSLpPe" style="text-align: right" title="Accretion expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,962&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal and accrued
    interest converted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230315__20230630_zCfSSCzz9So1" style="border-bottom: black 1pt solid; text-align: right" title="Principal and accrued interest converted"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,554&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30,
    2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230701__20240630_zPQTp9SJcDme" style="text-align: right" title="Balance, June 30, 2023"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,561&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accretion expense&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230701__20240630_zDYYc4CSjGa3" style="text-align: right" title="Accretion expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,489&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal and accrued
    interest converted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230701__20240630_zICELzkeyOA" style="border-bottom: black 1pt solid; text-align: right" title="Principal and accrued interest converted"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,479&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30,
    2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_iE_pn3n3_c20230701__20240630_zPFMd0apsUA3" style="text-align: right" title="Balance, June 30, 2023"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;571&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Less: Unamortized
    debt issuance costs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--PaymentsOfFinancingCosts_pn3n3_dxL_c20230701__20240630_z329JUk6wQ66" style="border-bottom: black 1pt solid; text-align: right" title="Add: uamortized debt issuance costs::XDX::0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1050"&gt;(&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Remaining principal
    balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iE_pn3n3_c20230701__20240630_z89uW0w9kQQl" style="border-bottom: black 1.5pt solid; text-align: right" title="Balance, June 30, 2023"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;550&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8AA_zY2YhXXZfl11" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_zWJVatfuywXk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
conversion, the portion of remaining unamortized issuance costs associated with the conversion are recognized as a component of
interest expense. &lt;span id="xdx_8BF_zvWjZ9Y2PN97"&gt;The following table discloses the components of interest expense associated with the Convertible Debentures.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ending June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Component of Interest Expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 26%; text-align: justify"&gt;Contractual &#160;interest&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ContractualInterest_c20230701__20240630_zNFOoCJrv9K" style="width: 14%; text-align: right" title="Contractual interest"&gt;279&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ContractualInterest_c20220701__20230630_zvrniZHfvDw8" style="width: 14%; text-align: right" title="Contractual interest"&gt;225&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Amortization of discount and issuance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AmortizationOfFinancingCosts_c20230701__20240630_zq65XXL4La31" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs"&gt;4,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AmortizationOfFinancingCosts_c20220701__20230630_zE9KM6YtcXGb" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs"&gt;1,737&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InterestAndDebtExpense_c20230701__20240630_zad4crZ0IL64" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--InterestAndDebtExpense_c20220701__20230630_zfgz1HD72KHf" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;1,962&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AD_z9LaIIKzUr3a" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Convertible Debentures contain events of default customary for instruments of their type (with customary grace periods, as applicable)
and provide that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to NioCorp, all outstanding Convertible Debentures will become due and payable immediately without further action or notice. If
any other type of event of default occurs and is continuing, then any holder may declare all of its Convertible Debentures to
be due and payable immediately. The Company&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;obtained a waiver from Yorkville with respect to any acceleration rights it may have
under the Convertible Debentures in connection with the restatements of the Company&#x2019;s consolidated financial statements for the
periods ended September 30, 2022 and December 31, 2022 and the delay in filing the Company&#x2019;s Quarterly Report on Form 10-Q for
the quarterly period ended March 31, 2023. The Yorkville Convertible Debt Financing Agreement also contains certain covenants
that, among other things, limit NioCorp&#x2019;s ability to use the proceeds from the Yorkville Convertible Debt Financing to repay
related party debt or to enter into any variable rate transaction other than with Yorkville, subject to certain exceptions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
on the Company&#x2019;s closing Common Share price of $&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z5kz1rz5fw47"&gt;1.73&lt;/span&gt; as of June 30, 2024, conversion of the remaining Convertible Debenture
principal balance of $552, including accrued interest, would require the issuance of approximately 257,000 Common Shares.
For each $0.10 change in the fair value of one Common Share, the total shares the Company would be obligated to issue would change
by approximately &lt;span id="xdx_90E_eus-gaap--OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_iI_c20240630_ziyBVOVqCHaa"&gt;11,500&lt;/span&gt; shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 19, 2024, the Company and Yorkville entered into a make-whole payment agreement under which Yorkville agreed to convert the
remaining principal and outstanding accrued interest of $554 remaining under the Convertible Debenture into Common Shares in exchange
for a $95 make-whole payment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;April
2024 Notes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 12, 2024, the Company issued and sold to Yorkville and Lind Global Fund II LP (together with Yorkville, the &#x201c;April
2024 Purchasers&#x201d;), $8,000 aggregate principal amount of unsecured notes (the &#x201c;April 2024 Notes&#x201d;), pursuant to
a securities purchase agreement, dated April 11, 2024 (the &#x201c;April 2024 Purchase Agreement&#x201d;), between the Company and
each of the April 2024 Purchasers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also issued to the April 2024 Purchasers, in proportion to the aggregate principal amount of April 2024 Notes issued to
each April 2024 Purchaser, Warrants (the &#x201c;April 2024 Warrants&#x201d;) to purchase up to 615,385 Common Shares (the &#x201c;April
2024 Warrants Shares&#x201d;), which are equal to 25% of the aggregate principal amount of April 2024 Notes issued to the April
2024 Purchasers divided by the exercise price of $3.25, subject to any adjustment to give effect to any stock dividend, stock
split or recapitalization. The April 2024 Warrants expire on April 12, 2027.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the April 2024 Purchase Agreement, the April 2024 Purchasers advanced an aggregate of $6,935 to the Company in consideration
of the issuance by the Company to the April 2024 Purchasers of $8,000 aggregate principal amount of the April 2024 Notes and April
2024 Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the terms of the April 2024 Notes, subject to certain exceptions, on the first day of each calendar month, beginning on June 1,
2024 (excluding August 2024) (the &#x201c;Payment Date&#x201d;), the Company will be required to repay a portion of the outstanding
balance of all of the April 2024 Notes, on a pro-rata basis, in an amount equal to the sum of (i) $1,400 of principal (or the
outstanding principal if less than such amount) in the aggregate among all of the outstanding Notes, plus (ii) 8.0% of the principal
amount being paid (the &#x201c;Payment Premium&#x201d;), and (iii) accrued and unpaid interest, if any, as of the Payment Date.
The Company is required to make payments on each Payment Date until the entire outstanding principal is repaid but will not have
an obligation to make a payment on a Payment Date if certain equity conditions (the &#x201c;Equity Conditions&#x201d;) are satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to certain limitations contained within the April 2024 Notes, holders of the April 2024 Notes will be entitled to convert the
principal amount of, accrued and unpaid interest, if any, and any Payment Premium that has become due and payable on each April
2024 Note, from time to time over their term, into a number of Common Shares equal to the quotient of the amount being converted
divided by a fixed conversion price of $2.75 per Common Share up to a maximum of 3,141,817 Common Shares (together with the April
2024 Warrant Shares, the &#x201c;April 2024 Underlying Shares&#x201d;). The terms of the April 2024 Notes restrict the conversion
of the April 2024 Notes by a holder if such a conversion would cause such holder to exceed certain ownership thresholds in the
Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
noted above, the Company is required to make payments on each Payment Date until the entire outstanding principal is repaid,
but will not have an obligation to make a payment on a Payment Date if the Equity Conditions are satisfied (a &#x201c;deferred
payment&#x201d;). The Equity Conditions means (i) on each of the five consecutive trading days prior a Payment Date (the
&#x201c;Measuring Period&#x201d;) the Underlying Shares Registration Statement (as defined below) is effective&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and available
for the resale by the Purchasers of all Underlying Shares, (ii) the Company has no knowledge of any fact that would cause the
Underlying Shares Registration Statement not to be effective and available for the resale of the Underlying Shares, (iii) on
each day during the Measuring Period, the Common Shares are designated for quotation on Nasdaq, or on such other market or
exchange on which the Common Shares are then listed or traded to the extent such other market or exchange is the principal
U.S. trading market for the Common Shares (the &#x201c;Principal U.S. Market&#x201d;), and have not been suspended from trading
nor have delisting or suspension of trading been threatened or pending, (iv) during the Measuring Period, an event of default
has not occurred, (v) on each trading day during the Measuring Period, the daily U.S. dollar volume-weighted average price
(&#x201c;VWAP&#x201d;) for a Common Share on the Principal U.S. Market as reported by Bloomberg Financial Markets is greater
than 120% of the Conversion Price, (vi) on each trading day during the Measuring Period the average daily volume traded
exceeded $500, and (vii) there is no limitation on conversion under the terms of Notes. Deferred payments, if any, that are
not subsequently converted into Common Shares by the holders of the April 2024 Notes will require repayment by
the Company upon maturity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
April 2024 Notes are the unsecured obligations of the Company and will mature on December 31, 2024. The April 2024 Notes will
incur a simple interest rate obligation of 0.0% per annum (which will increase to 18.0% per annum upon the occurrence of an event
of default). The outstanding principal amount, accrued and unpaid interest, if any, and the Payment Premium, if any, on the April
2024 Notes must be paid by NioCorp in cash when the same becomes due and payable under the terms of the April 2024 Notes at their
stated maturity, upon their redemption, or otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
April 2024 Notes may also be redeemed at the Company&#x2019;s option at any time and from time to time over their term at a redemption
price equal to the principal amount being redeemed, plus the Payment Premium, plus accrued and unpaid interest, if any, as of
the redemption date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
April 2024 Notes contain events of default customary for instruments of their type (with customer grace periods, as applicable)
and provide that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to the company, all outstanding April 2024 Notes will become due and payable immediately without further action or notice. If
any other type of event of default occurs and is continuing, then any holder may declare all of its April 2024 Notes to be due
and payable immediately.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
April 2024 Purchase Agreement contains customary representations, warranties, conditions and indemnification obligations by each
party. The representations, warranties and covenants contained in the April 2024 Purchase Agreement were made only for purposes
of the April 2024 Purchase Agreement and as of specific dates, were solely for the benefit of the parties to such agreement and
are subject to certain important limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
April 2024 Purchase Agreement also contains certain covenants that, among other things, limit NioCorp&#x2019;s ability to use the
proceeds from the April 2024 Purchase Agreement to repay related party debt or to enter into any variable rate transaction other
than with Yorkville, subject to certain exceptions, and to distribute proceeds from the April 2024 Purchase Agreement to subsidiaries
other than ECRC and 0896800 B.C. Ltd. (together with ECRC, the &#x201c;Guarantors&#x201d;), upon the entry by the Guarantors into
a global guaranty agreement, dated as of April 11, 2024, among the Guarantors in favor of the Purchasers (the &#x201c;Guaranty Agreement&#x201d;).
Pursuant to the Guaranty Agreement, the Guarantors guaranteed the full, prompt and unconditional payment when due (whether at
maturity , by acceleration or otherwise), and the performance of all liabilities, agreements and other obligations of NioCorp
to the April 2024 Purchasers contained in the April 2024 Notes, the April 2024 Warrants and the April 2024 Purchase Agreement,
to the extent such liabilities, agreements and obligations are payable in cash.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
upon the Company&#x2019;s analysis of the criteria contained in ASC 815, the Company determined that April 2024 Warrants met the
definition of a&#160;derivative liability, as any warrant exercise that could cause the holder to exceed 19.9% ownership of NioCorp
Common Shares would require shareholder approval. As such, the April 2024 Warrants were recognized as warrant liabilities on the
consolidated balance sheet and were measured at their inception date fair value and subsequently remeasured at each reporting
period with changes being recorded as a non-operating gain or loss in the consolidated statement of operations and comprehensive
loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company elected to value the April 2024 Notes at fair value in accordance with ASC 815-15-25. The fair value of the April 2024
Notes was estimated using a Monte Carlo simulation pricing model and the April 2024 Notes were&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;classified as Level 3 instruments.
The Company incurred transaction costs totaling $&lt;span id="xdx_90E_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zarXN1Tl7me" title="Transaction loss"&gt;474&lt;/span&gt; in connection with the issuance of the April 2024 Notes and due to the fair
value election noted above, these costs were expensed at closing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Components
and initial valuations associated with the April 2024 Notes were comprised of the following amounts:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_902_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240401__20240430_zo5PWB31vEwk" title="Warrant liabilities"&gt;902&lt;/span&gt;
    was recorded to warrant liabilities, representing the initial fair value of the April 2024 Warrants based on the assumptions
    outlined below.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_903_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_pn3n3_c20240401__20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zZNfCdGpUTM7" title="Fair value"&gt;10,315&lt;/span&gt; was recorded
    to the April 2024 Notes, representing the fair value based on the assumptions outlined below. The Company also recognized
    an opening transaction loss of $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pn3n3_c20240401__20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zqEHBE2MnU2d" title="Transaction loss"&gt;4,256&lt;/span&gt;, representing the difference between the fair value of the April 2024 Notes, including
    the fair value of the variable conversion features embedded therein, and cash received in the transaction.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfInterestRateDerivativesTableTextBlock_zHNvXdAmOAT3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zfUrMHRhCZu5"&gt;The
following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Key Valuation Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,&#160; &lt;br/&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;April 12,&#160; &lt;br/&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 54%; text-align: left"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhqSFnTS9d7e" style="width: 21%; text-align: center" title="Closing common share price"&gt;$1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zmBICTXydg34" style="width: 21%; text-align: center" title="Closing common share price"&gt;$3.11&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Term (expiry)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zaJ72QA4j4Ce" title="Term (expiry)"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zADAFpNQqTH9" title="Term (expiry)"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Weighted average of the equity volatility and implied volatility of the public warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zBICEfh0rBGg" style="text-align: center" title="Weighted average of the equity volatility and implied volatility of the public warrants"&gt;80%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIUl1VeCkHje" style="text-align: center" title="Weighted average of the equity volatility and implied volatility of the public warrants"&gt;66.0%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zdy5tTkY5Qdb" style="text-align: center" title="Risk-free rate"&gt;5.33%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zqR3GtXVGbL4" style="text-align: center" title="Risk-free rate"&gt;5.26%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Implied discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ImpliedDiscountRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zyuehdXX7kk3" style="text-align: center" title="Implied discount rate"&gt;15.0%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ImpliedDiscountRate_pid_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z4V10XbqMFRl" style="text-align: center" title="Implied discount rate"&gt;15.0%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_z6XJa1PWXF9e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_zJ9Smiw7Z0uf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zpAR7ydiCVOb"&gt;The
following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 47%; text-align: justify"&gt;Fair value, April 12, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20230701__20240630_z2jv5DxV4aAj" style="width: 10%; text-align: right" title="Fair value, April 12, 2024"&gt;10,315&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Principal payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20230701__20240630_zJI5vBB9C5pf" style="text-align: right" title="Principal payments"&gt;(1,512&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ChangeInFairValue_iN_di_c20230701__20240630_zx4TGDsCPam" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;(1,714&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt"&gt;Balance, June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_c20230701__20240630_zHeWpD3PZia7" style="border-bottom: Black 2pt solid; text-align: right" title="Balance, June 30, 2024"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Remaining principal balance, June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_c20230701__20240630_zjHqglcvRBN3" style="text-align: right" title="Remaining principal balance, June 30, 2024"&gt;7,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A1_zmFHIGoaU1j8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89F_ecustom--ShareholdersEquityAndShareBasedWarrantsTextBlock_zh3qMPNxLzI3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zQEb40a2NLt7"&gt;The
following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Key Valuation Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,&#160; &lt;br/&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;April 12,&#160; &lt;br/&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zPmCPTpX0pW3" style="width: 15%; text-align: right" title="Closing Common Share price"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z20QFBugWrD5" style="width: 15%; text-align: right" title="Closing Common Share price"&gt;3.24&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFsziBESTP1e" style="text-align: right" title="Term (years)"&gt;2.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQd3COrPHMv7" style="text-align: right" title="Term (years)"&gt;3.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFipjWoRMIF9" style="text-align: right" title="Expected volatility"&gt;66.34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwkJ8FX3AS7l" style="text-align: right" title="Expected volatility"&gt;62.39&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zURmgUpQIT27" style="text-align: right" title="Risk-free rate"&gt;4.57&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZymoChGO0h6" style="text-align: right" title="Risk-free rate"&gt;4.77&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_zSvcJIS5Y6s5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_z5JKzlucfzUh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zrCdDv1tM1Nh"&gt;The
following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June
30, 2024.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 47%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of April 12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z0iuzQNGBL5" style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;902&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--FairValueAdjustmentOfWarrants_iN_pn3n3_di_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z3qby1HDA9Jj" style="border-bottom: black 1pt solid; text-align: right"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of June 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zRvILZ43JrPb" style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;298&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AD_zdO0PJW0XbP6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000850">&lt;p id="xdx_891_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_znt2ASmxe8F3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;&lt;span id="xdx_8B2_zuddybIb4Vbi"&gt;Schedule
of convertible debt&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Current Portion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 0.25in"&gt;Yorkville convertible debentures:&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleSecurityMember_z4al58ZIKgad" style="width: 10%; text-align: right" title="Convertibled debt, current"&gt;571&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zm6prukscnK8" style="width: 10%; text-align: right" title="Convertibled debt, current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0854"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in"&gt;April 2024 notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zlWSwZHZYha8" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current"&gt;7,089&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zA3WMLa7U3Ok" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Total Current Portion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zqhajbNKEC34" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current"&gt;7,660&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zPkuDigqFcJ" style="border-bottom: Black 1pt solid; text-align: right" title="Convertibled debt, current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0862"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in"&gt;Noncurrent Portion &#x2013; Yorkville convertible debenture&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zyU1pL7QKcPe" style="border-bottom: Black 2pt solid; text-align: right" title="Convertible debt, noncurrent"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0864"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zH3wR4pfycCb" style="border-bottom: Black 2pt solid; text-align: right" title="Convertible debt, noncurrent"&gt;10,561&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleSecurityMember"
      decimals="-3"
      id="Fact000852"
      unitRef="USD">571000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2024-06-30_custom_April2024ConvertibleSecurityMember"
      decimals="-3"
      id="Fact000856"
      unitRef="USD">7089000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2024-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      id="Fact000860"
      unitRef="USD">7660000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      id="Fact000866"
      unitRef="USD">10561000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="From2021-02-162021-02-19"
      decimals="-3"
      id="Fact000868"
      unitRef="USD">11700000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:InvestmentInterestRate
      contextRef="AsOf2021-02-19"
      decimals="INF"
      id="Fact000869"
      unitRef="Pure">0.085</us-gaap:InvestmentInterestRate>
    <us-gaap:OtherCommitment
      contextRef="AsOf2021-02-19"
      decimals="-3"
      id="Fact000871"
      unitRef="USD">350000</us-gaap:OtherCommitment>
    <us-gaap:ProceedsFromInterestReceived
      contextRef="From2021-02-162021-02-19"
      decimals="-3"
      id="Fact000873"
      unitRef="USD">9650000</us-gaap:ProceedsFromInterestReceived>
    <us-gaap:DebtConversionDescription
      contextRef="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember"
      id="Fact000876">Pursuant
to the Lind III Agreement, Lind was entitled to convert the Lind III Convertible Security into Common Shares in monthly installments
over its term at a price per Common Share equal to 85% of the volume-weighted average price Common Shares on the TSX for the five
trading days immediately preceding to the date on which Lind provides notice to the Company of its election to convert. The Lind
III Agreement provided that Common Shares issuable upon conversion, together with the number of Common Shares issued upon exercise
of Warrants, shall not exceed 4,358,800 Common Shares.</us-gaap:DebtConversionDescription>
    <us-gaap:CommonUnitIssued
      contextRef="AsOf2021-02-19"
      decimals="INF"
      id="Fact000878"
      unitRef="Shares">855800</us-gaap:CommonUnitIssued>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000880"
      unitRef="CADPShares">9.70</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember7263812"
      decimals="-3"
      id="Fact000881"
      unitRef="USD">9477000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember"
      decimals="INF"
      id="Fact000883"
      unitRef="Pure">0.0040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember"
      decimals="-3"
      id="Fact000885"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember"
      decimals="INF"
      id="Fact000887"
      unitRef="Pure">0.5160</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2024-06-30_custom_LindIIIConvertibleSecurityMember7263843"
      decimals="-3"
      id="Fact000891"
      unitRef="USD">7938000</us-gaap:ConvertibleDebtCurrent>
    <niobf:TransactionCost
      contextRef="From2023-07-012024-06-30_custom_LindIIIConvertibleSecurityMember7263812"
      decimals="-3"
      id="Fact000893"
      unitRef="USD">173000</niobf:TransactionCost>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="From2021-02-172021-02-19"
      decimals="-3"
      id="Fact000895"
      unitRef="USD">350000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <niobf:ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000904">&lt;p id="xdx_895_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_z1i0WPYFDhT9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_zhg0BZ2GTAlh"&gt;Changes
in the Lind III Convertible Security are as follows&lt;/span&gt;:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; border-collapse: collapse; width: 70%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the year ending &lt;br/&gt;
June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 44%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beginning
    balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_znePfQEwOtqi" style="width: 10%; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,169&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value increase due to debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_ztsEgdWtpGJj" style="text-align: right" title="Fair value increase due to debt extinguishment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;201&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Conversions&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ConversionOfStockAmountIssued1_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zC9ggsIYxk2" style="text-align: right" title="Conversions"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,950&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accretion
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zynamc468rZ5" style="text-align: right" title="Accretion expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;95&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payment
    at maturity&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zutaLWwXJZkh" style="border-bottom: Black 1pt solid; text-align: right" title="Payment at maturity"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;515&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June
    30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zt6CCQWihBv3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0916"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</niobf:ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2022-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      id="Fact000906"
      unitRef="USD">2169000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      id="Fact000908"
      unitRef="USD">201000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      id="Fact000910"
      unitRef="USD">1950000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:AccretionExpense
      contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      id="Fact000912"
      unitRef="USD">95000</us-gaap:AccretionExpense>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      id="Fact000914"
      unitRef="USD">515000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000918">&lt;p id="xdx_897_eus-gaap--ScheduleOfExtinguishmentOfDebtTextBlock_z5sVttqay9U8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;&#160;&lt;span id="xdx_8BC_zCpNCSkq0uk1"&gt;The following table summarizes the components of the initial loss and final loss on extinguishment:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Component
    of loss&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230701__20240630_zuwKBTzqeyhe" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--MinimumConsentPaymentAtInception_pn3n3_z0lvL9KTt57k" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 77%; text-align: justify; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Minimum
    Consent Payment at inception&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;200&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--ASC470LossOnExtinguishment_pn3n3_zUh8DOXqOWIk" style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;201&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--AdjustmentOfWarrantsGrantedForServices_pn3n3_zVOTyhwsJj76" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify; width: 77%; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    fair value of Contingent Consent Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,221&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_pn3n3_zAI1LwFFQNHl" style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,622&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--AdditionalConsentPaymentbooked_pn3n3_zJow2YPMqar3" style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additional
    Consent Payment booked&lt;sup id="xdx_F4F_zp1q7smy2gme"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;300&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--GainsLossesOnRestructuringOfDebt_pn3n3_zJTCgIi1gapg" style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,922&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: justify"&gt;&lt;span id="xdx_F02_zkh2PLuTpzb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_zhOm4ESnSM54" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock>
    <niobf:MinimumConsentPaymentAtInception
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000920"
      unitRef="USD">200000</niobf:MinimumConsentPaymentAtInception>
    <niobf:ASC470LossOnExtinguishment
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000922"
      unitRef="USD">201000</niobf:ASC470LossOnExtinguishment>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000924"
      unitRef="USD">1221000</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000926"
      unitRef="USD">1622000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <niobf:AdditionalConsentPaymentbooked
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000928"
      unitRef="USD">300000</niobf:AdditionalConsentPaymentbooked>
    <us-gaap:GainsLossesOnRestructuringOfDebt
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000930"
      unitRef="USD">1922000</us-gaap:GainsLossesOnRestructuringOfDebt>
    <niobf:ScheduleOfWarrantValuationTableTextblock contextRef="From2023-07-01to2024-06-30" id="Fact000940">&lt;p id="xdx_89C_ecustom--ScheduleOfWarrantValuationTableTextblock_zhE2hs07LbYc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zUGu0r4iMI85"&gt;The
change in the fair value of the Contingent Consent Warrants is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 37%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    valuation, September 25, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iS_c20220701__20230630_zQIK8izaqrz6" style="width: 10%; text-align: right" title="Initial valuation, at beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,221&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ChangeInValuationOfWarrants_c20220701__20230630_zEMPS1TodF55" style="border-bottom: black 1pt solid; text-align: right" title="Change in valuation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;489&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    at June 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iE_c20220701__20230630_zPAsfAyTEG52" style="text-align: right" title="Valuation, at ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,710&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ChangeInValuationOfWarrants_c20230701__20240630_zf3RqufC5qwc" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;655&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    at June 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iE_c20230701__20240630_zUJWpt80Idq6" style="border-bottom: black 1.5pt solid; text-align: right" title="Valuation, at ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,365&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</niobf:ScheduleOfWarrantValuationTableTextblock>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-06-30"
      decimals="-3"
      id="Fact000942"
      unitRef="USD">1221000</us-gaap:WarrantsAndRightsOutstanding>
    <niobf:ChangeInValuationOfWarrants
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000944"
      unitRef="USD">489000</niobf:ChangeInValuationOfWarrants>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000946"
      unitRef="USD">1710000</us-gaap:WarrantsAndRightsOutstanding>
    <niobf:ChangeInValuationOfWarrants
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact000948"
      unitRef="USD">655000</niobf:ChangeInValuationOfWarrants>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000950"
      unitRef="USD">2365000</us-gaap:WarrantsAndRightsOutstanding>
    <niobf:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000952">&lt;p id="xdx_892_ecustom--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_zSUmcTMTX2Ac" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; visibility: hidden"&gt;&lt;span id="xdx_8BA_zBUzmwMhlFg3"&gt;Schedule of valuation date and the probability calculated&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key
    Valuation Input&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
30,&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
30,&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September&#160;25,&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCECFF"&gt;
    &lt;td style="vertical-align: bottom; width: 46%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    price on valuation date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zmA2MRDKFa6b" style="vertical-align: bottom; width: 10%; text-align: right" title="Share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.73&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zxaoQRZH10k3" style="vertical-align: bottom; width: 10%; text-align: right" title="Share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.03&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zfbGiT624Uak" style="vertical-align: bottom; width: 10%; text-align: right" title="Share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.82&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Volatility&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_z8DzHiw5SFZ5" style="vertical-align: bottom; text-align: right" title="Volatility"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;68.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zmTiN5M68p39" style="vertical-align: bottom; text-align: right" title="Volatility"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zfGp98M0egGa" style="vertical-align: bottom; text-align: right" title="Volatility"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;62.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCECFF"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk
    free rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zD3RKNi7vBcd" style="vertical-align: bottom; text-align: right" title="Risk free rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.40&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zxLbhvVnRKpf" style="vertical-align: bottom; text-align: right" title="Risk free rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.11&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_z7RRe4dMVIHe" style="vertical-align: bottom; text-align: right" title="Risk free rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Probability
    of issuance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20240630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_z5dUA5BPSK76" style="vertical-align: bottom; text-align: right" title="Probability of issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zxbvx5XAiIQj" style="vertical-align: bottom; text-align: right" title="Probability of issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;80.8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zd04jufot4vl" style="vertical-align: bottom; text-align: right" title="Probability of issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;59.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</niobf:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      id="Fact000954"
      unitRef="USDPShares">1.73</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-06-30_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      id="Fact000956"
      unitRef="USDPShares">5.03</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-09-25_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      id="Fact000958"
      unitRef="USDPShares">7.82</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-06-30_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact000960"
      unitRef="NUMBER">0.680</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-06-30_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact000962"
      unitRef="NUMBER">0.630</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-09-25_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact000964"
      unitRef="NUMBER">0.624</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact000966"
      unitRef="NUMBER">0.0440</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact000968"
      unitRef="NUMBER">0.0411</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-09-25_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact000970"
      unitRef="NUMBER">0.0393</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-06-30_custom_ProbabilityOfIssuanceMember"
      decimals="INF"
      id="Fact000972"
      unitRef="NUMBER">1.000</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-06-30_custom_ProbabilityOfIssuanceMember"
      decimals="INF"
      id="Fact000974"
      unitRef="NUMBER">0.808</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-09-25_custom_ProbabilityOfIssuanceMember"
      decimals="INF"
      id="Fact000976"
      unitRef="NUMBER">0.594</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-06-30_us-gaap_UnsecuredDebtMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      id="Fact000978"
      unitRef="USD">16000000</us-gaap:DebtInstrumentFaceAmount>
    <niobf:StockIssuedDuringPeriodSharesStockOptionsExercise
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      id="Fact000980"
      unitRef="Shares">1789267</niobf:StockIssuedDuringPeriodSharesStockOptionsExercise>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      id="Fact000982"
      unitRef="USDPShares">8.9422</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:LongTermDebtMaturitiesRepaymentTerms
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      id="Fact000984">18-month</us-gaap:LongTermDebtMaturitiesRepaymentTerms>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MinimumMember"
      decimals="INF"
      id="Fact000986"
      unitRef="Pure">0.050</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MaximumMember"
      decimals="INF"
      id="Fact000988"
      unitRef="Pure">0.150</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      id="Fact000997"
      unitRef="Pure">1.10</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <niobf:StockIssuedDuringPeriodSharesStockOptionsExercise
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      id="Fact000999"
      unitRef="Shares">1789267</niobf:StockIssuedDuringPeriodSharesStockOptionsExercise>
    <niobf:StockIssuedDuringPeriodSharesStockOptionsExercise1
      contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      id="Fact001001"
      unitRef="CADPShares">8.9422</niobf:StockIssuedDuringPeriodSharesStockOptionsExercise1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_srt_MaximumMember"
      decimals="INF"
      id="Fact001003"
      unitRef="USDPShares">50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="AsOf2023-01-26_us-gaap_WarrantMember"
      decimals="-3"
      id="Fact001012"
      unitRef="USD">2704000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:ServicingLiability
      contextRef="AsOf2023-03-16_us-gaap_WarrantMember"
      decimals="-3"
      id="Fact001014"
      unitRef="USD">3337000</us-gaap:ServicingLiability>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      id="Fact001018"
      unitRef="USD">2704000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact001020"
      unitRef="Pure">4.33</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <niobf:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate
      contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      id="Fact001022"
      unitRef="Pure">0</niobf:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact001024"
      unitRef="NUMBER">64.6</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      id="Fact001030"
      unitRef="USD">12656000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      id="Fact001032"
      unitRef="USD">503000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001034">&lt;p id="xdx_89A_eus-gaap--ConvertibleDebtTableTextBlock_zCZIt9LXAG1b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_ziH8btiidYhl"&gt;Changes
in the Convertible Debentures are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 46%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 2%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Opening balance,
    March 17, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230315__20230630_zmxNCG0LTaxa" style="text-align: right" title="Opening balance, March 17, 2023"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,153&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accretion expense&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230315__20230630_z7wTzvPSLpPe" style="text-align: right" title="Accretion expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,962&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal and accrued
    interest converted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230315__20230630_zCfSSCzz9So1" style="border-bottom: black 1pt solid; text-align: right" title="Principal and accrued interest converted"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,554&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30,
    2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230701__20240630_zPQTp9SJcDme" style="text-align: right" title="Balance, June 30, 2023"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,561&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accretion expense&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230701__20240630_zDYYc4CSjGa3" style="text-align: right" title="Accretion expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,489&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal and accrued
    interest converted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230701__20240630_zICELzkeyOA" style="border-bottom: black 1pt solid; text-align: right" title="Principal and accrued interest converted"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,479&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30,
    2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_iE_pn3n3_c20230701__20240630_zPFMd0apsUA3" style="text-align: right" title="Balance, June 30, 2023"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;571&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Less: Unamortized
    debt issuance costs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--PaymentsOfFinancingCosts_pn3n3_dxL_c20230701__20240630_z329JUk6wQ66" style="border-bottom: black 1pt solid; text-align: right" title="Add: uamortized debt issuance costs::XDX::0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1050"&gt;(&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Remaining principal
    balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iE_pn3n3_c20230701__20240630_z89uW0w9kQQl" style="border-bottom: black 1.5pt solid; text-align: right" title="Balance, June 30, 2023"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;550&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2023-03-14"
      decimals="-3"
      id="Fact001036"
      unitRef="USD">12153000</us-gaap:ConvertibleDebt>
    <us-gaap:AccretionExpenseIncludingAssetRetirementObligations
      contextRef="From2023-03-152023-06-30"
      decimals="-3"
      id="Fact001038"
      unitRef="USD">1962000</us-gaap:AccretionExpenseIncludingAssetRetirementObligations>
    <niobf:PrincipalAndAccruedInterestConverted
      contextRef="From2023-03-152023-06-30"
      decimals="-3"
      id="Fact001040"
      unitRef="USD">-3554000</niobf:PrincipalAndAccruedInterestConverted>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001042"
      unitRef="USD">10561000</us-gaap:ConvertibleDebt>
    <us-gaap:AccretionExpenseIncludingAssetRetirementObligations
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001044"
      unitRef="USD">4489000</us-gaap:AccretionExpenseIncludingAssetRetirementObligations>
    <niobf:PrincipalAndAccruedInterestConverted
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001046"
      unitRef="USD">-14479000</niobf:PrincipalAndAccruedInterestConverted>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001048"
      unitRef="USD">571000</us-gaap:ConvertibleDebt>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001052"
      unitRef="USD">550000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001054">&lt;p id="xdx_898_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_zWJVatfuywXk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
conversion, the portion of remaining unamortized issuance costs associated with the conversion are recognized as a component of
interest expense. &lt;span id="xdx_8BF_zvWjZ9Y2PN97"&gt;The following table discloses the components of interest expense associated with the Convertible Debentures.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ending June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Component of Interest Expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 26%; text-align: justify"&gt;Contractual &#160;interest&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ContractualInterest_c20230701__20240630_zNFOoCJrv9K" style="width: 14%; text-align: right" title="Contractual interest"&gt;279&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ContractualInterest_c20220701__20230630_zvrniZHfvDw8" style="width: 14%; text-align: right" title="Contractual interest"&gt;225&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Amortization of discount and issuance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AmortizationOfFinancingCosts_c20230701__20240630_zq65XXL4La31" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs"&gt;4,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AmortizationOfFinancingCosts_c20220701__20230630_zE9KM6YtcXGb" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs"&gt;1,737&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InterestAndDebtExpense_c20230701__20240630_zad4crZ0IL64" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--InterestAndDebtExpense_c20220701__20230630_zfgz1HD72KHf" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;1,962&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock>
    <niobf:ContractualInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001056"
      unitRef="USD">279000</niobf:ContractualInterest>
    <niobf:ContractualInterest
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001058"
      unitRef="USD">225000</niobf:ContractualInterest>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001060"
      unitRef="USD">4210000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001062"
      unitRef="USD">1737000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001064"
      unitRef="USD">4489000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001066"
      unitRef="USD">1962000</us-gaap:InterestAndDebtExpense>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      id="Fact001073"
      unitRef="CADPShares">1.73</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001074"
      unitRef="Shares">11500</us-gaap:OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2024-04-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact001088"
      unitRef="USD">474000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-04-012024-04-30"
      decimals="-3"
      id="Fact001090"
      unitRef="USD">902000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized
      contextRef="From2024-04-012024-04-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact001092"
      unitRef="USD">10315000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012024-04-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact001094"
      unitRef="USD">4256000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001096">&lt;p id="xdx_89A_eus-gaap--ScheduleOfInterestRateDerivativesTableTextBlock_zHNvXdAmOAT3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zfUrMHRhCZu5"&gt;The
following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Key Valuation Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,&#160; &lt;br/&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;April 12,&#160; &lt;br/&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 54%; text-align: left"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhqSFnTS9d7e" style="width: 21%; text-align: center" title="Closing common share price"&gt;$1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zmBICTXydg34" style="width: 21%; text-align: center" title="Closing common share price"&gt;$3.11&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Term (expiry)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zaJ72QA4j4Ce" title="Term (expiry)"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zADAFpNQqTH9" title="Term (expiry)"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Weighted average of the equity volatility and implied volatility of the public warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zBICEfh0rBGg" style="text-align: center" title="Weighted average of the equity volatility and implied volatility of the public warrants"&gt;80%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIUl1VeCkHje" style="text-align: center" title="Weighted average of the equity volatility and implied volatility of the public warrants"&gt;66.0%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zdy5tTkY5Qdb" style="text-align: center" title="Risk-free rate"&gt;5.33%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zqR3GtXVGbL4" style="text-align: center" title="Risk-free rate"&gt;5.26%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Implied discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ImpliedDiscountRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zyuehdXX7kk3" style="text-align: center" title="Implied discount rate"&gt;15.0%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ImpliedDiscountRate_pid_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z4V10XbqMFRl" style="text-align: center" title="Implied discount rate"&gt;15.0%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001098"
      unitRef="USDPShares">1.73</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001100"
      unitRef="USDPShares">3.11</us-gaap:SharePrice>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember"
      id="Fact001102">2024-12-31</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember"
      id="Fact001104">2024-12-31</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001106"
      unitRef="Pure">0.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001108"
      unitRef="Pure">0.660</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001110"
      unitRef="Pure">0.0533</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001112"
      unitRef="Pure">0.0526</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <niobf:ImpliedDiscountRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001114"
      unitRef="Pure">0.150</niobf:ImpliedDiscountRate>
    <niobf:ImpliedDiscountRate
      contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001116"
      unitRef="Pure">0.150</niobf:ImpliedDiscountRate>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001118">&lt;p id="xdx_890_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_zJ9Smiw7Z0uf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zpAR7ydiCVOb"&gt;The
following table sets forth a summary of the changes in the fair value of the April 2024 Notes for the year ended June 30, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 47%; text-align: justify"&gt;Fair value, April 12, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20230701__20240630_z2jv5DxV4aAj" style="width: 10%; text-align: right" title="Fair value, April 12, 2024"&gt;10,315&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Principal payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20230701__20240630_zJI5vBB9C5pf" style="text-align: right" title="Principal payments"&gt;(1,512&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ChangeInFairValue_iN_di_c20230701__20240630_zx4TGDsCPam" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;(1,714&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt"&gt;Balance, June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_c20230701__20240630_zHeWpD3PZia7" style="border-bottom: Black 2pt solid; text-align: right" title="Balance, June 30, 2024"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Remaining principal balance, June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_c20230701__20240630_zjHqglcvRBN3" style="text-align: right" title="Remaining principal balance, June 30, 2024"&gt;7,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001120"
      unitRef="USD">10315000</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001122"
      unitRef="USD">1512000</us-gaap:DebtInstrumentPeriodicPayment>
    <niobf:ChangeInFairValue
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001124"
      unitRef="USD">1714000</niobf:ChangeInFairValue>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001126"
      unitRef="USD">7089000</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001128"
      unitRef="USD">7128000</us-gaap:ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment>
    <niobf:ShareholdersEquityAndShareBasedWarrantsTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001130">&lt;p id="xdx_89F_ecustom--ShareholdersEquityAndShareBasedWarrantsTextBlock_zh3qMPNxLzI3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zQEb40a2NLt7"&gt;The
following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Key Valuation Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,&#160; &lt;br/&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;April 12,&#160; &lt;br/&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zPmCPTpX0pW3" style="width: 15%; text-align: right" title="Closing Common Share price"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z20QFBugWrD5" style="width: 15%; text-align: right" title="Closing Common Share price"&gt;3.24&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFsziBESTP1e" style="text-align: right" title="Term (years)"&gt;2.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQd3COrPHMv7" style="text-align: right" title="Term (years)"&gt;3.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFipjWoRMIF9" style="text-align: right" title="Expected volatility"&gt;66.34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwkJ8FX3AS7l" style="text-align: right" title="Expected volatility"&gt;62.39&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zURmgUpQIT27" style="text-align: right" title="Risk-free rate"&gt;4.57&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZymoChGO0h6" style="text-align: right" title="Risk-free rate"&gt;4.77&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ShareholdersEquityAndShareBasedWarrantsTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001132"
      unitRef="USDPShares">1.73</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001134"
      unitRef="USDPShares">3.24</us-gaap:SharePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      id="Fact001136">P2Y9M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      id="Fact001138">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001140"
      unitRef="Pure">0.6634</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001142"
      unitRef="Pure">0.6239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001144"
      unitRef="Pure">0.0457</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001146"
      unitRef="Pure">0.0477</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001148">&lt;p id="xdx_89C_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_z5JKzlucfzUh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.254in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zrCdDv1tM1Nh"&gt;The
following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability for the year ended June
30, 2024.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 47%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of April 12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z0iuzQNGBL5" style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;902&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--FairValueAdjustmentOfWarrants_iN_pn3n3_di_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z3qby1HDA9Jj" style="border-bottom: black 1pt solid; text-align: right"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of June 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240411__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zRvILZ43JrPb" style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;298&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-04-10_custom_EarnoutMember"
      decimals="-3"
      id="Fact001149"
      unitRef="USD">902000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-04-112024-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact001150"
      unitRef="USD">-604000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact001151"
      unitRef="USD">298000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001153">&lt;p id="xdx_800_ecustom--ScheduleOfClassBCommonStockOfECRCTableTextBlock_zzNEzJKKYE82" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_825_z2mAKcvliIuj" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CLASS
                                         B COMMON STOCK OF ECRC&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Business Combination Agreement, the Sponsor Support Agreement, and the Exchange Agreement, after the Closing, the GXII
founders have the right to exchange shares of Class B common stock of ECRC for Common Shares on a one-for-one basis, subject to
certain equitable adjustments, under certain conditions. All &lt;span style="color: #353535"&gt;&lt;span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zTqmkU1m8Oz1" title="Common stock, shares, issued"&gt;&lt;span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zyGs29QzoyI2" title="Common stock, shares, outstanding"&gt;7,957,404&lt;/span&gt;&lt;/span&gt; shares of Class B common stock
of ECRC that were issued in connection with the Closing were issued and outstanding as of&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="color: #353535"&gt;June 30, 2023. &lt;/span&gt;Of the issued
and outstanding shares of Class B common stock of ECRC, &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zeziB1rUy7t4" title="Earnout shares"&gt;4,565,808&lt;/span&gt; shares (the &#x201c;Vested Shares&#x201d;)&#x2009;were vested
as of the Closing Date and are exchangeable at any time, and from time to time, until the tenth anniversary of the Closing Date
(the &#x201c;Ten-Year Anniversary&#x201d;) and &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTH8QWiKpXu7" title="Earnout shares"&gt;3,391,596&lt;/span&gt; shares (the &#x201c;Earnout Shares&#x201d;) are exchangeable until the Ten-Year
Anniversary, subject to certain vesting conditions. Under certain circumstances, and subject to certain exceptions, NioCorp may
instead settle all or a portion of any exchange pursuant to the terms of the Exchange Agreement in cash, in lieu of Common Shares,
based on a volume-weighted average price of Common Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 28, 2024 and May 16, 2024, 243,692 Vested Shares and 40,000 Vested Shares, respectively, were exchanged for an equivalent
number of Common Shares. This exchange resulted in a change in the Company&#x2019;s ownership interest in ECRC and was accounted
for as an equity transaction in accordance with ASC 810-10-45-23, with no gain or loss recognized. Accordingly, the carrying amount
of the noncontrolling interest was adjusted to reflect the change in the Company&#x2019;s ownership interest with a corresponding
offset booked to equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
of the shares of Class B common stock of ECRC are subject to the Amended and Restated Registration Rights Agreement, dated as
of March 17, 2023 (the &#x201c;Registration Rights and Lock-up Agreement&#x201d;), among NioCorp, GXII, the Sponsor, the pre-Closing
directors and officers of NioCorp and the other parties thereto, including the members of the Sponsor. Pursuant to Registration
Rights and Lock-up Agreement, all shares of Class B common Stock of ECRC (including the Vested Shares and the Released Earnout
Shares) are subject to certain &#x201c;lock-up&#x201d; restrictions on transfer beginning upon the Closing and ending upon the earlier
of (i) one year after the Closing and (ii) the date on which the trading price of Common Shares exceeds certain thresholds or
the date on which NioCorp completes a transaction that results in all of NioCorp&#x2019;s shareholders having the right to exchange
their Common Shares for cash, securities or other property. Both Vested Shares and Released Earnout Shares may be exchanged by
the holders into Common Shares at any time. Under the Exchange Agreement, all Vested Shares and Earnout Shares must be exchanged
for Common Shares by the Ten-Year Anniversary except for Released Earnout Shares that have been vested for a period of fewer than
twenty-four months as of the Ten-Year Anniversary. Such Released Earnout Shares will be forfeited if not exchanged for Common
Shares by the date that is twenty-four months after the vesting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Vested
Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
the exchange of Vested Shares are contingently redeemable at the option of the noncontrolling interest shareholders, the Company
classifies the carrying amount of the redeemable noncontrolling interest in the mezzanine section on the consolidated balance
sheet, which is presented above the equity section and below liabilities. Adjustments to the carrying value of the redeemable noncontrolling interest associated with redemptions are recorded by reclassifying the proportionate amount of mezzanine equity to permanent equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Earnout
Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--DescriptionOfEarnOutShares_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_ze2DrMfIJODg" title="Description of earnout shares"&gt;The
Earnout Shares vest (the &#x201c;Released Earnout Shares&#x201d;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement.&lt;/span&gt; These shares will be forfeited if the market
share price milestones or an acceleration event is not reached prior to the Ten-Year Anniversary. At such time that the Earnout
Shares shall become vested, and therefore, become Released Earnout Shares, the shares will be transferred to the redeemable noncontrolling
interest in the mezzanine section of the Consolidated Balance Sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Earnout Shares were classified as a liability due to failure to meet the equity classification criteria under ASC 815-40, as Level
3 instruments under the fair value hierarchy and are considered a financial liability under ASC 480, Distinguishing Liabilities
from Equity. The Earnout Shares were measured at fair value on the Closing Date with subsequent changes in fair value recorded
in earnings. The Earnout Shares were valued utilizing a Monte Carlo simulation pricing model. The following table discloses the
primary inputs into the Monte Carlo models.&lt;/span&gt;&lt;/p&gt;





















&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zDefajNB1qE" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zmVlM2iqUTHk" style="display: none; visibility: hidden"&gt;The following table discloses the primary inputs into the Monte Carlo models.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Key Valuation Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, &lt;br/&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;March 17, &lt;br/&gt;
2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 25%; text-align: left"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJv4vq5K4bTb" style="width: 13%; text-align: center" title="Closing common share price"&gt;$1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJydUB0JDn5k" style="width: 13%; text-align: center" title="Closing common share price"&gt;$5.03&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zjcDHDNjyqr3" style="width: 13%; text-align: center" title="Closing common share price"&gt;$7.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Term (expiry)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlN1m5Fe2Jm8" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zW1FZ1Te9q55" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zLuZFFoxgCEa" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Implied volatility of Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zu1umMnDVy6a" title="Implied volatility of public warrants"&gt;65.0&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zCKwC7xnccL2" title="Implied volatility of public warrants"&gt;33.5&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zw3II2SHIbH8" title="Implied volatility of public warrants"&gt;19.5&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zPFG7rb1vSrb" title="Risk-free rate"&gt;4.35&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTZ1viASsVS8" title="Risk-free rate"&gt;3.83&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zOOGRta5PSok" title="Risk-free rate"&gt;3.39&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_z4GaHVg2OTEi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z9eWTOTSPLte" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zNWKTfXspJW4"&gt;The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 47%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of March 17, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230315__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zw5yyEtakKkc" style="width: 10%; text-align: right" title="Fair value at beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,195&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20230315__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z437Lf6iNWm7" style="border-bottom: black 1pt solid; text-align: right" title="Change in fair value"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,674&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of June 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zMQCqvLOjN0c" style="text-align: right" title="Fair value at beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,521&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zL4LH2VZupBd" style="border-bottom: black 1pt solid; text-align: right" title="Change in fair value"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,704&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of June 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zGe47ofFlYRh" style="border-bottom: black 1.5pt solid; text-align: right" title="Fair value at ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,817&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8AE_zrItpNfeQrrd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact001155"
      unitRef="Shares">7957404</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact001157"
      unitRef="Shares">7957404</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact001165"
      unitRef="Shares">4565808</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-07-012024-06-30_custom_EarnoutMember"
      decimals="INF"
      id="Fact001167"
      unitRef="Shares">3391596</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <niobf:DescriptionOfEarnOutShares
      contextRef="From2023-07-012024-06-30_custom_EarnoutMember"
      id="Fact001169">The
Earnout Shares vest (the &#x201c;Released Earnout Shares&#x201d;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement.</niobf:DescriptionOfEarnOutShares>
    <niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001178">&lt;p id="xdx_89C_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zDefajNB1qE" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zmVlM2iqUTHk" style="display: none; visibility: hidden"&gt;The following table discloses the primary inputs into the Monte Carlo models.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Key Valuation Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, &lt;br/&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;March 17, &lt;br/&gt;
2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 25%; text-align: left"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJv4vq5K4bTb" style="width: 13%; text-align: center" title="Closing common share price"&gt;$1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJydUB0JDn5k" style="width: 13%; text-align: center" title="Closing common share price"&gt;$5.03&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zjcDHDNjyqr3" style="width: 13%; text-align: center" title="Closing common share price"&gt;$7.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Term (expiry)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlN1m5Fe2Jm8" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zW1FZ1Te9q55" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zLuZFFoxgCEa" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Implied volatility of Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zu1umMnDVy6a" title="Implied volatility of public warrants"&gt;65.0&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zCKwC7xnccL2" title="Implied volatility of public warrants"&gt;33.5&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zw3II2SHIbH8" title="Implied volatility of public warrants"&gt;19.5&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zPFG7rb1vSrb" title="Risk-free rate"&gt;4.35&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTZ1viASsVS8" title="Risk-free rate"&gt;3.83&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230315__20230317__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zOOGRta5PSok" title="Risk-free rate"&gt;3.39&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001180"
      unitRef="USDPShares">1.73</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001182"
      unitRef="USDPShares">5.03</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001184"
      unitRef="USDPShares">7.00</us-gaap:SharePrice>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      id="Fact001186">2033-03-17</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      id="Fact001188">2033-03-17</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2023-03-152023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      id="Fact001190">2033-03-17</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001192"
      unitRef="Pure">0.650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001194"
      unitRef="Pure">0.335</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-03-152023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001196"
      unitRef="Pure">0.195</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001198"
      unitRef="Pure">0.0435</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001200"
      unitRef="Pure">0.0383</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-03-152023-03-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact001202"
      unitRef="Pure">0.0339</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001204">&lt;p id="xdx_891_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z9eWTOTSPLte" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zNWKTfXspJW4"&gt;The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 47%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of March 17, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230315__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zw5yyEtakKkc" style="width: 10%; text-align: right" title="Fair value at beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,195&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20230315__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z437Lf6iNWm7" style="border-bottom: black 1pt solid; text-align: right" title="Change in fair value"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,674&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of June 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zMQCqvLOjN0c" style="text-align: right" title="Fair value at beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,521&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zL4LH2VZupBd" style="border-bottom: black 1pt solid; text-align: right" title="Change in fair value"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,704&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of June 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zGe47ofFlYRh" style="border-bottom: black 1.5pt solid; text-align: right" title="Fair value at ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,817&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock>
    <us-gaap:ServicingLiabilityAtFairValueAmount
      contextRef="AsOf2023-03-14_custom_EarnoutMember"
      decimals="-3"
      id="Fact001206"
      unitRef="USD">13195000</us-gaap:ServicingLiabilityAtFairValueAmount>
    <us-gaap:ServicingLiabilityAtFairValueAdditions
      contextRef="From2023-03-152023-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact001208"
      unitRef="USD">2674000</us-gaap:ServicingLiabilityAtFairValueAdditions>
    <us-gaap:ServicingLiabilityAtFairValueAmount
      contextRef="AsOf2023-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact001210"
      unitRef="USD">10521000</us-gaap:ServicingLiabilityAtFairValueAmount>
    <us-gaap:ServicingLiabilityAtFairValueAdditions
      contextRef="From2023-07-012024-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact001212"
      unitRef="USD">6704000</us-gaap:ServicingLiabilityAtFairValueAdditions>
    <us-gaap:ServicingLiabilityAtFairValueAmount
      contextRef="AsOf2024-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact001214"
      unitRef="USD">3817000</us-gaap:ServicingLiabilityAtFairValueAmount>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001216">&lt;p id="xdx_80B_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_z6HNmwl1pUEf" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_821_zE1qMkJmXF2l" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;COMMON
                                         SHARES&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issuances&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fiscal
Year 2024 Issuances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 1, 2023, the Company closed a non-brokered private placement (the &#x201c;September 2023 Private Placement&#x201d;) of
units of the Company (the &#x201c;September 2023 Units&#x201d;). A total of &lt;span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230830__20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zA7YiU6lOAkf" title="Shares issue"&gt;250,000&lt;/span&gt; September 2023 Units were issued at a price
per September 2023 Unit of $&lt;span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zzge53SsQWwh" title="Price per unit"&gt;4.00&lt;/span&gt;, for total gross proceeds to the Company of $&lt;span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20230830__20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_z6CFZ3WVVRvh" title="Gross proceeds"&gt;1,000&lt;/span&gt;. Each September 2023 Unit consists of one
Common Share and one Warrant (&#x201c;September 2023 Warrant&#x201d;). Each September 2023 Warrant entitles the holder to acquire
one Common Share at a price of $&lt;span id="xdx_90E_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zXB5cVt35Lze" title="Shares price"&gt;4.60&lt;/span&gt; at any time prior to September 1, 2025. Proceeds of the September 2023 Private Placement
will be used for continued advancement of the Elk Creek Project and for working capital and general corporate purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
September 2023 Warrants were classified as an equity instrument and accordingly, the net proceeds of $&lt;span id="xdx_909_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930_zm232uZKM6nf"&gt;962&lt;/span&gt; were allocated based
on the relative fair values of the Common Shares and the September 2023 Warrants on the date of issuance. The amount allocated
to the fair value of the September 2023 Warrants was $&lt;span id="xdx_904_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpCaj6U5T0g1"&gt;254&lt;/span&gt; and the balance of the proceeds of $&lt;span id="xdx_905_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztcC797dXS9c"&gt;708&lt;/span&gt; was allocated to the Common
Shares. The fair value of the September 2023 Warrants issued was computed using the Black Scholes pricing model using the following
assumptions: an expected life of &lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmL4yKo4V1K9" title="Expected life::XDX::P2Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1229"&gt;2.0&lt;/span&gt;&lt;/span&gt; years, a risk-free interest rate of &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrzudoLdJ8i2" title="Risk-free rate"&gt;4.85&lt;/span&gt;%, an expected volatility of &lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uPure_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJ6syQxiY3J1" title="Expected volatility"&gt;71.63&lt;/span&gt;%, and an expected
dividend rate of &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrsFszMVX2n1" title="Expected dividend rate"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 22, 2023, the Company closed a non-brokered private placement (the &#x201c;December 2023 Private Placement&#x201d;) of
&lt;span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zvqVeAdD0gL8" title="Shares issue"&gt;413,432&lt;/span&gt; units of the Company (the &#x201c;December 2023 Units&#x201d;). Each December 2023 Unit consists of one Common Share and
one Warrant (&#x201c;December 2023 Warrant&#x201d;). Each December 2023 Warrant entitles the holder to acquire one Common Share
at a price of $&lt;span id="xdx_903_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zn1oBfdpF6og" title="Shares price"&gt;3.54&lt;/span&gt; at any time until December 22, 2025. &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zOCReH2wGVTc" title="Units issue and sold"&gt;274,587&lt;/span&gt; of the December 2023 Units were issued and sold to certain accredited
investors, who are not affiliated with the Company but with whom the Company had a pre-existing relationship, at a price of $&lt;span id="xdx_906_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_ziziWDmkS82" title="Shares price"&gt;3.08&lt;/span&gt;
per December 2023 Unit, and &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__srt--TitleOfIndividualAxis__srt--DirectorMember_zxzxscOG9kHc" title="Units issue and sold"&gt;138,845&lt;/span&gt; of the December 2023 Units were issued and sold to certain officers and directors of the Company
(the &#x201c;Insider Investors&#x201d;), at a price of $&lt;span id="xdx_909_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__srt--TitleOfIndividualAxis__srt--DirectorMember_zN8E7lQG4wA5" title="Shares price"&gt;3.205&lt;/span&gt; per December 2023 Unit. The price per December 2023 Unit paid by the
Insider Investors included $0.125 per December 2023 Warrant underlying each December 2023 Unit purchased by the Insider Investors
which allowed the Insider Investors to participate in the December 2023 Private Placement in accordance with the rules of Nasdaq.
The Company received aggregate gross proceeds from the December 2023 Private Placement of approximately $&lt;span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zIwH0dvqb8C" title="Gross proceeds"&gt;1,290&lt;/span&gt;. Proceeds of the
December 2023 Private Placement will be used for continued advancement of the Elk Creek Project and for working capital and general
corporate purposes. The Company recorded a non-cash expense of $&lt;span id="xdx_90C_eus-gaap--OtherCostAndExpenseOperating_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbU1WvBc5pMd" title="Other operating expenses"&gt;92&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--OperatingCostsAndExpenses_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z80GviyR3sFd" title="Employee related costs"&gt;10&lt;/span&gt; to other operating expense and employee related costs,
respectively, representing the excess of fair value of the December 2023 Units over the purchase price paid by Insider Investors.&lt;/span&gt;&lt;/p&gt;





















&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
December 2023 Warrants were classified as an equity instrument and accordingly, the estimated net proceeds of $1,241 were allocated
based on the relative fair values of the Common Shares and the December 2023 Warrants on the date of issuance. The amount allocated
to the fair value of the December 2023 Warrants was $&lt;span id="xdx_908_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVIdjTUGMow" title="Proceeds from equity"&gt;264&lt;/span&gt; and the balance of the proceeds of $&lt;span id="xdx_902_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze4zM8VnzkE" title="Proceeds from equity"&gt;977&lt;/span&gt; was allocated to the Common Shares.
The fair value of the December 2023 Warrants issued was computed using the Black Scholes pricing model using the following assumptions:
an expected life of &lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zicL57i0zUog" title="Expected life::XDX::P2Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1266"&gt;2.0&lt;/span&gt;&lt;/span&gt; years, a risk-free interest rate of &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrlPhIYkDDta" title="Risk-free rate"&gt;4.33&lt;/span&gt;%, an expected volatility of &lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uPure_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvJVRb30H41a" title="Expected volatility"&gt;54.8&lt;/span&gt;%, and an expected dividend rate
of &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpo4b9gKhX5d" title="Expected dividend rate"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 24, 2024, &lt;span id="xdx_90E_eus-gaap--SaleOfStockDescriptionOfTransaction_c20240623__20240624__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_znrjaRmmEF18" title="Description of stock transaction"&gt;the Company closed a non-brokered private placement (the &#x201c;June 2024 Private Placement&#x201d;) of units of
the Company (the &#x201c;June 2024 Units&#x201d;). A total of 315,000 June 2024 Units were issued at a price per June 2024 Unit
of $1.91, for total gross proceeds to the Company of $&lt;span id="xdx_903_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240623__20240624__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_za58kwM0qHt7" title="Proceeds from equity"&gt;602&lt;/span&gt;. Each June 2024 Unit consists of one Common Share and one Warrant (&#x201c;June
2024 Warrant&#x201d;). Each June 2024 Warrant entitles the holder to acquire one Common Share at a price of $2.20 at any time prior
to June 24, 2026. Proceeds of the June 2024 Private Placement will be used for continued advancement of the Elk Creek Project
and for working capital and general corporate purposes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
June 2024 Warrants were classified as an equity instrument and accordingly, the net proceeds of $602 were allocated based on the
relative fair values of the Common Shares and the June 2024 Warrants on the date of issuance. The amount allocated to the fair
value of the June 2024 Warrants was $&lt;span id="xdx_90E_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYNadUl6HeZh" title="Proceeds from equity"&gt;161&lt;/span&gt; and the balance of the proceeds of $&lt;span id="xdx_90A_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEsilUOwKh69" title="Proceeds from equity"&gt;441&lt;/span&gt; was allocated to Common Shares. The fair value
of the June 2024 Warrants issued was computed using the Black Scholes pricing model using the following assumptions: an expected
life of &lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zM52UVP5Y9d3" title="Expected life::XDX::P2Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1282"&gt;2.0&lt;/span&gt;&lt;/span&gt; years, a risk-free interest rate of &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z28LnKRE7yVg" title="Risk-free rate"&gt;4.73&lt;/span&gt;%, an expected volatility of &lt;span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uPure_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZhpJwDOWXwe" title="Expected volatility"&gt;73.92&lt;/span&gt;%, and an expected dividend rate of &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSPSuv7Vip8i" title="Expected dividend rate"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fiscal
Year 2023 Issuances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition to the Common Shares issued in connection with the GXII Transaction, as discussed in Note 5, the following Common Share
issuances occurred during fiscal year 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 28, 2023, &lt;span id="xdx_90F_eus-gaap--ConversionOfStockNewIssuance_c20230427__20230428__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--KingdonCapitalManagementLLCMember_zg605uNWs6y2"&gt;the Company closed a registered direct offering and issued 314,465 Common Shares for $2,000, before deducting
share issuance costs of $172. The Common Shares were sold pursuant to a securities purchase agreement, dated April 26, 2023, between
the Company and a fund managed by Kingdon Capital Management, LLC.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 9, 2023, &lt;span id="xdx_90C_eus-gaap--ConversionOfStockNewIssuance_c20230608__20230609__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleEquityFacilityFinancingAgreementMember_zjKwF4ksuwzf"&gt;the Company issued 100,000 Common Shares under the Yorkville Equity Facility Financing Agreement (discussed below)
in exchange for $488 in cash proceeds. The Company recorded a non-cash operating expense of $13 which represented the difference
between the proceeds received and the fair value of the Common Shares issued based on Nasdaq closing price per Common Share on
the issuance date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
                                         Options&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 19, 2024, the Company&#x2019;s shareholders voted to approve an amendment and restatement of its long-term incentive plan
(the &#x201c;2017 Amended Long-Term Incentive Plan&#x201d;) and the granting of incentive securities thereunder until January 19,
2027. Under the 2017 Amended Long-Term Incentive Plan, the Board may, in its discretion from time to time, grant options and share
units (in the form of restricted share units and performance share units) to directors, employees and certain other service providers
(as defined in the 2017 Amended Long-Term Incentive Plan) of the Company and affiliated entities selected by the Board.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to adjustment as described in the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares that may be reserved
for issuance to participants under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, may not exceed 10% of the issued and outstanding Common Shares from time to time, and the Common
Shares reserved for issuance upon settlement of share units will not exceed 5% of the issued and outstanding Common Shares from
time to time. The 2017 Amended Long-Term Incentive Plan limits the maximum number of Common Shares issued to insiders (as defined
under TSX rules for this purpose) within any 1-year period, or issuable to insiders at any time, in the aggregate, under all security-based
compensation arrangements (including the 2017 Amended Long-Term&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Incentive Plan) to 10% of the then issued and outstanding Common
Shares. The 2017 Amended Long-Term Incentive Plan also limits the aggregate number of Common Shares that may be reserved for issuance
to any one participant under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation arrangements
of the Company, to 5% of the then issued and outstanding Common Shares (on a non-diluted basis). Subject to the adjustment provisions
of the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares actually issued or transferred by the Company
upon the exercise of incentive stock options will be limited as described above.&lt;/span&gt;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Board has power over the granting, amendment, administration, or settlement of any award.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
option transactions are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_zWGZKuGVAEe2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_z0jy0iletlJc" style="display: none; visibility: hidden"&gt;Schedule of stock option&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Number of Options&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Aggregate Intrinsic Value&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average Remaining Contractual Life&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230701__20240630_zye0TeAXrv1b" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Beginning balance"&gt;1,541,500&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20230701__20240630_zqAAL9m57Goh" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Beginning balance"&gt;7.19&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230701__20240630_zUeNkdqhxVWd" style="text-align: right" title="Granted, in shares"&gt;1,625,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zwKafKcDrL35" style="text-align: right" title="Granted, per share"&gt;2.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230701__20240630_zWX5btsMY8Zb" style="text-align: right" title="Cancelled/expired, in shares"&gt;(7,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zd1ix0BCB8Yg" style="text-align: right" title="Cancelled/expired, per share"&gt;3.95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;Cancelled/expired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230701__20240630_zYPoYl8DeWhh" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, in shares"&gt;(663,200&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zkovxxki1jm2" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, per share"&gt;5.88&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20230701__20240630_zb2buhWzOMM3" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;2,495,500&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20230701__20240630_zWtr5uPr8tR6" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;4.78&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20230701__20240630_zyNXfsZgVxv2" title="Weighted average remaining contractual life::XDX::P3Y5M9D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1322"&gt;3.44&lt;/span&gt;&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_zq5LTkXk7RSl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2024, &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_pid_dp_uPure_c20230701__20240630_zkgY6nZaXhe6" title="Outstanding stock options vested"&gt;100&lt;/span&gt;% of the outstanding stock options were fully vested. The total intrinsic value of options exercised during
the year ended June 30, 2024 &lt;span style="background-color: white"&gt;was immaterial, and as of June 30, 2024, &lt;/span&gt;there were
no unrecognized compensation costs related to unvested share-based compensation arrangements granted. The Company recognized share-based
compensation expense of $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensation_pn3n3_dxL_c20230701__20240630_zuzaPTNtLga5" title="Share based compensation expense::XDX::2881"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1326"&gt;2,779&lt;/span&gt;&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensation_pn3n3_c20220701__20230630_zJmibczMz0tc" title="Share based compensation expense"&gt;1,794&lt;/span&gt; for the years ended June 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z2kBH6g6jsd2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the weighted average information and assumptions used to determine option costs:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 70%; margin-left: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20230701__20240630_zJT66EgqTjpc" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20220701__20230630_zMJX0iLpVci" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;Year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_za4ZZCglBnD3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 4pt"&gt;Fair value per option granted during the period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;$1.71&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;$3.09&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_zKro84PDHlkd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 4pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zf36kUWNMGyg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 4pt"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_zS7Liq7OcSJl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 4pt"&gt;Expected stock price volatility (historical basis)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 4pt"&gt;Expected option life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630_zUuwWwGG7Rlg" style="text-align: right" title="Expected option life in years::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1344"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220701__20230630_zh9CTGbFc9Pl" style="text-align: right" title="Expected option life in years::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1346"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zVO1iM18sgtj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to January 1, 2024, the Company concluded that under ASU 718, &lt;i&gt;Compensation &#x2013; Stock Compensation (Topic 718)&lt;/i&gt;, Options
previously issued on December 31, 2021, May 30, 2022, and March 27, 2023, which included a C$ strike price should remain equity-classified
as management determined that the Options qualified for an exemption from liability classification as the Options were denominated
in a currency in which a substantial portion of the Company&#x2019;s equity securities traded. Effective January 1, 2024, the Company
determined that due to historically decreasing trading volume on the TSX, this exemption no longer applied and accordingly, these
Options were classified as a liability based on their fair values on that date. The Company recorded a mark-to-market gain of
$147 in other operating expenses related to these option liabilities for the year ended June 30, 2024. The associated liability
related to these Canadian-denominated Options was nil at June 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 28, 2024, the Board approved a modification to Options previously issued on March 27, 2023, with dual strike prices of $6.95
and C$9.52, under which the option to exercise in C$ was removed. No other terms or conditions were amended by the Board. Based
on this amendment, the Company re-classified these Options to equity on March 28, 2024, based on their fair value on that date.&lt;/span&gt;&lt;/p&gt;





















&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zajsKuOKR16b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
transactions are summarized as follows. &lt;span id="xdx_8BC_zyqEmpR0lZz1"&gt;Weighted average exercise prices related to Canadian dollar denominated warrants were
converted to U.S. dollars using end of period foreign currency exchange rates.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 6pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;
                                   &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Warrants&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Balance, June 30, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20220701__20230630_z8XckUuBZlg4" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Beginning balance"&gt;1,851,622&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20220701__20230630_zlPFz7KFYO25" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Balance at beginning average price"&gt;8.99&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.375in; text-indent: -0.125in"&gt;Granted:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in"&gt;Yorkville financing warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--YorkvilleFinancingWarrants_pid_uShares_c20220701__20230630_zsM2GDSooiDh" style="text-align: right" title="Yorkville financing warrants"&gt;1,789,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_pid_uUSDPShares_c20220701__20230630_zuRZJAtK8XX7" style="text-align: right" title="Yorkville financing warrants average price"&gt;8.94&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in"&gt;GXII warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--GxiiWarrants_pid_uShares_c20220701__20230630_zHMJkushqd4a" style="text-align: right" title="GXII warrants"&gt;15,666,626&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_pid_uUSDPShares_c20220701__20230630_zJ7RdbGA8fG" style="text-align: right" title="GXII warrant average price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in"&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20220701__20230630_zwtkNzObpjxd" style="border-bottom: Black 1pt solid; text-align: right"&gt;(491,211&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20220701__20230630_z9twSZGNm2y1" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled"&gt;11.67&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Balance, June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20230701__20240630_zurKJrQeN0hh" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;18,816,304&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20230701__20240630_zjTCrM0X5K51" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at beginning average price"&gt;10.98&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.375in; text-indent: -0.125in"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20230701__20240630_z0W5fkGoigqf" style="text-align: right" title="Granted"&gt;1,593,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20230701__20240630_zPvax70AxKZh" style="text-align: right" title="Granted"&gt;3.33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in"&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20230701__20240630_z3hKFny45BZb" style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,846,560&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20230701__20240630_zcw1PQYD0wEb" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled"&gt;8.67&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Balance, June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20230701__20240630_zpRUOUmiGBv8" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;18,563,561&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iE_pid_uUSDPShares_c20230701__20240630_zE325rBL0CJ7" style="border-bottom: Black 2pt solid; text-align: right" title="Balance at ending average price"&gt;10.53&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_z7veq4cSjdr8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zfZlJxw1mQ28" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_zpt6fAXGWFI7"&gt;At
June 30, 2024, the Company has outstanding exercisable warrants, as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    Price&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expiry
    Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zoXC4JVPcOGg" style="width: 16%; text-align: right" title="Number of share outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;855,800&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zGpJ8aCGpI45" title="Exercise price"&gt;9.70&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zeHof6GKu6p" style="width: 60%; text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-02-19"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;February
    19, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zDEglaeylwUe" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;447,318&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zOMzWTH7SnI3" style="text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$8.94&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-right: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zhUsGKRWEASg" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zdGPamuZW8j" style="text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$4.60&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_z2x4fRJLJVIj" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-09-01"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1401"&gt;September
    1, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zYi3g4pIj88e" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;413,432&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zntLCYZYgUF1" style="text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$3.54&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zSP9E4t43nVc" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-12-22"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1406"&gt;December
    22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zIJjZwTBQP0d" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;315,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zQIyFNHSsqQb" style="text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zE506OVXL2qa" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-06-24"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1411"&gt;June
    24, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_z6HnfquTlHxc" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;615,385&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zFf6iyBUoy03" style="text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$3.25&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zpbNSKQf8iMl" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2027-04-12"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1416"&gt;April
    12, 2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z9oNsluQzth" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,666,626&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z0pvMgx2Hztl" style="text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$11.50&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zJ17oOr84gIc" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2028-03-17"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1421"&gt;March
    17, 2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630_zjf9tMeF7pac" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,563,561&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-right: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 2.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0F_zHWjoLgb5ZYh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_F1E_zX2isN3oIiNc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expires
    in 3 equal monthly tranches on July 17, 2024, August 17, 2024, and September 17, 2024.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A5_zwecu1KHXiVc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Closing, pursuant to the Business Combination Agreement, the Company assumed the GXII Warrant Agreement and
each GXII Warrant thereunder that was issued and outstanding immediately prior to the Closing Date was converted into one NioCorp
Assumed Warrant pursuant to the GXII Warrant Agreement, as amended by an Assignment, Assumption and Amendment Agreement, dated
March 17, 2023, among the Company, GXII, Continental Stock Transfer &amp;amp; Trust Company, as the existing warrant agent, and Computershare
Inc. and its affiliate, Computershare Trust Company, N.A, together as the successor warrant agent (the &#x201c;NioCorp Assumed
Warrant Agreement&#x201d;). In connection with the Closing, NioCorp issued (a) &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--GXIIPublicWarrantsMember_z1SYUjMrhvBf" title="Warrants traded prior to the closing"&gt;9,999,959&lt;/span&gt; public NioCorp Assumed Warrants (the &#x201c;Public
Warrants&#x201d;) in respect of the GXII Warrants that were publicly traded prior to the Closing and (b) &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--GXIIPrivateWarrantsMember_z7lUvDhskIcl" title="Warrants traded prior to the closing"&gt;5,666,667&lt;/span&gt; NioCorp Assumed
Warrants (the &#x201c;Private Warrants&#x201d;) to the Sponsor in respect of the GXII Warrants that it held prior to the Closing,
which NioCorp Assumed Warrants were subsequently distributed by the Sponsor to its members in connection with the Closing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zi7DUScxqMG7" title="Description of warrants"&gt;Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like).&lt;/span&gt; No fractional shares will be issued upon exercise of any NioCorp Assumed Warrants, and fractional shares that would otherwise
be due to the exercising holder will be rounded down to the nearest whole Common Share. In no event will the Company be required
to net cash settle any NioCorp Assumed Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Public
Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may elect to redeem the Public Warrants subject to certain conditions, in whole and not in part, at a price of $0.01 per
Public Warrant if (i) 30 days&#x2019; prior written notice of redemption is provided to the holders, &lt;/span&gt;&lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20230701__20240630_zsbTlpE3ms8g" title="Description of warrants"&gt;(ii)
the last reported sale price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span title="Description of warrants"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span title="Description of warrants"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span title="Description of warrants"&gt;within a 30-trading day period ending
on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders&lt;/span&gt; and &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii)
there is an effective registration statement covering the Common Shares issuable upon exercise of the Public Warrants, and a current
prospectus relating thereto, available through the redemption date. Upon issuance of a redemption notice by the Company, the warrant
holders will have until the redemption date to exercise for cash, or, at the Company&#x2019;s election, on a cashless basis. The
Public Warrants are not precluded from equity classification and are accounted for as such on the date of issuance, and each balance
sheet date thereafter. Because the 2023 Transactions resulted in an excess of liabilities over assets acquired, no value was ascribed
to the Public Warrants.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Private
Warrants &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Private Warrants: (i) will be exercisable either for cash or on a cashless basis at the holder&#x2019;s option and (ii) will not
be redeemable by the Company, in either case as long as the Private Warrants are held by the Sponsor, its members or any of their
permitted transferees (as prescribed in the NioCorp Assumed Warrant Agreement). In accordance with the NioCorp Assumed Warrant
Agreement, any Private Warrants that are held by someone other than the Sponsor, its members or any of their permitted transferees
are treated as Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for the Private Warrants assumed in the 2023 Transactions in accordance with the guidance contained in ASC 815-40.
Such guidance provides that because the Private Warrants do not meet the criteria for equity treatment thereunder, each Private
Warrant must be recorded as a liability. This liability is carried as a component of Warrant Liabilities on the consolidated balance
sheet and is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be
adjusted to its current fair value, with the change in fair value recognized in the consolidated statement of operations and comprehensive
loss. The Company will reassess the classification at each balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zHgR48wJZmoa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zLLrOhG6vMfk"&gt;The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a
Black Scholes model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;March 17, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 31%; text-align: justify"&gt;Stock price on valuation date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1Z5rDZjdkV4" style="width: 10%; text-align: right" title="Stock price on valuation date"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFE6f8V4pHcc" style="width: 10%; text-align: right" title="Stock price on valuation date"&gt;5.03&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKti9c2iZ2ub" style="width: 10%; text-align: right" title="Stock price on valuation date"&gt;7.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Strike price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zOtZwGvw2vs9" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWcBARjHuf42" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhgD62xwvIt6" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Implied volatility of Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4ENW3fVdG78" title="Implied volatility of public warrants"&gt;69.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zCWPeAEkl5yl" title="Implied volatility of public warrants"&gt;33.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeImYtHqK0Mf" title="Implied volatility of public warrants"&gt;19.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXiirYGbXKZb" title="Risk free rate"&gt;4.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFq3HWAZU19c" title="Risk free rate"&gt;4.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zMKev04i1UE2" title="Risk free rate"&gt;3.47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zcsificTC6ej" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDKPV2q7L2Wl" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zvsYn0LvsLYd" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expected warrant life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zcG5EAX3qLbj" title="Expected warrant life in years::XDX::P3Y8M12D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1472"&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjMLr3IZqMDe" title="Expected warrant life in years::XDX::P4Y8M12D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1474"&gt;4.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znJ3gJPKi7ci" title="Expected warrant life in years::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1476"&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zlDiwfsl7V6j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zbDEDzsTxw83" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zN3GUDOwHwG3"&gt;The
change in the Private Warrants liability is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 37%"&gt;Initial valuation, March 17, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230315__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_ze4dEjbfLz13" style="width: 10%; text-align: right" title="Initial valuation, at begining"&gt;2,987&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in valuation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230315__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zAkWZjJgEmzl" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation"&gt;292&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Valuation at June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zN4GuycS7h48" style="text-align: right" title="Initial valuation, at begining"&gt;3,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in valuation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zXXIPqLb19rj" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation"&gt;(1,926&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Valuation at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zNiq6OhMP5qk" style="border-bottom: Black 2pt solid; text-align: right" title="Initial valuation, at ending"&gt;1,353&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zVzwu0rhjBTa" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Yorkville
                                         Equity Facility Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Concurrent
with the closing of the GXII Transaction, the Yorkville Equity Facility Financing became effective. Pursuant to the
Yorkville Equity Facility Financing Agreement, Yorkville committed to purchase up to $65,000 of Common Shares (the
&#x201c;Commitment Amount&#x201d;), at NioCorp&#x2019;s direction from time to time for a period commencing upon the Closing
Date and ending on the earliest of (i) the first day of the month next following the 36-month anniversary of the Closing,
(ii) the date on which Yorkville shall have made payment of the full Commitment Amount and (iii) the date that the Yorkville
Equity Facility Financing Agreement otherwise terminates in accordance with its terms (the &#x201c;Commitment Period&#x201d;), subject to certain limitations and the&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;satisfaction
of the conditions in the Yorkville Equity Facility Financing Agreement. The Common Shares that may be sold pursuant to the Yorkville
Equity Facility Financing Agreement would be purchased by Yorkville at a purchase price equal to 97% of the daily volume-weighted
average price of the Common Shares on Nasdaq or such other principal U.S. market for the Common Shares if the Common Shares are
ever listed or traded on the New York Stock Exchange or the NYSE American as reported by Bloomberg Financial Markets (or, if not
available, a similar service provider of national recognized standing) during the applicable pricing period, which is a period
during a single trading day or a period of three consecutive trading days, at the Company&#x2019;s option and subject to certain
restrictions, in each case, defined based on when an Advance Notice (as defined in the Yorkville Equity Facility Financing Agreement)
is submitted, subject to certain limitations.&lt;/span&gt;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the Yorkville Equity Facility Financing Agreement, NioCorp issued 81,213 of Common Shares (the &#x201c;Commitment
Shares&#x201d;) valued at $650 to Yorkville as consideration for its irrevocable commitment to purchase Common Shares under the
Yorkville Equity Facility Financing Agreement. On June 9, 2023, NioCorp issued and sold 100,000 Common Shares to Yorkville under
the Yorkville Equity Facility Financing Agreement. Additionally, NioCorp is required to pay Yorkville an aggregate fee of $1,500
in cash (the &#x201c;Cash Fee&#x201d;), including $500 that NioCorp paid on the Closing Date and an additional $250 NioCorp was
paid as of June 30, 2023. NioCorp will pay the remaining $750 balance in installments over a 12-month period following the Closing
Date, provided that it will have the right to prepay without penalty all or part of the remaining installments of the Cash Fee
at any time. In addition, legal and other costs of $496 were incurred in connection with the Yorkville Equity Facility Financing
and were expensed on the effective date. The following amounts related to the Yorkville Equity Facility Financing Agreement were
expensed as other operating costs during the year ended June 30, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_z3ASikrYjJu1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zzt2wXsBEeM6" style="display: none; visibility: hidden"&gt;Schedule of expenses as other operating costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zeU06pPLzlEi" style="border-bottom: Black 1pt solid; text-align: right"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--YorkvilleCashFee_zCo8eoTA9VL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 57%; text-align: justify"&gt;Yorkville Cash Fee&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zMxZ7zqa5Uci" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Fair value of Commitment Shares issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;650&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OtherCostAndExpenseOperating_z0jMHASx6W26" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Legal and other related costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;496&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--OperatingCostsAndExpenses_z85GnfZNKj0e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt"&gt;Costs expensed to other operating expense&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;2,646&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zBQ86SNeRFa6" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-08-302023-09-02_us-gaap_PrivatePlacementMember_currency_CAD"
      decimals="INF"
      id="Fact001218"
      unitRef="Shares">250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-09-02_us-gaap_PrivatePlacementMember_currency_CAD"
      decimals="INF"
      id="Fact001220"
      unitRef="USDPShares">4.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-08-302023-09-02_us-gaap_PrivatePlacementMember_currency_CAD"
      decimals="-3"
      id="Fact001222"
      unitRef="USD">1000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <niobf:SaleOfStockPricePerShare1
      contextRef="AsOf2023-09-02_us-gaap_PrivatePlacementMember_currency_CAD"
      decimals="INF"
      id="Fact001224"
      unitRef="USDPShares">4.60</niobf:SaleOfStockPricePerShare1>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2023-09-012023-09-30"
      decimals="-3"
      id="Fact001225"
      unitRef="USD">962000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember"
      decimals="-3"
      id="Fact001226"
      unitRef="USD">254000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2023-09-012023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001227"
      unitRef="USD">708000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001231"
      unitRef="Pure">0.0485</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
      contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001233"
      unitRef="Pure">0.7163</niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001235"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD"
      decimals="INF"
      id="Fact001237"
      unitRef="Shares">413432</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <niobf:SaleOfStockPricePerShare1
      contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_currency_CAD"
      decimals="INF"
      id="Fact001239"
      unitRef="USDPShares">3.54</niobf:SaleOfStockPricePerShare1>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_InvestorMember"
      decimals="INF"
      id="Fact001241"
      unitRef="Shares">274587</us-gaap:StockIssuedDuringPeriodSharesOther>
    <niobf:SaleOfStockPricePerShare1
      contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_InvestorMember"
      decimals="INF"
      id="Fact001243"
      unitRef="USDPShares">3.08</niobf:SaleOfStockPricePerShare1>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD_srt_DirectorMember"
      decimals="INF"
      id="Fact001245"
      unitRef="Shares">138845</us-gaap:StockIssuedDuringPeriodSharesOther>
    <niobf:SaleOfStockPricePerShare1
      contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_currency_CAD_srt_DirectorMember"
      decimals="INF"
      id="Fact001247"
      unitRef="USDPShares">3.205</niobf:SaleOfStockPricePerShare1>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember_currency_CAD"
      decimals="-3"
      id="Fact001249"
      unitRef="USD">1290000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember"
      decimals="-3"
      id="Fact001251"
      unitRef="USD">92000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-07-012024-06-30_us-gaap_PrivatePlacementMember"
      decimals="-3"
      id="Fact001253"
      unitRef="USD">10000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember"
      decimals="-3"
      id="Fact001262"
      unitRef="USD">264000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001264"
      unitRef="USD">977000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001268"
      unitRef="Pure">0.0433</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001270"
      unitRef="Pure">0.548</niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001272"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SaleOfStockDescriptionOfTransaction
      contextRef="From2024-06-232024-06-24_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember"
      id="Fact001274">the Company closed a non-brokered private placement (the &#x201c;June 2024 Private Placement&#x201d;) of units of
the Company (the &#x201c;June 2024 Units&#x201d;). A total of 315,000 June 2024 Units were issued at a price per June 2024 Unit
of $1.91, for total gross proceeds to the Company of $602. Each June 2024 Unit consists of one Common Share and one Warrant (&#x201c;June
2024 Warrant&#x201d;). Each June 2024 Warrant entitles the holder to acquire one Common Share at a price of $2.20 at any time prior
to June 24, 2026. Proceeds of the June 2024 Private Placement will be used for continued advancement of the Elk Creek Project
and for working capital and general corporate purposes.</us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2024-06-232024-06-24_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember"
      decimals="-3"
      id="Fact001276"
      unitRef="USD">602000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember"
      decimals="-3"
      id="Fact001278"
      unitRef="USD">161000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2024-06-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001280"
      unitRef="USD">441000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001284"
      unitRef="Pure">0.0473</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
      contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001286"
      unitRef="Pure">0.7392</niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001288"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ConversionOfStockNewIssuance
      contextRef="From2023-04-272023-04-28_custom_KingdonCapitalManagementLLCMember"
      id="Fact001289">the Company closed a registered direct offering and issued 314,465 Common Shares for $2,000, before deducting
share issuance costs of $172. The Common Shares were sold pursuant to a securities purchase agreement, dated April 26, 2023, between
the Company and a fund managed by Kingdon Capital Management, LLC.</us-gaap:ConversionOfStockNewIssuance>
    <us-gaap:ConversionOfStockNewIssuance
      contextRef="From2023-06-082023-06-09_custom_YorkvilleEquityFacilityFinancingAgreementMember"
      id="Fact001290">the Company issued 100,000 Common Shares under the Yorkville Equity Facility Financing Agreement (discussed below)
in exchange for $488 in cash proceeds. The Company recorded a non-cash operating expense of $13 which represented the difference
between the proceeds received and the fair value of the Common Shares issued based on Nasdaq closing price per Common Share on
the issuance date.</us-gaap:ConversionOfStockNewIssuance>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001300">&lt;p id="xdx_89A_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_zWGZKuGVAEe2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_z0jy0iletlJc" style="display: none; visibility: hidden"&gt;Schedule of stock option&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Number of Options&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Aggregate Intrinsic Value&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average Remaining Contractual Life&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230701__20240630_zye0TeAXrv1b" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Beginning balance"&gt;1,541,500&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20230701__20240630_zqAAL9m57Goh" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Beginning balance"&gt;7.19&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230701__20240630_zUeNkdqhxVWd" style="text-align: right" title="Granted, in shares"&gt;1,625,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zwKafKcDrL35" style="text-align: right" title="Granted, per share"&gt;2.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230701__20240630_zWX5btsMY8Zb" style="text-align: right" title="Cancelled/expired, in shares"&gt;(7,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zd1ix0BCB8Yg" style="text-align: right" title="Cancelled/expired, per share"&gt;3.95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;Cancelled/expired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230701__20240630_zYPoYl8DeWhh" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, in shares"&gt;(663,200&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zkovxxki1jm2" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, per share"&gt;5.88&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20230701__20240630_zb2buhWzOMM3" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;2,495,500&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20230701__20240630_zWtr5uPr8tR6" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;4.78&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20230701__20240630_zyNXfsZgVxv2" title="Weighted average remaining contractual life::XDX::P3Y5M9D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1322"&gt;3.44&lt;/span&gt;&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact001302"
      unitRef="Shares">1541500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact001304"
      unitRef="CADPShares">7.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001306"
      unitRef="Shares">1625000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001308"
      unitRef="CADPShares">2.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001310"
      unitRef="Shares">7800</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001312"
      unitRef="CADPShares">3.95</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001314"
      unitRef="Shares">663200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001316"
      unitRef="CADPShares">5.88</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001318"
      unitRef="Shares">2495500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001320"
      unitRef="CADPShares">4.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001324"
      unitRef="Pure">1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001328"
      unitRef="USD">1794000</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001330">&lt;p id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z2kBH6g6jsd2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the weighted average information and assumptions used to determine option costs:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 70%; margin-left: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20230701__20240630_zJT66EgqTjpc" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20220701__20230630_zMJX0iLpVci" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;Year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_za4ZZCglBnD3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 4pt"&gt;Fair value per option granted during the period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;$1.71&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;$3.09&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_zKro84PDHlkd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 4pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zf36kUWNMGyg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 4pt"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_zS7Liq7OcSJl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 4pt"&gt;Expected stock price volatility (historical basis)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 4pt"&gt;Expected option life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630_zUuwWwGG7Rlg" style="text-align: right" title="Expected option life in years::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1344"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220701__20230630_zh9CTGbFc9Pl" style="text-align: right" title="Expected option life in years::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1346"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001332"
      unitRef="USDPShares">1.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001333"
      unitRef="USDPShares">3.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001335"
      unitRef="Pure">0.0425</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001336"
      unitRef="Pure">0.0330</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001338"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001339"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001341"
      unitRef="Pure">0.632</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001342"
      unitRef="Pure">0.636</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001355">&lt;p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zajsKuOKR16b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
transactions are summarized as follows. &lt;span id="xdx_8BC_zyqEmpR0lZz1"&gt;Weighted average exercise prices related to Canadian dollar denominated warrants were
converted to U.S. dollars using end of period foreign currency exchange rates.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 6pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;
                                   &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Warrants&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Balance, June 30, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20220701__20230630_z8XckUuBZlg4" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Beginning balance"&gt;1,851,622&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20220701__20230630_zlPFz7KFYO25" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Balance at beginning average price"&gt;8.99&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.375in; text-indent: -0.125in"&gt;Granted:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in"&gt;Yorkville financing warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--YorkvilleFinancingWarrants_pid_uShares_c20220701__20230630_zsM2GDSooiDh" style="text-align: right" title="Yorkville financing warrants"&gt;1,789,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_pid_uUSDPShares_c20220701__20230630_zuRZJAtK8XX7" style="text-align: right" title="Yorkville financing warrants average price"&gt;8.94&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in"&gt;GXII warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--GxiiWarrants_pid_uShares_c20220701__20230630_zHMJkushqd4a" style="text-align: right" title="GXII warrants"&gt;15,666,626&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_pid_uUSDPShares_c20220701__20230630_zJ7RdbGA8fG" style="text-align: right" title="GXII warrant average price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in"&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20220701__20230630_zwtkNzObpjxd" style="border-bottom: Black 1pt solid; text-align: right"&gt;(491,211&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20220701__20230630_z9twSZGNm2y1" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled"&gt;11.67&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Balance, June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20230701__20240630_zurKJrQeN0hh" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;18,816,304&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20230701__20240630_zjTCrM0X5K51" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at beginning average price"&gt;10.98&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.375in; text-indent: -0.125in"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20230701__20240630_z0W5fkGoigqf" style="text-align: right" title="Granted"&gt;1,593,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20230701__20240630_zPvax70AxKZh" style="text-align: right" title="Granted"&gt;3.33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in"&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20230701__20240630_z3hKFny45BZb" style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,846,560&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20230701__20240630_zcw1PQYD0wEb" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled"&gt;8.67&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Balance, June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20230701__20240630_zpRUOUmiGBv8" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;18,563,561&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iE_pid_uUSDPShares_c20230701__20240630_zE325rBL0CJ7" style="border-bottom: Black 2pt solid; text-align: right" title="Balance at ending average price"&gt;10.53&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-06-30"
      decimals="INF"
      id="Fact001357"
      unitRef="Shares">1851622</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2022-06-30"
      decimals="INF"
      id="Fact001359"
      unitRef="USDPShares">8.99</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <niobf:YorkvilleFinancingWarrants
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001361"
      unitRef="Shares">1789267</niobf:YorkvilleFinancingWarrants>
    <niobf:ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001363"
      unitRef="USDPShares">8.94</niobf:ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants>
    <niobf:GxiiWarrants
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001365"
      unitRef="Shares">15666626</niobf:GxiiWarrants>
    <niobf:ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001367"
      unitRef="USDPShares">11.50</niobf:ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants>
    <niobf:ClassOfWarrantOrRightExpired
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001368"
      unitRef="Shares">-491211</niobf:ClassOfWarrantOrRightExpired>
    <niobf:ClassOfWarrantOrRightExercisePriceExpired
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001370"
      unitRef="USDPShares">11.67</niobf:ClassOfWarrantOrRightExercisePriceExpired>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact001372"
      unitRef="Shares">18816304</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact001374"
      unitRef="USDPShares">10.98</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <niobf:ClassOfWarrantOrRightGranted
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001376"
      unitRef="Shares">1593817</niobf:ClassOfWarrantOrRightGranted>
    <niobf:ClassOfWarrantOrRightExercisePriceGranted
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001378"
      unitRef="USDPShares">3.33</niobf:ClassOfWarrantOrRightExercisePriceGranted>
    <niobf:ClassOfWarrantOrRightExpired
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001379"
      unitRef="Shares">-1846560</niobf:ClassOfWarrantOrRightExpired>
    <niobf:ClassOfWarrantOrRightExercisePriceExpired
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001381"
      unitRef="USDPShares">8.67</niobf:ClassOfWarrantOrRightExercisePriceExpired>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001383"
      unitRef="Shares">18563561</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001385"
      unitRef="USDPShares">10.53</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001387">&lt;p id="xdx_89E_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zfZlJxw1mQ28" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_zpt6fAXGWFI7"&gt;At
June 30, 2024, the Company has outstanding exercisable warrants, as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    Price&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expiry
    Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zoXC4JVPcOGg" style="width: 16%; text-align: right" title="Number of share outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;855,800&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zGpJ8aCGpI45" title="Exercise price"&gt;9.70&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zeHof6GKu6p" style="width: 60%; text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-02-19"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;February
    19, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zDEglaeylwUe" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;447,318&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zOMzWTH7SnI3" style="text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$8.94&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-right: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zhUsGKRWEASg" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zdGPamuZW8j" style="text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$4.60&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_z2x4fRJLJVIj" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-09-01"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1401"&gt;September
    1, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zYi3g4pIj88e" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;413,432&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zntLCYZYgUF1" style="text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$3.54&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zSP9E4t43nVc" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-12-22"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1406"&gt;December
    22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zIJjZwTBQP0d" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;315,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zQIyFNHSsqQb" style="text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zE506OVXL2qa" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2025-06-24"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1411"&gt;June
    24, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_z6HnfquTlHxc" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;615,385&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zFf6iyBUoy03" style="text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$3.25&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zpbNSKQf8iMl" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2027-04-12"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1416"&gt;April
    12, 2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z9oNsluQzth" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,666,626&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z0pvMgx2Hztl" style="text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$11.50&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_ddxL_c20240630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zJ17oOr84gIc" style="text-align: right; padding-right: 10pt" title="Expiry date::XDX::2028-03-17"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1421"&gt;March
    17, 2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240630_zjf9tMeF7pac" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,563,561&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-right: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 2.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0F_zHWjoLgb5ZYh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_F1E_zX2isN3oIiNc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expires
    in 3 equal monthly tranches on July 17, 2024, August 17, 2024, and September 17, 2024.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_ExercisePrice9.70Member"
      decimals="INF"
      id="Fact001389"
      unitRef="Shares">855800</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_currency_CAD_custom_ExercisePrice9.70Member"
      decimals="INF"
      id="Fact001391"
      unitRef="CADPShares">9.70</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_ExercisePrice8.94Member"
      decimals="INF"
      id="Fact001394"
      unitRef="Shares">447318</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_custom_ExercisePrice8.94Member"
      decimals="INF"
      id="Fact001396"
      unitRef="USDPShares">8.94</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_ExercisePrice4.60Member"
      decimals="INF"
      id="Fact001397"
      unitRef="Shares">250000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_custom_ExercisePrice4.60Member"
      decimals="INF"
      id="Fact001399"
      unitRef="USDPShares">4.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_ExercisePrice3.54Member"
      decimals="INF"
      id="Fact001402"
      unitRef="Shares">413432</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_custom_ExercisePrice3.54Member"
      decimals="INF"
      id="Fact001404"
      unitRef="USDPShares">3.54</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_ExercisePrice2.20Member"
      decimals="INF"
      id="Fact001407"
      unitRef="Shares">315000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_custom_ExercisePrice2.20Member"
      decimals="INF"
      id="Fact001409"
      unitRef="USDPShares">2.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_ExercisePrice3.25Member"
      decimals="INF"
      id="Fact001412"
      unitRef="Shares">615385</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_custom_ExercisePrice3.25Member"
      decimals="INF"
      id="Fact001414"
      unitRef="USDPShares">3.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_ExercisePrice11.50Member"
      decimals="INF"
      id="Fact001417"
      unitRef="Shares">15666626</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_custom_ExercisePrice11.50Member"
      decimals="INF"
      id="Fact001419"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001422"
      unitRef="Shares">18563561</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-07-012024-06-30_custom_GXIIPublicWarrantsMember"
      decimals="INF"
      id="Fact001425"
      unitRef="Shares">9999959</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-07-012024-06-30_custom_GXIIPrivateWarrantsMember"
      decimals="INF"
      id="Fact001427"
      unitRef="Shares">5666667</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember"
      id="Fact001429">Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like).</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees contextRef="From2023-07-01to2024-06-30" id="Fact001431">(ii)
the last reported sale price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001440">&lt;p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zHgR48wJZmoa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zLLrOhG6vMfk"&gt;The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a
Black Scholes model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;March 17, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 31%; text-align: justify"&gt;Stock price on valuation date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1Z5rDZjdkV4" style="width: 10%; text-align: right" title="Stock price on valuation date"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFE6f8V4pHcc" style="width: 10%; text-align: right" title="Stock price on valuation date"&gt;5.03&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKti9c2iZ2ub" style="width: 10%; text-align: right" title="Stock price on valuation date"&gt;7.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Strike price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zOtZwGvw2vs9" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWcBARjHuf42" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhgD62xwvIt6" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Implied volatility of Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4ENW3fVdG78" title="Implied volatility of public warrants"&gt;69.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zCWPeAEkl5yl" title="Implied volatility of public warrants"&gt;33.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeImYtHqK0Mf" title="Implied volatility of public warrants"&gt;19.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXiirYGbXKZb" title="Risk free rate"&gt;4.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFq3HWAZU19c" title="Risk free rate"&gt;4.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zMKev04i1UE2" title="Risk free rate"&gt;3.47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zcsificTC6ej" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDKPV2q7L2Wl" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zvsYn0LvsLYd" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expected warrant life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zcG5EAX3qLbj" title="Expected warrant life in years::XDX::P3Y8M12D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1472"&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjMLr3IZqMDe" title="Expected warrant life in years::XDX::P4Y8M12D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1474"&gt;4.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20230315__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znJ3gJPKi7ci" title="Expected warrant life in years::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1476"&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001442"
      unitRef="USDPShares">1.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001444"
      unitRef="USDPShares">5.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001446"
      unitRef="USDPShares">7.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001448"
      unitRef="USDPShares">11.50</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001450"
      unitRef="USDPShares">11.50</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001452"
      unitRef="USDPShares">11.50</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001454"
      unitRef="Pure">0.690</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001456"
      unitRef="Pure">0.335</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-03-152023-03-17_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001458"
      unitRef="Pure">0.195</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001460"
      unitRef="Pure">0.0445</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001462"
      unitRef="Pure">0.0418</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-03-152023-03-17_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001464"
      unitRef="Pure">0.0347</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001466"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001468"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-03-152023-03-17_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001470"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001478">&lt;p id="xdx_89B_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zbDEDzsTxw83" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zN3GUDOwHwG3"&gt;The
change in the Private Warrants liability is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 37%"&gt;Initial valuation, March 17, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230315__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_ze4dEjbfLz13" style="width: 10%; text-align: right" title="Initial valuation, at begining"&gt;2,987&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in valuation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230315__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zAkWZjJgEmzl" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation"&gt;292&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Valuation at June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zN4GuycS7h48" style="text-align: right" title="Initial valuation, at begining"&gt;3,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in valuation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zXXIPqLb19rj" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation"&gt;(1,926&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Valuation at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zNiq6OhMP5qk" style="border-bottom: Black 2pt solid; text-align: right" title="Initial valuation, at ending"&gt;1,353&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock>
    <niobf:ChangesInFairValueOfInitialValuation
      contextRef="AsOf2023-03-14_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact001480"
      unitRef="USD">2987000</niobf:ChangesInFairValueOfInitialValuation>
    <us-gaap:ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs
      contextRef="From2023-03-152023-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact001482"
      unitRef="USD">292000</us-gaap:ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs>
    <niobf:ChangesInFairValueOfInitialValuation
      contextRef="AsOf2023-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact001484"
      unitRef="USD">3279000</niobf:ChangesInFairValueOfInitialValuation>
    <us-gaap:ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs
      contextRef="From2023-07-012024-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact001486"
      unitRef="USD">-1926000</us-gaap:ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs>
    <niobf:ChangesInFairValueOfInitialValuation
      contextRef="AsOf2024-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact001488"
      unitRef="USD">1353000</niobf:ChangesInFairValueOfInitialValuation>
    <us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001498">&lt;p id="xdx_897_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_z3ASikrYjJu1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zzt2wXsBEeM6" style="display: none; visibility: hidden"&gt;Schedule of expenses as other operating costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230701__20240630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zeU06pPLzlEi" style="border-bottom: Black 1pt solid; text-align: right"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--YorkvilleCashFee_zCo8eoTA9VL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 57%; text-align: justify"&gt;Yorkville Cash Fee&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zMxZ7zqa5Uci" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Fair value of Commitment Shares issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;650&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OtherCostAndExpenseOperating_z0jMHASx6W26" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Legal and other related costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;496&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--OperatingCostsAndExpenses_z85GnfZNKj0e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt"&gt;Costs expensed to other operating expense&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;2,646&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock>
    <niobf:YorkvilleCashFee
      contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      id="Fact001500"
      unitRef="USD">1500000</niobf:YorkvilleCashFee>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      id="Fact001502"
      unitRef="USD">650000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      id="Fact001504"
      unitRef="USD">496000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-07-012024-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      id="Fact001506"
      unitRef="USD">2646000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001508">&lt;p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4eKlHaWxKOf" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_829_z8tIyz7Feacf" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RELATED
                                         PARTY TRANSACTIONS AND BALANCES&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company was party to a non-revolving credit facility agreement (the &#x201c;Smith Credit Facility&#x201d;) with Mark Smith, Chief
Executive Officer, President, and Executive Chairman of NioCorp, which expired on June 30, 2023. The Smith Credit Facility bore
interest at a rate of &lt;span id="xdx_903_eus-gaap--RelatedPartyTransactionRate_pid_dp_uPure_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zFLs49Ru3Er6" title="Interest at a rate"&gt;10&lt;/span&gt;% and drawdowns from the Smith Credit Facility were subject to a &lt;span id="xdx_904_ecustom--LineOfCreditFacilityPrepaymentFee_pid_dp_uPure_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zdoV39mhXN3d" title="Prepayment fee"&gt;2.5&lt;/span&gt;% establishment fee. Amounts outstanding
under the Smith Credit Facility were secured by all of the Company&#x2019;s assets pursuant to a general security agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zi0DW29dRwp2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zbYcDYi02tPc"&gt;Changes
in the Smith Credit Agreement principal balance are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For the year ending June 30,2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 57%; background-color: #CCEEFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beginning
    balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20220701__20230630_zvLcTJ5yFCRl" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;Amounts
    advanced&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AmountsAdvanced_pn3n3_c20220701__20230630_zGvahmC47mrb" style="vertical-align: bottom; text-align: right" title="Amounts advanced"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,130&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; background-color: #CCECFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;Repayments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: #CCECFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: #CCECFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20220701__20230630_zFkN7hObNvhd" style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: #CCECFF; text-align: right" title="Repayments"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,130&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: #CCECFF; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20220701__20230630_z2ENjS0AcD5j" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1520"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8AA_zUbKMvpONWhf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 22, 2023, the Company repaid Mr. Smith $&lt;span id="xdx_901_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230322__us-gaap--TypeOfArrangementAxis__custom--NonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zdbedpl4zKKb" title="Credit agreement"&gt;1,841&lt;/span&gt; of principal borrowed under the Smith Credit Facility. This repayment was
made out of funds transferred to the Company from the GXII trust account on the Closing Date. The Company repaid the remaining
principal balance of $&lt;span id="xdx_907_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_z3kHivj0Nai7" title="Principal amount outstanding"&gt;1,289&lt;/span&gt; on May 31, 2023. Accounts payable and accrued liabilities as of June 30, 2024 includes $&lt;span id="xdx_907_ecustom--EstablishmentFeesPayable_pn3n3_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_zK1bq0V0XkW5" title="Establishment fees payable"&gt;28&lt;/span&gt; of origination
fees payable under the Smith Credit Agreement. During fiscal year 2023 the Company paid a total of $&lt;span id="xdx_900_eus-gaap--AccruedLiabilitiesCurrent_iI_pn3n3_c20230630_zsKcCa1LoaJh"&gt;183&lt;/span&gt;, representing accrued
interest on the Smith Credit Agreement.&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="From2023-07-012024-06-30_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fact001510"
      unitRef="Pure">0.10</us-gaap:RelatedPartyTransactionRate>
    <niobf:LineOfCreditFacilityPrepaymentFee
      contextRef="From2023-07-012024-06-30_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fact001512"
      unitRef="Pure">0.025</niobf:LineOfCreditFacilityPrepaymentFee>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001514">&lt;p id="xdx_898_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zi0DW29dRwp2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zbYcDYi02tPc"&gt;Changes
in the Smith Credit Agreement principal balance are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For the year ending June 30,2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 57%; background-color: #CCEEFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beginning
    balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20220701__20230630_zvLcTJ5yFCRl" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; background-color: #CCEEFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;Amounts
    advanced&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AmountsAdvanced_pn3n3_c20220701__20230630_zGvahmC47mrb" style="vertical-align: bottom; text-align: right" title="Amounts advanced"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,130&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; background-color: #CCECFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;Repayments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: #CCECFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: #CCECFF"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20220701__20230630_zFkN7hObNvhd" style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: #CCECFF; text-align: right" title="Repayments"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,130&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: #CCECFF; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20220701__20230630_z2ENjS0AcD5j" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1520"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:RelatedPartyDepositLiabilities
      contextRef="AsOf2022-06-30"
      decimals="-3"
      id="Fact001515"
      unitRef="USD">2000000</us-gaap:RelatedPartyDepositLiabilities>
    <niobf:AmountsAdvanced
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001517"
      unitRef="USD">1130000</niobf:AmountsAdvanced>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001519"
      unitRef="USD">3130000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:LongTermLineOfCredit
      contextRef="AsOf2023-03-22_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember"
      decimals="-3"
      id="Fact001522"
      unitRef="USD">1841000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit
      contextRef="AsOf2023-05-31_custom_MarkSmithMember"
      decimals="-3"
      id="Fact001524"
      unitRef="USD">1289000</us-gaap:LongTermLineOfCredit>
    <niobf:EstablishmentFeesPayable
      contextRef="From2023-07-012024-06-30_custom_MarkSmithMember"
      decimals="-3"
      id="Fact001526"
      unitRef="USD">28000</niobf:EstablishmentFeesPayable>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001527"
      unitRef="USD">183000</us-gaap:AccruedLiabilitiesCurrent>
    <niobf:ExplorationExpendituresDisclosuresTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001535">&lt;p id="xdx_808_ecustom--ExplorationExpendituresDisclosuresTextBlock_zAPlN4B9j978" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_82C_zxLiF2y2jxa1" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;EXPLORATION
                                         EXPENDITURES&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_893_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zrUmCPvNDG57" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zEW02sgRxMqk" style="display: none; visibility: hidden"&gt;Schedule of exploration expenditures&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="padding-bottom: 1pt; text-align: center"&gt;For the year ended &lt;br/&gt;
June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 5.4pt"&gt;&#160;Feasibility study and engineering&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_z0TgLiCc3Xya" style="width: 10%; text-align: right"&gt;353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zZw16AZyDUGh" style="width: 10%; text-align: right"&gt;410&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;&#160;Field management and other&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_ztJXK1DHfYU1" style="text-align: right"&gt;503&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zjIM2zz2poy4" style="text-align: right"&gt;738&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;Metallurgical&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--MetallurgicalMember_zwIzBzW08n1b" style="text-align: right"&gt;1,678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--MetallurgicalMember_zVKXQvCj98Cb" style="text-align: right"&gt;4,174&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;Geologists and field staff&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z29Ug68eIXCh" style="border-bottom: Black 1pt solid; text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z4lMg6XsyCeh" style="border-bottom: Black 1pt solid; text-align: right"&gt;26&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 5.4pt"&gt;&#160;Total&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630_znMH3N4wvcZ" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures"&gt;2,552&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630_zpJ67NrBhQeh" style="border-bottom: Black 2pt solid; text-align: right"&gt;5,348&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zwFN6yUj2lnk" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</niobf:ExplorationExpendituresDisclosuresTextBlock>
    <niobf:ScheduleOfExplorationExpendituresTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001537">&lt;p id="xdx_893_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zrUmCPvNDG57" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zEW02sgRxMqk" style="display: none; visibility: hidden"&gt;Schedule of exploration expenditures&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="padding-bottom: 1pt; text-align: center"&gt;For the year ended &lt;br/&gt;
June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 5.4pt"&gt;&#160;Feasibility study and engineering&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_z0TgLiCc3Xya" style="width: 10%; text-align: right"&gt;353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zZw16AZyDUGh" style="width: 10%; text-align: right"&gt;410&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;&#160;Field management and other&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_ztJXK1DHfYU1" style="text-align: right"&gt;503&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zjIM2zz2poy4" style="text-align: right"&gt;738&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;Metallurgical&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--MetallurgicalMember_zwIzBzW08n1b" style="text-align: right"&gt;1,678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--MetallurgicalMember_zVKXQvCj98Cb" style="text-align: right"&gt;4,174&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;Geologists and field staff&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z29Ug68eIXCh" style="border-bottom: Black 1pt solid; text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z4lMg6XsyCeh" style="border-bottom: Black 1pt solid; text-align: right"&gt;26&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 5.4pt"&gt;&#160;Total&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630_znMH3N4wvcZ" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures"&gt;2,552&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630_zpJ67NrBhQeh" style="border-bottom: Black 2pt solid; text-align: right"&gt;5,348&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfExplorationExpendituresTableTextBlock>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012024-06-30_custom_FeasibilityStudyAndEngineeringMember"
      decimals="-3"
      id="Fact001538"
      unitRef="USD">353000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2022-07-012023-06-30_custom_FeasibilityStudyAndEngineeringMember"
      decimals="-3"
      id="Fact001539"
      unitRef="USD">410000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012024-06-30_custom_FieldManagementAndOtherMember"
      decimals="-3"
      id="Fact001540"
      unitRef="USD">503000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2022-07-012023-06-30_custom_FieldManagementAndOtherMember"
      decimals="-3"
      id="Fact001541"
      unitRef="USD">738000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012024-06-30_custom_MetallurgicalMember"
      decimals="-3"
      id="Fact001542"
      unitRef="USD">1678000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2022-07-012023-06-30_custom_MetallurgicalMember"
      decimals="-3"
      id="Fact001543"
      unitRef="USD">4174000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012024-06-30_custom_GeologistsAndFieldStaffMember"
      decimals="-3"
      id="Fact001544"
      unitRef="USD">18000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2022-07-012023-06-30_custom_GeologistsAndFieldStaffMember"
      decimals="-3"
      id="Fact001545"
      unitRef="USD">26000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001547"
      unitRef="USD">2552000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001548"
      unitRef="USD">5348000</us-gaap:ExplorationExpense>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001550">&lt;p id="xdx_80F_eus-gaap--LesseeOperatingLeasesTextBlock_zGxsbcstybTa" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_826_zq6vjV7Y0CU4" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;LEASES&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
February 2023, the Company entered into a &lt;span id="xdx_90F_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20230701__20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CorporateOfficeMember_zsLN8BflOW15" title="Other lease description"&gt;39-month corporate office lease extension and recognized a corresponding ROU asset and
lease liability of $198 associated with this extension, based on a discount rate of &lt;span id="xdx_90D_ecustom--DiscountRate_dp_uPure_c20230701__20240630_zR36QQLX1Tmd" title="Discount rate"&gt;16&lt;/span&gt;%.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2024 and 2023, the Company had one corporate office lease with a remaining lease term of &lt;span id="xdx_907_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20240630_zzCUMc7n15Bj" title="Remaining lease term::XDX::P2Y7M6D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1556"&gt;2.6&lt;/span&gt;&lt;/span&gt; years and &lt;span id="xdx_903_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20230630_zUEDHhLfWTKb" title="Remaining lease term::XDX::P3Y7M6D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1558"&gt;3.6&lt;/span&gt;&lt;/span&gt; years,
respectively. During the year ended June 30, 2024 and 2023, operating cash flows included cash payments of $&lt;span id="xdx_905_eus-gaap--OperatingLeasePayments_c20230701__20240630_zyu7tCP0eKd7" title="Cash payment"&gt;71&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--OperatingLeasePayments_c20220701__20230630_zSm28HK1LF29" title="Cash payment"&gt;93&lt;/span&gt;, respectively
related to the measurement of lease liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zFMDPesBUyD4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_zZwNhVP7znVa"&gt;The
Company incurred lease costs as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20230701__20240630_zdpHnoiu8ZHk" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20220701__20230630_zfGHLIRpd2B2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_ztcs0JNenlYa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;Operating Lease Cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--FixedRentExpense_z8wiWrFQMm9a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 0.125in"&gt;&#160;&#160;Fixed rent expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;90&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--VariableLeaseCost_zYilEpcHe0me" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&#160;&#160;Variable rent expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&#160;&#160;Short term lease cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_zMx8rbZIbR35" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;&#160;&#160;Sublease income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(32&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(33&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zVDNB18iZSb3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;&#160;&#160;Net lease cost &#x2013; other operating expense&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;81&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;73&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AD_zHKUfcwJmSg2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zIBH6df4xrIb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zIL0QupF7Sh"&gt;The
maturity of lease liabilities is as follows at June 30, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20240630_zVO867MS1l3i" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;Fiscal Year Lease Maturities&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zOLwY093Fgn2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 57%; text-align: left; padding-left: 0.125in"&gt;2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;96&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_znOgn2YDFFx7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;98&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzI5d_z6iGPLc1xjm7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--TotalLeasePayments_iI_pn3n3_mtLOLLPzI5d_zHxp79pTNTA5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;244&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--LessAmountOfPaymentsRepresentingInterest_iNI_pn3n3_di_zB2RmiaocxGb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less amount of payments representing interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_z7RPNTFnrOh5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Present value of lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;200&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--LessCurrentPortionOfOperatingLeaseLiability_iNI_pn3n3_di_zRkoiw9xk6U9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less current portion of operating lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(95&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--OperatingLeasesLiabilityNoncurrent_iI_pn3n3_z8eJ9hvacpNd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Noncurrent operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;105&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_z3Su5hebItt" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="From2023-07-012024-06-30_custom_CorporateOfficeMember"
      id="Fact001552">39-month corporate office lease extension and recognized a corresponding ROU asset and
lease liability of $198 associated with this extension, based on a discount rate of 16%.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <niobf:DiscountRate
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001554"
      unitRef="Pure">0.16</niobf:DiscountRate>
    <us-gaap:OperatingLeasePayments
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001560"
      unitRef="USD">71</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001562"
      unitRef="USD">93</us-gaap:OperatingLeasePayments>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001564">&lt;p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zFMDPesBUyD4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_zZwNhVP7znVa"&gt;The
Company incurred lease costs as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20230701__20240630_zdpHnoiu8ZHk" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20220701__20230630_zfGHLIRpd2B2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_ztcs0JNenlYa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;Operating Lease Cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--FixedRentExpense_z8wiWrFQMm9a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 0.125in"&gt;&#160;&#160;Fixed rent expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;90&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--VariableLeaseCost_zYilEpcHe0me" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&#160;&#160;Variable rent expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&#160;&#160;Short term lease cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_zMx8rbZIbR35" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;&#160;&#160;Sublease income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(32&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(33&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zVDNB18iZSb3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;&#160;&#160;Net lease cost &#x2013; other operating expense&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;81&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;73&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <niobf:FixedRentExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001569"
      unitRef="USD">90000</niobf:FixedRentExpense>
    <niobf:FixedRentExpense
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001570"
      unitRef="USD">83000</niobf:FixedRentExpense>
    <us-gaap:VariableLeaseCost
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001572"
      unitRef="USD">14000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001573"
      unitRef="USD">13000</us-gaap:VariableLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001575"
      unitRef="USD">9000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001576"
      unitRef="USD">10000</us-gaap:ShortTermLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001578"
      unitRef="USD">32000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001579"
      unitRef="USD">33000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001581"
      unitRef="USD">81000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001582"
      unitRef="USD">73000</us-gaap:LeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001584">&lt;p id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zIBH6df4xrIb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zIL0QupF7Sh"&gt;The
maturity of lease liabilities is as follows at June 30, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20240630_zVO867MS1l3i" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;Fiscal Year Lease Maturities&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zOLwY093Fgn2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 57%; text-align: left; padding-left: 0.125in"&gt;2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;96&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_znOgn2YDFFx7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;98&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzI5d_z6iGPLc1xjm7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--TotalLeasePayments_iI_pn3n3_mtLOLLPzI5d_zHxp79pTNTA5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;244&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--LessAmountOfPaymentsRepresentingInterest_iNI_pn3n3_di_zB2RmiaocxGb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less amount of payments representing interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_z7RPNTFnrOh5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Present value of lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;200&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--LessCurrentPortionOfOperatingLeaseLiability_iNI_pn3n3_di_zRkoiw9xk6U9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less current portion of operating lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(95&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--OperatingLeasesLiabilityNoncurrent_iI_pn3n3_z8eJ9hvacpNd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Noncurrent operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;105&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001586"
      unitRef="USD">96000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001588"
      unitRef="USD">98000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001590"
      unitRef="USD">50000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <niobf:TotalLeasePayments
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001592"
      unitRef="USD">244000</niobf:TotalLeasePayments>
    <niobf:LessAmountOfPaymentsRepresentingInterest
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001594"
      unitRef="USD">44000</niobf:LessAmountOfPaymentsRepresentingInterest>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001596"
      unitRef="USD">200000</us-gaap:OperatingLeaseLiability>
    <niobf:LessCurrentPortionOfOperatingLeaseLiability
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001598"
      unitRef="USD">95000</niobf:LessCurrentPortionOfOperatingLeaseLiability>
    <niobf:OperatingLeasesLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001600"
      unitRef="USD">105000</niobf:OperatingLeasesLiabilityNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001602">&lt;p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zMXvECizM2db" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_82D_z6W5ECWpJsb2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;INCOME
                                         TAXES&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_z9bgB1OQuWef" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_z2BFpEQH5sRh"&gt;Domestic
and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows:&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; padding-left: 5pt"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z57vaDVMMEd6" style="width: 10%; text-align: right" title="Total"&gt;8,319&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_znIGbYlP5VUj" style="width: 10%; text-align: right" title="Total"&gt;34,606&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zjd2vsIFj6Xi" style="text-align: right" title="Total"&gt;3,679&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zWVpHypcitNa" style="text-align: right" title="Total"&gt;6,006&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zzAPDkmYszX2" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zcE2d0hva516" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1616"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zfJxujeMcwoe" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;12,037&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zHNyoDRvRkii" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;40,612&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_z6gUo2qyACbf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;


















&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p id="xdx_896_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zQKS2yZlaJyk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zKmOYbnYfTne"&gt;The
following table is a reconciliation of income taxes at statutory rates:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20230701__20240630_zkoJDe5peD99" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20220701__20230630_zcURCFmpWzj5" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_zLcapFBp6554" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 54%; text-align: left; padding-left: 5pt"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;12,037&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;40,612&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_z4Aj6nOFUsbk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Combined Canadian federal and provincial statutory income tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_z0kWdi5AgPzc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Income tax benefit at statutory tax rates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,965&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_zgmSZqkdF78l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Foreign rate differential&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(62&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(131&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--EarnoutSharesLiability_zvAOBQaeeGK" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5pt"&gt;Earnout shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,810&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,841&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--WarrantLiability_z13vU622ux3c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;506&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,518&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--GxiiTransactionCosts_zY0iqsfhNwX7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;GXII transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1648"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(925&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zVXkJ8u5iGy1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt"&gt;Share based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(747&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(412&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AssetRetirementObligationAccretionExpense_iN_di_zMM7wzlve5oe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Accretion expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,138&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(496&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--ConvertibleNoteValuation_iN_di_zzNlctPWi7hc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Convertible note valuation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(607&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1658"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--ExtinguishmentOfDebtGainLossIncomeTax_zyMdhRxpNHHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Loss on debt extinguishment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1660"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(54&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--EffectOfLegislativeChanges_zvRSKnwWjus" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Capital loss rate differential&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1663"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_zNTU5WJBgTx8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Change in estimates related to prior years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(160&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_zuHweNmP1zfb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zRe8hs5irF0b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,718&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,341&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 5pt"&gt;Income tax benefit&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20230701__20240630_zHg9FOUnnAz1" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit::XDX::-139"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1675"&gt;139&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20220701__20230630_z1ZhZermPT97" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit::XDX::-304"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1677"&gt;304&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_zdEoOZ2VSwl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
tax benefit for the year ends June 30, 2024 and 2023 were derived solely from our U.S. operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z8sr4ADEJGdf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zFluBkuRj1Tf"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20240630_zcsLRmqQm5X7" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20230630_zjZzn2nJl5Ll" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzakr_zHHYB11mTGj5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 54%; text-align: left; padding-left: 0.25in"&gt;Net operating losses available for future periods&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;14,177&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;11,893&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zxQyGBDpziZ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Mineral interests&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,438&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,477&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_z12T6eRhe5Pa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Startup and organizational costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,987&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,132&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zQ0ysepiv2D3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Research and development costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zuIAc0JPPD21" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in"&gt;Share issuance/financing costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;635&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;446&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zM7WHQZtgW6j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Capital losses available for future periods&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzakr_zPHUuuadLk09" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;69&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;36&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iI_mtDTAGzakr_maDTALNz97R_zH8FslKJJ5z8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,181&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,463&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNz97R_zGnLV8BaggNf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;&#160;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(28,181&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(25,463&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNz97R_zKvv3YhPtfs9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1708"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_zAEXbRBhj7s5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--SummaryOfValuationAllowanceTextBlock_znJg9a2MUMp" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zlgJc4C0A8Y"&gt;Changes
in the valuation allowance are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 54%; text-align: left"&gt;Valuation allowance, beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20230701__20240630_zy8O1HuJiqMl" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year"&gt;(25,463&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20220701__20230630_zpQNsLKSooqe" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year"&gt;(18,948&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Current year additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20230701__20240630_z8oKQuFi0Bk3" style="text-align: right" title="Current year additions"&gt;(2,718&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20220701__20230630_z85LpOCidlBc" style="text-align: right" title="Current year additions"&gt;(4,341&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Startup and organizational costs acquired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20230701__20240630_z0bO8mMe3TD3" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1721"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20220701__20230630_zzoiCwC6VpGf" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired"&gt;(2,174&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Valuation allowance, end of year&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20230701__20240630_zmbFKoM7NRxj" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year"&gt;(28,181&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20220701__20230630_zRbdcmhhLzKe" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year"&gt;(25,463&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A1_zOdriCJbK0Bg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company acquired a federal income tax payable of $&lt;span id="xdx_90C_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_pn3n3_c20230701__20240630_zYjQPwyq48I3" title="Federal income tax payable"&gt;443&lt;/span&gt; in connection with the GXII Transaction. As a result of a post-transaction
loss at ECRC, partial releases of the valuation allowance attributed to the reduction of the acquired federal income tax payable
of $139 and $304 were recorded as an income tax benefit in the consolidated statement of operations and comprehensive loss for
the year ended June 30, 2024 and 2023, respectively. The Company establishes a valuation allowance against future income tax assets
if, based on available information, it is more likely than not that all of the assets will not be realized. The valuation allowance
of $&lt;span id="xdx_90E_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pn3n3_c20240630_zwtwN4vSnHe" title="Valuation allowance"&gt;28,181&lt;/span&gt; at June 30, 2024, relates mainly to net&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;operating loss carryforwards in Canada and mineral interests due to deferred
exploration expenditures in the United States, where the utilization of such attributes is not more likely than not.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has the following cumulative net operating losses for Canadian and U.S. income tax purposes and these carryforwards will
generally expire between 2028 and 2044. As a result of the Tax Cuts and Jobs Act of 2017, U.S. tax losses incurred for our tax
years ending on and after June 30, 2019, totaling $&lt;span id="xdx_900_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_c20190630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zd3Ac0dpWetc" title="Tax losses incurred"&gt;3,924&lt;/span&gt;, have no expiration.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zcb4TTHIh5xb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zUlCkb3Tqdy1" style="display: none; visibility: hidden"&gt;Schedule of cumulative net operating losses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-left: 4pt"&gt;Jurisdiction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; padding-left: 4pt"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zFYEneDdpFnc" style="width: 10%; text-align: right" title="Total"&gt;47,623&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z9aOqr2g4Un1" style="width: 10%; text-align: right" title="Total"&gt;40,267&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 4pt"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_z9HoM3kIozy7" style="text-align: right" title="Total"&gt;4,905&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zjMnTpQKmzl" style="text-align: right" title="Total"&gt;3,491&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 4pt"&gt;United Kingdom&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zaGPbrYeEioc" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;39&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zFqvrzdgQatb" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1753"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630_zurE3MeGlGec" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;52,567&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630_zQtPWQ385yo5" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;43,758&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zoygixFsPxV1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, the Company has a Canadian capital loss carryforward of $&lt;span id="xdx_907_ecustom--CapitalLossCaryforward_iI_c20240630__srt--CurrencyAxis__currency--CAD_zsIFwOVeDd3e" title="Capital loss carryforward"&gt;3,388&lt;/span&gt; as of June 30, 2024, which has no expiration date and
can be used to offset future capital gains, and U.S. state net operating loss carryforwards of $&lt;span id="xdx_909_ecustom--CapitalLossCaryforward_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zGKTfiJ2enU" title="Net operating loss carryforwards"&gt;7,018&lt;/span&gt; as of June 30, 2024 which
generally expire between 2031 and 2044.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At June 30, 2024 and 2023, we had no undistributed earnings of foreign subsidiaries that would be subject to income tax upon distribution to Canada from a foreign subsidiary. As such, as of June 30, 2024 and 2023, we did not provide for deferred taxes on any such earnings of our foreign subsidiaries.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company had no unrecognized tax benefits as of June 30, 2024 or 2023. The Company recognizes interest accrued related to unrecognized
tax benefits and penalties in its income tax provision. The Company has not recognized any interest or penalties in the fiscal
years presented in these consolidated financial statements. The Company is subject to income tax in the U.S. federal jurisdiction,
the United Kingdom, and Canada. Certain years remain subject to examination but there are currently no ongoing exams in any taxing
jurisdictions.&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001604">&lt;p id="xdx_890_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_z9bgB1OQuWef" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_z2BFpEQH5sRh"&gt;Domestic
and foreign components of loss before income taxes for the years ended June 30, 2024 and 2023 are as follows:&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; padding-left: 5pt"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z57vaDVMMEd6" style="width: 10%; text-align: right" title="Total"&gt;8,319&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_znIGbYlP5VUj" style="width: 10%; text-align: right" title="Total"&gt;34,606&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zjd2vsIFj6Xi" style="text-align: right" title="Total"&gt;3,679&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zWVpHypcitNa" style="text-align: right" title="Total"&gt;6,006&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zzAPDkmYszX2" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zcE2d0hva516" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1616"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zfJxujeMcwoe" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;12,037&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zHNyoDRvRkii" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;40,612&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_us-gaap_ForeignCountryMember"
      decimals="-3"
      id="Fact001606"
      unitRef="USD">8319000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_us-gaap_ForeignCountryMember"
      decimals="-3"
      id="Fact001608"
      unitRef="USD">34606000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-3"
      id="Fact001610"
      unitRef="USD">3679000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-3"
      id="Fact001612"
      unitRef="USD">6006000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      id="Fact001614"
      unitRef="USD">39000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001618"
      unitRef="USD">12037000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001620"
      unitRef="USD">40612000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001628">&lt;p id="xdx_896_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zQKS2yZlaJyk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zKmOYbnYfTne"&gt;The
following table is a reconciliation of income taxes at statutory rates:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20230701__20240630_zkoJDe5peD99" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20220701__20230630_zcURCFmpWzj5" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_zLcapFBp6554" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 54%; text-align: left; padding-left: 5pt"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;12,037&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;40,612&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_z4Aj6nOFUsbk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Combined Canadian federal and provincial statutory income tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_z0kWdi5AgPzc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Income tax benefit at statutory tax rates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,965&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_zgmSZqkdF78l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Foreign rate differential&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(62&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(131&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--EarnoutSharesLiability_zvAOBQaeeGK" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5pt"&gt;Earnout shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,810&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,841&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--WarrantLiability_z13vU622ux3c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;506&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,518&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--GxiiTransactionCosts_zY0iqsfhNwX7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;GXII transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1648"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(925&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zVXkJ8u5iGy1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt"&gt;Share based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(747&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(412&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AssetRetirementObligationAccretionExpense_iN_di_zMM7wzlve5oe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Accretion expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,138&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(496&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--ConvertibleNoteValuation_iN_di_zzNlctPWi7hc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Convertible note valuation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(607&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1658"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--ExtinguishmentOfDebtGainLossIncomeTax_zyMdhRxpNHHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Loss on debt extinguishment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1660"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(54&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--EffectOfLegislativeChanges_zvRSKnwWjus" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Capital loss rate differential&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1663"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_zNTU5WJBgTx8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Change in estimates related to prior years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(160&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_zuHweNmP1zfb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zRe8hs5irF0b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,718&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,341&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 5pt"&gt;Income tax benefit&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20230701__20240630_zHg9FOUnnAz1" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit::XDX::-139"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1675"&gt;139&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20220701__20230630_z1ZhZermPT97" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit::XDX::-304"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1677"&gt;304&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001630"
      unitRef="USD">12037000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001631"
      unitRef="USD">40612000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001633"
      unitRef="Pure">0.27</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001634"
      unitRef="Pure">0.27</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001636"
      unitRef="USD">3250000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001637"
      unitRef="USD">10965000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001639"
      unitRef="USD">-62000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001640"
      unitRef="USD">-131000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <niobf:EarnoutSharesLiability
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001642"
      unitRef="USD">1810000</niobf:EarnoutSharesLiability>
    <niobf:EarnoutSharesLiability
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001643"
      unitRef="USD">-2841000</niobf:EarnoutSharesLiability>
    <niobf:WarrantLiability
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001645"
      unitRef="USD">506000</niobf:WarrantLiability>
    <niobf:WarrantLiability
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001646"
      unitRef="USD">-1518000</niobf:WarrantLiability>
    <niobf:GxiiTransactionCosts
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001649"
      unitRef="USD">-925000</niobf:GxiiTransactionCosts>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001651"
      unitRef="USD">-747000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001652"
      unitRef="USD">-412000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001654"
      unitRef="USD">1138000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001655"
      unitRef="USD">496000</us-gaap:AssetRetirementObligationAccretionExpense>
    <niobf:ConvertibleNoteValuation
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001657"
      unitRef="USD">607000</niobf:ConvertibleNoteValuation>
    <us-gaap:ExtinguishmentOfDebtGainLossIncomeTax
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001661"
      unitRef="USD">-54000</us-gaap:ExtinguishmentOfDebtGainLossIncomeTax>
    <niobf:EffectOfLegislativeChanges
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001664"
      unitRef="USD">-2000</niobf:EffectOfLegislativeChanges>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001666"
      unitRef="USD">-160000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001667"
      unitRef="USD">14000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001669"
      unitRef="USD">5000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001670"
      unitRef="USD">45000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001672"
      unitRef="USD">-2718000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001673"
      unitRef="USD">-4341000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001679">&lt;p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z8sr4ADEJGdf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zFluBkuRj1Tf"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20240630_zcsLRmqQm5X7" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20230630_zjZzn2nJl5Ll" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzakr_zHHYB11mTGj5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 54%; text-align: left; padding-left: 0.25in"&gt;Net operating losses available for future periods&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;14,177&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;11,893&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zxQyGBDpziZ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Mineral interests&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,438&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,477&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_z12T6eRhe5Pa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Startup and organizational costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,987&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,132&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zQ0ysepiv2D3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Research and development costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zuIAc0JPPD21" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in"&gt;Share issuance/financing costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;635&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;446&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zM7WHQZtgW6j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Capital losses available for future periods&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzakr_zPHUuuadLk09" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;69&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;36&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iI_mtDTAGzakr_maDTALNz97R_zH8FslKJJ5z8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,181&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,463&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNz97R_zGnLV8BaggNf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;&#160;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(28,181&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(25,463&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNz97R_zKvv3YhPtfs9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1708"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001681"
      unitRef="USD">14177000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001682"
      unitRef="USD">11893000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <niobf:DeferredTaxAssetsMineralInterest
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001684"
      unitRef="USD">9438000</niobf:DeferredTaxAssetsMineralInterest>
    <niobf:DeferredTaxAssetsMineralInterest
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001685"
      unitRef="USD">9477000</niobf:DeferredTaxAssetsMineralInterest>
    <niobf:DeferredTaxAssetsStartupAndOorganizationalCosts
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001687"
      unitRef="USD">1987000</niobf:DeferredTaxAssetsStartupAndOorganizationalCosts>
    <niobf:DeferredTaxAssetsStartupAndOorganizationalCosts
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001688"
      unitRef="USD">2132000</niobf:DeferredTaxAssetsStartupAndOorganizationalCosts>
    <niobf:DeferredTaxAssetsResearchAndDevelopmentCosts
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001690"
      unitRef="USD">1419000</niobf:DeferredTaxAssetsResearchAndDevelopmentCosts>
    <niobf:DeferredTaxAssetsResearchAndDevelopmentCosts
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001691"
      unitRef="USD">1060000</niobf:DeferredTaxAssetsResearchAndDevelopmentCosts>
    <niobf:DeferredTaxAssetsShareIssuanceCosts
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001693"
      unitRef="USD">635000</niobf:DeferredTaxAssetsShareIssuanceCosts>
    <niobf:DeferredTaxAssetsShareIssuanceCosts
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001694"
      unitRef="USD">446000</niobf:DeferredTaxAssetsShareIssuanceCosts>
    <niobf:CapitalLossesAvailableForFuturePeriods
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001696"
      unitRef="USD">456000</niobf:CapitalLossesAvailableForFuturePeriods>
    <niobf:CapitalLossesAvailableForFuturePeriods
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001697"
      unitRef="USD">419000</niobf:CapitalLossesAvailableForFuturePeriods>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001699"
      unitRef="USD">69000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001700"
      unitRef="USD">36000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001702"
      unitRef="USD">28181000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001703"
      unitRef="USD">25463000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001705"
      unitRef="USD">28181000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001706"
      unitRef="USD">25463000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:SummaryOfValuationAllowanceTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001711">&lt;p id="xdx_895_eus-gaap--SummaryOfValuationAllowanceTextBlock_znJg9a2MUMp" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zlgJc4C0A8Y"&gt;Changes
in the valuation allowance are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 54%; text-align: left"&gt;Valuation allowance, beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20230701__20240630_zy8O1HuJiqMl" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year"&gt;(25,463&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20220701__20230630_zpQNsLKSooqe" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year"&gt;(18,948&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Current year additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20230701__20240630_z8oKQuFi0Bk3" style="text-align: right" title="Current year additions"&gt;(2,718&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20220701__20230630_z85LpOCidlBc" style="text-align: right" title="Current year additions"&gt;(4,341&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Startup and organizational costs acquired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20230701__20240630_z0bO8mMe3TD3" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1721"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20220701__20230630_zzoiCwC6VpGf" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired"&gt;(2,174&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Valuation allowance, end of year&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20230701__20240630_zmbFKoM7NRxj" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year"&gt;(28,181&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20220701__20230630_zRbdcmhhLzKe" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year"&gt;(25,463&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001713"
      unitRef="USD">25463000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2022-06-30"
      decimals="-3"
      id="Fact001715"
      unitRef="USD">18948000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <niobf:DeferredTaxAssetsValuationAllowanceAdditions
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001717"
      unitRef="USD">2718000</niobf:DeferredTaxAssetsValuationAllowanceAdditions>
    <niobf:DeferredTaxAssetsValuationAllowanceAdditions
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001719"
      unitRef="USD">4341000</niobf:DeferredTaxAssetsValuationAllowanceAdditions>
    <us-gaap:CostsIncurredDevelopmentCosts
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact001723"
      unitRef="USD">2174000</us-gaap:CostsIncurredDevelopmentCosts>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001725"
      unitRef="USD">28181000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001727"
      unitRef="USD">25463000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="From2023-07-01to2024-06-30"
      decimals="-3"
      id="Fact001729"
      unitRef="USD">443000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001731"
      unitRef="USD">28181000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsOtherLossCarryforwards
      contextRef="AsOf2019-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      id="Fact001739"
      unitRef="USD">3924000</us-gaap:DeferredTaxAssetsOtherLossCarryforwards>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001741">&lt;p id="xdx_896_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zcb4TTHIh5xb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zUlCkb3Tqdy1" style="display: none; visibility: hidden"&gt;Schedule of cumulative net operating losses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-left: 4pt"&gt;Jurisdiction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; padding-left: 4pt"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zFYEneDdpFnc" style="width: 10%; text-align: right" title="Total"&gt;47,623&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z9aOqr2g4Un1" style="width: 10%; text-align: right" title="Total"&gt;40,267&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 4pt"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_z9HoM3kIozy7" style="text-align: right" title="Total"&gt;4,905&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zjMnTpQKmzl" style="text-align: right" title="Total"&gt;3,491&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 4pt"&gt;United Kingdom&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zaGPbrYeEioc" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;39&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zFqvrzdgQatb" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1753"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630_zurE3MeGlGec" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;52,567&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630_zQtPWQ385yo5" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;43,758&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-06-30_us-gaap_ForeignCountryMember"
      decimals="-3"
      id="Fact001743"
      unitRef="USD">47623000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-06-30_us-gaap_ForeignCountryMember"
      decimals="-3"
      id="Fact001745"
      unitRef="USD">40267000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-06-30_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-3"
      id="Fact001747"
      unitRef="USD">4905000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-06-30_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-3"
      id="Fact001749"
      unitRef="USD">3491000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      id="Fact001751"
      unitRef="USD">39000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001755"
      unitRef="USD">52567000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001757"
      unitRef="USD">43758000</us-gaap:OperatingLossCarryforwards>
    <niobf:CapitalLossCaryforward
      contextRef="AsOf2024-06-30_currency_CAD"
      decimals="0"
      id="Fact001759"
      unitRef="USD">3388</niobf:CapitalLossCaryforward>
    <niobf:CapitalLossCaryforward
      contextRef="AsOf2024-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      id="Fact001761"
      unitRef="USD">7018000</niobf:CapitalLossCaryforward>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001763">&lt;p id="xdx_80B_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_z6kSW9bwKGYb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;16.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;span id="xdx_828_zhdaTYuH8g9h"&gt;FAIR VALUE MEASUREMENTS&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures the fair value of financial assets and liabilities based on U.S. GAAP guidance which defines fair value, establishes
a framework for measuring fair value, and expands disclosures about fair value measurements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company classifies financial assets and liabilities as held-for-trading, available-for-sale, held-to-maturity, loans and receivables,
or other financial liabilities depending on their nature. Financial assets and financial liabilities are recognized at fair value
on their initial recognition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets and liabilities classified as held-for-trading are measured at fair value, with gains and losses recognized in net income.
Financial assets classified as held-to-maturity, loans and receivables, and financial liabilities other than those classified
as held-for-trading are measured at amortized cost, using the effective interest method of amortization. Financial assets classified
as available-for-sale, including investments in equity securities, are measured at fair value, with unrealized gains and losses
being recognized in income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments including receivables, accounts payable and accrued liabilities, and related party loans are carried at amortized
cost, which management believes approximates fair value due to the short-term nature of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of June 30, 2024, and 2023, respectively, and indicate the fair value hierarchy of the valuation techniques the Company utilized
to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active
markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable, such as quoted
prices, interest rates, and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the financial
instrument and include situations where there is little, if any, market activity for the instrument.&lt;/span&gt;&lt;/p&gt;






















&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p id="xdx_89A_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zqR1VBqKFzgc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B4_ztZC8PdC0OQi" style="display: none; visibility: hidden"&gt;Schedule of fair values determined by level 3 inputs are unobservable data&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left; padding-left: 0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630_zHfnRgmMcD5k" style="width: 9%; text-align: right" title="Cash and cash equivalents"&gt;2,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyRxZhHo8qo8" style="width: 9%; text-align: right"&gt;2,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuDVZt1TPtDh" style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1776"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zN369ejReXih" style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1777"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Investment in equity securities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630_zOIyZjI5NWh5" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqe2eCldhxH8" style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQ4l33XBWen" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1781"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zihji5P0r9K6" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240630_zvcKadMnfjh7" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents"&gt;2,016&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zeI8BTDUYdN4" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,016&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzvUB5OU6Ip4" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1786"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoeVxg1XDiUg" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1787"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Cash and cash equivalents"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;April 2024 notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NotesPayable_iI_c20240630_zuYPO2SS3pS7" style="text-align: right" title="Cash and cash equivalents"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NotesPayable_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0beG8D1zJu1" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1790"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPpARldt2JD1" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1791"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqDGw7MQKQmc" style="text-align: right"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630_zcECAf2SJC42" style="text-align: right" title="Cash and cash equivalents"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zuniSErcRgH8" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1795"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1QuLWobF3Pg" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1796"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zRpHCnxP2JZd" style="text-align: right"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630_zvCFGjvx2cca" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents"&gt;4,016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMAd9oqQPJV4" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1800"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSL8Gmr1BLkg" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkpM0PKAKxhc" style="border-bottom: Black 1pt solid; text-align: right"&gt;2,365&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630_zTzQMwOS31Eg" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents"&gt;14,922&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zf6BSJcdfyqb" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1805"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfKOJWWtknL9" style="border-bottom: Black 2pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zR1PuZxqKHR4" style="border-bottom: Black 2pt solid; text-align: right"&gt;13,271&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left; padding-left: 0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630_zjKL33g94I7c" style="width: 9%; text-align: right"&gt;2,341&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z016rH6Konm5" style="width: 9%; text-align: right"&gt;2,341&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLnMX4mSWxud" style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1810"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbU94EDQpM84" style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1811"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Investment in equity securities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630_zesl4AemIP5f" style="border-bottom: Black 1pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZoSGIGJ00H8" style="border-bottom: Black 1pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPoMcCvmtIPk" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1814"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z6q6OpuNSPm1" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1815"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20230630_zmdeNUGbcMhe" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,350&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ztxdhphe9fXg" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,350&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zk2To6FAGcQi" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1818"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0ojJd3792ii" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1819"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630_z8xu1VMvKUS3" style="text-align: right"&gt;10,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpcoCm9ZFpuf" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1821"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKDHPxK7uY1i" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1822"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zte778YsURXj" style="text-align: right"&gt;10,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630_zEfg3D4LhXyf" style="border-bottom: Black 1pt solid; text-align: right"&gt;4,989&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zN7hMLfrEA44" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1825"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zo58gZJhjfmf" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,279&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYb5UcoqWp1i" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,710&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630_zgFQkBE7jSZ8" style="border-bottom: Black 2pt solid; text-align: right"&gt;15,510&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6MWMm3HZeZ2" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1829"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zp8Ki3EXr6A4" style="border-bottom: Black 2pt solid; text-align: right"&gt;3,279&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zSLNZntZD21i" style="border-bottom: Black 2pt solid; text-align: right"&gt;12,231&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_zZ4z7AS8qs52" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
&lt;span style="color: #353535"&gt;Yorkville Convertible Debt Financing &lt;/span&gt;discussed in Note 9 was initially recorded at fair value,
which represented a nonrecurring fair value measurement using a Level 3 input. At June 30, 2024, the estimated fair value of this
instrument approximated carrying value given that the instrument was issued in March 2023 and has a short time period until maturity.&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001772">&lt;p id="xdx_89A_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zqR1VBqKFzgc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B4_ztZC8PdC0OQi" style="display: none; visibility: hidden"&gt;Schedule of fair values determined by level 3 inputs are unobservable data&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left; padding-left: 0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630_zHfnRgmMcD5k" style="width: 9%; text-align: right" title="Cash and cash equivalents"&gt;2,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyRxZhHo8qo8" style="width: 9%; text-align: right"&gt;2,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuDVZt1TPtDh" style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1776"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zN369ejReXih" style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1777"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Investment in equity securities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630_zOIyZjI5NWh5" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqe2eCldhxH8" style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQ4l33XBWen" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1781"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zihji5P0r9K6" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240630_zvcKadMnfjh7" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents"&gt;2,016&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zeI8BTDUYdN4" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,016&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzvUB5OU6Ip4" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1786"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoeVxg1XDiUg" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1787"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Cash and cash equivalents"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;April 2024 notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NotesPayable_iI_c20240630_zuYPO2SS3pS7" style="text-align: right" title="Cash and cash equivalents"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NotesPayable_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0beG8D1zJu1" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1790"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPpARldt2JD1" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1791"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqDGw7MQKQmc" style="text-align: right"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630_zcECAf2SJC42" style="text-align: right" title="Cash and cash equivalents"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zuniSErcRgH8" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1795"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1QuLWobF3Pg" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1796"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zRpHCnxP2JZd" style="text-align: right"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630_zvCFGjvx2cca" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents"&gt;4,016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMAd9oqQPJV4" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1800"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSL8Gmr1BLkg" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkpM0PKAKxhc" style="border-bottom: Black 1pt solid; text-align: right"&gt;2,365&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630_zTzQMwOS31Eg" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents"&gt;14,922&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zf6BSJcdfyqb" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1805"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfKOJWWtknL9" style="border-bottom: Black 2pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zR1PuZxqKHR4" style="border-bottom: Black 2pt solid; text-align: right"&gt;13,271&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left; padding-left: 0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630_zjKL33g94I7c" style="width: 9%; text-align: right"&gt;2,341&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z016rH6Konm5" style="width: 9%; text-align: right"&gt;2,341&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLnMX4mSWxud" style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1810"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbU94EDQpM84" style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1811"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Investment in equity securities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630_zesl4AemIP5f" style="border-bottom: Black 1pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZoSGIGJ00H8" style="border-bottom: Black 1pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPoMcCvmtIPk" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1814"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z6q6OpuNSPm1" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1815"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20230630_zmdeNUGbcMhe" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,350&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ztxdhphe9fXg" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,350&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zk2To6FAGcQi" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1818"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0ojJd3792ii" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1819"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630_z8xu1VMvKUS3" style="text-align: right"&gt;10,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpcoCm9ZFpuf" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1821"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKDHPxK7uY1i" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1822"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zte778YsURXj" style="text-align: right"&gt;10,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630_zEfg3D4LhXyf" style="border-bottom: Black 1pt solid; text-align: right"&gt;4,989&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zN7hMLfrEA44" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1825"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zo58gZJhjfmf" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,279&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYb5UcoqWp1i" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,710&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630_zgFQkBE7jSZ8" style="border-bottom: Black 2pt solid; text-align: right"&gt;15,510&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6MWMm3HZeZ2" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1829"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zp8Ki3EXr6A4" style="border-bottom: Black 2pt solid; text-align: right"&gt;3,279&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zSLNZntZD21i" style="border-bottom: Black 2pt solid; text-align: right"&gt;12,231&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001774"
      unitRef="USD">2012000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact001775"
      unitRef="USD">2012000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001779"
      unitRef="USD">4000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact001780"
      unitRef="USD">4000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001784"
      unitRef="USD">2016000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact001785"
      unitRef="USD">2016000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001789"
      unitRef="USD">7089000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001792"
      unitRef="USD">7089000</us-gaap:NotesPayable>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001794"
      unitRef="USD">3817000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001797"
      unitRef="USD">3817000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001799"
      unitRef="USD">4016000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001801"
      unitRef="USD">1651000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001802"
      unitRef="USD">2365000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001804"
      unitRef="USD">14922000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001806"
      unitRef="USD">1651000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001807"
      unitRef="USD">13271000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001808"
      unitRef="USD">2341000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact001809"
      unitRef="USD">2341000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001812"
      unitRef="USD">9000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact001813"
      unitRef="USD">9000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001816"
      unitRef="USD">2350000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact001817"
      unitRef="USD">2350000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001820"
      unitRef="USD">10521000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001823"
      unitRef="USD">10521000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001824"
      unitRef="USD">4989000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001826"
      unitRef="USD">3279000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001827"
      unitRef="USD">1710000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001828"
      unitRef="USD">15510000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001830"
      unitRef="USD">3279000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001831"
      unitRef="USD">12231000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001833">&lt;p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zCjkZIUAAiy6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;span id="xdx_82F_zCq3f7wrP0b3"&gt;SUBSEQUENT
                                         EVENTS&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Yorkville
Consents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--SubsequentEventDescription_c20240902__20240904__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyuGoKceutHh" title="Subsequent event description"&gt;On
September 4, 2024, NioCorp entered into (i) a consent and waiver (the &#x201c;Yorkville Consent&#x201d;) to the April 2024 Note
issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together with the
Yorkville Consent, the &#x201c;Consents&#x201d;) to the April 2024 Note issued and sold to Lind Global Fund II LP pursuant to
the April 2024 Purchase Agreement. The Consents, among other things, reduced the amounts due to the April 2024 Purchasers
on September 1, 2024 by an aggregate of $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20240830__20240901__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrPFfZLz1xr2" title="Aggregate principal amount"&gt;1,176&lt;/span&gt; to an aggregate of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentIncreaseDecreaseOtherNet_pn5n6_c20240830__20240901__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zs7Hvk4DJPK1" title="Increased the amounts due"&gt;336&lt;/span&gt;, increased the amounts due to the April 2024 Purchasers on December 1, 2024 by an aggregate of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20241129__20241201__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zkSGqnsT48Ul" title="Aggregate principal amount"&gt;1,176&lt;/span&gt;, and prospectively waived any term of the April 2024 Notes that would otherwise be triggered upon a failure of
the Company to pay to the April 2024 Purchasers the remainder of the amount due on September 1, 2024. Except as modified by
the Consents, the terms of the April 2024 Notes as previously disclosed are unchanged.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Smith
Loan Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 11, 2024, the Company and Mark Smith entered into a Loan Agreement (the &#x201c;Smith Loan Agreement&#x201d;) pursuant
to which Mr. Smith agreed to make available to the Company a non-revolving, multiple draw credit facility of up to $&lt;span id="xdx_90D_eus-gaap--LineOfCreditFacilityFairValueOfAmountOutstanding_iI_c20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPCxwh2lKd51" title="Line of credit facility"&gt;2,000&lt;/span&gt;
(the &#x201c;Loan&#x201d;). The Loan is non-revolving and amounts paid back under the terms of the Smith Loan Agreement do not again
become available for drawdowns at the request of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will pay interest to Mr. Smith on amounts outstanding under the Loan and on any overdue interest at a rate equal to &lt;span id="xdx_906_eus-gaap--LongTermDebtPercentageBearingVariableInterestRate_iI_pid_dp_uPure_c20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPfkxf2b6hih" title="Interest rate"&gt;10&lt;/span&gt;%
per annum, calculated monthly in arrears, through to the date of repayment of the Loan. Mr. Smith&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;will also receive an
establishment fee equal to &lt;span id="xdx_90C_eus-gaap--InvestmentCompanyExpenseRatioIncludingIncentiveFee_pid_dp_uPure_c20240909__20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdF9V3V2kD2i" title="Establishment fee"&gt;2.5&lt;/span&gt;%
of the amount of any drawdown payable at the time of the drawdown as consideration of the advancement of such drawdown. Any
outstanding balance on the Loan, including accrued interest, shall be immediately due and payable by the Company on the
earlier of the date of expiration of the Smith Loan Agreement on June 30, 2025 and the occurrence of an event of default (the &#x201c;Due Date&#x201d;). The Company can repay the Loan at any time without notice and
without penalty, but any amount of principal or interest repaid by the Company prior to the Due Date will be subject to an
early payment fee of 2.5% of the value of any such payment. Amounts outstanding under the Smith Loan Agreement are secured by all of the Company&#x2019;s assets pursuant to a general
security agreement between the Company and Mr. Smith, dated September 11, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Lind
Consent Warrant Issuance&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 17, 2024, the Company&#x2019;s Common Share price was below the threshold price set forth in the Lind Consent,
and accordingly, the Company issued &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20240916__20240917__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_ztWGhcl6704j" title="Number of share issued"&gt;2,816,742&lt;/span&gt; Contingent Consent Warrants to Lind. Each Contingent Consent Warrant is
exercisable for one Common Share at an exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240917__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zZjnyfVO80tc" title="Exercise price"&gt;2.308&lt;/span&gt; and may be exercised at any time prior
to their expiration on September 17, 2028. The number of Contingent Consent Warrants issued was based on $&lt;span id="xdx_904_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20240916__20240917__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zmFZvJcF4Ujj" title="Warrants issued"&gt;5,000&lt;/span&gt; divided by
the five-day volume weighted average price of the Common Shares on September 16, 2024.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SubsequentEventDescription
      contextRef="From2024-09-022024-09-04_us-gaap_SubsequentEventMember"
      id="Fact001835">On
September 4, 2024, NioCorp entered into (i) a consent and waiver (the &#x201c;Yorkville Consent&#x201d;) to the April 2024 Note
issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together with the
Yorkville Consent, the &#x201c;Consents&#x201d;) to the April 2024 Note issued and sold to Lind Global Fund II LP pursuant to
the April 2024 Purchase Agreement. The Consents, among other things, reduced the amounts due to the April 2024 Purchasers
on September 1, 2024 by an aggregate of $1,176 to an aggregate of $336, increased the amounts due to the April 2024 Purchasers on December 1, 2024 by an aggregate of $1,176, and prospectively waived any term of the April 2024 Notes that would otherwise be triggered upon a failure of
the Company to pay to the April 2024 Purchasers the remainder of the amount due on September 1, 2024. Except as modified by
the Consents, the terms of the April 2024 Notes as previously disclosed are unchanged.</us-gaap:SubsequentEventDescription>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="From2024-08-302024-09-01_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact001837"
      unitRef="USD">1176000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtInstrumentIncreaseDecreaseOtherNet
      contextRef="From2024-08-302024-09-01_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact001839"
      unitRef="USD">336000000</us-gaap:DebtInstrumentIncreaseDecreaseOtherNet>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="From2024-11-292024-12-01_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact001841"
      unitRef="USD">1176000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="AsOf2024-09-11_custom_MarkSmithMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact001843"
      unitRef="USD">2000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LongTermDebtPercentageBearingVariableInterestRate
      contextRef="AsOf2024-09-11_custom_MarkSmithMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001845"
      unitRef="Pure">0.10</us-gaap:LongTermDebtPercentageBearingVariableInterestRate>
    <us-gaap:InvestmentCompanyExpenseRatioIncludingIncentiveFee
      contextRef="From2024-09-092024-09-11_custom_MarkSmithMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001853"
      unitRef="Pure">0.025</us-gaap:InvestmentCompanyExpenseRatioIncludingIncentiveFee>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-09-162024-09-17_us-gaap_SubsequentEventMember_custom_LindConsentWarrantIssuanceMember"
      decimals="INF"
      id="Fact001855"
      unitRef="Shares">2816742</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-17_us-gaap_SubsequentEventMember_custom_LindConsentWarrantIssuanceMember"
      decimals="INF"
      id="Fact001857"
      unitRef="USDPShares">2.308</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2024-09-162024-09-17_us-gaap_SubsequentEventMember_custom_LindConsentWarrantIssuanceMember"
      decimals="0"
      id="Fact001859"
      unitRef="USD">5000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000571"
          xlink:label="Fact000571"
          xlink:type="locator"/>
        <link:footnote id="Footnote000580" xlink:label="Footnote000580" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents 100% of Class A common stock owned by 0896800, and 4,282,116 and 4,565,808 Vested Shares and 3,391,596 and 3,391,596
Earnout Shares (each as defined below) held by third parties, and outstanding as of June 30, 2024 and 2023, respectively.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000571"
          xlink:to="Footnote000580"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000573"
          xlink:label="Fact000573"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000573"
          xlink:to="Footnote000580"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000682"
          xlink:label="Fact000682"
          xlink:type="locator"/>
        <link:footnote id="Footnote000697" xlink:label="Footnote000697" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.</link:footnote>
        <link:footnote id="Footnote000698" xlink:label="Footnote000698" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000682"
          xlink:to="Footnote000697"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000682"
          xlink:to="Footnote000698"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000684"
          xlink:label="Fact000684"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000684"
          xlink:to="Footnote000697"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000684"
          xlink:to="Footnote000698"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000686"
          xlink:label="Fact000686"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000686"
          xlink:to="Footnote000697"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000686"
          xlink:to="Footnote000698"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000688"
          xlink:label="Fact000688"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000688"
          xlink:to="Footnote000697"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000688"
          xlink:to="Footnote000698"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000690"
          xlink:label="Fact000690"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000690"
          xlink:to="Footnote000697"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000690"
          xlink:to="Footnote000698"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000692"
          xlink:label="Fact000692"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000692"
          xlink:to="Footnote000697"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000692"
          xlink:to="Footnote000698"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000694"
          xlink:label="Fact000694"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000694"
          xlink:to="Footnote000697"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000694"
          xlink:to="Footnote000698"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000696"
          xlink:label="Fact000696"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000696"
          xlink:to="Footnote000697"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000696"
          xlink:to="Footnote000698"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000775"
          xlink:label="Fact000775"
          xlink:type="locator"/>
        <link:footnote id="Footnote000785" xlink:label="Footnote000785" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000775"
          xlink:to="Footnote000785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000777"
          xlink:label="Fact000777"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000777"
          xlink:to="Footnote000785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000778"
          xlink:label="Fact000778"
          xlink:type="locator"/>
        <link:footnote id="Footnote000786" xlink:label="Footnote000786" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000778"
          xlink:to="Footnote000786"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000780"
          xlink:label="Fact000780"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000780"
          xlink:to="Footnote000786"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000928"
          xlink:label="Fact000928"
          xlink:type="locator"/>
        <link:footnote id="Footnote000931" xlink:label="Footnote000931" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000928"
          xlink:to="Footnote000931"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000954"
          xlink:label="Fact000954"
          xlink:type="locator"/>
        <link:footnote id="Footnote001423" xlink:label="Footnote001423" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Expires
    in 3 equal monthly tranches on July 17, 2024, August 17, 2024, and September 17, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000954"
          xlink:to="Footnote001423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000956"
          xlink:label="Fact000956"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000956"
          xlink:to="Footnote001423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000958"
          xlink:label="Fact000958"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000958"
          xlink:to="Footnote001423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000960"
          xlink:label="Fact000960"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000960"
          xlink:to="Footnote001423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000962"
          xlink:label="Fact000962"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000962"
          xlink:to="Footnote001423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000964"
          xlink:label="Fact000964"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000964"
          xlink:to="Footnote001423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000966"
          xlink:label="Fact000966"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000966"
          xlink:to="Footnote001423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000968"
          xlink:label="Fact000968"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000968"
          xlink:to="Footnote001423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000970"
          xlink:label="Fact000970"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000970"
          xlink:to="Footnote001423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000972"
          xlink:label="Fact000972"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000972"
          xlink:to="Footnote001423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000974"
          xlink:label="Fact000974"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000974"
          xlink:to="Footnote001423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000976"
          xlink:label="Fact000976"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000976"
          xlink:to="Footnote001423"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
